[{"batch": 1, "no": 1, "name_zh": "21-羟化酶缺乏症", "query_terms": [{"term": "Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency", "broad": false}, {"term": "21-Hydroxylase Deficiency", "broad": true}], "n_total": 8, "n_open": 2, "n_open_precise": 0, "n_broad": 8, "trials": [{"nct": "NCT03742011", "title": "Offspring Born to Mothers With Polycystic Ovary Syndrome in Guangzhou Cohort Study", "status": "RECRUITING", "start": "2012-02-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2000, "sponsor": "Guangzhou Women and Children's Medical Center", "conditions": ["PCOS", "Offspring, Adult", "Hyperandrogenism", "Epigenetics", "Insulin Resistance", "Endocrine Disorder", "Metabolic Disturbance"], "cn_sites": [{"facility": "Guangzhou Women and Children's Medical Center, China", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT02647827", "title": "Acupuncture or Metformin for Insulin Resistance in Women With PCOS", "status": "RECRUITING", "start": "2015-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 303, "sponsor": "Karolinska Institutet", "conditions": ["Polycystic Ovary Syndrome", "Insulin Resistance", "Hyperandrogenism"], "cn_sites": [{"facility": "Peking University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04536662", "title": "Comparisons of Different Forms of Glucocorticoid on the Recovery of Reproductive Function in Patients With 21α-hydroxylase Deficiency", "status": "UNKNOWN", "start": "2020-10-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Shanghai Jiao Tong University School of Medicine", "conditions": ["Congenital Adrenal Hyperplasia"], "cn_sites": [{"facility": "Ruijin hospital,Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04890444", "title": "China Adrenal Disease Registry", "status": "UNKNOWN", "start": "2021-06-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2000, "sponsor": "Shanghai Jiao Tong University School of Medicine", "conditions": ["Cushing Syndrome", "Aldosteronism", "Hypoadrenalism", "Congenital Adrenal Hyperplasia", "Adrenal Adenoma", "Adrenal Incidentaloma", "Adrenal Carcinoma", "Pheochromocytoma"], "cn_sites": [{"facility": "Endocrinology", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT05649631", "title": "The Effect of Low Sodium Diet on Idiopathic Hyperaldosteronism", "status": "COMPLETED", "start": "2021-07-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Shanghai Jiao Tong University School of Medicine", "conditions": ["Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)"], "cn_sites": [{"facility": "Yiran Jiang", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT05186675", "title": "Superselective Adrenal Arterial Embolization for Bilateral Idiopathic Hyperaldosteronism: A Prospective Cohort Study", "status": "UNKNOWN", "start": "2022-01-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Second Affiliated Hospital of Nanchang University", "conditions": ["Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)"], "cn_sites": [{"facility": "the Second Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT05927961", "title": "Spatial Proteomics Profiles of Aldosterone-producing Adenoma and Unilateral Hyperplasia", "status": "UNKNOWN", "start": "2023-08", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 30, "sponsor": "Third Military Medical University", "conditions": ["Primary Aldosteronism Due to Aldosterone Producing Adenoma", "Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)"], "cn_sites": [{"facility": "The Third Affiliated Hospital of the Third Military Medical University", "city": "Chongqing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06581744", "title": "Non Invasive Imaging Methods for Detecting PA：a Clinical PET Study of 18F-Pentixather", "status": "UNKNOWN", "start": "2024-06-12", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Fangfang Sun", "conditions": ["Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)"], "cn_sites": [{"facility": "First Affiliated Hospital of Dalian Medical University", "city": "Dalian", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}], "g_total": 2, "g_fetched": 2, "g_countries": [["France", 2]], "g_trials": [{"nct": "NCT07781267", "title": "Pediatric Congenital Adrenal Hyperplasia Management: Regret and Long-term Outcomes", "status": "RECRUITING", "start": "2026-07-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Lille", "countries": ["France"]}, {"nct": "NCT06900153", "title": "Parenting and CAH - 21-hydroxylase Deficiency", "status": "RECRUITING", "start": "2026-03-16", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}]}, {"batch": 1, "no": 2, "name_zh": "白化病", "query_terms": [{"term": "Oculocutaneous or ocular albinism", "broad": false}, {"term": "Albinism", "broad": true}], "n_total": 3, "n_open": 3, "n_open_precise": 0, "n_broad": 3, "trials": [{"nct": "NCT05970900", "title": "Preoperative Imatinib Mesylate Combined With Rectal-sparing Surgery in Patients With c-KIT Gene-mutant Rectal GIST", "status": "NOT_YET_RECRUITING", "start": "2023-10-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 23, "sponsor": "Fujian Medical University Union Hospital", "conditions": ["Gastrointestinal Stromal Tumor of Rectum"], "cn_sites": [{"facility": "Weizhong Jiang", "city": "Fuzhou", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07559864", "title": "Comparing Regorafenib Combined With Envafolimab to Physician's Choice in Patients With Metastatic Gastrointestinal Stromal Tumors Harboring KIT Exon 17 Mutations Refractory to Standard Treatment", "status": "RECRUITING", "start": "2025-07-14", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Jian Li", "conditions": ["GIST - Gastrointestinal Stromal Tumor", "KIT Gene Mutation"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07313618", "title": "Safety and Efficacy of a Single Suprachoroidal Injection of JWK010 Gene Therapy in Subjects With Oculocutaneous Albinism Type 1 (OCA1)", "status": "RECRUITING", "start": "2025-12-22", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "West China Hospital", "conditions": ["Oculocutaneous Albinism (OCA)"], "cn_sites": [{"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}], "g_total": 0, "g_fetched": 0, "g_countries": [], "g_trials": []}, {"batch": 1, "no": 3, "name_zh": "Alport 综合征", "query_terms": [{"term": "Alport syndrome", "broad": false}], "n_total": 6, "n_open": 2, "n_open_precise": 2, "n_broad": 0, "trials": [{"nct": "NCT04947813", "title": "Genotype-Phenotype Correlations in Patients With Alport Syndrome", "status": "RECRUITING", "start": "2021-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 8165, "sponsor": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": ["Alport Syndrome"], "cn_sites": [{"facility": "China Xinhua Hospital, Shanghai Jiao Tong University School of Medicine.", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05133050", "title": "Safety and Efficacy of ACEI in Alport Syndrome Patients With COL4A3/COL4A4/COL4A5 Variants", "status": "NOT_YET_RECRUITING", "start": "2022-01-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 510, "sponsor": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": ["Alport Syndrome"], "cn_sites": [{"facility": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02855268", "title": "Study of Lademirsen (SAR339375) in Patients With Alport Syndrome", "status": "TERMINATED", "start": "2019-11-02", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 43, "sponsor": "Genzyme, a Sanofi Company", "conditions": ["Alport Syndrome"], "cn_sites": [{"facility": "Investigational Site Number :1560001", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number :1560002", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number :1560004", "city": "Guangzhou", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT04937907", "title": "Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS)", "status": "COMPLETED", "start": "2021-09-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Shanghai Children's Hospital", "conditions": ["Alport Syndrome, X-Linked"], "cn_sites": [{"facility": "Shanghai Children's Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06226896", "title": "Effects of Dapagliflozin on Progression of Alport Syndrome", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-11-15", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 222, "sponsor": "Nanjing University School of Medicine", "conditions": ["Alport Syndrome"], "cn_sites": [{"facility": "Jinling Hospital", "city": "Nanjing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07211685", "title": "A Study to Learn About How Well BAY 3401016 Works in Adults With Alport Syndrome", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-11-19", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Bayer", "conditions": ["Alport Syndrome"], "cn_sites": [{"facility": "Peking University First Hospital - Department of Pediatrics", "city": "Beijing", "status": ""}, {"facility": "Children's Hospital of Chongqing Medical University - Department of Nephrology", "city": "Chongqing", "status": ""}, {"facility": "The First Affiliated Hospital, Sun Yat-sen University - Department of Pediatrics", "city": "Guangzhou", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology - Pediatric Nephrology and Immunology", "city": "Wuhan", "status": ""}, {"facility": "Children's Hospital, Zhejiang University School of Medicine - Department of Nephrology", "city": "Hangzhou", "status": ""}], "cn_site_count": 5, "broad_only": false}], "g_total": 12, "g_fetched": 10, "g_countries": [["United States", 4], ["United Kingdom", 3], ["Germany", 3], ["Romania", 1], ["Italy", 1], ["Netherlands", 1], ["Poland", 1], ["Spain", 1], ["Sweden", 1], ["France", 1]], "g_trials": [{"nct": "NCT07523581", "title": "EXACT Study: A Blinded Study in Patients With Alport Syndrome to Evaluate Exaluren Efficacy and Safety", "status": "RECRUITING", "start": "2026-06-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Eloxx Pharmaceuticals, Inc.", "countries": ["United Kingdom", "United States"]}, {"nct": "NCT07575347", "title": "Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)", "status": "RECRUITING", "start": "2026-05-04", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Stefan Lujinschi", "countries": ["Romania"]}, {"nct": "NCT06731192", "title": "Human Umbilical Cord Mesenchymal Stem Cells for Alport Syndrome", "status": "NOT_YET_RECRUITING", "start": "2025-01-01", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Guangzhou Women and Children's Medical Center", "countries": []}, {"nct": "NCT05944016", "title": "Phase 3 Clinical Trial with Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adult Patients", "status": "RECRUITING", "start": "2024-03-25", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital Goettingen", "countries": ["Germany"]}, {"nct": "NCT06526741", "title": "ASF Alport Patient Registry", "status": "RECRUITING", "start": "2023-08-24", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Alport Syndrome Foundation", "countries": ["United States"]}, {"nct": "NCT04571658", "title": "NEPTUNE Match Study", "status": "RECRUITING", "start": "2022-05-02", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Michigan", "countries": ["United States"]}, {"nct": "NCT05003986", "title": "Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases", "status": "RECRUITING", "start": "2021-08-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Travere Therapeutics, Inc.", "countries": ["Germany", "Italy", "Netherlands", "Poland", "Spain", "Sweden", "United Kingdom", "United States"]}, {"nct": "NCT05927467", "title": "Eurbio-Alport (RaDiCo Cohort) (RaDiCo Eurbio-Alport)", "status": "RECRUITING", "start": "2017-05-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Institut National de la Santé Et de la Recherche Médicale, France", "countries": ["France"]}, {"nct": "NCT06065852", "title": "National Registry of Rare Kidney Diseases", "status": "RECRUITING", "start": "2009-11-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "UK Kidney Association", "countries": ["United Kingdom"]}, {"nct": "NCT02378805", "title": "Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome", "status": "RECRUITING", "start": "1995-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital Goettingen", "countries": ["Germany"]}]}, {"batch": 1, "no": 4, "name_zh": "肌萎缩侧索硬化", "query_terms": [{"term": "Amyotrophic lateral sclerosis", "broad": false}], "n_total": 53, "n_open": 20, "n_open_precise": 20, "n_broad": 0, "trials": [{"nct": "NCT04008329", "title": "A Registered Cohort Study on Amyotrophic Lateral Sclerosis", "status": "RECRUITING", "start": "2019-07-05", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2000, "sponsor": "First Affiliated Hospital of Fujian Medical University", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Department of Neurology, First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04454892", "title": "Natural History and Clinical Features of Amyotrophic Lateral Sclerosis (ALS)", "status": "RECRUITING", "start": "2019-11-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 3000, "sponsor": "Peking University Third Hospital", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04885374", "title": "China Amyotrophic Lateral Sclerosis Registry of Patients With Traditional Chinese Medicine", "status": "RECRUITING", "start": "2021-03-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2000, "sponsor": "Dongzhimen Hospital, Beijing", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Dongzhimen Hospital, Beijing University of Chinese Medicine", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04961450", "title": "Explore Biomarkers of Motor Neuron Disease/Frontal Dementia Spectrum Disease in China", "status": "ENROLLING_BY_INVITATION", "start": "2021-06-24", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2500, "sponsor": "Peking University Third Hospital", "conditions": ["Amyotrophic Lateral Sclerosis", "Frontotemporal Dementia", "Motor Neuron Disease"], "cn_sites": [{"facility": "Dongsheng Fan", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05923905", "title": "Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients", "status": "RECRUITING", "start": "2023-01-18", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 64, "sponsor": "Peking University Third Hospital", "conditions": ["Sporadic and Familial Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06765564", "title": "Clinical Study of Induced Pluripotent Stem Cells Derived Motor Neuron Precursor Cell Therapy for Amyotrophic Lateral Sclerosis (ALS)", "status": "RECRUITING", "start": "2024-03-13", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 3, "sponsor": "Shanghai East Hospital", "conditions": ["ALS"], "cn_sites": [{"facility": "Shang hai East Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06782958", "title": "Safety, Tolerability, and Pharmacokinetics of FHND1002 Granules in Healthy Adults", "status": "ENROLLING_BY_INVITATION", "start": "2024-07-05", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 72, "sponsor": "Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.", "conditions": ["Amyotrophic Lateral Sclerosis (ALS)"], "cn_sites": [{"facility": "The first hospital of Lanzhou University", "city": "Lanzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06645197", "title": "An IIT Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of a Single Intrathecal Injection of SNUG01 in Patients with Amyotrophic Lateral Sclerosis", "status": "NOT_YET_RECRUITING", "start": "2024-10-16", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 7, "sponsor": "Peking University Third Hospital", "conditions": ["Amyotrophic Lateral Sclerosis (ALS)"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}, {"facility": "Fujian Medical University Union Hospital", "city": "Fujian", "status": ""}, {"facility": "JiangSu Provincce Hospital", "city": "Nanjing", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT06671236", "title": "Clinical Study of Regulatory T Cells (Tregs) in the Treatment of Neurodegenerative Diseases", "status": "RECRUITING", "start": "2024-11-21", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Novabio Therapeutics", "conditions": ["Amyotrophic Lateral Sclerosis (ALS)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06689982", "title": "Tofacitinib in Patients With Amyotrophic Lateral Sclerosis", "status": "NOT_YET_RECRUITING", "start": "2024-12-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Beijing Tiantan Hospital", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06598202", "title": "Exploring Nasal Drop Therapy With Small Extracellular Vesicles for ALS", "status": "RECRUITING", "start": "2024-12-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 38, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Xuanwu Hospital ,Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06556394", "title": "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RAG-17 in Subjects With Amyotrophic Lateral Sclerosis (ALS) With Superoxide Dismutase Type 1 (SOD1) Gene Mutation", "status": "RECRUITING", "start": "2024-12-24", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 32, "sponsor": "Ractigen Therapeutics.", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT06849609", "title": "A Study to Evaluate the Tolerability, Safety and Efficacy of VGN-R13 in Patients with ALS", "status": "RECRUITING", "start": "2025-01-16", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Hong Chen", "conditions": ["Amyotrophic Lateral Sclerosis (ALS)"], "cn_sites": [{"facility": "TongJi Hospital", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06829212", "title": "Research on Wireless Brain Implant System for General Control of External Devices", "status": "RECRUITING", "start": "2025-03", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 4, "sponsor": "Shanghai StairMed Technology Co., Ltd.", "conditions": ["Complete or Incomplete Paraplegia/quadriplegia", "Spinal Cord Injury", "Brainstem Stroke", "Amyotrophic Lateral Sclerosis", "Bilateral Upper Limb Amputation"], "cn_sites": [{"facility": "Huashan Hospital Affiliated to Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06765499", "title": "The Study Evaluating the Improvement of Nutritional Status and Frailty With Silkworm Pupa Powder Among Patients With Motor Neuron Disease", "status": "RECRUITING", "start": "2025-03-04", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "First People's Hospital of Hangzhou", "conditions": ["Motor Neuron Disease (MND)", "Amyotrophic Lateral Sclerosis (ALS)"], "cn_sites": [{"facility": "Hangzhou First People's Hospital", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06607900", "title": "hUC-MSC-sEV-001 Nasal Drops for Neurodegenerative Diseases", "status": "NOT_YET_RECRUITING", "start": "2025-07-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Alzheimer Disease", "Parkinson Disease", "Lewy Body Dementia", "Multiple System Atrophy", "Fronto-temporal Dementia", "Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Xuanwu Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07118319", "title": "The Safety, Tolerability and Preliminary Efficacy of Derived Motor Neuron Progenitor Cells (XS228CN) in Subjects With Amyotrophic Lateral Sclerosis", "status": "RECRUITING", "start": "2025-09-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.", "conditions": ["Amyotrophic Lateral Sclerosis (ALS)"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07169175", "title": "A Phase Ⅰ/Ⅱa Study of SNUG01 in Adult Subjects With ALS", "status": "NOT_YET_RECRUITING", "start": "2025-12-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 21, "sponsor": "SineuGene Therapeutics Co., Ltd.", "conditions": ["Amyotrophic Lateral Sclerosis (ALS)"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07539662", "title": "Unrelated Umbilical Cord Blood Transplantation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)", "status": "ENROLLING_BY_INVITATION", "start": "2025-12-29", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 8, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["ALS (Amyotrophic Lateral Sclerosis)"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06726577", "title": "TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis", "status": "RECRUITING", "start": "2026-05-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Talengen Institute of Life Sciences, Shenzhen, P.R. China.", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00397423", "title": "G-CSF Treatment for Amyotrophic Lateral Sclerosis: A RCT Study Assessing Clinical Response", "status": "COMPLETED", "start": "2006-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Peking University", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Dongsheng Fan", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00753571", "title": "Cistanche Total Glycosides for Amyotrophic Lateral Sclerosis: A Randomized Control Trial (RCT) Study Assessing Clinical Response", "status": "UNKNOWN", "start": "2008-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Peking University", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Dongsheng Fan, MD; Liping Wang,MD", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03085706", "title": "Transplantation of Autologous Peripheral Blood Mononuclear Cells for Amyotrophic Lateral Sclerosis", "status": "COMPLETED", "start": "2010-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 14, "sponsor": "The First Affiliated Hospital of Dalian Medical University", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "The First Affiliated Hospital of Dalian Medical University", "city": "Dalian", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01494480", "title": "The Clinical Trial on the Use of Umbilical Cord Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis", "status": "UNKNOWN", "start": "2012-03", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "General Hospital of Chinese Armed Police Forces", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Yihua An", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01935518", "title": "A Clinical Trial of Safety and Efficacy of Fasudil in Subjects With Amyotrophic Lateral Sclerosis (ALS)", "status": "UNKNOWN", "start": "2013-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Peking University Third Hospital", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04952025", "title": "Quantitative Analysis of Precise Brain Volume in Amyotrophic Lateral Sclerosis", "status": "COMPLETED", "start": "2015-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 32, "sponsor": "Peking University Third Hospital", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04454840", "title": "Treatment of Intravenous Infusion Plasma in Amyotrophic Lateral Sclerosis", "status": "COMPLETED", "start": "2016-05-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Peking University Third Hospital", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03103815", "title": "Trial of Amivita in Amyotrophic Lateral Sclerosis", "status": "UNKNOWN", "start": "2017-04-24", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Wujin People's Hospital", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Wujing People's Hospital", "city": "Changzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04455542", "title": "Peripheral Neurofilament Levels and Amyotrophic Lateral Sclerosis", "status": "COMPLETED", "start": "2017-08-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 103, "sponsor": "Peking University Third Hospital", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04948346", "title": "Correlation Between Intestinal Microflora Metabolites and Amyotrophic Lateral Sclerosis", "status": "COMPLETED", "start": "2018-01-31", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 40, "sponsor": "Peking University Third Hospital", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04956822", "title": "Application of Motor Unit Estimation Index in Amyotrophic Lateral Sclerosis and Related Diseases", "status": "UNKNOWN", "start": "2018-06-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 90, "sponsor": "Peking University Third Hospital", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04960540", "title": "Multimodal Brain Imaging Study", "status": "UNKNOWN", "start": "2019-08-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 40, "sponsor": "Peking University Third Hospital", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Peking Yniversity Third Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04952155", "title": "Low Dose IL-2 in the Treatment of Immune-associated ALS Syndrome", "status": "UNKNOWN", "start": "2020-01-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 13, "sponsor": "Peking University Third Hospital", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04328675", "title": "Registration Study of Amyotrophic Lateral Sclerosis (ALS) in Mainland China", "status": "UNKNOWN", "start": "2020-03-20", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 4752, "sponsor": "Peking University Third Hospital", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04950933", "title": "The Treatment of Amyotrophic Lateral Sclerosis With Huollingshengji Granules", "status": "UNKNOWN", "start": "2020-06-01", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 144, "sponsor": "Peking University Third Hospital", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04950647", "title": "Efficacy and Safety of Nitrazine in the Treatment of ALS", "status": "UNKNOWN", "start": "2020-07-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 150, "sponsor": "Peking University Third Hospital", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04953624", "title": "Appetite and Related Factors in Patients With ALS", "status": "UNKNOWN", "start": "2020-08-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Peking University Third Hospital", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04952038", "title": "Sleep Disorders and the Onset and Progression of ALS", "status": "UNKNOWN", "start": "2020-08-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Peking University Third Hospital", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04950231", "title": "Investigation on Home Care Needs of ALS Patients and Their Caregivers", "status": "COMPLETED", "start": "2020-09-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 20, "sponsor": "Peking University Third Hospital", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Peking Yniversity Third Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04518540", "title": "Explore Neuroprotective Effect of Lipoic Acid in Amyotrophic Lateral Sclerosis", "status": "UNKNOWN", "start": "2020-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 150, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Second Affiliated Hospital,Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04391361", "title": "The Safety and Effectiveness of Cholinergic Receptor Block Therapy in the Treatment of ALS", "status": "UNKNOWN", "start": "2020-11-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Ruijin Hospital", "conditions": ["Amyotrophic Lateral Sclerosis", "Respiratory Function", "Scopolamine"], "cn_sites": [{"facility": "Department of neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04953481", "title": "Home Care Needs and Current Nursing Status of Patients With Amyotrophic Lateral Sclerosis", "status": "UNKNOWN", "start": "2021-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 252, "sponsor": "Peking University Third Hospital", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04953494", "title": "Pleiotropy and Mechanism of Peripheral Nerve Related Genes in the Progression of Amyotrophic Lateral Sclerosis", "status": "UNKNOWN", "start": "2021-08-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 300, "sponsor": "Peking University Third Hospital", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05237284", "title": "Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS)", "status": "TERMINATED", "start": "2022-04-13", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 305, "sponsor": "Sanofi", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Investigational Site Number : 1560001", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560003", "city": "Chengdu", "status": ""}, {"facility": "Investigational Site Number : 1560005", "city": "Guangzhou", "status": ""}, {"facility": "Investigational Site Number : 1560002", "city": "Hangzhou", "status": ""}, {"facility": "Investigational Site Number : 1560004", "city": "Wuhan", "status": ""}, {"facility": "Investigational Site Number : 1560006", "city": "Xi'an", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT05903690", "title": "Safety and Tolerance of RAG-17 in Amyotrophic Lateral Sclerosis Patients With SOD1 Gene Mutation", "status": "COMPLETED", "start": "2023-05-24", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Beijing Tiantan Hospital", "conditions": ["Gene Mutation"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05892822", "title": "Amyotrophic Lateral Sclerosis Registry", "status": "UNKNOWN", "start": "2023-06-15", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "yilong Wang", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06454682", "title": "An IIT Clinical Study to Evaluate the Safety and Efficacy of a Single Intrathecal Injection of RJK002 in Patients With ALS", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-09-11", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "RJK Biopharma Ltd", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "The First Affiliated Hospital Fujian Medical University", "city": "Fuzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06181526", "title": "Safety and Preliminary Efficacy of Aleeto in Amyotrophic Lateral Sclerosis", "status": "UNKNOWN", "start": "2023-12-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Beijing Tiantan Hospital", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06849115", "title": "Effects of L-Carnitine in Amyotrophic Lateral Sclerosis Patients With CHCHD10 Mutations", "status": "COMPLETED", "start": "2024-07-18", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 4, "sponsor": "ChaodongWang", "conditions": ["Amyotrophic Lateral Sclerosis (ALS)"], "cn_sites": [{"facility": "Xuanwu Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06493279", "title": "Evaluate the Safety and Efficacy of Intrathecal Injection of RJK002 in Patients With Amyotrophic Lateral Sclerosis", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-09-24", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "RJK Biopharma Ltd", "conditions": ["Amyotrophic Lateral Sclerosis Als"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06643481", "title": "A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-10-17", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 251, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Amyotrophic Lateral Sclerosis (ALS)"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07223723", "title": "A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Chinese Participants With SOD-1 Amyotrophic Lateral Sclerosis (ALS)", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-12-11", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Biogen", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07618585", "title": "Safety and Efficacy of Intrathecal NTF001 Injection in ALS", "status": "ACTIVE_NOT_RECRUITING", "start": "2026-04-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Ruijin Hospital", "conditions": ["ALS - Amyotrophic Lateral Sclerosis", "ALS (Amyotrophic Lateral Sclerosis)"], "cn_sites": [{"facility": "Ruijin Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 230, "g_fetched": 184, "g_countries": [["United States", 72], ["France", 23], ["Italy", 22], ["Canada", 14], ["Germany", 12], ["Netherlands", 11], ["United Kingdom", 11], ["Belgium", 10], ["Spain", 9], ["Australia", 8], ["Poland", 8], ["Sweden", 6], ["Denmark", 5], ["Ireland", 5], ["Israel", 4], ["Switzerland", 3], ["Norway", 3], ["Taiwan", 2], ["Greece", 2], ["Czechia", 2], ["Serbia", 2], ["Japan", 2], ["Thailand", 2], ["Portugal", 2], ["United Arab Emirates", 2], ["South Korea", 2], ["Puerto Rico", 2], ["Slovenia", 2], ["Brazil", 1], ["Chile", 1], ["Turkey (Türkiye)", 1], ["Mexico", 1], ["Egypt", 1], ["Russia", 1], ["Ukraine", 1]], "g_trials": [{"nct": "NCT04667013", "title": "A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBN", "status": "NOT_YET_RECRUITING", "start": "2028-09-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Guangzhou Magpie Pharmaceuticals Co., Ltd.", "countries": []}, {"nct": "NCT06704347", "title": "Safety Study of XT-150 in Participants With ALS", "status": "NOT_YET_RECRUITING", "start": "2027-03", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Xalud Therapeutics, Inc.", "countries": ["United States"]}, {"nct": "NCT02478450", "title": "Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) Into Subjects With Amyotrophic Lateral Sclerosis (ALS)", "status": "NOT_YET_RECRUITING", "start": "2026-12", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Q Therapeutics, Inc.", "countries": []}, {"nct": "NCT07698496", "title": "Evaluation of the Feasibility and Efficacy of a Chronic Brain-computer Interface for Speech Rehabilitation in Patients With Locked-in-syndrome (LIS)", "status": "NOT_YET_RECRUITING", "start": "2026-10-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Grenoble", "countries": ["France"]}, {"nct": "NCT05470478", "title": "iBCI Optimization for Veterans With Paralysis", "status": "NOT_YET_RECRUITING", "start": "2026-10-02", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "VA Office of Research and Development", "countries": ["United States"]}, {"nct": "NCT07589764", "title": "Pilot Trial Utilizing β-hydroxy-β-methylbutyrate to Lower IGFBP7 Levels in People With ALS", "status": "NOT_YET_RECRUITING", "start": "2026-10-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Duke University", "countries": ["United States"]}, {"nct": "NCT07819890", "title": "Development in Home Mechanical Ventilation for Patient With Amyotrophic Lateral Sclerosis.", "status": "NOT_YET_RECRUITING", "start": "2026-10-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Rigshospitalet, Denmark", "countries": []}, {"nct": "NCT07823101", "title": "Imaging Assessment of Swallowing and Speech Muscles in Inclusion Body Myositis", "status": "RECRUITING", "start": "2026-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Johns Hopkins University", "countries": ["United States"]}, {"nct": "NCT07813858", "title": "Colchicine Effect on Amyotrophic Lateral Sclerosis Patients", "status": "NOT_YET_RECRUITING", "start": "2026-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Azienda Ospedaliero-Universitaria di Modena", "countries": ["Italy"]}, {"nct": "NCT07521930", "title": "Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)", "status": "RECRUITING", "start": "2026-09", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Johns Hopkins University", "countries": ["United States"]}, {"nct": "NCT07674667", "title": "FUNCtion ALS: Aiming to Restore UNC13A Function in People Living With ALS", "status": "RECRUITING", "start": "2026-08-20", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Trace Neuroscience, Inc.", "countries": ["Germany", "Netherlands", "United Kingdom"]}, {"nct": "NCT07224269", "title": "Effect of Terazosin on ATP Levels in People With Amyotrophic Lateral Sclerosis", "status": "RECRUITING", "start": "2026-08-12", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "University of Iowa", "countries": ["United States"]}, {"nct": "NCT07706270", "title": "Serum Neurofilaments in the Diagnosis of Amyotrophic Lateral Sclerosis", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Montpellier", "countries": []}, {"nct": "NCT07400393", "title": "Healey ALS MyMatch Common Screening Protocol", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Massachusetts General Hospital", "countries": []}, {"nct": "NCT07737977", "title": "Developing a Comprehensive Biomarker Panel for Monitoring Progression and Early Detection in ALS Patients", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Montpellier", "countries": ["France", "Spain"]}, {"nct": "NCT07571486", "title": "Therapeutic Approach of Repeated Transient Blood-brain Barrier Opening in Amyotrophic Lateral Sclerosis.", "status": "RECRUITING", "start": "2026-07-15", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT07321860", "title": "This Study Evaluates the Safety, Target Engagement, and Preliminary Efficacy of Galunisertib (TGF-βR1/ALK5 Inhibitor)Combined With Nerandomilast (PDE4 Inhibitor) in GREM2-positive ALS, a Biomarker-defined Subgroup Hypothesized to Reflect Heightened TGF-β/SMAD-driven Astrocytic and Fibrotic Signaling", "status": "NOT_YET_RECRUITING", "start": "2026-06-30", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Gipfel Life Sciences GmbH", "countries": []}, {"nct": "NCT07071935", "title": "A Clinical Trial of Early Ventilation in Amyotrophic Lateral Sclerosis (EVENT ALS)", "status": "RECRUITING", "start": "2026-06-11", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University of Pennsylvania", "countries": ["United States"]}, {"nct": "NCT07454733", "title": "Do Video Recordings of Multidisciplinary Clinics Improve Quality of Life for People With ALS and Their Caregivers?", "status": "NOT_YET_RECRUITING", "start": "2026-06-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Trustees of Dartmouth College", "countries": ["United States"]}, {"nct": "NCT07636538", "title": "Auto-calibrating System for Upper Limb Disability Assessment, Neurological and Occupational Rehabilitation", "status": "NOT_YET_RECRUITING", "start": "2026-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Pavia", "countries": []}, {"nct": "NCT07606235", "title": "Transcutaneous Superior Laryngeal Nerve Stimulation to Upregulate Swallowing Frequency and Urge to Swallow in Patients Living With ALS", "status": "NOT_YET_RECRUITING", "start": "2026-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Nova Southeastern University", "countries": []}, {"nct": "NCT07616050", "title": "Evaluation of the Impact of Virtual Park on Training Motivation in Adult Patients", "status": "NOT_YET_RECRUITING", "start": "2026-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Marta Mondellini", "countries": ["Italy"]}, {"nct": "NCT07533903", "title": "Functional Outcomes and Control Using Synchron BCI - Australia", "status": "RECRUITING", "start": "2026-05-22", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Synchron, Inc.", "countries": ["Australia"]}, {"nct": "NCT07726563", "title": "Plasmapheresis in Amyotrophic Lateral Sclerosis With Autoantibody Against NRIP 2 (PALADIN2)", "status": "RECRUITING", "start": "2026-05-19", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "National Taiwan University Hospital", "countries": ["Taiwan"]}, {"nct": "NCT07571200", "title": "A Master Protocol (OLMP): A Study of LY4256984 in Participants With Amyotrophic Lateral Sclerosis (ALS)", "status": "RECRUITING", "start": "2026-05-14", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Eli Lilly and Company", "countries": ["Belgium", "Canada", "Germany", "Netherlands", "Spain"]}]}, {"batch": 1, "no": 5, "name_zh": "Angelman 氏症候群（天使综合征）", "query_terms": [{"term": "Angelman syndrome", "broad": false}], "n_total": 1, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT03358823", "title": "Study on the Brain Network of Angelman Syndrome", "status": "COMPLETED", "start": "2017-05-20", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 150, "sponsor": "Fudan University", "conditions": ["Angelman Syndrome"], "cn_sites": [{"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 12, "g_fetched": 12, "g_countries": [["United States", 5], ["Australia", 2], ["Canada", 2], ["Italy", 2], ["France", 2], ["Germany", 1], ["Israel", 1], ["Japan", 1], ["Poland", 1], ["Singapore", 1], ["South Korea", 1], ["Spain", 1], ["United Kingdom", 1], ["Belgium", 1]], "g_trials": [{"nct": "NCT07782827", "title": "CHAMPION: A Study to Evaluate the Efficacy and Safety of Obudanersen (ION582) in Children and Adults With Angelman Syndrome (AS)", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Ionis Pharmaceuticals, Inc.", "countries": []}, {"nct": "NCT07417137", "title": "A Natural History Study of Angelman Syndrome", "status": "RECRUITING", "start": "2026-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Massachusetts General Hospital", "countries": ["United States"]}, {"nct": "NCT07605429", "title": "BEACON - Phase III Clinical Study of Rugonersen in Angelman Syndrome.", "status": "RECRUITING", "start": "2026-06-23", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "OHB Pediatrics Ltd.", "countries": ["United States"]}, {"nct": "NCT07181837", "title": "A Phase 1/2 Study of the Safety and Efficacy of MVX-220 in Angelman Syndrome", "status": "RECRUITING", "start": "2025-10-29", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "MavriX Bio, LLC", "countries": ["United States"]}, {"nct": "NCT06914609", "title": "REVEAL: A Phase 3 Study of Obudanersen (ION582) in Angelman Syndrome", "status": "RECRUITING", "start": "2025-06-10", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Ionis Pharmaceuticals, Inc.", "countries": ["Australia", "Canada", "Germany", "Israel", "Italy", "Japan", "Poland", "Singapore", "South Korea", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT06737718", "title": "Use of Eye Tracking to Study Social Perception Abnormalities in Children With Angelman Syndrome", "status": "RECRUITING", "start": "2025-02-25", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT06353620", "title": "Structural-functional Connectome in Drug-resistant Epilepsies and Neurodevelopmental Syndromes With Epilepsy", "status": "RECRUITING", "start": "2024-02-13", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS Eugenio Medea", "countries": ["Italy"]}, {"nct": "NCT06229769", "title": "Natural History Study for Patients With Angelman Syndrome", "status": "RECRUITING", "start": "2021-10-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Centre Hospitalier Universitaire de Liege", "countries": ["Belgium"]}, {"nct": "NCT04507997", "title": "Angelman Syndrome Natural History Study", "status": "RECRUITING", "start": "2018-08-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Boston Children's Hospital", "countries": ["Canada", "United States"]}, {"nct": "NCT05945576", "title": "IDMet (RaDiCo Cohort) (RaDiCo-IDMet)", "status": "RECRUITING", "start": "2017-03-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Institut National de la Santé Et de la Recherche Médicale, France", "countries": ["France"]}, {"nct": "NCT05293184", "title": "The Global Angelman Syndrome Registry", "status": "RECRUITING", "start": "2016-09-28", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Foundation for Angelman Syndrome Therapeutics, Australia", "countries": ["Australia"]}, {"nct": "NCT07136454", "title": "Expanded Access/Compassionate Use of Rugonersen in Patients With Angelman Syndrome", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "Oak Hill Bio Ltd", "countries": []}]}, {"batch": 1, "no": 6, "name_zh": "精氨酸酶缺乏症", "query_terms": [{"term": "Argininemia", "broad": false}, {"term": "Arginase Deficiency", "broad": false}], "n_total": 1, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT06683820", "title": "Triple Recipient Strategy Using Split, Domino, and Auxiliary Techniques", "status": "COMPLETED", "start": "2023-04-02", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 3, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Hepatocellular Carcinoma (HCC)"], "cn_sites": [{"facility": "2ndAffiliated Hospital, School of Medicine, Zhejiang University", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 5, "g_fetched": 5, "g_countries": [["United States", 4], ["Australia", 2]], "g_trials": [{"nct": "NCT07773246", "title": "Phase 1/2 Study of KRRO-121 in Healthy Volunteers and Patients With UCD", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Korro Bio, Inc.", "countries": ["Australia"]}, {"nct": "NCT07573059", "title": "Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated Patients", "status": "RECRUITING", "start": "2026-04-17", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Immedica Pharma US Inc", "countries": ["United States"]}, {"nct": "NCT04908319", "title": "Hepatic Histopathology in Urea Cycle Disorders", "status": "RECRUITING", "start": "2022-02-24", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Baylor College of Medicine", "countries": ["United States"]}, {"nct": "NCT04602325", "title": "Systemic Biomarkers of Brain Injury From Hyperammonemia", "status": "RECRUITING", "start": "2020-07-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Children's National Research Institute", "countries": ["United States"]}, {"nct": "NCT01793168", "title": "Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford", "status": "RECRUITING", "start": "2010-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sanford Health", "countries": ["Australia", "United States"]}]}, {"batch": 1, "no": 7, "name_zh": "热纳综合征（窒息性胸腔失养症）", "query_terms": [{"term": "Jeune syndrome", "broad": false}, {"term": "Asphyxiating Thoracic Dystrophy (Jeune Syndrome)", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 0, "g_fetched": 0, "g_countries": [], "g_trials": []}, {"batch": 1, "no": 8, "name_zh": "非典型溶血性尿毒症", "query_terms": [{"term": "Atypical hemolytic uremic syndrome", "broad": false}], "n_total": 7, "n_open": 2, "n_open_precise": 2, "n_broad": 0, "trials": [{"nct": "NCT05935215", "title": "Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)", "status": "RECRUITING", "start": "2024-02-28", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Atypical Hemolytic Uremic Syndrome"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Nanjing", "status": "WITHDRAWN"}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": "WITHDRAWN"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT05795140", "title": "Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS", "status": "RECRUITING", "start": "2024-05-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 65, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Atypical Hemolytic Uremic Syndrome"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04861259", "title": "A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-10-22", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 83, "sponsor": "Hoffmann-La Roche", "conditions": ["Atypical Hemolytic Uremic Syndrome"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04958265", "title": "A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS)", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-11-17", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 41, "sponsor": "Hoffmann-La Roche", "conditions": ["Atypical Hemolytic Uremic Syndrome"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "The children's hospital , Zhejiang university school of medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT04889430", "title": "Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy", "status": "COMPLETED", "start": "2022-01-17", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 34, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Atypical Hemolytic Uremic Syndrome"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05876351", "title": "Eculizumab in Pediatric and Adult Participants With Atypical Hemolytic Uremic Syndrome (aHUS) in China", "status": "COMPLETED", "start": "2023-07-14", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 25, "sponsor": "Alexion Pharmaceuticals, Inc.", "conditions": ["Atypical Hemolytic Uremic"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Changsha", "status": ""}, {"facility": "Research Site", "city": "Qingdao", "status": ""}, {"facility": "Research Site", "city": "Taiyuan", "status": ""}, {"facility": "Research Site", "city": "Wuhan", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT06099236", "title": "A Prospective, Non-interventional, Observational Study of Presentation, Treatment Patterns and Outcomes in Atypical Hemolytic Uremic Syndrome Patients", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-01-15", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 367, "sponsor": "AstraZeneca", "conditions": ["Atypical Hemolytic Uremic Syndrome(aHUS)"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Chongqing", "status": ""}, {"facility": "Research Site", "city": "Anhui", "status": ""}, {"facility": "Research Site", "city": "Fujian", "status": ""}, {"facility": "Research Site", "city": "Guangdong", "status": ""}, {"facility": "Research Site", "city": "Guangxi", "status": ""}, {"facility": "Research Site", "city": "Guizhou", "status": ""}, {"facility": "Research Site", "city": "Hainan", "status": ""}, {"facility": "Research Site", "city": "Hebei", "status": ""}, {"facility": "Research Site", "city": "Henan", "status": ""}, {"facility": "Research Site", "city": "Hong Kong", "status": ""}, {"facility": "Research Site", "city": "Hubei", "status": ""}, {"facility": "Research Site", "city": "Hunan", "status": ""}, {"facility": "Research Site", "city": "Jiangsu", "status": ""}, {"facility": "Research Site", "city": "Jiangxi", "status": ""}, {"facility": "Research Site", "city": "Liaoning", "status": ""}, {"facility": "Research Site", "city": "Shaanxi", "status": ""}, {"facility": "Research Site", "city": "Shandong", "status": ""}, {"facility": "Research Site", "city": "Shanghai", "status": ""}, {"facility": "Research Site", "city": "Shanxi", "status": ""}, {"facility": "Research Site", "city": "Sichuan", "status": ""}, {"facility": "Research Site", "city": "Tianjin", "status": ""}, {"facility": "Research Site", "city": "Xinjiang", "status": ""}, {"facility": "Research Site", "city": "Zhejiang", "status": ""}], "cn_site_count": 24, "broad_only": false}], "g_total": 14, "g_fetched": 12, "g_countries": [["Italy", 4], ["Australia", 3], ["France", 3], ["United Kingdom", 3], ["United States", 3], ["Poland", 2], ["Germany", 2], ["South Korea", 2], ["Japan", 1], ["Netherlands", 1], ["Belgium", 1], ["Canada", 1], ["Denmark", 1], ["Israel", 1], ["Russia", 1], ["Spain", 1], ["Switzerland", 1], ["Taiwan", 1], ["Turkey (Türkiye)", 1]], "g_trials": [{"nct": "NCT05684159", "title": "Study of NM8074 in Patients With aHUS With Evidence of Ongoing Thrombotic Microangiopathy", "status": "NOT_YET_RECRUITING", "start": "2027-11", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "NovelMed Therapeutics", "countries": []}, {"nct": "NCT07399730", "title": "Ravulizumab Outcomes in Polish Patients With aHUS", "status": "RECRUITING", "start": "2026-06-24", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "AstraZeneca", "countries": ["Poland"]}, {"nct": "NCT07308574", "title": "Post-Marketing Clinical Study of Ravulizumab in Participants With Clinical aHUS", "status": "RECRUITING", "start": "2025-12-19", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Alexion Pharmaceuticals, Inc.", "countries": ["Japan"]}, {"nct": "NCT06312644", "title": "Study of Ultomiris® (Ravulizumab) Safety in Pregnancy", "status": "RECRUITING", "start": "2024-12-16", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Alexion Pharmaceuticals, Inc.", "countries": ["Australia", "France", "Germany", "Italy", "South Korea", "United Kingdom", "United States"]}, {"nct": "NCT05996731", "title": "Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases", "status": "RECRUITING", "start": "2024-02-21", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Mario Negri Institute for Pharmacological Research", "countries": ["Italy"]}, {"nct": "NCT05726916", "title": "Eculizumab in Hypertensive Emergency-associated Hemolytic Uremic Syndrome", "status": "RECRUITING", "start": "2023-11-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT05805202", "title": "Functional Implications of Rare Gene Mutations in aHUS Open the Door to Personalized Therapy", "status": "RECRUITING", "start": "2023-05-03", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Mario Negri Institute for Pharmacological Research", "countries": ["Italy"]}, {"nct": "NCT04745195", "title": "Complement Prospective Evaluation of Thrombotic Microangiopathy on Endothelium", "status": "RECRUITING", "start": "2021-08-11", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Maastricht University Medical Center", "countries": ["Netherlands"]}, {"nct": "NCT01522183", "title": "Atypical Hemolytic-Uremic Syndrome (aHUS) Registry", "status": "RECRUITING", "start": "2013-03-18", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Alexion Pharmaceuticals, Inc.", "countries": ["Australia", "Belgium", "Canada", "Denmark", "France", "Germany", "Israel", "Italy", "Poland", "Russia", "South Korea", "Spain", "Switzerland", "Taiwan", "Turkey (Türkiye)", "United Kingdom", "United States"]}, {"nct": "NCT01793168", "title": "Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford", "status": "RECRUITING", "start": "2010-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sanford Health", "countries": ["Australia", "United States"]}, {"nct": "NCT06065852", "title": "National Registry of Rare Kidney Diseases", "status": "RECRUITING", "start": "2009-11-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "UK Kidney Association", "countries": ["United Kingdom"]}, {"nct": "NCT02355782", "title": "OMS721 Compassionate Use in Patients With Thrombotic Microangiopathy", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "Michal Nowicki", "countries": []}]}, {"batch": 1, "no": 9, "name_zh": "自身免疫性脑炎", "query_terms": [{"term": "Autoimmune encephalitis", "broad": false}], "n_total": 25, "n_open": 15, "n_open_precise": 15, "n_broad": 0, "trials": [{"nct": "NCT04561557", "title": "Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System", "status": "RECRUITING", "start": "2020-09-22", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Tongji Hospital", "conditions": ["Autoimmune Diseases", "Autoimmune Diseases of the Nervous System", "Neuromyelitis Optica Spectrum Disorder", "Myasthenia Gravis", "Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "Idiopathic Inflammatory Myopathies", "Multiple Sclerosis", "Autoimmune Encephalitis", "Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)", "POEMS Syndrome"], "cn_sites": [{"facility": "Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06173076", "title": "A Prospective Study to Evaluate Clinical Outcomes in Anti-LGI1 Encephalitis", "status": "RECRUITING", "start": "2022-05-18", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 60, "sponsor": "Shen Chun-Hong", "conditions": ["Autoimmune Encephalitis", "Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis"], "cn_sites": [{"facility": "2nd Affiliated Hospital, School of Medicine, Zhejiang University, China", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06388161", "title": "Neural Autoantibody Prevalence in New-onset Focal Seizures of Unknown Etiology", "status": "RECRUITING", "start": "2023-08-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 300, "sponsor": "Shen Chun-Hong", "conditions": ["Epilepsy", "Encephalitis Autoimmune"], "cn_sites": [{"facility": "2nd Affiliated Hospital, School of Medicine, Zhejiang University, China", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07653984", "title": "Cohort Study on Neuroimmune Diseases in the Reproductive Age", "status": "RECRUITING", "start": "2024-04-21", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Third Affiliated Hospital, Sun Yat-Sen University", "conditions": ["Neuromyelitis Optica Spectrum Disorders (NMOSD)", "Multiple Sclerosis", "Autoimmune Encephalitis", "Myasthenia Gravis", "Guillain-Barré Syndrome (GBS)", "Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)"], "cn_sites": [{"facility": "The Third Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06502015", "title": "Biomarkers in Autoimmune Disease of Nervous System", "status": "RECRUITING", "start": "2024-07-31", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 50000, "sponsor": "Tongji Hospital", "conditions": ["Autoimmune Diseases of the Nervous System", "Neuromyelitis Optica Spectrum Disorder", "Multiple Sclerosis", "Guillain-Barre Syndrome", "Acute Disseminated Encephalomyelitis", "Autoimmune Encephalitis", "Stiff-Person Syndrome", "Myasthenia Gravis", "Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "Idiopathic Inflammatory Myopathies", "Autoimmune Diseases"], "cn_sites": [{"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06584045", "title": "Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis)", "status": "RECRUITING", "start": "2024-09-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 250, "sponsor": "Tongji Hospital", "conditions": ["Encephalitis", "Encephalitis, Viral", "Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody", "Autoimmune Encephalitis"], "cn_sites": [{"facility": "Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06867991", "title": "Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis", "status": "RECRUITING", "start": "2024-11-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 200, "sponsor": "The First People's Hospital of Changzhou", "conditions": ["Anti-N-Methyl-D-Aspartate Receptor Encephalitis"], "cn_sites": [{"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "The First People's Hospital of Changzhou", "city": "Changzhou", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06510283", "title": "Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 Encephalitis", "status": "RECRUITING", "start": "2024-12-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Beijing Tongren Hospital", "conditions": ["Anti-N-Methyl-D-Aspartate Receptor Encephalitis"], "cn_sites": [{"facility": "Beijing Tongren Hospital,Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06760091", "title": "A Multicentric Cohort of Autoimmune Encephalitis", "status": "NOT_YET_RECRUITING", "start": "2025-02-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Autoimmune Encephalitis"], "cn_sites": [{"facility": "Xuanwu Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06939166", "title": "Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases", "status": "RECRUITING", "start": "2025-06-17", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Tianjin Huanhu Hospital", "conditions": ["Neuromyelitis Optica Spectrum Disorders", "Myasthenia Gravis", "Multiple Sclerosis", "Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "Autoimmune Encephalitis"], "cn_sites": [{"facility": "Tianjin Huanhu Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07337785", "title": "CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases", "status": "RECRUITING", "start": "2025-12-12", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Tongji Hospital", "conditions": ["Relapsing or Refractory Multiple Sclerosis (MS)", "Myasthenia Gravis (MG)", "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)", "Autoimmune Encephalitis (AE)"], "cn_sites": [{"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07333196", "title": "Tongji NADs Cohort", "status": "NOT_YET_RECRUITING", "start": "2026-03-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1550, "sponsor": "Tongji Hospital", "conditions": ["Multiple Sclerosis", "NMO Spectrum Disorder", "Autoimmune Encephalitis", "Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease", "Autoimmune Nodopathy", "Acute Inflammatory Demyelinating Polyradiculoneuropathy", "Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "Myasthenia Gravis", "Idiopathic Inflammatory Myopathies"], "cn_sites": [{"facility": "Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07526493", "title": "Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.", "status": "RECRUITING", "start": "2026-04-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Tongji Hospital", "conditions": ["Multiple Sclerosis (MS)", "Neuromyelitis Optica Spectrum Disorder (NMOSD)", "Autoimmune Encephalitis (AE)", "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)", "Myasthenia Gravis (MG)", "Anti-Myelin Oligodendrocyte Glycoprotein Immunoglobulin G Antibody-Associated Disease (MOGAD)", "Idiopathic Inflammatory Myopathies (IIM)"], "cn_sites": [{"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07686042", "title": "Efficacy and Safety of Low-Dose Blinatumomab in the Treatment of Refractory Autoimmune Encephalitis and Autoimmune Cerebellitis", "status": "NOT_YET_RECRUITING", "start": "2026-06-24", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Beijing Tiantan Hospital", "conditions": ["Autoimmune Encephalitis (AE)", "Autoimmune Cerebellitis"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07822776", "title": "Efgartigimod in Anti-NMDA Receptor Encephalitis.", "status": "RECRUITING", "start": "2026-06-25", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Beijing Tongren Hospital", "conditions": ["Encephalitis Autoimmune"], "cn_sites": [{"facility": "Beijing Tongren Hospital,Capital Medical University, Beijing, Beijing 100730", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02443350", "title": "Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in Beijing Area", "status": "UNKNOWN", "start": "2014-06", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 400, "sponsor": "Jia Wei Wang,MD", "conditions": ["Anti-N-Methyl-D-Aspartate Receptor Encephalitis"], "cn_sites": [{"facility": "Beijing Tongren Hospital,Capital Medical Universiy", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07722286", "title": "Relapse and Functional Outcomes in Anti-LGI1 Encephalitis", "status": "COMPLETED", "start": "2015-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 112, "sponsor": "Shen Chun-Hong", "conditions": ["Autoimmune Encephalitis", "LGI1 Encephalitis", "Limbic Encephalitis"], "cn_sites": [{"facility": "2nd Affiliated Hospital, School of Medicine, Zhejiang University, China", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03530462", "title": "To Explore Cognitive Neural Mechanism of Autoimmune Encephalitis by Using Neuropsychological Tests and Multi-modal MRI", "status": "COMPLETED", "start": "2017-04-07", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 22, "sponsor": "First Affiliated Hospital of Zhejiang University", "conditions": ["Cognitive Impairment", "Autoimmune Encephalitis"], "cn_sites": [{"facility": "The First Affiliated Hospital, Zhejiang University", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05422664", "title": "Acute Sympotomatic Seizure Secondary to Autoimmune Encephalitis and Autoimmune-associated Epilepsy", "status": "UNKNOWN", "start": "2018-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Liu Yonghong", "conditions": ["Autoimmune Encephalitis", "Epilepsy", "Seizures"], "cn_sites": [{"facility": "XijingH", "city": "Xi'an", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03542279", "title": "CPI Combination Therapy for Autoimmune Encephalitis", "status": "COMPLETED", "start": "2020-11-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 70, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Autoimmune Encephalitis"], "cn_sites": [{"facility": "Xuanwu Hospital of Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06443333", "title": "National, Multicentric Registry Study on Neuroimmunological Diseases in China", "status": "UNKNOWN", "start": "2020-12-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 7000, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Multiple Sclerosis", "NMO Spectrum Disorder", "Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease", "Myasthenia Gravis", "Autoimmune Encephalitis", "Acute Disseminated Encephalomyelitis"], "cn_sites": [{"facility": "Xuanwu Hospital ,Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07036042", "title": "Clinical Characteristics of Patients With Anti-Collapsin Response Mediator Protein 2 Antibodies in Encephalitis or Encephalomyelitis", "status": "COMPLETED", "start": "2022-06-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 300, "sponsor": "Nanfang Hospital, Southern Medical University", "conditions": ["Autoimmune Encephalitis"], "cn_sites": [{"facility": "Nanfang hospital", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05414890", "title": "Sensitivity and Specificity of TSA-CBA for Autoantibodies Against Neural Antigen Determination", "status": "UNKNOWN", "start": "2022-06-30", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2500, "sponsor": "Beijing Tiantan Hospital", "conditions": ["NMO Spectrum Disorder", "NMDA-R Encephalitis", "Diagnostic Self Evaluation", "Immune System Diseases", "Nervous System Diseases", "Autoimmune Diseases of the Nervous System", "Autoimmune Diseases"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05503264", "title": "A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-09-27", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 122, "sponsor": "Hoffmann-La Roche", "conditions": ["NMDAR Autoimmune Encephalitis", "LGI1 Autoimmune Encephalitis"], "cn_sites": [{"facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Beijing Tongren Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Tiantan Hospital,Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "West China Hospital - Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Affiliated Hospital of Jining Medical University", "city": "Jining", "status": ""}, {"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": ""}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": ""}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT06033846", "title": "Efficacy and Safety of Adjunctive Minocycline in the Treatment of Autoimmune Encephalitis", "status": "COMPLETED", "start": "2023-10-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Xijing Hospital", "conditions": ["Autoimmune Encephalitis"], "cn_sites": [{"facility": "Xijing Hospital", "city": "Xi'an", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 46, "g_fetched": 31, "g_countries": [["France", 9], ["United States", 7], ["Italy", 3], ["Spain", 2], ["United Kingdom", 1], ["Egypt", 1], ["South Korea", 1], ["Canada", 1], ["Netherlands", 1], ["Germany", 1], ["Switzerland", 1]], "g_trials": [{"nct": "NCT07783269", "title": "A Basket Study of CTA313 in Participants With Active Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-12", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Imviva Bio", "countries": []}, {"nct": "NCT07791212", "title": "Dissecting Immunological and Autoimmune Mechanisms of Neuropsychiatric Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-10-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "King's College London", "countries": ["United Kingdom"]}, {"nct": "NCT07804004", "title": "A Safety and Efficacy Study Evaluating CTX112 in Subjects With Refractory Neurologic Autoimmune Disease", "status": "NOT_YET_RECRUITING", "start": "2026-09-15", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "CRISPR Therapeutics", "countries": []}, {"nct": "NCT07583641", "title": "A Study to Learn About How Well the Medicine Efgartigimod Works to Treat Autoimmune Encephalitis In Children 12 Years or Older and Adults", "status": "RECRUITING", "start": "2026-08-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "argenx", "countries": ["United States"]}, {"nct": "NCT07707739", "title": "Plasma Exchange in Pediatric Autoimmune Encephalitis", "status": "RECRUITING", "start": "2026-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Menoufia University", "countries": ["Egypt"]}, {"nct": "NCT07732907", "title": "Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia", "status": "RECRUITING", "start": "2026-06-04", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Bristol-Myers Squibb", "countries": ["United States"]}, {"nct": "NCT07093333", "title": "A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric Disease", "status": "RECRUITING", "start": "2026-05-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Arialys Australia Pty Ltd", "countries": ["South Korea"]}, {"nct": "NCT07488117", "title": "Is [18F]-DPA-714 PET a Good Marker of Neuroinflammation in Autoimmune Encephalitis?", "status": "RECRUITING", "start": "2026-03-31", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Toulouse", "countries": ["France"]}, {"nct": "NCT07341828", "title": "A Study of C-CAR168 in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard Therapy", "status": "NOT_YET_RECRUITING", "start": "2026-02", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Huashan Hospital", "countries": []}, {"nct": "NCT07158229", "title": "Long-term Impact of NMDAR Encephalitis, Level 3", "status": "RECRUITING", "start": "2025-11-21", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Hospices Civils de Lyon", "countries": ["France"]}, {"nct": "NCT06863974", "title": "High-throughput Omic Technology for Identification of Biomarkers of Relapsing Acute Disseminated Encephalomyelitis in Immune Cell Network", "status": "RECRUITING", "start": "2025-11-16", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Angers", "countries": ["France"]}, {"nct": "NCT07131683", "title": "hUC-MSC-Exo Therapy for Autoimmune Encephalitis", "status": "NOT_YET_RECRUITING", "start": "2025-11-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Xuanwu Hospital, Beijing", "countries": []}, {"nct": "NCT07477015", "title": "Study of Pathogenic Mechanisms and Identification of Novel Autoantibodies in Autoimmune Encephalitis", "status": "RECRUITING", "start": "2025-07-31", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondazione Policlinico Universitario Agostino Gemelli IRCCS", "countries": ["Italy"]}, {"nct": "NCT06851143", "title": "18F-DPA-714 PET/MR in Dysfunctional Brain Diseases", "status": "NOT_YET_RECRUITING", "start": "2025-03-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Xijing Hospital", "countries": []}, {"nct": "NCT06697678", "title": "Risk Prediction Model for Severe Autoimmune Encephalitis", "status": "NOT_YET_RECRUITING", "start": "2025-01-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Xuanwu Hospital, Beijing", "countries": []}, {"nct": "NCT06941584", "title": "Analysis of the Role of AIRE in Autoimmune Neurological Diseases Associated With Autoantibodies", "status": "RECRUITING", "start": "2024-11-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondazione Policlinico Universitario Agostino Gemelli IRCCS", "countries": ["Italy"]}, {"nct": "NCT07133113", "title": "Medium-term Effects of Treatments in Autoimmune Encephalitis", "status": "RECRUITING", "start": "2024-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Hospices Civils de Lyon", "countries": ["France"]}, {"nct": "NCT06079294", "title": "Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism", "status": "RECRUITING", "start": "2024-05-31", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT06515106", "title": "Antibody-mediated LGI1 Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Chronic Phase of the Disease", "status": "RECRUITING", "start": "2023-12-18", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Fundacion Clinic per a la Recerca Biomédica", "countries": ["Spain"]}, {"nct": "NCT05849467", "title": "Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy", "status": "RECRUITING", "start": "2023-10-19", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "National Institute of Neurological Disorders and Stroke (NINDS)", "countries": ["United States"]}, {"nct": "NCT04806620", "title": "Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research", "status": "RECRUITING", "start": "2023-07-05", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Brain Inflammation Collaborative", "countries": ["United States"]}, {"nct": "NCT05934149", "title": "Lupus Landmark Study: A Prospective Registry and Biorepository", "status": "RECRUITING", "start": "2023-06-28", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Lupus Research Alliance", "countries": ["Canada", "United States"]}, {"nct": "NCT06019975", "title": "FDG-PET in the Diagnosis of Autoimmune Encephalitis", "status": "RECRUITING", "start": "2023-03-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Milano Bicocca", "countries": ["Italy"]}, {"nct": "NCT05198661", "title": "Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis Collection", "status": "RECRUITING", "start": "2022-08-02", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Hospices Civils de Lyon", "countries": ["France"]}, {"nct": "NCT04372615", "title": "The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis", "status": "RECRUITING", "start": "2022-03-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University of Utah", "countries": ["Netherlands", "Spain", "United States"]}]}, {"batch": 1, "no": 10, "name_zh": "自身免疫性垂体炎", "query_terms": [{"term": "Primary hypophysitis", "broad": false}, {"term": "Autoimmune Hypophysitis", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 0, "g_fetched": 0, "g_countries": [], "g_trials": []}, {"batch": 1, "no": 11, "name_zh": "自身免疫性胰岛素受体病", "query_terms": [{"term": "Insulin-resistance syndrome type B", "broad": false}, {"term": "Autoimmune Insulin Receptopathy (Type B insulin resistance)", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 1, "g_fetched": 1, "g_countries": [["Italy", 1]], "g_trials": [{"nct": "NCT07181733", "title": "BNP in Pediatric Metabolic Syndrome", "status": "RECRUITING", "start": "2024-05-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondazione IRCCS Policlinico San Matteo di Pavia", "countries": ["Italy"]}]}, {"batch": 1, "no": 12, "name_zh": "β-酮硫解酶缺乏症", "query_terms": [{"term": "Beta-ketothiolase deficiency", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 0, "g_fetched": 0, "g_countries": [], "g_trials": []}, {"batch": 1, "no": 13, "name_zh": "生物素酶缺乏症", "query_terms": [{"term": "Biotinidase deficiency", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 1, "g_fetched": 1, "g_countries": [["Italy", 1]], "g_trials": [{"nct": "NCT06723925", "title": "Neonatal Screening of Biotinidase Deficiency: Genotype-phenotype Correlation and Clinical Follow-up", "status": "RECRUITING", "start": "2021-04-21", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS Azienda Ospedaliero-Universitaria di Bologna", "countries": ["Italy"]}]}, {"batch": 1, "no": 14, "name_zh": "心脏离子通道病", "query_terms": [{"term": "Cardic Ion Channelopathies", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 0, "g_fetched": 0, "g_countries": [], "g_trials": []}, {"batch": 1, "no": 15, "name_zh": "原发性肉碱缺乏症", "query_terms": [{"term": "Systemic primary carnitine deficiency", "broad": false}, {"term": "Carnitine Deficiency", "broad": true}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 2, "g_fetched": 2, "g_countries": [["Canada", 1], ["United States", 1]], "g_trials": [{"nct": "NCT07201714", "title": "Oral Carnitine in Heart Failure Patients", "status": "RECRUITING", "start": "2025-11-12", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's", "countries": ["Canada"]}, {"nct": "NCT04602325", "title": "Systemic Biomarkers of Brain Injury From Hyperammonemia", "status": "RECRUITING", "start": "2020-07-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Children's National Research Institute", "countries": ["United States"]}]}, {"batch": 1, "no": 16, "name_zh": "Castleman病", "query_terms": [{"term": "Castleman disease", "broad": false}], "n_total": 8, "n_open": 2, "n_open_precise": 2, "n_broad": 0, "trials": [{"nct": "NCT05200715", "title": "AutoInflammatory Disease Alliance Registry (AIDA)", "status": "RECRUITING", "start": "2020-08-06", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 3500, "sponsor": "University of Siena", "conditions": ["Hereditary Autoinflammatory Diseases", "Schnitzler Syndrome", "Behcet Syndrome", "PFAPA Syndrome", "Still Disease", "Autoinflammatory Syndrome, Unspecified", "Uveitis", "Scleritis", "Vexas Syndrome", "Spondyloarthritis (SpA)", "Castleman Disease"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05283993", "title": "A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH", "status": "RECRUITING", "start": "2021-07-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2000, "sponsor": "Peking University First Hospital", "conditions": ["Multiple Myeloma", "Amyloidosis", "Cryoglobulinemia", "Castleman's Disease", "Light Chain Deposition Disease", "Heavy Chain Deposition Disease", "Polyneuropathy Organomegaly Endocrinopathy Monoclonal Gammopathy and Skin Changes", "Smoldering Multiple Myeloma", "Plasma Cell Leukemia", "Monoclonal Gammopathy of Undetermined Significance (MGUS)", "Monoclonal Gammopathy of Renal Significance (MGRS)", "Monoclonal Gammopathy of Neurological Significance (MGNS)"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01024036", "title": "A Study to Evaluate the Efficacy and Safety of CNTO328 Plus Best Supportive Care in Multicentric Castleman's Disease", "status": "COMPLETED", "start": "2010-03-18", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 79, "sponsor": "Janssen Research & Development, LLC", "conditions": ["Multicentric Castleman's Disease"], "cn_sites": [{"facility": "", "city": "Beijing", "status": ""}, {"facility": "", "city": "Chengdu", "status": ""}, {"facility": "", "city": "Guangzhou", "status": ""}, {"facility": "", "city": "Hangzhou", "status": ""}, {"facility": "", "city": "Shanghai", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT01400503", "title": "A Study to Evaluate the Safety of Long-term Treatment With Siltuximab in Patients With Multicentric Castleman's Disease", "status": "COMPLETED", "start": "2011-04-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Janssen Research & Development, LLC", "conditions": ["Multicentric Castleman's Disease"], "cn_sites": [{"facility": "", "city": "Beijing", "status": ""}, {"facility": "", "city": "Chengdu", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT03043105", "title": "TCP Regimen in Newly Diagnosed MCD:a Prospective, Single-center, Single-arm, Phase-II Pilot Trial", "status": "UNKNOWN", "start": "2017-01-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 25, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Multicentric Castleman Disease"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03982771", "title": "BCD Regimen in Newly Diagnosed Idiopathic Multicentric Castleman's Disease (iMCD)", "status": "UNKNOWN", "start": "2019-01-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Idiopathic Multicentric Castleman's Disease"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04743687", "title": "Zanuburutinib in Relapsed and Refractory iMCD: a Prospective, Single-center, Single-arm Trial", "status": "UNKNOWN", "start": "2021-01-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Idiopathic Multicentric Castleman's Disease"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05345522", "title": "A Study of Anti-IL-6R mAb Injection in Patients With iMCD", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-04-18", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 25, "sponsor": "Beijing VDJBio Co., LTD.", "conditions": ["Idiopathic Multicentric Castleman&#39;s Disease"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "West China Hospital of Sichuan Hospital", "city": "Chengdu", "status": ""}], "cn_site_count": 3, "broad_only": false}], "g_total": 14, "g_fetched": 12, "g_countries": [["United States", 9], ["Malawi", 1], ["Italy", 1]], "g_trials": [{"nct": "NCT07085039", "title": "Ruxolitinib in Previously Treated Idiopathic Multicentric Castleman Disease", "status": "RECRUITING", "start": "2025-12-18", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University of Pennsylvania", "countries": ["United States"]}, {"nct": "NCT07793006", "title": "New Approaches for the Diagnosis of Lymphoma and Multicentric Castleman Disease", "status": "RECRUITING", "start": "2025-03-17", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Indiana University", "countries": ["Malawi"]}, {"nct": "NCT06052618", "title": "Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)", "status": "RECRUITING", "start": "2025-03-17", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["United States"]}, {"nct": "NCT06643091", "title": "Nintedanib Treatment in Unicentric Castleman Disease", "status": "NOT_YET_RECRUITING", "start": "2024-11-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": []}, {"nct": "NCT05907759", "title": "Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease", "status": "RECRUITING", "start": "2024-07-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["United States"]}, {"nct": "NCT05663502", "title": "Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers", "status": "RECRUITING", "start": "2023-05-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "AIDS Malignancy Consortium", "countries": ["United States"]}, {"nct": "NCT06720870", "title": "An Italian Multicenter Retrospective Observational Study to Assess Effectiveness and Safety of Siltuximab for Patients with Castleman's Disease Treated in Italy in a Real-life Context", "status": "RECRUITING", "start": "2023-03-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS Azienda Ospedaliero-Universitaria di Bologna", "countries": ["Italy"]}, {"nct": "NCT04968288", "title": "Natural History of KSHV-Associated Multicentric Castleman s Disease", "status": "RECRUITING", "start": "2021-11-17", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["United States"]}, {"nct": "NCT03717844", "title": "Registry for Adults With Plasma Cell Disorders (PCD's)", "status": "RECRUITING", "start": "2018-02-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "UNC Lineberger Comprehensive Cancer Center", "countries": ["United States"]}, {"nct": "NCT03300830", "title": "Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease", "status": "RECRUITING", "start": "2017-12-20", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["United States"]}, {"nct": "NCT02817997", "title": "International Registry for Patients With Castleman Disease", "status": "RECRUITING", "start": "2016-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Pennsylvania", "countries": ["United States"]}, {"nct": "NCT00006518", "title": "Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer", "status": "RECRUITING", "start": "2000-12-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["United States"]}]}, {"batch": 1, "no": 17, "name_zh": "腓骨肌萎缩症", "query_terms": [{"term": "Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy", "broad": false}, {"term": "Charcot-Marie-Tooth Disease", "broad": true}], "n_total": 8, "n_open": 2, "n_open_precise": 2, "n_broad": 1, "trials": [{"nct": "NCT04010188", "title": "A Registered Cohort Study on Charcot-Marie-Tooth Disease", "status": "RECRUITING", "start": "2019-07-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Ning Wang, MD., PhD.", "conditions": ["Charcot-Marie-Tooth Disease"], "cn_sites": [{"facility": "First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07625020", "title": "Ultrasound-Guided Nerve Hydrodissection for Diabetic Lower Limb Entrapment Neuropathy", "status": "RECRUITING", "start": "2026-05-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 266, "sponsor": "Chongqing Medical University", "conditions": ["Diabetic Peripheral Neuropathy", "Entrapment Neuropathy"], "cn_sites": [{"facility": "The First Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04967716", "title": "Genetics of Charcot-Marie-Tooth Dystrophy and Related Diseases", "status": "UNKNOWN", "start": "2018-11-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Peking University Third Hospital", "conditions": ["Peroneal Muscular Atrophy"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05156281", "title": "Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2)", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-12-13", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1007, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Relapsing Multiple Sclerosis"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Wuhan", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Nanjing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Yinchuan", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Taiyuan", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Hangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Wenzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": ""}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT05147220", "title": "Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-12-16", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1000, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Relapsing Multiple Sclerosis"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Zhengzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Changsha", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Baotou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Hohhot", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Nanchang", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Changchun", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Chongqing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Tianjin", "status": ""}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT05187260", "title": "Antisense Oligonucleotide for Spinal Muscular Atrophy", "status": "UNKNOWN", "start": "2022-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "First Affiliated Hospital of Fujian Medical University", "conditions": ["Spinal Muscular Atrophy"], "cn_sites": [{"facility": "Department of Neurology, Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Department of Pediatrics, Fujian Medical University Union Hospital", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "Department of Neurology, First Affiliated Hospital Fujian Medical University", "city": "Fuzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT05793437", "title": "Effects of Permissive Hypercapnia on Concentration of Postoperative Plasma Neurofilament Light", "status": "COMPLETED", "start": "2023-04-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 84, "sponsor": "Affiliated Hospital of Jiaxing University", "conditions": ["Hypercapnia"], "cn_sites": [{"facility": "Affiliated Hospital of Jiaxing University", "city": "Jiaxing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05092841", "title": "A Study to Assess the Efficacy and Safety of PXT3003 in Charcot-Marie-Tooth Type 1A", "status": "COMPLETED", "start": "2021-09-28", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 176, "sponsor": "Tasly GeneNet Pharmaceuticals Co., Ltd", "conditions": ["Charcot-Marie-Tooth Type 1A"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}, {"facility": "Xuanwu Hospital Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "The First Bethune Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "The Third Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "The First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": ""}, {"facility": "Nanfang Hospital Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital，Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "The Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": ""}, {"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Harbin Medical University", "city": "Harbin", "status": ""}, {"facility": "The First Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": ""}, {"facility": "Inner Mongolia People's Hospital", "city": "Hohhot", "status": ""}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": ""}, {"facility": "The Second Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": ""}, {"facility": "The Affiliated Hospital of Nanjing University Medical School", "city": "Nanjing", "status": ""}, {"facility": "Zhongda Hospital Southeast University", "city": "Nanjing", "status": ""}, {"facility": "Qilu Hospital of Shandong University（Qingdao）", "city": "Qingdao", "status": ""}, {"facility": "Shanghai Jiaotong University School of Medicine Ruijin Hospital", "city": "Shanghai", "status": ""}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "The Second Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "Renmin Hospital of Wuhan University（Hubei General Hospital）", "city": "Wuhan", "status": ""}, {"facility": "The First Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi'an", "status": ""}, {"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": ""}], "cn_site_count": 25, "broad_only": true}], "g_total": 52, "g_fetched": 50, "g_countries": [["United States", 11], ["France", 9], ["Canada", 6], ["Italy", 6], ["Germany", 5], ["United Kingdom", 4], ["Turkey (Türkiye)", 3], ["Australia", 3], ["Spain", 2], ["Belgium", 2], ["Austria", 1], ["Chile", 1], ["Norway", 1], ["South Korea", 1], ["Switzerland", 1], ["Czechia", 1], ["Egypt", 1], ["Hungary", 1], ["Poland", 1], ["Romania", 1], ["Slovenia", 1], ["Martinique", 1]], "g_trials": [{"nct": "NCT07760636", "title": "Kinetics and Prognostic Value of NeuroFilament Light in Post-cardiac Arrest: A Prospective Multicenter Study", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT07447557", "title": "Study of Intrathecal ELP-02 for Charcot-Marie-Tooth Disease Type 4J (CMT4J)", "status": "RECRUITING", "start": "2026-08-07", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Elpida Therapeutics SPC", "countries": ["United States"]}, {"nct": "NCT07038239", "title": "Genotype/Phenotype Correlation of MORC2 Mutations", "status": "RECRUITING", "start": "2026-06-16", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Hospices Civils de Lyon", "countries": ["France"]}, {"nct": "NCT07591779", "title": "Physical Activity Level at Home in CMT1A Patients: Wearable Sensor Assessment", "status": "NOT_YET_RECRUITING", "start": "2026-06-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Limoges", "countries": ["France"]}, {"nct": "NCT07521722", "title": "DIV-AD BARCELONA: Alzheimer's Blood-Based Biomakers for a Diverse Community", "status": "NOT_YET_RECRUITING", "start": "2026-04-27", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Barcelonabeta Brain Research Center, Pasqual Maragall Foundation", "countries": ["Spain"]}, {"nct": "NCT07520812", "title": "Impact of Exercise Training on Serum Neurofilament Light Chain (NfL), Brain Volumetry, and Functional Outcomes in Multiple Sclerosis", "status": "NOT_YET_RECRUITING", "start": "2026-04-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Firat University", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT07478172", "title": "Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease", "status": "RECRUITING", "start": "2026-03-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Missouri-Columbia", "countries": ["United States"]}, {"nct": "NCT07321977", "title": "Assessment of a Portable Digital Device for Quantified Analysis of Markerless Walking in Volunteers With Neuromuscular Diseases or Asymptomatic Volunteers", "status": "RECRUITING", "start": "2026-03-03", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Institut de Myologie, France", "countries": ["France"]}, {"nct": "NCT07066683", "title": "Pilot Study to Evaluate Fatigue and Fatigability Profiles and Their Impact on Walking and Balance in Patients With Charcot-Marie-Tooth Type 1A Disease Using a Global Approach in Comparison to Healthy Volunteers", "status": "NOT_YET_RECRUITING", "start": "2026-02-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Strasbourg, France", "countries": ["France"]}, {"nct": "NCT07432035", "title": "Walking Function Outcomes Following Surgical Correction With Rehabilitation Versus Physical Therapy Alone in Charcot-Marie-Tooth Disease: A Bidirectional Cohort Study", "status": "NOT_YET_RECRUITING", "start": "2026-02-11", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Peking University Third Hospital", "countries": []}, {"nct": "NCT07312994", "title": "Analysis of NfL and GFAP in Different Dietary Patterns", "status": "RECRUITING", "start": "2025-12-18", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Salzburger Landeskliniken", "countries": ["Austria"]}, {"nct": "NCT07292220", "title": "A Study of a Blood Marker in Newborns With Brain Injury Caused by Lack of Oxygen at Birth", "status": "NOT_YET_RECRUITING", "start": "2025-12-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Mustafa Gürkan", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT07414069", "title": "High-Intensity Laser Therapy in Carpal Tunnel Syndrome: Clinical, Sonographic, and Electrophysiological Outcomes", "status": "RECRUITING", "start": "2025-11-02", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Ankara City Hospital Bilkent", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT07140614", "title": "A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of EDK060 in Adults With CMT1A.", "status": "RECRUITING", "start": "2025-09-30", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": ["Canada"]}, {"nct": "NCT07152197", "title": "Effects of Resistance Exercises in Hereditary Sensory-Motor Neuropathy (Charcot-Marie-Tooth Disease)", "status": "RECRUITING", "start": "2025-09-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Universidad de La Frontera", "countries": ["Chile"]}, {"nct": "NCT07095400", "title": "Evaluation of Functional and Biochemical Effectiveness of a Strength Training Protocol in Parkinson's Disease", "status": "NOT_YET_RECRUITING", "start": "2025-09-07", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Universidad Villanueva", "countries": ["Spain"]}, {"nct": "NCT07188415", "title": "CMT Gait, Mobility, Balance - AOFAS Grant", "status": "RECRUITING", "start": "2025-08-14", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Bopha Chrea", "countries": ["United States"]}, {"nct": "NCT06108349", "title": "Topical Cannabidiol for Treating Carpal Tunnel Syndrome", "status": "NOT_YET_RECRUITING", "start": "2025-07-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University of Virginia", "countries": []}, {"nct": "NCT07049588", "title": "Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease", "status": "RECRUITING", "start": "2025-06-24", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique Hopitaux De Marseille", "countries": ["France"]}, {"nct": "NCT06845644", "title": "Longitudinal Quantitative Neuromuscular MRI in Neuropathic Patients", "status": "RECRUITING", "start": "2025-05-23", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique Hopitaux De Marseille", "countries": ["France"]}, {"nct": "NCT06877442", "title": "Neurofilament Light Chain Correlation With Severity of Symptoms and Cognitive Decline in Mood Disorders", "status": "NOT_YET_RECRUITING", "start": "2025-05-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT07726043", "title": "Clinical Trial Evaluating the Impact of an Intensive Rehabilitation Program Combined With Tendon Vibratory Stimulation on Functional Balance in Individuals With Charcot-Marie-Tooth Disease Type 1A", "status": "RECRUITING", "start": "2025-04-28", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "UGECAM PACA et Corse", "countries": ["France"]}, {"nct": "NCT06881979", "title": "High-Tech Rehabilitation Pathway for Chronic Adult Neuromuscular Diseases - Fit4MedRob-Chronic MND Project", "status": "RECRUITING", "start": "2025-04-28", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Istituti Clinici Scientifici Maugeri SpA", "countries": ["Italy"]}, {"nct": "NCT06669949", "title": "Natural History of Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS)", "status": "RECRUITING", "start": "2025-04-22", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of California, San Francisco", "countries": ["United States"]}, {"nct": "NCT07476365", "title": "A Multi-omic Approach to the Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease (CMT1A)", "status": "RECRUITING", "start": "2025-03-24", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Medical Center Goettingen", "countries": ["Germany"]}]}, {"batch": 1, "no": 18, "name_zh": "瓜氨酸血症", "query_terms": [{"term": "Citrullinemia", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 3, "g_fetched": 3, "g_countries": [["United States", 2], ["Australia", 1]], "g_trials": [{"nct": "NCT07773246", "title": "Phase 1/2 Study of KRRO-121 in Healthy Volunteers and Patients With UCD", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Korro Bio, Inc.", "countries": ["Australia"]}, {"nct": "NCT04908319", "title": "Hepatic Histopathology in Urea Cycle Disorders", "status": "RECRUITING", "start": "2022-02-24", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Baylor College of Medicine", "countries": ["United States"]}, {"nct": "NCT04602325", "title": "Systemic Biomarkers of Brain Injury From Hyperammonemia", "status": "RECRUITING", "start": "2020-07-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Children's National Research Institute", "countries": ["United States"]}]}, {"batch": 1, "no": 19, "name_zh": "先天性肾上腺发育不良", "query_terms": [{"term": "Adrenal hypoplasia congenita", "broad": false}, {"term": "Congenital Adrenal Hypoplasia", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 5, "g_fetched": 5, "g_countries": [["United States", 4], ["Belgium", 1], ["Netherlands", 1], ["Spain", 1], ["United Kingdom", 1], ["Australia", 1]], "g_trials": [{"nct": "NCT06669949", "title": "Natural History of Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS)", "status": "RECRUITING", "start": "2025-04-22", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of California, San Francisco", "countries": ["United States"]}, {"nct": "NCT04885179", "title": "SPL Insufficiency Syndrome (SPLIS)/NPHS14: a SPLIS Observational Study and Patient Registry (International)", "status": "RECRUITING", "start": "2025-04-22", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of California, San Francisco", "countries": ["United States"]}, {"nct": "NCT04252001", "title": "Growing up With the Young Endocrine Support System (YESS!)", "status": "NOT_YET_RECRUITING", "start": "2024-12-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "dr. Laura C. G. de Graaff-Herder", "countries": ["Belgium", "Netherlands", "Spain", "United Kingdom"]}, {"nct": "NCT01793168", "title": "Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford", "status": "RECRUITING", "start": "2010-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sanford Health", "countries": ["Australia", "United States"]}, {"nct": "NCT04569149", "title": "Primordial Dwarfism Registry", "status": "RECRUITING", "start": "2008-03-11", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Nemours Children's Clinic", "countries": ["United States"]}]}, {"batch": 1, "no": 20, "name_zh": "先天性高胰岛素性低血糖血症", "query_terms": [{"term": "Congenital isolated hyperinsulinism", "broad": false}, {"term": "Congenital Hyperinsulinemic Hypoglycemia", "broad": false}], "n_total": 3, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT02560376", "title": "68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis", "status": "UNKNOWN", "start": "2014-02", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Insulinoma", "Nesidioblastosis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03930368", "title": "Application of Raw Corn Starch on Patients With Insulinoma", "status": "UNKNOWN", "start": "2019-04-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Hyperinsulinemic Hypoglycemia", "Insulinoma", "Raw Corn Starch"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05171751", "title": "Efficacy and Safety Evaluation of Octreotide in the Treatment of Congenital Hyperinsulinemia", "status": "COMPLETED", "start": "2021-11-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 50, "sponsor": "Beijing Children's Hospital", "conditions": ["Congenital Hyperinsulinaemic Hypoglycaemia", "Octreotide Adverse Reaction"], "cn_sites": [{"facility": "Department of Endocrinology, Genetics, Metabolism", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 5, "g_fetched": 5, "g_countries": [["United States", 3], ["Canada", 1]], "g_trials": [{"nct": "NCT07795047", "title": "Umbilical Cord Glucose", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Odense University Hospital", "countries": []}, {"nct": "NCT04706910", "title": "18F-DOPA II - PET Imaging Optimization", "status": "RECRUITING", "start": "2021-01-20", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "University of Alberta", "countries": ["Canada"]}, {"nct": "NCT04205604", "title": "18FluoroLDOPA PET Imaging for the Detection and Localization of Focal Congenital Hyperinsulinism", "status": "RECRUITING", "start": "2016-11-03", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Miguel Pampaloni", "countries": ["United States"]}, {"nct": "NCT02021604", "title": "Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma", "status": "RECRUITING", "start": "2013-10-09", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Cook Children's Health Care System", "countries": ["United States"]}, {"nct": "NCT01916148", "title": "18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "Children's Hospital of Philadelphia", "countries": ["United States"]}]}, {"batch": 1, "no": 21, "name_zh": "先天性肌无力综合征", "query_terms": [{"term": "Congenital myasthenic syndrome", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 8, "g_fetched": 8, "g_countries": [["United States", 6], ["Belgium", 2], ["Antigua and Barbuda", 1], ["Austria", 1], ["Brazil", 1], ["Canada", 1], ["France", 1], ["Germany", 1], ["Italy", 1], ["Japan", 1], ["Poland", 1], ["Spain", 1], ["United Kingdom", 1], ["Australia", 1]], "g_trials": [{"nct": "NCT07746089", "title": "A Study to Assess Efficacy and Safety of Adimanebart in Adult and Pediatric Participants With DOK7-,MUSK-, AGRN-, or LRP4- Congenital Myasthenic Syndromes (CMS)", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "argenx", "countries": []}, {"nct": "NCT07478172", "title": "Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease", "status": "RECRUITING", "start": "2026-03-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Missouri-Columbia", "countries": ["United States"]}, {"nct": "NCT06630650", "title": "A Prospective Natural History and Outcome Measure Validation Study of Congenital Myasthenic Syndromes", "status": "RECRUITING", "start": "2025-05-12", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Institute of Neurological Disorders and Stroke (NINDS)", "countries": ["United States"]}, {"nct": "NCT07226726", "title": "Patients With Congenital Myasthenic Syndrome Will be Treated With Mesenchymal Stem Cell Exosome Solution", "status": "RECRUITING", "start": "2025-01-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "The Foundation for Orthopaedics and Regenerative Medicine", "countries": ["Antigua and Barbuda", "United States"]}, {"nct": "NCT07136844", "title": "Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology", "status": "RECRUITING", "start": "2024-03-29", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Centre Hospitalier Universitaire de Liege", "countries": ["Belgium"]}, {"nct": "NCT06078553", "title": "A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutations in DOK7, MUSK, AGRN, or LRP4", "status": "RECRUITING", "start": "2024-02-13", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "argenx", "countries": ["Austria", "Belgium", "Brazil", "Canada", "France", "Germany", "Italy", "Japan", "Poland", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT01793168", "title": "Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford", "status": "RECRUITING", "start": "2010-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sanford Health", "countries": ["Australia", "United States"]}, {"nct": "NCT01403402", "title": "Congenital Muscle Disease Study of Patient and Family Reported Medical Information", "status": "RECRUITING", "start": "2009-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Cure CMD", "countries": ["United States"]}]}, {"batch": 1, "no": 22, "name_zh": "先天性肌强直（非营养不良性肌强直综合征）", "query_terms": [{"term": "Thomsen and Becker disease", "broad": false}, {"term": "Congenital myotonia", "broad": false}, {"term": "Congenital Myotonia Syndrome (Non-Dystrophic Myotonia, NDM)", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 17, "g_fetched": 17, "g_countries": [["United States", 10], ["France", 3], ["Italy", 2], ["Australia", 2], ["Netherlands", 2], ["United Kingdom", 2], ["Canada", 2], ["Belgium", 1], ["Denmark", 1], ["Germany", 1], ["Japan", 1], ["Spain", 1], ["Brazil", 1], ["Egypt", 1], ["New Zealand", 1]], "g_trials": [{"nct": "NCT07700225", "title": "Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension", "status": "RECRUITING", "start": "2026-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Virginia Commonwealth University", "countries": ["United States"]}, {"nct": "NCT07580365", "title": "VirtualPark_Pediatric", "status": "RECRUITING", "start": "2026-06-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Istituto di Sistemi e Tecnologie Industriali Intelligenti per il Manifatturiero Avanzato", "countries": ["Italy"]}, {"nct": "NCT07486934", "title": "Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1", "status": "RECRUITING", "start": "2026-05-14", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Dyne Therapeutics", "countries": ["Australia", "Belgium", "Denmark", "France", "Germany", "Italy", "Japan", "Netherlands", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT07415837", "title": "Evaluation of the Role of miR-1 in the Pathogenesis and as a Biomarker in Muscular Dystrophies and Congenital Myopathies", "status": "RECRUITING", "start": "2026-02-11", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Clermont-Ferrand", "countries": ["France"]}, {"nct": "NCT06747884", "title": "Trial Readiness and Endpoint Assessment in Pediatric Myotonic Dystrophy Extension", "status": "RECRUITING", "start": "2025-06-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Virginia Commonwealth University", "countries": ["Brazil", "United States"]}, {"nct": "NCT07502989", "title": "Muscle Health Measurements Using Electrical Impedance Myography", "status": "RECRUITING", "start": "2025-04-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Beth Israel Deaconess Medical Center", "countries": ["United States"]}, {"nct": "NCT06287762", "title": "A Natural History Study of RYR1-Related Disorders", "status": "RECRUITING", "start": "2025-03-11", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Institutes of Health Clinical Center (CC)", "countries": ["United States"]}, {"nct": "NCT06833489", "title": "Transcriptomic Analysis to Put an End to Misdiagnosis in Patients With Rare Muscle Diseases", "status": "RECRUITING", "start": "2025-03-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique Hopitaux De Marseille", "countries": ["France"]}, {"nct": "NCT06791369", "title": "The Prevalence of RYR1-related Disease", "status": "NOT_YET_RECRUITING", "start": "2025-02", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "King's College London", "countries": ["United Kingdom"]}, {"nct": "NCT06774703", "title": "Nemaline Myopathy Clinical Research Network (NM-CTRN)", "status": "NOT_YET_RECRUITING", "start": "2025-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Stanford University", "countries": ["Canada", "United States"]}, {"nct": "NCT07138963", "title": "Phenotype - Genotype Correlation in a Sample of Egyptian Patients With Congenital Myopathies and Congenital Muscular Dystrophies", "status": "RECRUITING", "start": "2024-06-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Ain Shams University", "countries": ["Egypt"]}, {"nct": "NCT06157268", "title": "The Natural History and Muscle Fatigability of Patients With Congenital Myopathies.", "status": "RECRUITING", "start": "2024-03-28", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Radboud University Medical Center", "countries": ["Netherlands"]}, {"nct": "NCT05004129", "title": "Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy", "status": "RECRUITING", "start": "2021-08-23", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "AMO Pharma Limited", "countries": ["Australia", "Canada", "New Zealand", "United States"]}, {"nct": "NCT02398786", "title": "Myotonic Dystrophy Family Registry", "status": "RECRUITING", "start": "2013-02", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Myotonic Dystrophy Foundation", "countries": ["United States"]}, {"nct": "NCT01403402", "title": "Congenital Muscle Disease Study of Patient and Family Reported Medical Information", "status": "RECRUITING", "start": "2009-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Cure CMD", "countries": ["United States"]}, {"nct": "NCT00272883", "title": "Molecular and Genetic Studies of Congenital Myopathies", "status": "RECRUITING", "start": "2003-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Boston Children's Hospital", "countries": ["United States"]}, {"nct": "NCT07119775", "title": "Tideglusib: Expanded Access Use in Congenital Myotonic Dystrophy", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "AMO Pharma Limited", "countries": []}]}, {"batch": 1, "no": 23, "name_zh": "先天性脊柱侧弯", "query_terms": [{"term": "Congenital Scoliosis", "broad": false}], "n_total": 2, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT06315933", "title": "Anesthesia Neurodevelopmental Impact in Congenital Scoliosis Children", "status": "RECRUITING", "start": "2020-07-13", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 150, "sponsor": "Peking Union Medical College Hospital", "conditions": ["General Anesthetics Toxicity"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05190393", "title": "Comparison of Techniques Between Concave Distraction and Convex Resection in the Treatment of Congenital Cervical Scoliosis", "status": "COMPLETED", "start": "2016-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 60, "sponsor": "Peking University Third Hospital", "conditions": ["Congenital Scoliosis Due to Bony Malformation", "Cervical Scoliosis"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 10, "g_fetched": 9, "g_countries": [["United States", 4], ["South Korea", 1], ["Netherlands", 1], ["Hong Kong", 1], ["Czechia", 1], ["Malaysia", 1], ["France", 1]], "g_trials": [{"nct": "NCT07602595", "title": "The BRIDGE Pain Study", "status": "RECRUITING", "start": "2026-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Children's Hospital Medical Center, Cincinnati", "countries": ["United States"]}, {"nct": "NCT06755138", "title": "Research on the Relationship Between Scoliosis, Pain, Quality of Life, and Trunk Muscle Compensation Patterns Among Patients with Duchenne Muscular Dystrophy.", "status": "RECRUITING", "start": "2024-12-24", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Seoul National University Hospital", "countries": ["South Korea"]}, {"nct": "NCT06093477", "title": "Studying Melatonin and Recovery in Teens", "status": "RECRUITING", "start": "2024-05-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Stanford University", "countries": ["United States"]}, {"nct": "NCT05924347", "title": "Early Scoliotic Changes in Children at Increased Risk for Scoliosis Development", "status": "RECRUITING", "start": "2023-06-16", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "UMC Utrecht", "countries": ["Netherlands"]}, {"nct": "NCT05146193", "title": "AI-Powered Scoliosis Auto-Analysis System Multicenter Development and Validations", "status": "RECRUITING", "start": "2022-05-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "The University of Hong Kong", "countries": ["Hong Kong"]}, {"nct": "NCT05281757", "title": "Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Complex", "status": "RECRUITING", "start": "2022-02-18", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Aesculap AG", "countries": ["Czechia", "Malaysia"]}, {"nct": "NCT05051254", "title": "Respiratory Muscles and Work of Breathing in Children", "status": "RECRUITING", "start": "2022-01-19", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT05071144", "title": "Advanced SPinal Innovations With Robotics and Enabling Technology Registry", "status": "RECRUITING", "start": "2021-12-13", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Boston Children's Hospital", "countries": ["United States"]}, {"nct": "NCT03059420", "title": "Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies", "status": "RECRUITING", "start": "2004-02-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Boston Children's Hospital", "countries": ["United States"]}]}, {"batch": 1, "no": 24, "name_zh": "冠状动脉扩张病", "query_terms": [{"term": "Coronary Artery Ectasia", "broad": false}], "n_total": 17, "n_open": 7, "n_open_precise": 7, "n_broad": 0, "trials": [{"nct": "NCT04573660", "title": "Abbott Vascular Medical Device Registry", "status": "RECRUITING", "start": "2020-10-25", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 3784, "sponsor": "Abbott Medical Devices", "conditions": ["Acute Myocardial Infarction", "Restenoses, Coronary", "Coronary Artery Lesions", "Venous Embolism", "Arterial Embolism"], "cn_sites": [{"facility": "The First Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "Jinhua Municipal Central Hospital", "city": "Jinhua", "status": "RECRUITING"}, {"facility": "Ningbo First Hospital", "city": "Ningbo", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT06993636", "title": "Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years", "status": "RECRUITING", "start": "2023-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 60, "sponsor": "Children's Hospital of Fudan University", "conditions": ["Kawasaki Disease", "Coronary Artery Aneurysm", "Rivaroxaban", "Anticoagulant Drugs", "Pharmacokinetics and Pharmacodynamics"], "cn_sites": [{"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06978439", "title": "Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki Disease", "status": "RECRUITING", "start": "2024-01-10", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Children's Hospital of Fudan University", "conditions": ["Kawasaki Disease", "Pilot Study", "Coronary Artery Aneurysm", "Rivaroxaban"], "cn_sites": [{"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06822712", "title": "Efficacy and Safety of Sirolimus-coated Coronary Balloon Dilatation Catheter for De Novo Coronary Bifurcation Lesions", "status": "RECRUITING", "start": "2025-03-03", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 250, "sponsor": "BrosMed Medical Co., Ltd", "conditions": ["Coronary Arterial Disease (CAD)"], "cn_sites": [{"facility": "The First Hospital of Lanzhou University", "city": "Lanzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05643651", "title": "Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease", "status": "RECRUITING", "start": "2025-06-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Children's Hospital of Fudan University", "conditions": ["Kawasaki Disease", "Coronary Artery Aneurysm"], "cn_sites": [{"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07415902", "title": "Coronary Artery Drug-Coated Balloon Dilatation Catheter Clinical Trial Protocol", "status": "NOT_YET_RECRUITING", "start": "2026-02-28", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 252, "sponsor": "DK Medical Technology (Suzhou) Co., Ltd.", "conditions": ["In-Stent Restenosis or De Novo Coronary Artery Lesions"], "cn_sites": [{"facility": "The Second Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07764081", "title": "Progression, Management, and Clinical Outcomes of Coronary Artery Aneurysms", "status": "RECRUITING", "start": "2026-07-31", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "Nanjing First Hospital, Nanjing Medical University", "conditions": ["Coronary Artery Disease", "Aneurysms", "Coronary Intervention"], "cn_sites": [{"facility": "Nanjing First Hospital", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01208116", "title": "A Prospective Study on Predictive Value of Non-Invasive Atherosclerotic Measurements in Elderly Chinese", "status": "UNKNOWN", "start": "2010-04", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1290, "sponsor": "Tianjin Medical University General Hospital", "conditions": ["Atherosclerosis", "Cardiovascular Disease"], "cn_sites": [{"facility": "Geriatric Department, Tianjin Medical University General Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02325817", "title": "Bingo Drug-eluting Balloon in Bifurcation", "status": "COMPLETED", "start": "2014-12-03", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 222, "sponsor": "Yinyi(Liaoning) Biotech Co., Ltd.", "conditions": ["Bifurcation Lesions", "Drug Eluting Balloon"], "cn_sites": [{"facility": "General Hospital of Shenyang Military Region", "city": "Shenyang", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03820622", "title": "The Safety and Efficacy of DIOR Balloon in Coronary Bifurcation Lesions", "status": "UNKNOWN", "start": "2019-03", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 220, "sponsor": "CCRF Inc., Beijing, China", "conditions": ["Percutaneous Coronary Intervention"], "cn_sites": [{"facility": "Daqing Oil General Hospital", "city": "Daqing", "status": ""}, {"facility": "Wuhan Asian Heart Hospital", "city": "Wuhan", "status": ""}, {"facility": "Nanjing First Hospital", "city": "Nanjing", "status": ""}, {"facility": "First Bethune Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "The Second Hospital of Dalian University", "city": "Dalian", "status": ""}, {"facility": "General Hospital of Northern Theater Command", "city": "Shengyang", "status": ""}, {"facility": "The First Hospital of China Medical University", "city": "Shengyang", "status": ""}, {"facility": "First Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}, {"facility": "Sir Run Run Shaw Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Beijing Anzhen Hospital Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Shanghai East Hospital,", "city": "Shanghai", "status": ""}, {"facility": "Tianjin Chest Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 13, "broad_only": false}, {"nct": "NCT04265989", "title": "A New Classification and Interventional Therapy for Coronary Artery Ectasia", "status": "UNKNOWN", "start": "2019-11-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "China National Center for Cardiovascular Diseases", "conditions": ["Coronary Artery Ectasia"], "cn_sites": [{"facility": "Fuwai Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05250193", "title": "DK Score Coronary Scoring Balloon: a RCT Trial to Evaluate Acute Lumen Gain (SCORE CHINA)", "status": "COMPLETED", "start": "2021-03-24", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 200, "sponsor": "DK Medical Technology (Suzhou) Co., Ltd.", "conditions": ["Coronary Stenosis"], "cn_sites": [{"facility": "Beijing Anzhen Hospital affiliated to Capital University of Medical", "city": "Beijing", "status": ""}, {"facility": "Xuzhou Third People Hospital", "city": "Xuzhou", "status": ""}, {"facility": "Taiyuan Central Hospital", "city": "Taiyuan", "status": ""}, {"facility": "Tianjin Chest Hospita", "city": "Tianjin", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT06214247", "title": "Wedge NC - Scoring Balloon Dilatation Catheter", "status": "COMPLETED", "start": "2021-08-27", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 198, "sponsor": "BrosMed Medical Co., Ltd", "conditions": ["Coronary Artery Disease"], "cn_sites": [{"facility": "Dongguan People's Hospital", "city": "Dongguan", "status": ""}, {"facility": "Dongguan Tongwah Hospital", "city": "Dongguan", "status": ""}, {"facility": "Sun Yat-sen Memorial Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "Affiliated Hangzhou First People's Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "The Affiliated Hospital of Hangzhou Normal University", "city": "Hangzhou", "status": ""}, {"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Huzhou Central Hospital", "city": "Huzhou", "status": ""}, {"facility": "Ningbo First Hospital", "city": "Ningbo", "status": ""}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": ""}, {"facility": "The Second Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": ""}, {"facility": "Wenzhou People's Hospital", "city": "Wenzhou", "status": ""}], "cn_site_count": 11, "broad_only": false}, {"nct": "NCT05368129", "title": "Safety and Efficacy of POT PTCA Balloon Dilatation Catheter for the Optimal Dilation After DES Implantation", "status": "COMPLETED", "start": "2022-06-08", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 48, "sponsor": "Nanjing First Hospital, Nanjing Medical University", "conditions": ["Coronary Artery Disease"], "cn_sites": [{"facility": "Nanjing First Hospital", "city": "Nanjing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05509296", "title": "Compare the Effectiveness and Safety of Two Different Kinds of Cutting Balloon in Coronary Artery Disease", "status": "COMPLETED", "start": "2022-09-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 136, "sponsor": "Sino Medical Sciences Technology Inc.", "conditions": ["Coronary Stenosis", "Coronary Artery Stenosis", "In-stent Restenosis"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}, {"facility": "Kaifeng Central Hospital", "city": "Kaifeng", "status": ""}, {"facility": "The First People's Hospital of Lianyungang", "city": "Lianyungang", "status": ""}, {"facility": "Tianjin Chest Hospital", "city": "Tianjin", "status": ""}, {"facility": "Tianjin Forth Central Hospital", "city": "Tianjin", "status": ""}, {"facility": "Wuxi People's Hospital", "city": "Wuxi", "status": ""}, {"facility": "Xuzhou cancer hospital", "city": "Xuzhou", "status": ""}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT05998252", "title": "Evaluate Safety and Efficacy of Alveo HP Balloon Dilatation Catheter for Balloon Dilatation of Coronary Artery Stenosis", "status": "COMPLETED", "start": "2022-12-27", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "BrosMed Medical Co., Ltd", "conditions": ["Coronary Artery Disease"], "cn_sites": [{"facility": "The Seventh People's Hospital of Zhengzhou", "city": "Zhenzhou", "status": ""}, {"facility": "Renmin Hospital of Wuhan University Hubei General Hospital", "city": "Wuhan", "status": ""}, {"facility": "Shanxi Cardiovascular Hospital", "city": "Taiyuan", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT05929313", "title": "Scoreflex TRIO - Scoring PTCA Catheter", "status": "COMPLETED", "start": "2023-04-27", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 210, "sponsor": "OrbusNeich", "conditions": ["Coronary Arteriosclerosis"], "cn_sites": [{"facility": "Sir Run Run Shaw Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Tong Ren Hospital Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Zhongshan Hospital Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 4, "broad_only": false}], "g_total": 19, "g_fetched": 12, "g_countries": [["United Kingdom", 2], ["Mexico", 1], ["Hong Kong", 1], ["Slovenia", 1], ["Spain", 1], ["Jordan", 1], ["Netherlands", 1], ["Turkey (Türkiye)", 1]], "g_trials": [{"nct": "NCT07692594", "title": "Heart and Blood Vessels Health in People With Cystic Fibrosis", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Liverpool Heart and Chest Hospital NHS Foundation Trust", "countries": ["United Kingdom"]}, {"nct": "NCT05692115", "title": "Ischemia and Inflammatory Markers Among Patients With Coronary Artery Ectasia", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT07511257", "title": "Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia", "status": "RECRUITING", "start": "2026-02-11", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Instituto Nacional de Cardiologia Ignacio Chavez", "countries": ["Mexico"]}, {"nct": "NCT07311512", "title": "PMPR and Chlorhexidine on Periodontal Disease and Vascular Function", "status": "RECRUITING", "start": "2026-01-23", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Mahdi Mutahar", "countries": ["United Kingdom"]}, {"nct": "NCT06631157", "title": "Essential Pro Study ( rEPIC04E-HK )", "status": "RECRUITING", "start": "2025-05-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fundación EPIC", "countries": ["Hong Kong"]}, {"nct": "NCT06926400", "title": "The Effectiveness and Safety of the Coronary Artery Serrated Cutting Balloon Dilation Catheter in the Pre-dilation of Coronary Artery Stenosis Lesions", "status": "NOT_YET_RECRUITING", "start": "2025-04-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "JW Medical Systems Ltd", "countries": []}, {"nct": "NCT07245069", "title": "Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients", "status": "RECRUITING", "start": "2025-02-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University Medical Centre Ljubljana", "countries": ["Slovenia"]}, {"nct": "NCT06788275", "title": "Aerobic Exercise-induced Effect on Endothelial Function in Patients With Ischaemic Heart Disease", "status": "RECRUITING", "start": "2024-11-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Instituto de Investigación Sanitaria y Biomédica de Alicante", "countries": ["Spain"]}, {"nct": "NCT05213429", "title": "Middle East Coronary Artery Ectasia Registry", "status": "RECRUITING", "start": "2024-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Jordanian Research and Artificial Intelligence Group", "countries": ["Jordan"]}, {"nct": "NCT06385067", "title": "Treatment of Primary Coronary Artery Vascular Lesions With Biolimus Coated Coronary Balloon Dilation Catheter", "status": "NOT_YET_RECRUITING", "start": "2024-05-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "JW Medical Systems Ltd", "countries": []}, {"nct": "NCT06558474", "title": "Optimization of Percutaenous Coronary Intervention With Liberal Use of Post-dilatation", "status": "RECRUITING", "start": "2023-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Cathreine BV", "countries": ["Netherlands"]}, {"nct": "NCT05897333", "title": "Turkish Isolated Coronary Ectasia Registry: The T-ICE Registry", "status": "RECRUITING", "start": "2022-03-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Gazi University", "countries": ["Turkey (Türkiye)"]}]}, {"batch": 1, "no": 25, "name_zh": "先天性纯红细胞再生障碍性贫血", "query_terms": [{"term": "Diamond-Blackfan anemia", "broad": false}], "n_total": 2, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT00171821", "title": "A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron Overload", "status": "COMPLETED", "start": "2005-04", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1784, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Transfusion-dependent Iron Overload"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Nanjing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT00600938", "title": "Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload", "status": "COMPLETED", "start": "2007-11", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 197, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Transfusional Iron Overload", "Transfusional Hemosiderosis"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Nanning", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 11, "g_fetched": 11, "g_countries": [["United States", 10], ["France", 1]], "g_trials": [{"nct": "NCT07186179", "title": "Mobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS)", "status": "RECRUITING", "start": "2026-06-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Northwell Health", "countries": ["United States"]}, {"nct": "NCT07476183", "title": "Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient Diamond-Blackfan Anemia", "status": "RECRUITING", "start": "2026-04-16", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Apriligen, Inc.", "countries": ["United States"]}, {"nct": "NCT04099966", "title": "AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion", "status": "RECRUITING", "start": "2021-04-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Mitchell Cairo", "countries": ["United States"]}, {"nct": "NCT04528355", "title": "Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC", "status": "RECRUITING", "start": "2020-08-20", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Paul Szabolcs", "countries": ["United States"]}, {"nct": "NCT03653338", "title": "T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias", "status": "RECRUITING", "start": "2018-08-02", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Paul Szabolcs", "countries": ["United States"]}, {"nct": "NCT03050268", "title": "Familial Investigations of Childhood Cancer Predisposition", "status": "RECRUITING", "start": "2017-04-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "St. Jude Children's Research Hospital", "countries": ["United States"]}, {"nct": "NCT04781790", "title": "French National Registry of Bone Marrow Failures", "status": "RECRUITING", "start": "2017-02-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT02720679", "title": "Investigation of the Genetics of Hematologic Diseases", "status": "RECRUITING", "start": "2016-06-17", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "St. Jude Children's Research Hospital", "countries": ["United States"]}, {"nct": "NCT01962415", "title": "Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT", "status": "RECRUITING", "start": "2014-02-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Paul Szabolcs", "countries": ["United States"]}, {"nct": "NCT00106015", "title": "Diamond Blackfan Anemia Registry (DBAR)", "status": "RECRUITING", "start": "2004-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Northwell Health", "countries": ["United States"]}, {"nct": "NCT00027274", "title": "Cancer in Inherited Bone Marrow Failure Syndromes", "status": "RECRUITING", "start": "2001-11-28", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["United States"]}]}, {"batch": 1, "no": 26, "name_zh": "Erdheim-Chester病", "query_terms": [{"term": "Erdheim-Chester disease", "broad": false}], "n_total": 2, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT04198818", "title": "A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors", "status": "TERMINATED", "start": "2020-01-07", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 37, "sponsor": "Haihe Biopharma Co., Ltd.", "conditions": ["Advanced Tumors", "Melanoma", "Non-Small-Cell Lung Cancer", "Erdheim-Chester Disease", "Other RAS/RAF/MEK/ERK Mutated Tumors"], "cn_sites": [{"facility": "Shanghai East hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05092815", "title": "The Efficacy and Safety of HLX208 in Adult Langerhans Cell Histiocytosis (LCH) and Erdheim-Chester Disease (ECD) With BRAF V600E Mutation", "status": "UNKNOWN", "start": "2021-12-06", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 25, "sponsor": "Shanghai Henlius Biotech", "conditions": ["Langerhans Cell Histiocytosis", "Erdheim-Chester Disease", "LCH", "ECD"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 11, "g_fetched": 11, "g_countries": [["United States", 8], ["United Kingdom", 3], ["Italy", 2], ["France", 1], ["Argentina", 1], ["Canada", 1], ["Czechia", 1], ["Germany", 1], ["Netherlands", 1], ["Poland", 1], ["Spain", 1]], "g_trials": [{"nct": "NCT07440290", "title": "DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.", "status": "RECRUITING", "start": "2026-04-01", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Cancer Research UK", "countries": ["United Kingdom"]}, {"nct": "NCT07173010", "title": "Pediatric Arthropathy Beyond Inflammation: Clinical Spectrum and Diagnostic Approach at Assiut University Children Hospital", "status": "NOT_YET_RECRUITING", "start": "2025-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT06712810", "title": "Q702 for the Treatment of Patients With Hematologic Malignancies", "status": "RECRUITING", "start": "2025-08-27", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Mayo Clinic", "countries": ["United States"]}, {"nct": "NCT07454343", "title": "ECD-Score: a Study on Erdheim-Chester Disease", "status": "RECRUITING", "start": "2024-12-23", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Meyer Children's Hospital IRCCS", "countries": ["France", "Italy", "United Kingdom", "United States"]}, {"nct": "NCT05768178", "title": "DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.", "status": "RECRUITING", "start": "2023-03-01", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Cancer Research UK", "countries": ["United Kingdom"]}, {"nct": "NCT05915208", "title": "Histiocytic Disorder Follow-up Study", "status": "RECRUITING", "start": "2022-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Alabama at Birmingham", "countries": ["United States"]}, {"nct": "NCT05093335", "title": "In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET", "status": "RECRUITING", "start": "2021-10-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Memorial Sloan Kettering Cancer Center", "countries": ["United States"]}, {"nct": "NCT04079179", "title": "Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders", "status": "RECRUITING", "start": "2021-04-19", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Carl Allen", "countries": ["United States"]}, {"nct": "NCT03990428", "title": "Supportive Care Needs of Caregivers of People With Erdheim-Chester Disease and Other Histiocytic Diseases", "status": "RECRUITING", "start": "2019-06-14", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Memorial Sloan Kettering Cancer Center", "countries": ["United States"]}, {"nct": "NCT03329274", "title": "Registry for Patients With Erdheim-Chester Disease and Other Histiocytoses", "status": "RECRUITING", "start": "2017-10-26", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Memorial Sloan Kettering Cancer Center", "countries": ["United States"]}, {"nct": "NCT02285582", "title": "International Rare Histiocytic Disorders Registry (IRHDR)", "status": "RECRUITING", "start": "2014-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "The Hospital for Sick Children", "countries": ["Argentina", "Canada", "Czechia", "Germany", "Italy", "Netherlands", "Poland", "Spain", "United States"]}]}, {"batch": 1, "no": 27, "name_zh": "法布雷病", "query_terms": [{"term": "Fabry disease", "broad": false}], "n_total": 15, "n_open": 7, "n_open_precise": 7, "n_broad": 0, "trials": [{"nct": "NCT00196742", "title": "Fabry Disease Registry & Pregnancy Sub-registry", "status": "RECRUITING", "start": "2001-07-31", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 9000, "sponsor": "Genzyme, a Sanofi Company", "conditions": ["Fabry Disease"], "cn_sites": [{"facility": "Investigational Site Number : 153165", "city": "Beijing", "status": "TERMINATED"}, {"facility": "Investigational Site Number : 1560003", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560002", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560004", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 153163", "city": "Shanghai", "status": "TERMINATED"}, {"facility": "Investigational Site Number : 1560001", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT07336394", "title": "Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques", "status": "RECRUITING", "start": "2010-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "Chinese Academy of Medical Sciences, Fuwai Hospital", "conditions": ["Danon Disease", "Fabry Disease", "Cardiac Amyloidosis", "Noonan Syndrome", "Cardiac Sarcoidosis", "Glycogen Storage Disease", "Idiopathic Cardiomyopathy"], "cn_sites": [{"facility": "Fuwai Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06207552", "title": "Evaluation of the Safety, Tolerability and Efficacy of a Gene Therapy Drug for the Treatment of Pediatric Fabry Disease", "status": "RECRUITING", "start": "2024-02-20", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Children's Hospital of Fudan University", "conditions": ["Fabry Disease"], "cn_sites": [{"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06539624", "title": "Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease", "status": "RECRUITING", "start": "2024-10-16", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "The Children's Hospital of Zhejiang University School of Medicine", "conditions": ["Fabry Disease"], "cn_sites": [{"facility": "Shanghai Children's Medical Center", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Children's Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06512571", "title": "CVI Alterations in FD: a Prospective, Multicenter, Observational Cohort Study", "status": "RECRUITING", "start": "2024-12-31", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 300, "sponsor": "China National Center for Cardiovascular Diseases", "conditions": ["Fabry Disease, Cardiac Variant"], "cn_sites": [{"facility": "Fuwai Hospital, National Centre for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06819514", "title": "The Safety and Efficacy of Intravenous EXG110 in Patients With Fabry Disease", "status": "NOT_YET_RECRUITING", "start": "2025-03-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 16, "sponsor": "Guangzhou Jiayin Biotech Ltd", "conditions": ["Fabry Disease"], "cn_sites": [{"facility": "General Hospital of Eastern Theater Command", "city": "Nanjing", "status": ""}, {"facility": "Children's Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "First Affiliated Hospital of Zhejiang University", "city": "Hangzhou", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07187440", "title": "A Study of Agalsidase Alfa Enyzme Replacement Therapy in Chinese Children and Adults With Fabry Disease", "status": "RECRUITING", "start": "2025-11-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Takeda", "conditions": ["Fabry Disease"], "cn_sites": [{"facility": "The First Affiliated Hospital Of USTC (AnHui Provincial Hospital)", "city": "Hefei", "status": "NOT_YET_RECRUITING"}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Fuzhou University Provincial Affiliated Hospital", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital ZheJiang University School Of Medicine", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "ShanTou Central Hospital", "city": "Shantou", "status": "RECRUITING"}, {"facility": "The University Of Hong Kong-ShenZhen Hospital", "city": "Shenzhen", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Harbin Medical University", "city": "Harbin", "status": "NOT_YET_RECRUITING"}, {"facility": "Affiliated Drum Tower Hospital, Medical School of Nanjing University", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital With NanJing Medical University(JiangSu Province Hospital)", "city": "Nanjing", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital Of Soochow University", "city": "Suzhou", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Xi 'an Jiaotong University", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Xi 'an Jiaotong University", "city": "Xi'an", "status": "NOT_YET_RECRUITING"}, {"facility": "Second Hospital Of ShanXi Medical University", "city": "Taiyuan", "status": "NOT_YET_RECRUITING"}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}, {"facility": "TianJin Chest Hospital", "city": "Tianjin", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 18, "broad_only": false}, {"nct": "NCT04965467", "title": "Fabry Aim Children Early (ACE) Project", "status": "WITHDRAWN", "start": "2021-07-27", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 0, "sponsor": "Children's Hospital of Fudan University", "conditions": ["Fabry Disease"], "cn_sites": [{"facility": "Anhui Provincial Children's Hospital", "city": "Hefei", "status": ""}, {"facility": "Beijing children's hospital，capital medical university", "city": "Beijing", "status": ""}, {"facility": "Children's Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "First Affiliated Hospital, Sun Yat-Sen University", "city": "Guangzhou", "status": ""}, {"facility": "Children's Hospital of Hebei Province", "city": "Hebei", "status": ""}, {"facility": "Children's Hospital Affiliated to Zhengzhou University/Henan Children's Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Wuhan Children's Hospital,Tongji Medical College, Huazhong University of Science and Technology.", "city": "Wuhan", "status": ""}, {"facility": "Hunan Children's Hospital", "city": "Hunan", "status": ""}, {"facility": "Inner Mongolia Maternity and Child Healthcare Hospital", "city": "Hohhot", "status": ""}, {"facility": "Children's Hospital of Nanjing Medical University", "city": "Nanjing", "status": ""}, {"facility": "Kunming Children's Hospital", "city": "Kunming", "status": ""}, {"facility": "Shandong Provincal Hospital", "city": "Shandong", "status": ""}, {"facility": "Shanxi Provincial Maternity and Children's Hospital", "city": "Shanxi", "status": ""}, {"facility": "West China Second University Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Sichuan provincial maternity and child health care hospital", "city": "Sichuan", "status": ""}, {"facility": "Tianjin Children's Hospital", "city": "Tianjin", "status": ""}, {"facility": "Xiamen Maternal and Child Care Hospital", "city": "Xiamen", "status": ""}, {"facility": "Xian Children's Hospital", "city": "Xi'an", "status": ""}, {"facility": "Xinjiang Urumqi Children's Hospital.", "city": "Xinjiang", "status": ""}, {"facility": "The Children's Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 21, "broad_only": false}, {"nct": "NCT05054387", "title": "China Post-marketing Surveillance (PMS) Study of Fabrazyme®", "status": "COMPLETED", "start": "2021-10-13", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 22, "sponsor": "Genzyme, a Sanofi Company", "conditions": ["Fabry Disease"], "cn_sites": [{"facility": "Investigational Site Number :1560003", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number :1560002", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number :1560001", "city": "Shanghai", "status": ""}, {"facility": "Investigational Site Number :1560004", "city": "Shanghai", "status": ""}, {"facility": "Investigational Site Number :1560006", "city": "Taiyuan", "status": ""}, {"facility": "Investigational Site Number :1560005", "city": "Wuhan", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT05206773", "title": "A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age With Fabry Disease", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-03-11", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 122, "sponsor": "Sanofi", "conditions": ["Fabry Disease"], "cn_sites": [{"facility": "No.8, Xishiku Street, Xicheng District_Site Number: 1560001", "city": "Beijing", "status": ""}, {"facility": "No.197,2nd Ruijin road, Huangpu district_Site Number: 1560003", "city": "Shanghai", "status": ""}, {"facility": "No.85 South Jiefang road, Yingze District_Site Number: 1560004", "city": "Taiyuan", "status": ""}, {"facility": "Investigational Site Number : 1560006", "city": "Zhengzhou", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT04974749", "title": "A Study of REPLAGAL® in Treatment-naive Chinese Participants With Fabry Disease", "status": "COMPLETED", "start": "2022-05-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Takeda", "conditions": ["Fabry Disease"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Xiangya Hospital, Central South University", "city": "Changsha", "status": ""}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "The Children's Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Shandong Provincial Hospital", "city": "Jinan", "status": ""}, {"facility": "Ruijin Hospital, Shanghai Jiaotong Uni. School of Med.", "city": "Shanghai", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT05280548", "title": "A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-05-03", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 104, "sponsor": "Sanofi", "conditions": ["Fabry Disease"], "cn_sites": [{"facility": "Investigational Site Number : 1560002", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560005", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560001", "city": "Chengdu", "status": ""}, {"facility": "Investigational Site Number : 1560007", "city": "Guangzhou", "status": ""}, {"facility": "Investigational Site Number : 1560003", "city": "Shanghai", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT05719337", "title": "Multi-Modality Echocardiographic Techniques in Pathological Left Ventricular Hypertrophy Adults", "status": "UNKNOWN", "start": "2023-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 660, "sponsor": "First Hospital of China Medical University", "conditions": ["Left Ventricular Hypertrophy"], "cn_sites": [{"facility": "the Second Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": "RECRUITING"}, {"facility": "the First Affiliated Hospital of Jiamusi University", "city": "Jiamusi", "status": "RECRUITING"}, {"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "the Affiliated Hospital of Inner Mongolia Medical University", "city": "Hohhot", "status": "RECRUITING"}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Ansteel Group General Hospita", "city": "Anshan", "status": "RECRUITING"}, {"facility": "Benxi Central Hospital", "city": "Benxi", "status": "RECRUITING"}, {"facility": "Chaoyang Central Hospital", "city": "Chaoyang", "status": "RECRUITING"}, {"facility": "Dalian Municipal Central Hospital", "city": "Dalian", "status": "RECRUITING"}, {"facility": "the Second Hospital of Dalian Medical University", "city": "Dalian", "status": "RECRUITING"}, {"facility": "Dandong Central Hospital", "city": "Dandong", "status": "RECRUITING"}, {"facility": "Fushun Central Hospital", "city": "Fushun", "status": "RECRUITING"}, {"facility": "the First Affiliated Hospital of Jinzhou Medical University", "city": "Jinzhou", "status": "RECRUITING"}, {"facility": "Affiliated Central Hospital of Shenyang Medical College", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Dadong Branch of First Affiliated Hospital of China Medical University", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Liaoning Cancer Hospital & Institute", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "the First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "the First Hospital of China Medical Univeristy", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "the Second Affiliated Hospital of Shenyang Medical College", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Liao Jian Group Tie Mei General Hospital", "city": "Tieling", "status": "RECRUITING"}, {"facility": "Tieling Central Hospital", "city": "Tieling", "status": "RECRUITING"}, {"facility": "Tianjin Chest Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 22, "broad_only": false}, {"nct": "NCT06169358", "title": "Screening Patients With Fabry Disease in Patients With Hypertrophic Cardiomyopathy or Left Ventricular Hypertrophy", "status": "UNKNOWN", "start": "2023-10-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 627, "sponsor": "Qilu Hospital of Shandong University", "conditions": ["Hypertrophic Cardiomyopathy", "Left Ventricular Hypertrophy", "Fabry Disease"], "cn_sites": [{"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06114329", "title": "Study of the Safety and Biologic Activity of AL01211 in Treatment Naive Males With Classic Fabry Disease", "status": "UNKNOWN", "start": "2023-10-25", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 16, "sponsor": "AceLink Therapeutics, Inc.", "conditions": ["Fabry Disease"], "cn_sites": [{"facility": "The First Affiliated Hospital of Sun Yat sen University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Ruijin Hospital, Shanghai Jiaotong University School Of Medicine", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 6, "broad_only": false}], "g_total": 45, "g_fetched": 38, "g_countries": [["United States", 10], ["Italy", 7], ["United Kingdom", 5], ["France", 4], ["Germany", 4], ["Spain", 3], ["Taiwan", 3], ["Japan", 2], ["South Korea", 2], ["Denmark", 2], ["Canada", 2], ["Romania", 1], ["Belgium", 1], ["Austria", 1], ["Norway", 1], ["Argentina", 1], ["Slovenia", 1], ["India", 1], ["Australia", 1]], "g_trials": [{"nct": "NCT07778667", "title": "A Study to Learn How Well Lucerastat Works and How Safe it is in Untreated Adult Male Participants With Fabry Disease", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Idorsia Pharmaceuticals Ltd.", "countries": []}, {"nct": "NCT07109375", "title": "Observational Study on Long-term Use of Pegunigalsidase Alfa in Fabry Patients in a Real-world Setting", "status": "RECRUITING", "start": "2026-06-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Chiesi Italia", "countries": ["Italy"]}, {"nct": "NCT07575347", "title": "Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)", "status": "RECRUITING", "start": "2026-05-04", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Stefan Lujinschi", "countries": ["Romania"]}, {"nct": "NCT07485660", "title": "Care Pathway for Patients With Fabry's Disease (Fabry-PATH)", "status": "NOT_YET_RECRUITING", "start": "2026-04", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Toulouse", "countries": ["France"]}, {"nct": "NCT06906367", "title": "A Study of Patients With Fabry Disease (US Specific)", "status": "RECRUITING", "start": "2026-02-13", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Amicus Therapeutics", "countries": ["United States"]}, {"nct": "NCT06904261", "title": "A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants", "status": "RECRUITING", "start": "2026-01-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Amicus Therapeutics", "countries": ["Belgium", "Germany", "Japan", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT07351136", "title": "Novel Diagnostic and Prognostic Predictors in Fabry Cardiomyopathy: Proof of Concept in a Rare Disease", "status": "NOT_YET_RECRUITING", "start": "2026-01-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Núcleo de Apoio à Investigação Clínica - FMUP", "countries": []}, {"nct": "NCT07235709", "title": "Effect of Agalsidase Alfa on Cardiac Inflammation in Patients With Fabry Disease: A [18F]-FDG PET-CMR Study", "status": "RECRUITING", "start": "2025-11-12", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Yonsei University", "countries": ["South Korea"]}, {"nct": "NCT06328608", "title": "A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease", "status": "RECRUITING", "start": "2025-07-29", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Chiesi Farmaceutici S.p.A.", "countries": ["Austria", "France", "Norway", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT07382128", "title": "Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes", "status": "RECRUITING", "start": "2025-06-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS Azienda Ospedaliero-Universitaria di Bologna", "countries": ["Italy"]}, {"nct": "NCT06941025", "title": "Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding", "status": "RECRUITING", "start": "2025-05-23", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Chiesi Farmaceutici S.p.A.", "countries": ["Germany", "Italy", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT06858397", "title": "A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease", "status": "RECRUITING", "start": "2025-05-14", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "GC Biopharma Corp", "countries": ["Argentina", "South Korea", "United States"]}, {"nct": "NCT06956573", "title": "Aortic Dimensions in Patients With Fabry Disease", "status": "NOT_YET_RECRUITING", "start": "2025-05-02", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Caen", "countries": []}, {"nct": "NCT06776419", "title": "the Role of cArdiac Inflammation, endoThelial Dysfunction, and FIbrosis in fabrY Disease", "status": "RECRUITING", "start": "2025-05-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Caroline Michaela Kistorp", "countries": ["Denmark"]}, {"nct": "NCT04252066", "title": "A Global Prospective Observational Study of Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding", "status": "RECRUITING", "start": "2025-03-18", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Amicus Therapeutics", "countries": ["United States"]}, {"nct": "NCT06884358", "title": "Functional Capacity in Anderson-Fabry Disease Patients", "status": "RECRUITING", "start": "2024-11-13", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS Policlinico S. Donato", "countries": ["Italy"]}, {"nct": "NCT06663358", "title": "A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients", "status": "RECRUITING", "start": "2024-11-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Chiesi Farmaceutici S.p.A.", "countries": ["Slovenia", "United Kingdom", "United States"]}, {"nct": "NCT07277361", "title": "Study of the Quality of Life of Patients With Fabry Disease Aged 65 and Over With and Without Specific Treatment", "status": "RECRUITING", "start": "2024-10-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Wladimir MAUHIN, Dr", "countries": ["France"]}, {"nct": "NCT06270316", "title": "Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease", "status": "RECRUITING", "start": "2024-06-05", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "UniQure Biopharma B.V.", "countries": ["United States"]}, {"nct": "NCT06325488", "title": "Fibrosis, Inflammation, Oxygenation of Renal Tissue In FabrY Disease", "status": "RECRUITING", "start": "2024-06-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Caroline Michaela Kistorp", "countries": ["Denmark"]}, {"nct": "NCT05698901", "title": "Biomarkers and Cardiac Imaging Diagnostic Assay for Monitoring Patients With Fabry Disease", "status": "RECRUITING", "start": "2023-09-19", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Mackay Memorial Hospital", "countries": ["Taiwan"]}, {"nct": "NCT05710692", "title": "Study to Evaluate the Safety, PK, PD, and Efficacy of PRX-102 in Japanese Patients With Fabry Disease", "status": "RECRUITING", "start": "2023-08-01", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Chiesi Farmaceutici S.p.A.", "countries": ["Japan"]}, {"nct": "NCT06610019", "title": "Cardiovascular Multimodality Imaging Study", "status": "RECRUITING", "start": "2023-05-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Montefiore Medical Center", "countries": ["United States"]}, {"nct": "NCT06813443", "title": "Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation", "status": "RECRUITING", "start": "2023-02-13", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS Azienda Ospedaliero-Universitaria di Bologna", "countries": ["Italy"]}, {"nct": "NCT05067868", "title": "A Study of Replagal in Children and Adults With Fabry Disease in India", "status": "RECRUITING", "start": "2022-11-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Shire", "countries": ["India"]}]}, {"batch": 1, "no": 28, "name_zh": "家族性地中海热", "query_terms": [{"term": "Familial Mediterranean fever", "broad": false}], "n_total": 19, "n_open": 6, "n_open_precise": 6, "n_broad": 0, "trials": [{"nct": "NCT07077473", "title": "Observing the Efficacy and Safety of Different Drugs Used in Real-world Familial Mediterranean Fever (FMF) Cases", "status": "RECRUITING", "start": "2018-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 12, "sponsor": "Tongji Hospital", "conditions": ["Familial Mediterranean Fever (FMF )"], "cn_sites": [{"facility": "Tongji Hospital", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05200715", "title": "AutoInflammatory Disease Alliance Registry (AIDA)", "status": "RECRUITING", "start": "2020-08-06", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 3500, "sponsor": "University of Siena", "conditions": ["Hereditary Autoinflammatory Diseases", "Schnitzler Syndrome", "Behcet Syndrome", "PFAPA Syndrome", "Still Disease", "Autoinflammatory Syndrome, Unspecified", "Uveitis", "Scleritis", "Vexas Syndrome", "Spondyloarthritis (SpA)", "Castleman Disease"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05845723", "title": "Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome", "status": "RECRUITING", "start": "2023-06-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 81, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Aneurysm", "Behcet Syndrome, Vascular Type"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06145893", "title": "A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease", "status": "RECRUITING", "start": "2023-11-13", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 162, "sponsor": "Ganzhou Hemay Pharmaceutical Co., Ltd", "conditions": ["Behçet's Disease"], "cn_sites": [{"facility": "Beijing Friendship hospital capital medical hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking university first hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking university third hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Xuanwu hospital capital medical university", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The first affiliated hospital of Xiamen University", "city": "Xiamen", "status": "RECRUITING"}, {"facility": "Guangdong second provincial central hospital", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Sun Yat-Sen memorial hospital", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "The third affiliated hospital sun yat-sen university", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "The university of Hong Kong-Shenzhen Hospital", "city": "Shenzhen", "status": "RECRUITING"}, {"facility": "Affiliated hospital of Guilin Medical university", "city": "Guilin", "status": "RECRUITING"}, {"facility": "The second hospital of Hebei medical university", "city": "Shijiazhuang", "status": "NOT_YET_RECRUITING"}, {"facility": "Xinxiang Central hospital", "city": "Xinxiang", "status": "RECRUITING"}, {"facility": "The first affiliated hospital of Nanchang university", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "The first affiliated hospital of Soochow university", "city": "Suzhou", "status": "RECRUITING"}, {"facility": "The affiliated hospital of Xuzhou medical university", "city": "Xuzhou", "status": "RECRUITING"}, {"facility": "Jilin Province People's hospital", "city": "Changchun", "status": "RECRUITING"}, {"facility": "Linyi People's Hospital", "city": "Linyi", "status": "NOT_YET_RECRUITING"}, {"facility": "Tongji hospital of Tongji university", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Second hospital of shanxi medical university", "city": "Taiyuan", "status": "NOT_YET_RECRUITING"}, {"facility": "The first affiliated hospital, Zhejiang University school of medicine", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "The first affiliated hospital of Wenzhou Medical university", "city": "Wenzhou", "status": "RECRUITING"}], "cn_site_count": 22, "broad_only": false}, {"nct": "NCT06849908", "title": "Baricitinib in the Treatment of Intestinal Behçet's Syndrome", "status": "RECRUITING", "start": "2024-11-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 56, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Behcet Syndrome, Intestinal Type"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06794008", "title": "BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2024-12-26", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Peking University People's Hospital", "conditions": ["Systemic Lupus Erythematosus", "Inflammatory Myopathy", "Systemic Sclerosis (SSc)", "ANCA-associated Vasculitis", "IgG4-Related Diseases", "Antiphospholipid Syndrome", "Acquired Thrombotic Thrombocytopenic Purpura", "Behcet Disease", "Sjogren Syndrome"], "cn_sites": [{"facility": "Department of Rheumatology and Immunology, Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03209219", "title": "Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease Uveitis", "status": "COMPLETED", "start": "2017-06-30", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 28, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Behçet Disease", "Uveitis"], "cn_sites": [{"facility": "Peking Union Medical College", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03554161", "title": "Tocilizumab for the Treatment of Refractory Behcet's Uveitis", "status": "TERMINATED", "start": "2018-05-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 3, "sponsor": "Wenjie Zheng", "conditions": ["Behcet Syndrome", "Uveitis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03566615", "title": "Does the Cap Increase the Finding of Polyps When Water Exchange Colonoscopy is Used", "status": "UNKNOWN", "start": "2018-07-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 1630, "sponsor": "VA Greater Los Angeles Healthcare System", "conditions": ["Colonoscopy", "Polyp of Colon"], "cn_sites": [{"facility": "Xijing Hospital of Digestive Diseases", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03923140", "title": "A Clinical Study of Tranilast in the Treatment of Cryopyrin-Associated Periodic Syndrome (CAPS)", "status": "UNKNOWN", "start": "2019-05-23", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 71, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Cryopyrin-Associated Periodic Syndromes"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04101604", "title": "Biomarkers of Common Eye Diseases", "status": "UNKNOWN", "start": "2019-09-26", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 220, "sponsor": "Sun Yat-sen University", "conditions": ["Uveitis", "Diabetic Retinopathy", "Age-related Macular Degeneration", "Polypoidal Choroidal Vasculopathy", "VKH Syndrome", "Behçet Disease"], "cn_sites": [{"facility": "Zhognshan Ophthalmic Center, Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04218565", "title": "Golimumab for the Treatment of Refractory Behcet's Uveitis", "status": "TERMINATED", "start": "2020-02-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 1, "sponsor": "Wenjie Zheng", "conditions": ["Behcet Syndrome", "Uveitis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04609397", "title": "A Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Behçet Disease", "status": "TERMINATED", "start": "2020-11-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 89, "sponsor": "Tianjin Hemay Pharmaceutical Co., Ltd", "conditions": ["Behçet Disease"], "cn_sites": [{"facility": "The First Affiliated Hospital of Bengbu Medical College", "city": "Bengbu", "status": ""}, {"facility": "Anhui provincial hospital", "city": "Hefei", "status": ""}, {"facility": "Beijing hospital", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University Shougang Hospital", "city": "Beijing", "status": ""}, {"facility": "Xuanwu Hospital Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital of Xiamen University", "city": "Xiamen", "status": ""}, {"facility": "Sun Yat-Sen Memorial Hospital,Sun Yat-Sen University", "city": "Guangzhou", "status": ""}, {"facility": "The University of Hong Kong-Shenzhen Hospital", "city": "Shenzhen", "status": ""}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": ""}, {"facility": "The Second Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "The First Affiliated Hospital of Baotou Medical College of Inner Mongolia University of science and technology", "city": "Baotou", "status": ""}, {"facility": "Jiangsu Provincial Hospital", "city": "Nanjing", "status": ""}, {"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "The Affiliated Hospital of Xuzhou Medical University", "city": "Xuzhou", "status": ""}, {"facility": "Jiu Jiang NO.1 people's Hospital", "city": "Jiujiang", "status": ""}, {"facility": "Jiangxi Pingxiang people's Hospital", "city": "Pingxiang", "status": ""}, {"facility": "China-Japan Union Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Jilin Provincial People's Hospital", "city": "Changchun", "status": ""}, {"facility": "Linyi people's Hospital", "city": "Linyi", "status": ""}, {"facility": "Huashan Hospital Affiliated to Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Renji Hospital, Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Tongji Hospital Of Tongji University Tang Jianping", "city": "Shanghai", "status": ""}, {"facility": "Zhongshan Hospital Affiliated to Fudan University", "city": "Shanghai", "status": ""}, {"facility": "The First Affiliated Hospital of Chengdu Medical College", "city": "Chengdu", "status": ""}, {"facility": "People's Hospital of Xinjiang Uygur Autonomous Region", "city": "Ürümqi", "status": ""}, {"facility": "First Affiliated Hospital，Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Provincial People's Hospital", "city": "Hangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": ""}], "cn_site_count": 31, "broad_only": false}, {"nct": "NCT05027373", "title": "Safety, Tolerability and Pharmacokinetic of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection", "status": "UNKNOWN", "start": "2021-08-13", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 34, "sponsor": "Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.", "conditions": ["Systemic Juvenile Idiopathic Arthritis", "Periodic Fever Syndrome"], "cn_sites": [{"facility": "Shanghai Xuhui District Central Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04065672", "title": "Low-dose IL-2 Treatment on Behcet's Disease", "status": "COMPLETED", "start": "2021-10-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "HeJing", "conditions": ["Behcet's Disease"], "cn_sites": [{"facility": "Department of Rheumatology and Immunology, Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06026020", "title": "Pathogenesis of Intestinal Behcet's Syndrome", "status": "UNKNOWN", "start": "2023-09", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 80, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Behcet's Syndrome, Intestinal Type"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07080346", "title": "Upadacitinib for Refractory Behcet's Syndrome", "status": "COMPLETED", "start": "2024-01-25", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 27, "sponsor": "Liu Tian", "conditions": ["Behcet Syndrome"], "cn_sites": [{"facility": "Department of Rheumatology and Immunology, Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07582991", "title": "Ustekinumab for Intestinal Behçet's Syndrome With Myelodysplastic Syndrome", "status": "COMPLETED", "start": "2024-03-24", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 8, "sponsor": "Liu Tian", "conditions": ["Behcet's Syndrome, Intestinal Type", "Myelodysplastic Syndrome"], "cn_sites": [{"facility": "Department of Rheumatology and Immunology, Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07634848", "title": "Ivarmacitinib for Refractory Behcet's Syndrome", "status": "WITHDRAWN", "start": "2026-06-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Liu Tian", "conditions": ["Behcet's Syndrome"], "cn_sites": [{"facility": "Department of Rheumatology and Immunology, Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 57, "g_fetched": 51, "g_countries": [["Turkey (Türkiye)", 11], ["France", 10], ["Egypt", 8], ["United States", 8], ["Italy", 4], ["Spain", 3], ["Switzerland", 2], ["Canada", 2], ["United Kingdom", 2], ["Netherlands", 2], ["Armenia", 2], ["Greece", 2], ["Israel", 2], ["South Korea", 1], ["Australia", 1], ["Austria", 1], ["Bulgaria", 1], ["Croatia", 1], ["Czechia", 1], ["Germany", 1], ["Hungary", 1], ["Japan", 1], ["Norway", 1], ["Poland", 1], ["Portugal", 1], ["Romania", 1], ["Taiwan", 1], ["Russia", 1]], "g_trials": [{"nct": "NCT07157189", "title": "Clinical, Laboratory, and Therapeutic Analysis of Behçet's Disease in Assiut", "status": "NOT_YET_RECRUITING", "start": "2026-09-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT07737470", "title": "Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": []}, {"nct": "NCT07803198", "title": "Asprosin in Behect Patients", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT07617558", "title": "Validity and Reliability of the International Physical Fitness Questionnaire and the Self-Perceived Health-Related Physical Fitness Questionnaire in Children and Adolescents With JIA and FMF", "status": "NOT_YET_RECRUITING", "start": "2026-07-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Istanbul University - Cerrahpasa", "countries": []}, {"nct": "NCT07702149", "title": "Diet Restiction in Subjects With Behcet Disease and Complaint of Tinnitus", "status": "RECRUITING", "start": "2026-06-04", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Cairo University", "countries": ["Egypt"]}, {"nct": "NCT07702123", "title": "Efficacy of Physical Activity Program in Metabolic-syndrome Females With Behcet Disease", "status": "RECRUITING", "start": "2026-06-02", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Cairo University", "countries": ["Egypt"]}, {"nct": "NCT07662603", "title": "Behcet Disease Patients With Pulmonary Endoarterectomy: Outcomes of Program of Inspiratory Msucle Trianing", "status": "RECRUITING", "start": "2026-05-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Cairo University", "countries": ["Egypt"]}, {"nct": "NCT07476625", "title": "Efficacy and Safety of Thalidomide for Pediatric PFAPA Syndrome", "status": "NOT_YET_RECRUITING", "start": "2026-04-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Wenjie Zheng", "countries": []}, {"nct": "NCT07517250", "title": "A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients", "status": "RECRUITING", "start": "2026-03-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": ["Switzerland"]}, {"nct": "NCT06544018", "title": "Circadian Rhythm Deregulation in Patients With CAPS", "status": "RECRUITING", "start": "2026-02-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Hospices Civils de Lyon", "countries": ["France"]}, {"nct": "NCT07247266", "title": "Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of JTE-162 in Subjects With Cryopyrin-Associated Periodic Syndrome (CAPS)", "status": "RECRUITING", "start": "2026-02-02", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Akros Pharma Inc.", "countries": ["Canada"]}, {"nct": "NCT07439341", "title": "AGE and CALLY Index in Familial Mediterranean Fever", "status": "NOT_YET_RECRUITING", "start": "2026-02-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Bursa City Hospital", "countries": []}, {"nct": "NCT07329556", "title": "Skin Autofluorescence Assessment of Advanced Glycation End Products in Rheumatic Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-01-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Bursa City Hospital", "countries": []}, {"nct": "NCT07375940", "title": "Clinical, Biochemical and Epigenetic Profile of Pediatric Behçet Disease", "status": "RECRUITING", "start": "2026-01-12", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Meyer Children's Hospital IRCCS", "countries": ["Italy", "United Kingdom"]}, {"nct": "NCT07248059", "title": "Prevalence of Oral Findings in Egyptian Patients Diagnosed With Familial Mediterranean Fever", "status": "NOT_YET_RECRUITING", "start": "2025-12", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Cairo University", "countries": ["Egypt"]}, {"nct": "NCT07077304", "title": "EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases", "status": "RECRUITING", "start": "2025-11-19", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT07135063", "title": "Cranial Nerve Functions in Behçet's Disease and Their Relationship With Clinical Parameters", "status": "NOT_YET_RECRUITING", "start": "2025-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Marmara University", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT07276087", "title": "Physical and Psychosocial Parameters in Takayasu Arteritis and Behçet's Disease: A Comparative Study With Healthy Controls", "status": "RECRUITING", "start": "2025-09-11", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "ÖZLEM NUR TOK YAMAN", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT06974877", "title": "Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load", "status": "RECRUITING", "start": "2025-09-10", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "countries": ["United States"]}, {"nct": "NCT07244614", "title": "Ustekinumab in BEhçet's Syndrome STudy", "status": "RECRUITING", "start": "2025-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Groupe français d'étude des Maladies Inflammatoires de loeil", "countries": ["France"]}, {"nct": "NCT06780462", "title": "Randomized Controlled Multicenter Study Comparing Steroid Therapy Plus Anticoagulants to Steroid Therapy Alone in Deep Venous Thrombosis of Behçet's Syndrome", "status": "RECRUITING", "start": "2025-06-24", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT06974942", "title": "Physical Activity in Adolescents With Familial Mediterranean Fever", "status": "NOT_YET_RECRUITING", "start": "2025-05-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Istanbul University - Cerrahpasa", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT07129538", "title": "Outcomes of Inspiratory Muscle Training in FMF Adolescents", "status": "RECRUITING", "start": "2025-05-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Cairo University", "countries": ["Egypt"]}, {"nct": "NCT07130305", "title": "is There an Effect of Adding Body Vibration to Intake of Vitamin D on Some Outcomes of Familial Mediterranean Fever", "status": "RECRUITING", "start": "2025-05-08", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Cairo University", "countries": ["Egypt"]}, {"nct": "NCT07130318", "title": "Mediterranean Diet in Familial Mediterranean Fever: Is Fatty Liver Affected by Addition of Aerobic Exercise", "status": "RECRUITING", "start": "2025-05-08", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Cairo University", "countries": ["Egypt"]}]}, {"batch": 1, "no": 29, "name_zh": "范可尼贫血", "query_terms": [{"term": "Fanconi anemia", "broad": false}], "n_total": 6, "n_open": 3, "n_open_precise": 3, "n_broad": 0, "trials": [{"nct": "NCT01995305", "title": "Use Massive Parallel Sequencing and Exome Capture Technology to Sequence the Exome of Fanconi Anemia Children and Their Patents", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "enrollment": null, "sponsor": "Xiaofan Zhu", "conditions": ["Fanconi Anemia", "Autosomal or Sex Linked Recessive Genetic Disease", "Bone Marrow Hematopoiesis Failure, Multiple Congenital Abnormalities, and Susceptibility to Neoplastic Diseases.", "Hematopoiesis Maintainance."], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": "AVAILABLE"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06287541", "title": "The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection", "status": "RECRUITING", "start": "2023-07-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 428, "sponsor": "The First Affiliated Hospital with Nanjing Medical University", "conditions": ["Non Muscle Invasive Bladder Cancer"], "cn_sites": [{"facility": "The First Affiliated Hospital of Nanjing Medical University", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07036731", "title": "A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing", "status": "RECRUITING", "start": "2025-02-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 428, "sponsor": "The First Affiliated Hospital with Nanjing Medical University", "conditions": ["Non Muscle Invasive Bladder Cancer"], "cn_sites": [{"facility": "The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00171821", "title": "A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron Overload", "status": "COMPLETED", "start": "2005-04", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1784, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Transfusion-dependent Iron Overload"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Nanjing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT06227429", "title": "A Non-interventional, Post-Marketing Study to Describe Outcome of Nitisinone Treatment in HT-1 Patients", "status": "WITHDRAWN", "start": "2025-09", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 0, "sponsor": "Swedish Orphan Biovitrum", "conditions": ["Hereditary Tyrosinemia, Type I"], "cn_sites": [{"facility": "Swedish Orphan Biovitrum Research Site", "city": "Beijing", "status": ""}, {"facility": "Swedish Orphan Biovitrum Research Site", "city": "Chongqing", "status": ""}, {"facility": "Swedish Orphan Biovitrum Research Site", "city": "Hefei", "status": ""}, {"facility": "Swedish Orphan Biovitrum Research Site", "city": "Wuhan", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT03351868", "title": "FANCA Gene Transfer for Fanconi Anemia Using a High-safety, High-efficiency, Self-inactivating Lentiviral Vector", "status": "TERMINATED", "start": "2026-06-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": ["Fanconi Anemia"], "cn_sites": [{"facility": "Shenzhen Geno-immune Medical Institute", "city": "Shenzhen", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 30, "g_fetched": 27, "g_countries": [["United States", 18], ["Spain", 4], ["France", 2], ["Hungary", 1], ["Poland", 1], ["Germany", 1], ["Japan", 1], ["Belgium", 1], ["Netherlands", 1], ["United Kingdom", 1]], "g_trials": [{"nct": "NCT07408583", "title": "Prenatal Transplantation for Fetuses With Fanconi Anemia", "status": "NOT_YET_RECRUITING", "start": "2028-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Agnieszka Czechowicz", "countries": ["United States"]}, {"nct": "NCT07765836", "title": "Vilastobart+Retifanlimab in BRCA or PALB2 Deficient PC", "status": "NOT_YET_RECRUITING", "start": "2027-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Massachusetts General Hospital", "countries": ["United States"]}, {"nct": "NCT07005297", "title": "Clinical Genetics Branch Eligibility Screening Survey", "status": "NOT_YET_RECRUITING", "start": "2026-09-23", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["United States"]}, {"nct": "NCT06744283", "title": "Experience and Management of Cancer Screening-Related Anxiety in Fanconi Anemia", "status": "RECRUITING", "start": "2026-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["United States"]}, {"nct": "NCT07459582", "title": "Accuracy of Home Lactate Meter and Accu-chek Glucometer in Patients With Glycogen Storage Disease", "status": "RECRUITING", "start": "2026-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Connecticut Children's Medical Center", "countries": ["United States"]}, {"nct": "NCT07649031", "title": "MRI as Noninvasive Innovative Approach in Detection and Monitoring of Malignant Oral Lesions in Fanconi Anemia Patients", "status": "RECRUITING", "start": "2026-06-23", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Minnesota", "countries": ["United States"]}, {"nct": "NCT07242261", "title": "Non-invasive Characterisation of Oral Carcinomas in Patients With Fanconi Anaemia", "status": "NOT_YET_RECRUITING", "start": "2026-04-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Institut Jean-Godinot", "countries": []}, {"nct": "NCT06910813", "title": "DFT383 in Pediatric Participants With Nephropathic Cystinosis", "status": "RECRUITING", "start": "2025-06-02", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": ["United States"]}, {"nct": "NCT06458712", "title": "Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies", "status": "RECRUITING", "start": "2024-11-21", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Duke Street Bio Ltd", "countries": ["France", "Hungary", "Poland", "Spain", "United States"]}, {"nct": "NCT06648096", "title": "Afatinib in Patients With Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)", "status": "RECRUITING", "start": "2024-11-08", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau", "countries": ["Germany", "Spain"]}, {"nct": "NCT05485766", "title": "Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer", "status": "RECRUITING", "start": "2024-07-16", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Okayama University", "countries": ["Japan"]}, {"nct": "NCT05903365", "title": "Observational Follow-up Study of Haplo-identical Transplants in Fanconi Disease", "status": "NOT_YET_RECRUITING", "start": "2023-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": []}, {"nct": "NCT04954599", "title": "Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI", "status": "RECRUITING", "start": "2023-05-30", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Maastricht University Medical Center", "countries": ["Belgium", "Netherlands", "Spain"]}, {"nct": "NCT05687149", "title": "Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia", "status": "RECRUITING", "start": "2023-03-23", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["United States"]}, {"nct": "NCT05973656", "title": "Role of Acetaldehyde in the Development of Oral Cancer", "status": "RECRUITING", "start": "2022-07-08", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Masonic Cancer Center, University of Minnesota", "countries": ["United States"]}, {"nct": "NCT04784052", "title": "Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab", "status": "RECRUITING", "start": "2021-12-07", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Porteus, Matthew, MD", "countries": ["United States"]}, {"nct": "NCT06213402", "title": "RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)", "status": "RECRUITING", "start": "2021-11-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Hospital Universitari Vall d'Hebron Research Institute", "countries": ["Spain"]}, {"nct": "NCT04232085", "title": "Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures", "status": "RECRUITING", "start": "2020-02-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins", "countries": ["United States"]}, {"nct": "NCT04038502", "title": "Carboplatin or Olaparib for BRcA Deficient Prostate Cancer", "status": "RECRUITING", "start": "2019-10-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "VA Office of Research and Development", "countries": ["United States"]}, {"nct": "NCT03579875", "title": "Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders", "status": "RECRUITING", "start": "2018-11-13", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Masonic Cancer Center, University of Minnesota", "countries": ["United States"]}, {"nct": "NCT03050268", "title": "Familial Investigations of Childhood Cancer Predisposition", "status": "RECRUITING", "start": "2017-04-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "St. Jude Children's Research Hospital", "countries": ["United States"]}, {"nct": "NCT04781790", "title": "French National Registry of Bone Marrow Failures", "status": "RECRUITING", "start": "2017-02-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT02720679", "title": "Investigation of the Genetics of Hematologic Diseases", "status": "RECRUITING", "start": "2016-06-17", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "St. Jude Children's Research Hospital", "countries": ["United States"]}, {"nct": "NCT02143830", "title": "HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy", "status": "RECRUITING", "start": "2014-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Children's Hospital Medical Center, Cincinnati", "countries": ["United States"]}, {"nct": "NCT06065852", "title": "National Registry of Rare Kidney Diseases", "status": "RECRUITING", "start": "2009-11-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "UK Kidney Association", "countries": ["United Kingdom"]}]}, {"batch": 1, "no": 30, "name_zh": "半乳糖血症", "query_terms": [{"term": "Galactosemia", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 2, "g_fetched": 2, "g_countries": [["Italy", 1], ["United States", 1]], "g_trials": [{"nct": "NCT07461519", "title": "Gonadic Function and Pubertal Development in Female Patients With Classic Galactosemia", "status": "RECRUITING", "start": "2025-02-12", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS Azienda Ospedaliero-Universitaria di Bologna", "countries": ["Italy"]}, {"nct": "NCT04948658", "title": "Gonadal Tissue Freezing for Fertility Preservation in Individuals at Risk for Ovarian Dysfunction, Premature Ovarian Insufficiency and Clinically Indicated Gonadectomy", "status": "RECRUITING", "start": "2021-09-13", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)", "countries": ["United States"]}]}, {"batch": 1, "no": 31, "name_zh": "戈谢病", "query_terms": [{"term": "Gaucher disease", "broad": false}, {"term": "Gaucher’s Disease", "broad": false}], "n_total": 12, "n_open": 5, "n_open_precise": 5, "n_broad": 0, "trials": [{"nct": "NCT00358943", "title": "International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry", "status": "RECRUITING", "start": "1991-04-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 12000, "sponsor": "Genzyme, a Sanofi Company", "conditions": ["Gaucher Disease", "Cerebroside Lipidosis Syndrome", "Glucocerebrosidase Deficiency Disease", "Glucosylceramide Beta-Glucosidase Deficiency Disease"], "cn_sites": [{"facility": "Investigational Site Number : 1560001", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 156003", "city": "Beijing", "status": "TERMINATED"}, {"facility": "Investigational Site Number : 152357", "city": "Guangzhou", "status": "TERMINATED"}, {"facility": "Investigational Site Number : 1560002", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 152358", "city": "Hangzhou", "status": "TERMINATED"}, {"facility": "Investigational Site Number : 152359", "city": "Hangzhou", "status": "TERMINATED"}, {"facility": "Investigational Site Number : 157252", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 150899", "city": "Shanghai", "status": "TERMINATED"}, {"facility": "Investigational Site Number : 151787", "city": "Shanghai", "status": "TERMINATED"}, {"facility": "Investigational Site Number : 152356", "city": "Shanghai", "status": "TERMINATED"}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT06272149", "title": "An Exploratory Clinical Trial of VGN-R08b in Patients With Type II Gaucher Disease", "status": "RECRUITING", "start": "2023-03-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": ["Type II Gaucher Disease"], "cn_sites": [{"facility": "Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06162338", "title": "A Study of the Safety and Preliminary Efficacy of LY-M001 Injection in the Treatment of Adult Patients With Gaucher Disease Type I", "status": "RECRUITING", "start": "2023-11-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 3, "sponsor": "He Huang", "conditions": ["Gaucher Disease Type I"], "cn_sites": [{"facility": "The First Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hanzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06818838", "title": "A Clinical Study Evaluating LY-M001 Injection in the Treatment of Adult Patients With Type I Gaucher Disease", "status": "RECRUITING", "start": "2024-07-05", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Lingyi Biotech Co., Ltd.", "conditions": ["Gaucher Disease Type 1"], "cn_sites": [{"facility": "Guangzhou First People's Hospital", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Shanxi Bethune Hospital", "city": "Taiyuan", "status": "RECRUITING"}, {"facility": "Hematology Hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT04637503", "title": "4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma", "status": "NOT_YET_RECRUITING", "start": "2026-12-31", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": ["Neuroblastoma"], "cn_sites": [{"facility": "Shenzhen Geno-Immune Medical Institute", "city": "Shenzhen", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01074944", "title": "A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease to Evaluate Once Daily Versus Twice Daily Dosing (EDGE)", "status": "COMPLETED", "start": "2010-06", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 170, "sponsor": "Genzyme, a Sanofi Company", "conditions": ["Gaucher Disease"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}, {"facility": "Shanghai Xinhua Hospital Shanghai Xinhua Hospital", "city": "Shanghai", "status": ""}, {"facility": "Tianjin Hematonosis Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT04656600", "title": "Study to Evaluate Efficacy and Safety of Imiglucerase Treatment in Chinese Patients With Gaucher Disease Type Ⅲ", "status": "COMPLETED", "start": "2021-03-02", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Sanofi", "conditions": ["Gaucher's Disease"], "cn_sites": [{"facility": "Investigational Site Number : 107", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 101", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 104", "city": "Chengdu", "status": ""}, {"facility": "Investigational Site Number : 102", "city": "Guangzhou", "status": ""}, {"facility": "Investigational Site Number : 105", "city": "Guangzhou", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT05222906", "title": "Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-04-18", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 43, "sponsor": "Sanofi", "conditions": ["Gaucher's Disease Type III"], "cn_sites": [{"facility": "National Taiwan University Hospital-Investigational Site Number: 1580001", "city": "Taipei", "status": ""}, {"facility": "Peking Union Medical College Hospital - Investigational Site Number: 1560001", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital - Investigational Site Number: 1560002", "city": "Guangzhou", "status": ""}, {"facility": "Xinhua Hospital - Investigational Site Number: 1560004", "city": "Shanghai", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT05447494", "title": "Phase 1/2 Study of CAN103 in Subjects With Gaucher Disease", "status": "UNKNOWN", "start": "2022-07-11", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "CANbridge (Suzhou) Bio-pharma Co., Ltd.", "conditions": ["Gaucher Disease, Type 1", "Gaucher Disease, Type 3"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05529992", "title": "A Study of Velaglucerase Alfa (VPRIV) in Chinese Children, Teenagers, and Adults With Type 1 Gaucher Disease", "status": "COMPLETED", "start": "2023-01-03", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Takeda", "conditions": ["Gaucher Disease"], "cn_sites": [{"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "Lanzhou University Second Hospital", "city": "Lanzhou", "status": ""}, {"facility": "The First Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "Guangzhou Women and Children's Medical Center", "city": "Guangzhou", "status": ""}, {"facility": "The Second Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Nanjing Children's Hospital", "city": "Nanjing", "status": ""}, {"facility": "Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT06523517", "title": "Efficacy and Safety of Eliglustat in Chinese Pediatric Patients With Gaucher Disease Type 1 and Type 3", "status": "UNKNOWN", "start": "2024-08-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 5, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Gaucher Disease"], "cn_sites": [{"facility": "Peking union medical college hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06528080", "title": "A Clinical Study for the Treatment of Pediatric and Adolescent Patients With Type 1 Gaucher Disease", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-08-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 3, "sponsor": "Shanghai Jiao Tong University School of Medicine", "conditions": ["Gaucher Disease"], "cn_sites": [{"facility": "Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 30, "g_fetched": 25, "g_countries": [["United States", 14], ["Israel", 3], ["United Kingdom", 3], ["Turkey (Türkiye)", 2], ["Argentina", 2], ["Spain", 2], ["India", 1], ["Pakistan", 1], ["Australia", 1], ["Brazil", 1], ["Canada", 1], ["Saudi Arabia", 1], ["Taiwan", 1]], "g_trials": [{"nct": "NCT05669729", "title": "A Survey to Assess Participants', Caregivers', and Nurses' Use and Understanding of Educational Material on Velaglucerase Alfa (VPRIV) Home Infusion", "status": "NOT_YET_RECRUITING", "start": "2026-09-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Takeda", "countries": []}, {"nct": "NCT07715084", "title": "Study to Evaluate the Efficacy and Safety of Nizubaglustat (AZ-3102) in Patients With Gaucher Disease Type 3 (GD3)", "status": "NOT_YET_RECRUITING", "start": "2026-09-28", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Azafaros B.V.", "countries": ["India", "Pakistan", "Turkey (Türkiye)"]}, {"nct": "NCT07603050", "title": "A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of VGN-R08b in Patients With Type III Gaucher's Disease", "status": "NOT_YET_RECRUITING", "start": "2026-05-14", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Shanghai Vitalgen BioPharma Co., Ltd.", "countries": []}, {"nct": "NCT07758816", "title": "Advancing Integrated Therapies for Gaucher Disease", "status": "RECRUITING", "start": "2026-05-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Yale University", "countries": ["United States"]}, {"nct": "NCT07223944", "title": "A Gaucher Disease Gene Therapy Trial With FLT201", "status": "RECRUITING", "start": "2026-04-07", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Spur Therapeutics", "countries": ["Argentina", "Australia", "Brazil", "Canada", "Israel", "Saudi Arabia", "Spain", "Turkey (Türkiye)", "United Kingdom", "United States"]}, {"nct": "NCT06573723", "title": "Institutional Registry of Rare Diseases", "status": "RECRUITING", "start": "2024-07-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Hospital Italiano de Buenos Aires", "countries": ["Argentina"]}, {"nct": "NCT06258577", "title": "Screening for Gaucher Disease and Acid Sphingomyelinase Deficiency", "status": "NOT_YET_RECRUITING", "start": "2024-05-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Chung-Hsing Wang", "countries": ["Taiwan"]}, {"nct": "NCT05843552", "title": "Extracellular Vesicles as Potential Biomarkers and Therapeutic Target in Gaucher Disease", "status": "RECRUITING", "start": "2023-08-14", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Minnesota", "countries": ["United States"]}, {"nct": "NCT05992532", "title": "GammaGA: Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple Myeloma", "status": "RECRUITING", "start": "2023-05-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fundación Española de Hematología y Hemoterapía", "countries": ["Spain"]}, {"nct": "NCT05586243", "title": "MAGNETIC RESONANCE SPECTROSCOPY BIOMARKERS IN TYPE 3 GAUCHER DISEASE (GD3)", "status": "RECRUITING", "start": "2023-01-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Minnesota", "countries": ["United States"]}, {"nct": "NCT05619900", "title": "Registry of Patients Diagnosed With Lysosomal Storage Diseases", "status": "RECRUITING", "start": "2022-05-31", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of California, San Francisco", "countries": ["United States"]}, {"nct": "NCT04532047", "title": "PEARL (PrEnAtal Enzyme Replacement Therapy for Lysosomal Storage Disorders)", "status": "RECRUITING", "start": "2021-07-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "University of California, San Francisco", "countries": ["United States"]}, {"nct": "NCT04528355", "title": "Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC", "status": "RECRUITING", "start": "2020-08-20", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Paul Szabolcs", "countries": ["United States"]}, {"nct": "NCT04388969", "title": "World Data on Ambroxol for Patients With GD and GBA Related PD", "status": "RECRUITING", "start": "2020-05-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Shaare Zedek Medical Center", "countries": ["Israel"]}, {"nct": "NCT06151002", "title": "PD Frontline (Part of RAPSODI GD) Remote Assessment of People With Parkinson's", "status": "RECRUITING", "start": "2020-02-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University College London Hospitals", "countries": ["United Kingdom"]}, {"nct": "NCT03721068", "title": "Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma", "status": "RECRUITING", "start": "2019-02-19", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "UNC Lineberger Comprehensive Cancer Center", "countries": ["United States"]}, {"nct": "NCT03190837", "title": "A Long-term Follow-up Study of Gaucher Disease", "status": "RECRUITING", "start": "2017-06-12", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Duke University", "countries": ["United States"]}, {"nct": "NCT05253560", "title": "Prodromal Parkinsonian Features in GBA1 Mutation Carriers", "status": "RECRUITING", "start": "2017-05-16", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Shaare Zedek Medical Center", "countries": ["Israel"]}, {"nct": "NCT02437396", "title": "Oxidative Stress and Inflammatory Biomarkers in Gaucher Disease", "status": "RECRUITING", "start": "2015-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Minnesota", "countries": ["United States"]}, {"nct": "NCT01962415", "title": "Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT", "status": "RECRUITING", "start": "2014-02-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Paul Szabolcs", "countries": ["United States"]}, {"nct": "NCT03240653", "title": "Gaucherite - A Study to Stratify Gaucher Disease", "status": "RECRUITING", "start": "2014-01-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Cambridge University Hospitals NHS Foundation Trust", "countries": ["United Kingdom"]}, {"nct": "NCT03333200", "title": "Longitudinal Study of Neurodegenerative Disorders", "status": "RECRUITING", "start": "2012-01-11", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Pittsburgh", "countries": ["United States"]}, {"nct": "NCT03291223", "title": "Gaucher Disease Outcome Survey (GOS)", "status": "RECRUITING", "start": "2010-12-29", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Shire", "countries": ["United States"]}, {"nct": "NCT00029965", "title": "Natural History of Glycosphingolipid Storage Disorders and Glycoprotein Disorders", "status": "RECRUITING", "start": "2002-02-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Human Genome Research Institute (NHGRI)", "countries": ["United States"]}, {"nct": "NCT07675031", "title": "Managed Access Program of Venglustat in Pediatric and Adult Patients With Type 3 Gaucher Disease (GD3).", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "Sanofi", "countries": []}]}, {"batch": 1, "no": 32, "name_zh": "全身型重症肌无力", "query_terms": [{"term": "Myasthenia gravis", "broad": false}, {"term": "Generalized Myasthenia Gravis", "broad": false}], "n_total": 90, "n_open": 46, "n_open_precise": 46, "n_broad": 0, "trials": [{"nct": "NCT04182984", "title": "TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study", "status": "RECRUITING", "start": "2019-11-04", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Tang-Du Hospital", "conditions": ["Ocular Myasthenia Gravis"], "cn_sites": [{"facility": "Tangdu Hospotal", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04202341", "title": "Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)", "status": "RECRUITING", "start": "2019-12-02", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Alexion Pharmaceuticals, Inc.", "conditions": ["Generalized Myasthenia Gravis"], "cn_sites": [{"facility": "Clinical Trial Site", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Changchun", "status": "RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Qingdao", "status": "RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Shijiazhuang", "status": "RECRUITING"}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT04561557", "title": "Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System", "status": "RECRUITING", "start": "2020-09-22", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Tongji Hospital", "conditions": ["Autoimmune Diseases", "Autoimmune Diseases of the Nervous System", "Neuromyelitis Optica Spectrum Disorder", "Myasthenia Gravis", "Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "Idiopathic Inflammatory Myopathies", "Multiple Sclerosis", "Autoimmune Encephalitis", "Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)", "POEMS Syndrome"], "cn_sites": [{"facility": "Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04837625", "title": "Study of Myasthenic Crisis in China", "status": "RECRUITING", "start": "2020-10-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 300, "sponsor": "Huashan Hospital", "conditions": ["Myasthenia Gravis", "Myasthenic Crisis"], "cn_sites": [{"facility": "Huashan Hospital Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04951622", "title": "A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis", "status": "RECRUITING", "start": "2021-07-15", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 199, "sponsor": "Janssen Research & Development, LLC", "conditions": ["Myasthenia Gravis"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Xuanwu Hospital ,Capital Medical University", "city": "Beijing", "status": "COMPLETED"}, {"facility": "Beijing Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The First Bethune Hospital of Jilin University", "city": "Changchun", "status": "RECRUITING"}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": "COMPLETED"}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": "COMPLETED"}, {"facility": "The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Sir Run Run Shaw Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": "COMPLETED"}, {"facility": "Qianfoshan hospital of Shandong Province", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": "COMPLETED"}, {"facility": "Huashan Hospital Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Air Force Medical University - Tangdu Hospital", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 14, "broad_only": false}, {"nct": "NCT05067348", "title": "Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis", "status": "RECRUITING", "start": "2022-07-21", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 64, "sponsor": "Tang-Du Hospital", "conditions": ["Myasthenia Gravis, Generalized"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": "NOT_YET_RECRUITING"}, {"facility": "Tangdu Hospital, The Fourth Military Medical University", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "Huashan Hospital", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}, {"facility": "Tianjin medical university general hospital", "city": "Tianjin", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT06006832", "title": "A Prospective Cohort Study of Myasthenia Gravis in China", "status": "RECRUITING", "start": "2023-08-20", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 202, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Myasthenia Gravis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07146425", "title": "Construction of A Multimodal Digital Assessment Model for Myasthenia Gravis", "status": "RECRUITING", "start": "2023-08-31", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 180, "sponsor": "Huashan Hospital", "conditions": ["Myasthenia Gravis"], "cn_sites": [{"facility": "Huashan Hospital, affiliated to Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04535843", "title": "Precision Diagnosis and Prospective Cohort Study for Myasthenia Gravis: Multicenter Analysis in China", "status": "RECRUITING", "start": "2024-02-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Huashan Hospital", "conditions": ["Myasthenia Gravis"], "cn_sites": [{"facility": "Shanghai Chest Hospital", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Obsterics and Gynecology Hospital of Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Huashan Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT06241521", "title": "Myasthenia Gravis Registry in China", "status": "RECRUITING", "start": "2024-02-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1500, "sponsor": "Huashan Hospital", "conditions": ["Myasthenia Gravis"], "cn_sites": [{"facility": "Beijing Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Xuanwu hospital, Capital medical university", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "The Third Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Xiangya hospital, Central south university", "city": "Changsha", "status": "RECRUITING"}, {"facility": "The First Hospital, Soochow University", "city": "Suzhou", "status": "RECRUITING"}, {"facility": "Affiliated Hospital of Xuzhou Medical University", "city": "Xuzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "The First Hospital, Jilin University", "city": "Changchun", "status": "RECRUITING"}, {"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Tangdu Hospital, The Air Force Medical University", "city": "Xi’an", "status": "RECRUITING"}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 16, "broad_only": false}, {"nct": "NCT06249438", "title": "A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy", "status": "RECRUITING", "start": "2024-03-20", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "RenJi Hospital", "conditions": ["Systemic Lupus Erythematosus (SLE)", "Immune-mediated Necrotizing Myopathy (IMNM)", "Neuromyelitis Optica Spectrum Disorders (NMOSD)", "Multiple Sclerosis (MS)", "Myasthenia Gravis", "Systemic Sclerosis (SSc)"], "cn_sites": [{"facility": "Department of Rheumatology, RenJi Hospital, School of Medicine, Shanghai JiaoTong University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07653984", "title": "Cohort Study on Neuroimmune Diseases in the Reproductive Age", "status": "RECRUITING", "start": "2024-04-21", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Third Affiliated Hospital, Sun Yat-Sen University", "conditions": ["Neuromyelitis Optica Spectrum Disorders (NMOSD)", "Multiple Sclerosis", "Autoimmune Encephalitis", "Myasthenia Gravis", "Guillain-Barré Syndrome (GBS)", "Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)"], "cn_sites": [{"facility": "The Third Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06463587", "title": "Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)", "status": "RECRUITING", "start": "2024-06-25", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 264, "sponsor": "Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany", "conditions": ["Generalized Myasthenia Gravis"], "cn_sites": [{"facility": "The First Affiliated Hospital of Bengbu Medical College", "city": "Anhui Sheng", "status": "RECRUITING"}, {"facility": "Xuanwu Hospital Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Guangzhou University of Chinese Medicine - 300164595", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Affiliated Hospital of Zunyi Medical University", "city": "Zunyi", "status": "RECRUITING"}, {"facility": "Shijiazhuang People's Hospital", "city": "Shijiazhuang", "status": "RECRUITING"}, {"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Xiangya Hospital, Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "The First Hospital of Jilin University - The First Hospital of Jilin University", "city": "Changchun", "status": "RECRUITING"}, {"facility": "China-Japan Union Hospital of Jilin University - 300173736", "city": "Changchun", "status": "RECRUITING"}, {"facility": "Shengjing Hospital of China Medical University", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Huashan Hospital, Fudan University - Neurology", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Xi 'an International Medical Center", "city": "Xi’an", "status": "RECRUITING"}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": "RECRUITING"}], "cn_site_count": 15, "broad_only": false}, {"nct": "NCT06447597", "title": "A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis.", "status": "RECRUITING", "start": "2024-07-01", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 104, "sponsor": "Shanghai Jiaolian Drug Research and Development Co., Ltd", "conditions": ["Generalized Myasthenia Gravis"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The First Bethune Hospital of Jilin University", "city": "Changchun", "status": "RECRUITING"}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Sichuan Provincial People's Hospital", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Nanfang Hospital, Southern Medical University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Shandong Provincial Qianfoshan Hospital", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Shandong University Cheeloo College of Medicine", "city": "Jinan", "status": "RECRUITING"}, {"facility": "First People's Hospital of Yunnan Province", "city": "Kunming", "status": "RECRUITING"}, {"facility": "Jiangxi Provincial People's Hospital", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Shandong University Cheeloo College of Medicine", "city": "Qingdao", "status": "RECRUITING"}, {"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Shenzhen Hospital of University of Hong Kong", "city": "Shenzhen", "status": "RECRUITING"}, {"facility": "Renmin Hospital of Wuhan University", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Tongji Medical College of HUST", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Tangdu Hospital", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "Affiliated Hospital of Zunyi Medical College", "city": "Zunyi", "status": "RECRUITING"}], "cn_site_count": 18, "broad_only": false}, {"nct": "NCT06371040", "title": "Safety and Efficacy of CD19-BCMA Targeted CAR-T Therapy for Refractory Generalized Myasthenia Gravis", "status": "RECRUITING", "start": "2024-07-12", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Ting Chang, MD", "conditions": ["Myasthenia Gravis"], "cn_sites": [{"facility": "Tangdu Hospital, The Fourth Military Medical University", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06456580", "title": "A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)", "status": "RECRUITING", "start": "2024-07-17", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 180, "sponsor": "Vor Biopharma", "conditions": ["Generalized Myasthenia Gravis"], "cn_sites": [{"facility": "AnHui Provincial Hospital", "city": "Hefei", "status": "RECRUITING"}, {"facility": "Beijing Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "The Second Hospital & Clinical Medical School. Lan Zhou University", "city": "Lanzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital, Sun Yat-Sen University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Affiliated Hospital of ZunYi Medical University", "city": "Zunyi", "status": "RECRUITING"}, {"facility": "TongJi Medical College of HUST", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "XiangYa Hospital of Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Jilin University China-Japan Union Hospital", "city": "Changchun", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of PLA Air Force Military Medical University", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "Xi'An GaoXin Hospital", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "QiLU Hospital of ShanDong University", "city": "Jinan", "status": "RECRUITING"}, {"facility": "The 960th Hospital of the Joint Service Support Force of the Chinese People's Liberation Army", "city": "Jinan", "status": "RECRUITING"}, {"facility": "The First People's Hospital of JiNing Medical University", "city": "Jining", "status": "RECRUITING"}, {"facility": "Huashan Hospital of the ShangHai FuDan University Medical College", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "First Hospital of ShanXi Medical University", "city": "Taiyuan", "status": "RECRUITING"}, {"facility": "NingBo Medical Center LiHuiLi Hospital", "city": "Ningbo", "status": "RECRUITING"}, {"facility": "The 1 School of Medicine, School of Information and Engineering. The 1 Affiliated Hospital of WMU.", "city": "Wenzhou", "status": "RECRUITING"}], "cn_site_count": 19, "broad_only": false}, {"nct": "NCT06502015", "title": "Biomarkers in Autoimmune Disease of Nervous System", "status": "RECRUITING", "start": "2024-07-31", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 50000, "sponsor": "Tongji Hospital", "conditions": ["Autoimmune Diseases of the Nervous System", "Neuromyelitis Optica Spectrum Disorder", "Multiple Sclerosis", "Guillain-Barre Syndrome", "Acute Disseminated Encephalomyelitis", "Autoimmune Encephalitis", "Stiff-Person Syndrome", "Myasthenia Gravis", "Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "Idiopathic Inflammatory Myopathies", "Autoimmune Diseases"], "cn_sites": [{"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06744920", "title": "A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis", "status": "RECRUITING", "start": "2025-02-07", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 180, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Generalized Myasthenia Gravis"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Hefei", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Shijiazhuang", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Wuxi", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Changchun", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Qingdao", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT06759948", "title": "An Early Exploratory Clinical Study of GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis", "status": "NOT_YET_RECRUITING", "start": "2025-02-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Chongbo Zhao", "conditions": ["Generalized Myasthenia Gravis (gMG)"], "cn_sites": [{"facility": "Huashan Hospital, affiliated to Fudan University, Shanghai,", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06485232", "title": "Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.", "status": "NOT_YET_RECRUITING", "start": "2025-02-28", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 25, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Neuromyelitis Optica Spectrum Disorders", "Myasthenia Gravis, Generalized", "Multiple Sclerosis", "Chronic Inflammatory Demyelinating Polyradiculoneuropathy"], "cn_sites": [{"facility": "Xuanwu Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06688435", "title": "A Study to Evaluate the Safety and Preliminary Efficacy of SYS6020 CAR T-cells in Patients With Refractory Generalized Myasthenia Gravis", "status": "RECRUITING", "start": "2025-03-04", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "CSPC ZhongQi Pharmaceutical Technology Co., Ltd.", "conditions": ["Myasthenia Gravis"], "cn_sites": [{"facility": "Qilu Hospital, Shandong University", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06933563", "title": "UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Myasthenia Gravis", "status": "NOT_YET_RECRUITING", "start": "2025-04", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Zhejiang University", "conditions": ["Myasthenia Gravis"], "cn_sites": [{"facility": "The first affiliated hospital of medical college of zhejiang university", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07022197", "title": "Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases", "status": "RECRUITING", "start": "2025-04-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 27, "sponsor": "Tianjin Medical University General Hospital", "conditions": ["Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "NMO Spectrum Disorder", "Myasthenia Gravis", "Idiopathic Inflammatory Myopathies"], "cn_sites": [{"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06978738", "title": "UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2025-05", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Changzhou No.2 People's Hospital", "conditions": ["Systemic Lupus Erythematosus", "Autoimmune Hemolytic Anemia", "Myasthenia Gravis", "Systemic Sclerosis", "ANCA-Associated Vasculitis", "Inflammatory Myopathy", "IgG4-RD"], "cn_sites": [{"facility": "Changzhou No.2 People's Hospital", "city": "Changzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06939166", "title": "Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases", "status": "RECRUITING", "start": "2025-06-17", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Tianjin Huanhu Hospital", "conditions": ["Neuromyelitis Optica Spectrum Disorders", "Myasthenia Gravis", "Multiple Sclerosis", "Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "Autoimmune Encephalitis"], "cn_sites": [{"facility": "Tianjin Huanhu Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07058298", "title": "GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis(24103)", "status": "RECRUITING", "start": "2025-07-15", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Daishi Tian", "conditions": ["Generalized Myasthenia Gravis (gMG)"], "cn_sites": [{"facility": "Tongji Hospital of Tongji Medical Colledge, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07215650", "title": "Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG)", "status": "RECRUITING", "start": "2025-09-16", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 44, "sponsor": "Candid Therapeutics", "conditions": ["Generalized Myasthenia Gravis"], "cn_sites": [{"facility": "Union Hospital Affiliated to Fujian Medical University", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "The Third Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "The Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": "RECRUITING"}, {"facility": "Huashan Hospital Affiliated to Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "The First Hospital of Shanxi Medical University", "city": "Taiyuan", "status": "RECRUITING"}, {"facility": "Sichuan Provincial People's Hospital", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT07246564", "title": "Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia Gravis", "status": "RECRUITING", "start": "2025-12-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "UCB Biopharma SRL", "conditions": ["Myasthenia Gravis"], "cn_sites": [{"facility": "Mg0033 20040", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Mg0033 20261", "city": "Changchun", "status": "RECRUITING"}, {"facility": "Mg0033 20295", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Mg0033 20348", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "Mg0033 20269", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Mg0033 20185", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Mg0033 20347", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Mg0033 20172", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Mg0033 20184", "city": "Shenzhen", "status": "RECRUITING"}, {"facility": "Mg0033 20204", "city": "Suzhou", "status": "RECRUITING"}, {"facility": "Mg0033 20180", "city": "Wuhan", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Mg0033 20349", "city": "Xuzhou SHI", "status": "RECRUITING"}], "cn_site_count": 12, "broad_only": false}, {"nct": "NCT07231523", "title": "EFG vs IVIG in TAMG", "status": "NOT_YET_RECRUITING", "start": "2025-12-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 64, "sponsor": "Shanghai Zhongshan Hospital", "conditions": ["Efgartigimod", "Intravenous Immunoglobulin", "Myasthenia Gravis Associated With Thymoma"], "cn_sites": [{"facility": "Shanghai Zhongshan Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07337785", "title": "CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases", "status": "RECRUITING", "start": "2025-12-12", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Tongji Hospital", "conditions": ["Relapsing or Refractory Multiple Sclerosis (MS)", "Myasthenia Gravis (MG)", "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)", "Autoimmune Encephalitis (AE)"], "cn_sites": [{"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07249632", "title": "A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG)", "status": "RECRUITING", "start": "2026-01-13", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "RemeGen Co., Ltd.", "conditions": ["Myasthenia Gravis, Ocular"], "cn_sites": [{"facility": "Beijing Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07392528", "title": "Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-03", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Tianjin Huanhu Hospital", "conditions": ["Neuromyelitis Optica Spectrum Disorders", "Multiple Sclerosis", "Myasthenia Gravis"], "cn_sites": [{"facility": "Tianjin Huanhu Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07333196", "title": "Tongji NADs Cohort", "status": "NOT_YET_RECRUITING", "start": "2026-03-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1550, "sponsor": "Tongji Hospital", "conditions": ["Multiple Sclerosis", "NMO Spectrum Disorder", "Autoimmune Encephalitis", "Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease", "Autoimmune Nodopathy", "Acute Inflammatory Demyelinating Polyradiculoneuropathy", "Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "Myasthenia Gravis", "Idiopathic Inflammatory Myopathies"], "cn_sites": [{"facility": "Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07298928", "title": "A Study on the Efficacy and Safety of Telitacicept in the Treatment of Children Ocular Myasthenia Gravis", "status": "NOT_YET_RECRUITING", "start": "2026-03-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "The Children's Hospital of Zhejiang University School of Medicine", "conditions": ["Effectiveness"], "cn_sites": [{"facility": "Shenzhen children's Hospital of China Medical University", "city": "Shenzhen", "status": ""}, {"facility": "Children's Hospital Affiliated to Shandong University", "city": "Jinan", "status": ""}, {"facility": "The Children's Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07470151", "title": "Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2026-03-12", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": ["System Lupus Erythematosus(SLE)", "Scleroderma", "Myasthenia Gravis (MG)"], "cn_sites": [{"facility": "Union hospital Tongji medical college Huazhong university of science and technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07413835", "title": "Efficacy and Safety of HN2302 in Refractory Myasthenia Gravis(MG)", "status": "RECRUITING", "start": "2026-03-17", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "The Affiliated Hospital of Xuzhou Medical University", "conditions": ["Refractory Myasthenia Gravis"], "cn_sites": [{"facility": "The Affiliated Hospital of Xuzhou Medical University", "city": "Xuzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07526493", "title": "Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.", "status": "RECRUITING", "start": "2026-04-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Tongji Hospital", "conditions": ["Multiple Sclerosis (MS)", "Neuromyelitis Optica Spectrum Disorder (NMOSD)", "Autoimmune Encephalitis (AE)", "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)", "Myasthenia Gravis (MG)", "Anti-Myelin Oligodendrocyte Glycoprotein Immunoglobulin G Antibody-Associated Disease (MOGAD)", "Idiopathic Inflammatory Myopathies (IIM)"], "cn_sites": [{"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07583030", "title": "A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-04-20", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 44, "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": ["Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE)", "Relapsed/Refractory IgG4-Related Disease (r/r IgG4-RD)", "Progressive Multiple Sclerosis (PMS)", "Relapsed/Refractory Myasthenia Gravis(r/r MS)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": ""}, {"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Shanxi Bethune Hospital", "city": "Taiyuan", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT07463521", "title": "A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis", "status": "RECRUITING", "start": "2026-05-27", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "UCB Biopharma SRL", "conditions": ["Ocular Myasthenia Gravis"], "cn_sites": [{"facility": "Mg0038 31901", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Mg0038 31906", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Mg0038 31907", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Mg0038 31902", "city": "Suzhou", "status": "RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT07622342", "title": "A Phase II Study of SHR-2173 Injection in Patients With Myasthenia Gravis", "status": "NOT_YET_RECRUITING", "start": "2026-06", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Guangdong Hengrui Pharmaceutical Co., Ltd", "conditions": ["Generalized Myasthenia Gravis"], "cn_sites": [{"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07593911", "title": "A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 75, "sponsor": "Beijing GoBroad Hospital", "conditions": ["Systemic Lupus Erthematosus (SLE)", "Lupus Nephritis (LN)", "Multiple Sclerosis", "Myasthenia Gravis (MG)", "IgG4-Related Diseases", "Rheumatoid Arthritis (RA)"], "cn_sites": [{"facility": "Beijing GoBroad Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07676266", "title": "A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "The Affiliated Hospital of Qingdao University", "conditions": ["Multiple Sclerosis (MS)", "Myasthenia Gravis (MG)", "Neuromyelitis Optica Spectrum Disorder", "Systemic Lupus Erythematosus", "Systemic Sclerosis", "Immune-Mediated Necrotizing Myopathy"], "cn_sites": [{"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07714798", "title": "Universal STAR-T Cell Injection in Generalized Myasthenia Gravis", "status": "NOT_YET_RECRUITING", "start": "2026-07-06", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Daishi Tian", "conditions": ["Generalized Myasthenia Gravis"], "cn_sites": [{"facility": "Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science & Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07596784", "title": "Efficacy and Safety of Ravulizumab in Chinese Adults Participants With Generalized Myasthenia Gravis (gMG)", "status": "RECRUITING", "start": "2026-07-20", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Alexion Pharmaceuticals, Inc.", "conditions": ["Generalized Myasthenia Gravis", "gMG"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Changchun", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Fuzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Jinan", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Shijiazhuang", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Taiyuan", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Tianjin", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Zhengzhou", "status": "RECRUITING"}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT07818291", "title": "An Open-label, Dose-escalation Phase Ib Study of EA5 Injection in Adults With Anti-AChR Antibody-Positive Generalized Myasthenia Gravis", "status": "NOT_YET_RECRUITING", "start": "2026-09-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Shanghai Lanyi Therapeutics Co., Ltd.", "conditions": ["Generalized Myasthenia Gravis (gMG)"], "cn_sites": [{"facility": "Beijing Hospital", "city": "Beijing", "status": ""}, {"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07556120", "title": "Efficacy and Safety of HN2301 in Patients With Generalized Myasthenia Gravis (MG)", "status": "NOT_YET_RECRUITING", "start": "2026-12-31", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Shenzhen MagicRNA Biotechnology Co., Ltd", "conditions": ["Generalized Myasthenia Gravis"], "cn_sites": [{"facility": "The First Affiliated Hospital of University of Science and Technology of China", "city": "Hefei", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01325571", "title": "A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis", "status": "COMPLETED", "start": "2011-03", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 83, "sponsor": "Astellas Pharma Inc", "conditions": ["Myasthenia Gravis"], "cn_sites": [{"facility": "", "city": "Beijing", "status": ""}, {"facility": "", "city": "Guangdong", "status": ""}, {"facility": "", "city": "Jiangsu", "status": ""}, {"facility": "", "city": "Jilin City", "status": ""}, {"facility": "", "city": "Shandong", "status": ""}, {"facility": "", "city": "Shanghai", "status": ""}, {"facility": "", "city": "Sichuan", "status": ""}, {"facility": "", "city": "Wuhan", "status": ""}, {"facility": "", "city": "Zhejiang", "status": ""}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT01727193", "title": "The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy", "status": "COMPLETED", "start": "2012-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 290, "sponsor": "First Affiliated Hospital, Sun Yat-Sen University", "conditions": ["Myasthenia Gravis"], "cn_sites": [{"facility": "The First Affiliated Hospital, SUN YAT-SEN UNIVERSITY", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02317224", "title": "The Safety and Efficacy of \"3-Hole\" Subxiphorid Approach in the Treatment of Anterior Mediastinal Tumor", "status": "UNKNOWN", "start": "2014-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 240, "sponsor": "Tang-Du Hospital", "conditions": ["Thymectomy", "Myasthenia Gravis"], "cn_sites": [{"facility": "Tangdu hospital", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03597373", "title": "Variables Predicting Reintubation After Thymectomy in Patients With Myasthenia Gravis", "status": "UNKNOWN", "start": "2017-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 99, "sponsor": "First Affiliated Hospital, Sun Yat-Sen University", "conditions": ["Myasthenia Gravis"], "cn_sites": [{"facility": "Genglong Liu", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04101578", "title": "Clinical Prognosis and Progression of Myasthenia Gravis Patients", "status": "UNKNOWN", "start": "2017-02-08", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2000, "sponsor": "Da, Yuwei, M.D.", "conditions": ["Myasthenia Gravis"], "cn_sites": [{"facility": "Xuan Wu Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05380128", "title": "Association Study Between VDR Gene Polymorphisms and Risk and Features of MG in Han Chinese Population", "status": "COMPLETED", "start": "2017-06-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 297, "sponsor": "Beijing Tongren Hospital", "conditions": ["Myasthenia Gravis, Ocular", "Gene Polymorphism"], "cn_sites": [{"facility": "Beijing Tongren Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03613272", "title": "The Curative Effect of Extended Thymectomy Performed Through Subxiphoid-right VATS Approach With Elevation of Sternum", "status": "UNKNOWN", "start": "2018-07-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 200, "sponsor": "Jiang Fan", "conditions": ["Thymoma", "Myasthenia Gravis", "Mediastinal Tumor"], "cn_sites": [{"facility": "The Second Affiliated Hospital of Hainan Medical University", "city": "Haikou", "status": "RECRUITING"}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Shanxi Provincial Cancer Hospital", "city": "Taiyuan", "status": "RECRUITING"}, {"facility": "Shaoxing Center Hospital", "city": "Shaoxing", "status": "RECRUITING"}, {"facility": "Taizhou Center Hospital (Taizhou Unoversity Hospital)", "city": "Taizhou", "status": "RECRUITING"}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT04431895", "title": "Safety And Efficacy Of Tofacitinib In Patients With Refractory Myasthenia Gravis: A Pilot Study", "status": "COMPLETED", "start": "2020-06-11", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 19, "sponsor": "Huashan Hospital", "conditions": ["Myasthenia Gravis, Generalized"], "cn_sites": [{"facility": "Huashan Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04302103", "title": "A Study of TACI（Transmembrane Activator and Calcium-modulator and Cyclophilin Ligand (CAML) Interactor）-Antibody Fusion Protein Injection (RC18) in Subjects With Systemic Myasthenia Gravis", "status": "COMPLETED", "start": "2020-07-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 29, "sponsor": "RemeGen Co., Ltd.", "conditions": ["Systemic Myasthenia Gravis"], "cn_sites": [{"facility": "The First Affiliated Hospital of Bengbu Medical University", "city": "Bengbu", "status": ""}, {"facility": "The First Affiliated Hospital of USTC;Anhui Provincial Hospital", "city": "Hefei", "status": ""}, {"facility": "Affiliated Hospital of Zunyi Medical University", "city": "Zunyi", "status": ""}, {"facility": "Nanyang First People's Hospital", "city": "Nanyang", "status": ""}, {"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "Jiangxi Provincial People's Hospital", "city": "Nanchang", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "The Second Affiliated Hospital of Dalian Medical University", "city": "Dalian", "status": ""}, {"facility": "The First Affiliated Hospital of Jinzhou Medical University", "city": "Jinzhou", "status": ""}, {"facility": "The Second Affiliated Hospital of Air Force Medical University", "city": "Xi'an", "status": ""}, {"facility": "West China Hospital, Sichuan University", "city": "Xi'an", "status": ""}, {"facility": "First Hospital of Shanxi Medical University", "city": "Taiyuan", "status": ""}, {"facility": "West China School of Medicine；West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Affiliated Hospital of North Sichuan Medical College", "city": "Nanchong", "status": ""}, {"facility": "Zhejiang Provincial People's Hospital", "city": "Hangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": ""}, {"facility": "Beijing Anzhen Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Beijing Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Beijing Tongren Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "The Third Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "The Second Hospital & Clinical medical school ； Lanzhou University", "city": "Lanzhou", "status": ""}, {"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 24, "broad_only": false}, {"nct": "NCT04346888", "title": "A Study to Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG Patients", "status": "COMPLETED", "start": "2020-07-23", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Harbour BioMed (Guangzhou) Co. Ltd.", "conditions": ["Myasthenia Gravis"], "cn_sites": [{"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05332587", "title": "Efficacy and Safety of Low-dose Rituximab in the Treatment of Refractory Myasthenia Gravis", "status": "UNKNOWN", "start": "2020-08-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "First Affiliated Hospital, Sun Yat-Sen University", "conditions": ["Refractory Myasthenia Gravis", "Rituximab"], "cn_sites": [{"facility": "First Affiliated Hospital, Sun Yat-Sen University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04524273", "title": "Myasthenia Gravis Inebilizumab Trial", "status": "ACTIVE_NOT_RECRUITING", "start": "2020-10-15", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 238, "sponsor": "Amgen", "conditions": ["Myasthenia Gravis"], "cn_sites": [{"facility": "Viela Bio Investigative Site 4009", "city": "Beijing", "status": ""}, {"facility": "Viela Bio Investigative Site - 4007", "city": "Beijing", "status": ""}, {"facility": "Viela Bio Investigative Site 4003", "city": "Beijing", "status": ""}, {"facility": "Viela Bio Investigative Site - 4005", "city": "Guiyang", "status": ""}, {"facility": "Viela Bio Investigative site 4010", "city": "Hunan", "status": ""}, {"facility": "Viela Bio Investigative Site - 4011", "city": "Jinan", "status": ""}, {"facility": "Viela Bio Investigative Site - 4006", "city": "Shanghai", "status": ""}, {"facility": "Viela Bio Investigative Site - 4008", "city": "Suzhou", "status": ""}, {"facility": "Viela Bio Investigative Site - 4004", "city": "Tianjin", "status": ""}, {"facility": "Viela Bio Investigative Site 4012", "city": "Xi'an", "status": ""}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT06443333", "title": "National, Multicentric Registry Study on Neuroimmunological Diseases in China", "status": "UNKNOWN", "start": "2020-12-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 7000, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Multiple Sclerosis", "NMO Spectrum Disorder", "Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease", "Myasthenia Gravis", "Autoimmune Encephalitis", "Acute Disseminated Encephalomyelitis"], "cn_sites": [{"facility": "Xuanwu Hospital ,Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04674605", "title": "A Prospective Cohort Study Of Myasthenia Gravis", "status": "UNKNOWN", "start": "2020-12-31", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "First Affiliated Hospital of Chongqing Medical University", "conditions": ["Myasthenia Gravis", "Myasthenia Gravis Crisis"], "cn_sites": [{"facility": "The First Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05091177", "title": "Study on Correlation Between Cytomegalovirus and Ocular Myasthenia Gravis", "status": "UNKNOWN", "start": "2021-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 125, "sponsor": "XiaoYong Liu", "conditions": ["Ocular Myasthenia Gravis", "Cytomegalovirus Infections"], "cn_sites": [{"facility": "The First Affiliated Hospital of Jinan University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04768465", "title": "Tacrolimus Combined With Low-dose Prednisone for Treatment of Myasthenia Gravis", "status": "UNKNOWN", "start": "2021-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 160, "sponsor": "Da, Yuwei, M.D.", "conditions": ["Myasthenia Gravis"], "cn_sites": [{"facility": "Yuwei Da", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05219097", "title": "The Specificity, Sensitivity and Clinical Correlation of CBA, RIPA and ELISA in Detecting AChR and MuSK IgG of Myasthenia Gravis", "status": "COMPLETED", "start": "2021-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2663, "sponsor": "Tianjin Medical University General Hospital", "conditions": ["Detection Autoantibody of Myasthenia Gravis"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05024071", "title": "Effect of Core Strength Training on Wushu C-level Difficulty Movements ,12 Weeks of Core Strength Training", "status": "COMPLETED", "start": "2021-02-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Universiti Putra Malaysia", "conditions": ["Experimental Myasthenia"], "cn_sites": [{"facility": "Ningxia sports vocational and Technical College", "city": "Yinchuan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05039190", "title": "Evaluate the Efficacy and Safety of HBM9161(HL161)Subcutaneous Injection in Patients With Generalized MG Patients", "status": "COMPLETED", "start": "2021-09-25", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 132, "sponsor": "Harbour BioMed (Guangzhou) Co. Ltd.", "conditions": ["Myasthenia Gravis"], "cn_sites": [{"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04963270", "title": "A Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis", "status": "TERMINATED", "start": "2021-10-19", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 188, "sponsor": "Hoffmann-La Roche", "conditions": ["Generalized Myasthenia Gravis"], "cn_sites": [{"facility": "Beijing Tongren Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Tiantan Hospital,Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "West China Hospital - Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "The Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": ""}, {"facility": "Sir Run Run Shaw Hospital", "city": "Hangzhou", "status": ""}, {"facility": "The First Affiliated Hospital Of Shandong First Medical University", "city": "Jinan", "status": ""}, {"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "Tongji Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Tangdu Hospital", "city": "Xi'an", "status": ""}], "cn_site_count": 12, "broad_only": false}, {"nct": "NCT05132569", "title": "Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia Gravis", "status": "TERMINATED", "start": "2021-12-03", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Sanofi", "conditions": ["Myasthenia Gravis"], "cn_sites": [{"facility": "Investigational Site Number :1560003", "city": "Chengdu", "status": ""}, {"facility": "Investigational Site Number :1560001", "city": "Shanghai", "status": ""}, {"facility": "Investigational Site Number :1560002", "city": "Wuhan", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT05070858", "title": "A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-12-14", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 288, "sponsor": "Regeneron Pharmaceuticals", "conditions": ["Generalized Myasthenia Gravis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Guangdong Hospital of Traditional Chinese Medicine", "city": "Guangdong", "status": ""}, {"facility": "Nanfang Hospital Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "The University of Hong Kong-Shenzhen Hospital", "city": "Shenzhen", "status": ""}, {"facility": "The First Affiliated Hospital of Guangzhou University of Chinese Medicine", "city": "Guangzhou", "status": ""}, {"facility": "Hainan General Hospital", "city": "Haikou", "status": ""}, {"facility": "Renmin Hospital of Wuhan University - Hubei Provincial People's Hospital", "city": "Wuhan", "status": ""}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Qilu Hospital of Shandong University (Qingdan)", "city": "Qingdao", "status": ""}, {"facility": "Huashan Hospital Fudan University", "city": "Shanghai", "status": ""}, {"facility": "The Second Affiliated Hospital of the Chinese Peoples' Liberation Army Air Force Medical University", "city": "Xi’an", "status": ""}, {"facility": "Sichuan Provincial People's Hospital", "city": "Chengdu", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 15, "broad_only": false}, {"nct": "NCT05248568", "title": "Effect of Core Training on Physical Fitness and Offensive Skills, 12 Weeks Core Training", "status": "UNKNOWN", "start": "2022-04-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 46, "sponsor": "Universiti Putra Malaysia", "conditions": ["Experimental Myasthenia"], "cn_sites": [{"facility": "Wuhan Sports University", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05262582", "title": "Comparison of Single Port and Two Ports Robotic Assisted Thoracic Surgery for Thymectomy", "status": "UNKNOWN", "start": "2022-05-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Shanghai Pulmonary Hospital, Shanghai, China", "conditions": ["Thymoma", "Myasthenia Gravis Associated With Thymoma", "Thymectomy"], "cn_sites": [{"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05332210", "title": "Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia Gravis", "status": "COMPLETED", "start": "2022-06-30", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 111, "sponsor": "Harbour BioMed (Guangzhou) Co. Ltd.", "conditions": ["Myasthenia Gravis"], "cn_sites": [{"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07071246", "title": "Rituximab for the Treatment of New-onset AChR-Myasthenia Gravis", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Tang-Du Hospital", "conditions": ["Treatment"], "cn_sites": [{"facility": "Tangdu Hospital, Fourth Military Medical University", "city": "Xi'an", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05556096", "title": "Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-11-21", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 260, "sponsor": "Alexion Pharmaceuticals, Inc.", "conditions": ["Generalized Myasthenia Gravis"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Changchun", "status": ""}, {"facility": "Research Site", "city": "Changsha", "status": ""}, {"facility": "Research Site", "city": "Chengdu", "status": ""}, {"facility": "Research Site", "city": "Fuzhou", "status": ""}, {"facility": "Research Site", "city": "Hangzhou", "status": ""}, {"facility": "Research Site", "city": "Jinan", "status": ""}, {"facility": "Research Site", "city": "Qingdao", "status": ""}, {"facility": "Research Site", "city": "Shanghai", "status": ""}, {"facility": "Research Site", "city": "Suzhou", "status": ""}, {"facility": "Research Site", "city": "Wuhan", "status": ""}, {"facility": "Research Site", "city": "Xi'an", "status": ""}], "cn_site_count": 12, "broad_only": false}, {"nct": "NCT05737160", "title": "Study of Telitacicept in Generalized Myasthenia Gravis", "status": "COMPLETED", "start": "2023-03-28", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 114, "sponsor": "RemeGen Co., Ltd.", "conditions": ["Myasthenia Gravis, Generalized"], "cn_sites": [{"facility": "The First Affiliated Hospital of Bengbu Medical College", "city": "Bengbu", "status": ""}, {"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": ""}, {"facility": "Beijing Hospital", "city": "Beijing", "status": ""}, {"facility": "Xuanwu Hospital of Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Lanzhou University Second Hospital", "city": "Lanzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "Affiliated Hospital of Zunyi Medical University", "city": "Zunyi", "status": ""}, {"facility": "The Second Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "The Second Affiliated Hospital of Harbin Medical University", "city": "Harbin", "status": ""}, {"facility": "Nanyang First People's Hospital", "city": "Nanyang", "status": ""}, {"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": ""}, {"facility": "Renmin Hospital of Wuhan University", "city": "Wuhan", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Wuhan Hospital of Traditional Chinese and Western Medicine (Wuhan No.1 Hospital)", "city": "Wuhan", "status": ""}, {"facility": "Zhongnan Hospital of Wuhan University", "city": "Wuhan", "status": ""}, {"facility": "Third Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "Inner Mongolia Autonomous Region People's Hospital", "city": "Hohhot", "status": ""}, {"facility": "Nanjing First Hospital", "city": "Nanjing", "status": ""}, {"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "Jiangxi Provincial People's Hospital", "city": "Nanchang", "status": ""}, {"facility": "China-Japan Union Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Dalian Municipal Central Hospital", "city": "Dalian", "status": ""}, {"facility": "The First Affiliated Hospital of Dalian Medical University", "city": "Dalian", "status": ""}, {"facility": "The Second Affiliated Hospital of Dalian Medical University", "city": "Dalian", "status": ""}, {"facility": "The First Affiliated Hospital of Jinzhou Medical University", "city": "Jinzhou", "status": ""}, {"facility": "Shengjing Hospital Affiliated to China Medical University", "city": "Shenyang", "status": ""}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "The People's Hospital of Liaoning Province", "city": "Shenyang", "status": ""}, {"facility": "The Second Affiliated Hospital of PLA Air Force Military Medical University", "city": "Xi'an", "status": ""}, {"facility": "Xi'an Hi-tech Hospital", "city": "Xi'an", "status": ""}, {"facility": "Xianyang Hospital of Yan'an University", "city": "Xianyang", "status": ""}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": ""}, {"facility": "Jining No.1 People's Hospital", "city": "Jining", "status": ""}, {"facility": "Huashan Hospital Affiliated to Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shanxi Bethune Hospital", "city": "Taiyuan", "status": ""}, {"facility": "Shanxi Provincial People's Hospital", "city": "Taiyuan", "status": ""}, {"facility": "The First Hospital of Shanxi Medical University", "city": "Taiyuan", "status": ""}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Affiliated Hospital of North Sichuan Medical College", "city": "Nanchong", "status": ""}, {"facility": "First Affiliated Hospital of Xinjiang Medical University", "city": "Ürümqi", "status": ""}, {"facility": "The First Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}, {"facility": "The First People's Hospital of Yunnan Province", "city": "Kunming", "status": ""}, {"facility": "The Second Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}, {"facility": "Sir Run Run Shaw Hospital, affiliated with to Zhejiang University College of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Provincial People's Hospital", "city": "Hangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": ""}], "cn_site_count": 51, "broad_only": false}, {"nct": "NCT05716035", "title": "Open-Label Extension of Tocilizumab in Subjects With Generalized Myasthenia Gravis", "status": "UNKNOWN", "start": "2023-04-01", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 64, "sponsor": "Tang-Du Hospital", "conditions": ["Myasthenia Gravis, Generalized"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": "NOT_YET_RECRUITING"}, {"facility": "Tangdu Hospital, The Fourth Military Medical University", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "Huashan Hospital", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}, {"facility": "Tianjin medical university general hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT05828225", "title": "Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of Refractory Myasthenia Gravis", "status": "UNKNOWN", "start": "2023-04-30", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Zhejiang University", "conditions": ["Myasthenia Gravis"], "cn_sites": [{"facility": "The first affiliated hospital of medical college of zhejiang university", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05888558", "title": "Screening of Serum Exosomal miRNA as a Biomarker for Ocular Muscle Myasthenia Gravis", "status": "UNKNOWN", "start": "2023-07-04", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 160, "sponsor": "First Affiliated Hospital of Jinan University", "conditions": ["Myasthenia Gravis"], "cn_sites": [{"facility": "First Affiliated Hospital of Jinan University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07154095", "title": "A Single-Center, Randomized, Open-Label, Two-Sequence, Two-Period, Crossover Study Comparing the Pharmacokinetics and Safety of Pyridostigmine Sustained-Release and Immediate-Release Tablets Following Single and Multiple Doses in Healthy Chinese Participants", "status": "COMPLETED", "start": "2023-08-10", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "West China Second University Hospital", "conditions": ["Myasthenia Gravis", "Pharmacokinetics"], "cn_sites": [{"facility": "West China Second University Hospital", "city": "Chengdu", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07472777", "title": "Long-term Efficacy of Modified Guilu Erxian Glue for Myasthenia Gravis", "status": "COMPLETED", "start": "2024-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 231, "sponsor": "Beijing University of Chinese Medicine", "conditions": ["Myasthenia Gravis (MG)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Henan University of Chinese Medicine", "city": "Zhengzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06298552", "title": "A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-04-16", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 119, "sponsor": "argenx", "conditions": ["Generalized Myasthenia Gravis", "gMG", "Myasthenia Gravis, Generalized", "Myasthenia Gravis"], "cn_sites": [{"facility": "Xuanwu Hospital Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital", "city": "Chongqing", "status": ""}, {"facility": "The First Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Guangxi Medical University", "city": "Guangxi", "status": ""}, {"facility": "The First Affiliated Hospital of Guangzhou University Chinese Medicine", "city": "Guangzhou", "status": ""}, {"facility": "Guangdong Province Traditional Chinese Medical Hospital", "city": "Guangzhou", "status": ""}, {"facility": "The Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": ""}, {"facility": "Ningbo Medical Center Lihuili Hospital", "city": "Ningbo", "status": ""}, {"facility": "Qilu Hospital of Shandong University", "city": "Qingdao", "status": ""}, {"facility": "Huashan Hospital Fudan University", "city": "Shanghai", "status": ""}, {"facility": "First Hospital of Shanxi Medical University", "city": "Taiyuan", "status": ""}, {"facility": "Tongji Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 14, "broad_only": false}, {"nct": "NCT06436768", "title": "Efficacy and Safety of Sugammadex in Thoracoscopy Thymectomy for Chinese Adults With Myasthenia Gravis", "status": "COMPLETED", "start": "2024-06-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 62, "sponsor": "Beijing Tongren Hospital", "conditions": ["Reversal of Neuromuscular Blockade"], "cn_sites": [{"facility": "Beijing tongren Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital with Nanjing Medical University", "city": "Nanjing", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06707727", "title": "Characteristics and Prognostic Outcomes of Diaphragmatic Ultrasound in Myasthenia Gravis", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-07-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "First Affiliated Hospital of Chongqing Medical University", "conditions": ["Myasthaenia Gravis"], "cn_sites": [{"facility": "The First Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06517758", "title": "A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-07-31", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 146, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Generalized Myasthenia Gravis"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Hefei", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shenzhen", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shijiazhuang", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Changsha", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Suzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Xi'an", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Xianyang", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Fujian", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Jinan", "status": ""}], "cn_site_count": 11, "broad_only": false}, {"nct": "NCT06558279", "title": "A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-09-18", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 141, "sponsor": "argenx", "conditions": ["Myasthenia Gravis, Ocular"], "cn_sites": [{"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": ""}, {"facility": "Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital", "city": "Chengdu", "status": ""}, {"facility": "The First Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Guangdong Province Traditional Chinese Medical Hospital", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Guangzhou University Chinese Medicine", "city": "Guangzhou", "status": ""}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University - Xianghu Campus", "city": "Nanchang", "status": ""}, {"facility": "Huashan Hospital Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shijiazhuang People's Hospital - Fangbeilu Campus", "city": "Shijiazhuang", "status": ""}, {"facility": "Tongji Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Renmin Hospital of Wuhan University - Main Campus", "city": "Wuhan", "status": ""}], "cn_site_count": 12, "broad_only": false}, {"nct": "NCT06700616", "title": "A Study in Patients With Myasthenia Gravis in China", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-09-26", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1199, "sponsor": "AstraZeneca", "conditions": ["Myasthenia Gravis"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Chengdu", "status": ""}, {"facility": "Research Site", "city": "Fuzhou", "status": ""}, {"facility": "Research Site", "city": "Guangzhou", "status": ""}, {"facility": "Research Site", "city": "Guiyang", "status": ""}, {"facility": "Research Site", "city": "Harbin", "status": ""}, {"facility": "Research Site", "city": "Hebei", "status": ""}, {"facility": "Research Site", "city": "Henan", "status": ""}, {"facility": "Research Site", "city": "Inner Mongolia", "status": ""}, {"facility": "Research Site", "city": "Jiangsu", "status": ""}, {"facility": "Research Site", "city": "Lanzhou", "status": ""}, {"facility": "Research Site", "city": "Nanning", "status": ""}, {"facility": "Research Site", "city": "Qingdao", "status": ""}, {"facility": "Research Site", "city": "Taiyuan", "status": ""}, {"facility": "Research Site", "city": "Tianjin", "status": ""}, {"facility": "Research Site", "city": "Ürümqi", "status": ""}, {"facility": "Research Site", "city": "Wenzhou", "status": ""}, {"facility": "Research Site", "city": "Wuhan", "status": ""}, {"facility": "Research Site", "city": "Xi'an", "status": ""}, {"facility": "Research Site", "city": "Yinchuan", "status": ""}], "cn_site_count": 20, "broad_only": false}, {"nct": "NCT06419166", "title": "An Exploratory Clinical Study of GC012F Injection for Refractory gMG", "status": "WITHDRAWN", "start": "2024-12-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Zhejiang University", "conditions": ["Refractory Generalized Myasthenia Gravis"], "cn_sites": [{"facility": "The First Affiliated Hospital,College of Medicine, Zhejiang University", "city": "Hanzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06764160", "title": "Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Eculizumab in Chinese Adults With gMG", "status": "COMPLETED", "start": "2025-01-06", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Alexion Pharmaceuticals, Inc.", "conditions": ["Generalized Myasthenia Gravis (gMG)", "Refractory gMG"], "cn_sites": [{"facility": "Research Site", "city": "Changchun", "status": ""}, {"facility": "Research Site", "city": "Fuzhou", "status": ""}, {"facility": "Research Site", "city": "Guangzhou", "status": ""}, {"facility": "Research Site", "city": "Qingdao", "status": ""}, {"facility": "Research Site", "city": "Shanghai", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT06958939", "title": "The Safety and Efficacy of S103 in the Treatment of Refractory Generalized Myasthenia Gravis", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-05-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Ting Chang, MD", "conditions": ["Myasthenia Gravis, Generalized"], "cn_sites": [{"facility": "The Second Affiliated Hospital of Air Force Medical University", "city": "Xi'an", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06869278", "title": "A Study of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases", "status": "WITHDRAWN", "start": "2025-06-17", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": ["Multiple Sclerosis (MS)", "Neuromyelitis Optica Spectrum Disease (NMOSD)", "Anti-Myelin Oligodendrocyte Glycoprotein-IgG Associated Disorders (MOGAD)", "Myasthenia Gravis"], "cn_sites": [{"facility": "The Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": ""}, {"facility": "The First Affiliated Hospital of SOOCHOW University", "city": "Suzhou", "status": ""}, {"facility": "Union Hospital Tongji Medical College HUAZHONG University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT06965309", "title": "Efficacy and Safety of HN2301 in Refractory Myasthenia Gravis(MG)", "status": "TERMINATED", "start": "2026-01-19", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Shenzhen MagicRNA Biotechnology Co., Ltd", "conditions": ["Refractory Myasthenia Gravis"], "cn_sites": [{"facility": "Shanghai General Hospital (Songjiang Branch) of Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 132, "g_fetched": 86, "g_countries": [["United States", 46], ["Italy", 20], ["France", 14], ["Poland", 14], ["Spain", 10], ["Germany", 10], ["United Kingdom", 8], ["Belgium", 7], ["Australia", 6], ["Japan", 5], ["Netherlands", 5], ["Canada", 4], ["Israel", 4], ["Brazil", 3], ["Serbia", 3], ["Greece", 3], ["Georgia", 3], ["Taiwan", 3], ["Argentina", 2], ["Switzerland", 2], ["Czechia", 2], ["Denmark", 2], ["South Korea", 2], ["Austria", 2], ["Turkey (Türkiye)", 1], ["Bulgaria", 1], ["Russia", 1], ["Hungary", 1], ["Mexico", 1], ["Romania", 1], ["Saudi Arabia", 1]], "g_trials": [{"nct": "NCT07465289", "title": "A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis", "status": "NOT_YET_RECRUITING", "start": "2026-09-16", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "UCB Biopharma SRL", "countries": []}, {"nct": "NCT07571525", "title": "Thymic Disease, Autoimmunity, and Neuromuscular Junction Integrity in Myasthenia Gravis", "status": "NOT_YET_RECRUITING", "start": "2026-09-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS San Raffaele", "countries": ["Italy"]}, {"nct": "NCT07787247", "title": "Feasibility of Remote Monitoring of Patients With Myasthenia Gravis", "status": "RECRUITING", "start": "2026-08-19", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "George Washington University", "countries": ["United States"]}, {"nct": "NCT07673744", "title": "A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)", "status": "RECRUITING", "start": "2026-07-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "TG Therapeutics, Inc.", "countries": ["United States"]}, {"nct": "NCT07677852", "title": "Sexual and Urinary Dysfunctions in Generalized Myasthenia", "status": "NOT_YET_RECRUITING", "start": "2026-07-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Centre Hospitalier Universitaire de Nice", "countries": ["France"]}, {"nct": "NCT06987539", "title": "A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)", "status": "RECRUITING", "start": "2026-07-21", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Amgen", "countries": ["Argentina", "Brazil", "France", "Poland", "Spain", "United States"]}, {"nct": "NCT07673627", "title": "ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis", "status": "RECRUITING", "start": "2026-07-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "argenx", "countries": ["United States"]}, {"nct": "NCT07647510", "title": "A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)", "status": "RECRUITING", "start": "2026-06-29", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Dianthus Therapeutics", "countries": ["United States"]}, {"nct": "NCT07570589", "title": "Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO® (Rozanolixizumab)", "status": "RECRUITING", "start": "2026-06-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Centre Hospitalier Universitaire de Nice", "countries": ["France"]}, {"nct": "NCT07717281", "title": "PANORAMA: Neuromuscular Organoids for Refractory AChR+ Myasthenia Gravis", "status": "RECRUITING", "start": "2026-06-04", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico", "countries": ["Italy"]}, {"nct": "NCT07501702", "title": "A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis", "status": "RECRUITING", "start": "2026-05-13", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Vertex Pharmaceuticals Incorporated", "countries": ["Australia", "Poland", "Turkey (Türkiye)", "United Kingdom", "United States"]}, {"nct": "NCT07596901", "title": "Study of Aritinercept in Patients With Generalized Myasthenia Gravis", "status": "RECRUITING", "start": "2026-04-22", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Aurinia Pharmaceuticals Inc.", "countries": ["United States"]}, {"nct": "NCT07304154", "title": "A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases", "status": "RECRUITING", "start": "2026-04-10", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Kite, A Gilead Company", "countries": ["Australia", "Canada", "United States"]}, {"nct": "NCT06866652", "title": "Evaluating Dyspnea in Autoimmune Myasthenia Gravis \"Why am I Short of Breath?\"", "status": "RECRUITING", "start": "2026-04-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Institut de Myologie, France", "countries": ["France"]}, {"nct": "NCT07512375", "title": "The Effectiveness of an ETP Programme in Myasthenia Gravis: a Proof-of-concept Study.", "status": "NOT_YET_RECRUITING", "start": "2026-04", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Grenoble", "countries": []}, {"nct": "NCT07323316", "title": "Holistic Assessment and Remote Digital MONitoring of mYasthenia Gravis Via MyoSense 360", "status": "NOT_YET_RECRUITING", "start": "2026-04", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Ad scientiam", "countries": []}, {"nct": "NCT07499323", "title": "Talquetamab in Patients With Refractory Generalized Myasthenia Gravis", "status": "NOT_YET_RECRUITING", "start": "2026-03-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "First Affiliated Hospital of Chongqing Medical University", "countries": []}, {"nct": "NCT07761026", "title": "AXIS MG Patient Registry", "status": "RECRUITING", "start": "2026-03-19", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Autoimmune Neurology Alliance", "countries": ["United States"]}, {"nct": "NCT07478172", "title": "Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease", "status": "RECRUITING", "start": "2026-03-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Missouri-Columbia", "countries": ["United States"]}, {"nct": "NCT07221838", "title": "A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab", "status": "RECRUITING", "start": "2026-03-04", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Alexion Pharmaceuticals, Inc.", "countries": ["Germany", "Italy", "Japan", "United States"]}, {"nct": "NCT07595653", "title": "A Study to Evaluate the Impact of Efgartigimod on Overall Disease Experience of People Suffering From Generalized Myasthenia Gravis (gMG) in Italy", "status": "RECRUITING", "start": "2026-02-25", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "argenx", "countries": ["Italy"]}, {"nct": "NCT07250750", "title": "A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis", "status": "RECRUITING", "start": "2026-02-05", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "ImmunAbs Inc.", "countries": ["Bulgaria", "Italy", "Poland", "Serbia", "Spain", "United States"]}, {"nct": "NCT07372807", "title": "Ripertamab for the Treatment of Myasthenia Gravis", "status": "NOT_YET_RECRUITING", "start": "2026-02", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Zhongming Qiu", "countries": []}, {"nct": "NCT07033559", "title": "Detecting Fatigue From Voice in Generalised Myasthenia Gravis", "status": "NOT_YET_RECRUITING", "start": "2026-02", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Thymia Limited", "countries": []}, {"nct": "NCT07215949", "title": "Zilucoplan for Severe gMG Exacerbations", "status": "RECRUITING", "start": "2026-01-20", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Miriam Freimer", "countries": ["United States"]}]}, {"batch": 1, "no": 33, "name_zh": "Gitelman 综合征", "query_terms": [{"term": "Gitelman syndrome", "broad": false}], "n_total": 1, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT06922370", "title": "The Osteoarticular Manifestations in Patients With Gitelman Syndrome", "status": "RECRUITING", "start": "2021-11-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 120, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Gitelman Syndrome", "CPPD - Calcium Pyrophosphate Deposition Disease"], "cn_sites": [{"facility": "the second affiliated hospital, Zhejiang University School of medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}], "g_total": 2, "g_fetched": 1, "g_countries": [["United Kingdom", 1]], "g_trials": [{"nct": "NCT06065852", "title": "National Registry of Rare Kidney Diseases", "status": "RECRUITING", "start": "2009-11-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "UK Kidney Association", "countries": ["United Kingdom"]}]}, {"batch": 1, "no": 34, "name_zh": "戊二酸血症I型", "query_terms": [{"term": "Glutaryl-CoA dehydrogenase deficiency", "broad": false}, {"term": "Glutaric Acidemia Type I", "broad": false}], "n_total": 1, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT06217861", "title": "A Study to Evaluate the Tolerability, Safety and Efficacy of VGM-R02b", "status": "RECRUITING", "start": "2024-04-29", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Shanghai Vitalgen BioPharma Co., Ltd.", "conditions": ["Glutaric Acidemia Type I", "Glutaric Aciduria Type I"], "cn_sites": [{"facility": "The Children's Hospital Zhejiang University Shcool of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}], "g_total": 2, "g_fetched": 1, "g_countries": [["United States", 1]], "g_trials": [{"nct": "NCT04602325", "title": "Systemic Biomarkers of Brain Injury From Hyperammonemia", "status": "RECRUITING", "start": "2020-07-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Children's National Research Institute", "countries": ["United States"]}]}, {"batch": 1, "no": 35, "name_zh": "糖原累积病（I型、Ⅱ型）", "query_terms": [{"term": "Glycogen storage disease", "broad": false}], "n_total": 9, "n_open": 5, "n_open_precise": 5, "n_broad": 0, "trials": [{"nct": "NCT00231400", "title": "Pompe Disease Registry Protocol", "status": "RECRUITING", "start": "2004-09-15", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2000, "sponsor": "Genzyme, a Sanofi Company", "conditions": ["Glycogen Storage Disease Type II", "Pompe Disease"], "cn_sites": [{"facility": "Investigational Site Number : 152380", "city": "Beijing", "status": "TERMINATED"}, {"facility": "Investigational Site Number : 153202", "city": "Beijing", "status": "TERMINATED"}, {"facility": "Investigational Site Number : 153203", "city": "Beijing", "status": "COMPLETED"}, {"facility": "Investigational Site Number : 152379", "city": "Guangzhou", "status": "TERMINATED"}, {"facility": "Investigational Site Number : 152381", "city": "Jinan", "status": "TERMINATED"}, {"facility": "Investigational Site Number : 157250", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 152382", "city": "Shanghai", "status": "TERMINATED"}, {"facility": "Investigational Site Number : 152356", "city": "Shanghai", "status": "TERMINATED"}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT07336394", "title": "Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques", "status": "RECRUITING", "start": "2010-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "Chinese Academy of Medical Sciences, Fuwai Hospital", "conditions": ["Danon Disease", "Fabry Disease", "Cardiac Amyloidosis", "Noonan Syndrome", "Cardiac Sarcoidosis", "Glycogen Storage Disease", "Idiopathic Cardiomyopathy"], "cn_sites": [{"facility": "Fuwai Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06178432", "title": "Evaluation of the Safety, Tolerability and Efficacy of Gene Therapy Drug for Late Onset Pompe Disease (LOPD)", "status": "NOT_YET_RECRUITING", "start": "2023-12", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Huashan Hospital", "conditions": ["Pompe Disease (Late-onset)"], "cn_sites": [{"facility": "Huashan Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06391736", "title": "Evaluation of the Safety and Efficacy of Late-onset Pompe Disease Gene Therapy Drug", "status": "RECRUITING", "start": "2024-04-19", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 33, "sponsor": "GeneCradle Inc", "conditions": ["Pompe Disease (Late-onset)"], "cn_sites": [{"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06666413", "title": "China Post-approval Commitment (PAC) Study of Avalglucosidase Alfa in Participants With IOPD", "status": "RECRUITING", "start": "2025-05-07", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 13, "sponsor": "Genzyme, a Sanofi Company", "conditions": ["Glycogen Storage Disease Type II", "Pompe's Disease"], "cn_sites": [{"facility": "Investigational Site Number: 1560001", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03687333", "title": "Evaluate Efficacy and Safety in Chinese Patients With Infantile-Onset Pompe Disease With One Year Alglucosidase Alfa Treatment", "status": "COMPLETED", "start": "2018-12-04", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Genzyme, a Sanofi Company", "conditions": ["Glycogen Storage Disease Type II"], "cn_sites": [{"facility": "Investigational site number", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04676373", "title": "Study to Evaluate Efficacy and Safety in Chinese Patients With Late Onset Pompe Disease With Alglucosidase Alfa Treatmen", "status": "COMPLETED", "start": "2021-03-10", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 41, "sponsor": "Genzyme, a Sanofi Company", "conditions": ["Pompe's Disease"], "cn_sites": [{"facility": "Investigational Site", "city": "China", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04910776", "title": "Clinical Study for Treatment-naïve IOPD Babies to Evaluate Efficacy and Safety of ERT With Avalglucosidase Alfa", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-09-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 17, "sponsor": "Sanofi", "conditions": ["Glycogen Storage Disease Type II"], "cn_sites": [{"facility": "Investigational Site Number : 1560002", "city": "Qingdao", "status": ""}, {"facility": "Investigational Site Number : 1560001", "city": "Shanghai", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05960617", "title": "Efficacy and Safety of Empagliflozin in GSD-Ib Patients", "status": "WITHDRAWN", "start": "2023-07-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": ["Glycogen Storage Disease Type IB"], "cn_sites": [{"facility": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 48, "g_fetched": 43, "g_countries": [["United States", 23], ["Italy", 11], ["Germany", 7], ["United Kingdom", 6], ["France", 5], ["Belgium", 4], ["Netherlands", 4], ["Denmark", 3], ["Spain", 3], ["Brazil", 2], ["Taiwan", 2], ["Czechia", 2], ["Australia", 2], ["Switzerland", 1], ["Canada", 1], ["Japan", 1], ["India", 1], ["Austria", 1], ["Greece", 1], ["Hungary", 1], ["Poland", 1], ["Slovenia", 1], ["Israel", 1], ["Croatia", 1]], "g_trials": [{"nct": "NCT05402332", "title": "Evaluating the Efficacy and Safety of D-galactose in PGM1-CDG (AVTX-801)", "status": "NOT_YET_RECRUITING", "start": "2026-10-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Eva Morava-Kozicz", "countries": ["United States"]}, {"nct": "NCT07787650", "title": "A Study of S-606001 as Monotherapy in Participants With Late-onset Pompe Disease (LOPD)", "status": "NOT_YET_RECRUITING", "start": "2026-09-30", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Shionogi", "countries": []}, {"nct": "NCT07738107", "title": "ATR 1072 in Participants With PRKAG2 Syndrome", "status": "RECRUITING", "start": "2026-09-14", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Atrium Therapeutics", "countries": ["United States"]}, {"nct": "NCT07750990", "title": "An Extension Study of S-606001 in Participants With Late-onset Pompe Disease (LOPD)", "status": "NOT_YET_RECRUITING", "start": "2026-08-31", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Shionogi", "countries": []}, {"nct": "NCT07739394", "title": "Diazoxide in the Treatment of Type 1 Glycogenosis", "status": "NOT_YET_RECRUITING", "start": "2026-08-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Central Hospital, Nancy, France", "countries": []}, {"nct": "NCT07459582", "title": "Accuracy of Home Lactate Meter and Accu-chek Glucometer in Patients With Glycogen Storage Disease", "status": "RECRUITING", "start": "2026-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Connecticut Children's Medical Center", "countries": ["United States"]}, {"nct": "NCT07354724", "title": "A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL952 in Adult Participants With Late-Onset Pompe Disease", "status": "RECRUITING", "start": "2026-05-12", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Denali Therapeutics Inc.", "countries": ["United States"]}, {"nct": "NCT07282847", "title": "A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD)", "status": "RECRUITING", "start": "2026-04-15", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "AskBio Inc", "countries": ["United States"]}, {"nct": "NCT07664930", "title": "Phrenic Nerve and Diaphragm Electrophysiology in Pompe Disease", "status": "RECRUITING", "start": "2026-03-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS National Neurological Institute \"C. Mondino\" Foundation", "countries": ["Italy"]}, {"nct": "NCT07478172", "title": "Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease", "status": "RECRUITING", "start": "2026-03-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Missouri-Columbia", "countries": ["United States"]}, {"nct": "NCT07645898", "title": "Use of Continuous Glucose Monitoring to Evaluate Postprandial Response to Raw Cornstarch Supplementation in Adult Glycogen Storage Disease Type I", "status": "RECRUITING", "start": "2026-02-05", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Federico II University", "countries": ["Italy"]}, {"nct": "NCT07123155", "title": "Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)", "status": "RECRUITING", "start": "2025-10-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Shionogi", "countries": ["Belgium", "Denmark", "France", "Germany", "Italy", "Netherlands", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT06852612", "title": "Dietary Treatment Strategies and Metabolic Control in Glycogen Storage Disease Type I", "status": "RECRUITING", "start": "2025-04-24", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Insel Gruppe AG, University Hospital Bern", "countries": ["Switzerland"]}, {"nct": "NCT06843330", "title": "Accuracy of Lactate Meter in GSDIa", "status": "RECRUITING", "start": "2025-04-14", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Connecticut Children's Medical Center", "countries": ["United States"]}, {"nct": "NCT06833489", "title": "Transcriptomic Analysis to Put an End to Misdiagnosis in Patients With Rare Muscle Diseases", "status": "RECRUITING", "start": "2025-03-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique Hopitaux De Marseille", "countries": ["France"]}, {"nct": "NCT06795152", "title": "Rare Glycogen Storage Diseases Natural History Study", "status": "RECRUITING", "start": "2024-12-23", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Duke University", "countries": ["United States"]}, {"nct": "NCT06735755", "title": "A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Disease Type Ia (GSDIa)", "status": "RECRUITING", "start": "2024-12-06", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Beam Therapeutics Inc.", "countries": ["United States"]}, {"nct": "NCT06636383", "title": "Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program", "status": "RECRUITING", "start": "2024-11-04", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Ultragenyx Pharmaceutical Inc", "countries": ["Brazil", "Canada", "Denmark", "Germany", "Italy", "Japan", "Netherlands", "Spain", "United States"]}, {"nct": "NCT06557369", "title": "A Clinical Trial Evaluating the Safety and Efficacy of a New Light Combination Therapy Addressing Intermediate AMD", "status": "RECRUITING", "start": "2024-11", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Oculox Technologies SA", "countries": ["Italy"]}, {"nct": "NCT07303140", "title": "Non-invasive Assessment of Liver Fibrosis in a French Cohort of Pediatric Patients With Type III Glycogen Storage Disease: Current State and Perspectives", "status": "RECRUITING", "start": "2024-10-18", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Strasbourg, France", "countries": ["France"]}, {"nct": "NCT06575829", "title": "Treatment Frequency Reduction in Pompe Disease", "status": "NOT_YET_RECRUITING", "start": "2024-10-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Erasmus Medical Center", "countries": []}, {"nct": "NCT06396546", "title": "'Glycogen Storage Diseases (GSDs) in Indian Children- Establishing an Indian GSD (I-GSD) Registry'", "status": "RECRUITING", "start": "2024-05-02", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Institute of Liver and Biliary Sciences, India", "countries": ["India"]}, {"nct": "NCT07136844", "title": "Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology", "status": "RECRUITING", "start": "2024-03-29", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Centre Hospitalier Universitaire de Liege", "countries": ["Belgium"]}, {"nct": "NCT06121011", "title": "A Global Prospective Observational Registry of Patients With Pompe Disease", "status": "RECRUITING", "start": "2024-02-16", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Amicus Therapeutics", "countries": ["Austria", "Belgium", "Denmark", "Germany", "Greece", "Hungary", "Italy", "Netherlands", "Poland", "Slovenia", "United Kingdom", "United States"]}, {"nct": "NCT06214507", "title": "Danon Disease Natural History Study", "status": "RECRUITING", "start": "2023-12-20", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Rocket Pharmaceuticals Inc.", "countries": ["Germany", "Israel", "Italy", "Spain", "United Kingdom", "United States"]}]}, {"batch": 1, "no": 36, "name_zh": "血友病", "query_terms": [{"term": "Hemophilia", "broad": false}], "n_total": 114, "n_open": 30, "n_open_precise": 30, "n_broad": 0, "trials": [{"nct": "NCT04645199", "title": "National Longitudinal Cohort of Hematological Diseases", "status": "RECRUITING", "start": "2020-12-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2300, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Multiple Myeloma", "Acute Myeloid Leukemia", "Hemophilia", "Hemophilia A", "Hemophilia B", "Myelodysplastic Syndrome", "MDS", "Lymphoma", "Leukemia", "Aplastic Anemia", "Bleeding Disorder", "Bone Marrow Transplantation", "Blood Disease Infection", "Autoimmune Hemolytic Anemia, AIHA", "Essential Thrombocythemia, ET", "Large Granular Lymphocyte Leukemia, LGLL", "Paroxysmal Nocturnal Hemoglobinuria, PNH"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04728841", "title": "Gene Therapy for Chinese Hemophilia A", "status": "RECRUITING", "start": "2021-03-04", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Hemophilia A", "Gene Therapy"], "cn_sites": [{"facility": "Chinese Academy of Medical Science and Blood Disease Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05145127", "title": "Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors", "status": "RECRUITING", "start": "2021-11-17", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 245, "sponsor": "Pfizer", "conditions": ["Hemophilia A", "Hemophilia B"], "cn_sites": [{"facility": "Nanfang Hospital, Southern Medical University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "The Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": "RECRUITING"}, {"facility": "Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Jiangxi Provincial People's Hospital", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Institute of hematology&blood disease hospital", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT05641610", "title": "A Study to Evaluate the Safety and Efficacy of ZS801 in Adult Hemophilia B Patients", "status": "RECRUITING", "start": "2022-02-16", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 21, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Hemophilia B"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05454774", "title": "A Study of FVIII Gene Therapy for Hemophilia A", "status": "RECRUITING", "start": "2022-07-19", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 8, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05611801", "title": "A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B", "status": "RECRUITING", "start": "2022-12-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Pfizer", "conditions": ["Hemophilia A", "Hemophilia B"], "cn_sites": [{"facility": "Beijing Children's hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Southern Medical University Nanfang Hospital", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "The Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": "RECRUITING"}, {"facility": "Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Tongji Hospital of Tongji Medical College of HUST/Pediatric Hematology Department Pharmacy", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Jiangxi Provincial People's Hospital", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Institute of hematology&blood disease hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT05709288", "title": "Gene Therapy for Hemophilia B Patients Aged 12-18 Years Old", "status": "RECRUITING", "start": "2023-03-23", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Hemophilia B"], "cn_sites": [{"facility": "Institute of haematology and Blood diseases hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05630651", "title": "The Efficacy and Safety of ZS801 in Chinese Hemophilia B Patients.", "status": "RECRUITING", "start": "2023-04-19", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Hemophilia B"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05849740", "title": "An Exploratory Study of Cluster of Differentiation 38 (CD38) Monoclonal Antibody Combined Corticosteroid in Acquired Hemophilia A", "status": "RECRUITING", "start": "2023-05-22", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 25, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Acquired Hemophilia"], "cn_sites": [{"facility": "Chinese Academy of Medical Science and Blood Disease Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07205523", "title": "High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)", "status": "RECRUITING", "start": "2023-09-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "Yigeng Cao,MD,PhD", "conditions": ["Hematopoietic Stem Cell Transplantation (HSCT)", "Acute Myeloid Leukemia (AML)", "Leukemias, Acute Myeloid", "Myeloid Leukemias, Acute", "Hemophilia", "Myelodysplastic Syndrome", "MDS", "Lymphoma", "Leukemia", "Aplastic Anemia", "Bleeding Disorders", "Bone Marrow Transplantation", "Multiple Myeloma", "Myeloma, Multiple", "Immune Reconstitution"], "cn_sites": [{"facility": "Affiliated Hospital of Qinghai University", "city": "Xining", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05888870", "title": "ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer Inhibitor", "status": "RECRUITING", "start": "2023-11-22", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Hemophilia A With Inhibitor"], "cn_sites": [{"facility": "Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06111638", "title": "Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs", "status": "RECRUITING", "start": "2024-01-03", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 55, "sponsor": "Shanghai Xinzhi BioMed Co., Ltd.", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "Peking Union Medical College Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Southern Hospital, Southern Medical University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": "RECRUITING"}, {"facility": "Wuhan Union Hospital Affiliated to Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": "RECRUITING"}, {"facility": "The Affiliated Hospital of Northwest University Xi'an No.3 Hospital", "city": "Xi’an", "status": "RECRUITING"}, {"facility": "Sichuan Provincial People's Hospital", "city": "Chengde", "status": "RECRUITING"}, {"facility": "Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": "RECRUITING"}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT06238908", "title": "Safety and Efficacy Study of NGGT003 in Hemophilia A Patients", "status": "RECRUITING", "start": "2024-01-17", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07437404", "title": "Efficacy and Safety Evaluation Study of SCT800 in Previously Untreated Hemophilia A Patients.", "status": "RECRUITING", "start": "2024-04-26", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Sinocelltech Ltd.", "conditions": ["Haemophilia A"], "cn_sites": [{"facility": "Beijing children's hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07644832", "title": "An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII Deficiency", "status": "RECRUITING", "start": "2024-05-31", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 76, "sponsor": "Shanghai RAAS Blood Products Co., Ltd.", "conditions": ["Hemophilia A", "Hemophilia B", "Factor VII Deficiency"], "cn_sites": [{"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of University of Science and Technology of China", "city": "Hefei", "status": "RECRUITING"}, {"facility": "Jinan Central Hospital", "city": "Jinan", "status": "RECRUITING"}, {"facility": "The First Hospital of Lanzhou University", "city": "Lanzhou", "status": "RECRUITING"}, {"facility": "Ruijin Hospital Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": "COMPLETED"}, {"facility": "The Second Hospital of Shanxi Medical University", "city": "Taiyuan", "status": "RECRUITING"}, {"facility": "Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": "COMPLETED"}, {"facility": "Xian Central Hospital", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "Zhengzhou People's Hospital", "city": "Zhengzhou", "status": "RECRUITING"}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT06727669", "title": "Longitudinal Cohort of Thrombosis and Hemostasis Diseases", "status": "RECRUITING", "start": "2024-11-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 3000, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia", "Thrombotic Thrombocytopenic Purpura", "Hemophilia A, Acquired", "Disseminated Intravascular Coagulation", "Thrombophilia", "Deep Vein Thrombosis", "Pulmonary Embolism", "Thrombotic Microangiopathies", "Coagulation Factor Deficiency", "Hemophilia A", "Hemophilia B", "Hemophilia B, Acquired", "Platelet Dysfunction", "Arterial Thromboembolism", "Bleeding Disorder", "Thrombosis"], "cn_sites": [{"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Department of Hematology, Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Department of Hematology, Beijing Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Xinqiao Hospital, Army Military Medical University", "city": "Chongqing", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT06864975", "title": "Assessing Different FVIII Doses and Frequencies in Immune Tolerance Induction (ITI) with ADVATE Among Hemophilia a Boys with Inhibitor (INITIATE Study)", "status": "RECRUITING", "start": "2025-03-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 110, "sponsor": "Runhui WU", "conditions": ["Hemophilia a with Inhibitor"], "cn_sites": [{"facility": "Beijing Children's hospitial", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06833983", "title": "To Evaluate the Clinical Study of GS1191-0445 Injection in the Treatment of Hemophilia A", "status": "RECRUITING", "start": "2025-03-31", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Gritgen Therapeutics Co., Ltd.", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": "NOT_YET_RECRUITING"}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "First Hospital of Lanzhou University", "city": "Lanzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Nanfang Hospital Southern Medical University", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "North China University of Science and Technology Affiliated Hospital", "city": "Tangshan", "status": "NOT_YET_RECRUITING"}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}, {"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": "NOT_YET_RECRUITING"}, {"facility": "Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School", "city": "Nanjing", "status": "NOT_YET_RECRUITING"}, {"facility": "Jiangxi Provincial People's Hospital", "city": "Nanchang", "status": "NOT_YET_RECRUITING"}, {"facility": "Central Hospital Affiliated to Shandong First Medical University", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "The second Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 13, "broad_only": false}, {"nct": "NCT07285460", "title": "A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B", "status": "RECRUITING", "start": "2025-12-18", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 85, "sponsor": "Sanofi", "conditions": ["Hemophilia"], "cn_sites": [{"facility": "Investigational Site Number : 1560001", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06992076", "title": "Adult and Adolescent Hemophilia Patients Treated With Marstacimab: a Patient Experience Registry", "status": "RECRUITING", "start": "2026-02-15", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Hemophilia"], "cn_sites": [{"facility": "The First Affiliated Hospital of Xiamen University", "city": "Xiamen", "status": "RECRUITING"}, {"facility": "Institute of haematology and Blood diseases hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07406139", "title": "PCC Treatment for Hemophilia Patients With Inhibitor（2022PCC-A）", "status": "RECRUITING", "start": "2026-03-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Hemophilia", "Inhibitors"], "cn_sites": [{"facility": "Institute of haematology and Blood diseases hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07545395", "title": "Safety of KN057 Prophylaxis in Patients With Haemophilia A or B", "status": "RECRUITING", "start": "2026-03-13", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 70, "sponsor": "Suzhou Alphamab Co., Ltd.", "conditions": ["Hemophilia A or B"], "cn_sites": [{"facility": "Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07416604", "title": "A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A", "status": "RECRUITING", "start": "2026-04-27", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 360, "sponsor": "Hoffmann-La Roche", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "Nanfang Hospital, Southern Medical University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Chengdu Women's and Children's Central Hospital", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences", "city": "Tianjin", "status": "SUSPENDED"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07789587", "title": "A Study of Bometase Alfa for Bleeding Control in Acquired Hemophilia A", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Acquired Hemophilia A"], "cn_sites": [{"facility": "Chinese Academy of Medical Science and Blood Disease Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07657715", "title": "Effects of Dexmedetomidine on Sublingual Microcirculation and Vascular Waterfall Phenomenon in Patients With Septic Shock", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "First Affiliated Hospital of Wannan Medical College", "conditions": ["Septic Shock", "Sepsis", "Critical Illness"], "cn_sites": [{"facility": "The First Affiliated Hospital of Bengbu Medical University", "city": "Bengbu", "status": ""}, {"facility": "The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)", "city": "Wuhu", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07657702", "title": "Effects of Anisodamine on Sublingual Microcirculation and Vascular Waterfall Phenomenon in Patients With Septic Shock", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "First Affiliated Hospital of Wannan Medical College", "conditions": ["Septic Shock", "Sepsis", "Critical Illness"], "cn_sites": [{"facility": "The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)", "city": "Wuhu", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07788469", "title": "A Study of Elranatamab for Inhibitor Eradication in Patients With Hemophilia A", "status": "NOT_YET_RECRUITING", "start": "2026-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Hemophilia A With Inhibitors"], "cn_sites": [{"facility": "Chinese Academy of Medical Science and Blood Disease Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06136507", "title": "Study of Efficacy and Safety of FRSW107 in Pediatric Patients With Severe Hemophilia A", "status": "NOT_YET_RECRUITING", "start": "2026-12-25", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 76, "sponsor": "Hangzhou Gensciences Biopharmaceutical Co., Ltd.", "conditions": ["Severe Hemophilia A"], "cn_sites": [{"facility": "Children's Hospital Affiliated to Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "Guangzhou Women and Children Medical Center", "city": "Guangzhou", "status": ""}, {"facility": "Nanfang Hospital, Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Affiliated Hospital of Guizhou Medical University", "city": "Guizhou", "status": ""}, {"facility": "Children's Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Anhui Children's Hospital", "city": "Hefei", "status": ""}, {"facility": "The Second Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": ""}, {"facility": "Nanjing Children's Hospital", "city": "Nanjing", "status": ""}, {"facility": "Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": ""}, {"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": ""}, {"facility": "Shanxi Children's Hospital", "city": "Taiyuan", "status": ""}, {"facility": "Beijing Children's Hospital Affiliated to Capital Medical University", "city": "Tianjing", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 13, "broad_only": false}, {"nct": "NCT03961243", "title": "Lentiviral FIX Gene Therapy", "status": "NOT_YET_RECRUITING", "start": "2027-06-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": ["Hemophilia B"], "cn_sites": [{"facility": "Shenzhen Geno-immune Medical Institute", "city": "Shenzhen", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03217032", "title": "Lentiviral FVIII Gene Therapy", "status": "NOT_YET_RECRUITING", "start": "2027-06-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "Shenzhen Geno-immune Medical Institute", "city": "Shenzhen", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00868530", "title": "Study Evaluating On-Demand Treatment Of Xyntha In Chinese Subjects", "status": "COMPLETED", "start": "2008-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 53, "sponsor": "Pfizer", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "Pfizer Investigational Site", "city": "Suzhou", "status": ""}, {"facility": "Pfizer Investigational Site", "city": "Heping District", "status": ""}, {"facility": "Pfizer Investigational Site", "city": "Hangzhou", "status": ""}, {"facility": "Pfizer Investigational Site", "city": "Beijing", "status": ""}, {"facility": "Pfizer Investigational Site", "city": "Guangzhou", "status": ""}, {"facility": "Pfizer Investigational Site", "city": "Shanghai", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT00866606", "title": "Study Evaluating On-Demand Treatment With BeneFIX In Chinese Subjects", "status": "COMPLETED", "start": "2009-02", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 35, "sponsor": "Wyeth is now a wholly owned subsidiary of Pfizer", "conditions": ["Hemophilia B"], "cn_sites": [{"facility": "Pfizer Investigational Site", "city": "Guangzhou", "status": ""}, {"facility": "Pfizer Investigational Site", "city": "Suzhou", "status": ""}, {"facility": "Pfizer Investigational Site", "city": "Tianjin", "status": ""}, {"facility": "Pfizer Investigational Site", "city": "Hangzhou", "status": ""}, {"facility": "Pfizer Investigational Site", "city": "Beijing", "status": ""}, {"facility": "Pfizer Investigational Site", "city": "Shanghai", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT00797381", "title": "Efficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia", "status": "UNKNOWN", "start": "2009-05", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Shanghai Public Health Clinical Center", "conditions": ["HIV Infection", "Hemophilia A"], "cn_sites": [{"facility": "Shanghai Public Health Clinical Center", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01027364", "title": "Study of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Participants With Hemophilia B", "status": "COMPLETED", "start": "2009-12", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 123, "sponsor": "Bioverativ Therapeutics Inc.", "conditions": ["Severe Hemophilia B"], "cn_sites": [{"facility": "Research site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Guangzhou", "status": ""}, {"facility": "Research Site", "city": "Shanghai", "status": ""}, {"facility": "Research Site", "city": "Tianjin", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT01233258", "title": "A Trial to Compare Prophylaxis Therapy to On-demand Therapy With a New Full Length Recombinant FVIII in Patients With Severe Hemophilia A", "status": "COMPLETED", "start": "2011-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 80, "sponsor": "Bayer", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "", "city": "Guangzhou", "status": ""}, {"facility": "", "city": "Suzhou", "status": ""}, {"facility": "", "city": "Beijing", "status": ""}, {"facility": "", "city": "Shanghai", "status": ""}, {"facility": "", "city": "Tianjin", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT02078427", "title": "ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)", "status": "COMPLETED", "start": "2011-06-28", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 951, "sponsor": "Baxalta now part of Shire", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": ""}, {"facility": "Nanfang Hospital Affiliated to Nanfang Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Institute of Hematology, Blood Disease Hospital, PUMC&CAMS", "city": "Tianjin", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical College of Huazhong University of Science & Technology", "city": "Wuhan", "status": ""}, {"facility": "The Affiliated Hospital of Xuzhou Medical University", "city": "Xuzhou", "status": ""}, {"facility": "The Blood Center of Shandong Province", "city": "Jinan", "status": ""}, {"facility": "Beijing Children's Hospital Affiliated to Capital University of Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School", "city": "Nanjing", "status": ""}, {"facility": "Shenzhen Second People's Hospital", "city": "Shenzhen", "status": ""}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT01425723", "title": "Long-Term Safety and Efficacy of rFIXFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia B", "status": "COMPLETED", "start": "2011-12-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Bioverativ Therapeutics Inc.", "conditions": ["Severe Hemophilia B"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Guangzhou", "status": ""}, {"facility": "Research Site", "city": "Shanghai", "status": ""}, {"facility": "Research Site", "city": "Tianjing", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT01625390", "title": "A Phase 2/ 3 Trial to Evaluate the Efficacy and Safety of BAY86-6150", "status": "COMPLETED", "start": "2012-06", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Bayer", "conditions": ["Hemophilia A, Hemophilia B"], "cn_sites": [{"facility": "", "city": "Guangzhou", "status": ""}, {"facility": "", "city": "Beijing", "status": ""}, {"facility": "", "city": "Tianjin", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT01493778", "title": "Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A", "status": "COMPLETED", "start": "2012-09-17", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Novo Nordisk A/S", "conditions": ["Congenital Bleeding Disorder", "Haemophilia A"], "cn_sites": [{"facility": "Novo Nordisk Investigational Site", "city": "Beijing", "status": ""}, {"facility": "Novo Nordisk Investigational Site", "city": "Chonqqing", "status": ""}, {"facility": "Novo Nordisk Investigational Site", "city": "Guangzhou", "status": ""}, {"facility": "Novo Nordisk Investigational Site", "city": "Tianjin", "status": ""}, {"facility": "Novo Nordisk Investigational Site", "city": "Hangzhou", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT01810666", "title": "Prophylaxis Versus on Demand Treatment for Children With Hemophilia A", "status": "COMPLETED", "start": "2013-03", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Bayer", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "", "city": "Guangzhou", "status": ""}, {"facility": "", "city": "Wuhan", "status": ""}, {"facility": "", "city": "Beijing", "status": ""}, {"facility": "", "city": "Tianjin", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT02170402", "title": "China ADVATE PTP Study", "status": "COMPLETED", "start": "2014-06-26", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 82, "sponsor": "Baxalta now part of Shire", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Dongcheng", "status": ""}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Cangzhou Central Hospital", "city": "Cangzhou", "status": ""}, {"facility": "Tongji Hosp, Tongji Med. Col, Huazhong Univ. of Sci. & Tech/ Wuhan Union Hospital", "city": "Wuhan", "status": ""}, {"facility": "Tongji Hospital of Tongji Medical College of Hongzhong Science and Techology University", "city": "Wuhan", "status": ""}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": ""}, {"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "The First Affiliated Hospital of College of Medicine, Zhengjiang University", "city": "Hangzhou", "status": ""}, {"facility": "Beijing Children's Hospital Affiliated to Capital University of Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Hospital of Blood Disease, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}], "cn_site_count": 11, "broad_only": false}, {"nct": "NCT02263066", "title": "Retrospective Study in Chinese Pediatric Hemophilia A Patients With rFⅧ Contained Regular Prophylaxis", "status": "COMPLETED", "start": "2014-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 181, "sponsor": "Bayer", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "", "city": "Many Locations", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02336178", "title": "Safety and Efficacy of Benefix in Patients With Hemophilia B in Usual Care Settings in China", "status": "COMPLETED", "start": "2015-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 70, "sponsor": "Pfizer", "conditions": ["HEMOPHILIA B"], "cn_sites": [{"facility": "Nanfang Hospital, Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "The Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": ""}, {"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Xiangya Hospital of Centre-South University", "city": "Changsha", "status": ""}, {"facility": "Department of Hematology,The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "Department of Hematology,The Affiliated Hospital of Xuzhou Medical University", "city": "Xuzhou", "status": ""}, {"facility": "Department of Hematology,Jiangxi Provincial People's Hospital", "city": "Nanchang", "status": ""}, {"facility": "Blood Center of Shandong Province", "city": "Jinan", "status": ""}, {"facility": "Ruijin Hospital Affiliated to Shanghai JiaoTong University School of Medicine/Hematology Department", "city": "Shanghai", "status": ""}, {"facility": "Shanxi Medical University Second Hospital", "city": "Taiyuan", "status": ""}, {"facility": "Chengdu Women's and Children's Central Hospital", "city": "Chengdu", "status": ""}, {"facility": "Blood Diseases Hospital, Chinese Academy of Medical Science (Institute of Hematology)", "city": "Tianjin", "status": ""}, {"facility": "Department of Hematology,The First Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}, {"facility": "Hematology Department,Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Children's Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}], "cn_site_count": 16, "broad_only": false}, {"nct": "NCT02213250", "title": "An Open-Label, Single Dose Pharmacokinetic Study of Benefix (Recombinant Factor IX) in Male Chinese Subjects With Hemophilia B", "status": "COMPLETED", "start": "2015-03", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Pfizer", "conditions": ["Hemophilia B"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Hematology Department,Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT02492984", "title": "PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Hemophilia A", "status": "COMPLETED", "start": "2015-04", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 85, "sponsor": "Pfizer", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "The Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": ""}, {"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Department of Hematology,The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "Department of Hematology,Jiangxi Provincial People's Hospital", "city": "Nanchang", "status": ""}, {"facility": "Blood Center of Shandong Province", "city": "Jinan", "status": ""}, {"facility": "Chengdu Women's and Children's Central Hospital", "city": "Chengdu", "status": ""}, {"facility": "Blood Diseases Hospital, Chinese Academy of Medical Science (Institute of Hematology)", "city": "Tianjin", "status": ""}, {"facility": "Department of Hematology,The First Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}, {"facility": "Beijing Children's hospital", "city": "Beijing", "status": ""}, {"facility": "The second affiliated hospital of chongqing medical university", "city": "Chongqing", "status": ""}, {"facility": "Children's Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "Hematology Department, Nanfang Hospital, Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine/Hematology Department", "city": "Shanghai", "status": ""}, {"facility": "Department of Hematology/Children's Hospital of Shanghai", "city": "Shanghai", "status": ""}], "cn_site_count": 15, "broad_only": false}, {"nct": "NCT02476942", "title": "A Prospective Study to Collect High-Quality Documentation of Bleeds, Health-Related Quality of Life (HRQoL), and Safety Outcomes in Patients With Hemophilia A Treated With Standard-of-Care Treatment", "status": "COMPLETED", "start": "2015-05-26", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 221, "sponsor": "Hoffmann-La Roche", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Nanfang Hospital, Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Tianjin Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT02461992", "title": "Study of PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Male Chinese Subjects With Hemophilia A", "status": "COMPLETED", "start": "2015-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 13, "sponsor": "Pfizer", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "Phase I Unit, Clinical Pharmacology Research Center, Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Hematology Department,Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT02634723", "title": "Retrospective Chart Review to Evaluate Safety and Tolerability of ADVATE Among Previously Untreated Patients in China With Moderate to Severe Hemophilia A", "status": "COMPLETED", "start": "2015-12-23", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 21, "sponsor": "Baxalta now part of Shire", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "Institute of Hematology and Oncology, Harbin The First Hospital", "city": "Harbin", "status": ""}, {"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical College of Huazhong University of Science & Technology", "city": "Wuhan", "status": ""}, {"facility": "Nanjing Children's Hospital Affiliated to Nanjing Medical University", "city": "Nanjing", "status": ""}, {"facility": "Shandong Blood Center", "city": "Jinan", "status": ""}, {"facility": "Zhejiang Provincial Hospital of TCM/The First Affiliated Hospital of Zhejiang Chinese Medical University", "city": "Hangzhou", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT03598725", "title": "Low-dose ITI Strategy for Children in Hemophilia A With High-titer Inhibitor and Poor ITI Risk in China", "status": "UNKNOWN", "start": "2016-01-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 55, "sponsor": "Beijing Children's Hospital", "conditions": ["Hemophilia A With Inhibitor"], "cn_sites": [{"facility": "Beijing Children's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02930317", "title": "Evaluate Efficacy and Safety of Recombinant Factor VIII （rFVIII）Treatment of Severe or Moderately Severe Hemophilia A", "status": "UNKNOWN", "start": "2016-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "Anhui provincial hospital", "city": "Hefei", "status": "RECRUITING"}, {"facility": "Ruijin Hospital Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}, {"facility": "Second hospital of Shanxi Medical University", "city": "Taiyuan", "status": "NOT_YET_RECRUITING"}, {"facility": "Blood Diseases Hospital, Chinese Academy of Medical Science (Institute of Hematology)", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT02999308", "title": "A Clinical Phenotype Based Individualized Prophylaxis in Chinese Hemophilia A Children", "status": "UNKNOWN", "start": "2016-08", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Beijing Children's Hospital", "conditions": ["Haemophilia"], "cn_sites": [{"facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02888223", "title": "Pharmacokinetic Study of SCT800 in Previously Treated Patients With Hemophilia A", "status": "UNKNOWN", "start": "2016-09", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 16, "sponsor": "Sinocelltech Ltd.", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "Xiangya Hospital of Centre-South University", "city": "Changsha", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02921945", "title": "Efficacy and Safety Study of SCT800 for On-demand Treatment With in Patients With Hemophilia A", "status": "UNKNOWN", "start": "2016-10", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Sinocelltech Ltd.", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "Xiangya Hospital of Centre-South University", "city": "Changsha", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02938585", "title": "Efficacy and Safety of Turoctocog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A", "status": "COMPLETED", "start": "2016-12-12", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 68, "sponsor": "Novo Nordisk A/S", "conditions": ["Congenital Bleeding Disorder", "Haemophilia A"], "cn_sites": [{"facility": "Novo Nordisk Investigational Site", "city": "Beijing", "status": ""}, {"facility": "Novo Nordisk Investigational Site", "city": "Chonqqing", "status": ""}, {"facility": "Novo Nordisk Investigational Site", "city": "Fuzhou", "status": ""}, {"facility": "Novo Nordisk Investigational Site", "city": "Guangzhou", "status": ""}, {"facility": "Novo Nordisk Investigational Site", "city": "Guiyang", "status": ""}, {"facility": "Novo Nordisk Investigational Site", "city": "Wuhan", "status": ""}, {"facility": "Novo Nordisk Investigational Site", "city": "Xining", "status": ""}, {"facility": "Novo Nordisk Investigational Site", "city": "Shanghai", "status": ""}, {"facility": "Novo Nordisk Investigational Site", "city": "Tianjin", "status": ""}, {"facility": "Novo Nordisk Investigational Site", "city": "Kunming", "status": ""}, {"facility": "Novo Nordisk Investigational Site", "city": "Hangzhou", "status": ""}], "cn_site_count": 11, "broad_only": false}, {"nct": "NCT07101224", "title": "Data Registry in Chinese Hemophilia A and B Patients", "status": "COMPLETED", "start": "2017-05-07", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Hemophilia A", "Hemophilia B"], "cn_sites": [{"facility": "Hospital of Blood disease", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03384277", "title": "Trial of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab", "status": "COMPLETED", "start": "2017-12-29", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 66, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Acquired Hemophilia A"], "cn_sites": [{"facility": "Ethics Committee of Blood disease hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03417102", "title": "A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors", "status": "COMPLETED", "start": "2018-02-14", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Genzyme, a Sanofi Company", "conditions": ["Hemophilia A", "Hemophilia B"], "cn_sites": [{"facility": "Investigational Site Number 8604", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number 8602", "city": "Guangzhou", "status": ""}, {"facility": "Investigational Site Number 8605", "city": "Hangzhou", "status": ""}, {"facility": "Investigational Site Number 8603", "city": "Shanghai", "status": ""}, {"facility": "Investigational Site Number 8601", "city": "Tianjin", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT03417245", "title": "A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors", "status": "COMPLETED", "start": "2018-03-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Genzyme, a Sanofi Company", "conditions": ["Hemophilia A", "Hemophilia B"], "cn_sites": [{"facility": "Investigational Site Number 8604", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number 8602", "city": "Guangzhou", "status": ""}, {"facility": "Investigational Site Number 8605", "city": "Hangzhou", "status": ""}, {"facility": "Investigational Site Number 8603", "city": "Shanghai", "status": ""}, {"facility": "Investigational Site Number 8601", "city": "Tianjin", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT03380780", "title": "A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Emicizumab in Healthy Chinese Volunteers", "status": "COMPLETED", "start": "2018-03-12", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 16, "sponsor": "Hoffmann-La Roche", "conditions": ["Healthy Volunteers", "Hemophilia A"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03914716", "title": "Imaging of Arthropathy in Boys With Hemophilia in China", "status": "COMPLETED", "start": "2018-03-21", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 49, "sponsor": "Andrea Doria", "conditions": ["Hemophilia"], "cn_sites": [{"facility": "Beijing Children's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03315455", "title": "Efficacy, Safety, and Pharmacokinetic Study of Prophylactic Emicizumab Versus No Prophylaxis in Hemophilia A Participants", "status": "COMPLETED", "start": "2018-04-26", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 85, "sponsor": "Hoffmann-La Roche", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Xiangya Hospital of Centre-South University", "city": "Changsha", "status": ""}, {"facility": "Southern Medical University Nanfang Hospital", "city": "Guangdong Province Guangzhou City", "status": ""}, {"facility": "Ruijin Hospital Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Tianjin Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": ""}, {"facility": "Xiehe Hospital, Tongji Medical College Huazhong University of Science & Technology", "city": "Wuhan", "status": ""}, {"facility": "Tongji Hosp, Tongji Med. Col, Huazhong Univ. of Sci. & Tech", "city": "Wuhan", "status": ""}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT03622476", "title": "Pharmacokinetic (PK)Research on Chinese Children of Hemophilia", "status": "UNKNOWN", "start": "2018-06-30", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 155, "sponsor": "Beijing Children's Hospital", "conditions": ["Pharmacokinetics"], "cn_sites": [{"facility": "Beijing Children's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03549871", "title": "A Study of Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis", "status": "COMPLETED", "start": "2018-07-25", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 80, "sponsor": "Genzyme, a Sanofi Company", "conditions": ["Hemophilia"], "cn_sites": [{"facility": "Investigational Site Number 8604", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03700229", "title": "Study to Evaluate Rituximab and Bortezomib in Patients With Newly Diagnosed Acquired Hemophilia A", "status": "UNKNOWN", "start": "2018-10-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 22, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Acquired Hemophilia A"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03754790", "title": "Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX", "status": "ACTIVE_NOT_RECRUITING", "start": "2019-01-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 281, "sponsor": "Genzyme, a Sanofi Company", "conditions": ["Hemophilia"], "cn_sites": [{"facility": "Investigational Site Number : 1560004", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560007", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560014", "city": "Changsha", "status": ""}, {"facility": "Investigational Site Number : 1560009", "city": "Chengdu", "status": ""}, {"facility": "Investigational Site Number : 1560002", "city": "Guangzhou", "status": ""}, {"facility": "Investigational Site Number : 1560011", "city": "Guiyang", "status": ""}, {"facility": "Investigational Site Number : 1560005", "city": "Hangzhou", "status": ""}, {"facility": "Investigational Site Number : 1560008", "city": "Jinan", "status": ""}, {"facility": "Investigational Site Number : 1560012", "city": "Kunming", "status": ""}, {"facility": "Investigational Site Number : 1560013", "city": "Lanzhou", "status": ""}, {"facility": "Investigational Site Number : 1560010", "city": "Qingdao", "status": ""}, {"facility": "Investigational Site Number : 1560003", "city": "Shanghai", "status": ""}, {"facility": "Investigational Site Number : 1560006", "city": "Suzhou", "status": ""}], "cn_site_count": 13, "broad_only": false}, {"nct": "NCT03815318", "title": "Evaluation of SCT800 in Prophylaxis Therapy on Previous Treated Patients With Severe Hemophilia A", "status": "COMPLETED", "start": "2019-01-21", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 73, "sponsor": "Sinocelltech Ltd.", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03747653", "title": "A Study to Evaluate the Pharmacokinetics of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection", "status": "UNKNOWN", "start": "2019-03-08", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 12, "sponsor": "Kaifeng Pharmaceutical (Group) Co., Ltd.", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Southern Medical University Nanfang Hospital", "city": "Guangzhou", "status": ""}, {"facility": "Jinan Central Hospital", "city": "Jinan", "status": ""}, {"facility": "Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College", "city": "Tianjin", "status": ""}, {"facility": "Hematology Department, Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT04060836", "title": "Pharmacokinetics Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A.", "status": "UNKNOWN", "start": "2019-05-08", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "AnHui Provincial Hospital", "city": "Hefei", "status": "RECRUITING"}, {"facility": "The First Hospital of LanZhou University", "city": "Lanzhou", "status": "RECRUITING"}, {"facility": "HeNan Cancer Provincial Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT04061109", "title": "Safety, Efficacy Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A.", "status": "UNKNOWN", "start": "2019-05-15", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 64, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "AnHui Provincial Hospital", "city": "Hefei", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "FuJian Medical University Union Hospital", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "The First Hospital of LanZhou University", "city": "Lanzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": "RECRUITING"}, {"facility": "HeNan Provincial Peoples Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "HeNan Cancer Provincial Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Jiangxi Provincial People's Hospital", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 11, "broad_only": false}, {"nct": "NCT03947567", "title": "Safety and Efficacy of Long-term Treatment With SCT800 in Previously Treated Hemophilia A Patients.", "status": "UNKNOWN", "start": "2019-07-26", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 240, "sponsor": "Sinocelltech Ltd.", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04135300", "title": "Gene Therapy for Chinese Hemophilia B", "status": "COMPLETED", "start": "2019-10-16", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Hemophilia B"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04747964", "title": "A Safety Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor", "status": "COMPLETED", "start": "2020-01-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 16, "sponsor": "Staidson (Beijing) Biopharmaceuticals Co., Ltd", "conditions": ["Hemophilia"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03938792", "title": "Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B", "status": "COMPLETED", "start": "2020-03-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 188, "sponsor": "Pfizer", "conditions": ["Hemophilia A", "Hemophilia B"], "cn_sites": [{"facility": "Nanfang Hospital, Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "The Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": ""}, {"facility": "Jiangxi Provincial People's Hospital", "city": "Nanchang", "status": ""}, {"facility": "Institute of Hematology, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}, {"facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT04565236", "title": "A Post Approval Commitment Study to Gain More Information on How Safe and Effective KOVALTRY is in Chinese Children, Adolescents /Adults With Severe Hemophilia A", "status": "COMPLETED", "start": "2020-09-22", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 45, "sponsor": "Bayer", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "The Children's Hospital Zhejiang University School of Med", "city": "Hangzhou", "status": ""}, {"facility": "Shijiazhuang General Hospital", "city": "Shijiazhuang", "status": ""}, {"facility": "NJ Drum Tower Hospital, the Affil Hos of NJ Univ Med School", "city": "Nanjing", "status": ""}, {"facility": "1st Affiliated hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "Jiangxi Provincial People's Hospital", "city": "Nanchang", "status": ""}, {"facility": "Children's Hospital of Shanxi", "city": "Taiyuan", "status": ""}, {"facility": "Chengdu Women & Children's Central Hospital", "city": "Chengdu", "status": ""}, {"facility": "Peking Union Medical College Hospital CAMS", "city": "Beijing", "status": ""}, {"facility": "Childrens Hospital of Shanghai", "city": "Shanghai", "status": ""}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT04456387", "title": "An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A.", "status": "COMPLETED", "start": "2020-10-15", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 119, "sponsor": "Zhengzhou Gensciences Inc", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": ""}, {"facility": "Capital Medical University affiliated Beijing Children's Hospital", "city": "Beijing", "status": ""}, {"facility": "Chongqing Three Gorges Central Hospital", "city": "Chongqing", "status": ""}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": ""}, {"facility": "The First Hospital of Lanzhou University", "city": "Lanzhou", "status": ""}, {"facility": "The Second Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Nanfang Hospital of Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "The Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": ""}, {"facility": "Henan provincial People's Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "The Affiliated Hospital of Xuzhou Medical College", "city": "Xuzhou", "status": ""}, {"facility": "Jiangxi Provincial People's Hospital", "city": "Nanchang", "status": ""}, {"facility": "Jinan central hospital", "city": "Ji'nan", "status": ""}, {"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": ""}, {"facility": "The Second Hospital of Shanxi Medical University", "city": "Taiyuan", "status": ""}, {"facility": "Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College", "city": "Tianjin", "status": ""}], "cn_site_count": 17, "broad_only": false}, {"nct": "NCT04768699", "title": "Study of Recombinant Human Coagulation Factor VIIa for Injection (FⅦa) in Patients With Hemophilia.", "status": "UNKNOWN", "start": "2020-12-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Hemophilia A With Inhibitor", "Hemophilia B With Inhibitor"], "cn_sites": [{"facility": "Hematology Hospital of Chinese Academy of Medical Sciences", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04644575", "title": "Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-02-23", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 261, "sponsor": "Bioverativ, a Sanofi company", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "Investigational Site Number : 1560002", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560006", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560001", "city": "Guangzhou", "status": ""}, {"facility": "Investigational Site Number : 1560003", "city": "Hangzhou", "status": ""}, {"facility": "Investigational Site Number : 1560004", "city": "Hangzhou", "status": ""}, {"facility": "Investigational Site Number : 1560005", "city": "Jinan", "status": ""}, {"facility": "Investigational Site Number : 1560009", "city": "Kunming", "status": ""}, {"facility": "Investigational Site Number : 1560010", "city": "Kunming", "status": ""}, {"facility": "Investigational Site Number : 1560013", "city": "Lanzhou", "status": ""}, {"facility": "Investigational Site Number : 1560007", "city": "Suzhou", "status": ""}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT04845399", "title": "Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A", "status": "COMPLETED", "start": "2021-04-16", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 101, "sponsor": "Zhengzhou Gensciences Inc", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": ""}, {"facility": "Capital Medical University affiliated Beijing Children's Hospital", "city": "Beijing", "status": ""}, {"facility": "Chongqing Three Gorges Central Hospital", "city": "Chongqing", "status": ""}, {"facility": "The First Hospital of Lanzhou University", "city": "Lanzhou", "status": ""}, {"facility": "The Second Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Nanfang Hospital of Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "The Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": ""}, {"facility": "Henan provincial People's Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "The Affiliated Hospital of Xuzhou Medical College", "city": "Xuzhou", "status": ""}, {"facility": "Jiangxi Provincial People's Hospital", "city": "Nanchang", "status": ""}, {"facility": "Jinan central hospital", "city": "Ji'nan", "status": ""}, {"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": ""}, {"facility": "The Second Hospital of Shanxi Medical University", "city": "Taiyuan", "status": ""}, {"facility": "Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College.", "city": "Tianjin", "status": ""}], "cn_site_count": 16, "broad_only": false}, {"nct": "NCT04878731", "title": "Study to Evaluate Safety and Tolerability of a Single Dose of PF-06741086 in Chinese Adult Participants With Severe Hemophilia", "status": "COMPLETED", "start": "2021-04-16", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Pfizer", "conditions": ["Severe Hemophilia"], "cn_sites": [{"facility": "Institute of Hematology, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05251090", "title": "A Study to Evaluate the Safety and Pharmacokinetic of Recombinant Human Coagulation Factor VIII ，Fc Fusion Protein for Injection", "status": "COMPLETED", "start": "2021-06-16", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 13, "sponsor": "Hangzhou Gensciences Biopharmaceutical Co., Ltd.", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "Beijing Children's Hospital,Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Shenzhen Children's Hospita", "city": "Shenzhen", "status": ""}, {"facility": "Nanfang Hospital of Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology", "city": "Wuhan", "status": ""}, {"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": ""}, {"facility": "Chengdu Women's and Children's Central Hospital", "city": "Chengdu", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT04864743", "title": "A Study to Evaluate the Pharmacokinetics，Safety and Tolerability of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection", "status": "COMPLETED", "start": "2021-06-22", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 13, "sponsor": "Hangzhou Gensciences Biopharmaceutical Co., Ltd.", "conditions": ["Severe Hemophilia A"], "cn_sites": [{"facility": "Nanfang Hospital of Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "People's Hospital of Zhengzhou", "city": "Zhengzhou", "status": ""}, {"facility": "Jinan central hospital", "city": "Jinan", "status": ""}, {"facility": "Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College.", "city": "Tianjin", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT05082116", "title": "Efficacy and Safety of Turoctocog Alfa Pegol (N8-GP) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A (pathfinder10)", "status": "COMPLETED", "start": "2021-09-27", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Novo Nordisk A/S", "conditions": ["Haemophilia A"], "cn_sites": [{"facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Fujian Medical University Union Hospital-Hematology", "city": "Fuzhou", "status": ""}, {"facility": "Nanfang Hospital, Southern Medical University-Haematology", "city": "Guangzhou", "status": ""}, {"facility": "The Affiliated Hospital of Guizhou Medical University-Hematology", "city": "Guiyang", "status": ""}, {"facility": "Xiangya Hospital Central-South University", "city": "Changsha", "status": ""}, {"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "Qinghai Provincial People's Hospital", "city": "Xining", "status": ""}, {"facility": "Jinan Central Hospital", "city": "Jinan", "status": ""}, {"facility": "Institute of Hematology and Blood Diseases Hospital, Tianjin-Hematology", "city": "Tianjin", "status": ""}, {"facility": "Institute of hematology and Blood Diseases Hospital, Tianjin", "city": "Tianjin", "status": ""}, {"facility": "The Second Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}], "cn_site_count": 11, "broad_only": false}, {"nct": "NCT05027230", "title": "A Safety and Efficacy Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor", "status": "COMPLETED", "start": "2021-10-12", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 77, "sponsor": "Staidson (Beijing) Biopharmaceuticals Co., Ltd", "conditions": ["Hemophilia"], "cn_sites": [{"facility": "Hospital of Hematology, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05053139", "title": "A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors", "status": "COMPLETED", "start": "2021-12-02", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 281, "sponsor": "Novo Nordisk A/S", "conditions": ["Haemophilia A", "Haemophilia A With Inhibitors"], "cn_sites": [{"facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Haemotology, Nanfang Hospital, Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Nanfang Hospital, Southern Medical University-Haematology", "city": "Guangzhou", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical College of HUST-Hematology", "city": "Wuhan", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical College of HUST", "city": "Wuhan", "status": ""}, {"facility": "Xiangya Hospital Central-South University", "city": "Changsha", "status": ""}, {"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "Jinan Central Hospital", "city": "Ji'Nan", "status": ""}, {"facility": "Jinan Central Hospital", "city": "Jinan", "status": ""}, {"facility": "Chengdu Women's and Children's Central Hospital", "city": "Chengdu", "status": ""}, {"facility": "Institute of Hematology and Blood Diseases Hospital, Tianjin-Hematology", "city": "Tianjin", "status": ""}, {"facility": "The Second Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}, {"facility": "Children's Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "The Children's Hospital, Zhejiang University school of medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 14, "broad_only": false}, {"nct": "NCT05152732", "title": "Safety and Tolerability of VGB-R04 in Patients With Haemophilia B", "status": "UNKNOWN", "start": "2021-12-28", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 3, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Hemophilia B"], "cn_sites": [{"facility": "Blood diseases hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05203679", "title": "Evaluation of the Safety and Efficacy of Hemophilia B Gene Therapy Drug", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-12-30", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 32, "sponsor": "Shanghai Xinzhi BioMed Co., Ltd.", "conditions": ["Hemophilia B"], "cn_sites": [{"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Nanfang Hospital Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "The Second People's Hospital of Shenzhen", "city": "Shenzhen", "status": ""}, {"facility": "North China University of Science and Technology Affiliated Hospital", "city": "Tangshan", "status": ""}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "The Second Hospital of Shanxi Medical University", "city": "Taiyuan", "status": ""}, {"facility": "Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College", "city": "Tianjin", "status": ""}, {"facility": "The second Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT05920512", "title": "Combination Regimen With Sodium Valproate for Severe Hemophilia: a Single-arm, Phase 1, Pilot Trial.", "status": "UNKNOWN", "start": "2022-04-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Xue-chun Lu", "conditions": ["Hemophilia"], "cn_sites": [{"facility": "PLA General Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05306418", "title": "A Research Study Looking at Mim8 in Children With Haemophilia A With or Without Inhibitors", "status": "COMPLETED", "start": "2022-04-04", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 70, "sponsor": "Novo Nordisk A/S", "conditions": ["Haemophilia A With or Without Inhibitors"], "cn_sites": [{"facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Beijing Children's Hospital，Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Nanfang Hospital, Southern Medical University-Haematology", "city": "Guangzhou", "status": ""}, {"facility": "Chengdu Women's and Children's Central Hospital", "city": "Chengdu", "status": ""}, {"facility": "Institute of Hematology and Blood Diseases Hospital, Tianjin-Hematology", "city": "Tianjin", "status": ""}, {"facility": "Children's Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT05265286", "title": "A Study of Repeat Dosing of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection", "status": "COMPLETED", "start": "2022-04-14", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Hangzhou Gensciences Biopharmaceutical Co., Ltd.", "conditions": ["Severe Hemophilia A"], "cn_sites": [{"facility": "People'S Hospital of Zhengzhou", "city": "Zhengzhou", "status": ""}, {"facility": "Affiliated Hospital of Jiangnan University", "city": "Wuxi", "status": ""}, {"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": ""}, {"facility": "People'S Hospital of Rizhao", "city": "Rizhao", "status": ""}, {"facility": "Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College.", "city": "Tianjin", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT05487976", "title": "Clinical Study of Recombinant Human Activated Coagulation Factor VII for Injection in Patients With Hemophilia With Inhibitor", "status": "UNKNOWN", "start": "2022-04-28", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Hemophilia A", "Hemophilia B"], "cn_sites": [{"facility": "The Second Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "The First Hospital of Lanzhou University", "city": "Lanzhou", "status": "RECRUITING"}, {"facility": "Nanfang Hospital, Southern Medical University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": "RECRUITING"}, {"facility": "Affiliated Hospital of North China University of Science and Technology", "city": "Tangshan", "status": "RECRUITING"}, {"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Jiangxi Provincial People's Hospital", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Hematology Hospital of Chinese Academy of Medical Sciences", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT05365217", "title": "A Research Study Investigating Nonacog Beta Pegol (N9-GP) for Treatment and Prevention of Bleedings in Chinese People With Haemophilia B", "status": "COMPLETED", "start": "2022-05-18", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Novo Nordisk A/S", "conditions": ["Haemophilia B"], "cn_sites": [{"facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Fujian Medical University Union Hospital-Hematology", "city": "Fuzhou", "status": ""}, {"facility": "Nanfang Hospital, Southern Medical University-Haematology", "city": "Guangzhou", "status": ""}, {"facility": "The Affiliated Hospital of Guizhou Medical University-Hematology", "city": "Guiyang", "status": ""}, {"facility": "Henan Cancer Hospital-Hematology", "city": "Zhengzhou", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical College of HUST-Hematology", "city": "Wuhan", "status": ""}, {"facility": "Xiangya Hospital Central-South University", "city": "Changsha", "status": ""}, {"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "Jinan Central Hospital", "city": "Jinan", "status": ""}, {"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": ""}, {"facility": "Institute of Hematology and Blood Diseases Hospital, Tianjin-Hematology", "city": "Tianjin", "status": ""}, {"facility": "The Second Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}, {"facility": "Children's Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 14, "broad_only": false}, {"nct": "NCT05441553", "title": "A Study to Evaluate the Safety and Efficacy of VGB-R04 in Adult Hemophilia B Patients", "status": "UNKNOWN", "start": "2022-07", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 26, "sponsor": "Shanghai Vitalgen BioPharma Co., Ltd.", "conditions": ["Hemophilia B"], "cn_sites": [{"facility": "Shanghai Vitalgen Biopharma Co.,Ltd.", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05421429", "title": "KN057 Multiple Dose Study in Moderately Severe to Severe Hemophilia", "status": "COMPLETED", "start": "2022-07-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Suzhou Alphamab Co., Ltd.", "conditions": ["Hemophilia"], "cn_sites": [{"facility": "Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}, {"facility": "stitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05523128", "title": "The Efficacy and Safety of ZS802 in Chinese Hemophilia A Patients.", "status": "UNKNOWN", "start": "2022-09-29", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05651061", "title": "A Phase I of SS109 in Hemophilia A or and B With Inhibitors", "status": "COMPLETED", "start": "2022-12-14", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 27, "sponsor": "Hangzhou Gensciences Biopharmaceutical Co., Ltd.", "conditions": ["Hemophilia A With Inhibitor", "Hemophilia B With Inhibitor", "Factor VII Deficiency"], "cn_sites": [{"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": ""}, {"facility": "Henan Provincial Cancer Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Xiangya Hospital, Central South University", "city": "Changsha", "status": ""}, {"facility": "Affiliated Hospital of Xuzhou Medical University", "city": "Xuzhou", "status": ""}, {"facility": "Jiangxi Provincial People's Hospital", "city": "Nanchang", "status": ""}, {"facility": "The First Affiliated Hospital of Shandong First Medical University", "city": "Jinan", "status": ""}, {"facility": "The Second Hospital of Shanxi Medical University", "city": "Taiyuan", "status": ""}, {"facility": "Xi'an Central Hospital", "city": "Xi’an", "status": ""}, {"facility": "Hematology Hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}, {"facility": "The Second Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT05636163", "title": "Neutrophil-to-lymphocyte and Platelet-to-lymphocyte Ratio in Predicting the Incidence of Nausea and Vomiting", "status": "UNKNOWN", "start": "2022-12-15", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 120, "sponsor": "Qianfoshan Hospital", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "Shandong Provincial Qianfoshan Hospital, The First Hospital affiliated of Shandong First Medical University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05619926", "title": "Safety and Efficacy of STSP-0601 in Adult Patients With Hemophilia A or B Without Inhibitor", "status": "COMPLETED", "start": "2023-01-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 32, "sponsor": "Staidson (Beijing) Biopharmaceuticals Co., Ltd", "conditions": ["Hemophilia"], "cn_sites": [{"facility": "The Second Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "Lanzhou University First Hospita", "city": "Lanzhou", "status": ""}, {"facility": "Shenzhen Second People's Hospital", "city": "Shenzhen", "status": ""}, {"facility": "North China University of Technology Affiliated Hospital", "city": "Tangshan", "status": ""}, {"facility": "The First Affiliated Hospital of Nanyang Medical College", "city": "Nanyang", "status": ""}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "Nanjing Gulou Hospital", "city": "Nanjing", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": ""}, {"facility": "Xi'an Central Hospital", "city": "Xi’an", "status": ""}, {"facility": "Hospital of Hematology, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}, {"facility": "The Second Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}], "cn_site_count": 12, "broad_only": false}, {"nct": "NCT05662319", "title": "A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-02-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 91, "sponsor": "Sanofi", "conditions": ["Hemophilia"], "cn_sites": [{"facility": "Investigational Site Number : 1560003", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560001", "city": "Guangzhou", "status": ""}, {"facility": "Investigational Site Number : 1560002", "city": "Jinan", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT05685238", "title": "A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-02-13", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 451, "sponsor": "Novo Nordisk A/S", "conditions": ["Haemophilia A", "Haemophilia A With Inhibitors"], "cn_sites": [{"facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Beijing Children's Hospital，Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Haemotology, Nanfang Hospital, Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Nanfang Hospital, Southern Medical University-Haematology", "city": "Guangzhou", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical College of HUST", "city": "Wuhan", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology-Hematology", "city": "Wuhan", "status": ""}, {"facility": "Xiangya Hospital Central-South University", "city": "Changsha", "status": ""}, {"facility": "Jinan Central Hospital Affiliated to Shandong University", "city": "Jinan", "status": ""}, {"facility": "Jinan Central Hospital", "city": "Jinan", "status": ""}, {"facility": "Chengdu Women's and Children's Central Hospital", "city": "Chengdu", "status": ""}, {"facility": "Institute of Hematology and Blood Diseases Hospital, Tianjin-Hematology", "city": "Tianjin", "status": ""}, {"facility": "Children's Hospital, Zhejiang University School of Medicine-Hematology", "city": "Huzhou", "status": ""}], "cn_site_count": 12, "broad_only": false}, {"nct": "NCT05707351", "title": "A Study of Adynovate in Previously Treated Chinese Teenagers and Adults With Severe Hemophilia A", "status": "COMPLETED", "start": "2023-03-27", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 37, "sponsor": "Takeda", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Nanfang Hospital Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Anhui Province Hospital", "city": "Hefei", "status": ""}, {"facility": "Jinan Central Hospital", "city": "Jinan", "status": ""}, {"facility": "Shenzhen Second People's Hospital", "city": "Shenzhen", "status": ""}, {"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}, {"facility": "Tongji Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 12, "broad_only": false}, {"nct": "NCT07548411", "title": "To Evaluate the Safety and Efficacy of GS1191-0445 Injection in the Treatment of Severe Hemophilia A", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-07-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 7, "sponsor": "Gritgen Therapeutics Co., Ltd.", "conditions": ["Severe Hemophilia A"], "cn_sites": [{"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College", "city": "Tianjin", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06010953", "title": "SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand Treatment", "status": "COMPLETED", "start": "2023-10-12", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Hangzhou Gensciences Biopharmaceutical Co., Ltd.", "conditions": ["Male", "Hemophilia A With Inhibitor", "Hemophilia B With Inhibitor", "Hemophilia"], "cn_sites": [{"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": ""}, {"facility": "The First Affiliated Hospital of Shandong First Medical University", "city": "Jinan", "status": ""}, {"facility": "The Second Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}, {"facility": "Jiangxi Provincial People's Hospital", "city": "Nanchang", "status": ""}, {"facility": "Yangping Song", "city": "Shanxi", "status": ""}, {"facility": "Hematology Hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}, {"facility": "Xi'an Central Hospital", "city": "Xi'an", "status": ""}, {"facility": "Affiliated Hospital of Xuzhou Medical University", "city": "Xuzhou", "status": ""}, {"facility": "Henan Provincial Cancer Hospital", "city": "Zhengzhou", "status": ""}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT04244981", "title": "Efficacy of Prothrombin Complex Concentrate Reducing Perioperative Blood Loss in Cardiac Surgery", "status": "TERMINATED", "start": "2023-10-25", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 476, "sponsor": "SHI Jia", "conditions": ["Valvular Heart Surgery"], "cn_sites": [{"facility": "Cardiovascular Institute and Fuwai Hospital, CAMS&PUMC", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06142552", "title": "Phase 3 Clinical Project of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein", "status": "COMPLETED", "start": "2023-12-27", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 124, "sponsor": "Hangzhou Gensciences Biopharmaceutical Co., Ltd.", "conditions": ["Severe Hemophilia A"], "cn_sites": [{"facility": "Beijing tongren hospital,CMU", "city": "Beijing", "status": ""}, {"facility": "XiangYa Hospital CentralSouth University", "city": "Changsha", "status": ""}, {"facility": "The Second Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Nanfang Hospital of Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital，Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": ""}, {"facility": "Jinan central hospital", "city": "Jinan", "status": ""}, {"facility": "The First Affiliated Hospital of Shandong First Medical University", "city": "Jinan", "status": ""}, {"facility": "The Second Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}, {"facility": "The First Hospital of Lanzhou University", "city": "Lanzhou", "status": ""}, {"facility": "Jiangxi Provincial People's Hospital", "city": "Nanchang", "status": ""}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": ""}, {"facility": "Affiliated Hospital of Nantong University", "city": "Nantong", "status": ""}, {"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": ""}, {"facility": "Ruijin Hospital, Shanghai Jiaotong University School Of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Shenzhen Second People's Hospital", "city": "Shenzhen", "status": ""}, {"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "The Second Hospital of Shanxi Medical University", "city": "Taiyuan", "status": ""}, {"facility": "North China University of Science and Technology Affiliated Hospital", "city": "Tangshan", "status": ""}, {"facility": "Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College", "city": "Tianjin", "status": ""}, {"facility": "Affiliated Hospital of Jiangnan University", "city": "Wuxi", "status": ""}, {"facility": "The First Affiliated Hospital of Xiamen University", "city": "Xiamen", "status": ""}, {"facility": "Zhenyu Li", "city": "Xuzhou", "status": ""}, {"facility": "Subei People's Hospital of Jiangsu province", "city": "Yangzhou", "status": ""}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Zhengzhou People's Hospital", "city": "Zhengzhou", "status": ""}], "cn_site_count": 28, "broad_only": false}, {"nct": "NCT06312475", "title": "Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B With Inhibitors", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-01-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 53, "sponsor": "Suzhou Alphamab Co., Ltd.", "conditions": ["Hemophilia A With Inhibitor", "Hemophilia B With Inhibitor"], "cn_sites": [{"facility": "Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06289166", "title": "Safety and Efficacy of STSP-0601 in Adult Patients with Hemophilia a or B with Inhibitor", "status": "COMPLETED", "start": "2024-03-18", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 25, "sponsor": "Staidson (Beijing) Biopharmaceuticals Co., Ltd", "conditions": ["Hemophilia"], "cn_sites": [{"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": ""}, {"facility": "The Second Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "Fujian Medical University Affiliated Union Medical College Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Lanzhou University First Hospital", "city": "Lanzhou", "status": ""}, {"facility": "Southern Medical University Southern Hospital", "city": "Guangzhou", "status": ""}, {"facility": "Shenzhen Second People's Hospital", "city": "Shenzhen", "status": ""}, {"facility": "Guizhou Medical University Affiliated Hospital", "city": "Guiyang", "status": ""}, {"facility": "Harbin First Hospital Hematology Tumor Research Center", "city": "Harbin", "status": ""}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "Nanjing University School of Medicine Affiliated Gulou Hospital", "city": "Nanjing", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": ""}, {"facility": "The first hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Shengjing Hospital Affiliated to China Medical University", "city": "Shenyang", "status": ""}, {"facility": "Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": ""}, {"facility": "Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Xi'an Central Hospital", "city": "Xi’an", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Hospital of Hematology, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}, {"facility": "The Second Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}], "cn_site_count": 20, "broad_only": false}, {"nct": "NCT06569108", "title": "Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Without Inhibitors", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-04-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 125, "sponsor": "Suzhou Alphamab Co., Ltd.", "conditions": ["Hemophilia A Without Inhibitor", "Hemophilia B Without Inhibitor"], "cn_sites": [{"facility": "Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06399289", "title": "Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Chinese Subjects With Hemophilia B Previously Treated With FIX Therapy", "status": "COMPLETED", "start": "2024-07-28", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 23, "sponsor": "CSL Behring", "conditions": ["Hemophilia B"], "cn_sites": [{"facility": "Beijing Children's Hospital", "city": "Beijing", "status": ""}, {"facility": "Union Hospital Affiliated to Fujian Medical University", "city": "Fuzhou", "status": ""}, {"facility": "Nanfang Hospital of Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": ""}, {"facility": "North China University Of Science And Technology Affiliated Hospital", "city": "Tangshan", "status": ""}, {"facility": "Jinan Central Hospital", "city": "Jinan", "status": ""}, {"facility": "Hospital of Hematology, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT06297655", "title": "A Clinical Study of Recombinant Human Coagulation Factor VIII for Injection in Patients With Severe Hemophilia A", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-11-12", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.", "conditions": ["Hemophilia A"], "cn_sites": [{"facility": "Fuyang Hospital Affiliated to Anhui Medical University", "city": "Fuyang", "status": ""}, {"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": ""}, {"facility": "The Second Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "The First Hospital of Lanzhou University", "city": "Lanzhou", "status": ""}, {"facility": "Nanfang Hospital, Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": ""}, {"facility": "Henan Tumor Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": ""}, {"facility": "Nanjing Drug Tower Hospital", "city": "Nanjing", "status": ""}, {"facility": "Jiangxi Provincial People's Hospital", "city": "Nanchang", "status": ""}, {"facility": "Hematology Hospital of Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}, {"facility": "The Second Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}], "cn_site_count": 12, "broad_only": false}, {"nct": "NCT07454239", "title": "EPOCH-Economics and Patient Outcomes in China in Haemophilia", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-11-14", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Hemophilia"], "cn_sites": [{"facility": "Instiute of Hematology and Blood Diseases Hospital CAMS＆PUMC", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06738485", "title": "Recombinant Single-chain Factor VIII (rVIII-SingleChain) in Chinese Participants With Hemophilia A Previously Treated With FVIII Products", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-01-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "CSL Behring", "conditions": ["Congenital Hemophilia A"], "cn_sites": [{"facility": "The Second Hospital of Anhui Medical University", "city": "Hefei", "status": ""}, {"facility": "Beijing Children's Hospital", "city": "Beijing", "status": ""}, {"facility": "Children's Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Guangzhou Women and Children's Medical Center", "city": "Guangzhou", "status": ""}, {"facility": "Nanfang Hospital of Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Liuzhou People's Hospital", "city": "Liuzhou", "status": ""}, {"facility": "North China University of Science and Technology Affiliated Hospital", "city": "Tangshan", "status": ""}, {"facility": "Hospital of Hematology, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}, {"facility": "Henan children's hospital Zhengzhou children's Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Hunan Provincial Children's Hospital", "city": "Changsha", "status": ""}, {"facility": "Nanjing Children's Hospital", "city": "Nanjing", "status": ""}, {"facility": "XuZhou Children's Hospital", "city": "Xuzhou", "status": ""}, {"facility": "Jiangxi Provincial People's Hospital", "city": "Nanchang", "status": ""}, {"facility": "Quinghai Provincial People's Hospital", "city": "Xining", "status": ""}, {"facility": "Jinan Central Hospital", "city": "Jinan", "status": ""}, {"facility": "Qingdao Women and Children's Hospital", "city": "Qingdao", "status": ""}, {"facility": "Shanghai Jiaotong University School of Medicine, Ruijin Hospital", "city": "Shanghai", "status": ""}, {"facility": "The second affiliated hospital of Kunming Medical University", "city": "Kunming", "status": ""}, {"facility": "The Children's Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 20, "broad_only": false}, {"nct": "NCT06922045", "title": "Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-03-26", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Jiangsu BioJeTay Biotechnology Co., Ltd.", "conditions": ["Hemophilia"], "cn_sites": [{"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": ""}, {"facility": "Lanzhou University First Hospital", "city": "Lanzhou", "status": ""}, {"facility": "Nanfang Hospital, Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Shenzhen Second People's Hospital", "city": "Shenzhen", "status": ""}, {"facility": "The First affiliated hospital of Guangxi Medical University", "city": "Nanning", "status": ""}, {"facility": "North China University of Science and Technology Affiliated Hospital", "city": "Tangshan", "status": ""}, {"facility": "Harbin First Hospital Hematology Tumor Research Center", "city": "Harbin", "status": ""}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Huazhong University of Science and Technology Union Hospital", "city": "Wuhan", "status": ""}, {"facility": "Jiangsu Provincial Hospital", "city": "Nanjing", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": ""}, {"facility": "Jinan Central Clinical College of Shandong First Medical University", "city": "Jinan", "status": ""}, {"facility": "Second hospital of Shanxi Medical University", "city": "Taiyuan", "status": ""}, {"facility": "Xi'an Central Hospital", "city": "Xi’an", "status": ""}, {"facility": "Sichuan Academy of Medical Sciences＆Sichuan Provincial People's Hospital", "city": "Chengdu", "status": ""}, {"facility": "Hospital of Hematology, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}, {"facility": "The Second Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}, {"facility": "Wenzhou People's Hospital", "city": "Wenzhou", "status": ""}], "cn_site_count": 18, "broad_only": false}, {"nct": "NCT07663903", "title": "Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) On-Demand Treatment", "status": "ACTIVE_NOT_RECRUITING", "start": "2026-04-14", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Hangzhou Gensciences Biopharmaceutical Co., Ltd.", "conditions": ["Severe Hemophilia A"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College", "city": "Tianjin", "status": ""}, {"facility": "Fuyang Hospital, Affiliated to Anhui Medical University", "city": "Fuyang", "status": ""}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Ganzhou People's Hospital", "city": "Ganzhou", "status": ""}, {"facility": "Nanfang Hospital of Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": ""}, {"facility": "Huai'an Second People's Hospital", "city": "Huai'an", "status": ""}, {"facility": "Jinan central hospital", "city": "Jinan", "status": ""}, {"facility": "The Second Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}, {"facility": "The First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": ""}, {"facility": "Affiliated Hospital of Nantong University", "city": "Nantong", "status": ""}, {"facility": "The First Affiliated Hospital of Nanyang Medical College", "city": "Nanyang", "status": ""}, {"facility": "Qinghai Provincial People's Hospital", "city": "Qinghai", "status": ""}, {"facility": "Rizhao People's Hospital", "city": "Rizhao", "status": ""}, {"facility": "The Second Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "The Second Hospital of Shanxi Medical University", "city": "Taiyuan", "status": ""}, {"facility": "North China University of Science and Technology Affiliated Hospital", "city": "Tangshan", "status": ""}, {"facility": "Wenzhou People's Hospital", "city": "Wenzhou", "status": ""}, {"facility": "Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology.", "city": "Wuhan", "status": ""}, {"facility": "Affiliated Hospital of Jiangnan University", "city": "Wuxi", "status": ""}, {"facility": "Xi'an Central Hospital", "city": "Xi'an", "status": ""}, {"facility": "Subei People's Hospital of Jiangsu province", "city": "Yangzhou", "status": ""}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Zhengzhou People's Hospital", "city": "Zhengzhou", "status": ""}], "cn_site_count": 24, "broad_only": false}, {"nct": "NCT07684898", "title": "Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) as Prophylactic Treatment.", "status": "ACTIVE_NOT_RECRUITING", "start": "2026-06-12", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Hangzhou Gensciences Biopharmaceutical Co., Ltd.", "conditions": ["Severe Hemophilia A"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College", "city": "Tianjin", "status": ""}, {"facility": "Fuyang Hospital, Affiliated to Anhui Medical University", "city": "Fuyang", "status": ""}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Nanfang Hospital of Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": ""}, {"facility": "Jinan central hospital", "city": "Jinan", "status": ""}, {"facility": "The Second Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}, {"facility": "The First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": ""}, {"facility": "Affiliated Hospital of Nantong University", "city": "Nantong", "status": ""}, {"facility": "The First Affiliated Hospital of Nanyang Medical College", "city": "Nanyang", "status": ""}, {"facility": "Qinghai Provincial People's Hospital", "city": "Qinghai", "status": ""}, {"facility": "The Second Hospital of Shanxi Medical University", "city": "Taiyuan", "status": ""}, {"facility": "North China University of Science and Technology Affiliated Hospital", "city": "Tangshan", "status": ""}, {"facility": "Wenzhou People's Hospital", "city": "Wenzhou", "status": ""}, {"facility": "Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology.", "city": "Wuhan", "status": ""}, {"facility": "Affiliated Hospital of Jiangnan University", "city": "Wuxi", "status": ""}, {"facility": "Xi'an Central Hospital", "city": "Xi'an", "status": ""}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Zhengzhou People's Hospital", "city": "Zhengzhou", "status": ""}], "cn_site_count": 19, "broad_only": false}], "g_total": 125, "g_fetched": 95, "g_countries": [["United States", 32], ["France", 18], ["Spain", 18], ["Germany", 17], ["Canada", 12], ["United Kingdom", 11], ["Italy", 10], ["Turkey (Türkiye)", 8], ["Taiwan", 7], ["South Korea", 6], ["Sweden", 6], ["Japan", 4], ["Brazil", 4], ["Netherlands", 4], ["Switzerland", 4], ["Austria", 4], ["Belgium", 4], ["Australia", 4], ["India", 3], ["Denmark", 3], ["Finland", 3], ["Poland", 3], ["Israel", 3], ["Croatia", 3], ["Bulgaria", 3], ["Russia", 3], ["Singapore", 2], ["Argentina", 2], ["Hungary", 2], ["South Africa", 2], ["Serbia", 2], ["Egypt", 2], ["Portugal", 2], ["Czechia", 2], ["Ireland", 2], ["Greece", 2], ["Norway", 2], ["Mexico", 2], ["Belarus", 2], ["Iran", 1], ["Chile", 1], ["Pakistan", 1], ["Uruguay", 1], ["Bangladesh", 1], ["Thailand", 1], ["Hong Kong", 1], ["Saudi Arabia", 1], ["North Macedonia", 1], ["New Zealand", 1], ["Azerbaijan", 1], ["Estonia", 1], ["Lithuania", 1]], "g_trials": [{"nct": "NCT07719647", "title": "Ultrasound Assessment of Joint Health in Patients With Mild Hemophilia (Factor Levels 5-40%)", "status": "NOT_YET_RECRUITING", "start": "2027-02", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT07158606", "title": "Understanding Treatment Outcomes and Immunologic Mechanisms in Altuviiio Immune Tolerance Induction", "status": "NOT_YET_RECRUITING", "start": "2026-12-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Versiti Blood Health", "countries": ["United States"]}, {"nct": "NCT07724834", "title": "CD19-B Cell Depletion in PAIS-ME/CFS Patients", "status": "NOT_YET_RECRUITING", "start": "2026-12-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Charite University, Berlin, Germany", "countries": ["Germany"]}, {"nct": "NCT07714213", "title": "Post-acute Infectious Syndrome - Aripiprazole Symptom Evaluation (PAIS-AriSE)", "status": "NOT_YET_RECRUITING", "start": "2026-10-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Christiana Franke", "countries": ["Germany"]}, {"nct": "NCT05932914", "title": "Liver Biopsy Following Gene Therapy For Hemophilia", "status": "NOT_YET_RECRUITING", "start": "2026-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "St. Jude Children's Research Hospital", "countries": ["United States"]}, {"nct": "NCT07421154", "title": "Study of a Smart Sharps Disposal Device in Patients With Hemophilia", "status": "NOT_YET_RECRUITING", "start": "2026-09-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Pennsylvania", "countries": ["United States"]}, {"nct": "NCT07226206", "title": "A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A", "status": "RECRUITING", "start": "2026-09-08", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Hoffmann-La Roche", "countries": ["United States"]}, {"nct": "NCT07681089", "title": "A Phase 2 Study of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia", "status": "RECRUITING", "start": "2026-09-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Kiminori Kimura, MD", "countries": ["Japan"]}, {"nct": "NCT07446010", "title": "Post Approval Observational Study to Learn More About How Safe Octocog Alfa is and How Well it Works in Patients With Severe Hemophilia A in India", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Bayer", "countries": ["India"]}, {"nct": "NCT04563520", "title": "SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis", "status": "RECRUITING", "start": "2026-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Emory University", "countries": ["United States"]}, {"nct": "NCT07791836", "title": "Prevalence of Inhibitor Development in Hemophilia A Patients Receiving Coageight: A Multicenter Cross-sectional Observational Study", "status": "NOT_YET_RECRUITING", "start": "2026-08-23", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "AryoGen Pharmed Co.", "countries": ["Iran"]}, {"nct": "NCT07736976", "title": "Comparison of 30-Second Sit-to-Stand Test Performance Between Individuals With Hemophilia and Healthy Peers", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Bahçeşehir University", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT07787091", "title": "A First-in Human Study of ARD001 in Healthy Volunteers and People With Hemophilia A", "status": "RECRUITING", "start": "2026-08", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Arditus Pte Ltd", "countries": ["Singapore"]}, {"nct": "NCT07653139", "title": "Patient Preferences in Treatment of Haemophilia A With and Without Inhibitors: a Discrete Choice Experiment in Germany", "status": "NOT_YET_RECRUITING", "start": "2026-07-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Novo Nordisk A/S", "countries": ["Germany"]}, {"nct": "NCT07682519", "title": "Multimodal Telerehabilitation Versus Face-to-Face Care for Adults With Hemophilia and Chronic Pain", "status": "RECRUITING", "start": "2026-07-02", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Chile", "countries": ["Chile"]}, {"nct": "NCT07582276", "title": "A Prospective Assessment of Bone Health in Patients With Severe Hemophilia A on Factor VIII vs Factor Mimetic Prophylaxis (Efa Emi Bone Health Study)", "status": "NOT_YET_RECRUITING", "start": "2026-07-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Arkansas Children's Hospital Research Institute", "countries": []}, {"nct": "NCT07692217", "title": "TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Texas Southwestern Medical Center", "countries": ["United States"]}, {"nct": "NCT07088458", "title": "An Observational Study to Learn More About How Well Damoctocog Alfa Pegol Works in Previously Treated Children With Hemophilia A", "status": "NOT_YET_RECRUITING", "start": "2026-06-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Bayer", "countries": []}, {"nct": "NCT07416526", "title": "A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A", "status": "RECRUITING", "start": "2026-05-15", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Hoffmann-La Roche", "countries": ["Argentina", "Brazil", "Denmark", "France", "Germany", "Hungary", "Italy", "Japan", "Netherlands", "South Africa", "South Korea", "Spain", "Taiwan", "United Kingdom", "United States"]}, {"nct": "NCT07539402", "title": "Searching Patterns In the Robustness of Immunological FVIII Tolerance", "status": "NOT_YET_RECRUITING", "start": "2026-05-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)", "countries": ["Netherlands"]}, {"nct": "NCT07579585", "title": "Effects of Photobiomodulation in Hemophilia Patients.", "status": "RECRUITING", "start": "2026-04-05", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Riphah International University", "countries": ["Pakistan"]}, {"nct": "NCT07452575", "title": "3D Ultrasound in Hemophilic Ankles", "status": "NOT_YET_RECRUITING", "start": "2026-04-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "The Hospital for Sick Children", "countries": []}, {"nct": "NCT05936580", "title": "Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery", "status": "RECRUITING", "start": "2026-04", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Octapharma", "countries": ["Finland", "France", "Germany", "Italy", "Serbia", "Spain", "Switzerland", "United Kingdom", "United States", "Uruguay"]}, {"nct": "NCT07161596", "title": "Oral Health Status and Oral Health Related Quality of Life in a Group pf Egyptian Hemophilic Children", "status": "NOT_YET_RECRUITING", "start": "2026-04", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Cairo University", "countries": ["Egypt"]}, {"nct": "NCT07420387", "title": "Effectiveness of an Educational Program for Pain Management in Patients With Hemophilic Arthropathy", "status": "NOT_YET_RECRUITING", "start": "2026-03-27", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Investigación en Hemofilia y Fisioterapia", "countries": ["Spain"]}]}, {"batch": 1, "no": 37, "name_zh": "肝豆状核变性", "query_terms": [{"term": "Wilson disease", "broad": false}, {"term": "Hepatolenticular Degeneration(Wilson Disease)", "broad": false}], "n_total": 16, "n_open": 10, "n_open_precise": 10, "n_broad": 0, "trials": [{"nct": "NCT04965558", "title": "Clinical Features and Outcome in Patients With Osseomuscular Type of Wilson's Disease", "status": "RECRUITING", "start": "2004-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Clinical Features and Outcome"], "cn_sites": [{"facility": "Second Affiliated Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04965545", "title": "Role for Biochemical Assays and Kayser-Fleischer Rings in Diagnosis of Wilson Disease", "status": "RECRUITING", "start": "2004-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Wilson Disease"], "cn_sites": [{"facility": "Second Affiliated Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03131427", "title": "China Registry for Genetic / Metabolic Liver Diseases", "status": "RECRUITING", "start": "2015-06-13", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 20000, "sponsor": "Beijing Friendship Hospital", "conditions": ["Genetic/Metabolic Liver Diseases"], "cn_sites": [{"facility": "Beijing Ditan Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Anzhen Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing YouAn Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Nanfang Hospital of Southern Medical University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Hebei Medical University Third Hospital", "city": "Shijiazhuang", "status": "RECRUITING"}, {"facility": "Henan Provincial Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Zhongshan Hospital, Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Jinshan Hospital of Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "West China Women's and Children's Hospital, Sichuan University", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Affiliated Hospital, Logistics University of People's Armed Police Force", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital", "city": "Ürümqi", "status": "RECRUITING"}], "cn_site_count": 12, "broad_only": false}, {"nct": "NCT04012658", "title": "A Registered Cohort Study on Wilson's Disease", "status": "RECRUITING", "start": "2019-07-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2000, "sponsor": "Wan-Jin Chen", "conditions": ["Wilson's Disease"], "cn_sites": [{"facility": "First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06196931", "title": "Clinical Value of DWI-ADC Matching in the Short-term Prognosis of Wilson's Disease", "status": "NOT_YET_RECRUITING", "start": "2024-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Hospital Affiliated to the Institute of Neurology, Anhui University of Chinese Medicine", "conditions": ["Hepatolenticular Degeneration; Wilson"], "cn_sites": [{"facility": "The affiliated hospital of Institute of Neurology in Anhui University of Chinese Medicine", "city": "Hefei", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06650319", "title": "A Clinical Study to Evaluate the Safety and Efficacy of LY-M003 Injection in Patients With Wilson Disease", "status": "RECRUITING", "start": "2024-09-24", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Chaohui Yu", "conditions": ["Wilson Disease"], "cn_sites": [{"facility": "First Affiliated Hospital of Zhejiang University", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07173933", "title": "Phase I/II Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of GC310 Injection in Patients With Wilson's Disease (WD)", "status": "NOT_YET_RECRUITING", "start": "2025-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "GeneCradle Inc", "conditions": ["Wilson Disease"], "cn_sites": [{"facility": "Peking Union Medical College", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07240896", "title": "A Clinical Study on the Treatment of Wilson Disease With ATP7B mRNA/LNP (DSL101)", "status": "RECRUITING", "start": "2025-12-31", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "DSciLab Co., Ltd.", "conditions": ["Wilsons Disease"], "cn_sites": [{"facility": "The First Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07641140", "title": "Phase I/II Clinical Study to Evaluate the Safety, Tolerability and Efficacy of LY-M003 Injection in Adult Patients With Wilson's Disease", "status": "NOT_YET_RECRUITING", "start": "2026-06-15", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Lingyi Biotech Co., Ltd.", "conditions": ["Wilson's Disease"], "cn_sites": [{"facility": "The First Affiliated Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07465718", "title": "Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients.", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 38, "sponsor": "Orphalan", "conditions": ["Wilson's Disease"], "cn_sites": [{"facility": "Beijing YouAn Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Beijing Friendship Hospital,Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT04965571", "title": "Clinical Features and Outcome of Wilson's Disease With Generalized Epilepsy in Chinese Patients", "status": "COMPLETED", "start": "2010-09-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 13, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Wilson Disease", "Generalized Epilepsy"], "cn_sites": [{"facility": "Second Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06762509", "title": "The Clinical Study of Botulinum Toxin Type A Injection in the Treatment of Wilson Disease", "status": "COMPLETED", "start": "2016-12-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 60, "sponsor": "The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine", "conditions": ["Wilson Disease"], "cn_sites": [{"facility": "the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, #117 Meishan Street, Shushan District Hefei 230037, China", "city": "Hefei", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03589820", "title": "Plasma Exchange and Continuous Hemodiafiltration in Treatment of Wilson's Disease-related Liver Failure", "status": "UNKNOWN", "start": "2018-06-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Third Affiliated Hospital, Sun Yat-Sen University", "conditions": ["Wilson Disease", "Liver Failure"], "cn_sites": [{"facility": "The Third Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03957720", "title": "The Individual Therapy for Patients With Wilson's Disease", "status": "UNKNOWN", "start": "2019-03-15", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 400, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Wilson's Disease"], "cn_sites": [{"facility": "econd Affiliated Hospital,Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05305872", "title": "Gandouling in the Treatment of Wilson's Disease", "status": "UNKNOWN", "start": "2023-01-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 240, "sponsor": "Jun Li", "conditions": ["Wilson's Disease"], "cn_sites": [{"facility": "Jun Li", "city": "Hefei", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06663878", "title": "An Exploratory Study to Evaluate the Tolerability and Safety of MWAV201 in Subjects With Wilson Disease", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-10-28", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": ["Wilson Disease"], "cn_sites": [{"facility": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 29, "g_fetched": 19, "g_countries": [["France", 8], ["United States", 3], ["Italy", 2], ["Germany", 2], ["Spain", 2], ["United Kingdom", 2], ["New Zealand", 1], ["India", 1], ["Argentina", 1], ["Belgium", 1], ["Poland", 1], ["Saudi Arabia", 1]], "g_trials": [{"nct": "NCT07748403", "title": "A Study of the Safety and Efficacy of Prime Editing (PM577) in Participants With Wilson Disease (WD)", "status": "RECRUITING", "start": "2026-09", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Prime Medicine, Inc.", "countries": ["New Zealand", "United States"]}, {"nct": "NCT07208565", "title": "Endocrine Dysfunction in Pediatric Wilson's Disease", "status": "NOT_YET_RECRUITING", "start": "2026-06-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT07476417", "title": "Oral Health, Dento-facial Condition and OHRQoL in Subjects With Mowat-Wilson Syndrome: an Epidemiologic Study.", "status": "NOT_YET_RECRUITING", "start": "2026-04-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Milan", "countries": ["Italy"]}, {"nct": "NCT07075393", "title": "Description of Renal Involvement in Wilson's Disease", "status": "NOT_YET_RECRUITING", "start": "2026-02", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondation Ophtalmologique Adolphe de Rothschild", "countries": ["France"]}, {"nct": "NCT07301216", "title": "Off Treatment Urinary Copper Excretion in Wilson Disease, Pilot Study", "status": "RECRUITING", "start": "2026-01-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Yale University", "countries": ["United States"]}, {"nct": "NCT07241832", "title": "Multifaceted Assessment of Patients With Wilson's Disease in a Low-Resource Setting in Upper Egypt: Service Integration, Psychosocial Burden, Dietary Practices, and the Geo-Spatial Disease Map", "status": "NOT_YET_RECRUITING", "start": "2025-12-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT06945081", "title": "Wilson's Disease Treated With D-Penicillamine: Characterization of Skin Damage Secondary to Treatment by Measuring Skin Elasticity", "status": "RECRUITING", "start": "2025-11-28", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Centre Hospitalier Universitaire de Saint Etienne", "countries": ["France"]}, {"nct": "NCT06430359", "title": "Circadian Variation of Urinary Copper Excretion in Wilson Disease Patients", "status": "RECRUITING", "start": "2025-01-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Hospices Civils de Lyon", "countries": ["France"]}, {"nct": "NCT06698991", "title": "Daily Versus Alternate Day Plasma Exchange in Wilson Disease With Acute Liver Failure in Children", "status": "NOT_YET_RECRUITING", "start": "2024-11-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Institute of Liver and Biliary Sciences, India", "countries": ["India"]}, {"nct": "NCT06573723", "title": "Institutional Registry of Rare Diseases", "status": "RECRUITING", "start": "2024-07-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Hospital Italiano de Buenos Aires", "countries": ["Argentina"]}, {"nct": "NCT06051734", "title": "Early Detection of Cardiac Affection in Patients of Wilson's Disease", "status": "NOT_YET_RECRUITING", "start": "2023-10-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT05444127", "title": "Oral Health and Wilson's Disease: SOMAWI", "status": "RECRUITING", "start": "2023-05-17", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondation Ophtalmologique Adolphe de Rothschild", "countries": ["France"]}, {"nct": "NCT05493605", "title": "Cardiac Involvement in Wilson's Disease", "status": "RECRUITING", "start": "2023-03-02", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Fondation Ophtalmologique Adolphe de Rothschild", "countries": ["France"]}, {"nct": "NCT05239858", "title": "International Wilson's Disease Patient Registry (iWilson Registry)", "status": "RECRUITING", "start": "2022-06-29", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Orphalan", "countries": ["Belgium", "France", "Germany", "Poland", "Saudi Arabia", "Spain", "United Kingdom"]}, {"nct": "NCT05183165", "title": "Description of the Copper Concentration in Breast Milk in Women Treated for Wilson's Disease", "status": "RECRUITING", "start": "2022-05-11", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Fondation Ophtalmologique Adolphe de Rothschild", "countries": ["France"]}, {"nct": "NCT06466291", "title": "Spanish Wilson Disease Registry", "status": "RECRUITING", "start": "2021-12-02", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Asociación Española para el Estudio del Hígado", "countries": ["Spain"]}, {"nct": "NCT04880356", "title": "Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.", "status": "RECRUITING", "start": "2021-03-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta", "countries": ["Italy"]}, {"nct": "NCT03334292", "title": "Natural History of Wilson Disease", "status": "RECRUITING", "start": "2017-12-18", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Yale University", "countries": ["Germany", "United Kingdom", "United States"]}, {"nct": "NCT05231876", "title": "French Wilson Disease Registry", "status": "RECRUITING", "start": "2005-01-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondation Ophtalmologique Adolphe de Rothschild", "countries": ["France"]}]}, {"batch": 1, "no": 38, "name_zh": "遗传性血管性水肿", "query_terms": [{"term": "Hereditary angioedema", "broad": false}], "n_total": 6, "n_open": 3, "n_open_precise": 3, "n_broad": 0, "trials": [{"nct": "NCT06679881", "title": "Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE", "status": "RECRUITING", "start": "2025-02-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 170, "sponsor": "Pharvaris Netherlands B.V.", "conditions": ["Hereditary Angioedema (HAE)"], "cn_sites": [{"facility": "Study Site", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06960213", "title": "STOP-HAE: A Phase 3 Study of ADX-324 in HAE", "status": "RECRUITING", "start": "2025-08-28", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "ADARx Pharmaceuticals, Inc.", "conditions": ["Hereditary Angioedema", "HAE", "Hereditary Angioedema - Type 1", "Hereditary Angioedema - Type 2"], "cn_sites": [{"facility": "ADARx Clinical Site", "city": "Beijing", "status": "RECRUITING"}, {"facility": "ADARx Clinical Site", "city": "Harbin", "status": "NOT_YET_RECRUITING"}, {"facility": "ADARx Clinical Site", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07428499", "title": "Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)", "status": "RECRUITING", "start": "2026-04-02", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "ADARx Pharmaceuticals, Inc.", "conditions": ["Hereditary Angioedema (HAE)", "Hereditary Angioedema - Type 1", "Hereditary Angioedema - Type 2", "HAE"], "cn_sites": [{"facility": "ADARx Clinical Site", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "ADARx Clinical Site", "city": "Harbin", "status": "NOT_YET_RECRUITING"}, {"facility": "ADARx Clinical Site", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT05460325", "title": "A Study of Lanadelumab (SHP643) in Chinese Participants With Hereditary Angioedema (HAE)", "status": "COMPLETED", "start": "2022-06-22", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Takeda", "conditions": ["Hereditary Angioedema (HAE)"], "cn_sites": [{"facility": "The Second Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology", "city": "Wuhan", "status": ""}, {"facility": "Yantai Yuhuangding Hospital", "city": "Yantai", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT06346899", "title": "A Study of Lanadelumab (Takhzyro) and Icatibant (Firazyr®) in Persons With HAE in China", "status": "COMPLETED", "start": "2024-07-20", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 115, "sponsor": "Takeda", "conditions": ["Hereditary Angioedema (HAE)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": ""}, {"facility": "The First Affiliated Hospital ,Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "The Second Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Tongji Hospital,Tongji Medical College,Huazhong University of Science & Technology", "city": "Wuhan", "status": ""}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "Qianfo Mountain Hospital, Shandong Province", "city": "Jinan", "status": ""}, {"facility": "Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Shanxi Bethune hospital", "city": "Taiyuan", "status": ""}, {"facility": "The Second Affiliated hospital of Xian Jiaotong University", "city": "Xian", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "First Affiliated hospital of Kunming Medical University", "city": "Kunming", "status": ""}, {"facility": "The Second Affiliated hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 13, "broad_only": false}, {"nct": "NCT06846398", "title": "A Phase 2 in Adult Subjects With Hereditary Angioedema", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-02-28", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 25, "sponsor": "Shanghai Argo Biopharmaceutical Co., Ltd.", "conditions": ["Hereditary Angioedema (HAE)"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "The First Hospital of Lanzhou University", "city": "Lanzhou", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Yantai Yuhuangding Hospital", "city": "Yantai", "status": ""}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "First Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}], "cn_site_count": 6, "broad_only": false}], "g_total": 27, "g_fetched": 24, "g_countries": [["United States", 10], ["Italy", 4], ["Spain", 3], ["Australia", 2], ["Poland", 2], ["Austria", 2], ["Bulgaria", 2], ["Canada", 2], ["France", 2], ["Germany", 2], ["Netherlands", 2], ["Turkey (Türkiye)", 2], ["United Kingdom", 2], ["Argentina", 2], ["Armenia", 2], ["Egypt", 1], ["Algeria", 1], ["Saudi Arabia", 1], ["Hungary", 1], ["New Zealand", 1], ["Switzerland", 1], ["Albania", 1], ["India", 1], ["Mexico", 1], ["Montenegro", 1], ["Peru", 1], ["Romania", 1], ["Serbia", 1], ["Ukraine", 1]], "g_trials": [{"nct": "NCT07218393", "title": "A Study About the Diagnosis and Management of Hereditary Angioedema (HAE) in Egypt", "status": "NOT_YET_RECRUITING", "start": "2026-12-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Takeda", "countries": ["Egypt"]}, {"nct": "NCT07445087", "title": "A Study of Takhzyro in Teenagers and Adults With Hereditary Angioedema (HAE) in South Korea", "status": "NOT_YET_RECRUITING", "start": "2026-10-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Takeda", "countries": []}, {"nct": "NCT07654829", "title": "Safety and Effectiveness of Sebetralstat (KVD900) for Short-Term Prophylaxis Before Procedures in People With Hereditary Angioedema (KONTROL)", "status": "RECRUITING", "start": "2026-08-17", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "KalVista Pharmaceuticals, Ltd.", "countries": ["United States"]}, {"nct": "NCT07293364", "title": "A Study to Learn About the C1-Inhibitor Function as Diagnosis for Hereditary Angioedema", "status": "RECRUITING", "start": "2026-05-12", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Takeda", "countries": ["Algeria"]}, {"nct": "NCT07263685", "title": "A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE) in the Kingdom of Saudi Arabia", "status": "RECRUITING", "start": "2026-04-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Takeda", "countries": ["Saudi Arabia"]}, {"nct": "NCT07298447", "title": "Donidalorsen Treatment in Children With Hereditary Angioedema", "status": "RECRUITING", "start": "2026-04-21", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Ionis Pharmaceuticals, Inc.", "countries": ["Australia", "Italy", "Poland", "Spain", "United States"]}, {"nct": "NCT07448181", "title": "Real-life Ecological Momentary Assessment of Lived Burden in Hereditary AngioEdema", "status": "RECRUITING", "start": "2026-02-23", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Istituti Clinici Scientifici Maugeri SpA", "countries": ["Italy"]}, {"nct": "NCT07266805", "title": "Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency", "status": "RECRUITING", "start": "2025-10-16", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Pharvaris Netherlands B.V.", "countries": ["Australia", "Austria", "Bulgaria", "Canada", "France", "Germany", "Hungary", "Italy", "Netherlands", "New Zealand", "Poland", "Spain", "Switzerland", "Turkey (Türkiye)", "United Kingdom", "United States"]}, {"nct": "NCT06919003", "title": "Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE TRIAL)", "status": "RECRUITING", "start": "2025-09-22", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "countries": ["United States"]}, {"nct": "NCT07021495", "title": "SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)", "status": "RECRUITING", "start": "2025-07-29", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Leiden University Medical Center", "countries": ["Netherlands"]}, {"nct": "NCT07001280", "title": "A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)", "status": "RECRUITING", "start": "2025-07-21", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "CSL Behring", "countries": ["Austria", "Canada", "Germany", "United Kingdom", "United States"]}, {"nct": "NCT07046806", "title": "Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients", "status": "RECRUITING", "start": "2025-03-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Institute for Asthma and Allergy", "countries": ["United States"]}, {"nct": "NCT06811467", "title": "Suicide Ideation in Hereditary Angioedema", "status": "NOT_YET_RECRUITING", "start": "2025-03-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Ivan Cherrez Ojeda", "countries": []}, {"nct": "NCT06782230", "title": "ScATtEred Rare Disease Biobanks: a Model of Sample/Data Collection With susTainablE and Shared Criteria", "status": "RECRUITING", "start": "2024-08-31", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS Policlinico S. Donato", "countries": ["Italy"]}, {"nct": "NCT06573723", "title": "Institutional Registry of Rare Diseases", "status": "RECRUITING", "start": "2024-07-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Hospital Italiano de Buenos Aires", "countries": ["Argentina"]}, {"nct": "NCT06361537", "title": "Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema Attacks", "status": "RECRUITING", "start": "2024-04-30", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Octapharma", "countries": ["Albania", "Argentina", "Armenia", "Bulgaria", "India", "Mexico", "Montenegro", "Peru", "Romania", "Serbia", "Turkey (Türkiye)", "Ukraine", "United States"]}, {"nct": "NCT06210698", "title": "Angioedema Biomarker Research Study", "status": "RECRUITING", "start": "2024-01-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Foundation For Rare Disease Research", "countries": ["United States"]}, {"nct": "NCT05904301", "title": "Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases", "status": "RECRUITING", "start": "2023-06-21", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Santé Arménie French-Armenian Research Center", "countries": ["Armenia"]}, {"nct": "NCT05833620", "title": "Identification and Characterization of Genetic Variants in Hereditary Angioedema", "status": "NOT_YET_RECRUITING", "start": "2023-05", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Hospital Universitari Vall d'Hebron Research Institute", "countries": ["Spain"]}, {"nct": "NCT04334031", "title": "Deployment o the Multidisciplinary Prospective Cohort Imminent", "status": "RECRUITING", "start": "2020-07-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Lille", "countries": ["France"]}, {"nct": "NCT05584488", "title": "Allergy and Immunology Natural History Study", "status": "RECRUITING", "start": "2010-07-16", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Columbia University", "countries": ["United States"]}, {"nct": "NCT07759141", "title": "EAP for Deucrictibant Immediate-release", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "Pharvaris Netherlands B.V.", "countries": []}, {"nct": "NCT07159464", "title": "Post Study Access of CSL312 (Garadacimab) for Pediatric Participants With Hereditary Angioedema Who Have Completed the CSL312_3003 Study", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "CSL Behring", "countries": []}, {"nct": "NCT07216378", "title": "Treatment of Angioedema Attacks in Pediatric (Ages 2-11) Post-Trial and Naive Patients With HAE With Sebetralstat", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "KalVista Pharmaceuticals, Ltd.", "countries": ["United States"]}]}, {"batch": 1, "no": 39, "name_zh": "遗传性大疱性表皮松解症", "query_terms": [{"term": "Inherited epidermolysis bullosa", "broad": false}, {"term": "Hereditary Epidermolysis Bullosa", "broad": false}], "n_total": 1, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT06073132", "title": "An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-04-04", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 80, "sponsor": "TWi Biotechnology, Inc.", "conditions": ["Generalized Epidermolysis Bullosa Simplex"], "cn_sites": [{"facility": "Dermatology Hospital of Southern Medical University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 27, "g_fetched": 27, "g_countries": [["United States", 15], ["France", 6], ["Greece", 2], ["Spain", 2], ["Italy", 1], ["Sweden", 1], ["Canada", 1], ["Japan", 1], ["United Kingdom", 1], ["Iran", 1], ["Netherlands", 1]], "g_trials": [{"nct": "NCT07482813", "title": "An Open Label Extension Safety Study to Evaluate SD-101 in Epidermolysis Bullosa", "status": "NOT_YET_RECRUITING", "start": "2026-11-15", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Paradigm Therapeutics", "countries": []}, {"nct": "NCT07717736", "title": "Phase 4 Master Protocol for Patients Prescribed Prademagene Zamikeracel for the Treatment of Wounds", "status": "NOT_YET_RECRUITING", "start": "2026-11", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Abeona Therapeutics, Inc", "countries": []}, {"nct": "NCT07240649", "title": "Emerging Indications for Hyperbaric Oxygen Treatment", "status": "NOT_YET_RECRUITING", "start": "2026-11", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Jay C. Buckey Jr.", "countries": []}, {"nct": "NCT07756138", "title": "Filsuvez in Moderate-to-Severe Epidermolysis Bullosa Simplex", "status": "NOT_YET_RECRUITING", "start": "2026-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Stanford University", "countries": ["United States"]}, {"nct": "NCT07780981", "title": "Impact of Body Positioning on EndoFLIP Measurements: A Comparative Study of Supine and Left Lateral Decubitus Positions", "status": "RECRUITING", "start": "2026-07-24", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Johns Hopkins University", "countries": ["United States"]}, {"nct": "NCT07482787", "title": "Efficacy and Safety Study to Evaluate SD-101 in Epidermolysis Bullosa", "status": "RECRUITING", "start": "2026-07-21", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Paradigm Therapeutics", "countries": ["United States"]}, {"nct": "NCT07684105", "title": "Treatment of Dysphagia in Patients With Dystrophic Epidermolysis Bullosa With Budesonide: a Retrospective Bicentric Study Nice - Paris St Louis / Necker (EBUDE Study)", "status": "NOT_YET_RECRUITING", "start": "2026-07-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Centre Hospitalier Universitaire de Nice", "countries": ["France"]}, {"nct": "NCT07011589", "title": "Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART)", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "M. Peter Marinkovich", "countries": ["United States"]}, {"nct": "NCT06594393", "title": "A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study", "status": "RECRUITING", "start": "2026-01-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Xinnate AB", "countries": ["France", "Greece", "Italy", "Spain", "Sweden", "United States"]}, {"nct": "NCT07193134", "title": "GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment", "status": "RECRUITING", "start": "2026-01-07", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "CHU de Quebec-Universite Laval", "countries": ["Canada"]}, {"nct": "NCT07027345", "title": "A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex", "status": "RECRUITING", "start": "2025-09-11", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "BioMendics, LLC", "countries": ["United States"]}, {"nct": "NCT06834035", "title": "Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa", "status": "RECRUITING", "start": "2025-08-04", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "M. Peter Marinkovich", "countries": ["United States"]}, {"nct": "NCT07700966", "title": "A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) in the Post-Marketing Setting", "status": "RECRUITING", "start": "2025-07-25", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Abeona Therapeutics, Inc", "countries": ["United States"]}, {"nct": "NCT07016750", "title": "A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa", "status": "RECRUITING", "start": "2025-06-20", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Krystal Biotech, Inc.", "countries": ["United States"]}, {"nct": "NCT06917690", "title": "A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Bullosa", "status": "RECRUITING", "start": "2025-04-18", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Chiesi Farmaceutici S.p.A.", "countries": ["Japan"]}, {"nct": "NCT06423573", "title": "A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez", "status": "RECRUITING", "start": "2024-12-18", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Amryt Pharma", "countries": ["France", "Greece", "Spain", "United Kingdom"]}, {"nct": "NCT04173650", "title": "MSC EVs in Dystrophic Epidermolysis Bullosa", "status": "RECRUITING", "start": "2024-08-13", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Aegle Therapeutics", "countries": ["United States"]}, {"nct": "NCT06509984", "title": "A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized", "status": "RECRUITING", "start": "2024-08-06", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Centre Hospitalier Universitaire de Nice", "countries": ["France"]}, {"nct": "NCT06563414", "title": "A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)", "status": "RECRUITING", "start": "2024-08-02", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Krystal Biotech, Inc.", "countries": ["United States"]}, {"nct": "NCT06136403", "title": "A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genodermatoses", "status": "RECRUITING", "start": "2024-03-18", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Centre Hospitalier Universitaire de Nice", "countries": ["France"]}, {"nct": "NCT07230223", "title": "Effect of Ev.FV on Wound Healing in Dystrophic Epidermolysis Bullosa", "status": "RECRUITING", "start": "2024-01-09", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Isfahan University of Medical Sciences", "countries": ["Iran"]}, {"nct": "NCT06330350", "title": "Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling", "status": "RECRUITING", "start": "2024-01-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Maastricht University Medical Center", "countries": ["Netherlands"]}, {"nct": "NCT05649098", "title": "Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders", "status": "RECRUITING", "start": "2023-06-12", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Northwestern University", "countries": ["United States"]}, {"nct": "NCT04917887", "title": "Long-Term Follow-up Protocol", "status": "RECRUITING", "start": "2021-05-25", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Krystal Biotech, Inc.", "countries": ["United States"]}, {"nct": "NCT03526159", "title": "Gentamicin for Junctional Epidermolysis Bullosa", "status": "RECRUITING", "start": "2018-06-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University of Southern California", "countries": ["United States"]}]}, {"batch": 1, "no": 40, "name_zh": "遗传性果糖不耐受症", "query_terms": [{"term": "Hereditary fructose intolerance", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 1, "g_fetched": 1, "g_countries": [["France", 1]], "g_trials": [{"nct": "NCT07337707", "title": "New Microbiota-endocrine Axis in Fructose Malabsorption-caused Visceral Hypersensitivity in Irritable Bowel Syndrome.", "status": "NOT_YET_RECRUITING", "start": "2026-02", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Rouen", "countries": ["France"]}]}, {"batch": 1, "no": 41, "name_zh": "遗传性低镁血症", "query_terms": [{"term": "Hereditary Hypomagnesemia", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 1, "g_fetched": 1, "g_countries": [["United Kingdom", 1]], "g_trials": [{"nct": "NCT06065852", "title": "National Registry of Rare Kidney Diseases", "status": "RECRUITING", "start": "2009-11-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "UK Kidney Association", "countries": ["United Kingdom"]}]}, {"batch": 1, "no": 42, "name_zh": "遗传性多发脑梗死性痴呆", "query_terms": [{"term": "CADASIL", "broad": false}, {"term": "Hereditary Multi-infarct Dementia (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy, CADASIL)", "broad": false}], "n_total": 3, "n_open": 2, "n_open_precise": 2, "n_broad": 0, "trials": [{"nct": "NCT04310098", "title": "CADASIL Registry Study", "status": "RECRUITING", "start": "2020-03-09", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "Bin Cai", "conditions": ["Cadasil"], "cn_sites": [{"facility": "Department of Neurology , First Affiliated Hospital Fujian Medical University", "city": "Fuzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07692399", "title": "Safety and Efficacy of Edaravone Dexborneol Sublingual Tablets for Blood-Brain Barrier Dysfunction in CADASIL", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Huashan Hospital", "conditions": ["CADASIL"], "cn_sites": [{"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05902039", "title": "MRI Study of Blood-brain Barrier Function in CADASIL", "status": "UNKNOWN", "start": "2021-04-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Peking University First Hospital", "conditions": ["Cadasil", "Blood Brain Barrier Defect"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}], "g_total": 18, "g_fetched": 16, "g_countries": [["United States", 6], ["Italy", 3], ["Australia", 1], ["Spain", 1], ["South Korea", 1], ["Switzerland", 1], ["Taiwan", 1], ["United Arab Emirates", 1], ["Germany", 1]], "g_trials": [{"nct": "NCT07650110", "title": "Biological Collection of the Rare Diseases of the Brain and Eye Vessels Cohort - 2", "status": "NOT_YET_RECRUITING", "start": "2026-06-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": []}, {"nct": "NCT07349004", "title": "Neurogenetic And Hemodynamic Of Migraine Aura And Pfo", "status": "RECRUITING", "start": "2025-11-24", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Azienda Usl di Bologna", "countries": ["Italy"]}, {"nct": "NCT06859658", "title": "Development and Validation of a Functional MRI Biomarker of Cerebral Small Vessel Dysfunction in CADASIL", "status": "NOT_YET_RECRUITING", "start": "2025-04-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": []}, {"nct": "NCT06933212", "title": "Effect of the Mediterranean Diet in Patients Affected by CADASIL and Cerebral Amyloid Angiopathy.", "status": "RECRUITING", "start": "2024-10-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta", "countries": ["Italy"]}, {"nct": "NCT06148051", "title": "AusCADASIL: An Australian Cohort of CADASIL", "status": "RECRUITING", "start": "2023-11-25", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Perminder Sachdev", "countries": ["Australia"]}, {"nct": "NCT06938100", "title": "Genotype, Clinical Features and Imaging of Neuroradiological Abnormalities in CADASIL", "status": "RECRUITING", "start": "2023-11-21", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta", "countries": ["Italy", "Spain"]}, {"nct": "NCT07497867", "title": "Long-term Prospective Study of Korean CADASIL Patients", "status": "RECRUITING", "start": "2023-07-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Jeju National University Hospital", "countries": ["South Korea"]}, {"nct": "NCT05677880", "title": "Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study", "status": "RECRUITING", "start": "2022-06-03", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Wisconsin, Madison", "countries": ["United States"]}, {"nct": "NCT05567744", "title": "Registry for CADASIL", "status": "RECRUITING", "start": "2022-06-03", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Wisconsin, Madison", "countries": ["United States"]}, {"nct": "NCT05072483", "title": "Natural History Study of CADASIL", "status": "RECRUITING", "start": "2022-04-18", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "countries": ["United States"]}, {"nct": "NCT04753970", "title": "Retina is a Marker for Cerebrovascular Heath", "status": "RECRUITING", "start": "2021-02-09", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Mayo Clinic", "countries": ["United States"]}, {"nct": "NCT05734378", "title": "Prognosis of Cerebral Small Vessel Disease", "status": "RECRUITING", "start": "2020-12-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Insel Gruppe AG, University Hospital Bern", "countries": ["Switzerland"]}, {"nct": "NCT05473637", "title": "Taiwan Associated Genetic and Nongenetic Small Vessel Disease", "status": "RECRUITING", "start": "2019-01-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Taiwan University Hospital", "countries": ["Taiwan"]}, {"nct": "NCT03047369", "title": "The Myelin Disorders Biorepository Project", "status": "RECRUITING", "start": "2016-12-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Children's Hospital of Philadelphia", "countries": ["United States"]}, {"nct": "NCT02795052", "title": "Neurologic Stem Cell Treatment Study", "status": "RECRUITING", "start": "2016-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "MD Stem Cells", "countries": ["United Arab Emirates", "United States"]}, {"nct": "NCT07771335", "title": "The Erlanger Stroke Project is an Ongoing Prospective Population-based Stroke Registry in Germany, Including All Hospitalized and Nonhospitalized Patients With Stroke in the City of Erlangen (120.000 Inhabitants).", "status": "RECRUITING", "start": "1994-04-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Erlangen-Nürnberg Medical School", "countries": ["Germany"]}]}, {"batch": 1, "no": 43, "name_zh": "遗传性痉挛性截瘫", "query_terms": [{"term": "Hereditary spastic paraplegia", "broad": false}], "n_total": 5, "n_open": 3, "n_open_precise": 3, "n_broad": 0, "trials": [{"nct": "NCT06478238", "title": "Calcium Folinate Treatment of Spastic Paraplegia 56", "status": "RECRUITING", "start": "2024-07-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Shanghai 6th People's Hospital", "conditions": ["Hereditary Spastic Paraplegia"], "cn_sites": [{"facility": "Shanghai 6th People's Hospita", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06844734", "title": "A Prospective Cohort Study of ITB Treatment for HSP", "status": "RECRUITING", "start": "2025-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 50, "sponsor": "Shanghai 6th People's Hospital", "conditions": ["Hereditary Spastic Paraplegia"], "cn_sites": [{"facility": "Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06936163", "title": "A Prospective Cohort Study of Surgical Treatment for Foot Deformities in HSP", "status": "RECRUITING", "start": "2025-03-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Shanghai 6th People's Hospital", "conditions": ["Hereditary Spastic Paraplegia"], "cn_sites": [{"facility": "Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04101643", "title": "PCSK9 Inhibitor Treatment for Patients With SPG5", "status": "UNKNOWN", "start": "2019-09-29", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "First Affiliated Hospital of Fujian Medical University", "conditions": ["Hereditary Spastic Paraplegia Type 5"], "cn_sites": [{"facility": "Department of Neurology , First Affiliated Hospital Fujian Medical University", "city": "Fuzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05196178", "title": "Spinal Cord Stimulation Therapy for Hereditary Spastic Paraplegias Patients", "status": "UNKNOWN", "start": "2021-11-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Motor Function", "Gait"], "cn_sites": [{"facility": "Xuanwu Hospital,Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}], "g_total": 22, "g_fetched": 19, "g_countries": [["United States", 10], ["Italy", 5], ["Germany", 3], ["Spain", 2], ["Austria", 2], ["France", 2], ["Czechia", 1], ["Ireland", 1], ["Netherlands", 1], ["Poland", 1], ["Belgium", 1], ["Canada", 1]], "g_trials": [{"nct": "NCT07417943", "title": "Neuromodulation to Enhance Motor Function in HSP", "status": "RECRUITING", "start": "2026-04-09", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Rahul Sachdeva", "countries": ["United States"]}, {"nct": "NCT06692712", "title": "Phase 3 Efficacy Study With Concurrent Control of IT MELPIDA in SPG50.Concurrent Controls.", "status": "RECRUITING", "start": "2026-04-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Elpida Therapeutics SPC", "countries": ["Spain", "United States"]}, {"nct": "NCT07478172", "title": "Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease", "status": "RECRUITING", "start": "2026-03-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Missouri-Columbia", "countries": ["United States"]}, {"nct": "NCT06948019", "title": "Safety and Efficacy of AAV9/AP4B1 (BFB-101) For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47)", "status": "NOT_YET_RECRUITING", "start": "2025-08", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "BlackfinBio Ltd", "countries": ["United States"]}, {"nct": "NCT06742697", "title": "Flexibility, Resistance, Aerobic, Movement Execution Training in Adults With Hereditary Spastic Paraplegia", "status": "RECRUITING", "start": "2024-12-23", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "IRCCS Eugenio Medea", "countries": ["Italy"]}, {"nct": "NCT07798674", "title": "TreatHSP Platform: Adaptive Natural History Platform for Ataxias, HSPs, and Spastic Ataxias", "status": "RECRUITING", "start": "2024-07-16", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Heidelberg University", "countries": ["Austria", "Czechia", "France", "Germany", "Ireland", "Italy", "Netherlands", "Poland", "Spain"]}, {"nct": "NCT06553976", "title": "Spastic Paraplegia - Centers of Excellence Research Network", "status": "RECRUITING", "start": "2024-06-04", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Boston Children's Hospital", "countries": ["United States"]}, {"nct": "NCT06229626", "title": "Evaluation of an Intensive Training Program for Patients with Hereditary Spastic Paraparesis SPG4/Spast", "status": "RECRUITING", "start": "2024-04-04", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT07136844", "title": "Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology", "status": "RECRUITING", "start": "2024-03-29", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Centre Hospitalier Universitaire de Liege", "countries": ["Belgium"]}, {"nct": "NCT06572046", "title": "STOP-HSP.Net: a Registry for Hereditary Spastic Paraplegia as an Integration Tool for Future Therapeutic Strategies", "status": "RECRUITING", "start": "2024-01-24", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS Fondazione Stella Maris", "countries": ["Italy"]}, {"nct": "NCT06092346", "title": "A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders", "status": "RECRUITING", "start": "2023-12-19", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Human Genome Research Institute (NHGRI)", "countries": ["United States"]}, {"nct": "NCT05848271", "title": "Natural History Study of Patients with HPDL Mutations", "status": "RECRUITING", "start": "2023-05-18", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of California, San Diego", "countries": ["United States"]}, {"nct": "NCT07090057", "title": "The Effect of Targeting the Plantaris Muscle-tendon in Surgical Correction of Ankle Equinus in Children", "status": "RECRUITING", "start": "2023-03-13", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Alberta", "countries": ["Canada"]}, {"nct": "NCT05518188", "title": "Melpida: Recombinant Adeno-associated Virus (Serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt)", "status": "RECRUITING", "start": "2023-02-15", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Elpida Therapeutics SPC", "countries": ["United States"]}, {"nct": "NCT05354622", "title": "Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)", "status": "RECRUITING", "start": "2022-04-25", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Boston Children's Hospital", "countries": ["United States"]}, {"nct": "NCT04712812", "title": "Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia", "status": "RECRUITING", "start": "2020-04-27", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Boston Children's Hospital", "countries": ["United States"]}, {"nct": "NCT03981276", "title": "Phenotypes, Biomarkers and Pathophysiology in Hereditary Spastic Paraplegias and Related Disorders", "status": "RECRUITING", "start": "2019-10-14", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Dr. Rebecca Schule", "countries": ["Austria", "Germany", "Italy"]}, {"nct": "NCT03206190", "title": "The preSPG4 Study - Studying the Prodromal and Early Phase of SPG4", "status": "RECRUITING", "start": "2018-07-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital Tuebingen", "countries": ["Germany"]}, {"nct": "NCT06728787", "title": "Robot-assisted Walking Treatment in Hereditary Spastic Paraplegia (HSP)", "status": "RECRUITING", "start": "2012-01-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS Eugenio Medea", "countries": ["Italy"]}]}, {"batch": 1, "no": 44, "name_zh": "全羧化酶合成酶缺乏症", "query_terms": [{"term": "Holocarboxylase synthetase deficiency", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 1, "g_fetched": 1, "g_countries": [["Italy", 1]], "g_trials": [{"nct": "NCT06723925", "title": "Neonatal Screening of Biotinidase Deficiency: Genotype-phenotype Correlation and Clinical Follow-up", "status": "RECRUITING", "start": "2021-04-21", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS Azienda Ospedaliero-Universitaria di Bologna", "countries": ["Italy"]}]}, {"batch": 1, "no": 45, "name_zh": "同型半胱氨酸血症", "query_terms": [{"term": "Homocystinuria without methylmalonic aciduria", "broad": false}, {"term": "Homocysteinemia", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 0, "g_fetched": 0, "g_countries": [], "g_trials": []}, {"batch": 1, "no": 46, "name_zh": "纯合子家族性高胆固醇血症", "query_terms": [{"term": "Homozygous familial hypercholesterolemia", "broad": false}, {"term": "Homozygous Hypercholesterolemia", "broad": false}], "n_total": 13, "n_open": 5, "n_open_precise": 5, "n_broad": 0, "trials": [{"nct": "NCT06125847", "title": "NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia", "status": "RECRUITING", "start": "2023-10-29", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 21, "sponsor": "First Affiliated Hospital Xi'an Jiaotong University", "conditions": ["Homozygous Familial Hypercholesterolemia"], "cn_sites": [{"facility": "First Affiliated Hospital of Xian Jiaotong University", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06597006", "title": "Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia", "status": "RECRUITING", "start": "2025-02-28", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Familial Hypercholesterolemia - Homozygous"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07133815", "title": "Evaluate the Long-term Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia", "status": "NOT_YET_RECRUITING", "start": "2025-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 55, "sponsor": "Beijing Suncadia Pharmaceuticals Co., Ltd", "conditions": ["Homozygous Familial Hypercholesterolemia"], "cn_sites": [{"facility": "Xiangya Second Hospital of Central South University", "city": "Changsha", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07489209", "title": "A Dose-exploration Study of EDP167 in HoFH", "status": "RECRUITING", "start": "2026-02-06", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Eddingpharm (Zhuhai) Co., Ltd.", "conditions": ["Homozygous Familial Hypercholesterolemia (HoFH)"], "cn_sites": [{"facility": "Fuwai Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07591298", "title": "Phase II Clinical Trial to Evaluate the Efficacy and Safety of SYH2070 Injection in Participants With Homozygous Familial Hypercholesterolemia", "status": "RECRUITING", "start": "2026-05-24", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.", "conditions": ["Diagnosed With HoFH"], "cn_sites": [{"facility": "The Second Xiangya Hospital", "city": "Changsha", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01878604", "title": "Gene Analysis and Treatment Optimization in Chinese Homozygous Familial Hypercholesterolemia", "status": "COMPLETED", "start": "2001-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 5, "sponsor": "Central South University", "conditions": ["Homozygous Familial Hypercholesterolemia"], "cn_sites": [{"facility": "Cardiology department of 2nd Xiangya Hospital", "city": "Changsha", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03933293", "title": "A Study to Evaluate the Safety and Efficacy of the PCSK9 Inhibitor AK102 in Patients With HoFH", "status": "COMPLETED", "start": "2019-05-13", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Akeso", "conditions": ["Homozygous Familial Hypercholesterolemia"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Anzhen Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT04031742", "title": "A Study to Evaluate Safety and Efficacy of IBI306, a PCSK9 Monoclonal Antibody in Chinese Subjects With Homozygous Familial Hypercholesterolemia", "status": "COMPLETED", "start": "2019-09-29", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Innovent Biologics (Suzhou) Co. Ltd.", "conditions": ["Homozygous Familial Hypercholesterolemia"], "cn_sites": [{"facility": "Beijing Anzhen Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04948008", "title": "Evaluate the Efficacy and Safety of IBI306 in Subjects With Homozygous Familial Hypercholesterolemia", "status": "UNKNOWN", "start": "2019-11-05", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 8, "sponsor": "Shenzhen People's Hospital", "conditions": ["Familial Hypercholesterolemia - Homozygous", "Lipid Metabolism Disorders", "Proprotein Convertase Subtilisin/Kexin 9"], "cn_sites": [{"facility": "xili People's Hospital", "city": "Shenzhen", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04515927", "title": "To Evaluate the Efficacy and Safety of JS002 in HoFH Patients", "status": "COMPLETED", "start": "2020-08-17", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 31, "sponsor": "Shanghai Junshi Bioscience Co., Ltd.", "conditions": ["Hyperlipemia"], "cn_sites": [{"facility": "Beijing Anzhen Hospital Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06009393", "title": "Evaluate the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia", "status": "COMPLETED", "start": "2023-12-22", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 26, "sponsor": "Beijing Suncadia Pharmaceuticals Co., Ltd", "conditions": ["Homozygous Familial Hypercholesterolemia"], "cn_sites": [{"facility": "The Second Xiangya Hospital of Central South University Hospital", "city": "Changsha", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06712771", "title": "A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of VSA003 in Chinese HoFH Patients", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-11-27", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 46, "sponsor": "Visirna Therapeutics HK Limited", "conditions": ["Homozygous Familial Hypercholesterolemia (HoFH)"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06723652", "title": "A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia", "status": "COMPLETED", "start": "2025-02-13", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 55, "sponsor": "Beijing Suncadia Pharmaceuticals Co., Ltd", "conditions": ["Homozygous Familial Hypercholesterolemia"], "cn_sites": [{"facility": "The Second Xiangya Hospital of Central South University Hospital", "city": "Changsha", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 13, "g_fetched": 8, "g_countries": [["United States", 5], ["Netherlands", 3], ["France", 2], ["Italy", 2], ["Turkey (Türkiye)", 2], ["United Kingdom", 2], ["South Africa", 2], ["Spain", 2], ["Australia", 1], ["New Zealand", 1], ["Argentina", 1], ["Brazil", 1], ["Canada", 1], ["Czechia", 1], ["Germany", 1], ["Greece", 1], ["Hungary", 1], ["Israel", 1], ["Jordan", 1], ["Lebanon", 1], ["Malaysia", 1], ["Norway", 1], ["Poland", 1], ["Russia", 1], ["Slovakia", 1], ["Slovenia", 1], ["Switzerland", 1], ["Taiwan", 1]], "g_trials": [{"nct": "NCT07473843", "title": "Study of Zodasiran in Adolescent Participants With Homozygous Familial Hypercholesterolemia", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Arrowhead Pharmaceuticals", "countries": []}, {"nct": "NCT07447648", "title": "Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque Volumes Measured by Coronary Computed Tomography Angiography (CCTA) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)", "status": "RECRUITING", "start": "2026-04-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)", "countries": ["France", "Italy", "Netherlands", "Turkey (Türkiye)"]}, {"nct": "NCT07470723", "title": "The ORIGIN-FH Study", "status": "RECRUITING", "start": "2026-02-14", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Wisconsin, Madison", "countries": ["United States"]}, {"nct": "NCT07491172", "title": "A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias", "status": "RECRUITING", "start": "2024-06-21", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "CRISPR Therapeutics AG", "countries": ["Australia", "New Zealand", "United Kingdom", "United States"]}, {"nct": "NCT05682378", "title": "Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies", "status": "RECRUITING", "start": "2023-02-10", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": ["Argentina", "Brazil", "Canada", "Czechia", "France", "Germany", "Greece", "Hungary", "Israel", "Italy", "Jordan", "Lebanon", "Malaysia", "Netherlands", "Norway", "Poland", "Russia", "Slovakia", "Slovenia", "South Africa", "Spain", "Switzerland", "Taiwan", "Turkey (Türkiye)", "United Kingdom", "United States"]}, {"nct": "NCT04815005", "title": "HoFH, the International Clinical Collaborators Registry", "status": "RECRUITING", "start": "2017-01-24", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Pennsylvania", "countries": ["Netherlands", "South Africa", "United States"]}, {"nct": "NCT04370899", "title": "Early Detection of Familial Hypercholesterolemia in Children", "status": "RECRUITING", "start": "2013-03-14", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Institut Investigacio Sanitaria Pere Virgili", "countries": ["Spain"]}, {"nct": "NCT01109368", "title": "The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository", "status": "RECRUITING", "start": "2010-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "The Rogosin Institute", "countries": ["United States"]}]}, {"batch": 1, "no": 47, "name_zh": "亨廷顿舞蹈病", "query_terms": [{"term": "Huntington disease", "broad": false}], "n_total": 12, "n_open": 3, "n_open_precise": 3, "n_broad": 0, "trials": [{"nct": "NCT07326709", "title": "A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease", "status": "RECRUITING", "start": "2026-03-24", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 770, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Huntington Disease"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Tongji Hos Affiliated Tongji Medical College of Huazhong", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "The Second Xiangya Hospital of Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "West China Hospital of Sichuan Uni", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hosp Of Zhejiang Univ School Of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT07513844", "title": "Optimizing Parameters of Low-Intensity Focused Ultrasound for Pallidal Modulation in Huntington's Disease", "status": "RECRUITING", "start": "2026-04-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "First Affiliated Hospital of Fujian Medical University", "conditions": ["Huntington Disease"], "cn_sites": [{"facility": "Department of Rehabilitation Medicine, The First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07516899", "title": "Mass Balance Study of [14C] LPM3770164 in Healthy Participants", "status": "NOT_YET_RECRUITING", "start": "2026-04-30", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 8, "sponsor": "Luye Pharma Group Ltd.", "conditions": ["Huntington Disease"], "cn_sites": [{"facility": "Affiliated Hospital of Jiangnan University", "city": "Wuxi", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04244513", "title": "Deep Brain Stimulation Treatment for Chorea in Huntington's Disease", "status": "UNKNOWN", "start": "2020-02-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Beijing Municipal Administration of Hospitals", "conditions": ["Huntington Disease", "Deep Brain Stimulation"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT04071639", "title": "Symptomatic Therapy for Patients With Huntington's Disease", "status": "UNKNOWN", "start": "2020-03-12", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Huntington Disease"], "cn_sites": [{"facility": "Second Affiliated Hospital,Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05238701", "title": "A Dose-escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of LPM3770164 in Healthy Subjects", "status": "COMPLETED", "start": "2022-02-25", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 104, "sponsor": "Luye Pharma Group Ltd.", "conditions": ["Huntington Disease", "Tardive Dyskinesia"], "cn_sites": [{"facility": "Shanghai Mental Health Center", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06024265", "title": "The Safety and Tolerability Study With ER2001 Intravenous Injection in Adults With Early Manifest Huntington's Disease", "status": "COMPLETED", "start": "2023-04-04", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "ExoRNA Bioscience", "conditions": ["Huntington Disease"], "cn_sites": [{"facility": "First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06216054", "title": "Safety, Tolerability and Pharmacokinetic of Multiple-ascending Doses of LPM3770164 in Healthy Subjects", "status": "COMPLETED", "start": "2023-12-19", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Luye Pharma Group Ltd.", "conditions": ["Tardive Dyskinesia", "Huntington Disease"], "cn_sites": [{"facility": "Shanghai Mental Health Center", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07601516", "title": "Real World Effectiveness and Safety of Deutetrabenazine in Adult Chinese Participants With Huntington's Disease (HD) Chorea in China", "status": "COMPLETED", "start": "2024-02-02", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Teva Branded Pharmaceutical Products R&D LLC", "conditions": ["Huntington's Disease", "Chorea"], "cn_sites": [{"facility": "Teva Investigational Site 03", "city": "Beijing", "status": ""}, {"facility": "Teva Investigational Site 02", "city": "Beijing", "status": ""}, {"facility": "Teva Investigational Site 01", "city": "Chengdu", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07344519", "title": "The Safety and Tolerability Study With ER2001 Intravenous Injection Repetitive Treatment in Adults With Early Manifest Huntington's Disease.", "status": "COMPLETED", "start": "2024-06-25", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 8, "sponsor": "ExoRNA Bioscience", "conditions": ["Huntington Disease"], "cn_sites": [{"facility": "First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06474650", "title": "Effect of Food on the Pharmacokinetics of LPM3770164 Sustained-release Tablets", "status": "COMPLETED", "start": "2024-07-31", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 16, "sponsor": "Luye Pharma Group Ltd.", "conditions": ["Huntington Disease", "Tardive Dyskinesia"], "cn_sites": [{"facility": "Shanghai Mental Health Center", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07339514", "title": "A Phase I Clinical Study of ER2001 Injection for the Treatment of Early Manifest Huntington's Disease.", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-02-11", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 27, "sponsor": "ExoRNA Bioscience", "conditions": ["Huntington Disease"], "cn_sites": [{"facility": "First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "First Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}], "cn_site_count": 3, "broad_only": false}], "g_total": 47, "g_fetched": 44, "g_countries": [["United States", 20], ["France", 12], ["United Kingdom", 7], ["Germany", 6], ["Belgium", 5], ["Canada", 5], ["Netherlands", 5], ["Spain", 5], ["Italy", 4], ["Poland", 3], ["Portugal", 3], ["Australia", 3], ["New Zealand", 3], ["Switzerland", 2], ["Argentina", 2], ["Chile", 2], ["Colombia", 2], ["Denmark", 2], ["Israel", 2], ["Czechia", 1], ["Brazil", 1], ["Georgia", 1], ["Sweden", 1], ["Norway", 1], ["Austria", 1], ["Ireland", 1]], "g_trials": [{"nct": "NCT07280650", "title": "Feasibility and Acceptability of an LLM-based Chatbot for Family Caregivers: Evaluation Study", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Michigan", "countries": ["United States"]}, {"nct": "NCT07609108", "title": "Pridopidine Phase 3 Study in Huntington's Disease", "status": "RECRUITING", "start": "2026-07-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Prilenia", "countries": ["Belgium", "Canada", "Czechia", "France", "Germany", "Italy", "Netherlands", "Poland", "Portugal", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT07536061", "title": "A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease", "status": "RECRUITING", "start": "2026-05-12", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Sarepta Therapeutics, Inc.", "countries": ["Australia", "New Zealand", "Switzerland", "United Kingdom"]}, {"nct": "NCT07451613", "title": "Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease", "status": "RECRUITING", "start": "2026-04-06", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Leslie Thompson", "countries": ["United States"]}, {"nct": "NCT07409597", "title": "Autobiographical Memory, Future Thought, and Eye Movements in Huntington's Disease", "status": "NOT_YET_RECRUITING", "start": "2026-04-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Angers", "countries": ["France"]}, {"nct": "NCT06634628", "title": "iMagemHTT-009- FIH Evaluation of Novel Mutant Huntingtin PET Radioligand [11C]CHDI-00491009", "status": "RECRUITING", "start": "2026-02-24", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "CHDI Foundation, Inc.", "countries": ["Belgium"]}, {"nct": "NCT07315984", "title": "Multi-Modal Digital Monitoring of Disease Symptoms Huntington's Disease", "status": "NOT_YET_RECRUITING", "start": "2026-01-31", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "BioSensics", "countries": ["United States"]}, {"nct": "NCT07378644", "title": "Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease", "status": "RECRUITING", "start": "2026-01-06", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Skyhawk Therapeutics, Inc.", "countries": ["Argentina", "Brazil", "Canada", "Chile", "Colombia", "Georgia", "Germany", "Spain", "United States"]}, {"nct": "NCT07253038", "title": "Evaluation of Three Tests to Assess Social Cognition in Huntington Disease", "status": "RECRUITING", "start": "2025-12-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Region Skane", "countries": ["Sweden"]}, {"nct": "NCT06828471", "title": "Social Cognition Training in Individuals With Huntington's Disease", "status": "RECRUITING", "start": "2025-11-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Rush University Medical Center", "countries": ["United States"]}, {"nct": "NCT06843252", "title": "Home-based TDCS (Transcranial Direct Current Stimulation) for Cognitive and Behavioral Symptoms in Huntington's Disease", "status": "RECRUITING", "start": "2025-09-02", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "The University of Texas Health Science Center at San Antonio", "countries": ["United States"]}, {"nct": "NCT06774443", "title": "Hinting Task for Huntington's Disease", "status": "RECRUITING", "start": "2025-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Medical Center Groningen", "countries": ["Netherlands"]}, {"nct": "NCT06976983", "title": "Transcranial Static Magnetic Stimulation (tSMS) in Huntington's Disease (HD)", "status": "NOT_YET_RECRUITING", "start": "2025-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Neuromed IRCCS", "countries": []}, {"nct": "NCT06807892", "title": "Comparison of Two Cognitive-Motor Rehabilitation Approaches Via Exergames: a Study of Cognitive, Motor and Behavioral Functions in Huntington's Disease Patients", "status": "RECRUITING", "start": "2025-07-31", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Angers", "countries": ["France"]}, {"nct": "NCT06546488", "title": "Cognitive Assessment Tools for Huntington's Disease.", "status": "RECRUITING", "start": "2025-06-20", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Ohio State University", "countries": ["United States"]}, {"nct": "NCT07010705", "title": "Digital Measures for Clinical Trial Endpoints in Huntington's Disease", "status": "RECRUITING", "start": "2025-06-20", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Rochester", "countries": ["United States"]}, {"nct": "NCT06448546", "title": "Gut Microbiomes in HD", "status": "RECRUITING", "start": "2025-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Central Florida", "countries": ["United States"]}, {"nct": "NCT06853743", "title": "The NAD-HD Study: A Study to Investigate Efficacy and Safety of Nicotinamide Riboside Compared With Placebo in Huntington's Disease", "status": "RECRUITING", "start": "2025-03-18", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Oslo University Hospital", "countries": ["Norway"]}, {"nct": "NCT06876857", "title": "University of Central Florida CereBank", "status": "RECRUITING", "start": "2025-02-25", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Central Florida", "countries": ["United States"]}, {"nct": "NCT06826612", "title": "A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease", "status": "RECRUITING", "start": "2025-02-21", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Hoffmann-La Roche", "countries": ["United States"]}, {"nct": "NCT06626308", "title": "Early Biomarkers in Premanifest Huntington's Disease Gene Carriers: a Pilot Study", "status": "RECRUITING", "start": "2025-02-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Grenoble", "countries": ["France"]}, {"nct": "NCT06693466", "title": "Huntington's Disease and Pain", "status": "NOT_YET_RECRUITING", "start": "2025-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Leiden University Medical Center", "countries": ["Netherlands"]}, {"nct": "NCT05360082", "title": "Comparison Between [11C]UCB-J and [18F]SynVest-1 PET in HD.", "status": "RECRUITING", "start": "2024-11-18", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Universitaire Ziekenhuizen KU Leuven", "countries": ["Belgium"]}, {"nct": "NCT06147414", "title": "Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders", "status": "RECRUITING", "start": "2024-10-23", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT06414967", "title": "Study to Evaluate Music Therapy on Irritability and Impulsivity in Patients With Huntington's Disease (MUSIC-HD)", "status": "RECRUITING", "start": "2024-10-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Poitiers University Hospital", "countries": ["France"]}]}, {"batch": 1, "no": 48, "name_zh": "HHH综合征", "query_terms": [{"term": "Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome", "broad": false}, {"term": "Hyperornithinaemia-Hyperammonaemia-Homocitrullinuria Syndrome", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 1, "g_fetched": 1, "g_countries": [["United States", 1]], "g_trials": [{"nct": "NCT04602325", "title": "Systemic Biomarkers of Brain Injury From Hyperammonemia", "status": "RECRUITING", "start": "2020-07-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Children's National Research Institute", "countries": ["United States"]}]}, {"batch": 1, "no": 49, "name_zh": "高苯丙氨酸血症", "query_terms": [{"term": "Phenylalanine hydroxylase deficiency", "broad": false}, {"term": "Hyperphenylalaninemia", "broad": false}], "n_total": 7, "n_open": 4, "n_open_precise": 4, "n_broad": 0, "trials": [{"nct": "NCT06687733", "title": "Safety and Efficacy Study of NGGT002 in Adult Patients With Phenylketonuria", "status": "RECRUITING", "start": "2024-07-16", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "NGGT (Suzhou) Biotechnology Co., Ltd.", "conditions": ["Phenylketonurias"], "cn_sites": [{"facility": "First Affiliated Hospital of Bengbu Medical College", "city": "Bengbu", "status": "RECRUITING"}, {"facility": "Xinhua Hospital Affifiated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07672756", "title": "A Clinical Study on the Safety and Tolerability of PL54 Injection in Adult Patients With Phenylketonuria (PKU)", "status": "RECRUITING", "start": "2025-07-20", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 48, "sponsor": "Chongqing Peg-Bio Biopharm Co., Ltd.", "conditions": ["Phenylketonuria (PKU)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07685210", "title": "GenSci144 Tablets Phase I Clinical Trial", "status": "RECRUITING", "start": "2026-06-22", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 48, "sponsor": "Changchun GeneScience Pharmaceutical Co., Ltd.", "conditions": ["Phenylketonuria"], "cn_sites": [{"facility": "The First Affiliated Hospital of Shandong First Medical University (Shandong Qianfoshan Hospital).", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07318909", "title": "To Evaluate the Safety and Efficacy of GS1168 Injection in Adult Phenylketonuria", "status": "NOT_YET_RECRUITING", "start": "2027-12-31", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Gritgen Therapeutics Co., Ltd.", "conditions": ["Phenylketonuria (PKU)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03864029", "title": "Retrospective Observational Safety Effectiveness With Kuvan in hpA", "status": "COMPLETED", "start": "2017-10-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 26, "sponsor": "BioMarin Pharmaceutical", "conditions": ["Tetrahydrobiopterin Deficiency"], "cn_sites": [{"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06061614", "title": "Safety and Efficacy Study of NGGT002 in PKU Adult Subjects", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-03-30", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "The First Affiliated Hospital of Bengbu Medical University", "conditions": ["Phenylketonurias"], "cn_sites": [{"facility": "The First Affiliated Hospital of Bengbu Medical College", "city": "Bengbu", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05948020", "title": "Efficacy and Safety of Orally Administered Engineered Probiotics (CBT102-A) for the Treatment of Children With Phenylketonuria", "status": "COMPLETED", "start": "2023-09-02", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Children's Hospital of Fudan University", "conditions": ["Phenylketonuria"], "cn_sites": [{"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 35, "g_fetched": 31, "g_countries": [["United States", 16], ["United Kingdom", 5], ["France", 5], ["Poland", 4], ["Australia", 4], ["Germany", 3], ["Canada", 2], ["Switzerland", 2], ["Italy", 2], ["Czechia", 1], ["Japan", 1], ["Netherlands", 1], ["Spain", 1], ["Denmark", 1], ["Egypt", 1], ["Ireland", 1], ["Taiwan", 1]], "g_trials": [{"nct": "NCT07802366", "title": "Acceptability and Tolerance Market Research of a Slow Release, Phenylalanine-free Protein Substitute for the Dietary Management of Phenylketonuria", "status": "NOT_YET_RECRUITING", "start": "2026-10-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "metaX Institut fuer Diatetik GmbH", "countries": ["United Kingdom"]}, {"nct": "NCT07825883", "title": "The Impact of Frequency of Home Phenylalanine Measurements on Metabolic Control in a Population of Patients With Classic Phenylketonuria", "status": "RECRUITING", "start": "2026-09-11", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Michał Kania", "countries": ["Poland"]}, {"nct": "NCT07551921", "title": "PheCheck™ Validation Study", "status": "RECRUITING", "start": "2026-08-20", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Aptatek BioSciences, Inc", "countries": ["United States"]}, {"nct": "NCT07713758", "title": "A Trial to Examine if Repinatrabit is Processed Differently in Adults With Reduced Liver or Kidney Function Compared to Adults With Normal Liver and Kidney Function", "status": "RECRUITING", "start": "2026-07-17", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "countries": ["United States"]}, {"nct": "NCT07671859", "title": "PKU Microtablets Case Studies", "status": "NOT_YET_RECRUITING", "start": "2026-07-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Nutricia UK Ltd", "countries": ["United Kingdom"]}, {"nct": "NCT07694440", "title": "A Study of MZE782 in Adults With PKU", "status": "RECRUITING", "start": "2026-06-23", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Maze Therapeutics", "countries": ["United States"]}, {"nct": "NCT07477691", "title": "Immune Modulation During Palynziq® Treatment in Adults (IMPALA)", "status": "RECRUITING", "start": "2026-05-29", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "BioMarin Pharmaceutical", "countries": ["United States"]}, {"nct": "NCT07241234", "title": "A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With Phenylketonuria", "status": "RECRUITING", "start": "2026-04-17", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Agios Pharmaceuticals, Inc.", "countries": ["Poland", "United States"]}, {"nct": "NCT07446400", "title": "A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together", "status": "RECRUITING", "start": "2026-03-31", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "countries": ["Australia"]}, {"nct": "NCT07484945", "title": "Multiomics Approach in Adult Patients With Phenylketonuria", "status": "RECRUITING", "start": "2026-03-23", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Tours", "countries": ["France"]}, {"nct": "NCT07406009", "title": "The Psychosocial Functioning of Adults With Phenylketonuria.", "status": "NOT_YET_RECRUITING", "start": "2026-01-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Central Hospital, Nancy, France", "countries": []}, {"nct": "NCT07220265", "title": "Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers", "status": "RECRUITING", "start": "2025-12-19", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Missouri-Columbia", "countries": ["United States"]}, {"nct": "NCT07698743", "title": "Eating Disorders in Patients With Phenylketonuria", "status": "RECRUITING", "start": "2025-12-04", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Central Hospital, Nancy, France", "countries": ["France"]}, {"nct": "NCT06971731", "title": "A Study of JNT-517 in Participants With Phenylketonuria (PKU)", "status": "RECRUITING", "start": "2025-10-20", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "countries": ["Australia", "Canada", "Czechia", "France", "Germany", "Japan", "Netherlands", "Poland", "Spain", "United States"]}, {"nct": "NCT07728032", "title": "Impact Of A Phe-Restricted Diet On Gut Health In Children With PKU", "status": "RECRUITING", "start": "2025-10-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Birmingham Women's and Children's NHS Foundation Trust", "countries": ["United Kingdom"]}, {"nct": "NCT06628128", "title": "A Long-Term Study of JNT-517 in Participants With Phenylketonuria", "status": "RECRUITING", "start": "2025-08-11", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "countries": ["Australia", "United States"]}, {"nct": "NCT06941532", "title": "GMP Powdered Substitutes in PKU and TYR", "status": "RECRUITING", "start": "2025-05-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Nutricia UK Ltd", "countries": ["United Kingdom"]}, {"nct": "NCT06969209", "title": "Brain Aging in Phenylketonuria", "status": "RECRUITING", "start": "2025-01-13", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Insel Gruppe AG, University Hospital Bern", "countries": ["Switzerland"]}, {"nct": "NCT06332807", "title": "AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)", "status": "RECRUITING", "start": "2025-01-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "NGGT INC.", "countries": ["United States"]}, {"nct": "NCT06337864", "title": "Effect of Large Neutral Amino Acids in Adults With Classical Phenylketonuria", "status": "RECRUITING", "start": "2024-11-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Rigshospitalet, Denmark", "countries": ["Denmark"]}, {"nct": "NCT06560736", "title": "Development of Novel Psychological Assessment Tools and Anxiety Intervention for Phenylketonuria", "status": "RECRUITING", "start": "2024-10-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Missouri-Columbia", "countries": ["United States"]}, {"nct": "NCT06718842", "title": "Walking Program in Fatty Liver Children With Phenylketonuria", "status": "RECRUITING", "start": "2024-09-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Cairo University", "countries": ["Egypt"]}, {"nct": "NCT06289348", "title": "Announcement of Rare Metabolic Diseases in Systematic Newborn Screening: the Phenylketonuria Experience.", "status": "RECRUITING", "start": "2024-05-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT06302348", "title": "A Study of Sepiapterin in Participants With Phenylketonuria (PKU)", "status": "RECRUITING", "start": "2024-03-04", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "PTC Therapeutics", "countries": ["Australia", "France", "Ireland", "Poland", "United Kingdom", "United States"]}, {"nct": "NCT06305234", "title": "A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)", "status": "RECRUITING", "start": "2024-01-20", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "BioMarin Pharmaceutical", "countries": ["United States"]}]}, {"batch": 1, "no": 50, "name_zh": "低碱性磷酸酶血症", "query_terms": [{"term": "Hypophosphatasia", "broad": false}], "n_total": 2, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT06079281", "title": "Phase 3 Study of ALXN1850 Versus Placebo in Adolescent and Adult Participants With HPP Who Have Not Previously Been Treated With Asfotase Alfa", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-01-03", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 124, "sponsor": "Alexion Pharmaceuticals, Inc.", "conditions": ["Hypophosphatasia"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Changsha", "status": ""}, {"facility": "Research Site", "city": "Chengdu", "status": ""}, {"facility": "Research Site", "city": "Nanchang", "status": ""}, {"facility": "Research Site", "city": "Qingdao", "status": ""}, {"facility": "Research Site", "city": "Shanghai", "status": ""}, {"facility": "Research Site", "city": "Shenzhen", "status": ""}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT06079359", "title": "Phase 3 Study of ALXN1850 in Treatment-Naïve Pediatric Participants With HPP", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-05-14", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Alexion Pharmaceuticals, Inc.", "conditions": ["Hypophosphatasia"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Guangzhou", "status": ""}, {"facility": "Research Site", "city": "Shanghai", "status": ""}, {"facility": "Research Site", "city": "Shenzhen", "status": ""}], "cn_site_count": 4, "broad_only": false}], "g_total": 8, "g_fetched": 8, "g_countries": [["United States", 3], ["Germany", 2], ["Belgium", 1], ["Russia", 1], ["New Zealand", 1], ["United Kingdom", 1], ["France", 1], ["Australia", 1]], "g_trials": [{"nct": "NCT07594639", "title": "GRACE II (General Retrospective Analysis of Commercial Experience With AGN1 LOEP)", "status": "NOT_YET_RECRUITING", "start": "2026-06-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "AgNovos Healthcare, LLC", "countries": ["Belgium"]}, {"nct": "NCT07390240", "title": "The Effect of Monoallelic Variants in the ALPL Gene on the Natural Course of Hypophosphatasia in Russia", "status": "RECRUITING", "start": "2025-12-29", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "AstraZeneca", "countries": ["Russia"]}, {"nct": "NCT07179640", "title": "A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALE1 in Healthy Adults and Adults With Hypophosphatasia in Order to Identify Suitable Doses of ALE1", "status": "RECRUITING", "start": "2025-09-30", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Alesta Therapeutics", "countries": ["Germany", "New Zealand", "United Kingdom"]}, {"nct": "NCT06574282", "title": "Characteristics of Hypophosphatasia in Adult Patients in Rheumatology and Their Value in Developing an Algorithm to HPP-diagnosis - the COHIR Multi-center Study", "status": "RECRUITING", "start": "2024-08-25", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Bonn", "countries": ["Germany"]}, {"nct": "NCT05596539", "title": "Prospective, Longitudinal, Observational Registry of Adult Patients With Hypophosphatasia (REG-HYPO)", "status": "RECRUITING", "start": "2023-03-22", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT05234567", "title": "A Prospective Sub-Study of the Global Hypophosphatasia Registry", "status": "RECRUITING", "start": "2022-08-25", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Alexion Pharmaceuticals, Inc.", "countries": ["United States"]}, {"nct": "NCT02237625", "title": "Natural History Study of Patients With Hypophosphatasia (HPP)", "status": "RECRUITING", "start": "2014-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Duke University", "countries": ["United States"]}, {"nct": "NCT01793168", "title": "Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford", "status": "RECRUITING", "start": "2010-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sanford Health", "countries": ["Australia", "United States"]}]}, {"batch": 1, "no": 51, "name_zh": "低磷性佝偻病", "query_terms": [{"term": "Hypophosphatemic rickets", "broad": false}], "n_total": 3, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT03820518", "title": "Using Different Doses of Active Vitamin D Combined With Neutral Phosphate in Children With X-linked Hypophosphatemia", "status": "UNKNOWN", "start": "2017-01-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Peking Union Medical College Hospital", "conditions": ["X-linked Hypophosphatemia"], "cn_sites": [{"facility": "Department of Endocrinology, Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04842019", "title": "Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With XLH", "status": "COMPLETED", "start": "2021-09-28", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Kyowa Kirin Co., Ltd.", "conditions": ["X-linked Hypophosphatemia (XLH)"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "The First Medical Center of Chinese People's Liberation Army General Hospital", "city": "Beijing", "status": ""}, {"facility": "Nanfang Hospital", "city": "Guangzhou", "status": ""}, {"facility": "The Second Affiliated Hospital of Zhejiang University", "city": "Hangzhou", "status": ""}, {"facility": "Shanghai 6th Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT04842032", "title": "Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Pediatric Chinese Patients With XLH", "status": "COMPLETED", "start": "2021-11-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 28, "sponsor": "Kyowa Kirin Co., Ltd.", "conditions": ["X-linked Hypophosphatemia (XLH)"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Guangzhou Women and Children Medical Center", "city": "Guangzhou", "status": ""}, {"facility": "Shanghai 6th Hospital", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Xinhua Hopsital", "city": "Shanghai", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 5, "broad_only": false}], "g_total": 10, "g_fetched": 10, "g_countries": [["France", 5], ["United Kingdom", 3], ["Germany", 2], ["Spain", 2], ["United States", 2], ["South Korea", 1], ["Belgium", 1], ["Bulgaria", 1], ["Czechia", 1], ["Denmark", 1], ["Hungary", 1], ["Ireland", 1], ["Israel", 1], ["Italy", 1], ["Latvia", 1], ["Netherlands", 1], ["Norway", 1], ["Portugal", 1], ["Slovakia", 1], ["Slovenia", 1], ["Sweden", 1], ["Switzerland", 1]], "g_trials": [{"nct": "NCT07666269", "title": "Morphology in Oral Rare Syndromes & Artificial Intelligence for Clinical Diagnosis", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Bordeaux", "countries": ["France"]}, {"nct": "NCT07183579", "title": "Effective Dosing of Burosumab in XLH", "status": "RECRUITING", "start": "2025-11-03", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Nottingham", "countries": ["United Kingdom"]}, {"nct": "NCT06921720", "title": "Phosphorus-31 Spectroscopy in Phosphate Diabetes", "status": "RECRUITING", "start": "2025-05-16", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Hospices Civils de Lyon", "countries": ["France"]}, {"nct": "NCT06525636", "title": "A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia", "status": "RECRUITING", "start": "2024-10-09", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Kyowa Kirin Co., Ltd.", "countries": ["France", "Germany", "Spain", "United States"]}, {"nct": "NCT06202027", "title": "Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean Patients", "status": "RECRUITING", "start": "2023-08-11", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Kyowa Kirin Korea Co., Ltd.", "countries": ["South Korea"]}, {"nct": "NCT04159675", "title": "Burosumab and 1-25 (OH) Vitamin D on Human Osteoblasts", "status": "RECRUITING", "start": "2020-09-04", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Hospices Civils de Lyon", "countries": ["France"]}, {"nct": "NCT03771105", "title": "The Impact of Phosphate Metabolism on Healthy Aging", "status": "RECRUITING", "start": "2019-01-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Yale University", "countries": ["United States"]}, {"nct": "NCT03193476", "title": "Registry for Patients With X-Linked Hypophosphatemia", "status": "RECRUITING", "start": "2017-09-12", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Kyowa Kirin Pharmaceutical Development Ltd", "countries": ["Belgium", "Bulgaria", "Czechia", "Denmark", "France", "Germany", "Hungary", "Ireland", "Israel", "Italy", "Latvia", "Netherlands", "Norway", "Portugal", "Slovakia", "Slovenia", "Spain", "Sweden", "Switzerland", "United Kingdom"]}, {"nct": "NCT06065852", "title": "National Registry of Rare Kidney Diseases", "status": "RECRUITING", "start": "2009-11-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "UK Kidney Association", "countries": ["United Kingdom"]}, {"nct": "NCT03775187", "title": "Expanded Access to Burosumab", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "Kyowa Kirin Co., Ltd.", "countries": []}]}, {"batch": 1, "no": 52, "name_zh": "特发性心肌病", "query_terms": [{"term": "Idiopathic Cardiomyopathy", "broad": false}], "n_total": 4, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT07336394", "title": "Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques", "status": "RECRUITING", "start": "2010-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "Chinese Academy of Medical Sciences, Fuwai Hospital", "conditions": ["Danon Disease", "Fabry Disease", "Cardiac Amyloidosis", "Noonan Syndrome", "Cardiac Sarcoidosis", "Glycogen Storage Disease", "Idiopathic Cardiomyopathy"], "cn_sites": [{"facility": "Fuwai Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01917149", "title": "Supramaximal Titrated Inhibition of RAAS in Dilated Cardiomyopathy", "status": "COMPLETED", "start": "2005-03", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 480, "sponsor": "Xijing Hospital", "conditions": ["Dilated Cardiomyopathy"], "cn_sites": [{"facility": "Xijing Hospital, Department of Cardiology", "city": "Xi'an", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01219452", "title": "Intramuscular Injection of Mesenchymal Stem Cell for Treatment of Children With Idiopathic Dilated Cardiomyopathy", "status": "UNKNOWN", "start": "2010-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Qingdao University", "conditions": ["Dilated Cardiomyopathy"], "cn_sites": [{"facility": "Stem Cell Research Center of Medical School Hospital of Qingdao University", "city": "Qingdao", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02292043", "title": "Effects of HTEA ON Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy or Post-myocardial Infarction", "status": "UNKNOWN", "start": "2013-05", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 60, "sponsor": "Harbin Medical University", "conditions": ["Congestive Heart Failure"], "cn_sites": [{"facility": "Ren Xiaohui", "city": "Harbin", "status": "RECRUITING"}, {"facility": "the first affiliated hospital of Harbin Medical University", "city": "Harbin", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}], "g_total": 10, "g_fetched": 9, "g_countries": [["United States", 2], ["France", 2], ["Belgium", 1], ["Lithuania", 1], ["Bosnia and Herzegovina", 1], ["Serbia", 1], ["United Kingdom", 1], ["Greece", 1], ["Italy", 1], ["Australia", 1]], "g_trials": [{"nct": "NCT07737470", "title": "Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": []}, {"nct": "NCT07224178", "title": "Left Atrial Strain and Cryptogenic Stroke", "status": "RECRUITING", "start": "2025-12-17", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Pittsburgh", "countries": ["United States"]}, {"nct": "NCT07077304", "title": "EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases", "status": "RECRUITING", "start": "2025-11-19", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT07116525", "title": "A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter", "status": "RECRUITING", "start": "2025-09-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Biosense Webster, Inc.", "countries": ["Belgium", "France", "Lithuania"]}, {"nct": "NCT06920030", "title": "Performance of the Cardiac Microcurrent (C-MIC) System With a Less Invasively Placed Left Ventricular Lead", "status": "RECRUITING", "start": "2025-04-09", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Berlin Heals GmbH", "countries": ["Bosnia and Herzegovina", "Serbia"]}, {"nct": "NCT06446271", "title": "Biomarkers in SCOTland CardiomyopatHy Registry (Bio-SCOTCH)", "status": "RECRUITING", "start": "2024-06-26", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "NHS Greater Glasgow and Clyde", "countries": ["United Kingdom"]}, {"nct": "NCT06949748", "title": "Flecainide in Idiopathic Premature Ventricular Contractions and Related Cardiomyopathy", "status": "RECRUITING", "start": "2024-04-26", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Athens", "countries": ["Greece"]}, {"nct": "NCT06356727", "title": "Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remodeling", "status": "RECRUITING", "start": "2024-01-03", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Azienda Ospedaliera Universitaria Integrata Verona", "countries": ["Italy"]}, {"nct": "NCT01793168", "title": "Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford", "status": "RECRUITING", "start": "2010-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sanford Health", "countries": ["Australia", "United States"]}]}, {"batch": 1, "no": 53, "name_zh": "特发性低促性腺激素性性腺功能减退症", "query_terms": [{"term": "Congenital hypogonadotropic hypogonadism", "broad": false}, {"term": "Idiopathic Hypogonadotropic Hypogonadism", "broad": false}], "n_total": 5, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT06561594", "title": "To Evaluate Recombinant Human Follicle Stimulating Hormone-CTP Fusion Protein Injection or Placebo Combined With Chorionic Gonadotropin for Injection", "status": "NOT_YET_RECRUITING", "start": "2024-09-20", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Changchun GeneScience Pharmaceutical Co., Ltd.", "conditions": ["Idiopathic Hypogonadotropic Hypogonadism"], "cn_sites": [{"facility": "Anhui Children's Hospital", "city": "Hefei", "status": ""}, {"facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Peking Union Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "Sun Yat-sen Memorial Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "Women and Children's Medical Center Affiliated to Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": ""}, {"facility": "Henan Children's Hospital Zhengzhou Children's Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Nanjing Children's Hospital", "city": "Nanjing", "status": ""}, {"facility": "Jiangxi Children's Hospital", "city": "Nanchang", "status": ""}, {"facility": "Shengjing Hospital affiliated to China Medical University", "city": "Shenyang", "status": ""}, {"facility": "Affiliated Hospital of Jining Medical College", "city": "Jining", "status": ""}, {"facility": "Shanghai Children's Hospital", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Affiliated Pediatric Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Chengdu Women and Children's Central Hospital", "city": "Chengdu", "status": ""}], "cn_site_count": 17, "broad_only": false}, {"nct": "NCT01403532", "title": "Sequential Therapy for Hypogonadotropic Hypogonadism", "status": "COMPLETED", "start": "2009-09", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Shanghai Jiao Tong University School of Medicine", "conditions": ["Hypogonadotropic Hypogonadism", "Kallmann Syndrome"], "cn_sites": [{"facility": "Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02880280", "title": "Human Menopausal Gonadotropin Combining With Human Chorionic Gonadotropin Treat Congenital Hypogonadotropic Hypogonadism", "status": "UNKNOWN", "start": "2016-08", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Beijing Children's Hospital", "conditions": ["Kallmann Syndrome", "Hypogonadotropic Hypogonadism"], "cn_sites": [{"facility": "Beijing Children's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03687606", "title": "Efficacy and Safety of Long Term Use of hCG or hCG Plus hMG in Males With Isolated Hypogonadotropic Hypogonadism (IHH)", "status": "UNKNOWN", "start": "2018-10-18", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 210, "sponsor": "Tongji Hospital", "conditions": ["Isolated Hypogonadotropic Hypogonadism", "Kallmann Syndrome", "Infertility"], "cn_sites": [{"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05569577", "title": "An Open Labeled RCT on the Effect of Additional hCG Injection for LPS on Pregnancy Outcomes in IHH Patients", "status": "UNKNOWN", "start": "2021-01-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 46, "sponsor": "Fudan University", "conditions": ["Luteal Phase Deficiency", "Luteal Phase Support", "Idiopathic Hypogonadotropic Hypogonadism"], "cn_sites": [{"facility": "OB & GYN Hospital of Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Obstetrics and Gynecology Hospital of Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}], "g_total": 4, "g_fetched": 5, "g_countries": [["United States", 3], ["Belgium", 1], ["Netherlands", 1], ["Spain", 1], ["United Kingdom", 1], ["Switzerland", 1], ["Australia", 1]], "g_trials": [{"nct": "NCT04252001", "title": "Growing up With the Young Endocrine Support System (YESS!)", "status": "NOT_YET_RECRUITING", "start": "2024-12-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "dr. Laura C. G. de Graaff-Herder", "countries": ["Belgium", "Netherlands", "Spain", "United Kingdom"]}, {"nct": "NCT05896293", "title": "Kisspeptin Administration Subcutaneously to Patients With IHH", "status": "RECRUITING", "start": "2023-02-03", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Stephanie B. Seminara, MD", "countries": ["United States"]}, {"nct": "NCT01500447", "title": "Inherited Reproductive Disorders", "status": "RECRUITING", "start": "2012-04-25", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Institute of Environmental Health Sciences (NIEHS)", "countries": ["United States"]}, {"nct": "NCT01601171", "title": "Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate", "status": "RECRUITING", "start": "2012-03", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Centre Hospitalier Universitaire Vaudois", "countries": ["Switzerland"]}, {"nct": "NCT01793168", "title": "Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford", "status": "RECRUITING", "start": "2010-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sanford Health", "countries": ["Australia", "United States"]}]}, {"batch": 1, "no": 54, "name_zh": "特发性肺动脉高压", "query_terms": [{"term": "Idiopathic pulmonary arterial hypertension", "broad": false}], "n_total": 90, "n_open": 18, "n_open_precise": 18, "n_broad": 0, "trials": [{"nct": "NCT02061787", "title": "the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension", "status": "RECRUITING", "start": "2010-09", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 4000, "sponsor": "Chinese Pulmonary Vascular Disease Research Group", "conditions": ["Pulmonary Hypertension", "Chronic Thromboembolic Pulmonary Hypertension", "Pulmonary Arterial Hypertension Associated With Schistosomiasis (Disorder)"], "cn_sites": [{"facility": "center of pulmonary vascular disease, Fuwai hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07184814", "title": "Clinical Features and Prognosis of Takayasu's Arteritis With Pulmonary Arteries Involvement", "status": "RECRUITING", "start": "2016-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 150, "sponsor": "China-Japan Friendship Hospital", "conditions": ["Takayasu Arteritis With Pulmonary Artery Involvement", "Pulmonary Arterial Hypertension Associated With Connective Tissue Disease"], "cn_sites": [{"facility": "China-Japan Friendship hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06954727", "title": "China Pulmonary Vascular Disease Intervention Diagnosis and Management Study-right Heart Catheterization", "status": "RECRUITING", "start": "2018-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 10000, "sponsor": "China-Japan Friendship Hospital", "conditions": ["Pulmonary Hypertension", "Pulmonary Embolism (Diagnosis)", "Pulmonary Arterial Hypertension", "Right Heart Catheterization"], "cn_sites": [{"facility": "China-Japan Friendship Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03683186", "title": "A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension", "status": "ENROLLING_BY_INVITATION", "start": "2019-09-23", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1000, "sponsor": "United Therapeutics", "conditions": ["PAH", "Pulmonary Hypertension", "Pulmonary Arterial Hypertension", "Hypertension", "Connective Tissue Diseases", "Familial Primary Pulmonary Hypertension", "Vascular Diseases", "Cardiovascular Diseases", "Hypertension, Pulmonary", "Lung Diseases", "Respiratory Tract Disease"], "cn_sites": [{"facility": "Beijing Shijitan Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Guangdong Provincial People's Hospital", "city": "Guangzhou", "status": ""}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": ""}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": ""}, {"facility": "Fuwai Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT05368467", "title": "National Registry and Cohort Study of Pulmonary Vascular Disease", "status": "RECRUITING", "start": "2022-03-29", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "Nanjing First Hospital, Nanjing Medical University", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Guangdong Provincial Peoples Hospital", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Nanjing First Hospital", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "General Hospital of Tianjin Medical University", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "Beijing Anzhen Hospital of Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "China-japan Friendship Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Xiangya Second Hospital, Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "West China Hospital, Sichuan University", "city": "Chendu", "status": "RECRUITING"}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "General Hospital of Northen Theater of Command", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Tongji Hospital, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Zhongnan Hospital of Wuhan University", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "First Affiliated Hospital of Xi'An Jiaotong University", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "First Hospital of Zhengzhou University", "city": "Zhengzhou", "status": "RECRUITING"}], "cn_site_count": 13, "broad_only": false}, {"nct": "NCT05179876", "title": "A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option", "status": "RECRUITING", "start": "2022-05-04", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 280, "sponsor": "Actelion", "conditions": ["Hypertension, Pulmonary"], "cn_sites": [{"facility": "Beijing Anzhen Hospital 1", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Anzhen Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The Second Xiangya Hospital of Central South Hospital", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Jiangsu Province Hospital", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Qingdao Women and Children's Hospital", "city": "Qingdao", "status": "RECRUITING"}, {"facility": "Childrens Hospital of Shanghai", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Xian Jiaotong University", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT05566002", "title": "Artificial Intelligence-assisted Evaluation of Pulmonary HYpertension", "status": "RECRUITING", "start": "2022-06-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2000, "sponsor": "Chinese Pulmonary Vascular Disease Research Group", "conditions": ["Pulmonary Hypertension", "Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06605794", "title": "FreeFlow Percutaneous Atrial Septal Shunt for IPAH", "status": "RECRUITING", "start": "2023-09-11", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Shanghai Zhongshan Hospital", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "180 Fenglin Road", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07604805", "title": "Efficacy and Safety of Qishen Yiqi Dropping Pills in Patients With Severe Pulmonary Hypertension", "status": "RECRUITING", "start": "2023-10-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Guangdong Provincial People's Hospital", "conditions": ["Idiopathic Pulmonary Hypertension"], "cn_sites": [{"facility": "Guangdong Provincial People's Hospital", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06528418", "title": "Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath", "status": "RECRUITING", "start": "2024-06-30", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 10000, "sponsor": "ChromX Health", "conditions": ["Lung Cancer", "Lung Infection", "COPD", "Bronchitis", "Pulmonary Fibrosis", "Pulmonary Embolism", "Pulmonary Arterial Hypertension", "Pulmonary Tuberculosis", "Pulmonary Abscess", "Emphysema", "Lung Injury", "Cystic Fibrosis of the Lung", "Bronchial Asthma", "Bronchiectasis", "Interstitial Lung Disease", "Preserved Ratio Impaired Spirometry"], "cn_sites": [{"facility": "The First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07149935", "title": "Continuous Effect Of Rehabilitation Training On Pulmonary Arterial Hypertension Patients", "status": "RECRUITING", "start": "2024-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 104, "sponsor": "RenJi Hospital", "conditions": ["Pulmonary Hypertension"], "cn_sites": [{"facility": "Renji Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06554301", "title": "A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension", "status": "RECRUITING", "start": "2024-10-20", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 72, "sponsor": "China National Center for Cardiovascular Diseases", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Fuwai Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06753981", "title": "Efficacy and Safety of Triple-targeted Drug Therapy in Treatment-naive Patients With Non-low-risk PAH: A Real-world, Multicenter Study", "status": "RECRUITING", "start": "2024-12-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 48, "sponsor": "Qianfoshan Hospital", "conditions": ["Arterial Pulmonary Hypertension (PAH)"], "cn_sites": [{"facility": "Department of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, #16766, Jingshi Road, Jinan City, Shandong Province, China", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07039604", "title": "Real-World Study of PADN for the Treatment of PAH", "status": "RECRUITING", "start": "2025-03-19", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Pulnovo Medical (Wuxi) Co., Ltd.", "conditions": ["Pulmonary Hypertension", "Hypertension, Pulmonary Arterial"], "cn_sites": [{"facility": "The First Affiliated Hospital with Nanjing Medical University", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06922916", "title": "Perioperative Risk Factors Related to the Prognosis of Lung Transplantation: A Retrospective Study", "status": "NOT_YET_RECRUITING", "start": "2025-04-22", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 250, "sponsor": "Zhejiang University", "conditions": ["COPD", "Interstitial Pneumonia", "Bronchiectasis", "Respiratory Failure", "Idiopathic Pulmonary Fibrosis (IPF)", "Silicosis", "Pulmonary Tuberculosis", "Pulmonary Hypertension", "Pulmonary Heart Disease"], "cn_sites": [{"facility": "The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310000", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06968962", "title": "Comparison of Sequential to Initial Combination Therapy in PAH", "status": "RECRUITING", "start": "2025-05-14", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 376, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Pulmonary Arterial Hypertension (PAH)"], "cn_sites": [{"facility": "The Second Affiliated Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07593027", "title": "A Phase Ⅰb/Ⅱa Clinical Study of IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension Receiving Background Therapy.", "status": "RECRUITING", "start": "2026-04-30", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.", "conditions": ["Pulmonary Arterial Hypertension PAH"], "cn_sites": [{"facility": "Xuanwu Hospital Capital Medical University", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "The first hospital of Jilin University", "city": "Jilin City", "status": "RECRUITING"}, {"facility": "Fujian Medical University Union Hospita", "city": "Fuzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Xiamen Hospital of T.C.M.", "city": "Xiamen", "status": "RECRUITING"}, {"facility": "Gansu Provincial Hospital", "city": "Lanzhou", "status": "RECRUITING"}, {"facility": "Guangdong Provincial People's Hospital", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "The Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": "NOT_YET_RECRUITING"}, {"facility": "Fuwai Center China Cardiovascular Hospital", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Wuhan Asia Heart Hospital", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Zhongnan Hospital of Wuhan University", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Xiangya Hospital of Central South University", "city": "Changsha", "status": "NOT_YET_RECRUITING"}, {"facility": "Xuzhou Central Hospital", "city": "Xuzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": "NOT_YET_RECRUITING"}, {"facility": "General Hospital of the Northern Theater Command", "city": "Shenyang", "status": "NOT_YET_RECRUITING"}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Shanghai Chest Hospital", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}, {"facility": "Shanghai Tongji Hospital", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Sichuan Provincial People's Hospital", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Hospital of Tianjin Medical University", "city": "Tianjin", "status": "NOT_YET_RECRUITING"}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "Kunming Yan'an Hospital", "city": "Kunming", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 26, "broad_only": false}, {"nct": "NCT07667829", "title": "Vasopressor Agents in Pulmonary Hypertension Crisis", "status": "NOT_YET_RECRUITING", "start": "2026-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 75, "sponsor": "China National Center for Cardiovascular Diseases", "conditions": ["Pulmonary Arterial Hypertension (PAH)", "Chronic Thromboembolic Pulmonary Hypertension (CTEPH)", "Hypertension, Pulmonary"], "cn_sites": [{"facility": "Chinese Academy of Medical Sciences, Fuwai Hospital", "city": "Beijing", "status": ""}, {"facility": "Guangdong Provincial People's Hospital", "city": "Guangzhou", "status": ""}, {"facility": "Zhongnan Hospital of Wuhan University", "city": "Wuhan", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT00257413", "title": "Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial Hypertension", "status": "COMPLETED", "start": "", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": null, "sponsor": "Zhejiang University", "conditions": ["Idiopathic Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Department of Cardiology, the First Affiliated Hospital, College of Medicine, Zhejiang University", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00091715", "title": "Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class II", "status": "COMPLETED", "start": "2004-04", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 185, "sponsor": "Actelion", "conditions": ["Pulmonary Hypertension"], "cn_sites": [{"facility": "Queen Mary Hospital", "city": "Hong Kong", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00641836", "title": "Safety and Feasibility of Autologous Endothelial Progenitor Cells Transplantation in Patients With Idiopathic Pulmonary Arterial Hypertension", "status": "COMPLETED", "start": "2005-07", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 98, "sponsor": "Zhejiang University", "conditions": ["Idiopathic Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Department of Cardiology, the First Affiliated Hospital, College of Medicine, Zhejiang University", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00240656", "title": "Spironolactone Combined With Captopril and Carvedilol for the Treatment of Pulmonary Arterial Hypertension", "status": "COMPLETED", "start": "2005-10", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": null, "sponsor": "Hebei Medical University", "conditions": ["Hypertension, Pulmonary"], "cn_sites": [{"facility": "The First Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00372346", "title": "Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial Hypertension", "status": "UNKNOWN", "start": "2006-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Zhejiang University", "conditions": ["Idiopathic Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Department of Cardiology, the First Affiliated Hospital, College of Medicine, Zhejiang University", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00325403", "title": "FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)", "status": "COMPLETED", "start": "2006-10", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 349, "sponsor": "United Therapeutics", "conditions": ["Pulmonary Hypertension"], "cn_sites": [{"facility": "Beijing Shijitan Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT01027949", "title": "An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension", "status": "COMPLETED", "start": "2007-01-16", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 894, "sponsor": "United Therapeutics", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Beijing Shijitan Hospital, Cadres Respiratory Department", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital, Respiratory Medicine Department", "city": "Beijing", "status": ""}, {"facility": "Shanghai Pulmonary Hospital, Respiratory Medicine Department", "city": "Shanghai", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT00615823", "title": "Atorvastatin in Pulmonary Hypertension", "status": "COMPLETED", "start": "2007-02", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 220, "sponsor": "Chinese Academy of Medical Sciences, Fuwai Hospital", "conditions": ["Hypertension, Pulmonary"], "cn_sites": [{"facility": "Cardiovascular Institute and Fu Wai Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00430716", "title": "To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension.", "status": "TERMINATED", "start": "2008-04-08", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 130, "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Beijing Shijitan Hospital", "city": "Beijing", "status": ""}, {"facility": "Shanghai Pulmonology Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT00660179", "title": "Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension", "status": "COMPLETED", "start": "2008-05", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 742, "sponsor": "Actelion", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Guangdong General Hospital, Cardiology Department", "city": "Guangzhou", "status": ""}, {"facility": "Jiangsu Province Hospital - Pneumology Department", "city": "Nanjing", "status": ""}, {"facility": "Beijing Anzhen Hospital of the Capital University of Medical Sciences, Cardiology Department", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medcical College Hospital, Rheumatology Department", "city": "Beijing", "status": ""}, {"facility": "Chinese PLA General Hospital (301 Hospital), Cardiology Department", "city": "Beijing", "status": ""}, {"facility": "Renji Hospital, Rheumatology Dept", "city": "Shanghai", "status": ""}, {"facility": "Zhongshan Hospital Fudan University, Cardiology Dept", "city": "Shanghai", "status": ""}, {"facility": "Renji Hospital, Cardiology Dept", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Pulmonary Hospital, Dept of Pulmonary Circulation", "city": "Shanghai", "status": ""}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT00718952", "title": "The Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension", "status": "COMPLETED", "start": "2008-07", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Tongji University", "conditions": ["Pulmonary Hypertension"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking Union Hospital, Peking Union Medical College", "city": "Beijing", "status": ""}, {"facility": "Beijing Shijitan Hospital, Peking University", "city": "Beijing", "status": ""}, {"facility": "The First Clinical College of Harbin Medical University", "city": "Harbin", "status": ""}, {"facility": "Xiangya Hospital, Central-South University", "city": "Changsha", "status": ""}, {"facility": "The General Hospital of Shenyang Military Command", "city": "Shenyang", "status": ""}, {"facility": "Renji Hospital, Shanghai Jiaotong University", "city": "Shanghai", "status": ""}, {"facility": "The First Affiliated Hospital of Medical College of Xian Jiaotong University", "city": "Xi’an", "status": ""}, {"facility": "Shanghai Pulmonary Hospital ,Tongji University", "city": "Shanghai", "status": ""}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT00706082", "title": "Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc)", "status": "TERMINATED", "start": "2008-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 490, "sponsor": "Actelion", "conditions": ["Systemic Sclerosis", "Pulmonary Arterial Hypertension", "Pulmonary Hypertension"], "cn_sites": [{"facility": "Peking Union Medical College Hospital (West Campus) Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00667823", "title": "Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension", "status": "COMPLETED", "start": "2008-10-17", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 550, "sponsor": "Actelion", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Beijing Anzhen Hospital of the Capital University of Medical Sciences, Cardiology Department", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital, Rheumatology Department", "city": "Beijing", "status": ""}, {"facility": "Guangdong General Hospital, Cardiology Department", "city": "Guangzhou", "status": ""}, {"facility": "Jiangsu Province Hospital - Pneumology Department", "city": "Nanjing", "status": ""}, {"facility": "Renji Hospital, Rheumatology Department", "city": "Shanghai", "status": ""}, {"facility": "Zhongshan Hospital Fudan University, Cardiology Department", "city": "Shanghai", "status": ""}, {"facility": "Renji Hospital, Cardiology Department", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Pulmonary Hospital Department of Pulmonary Circulation", "city": "Shanghai", "status": ""}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT00795639", "title": "Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS)", "status": "TERMINATED", "start": "2008-12", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 183, "sponsor": "Pfizer", "conditions": ["Pulmonary Arterial Hypertension", "Pulmonary Hypertension"], "cn_sites": [{"facility": "Pfizer Investigational Site", "city": "Changsha", "status": ""}, {"facility": "Pfizer Investigational Site", "city": "Xi’an", "status": ""}, {"facility": "Pfizer Investigational Site", "city": "Beijing", "status": ""}, {"facility": "Pfizer Investigational Site", "city": "Shanghai", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT00810693", "title": "A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH)", "status": "COMPLETED", "start": "2008-12-17", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 445, "sponsor": "Bayer", "conditions": ["Pulmonary Hypertension"], "cn_sites": [{"facility": "", "city": "Guangzhou", "status": ""}, {"facility": "", "city": "Beijing", "status": ""}, {"facility": "", "city": "Shanghai", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT00863681", "title": "BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension", "status": "COMPLETED", "start": "2009-03-12", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 396, "sponsor": "Bayer", "conditions": ["Hypertension, Pulmonary"], "cn_sites": [{"facility": "", "city": "Guangzhou", "status": ""}, {"facility": "", "city": "Beijing", "status": ""}, {"facility": "", "city": "Shanghai", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT00796666", "title": "Study Looking at Combination Therapy (Sitaxsentan+Sildenafil) Vs. Monotherapy (Sitaxsentan Alone) SR-PAAS -Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil", "status": "TERMINATED", "start": "2009-05", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 131, "sponsor": "Pfizer", "conditions": ["Pulmonary Arterial Hypertension", "Pulmonary Hypertension"], "cn_sites": [{"facility": "Pfizer Investigational Site", "city": "Changsha", "status": ""}, {"facility": "Pfizer Investigational Site", "city": "Beijing", "status": ""}, {"facility": "Pfizer Investigational Site", "city": "Shanghai", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT01417338", "title": "Registry for Pulmonary Hypertension in China", "status": "UNKNOWN", "start": "2009-08", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 3079, "sponsor": "Chinese Academy of Medical Sciences, Fuwai Hospital", "conditions": ["Pulmonary Arterial Hypertension", "Chronic Thromboembolic Pulmonary Hypertension", "Death"], "cn_sites": [{"facility": "Fu Wai Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01106014", "title": "Selexipag (ACT-293987) in Pulmonary Arterial Hypertension", "status": "COMPLETED", "start": "2009-12-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1156, "sponsor": "Actelion", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Peking Union Medical College Hospital, Rheumatology Department", "city": "Beijing", "status": ""}, {"facility": "Cardiovascular Institute & Fuwai Hospital-Pulmonary Vascular Center", "city": "Beijing", "status": ""}, {"facility": "Beijing Shijitan Hospital", "city": "Beijing", "status": ""}, {"facility": "Guangdong General Hospital, Cardiology Department", "city": "Guangzhou", "status": ""}, {"facility": "Renji Hospital, Rheumatology Department", "city": "Shanghai", "status": ""}, {"facility": "Renji Hospital, Cardiology Department", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Pulmonary Hospital, Department of Pulmonary Circulation", "city": "Shanghai", "status": ""}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT01112306", "title": "ACT-293987 in Pulmonary Arterial Hypertension", "status": "COMPLETED", "start": "2010-07-07", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 709, "sponsor": "Actelion", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "", "city": "Beijing", "status": ""}, {"facility": "", "city": "Guangzhou", "status": ""}, {"facility": "", "city": "Shanghai", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT01338415", "title": "FUTURE 3 Study Extension", "status": "COMPLETED", "start": "2011-03-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 58, "sponsor": "Actelion", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Cardiovascular Institute and Fuwai Hospital", "city": "Beijing", "status": ""}, {"facility": "Shanghai Children's Medical Center - Site 5102", "city": "Shanghai", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT01447628", "title": "IV Iron Replacement for Iron Deficiency in Idiopathic Pulmonary Arterial Hypertension (IPAH) Patients", "status": "COMPLETED", "start": "2011-03-29", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 56, "sponsor": "Imperial College London", "conditions": ["Pulmonary Arterial Hypertension", "Iron Deficiency"], "cn_sites": [{"facility": "Fuwai Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03567668", "title": "Surgical Valvuloplasty for Congenital Mitral Insufficiency", "status": "UNKNOWN", "start": "2012-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Hong Liu", "conditions": ["Mitral Insufficiency", "Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "TEDA International Cardiovascular Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01560624", "title": "Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy", "status": "COMPLETED", "start": "2012-06-26", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 690, "sponsor": "United Therapeutics", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Beijing Chao-Yang Hospital", "city": "Beijing", "status": ""}, {"facility": "Guangdong General Hospital", "city": "Guangzhou", "status": ""}, {"facility": "Wuhan Asia Heart Hospital", "city": "Wuhan", "status": ""}, {"facility": "Xiangya Hospital", "city": "Changsha", "status": ""}, {"facility": "The First Affiliated Hospital of Nanjing Medical University", "city": "Nanjing", "status": ""}, {"facility": "The Second Affiliated Hospital of Nanchang Medical University", "city": "Nanchang", "status": ""}, {"facility": "Zhongshan Hospital Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "West China Hospital", "city": "Chengdu", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Shijitan Hospital", "city": "Beijing", "status": ""}, {"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": ""}, {"facility": "Renji Hospital of Shanghai Jiaotong University", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Pulmonary Hospital of Tongji University", "city": "Shanghai", "status": ""}, {"facility": "Shenyang General Hospital of Shenyang Military Command", "city": "Shenyang", "status": ""}], "cn_site_count": 16, "broad_only": false}, {"nct": "NCT01712997", "title": "Study of the Initial Combination of Bosentan With Iloprost in the Treatment of Pulmonary Hypertension Patients", "status": "UNKNOWN", "start": "2012-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "Air Force Military Medical University, China", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "The department of pulmonary and critical care medicine, Tangdu hospital", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "The department of pulmonary and critical care medicine, Xijing hospital", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT01808313", "title": "Efficacy Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension (PAH)", "status": "COMPLETED", "start": "2012-12-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 134, "sponsor": "GlaxoSmithKline", "conditions": ["Vascular Disease"], "cn_sites": [{"facility": "GSK Investigational Site", "city": "Harbin", "status": ""}, {"facility": "GSK Investigational Site", "city": "Wuhan", "status": ""}, {"facility": "GSK Investigational Site", "city": "Hunan", "status": ""}, {"facility": "GSK Investigational Site", "city": "Changchun", "status": ""}, {"facility": "GSK Investigational Site", "city": "Xi'an", "status": ""}, {"facility": "GSK Investigational Site", "city": "Jinan", "status": ""}, {"facility": "GSK Investigational Site", "city": "Beijing", "status": ""}, {"facility": "GSK Investigational Site", "city": "Shanghai", "status": ""}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT07164157", "title": "The Risk of Adverse Pregnancy Outcomes for Long-term Exposure to Air Pollution in Pregnant Patients With Pulmonary Hypertension", "status": "COMPLETED", "start": "2013-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1200, "sponsor": "Wei Huang", "conditions": ["Pulmonary Arterial Hypertension", "Air Pollution", "Maternal Outcome"], "cn_sites": [{"facility": "The First Affiliated Hospital, Chongqing Medical University", "city": "Chongqing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01637675", "title": "Efficacy and Safety Study of Sodium Tanshinone IIA Sulfonate on Pulmonary Hypertension", "status": "UNKNOWN", "start": "2013-05", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "The First Affiliated Hospital of Guangzhou Medical University", "conditions": ["Pulmonary Hypertension", "Pulmonary Arterial Hypertension", "Cardiovascular Diseases", "Lung Diseases", "Tanshinone IIA Sulfonate"], "cn_sites": [{"facility": "The First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01743001", "title": "Clinical Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome", "status": "COMPLETED", "start": "2013-05-21", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 226, "sponsor": "Actelion", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Guangdong General Hospital, Cardiology Dpt", "city": "Guangzhou", "status": ""}, {"facility": "Wu Han Asia Heart Hosp", "city": "Wuhan", "status": ""}, {"facility": "The General Hosp of Shenyang Military Region", "city": "Shenyang", "status": ""}, {"facility": "Beijing Anzhen Hospital, Cardiology Dpt", "city": "Beijing", "status": ""}, {"facility": "Cardiovascular Institute&Fuwai Hospital", "city": "Beijing", "status": ""}, {"facility": "Shanghai Pulmonary Hospital, Dept of Pulmonary Circulation", "city": "Shanghai", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT01739400", "title": "Clinical Study to Assess the Long-term Safety, Tolerability, and Efficacy of Macitentan in Subjects With Eisenmenger Syndrome", "status": "TERMINATED", "start": "2013-09-10", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 217, "sponsor": "Actelion", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Guangdong General Hospital, Cardiology Dpt", "city": "Guangzhou", "status": ""}, {"facility": "Wu Han Asia Heart Hosp", "city": "Wuhan", "status": ""}, {"facility": "The General Hosp of Shenyang Military Region", "city": "Shenyang", "status": ""}, {"facility": "Beijing Anzhen Hospital, Cardiology Dpt", "city": "Beijing", "status": ""}, {"facility": "Cardiovascular Institute&Fuwai Hospital", "city": "Beijing", "status": ""}, {"facility": "Shanghai Pulmonary Hospital, Dept of Pulmonary Circulation", "city": "Shanghai", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT01560637", "title": "An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension", "status": "COMPLETED", "start": "2013-09-11", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 471, "sponsor": "United Therapeutics", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Beijing Chao-Yang Hospital", "city": "Beijing", "status": ""}, {"facility": "Guangdong General Hospital", "city": "Guangzhou", "status": ""}, {"facility": "Wuhan Asia Heart Hospital", "city": "Wuhan", "status": ""}, {"facility": "Xiangya Hospital", "city": "Changsha", "status": ""}, {"facility": "The First Affiliated Hospital of Nanjing Medical University", "city": "Nanjing", "status": ""}, {"facility": "The Second Affiliated Hospital of Nanchang Medical University", "city": "Nanchang", "status": ""}, {"facility": "Zhongshan Hospital Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "West China Hospital", "city": "Chengdu", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Shijitan Hospital", "city": "Beijing", "status": ""}, {"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": ""}, {"facility": "Renji Hospital of Shanghai Jiaotong University", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Pulmonary Hospital of Tongji University", "city": "Shanghai", "status": ""}, {"facility": "Shenyang General Hospital of Shenyang Military Command", "city": "Shenyang", "status": ""}], "cn_site_count": 16, "broad_only": false}, {"nct": "NCT02023450", "title": "Testing of HIV Protease Inhibitors to Suppress Inflammation and Improve Cardio Pulmonary Hemodynamics in Subjects With Pulmonary Arterial Hypertension", "status": "UNKNOWN", "start": "2013-12", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "The Third Xiangya Hospital of Central South University", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Xiangya hospital", "city": "Changsha", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02267200", "title": "The Screening and Analysis of Plasma Biomarkers in Irreversible PAH-CHD", "status": "COMPLETED", "start": "2014-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 30, "sponsor": "Shanghai Jiao Tong University School of Medicine", "conditions": ["Hypertension,Pulmonary"], "cn_sites": [{"facility": "Shanghai Children's Medical Center", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02284737", "title": "A Study to Investigate the Efficacy of PADN to Improved Functional Capacity and Hemodynamics in Patients With PAH", "status": "TERMINATED", "start": "2014-11-28", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Nanjing First Hospital, Nanjing Medical University", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Nanjing First Hospital", "city": "Nanjing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02893995", "title": "Safety, Tolerability, Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial Hypertension", "status": "WITHDRAWN", "start": "2017-02", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "United Therapeutics", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Beijing Chao-Yang Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Anzhen Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Fu Wai Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Shijitan Hospital", "city": "Beijing", "status": ""}, {"facility": "Xiangya Hospital Centre South University", "city": "Changsha", "status": ""}, {"facility": "Guangdong General Hospital", "city": "Guangzhou", "status": ""}, {"facility": "Zhongshan Hospital affiliated with Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": ""}, {"facility": "Wuhan Asia Heart Hospital", "city": "Wuhan", "status": ""}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT02882126", "title": "An Open Label Extension Study to Evaluate the Safety of Continued Therapy of Subcutanous Remodulin® in Pulmonary Arterial Hypertension", "status": "WITHDRAWN", "start": "2017-06", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "United Therapeutics", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Beijing Chao-Yang Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Anzhen Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Fu Wai Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Shijitan Hospital", "city": "Beijing", "status": ""}, {"facility": "Xiangya Hospital Centre South University", "city": "Changsha", "status": ""}, {"facility": "Guangdong General Hospital", "city": "Guangzhou", "status": ""}, {"facility": "Zhongshan Hospital affiliated with Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": ""}, {"facility": "Wuhan Asia Heart Hospital", "city": "Wuhan", "status": ""}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT02932410", "title": "A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)", "status": "COMPLETED", "start": "2017-10-24", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 165, "sponsor": "Actelion", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Beijing Anzhen Hospital of The Capital University of Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "Qingdao Women and Children's Hospital", "city": "Qingdao", "status": ""}, {"facility": "Childrens Hospital of Shanghai", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Children's Medical Center", "city": "Shanghai", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT04053296", "title": "Long-term Outcomes of Pregnant Women With PAH", "status": "UNKNOWN", "start": "2017-11-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 120, "sponsor": "RenJi Hospital", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Renji Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03954405", "title": "Multi-marker Approach for Risk Assessment in PAH", "status": "UNKNOWN", "start": "2017-11-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Wuhan Asia Heart Hospital", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Wuhan Asian Heart Hospital", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03282266", "title": "Safety and Efficacy of Pulmonary Artery Denervation in Patients With Pulmonary Arterial Hypertension", "status": "COMPLETED", "start": "2018-01-18", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 128, "sponsor": "Nanjing First Hospital, Nanjing Medical University", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Nanjing First Hospital", "city": "Nanjing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03883048", "title": "Idiopathic Bronchiectasis and Pulmonary Hypertension", "status": "COMPLETED", "start": "2018-06-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1606, "sponsor": "Shanghai Pulmonary Hospital, Shanghai, China", "conditions": ["Bronchiectasis", "Pulmonary Hypertension"], "cn_sites": [{"facility": "Shanghai Pulmonary Hospital, Tongji University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05478226", "title": "ADAMTSL4 in Idiopathic Pulmonary Hypertension and CTEPH", "status": "COMPLETED", "start": "2018-07-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 67, "sponsor": "Wei Huang", "conditions": ["Pulmonary Hypertension"], "cn_sites": [{"facility": "the First Affiliated Hospital, Chongqing Medical University", "city": "Chongqing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03554330", "title": "Combined Use of Radiofrequency-ablation and Balloon-septostomy in the Creation of a Stable Inter-atrial Communication", "status": "UNKNOWN", "start": "2018-07-12", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "China National Center for Cardiovascular Diseases", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences,Fuwai Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03492177", "title": "A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension", "status": "ACTIVE_NOT_RECRUITING", "start": "2018-07-23", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 63, "sponsor": "Actelion", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Beijing Anzhen Hospital", "city": "Beijing", "status": ""}, {"facility": "Shanghai Childrens Medical Center", "city": "Shanghai", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05437224", "title": "Efficacy and Safety Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension", "status": "COMPLETED", "start": "2018-12-18", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 80, "sponsor": "RenJi Hospital", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Renji Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03977428", "title": "Central China Congenital Heart Disease Associated Pulmonary Arterial Hypertension Cohort Study", "status": "UNKNOWN", "start": "2019-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Wuhan Asia Heart Hospital", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Wuhan Asian Heart Hospital", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05417373", "title": "Algorithms to Diagnose Pulmonary Arterial Hypertension", "status": "UNKNOWN", "start": "2019-01-17", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 250, "sponsor": "RenJi Hospital", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Renji Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03626688", "title": "A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients", "status": "COMPLETED", "start": "2019-01-24", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 687, "sponsor": "United Therapeutics", "conditions": ["PAH", "Pulmonary Hypertension", "Pulmonary Arterial Hypertension", "Hypertension", "Connective Tissue Diseases", "Familial Primary Pulmonary Hypertension", "Vascular Diseases", "Cardiovascular Diseases", "Hypertension, Pulmonary", "Lung Diseases", "Respiratory Tract Disease"], "cn_sites": [{"facility": "Beijing Shijitan Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Guangdong Provincial People's Hospital", "city": "Guangzhou", "status": ""}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": ""}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": ""}, {"facility": "Fuwai Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT05948644", "title": "The Safety, Tolerability, and Pharmacokinetics of TPN171H Tablets in Patients With Pulmonary Arterial Hypertension", "status": "COMPLETED", "start": "2019-04-08", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Vigonvita Life Sciences", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Fu Zhu", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03904693", "title": "Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)", "status": "COMPLETED", "start": "2019-07-29", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 187, "sponsor": "Actelion", "conditions": ["Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)"], "cn_sites": [{"facility": "Beijing Anzhen Hospital", "city": "Beijing", "status": ""}, {"facility": "The Second Xiangya Hospital of Central South Hospital", "city": "Changsha", "status": ""}, {"facility": "The First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Jiangsu Province Hospital", "city": "Nanjing", "status": ""}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": ""}, {"facility": "The General Hospital of Northern Theater Command", "city": "Shenyang", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "The First Affiliated Hospital of Xian Jiaotong University", "city": "Xi'an", "status": ""}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT04055415", "title": "Clinical Study of Adipose Derived Mesenchymal Stem Cells for Treatment of Pulmonary Arterial Hypertension", "status": "UNKNOWN", "start": "2019-08-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Liaocheng People's Hospital", "conditions": ["Pulmonary Hypertension"], "cn_sites": [{"facility": "Liaocheng city people's hospital", "city": "Liaocheng", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04175600", "title": "A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension", "status": "ACTIVE_NOT_RECRUITING", "start": "2020-01-16", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 138, "sponsor": "Actelion", "conditions": ["Hypertension, Pulmonary"], "cn_sites": [{"facility": "Beijing Anzhen Hospital", "city": "Beijing", "status": ""}, {"facility": "Guangzhou Women And Children's Medical Center", "city": "Guangzhou", "status": ""}, {"facility": "Qingdao Women and Children's Hospital 1", "city": "Qingdao", "status": ""}, {"facility": "Qingdao Women and Children's Hospital", "city": "Qingdao", "status": ""}, {"facility": "Shanghai Childrens Medical Center", "city": "Shanghai", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "The General Hospital of Northern Theater Command", "city": "Shenyang", "status": ""}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT04273945", "title": "Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension", "status": "ACTIVE_NOT_RECRUITING", "start": "2020-06-30", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 935, "sponsor": "Actelion", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Beijing Chaoyang Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Anzhen Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "The Second Xiangya Hospital of Central South Hospital", "city": "Changsha", "status": ""}, {"facility": "West China Hospital Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "The First Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "The First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": ""}, {"facility": "Renji Hospital", "city": "Shanghai", "status": ""}, {"facility": "Zhongshan Hospital Fudan University", "city": "Shanghai", "status": ""}, {"facility": "The General Hospital of Northern Theater Command", "city": "Shenyang", "status": ""}, {"facility": "Shengjing Hospital Of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "The First Affiliated Hospital of Xian Jiaotong University", "city": "Xi'an", "status": ""}], "cn_site_count": 14, "broad_only": false}, {"nct": "NCT04528056", "title": "Pilot Study of the Safety and Efficacy of Sulfasalazine in Pulmonary Arterial Hypertension", "status": "UNKNOWN", "start": "2020-08-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 80, "sponsor": "RenJi Hospital", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Renji Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04503733", "title": "A Study of GMA301 in Subjects With Pulmonary Arterial Hypertension", "status": "UNKNOWN", "start": "2020-10-22", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 48, "sponsor": "Gmax Biopharm LLC.", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Peking Union Medical College Hospital - Dongcheng District", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Xiangya Hospital, Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "Guangdong General Hospital", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT04483115", "title": "Acute Haemodynamic Study of TPN171H in Patients with Pulmonary Arterial Hypertension", "status": "COMPLETED", "start": "2020-11-16", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Vigonvita Life Sciences", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Fuwai Hospital CAMS&PUMC", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "Gansu Provincial Hospital", "city": "Lanzhou", "status": ""}, {"facility": "Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology", "city": "Wuhan", "status": ""}, {"facility": "The Second Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "First Affiliated Hospital Of Gannan Medical University", "city": "Ganzhou", "status": ""}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT05569655", "title": "Efficacy and Safety Evaluation of Tolvaptan in the Treatment of Patients With RHF Caused by PAH", "status": "UNKNOWN", "start": "2021-04-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Chinese Pulmonary Vascular Disease Research Group", "conditions": ["Pulmonary Arterial Hypertension", "Randomized Controlled Trial"], "cn_sites": [{"facility": "center of pulmonary vascular disease, Fuwai hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04955990", "title": "A Study of Real-world Cohort of Pulmonary Arterial Hypertension (PAH) Participants", "status": "TERMINATED", "start": "2021-10-14", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 232, "sponsor": "Actelion", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Beijing Anzhen Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Fuwai Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "West China Hospital Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT05036135", "title": "A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)", "status": "TERMINATED", "start": "2021-12-02", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 202, "sponsor": "Aerovate Therapeutics", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Chongqing Medical University - The First Affiliated Hospital", "city": "Chongqing", "status": ""}, {"facility": "Guangdong Provincial People's Hospital", "city": "Guangdong", "status": ""}, {"facility": "Central South University - The Second Xiangya Hospital", "city": "Hunan", "status": ""}, {"facility": "Yanan Hospital of Kunming City", "city": "Kunming", "status": ""}, {"facility": "Gansu Provincial People's Hospital", "city": "Lanzhou", "status": ""}, {"facility": "Southeast University (SEU) - Zhongda Hospital", "city": "Nanjing", "status": ""}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT05185011", "title": "Study of the Pharmacokinetics and Safety of TPN171H Tablets in Subjects With Mild ,Moderate Hepatic Insufficiency and Normal Liver Function", "status": "COMPLETED", "start": "2021-12-16", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Vigonvita Life Sciences", "conditions": ["Erectile Dysfunction", "Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "The First Affiliated Hospital of Jilin University", "city": "Changchun", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05546125", "title": "a Non-interventional Study of Sildenafil in the Treatment of Pulmonary Arterial Hypertension (PAH) in Adults From China", "status": "COMPLETED", "start": "2021-12-23", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Pfizer Pharmaceuticals Ltd.", "conditions": ["Pulmonary Arterial Hypertension (PAH)"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Guangdong Provincial People's Hospital", "city": "Guangdong", "status": ""}, {"facility": "The Second Xiangya Hospital Of Central South University", "city": "Changsha", "status": ""}, {"facility": "The First Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi'an", "status": ""}, {"facility": "Affiliated Hospital of Jining Medical College", "city": "Jining", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "Yanan Hospital of Kunming City", "city": "Kunming", "status": ""}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT05208814", "title": "A Study to Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients with Renal Insufficiency and Healthy Subjects", "status": "COMPLETED", "start": "2022-03-31", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 16, "sponsor": "Vigonvita Life Sciences", "conditions": ["Pulmonary Arterial Hypertension", "Erectile Dysfunction"], "cn_sites": [{"facility": "West China Hospital", "city": "Chengdu", "status": ""}, {"facility": "Chengdu Xinhua Hospital", "city": "Chengdu", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06196801", "title": "Efficacy of Triple-Combination Therapy in Severe PAH-CHD", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-06-17", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 80, "sponsor": "Guangdong Provincial People's Hospital", "conditions": ["Congenital Heart Disease", "Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05587400", "title": "Consistency of Electrical Cardiometry and Pulmonary Artery Catheter", "status": "UNKNOWN", "start": "2022-07-27", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 199, "sponsor": "Shanghai Zhongshan Hospital", "conditions": ["Pulmonary Arterial Hypertension", "Right Ventricular Dysfunction"], "cn_sites": [{"facility": "Zhongshan hospital Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04972656", "title": "Treatment With Ambrisentan in Patients With Borderline Pulmonary Arterial Hypertension", "status": "UNKNOWN", "start": "2022-09-05", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 420, "sponsor": "Nanjing First Hospital, Nanjing Medical University", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Nanjing First Hospital", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05557942", "title": "Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL)", "status": "TERMINATED", "start": "2022-11-02", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 186, "sponsor": "Aerovate Therapeutics", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Chongqing Medical University - The First Affiliated Hospital", "city": "Chongqing", "status": ""}, {"facility": "Guangdong Provincial People's Hospital", "city": "Guangdong", "status": ""}, {"facility": "Central South University - The Second Xiangya Hospital", "city": "Hunan", "status": ""}, {"facility": "Yanan Hospital of Kunming City", "city": "Kunming", "status": ""}, {"facility": "Gansu Provincial People's Hospital", "city": "Lanzhou", "status": ""}, {"facility": "Southeast University (SEU) - Zhongda Hospital", "city": "Nanjing", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT06582459", "title": "Efficacy and Safety of High-Flow Nasal Cannula Versus Noninvasive Ventilation for Pulmonary Arterial Hypertension-Associated Acute Respiratory Failure", "status": "UNKNOWN", "start": "2023-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 90, "sponsor": "The First People's Hospital of Neijiang", "conditions": ["Pulmonary Arterial Hypertension", "Acute Respiratory Failure", "High-flow Nasal Cannula", "Noninvasive Ventilation"], "cn_sites": [{"facility": "The First People's Hospital of Neijiang City", "city": "Neijiang", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05828147", "title": "Anti-CD20 Antibodies for Treatment of SLE-PAH", "status": "UNKNOWN", "start": "2023-05-25", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Chinese SLE Treatment And Research Group", "conditions": ["Systemic Lupus Erythematosus", "Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06137742", "title": "A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension", "status": "COMPLETED", "start": "2023-11-17", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 97, "sponsor": "Pfizer", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Guangdong Provincial People's Hospital", "city": "Guangzhou", "status": ""}, {"facility": "The Second Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "Zhongda Hospital Southeast University", "city": "Nanjing", "status": ""}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT06664801", "title": "A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) (MK-7962-024)", "status": "COMPLETED", "start": "2024-11-14", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 164, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Guangdong Provincial People s Hospital ( Site 2000)", "city": "Guangzhou", "status": ""}, {"facility": "The Second Xiangya Hospital of Central South University ( Site 2002)", "city": "Changsha", "status": ""}, {"facility": "Shanghai Pulmonary Hospital ( Site 2004)", "city": "Shanghai", "status": ""}, {"facility": "Yan an Hospital of Kunming City ( Site 2011)", "city": "Kunming", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT06925750", "title": "A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-031/LIGHTRAY EXTENSION)", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-05-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 130, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Pulmonary Arterial Hypertension"], "cn_sites": [{"facility": "Guangdong Provincial People's Hospital-Cardiology ( Site 2000)", "city": "Guangzhou", "status": ""}, {"facility": "The Second Xiangya Hospital of Central South University ( Site 2002)", "city": "Changsha", "status": ""}, {"facility": "Shanghai Pulmonary Hospital ( Site 2004)", "city": "Shanghai", "status": ""}, {"facility": "Yan an Hospital of Kunming City ( Site 2011)", "city": "Kunming", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT07073820", "title": "A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-11-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 42, "sponsor": "Pfizer", "conditions": ["Pulmonary Hypertension"], "cn_sites": [{"facility": "Guangdong Provincial People's Hospital", "city": "Guangzhou", "status": ""}, {"facility": "The Second Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "Zhongda Hospital Southeast University", "city": "Nanjing", "status": ""}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 4, "broad_only": false}], "g_total": 150, "g_fetched": 133, "g_countries": [["United States", 47], ["Switzerland", 20], ["France", 15], ["Spain", 12], ["United Kingdom", 12], ["Brazil", 12], ["Germany", 10], ["Canada", 9], ["Australia", 9], ["Italy", 8], ["Belgium", 7], ["Poland", 7], ["Argentina", 6], ["Israel", 5], ["New Zealand", 5], ["South Korea", 5], ["Netherlands", 5], ["Portugal", 5], ["Japan", 4], ["Latvia", 4], ["Czechia", 4], ["Mexico", 4], ["Greece", 3], ["Romania", 3], ["Serbia", 3], ["Colombia", 3], ["Denmark", 2], ["Austria", 2], ["Hungary", 2], ["Turkey (Türkiye)", 2], ["Taiwan", 2], ["Egypt", 1], ["Bolivia", 1], ["Norway", 1], ["Finland", 1], ["Chile", 1], ["Ireland", 1], ["Lithuania", 1], ["Saudi Arabia", 1], ["Singapore", 1], ["Slovakia", 1], ["South Africa", 1], ["Croatia", 1], ["Sweden", 1]], "g_trials": [{"nct": "NCT05660863", "title": "A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of MN-08 Tablets", "status": "NOT_YET_RECRUITING", "start": "2027-09-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Guangzhou Magpie Pharmaceuticals Co., Ltd.", "countries": []}, {"nct": "NCT07172334", "title": "What is the Role of the Exposome in Pulmonary Hypertension", "status": "NOT_YET_RECRUITING", "start": "2027-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Poitiers University Hospital", "countries": ["France"]}, {"nct": "NCT07600723", "title": "A Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) in India (MK-7962-037)", "status": "NOT_YET_RECRUITING", "start": "2026-11-04", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Merck Sharp & Dohme LLC", "countries": []}, {"nct": "NCT07632898", "title": "Open-Label Study of IKT-001 in Pulmonary Arterial Hypertension (PAH)", "status": "NOT_YET_RECRUITING", "start": "2026-10-23", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Inhibikase Therapeutics", "countries": []}, {"nct": "NCT07777367", "title": "Exercise Performance on Ambient Air vs. Low-Flow Liquid Oxygen Therapy in Chronic Lung Diseases", "status": "RECRUITING", "start": "2026-10-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Silvia Ulrich Somaini", "countries": ["Switzerland"]}, {"nct": "NCT07777445", "title": "Exercise Performance on Ambient Air vs. Low-Flow Liquid Oxygen Therapy in Pulmonary Vascular Disease (PVD)", "status": "RECRUITING", "start": "2026-10-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Silvia Ulrich Somaini", "countries": ["Switzerland"]}, {"nct": "NCT07737522", "title": "Myocardial Metabolic Flux in Pulmonary Arterial Hypertension", "status": "NOT_YET_RECRUITING", "start": "2026-10-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Imperial College London", "countries": []}, {"nct": "NCT07781709", "title": "Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass-Substudy", "status": "NOT_YET_RECRUITING", "start": "2026-09-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Pennsylvania", "countries": ["United States"]}, {"nct": "NCT07700303", "title": "Withdrawal of Prostacyclin Pathway Therapy in Patients With Pulmonary Arterial Hypertension Receiving Sotatercept (WATERLOO)", "status": "NOT_YET_RECRUITING", "start": "2026-09-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Alberta", "countries": ["Canada"]}, {"nct": "NCT07804524", "title": "Assessment of Total Pulmonary Resistance sPAP/CO Between High Altitude HA vs. Sea Level LA in Patients With Pulmonary Arterial Hypertension PAH", "status": "NOT_YET_RECRUITING", "start": "2026-09-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Silvia Ulrich Somaini", "countries": ["Switzerland"]}, {"nct": "NCT07797088", "title": "Assessment of Six-minute Walking Distance Between Sea Level LA vs. High Altitude HA After Re-ascent in Healthy Individuals", "status": "NOT_YET_RECRUITING", "start": "2026-09-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Silvia Ulrich Somaini", "countries": ["Switzerland"]}, {"nct": "NCT07804589", "title": "Assessment of Total Pulmonary Resistance sPAP/CO Between Sea Level LA vs. High Altitude HA After Re-ascent in Healthy Individuals", "status": "NOT_YET_RECRUITING", "start": "2026-09-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Silvia Ulrich Somaini", "countries": ["Switzerland"]}, {"nct": "NCT07804576", "title": "Assessment of Lung Function (Lufu) at Sea Level LA vs. High Altitude HA in Patients With Pulmonary Arterial Hypertension PAH", "status": "NOT_YET_RECRUITING", "start": "2026-09-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Silvia Ulrich Somaini", "countries": ["Switzerland"]}, {"nct": "NCT07646860", "title": "A Study of Sotatercept (MK-7962) in Japanese Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-032)", "status": "RECRUITING", "start": "2026-09-25", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Merck Sharp & Dohme LLC", "countries": ["Japan"]}, {"nct": "NCT07797166", "title": "Assessment of Six-minute Walking Distance Between Sea Level LA vs. High Altitude HA After Re-ascent in Patients With Pulmonary Arterial Hypertension PAH", "status": "NOT_YET_RECRUITING", "start": "2026-09-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Silvia Ulrich Somaini", "countries": ["Switzerland"]}, {"nct": "NCT07804537", "title": "Assessment of Lung Function (Lufu) at Sea Level LA vs. High Altitude HA in Healthy Individuals", "status": "NOT_YET_RECRUITING", "start": "2026-09-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Silvia Ulrich Somaini", "countries": ["Switzerland"]}, {"nct": "NCT07801859", "title": "Assessment of Heart Rate Variability HRV During Descent DE From 2850m to Sea Level and During Re-ascent A From Sea Level to 2850m in Patients With Pulmonary Arterial Hypertension PAH", "status": "NOT_YET_RECRUITING", "start": "2026-09-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Silvia Ulrich Somaini", "countries": ["Switzerland"]}, {"nct": "NCT07804693", "title": "Assessment of Total Pulmonary Resistance sPAP/CO Between Sea Level LA vs. High Altitude HA After Re-ascent in Patients With Pulmonary Arterial Hypertension PAH", "status": "NOT_YET_RECRUITING", "start": "2026-09-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Silvia Ulrich Somaini", "countries": ["Switzerland"]}, {"nct": "NCT07804485", "title": "Assessment of Total Pulmonary Resistance sPAP/CO Between High Altitude HA vs. Sea Level LA in Healthy Individuals H", "status": "NOT_YET_RECRUITING", "start": "2026-09-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Silvia Ulrich Somaini", "countries": ["Switzerland"]}, {"nct": "NCT07801950", "title": "Sleep-Assessment in Patients Between High Altitude HA vs. Sea Level LA in Healthy Individuals H", "status": "NOT_YET_RECRUITING", "start": "2026-09-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Silvia Ulrich Somaini", "countries": ["Switzerland"]}, {"nct": "NCT07801846", "title": "Assessment of Heart Rate Variability HRV During Descent DE From 2850m to Sea Level and During Re-ascent A From Sea Level to 2850m in Healthy Individuals H", "status": "NOT_YET_RECRUITING", "start": "2026-09-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Silvia Ulrich Somaini", "countries": ["Switzerland"]}, {"nct": "NCT07801963", "title": "Sleep-Assessment in Patients Between High Altitude HA vs. Sea Level LA in Patients With Pulmonary Arterial Hypertension PAH", "status": "NOT_YET_RECRUITING", "start": "2026-09-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Silvia Ulrich Somaini", "countries": ["Switzerland"]}, {"nct": "NCT07804472", "title": "Assessment of Six-minute Walking Distance 6MWD Between High Altitude HA vs. Sea Level LA in Patients With Pulmonary Arterial Hypertension PAH", "status": "NOT_YET_RECRUITING", "start": "2026-09-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Silvia Ulrich Somaini", "countries": ["Switzerland"]}, {"nct": "NCT07801872", "title": "Assessment of Six-minute Walking Distance 6MWD Between High Altitude HA vs. Sea Level LA in Healthy Individuals H", "status": "NOT_YET_RECRUITING", "start": "2026-09-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Silvia Ulrich Somaini", "countries": ["Switzerland"]}, {"nct": "NCT07613099", "title": "Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging", "status": "RECRUITING", "start": "2026-09-23", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "countries": ["United States"]}]}, {"batch": 1, "no": 55, "name_zh": "特发性肺纤维化", "query_terms": [{"term": "Idiopathic pulmonary fibrosis", "broad": false}], "n_total": 72, "n_open": 22, "n_open_precise": 22, "n_broad": 0, "trials": [{"nct": "NCT06125327", "title": "SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)", "status": "RECRUITING", "start": "2023-06-06", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 210, "sponsor": "Guangzhou JOYO Pharma Co., Ltd", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06267183", "title": "A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers.", "status": "RECRUITING", "start": "2024-01-12", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 53, "sponsor": "Shanghai Synvida Biotechnology Co.,Ltd.", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "Shanghai Xuhui District Central Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06238622", "title": "A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast", "status": "RECRUITING", "start": "2024-05-06", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1700, "sponsor": "Boehringer Ingelheim", "conditions": ["Idiopathic Pulmonary Fibrosis", "Progressive Pulmonary Fibrosis"], "cn_sites": [{"facility": "Beijing Chao-Yang Hospital", "city": "Beijing", "status": "COMPLETED"}, {"facility": "China-Japan Friendship Hospital", "city": "Beijing", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "The Second Xiangya Hospital Of Central South University", "city": "Changsha", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "People's Hospital of Sichuan Province", "city": "Chengdu", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "NanFang Hosptial", "city": "Guangzhou", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Hangzhou First People's Hospital", "city": "Hangzhou", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Zhejiang Hospital", "city": "Hangzhou", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine", "city": "Hangzhou", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "The Affiliated Hospital of Inner Mongolia Medical University", "city": "Hohhot", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "The First Hospital of Jiaxing", "city": "Jiaxing", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Jinhua Municipal Central Hospital", "city": "Jinhua", "status": "COMPLETED"}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Ningbo Medical Center Lihuili Hospital", "city": "Ningbo", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "The First Affiliated Hospital of Ningbo University", "city": "Ningbo", "status": "COMPLETED"}, {"facility": "Ruijin Hospital Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": "COMPLETED"}, {"facility": "Shanghai Chest Hospital", "city": "Shanghai", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Zhongshan Hospital Affiliated to Fudan University", "city": "Shanghai", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Huadong Hospital affiliated to Fudan University", "city": "Shanghai", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "China Shenyang Chest Hospital", "city": "Shenyang", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Shenzhen People's Hospital", "city": "Shenzhen", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "The University of Hong Kong-Shenzhen Hospital", "city": "Shenzhen", "status": "COMPLETED"}, {"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Tongji Hospital Affiliated Tongji Medical College Huazhong University of S & T", "city": "Wuhan", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Renmin Hospital of Wuhan University", "city": "Wuhan", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Wuxi People's Hospital", "city": "Wuxi", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Second Affiliated Hospital of medical college of Xi'an JiaoTong University", "city": "Xi'an", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "The Affiliated Hospital of Xuzhou Medical College", "city": "Xuzhou", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Yichang Central People's Hospital", "city": "Yichang", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "General Hospital of Ningxia Medical University", "city": "Yinchuan", "status": "ACTIVE_NOT_RECRUITING"}], "cn_site_count": 37, "broad_only": false}, {"nct": "NCT06629623", "title": "Current Status of Diagnosis, Treatment and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis", "status": "ENROLLING_BY_INVITATION", "start": "2024-07-30", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 310, "sponsor": "Chu Hongling", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06922916", "title": "Perioperative Risk Factors Related to the Prognosis of Lung Transplantation: A Retrospective Study", "status": "NOT_YET_RECRUITING", "start": "2025-04-22", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 250, "sponsor": "Zhejiang University", "conditions": ["COPD", "Interstitial Pneumonia", "Bronchiectasis", "Respiratory Failure", "Idiopathic Pulmonary Fibrosis (IPF)", "Silicosis", "Pulmonary Tuberculosis", "Pulmonary Hypertension", "Pulmonary Heart Disease"], "cn_sites": [{"facility": "The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310000", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07019714", "title": "Daoyin Technique for Improving Exercise Endurance in IPF", "status": "NOT_YET_RECRUITING", "start": "2025-06-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 236, "sponsor": "Affiliated Hospital of Liaoning University of Traditional Chinese Medicine", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "The Affiliated Hospital of Liaoning University of Traditional Chinese Medicinenese Medicine", "city": "Shenyang", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06914713", "title": "Jin-shui Huan-xian Formula for Retarding the Decline of Pulmonary Function in IPF", "status": "NOT_YET_RECRUITING", "start": "2025-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 384, "sponsor": "Henan University of Traditional Chinese Medicine", "conditions": ["Idiopathic Pulmonary Fibrosis(IPF)"], "cn_sites": [{"facility": "the First Affiliated Hospital of Henan University of Chinese Medicine", "city": "Zhengzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07131150", "title": "Menstrual Blood-Derived Mesenchymal Stem Cell Injection (SC01009) in the Treatment of Idiopathic Pulmonary Fibrosis", "status": "NOT_YET_RECRUITING", "start": "2025-08-31", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 66, "sponsor": "Ruijin Hospital", "conditions": ["Idiopathic Pulmonary Fibrosis (IPF)"], "cn_sites": [{"facility": "Peking Union Medical College Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "Beijing Chaoyang Hospital Affiliated to Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "China-Japan Friendship Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing FriendBeijing Friendship Hospital, Capital Medical UniversityBeijing Friendship Hospital, Capital Medical Universityship Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "The Fifth Medical Center of PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Shenzhen People's Hospital", "city": "Shenzhen", "status": ""}, {"facility": "The Second Hospital of Hebei Medical University", "city": "Hebei", "status": ""}, {"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "The Second Xiangya Hospital of Central South University The Third Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "Drum Tower Hospital Affiliated to Nanjing University Medical School", "city": "Nanjing", "status": ""}, {"facility": "The Affiliated Hospital of Xuzhou Medical University", "city": "Xuzhou", "status": ""}, {"facility": "The Second Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Ningxia Medical University General Hospital", "city": "Yinchuan", "status": ""}, {"facility": "Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Chest Hospital", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": ""}, {"facility": "Air Force Medical University Xijing Hospital", "city": "Xi’an", "status": ""}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Sichuan Provincial People's Hospital", "city": "Chengdu", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 22, "broad_only": false}, {"nct": "NCT07162870", "title": "Idiopathic Pulmonary Fibrosis Cohort of TCM", "status": "NOT_YET_RECRUITING", "start": "2025-09-05", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "Henan University of Traditional Chinese Medicine", "conditions": ["Idiopathic Pulmonary Fibrosis (IPF)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Henan University of Chinese Medicine", "city": "Zhengzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07178392", "title": "Disease-syndrome Characteristics of IPF", "status": "NOT_YET_RECRUITING", "start": "2025-09-15", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2864, "sponsor": "Henan University of Traditional Chinese Medicine", "conditions": ["Idiopathic Pulmonary Fibrosis (IPF)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Henan University of Chinese Medicine", "city": "Zhengzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07082842", "title": "Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF", "status": "RECRUITING", "start": "2025-10-27", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 472, "sponsor": "Sunshine Lake Pharma Co., Ltd.", "conditions": ["Idiopathic Pulmonary Fibrosis (IPF)"], "cn_sites": [{"facility": "China-Japan Friendship Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07121413", "title": "A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary Fibrosis", "status": "RECRUITING", "start": "2025-11-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 48, "sponsor": "Shanghai Synvida Biotechnology Co.,Ltd.", "conditions": ["Idiopathic Pulmonary Fibrosis(IPF)"], "cn_sites": [{"facility": "Sichuan Provincial People's Hospital", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Hangzhou First People's Hospital", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "The Affiliated Hospital of Inner Mongolia Medical University", "city": "Neimeng", "status": "RECRUITING"}, {"facility": "Dongfang Hospital Affiliated to Tongji University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Huadong Hospital Affiliated to Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "General Hospital of Tianjin Medical University", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "The Affiliated Hospital of Xuzhou Medical University", "city": "Xuzhou", "status": "RECRUITING"}, {"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": "RECRUITING"}], "cn_site_count": 12, "broad_only": false}, {"nct": "NCT07464912", "title": "A Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)", "status": "RECRUITING", "start": "2025-12-24", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 508, "sponsor": "Beijing Tide Pharmaceutical Co., Ltd", "conditions": ["Idiopathic Pulmonary Fibrosis (IPF)"], "cn_sites": [{"facility": "China-Japan Friendship Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07820254", "title": "Inspiratory Flow Rate Capability in Pulmonary Fibrosis Patients", "status": "RECRUITING", "start": "2026-01-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 60, "sponsor": "Shanghai Pulmonary Hospital, Shanghai, China", "conditions": ["Idiopathic Pulmonary Fibrosis", "Progressive Pulmonary Fibrosis"], "cn_sites": [{"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07359963", "title": "Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND007 Cell Therapy", "status": "NOT_YET_RECRUITING", "start": "2026-02-15", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Regend Therapeutics", "conditions": ["Idiopathic Pulmonary Fibrosis (IPF)"], "cn_sites": [{"facility": "The Fourth Hospital of Zhejiang University School of Medicine", "city": "Yiwu", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07447102", "title": "Phase II Clinical Study of BC006 in Patients With Idiopathic Pulmonary Fibrosis", "status": "RECRUITING", "start": "2026-04-27", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 96, "sponsor": "Dragonboat Biopharmaceutical Company Limited", "conditions": ["Idiopathic Pulmonary Fibrosis (IPF)"], "cn_sites": [{"facility": "Dragonboat Biopharmaceutical,Co.,Ltd", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07515066", "title": "Safety and Efficacy of Nebulized 3D-cultured Human Placental Mesenchymal Stem Cell-derived Extracellular Vesicles (hPMSC-EVs) for Idiopathic Pulmonary Fibrosis", "status": "NOT_YET_RECRUITING", "start": "2026-05-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Huan Ye", "conditions": ["Idiopathic Pulmonary Fibrosis (IPF)"], "cn_sites": [{"facility": "Beijing Chest Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07593690", "title": "A Phase I Study of HW241045 in Healthy Subjects", "status": "NOT_YET_RECRUITING", "start": "2026-06", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 102, "sponsor": "Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.", "conditions": ["Idiopathic Pulmonary Fibrosis (IPF)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Shandong First Medical University(Shandong Provincial Qianfoshan Hospital)", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07652658", "title": "A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.", "status": "RECRUITING", "start": "2026-06-11", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 359, "sponsor": "AstraZeneca", "conditions": ["Idiopathic Pulmonary Fibrosis (IPF)"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Changchun", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Changsha", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Lanzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Nanchang", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Nanjing", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Shenyang", "status": "WITHDRAWN"}, {"facility": "Research Site", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Xuzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 13, "broad_only": false}, {"nct": "NCT07719023", "title": "A Phase 3 Study of Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis", "status": "NOT_YET_RECRUITING", "start": "2026-08-31", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 263, "sponsor": "Shanghai Ark Biopharmaceutical Co., Ltd.", "conditions": ["Idiopathic Pulmonary Fibrosis (IPF)"], "cn_sites": [{"facility": "China-Japan Friendship Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07687459", "title": "Study Evaluation Rentosertib (INS018_055) Administered Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF)", "status": "RECRUITING", "start": "2026-09-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 320, "sponsor": "InSilico Medicine Hong Kong Limited", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "Anhui Chest Hospital", "city": "Hefei", "status": "NOT_YET_RECRUITING"}, {"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": "NOT_YET_RECRUITING"}, {"facility": "Beijing Chaoyang Hospital, Capital Medical University", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Fuzhou University Affiliated Provincial Hospital", "city": "Fuzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Affiliated Hospital of Xiamen Medical College", "city": "Xiamen", "status": "RECRUITING"}, {"facility": "Nanfang Hospital, Southern Medical University", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": "NOT_YET_RECRUITING"}, {"facility": "Hainan General Hospital", "city": "Haikou", "status": "RECRUITING"}, {"facility": "Hebei Medical University Third Hospital", "city": "Shijiazhuang", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": "NOT_YET_RECRUITING"}, {"facility": "The People's Hospital of Anyang City", "city": "Anyang", "status": "RECRUITING"}, {"facility": "Nanyang First People's Hospital", "city": "Nanyang", "status": "RECRUITING"}, {"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Renmin Hospital of Wuhan University", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}, {"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}, {"facility": "Yichang Central People's Hospital", "city": "Yichang", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Xiangya Hospital of Central South University", "city": "Changsha", "status": "NOT_YET_RECRUITING"}, {"facility": "The Xiangya Hospital of Central South University", "city": "Changsha", "status": "NOT_YET_RECRUITING"}, {"facility": "The Affiliated Hospital of Inner Mongolia Medical University", "city": "Hohhot", "status": "NOT_YET_RECRUITING"}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "The Affiliated Hospital of Xuzhou Medical University", "city": "Xuzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Jiangxi Provincial People' Hospital", "city": "Nanchang", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Hospital of Jilin University", "city": "Changchun", "status": "NOT_YET_RECRUITING"}, {"facility": "Shengjing Hospital of China Medical University", "city": "Shenyang", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Xi'an Medical College", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "Introduction of the First Affiliated Hospital of Shandong First Medical University", "city": "Jinan", "status": "NOT_YET_RECRUITING"}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": "NOT_YET_RECRUITING"}, {"facility": "Shanghai Pulmonary Hospital Affiliated to Tongji University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Shanxi Bethune Hospital", "city": "Taiyuan", "status": "NOT_YET_RECRUITING"}, {"facility": "Yuncheng Central Hospital", "city": "Yuncheng", "status": "NOT_YET_RECRUITING"}, {"facility": "Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}, {"facility": "Tianjin Chest Hospital", "city": "Tianjin", "status": "NOT_YET_RECRUITING"}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Xinjiang Medical University", "city": "Ürümqi", "status": "NOT_YET_RECRUITING"}, {"facility": "The First People Hospital of Yunnan Province", "city": "Kunming", "status": "NOT_YET_RECRUITING"}, {"facility": "Affiliated Hangzhou First People's Hospital,School of Medicine, Westlake University", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Sir Run Run Shaw Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Hospital of Jiaxing", "city": "Jiaxing", "status": "NOT_YET_RECRUITING"}, {"facility": "Ningbo Medical Center Lihuili Hospital", "city": "Ningbo", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Ningbo University", "city": "Ningbo", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 47, "broad_only": false}, {"nct": "NCT07441408", "title": "Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis", "status": "NOT_YET_RECRUITING", "start": "2026-12-16", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 2380, "sponsor": "Bristol-Myers Squibb", "conditions": ["Pulmonary Fibrosis"], "cn_sites": [{"facility": "Local Institution - 0563", "city": "Hefei", "status": ""}, {"facility": "Local Institution - 0569", "city": "Hefei", "status": ""}, {"facility": "Local Institution - 0555", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 0558", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 0538", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 0557", "city": "Shenzhen", "status": ""}, {"facility": "Local Institution - 0543", "city": "Guangzhou", "status": ""}, {"facility": "Local Institution - 0553", "city": "Guangzhou", "status": ""}, {"facility": "Local Institution - 0561", "city": "Shenzhen Shi", "status": ""}, {"facility": "Local Institution - 0539", "city": "Zhengzhou", "status": ""}, {"facility": "Local Institution - 0567", "city": "Zhengzhou", "status": ""}, {"facility": "Local Institution - 0544", "city": "Shijiazhuang", "status": ""}, {"facility": "Local Institution - 0568", "city": "Yichang Shi", "status": ""}, {"facility": "Local Institution - 0556", "city": "Wuhan", "status": ""}, {"facility": "Local Institution - 0549", "city": "Changsha", "status": ""}, {"facility": "Local Institution - 0573", "city": "Suzhou", "status": ""}, {"facility": "Local Institution - 0570", "city": "Wuxi", "status": ""}, {"facility": "Local Institution - 0551", "city": "Shenyang", "status": ""}, {"facility": "Local Institution - 0554", "city": "Shenyang", "status": ""}, {"facility": "Local Institution - 0541", "city": "Chengdu", "status": ""}, {"facility": "Local Institution - 0548", "city": "Shandong", "status": ""}, {"facility": "Local Institution - 0575", "city": "Shanghai", "status": ""}, {"facility": "Local Institution - 0572", "city": "Shanghai", "status": ""}, {"facility": "Local Institution - 0550", "city": "Chengdu", "status": ""}, {"facility": "Local Institution - 0547", "city": "Tianjin", "status": ""}, {"facility": "Local Institution - 0577", "city": "Tianjin", "status": ""}, {"facility": "Local Institution - 0574", "city": "Hangzhou", "status": ""}, {"facility": "Local Institution - 0576", "city": "Hangzhou", "status": ""}, {"facility": "Local Institution - 0571", "city": "Ningbo", "status": ""}, {"facility": "Local Institution - 0552", "city": "Hangzhou", "status": ""}, {"facility": "Local Institution - 0540", "city": "Hohhot", "status": ""}, {"facility": "Local Institution - 0559", "city": "Lanzhou", "status": ""}, {"facility": "Local Institution - 0542", "city": "Nanjing", "status": ""}, {"facility": "Local Institution - 0566", "city": "Shanghai", "status": ""}, {"facility": "Local Institution - 0562", "city": "Shanghai", "status": ""}, {"facility": "Local Institution - 0565", "city": "Shanghai", "status": ""}, {"facility": "Local Institution - 0546", "city": "Shanghai Shi", "status": ""}, {"facility": "Local Institution - 0564", "city": "Xi'an", "status": ""}, {"facility": "Local Institution - 0545", "city": "Xuzhou", "status": ""}, {"facility": "Local Institution - 0560", "city": "Yinchuan", "status": ""}], "cn_site_count": 40, "broad_only": false}, {"nct": "NCT00514683", "title": "Safety And Efficacy of BIBF 1120 in Idiopathic Pulmonary Fibrosis", "status": "COMPLETED", "start": "2007-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 432, "sponsor": "Boehringer Ingelheim", "conditions": ["Pulmonary Fibrosis"], "cn_sites": [{"facility": "1199.30.86001 Boehringer Ingelheim Investigational Site", "city": "Beijing", "status": ""}, {"facility": "1199.30.86002 Boehringer Ingelheim Investigational Site", "city": "Beijing", "status": ""}, {"facility": "1199.30.86005 Boehringer Ingelheim Investigational Site", "city": "Nanjing", "status": ""}, {"facility": "1199.30.86003 Boehringer Ingelheim Investigational Site", "city": "Shanghai", "status": ""}, {"facility": "1199.30.86004 Boehringer Ingelheim Investigational Site", "city": "Shenyang", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT01170065", "title": "Roll Over Study From 1199.30 BIBF 1120 in Idiopathic Pulmonary Fibrosis (IPF)", "status": "COMPLETED", "start": "2010-06-25", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 198, "sponsor": "Boehringer Ingelheim", "conditions": ["Pulmonary Fibrosis"], "cn_sites": [{"facility": "Beijing Chao-Yang Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": ""}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT01335464", "title": "Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients", "status": "COMPLETED", "start": "2011-04", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 515, "sponsor": "Boehringer Ingelheim", "conditions": ["Pulmonary Fibrosis"], "cn_sites": [{"facility": "1199.32.86001 Boehringer Ingelheim Investigational Site", "city": "Beijing", "status": ""}, {"facility": "1199.32.86002 Boehringer Ingelheim Investigational Site", "city": "Beijing", "status": ""}, {"facility": "1199.32.86005 Boehringer Ingelheim Investigational Site", "city": "Changsha", "status": ""}, {"facility": "1199.32.86004 Boehringer Ingelheim Investigational Site", "city": "Chengdu", "status": ""}, {"facility": "1199.32.86003 Boehringer Ingelheim Investigational Site", "city": "Nanchang", "status": ""}, {"facility": "1199.32.86006 Boehringer Ingelheim Investigational Site", "city": "Xi'an", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT01335477", "title": "Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients II", "status": "COMPLETED", "start": "2011-05", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 551, "sponsor": "Boehringer Ingelheim", "conditions": ["Pulmonary Fibrosis"], "cn_sites": [{"facility": "1199.34.86056 Boehringer Ingelheim Investigational Site", "city": "Beijing", "status": ""}, {"facility": "1199.34.86052 Boehringer Ingelheim Investigational Site", "city": "Shanghai", "status": ""}, {"facility": "1199.34.86054 Boehringer Ingelheim Investigational Site", "city": "Shanghai", "status": ""}, {"facility": "1199.34.86055 Boehringer Ingelheim Investigational Site", "city": "Shanghai", "status": ""}, {"facility": "1199.34.86058 Boehringer Ingelheim Investigational Site", "city": "Shanghai", "status": ""}, {"facility": "1199.34.86051 Boehringer Ingelheim Investigational Site", "city": "Shenyang", "status": ""}, {"facility": "1199.34.86053 Boehringer Ingelheim Investigational Site", "city": "Shenyang", "status": ""}, {"facility": "1199.34.86057 Boehringer Ingelheim Investigational Site", "city": "Yinchuan", "status": ""}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT01504334", "title": "Safety and Efficacy Study of Pirfenidone to Treat Idiopathic Pulmonary Fibrosis(IPF)", "status": "UNKNOWN", "start": "2012-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 80, "sponsor": "Beijing Kawin Technology Share-Holding Co., Ltd.", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01619085", "title": "Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis", "status": "COMPLETED", "start": "2012-06-06", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 752, "sponsor": "Boehringer Ingelheim", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Friendship Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Xiangya Hospital, Central South University", "city": "Changsha", "status": ""}, {"facility": "West China Hospital", "city": "Chengdu", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": ""}, {"facility": "Zhongshan Hospital Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": ""}, {"facility": "General Hospital of Shenyang Military Region", "city": "Shenyang", "status": ""}, {"facility": "Xijing Hospital", "city": "Xi'an", "status": ""}, {"facility": "General Hospital of Ningxia Medical University", "city": "Yinchuan", "status": ""}], "cn_site_count": 11, "broad_only": false}, {"nct": "NCT02485886", "title": "68Ga-BMV101 PET/CT in Patients With Idiopathic Pulmonary Fibrosis", "status": "UNKNOWN", "start": "2015-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02509364", "title": "Study of the Etiology and Immunological Pathogenesis in Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF)", "status": "UNKNOWN", "start": "2015-08", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 300, "sponsor": "Shanghai Pulmonary Hospital, Shanghai, China", "conditions": ["Interstitial Lung Diseases"], "cn_sites": [{"facility": "Shanghai Pulmonary Hospital, Tongji University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02745184", "title": "Clinical Efficacy and Safety of Autologous Lung Stem Cell Transplantation in Patients With Idiopathic Pulmonary Fibrosis", "status": "COMPLETED", "start": "2017-03-30", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Shanghai East Hospital", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "Shanghai East Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03666234", "title": "Idiopathic Pulmonary Fibrosis Registry China Study", "status": "UNKNOWN", "start": "2018-07-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 800, "sponsor": "Dai Huaping", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "Huaping Dai", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03619616", "title": "Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose of ZSP1603 in Healthy Adults", "status": "COMPLETED", "start": "2018-07-16", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Guangdong Zhongsheng Pharmaceutical Co., Ltd.", "conditions": ["Idiopathic Pulmonary Fibrosis(IPF)", "Solid Tumor"], "cn_sites": [{"facility": "The Third Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03711435", "title": "Traditional Chinese Medicine(TCM) Syndrome Classification of Idiopathic Pulmonary Fibrosis(IPF) and Metabolomics", "status": "COMPLETED", "start": "2018-10-20", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 75, "sponsor": "Xuzhou Traditional Chinese Medicine Hospital", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "Xuzhou Traditional Chinese Medicine Hospital", "city": "Xuzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03955146", "title": "Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)", "status": "TERMINATED", "start": "2019-06-18", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 393, "sponsor": "Kyntra Bio", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "Second Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": ""}, {"facility": "BeiJing Chao-Yang Hospital,Capital medical university", "city": "Beijing", "status": ""}, {"facility": "China-Japan friendship hospital", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Nanfang Hospital of Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Shenzhen people's hospital", "city": "Shenzhen", "status": ""}, {"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Henan Provincial chest hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Union Hospital，Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "The Second Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "Affiliated Hospital of Inner Mongolia Medical University", "city": "Hohhot", "status": ""}, {"facility": "People's Hospital of Inner Mongolia Autonomous Region", "city": "Hohhot", "status": ""}, {"facility": "The second hospital of Dalian medical university", "city": "Dalian", "status": ""}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "General Hospital of Ningxia Medical University", "city": "Yinchuan", "status": ""}, {"facility": "Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "The Second Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi’an", "status": ""}, {"facility": "Huaxi Hospital of Sichuan University.", "city": "Chengdu", "status": ""}, {"facility": "General Hospital of Tianjin Medical University", "city": "Tianjin", "status": ""}, {"facility": "Hangzhou First People's Hospital", "city": "Hangzhou", "status": ""}], "cn_site_count": 22, "broad_only": false}, {"nct": "NCT05146934", "title": "The Relationship Between Hormone Sensitivity and Imaging of Idiopathic Interstitial Pneumonia by Artificial Intelligence", "status": "COMPLETED", "start": "2019-12-30", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 150, "sponsor": "Peking University Third Hospital", "conditions": ["Idiopathic Interstitial Pneumonia"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04512170", "title": "Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female Subjects", "status": "COMPLETED", "start": "2020-07-13", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 72, "sponsor": "Sunshine Lake Pharma Co., Ltd.", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "Shanghai Xuhui Central Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04419506", "title": "A Study to Test How Taking BI 1015550 for 12 Weeks Affects Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)", "status": "COMPLETED", "start": "2020-07-28", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 147, "sponsor": "Boehringer Ingelheim", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "The Second Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "West China Hospital", "city": "Chengdu", "status": ""}, {"facility": "Zhongshan Hospital Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT04308681", "title": "A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis", "status": "COMPLETED", "start": "2020-07-29", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 403, "sponsor": "Bristol-Myers Squibb", "conditions": ["Pulmonary Fibrosis"], "cn_sites": [{"facility": "Local Institution - 0187", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 0183", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 0188", "city": "Wuhan", "status": ""}, {"facility": "Local Institution - 0189", "city": "Shanghai", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT04511884", "title": "Screening Microorganism of Cryptogenic Mechanical Pneumonia Through Next Generation Sequencing to Lung Tissue Fluid", "status": "UNKNOWN", "start": "2020-08-07", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Shanghai Pulmonary Hospital, Shanghai, China", "conditions": ["Cryptogenic Organizing Pneumonia", "Idiopathic Interstitial Pneumonias"], "cn_sites": [{"facility": "BAI Jiu-wu", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Shanghai Pulmonary Hospital, Tongji University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT04187690", "title": "Jin-shui Huan-xian Granule in the Treatment of IPF", "status": "UNKNOWN", "start": "2020-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 312, "sponsor": "Henan University of Traditional Chinese Medicine", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "the First Affiliated Hospital of Henan University of Chinese Medicine", "city": "Zhengzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04312594", "title": "Study of Jaktinib Hydrochloride Tablets in Participants With Idiopathic Pulmonary Fibrosis", "status": "COMPLETED", "start": "2020-09-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 91, "sponsor": "Suzhou Zelgen Biopharmaceuticals Co.,Ltd", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04419558", "title": "Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)", "status": "TERMINATED", "start": "2020-09-30", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 372, "sponsor": "Kyntra Bio", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "BeiJing Chao-Yang Hospital,Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Beijing Frindship hosiptal capital Medical University", "city": "Beijing", "status": ""}, {"facility": "China Japan Friendship hospital", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Sichuan People's Hospital", "city": "Chengdu", "status": ""}, {"facility": "Guangdong Provincial People's Hospital", "city": "Guangzhou", "status": ""}, {"facility": "The Second Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Ruijin Hospital, Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Oriental Hospital", "city": "Shanghai", "status": ""}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "General Hospital of Tianjin Medical University", "city": "Tianjing", "status": ""}, {"facility": "Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "The Second Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi'an", "status": ""}, {"facility": "General Hospital of Ningxia Medical University", "city": "Yinchuan", "status": ""}], "cn_site_count": 15, "broad_only": false}, {"nct": "NCT04552899", "title": "A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis", "status": "TERMINATED", "start": "2021-03-19", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 665, "sponsor": "Hoffmann-La Roche", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "CMU-Beijing Chao-Yang Hospital-Beijing Institute of Respiratory Medicine", "city": "Beijing", "status": ""}, {"facility": "China-Japan Friendship Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Friendship Hospital Affiliated of Capital University of Medical Science", "city": "Beijing", "status": ""}, {"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital; Pharmacy", "city": "Beijing", "status": ""}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": ""}, {"facility": "The Second Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "The Third Xiangya Hospital Of Central South University", "city": "Changsha", "status": ""}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Southern Medical University Nanfang Hospital", "city": "Guangdong Province Guangzhou City", "status": ""}, {"facility": "The First Affilicated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "1st Affiliated Hospital of Zhejiang University; Clinical Trial Pharmacy", "city": "Hangzhou", "status": ""}, {"facility": "Inner Mongolia Autonomous Region People's Hospital", "city": "Hohhot", "status": ""}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": ""}, {"facility": "The 1st Affiliated Hospital of Nanchang Unversity", "city": "Nanchang", "status": ""}, {"facility": "Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School", "city": "Nanjing", "status": ""}, {"facility": "Ningbo First Hospital", "city": "Ningbo", "status": ""}, {"facility": "Ruijin Hospital Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Huadong Hospital Affiliated to Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": ""}, {"facility": "China Medical University (CMU) First Affiliated Hospital", "city": "Shenyang", "status": ""}, {"facility": "Shengjing Hospital of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "Hebei Medical University - The Second Hospital", "city": "Shijiazhuang", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "Tongji Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Wuxi People's Hospital", "city": "Wuxi", "status": ""}, {"facility": "Tangdu Hospital, The Fourth Military Medical University; Neurology Department", "city": "Xi'an", "status": ""}, {"facility": "Qinghai Provincial People?s Hospital", "city": "Xining", "status": ""}, {"facility": "Henan University of Traditional Chinese Medicine (HUTCM) The First Affiliated Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": ""}], "cn_site_count": 31, "broad_only": false}, {"nct": "NCT06160440", "title": "The Safety, Tolerability, and Pharmacokinetic Study of SC1011 in Healthy Subjects.", "status": "COMPLETED", "start": "2021-06-03", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 55, "sponsor": "Guangzhou JOYO Pharma Co., Ltd", "conditions": ["Diopathic Pulmonary Fibrosis", "Pulmonary Fibrosis"], "cn_sites": [{"facility": "First Affiliated Hospital of Guang Zhou University of Chinese Medicine", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05383131", "title": "To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy Volunteers", "status": "COMPLETED", "start": "2021-06-23", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 33, "sponsor": "Sunshine Lake Pharma Co., Ltd.", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "Shanghai Xuhui Central Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07588646", "title": "Study To Investigate The Potential DDI Between HEC585 And Pirfenidone/Nintedanib In Healthy Subjects", "status": "COMPLETED", "start": "2021-06-29", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 33, "sponsor": "Sunshine Lake Pharma Co., Ltd.", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "Shanghai Xuhui Central Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05060822", "title": "Phase ll Study of HEC585 in Patients With IPF", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-06-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 270, "sponsor": "Sunshine Lake Pharma Co., Ltd.", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "China-Japan Friendship Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05657184", "title": "Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND001", "status": "COMPLETED", "start": "2021-07-19", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Regend Therapeutics", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Ruijin Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT04986540", "title": "A Trial of SHR - 1906 in Healthy Subjects", "status": "COMPLETED", "start": "2021-08-10", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 72, "sponsor": "Guangdong Hengrui Pharmaceutical Co., Ltd", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "Phase I Clinical Research Unit, Qianfoshan Hospital of Shandong Province", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04594707", "title": "A Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis", "status": "TERMINATED", "start": "2021-08-30", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 117, "sponsor": "Hoffmann-La Roche", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "Beijing Friendship Hospital Affiliated of Capital University of Medical Science", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital; Pharmacy", "city": "Beijing", "status": ""}, {"facility": "The Second Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "The Third Xiangya Hospital Of Central South University", "city": "Changsha", "status": ""}, {"facility": "Shengjing Hospital of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "Hebei Medical University - The Second Hospital", "city": "Shijiazhuang", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "Tongji Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Wuxi People's Hospital", "city": "Wuxi", "status": ""}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": ""}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT05828953", "title": "Anlotinib Capsules in the Treatment for IPF/PF-ILDs", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-09-28", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "First Affiliated Hospital of Wenzhou Medical University", "conditions": ["Interstitial Lung Diseases"], "cn_sites": [{"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05119972", "title": "Tolerability, Pharmacokinetics and Efficacy of ZSP1603 in Patients With Idiopathic Pulmonary Fibrosis （IPF）", "status": "COMPLETED", "start": "2021-10-21", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Guangdong Raynovent Biotech Co., Ltd", "conditions": ["Idiopathic Pulmonary Fibrosis (IPF)"], "cn_sites": [{"facility": "Shanghai Lung Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05424887", "title": "A Study to Evaluate the Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis", "status": "UNKNOWN", "start": "2022-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 105, "sponsor": "Shanghai Ark Biopharmaceutical Co., Ltd.", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "China-Japan Friendship Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06135363", "title": "Safety, Tolerability and Pharmacokinetic Study of SC1011 in Healthy Subjects", "status": "COMPLETED", "start": "2022-08-11", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 45, "sponsor": "Guangzhou JOYO Pharma Co., Ltd", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "Shanghai Xuhui District Central Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05321069", "title": "A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)", "status": "COMPLETED", "start": "2022-10-06", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1177, "sponsor": "Boehringer Ingelheim", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "China-Japan Friendship Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "The Second Xiangya Hospital Of Central South University", "city": "Changsha", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "NanFang Hosptial", "city": "Guangzhou", "status": ""}, {"facility": "Hangzhou First People's Hospital", "city": "Hangzhou", "status": ""}, {"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": ""}, {"facility": "The First hospital of Jiaxing", "city": "Jiaxing", "status": ""}, {"facility": "Jinhua Municipal Central Hospital", "city": "Jinhua", "status": ""}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": ""}, {"facility": "The First Affiliated Hospital of Ningbo University", "city": "Ningbo", "status": ""}, {"facility": "Ruijin Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Chest Hospital", "city": "Shanghai", "status": ""}, {"facility": "Zhongshan Hospital Affiliated to Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Huadong Hospital affiliated to Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": ""}, {"facility": "China Shenyang Chest Hospital", "city": "Shenyang", "status": ""}, {"facility": "Shenzhen People's Hospital", "city": "Shenzhen", "status": ""}, {"facility": "The University of Hong Kong-Shenzhen Hospital", "city": "Shenzhen", "status": ""}, {"facility": "People's Hospital of Sichuan Province", "city": "Sichuan", "status": ""}, {"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "Wuhan Union Hospital", "city": "Wuhan", "status": ""}, {"facility": "Tongji Hospital Affiliated Tongji Medical College Huazhong University of S & T", "city": "Wuhan", "status": ""}, {"facility": "Renmin Hospital of Wuhan University", "city": "Wuhan", "status": ""}, {"facility": "Wuxi People's Hospital", "city": "Wuxi", "status": ""}, {"facility": "Second Affiliated Hospital of Xi'an JiaoTong University", "city": "Xi'an", "status": ""}, {"facility": "Affiliated Hospital, Xuzhou Medical college", "city": "Xuzhou", "status": ""}, {"facility": "Yichang Central People's Hospital", "city": "Yichang", "status": ""}], "cn_site_count": 33, "broad_only": false}, {"nct": "NCT05468502", "title": "Phase I/IIa Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)", "status": "COMPLETED", "start": "2022-10-10", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 17, "sponsor": "Shanghai Life Science & Technology", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "Shanghai Sixth People's Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05722964", "title": "Study on Intravenous Injection of SHR-1906 in the Treatment of Idiopathic Pulmonary Fibrosis", "status": "COMPLETED", "start": "2023-03-29", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Guangdong Hengrui Pharmaceutical Co., Ltd", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "China-Japan Friendship Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05895565", "title": "A Multiple Ascending Doses (MAD) Study of PMG1015 in Idiopathic Pulmonary Fibrosis Subjects", "status": "COMPLETED", "start": "2023-05-19", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 29, "sponsor": "Pulmongene Ltd.", "conditions": ["IPF"], "cn_sites": [{"facility": "The Second Hospital of Anhui Medical University", "city": "Hefei", "status": ""}, {"facility": "China-Japan Friendship Hospital", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Tongji Hospital Tongji Medical College of HUST", "city": "Wuhan", "status": ""}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": ""}, {"facility": "Shanghai Chest Hospital", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT05938920", "title": "Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF)", "status": "COMPLETED", "start": "2023-06-19", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 71, "sponsor": "InSilico Medicine Hong Kong Limited", "conditions": ["Idiopathic Pulmonary Fibrosis (IPF)"], "cn_sites": [{"facility": "Anhui Chest Hospital", "city": "Hefei", "status": ""}, {"facility": "The Second Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": ""}, {"facility": "Peking University Shougang Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "Nanfang Hospital of Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Hainan General Hospital", "city": "Haikou", "status": ""}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": ""}, {"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "The Second Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": ""}, {"facility": "Jiangxi Provincial People's Hospital", "city": "Nanchang", "status": ""}, {"facility": "The Shengjing Hospital of China medical university", "city": "Shenyang", "status": ""}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": ""}, {"facility": "Shanghai Chest Hospital", "city": "Shanghai", "status": ""}, {"facility": "Zhongshan hospital Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": ""}, {"facility": "Shanxi Bethune Hospital", "city": "Taiyuan", "status": ""}, {"facility": "The West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "General Hospital of Tianjin Medical University", "city": "Tianjin", "status": ""}, {"facility": "The First Affiliated Hospital - Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 22, "broad_only": false}, {"nct": "NCT05912049", "title": "A Study to Evaluate the Safety, Tolerability, Pharmacokinetic Properties and Immunogenicity of 9MW3811 in Healthy Subjects", "status": "UNKNOWN", "start": "2023-07-26", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Mabwell (Shanghai) Bioscience Co., Ltd.", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06589921", "title": "Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions", "status": "COMPLETED", "start": "2023-08-25", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Overseas Pharmaceuticals, Ltd.", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06003426", "title": "A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-09-14", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1255, "sponsor": "Bristol-Myers Squibb", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "Local Institution - 0263", "city": "Hefei", "status": ""}, {"facility": "Local Institution - 0222", "city": "Hefei", "status": ""}, {"facility": "Local Institution - 0410", "city": "Hefei", "status": ""}, {"facility": "Local Institution - 0238", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 0470", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 0257", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 0242", "city": "Guangzhou", "status": ""}, {"facility": "Local Institution - 0480", "city": "Guangzhou", "status": ""}, {"facility": "Local Institution - 0295", "city": "Shenzhen", "status": ""}, {"facility": "Local Institution - 0492", "city": "Shenzhen Shi", "status": ""}, {"facility": "Local Institution - 0294", "city": "Zhengzhou", "status": ""}, {"facility": "Local Institution - 0360", "city": "Zhengzhou", "status": ""}, {"facility": "Local Institution - 0233", "city": "Shijiazhuang", "status": ""}, {"facility": "Local Institution - 0482", "city": "Yichang Shi", "status": ""}, {"facility": "Local Institution - 0369", "city": "Wuhan", "status": ""}, {"facility": "Local Institution - 0252", "city": "Wuhan", "status": ""}, {"facility": "Local Institution - 0424", "city": "Suzhou", "status": ""}, {"facility": "Local Institution - 0262", "city": "Wuxi", "status": ""}, {"facility": "Local Institution - 0483", "city": "Xuzhou", "status": ""}, {"facility": "Local Institution - 0431", "city": "Nanchang", "status": ""}, {"facility": "Local Institution - 0479", "city": "Shenyang", "status": ""}, {"facility": "Local Institution - 0241", "city": "Shenyang", "status": ""}, {"facility": "Local Institution - 0292", "city": "Shenyang", "status": ""}, {"facility": "Local Institution - 0255", "city": "Shanghai", "status": ""}, {"facility": "Local Institution - 0230", "city": "Shanghai", "status": ""}, {"facility": "Local Institution - 0243", "city": "Chengdu", "status": ""}, {"facility": "Local Institution - 0391", "city": "Tianjin", "status": ""}, {"facility": "Local Institution - 0365", "city": "Tianjin", "status": ""}, {"facility": "Local Institution - 0488", "city": "Hangzhou", "status": ""}, {"facility": "Local Institution - 0351", "city": "Ningbo", "status": ""}, {"facility": "Local Institution - 0249", "city": "Hangzhou", "status": ""}, {"facility": "Local Institution - 0244", "city": "Changsha", "status": ""}, {"facility": "Local Institution - 0371", "city": "Chengdu", "status": ""}, {"facility": "Local Institution - 0258", "city": "Guangzhou", "status": ""}, {"facility": "Local Institution - 0237", "city": "Hohhot", "status": ""}, {"facility": "Local Institution - 0403", "city": "Jinan", "status": ""}, {"facility": "Local Institution - 0358", "city": "Nanjing", "status": ""}, {"facility": "Local Institution - 0266", "city": "Shanghai", "status": ""}, {"facility": "Local Institution - 0408", "city": "Shanghai", "status": ""}, {"facility": "Local Institution - 0232", "city": "Shanghai", "status": ""}, {"facility": "Local Institution - 0261", "city": "Shijiazhuang", "status": ""}, {"facility": "Local Institution - 0374", "city": "Xi'an", "status": ""}], "cn_site_count": 42, "broad_only": false}, {"nct": "NCT06097260", "title": "Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis", "status": "TERMINATED", "start": "2023-11-16", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 320, "sponsor": "Pliant Therapeutics, Inc.", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "The Second Hospital of Anhui Medical University", "city": "Hefei", "status": ""}, {"facility": "The First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Nanfang Hospital of Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "The 3rd Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "Henan Provincial Chest Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Yichang Central People's Hospital", "city": "Yichang", "status": ""}, {"facility": "The second Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "Wuxi People's Hospital", "city": "Wuxi", "status": ""}, {"facility": "The Affiliated Hospital of Xuzhou Medical College", "city": "Xuzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": ""}, {"facility": "Shengjing Hospital of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": ""}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Sichuan Academy of Medical Sciences · Sichuan Provincial People's Hospital", "city": "Chengdu", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "Hangzhou First People's Hospital", "city": "Hangzhou", "status": ""}], "cn_site_count": 17, "broad_only": false}, {"nct": "NCT06081621", "title": "A Clinical Study to Evaluate the Efficacy and Safety of REGEND001 Cell Therapy on Idiopathic Pulmonary Fibrosis (IPF)", "status": "COMPLETED", "start": "2023-12-11", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 23, "sponsor": "Regend Therapeutics", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "The Second Affiliated Hospital of Xiamen Medical College", "city": "Xiamen", "status": ""}, {"facility": "Ruijin Hospital, Shanghai Jiaotong University School Of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Renji Hospital, Shanghai Jiaotong University School Of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT06230822", "title": "Safety, Tolerability and Efficacy of VUM02 Injection in Treatment of Idiopathic Pulmonary Fibrosis (IPF)", "status": "COMPLETED", "start": "2024-03-05", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Wuhan Optics Valley Vcanbiopharma Co., Ltd.", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "The First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "The First People's Hospital of Kashi Prefecture, Xinjiang", "city": "Kashgar", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT06588517", "title": "Comparative Pharmacokinetic(PK) Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions", "status": "COMPLETED", "start": "2024-04-08", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Overseas Pharmaceuticals, Ltd.", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06360094", "title": "A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis", "status": "TERMINATED", "start": "2024-08-28", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 85, "sponsor": "Boehringer Ingelheim", "conditions": ["Idiopathic Pulmonary Fibrosis", "Progressive Pulmonary Fibrosis"], "cn_sites": [{"facility": "The Second Xiangya Hospital Of Central South University", "city": "Changsha", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "People's Hospital of Sichuan Province", "city": "Chengdu", "status": ""}, {"facility": "First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Zhejiang Hospital", "city": "Hangzhou", "status": ""}, {"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": ""}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": ""}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": ""}, {"facility": "China Shenyang Chest Hospital", "city": "Shenyang", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "Affiliated Hospital, Xuzhou Medical college", "city": "Xuzhou", "status": ""}], "cn_site_count": 11, "broad_only": false}, {"nct": "NCT06335303", "title": "A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)", "status": "COMPLETED", "start": "2024-09-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 322, "sponsor": "Boehringer Ingelheim", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "Beijing Chao-Yang Hospital", "city": "Beijing", "status": ""}, {"facility": "The Second Xiangya Hospital Of Central South University", "city": "Changsha", "status": ""}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "People's Hospital of Sichuan Province", "city": "Chengdu", "status": ""}, {"facility": "First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Hangzhou First People's Hospital", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Hospital", "city": "Hangzhou", "status": ""}, {"facility": "Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": ""}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": ""}, {"facility": "China Shenyang Chest Hospital", "city": "Shenyang", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "Tongji Hospital Affiliated Tongji Medical College Huazhong University of S & T", "city": "Wuhan", "status": ""}, {"facility": "Affiliated Hospital, Xuzhou Medical college", "city": "Xuzhou", "status": ""}], "cn_site_count": 14, "broad_only": false}, {"nct": "NCT06569381", "title": "Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets in Healthy Subjects Under Fasting and Fed Conditions", "status": "COMPLETED", "start": "2024-09-18", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Overseas Pharmaceuticals, Ltd.", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06764862", "title": "Evaluating the Efficacy and Safety of of HSK44459 in People With Idiopathic Pulmonary Fibrosis", "status": "COMPLETED", "start": "2025-01-17", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 186, "sponsor": "Haisco Pharmaceutical Group Co., Ltd.", "conditions": ["Idiopathic Pulmonary Fibrosis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06821464", "title": "A Trial of HRS-9813 in Healthy Subjects", "status": "COMPLETED", "start": "2025-02-17", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 45, "sponsor": "Guangdong Hengrui Pharmaceutical Co., Ltd", "conditions": ["Idiopathic Pulmonary Fibrosis/Progressive Pulmonary Fibrosis"], "cn_sites": [{"facility": "Shanghai General Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 115, "g_fetched": 94, "g_countries": [["United States", 37], ["United Kingdom", 10], ["Australia", 9], ["Italy", 9], ["Canada", 8], ["Spain", 8], ["Germany", 7], ["South Korea", 7], ["Japan", 5], ["France", 5], ["Turkey (Türkiye)", 4], ["New Zealand", 3], ["Poland", 3], ["Greece", 3], ["Argentina", 3], ["Belgium", 3], ["Denmark", 3], ["Netherlands", 3], ["Portugal", 2], ["Serbia", 2], ["Ireland", 2], ["Czechia", 2], ["North Macedonia", 1], ["Bulgaria", 1], ["South Africa", 1], ["Taiwan", 1], ["Chile", 1], ["Israel", 1], ["Switzerland", 1], ["Estonia", 1], ["Brazil", 1], ["Croatia", 1], ["Egypt", 1], ["Antigua and Barbuda", 1], ["Singapore", 1]], "g_trials": [{"nct": "NCT07674745", "title": "Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary Fibrosis", "status": "NOT_YET_RECRUITING", "start": "2026-10-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University of Alabama at Birmingham", "countries": ["United States"]}, {"nct": "NCT07520110", "title": "Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis", "status": "NOT_YET_RECRUITING", "start": "2026-09-28", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "University of Massachusetts, Worcester", "countries": ["United States"]}, {"nct": "NCT07723638", "title": "New Diagnostic Approaches in the Management of Inflammatory Lung Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Fondazione Don Carlo Gnocchi ETS", "countries": []}, {"nct": "NCT07783230", "title": "Blood Cell Count Derived Inflammatory Indexes in Acute Exacerbation of Idiopathic Pulmonary Fibrosis", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT07728721", "title": "Evaluating the Efficacy and Safety of of HSK50042 in People With Idiopathic Pulmonary Fibrosis", "status": "NOT_YET_RECRUITING", "start": "2026-08-25", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Haisco Pharmaceutical Group Co., Ltd.", "countries": []}, {"nct": "NCT05988463", "title": "Dose-Escalation Study of Artesunate Patients With IPF", "status": "RECRUITING", "start": "2026-08-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Joseph C. Wu", "countries": ["United States"]}, {"nct": "NCT07673237", "title": "Remote Evaluation and Surveillance of Patients With Interstitial Lung Disease: Transforming ILD Care Delivery With Remote Monitoring", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of California, San Francisco", "countries": ["United States"]}, {"nct": "NCT07722507", "title": "Antifibrotic Therapy Decision-Making in Pulmonary Fibrosis", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Bristol-Myers Squibb", "countries": ["Japan"]}, {"nct": "NCT07743996", "title": "Emotional and Social Experiences of Antifibrotic (AF) Therapy Among Idiopathic Pulmonary Fibrosis (IPF)/Progressive Pulmonary Fibrosis (PPF) Patients: A Real-World Study", "status": "RECRUITING", "start": "2026-08-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Boehringer Ingelheim", "countries": ["Japan"]}, {"nct": "NCT07728448", "title": "Predictors of Pulmonary Embolism in Interstitial Lung Disease With Worsening Symptoms", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT07516951", "title": "A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis", "status": "RECRUITING", "start": "2026-07-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Chiesi Farmaceutici S.p.A.", "countries": ["North Macedonia", "United States"]}, {"nct": "NCT07422870", "title": "GRAnulomatous MAstitis REGistry Study", "status": "RECRUITING", "start": "2026-07-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "European Breast Cancer Research Association of Surgical Trialists", "countries": ["Germany"]}, {"nct": "NCT07613216", "title": "A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary Hypertension", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Cosmos Rx, Inc", "countries": ["United States"]}, {"nct": "NCT07600021", "title": "A Phase II Study to Evaluate the Efficacy and Safety of SYH2059 Tablets in Adult Patients With Idiopathic Pulmonary Fibrosis", "status": "NOT_YET_RECRUITING", "start": "2026-06-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "InnovStone Therapeutics Limited", "countries": []}, {"nct": "NCT07671911", "title": "Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets", "status": "RECRUITING", "start": "2026-06-29", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Trevi Therapeutics", "countries": ["United States"]}, {"nct": "NCT07682337", "title": "Study of Single and Multiple Oral Doses of SCB0020160 in Healthy Adult Male Subjects", "status": "NOT_YET_RECRUITING", "start": "2026-06-29", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "SCBIO Inc.", "countries": ["Australia"]}, {"nct": "NCT07284602", "title": "Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)", "status": "RECRUITING", "start": "2026-06-26", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "PureTech", "countries": ["United States"]}, {"nct": "NCT07404423", "title": "OPEN-IPF: Observational Prediction modEl for cliNical Outcomes in Idiopathic Pulmonary Fibrosis", "status": "NOT_YET_RECRUITING", "start": "2026-06-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Modena and Reggio Emilia", "countries": []}, {"nct": "NCT07679893", "title": "Phase 2 Clinical Trial of MNKD-201 (Nintedanib Dry Powder Inhalation) in Patients With Idiopathic Pulmonary Fibrosis", "status": "RECRUITING", "start": "2026-05-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Mannkind Corporation", "countries": ["Canada"]}, {"nct": "NCT07572383", "title": "Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis", "status": "RECRUITING", "start": "2026-05-14", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Peter Caravan", "countries": ["United States"]}, {"nct": "NCT07583589", "title": "Nintedanib With or Without Dextromethorphan in Patients With Idiopathic Pulmonary Fibrosis (IPF)", "status": "NOT_YET_RECRUITING", "start": "2026-05-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "First Affiliated Hospital of Wenzhou Medical University", "countries": []}, {"nct": "NCT07454291", "title": "A Study to Evaluate Pharmacokinetics and Drug-drug Interactions of ENV-101 (Taladegib) in Healthy Participants", "status": "RECRUITING", "start": "2026-04-28", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Endeavor Biomedicines, Inc.", "countries": ["Australia"]}, {"nct": "NCT07707245", "title": "Identification of Diagnostic and Prognostic Biomarkers in the Pathological Continuum of Bronco Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis and Pulmonary Neoplasia", "status": "RECRUITING", "start": "2026-04-22", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Fondazione Don Carlo Gnocchi ETS", "countries": ["Italy"]}, {"nct": "NCT07519070", "title": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis", "status": "NOT_YET_RECRUITING", "start": "2026-04-05", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Haisco Pharmaceutical Group Co., Ltd.", "countries": []}, {"nct": "NCT07194382", "title": "AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF", "status": "RECRUITING", "start": "2026-03-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Avalyn Pharma Inc.", "countries": ["Australia", "Canada", "Germany", "New Zealand", "Spain", "United Kingdom"]}]}, {"batch": 1, "no": 56, "name_zh": "IgG4相关性疾病", "query_terms": [{"term": "IgG4-related disease", "broad": false}, {"term": "IgG4 related Disease", "broad": false}], "n_total": 41, "n_open": 20, "n_open_precise": 20, "n_broad": 0, "trials": [{"nct": "NCT01670695", "title": "A Prospective Cohort Study of IgG4RD in China", "status": "RECRUITING", "start": "2012-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "Peking Union Medical College Hospital", "conditions": ["IgG4-related Disease"], "cn_sites": [{"facility": "Deptment of Rheumatology, Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03023371", "title": "National Registry of IgG4-RD in China", "status": "RECRUITING", "start": "2016-12", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 900, "sponsor": "Peking Union Medical College Hospital", "conditions": ["IgG4-Related Disease"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05789030", "title": "Treatment Strategies for IgG4-RD Patients With Superficial Organ Involvement", "status": "RECRUITING", "start": "2022-07-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Autoimmune Diseases"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06663618", "title": "Short-term Glucocorticoid Combined with MMF for IgG4-RD", "status": "RECRUITING", "start": "2023-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 63, "sponsor": "Wen Zhang", "conditions": ["IgG4-related Disease"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06285279", "title": "The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases", "status": "RECRUITING", "start": "2024-03-04", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Nanjing University School of Medicine", "conditions": ["Lupus Nephritis", "ANCA-associated Vasculitis", "Membranous Nephropathy - PLA2R Induced", "IgG4-Related Diseases"], "cn_sites": [{"facility": "Jinling Hospital", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06497387", "title": "Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease", "status": "RECRUITING", "start": "2024-07", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Tongji Hospital", "conditions": ["Lupus Nephritis", "IgG4-related Disease"], "cn_sites": [{"facility": "Tongji Hospital", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06497361", "title": "Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related Disease", "status": "RECRUITING", "start": "2024-07", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Tongji Hospital", "conditions": ["Lupus Nephritis", "IgG4-related Disease"], "cn_sites": [{"facility": "Tongji Hospital", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06794008", "title": "BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2024-12-26", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Peking University People's Hospital", "conditions": ["Systemic Lupus Erythematosus", "Inflammatory Myopathy", "Systemic Sclerosis (SSc)", "ANCA-associated Vasculitis", "IgG4-Related Diseases", "Antiphospholipid Syndrome", "Acquired Thrombotic Thrombocytopenic Purpura", "Behcet Disease", "Sjogren Syndrome"], "cn_sites": [{"facility": "Department of Rheumatology and Immunology, Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06978738", "title": "UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2025-05", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Changzhou No.2 People's Hospital", "conditions": ["Systemic Lupus Erythematosus", "Autoimmune Hemolytic Anemia", "Myasthenia Gravis", "Systemic Sclerosis", "ANCA-Associated Vasculitis", "Inflammatory Myopathy", "IgG4-RD"], "cn_sites": [{"facility": "Changzhou No.2 People's Hospital", "city": "Changzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07104058", "title": "A Study on the Effect of MRD Detected by FAPI PET / CT on the Recurrence of IgG4-RD", "status": "RECRUITING", "start": "2025-05-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 46, "sponsor": "Luo Yaping", "conditions": ["IgG4-Related Diseases"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06978647", "title": "A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases", "status": "RECRUITING", "start": "2025-05-19", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "China Immunotech (Beijing) Biotechnology Co., Ltd.", "conditions": ["Systemic Lupus Erythematosus (SLE)", "Systemic Sclerosis (SSc)", "Inflammatory Myopathy", "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis", "Antiphospholipid Syndrome (APS)", "Rheumatoid Arthritis (RA)", "IgG4-Related Diseases", "Sjogren&#39;s Syndrome"], "cn_sites": [{"facility": "The First Medical Center of Chinese PLA General Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07068165", "title": "A Randomized Controlled Study of the Efficacy and Safety of Lenalidomide in the Treatment of Active IgG4-related Disease", "status": "RECRUITING", "start": "2025-07-07", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 198, "sponsor": "Peking Union Medical College Hospital", "conditions": ["IgG4 Related Disease"], "cn_sites": [{"facility": "Peking Union Medical College Hospital, Beijing, Beijing 100050", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07148791", "title": "Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease", "status": "RECRUITING", "start": "2025-09-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Chinese PLA General Hospital", "conditions": ["IgG4 Related Disease", "B-cell Mediated Autoimmune Disorders"], "cn_sites": [{"facility": "Department of Rheumatology and Immunology, the First Medical Center, Chinese PLA General Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07190196", "title": "A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease", "status": "RECRUITING", "start": "2025-09-26", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 124, "sponsor": "Sanofi", "conditions": ["Immunoglobulin G4 Related Disease"], "cn_sites": [{"facility": "Investigational Site Number : 1560008", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560004", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560001", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560012", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560010", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560003", "city": "Jiazhuang", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560013", "city": "Taiyuan", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560005", "city": "Taiyuan", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560011", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560009", "city": "Yantai", "status": "RECRUITING"}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT07298590", "title": "An Exploratory Clinical Study on the Safety and Efficacy of CD19/BCMA CAR-NK in the Treatment of Relapsed and Refractory IgG4-related Disease", "status": "NOT_YET_RECRUITING", "start": "2025-12-30", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Changhai Hospital", "conditions": ["IgG4 Related Disease"], "cn_sites": [{"facility": "Changhai Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07583030", "title": "A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-04-20", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 44, "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": ["Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE)", "Relapsed/Refractory IgG4-Related Disease (r/r IgG4-RD)", "Progressive Multiple Sclerosis (PMS)", "Relapsed/Refractory Myasthenia Gravis(r/r MS)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": ""}, {"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Shanxi Bethune Hospital", "city": "Taiyuan", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT07593911", "title": "A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 75, "sponsor": "Beijing GoBroad Hospital", "conditions": ["Systemic Lupus Erthematosus (SLE)", "Lupus Nephritis (LN)", "Multiple Sclerosis", "Myasthenia Gravis (MG)", "IgG4-Related Diseases", "Rheumatoid Arthritis (RA)"], "cn_sites": [{"facility": "Beijing GoBroad Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07719543", "title": "Efficacy and Safety of Lenalidomide in Patients With IgG4-Related Disease", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 146, "sponsor": "Chinese PLA General Hospital", "conditions": ["Immunoglobulin G4-Related Disease"], "cn_sites": [{"facility": "The First Medical Center of Chinese PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "Hainan Hospital of Chinese PLA General Hospital", "city": "Sanya", "status": ""}, {"facility": "General Hospital of Central Theater Command", "city": "Wuhan", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07806045", "title": "Nebulized UC-EVs for Recurrent or Refractory IMIDs With Lung Involvement", "status": "NOT_YET_RECRUITING", "start": "2026-10-14", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Qiubai Li", "conditions": ["IgG4 Related Disease", "Systemic Sclerosis (SSc)"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07222553", "title": "Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Inebilizumab in Pediatric Participants With IgG4-RD", "status": "NOT_YET_RECRUITING", "start": "2026-10-31", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Amgen", "conditions": ["Immunoglobulin G4-related Disease"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "The Second Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT01665196", "title": "18F-FDG PET/CT for IgG4-Related Disease", "status": "UNKNOWN", "start": "2012-09", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Autoimmune Disease"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01758393", "title": "Glucocorticoids in Patients With IgG4-RD", "status": "UNKNOWN", "start": "2012-12", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Peking Union Medical College Hospital", "conditions": ["IgG4-related Disease"], "cn_sites": [{"facility": "Deptment of Rheumatology, Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02458196", "title": "Study of Treatment Response on IgG4 Related Disease (IgG4RD)", "status": "UNKNOWN", "start": "2015-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Autoimmune Disease"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02703194", "title": "Leflunomide for Maintenance of Remission in IgG4 Related Disease", "status": "COMPLETED", "start": "2016-03", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 68, "sponsor": "Chinese PLA General Hospital", "conditions": ["Immunoglobulin G4 Related Sclerosing Disease"], "cn_sites": [{"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02797665", "title": "Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids", "status": "UNKNOWN", "start": "2016-05", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Autoimmune Pancreatitis", "IgG4-related Sclerosing Cholangitis", "Obstructive Jaundice"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03368274", "title": "To Evaluate the Clinical Efficacy of Iguratimod in the Treatment of IgG4 Related Disease (IgG4-RD) With Mild Symptom", "status": "UNKNOWN", "start": "2017-09-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Wen Zhang", "conditions": ["IgG4-related Disease"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03715699", "title": "Leflunomide Treatment for IgG4-RD", "status": "UNKNOWN", "start": "2018-07-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 70, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Autoimmune Disease"], "cn_sites": [{"facility": "Yunyun Fei", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04125511", "title": "Characterizing IgG4-RD With 68Ga-FAPI PET/CT", "status": "UNKNOWN", "start": "2019-11-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Peking Union Medical College Hospital", "conditions": ["IgG4-related Disease"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04539197", "title": "Circulating Plasmablast in Diagnosis and Relapse Prediction of IgG4-RD", "status": "UNKNOWN", "start": "2020-06-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 660, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Plasmablast/Plasma Cells in Diagnosis of IgG4-RD", "Plasmablast/Plasma Cells in Relapse Prediction of IgG4-RD"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04124861", "title": "Withdraw Drug in Stable IgG4-Related Disease", "status": "UNKNOWN", "start": "2020-06-23", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 138, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Autoimmune Diseases"], "cn_sites": [{"facility": "Beijing Friendship Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04540497", "title": "A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease", "status": "ACTIVE_NOT_RECRUITING", "start": "2020-12-04", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 135, "sponsor": "Amgen", "conditions": ["IgG4 Related Disease"], "cn_sites": [{"facility": "Viela Bio Investigative Site", "city": "Hohhot", "status": ""}, {"facility": "Viela Bio Investigative Site 1", "city": "Beijing", "status": ""}, {"facility": "Viela Bio Investigative Site 2", "city": "Beijing", "status": ""}, {"facility": "Viela Bio Investigative Site 3", "city": "Beijing", "status": ""}, {"facility": "Viela Bio Investigative Site 4", "city": "Beijing", "status": ""}, {"facility": "Viela Bio Investigative Site 5", "city": "Beijing", "status": ""}, {"facility": "Viela Bio Investigative Site", "city": "Guandong", "status": ""}, {"facility": "Viela Bio Investigative Site", "city": "Shang’ai", "status": ""}, {"facility": "Viela Bio Investigative Site", "city": "Shenyang", "status": ""}, {"facility": "Viela Bio Investigative Site", "city": "Wuhan", "status": ""}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT04660565", "title": "Belimumab Treatment for IgG4-related Disease", "status": "UNKNOWN", "start": "2021-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Peking Union Medical College Hospital", "conditions": ["IgG4-related Disease"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05789017", "title": "Treatment Strategies for IgG4-RD Patients With Internal Organ Involvement", "status": "UNKNOWN", "start": "2022-07-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Autoimmune Diseases"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05463445", "title": "Multicenter Observational Study of PSC and IgG4-SC in China", "status": "UNKNOWN", "start": "2022-07-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "RenJi Hospital", "conditions": ["Primary Sclerosing Cholangitis", "IgG4-related Sclerosing Cholangitis"], "cn_sites": [{"facility": "RenJi Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05625581", "title": "Tofatib Treatment for IgG4-related Disease", "status": "UNKNOWN", "start": "2022-11-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 40, "sponsor": "Changhai Hospital", "conditions": ["IgG4-related Disease"], "cn_sites": [{"facility": "Shanghai Changhai Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05662241", "title": "A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-01-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 194, "sponsor": "Zenas BioPharma (USA), LLC", "conditions": ["IgG4 Related Disease"], "cn_sites": [{"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "The Second Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhai", "status": ""}, {"facility": "Yantai Yuhuangding Hospital", "city": "Yantai", "status": ""}, {"facility": "Renji Hospital, Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Shanxi Bethune Hospital", "city": "Taiyuan", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT05781516", "title": "Baricitinib Plus Glucocorticoid for Eosinophilia in IgG4-RD", "status": "UNKNOWN", "start": "2023-01-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 74, "sponsor": "Wen Zhang", "conditions": ["IgG4-related Disease With Eosinophilia"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07827469", "title": "Tofacitinib in the Treatment of IgG4 Related Diseases", "status": "COMPLETED", "start": "2023-04-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 58, "sponsor": "Peking University People's Hospital", "conditions": ["Immunoglobulin G4-Related Disease", "Janus Kinase Inhibitors"], "cn_sites": [{"facility": "Peking Univercity, People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05974683", "title": "Treatment Strategies in IgG4-RD Patients With Re-elevation of Serum IgG4 Level During Maintenance Remission Period", "status": "UNKNOWN", "start": "2023-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 108, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Autoimmune Diseases"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06361745", "title": "Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases", "status": "UNKNOWN", "start": "2024-04-02", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "PersonGen BioTherapeutics (Suzhou) Co., Ltd.", "conditions": ["Systemic Lupus Erythematosus", "Idiopathic Inflammatory Myopathies", "Systemic Sclerosis", "IgG4 Related Disease", "Primary Sjögren Syndrome"], "cn_sites": [{"facility": "PersonGen.Anke Cellular Therapeutice Co., Ltd", "city": "Hefei", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07339540", "title": "the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-11-04", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 45, "sponsor": "Tongji Hospital", "conditions": ["Recurrent or Refractory Systemic Lupus Erythematosus", "Recurrent or Refractory IgG4 Related Diseases", "Recurrent or Refractory Systemic Sclerosis", "Recurrent or Refractory Idiopathic Inflammatory Myopathy", "Recurrent or Refractory ANCA Associated Vasculitis"], "cn_sites": [{"facility": "Tongji Hospital, Affiliated to Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 33, "g_fetched": 13, "g_countries": [["Ukraine", 1], ["Japan", 1], ["United States", 1], ["Belgium", 1], ["Germany", 1], ["Argentina", 1], ["Netherlands", 1], ["Israel", 1], ["Spain", 1]], "g_trials": [{"nct": "NCT07793903", "title": "BCT301 in Treating Refractory/Recurrent IgG4-related Disease", "status": "NOT_YET_RECRUITING", "start": "2026-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Peking University Third Hospital", "countries": []}, {"nct": "NCT07621939", "title": "A Study of IMM0306 in IgG4-Related Disease", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "ImmuneOnco Biopharmaceuticals (Shanghai) Inc.", "countries": []}, {"nct": "NCT07536841", "title": "Validation of the Odesa Criteria 2026 for Autoimmune Pancreatitis", "status": "RECRUITING", "start": "2026-05-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Military Medical Clinical Center of the Southern Region, Ukraine", "countries": ["Ukraine"]}, {"nct": "NCT07061938", "title": "Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease", "status": "RECRUITING", "start": "2026-01-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Acepodia Biotech, Inc.", "countries": ["Japan", "United States"]}, {"nct": "NCT07535554", "title": "The Investigators Will Evaluate the Diagnostic Performance of [18F]-AlF-FAPI-74 PET/CT in Inflammatory Disorders and Compare it With the Current Gold Standard for Inflammation, FDG PET/CT, in Three Patient Cohort: Patients Presenting With Fever of Unknown Origin, IgG4-RD and AxSpA.", "status": "RECRUITING", "start": "2025-09-17", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Universitaire Ziekenhuizen KU Leuven", "countries": ["Belgium"]}, {"nct": "NCT06696027", "title": "AYLo - AutoimmunitY and Loss of y", "status": "RECRUITING", "start": "2024-11-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Bonn", "countries": ["Germany"]}, {"nct": "NCT06655831", "title": "Key Mechanisms of Abnormal T Cell Activation and Differentiation in IgG4-Related Ophthalmic Disease", "status": "NOT_YET_RECRUITING", "start": "2024-11-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Peking University Third Hospital", "countries": []}, {"nct": "NCT06270524", "title": "Study of the C5a/C5aR1 Axis in IgG4-associated Disease: a Potential Therapeutic Target", "status": "NOT_YET_RECRUITING", "start": "2024-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique Hopitaux De Marseille", "countries": []}, {"nct": "NCT06573723", "title": "Institutional Registry of Rare Diseases", "status": "RECRUITING", "start": "2024-07-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Hospital Italiano de Buenos Aires", "countries": ["Argentina"]}, {"nct": "NCT06285539", "title": "Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases", "status": "RECRUITING", "start": "2024-03-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "UMC Utrecht", "countries": ["Netherlands"]}, {"nct": "NCT05746689", "title": "Study of Sirolimus in IgG4-related Disease", "status": "NOT_YET_RECRUITING", "start": "2023-03-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Peking University International Hospital", "countries": []}, {"nct": "NCT03473912", "title": "Meir Medical Center Rheumatologic Biobank", "status": "RECRUITING", "start": "2018-04-16", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Meir Medical Center", "countries": ["Israel"]}, {"nct": "NCT05681975", "title": "Immunoglobulin G4 and Immunoglobulin E Antibodies in a Population With Adverse Reactions to Foodstuffs-related Symptoms", "status": "RECRUITING", "start": "2017-10-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Universidad Politecnica de Madrid", "countries": ["Spain"]}]}, {"batch": 1, "no": 57, "name_zh": "先天性胆汁酸合成障碍", "query_terms": [{"term": "Congenital bile acid synthesis defect", "broad": false}, {"term": "Inborn Errors of Bile Acid Synthesis", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 0, "g_fetched": 0, "g_countries": [], "g_trials": []}, {"batch": 1, "no": 58, "name_zh": "异戊酸血症", "query_terms": [{"term": "Isovaleric acidemia", "broad": false}], "n_total": 1, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT02322060", "title": "In Vitro Activation of Dormant Follicles for Patients With Primary Ovarian Insufficiency", "status": "COMPLETED", "start": "2014-09", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 35, "sponsor": "The First Affiliated Hospital of Zhengzhou University", "conditions": ["in Vitro Activation", "Dormant Follicle", "Primary Ovarian Insufficiency", "Ovarian Resistance Syndrome"], "cn_sites": [{"facility": "Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 1, "g_fetched": 1, "g_countries": [], "g_trials": [{"nct": "NCT07028918", "title": "A Prospective Single-Arm Study（NCLDR）", "status": "NOT_YET_RECRUITING", "start": "2025-08-30", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Qilu Hospital of Shandong University", "countries": []}]}, {"batch": 1, "no": 59, "name_zh": "卡尔曼综合征", "query_terms": [{"term": "Kallmann syndrome", "broad": false}], "n_total": 3, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT01403532", "title": "Sequential Therapy for Hypogonadotropic Hypogonadism", "status": "COMPLETED", "start": "2009-09", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Shanghai Jiao Tong University School of Medicine", "conditions": ["Hypogonadotropic Hypogonadism", "Kallmann Syndrome"], "cn_sites": [{"facility": "Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02880280", "title": "Human Menopausal Gonadotropin Combining With Human Chorionic Gonadotropin Treat Congenital Hypogonadotropic Hypogonadism", "status": "UNKNOWN", "start": "2016-08", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Beijing Children's Hospital", "conditions": ["Kallmann Syndrome", "Hypogonadotropic Hypogonadism"], "cn_sites": [{"facility": "Beijing Children's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03687606", "title": "Efficacy and Safety of Long Term Use of hCG or hCG Plus hMG in Males With Isolated Hypogonadotropic Hypogonadism (IHH)", "status": "UNKNOWN", "start": "2018-10-18", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 210, "sponsor": "Tongji Hospital", "conditions": ["Isolated Hypogonadotropic Hypogonadism", "Kallmann Syndrome", "Infertility"], "cn_sites": [{"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}], "g_total": 3, "g_fetched": 3, "g_countries": [["Netherlands", 1], ["United States", 1], ["Switzerland", 1]], "g_trials": [{"nct": "NCT04463316", "title": "GROWing Up With Rare GENEtic Syndromes", "status": "RECRUITING", "start": "2018-10-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "dr. Laura C. G. de Graaff-Herder", "countries": ["Netherlands"]}, {"nct": "NCT01500447", "title": "Inherited Reproductive Disorders", "status": "RECRUITING", "start": "2012-04-25", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Institute of Environmental Health Sciences (NIEHS)", "countries": ["United States"]}, {"nct": "NCT01601171", "title": "Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate", "status": "RECRUITING", "start": "2012-03", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Centre Hospitalier Universitaire Vaudois", "countries": ["Switzerland"]}]}, {"batch": 1, "no": 60, "name_zh": "朗格汉斯组织细胞增生症", "query_terms": [{"term": "Langerhans cell histiocytosis", "broad": false}], "n_total": 57, "n_open": 18, "n_open_precise": 18, "n_broad": 0, "trials": [{"nct": "NCT03491605", "title": "Surveillance and Tracking the Outcomes of Chronic Latent EBV Infection", "status": "RECRUITING", "start": "2019-07-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 10000, "sponsor": "Huazhong University of Science and Technology", "conditions": ["EBV Infection"], "cn_sites": [{"facility": "Tongji hospital, Tongji medical collage of HUST", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05936086", "title": "A Randomized Controlled Study of High-dose Cyclophosphamide Induction Therapy in Adult Patients With HLH", "status": "RECRUITING", "start": "2023-04-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 160, "sponsor": "shifeng Lou", "conditions": ["Hemophagocytic Syndrome"], "cn_sites": [{"facility": "The Second affiliated Hosptial of Chongqing medical University", "city": "Chongqing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05988177", "title": "Efficacy and Safety of Carrimycin Tablets in HLH Patients With Carbapenem-resistant Infections", "status": "NOT_YET_RECRUITING", "start": "2023-08-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Beijing Friendship Hospital", "conditions": ["Carbapenem Resistant Bacterial Infection", "Hemophagocytic Lymphohistiocytoses"], "cn_sites": [{"facility": "Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05997602", "title": "To Evaluate the Efficacy, Safety, and PK Characteristics of FCN-159 in Pediatric Patients With Refractory/Recurrent LCH", "status": "RECRUITING", "start": "2023-09-28", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 56, "sponsor": "Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.", "conditions": ["Langerhans Cell Histiocytosis", "LCH"], "cn_sites": [{"facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Children's Hospital Affiliated to the Capital Institute of Pediatrics", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Children's Hospital of Chongqing Medical University", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "Sun Yat-Sen Memorial Hpsipital,Sun Yat-Sen Unniversity", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital,Sun Yat-sen University", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": "NOT_YET_RECRUITING"}, {"facility": "Henan Children's Hospital Zhengzhou Children's Hospital", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}, {"facility": "West China Second University Hospital,Sihuan University/West China women's and Children's Hospital", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}, {"facility": "Children's Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Children's Hospital of Soochow University", "city": "Suzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 11, "broad_only": false}, {"nct": "NCT06078969", "title": "Oral Prednisone in Treating LCH of Bone in Childhood and Adolescence", "status": "RECRUITING", "start": "2023-11-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 118, "sponsor": "Shanghai Changzheng Hospital", "conditions": ["Langerhans Cell Histiocytosis of Bone"], "cn_sites": [{"facility": "Shanghai Changzheng Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06131489", "title": "Segmental Resection Combined With DEP Regimen for EBV-HLH Patients With Intestinal Involvement", "status": "NOT_YET_RECRUITING", "start": "2023-12-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 20, "sponsor": "Beijing Friendship Hospital", "conditions": ["Hemophagocytic Lymphohistiocytosis", "Epstein-Barr Virus", "Bowel Resection"], "cn_sites": [{"facility": "Zhao Wang", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06614998", "title": "Establishment of an Early Warning Screening System for Hemophagocytic Lymphohistiocytosis a Multi-center, Prospective Study", "status": "RECRUITING", "start": "2024-05-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 80, "sponsor": "The Affiliated Hospital of Xuzhou Medical University", "conditions": ["Hemophagocytic Syndrome"], "cn_sites": [{"facility": "Affilitated Hospital of Xuzhou Medical University", "city": "Xuzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06902792", "title": "Adebrelimab Combined With Trametinib in the Treatment of Refractory Recurrent Langerhans Cell Histiocytosis in Children and Adolescents", "status": "ENROLLING_BY_INVITATION", "start": "2025-02-06", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Second Affiliated Hospital of Wenzhou Medical University", "conditions": ["Histiocytosis, Langerhans-Cell"], "cn_sites": [{"facility": "Second Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07187193", "title": "Efficacy and Safety of Low-Dose Cytarabine Combined With Thalidomide in Adult Patients With Untreated LCH", "status": "RECRUITING", "start": "2025-04-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Cancer Institute and Hospital, Chinese Academy of Medical Sciences", "conditions": ["Langerhans Cell Histiocytosis"], "cn_sites": [{"facility": "Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07187167", "title": "Efficacy and Safety of the RD Regimen(Lenalidomide, Dexamethasone) for Rosai-Dorfman Disease", "status": "RECRUITING", "start": "2025-04-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Cancer Institute and Hospital, Chinese Academy of Medical Sciences", "conditions": ["Rosai-Dorfman Disease"], "cn_sites": [{"facility": "Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06951971", "title": "Dose-modified Emapalumab and Ruxolitinib (E-Ru) Regimens for Hemophagocytic Lymphohistiocytosis", "status": "NOT_YET_RECRUITING", "start": "2025-06-01", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "The First Affiliated Hospital of Soochow University", "conditions": ["Hemophagocytic Lymphohistiocytosis (HLH)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07022834", "title": "Real-world Study of Darafenib or Trametinib and Clofarabine for High-risk/Recurrent/Refractory Langerhans Cell Histiocytosis in Children", "status": "RECRUITING", "start": "2025-06-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "West China Second University Hospital", "conditions": ["Langerhans Cell Histiocytosis (LCH)"], "cn_sites": [{"facility": "Department of Pediatric Hematology and Oncology, West China Second University Hospital, Sichuan University, Chengdu, China", "city": "Chengdu", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07339345", "title": "Prospective Single-Arm Clinical Trial of GO Regimen for HLH.", "status": "RECRUITING", "start": "2025-06-27", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 28, "sponsor": "Beijing Friendship Hospital", "conditions": ["Lymphohistiocytosis, Hemophagocytic"], "cn_sites": [{"facility": "beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07270835", "title": "Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma", "status": "RECRUITING", "start": "2025-11-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "The First Affiliated Hospital of Soochow University", "conditions": ["Hemophagocytic Lymphohistiocytosis", "B Cell Lymphoma"], "cn_sites": [{"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07431060", "title": "Modified LCH-III Regimen With or Without Luvometinib for Multisystem Pediatric Langerhans Cell Histiocytosis", "status": "RECRUITING", "start": "2026-02-13", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "West China Second University Hospital", "conditions": ["Langerhans Cell Histiocytosis (LCH)"], "cn_sites": [{"facility": "West China Second Hospital, Sichuan University", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": "RECRUITING"}, {"facility": "Anhui Provincial Children's Hospital", "city": "Hefei", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": "RECRUITING"}, {"facility": "Jiangxi Provincial Children's Hospital", "city": "Jiangxi", "status": "RECRUITING"}, {"facility": "Kunming Children's Hospital", "city": "Kunming", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Xinjiang Medical University", "city": "Ürümqi", "status": "RECRUITING"}, {"facility": "Xi'an Children's Hospital", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "Xi'an Northwest Women's and Children's Hospital", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "Zunyi Medical University Affiliated Hospital, Guizhou Provincial Children's Hospital", "city": "Zunyi", "status": "RECRUITING"}], "cn_site_count": 11, "broad_only": false}, {"nct": "NCT07525466", "title": "Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and Golidocitinib (MEPL-G) in the Treatment of NK/T-cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis (NKTCL-HLH)", "status": "RECRUITING", "start": "2026-04-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 25, "sponsor": "Beijing Tongren Hospital", "conditions": ["Extranodal NK T Cell Lymphoma", "Hemophagocytic Lymphohistiocytosis (HLH)"], "cn_sites": [{"facility": "Beijing Tongren Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07371182", "title": "Luvometinib in Pediatric SS-LCH With Special-site Single/Multifocal Bone Lesions", "status": "RECRUITING", "start": "2026-06-19", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 62, "sponsor": "West China Second University Hospital", "conditions": ["Langerhans Cell Histiocytosis (LCH)"], "cn_sites": [{"facility": "The Second Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": "RECRUITING"}, {"facility": "Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": "RECRUITING"}, {"facility": "Zunyi Medical University Affiliated Hospital, Guizhou Provincial Children's Hospital", "city": "Zunyi", "status": "RECRUITING"}, {"facility": "Jiangxi Provincial Children's Hospital", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Xi'an Children's Hospital", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "Xi'an Northwest Women's and Children's Hospital", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "West China Second Hospital, Sichuan University", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Xinjiang Medical University", "city": "Ürümqi", "status": "RECRUITING"}, {"facility": "Kunming Children's Hospital", "city": "Kunming", "status": "RECRUITING"}, {"facility": "Anhui Provincial Children's Hospital", "city": "Hefei", "status": "RECRUITING"}], "cn_site_count": 11, "broad_only": false}, {"nct": "NCT07728201", "title": "Response-adapted Luvometinib With or Without Cytarabine in Langerhans Cell Histiocytosis", "status": "NOT_YET_RECRUITING", "start": "2026-06-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University", "conditions": ["Langerhans Cell Histiocytosis"], "cn_sites": [{"facility": "Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05284942", "title": "Central China Rosai-Dorfman Disease Registry", "status": "UNKNOWN", "start": "2011-10-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Tongji Hospital", "conditions": ["Rosai-Dorfman Disease", "Langerhans Cell Histiocytosis"], "cn_sites": [{"facility": "Tongji Hospital", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01818908", "title": "Trial of DA-EPOCH Regimen for NHL With HLH", "status": "UNKNOWN", "start": "2012-06", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "The First Affiliated Hospital with Nanjing Medical University", "conditions": ["NHL With Hemophagocytic Lymphohistiocytosis"], "cn_sites": [{"facility": "ChangZhou No.2 People's Hospital", "city": "Changzhou", "status": ""}, {"facility": "HuaiAn First People's Hospital", "city": "HuaiAn", "status": ""}, {"facility": "JiangSu Province Hospital", "city": "Nanjing", "status": ""}, {"facility": "WuXi People's Hospital", "city": "Wuxi", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT02389400", "title": "Methotrexate and Cytosine in Adult Langerhans Cell Histiocytosis", "status": "COMPLETED", "start": "2014-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 43, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Langerhans Cell Histiocytosis"], "cn_sites": [{"facility": "Peking union medical college hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02862054", "title": "Splenectomy as a Treatment for Patient With Relapsed Haemophagocytic Lymphohistiocytosis of Unknown Etiology", "status": "UNKNOWN", "start": "2015-01", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Beijing Friendship Hospital", "conditions": ["Hemophagocytic Lymphohistiocytosis"], "cn_sites": [{"facility": "beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02631109", "title": "L-DEP Regimen as a Salvage Therapy for Refractory Epstein Barr Virus-induced Hemophagocytic Lymphohistiocytosis", "status": "UNKNOWN", "start": "2015-12", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Beijing Friendship Hospital", "conditions": ["Hemophagocytic Lymphohistiocytosis"], "cn_sites": [{"facility": "Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02912702", "title": "L-DEP as an Initial Treatment for EBV-HLH", "status": "UNKNOWN", "start": "2016-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Beijing Friendship Hospital", "conditions": ["Hemophagocytic Lymphohistiocytosis"], "cn_sites": [{"facility": "Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03795909", "title": "Ruxolitinib Combined With Dexamethasone for HLH", "status": "UNKNOWN", "start": "2017-03-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Capital Research Institute of Pediatrics", "conditions": ["Hemophagocytic Lymphohistiocytosis"], "cn_sites": [{"facility": "Yan Yue", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03201627", "title": "Study of Lithium Carbonate to Treat Niemann-Pick Type C1 Disease", "status": "UNKNOWN", "start": "2017-07-05", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": ["Niemann-Pick Disease, Type C1"], "cn_sites": [{"facility": "Xin Hua Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03533790", "title": "DEP-Ru Regimen as a Salvage Therapy for HLH", "status": "UNKNOWN", "start": "2018-06", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 80, "sponsor": "Beijing Friendship Hospital", "conditions": ["Hemophagocytic Lymphohistiocytosis"], "cn_sites": [{"facility": "Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04773366", "title": "A Prospective Study for the Treatment of Children With Newly Diagnosed LCH Using a Cytarabine Contained Protocol", "status": "UNKNOWN", "start": "2018-07-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 200, "sponsor": "Shanghai Children's Medical Center", "conditions": ["Langerhans Cell Histiocytosis"], "cn_sites": [{"facility": "Shanghai Children's Medical Center", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03742115", "title": "Etoposide in the First-line Treatment of Adult EBV-HLH", "status": "UNKNOWN", "start": "2018-12-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "Beijing Friendship Hospital", "conditions": ["Hemophagocytic Lymphohistiocytosis"], "cn_sites": [{"facility": "Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04120090", "title": "Ruxolitinib as a Salvage Therapy for Hemophagocytic Lymphohistiocytosis", "status": "UNKNOWN", "start": "2019-07-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 80, "sponsor": "Beijing Friendship Hospital", "conditions": ["Hemophagocytic Lymphohistiocytosis"], "cn_sites": [{"facility": "Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04077905", "title": "Pegylated Liposomal Doxorubicin as a Induction Therapy for Lymphoma Induced Hemophagocytic Lymphohistiocytosis.", "status": "UNKNOWN", "start": "2019-08-31", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 160, "sponsor": "Beijing Friendship Hospital", "conditions": ["Hemophagocytic Lymphohistiocytosis"], "cn_sites": [{"facility": "Beijing Friendship Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04121819", "title": "AraC for Newly Diagnosed Adult Langerhans Cell Histiocytosis", "status": "UNKNOWN", "start": "2019-10-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Langerhans Cell Histiocytosis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04120519", "title": "Thalidomide, Cyclophosphamide and Dexamethasone for Recurrent/Refractory Adult Langerhans Cell Histiocytosis", "status": "UNKNOWN", "start": "2019-10-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Langerhans Cell Histiocytosis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04198818", "title": "A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors", "status": "TERMINATED", "start": "2020-01-07", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 37, "sponsor": "Haihe Biopharma Co., Ltd.", "conditions": ["Advanced Tumors", "Melanoma", "Non-Small-Cell Lung Cancer", "Erdheim-Chester Disease", "Other RAS/RAF/MEK/ERK Mutated Tumors"], "cn_sites": [{"facility": "Shanghai East hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04405375", "title": "GPED Regimen for Relapsed/Refractory or Advanced ENKTCL", "status": "UNKNOWN", "start": "2020-03-21", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 29, "sponsor": "Beijing Tongren Hospital", "conditions": ["Extranodal NK/T-cell Lymphoma, Nasal Type"], "cn_sites": [{"facility": "Beijing Tongren Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03910621", "title": "Safety and Efficacy of Miglustat in Chinese NPC Patients", "status": "COMPLETED", "start": "2020-04-02", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 17, "sponsor": "Actelion", "conditions": ["Niemann-Pick Disease, Type C"], "cn_sites": [{"facility": "Peking University first Hospital", "city": "Beijing", "status": ""}, {"facility": "Xin Hua Hospital, Shanghai Jiao Tong University", "city": "Shanghai", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT04326348", "title": "A Study of TQ05105 Tablets in Subjects With Hemophagocytic Lymphohistiocytosis（HLH）", "status": "UNKNOWN", "start": "2020-07-17", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Hemophagocytic Lymphohistiocytosis"], "cn_sites": [{"facility": "Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04500886", "title": "Evaluate the Efficacy and Safety of PEG-rhG-CSF in Patients With Hemophagocytic Syndrome", "status": "UNKNOWN", "start": "2020-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.", "conditions": ["Hemophagocytic Syndrome"], "cn_sites": [{"facility": "Beijing Friendship Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05164978", "title": "DEP Combine With PD-1 Antibody as an Treatment for EBV-HLH", "status": "UNKNOWN", "start": "2021-05-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Beijing Friendship Hospital", "conditions": ["Hemophagocytic Lymphohistiocytosis"], "cn_sites": [{"facility": "Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04999878", "title": "A Prospective Clinical Study of Ruxolitinib and Etoposide Combined With DDGP Regimen (RUE-DDGP) in Induction Therapy of T/NK Cell Lymphoma-associated Hemophagocytic Syndrome.", "status": "UNKNOWN", "start": "2021-05-30", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Zhengzhou University", "conditions": ["Hemophagocytic Syndrome", "T/NK-Cell Lymphoma"], "cn_sites": [{"facility": "Oncology Department of The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04924647", "title": "Lenalidomide and Dexamethasone for Rosai-Dorfman Disease", "status": "UNKNOWN", "start": "2021-06-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 16, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Rosai-Dorfman Disease"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05137522", "title": "Chidamide Combines With VP-16 and Methylprednisolone in the Treatment of HLH", "status": "UNKNOWN", "start": "2021-07-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Beijing Friendship Hospital", "conditions": ["Chidamide", "Hemophagocytic Lymphohistiocytosis"], "cn_sites": [{"facility": "Beijing Friendship Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05008666", "title": "Induction Chemotherapy Sequential Sintilimab Combined With Dual Epigenetic Drugs for ENKTL-HLH", "status": "UNKNOWN", "start": "2021-12-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 37, "sponsor": "Sun Yat-sen University", "conditions": ["Safety and Efficacy"], "cn_sites": [{"facility": "Department of Medical Oncology,Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05092815", "title": "The Efficacy and Safety of HLX208 in Adult Langerhans Cell Histiocytosis (LCH) and Erdheim-Chester Disease (ECD) With BRAF V600E Mutation", "status": "UNKNOWN", "start": "2021-12-06", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 25, "sponsor": "Shanghai Henlius Biotech", "conditions": ["Langerhans Cell Histiocytosis", "Erdheim-Chester Disease", "LCH", "ECD"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05353179", "title": "Study on Pharmacokinetics of Meperizumab Injection and NUCALA® in Healthy Male Volunteers", "status": "UNKNOWN", "start": "2022-06", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 88, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Granulomatosis With Polyangiitis", "Hemophagocytic Syndrome"], "cn_sites": [{"facility": "Affiliated Hospital of Changchun University of Traditional Chinese Medicine", "city": "Changchun", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05315336", "title": "L-DEP/DEP Regimen and PD-1 Antibody as a Treatment for Relapse/Refractory EBV-HLH", "status": "UNKNOWN", "start": "2022-06-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Beijing Friendship Hospital", "conditions": ["Hemophagocytic Lymphohistiocytosis"], "cn_sites": [{"facility": "Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05546060", "title": "Efficacy and Safety of Venetoclax Combined With Dexamethasone and Etoposide in HLH", "status": "UNKNOWN", "start": "2022-07-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Beijing Friendship Hospital", "conditions": ["Hemophagocytic Lymphohistiocytosis"], "cn_sites": [{"facility": "Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05491304", "title": "Cytokine Guided Risk Stratification and Treatment in Pediatric Hemophagocytic Lymphohistiocytosis", "status": "UNKNOWN", "start": "2022-09-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 400, "sponsor": "The Children's Hospital of Zhejiang University School of Medicine", "conditions": ["Hemophagocytic Lymphohistiocytoses", "Cytokine Storm"], "cn_sites": [{"facility": "The Children's Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05477446", "title": "Safety and Efficacy of CD207 Targeted CAR-T Cell Therapy in Patients With R/R Langerhans Cell Histiocytosis", "status": "UNKNOWN", "start": "2022-10-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Beijing Friendship Hospital", "conditions": ["Langerhans Cell Histiocytosis"], "cn_sites": [{"facility": "Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05600959", "title": "Sensitivity and Specificity of Cytokines in the Diagnosis of Lymphoma-associated HLH", "status": "UNKNOWN", "start": "2022-11-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 60, "sponsor": "Beijing Friendship Hospital", "conditions": ["Hemophagocytic Lymphohistiocytoses", "Lymphoma"], "cn_sites": [{"facility": "Zhao Wang", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05677178", "title": "Response Prediction in EBV-HLH Using Metabonomics Analysis", "status": "UNKNOWN", "start": "2023-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 30, "sponsor": "Beijing Friendship Hospital", "conditions": ["Hemophagocytic Lymphohistiocytoses", "EBV", "Metabonomics"], "cn_sites": [{"facility": "Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05744063", "title": "A Post-authorization Study to Describe the Safety and Efficacy of Emapalumab for the Treatment of pHLH in Treatment Experienced Chinese Patients", "status": "COMPLETED", "start": "2023-02-03", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 13, "sponsor": "Swedish Orphan Biovitrum", "conditions": ["Primary Hemophagocytic Lymphohistiocytosis"], "cn_sites": [{"facility": "Swedish Orphan Biovitrum Research site", "city": "Shanghai", "status": ""}, {"facility": "Swedish Orphan Biovitrum Research site", "city": "Beijing", "status": ""}, {"facility": "Swedish Orphan Biovitrum Research site", "city": "Chongqing", "status": ""}, {"facility": "Swedish Orphan Biovitrum Research site", "city": "Guangzhou", "status": ""}, {"facility": "Swedish Orphan Biovitrum Research site", "city": "Nanjing", "status": ""}, {"facility": "Swedish Orphan Biovitrum Research site", "city": "Zhengzhou", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT07011329", "title": "Brain Alterations Based on Multiplex MR Imaging in Nasopharyngeal Carcinoma Patients After Treatment, and Their Correlation With Clinical Cognitive Scores.", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-04-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 60, "sponsor": "Hubei Cancer Hospital", "conditions": ["Nasopharyngeal Carcinoma (NPC)"], "cn_sites": [{"facility": "Department of Radiology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07034209", "title": "A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic Characteristics, and Immunogenicity of Plonmarlimab in Subjects With Rheumatic and Immunological Disease-associated Haemophagocytic Lymphohistiocytosis (HLH) (Also Known as Macrophage Activation Syndrome (MAS))", "status": "COMPLETED", "start": "2023-04-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "TJ Biopharma Co., Ltd.", "conditions": ["Hemophagocytic Lymphohistiocytoses"], "cn_sites": [{"facility": "Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Renji Hospital of Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Beijing Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Peking University People's Hospital", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital of Nanjing Medical University", "city": "Nanjing", "status": ""}, {"facility": "Ruijin Hospital Of Shanghai Jiao tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT05775705", "title": "L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH", "status": "COMPLETED", "start": "2023-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Beijing Friendship Hospital", "conditions": ["PD-1 Antibody", "Hemophagocytic Lymphohistiocytosis", "Epstein-Barr Virus", "Lymphoma"], "cn_sites": [{"facility": "Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06491719", "title": "A Study on Efficacy and Safety of iNK Cells for CAEBV /EBV-HLH After Allo-HSCT", "status": "UNKNOWN", "start": "2024-07-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Beijing Friendship Hospital", "conditions": ["CAEBV (Chronic Active Epstein-Barr Virus Infection) Syndrome", "EBV", "Hemophagocytic Lymphohistiocytoses"], "cn_sites": [{"facility": "Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07204041", "title": "Efficacy and Safety of XTD Regimen (Selinexor, Thalidomide and Dexamethasone) in Adult Patients With Relapsed/Refractory LCH", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-08-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Cancer Institute and Hospital, Chinese Academy of Medical Sciences", "conditions": ["Langerhans Cell Histiocytosis (LCH)"], "cn_sites": [{"facility": "Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, beijing,", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 69, "g_fetched": 52, "g_countries": [["United States", 30], ["United Kingdom", 8], ["France", 8], ["Australia", 7], ["Canada", 5], ["Germany", 5], ["Italy", 5], ["Spain", 5], ["Poland", 5], ["Brazil", 3], ["Argentina", 3], ["Portugal", 3], ["Switzerland", 3], ["India", 2], ["Mexico", 2], ["Pakistan", 2], ["Turkey (Türkiye)", 2], ["Czechia", 2], ["Netherlands", 2], ["Sweden", 1], ["Egypt", 1], ["Slovakia", 1], ["Austria", 1], ["Israel", 1], ["South Korea", 1], ["New Zealand", 1], ["Puerto Rico", 1], ["Saudi Arabia", 1]], "g_trials": [{"nct": "NCT07660783", "title": "Naive T Cell Deplete Grafts for GVHD Prevention in Non-Malignant Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Fred Hutchinson Cancer Center", "countries": ["United States"]}, {"nct": "NCT07626398", "title": "All-Trans Retinoic Acid for the Treatment of Hemophagocytic Lymphohistiocytosis", "status": "NOT_YET_RECRUITING", "start": "2026-06-01", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Beijing Anzhen Hospital", "countries": []}, {"nct": "NCT07440290", "title": "DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.", "status": "RECRUITING", "start": "2026-04-01", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Cancer Research UK", "countries": ["United Kingdom"]}, {"nct": "NCT07497438", "title": "Comparison of Two Etoposide Initiation Strategies for Severe Hemophagocytic Lymphohistiocytosis", "status": "NOT_YET_RECRUITING", "start": "2026-04", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT07399704", "title": "A Study to Evaluate the Safety and Efficacy of Nizubaglustat (AZ-3102) in Patients With GM2 Gangliosidosis or Niemann-Pick Type C Disease", "status": "RECRUITING", "start": "2026-02-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Azafaros B.V.", "countries": ["Brazil"]}, {"nct": "NCT06712810", "title": "Q702 for the Treatment of Patients With Hematologic Malignancies", "status": "RECRUITING", "start": "2025-08-27", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Mayo Clinic", "countries": ["United States"]}, {"nct": "NCT07082725", "title": "A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC)", "status": "RECRUITING", "start": "2025-06-30", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Azafaros B.V.", "countries": ["Argentina", "Australia", "Brazil", "Canada", "Germany", "India", "Italy", "Mexico", "Pakistan", "Portugal", "Spain", "Switzerland", "Turkey (Türkiye)", "United Kingdom", "United States"]}, {"nct": "NCT07054515", "title": "A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis", "status": "RECRUITING", "start": "2025-06-30", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Azafaros B.V.", "countries": ["Argentina", "Australia", "Brazil", "Canada", "France", "Germany", "India", "Italy", "Mexico", "Pakistan", "Portugal", "Spain", "Sweden", "Switzerland", "Turkey (Türkiye)", "United Kingdom", "United States"]}, {"nct": "NCT06985212", "title": "National Multicentre Study of the Natural History of Acid Sphingo-myelinase Deficiency in Adults and Children", "status": "NOT_YET_RECRUITING", "start": "2025-05-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Wladimir MAUHIN, Dr", "countries": ["France"]}, {"nct": "NCT06869499", "title": "Study of the Prevalence of Acid Sphingomyelinase Deficiency/Niemann Pick AB and B Disease in Patients With Diffuse Interstitial Lung Disease", "status": "NOT_YET_RECRUITING", "start": "2025-05", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Wladimir MAUHIN, Dr", "countries": ["France"]}, {"nct": "NCT06734624", "title": "The Microbiome in Blood Cancer and HLH", "status": "NOT_YET_RECRUITING", "start": "2025-01-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Nottingham", "countries": ["United Kingdom"]}, {"nct": "NCT07454343", "title": "ECD-Score: a Study on Erdheim-Chester Disease", "status": "RECRUITING", "start": "2024-12-23", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Meyer Children's Hospital IRCCS", "countries": ["France", "Italy", "United Kingdom", "United States"]}, {"nct": "NCT05762640", "title": "Ruxolitinib as First Line Treatment in Primary Haemophagocytic Lymphohistiocytosis (R-HLH)", "status": "RECRUITING", "start": "2024-11-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT06160791", "title": "Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)", "status": "RECRUITING", "start": "2024-10-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Jerry Lee, MD, MSc, MPhil", "countries": ["United States"]}, {"nct": "NCT06504030", "title": "Modified DEP Regimens for the Treatment of Hemophagocytic Lymphohistiocytosis", "status": "NOT_YET_RECRUITING", "start": "2024-08-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "The First Affiliated Hospital of Soochow University", "countries": []}, {"nct": "NCT06339177", "title": "Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study", "status": "RECRUITING", "start": "2024-07-02", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "countries": ["United States"]}, {"nct": "NCT06582745", "title": "Targeted Approach to Langerhans Cell Histiocytosis (LCH) Using MEK Inhibitor, Trametinib", "status": "RECRUITING", "start": "2024-06-24", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Cook Children's Health Care System", "countries": ["United States"]}, {"nct": "NCT06192576", "title": "A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD)", "status": "RECRUITING", "start": "2024-04-16", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sanofi", "countries": ["United States"]}, {"nct": "NCT05828069", "title": "A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis", "status": "RECRUITING", "start": "2024-03-28", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["Australia", "Canada", "United States"]}, {"nct": "NCT06197204", "title": "Biomarkers for Diagnostic, Prognostic and of Response to Treatment in Adult Langerhans Cell Histiocytosis", "status": "RECRUITING", "start": "2024-03-25", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT07800234", "title": "Establishing a National Egyptian HLH Registry (NEHR)", "status": "RECRUITING", "start": "2024-03-02", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Ain Shams University", "countries": ["Egypt"]}, {"nct": "NCT06153173", "title": "Mirdametinib in Histiocytic Disorders", "status": "RECRUITING", "start": "2024-02-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Children's Hospital Medical Center, Cincinnati", "countries": ["United States"]}, {"nct": "NCT05702502", "title": "Assessing the Presence of CT-DNA in Lymphoma Associated HLH", "status": "RECRUITING", "start": "2023-06-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Nottingham University Hospitals NHS Trust", "countries": ["United Kingdom"]}, {"nct": "NCT05992532", "title": "GammaGA: Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple Myeloma", "status": "RECRUITING", "start": "2023-05-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fundación Española de Hematología y Hemoterapía", "countries": ["Spain"]}, {"nct": "NCT05898477", "title": "Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic Lymphohistiocytosis", "status": "RECRUITING", "start": "2023-05-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Alabama at Birmingham", "countries": ["United States"]}]}, {"batch": 1, "no": 61, "name_zh": "莱伦氏综合征", "query_terms": [{"term": "Laron syndrome", "broad": false}], "n_total": 1, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT00368173", "title": "IGF-I/IGFBP-3 Therapy in Children and Adolescents With Growth Hormone Insenitivity Syndrome (GHIS) Such as Laron Syndrome", "status": "COMPLETED", "start": "", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": null, "sponsor": "Insmed Incorporated", "conditions": ["Growth Hormone Insensitivity Syndrome (GHIS)", "Laron Syndrome"], "cn_sites": [{"facility": "Dr. Kwok-leung NG", "city": "Hong Kong", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 0, "g_fetched": 0, "g_countries": [], "g_trials": []}, {"batch": 1, "no": 62, "name_zh": "Leber遗传性视神经病变", "query_terms": [{"term": "Leber hereditary optic neuropathy", "broad": false}], "n_total": 5, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT04912843", "title": "Gene Therapy Clinical Trial for the Treatment Of Leber's HereDitary Optic Neuropathy", "status": "RECRUITING", "start": "2021-06-18", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 102, "sponsor": "Wuhan Neurophth Biotechnology Limited Company", "conditions": ["Leber's Hereditary Optic Neuropathy (LHON)"], "cn_sites": [{"facility": "Beijing Tongren Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01267422", "title": "Safety and Efficacy Study of rAAV2-ND4 Treatment of Leber Hereditary Optic Neuropathy (LHON)", "status": "COMPLETED", "start": "2011-04", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Bin Li", "conditions": ["Leber Hereditary Optic Neuropathy"], "cn_sites": [{"facility": "Department of Ophthalmology ，Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03153293", "title": "A Single Intravitreal Injection of rAAV2-ND4 for the Treatment of Leber's Hereditary Optic Neuropathy", "status": "UNKNOWN", "start": "2017-12-27", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 159, "sponsor": "Huazhong University of Science and Technology", "conditions": ["Leber Hereditary Optic Neuropathy"], "cn_sites": [{"facility": "Department of Ophthalmology，Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05820152", "title": "Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND1 Mutations", "status": "TERMINATED", "start": "2023-08-15", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 11, "sponsor": "Neurophth Therapeutics Inc", "conditions": ["Leber Hereditary Optic Neuropathy (LHON)"], "cn_sites": [{"facility": "The First Medical Center of the General Hospital of the Chinese People's Liberation Army", "city": "Beijing", "status": ""}, {"facility": "Zhongshan Ophthalmic Center, Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "Optometry Affiliated to Wenzhou Medical University", "city": "Wenzhou", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07406854", "title": "A Phase 3, Multicenter, Randomized, Double-Masked, Sham-Controlled Clinical Trial for Leber's Hereditary Optic Neuropathy (LHON) Associated With ND4 Mutation", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-09-19", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 95, "sponsor": "Wuhan Neurophth Biotechnology Limited Company", "conditions": ["Leber Hereditary Optic Neuropathy (LHON)"], "cn_sites": [{"facility": "Beijing Tongren Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 12, "g_fetched": 11, "g_countries": [["United States", 7], ["France", 4], ["Canada", 2], ["Belgium", 1], ["Brazil", 1], ["Germany", 1], ["Netherlands", 1], ["Spain", 1], ["United Kingdom", 1], ["Austria", 1], ["United Arab Emirates", 1], ["Australia", 1]], "g_trials": [{"nct": "NCT06792500", "title": "A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)", "status": "NOT_YET_RECRUITING", "start": "2026-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "George Washington University", "countries": ["United States"]}, {"nct": "NCT07258667", "title": "Pilot Study of the Efficacy of Nicotinamide (Vitamin B3) in Leber's Hereditary Optic Neuropathy", "status": "NOT_YET_RECRUITING", "start": "2026-04", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Angers", "countries": ["France"]}, {"nct": "NCT07303296", "title": "Efficacy and Safety Study of Bilateral IVT Injection of GS010 at Two Dose Levels in LHON Patients", "status": "RECRUITING", "start": "2026-01-22", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "GenSight Biologics", "countries": ["France"]}, {"nct": "NCT07075887", "title": "Optic Nerve Head Evaluation Through Multimodal Blood Flow Analysis: a Prospective Observational, Multi-center Study", "status": "NOT_YET_RECRUITING", "start": "2025-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Barboni", "countries": []}, {"nct": "NCT06891443", "title": "Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)", "status": "RECRUITING", "start": "2025-06-04", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Laboratoires Thea", "countries": ["Belgium", "Brazil", "Canada", "France", "Germany", "Netherlands", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT06682819", "title": "Metabolomics Analysis According to the Retinal Nerve Fiber Layer in Patients With NOHL Mutations (MétabOCT)", "status": "RECRUITING", "start": "2023-03-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Hôpital Necker-Enfants Malades", "countries": ["France"]}, {"nct": "NCT03475173", "title": "New Non-invasive Modalities for Assessing Retinal Structure and Function", "status": "RECRUITING", "start": "2019-05-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Randy Kardon", "countries": ["United States"]}, {"nct": "NCT03011541", "title": "Stem Cell Ophthalmology Treatment Study II", "status": "RECRUITING", "start": "2016-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "MD Stem Cells", "countries": ["Austria", "United Arab Emirates", "United States"]}, {"nct": "NCT02435940", "title": "Inherited Retinal Degenerative Disease Registry", "status": "RECRUITING", "start": "2014-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Foundation Fighting Blindness", "countries": ["United States"]}, {"nct": "NCT01694940", "title": "North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)", "status": "RECRUITING", "start": "2011-01-31", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Columbia University", "countries": ["Canada", "United States"]}, {"nct": "NCT01793168", "title": "Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford", "status": "RECRUITING", "start": "2010-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sanford Health", "countries": ["Australia", "United States"]}]}, {"batch": 1, "no": 63, "name_zh": "长链3-羟酰基辅酶A脱氢酶缺乏症", "query_terms": [{"term": "Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 2, "g_fetched": 2, "g_countries": [["United States", 1]], "g_trials": [{"nct": "NCT04602325", "title": "Systemic Biomarkers of Brain Injury From Hyperammonemia", "status": "RECRUITING", "start": "2020-07-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Children's National Research Institute", "countries": ["United States"]}, {"nct": "NCT03773770", "title": "Expanded Access to Triheptanoin", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "Ultragenyx Pharmaceutical Inc", "countries": []}]}, {"batch": 1, "no": 64, "name_zh": "淋巴管肌瘤病", "query_terms": [{"term": "Lymphangioleiomyomatosis", "broad": false}], "n_total": 4, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT03193892", "title": "A National Registry on Chinese Patients With Lymphangioleiomyomatosis", "status": "RECRUITING", "start": "2017-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1500, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Pulmonary Function"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03525834", "title": "Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.", "status": "COMPLETED", "start": "2018-11-09", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Renal Angiomyolipoma"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Wuhan", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Chengdu", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT04273334", "title": "Application of 68Ga NEB PET Imaging in the Diagnosis and Evaluation of Lymphatic Disorders", "status": "UNKNOWN", "start": "2019-10-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Lymphatic Disorders"], "cn_sites": [{"facility": "Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05087134", "title": "Characterizing LAM With 11C-Choline PET/CT", "status": "UNKNOWN", "start": "2021-11", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Lymphangioleiomyomatosis"], "cn_sites": [{"facility": "Peking union medical college hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 10, "g_fetched": 9, "g_countries": [["United States", 6], ["Italy", 1], ["Taiwan", 1], ["Canada", 1], ["France", 1]], "g_trials": [{"nct": "NCT06889168", "title": "Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)", "status": "RECRUITING", "start": "2025-10-20", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Columbia University", "countries": ["United States"]}, {"nct": "NCT07304856", "title": "Role of Extracellular Vesicles as Biomarkers of Pulmonary Involvement in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex", "status": "RECRUITING", "start": "2025-04-16", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Milan", "countries": ["Italy"]}, {"nct": "NCT06405997", "title": "The Genotype and Phenotype of Lymphangioleiomyomatosis", "status": "RECRUITING", "start": "2024-05-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Taiwan University Hospital", "countries": ["Taiwan"]}, {"nct": "NCT06160310", "title": "Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)", "status": "RECRUITING", "start": "2023-07-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "David M. Ritter", "countries": ["United States"]}, {"nct": "NCT05676099", "title": "TSC Biosample Repository and Natural History Database", "status": "RECRUITING", "start": "2016-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Tuberous Sclerosis Association", "countries": ["Canada", "United States"]}, {"nct": "NCT02432560", "title": "Safety and Durability of Sirolimus for Treatment of LAM", "status": "RECRUITING", "start": "2015-03", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Cincinnati", "countries": ["United States"]}, {"nct": "NCT01799538", "title": "Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis", "status": "RECRUITING", "start": "2013-06-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "countries": ["United States"]}, {"nct": "NCT01484236", "title": "National Lymphangioleiomyomatosis Registry, France", "status": "RECRUITING", "start": "2012-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Vincent COTTIN", "countries": ["France"]}, {"nct": "NCT00001465", "title": "Study of the Disease Process of Lymphangioleiomyomatosis", "status": "RECRUITING", "start": "1995-12-18", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "countries": ["United States"]}]}, {"batch": 1, "no": 65, "name_zh": "赖氨酸尿蛋白不耐受症", "query_terms": [{"term": "Lysinuric protein intolerance", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 0, "g_fetched": 0, "g_countries": [], "g_trials": []}, {"batch": 1, "no": 66, "name_zh": "溶酶体酸性脂肪酶缺乏症", "query_terms": [{"term": "Lysosomal acid lipase deficiency", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 3, "g_fetched": 3, "g_countries": [["United States", 3], ["Australia", 1], ["Belgium", 1], ["Brazil", 1], ["Bulgaria", 1], ["Canada", 1], ["Croatia", 1], ["Czechia", 1], ["France", 1], ["Germany", 1], ["Greece", 1], ["Ireland", 1], ["Israel", 1], ["Italy", 1], ["Mexico", 1], ["Netherlands", 1], ["Portugal", 1], ["Russia", 1], ["Saudi Arabia", 1], ["Slovenia", 1], ["Spain", 1], ["United Kingdom", 1]], "g_trials": [{"nct": "NCT05619900", "title": "Registry of Patients Diagnosed With Lysosomal Storage Diseases", "status": "RECRUITING", "start": "2022-05-31", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of California, San Francisco", "countries": ["United States"]}, {"nct": "NCT04532047", "title": "PEARL (PrEnAtal Enzyme Replacement Therapy for Lysosomal Storage Disorders)", "status": "RECRUITING", "start": "2021-07-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "University of California, San Francisco", "countries": ["United States"]}, {"nct": "NCT01633489", "title": "Lysosomal Acid Lipase (LAL) Deficiency Registry", "status": "RECRUITING", "start": "2013-05-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Alexion Pharmaceuticals, Inc.", "countries": ["Australia", "Belgium", "Brazil", "Bulgaria", "Canada", "Croatia", "Czechia", "France", "Germany", "Greece", "Ireland", "Israel", "Italy", "Mexico", "Netherlands", "Portugal", "Russia", "Saudi Arabia", "Slovenia", "Spain", "United Kingdom", "United States"]}]}, {"batch": 1, "no": 67, "name_zh": "枫糖尿症", "query_terms": [{"term": "Maple syrup urine disease", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 4, "g_fetched": 4, "g_countries": [["United States", 2]], "g_trials": [{"nct": "NCT06664840", "title": "MyRareDiet A Novel Diet Tracking Tool", "status": "NOT_YET_RECRUITING", "start": "2024-11-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Oregon Health and Science University", "countries": []}, {"nct": "NCT06581991", "title": "Liquid Valine and Isoleucine in Maple Syrup Urine Disease", "status": "NOT_YET_RECRUITING", "start": "2024-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Meta Healthcare Ltd", "countries": []}, {"nct": "NCT04602325", "title": "Systemic Biomarkers of Brain Injury From Hyperammonemia", "status": "RECRUITING", "start": "2020-07-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Children's National Research Institute", "countries": ["United States"]}, {"nct": "NCT01659749", "title": "Educational, Social Support, and Nutritional Interventions and Their Cumulative Effect on Pregnancy Outcomes and Quality of Life in Teen and Adult Women With Phenylketonuria", "status": "RECRUITING", "start": "1995-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Emory University", "countries": ["United States"]}]}, {"batch": 1, "no": 68, "name_zh": "马凡综合征", "query_terms": [{"term": "Marfan syndrome", "broad": false}], "n_total": 3, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT07672210", "title": "PregnAncy-Related Aortic DISsEction in China", "status": "RECRUITING", "start": "2026-03-17", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "DeltaHealth Hospital · Shanghai", "conditions": ["Pregnancy Complication", "Aortic Dissection", "Marfan Syndrome", "Loeys-Dietz Syndrome", "Vascular Ehlers-Danlos Syndrome", "Maternal and Neonatal Outcomes"], "cn_sites": [{"facility": "DeltaHealth Hospital Shanghai", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Beijing Anzhen Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Guangdong Provincial Hospital", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Wuhan Union Hospital", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT05578469", "title": "Surgical Treatment of Marfan Syndrome With Subluxation Lens", "status": "UNKNOWN", "start": "2016-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 50, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Marfan Syndrome", "Lens Subluxation or Dislocation"], "cn_sites": [{"facility": "Second Affiliated Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07008274", "title": "Laparoscopic Sleeve Gastrectomy-Induced Decline in Plasma Asprosin and Its Association With Metabolic Recovery", "status": "COMPLETED", "start": "2021-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 85, "sponsor": "Northern Jiangsu People's Hospital", "conditions": ["Obesity, Morbid"], "cn_sites": [{"facility": "Shuai Zhao", "city": "Yangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 19, "g_fetched": 18, "g_countries": [["Italy", 3], ["France", 3], ["Turkey (Türkiye)", 2], ["United States", 2], ["Poland", 1], ["Spain", 1], ["Brazil", 1]], "g_trials": [{"nct": "NCT07793747", "title": "Serum Asprosin, Metabolic Syndrome, and Cardiometabolic Risk in Rheumatoid Arthritis", "status": "NOT_YET_RECRUITING", "start": "2026-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT07803198", "title": "Asprosin in Behect Patients", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT07358533", "title": "Metabolic Obesity in Normal Weight (MONW): Diagnostic Markers Stud", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Pomeranian Medical University Szczecin", "countries": ["Poland"]}, {"nct": "NCT07591844", "title": "Effect of Periodontal Therapy on Asprosin in Stable Angina", "status": "NOT_YET_RECRUITING", "start": "2026-05-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Ondokuz Mayıs University", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT07495267", "title": "Nutritional Ketosis Marfan", "status": "NOT_YET_RECRUITING", "start": "2026-03-13", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Washington University School of Medicine", "countries": []}, {"nct": "NCT07419386", "title": "Clinical and Psychosocial Factors Associated With Physical Activity Level in Adults With Marfan Syndrome", "status": "NOT_YET_RECRUITING", "start": "2026-02-22", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Oviedo", "countries": ["Spain"]}, {"nct": "NCT07169669", "title": "Multicentre Longitudinal Study of Bone Mineralisation Characteristics in Marfan Syndrome and Ehlers-Danlos Syndrome", "status": "NOT_YET_RECRUITING", "start": "2025-10-31", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS Policlinico S. Donato", "countries": []}, {"nct": "NCT06546137", "title": "National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Unified Health System Through a Multicenter Registry", "status": "RECRUITING", "start": "2025-04-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Hospital do Coracao", "countries": ["Brazil"]}, {"nct": "NCT06735313", "title": "Changes in Salivary Asprosin, IL-39, IL-40 and IL-1β Levels in Diabetic Patients with Periodontitis", "status": "NOT_YET_RECRUITING", "start": "2025-01-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Necmettin Erbakan University", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT06592560", "title": "Asprosin in Breast Cancer", "status": "NOT_YET_RECRUITING", "start": "2024-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Marina Hanna Thabet Ghobrial", "countries": []}, {"nct": "NCT06782230", "title": "ScATtEred Rare Disease Biobanks: a Model of Sample/Data Collection With susTainablE and Shared Criteria", "status": "RECRUITING", "start": "2024-08-31", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS Policlinico S. Donato", "countries": ["Italy"]}, {"nct": "NCT06720883", "title": "Robotically Assisted Surgery For Perihilar Cholangiocarcinoma: A Prospective Study", "status": "RECRUITING", "start": "2024-06-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Azienda Ospedaliera di Padova", "countries": ["Italy"]}, {"nct": "NCT05809323", "title": "Marfan Syndrome Moderate Exercise Trial II", "status": "RECRUITING", "start": "2023-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Baylor College of Medicine", "countries": ["United States"]}, {"nct": "NCT05838235", "title": "Adapted Physical Activity Program (APA) for Effort Rehabilitation of Children and Teenagers With Marfan Syndrome", "status": "RECRUITING", "start": "2023-04-24", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Toulouse", "countries": ["France"]}, {"nct": "NCT05702476", "title": "Marfan Syndrome (MFS) and Facial Dysmorphism: Non-invasive 3D Assessment", "status": "RECRUITING", "start": "2023-01-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS Policlinico S. Donato", "countries": ["Italy"]}, {"nct": "NCT04970459", "title": "Biological Collection for Marfan and Related Syndromes", "status": "RECRUITING", "start": "2022-01-24", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Toulouse", "countries": ["France"]}, {"nct": "NCT04194619", "title": "Pregnancy in Women With Rare Multisystemic Vascular Diseases: COGRare5 Study", "status": "RECRUITING", "start": "2020-02-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Hospices Civils de Lyon", "countries": ["France"]}, {"nct": "NCT02050113", "title": "Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices", "status": "RECRUITING", "start": "2014-03", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Andres Schanzer", "countries": ["United States"]}]}, {"batch": 1, "no": 69, "name_zh": "McCune-Albrigh综合征", "query_terms": [{"term": "McCune-Albright syndrome", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 4, "g_fetched": 4, "g_countries": [["United States", 2], ["Netherlands", 1], ["Italy", 1]], "g_trials": [{"nct": "NCT05966064", "title": "DEnosumab for the Treatment of FIbrous Dysplasia/McCune-Albright Syndrome in Adults (DeFiD)", "status": "RECRUITING", "start": "2023-06-13", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Natasha Appelman-Dijkstra", "countries": ["Netherlands"]}, {"nct": "NCT07569731", "title": "Fibrous Dysplasia: An Epidemiological and Correlational Evaluation of Multimodal Data", "status": "RECRUITING", "start": "2022-05-12", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Istituto Ortopedico Rizzoli", "countries": ["Italy"]}, {"nct": "NCT03231644", "title": "Fibrous Dysplasia, McCune-Albright Syndrome Patient Registry", "status": "RECRUITING", "start": "2016-10-31", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Tovah Burstein", "countries": ["United States"]}, {"nct": "NCT00001727", "title": "Screening and Natural History of Patients With Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome", "status": "RECRUITING", "start": "1998-12-13", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Institute of Dental and Craniofacial Research (NIDCR)", "countries": ["United States"]}]}, {"batch": 1, "no": 70, "name_zh": "中链酰基辅酶A脱氢酶缺乏症", "query_terms": [{"term": "Medium chain acyl-CoA dehydrogenase deficiency", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 5, "g_fetched": 5, "g_countries": [["United States", 3], ["Denmark", 1]], "g_trials": [{"nct": "NCT07734090", "title": "Natural History of MADD", "status": "RECRUITING", "start": "2026-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Icahn School of Medicine at Mount Sinai", "countries": ["United States"]}, {"nct": "NCT06773026", "title": "Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Pediatric and Adults Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)", "status": "RECRUITING", "start": "2025-06-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Jerry Vockley, MD, PhD", "countries": ["United States"]}, {"nct": "NCT06623032", "title": "Metabolic Effects of Medium-Chain Fatty Acids in Patients With Medium-Chain Acyl-CoA Dehydrogenase Deficiency and Healthy Individuals", "status": "RECRUITING", "start": "2024-10-18", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Copenhagen", "countries": ["Denmark"]}, {"nct": "NCT04602325", "title": "Systemic Biomarkers of Brain Injury From Hyperammonemia", "status": "RECRUITING", "start": "2020-07-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Children's National Research Institute", "countries": ["United States"]}, {"nct": "NCT03773770", "title": "Expanded Access to Triheptanoin", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "Ultragenyx Pharmaceutical Inc", "countries": []}]}, {"batch": 1, "no": 71, "name_zh": "甲基丙二酸血症", "query_terms": [{"term": "Methylmalonic acidemia with homocystinuria", "broad": false}, {"term": "Methylmalonic acidemia without homocystinuria", "broad": false}, {"term": "Methylmalonic Academia", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 1, "g_fetched": 2, "g_countries": [["Italy", 1]], "g_trials": [{"nct": "NCT07163364", "title": "A Study to Evaluate the Effects and Safety of Hydroxocobalamin in Participants With Combined Methylmalonic Academia (cblC Type)", "status": "NOT_YET_RECRUITING", "start": "2025-08-31", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "CSPC ZhongQi Pharmaceutical Technology Co., Ltd.", "countries": []}, {"nct": "NCT04880356", "title": "Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.", "status": "RECRUITING", "start": "2021-03-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta", "countries": ["Italy"]}]}, {"batch": 1, "no": 72, "name_zh": "线粒体脑肌病", "query_terms": [{"term": "Mitochodrial Encephalomyopathy", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 0, "g_fetched": 0, "g_countries": [], "g_trials": []}, {"batch": 1, "no": 73, "name_zh": "黏多糖贮积症", "query_terms": [{"term": "Mucopolysaccharidosis", "broad": false}], "n_total": 4, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT06519552", "title": "A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of JWK008 in Patients With Mucopolysaccharidosis Type I", "status": "RECRUITING", "start": "2024-07-22", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "West China Hospital", "conditions": ["Mucopolysaccharidosis Type I"], "cn_sites": [{"facility": "West China Hospital, Sichuan Universit", "city": "Chengdu", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05134571", "title": "China Post-marketing Surveillance (PMS) Study of Aldurazyme®", "status": "COMPLETED", "start": "2021-10-28", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Genzyme, a Sanofi Company", "conditions": ["Mucopolysaccharidosis I"], "cn_sites": [{"facility": "Investigational Site Number :1560003", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number :1560002", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number :1560004", "city": "Guangzhou", "status": ""}, {"facility": "Investigational Site Number :1560006", "city": "Hangzhou", "status": ""}, {"facility": "Investigational Site Number :1560001", "city": "Wuhan", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT05798416", "title": "Effect of Inhalation of Low Dose CO2 on Exercise Performance at High Altitude", "status": "COMPLETED", "start": "2023-02-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 28, "sponsor": "State Key Laboratory of Respiratory Disease", "conditions": ["High Altitude", "Inhalation; Gas", "Acute Mountain Sickness"], "cn_sites": [{"facility": "The First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06393998", "title": "CO2 Supplement for Treatment of Acute Mountain Sickness", "status": "COMPLETED", "start": "2024-06-07", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 46, "sponsor": "State Key Laboratory of Respiratory Disease", "conditions": ["Acute Mountain Sickness", "High Altitude", "Inhalation; Gas"], "cn_sites": [{"facility": "Guangzhou Medical University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 43, "g_fetched": 42, "g_countries": [["United States", 26], ["France", 8], ["United Kingdom", 6], ["Spain", 6], ["Australia", 4], ["Germany", 2], ["Canada", 2], ["Norway", 2], ["Singapore", 2], ["Portugal", 2], ["Sweden", 2], ["Japan", 1], ["Russia", 1], ["Italy", 1], ["Argentina", 1], ["Brazil", 1], ["Netherlands", 1], ["Mexico", 1]], "g_trials": [{"nct": "NCT07818759", "title": "Single Injection of rAAV9-CMV-hNAGLUop Gene for Patients With Mucopolysaccharidosis (MPS) IIIB", "status": "NOT_YET_RECRUITING", "start": "2027-01-18", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "NeuroGT", "countries": ["United States"]}, {"nct": "NCT07579910", "title": "Intracerebroventricular Tralesinidase Alfa in Participants With MPS IIIB (Sanfilippo Syndrome Type B)", "status": "NOT_YET_RECRUITING", "start": "2026-12", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Spruce Biosciences", "countries": []}, {"nct": "NCT07712003", "title": "Natural History to Assess Disease in Patients With MPS IIIC", "status": "NOT_YET_RECRUITING", "start": "2026-11-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Phoenix Nest", "countries": ["United States"]}, {"nct": "NCT07640984", "title": "A Phase I/II Trial of JR-446 in Mucopolysaccharidosis Type IIIB (MPS IIIB)", "status": "NOT_YET_RECRUITING", "start": "2026-09-09", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "JCR Pharmaceuticals Co., Ltd.", "countries": ["Germany", "United Kingdom", "United States"]}, {"nct": "NCT07666269", "title": "Morphology in Oral Rare Syndromes & Artificial Intelligence for Clinical Diagnosis", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Bordeaux", "countries": ["France"]}, {"nct": "NCT07591584", "title": "A Study Evaluating the Impact of Regular FODMAP-targeting Digestive Enzyme Blend Use on Gastrointestinal Symptoms in Individuals With Self-Reported Bloating", "status": "RECRUITING", "start": "2026-05-04", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Kiwi Health Inc", "countries": ["United States"]}, {"nct": "NCT06333041", "title": "Study of Cannabidiol in Sanfilippo Syndrome", "status": "RECRUITING", "start": "2026-04-01", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center", "countries": ["United States"]}, {"nct": "NCT07516587", "title": "Study to Investigate the Efficacy of a Digestive Health Dietary Supplement on Post-meal Bloating in Healthy Participants", "status": "NOT_YET_RECRUITING", "start": "2026-04", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Arrae", "countries": ["United States"]}, {"nct": "NCT07449143", "title": "Physical Activity Intervention for MPS", "status": "RECRUITING", "start": "2026-03-20", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Brunel University", "countries": ["United Kingdom"]}, {"nct": "NCT05858606", "title": "Multidisciplinary Evaluation and a Genome-wide Analysis in a Cohort of Idiopathic Short Stature Patients", "status": "RECRUITING", "start": "2026-03-16", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Montpellier", "countries": ["France"]}, {"nct": "NCT07169279", "title": "Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH)", "status": "RECRUITING", "start": "2025-11-19", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "QED Therapeutics, a BridgeBio company", "countries": ["Australia", "Canada", "Norway", "Singapore", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT07361536", "title": "Cardiac Structure and Function in MPS", "status": "RECRUITING", "start": "2025-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Children's Hospital of Orange County", "countries": ["United States"]}, {"nct": "NCT07173010", "title": "Pediatric Arthropathy Beyond Inflammation: Clinical Spectrum and Diagnostic Approach at Assiut University Children Hospital", "status": "NOT_YET_RECRUITING", "start": "2025-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT07136896", "title": "Nutritional Assessment in Patient of Mucopolysaccharide \"", "status": "NOT_YET_RECRUITING", "start": "2025-08-16", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT06675097", "title": "Assessment of the Impact of Intestinal Gas Emission Quality on the Postoperative Course After Abdominal Surgery", "status": "RECRUITING", "start": "2025-01-31", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Angers", "countries": ["France"]}, {"nct": "NCT06749366", "title": "Uncovering Genes Behind Cartilage Tumors and Vascular Anomalies Using Genomic Sequencing", "status": "RECRUITING", "start": "2025-01-27", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)", "countries": ["United States"]}, {"nct": "NCT06614894", "title": "An Open Label Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacologic Properties of High Dose Ambroxol Hydrochloride in Adult (≥ 18 Years of Age) Subjects With MPS III", "status": "RECRUITING", "start": "2024-12-01", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Ozlem Goker-Alpan", "countries": ["United States"]}, {"nct": "NCT05825131", "title": "Natural History Study of Participants With Sanfilippo Syndrome Type IIIC", "status": "RECRUITING", "start": "2024-11-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Phoenix Nest", "countries": ["France", "United States"]}, {"nct": "NCT06488924", "title": "An Open-label Phase I/II Study of JR-446 in Mucopolysaccharidosis Type IIIB", "status": "RECRUITING", "start": "2024-11-05", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "JCR Pharmaceuticals Co., Ltd.", "countries": ["Japan"]}, {"nct": "NCT06551961", "title": "Effect of Chronic Feeding of Inulin And Methylcellulose on Colonic Fermentation", "status": "RECRUITING", "start": "2024-09-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Nottingham", "countries": ["United Kingdom"]}, {"nct": "NCT06410976", "title": "Prospective Clinical Assessment Study in Children With Hypochondroplasia", "status": "RECRUITING", "start": "2024-06-05", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "QED Therapeutics, a BridgeBio company", "countries": ["Australia", "Canada", "France", "Norway", "Portugal", "Singapore", "Spain", "Sweden", "United Kingdom", "United States"]}, {"nct": "NCT05682144", "title": "ISP-001: Sleeping Beauty Transposon-Engineered B Cells for MPS I", "status": "RECRUITING", "start": "2023-04-12", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Immusoft of CA, Inc.", "countries": ["United States"]}, {"nct": "NCT05408715", "title": "A Natural History Study in Children With a Type II Collagen Disorder With Short Stature", "status": "RECRUITING", "start": "2022-06-29", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Innoskel", "countries": ["France", "Spain"]}, {"nct": "NCT05619900", "title": "Registry of Patients Diagnosed With Lysosomal Storage Diseases", "status": "RECRUITING", "start": "2022-05-31", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of California, San Francisco", "countries": ["United States"]}, {"nct": "NCT05031507", "title": "Study of Skeletal Disorders", "status": "RECRUITING", "start": "2022-01-18", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)", "countries": ["United States"]}]}, {"batch": 1, "no": 74, "name_zh": "多灶性运动神经病", "query_terms": [{"term": "Multifocal motor neuropathy", "broad": false}], "n_total": 3, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT05988073", "title": "A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-11-29", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 413, "sponsor": "argenx", "conditions": ["Multifocal Motor Neuropathy"], "cn_sites": [{"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": ""}, {"facility": "Huashan Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT06537999", "title": "A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-09-17", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 46, "sponsor": "Dianthus Therapeutics", "conditions": ["Multifocal Motor Neuropathy"], "cn_sites": [{"facility": "Cinical Study Site", "city": "Beijing", "status": ""}, {"facility": "Clinical Study Site", "city": "Beijing", "status": ""}, {"facility": "Cinical Study Site", "city": "Shanghai", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT06742190", "title": "A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-12-18", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 154, "sponsor": "argenx", "conditions": ["Multifocal Motor Neuropathy (MMN)", "MMN"], "cn_sites": [{"facility": "Huashan Hospital Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 2, "g_fetched": 2, "g_countries": [["Georgia", 1], ["Australia", 1], ["United States", 1]], "g_trials": [{"nct": "NCT07610564", "title": "A Study to Assess the Effect of Empasiprubart on Nerve Morphology by Ultrasound in Adults With Multifocal Motor Neuropathy", "status": "RECRUITING", "start": "2026-07-27", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "argenx", "countries": ["Georgia"]}, {"nct": "NCT01793168", "title": "Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford", "status": "RECRUITING", "start": "2010-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sanford Health", "countries": ["Australia", "United States"]}]}, {"batch": 1, "no": 75, "name_zh": "多种酰基辅酶A脱氢酶缺乏症", "query_terms": [{"term": "Multiple acyl-CoA dehydrogenase deficiency", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 3, "g_fetched": 3, "g_countries": [["United States", 2], ["Belgium", 1], ["Finland", 1], ["France", 1], ["Italy", 1], ["Portugal", 1], ["Spain", 1], ["Switzerland", 1], ["United Kingdom", 1]], "g_trials": [{"nct": "NCT07734090", "title": "Natural History of MADD", "status": "RECRUITING", "start": "2026-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Icahn School of Medicine at Mount Sinai", "countries": ["United States"]}, {"nct": "NCT06293339", "title": "Durability of Protection After Single Immunisation With GA2 Sporozoites (CoGA-Rechallenge)", "status": "NOT_YET_RECRUITING", "start": "2025-03-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Leiden University Medical Center", "countries": []}, {"nct": "NCT05234723", "title": "Ganciclovir Resistant/Refractory Cytomegalovirus Infection in SOT Recipients and HSCT Patients", "status": "RECRUITING", "start": "2023-06-19", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS Azienda Ospedaliero-Universitaria di Bologna", "countries": ["Belgium", "Finland", "France", "Italy", "Portugal", "Spain", "Switzerland", "United Kingdom", "United States"]}]}, {"batch": 1, "no": 76, "name_zh": "多发性硬化", "query_terms": [{"term": "Multiple Sclerosis", "broad": false}], "n_total": 91, "n_open": 39, "n_open_precise": 39, "n_broad": 0, "trials": [{"nct": "NCT04106830", "title": "Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)", "status": "RECRUITING", "start": "2019-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "Beijing Tiantan Hospital", "conditions": ["NMO Spectrum Disorder", "MRI", "Multiple Sclerosis", "MOGAD"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04561557", "title": "Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System", "status": "RECRUITING", "start": "2020-09-22", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Tongji Hospital", "conditions": ["Autoimmune Diseases", "Autoimmune Diseases of the Nervous System", "Neuromyelitis Optica Spectrum Disorder", "Myasthenia Gravis", "Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "Idiopathic Inflammatory Myopathies", "Multiple Sclerosis", "Autoimmune Encephalitis", "Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)", "POEMS Syndrome"], "cn_sites": [{"facility": "Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05154370", "title": "China National Registry of Neuro-Inflammatory Diseases", "status": "RECRUITING", "start": "2021-12-15", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 10000, "sponsor": "Beijing Tiantan Hospital", "conditions": ["Multiple Sclerosis", "NMO Spectrum Disorder", "Clinically Isolated Syndrome", "CNS Demyelinating Autoimmune Diseases", "Acute Disseminated Encephalomyelitis", "Primay Angiitis of the Central Nervous System", "Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06643858", "title": "Normal Chinese Lifespan Brain Charts Initiative (NCLBCI)", "status": "ENROLLING_BY_INVITATION", "start": "2023-12-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 10000, "sponsor": "Beijing Tiantan Hospital", "conditions": ["Healthy", "Multiple Sclerosis", "Neuromyelitis Optica Spectrum Disorders", "Neurodegenerative Diseases", "Cerebrovascular Diseases"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07353216", "title": "Exploring the Efficacy and Safety of Ofatumumab in Patients With Relapsing Multiple Sclerosis (RMS) and Its Impact on Serum Neurofilament Light Chain (sNfL) Levels", "status": "RECRUITING", "start": "2023-12-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 80, "sponsor": "Third Affiliated Hospital, Sun Yat-Sen University", "conditions": ["Multiple Sclerosis"], "cn_sites": [{"facility": "The Third Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06541626", "title": "Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases", "status": "RECRUITING", "start": "2024-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 450, "sponsor": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University", "conditions": ["Multiple Sclerosis, MS", "Neuromyelitis Optica Spectrum Disorders", "Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease", "Acute Disseminated Encephalomyelitis", "Clinically Isolated Syndrome", "Demyelinating Disorder"], "cn_sites": [{"facility": "Sun Yat-sen Memorial Hospital", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06249438", "title": "A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy", "status": "RECRUITING", "start": "2024-03-20", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "RenJi Hospital", "conditions": ["Systemic Lupus Erythematosus (SLE)", "Immune-mediated Necrotizing Myopathy (IMNM)", "Neuromyelitis Optica Spectrum Disorders (NMOSD)", "Multiple Sclerosis (MS)", "Myasthenia Gravis", "Systemic Sclerosis (SSc)"], "cn_sites": [{"facility": "Department of Rheumatology, RenJi Hospital, School of Medicine, Shanghai JiaoTong University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07653984", "title": "Cohort Study on Neuroimmune Diseases in the Reproductive Age", "status": "RECRUITING", "start": "2024-04-21", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Third Affiliated Hospital, Sun Yat-Sen University", "conditions": ["Neuromyelitis Optica Spectrum Disorders (NMOSD)", "Multiple Sclerosis", "Autoimmune Encephalitis", "Myasthenia Gravis", "Guillain-Barré Syndrome (GBS)", "Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)"], "cn_sites": [{"facility": "The Third Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06782958", "title": "Safety, Tolerability, and Pharmacokinetics of FHND1002 Granules in Healthy Adults", "status": "ENROLLING_BY_INVITATION", "start": "2024-07-05", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 72, "sponsor": "Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.", "conditions": ["Amyotrophic Lateral Sclerosis (ALS)"], "cn_sites": [{"facility": "The first hospital of Lanzhou University", "city": "Lanzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06502015", "title": "Biomarkers in Autoimmune Disease of Nervous System", "status": "RECRUITING", "start": "2024-07-31", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 50000, "sponsor": "Tongji Hospital", "conditions": ["Autoimmune Diseases of the Nervous System", "Neuromyelitis Optica Spectrum Disorder", "Multiple Sclerosis", "Guillain-Barre Syndrome", "Acute Disseminated Encephalomyelitis", "Autoimmune Encephalitis", "Stiff-Person Syndrome", "Myasthenia Gravis", "Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "Idiopathic Inflammatory Myopathies", "Autoimmune Diseases"], "cn_sites": [{"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06474520", "title": "Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD)", "status": "RECRUITING", "start": "2024-08-08", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 250, "sponsor": "Tongji Hospital", "conditions": ["Idiopathic Inflammatory Demyelinating Disease", "Multiple Sclerosis", "Neuromyelitis Optica Spectrum Disorder", "Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease", "Acute Disseminated Encephalomyelitis"], "cn_sites": [{"facility": "Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06671236", "title": "Clinical Study of Regulatory T Cells (Tregs) in the Treatment of Neurodegenerative Diseases", "status": "RECRUITING", "start": "2024-11-21", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Novabio Therapeutics", "conditions": ["Amyotrophic Lateral Sclerosis (ALS)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06794008", "title": "BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2024-12-26", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Peking University People's Hospital", "conditions": ["Systemic Lupus Erythematosus", "Inflammatory Myopathy", "Systemic Sclerosis (SSc)", "ANCA-associated Vasculitis", "IgG4-Related Diseases", "Antiphospholipid Syndrome", "Acquired Thrombotic Thrombocytopenic Purpura", "Behcet Disease", "Sjogren Syndrome"], "cn_sites": [{"facility": "Department of Rheumatology and Immunology, Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06968039", "title": "Effectiveness of Personalized Alternating Current Stimulation for Treating Cognitive Impairment in CNS Demyelination Patients", "status": "RECRUITING", "start": "2024-12-31", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 85, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Multiple Sclerosis", "Electric Stimulation"], "cn_sites": [{"facility": "Xuanwu Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06485232", "title": "Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.", "status": "NOT_YET_RECRUITING", "start": "2025-02-28", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 25, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Neuromyelitis Optica Spectrum Disorders", "Myasthenia Gravis, Generalized", "Multiple Sclerosis", "Chronic Inflammatory Demyelinating Polyradiculoneuropathy"], "cn_sites": [{"facility": "Xuanwu Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07087873", "title": "Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating Diseases", "status": "RECRUITING", "start": "2025-05-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 128, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Idiopathic Inflammatory Demyelinating Disorders of the Central Nervous System", "MS (Multiple Sclerosis)", "NMOSD", "Acute Disseminated Encephalomyelitis", "Transcranial Alternating Current Stimulation"], "cn_sites": [{"facility": "Xuanwu Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06939166", "title": "Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases", "status": "RECRUITING", "start": "2025-06-17", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Tianjin Huanhu Hospital", "conditions": ["Neuromyelitis Optica Spectrum Disorders", "Myasthenia Gravis", "Multiple Sclerosis", "Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "Autoimmune Encephalitis"], "cn_sites": [{"facility": "Tianjin Huanhu Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06607900", "title": "hUC-MSC-sEV-001 Nasal Drops for Neurodegenerative Diseases", "status": "NOT_YET_RECRUITING", "start": "2025-07-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Alzheimer Disease", "Parkinson Disease", "Lewy Body Dementia", "Multiple System Atrophy", "Fronto-temporal Dementia", "Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Xuanwu Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07361094", "title": "Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2025-11-06", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Beijing Boren Hospital", "conditions": ["Relapsed/Refractory Systemic Lupus Erythematosus", "Relapsed/Refractory Systemic Sclerosis", "Relapsed/Refractory Idiopathic Inflammatory Myopathies", "Relapsed/Refractory sjögren's Syndrome", "Relapsed/Refractory Autoimmune Hemolytic Anemia", "Relapsed/Refractory Multiple Sclerosis"], "cn_sites": [{"facility": "Beijing GoBroad Boren Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07225504", "title": "A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis", "status": "RECRUITING", "start": "2025-11-11", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1275, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Secondary Progressive Multiple Sclerosis (SPMS)"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Hohhot", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Suzhou", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Changchun", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Yinchuan", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Xianyang", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Taiyuan", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Wenzhou", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 16, "broad_only": false}, {"nct": "NCT07305116", "title": "CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease", "status": "RECRUITING", "start": "2025-12-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "The Children's Hospital of Zhejiang University School of Medicine", "conditions": ["Autoimmune Diseases", "Systemic Lupus Erthematosus (SLE)", "Multi-Drug Resistant Nephrotic Syndrome", "IgA Nephropathy (IgAN)", "Systemic Sclerosis (SSc)", "ANCA Associated Systemic Vasculitis"], "cn_sites": [{"facility": "Children's Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07337785", "title": "CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases", "status": "RECRUITING", "start": "2025-12-12", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Tongji Hospital", "conditions": ["Relapsing or Refractory Multiple Sclerosis (MS)", "Myasthenia Gravis (MG)", "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)", "Autoimmune Encephalitis (AE)"], "cn_sites": [{"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07325292", "title": "Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis", "status": "RECRUITING", "start": "2026-01-14", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 160, "sponsor": "Sanofi", "conditions": ["Multiple Sclerosis"], "cn_sites": [{"facility": "Investigational Site Number : 1560005", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560004", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1561029", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560010", "city": "Jiazhuang", "status": "RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT07392528", "title": "Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-03", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Tianjin Huanhu Hospital", "conditions": ["Neuromyelitis Optica Spectrum Disorders", "Multiple Sclerosis", "Myasthenia Gravis"], "cn_sites": [{"facility": "Tianjin Huanhu Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07333196", "title": "Tongji NADs Cohort", "status": "NOT_YET_RECRUITING", "start": "2026-03-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1550, "sponsor": "Tongji Hospital", "conditions": ["Multiple Sclerosis", "NMO Spectrum Disorder", "Autoimmune Encephalitis", "Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease", "Autoimmune Nodopathy", "Acute Inflammatory Demyelinating Polyradiculoneuropathy", "Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "Myasthenia Gravis", "Idiopathic Inflammatory Myopathies"], "cn_sites": [{"facility": "Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07303790", "title": "This is an Early Exploratory Study to Assess the Tolerability and Safety of GC012F in Patients With Multiple Sclerosis", "status": "RECRUITING", "start": "2026-03-09", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Daishi Tian", "conditions": ["Multiple Sclerosis"], "cn_sites": [{"facility": "Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science & Technology", "city": "Hubei", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07507201", "title": "Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease", "status": "RECRUITING", "start": "2026-04-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "The Children's Hospital of Zhejiang University School of Medicine", "conditions": ["Autoimmune Diseases", "Systemic Lupus Erthematosus (SLE)", "Multi-Drug Resistant Nephrotic Syndrome", "IgA Nephropathy (IgAN)", "Systemic Sclerosis (SSc)", "ANCA Associated Systemic Vasculitis"], "cn_sites": [{"facility": "Children's Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07526493", "title": "Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.", "status": "RECRUITING", "start": "2026-04-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Tongji Hospital", "conditions": ["Multiple Sclerosis (MS)", "Neuromyelitis Optica Spectrum Disorder (NMOSD)", "Autoimmune Encephalitis (AE)", "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)", "Myasthenia Gravis (MG)", "Anti-Myelin Oligodendrocyte Glycoprotein Immunoglobulin G Antibody-Associated Disease (MOGAD)", "Idiopathic Inflammatory Myopathies (IIM)"], "cn_sites": [{"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07523100", "title": "A Study on the Safety and Tolerability of Universal STAR-T Cell Therapy for Multiple Sclerosis.", "status": "NOT_YET_RECRUITING", "start": "2026-04-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Daishi Tian", "conditions": ["Multiple Sclerosis (MS)"], "cn_sites": [{"facility": "Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science & Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07583030", "title": "A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-04-20", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 44, "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": ["Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE)", "Relapsed/Refractory IgG4-Related Disease (r/r IgG4-RD)", "Progressive Multiple Sclerosis (PMS)", "Relapsed/Refractory Myasthenia Gravis(r/r MS)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": ""}, {"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Shanxi Bethune Hospital", "city": "Taiyuan", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT07586267", "title": "CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease", "status": "RECRUITING", "start": "2026-05-08", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "The Children's Hospital of Zhejiang University School of Medicine", "conditions": ["Autoimmune Diseases", "Systemic Lupus Erthematosus (SLE)", "Multi-Drug Resistant Nephrotic Syndrome", "IgA Nephropathy (IgAN)", "Systemic Sclerosis (SSc)", "ANCA Associated Systemic Vasculitis"], "cn_sites": [{"facility": "Children's Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07587125", "title": "Safety and Efficacy of S103 Cells in Progressive/Refractory Multiple Sclerosis", "status": "RECRUITING", "start": "2026-05-08", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Xijing Hospital", "conditions": ["Multiple Sclerosis (MS) Primary Progressive", "Multiple Sclerosis", "Multiple Sclerosis (MS) Secondary Progressive", "Refractory Multiple Sclerosis"], "cn_sites": [{"facility": "Xijing Hospital", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07593911", "title": "A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 75, "sponsor": "Beijing GoBroad Hospital", "conditions": ["Systemic Lupus Erthematosus (SLE)", "Lupus Nephritis (LN)", "Multiple Sclerosis", "Myasthenia Gravis (MG)", "IgG4-Related Diseases", "Rheumatoid Arthritis (RA)"], "cn_sites": [{"facility": "Beijing GoBroad Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07676266", "title": "A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "The Affiliated Hospital of Qingdao University", "conditions": ["Multiple Sclerosis (MS)", "Myasthenia Gravis (MG)", "Neuromyelitis Optica Spectrum Disorder", "Systemic Lupus Erythematosus", "Systemic Sclerosis", "Immune-Mediated Necrotizing Myopathy"], "cn_sites": [{"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07674147", "title": "RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "The Children's Hospital of Zhejiang University School of Medicine", "conditions": ["Autoimmune Diseases", "SLE - Systemic Lupus Erythematosus", "SSc-Systemic Sclerosis", "IIM- Idiopathic Inflammatory Myopathies", "IgAN - IgA Nephropathy", "Multi-Drug Resistant Nephrotic Syndrome"], "cn_sites": [{"facility": "Nanjing Children's Hospital", "city": "Nanjing", "status": ""}, {"facility": "Children's Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07776743", "title": "A Study of Rocbrutinib in PRL-Positive Relapsing-Remitting Multiple Sclerosis", "status": "RECRUITING", "start": "2026-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Guangzhou Lupeng Pharmaceutical Company LTD.", "conditions": ["Relapsing-remitting Multiple Sclerosis (RRMS)"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07827716", "title": "A Study to Evaluate the Preliminary Efficacy and Safety of Terfenadine in Patients With Relapsing-Remitting Multiple Sclerosis", "status": "RECRUITING", "start": "2026-08-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Chuan Qin", "conditions": ["Relapsing Remitting Multiple Sclerosis"], "cn_sites": [{"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07756268", "title": "Phase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple Sclerosis", "status": "NOT_YET_RECRUITING", "start": "2026-09-16", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 25, "sponsor": "Tongji Hospital", "conditions": ["Multiple Sclerosis"], "cn_sites": [{"facility": "Tongji Hospital, Tongji Medical College of Hust", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07748637", "title": "A Clinical Study to Evaluate the Safety and Efficacy of GT802 Injection in the Treatment of Relapsing/Refractory Multiple Sclerosis", "status": "NOT_YET_RECRUITING", "start": "2026-10-28", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Daishi Tian", "conditions": ["Multiple Sclerosis (MS)"], "cn_sites": [{"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07327164", "title": "Precision Medicine for Neurocutaneous Syndromes in Western China", "status": "COMPLETED", "start": "2000-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1200, "sponsor": "West China Hospital", "conditions": ["Neurocutaneous Syndromes", "Neurofibromatosis Type 1 (NF1)", "Tuberous Sclerosis Complex (TSC)", "Sturge-Weber Syndrome (SWS)", "Von Hippel-Lindau Disease"], "cn_sites": [{"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00818103", "title": "Characteristic Study on Chinese Patients With Multiple Sclerosis", "status": "UNKNOWN", "start": "2006-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 600, "sponsor": "Sun Yat-sen University", "conditions": ["Multiple Sclerosis"], "cn_sites": [{"facility": "Department of Neurology, The Third Affilated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00370071", "title": "Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250µg in Patients of Chinese Origin With Multiple Sclerosis", "status": "COMPLETED", "start": "2006-11", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 39, "sponsor": "Bayer", "conditions": ["Multiple Sclerosis"], "cn_sites": [{"facility": "", "city": "Beijing", "status": ""}, {"facility": "", "city": "Shanghai", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT00787657", "title": "Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment", "status": "COMPLETED", "start": "2008-06", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1723, "sponsor": "Bayer", "conditions": ["Relapsing Remitting Multiple Sclerosis (RRMS)"], "cn_sites": [{"facility": "", "city": "Many Locations", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00751881", "title": "An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis", "status": "COMPLETED", "start": "2008-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1169, "sponsor": "Sanofi", "conditions": ["Multiple Sclerosis"], "cn_sites": [{"facility": "Sanofi-Aventis Investigational Site Number 156023", "city": "Baotou", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156031", "city": "Beijing", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156006", "city": "Beijing", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156010", "city": "Beijing", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156005", "city": "Beijing", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156032", "city": "Beijing", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156024", "city": "Beijing", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156030", "city": "Beijing", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156001", "city": "Beijing", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156008", "city": "Beijing", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156007", "city": "Changchun", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156002", "city": "Chengdu", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156025", "city": "Guangzhou", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156012", "city": "Guangzhou", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156027", "city": "Haikou", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156021", "city": "Hangzhou", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156033", "city": "Jinan", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156034", "city": "Nanjing", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156011", "city": "Nanjing", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156019", "city": "Qingdao", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156029", "city": "Shanghai", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156016", "city": "Shanghai", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156009", "city": "Shenyang", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156022", "city": "Shijiazhuang", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156018", "city": "Suzhou", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156028", "city": "Taiyuan", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156003", "city": "Tianjin", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156035", "city": "Tianjin", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156017", "city": "Wenzhou", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156004", "city": "Wuhan", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156014", "city": "Xi'an", "status": ""}, {"facility": "Sanofi-Aventis Investigational Site Number 156015", "city": "Xi'an", "status": ""}], "cn_site_count": 32, "broad_only": false}, {"nct": "NCT01364246", "title": "Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis Optica", "status": "UNKNOWN", "start": "2010-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Shenzhen Beike Bio-Technology Co., Ltd.", "conditions": ["Progressive Multiple Sclerosis", "Neuromyelitis Optica."], "cn_sites": [{"facility": "Nanjing University Medical College Affiliated Drum Tower Hospital", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04952246", "title": "Clinical Isolation Syndrome of Spinal Cord and Multiple Sclerosis", "status": "UNKNOWN", "start": "2010-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 150, "sponsor": "Peking University Third Hospital", "conditions": ["Clinical Isolation Syndrome of Spinal Cord", "Multiple Sclerosis"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01181115", "title": "Avonex Safety and Tolerability in Chinese Subjects With Relapsing Multiple Sclerosis (MS)", "status": "COMPLETED", "start": "2010-04", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Biogen", "conditions": ["Multiple Sclerosis"], "cn_sites": [{"facility": "Research Site", "city": "Baotou", "status": ""}, {"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Changchun", "status": ""}, {"facility": "Research Site", "city": "Chengdu", "status": ""}, {"facility": "Research Site", "city": "Guangzhou", "status": ""}, {"facility": "Research Site", "city": "Hangzhou", "status": ""}, {"facility": "Research Site", "city": "Nanchang", "status": ""}, {"facility": "Research Site", "city": "Shanghai", "status": ""}, {"facility": "Research Site", "city": "Taiyuan", "status": ""}, {"facility": "Research Site", "city": "Xi'an", "status": ""}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT01436838", "title": "China Betaferon Adherence, Coping and Nurse Support Study", "status": "COMPLETED", "start": "2012-03", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 110, "sponsor": "Bayer", "conditions": ["Multiple Sclerosis, Chronic Progressive"], "cn_sites": [{"facility": "", "city": "Many Locations", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01665144", "title": "Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)", "status": "COMPLETED", "start": "2012-12-20", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1651, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Secondary Progressive Multiple Sclerosis"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Changchun", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Taiyuan", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Xi’an", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Chengdu", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT02046629", "title": "A Study to Evaluate the Pharmacokinetic Profiles of Single 14 mg Teriflunomide Tablet in Healthy Chinese Volunteers", "status": "COMPLETED", "start": "2014-05", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Sanofi", "conditions": ["Multiple Sclerosis"], "cn_sites": [{"facility": "Investigational Site Number 156001", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02201108", "title": "Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis", "status": "COMPLETED", "start": "2014-07-16", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 166, "sponsor": "Genzyme, a Sanofi Company", "conditions": ["Multiple Sclerosis"], "cn_sites": [{"facility": "Investigational Site Number : 156001", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 156002", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 156010", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 156006", "city": "Changchun", "status": ""}, {"facility": "Investigational Site Number : 156007", "city": "Changsha", "status": ""}, {"facility": "Investigational Site Number : 156008", "city": "Chengdu", "status": ""}, {"facility": "Investigational Site Number : 156005", "city": "Chongqing", "status": ""}, {"facility": "Investigational Site Number : 156012", "city": "Guangzhou", "status": ""}, {"facility": "Investigational Site Number : 156003", "city": "Shanghai", "status": ""}, {"facility": "Investigational Site Number : 156004", "city": "Shanghai", "status": ""}, {"facility": "Investigational Site Number : 156011", "city": "Shijiazhuang", "status": ""}, {"facility": "Investigational Site Number : 156009", "city": "Taiyuan", "status": ""}], "cn_site_count": 12, "broad_only": false}, {"nct": "NCT02836327", "title": "Multimodel Magnetic Resonance Imaging (MRI)of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders", "status": "UNKNOWN", "start": "2014-09", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 300, "sponsor": "Chinese PLA General Hospital", "conditions": ["Multiple Sclerosis", "Neuromyelitis Optica Spectrum Disorders"], "cn_sites": [{"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03363763", "title": "Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex", "status": "TERMINATED", "start": "2017-04-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Aucta Pharmaceuticals, Inc", "conditions": ["Angiofibroma of Face", "Tuberous Sclerosis"], "cn_sites": [{"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03356769", "title": "Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex", "status": "UNKNOWN", "start": "2017-11-20", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 98, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Tuberous Sclerosis Complex", "Aspirin", "Epilepsy", "Cognitive Decline", "Skin Lesions"], "cn_sites": [{"facility": "Department of Neurology, Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03650452", "title": "A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies", "status": "COMPLETED", "start": "2018-08-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 141, "sponsor": "Takeda", "conditions": ["Epilepsy", "Dravet Syndrome", "Lennox-Gastaut Syndrome"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Capital Medical University (CMU) - Beijing Children's Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Children's Hospital,Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT03525834", "title": "Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.", "status": "COMPLETED", "start": "2018-11-09", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Renal Angiomyolipoma"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Wuhan", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Chengdu", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT04198207", "title": "The Effectiveness and Safety of Vagus Nerve Stimulation for TRE", "status": "COMPLETED", "start": "2019-12-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 70, "sponsor": "Beijing Children's Hospital", "conditions": ["Tuberous Sclerosis Complex", "Epilepsy"], "cn_sites": [{"facility": "Beijing Children's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04198181", "title": "The Effectiveness and Safety of Resective Epilepsy Surgery for TRE", "status": "ACTIVE_NOT_RECRUITING", "start": "2019-12-12", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Beijing Children's Hospital", "conditions": ["Tuberous Sclerosis Complex", "Epilepsy"], "cn_sites": [{"facility": "Beijing Children's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04521439", "title": "Accurate Diagnosis of Multiple Sclerosis Using PET/MR", "status": "COMPLETED", "start": "2020-02-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 49, "sponsor": "Ruijin Hospital", "conditions": ["Multiple Sclerosis"], "cn_sites": [{"facility": "Shanghai Ruijin Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04410965", "title": "Evaluation of the Relationship Between ABCG2 Mutation and Teriflunomide Exposure and Safety in Chinese RMS Patients Treated With Teriflunomide 14 mg Once Daily for 24 Weeks", "status": "COMPLETED", "start": "2020-05-20", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 82, "sponsor": "Sanofi", "conditions": ["Multiple Sclerosis"], "cn_sites": [{"facility": "Investigational Site Number", "city": "China", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04950933", "title": "The Treatment of Amyotrophic Lateral Sclerosis With Huollingshengji Granules", "status": "UNKNOWN", "start": "2020-06-01", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 144, "sponsor": "Peking University Third Hospital", "conditions": ["Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04410978", "title": "Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1)", "status": "COMPLETED", "start": "2020-06-30", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 974, "sponsor": "Sanofi", "conditions": ["Relapsing Multiple Sclerosis"], "cn_sites": [{"facility": "Investigational Site Number :1560022", "city": "Baotou", "status": ""}, {"facility": "Investigational Site Number :1560006", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number :1560010", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number :1560012", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number :1560023", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number :1560001", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number :1560009", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number :1560025", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number :1560021", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number :1560004", "city": "Changchun", "status": ""}, {"facility": "Investigational Site Number :1560015", "city": "Changsha", "status": ""}, {"facility": "Investigational Site Number :1560005", "city": "Chengdu", "status": ""}, {"facility": "Investigational Site Number :1560019", "city": "Chongqing", "status": ""}, {"facility": "Investigational Site Number :1560035", "city": "Fuzhou", "status": ""}, {"facility": "Investigational Site Number :1560016", "city": "Guangzhou", "status": ""}, {"facility": "Investigational Site Number :1560028", "city": "Guangzhou", "status": ""}, {"facility": "Investigational Site Number :1560002", "city": "Guangzhou", "status": ""}, {"facility": "Investigational Site Number :1560027", "city": "Hohhot", "status": ""}, {"facility": "Investigational Site Number :1560044", "city": "Nanjing", "status": ""}, {"facility": "Investigational Site Number :1560042", "city": "Nanjing", "status": ""}, {"facility": "Investigational Site Number :1560003", "city": "Shanghai", "status": ""}, {"facility": "Investigational Site Number :1560018", "city": "Shenyang", "status": ""}, {"facility": "Investigational Site Number :1560014", "city": "Shijiazhuang", "status": ""}, {"facility": "Investigational Site Number :1560008", "city": "Taiyuan", "status": ""}, {"facility": "Investigational Site Number :1560020", "city": "Tianjin", "status": ""}, {"facility": "Investigational Site Number :1560011", "city": "Wuhan", "status": ""}, {"facility": "Investigational Site Number :1560017", "city": "Xi'an", "status": ""}, {"facility": "Investigational Site Number :1560033", "city": "Yinchuan", "status": ""}], "cn_site_count": 28, "broad_only": false}, {"nct": "NCT04458051", "title": "Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)", "status": "COMPLETED", "start": "2020-08-13", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 767, "sponsor": "Sanofi", "conditions": ["Primary Progressive Multiple Sclerosis"], "cn_sites": [{"facility": "Investigational Site Number : 1560003", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560012", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560009", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560025", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560004", "city": "Changchun", "status": ""}, {"facility": "Investigational Site Number : 1560015", "city": "Changsha", "status": ""}, {"facility": "Investigational Site Number : 1560005", "city": "Chengdu", "status": ""}, {"facility": "Investigational Site Number : 1560035", "city": "Fuzhou", "status": ""}, {"facility": "Investigational Site Number : 1560002", "city": "Guangzhou", "status": ""}, {"facility": "Investigational Site Number : 1560027", "city": "Hohhot", "status": ""}, {"facility": "Investigational Site Number : 1560001", "city": "Shanghai", "status": ""}, {"facility": "Investigational Site Number : 1560008", "city": "Taiyuan", "status": ""}, {"facility": "Investigational Site Number : 1560026", "city": "Wenzhou", "status": ""}], "cn_site_count": 13, "broad_only": false}, {"nct": "NCT04411641", "title": "Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES)", "status": "COMPLETED", "start": "2020-09-24", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1131, "sponsor": "Sanofi", "conditions": ["Non-relapsing Secondary Progressive Multiple Sclerosis"], "cn_sites": [{"facility": "Investigational Site Number :1560006", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number :1560012", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number :1560021", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number :1560003", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number :1560009", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number :1560004", "city": "Changchun", "status": ""}, {"facility": "Investigational Site Number :1560015", "city": "Changsha", "status": ""}, {"facility": "Investigational Site Number :1560005", "city": "Chengdu", "status": ""}, {"facility": "Investigational Site Number :1560019", "city": "Chongqing", "status": ""}, {"facility": "Investigational Site Number :1560035", "city": "Fuzhou", "status": ""}, {"facility": "Investigational Site Number :1560001", "city": "Guangzhou", "status": ""}, {"facility": "Investigational Site Number :1560007", "city": "Hangzhou", "status": ""}, {"facility": "Investigational Site Number :1560014", "city": "Shijiazhuang", "status": ""}, {"facility": "Investigational Site Number :1560008", "city": "Taiyuan", "status": ""}, {"facility": "Investigational Site Number :1560017", "city": "Xi'an", "status": ""}], "cn_site_count": 15, "broad_only": false}, {"nct": "NCT06443333", "title": "National, Multicentric Registry Study on Neuroimmunological Diseases in China", "status": "UNKNOWN", "start": "2020-12-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 7000, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Multiple Sclerosis", "NMO Spectrum Disorder", "Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease", "Myasthenia Gravis", "Autoimmune Encephalitis", "Acute Disseminated Encephalomyelitis"], "cn_sites": [{"facility": "Xuanwu Hospital ,Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04667949", "title": "Study of Efficacy and Safety of Fingolimod (Gilenya) 0.5 mg in Chinese Patients With Relapsing Multiple Sclerosis (RMS) Patients", "status": "COMPLETED", "start": "2021-02-20", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 98, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Relapsing Multiple Sclerosis (RMS)"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Zhengzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Wuhan", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Suzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Changchun", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Chengdu", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Wenzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": ""}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT04711148", "title": "A Phase 2 Study of Orelabrutinib in Patients With Relapsing-Remitting Multiple Sclerosis", "status": "UNKNOWN", "start": "2021-03-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 160, "sponsor": "Beijing InnoCare Pharma Tech Co., Ltd.", "conditions": ["Relapsing Remitting Multiple Sclerosis"], "cn_sites": [{"facility": "The First Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital of Chongqing Medical University", "city": "Yuzhong", "status": ""}, {"facility": "Tongji Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Xiangya Hospital, Central South University", "city": "Changsha", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Shengjing Hospital of China Medical University", "city": "Shengyang", "status": ""}, {"facility": "The 1st Affiliated Hospital of Shanxi Medical University", "city": "Taiyuan", "status": ""}, {"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": ""}, {"facility": "The Second Affiliated Hospital of Air Force Military Medical University", "city": "Xi’an", "status": ""}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "The Second Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 13, "broad_only": false}, {"nct": "NCT04586010", "title": "A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-03-17", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 746, "sponsor": "Hoffmann-La Roche", "conditions": ["Relapsing Multiple Sclerosis"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Tiantan Hospital,Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "the First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": ""}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "The First Affiliated Hospital, Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "The First Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "The second Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "The affiliated Hospital of Guiyang Medical College", "city": "Guiyang", "status": ""}, {"facility": "The First People?s Hospital of Yunnan Province", "city": "Kunming", "status": ""}, {"facility": "The Second Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "1st Affiliated Hospital of Shanxi Medical University", "city": "Taiyuan", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "Xinjiang People Hospital", "city": "Ürümqi", "status": ""}, {"facility": "Tongji Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Tangdu Hospital, The Fourth Military Medical University", "city": "Xi'an", "status": ""}], "cn_site_count": 17, "broad_only": false}, {"nct": "NCT04625153", "title": "RC18 in Patients With Relapsing Remitting Multiple Sclerosis：a Phase II Trial", "status": "TERMINATED", "start": "2021-05-13", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 8, "sponsor": "RemeGen Co., Ltd.", "conditions": ["Multiple Sclerosis, Relapsing-Remitting"], "cn_sites": [{"facility": "the Third Affiliated Hospital,Sun Yat-Sen University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05297474", "title": "Structural and Functional Impairment of Multiple Organs in Patients With Systemic Sclerosis: A MR Imaging Study", "status": "UNKNOWN", "start": "2021-07-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 95, "sponsor": "Tsinghua University", "conditions": ["Systemic Sclerosis", "Multisystem Disorder"], "cn_sites": [{"facility": "Huilin He", "city": "Beijing", "status": "RECRUITING"}, {"facility": "China Center for Biomedical Imaging Research, Department of Biomedical Engineering, Tsinghua University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05083923", "title": "A Study of Diroximel Fumarate (DRF) in Adult Participants From the Asia-Pacific Region With Relapsing Forms of Multiple Sclerosis (RMS)", "status": "COMPLETED", "start": "2021-11-18", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 136, "sponsor": "Biogen", "conditions": ["Relapsing Forms of Multiple Sclerosis"], "cn_sites": [{"facility": "The First Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": ""}, {"facility": "Beijing Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Lanzhou University Second Hospital", "city": "Lanzhou", "status": ""}, {"facility": "Dongguan People's Hospital", "city": "Dongguan", "status": ""}, {"facility": "The First Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "Guangzhou First People's Hospital", "city": "Guangzhou", "status": ""}, {"facility": "The Second Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Nanfang Hospital of Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "The Third Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "Tangshan Gongren Hospital", "city": "Tangshan", "status": ""}, {"facility": "The First Affiliated Hospital of Harbin Medical University", "city": "Harbin", "status": ""}, {"facility": "The Second Affiliated Hospital of Harbin Medical University", "city": "Harbin", "status": ""}, {"facility": "Xiangya Hospital, Central South University", "city": "Changsha", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology", "city": "Wuhan", "status": ""}, {"facility": "The Affiliated Hospital of Inner Mongolia Medical University", "city": "Hohhot", "status": ""}, {"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "Jiangxi Provincial People's Hospital", "city": "Nanchang", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Shengjing Hospital of China Medical University", "city": "Shengyang", "status": ""}, {"facility": "General Hospital of Ningxia Medical University", "city": "Yinchuan", "status": ""}, {"facility": "Tangdu Hospital, Fourth Military Medical University", "city": "Xi'an", "status": ""}, {"facility": "Renji Hospital Shanghai Jiaotong University School of Medicine - West Branch", "city": "Shanghai", "status": ""}, {"facility": "Shanxi Provincial People's Hospital", "city": "Taiyuan", "status": ""}, {"facility": "Sichuan Provincial People's Hospital", "city": "Chengdu", "status": ""}, {"facility": "Tianjin Medical University Affiliated General Hospital", "city": "Tianjin", "status": ""}, {"facility": "First Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}], "cn_site_count": 29, "broad_only": false}, {"nct": "NCT05156281", "title": "Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2)", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-12-13", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1007, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Relapsing Multiple Sclerosis"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Wuhan", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Nanjing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Yinchuan", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Taiyuan", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Hangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Wenzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": ""}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT05147220", "title": "Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-12-16", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1000, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Relapsing Multiple Sclerosis"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Zhengzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Changsha", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Baotou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Hohhot", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Nanchang", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Changchun", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Chongqing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Tianjin", "status": ""}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT05323734", "title": "Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy", "status": "COMPLETED", "start": "2022-04-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 129, "sponsor": "Marinus Pharmaceuticals", "conditions": ["Tuberous Sclerosis Complex"], "cn_sites": [{"facility": "First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Jiangxi Provincial Children's Hospital", "city": "Jiangxi", "status": ""}, {"facility": "Beijing Children Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "The Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": ""}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "Chengdu's Women and Children's Central Hospital", "city": "Chengdu", "status": ""}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT05432713", "title": "A Study of LP-168 in Healthy Volunteers", "status": "COMPLETED", "start": "2022-05-14", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 70, "sponsor": "Guangzhou Lupeng Pharmaceutical Company LTD.", "conditions": ["Multiple Sclerosis", "NMO Spectrum Disorder"], "cn_sites": [{"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05604170", "title": "Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy", "status": "TERMINATED", "start": "2022-05-16", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 117, "sponsor": "Marinus Pharmaceuticals", "conditions": ["Tuberous Sclerosis Complex"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Children Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "The Affiliated Hospital of Guizhou Medical University", "city": "Beijing", "status": ""}, {"facility": "First Hospital of Jilin University", "city": "Jilin City", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT05199571", "title": "Study of Efficacy and Safety of Ofatumumab in Relapsing Multiple Sclerosis (RMS) Patients in China", "status": "COMPLETED", "start": "2022-07-22", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 99, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Relapsing Multiple Sclerosis"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Lanzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shijiazhuang", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Harbin", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Wuhan", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Suzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shenyang", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Taiyuan", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Ürümqi", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Hangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shenzhen", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Tianjin", "status": ""}], "cn_site_count": 14, "broad_only": false}, {"nct": "NCT05496894", "title": "A Study of Mitoxantrone Hydrochloride Liposome Injection for Relapsing Multiple Sclerosis", "status": "WITHDRAWN", "start": "2022-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.", "conditions": ["Relapsing Multiple Sclerosis"], "cn_sites": [{"facility": "Xuanwu Hospital Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05414487", "title": "Effects of Ofatumumab Treatment on Immune Cells and Meningeal Lymphatic Drainage in Patients With Demyelinating Diseases", "status": "UNKNOWN", "start": "2022-10-15", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 34, "sponsor": "Tianjin Medical University General Hospital", "conditions": ["Multiple Sclerosis", "Neuromyelitis Optica Spectrum Disorder", "Demyelinating Diseases of the Central Nervous System"], "cn_sites": [{"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05630547", "title": "A Study to Evaluate the Effect of SAR443820 on Serum Neurofilament Levels in Male and Female Adult Participants With Multiple Sclerosis", "status": "TERMINATED", "start": "2022-12-19", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 174, "sponsor": "Sanofi", "conditions": ["Multiple Sclerosis"], "cn_sites": [{"facility": "Investigational Site Number : 1560003", "city": "Chengdu", "status": ""}, {"facility": "Investigational Site Number : 1560002", "city": "Shanghai", "status": ""}, {"facility": "Investigational Site Number : 1560001", "city": "Tianjin", "status": ""}, {"facility": "Investigational Site Number : 1560004", "city": "Xi'an", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT05658484", "title": "A Study of Dimethyl Fumarate (DMF) in Relapsing Forms of Multiple Sclerosis (RMS) Participants in China", "status": "COMPLETED", "start": "2023-06-09", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Biogen", "conditions": ["Multiple Sclerosis"], "cn_sites": [{"facility": "Beijing Hospital", "city": "Beijing", "status": ""}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "The First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": ""}, {"facility": "The Third Affiliated Hospital of Sun Yat-Sen University", "city": "Guangzhou", "status": ""}, {"facility": "The Second Hospital of Hebei Medical University", "city": "Hebei", "status": ""}, {"facility": "The First People's Hospital of Yunnan Province", "city": "Kunming", "status": ""}, {"facility": "Renji Hospital, Shanghai Jiatong Uni. School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": ""}, {"facility": "The First Hospital of China Medical University", "city": "Shengyang", "status": ""}, {"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Shanxi Medical University", "city": "Taiyuan", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": ""}, {"facility": "Second Affiliated Hospital of Air Force Medical University", "city": "Xi'an", "status": ""}], "cn_site_count": 15, "broad_only": false}, {"nct": "NCT06141473", "title": "Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-12-13", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1655, "sponsor": "Sanofi", "conditions": ["Multiple Sclerosis"], "cn_sites": [{"facility": "Investigational Site Number : 1560007", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560005", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560008", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560003", "city": "Changchun", "status": ""}, {"facility": "Investigational Site Number : 1560011", "city": "Changsha", "status": ""}, {"facility": "Investigational Site Number : 1560004", "city": "Chengdu", "status": ""}, {"facility": "Investigational Site Number : 1561029", "city": "Chengdu", "status": ""}, {"facility": "Investigational Site Number : 1560015", "city": "Chongqing", "status": ""}, {"facility": "Investigational Site Number : 1560020", "city": "Dongguan", "status": ""}, {"facility": "Investigational Site Number : 1561028", "city": "Fuzhou", "status": ""}, {"facility": "Investigational Site Number : 1561026", "city": "Guangzhou", "status": ""}, {"facility": "Investigational Site Number : 1560002", "city": "Guangzhou", "status": ""}, {"facility": "Investigational Site Number : 1561023", "city": "Hangzhou", "status": ""}, {"facility": "Investigational Site Number : 1561027", "city": "Harbin", "status": ""}, {"facility": "Investigational Site Number : 1560019", "city": "Hohhot", "status": ""}, {"facility": "Investigational Site Number : 1560040", "city": "Hohhot", "status": ""}, {"facility": "Investigational Site Number : 1560010", "city": "Jiazhuang", "status": ""}, {"facility": "Investigational Site Number : 1561025", "city": "Jinan", "status": ""}, {"facility": "Investigational Site Number : 1560018", "city": "Nanjing", "status": ""}, {"facility": "Investigational Site Number : 1560001", "city": "Shanghai", "status": ""}, {"facility": "Investigational Site Number : 1560043", "city": "Shanghai", "status": ""}, {"facility": "Investigational Site Number : 1560014", "city": "Shenyang", "status": ""}, {"facility": "Investigational Site Number : 1560030", "city": "Suzhou", "status": ""}, {"facility": "Investigational Site Number : 1560006", "city": "Taiyuan", "status": ""}, {"facility": "Investigational Site Number : 1560012", "city": "Tianjin", "status": ""}, {"facility": "Investigational Site Number : 1560016", "city": "Wenzhou", "status": ""}, {"facility": "Investigational Site Number : 1560009", "city": "Wuhan", "status": ""}, {"facility": "Investigational Site Number : 1560013", "city": "Xi'an", "status": ""}, {"facility": "Investigational Site Number : 1560021", "city": "Yinchuan", "status": ""}], "cn_site_count": 29, "broad_only": false}, {"nct": "NCT06141486", "title": "Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-12-27", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 943, "sponsor": "Sanofi", "conditions": ["Multiple Sclerosis"], "cn_sites": [{"facility": "Investigational Site Number : 1560007", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560005", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560008", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560003", "city": "Changchun", "status": ""}, {"facility": "Investigational Site Number : 1560011", "city": "Changsha", "status": ""}, {"facility": "Investigational Site Number : 1560004", "city": "Chengdu", "status": ""}, {"facility": "Investigational Site Number : 1560045", "city": "Fuzhou", "status": ""}, {"facility": "Investigational Site Number : 1560002", "city": "Guangzhou", "status": ""}, {"facility": "Investigational Site Number : 1561027", "city": "Harbin", "status": ""}, {"facility": "Investigational Site Number : 1560010", "city": "Jiazhuang", "status": ""}, {"facility": "Investigational Site Number : 1560001", "city": "Shanghai", "status": ""}, {"facility": "Investigational Site Number : 1560006", "city": "Taiyuan", "status": ""}, {"facility": "Investigational Site Number : 1560012", "city": "Tianjin", "status": ""}, {"facility": "Investigational Site Number : 1560009", "city": "Wuhan", "status": ""}, {"facility": "Investigational Site Number : 1560013", "city": "Xi'an", "status": ""}, {"facility": "Investigational Site Number : 1560034", "city": "Zhengzhou", "status": ""}], "cn_site_count": 16, "broad_only": false}, {"nct": "NCT06372145", "title": "A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-04-16", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 2500, "sponsor": "Sanofi", "conditions": ["Relapsing Multiple Sclerosis", "Secondary Progressive Multiple Sclerosis", "Progressive Relapsing Multiple Sclerosis"], "cn_sites": [{"facility": "Investigational Site Number : 1560006", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560023", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560009", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560025", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560004", "city": "Changchun", "status": ""}, {"facility": "Investigational Site Number : 1560015", "city": "Changsha", "status": ""}, {"facility": "Investigational Site Number : 1560005", "city": "Chengdu", "status": ""}, {"facility": "Investigational Site Number : 1560019", "city": "Chongqing", "status": ""}, {"facility": "Investigational Site Number : 1560035", "city": "Fuzhou", "status": ""}, {"facility": "Investigational Site Number : 1569903", "city": "Guangzhou", "status": ""}, {"facility": "Investigational Site Number : 1560027", "city": "Hohhot", "status": ""}, {"facility": "Investigational Site Number : 1560044", "city": "Nanjing", "status": ""}, {"facility": "Investigational Site Number : 1560042", "city": "Nanjing", "status": ""}, {"facility": "Investigational Site Number : 1569901", "city": "Shanghai", "status": ""}, {"facility": "Investigational Site Number : 1560018", "city": "Shenyang", "status": ""}, {"facility": "Investigational Site Number : 1560014", "city": "Shijiazhuang", "status": ""}, {"facility": "Investigational Site Number : 1560008", "city": "Taiyuan", "status": ""}, {"facility": "Investigational Site Number : 1560020", "city": "Tianjin", "status": ""}, {"facility": "Investigational Site Number : 1560026", "city": "Wenzhou", "status": ""}, {"facility": "Investigational Site Number : 1560011", "city": "Wuhan", "status": ""}, {"facility": "Investigational Site Number : 1560017", "city": "Xi'an", "status": ""}], "cn_site_count": 21, "broad_only": false}, {"nct": "NCT06396039", "title": "A Study to Assess the Effectiveness and Safety of Ozanimod in Chinese Adults With Relapsing Multiple Sclerosis", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-05-15", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 84, "sponsor": "Bristol-Myers Squibb", "conditions": ["Relapsing Multiple Sclerosis"], "cn_sites": [{"facility": "Local Institution - 0002", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 0012", "city": "Guangzhou", "status": ""}, {"facility": "Local Institution - 0022", "city": "Guangzhou", "status": ""}, {"facility": "Local Institution - 0008", "city": "Shenzhen", "status": ""}, {"facility": "Local Institution - 0004", "city": "Shijiazhuang", "status": ""}, {"facility": "Local Institution - 0006", "city": "Harbin", "status": ""}, {"facility": "Local Institution - 0018", "city": "Zhengzhou", "status": ""}, {"facility": "Local Institution - 0007", "city": "Wuhan", "status": ""}, {"facility": "Local Institution - 0003", "city": "Nanchang", "status": ""}, {"facility": "Local Institution - 0005", "city": "Changchun", "status": ""}, {"facility": "Local Institution - 0015", "city": "Taiyuan", "status": ""}, {"facility": "Local Institution - 0023", "city": "Ürümqi", "status": ""}, {"facility": "Local Institution - 0016", "city": "Shanghai", "status": ""}, {"facility": "Local Institution - 0011", "city": "Chengdu", "status": ""}, {"facility": "Local Institution - 0024", "city": "Kunming", "status": ""}, {"facility": "Local Institution - 0019", "city": "Hangzhou", "status": ""}, {"facility": "Local Institution - 0017", "city": "Wenzhou", "status": ""}, {"facility": "Local Institution - 0009", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 0025", "city": "Fuzhou", "status": ""}, {"facility": "Local Institution - 0010", "city": "Guiyang", "status": ""}, {"facility": "Local Institution - 0013", "city": "Hohhot", "status": ""}, {"facility": "Local Institution - 0014", "city": "Shanghai", "status": ""}, {"facility": "Local Institution - 0021", "city": "Shenyang", "status": ""}, {"facility": "Local Institution - 0001", "city": "Tianjin", "status": ""}, {"facility": "Local Institution - 0020", "city": "Xianyang", "status": ""}], "cn_site_count": 25, "broad_only": false}, {"nct": "NCT06652308", "title": "Mood Disorders in Multiple Sclerosis Patients", "status": "COMPLETED", "start": "2024-07-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 85, "sponsor": "Islamic Azad University, Sanandaj", "conditions": ["Multiple Sclerosis (MS)", "Unipolar Depression", "Bipolar Disorder", "Mood Disorders"], "cn_sites": [{"facility": "Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06564311", "title": "A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-08-26", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 93, "sponsor": "Zenas BioPharma (USA), LLC", "conditions": ["Relapsing Multiple Sclerosis"], "cn_sites": [{"facility": "Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "The First Affiliation Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "People's Hospital of Xinjiang Uyaur Autonomous Region", "city": "Ürümqi", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical Center of HUST", "city": "Wuhan", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT06653283", "title": "Application of Multiparametric Structural and Functional MRI in Unraveling the Substrates of Cognitive Impairment and Disability in Multiple Sclerosis", "status": "UNKNOWN", "start": "2024-10-20", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 104, "sponsor": "Zhuo Wang", "conditions": ["Multiple Sclerosis"], "cn_sites": [{"facility": "MRI", "city": "Lanzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06869278", "title": "A Study of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases", "status": "WITHDRAWN", "start": "2025-06-17", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": ["Multiple Sclerosis (MS)", "Neuromyelitis Optica Spectrum Disease (NMOSD)", "Anti-Myelin Oligodendrocyte Glycoprotein-IgG Associated Disorders (MOGAD)", "Myasthenia Gravis"], "cn_sites": [{"facility": "The Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": ""}, {"facility": "The First Affiliated Hospital of SOOCHOW University", "city": "Suzhou", "status": ""}, {"facility": "Union Hospital Tongji Medical College HUAZHONG University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07483450", "title": "A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Ocrelizumab in Participants With Relapsing Multiple Sclerosis and Primary Progressive Multiple Sclerosis", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-07-04", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Hoffmann-La Roche", "conditions": ["Relapsing Multiple Sclerosis", "Primary Progressive Multiple Sclerosis"], "cn_sites": [{"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Hospital of Ministry of Health", "city": "Beijing", "status": ""}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "The First Affiliated Hospital, Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "The First Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "The Third Affiliated Hospital of Sun Yat-Sen University", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of College of Medicine, Zhejiang University", "city": "Hangzhou", "status": ""}, {"facility": "Inner Mongolia Autonomous Region People's Hospital", "city": "Hohhot", "status": ""}, {"facility": "Lanzhou University Second Hospital", "city": "Lanzhou", "status": ""}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "The Second Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "1st Affiliated Hospital of Shanxi Medical University", "city": "Taiyuan", "status": ""}, {"facility": "Xinjiang People Hospital", "city": "Ürümqi", "status": ""}, {"facility": "Tongji Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 17, "broad_only": false}, {"nct": "NCT07364487", "title": "This is an Open-Label Study to Assess the Safety and Efficacy of GC012F in Patients With Multiple Sclerosis", "status": "WITHDRAWN", "start": "2026-01-26", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Huashan Hospital", "conditions": ["Multiple Sclerosis"], "cn_sites": [{"facility": "Huashan Hospital Affiliated to Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 603, "g_fetched": 188, "g_countries": [["United States", 61], ["France", 20], ["Turkey (Türkiye)", 15], ["Italy", 14], ["Spain", 11], ["Switzerland", 11], ["Germany", 10], ["Australia", 9], ["Canada", 9], ["United Kingdom", 8], ["Sweden", 7], ["Denmark", 7], ["Portugal", 6], ["Poland", 5], ["Belgium", 4], ["Czechia", 4], ["Puerto Rico", 3], ["Netherlands", 3], ["Mexico", 3], ["United Arab Emirates", 2], ["Slovakia", 2], ["Russia", 2], ["Argentina", 2], ["Brazil", 2], ["Ukraine", 2], ["Greece", 2], ["Taiwan", 2], ["Luxembourg", 1], ["Norway", 1], ["Ireland", 1], ["Serbia", 1], ["South Africa", 1], ["Romania", 1], ["Israel", 1], ["Japan", 1], ["South Korea", 1], ["Egypt", 1], ["Hong Kong", 1], ["Martinique", 1]], "g_trials": [{"nct": "NCT07825389", "title": "A Study of C-CAR168 in Participants With Progressive Multiple Sclerosis", "status": "NOT_YET_RECRUITING", "start": "2027-02", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "AbelZeta Inc.", "countries": []}, {"nct": "NCT05179577", "title": "A Study to Investigate Arbaclofen ER Tablets for the Treatment of Spasticity in Patients With Multiple Sclerosis", "status": "NOT_YET_RECRUITING", "start": "2027-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "RVL Pharmaceuticals, Inc.", "countries": []}, {"nct": "NCT04768777", "title": "Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis", "status": "NOT_YET_RECRUITING", "start": "2026-12-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Alabama at Birmingham", "countries": ["United States"]}, {"nct": "NCT07809828", "title": "Driving Performance in Parkinson's Disease and Multiple Sclerosis Using a Driving Simulator", "status": "NOT_YET_RECRUITING", "start": "2026-11-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital Olomouc", "countries": []}, {"nct": "NCT07782450", "title": "A Study to Learn About a Medicine Called PF-08154225 in Participants With Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-10-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Pfizer", "countries": []}, {"nct": "NCT07826689", "title": "A Phase 1/2a Study of Oral PRO-1562 in Healthy Subjects and Patients With Relapsing Multiple Sclerosis", "status": "NOT_YET_RECRUITING", "start": "2026-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Progentos Therapeutics", "countries": ["Australia"]}, {"nct": "NCT07606521", "title": "A Biosimilar Trial to Investigate PK, PD, Safety With PB018 Versus US-licensed Ocrevus and EU-approved Ocrevus", "status": "NOT_YET_RECRUITING", "start": "2026-10", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Polpharma Biologics International AG", "countries": []}, {"nct": "NCT07815990", "title": "Aerobic Fitness in Multiple Sclerosis: The Relationship Between Balance and Sensory Dual-Tasking", "status": "NOT_YET_RECRUITING", "start": "2026-09-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Suleyman Demirel University", "countries": []}, {"nct": "NCT07804004", "title": "A Safety and Efficacy Study Evaluating CTX112 in Subjects With Refractory Neurologic Autoimmune Disease", "status": "NOT_YET_RECRUITING", "start": "2026-09-15", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "CRISPR Therapeutics", "countries": []}, {"nct": "NCT07741864", "title": "Effectiveness of a Mindfulness-Based Intervention for Pain Management in Patients With Multiple Sclerosis (MPIMS).", "status": "NOT_YET_RECRUITING", "start": "2026-09-02", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Hospital Universitario Virgen Macarena", "countries": ["Spain"]}, {"nct": "NCT07609719", "title": "A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy", "status": "RECRUITING", "start": "2026-09-02", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Genentech, Inc.", "countries": ["Puerto Rico", "United States"]}, {"nct": "NCT07517185", "title": "The HIt HArd and hiT Early in Multiple Sclerosis Trial", "status": "RECRUITING", "start": "2026-09-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Uppsala University", "countries": ["Sweden"]}, {"nct": "NCT07680322", "title": "A Phase 2 Study of the Safety and Efficacy of AV078 in Participants With Tuberous Sclerosis Complex (TSC) Refractory Epilepsy", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Aeovian Pharmaceuticals, Inc.", "countries": []}, {"nct": "NCT07555379", "title": "Bilateral Anodal Cerebellar tDCS for Multidomain Dysfunctions in Patients With Multiple Sclerosis", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Sharjah", "countries": ["United Arab Emirates"]}, {"nct": "NCT07771868", "title": "High-Intensity Interval Training for Walking and Function Across Different Multiple Sclerosis Disability Levels", "status": "RECRUITING", "start": "2026-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Hacettepe University", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT07221799", "title": "OER Glibenclamide for Neuropathic Pain in Multiple Sclerosis", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "University of Maryland, Baltimore", "countries": ["United States"]}, {"nct": "NCT07765212", "title": "Evaluating the Use of Oral Indapamide to Reduce Disabiltiy Progression in Progressive Multiple Sclerosis (MS)", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Eva M.M. Strijbis", "countries": []}, {"nct": "NCT07606742", "title": "Delivery of a Culturally Tailored Exercise Training Intervention for Hispanics With Multiple Sclerosis", "status": "RECRUITING", "start": "2026-08-24", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "The University of Texas Health Science Center, Houston", "countries": ["United States"]}, {"nct": "NCT07759115", "title": "Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study", "status": "RECRUITING", "start": "2026-08-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Texas at Austin", "countries": ["United States"]}, {"nct": "NCT07786506", "title": "Intermittent Theta-Burst Stimulation for Lower-Limb Spasticity and Pain in Multiple Sclerosis", "status": "NOT_YET_RECRUITING", "start": "2026-08-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Comenius University", "countries": ["Slovakia"]}, {"nct": "NCT07434934", "title": "Augmented Reality-Based Dual-Task Training in People With Multiple Sclerosis", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Sharjah", "countries": ["United Arab Emirates"]}, {"nct": "NCT07672535", "title": "Inspiratory Muscle Training in Individuals With Multiple Sclerosis", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Istanbul University - Cerrahpasa", "countries": []}, {"nct": "NCT07643974", "title": "Coupled Gentamicin-Lactobacillus Rhamnosus in NLUTD", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Medstar Health Research Institute", "countries": ["United States"]}, {"nct": "NCT07742579", "title": "Online Mindfulness-Based Cognitive Therapy for People With Multiple Sclerosis With Mild-Moderate Depression", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Robert Simpson", "countries": []}, {"nct": "NCT07788573", "title": "The Role of the FCRL5 Protein in the Pathophysiology of Multiple Sclerosis and Response to Treatment", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Université Catholique de Louvain", "countries": ["Belgium"]}]}, {"batch": 1, "no": 77, "name_zh": "多系统萎缩", "query_terms": [{"term": "Multiple system atrophy", "broad": false}], "n_total": 46, "n_open": 25, "n_open_precise": 25, "n_broad": 0, "trials": [{"nct": "NCT04912843", "title": "Gene Therapy Clinical Trial for the Treatment Of Leber's HereDitary Optic Neuropathy", "status": "RECRUITING", "start": "2021-06-18", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 102, "sponsor": "Wuhan Neurophth Biotechnology Limited Company", "conditions": ["Leber's Hereditary Optic Neuropathy (LHON)"], "cn_sites": [{"facility": "Beijing Tongren Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06101940", "title": "Chinese Multicenter Clinical Outcome Cohort Study of Myotonic Dystrophy Type 1 (C-DMCOS-DM1)", "status": "ENROLLING_BY_INVITATION", "start": "2021-08-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "Huashan Hospital", "conditions": ["Myotonic Dystrophy 1"], "cn_sites": [{"facility": "Chinese People's Liberation Army General Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "First Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Southern Hospital of Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "The Third Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "Wuhan University People's Hospital", "city": "Wuhan", "status": ""}, {"facility": "Zhongda Hospital Southeast University", "city": "Nanjing", "status": ""}, {"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "The First People's Hospital of Yancheng", "city": "Yancheng", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University）", "city": "Nanchang", "status": ""}, {"facility": "The First Bethune Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Chifeng Municipal Hospital", "city": "Chifeng", "status": ""}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "First Hospital of Shanxi Medical University", "city": "Taiyuan", "status": ""}, {"facility": "Xi'an Gaoxin Hospital", "city": "Xi’an", "status": ""}, {"facility": "Xi'an People's Hospital", "city": "Xi’an", "status": ""}, {"facility": "Sichuan Provincial People's Hospital", "city": "Chengdu", "status": ""}, {"facility": "The General Hospital of Western Theater Command", "city": "Chengdu", "status": ""}, {"facility": "Yunnan Provincial People's Hospital", "city": "Kunming", "status": ""}, {"facility": "Huashan Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 22, "broad_only": false}, {"nct": "NCT05824169", "title": "Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 1 Patients", "status": "RECRUITING", "start": "2023-02-25", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "GeneCradle Inc", "conditions": ["Spinal Muscular Atrophy"], "cn_sites": [{"facility": "Peking University， First Hospital, Department of Pediatrics", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Bayi Children's Hospital, Seventh Medical Center, PLA general hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Shengjing Hospital of China Medical University", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Children's Hospital of Soochow University", "city": "Suzhou", "status": "RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT07392411", "title": "Study on Artificial Intelligence-Based Facial and Speech-Related Patterns in Parkinson's Disease and Their Digital Biomarkers", "status": "RECRUITING", "start": "2023-07-25", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 720, "sponsor": "Beijing Tiantan Hospital", "conditions": ["Parkinson's Disease", "Progressive Supranuclear Palsy(PSP)", "Multiple System Atrophy", "Healthy Control"], "cn_sites": [{"facility": "首都医科大学附属北京天坛医院", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06421831", "title": "Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 3 Patients", "status": "RECRUITING", "start": "2024-05-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 21, "sponsor": "GeneCradle Inc", "conditions": ["Spinal Muscular Atrophy Type 3"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06949865", "title": "AI-Enhanced Optimization of Acute Levodopa Challenge Test", "status": "RECRUITING", "start": "2024-05-28", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2000, "sponsor": "Beijing Tiantan Hospital", "conditions": ["Vascular Parkinsonism", "Drug-induced Parkinsonism", "Corticobasal Degeneration (CBD)", "Parkinson Disease (PD)", "Dementia With Lewy Body Disease", "Progressive Supranuclear Palsy(PSP)", "Multiple System Atrophy (MSA)"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Affiliated to Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07353463", "title": "Shanghai Clinical Cohort - Parkinson's Disease (Reserve)", "status": "RECRUITING", "start": "2025-04-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 700, "sponsor": "Ruijin Hospital", "conditions": ["Parkinson's Disease (PD)", "Multiple System Atrophy"], "cn_sites": [{"facility": "Department of neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06765733", "title": "The Study of Safety and Preliminary Efficacy of Aleeto in Patients With MultIple System Atrophy", "status": "RECRUITING", "start": "2025-05-31", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Beijing Tiantan Hospital", "conditions": ["Multiple System Atrophy - Parkinsonian Subtype (MSA-P)", "Multiple System Atrophy, MSA"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07644013", "title": "Prospective Multicenter Registry Study of Multiple System Atrophy in China", "status": "RECRUITING", "start": "2025-06-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 214, "sponsor": "Peking University First Hospital", "conditions": ["Multiple System Atrophy", "Parkinson's Disease", "Atypical Parkinsonism"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06607900", "title": "hUC-MSC-sEV-001 Nasal Drops for Neurodegenerative Diseases", "status": "NOT_YET_RECRUITING", "start": "2025-07-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Alzheimer Disease", "Parkinson Disease", "Lewy Body Dementia", "Multiple System Atrophy", "Fronto-temporal Dementia", "Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Xuanwu Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07036939", "title": "Efficacy and Safety of Bilateral Cervical Lymphatic-Venous Anastomosis in the Treatment of Multiple System Atrophy", "status": "NOT_YET_RECRUITING", "start": "2025-07-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 46, "sponsor": "Ruijin Hospital", "conditions": ["Multiple System Atrophy"], "cn_sites": [{"facility": "Ruijin Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07805967", "title": "Multi-Center Study of Natural History in Atypical Parkinsonian Syndromes (MAPS-NH)", "status": "RECRUITING", "start": "2025-11-12", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Second Affiliated Hospital of Soochow University", "conditions": ["Multiple System Atrophy", "Dementia With Lewy Bodies (DLB)", "Progressive Supranuclear Palsy (PSP)", "Corticobasal Degeneration (CBD)"], "cn_sites": [{"facility": "Changshu Hospital Affiliated to Nanjing University of Chinese Medicine", "city": "Changshu", "status": "RECRUITING"}, {"facility": "The second People's Hospital of Huai'an", "city": "Huai'an", "status": "NOT_YET_RECRUITING"}, {"facility": "The First People's Hospial of Kunshan", "city": "Kunshan", "status": "NOT_YET_RECRUITING"}, {"facility": "Jiangsu Province Official Hospital", "city": "Nanjing", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Affiliated Hospital of Nantong University", "city": "Nantong", "status": "NOT_YET_RECRUITING"}, {"facility": "Jiangsu Province (Suqian) Hospital", "city": "Suqian", "status": "RECRUITING"}, {"facility": "The Forth Affiliated Hospital of Soochow University", "city": "Suzhou", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Soochow University", "city": "Suzhou", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Xuzhou Medical University", "city": "Xuzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Yancheng Third People's Hospital", "city": "Yancheng", "status": "RECRUITING"}, {"facility": "Affiliated Hospital of Yangzhou University", "city": "Yangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine/Zhangjiagang Traditional Chinese Medicine Hospital", "city": "Zhangjiagang", "status": "NOT_YET_RECRUITING"}, {"facility": "The Forth People's Hospital of Zhenjiang", "city": "Zhenjiang", "status": "RECRUITING"}, {"facility": "Yantai Yuhuangding Hospital", "city": "Yantai", "status": "NOT_YET_RECRUITING"}, {"facility": "Mianyang 404 Hospital", "city": "Mianyang", "status": "NOT_YET_RECRUITING"}, {"facility": "Jiaxing Second Hospital", "city": "Jiaxing", "status": "NOT_YET_RECRUITING"}, {"facility": "Deyang People's Hospital", "city": "Deyang", "status": "NOT_YET_RECRUITING"}, {"facility": "Changxing people' s hospital", "city": "Huzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Affiliated Hospital of Nantong University", "city": "Nantong", "status": "NOT_YET_RECRUITING"}, {"facility": "The Affiliated Hospital of Xuzhou Medical University", "city": "Xuzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 20, "broad_only": false}, {"nct": "NCT07570212", "title": "Individualized Transcranial Magnetic Stimulation in Parkinsonian Disorders", "status": "RECRUITING", "start": "2025-12-22", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Peking University First Hospital", "conditions": ["Parkinson's Disease", "Multiple System Atrophy", "Progressive Supranuclear Palsy"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07289477", "title": "A Phase I/III Clinical Study to Evaluate NouvNeu001 Injection for Multiple System Atrophy", "status": "RECRUITING", "start": "2026-01-05", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "iRegene Therapeutics Co., Ltd.", "conditions": ["Multiple System Atrophy - Parkinsonian Subtype (MSA-P)"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07336446", "title": "A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs", "status": "RECRUITING", "start": "2026-01-27", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 300, "sponsor": "AstraZeneca", "conditions": ["Prostate Cancer"], "cn_sites": [{"facility": "Research Site", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07476456", "title": "Skeletal Muscle Multi-omics Analysis and Risk Tailoring in Sudden Cardiac Death", "status": "NOT_YET_RECRUITING", "start": "2026-03-16", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 421, "sponsor": "China National Center for Cardiovascular Diseases", "conditions": ["Sudden Cardiac Death"], "cn_sites": [{"facility": "Beilishi Road 167", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07519837", "title": "Study on the Pathogenesis and Reversal Strategies of Cancer Cachexia Based on Multi-Omics", "status": "RECRUITING", "start": "2026-03-18", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 1000, "sponsor": "China Medical University, China", "conditions": ["Cachexia; Cancer; Sarcopenia"], "cn_sites": [{"facility": "The First Affiliated Hospital of China Medical University", "city": "Shenyang", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07554807", "title": "A Randomized, Double-blind, Placebo-controlled, Prospective, Multi-center Trial Evaluating the Improvement of Nutritional Status and Sarcopenia With Silkworm Pupa Tablets in Patients With Malignancies", "status": "NOT_YET_RECRUITING", "start": "2026-04-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 480, "sponsor": "First Affiliated Hospital of Zhejiang University", "conditions": ["Nutritional Deficiency", "Gastrointestinal Cancers", "Sarcopenia"], "cn_sites": [{"facility": "Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University", "city": "Hangzhou", "status": ""}, {"facility": "The First Affiliated Hospital, College of Medicine, Zhejiang University", "city": "Hangzhou", "status": ""}, {"facility": "The Second Affiliated Hospital, College of Medicine, Zhejiang University", "city": "Hangzhou", "status": ""}, {"facility": "Hangzhou Institute of Medicine Chinese Academy of Sciences", "city": "Hangzhou", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT07518810", "title": "Efficacy and Safety of Butylphthalide in the Treatment of Multiple System Atrophy", "status": "NOT_YET_RECRUITING", "start": "2026-04-10", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 150, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Multiple System Atrophy"], "cn_sites": [{"facility": "The First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": ""}, {"facility": "HuZhou Central Hospital", "city": "Huzhou", "status": ""}, {"facility": "The Second Hospital of Jiaxing", "city": "Jiaxing", "status": ""}, {"facility": "Ningbo Second Hospital", "city": "Ningbo", "status": ""}, {"facility": "Taizhou Hospital of Zhejiang Province", "city": "Taizhou", "status": ""}, {"facility": "Affiliated Beijing Chaoyang Hospital of Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT07670286", "title": "Spatial Multi-omics and Intelligent Early Warning of Pancreatic Cancer Cachexia", "status": "RECRUITING", "start": "2026-04-24", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Pancreatic Cancer", "Cachexia; Cancer; Sarcopenia"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07221669", "title": "A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)", "status": "RECRUITING", "start": "2026-04-28", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Biogen", "conditions": ["Muscular Atrophy, Spinal"], "cn_sites": [{"facility": "The Third Affiliated Hospital of Zhengzhou University - North Campus", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Guangzhou Woman and Children's Medical Center_Guangzhou", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Childrens Hospital of Fudan University_Shanghai", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07514923", "title": "The Study of Safety and Preliminary Efficacy of ALT001 in Patients With MultIple System Atrophy-Cerebellar Type", "status": "RECRUITING", "start": "2026-06-10", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "yilong Wang", "conditions": ["Multiple System Atrophy - Cerebellar Subtype (MSA-C)"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07604116", "title": "A Study to Evaluate Satety, Tolerability, Biodistribution, Radiation Dosimetry, and Pharmacokinetics of SST001 in Healthy Volunteers, Patients With PD and Patients With MSA", "status": "RECRUITING", "start": "2026-06-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Synusight Biotech (Shanghai) Co., Ltd.", "conditions": ["Multiple System Atrophy (MSA)", "Parkinson's Disease (PD)"], "cn_sites": [{"facility": "Affiliated Hospital of Jiangnan University", "city": "Wuxi", "status": "RECRUITING"}, {"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07476352", "title": "Expansion Study of ALT001 in Patients With Multiple System Atrophy", "status": "RECRUITING", "start": "2026-06-15", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "yilong Wang", "conditions": ["Multiple System Atrophy"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07774585", "title": "A Prospective Exploratory Study of the Safety and Preliminary Efficacy of the α-Syn H21 Monoclonal Antibody in Patients With Multiple System Atrophy", "status": "NOT_YET_RECRUITING", "start": "2026-09-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 3, "sponsor": "Ruijin Hospital", "conditions": ["Multiple System Atrophy"], "cn_sites": [{"facility": "Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai 200025", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02908685", "title": "A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Risdiplam (RO7034067) in Type 2 and 3 Spinal Muscular Atrophy (SMA) Participants", "status": "COMPLETED", "start": "2016-10-19", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 231, "sponsor": "Hoffmann-La Roche", "conditions": ["Muscular Atrophy, Spinal"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT03908515", "title": "Multi-center Clinical Observation of FCVB in Guangdong Province", "status": "UNKNOWN", "start": "2019-05-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Sun Yat-sen University", "conditions": ["Retina Detachment", "Eye Injuries", "Eye Atrophy", "Silicone Emulsion"], "cn_sites": [{"facility": "Zhongshan Ophthalmic Center of Sun yat-sen Universtiy", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04313530", "title": "TMS Treatment in Multiple System Atrophy With Fatigue", "status": "UNKNOWN", "start": "2019-10-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 22, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Transcranial Magnetic Stimulation", "Multiple System Atrophy", "Fatigue"], "cn_sites": [{"facility": "The Neurology Department of Xuanwu Hospital,Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04060199", "title": "Study to Assess the Efficacy and Safety of Viltolarsen in Ambulant Boys With DMD (RACER53)", "status": "COMPLETED", "start": "2020-04-14", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 77, "sponsor": "NS Pharma, Inc.", "conditions": ["Duchenne Muscular Dystrophy"], "cn_sites": [{"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "The Third Medical Center of PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "Hunan Children's Hospital", "city": "Changsha", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT04193527", "title": "A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients", "status": "COMPLETED", "start": "2020-06-28", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 172, "sponsor": "GE Healthcare", "conditions": ["Parkinsonian Syndrome", "Parkinson Disease(PD)", "Multiple System Atrophy (MSA)", "Progressive Supranuclear Palsy (PSP)", "Essential Tremor"], "cn_sites": [{"facility": "Beijing Anzhen Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Nanfang Hospital, Nanfang Medical Univeristy", "city": "Guangdong", "status": ""}, {"facility": "Nanjing First Hospital", "city": "Nanjing", "status": ""}, {"facility": "The Second Affilicated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "Shanghai General Hospital", "city": "Hongkou", "status": ""}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Friendship Hospital Afflication to Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Ruijin Hospital, Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT04723160", "title": "Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph", "status": "COMPLETED", "start": "2020-08-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 748, "sponsor": "Visionary Intelligence Ltd.", "conditions": ["Diabetic Retinopathy", "Retinal Vein Occlusion", "Retinal Artery Occlusion", "Central Serous Chorioretinopathy", "Pathologic Myopia", "Retinitis Pigmentosa", "Epiretinal Membrane", "Macular Holes", "Nonexudative Age-related Macular Degeneration", "Exudative Age Related Macular Degeneration", "Suspect Glaucoma", "Optic Atrophy", "Retinal Detachment"], "cn_sites": [{"facility": "Peking Union Medical College Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "The Second Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Tianjin Medical University Eye Hospital", "city": "Tianjin", "status": ""}, {"facility": "Eye Hospital, WMU Zhejiang Eye Hospital", "city": "Wenzhou", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT04617873", "title": "DBS and SCS Therapy Improve Motor Function in Multiple System Atrophy With Predominant Parkinsonism", "status": "UNKNOWN", "start": "2021-01-05", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "zhangyuqing", "conditions": ["Multiple System Atrophy, Parkinson Variant (Disorder)"], "cn_sites": [{"facility": "Capital Medical University of Xuanwu Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04768062", "title": "Study to Assess the Safety and Efficacy of Viltolarsen in Ambulant Boys With DMD (RACER53-X)", "status": "UNKNOWN", "start": "2021-04-13", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 74, "sponsor": "NS Pharma, Inc.", "conditions": ["Duchenne Muscular Dystrophy"], "cn_sites": [{"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "Hunan Children's Hospital", "city": "Changsha", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT05638815", "title": "An Observational Study of Parkinson's Disease and Other Synucleinopathies (EASE-PD)", "status": "COMPLETED", "start": "2021-11-23", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 89, "sponsor": "SciNeuro", "conditions": ["Parkinson's Disease", "Multiple System Atrophy"], "cn_sites": [{"facility": "Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Nanjing Brain Hospital", "city": "Nanjing", "status": ""}, {"facility": "The Affiliated Hospital of Xuzhou Medical University", "city": "Xuzhou", "status": ""}, {"facility": "Ruijin Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT06221644", "title": "Synapse Alterations in MSA Patients", "status": "COMPLETED", "start": "2022-04-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 90, "sponsor": "Xiangya Hospital of Central South University", "conditions": ["Multiple System Atrophy"], "cn_sites": [{"facility": "Jian Li", "city": "Changsha", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05453058", "title": "Observational Study in Multiple System Atrophy", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-06-25", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 90, "sponsor": "H. Lundbeck A/S", "conditions": ["Multiple System Atrophy"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Beijing Xuanwu Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Beijing Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Huashan Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "The Second Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT05557786", "title": "Treatment of Transcranial Alternating Current Stimulation（tACS）on Cerebellar Ataxia", "status": "COMPLETED", "start": "2022-08-07", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 164, "sponsor": "First Affiliated Hospital of Fujian Medical University", "conditions": ["Spinocerebellar Ataxia Type 3", "Multiple System Atrophy-cerebellar Type"], "cn_sites": [{"facility": "Department of Neurology, The First Affiliated Hospital Fujian Medical University", "city": "Fuzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06490926", "title": "NMR Based Metabolomic Study of Serum Biomarkers in Patients With Parkinson's Disease and Atypical Parkinsonian Syndrome", "status": "UNKNOWN", "start": "2023-02-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 180, "sponsor": "Fujian Medical University Union Hospital", "conditions": ["Progressive Supranuclear Palsy", "Multiple System Atrophy", "Parkinson's Disease"], "cn_sites": [{"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05901987", "title": "Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 2 Patients", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-08-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 33, "sponsor": "GeneCradle Inc", "conditions": ["SMA II"], "cn_sites": [{"facility": "Peking University， First Hospital, Department of Pediatrics", "city": "Beijing", "status": ""}, {"facility": "Bayi Children's Hospital, Seventh Medical Center, PLA general hospital", "city": "Beijing", "status": ""}, {"facility": "West China Second University Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Children's Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "Tongji Medical college of Huazhong University of Science&Technology, Affiliated Children's Hospital", "city": "Wuhan", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT05820152", "title": "Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND1 Mutations", "status": "TERMINATED", "start": "2023-08-15", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 11, "sponsor": "Neurophth Therapeutics Inc", "conditions": ["Leber Hereditary Optic Neuropathy (LHON)"], "cn_sites": [{"facility": "The First Medical Center of the General Hospital of the Chinese People's Liberation Army", "city": "Beijing", "status": ""}, {"facility": "Zhongshan Ophthalmic Center, Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "Optometry Affiliated to Wenzhou Medical University", "city": "Wenzhou", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT06393244", "title": "A Theory-based Home-based Multi-component Exercise Training Among Older Adults With Type 2 Diabetes Mellitus", "status": "UNKNOWN", "start": "2024-03-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 96, "sponsor": "Cheng Li", "conditions": ["Diabetes Mellitus Type 2", "Sarcopenia"], "cn_sites": [{"facility": "Yuexiu District Baiyun Street community health service center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06298825", "title": "S-ADHF：Sarcopenia in Patients With ADHF", "status": "UNKNOWN", "start": "2024-04-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Guangdong Provincial People's Hospital", "conditions": ["Acute Decompensated Heart Failure"], "cn_sites": [{"facility": "Huan Ma", "city": "Guangdong", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06890390", "title": "TSPO PET in the Evaluation of Neuroinflammation in Patients with Multiple System Atrophy", "status": "UNKNOWN", "start": "2024-09-14", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 90, "sponsor": "Min Zhao,MD", "conditions": ["Multiple System Atrophy - Cerebellar Subtype (MSA-C)", "Multiple System Atrophy - Parkinsonian Subtype (MSA-P)"], "cn_sites": [{"facility": "Third Xiangya Hospital of Central South University", "city": "Hunan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06890377", "title": "Targeted Α-synuclein PET Imaging in the Diagnosis of Multiple System Atrophy", "status": "UNKNOWN", "start": "2024-09-14", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 90, "sponsor": "Min Zhao,MD", "conditions": ["Multiple System Atrophy - Cerebellar Subtype (MSA-C)", "Multiple System Atrophy - Parkinsonian Subtype (MSA-P)"], "cn_sites": [{"facility": "Third Xiangya Hospital of Central South University", "city": "Hunan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06738862", "title": "[18F] - FD17 PET Imaging of α-synuclein: A Clinical Study in α-synucleinopathy Patients", "status": "COMPLETED", "start": "2024-12-14", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 55, "sponsor": "Ruijin Hospital", "conditions": ["α-synucleinopathy", "Parkinson&#39;s Disease (PD)", "Multiple System Atrophy", "Rapid Eye Movement Sleep Behavior Disorder", "PET"], "cn_sites": [{"facility": "Department of neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07657520", "title": "High-Altitude Neurodegeneration Cohort (HANC) Study", "status": "WITHDRAWN", "start": "2026-06-13", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 0, "sponsor": "West China Hospital", "conditions": ["Multiple System Atrophy"], "cn_sites": [{"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 122, "g_fetched": 98, "g_countries": [["United States", 38], ["Italy", 13], ["United Kingdom", 11], ["France", 10], ["Germany", 9], ["Spain", 8], ["South Korea", 7], ["Belgium", 5], ["Canada", 5], ["Austria", 5], ["Japan", 4], ["Israel", 4], ["Netherlands", 4], ["Poland", 3], ["Australia", 3], ["New Zealand", 3], ["Taiwan", 3], ["Turkey (Türkiye)", 3], ["Norway", 3], ["Denmark", 2], ["Switzerland", 2], ["Serbia", 2], ["Sweden", 2], ["United Arab Emirates", 2], ["Egypt", 1], ["Mexico", 1], ["India", 1], ["Portugal", 1], ["Hong Kong", 1], ["Argentina", 1]], "g_trials": [{"nct": "NCT07808905", "title": "Evaluate the Efficacy and Safety of EN001 in Patients With Sarcopenia", "status": "NOT_YET_RECRUITING", "start": "2027-03-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "ENCell", "countries": ["South Korea"]}, {"nct": "NCT07825402", "title": "A Trial of ONO-2808 in Participants With the Parkinsonian Subtype of Multiple System Atrophy (MSA-P)", "status": "NOT_YET_RECRUITING", "start": "2027-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Ono Pharmaceutical Co., Ltd.", "countries": []}, {"nct": "NCT07465198", "title": "Autologous Stem Cell Therapy in Patients With Multiple System Atrophy", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Biocells Medical", "countries": ["Poland"]}, {"nct": "NCT05522426", "title": "Open Label, Multi-Center Study, Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System for Facial Fat Grafting", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Syntr Health Technologies, Inc.", "countries": ["United States"]}, {"nct": "NCT04753320", "title": "Remote Monitoring in Progressive Supranuclear Palsy (PSP)", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Massachusetts General Hospital", "countries": ["United States"]}, {"nct": "NCT07827963", "title": "VisMemoPD Protocol: an Observational Pilot Study on Spatial and Topographical Memory in Patients With Parkinson's Disease and Parkinsonism", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS San Raffaele Roma", "countries": ["Italy"]}, {"nct": "NCT07446907", "title": "Optimizing Adaptive Intensive Behavioral Therapy for Obesity During the Transition to Older Adulthood", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Alabama at Birmingham", "countries": ["United States"]}, {"nct": "NCT07798609", "title": "A Trial to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of SFL-0821 in Adults With FSHD", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Soufflé Therapeutics, Inc.", "countries": ["Australia", "New Zealand"]}, {"nct": "NCT07815158", "title": "Multi-Component Nutrition, Intrinsic Capacity, and Physical Function in Older Adults", "status": "NOT_YET_RECRUITING", "start": "2026-08-31", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "National Yang Ming Chiao Tung University", "countries": ["Taiwan"]}, {"nct": "NCT07740538", "title": "Malnutrition and Sarcopenia Among Primary Ciliary Dyskinesia", "status": "NOT_YET_RECRUITING", "start": "2026-08-03", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Izmir Democracy University", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT07740551", "title": "Comparison of Individuals With Primary Ciliary Dyskinesia and Healthy Controls", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Izmir Democracy University", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT07726498", "title": "STRIDE: Strength of The Calf Muscles and Their Role In Declining Effectiveness of Movement With Aging", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Leicester", "countries": ["United Kingdom"]}, {"nct": "NCT07640542", "title": "Test-retest Trial With [11C]MODAG-005 in PD or MSA and AMHC - Pilot Phase", "status": "RECRUITING", "start": "2026-07-29", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "MODAG GmbH", "countries": ["Germany"]}, {"nct": "NCT07531719", "title": "A Study of Risdiplam in Participants With Type I and Type II Spinal Muscle Atrophy (SMA)", "status": "RECRUITING", "start": "2026-07-22", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Hoffmann-La Roche", "countries": ["Egypt"]}, {"nct": "NCT07729852", "title": "Open-Label Access to ATH434 for Patients Who Completed Study ATH434-201 in France", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Alterity Therapeutics", "countries": ["France"]}, {"nct": "NCT07617012", "title": "The Safety, Tolerability, and Efficacy of Dopaminergic Neural Progenitor Cells (XS411CN Cell Injection) for the Treatment of Multiple System Atrophy Parkinsonian Variant (MSA-P).", "status": "NOT_YET_RECRUITING", "start": "2026-06-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.", "countries": []}, {"nct": "NCT07604883", "title": "Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes", "status": "NOT_YET_RECRUITING", "start": "2026-06-04", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "International Institute of Molecular and Cell Biology in Warsaw", "countries": ["Poland"]}, {"nct": "NCT07617688", "title": "Evaluation of the Pharmacokinetics, Biodistribution and Radiation Dosimetry of [18F]MODAG-009 Positron Emission Tomography (PET) Radiotracers in Adult Healthy Volunteers", "status": "RECRUITING", "start": "2026-05-27", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "MODAG GmbH", "countries": ["United States"]}, {"nct": "NCT07640555", "title": "Evaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies", "status": "RECRUITING", "start": "2026-05-13", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "MODAG GmbH", "countries": ["United States"]}, {"nct": "NCT07390552", "title": "A Study of PLH-2301 in Subjects With Sarcopenia", "status": "RECRUITING", "start": "2026-05-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Pluto Inc.", "countries": ["South Korea"]}, {"nct": "NCT07567378", "title": "CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry", "status": "NOT_YET_RECRUITING", "start": "2026-05", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "JULIO GRANADOS MONTIEL", "countries": ["Mexico"]}, {"nct": "NCT07429240", "title": "PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD)", "status": "RECRUITING", "start": "2026-04-24", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Precision BioSciences, Inc.", "countries": ["United States"]}, {"nct": "NCT07467187", "title": "Invasive Home Ventilation in Denmark", "status": "RECRUITING", "start": "2026-04-13", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Rigshospitalet, Denmark", "countries": ["Denmark"]}, {"nct": "NCT07477574", "title": "Muscle-Specific Multimodal AI for Sarcopenia Diagnosis", "status": "NOT_YET_RECRUITING", "start": "2026-03-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Seoul National University Bundang Hospital", "countries": []}, {"nct": "NCT07509125", "title": "Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders", "status": "RECRUITING", "start": "2026-02-13", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Universitaire Ziekenhuizen KU Leuven", "countries": ["Belgium"]}]}, {"batch": 1, "no": 78, "name_zh": "肌强直性营养不良", "query_terms": [{"term": "Myotonic dystrophy", "broad": false}], "n_total": 2, "n_open": 2, "n_open_precise": 2, "n_broad": 0, "trials": [{"nct": "NCT06979024", "title": "A Registered Observational Cohort Study of Myotonic Dystrophy Type 1", "status": "ENROLLING_BY_INVITATION", "start": "2008-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 300, "sponsor": "First Affiliated Hospital of Fujian Medical University", "conditions": ["Myotonic Dystrophy Type 1 (DM1)"], "cn_sites": [{"facility": "First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06101940", "title": "Chinese Multicenter Clinical Outcome Cohort Study of Myotonic Dystrophy Type 1 (C-DMCOS-DM1)", "status": "ENROLLING_BY_INVITATION", "start": "2021-08-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "Huashan Hospital", "conditions": ["Myotonic Dystrophy 1"], "cn_sites": [{"facility": "Chinese People's Liberation Army General Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "First Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Southern Hospital of Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "The Third Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "Wuhan University People's Hospital", "city": "Wuhan", "status": ""}, {"facility": "Zhongda Hospital Southeast University", "city": "Nanjing", "status": ""}, {"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "The First People's Hospital of Yancheng", "city": "Yancheng", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University）", "city": "Nanchang", "status": ""}, {"facility": "The First Bethune Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Chifeng Municipal Hospital", "city": "Chifeng", "status": ""}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "First Hospital of Shanxi Medical University", "city": "Taiyuan", "status": ""}, {"facility": "Xi'an Gaoxin Hospital", "city": "Xi’an", "status": ""}, {"facility": "Xi'an People's Hospital", "city": "Xi’an", "status": ""}, {"facility": "Sichuan Provincial People's Hospital", "city": "Chengdu", "status": ""}, {"facility": "The General Hospital of Western Theater Command", "city": "Chengdu", "status": ""}, {"facility": "Yunnan Provincial People's Hospital", "city": "Kunming", "status": ""}, {"facility": "Huashan Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 22, "broad_only": false}], "g_total": 46, "g_fetched": 46, "g_countries": [["United States", 23], ["France", 11], ["Italy", 10], ["United Kingdom", 10], ["Canada", 9], ["Belgium", 6], ["Germany", 6], ["Spain", 6], ["Australia", 5], ["New Zealand", 5], ["Netherlands", 4], ["Denmark", 2], ["Egypt", 2], ["Japan", 1], ["Argentina", 1], ["Israel", 1], ["Brazil", 1], ["Norway", 1], ["South Korea", 1], ["Taiwan", 1], ["Thailand", 1], ["Czechia", 1], ["Hungary", 1], ["Poland", 1], ["Romania", 1], ["Slovenia", 1]], "g_trials": [{"nct": "NCT07075965", "title": "Calcium Channel Blocker in Myotonic Dystrophy Type 1", "status": "NOT_YET_RECRUITING", "start": "2026-12-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "University of Rochester", "countries": []}, {"nct": "NCT07587242", "title": "A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping", "status": "RECRUITING", "start": "2026-09-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Avidity Biosciences, Inc.", "countries": ["Belgium", "France", "Germany", "Italy", "Spain", "United Kingdom"]}, {"nct": "NCT07700225", "title": "Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension", "status": "RECRUITING", "start": "2026-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Virginia Commonwealth University", "countries": ["United States"]}, {"nct": "NCT07732439", "title": "An Ambispective Natural History Study in Myotonic Dystrophy Patients Linking Retrospective Data Captured From the DM-Scope Registry With a Prospective 24-month Follow-up Period", "status": "NOT_YET_RECRUITING", "start": "2026-08-03", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Lupin Ltd.", "countries": ["France"]}, {"nct": "NCT07580365", "title": "VirtualPark_Pediatric", "status": "RECRUITING", "start": "2026-06-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Istituto di Sistemi e Tecnologie Industriali Intelligenti per il Manifatturiero Avanzato", "countries": ["Italy"]}, {"nct": "NCT07608432", "title": "Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)", "status": "RECRUITING", "start": "2026-06", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Dyne Therapeutics", "countries": ["United States"]}, {"nct": "NCT07486934", "title": "Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1", "status": "RECRUITING", "start": "2026-05-14", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Dyne Therapeutics", "countries": ["Australia", "Belgium", "Denmark", "France", "Germany", "Italy", "Japan", "Netherlands", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT07321977", "title": "Assessment of a Portable Digital Device for Quantified Analysis of Markerless Walking in Volunteers With Neuromuscular Diseases or Asymptomatic Volunteers", "status": "RECRUITING", "start": "2026-03-03", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Institut de Myologie, France", "countries": ["France"]}, {"nct": "NCT07415837", "title": "Evaluation of the Role of miR-1 in the Pathogenesis and as a Biomarker in Muscular Dystrophies and Congenital Myopathies", "status": "RECRUITING", "start": "2026-02-11", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Clermont-Ferrand", "countries": ["France"]}, {"nct": "NCT07220603", "title": "An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE)", "status": "RECRUITING", "start": "2025-12-23", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "PepGen Inc", "countries": ["Canada"]}, {"nct": "NCT06844214", "title": "A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 55 Years of Age With Non-congenital Myotonic Dystrophy Type 1", "status": "RECRUITING", "start": "2025-07-23", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Sanofi", "countries": ["Argentina", "Australia", "Canada", "Israel", "United Kingdom", "United States"]}, {"nct": "NCT06747884", "title": "Trial Readiness and Endpoint Assessment in Pediatric Myotonic Dystrophy Extension", "status": "RECRUITING", "start": "2025-06-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Virginia Commonwealth University", "countries": ["Brazil", "United States"]}, {"nct": "NCT07385443", "title": "The Spanish National Registry for Myotonic Dystrophy Type 1", "status": "RECRUITING", "start": "2025-06-02", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fundació Institut Germans Trias i Pujol", "countries": ["Spain"]}, {"nct": "NCT07362875", "title": "Development of Quantitative Muscle Imaging as a Biomarker of Disease Endpoints in Myotonic Dystrophy", "status": "RECRUITING", "start": "2025-05-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Wake Forest University Health Sciences", "countries": ["United States"]}, {"nct": "NCT07502989", "title": "Muscle Health Measurements Using Electrical Impedance Myography", "status": "RECRUITING", "start": "2025-04-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Beth Israel Deaconess Medical Center", "countries": ["United States"]}, {"nct": "NCT06716931", "title": "Investigating Exercise in Myotonic Dystrophy Type 2 (DM2)", "status": "RECRUITING", "start": "2025-03-04", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Massachusetts General Hospital", "countries": ["United States"]}, {"nct": "NCT06833489", "title": "Transcriptomic Analysis to Put an End to Misdiagnosis in Patients With Rare Muscle Diseases", "status": "RECRUITING", "start": "2025-03-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique Hopitaux De Marseille", "countries": ["France"]}, {"nct": "NCT06523400", "title": "The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2", "status": "RECRUITING", "start": "2025-02-13", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Lupin Ltd.", "countries": ["Belgium", "Denmark", "Germany", "Italy", "Spain", "United Kingdom"]}, {"nct": "NCT06708468", "title": "Personalized Training for People With Rare Neuromuscular Disorders", "status": "RECRUITING", "start": "2024-12-13", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Oslo University Hospital", "countries": ["Norway"]}, {"nct": "NCT06667453", "title": "A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1", "status": "RECRUITING", "start": "2024-12-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "PepGen Inc", "countries": ["Canada", "New Zealand", "South Korea", "United Kingdom"]}, {"nct": "NCT05532813", "title": "Evaluation of the Efficacy and Safety of Metformin in the Myotonic Dystrophy Type 1 (Steinert's Disease)", "status": "RECRUITING", "start": "2024-11-29", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT06147414", "title": "Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders", "status": "RECRUITING", "start": "2024-10-23", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT06300307", "title": "Study of ATX-01 in Participants With DM1", "status": "RECRUITING", "start": "2024-10-15", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "ARTHEx Biotech S.L.", "countries": ["Canada", "France", "Italy", "Netherlands", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT06596850", "title": "Wheelchair Skills Training for People with ARSACS and DM1", "status": "NOT_YET_RECRUITING", "start": "2024-09-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Laval University", "countries": ["Canada"]}, {"nct": "NCT07138963", "title": "Phenotype - Genotype Correlation in a Sample of Egyptian Patients With Congenital Myopathies and Congenital Muscular Dystrophies", "status": "RECRUITING", "start": "2024-06-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Ain Shams University", "countries": ["Egypt"]}]}, {"batch": 1, "no": 79, "name_zh": "N-乙酰谷氨酸合成酶缺乏症", "query_terms": [{"term": "Hyperammonemia due to N-acetylglutamate synthase deficiency", "broad": false}, {"term": "N-acetylglutamate Synthase Deficiency", "broad": true}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 0, "g_fetched": 0, "g_countries": [], "g_trials": []}, {"batch": 1, "no": 80, "name_zh": "新生儿糖尿病", "query_terms": [{"term": "Neonatal diabetes mellitus", "broad": false}], "n_total": 14, "n_open": 2, "n_open_precise": 2, "n_broad": 0, "trials": [{"nct": "NCT07492004", "title": "China Monogenic Diabetes Registry", "status": "RECRUITING", "start": "2021-02-28", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 5000, "sponsor": "Tianjin Medical University General Hospital", "conditions": ["Neonatal Diabetes", "Monogenic Diabetes", "Maturity Onset Diabetes of the Young"], "cn_sites": [{"facility": "Tianjin medical university general hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07314502", "title": "Prenatal Exercise Including Perineal Massage and Maternal-Neonatal Outcomes", "status": "NOT_YET_RECRUITING", "start": "2026-01-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 2000, "sponsor": "South China Normal University", "conditions": ["Postpartum Urinary Incontinence", "Postpartum Depression (PPD)", "Neonatal Complications", "Gestational Diabetes"], "cn_sites": [{"facility": "South China Normal University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01783717", "title": "Effects of Exenatide on Obesity and/or Diabetes Mellitus Due to Hypothalamic Damage", "status": "UNKNOWN", "start": "2012-12", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Huashan Hospital", "conditions": ["Hypothalamic Obesity", "Diabetes Mellitus"], "cn_sites": [{"facility": "Department of Endocrinology and Metabolism", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03569501", "title": "Impact of DHA/Oat on Metabolic Health in Gestational Diabetes Mellitus", "status": "UNKNOWN", "start": "2017-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 80, "sponsor": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": ["Gestational Diabetes Mellitus in Pregnancy"], "cn_sites": [{"facility": "Xinhua Hospital Affliated to Shanghai Jiao Tong University School of Medicine;", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04399434", "title": "Gut Microbiota, SCFAs and Glucolipid Metabolism in Pregnant Women With Abnormal Fetal Size and Their Newborns", "status": "UNKNOWN", "start": "2019-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 120, "sponsor": "Second Affiliated Hospital of Wenzhou Medical University", "conditions": ["Fetal Growth Restriction", "Gut Microbiota", "Fetal Macrosomia", "Glucolipid Metabolism"], "cn_sites": [{"facility": "department of obstetrics of Second Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03928899", "title": "The Best Timing of Delivery in Women With GDM Study", "status": "UNKNOWN", "start": "2019-07-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 230, "sponsor": "Peking University First Hospital", "conditions": ["Gestational Diabetes", "Induction of Labor Affected Fetus / Newborn"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04182503", "title": "Environmental Factors and Embryonic Development Project", "status": "UNKNOWN", "start": "2019-08-12", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100000, "sponsor": "Jinling Hospital, China", "conditions": ["Spontaneous Abortion", "Fetal Death", "Stillbirth", "Birth Defects", "Preterm Birth", "Low Birth Weight", "Pregnancy With Medical Condition (Non-Specific)", "Gestational Diabetes", "Gestational Hypertension"], "cn_sites": [{"facility": "Haidian Maternal and Child Healthcare Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Guangdong General Hospital", "city": "Guangzhou", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Meitan People's Hospital", "city": "Zunyi", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Renhuai Hospital of Traditional Chinese Medicine", "city": "Zunyi", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "The First Affiliated Hospital of Zunyi Medical University", "city": "Zunyi", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "The Second Affliated Hospital of Zunyi Medical University", "city": "Zunyi", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "People's Hospital of Qichun County", "city": "Huanggang", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Huangshi Maternal and Child Healthcare Hospital", "city": "Huangshi", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Shiyan Maternal and Child Healthcare Hospital", "city": "Shiyan", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Maternal and Child Healthcare and Family Planning Service Center of Zengdu District", "city": "Suizhou", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Huangpi Maternal and Child Healthcare Hospital", "city": "Wuhan", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Maternal and Child Healthcare Hospital of HuBei", "city": "Wuhan", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Xiangyang No. 1 People's Hospital, Hubei University of Medicine", "city": "Xiangyang", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Anlu Maternal and Child healthcare Hospital", "city": "Xiaogan", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Changzhou Second People's Hospital", "city": "Changzhou", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Nantong Maternal and Child Healthcare Hospital", "city": "Nantong", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Shuyang Hospital Affiliated to Xuzhou Medical University", "city": "Suqian", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Center for Reproductive Medicine, Shandong University", "city": "Jinan", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Women's Hospital, School of Medicine, Zhejiang University", "city": "Hanzhou", "status": "ACTIVE_NOT_RECRUITING"}], "cn_site_count": 19, "broad_only": false}, {"nct": "NCT04369313", "title": "Effect of DCC on Neonatal Jaundice and Blood Gas Analysis in Infants Born to GDM Mothers", "status": "UNKNOWN", "start": "2019-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 70, "sponsor": "Second Affiliated Hospital of Wenzhou Medical University", "conditions": ["Gestational Diabetes Mellitus", "Neonatal Hyperbilirubinemia", "Neonatal Asphyxia"], "cn_sites": [{"facility": "department of obstetrics of Second Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04101604", "title": "Biomarkers of Common Eye Diseases", "status": "UNKNOWN", "start": "2019-09-26", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 220, "sponsor": "Sun Yat-sen University", "conditions": ["Uveitis", "Diabetic Retinopathy", "Age-related Macular Degeneration", "Polypoidal Choroidal Vasculopathy", "VKH Syndrome", "Behçet Disease"], "cn_sites": [{"facility": "Zhognshan Ophthalmic Center, Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04723160", "title": "Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph", "status": "COMPLETED", "start": "2020-08-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 748, "sponsor": "Visionary Intelligence Ltd.", "conditions": ["Diabetic Retinopathy", "Retinal Vein Occlusion", "Retinal Artery Occlusion", "Central Serous Chorioretinopathy", "Pathologic Myopia", "Retinitis Pigmentosa", "Epiretinal Membrane", "Macular Holes", "Nonexudative Age-related Macular Degeneration", "Exudative Age Related Macular Degeneration", "Suspect Glaucoma", "Optic Atrophy", "Retinal Detachment"], "cn_sites": [{"facility": "Peking Union Medical College Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "The Second Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Tianjin Medical University Eye Hospital", "city": "Tianjin", "status": ""}, {"facility": "Eye Hospital, WMU Zhejiang Eye Hospital", "city": "Wenzhou", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT05073978", "title": "B-vitamin Levels and Adverse Pregnancy Outcomes", "status": "COMPLETED", "start": "2020-12-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 7500, "sponsor": "Westlake University", "conditions": ["Birth Defect", "Pregnancy Loss", "Pregnancy Complications", "Pregnancy Induced Hypertension", "Recurrent Pregnancy Loss", "Health Problems in Pregnancy", "Gestational Diabetes", "Gestational Hypertension", "Preterm Birth"], "cn_sites": [{"facility": "Beijing Obstetrics and Gynecology Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03958760", "title": "Characteristics, Treatment, and Economic Burden of Patients With CVD,CKD or at High Cardiovascular Risk", "status": "COMPLETED", "start": "2021-02-28", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200000, "sponsor": "West China Hospital", "conditions": ["Cardiovascular Abnormalities", "Chronic Kidney Diseases", "Diabetes"], "cn_sites": [{"facility": "Tian Jin Healthcare Big Data Co. Ltd", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05760768", "title": "The Effect of Individualized Exercise Guidance on Pregnancy Outcome", "status": "COMPLETED", "start": "2021-12-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 326, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Pregnancy Outcome", "Gestational Weight Gain", "Mediation", "Macrosomia, Fetal"], "cn_sites": [{"facility": "Department of ob gyn, Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06076720", "title": "Evaluation of New Head-mounted Visual Aids Among Patients With Low Vision", "status": "UNKNOWN", "start": "2023-10-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Zhongshan Ophthalmic Center, Sun Yat-sen University", "conditions": ["Glaucoma", "Age-related Macular Degeneration", "Retinitis Pigmentosa", "Diabetic Retinopathy"], "cn_sites": [{"facility": "Zhongshan Ophthalmic Center, Sun Yat-sen University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 78, "g_fetched": 76, "g_countries": [["United States", 28], ["France", 8], ["United Kingdom", 7], ["Australia", 4], ["Canada", 4], ["Italy", 3], ["Netherlands", 3], ["Spain", 3], ["Denmark", 3], ["Germany", 3], ["Egypt", 3], ["Austria", 3], ["Pakistan", 2], ["Indonesia", 2], ["Poland", 2], ["Singapore", 2], ["Hungary", 2], ["Turkey (Türkiye)", 2], ["Belgium", 1], ["Taiwan", 1], ["Kazakhstan", 1], ["Japan", 1], ["Sweden", 1], ["Zambia", 1], ["Antigua and Barbuda", 1], ["Argentina", 1], ["United Arab Emirates", 1]], "g_trials": [{"nct": "NCT07083557", "title": "Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)", "status": "RECRUITING", "start": "2027-01-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Bettina Mittendorfer", "countries": ["United States"]}, {"nct": "NCT07615803", "title": "Study on Influencing Factors of Skin Complications Related to Insulin Injection in Children With Type 1 Diabetes Mellitus", "status": "NOT_YET_RECRUITING", "start": "2026-12-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "The Children's Hospital of Zhejiang University School of Medicine", "countries": []}, {"nct": "NCT07808151", "title": "Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer", "status": "NOT_YET_RECRUITING", "start": "2026-09-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Solstice Oncology, Inc.", "countries": ["Belgium", "Italy", "Netherlands", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT07780188", "title": "Lean Beef as Part of a Healthy Meal Plan in Adolescents With Polycystic Ovary Syndrome (PCOS)/Polyendocrine Metabolic Ovarian Syndrome (PMOS)", "status": "RECRUITING", "start": "2026-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Texas A&M University", "countries": ["United States"]}, {"nct": "NCT07675720", "title": "Concurrent Training vs Soleus Push-Ups on Neurogenesis-Related Biomarkers in Diabetic Neuropathy Patients", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Riphah International University", "countries": ["Pakistan"]}, {"nct": "NCT07688070", "title": "Verapamil Effect in Cystic Fibrosis-related Dysglycemia", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Rhode Island Hospital", "countries": ["United States"]}, {"nct": "NCT07559773", "title": "The ROOT Study: Scaling the 'Standard of Care Plus' Obstetric Nutrition Model to Optimize Maternal and Infant Health", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "GrowBaby Life Project", "countries": []}, {"nct": "NCT07575152", "title": "Estimation of Fetal Weight by Measuring Abdominal Circumference, Abdominal Subcutaneous Soft Tissue Thickness, Femur Length and Mid-thigh Soft Tissue Thickness", "status": "NOT_YET_RECRUITING", "start": "2026-07-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT06513026", "title": "Milk for Diabetes Prevention", "status": "RECRUITING", "start": "2026-05-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Albert Einstein College of Medicine", "countries": ["United States"]}, {"nct": "NCT07310849", "title": "Digital Care for Holistic Health in Older Adults With Diabetes and Multimorbidity", "status": "RECRUITING", "start": "2026-05-12", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Chang Gung University of Science and Technology", "countries": ["Taiwan"]}, {"nct": "NCT06451757", "title": "KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases", "status": "RECRUITING", "start": "2026-04-14", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Khondrion BV", "countries": ["Denmark", "France", "Germany", "Italy", "Netherlands", "United Kingdom", "United States"]}, {"nct": "NCT07490964", "title": "Polycystic Ovary Syndrome in Type 1 Diabetes", "status": "RECRUITING", "start": "2026-04-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal", "countries": ["Spain"]}, {"nct": "NCT07382869", "title": "to Investigate Impact of Diet and Physical Activity Based Nurse Led Interventions on Maternal Outcomes and Neonatal Outcomes in Women With Gestational Diabetes Mellitus (GDM)", "status": "NOT_YET_RECRUITING", "start": "2026-03-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Health Sciences Lahore", "countries": ["Pakistan"]}, {"nct": "NCT07475065", "title": "The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy", "status": "NOT_YET_RECRUITING", "start": "2026-03-01", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Universitas Sebelas Maret", "countries": ["Indonesia"]}, {"nct": "NCT07462793", "title": "COntinuous Glucose Monitoring in nEwborns of Mothers With Insulin-Treated Gestational Diabetes Mellitus", "status": "NOT_YET_RECRUITING", "start": "2026-03", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Institute of Mother and Child, Warsaw, Poland", "countries": ["Poland"]}, {"nct": "NCT07412561", "title": "Instrumental Assessment of Plantar Hyperkeratosis in Healthy Subjects and Patients With Diabetes", "status": "NOT_YET_RECRUITING", "start": "2026-02", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Seville", "countries": []}, {"nct": "NCT07336966", "title": "Does Recessive Optic Atrophy Due to WFS1 Exist?", "status": "NOT_YET_RECRUITING", "start": "2026-02", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Hôpital Necker-Enfants Malades", "countries": []}, {"nct": "NCT07298174", "title": "Wide Field OCTA in Ocular Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS San Raffaele", "countries": []}, {"nct": "NCT07313085", "title": "Mechanisms of Fecal Incontinence in Wolfram Syndrome", "status": "NOT_YET_RECRUITING", "start": "2025-12-20", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Hôpital Necker-Enfants Malades", "countries": ["France"]}, {"nct": "NCT07470320", "title": "Placental Biology in Health and Disease", "status": "RECRUITING", "start": "2025-12-16", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Oxford", "countries": ["United Kingdom"]}, {"nct": "NCT06883344", "title": "Automated Insulin for Management of Intrapartum Glycemia", "status": "RECRUITING", "start": "2025-12-05", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of California, San Francisco", "countries": ["United States"]}, {"nct": "NCT06993103", "title": "Pasteurised Donor Human Milk Supplementation for Term Babies", "status": "RECRUITING", "start": "2025-12-04", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "The University of Queensland", "countries": ["Australia"]}, {"nct": "NCT07241221", "title": "Antenatal Myo-inositol Supplementation in Pre-existing Diabetes", "status": "RECRUITING", "start": "2025-12", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "National University Hospital, Singapore", "countries": ["Singapore"]}, {"nct": "NCT07236723", "title": "Vitamin D, Nerve Growth Factor and Nerve Conduction Studies in Adult Male Type 2 Diabetic Neuropathy Patients", "status": "NOT_YET_RECRUITING", "start": "2025-12", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Aswan University", "countries": ["Egypt"]}, {"nct": "NCT06837181", "title": "Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)", "status": "RECRUITING", "start": "2025-09-18", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Jaeb Center for Health Research", "countries": ["United States"]}]}, {"batch": 1, "no": 81, "name_zh": "视神经脊髓炎", "query_terms": [{"term": "Neuromyelitis optica spectrum disorder", "broad": false}, {"term": "Neuromyelitis Optica", "broad": true}], "n_total": 75, "n_open": 35, "n_open_precise": 35, "n_broad": 0, "trials": [{"nct": "NCT04106830", "title": "Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)", "status": "RECRUITING", "start": "2019-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "Beijing Tiantan Hospital", "conditions": ["NMO Spectrum Disorder", "MRI", "Multiple Sclerosis", "MOGAD"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04561557", "title": "Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System", "status": "RECRUITING", "start": "2020-09-22", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Tongji Hospital", "conditions": ["Autoimmune Diseases", "Autoimmune Diseases of the Nervous System", "Neuromyelitis Optica Spectrum Disorder", "Myasthenia Gravis", "Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "Idiopathic Inflammatory Myopathies", "Multiple Sclerosis", "Autoimmune Encephalitis", "Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)", "POEMS Syndrome"], "cn_sites": [{"facility": "Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05154370", "title": "China National Registry of Neuro-Inflammatory Diseases", "status": "RECRUITING", "start": "2021-12-15", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 10000, "sponsor": "Beijing Tiantan Hospital", "conditions": ["Multiple Sclerosis", "NMO Spectrum Disorder", "Clinically Isolated Syndrome", "CNS Demyelinating Autoimmune Diseases", "Acute Disseminated Encephalomyelitis", "Primay Angiitis of the Central Nervous System", "Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05145361", "title": "Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD)", "status": "RECRUITING", "start": "2022-04-07", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 45, "sponsor": "Shanghai Pharmaceuticals Holding Co., Ltd", "conditions": ["NMO Spectrum Disorder"], "cn_sites": [{"facility": "Beijing Tiantan Hospital Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "First Hospital of Shanxi Medical University", "city": "Taiyuan", "status": "RECRUITING"}, {"facility": "Tangdu hospital,fourth military medical university", "city": "Xi’an", "status": "RECRUITING"}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT05504694", "title": "Ofatumumab in AQP4-IgG Seropositive NMOSD", "status": "RECRUITING", "start": "2022-06-28", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 5, "sponsor": "Tang-Du Hospital", "conditions": ["Neuromyelitis Optica Spectrum Disorder"], "cn_sites": [{"facility": "Tangdu Hospital", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06697535", "title": "A Study to Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD)", "status": "RECRUITING", "start": "2023-05-24", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 35, "sponsor": "Guangzhou JOYO Pharma Co., Ltd", "conditions": ["Neuromyelitis Optica Spectrum Disorders"], "cn_sites": [{"facility": "Xiangya Hospital，Central South University", "city": "Changsha", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06643858", "title": "Normal Chinese Lifespan Brain Charts Initiative (NCLBCI)", "status": "ENROLLING_BY_INVITATION", "start": "2023-12-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 10000, "sponsor": "Beijing Tiantan Hospital", "conditions": ["Healthy", "Multiple Sclerosis", "Neuromyelitis Optica Spectrum Disorders", "Neurodegenerative Diseases", "Cerebrovascular Diseases"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06541626", "title": "Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases", "status": "RECRUITING", "start": "2024-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 450, "sponsor": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University", "conditions": ["Multiple Sclerosis, MS", "Neuromyelitis Optica Spectrum Disorders", "Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease", "Acute Disseminated Encephalomyelitis", "Clinically Isolated Syndrome", "Demyelinating Disorder"], "cn_sites": [{"facility": "Sun Yat-sen Memorial Hospital", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05966467", "title": "Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies", "status": "RECRUITING", "start": "2024-02-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 122, "sponsor": "Alexion Pharmaceuticals, Inc.", "conditions": ["Neuromyelitis Optica Spectrum Disorder", "NMOSD", "AQP4+ NMOSD"], "cn_sites": [{"facility": "Clinical Trial Site", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Henan", "status": "NOT_YET_RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Sichuan", "status": "NOT_YET_RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT06249438", "title": "A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy", "status": "RECRUITING", "start": "2024-03-20", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "RenJi Hospital", "conditions": ["Systemic Lupus Erythematosus (SLE)", "Immune-mediated Necrotizing Myopathy (IMNM)", "Neuromyelitis Optica Spectrum Disorders (NMOSD)", "Multiple Sclerosis (MS)", "Myasthenia Gravis", "Systemic Sclerosis (SSc)"], "cn_sites": [{"facility": "Department of Rheumatology, RenJi Hospital, School of Medicine, Shanghai JiaoTong University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07653984", "title": "Cohort Study on Neuroimmune Diseases in the Reproductive Age", "status": "RECRUITING", "start": "2024-04-21", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Third Affiliated Hospital, Sun Yat-Sen University", "conditions": ["Neuromyelitis Optica Spectrum Disorders (NMOSD)", "Multiple Sclerosis", "Autoimmune Encephalitis", "Myasthenia Gravis", "Guillain-Barré Syndrome (GBS)", "Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)"], "cn_sites": [{"facility": "The Third Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06413654", "title": "A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)", "status": "RECRUITING", "start": "2024-07-17", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 132, "sponsor": "Shanghai Jiaolian Drug Research and Development Co., Ltd", "conditions": ["Neuromyelitis Optica Spectrum Disorders"], "cn_sites": [{"facility": "Beijing Anzhen Hospital，Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Tiantan Hospital，Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Tongren Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The First Medical Center of PLA General Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The Third Medical Center of PLA General Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Cangzhou Central Hospital", "city": "Cangzhou", "status": "RECRUITING"}, {"facility": "The Second Xiangya Hospital of Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Sichuan Provincial People's Hospital", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "Guangzhou First People's Hospital", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Sun Yat-sen Memorial Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "The Third Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Zhujiang Hospital of Southern Medical University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "The Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "The Fourth Affiliated Hospital of Harbin Medical University", "city": "Harbin", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Harbin Medical University", "city": "Harbin", "status": "RECRUITING"}, {"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": "RECRUITING"}, {"facility": "Huizhou First Hospital", "city": "Huizhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Shandong First Medical University", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Affiliated Hospital of Jining Medical University", "city": "Jining", "status": "RECRUITING"}, {"facility": "First Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": "RECRUITING"}, {"facility": "First People's Hospital of Yunnan Province", "city": "Kunming", "status": "RECRUITING"}, {"facility": "Jiangxi Provincial People's Hospital", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Nanyang Central Hospital", "city": "Nanyang", "status": "RECRUITING"}, {"facility": "Qilu Hospital of Shandong University (Qingdao)", "city": "Qingdao", "status": "RECRUITING"}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Shenzhen Hospital of University of Hong Kong", "city": "Shenzhen", "status": "RECRUITING"}, {"facility": "The Second Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": "RECRUITING"}, {"facility": "Taihe Hospital", "city": "Shiyan", "status": "RECRUITING"}, {"facility": "First Hospital of Shanxi Medical University", "city": "Taiyuan", "status": "RECRUITING"}, {"facility": "Shanxi Provincial People's Hospital", "city": "Taiyuan", "status": "RECRUITING"}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": "RECRUITING"}, {"facility": "Renmin Hospital of Wuhan University", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Tongji Hospital", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of the Chinese People's Liberation Army Air Force Medical University", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "Xi'an International Medical Center Hospital", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Xiamen University", "city": "Xiamen", "status": "RECRUITING"}, {"facility": "Zhongshan Hospital Xiamen University", "city": "Xiamen", "status": "RECRUITING"}, {"facility": "Yan'an University Xianyang Hospital", "city": "Xianyang", "status": "RECRUITING"}, {"facility": "Yantai Mountain Hospital in Yantai City", "city": "Yantai", "status": "RECRUITING"}, {"facility": "The Central Hospital of Yongzhou", "city": "Yongzhou", "status": "RECRUITING"}, {"facility": "Zaozhuang Municipal Hospital", "city": "Zaozhuang", "status": "RECRUITING"}, {"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Zigong First People's Hospital", "city": "Zigong", "status": "RECRUITING"}], "cn_site_count": 51, "broad_only": false}, {"nct": "NCT06502015", "title": "Biomarkers in Autoimmune Disease of Nervous System", "status": "RECRUITING", "start": "2024-07-31", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 50000, "sponsor": "Tongji Hospital", "conditions": ["Autoimmune Diseases of the Nervous System", "Neuromyelitis Optica Spectrum Disorder", "Multiple Sclerosis", "Guillain-Barre Syndrome", "Acute Disseminated Encephalomyelitis", "Autoimmune Encephalitis", "Stiff-Person Syndrome", "Myasthenia Gravis", "Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "Idiopathic Inflammatory Myopathies", "Autoimmune Diseases"], "cn_sites": [{"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06474520", "title": "Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD)", "status": "RECRUITING", "start": "2024-08-08", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 250, "sponsor": "Tongji Hospital", "conditions": ["Idiopathic Inflammatory Demyelinating Disease", "Multiple Sclerosis", "Neuromyelitis Optica Spectrum Disorder", "Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease", "Acute Disseminated Encephalomyelitis"], "cn_sites": [{"facility": "Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06485232", "title": "Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.", "status": "NOT_YET_RECRUITING", "start": "2025-02-28", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 25, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Neuromyelitis Optica Spectrum Disorders", "Myasthenia Gravis, Generalized", "Multiple Sclerosis", "Chronic Inflammatory Demyelinating Polyradiculoneuropathy"], "cn_sites": [{"facility": "Xuanwu Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06620809", "title": "The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders", "status": "RECRUITING", "start": "2025-03-28", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 69, "sponsor": "Tongji Hospital", "conditions": ["Neuromyelitis Optica Spectrum Disorders"], "cn_sites": [{"facility": "Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06829524", "title": "HANDLE-a Real World Study on Satralizumab in NMOSD", "status": "RECRUITING", "start": "2025-03-31", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Huashan Hospital", "conditions": ["Neuromyelitis Optica Spectrum Disorders (NMOSD)"], "cn_sites": [{"facility": "Huashan Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07022197", "title": "Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases", "status": "RECRUITING", "start": "2025-04-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 27, "sponsor": "Tianjin Medical University General Hospital", "conditions": ["Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "NMO Spectrum Disorder", "Myasthenia Gravis", "Idiopathic Inflammatory Myopathies"], "cn_sites": [{"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06763848", "title": "Protein A immuNoaDsorption for the Treatment of Acute Episodes of Neuromyelitis Optica Spectrum Disorder", "status": "RECRUITING", "start": "2025-04-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 144, "sponsor": "Third Affiliated Hospital, Sun Yat-Sen University", "conditions": ["Neuromyelitis Optica Spectrum Disorders"], "cn_sites": [{"facility": "The Third Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06939166", "title": "Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases", "status": "RECRUITING", "start": "2025-06-17", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Tianjin Huanhu Hospital", "conditions": ["Neuromyelitis Optica Spectrum Disorders", "Myasthenia Gravis", "Multiple Sclerosis", "Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "Autoimmune Encephalitis"], "cn_sites": [{"facility": "Tianjin Huanhu Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06885957", "title": "Monoclonal Antibody-Based Therapies for AQP4-Positive NMOSD", "status": "RECRUITING", "start": "2025-07-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Tongji Hospital", "conditions": ["NMO Spectrum Disorder"], "cn_sites": [{"facility": "Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07266051", "title": "Prospective Cohort Study of Neuromyelitis Optica Spectrum Disorders (NMOSD)", "status": "NOT_YET_RECRUITING", "start": "2025-12", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 4000, "sponsor": "Xiamen Hospital of Traditional Chinese Medicine", "conditions": ["NMOSD"], "cn_sites": [{"facility": "The First Affiliated Hospital of Xiamen university", "city": "Xiamen", "status": ""}, {"facility": "The Second Affiliated Hospital of Xiamen Medical College", "city": "Xiamen", "status": ""}, {"facility": "Xiamen Hospital of Traditional Chinese Medicine", "city": "Xiamen", "status": ""}, {"facility": "Zhongshan Hospital (Xiamen), Fudan University", "city": "Xiamen", "status": ""}, {"facility": "Zhongshan Hospital Xiamen University", "city": "Xiamen", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT07377305", "title": "Efficacy and Safety of Transcranial Temporal Interference Stimulation (tTIS) for Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder (NMOSD)", "status": "RECRUITING", "start": "2025-12-08", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Tang-Du Hospital", "conditions": ["NMO Spectrum Disorder"], "cn_sites": [{"facility": "Tangdu Hospital", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07420296", "title": "Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder", "status": "RECRUITING", "start": "2026-01-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 198, "sponsor": "Tianjin Medical University General Hospital", "conditions": ["Neuromyelitis Optica Spectrum Disorders (NMOSD)"], "cn_sites": [{"facility": "Tianjin Medical University General Hospital, Department of Neurology", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07410039", "title": "Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study", "status": "RECRUITING", "start": "2026-02-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 200, "sponsor": "Chinese PLA General Hospital", "conditions": ["Neuromyelitis Optica Spectrum Disorder Attack"], "cn_sites": [{"facility": "the First Medical Center of Chinese PLA General Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07392528", "title": "Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-03", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Tianjin Huanhu Hospital", "conditions": ["Neuromyelitis Optica Spectrum Disorders", "Multiple Sclerosis", "Myasthenia Gravis"], "cn_sites": [{"facility": "Tianjin Huanhu Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07333196", "title": "Tongji NADs Cohort", "status": "NOT_YET_RECRUITING", "start": "2026-03-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1550, "sponsor": "Tongji Hospital", "conditions": ["Multiple Sclerosis", "NMO Spectrum Disorder", "Autoimmune Encephalitis", "Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease", "Autoimmune Nodopathy", "Acute Inflammatory Demyelinating Polyradiculoneuropathy", "Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "Myasthenia Gravis", "Idiopathic Inflammatory Myopathies"], "cn_sites": [{"facility": "Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07526493", "title": "Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.", "status": "RECRUITING", "start": "2026-04-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Tongji Hospital", "conditions": ["Multiple Sclerosis (MS)", "Neuromyelitis Optica Spectrum Disorder (NMOSD)", "Autoimmune Encephalitis (AE)", "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)", "Myasthenia Gravis (MG)", "Anti-Myelin Oligodendrocyte Glycoprotein Immunoglobulin G Antibody-Associated Disease (MOGAD)", "Idiopathic Inflammatory Myopathies (IIM)"], "cn_sites": [{"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05199688", "title": "A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)", "status": "RECRUITING", "start": "2026-05-06", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 8, "sponsor": "Hoffmann-La Roche", "conditions": ["Neuromyelitis Optica Spectrum Disorder", "NMOSD"], "cn_sites": [{"facility": "Guangzhou Women and Children's Medical Center", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07592754", "title": "The Safety and Efficacy of KSVCBD Injection in Neuromyelitis Optica Spectrum Disorder.", "status": "NOT_YET_RECRUITING", "start": "2026-05-15", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Chinese PLA General Hospital", "conditions": ["Neuromyelitis Optica Spectrum Disease (NMOSD)"], "cn_sites": [{"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07699770", "title": "Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial", "status": "NOT_YET_RECRUITING", "start": "2026-06-15", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 110, "sponsor": "Tang-Du Hospital", "conditions": ["Neuromyelitis Optica Spectrum Disorders (NMOSD)", "Neuropathic Pain"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "the First Hospital of Tsinghua University", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "The First Affiliated Hospital of Harbin Medical University", "city": "Harbin", "status": ""}, {"facility": "Inner Mongolia People's Hospital", "city": "Hohhot", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "Tangdu Hospotal", "city": "Xi'an", "status": ""}, {"facility": "Xinjiang Uygur Autonomous Region People's Hospital", "city": "Ürümqi", "status": ""}, {"facility": "The First Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT07676266", "title": "A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "The Affiliated Hospital of Qingdao University", "conditions": ["Multiple Sclerosis (MS)", "Myasthenia Gravis (MG)", "Neuromyelitis Optica Spectrum Disorder", "Systemic Lupus Erythematosus", "Systemic Sclerosis", "Immune-Mediated Necrotizing Myopathy"], "cn_sites": [{"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07557420", "title": "Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Study of Ravulizumab in Chinese Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD)", "status": "RECRUITING", "start": "2026-07-20", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 19, "sponsor": "Alexion Pharmaceuticals, Inc.", "conditions": ["NMOSD", "Neuromyelitis Optica Spectrum Disorder"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Dongguan", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Jinan", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Shijiazhuang", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Taiyuan", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Wenzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT07762872", "title": "A Multicenter Prospective Real-World Effectiveness and Safety of Satralizumab in the Early Treatment of Attacks in NMOSD", "status": "RECRUITING", "start": "2026-07-20", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 50, "sponsor": "Junwei Hao, MD", "conditions": ["Neuromyelitis Optica Spectrum Disorders (NMOSD)"], "cn_sites": [{"facility": "Xuanwu Hospital Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07809724", "title": "Efficacy and Safety of Low-Dose IL-2 in Neuromyelitis Optica Spectrum Disorder", "status": "NOT_YET_RECRUITING", "start": "2026-08-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Peking University People's Hospital", "conditions": ["Neuromyelitis Optica Spectrum Disorder (NMOSD)"], "cn_sites": [{"facility": "Department of Rheumatology and Immunology, Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02021825", "title": "Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders", "status": "UNKNOWN", "start": "2009-03", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Neuromyelitis Optica", "Neuromyelitis Optica Spectrum Disorders"], "cn_sites": [{"facility": "Department of Neurology, Xuanwu Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01364246", "title": "Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis Optica", "status": "UNKNOWN", "start": "2010-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Shenzhen Beike Bio-Technology Co., Ltd.", "conditions": ["Progressive Multiple Sclerosis", "Neuromyelitis Optica."], "cn_sites": [{"facility": "Nanjing University Medical College Affiliated Drum Tower Hospital", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02249676", "title": "Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders", "status": "COMPLETED", "start": "2013-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Tianjin Medical University General Hospital", "conditions": ["Devic's Syndrome", "Devic's Neuromyelitis Optica", "Devic Syndrome", "Devic's Disease", "Devic Disease"], "cn_sites": [{"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02836327", "title": "Multimodel Magnetic Resonance Imaging (MRI)of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders", "status": "UNKNOWN", "start": "2014-09", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 300, "sponsor": "Chinese PLA General Hospital", "conditions": ["Multiple Sclerosis", "Neuromyelitis Optica Spectrum Disorders"], "cn_sites": [{"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02893111", "title": "Efficacy and Safety of Bortezomib as add-on Treatment in Relapsing Neuromyelitis Optica Spectrum Disorder", "status": "COMPLETED", "start": "2015-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 5, "sponsor": "Tianjin Medical University General Hospital", "conditions": ["Neuromyelitis Optica Spectrum Disorder"], "cn_sites": [{"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03062579", "title": "A Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSD", "status": "COMPLETED", "start": "2017-02-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Fu-Dong Shi", "conditions": ["Neuromyelitis Optica Spectrum Disorders", "Neuromyelitis Optica", "Devic's Disease"], "cn_sites": [{"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03350633", "title": "Tocilizumab vs Azathioprine in Neuromyelitis Optica Spectrum Disorders", "status": "COMPLETED", "start": "2017-11-01", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 118, "sponsor": "Tianjin Medical University General Hospital", "conditions": ["Neuromyelitis Optica Spectrum Disorders", "Neuromyelitis Optica"], "cn_sites": [{"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03330418", "title": "A Phase III Study of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Neuromyelitis Optica Spectrum Disorders", "status": "TERMINATED", "start": "2018-01-29", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 178, "sponsor": "RemeGen Co., Ltd.", "conditions": ["Neuromyelitis Optica Spectrum Disorders"], "cn_sites": [{"facility": "Beijing Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03514030", "title": "Clinic Registry Study of Optic Neuromyelitis Spectrum Disease in China", "status": "UNKNOWN", "start": "2018-04-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 400, "sponsor": "Beijing Tongren Hospital", "conditions": ["NMO Spectrum Disorder;Registry Study"], "cn_sites": [{"facility": "Beijing Tongren Hospital,Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03605238", "title": "Treatment of Relapsed and/or Refractory AQP4-IgG Seropositive NMOSD by Tandem CAR T Cells Targeting CD19 and CD20", "status": "WITHDRAWN", "start": "2018-08-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Chinese PLA General Hospital", "conditions": ["Neuromyelitis Optica Spectrum Disorder"], "cn_sites": [{"facility": "People's Liberation of Army General Hospital (PLAGH)", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04101058", "title": "Treatment Response Among Chinese Neuromyelitis Optica Spectrum Disorders", "status": "UNKNOWN", "start": "2019-01-21", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Third Affiliated Hospital, Sun Yat-Sen University", "conditions": ["Neuromyelitis Optica Spectrum Disorders"], "cn_sites": [{"facility": "Wei Qiu", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05896605", "title": "Monitoring of Azathioprine Metabolite Concentrations and Cytokine Levels in Neuromyelitis Optica Spectrum Disorder", "status": "COMPLETED", "start": "2020-01-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 63, "sponsor": "First Affiliated Hospital of Guangxi Medical University", "conditions": ["NMO Spectrum Disorder", "Azathioprine Adverse Reaction"], "cn_sites": [{"facility": "Qingmeng Huang", "city": "Nanning", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04227470", "title": "A Study of HBM9161 in NMOSD Patients", "status": "COMPLETED", "start": "2020-03-31", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Harbour BioMed (Guangzhou) Co. Ltd.", "conditions": ["NMO Spectrum Disorder"], "cn_sites": [{"facility": "Nanfang Hospital", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04388072", "title": "An Diagnostic Cohort on AQP4-Immunoglobulin G Detection Kit", "status": "COMPLETED", "start": "2020-05-15", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "First Affiliated Hospital of Fujian Medical University", "conditions": ["Neuromyelitis Optica Spectrum Disorders"], "cn_sites": [{"facility": "Department of Neurology,First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": ""}, {"facility": "Third Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT04146285", "title": "A Phase I Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders", "status": "COMPLETED", "start": "2020-09-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Bio-Thera Solutions", "conditions": ["Neuromyelitis Optica Spectrum Disorders"], "cn_sites": [{"facility": "Huashan Hospital affiliated to Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04601142", "title": "Association Between the Effect of Glucocorticoid Pulse Therapy on Neuromyelitis Optica (NMO) and Gene Polymorphism", "status": "UNKNOWN", "start": "2020-10-31", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 350, "sponsor": "Beijing Tongren Hospital", "conditions": ["Glucocorticoid Resistance", "Gene", "Neuromyelitis Optica"], "cn_sites": [{"facility": "Beijing Tongren Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06443333", "title": "National, Multicentric Registry Study on Neuroimmunological Diseases in China", "status": "UNKNOWN", "start": "2020-12-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 7000, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Multiple Sclerosis", "NMO Spectrum Disorder", "Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease", "Myasthenia Gravis", "Autoimmune Encephalitis", "Acute Disseminated Encephalomyelitis"], "cn_sites": [{"facility": "Xuanwu Hospital ,Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04670770", "title": "An Open Label Study of the Effects of SHR1459 in NMOSDs Patients", "status": "COMPLETED", "start": "2021-01-20", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Reistone Biopharma Company Limited", "conditions": ["Neuromyelitis Optica Spectrum Disorders"], "cn_sites": [{"facility": "Xiangya Hospital Of Central South University", "city": "Changsha", "status": ""}, {"facility": "West China Hospital Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Lanzhou University Second Hospital", "city": "Lanzhou", "status": ""}, {"facility": "People's Hospital of Rizhao", "city": "Rizhao", "status": ""}, {"facility": "Huashan Hospital Affiliated To Fudan University", "city": "Shanghai", "status": ""}, {"facility": "First Hospital Of Shanxi Medical University", "city": "Taiyuan", "status": ""}, {"facility": "Tangdu Hosiptal", "city": "Xi'an", "status": ""}, {"facility": "The First Affiliated Hospital Of Zhengzhou University", "city": "Zhengzhou", "status": ""}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT05154734", "title": "Efficacy and Safety of Belimumab in Neuromyelitis Optica Spectrum Disorders", "status": "COMPLETED", "start": "2021-12-12", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 14, "sponsor": "Tianjin Medical University General Hospital", "conditions": ["NMO Spectrum Disorder"], "cn_sites": [{"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05871658", "title": "Efficacy of Electroacupuncture in NMOSD Patients With Pain: Study Protocol", "status": "COMPLETED", "start": "2022-03-21", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Yuanqi Zhao,MD", "conditions": ["Neuromyelitis Optica Spectrum Disorders", "Pain"], "cn_sites": [{"facility": "Guangdong Provincial Hospital of Chinese Medicine", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05284175", "title": "A Study of Orelabrutinib in Patients With AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder", "status": "UNKNOWN", "start": "2022-04", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 23, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Neuromyelitis Optica Spectrum Disorder"], "cn_sites": [{"facility": "Peking Union Medical College Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05356858", "title": "An Open Label Study of the Effects and Safety of Zanubrutinib in NMOSDs Adult Patients", "status": "TERMINATED", "start": "2022-05-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Neuromyelitis Optica"], "cn_sites": [{"facility": "XuanWu Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05432713", "title": "A Study of LP-168 in Healthy Volunteers", "status": "COMPLETED", "start": "2022-05-14", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 70, "sponsor": "Guangzhou Lupeng Pharmaceutical Company LTD.", "conditions": ["Multiple Sclerosis", "NMO Spectrum Disorder"], "cn_sites": [{"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05414890", "title": "Sensitivity and Specificity of TSA-CBA for Autoantibodies Against Neural Antigen Determination", "status": "UNKNOWN", "start": "2022-06-30", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2500, "sponsor": "Beijing Tiantan Hospital", "conditions": ["NMO Spectrum Disorder", "NMDA-R Encephalitis", "Diagnostic Self Evaluation", "Immune System Diseases", "Nervous System Diseases", "Autoimmune Diseases of the Nervous System", "Autoimmune Diseases"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05314010", "title": "A Study of MIL62 in Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD)", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-08-18", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 102, "sponsor": "Beijing Mabworks Biotech Co., Ltd.", "conditions": ["Neuromyelitis Optica Spectrum Disorder"], "cn_sites": [{"facility": "Ethics Committee of Chinese PLA General Hosptial", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05414487", "title": "Effects of Ofatumumab Treatment on Immune Cells and Meningeal Lymphatic Drainage in Patients With Demyelinating Diseases", "status": "UNKNOWN", "start": "2022-10-15", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 34, "sponsor": "Tianjin Medical University General Hospital", "conditions": ["Multiple Sclerosis", "Neuromyelitis Optica Spectrum Disorder", "Demyelinating Diseases of the Central Nervous System"], "cn_sites": [{"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05403138", "title": "Safety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorders", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-11-01", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 135, "sponsor": "Tianjin Medical University General Hospital", "conditions": ["Neuromyelitis Optica", "Neuromyelitis Optica Spectrum Disorder", "NMO Spectrum Disorder"], "cn_sites": [{"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05551598", "title": "Efficacy and Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD)", "status": "COMPLETED", "start": "2022-11-28", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 46, "sponsor": "CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.", "conditions": ["Neuromyelitis Optica Spectrum Disorder"], "cn_sites": [{"facility": "Xuanwu Hospital Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05792462", "title": "Efficacy and Safety of Baricitinib in Neuromyelitis Optica Spectrum Disorders", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-04-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 11, "sponsor": "Tianjin Medical University General Hospital", "conditions": ["NMO Spectrum Disorder"], "cn_sites": [{"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05828212", "title": "Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of R/R Neuromyelitis Optica", "status": "COMPLETED", "start": "2023-05-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Zhejiang University", "conditions": ["Neuromyelitis Optica"], "cn_sites": [{"facility": "The first affiliated hospital of medical college of zhejiang university", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06044350", "title": "A Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-08-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 162, "sponsor": "Bio-Thera Solutions", "conditions": ["Optic Neuromyelitis Spectrum Disease"], "cn_sites": [{"facility": "The First Affiliated Hospital of the Baotou Medical College of Inner Mongolia University of Science and Technology", "city": "Baotou", "status": ""}, {"facility": "Beijing Hospital", "city": "Beijing", "status": ""}, {"facility": "China-japan friendship Hospital", "city": "Beijing", "status": ""}, {"facility": "The first hospital of Peking University", "city": "Beijing", "status": ""}, {"facility": "The Central South University Xiang Ya Hospital", "city": "Changsha", "status": ""}, {"facility": "Xiangya 2nd hospital of central south university", "city": "Changsha", "status": ""}, {"facility": "First affiliated hospital of chongqing medical university", "city": "Chongqing", "status": ""}, {"facility": "The first affiliated hospital of Dalian Medical University", "city": "Dalian", "status": ""}, {"facility": "First affiliated hospital of fujian medical university", "city": "Fuzhou", "status": ""}, {"facility": "Sun Yat-sen Memorial Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "The first hospital affiliated to sun yat-sen university", "city": "Guangzhou", "status": ""}, {"facility": "The first People's Hospital of Guangzhou", "city": "Guangzhou", "status": ""}, {"facility": "The third hospital affiliated to sun yat-sen university", "city": "Guangzhou", "status": ""}, {"facility": "People's Hospital of Zhejiang province", "city": "Hangzhou", "status": ""}, {"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": ""}, {"facility": "Second Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": ""}, {"facility": "Shandong University Qilu Hospital", "city": "Jinan", "status": ""}, {"facility": "Jingzhou Central Hospital", "city": "Jingzhou", "status": ""}, {"facility": "First Affiliated Hospital of the Kunming Medical University", "city": "Kunming", "status": ""}, {"facility": "Second Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": ""}, {"facility": "Affiliated Hospital of North Sichuan Medical College", "city": "Nanchong", "status": ""}, {"facility": "Drum Tower Hospital affiliated to Medical College of Nanjing University", "city": "Nanjing", "status": ""}, {"facility": "Southeast university affiliated zhongda hospital", "city": "Nanjing", "status": ""}, {"facility": "The Chinese people's liberation army general hospital in eastern theater", "city": "Nanjing", "status": ""}, {"facility": "The first People's Hospital of Nantong", "city": "Nantong", "status": ""}, {"facility": "Qingdao municipal hospital", "city": "Qingdao", "status": ""}, {"facility": "Mount Hua Hospital affiliated to Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shuguang hospital affiliated to Shanghai University of Traditional Chinese medicine", "city": "Shanghai", "status": ""}, {"facility": "Zhongshan hospital affiliated to Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shenzhen city people's hospital", "city": "Shenzhen", "status": ""}, {"facility": "Second Hebei Medical University Hospital", "city": "Shijia Zhuang", "status": ""}, {"facility": "The Third Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "First Affiliated Hospital of Suzhou University", "city": "Suzhou", "status": ""}, {"facility": "The Second Affiliated Hospital of Suzhou University", "city": "Suzhou", "status": ""}, {"facility": "The first hospital of shanxi medical university", "city": "Taiyuan", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "The first hospital affiliated to wenzhou medical college", "city": "Wenzhou", "status": ""}, {"facility": "Tongji hospital affiliated to tongji medical college huazhong university of science and technology", "city": "Wuhan", "status": ""}, {"facility": "Xiehe hospital affiliated to tongji medical college huazhong university of science and technology", "city": "Wuhan", "status": ""}, {"facility": "Wuxi city people's hospital", "city": "Wuxi", "status": ""}, {"facility": "Second Affiliated Hospital of the People's Liberation Army Air Force Military Medical University", "city": "Xi'an", "status": ""}, {"facility": "Xi'an high-tech Hospital Co. , Ltd.", "city": "Xi'an", "status": ""}, {"facility": "Yan 'an University Xianyang Hospital Co. , Ltd.", "city": "Xianyang", "status": ""}, {"facility": "Henan province people's hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Zhengzhou university first affiliated hospital", "city": "Zhenzhou", "status": ""}], "cn_site_count": 45, "broad_only": false}, {"nct": "NCT06888622", "title": "BLAZE-Limiting Approach in NMOSD", "status": "COMPLETED", "start": "2023-10-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 9, "sponsor": "Huashan Hospital", "conditions": ["Neuromyelitis Optica Spectrum Disorders (NMOSD)"], "cn_sites": [{"facility": "Huashan Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06212245", "title": "A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders", "status": "UNKNOWN", "start": "2024-02-25", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 33, "sponsor": "Hansoh BioMedical R&D Company", "conditions": ["Neuromyelitis Optica Spectrum Disorders"], "cn_sites": [{"facility": "IRB of Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06180278", "title": "Long-term, Open-label, Safety Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD)", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-04-02", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 32, "sponsor": "Amgen", "conditions": ["Neuromyelitis Optica Spectrum Disorder"], "cn_sites": [{"facility": "Prince of Wales Hospital (PWH) - The Chinese University of Hong Kong (CUHK) - Ophtalmology", "city": "Hong Kong", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05909943", "title": "Efficacy and Safety of Ruxolitinib in Neuromyelitis Optica Spectrum Disorders", "status": "WITHDRAWN", "start": "2024-06-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Tianjin Medical University General Hospital", "conditions": ["Neuromyelitis Optica Spectrum Disorder Relapse"], "cn_sites": [{"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05891379", "title": "Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders", "status": "UNKNOWN", "start": "2024-07-09", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 50, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Neuromyelitis Optica Spectrum Disorder"], "cn_sites": [{"facility": "Xuanwu Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06548620", "title": "A Study of RD06-04 in Patients With Active Autoimmune Diseases", "status": "WITHDRAWN", "start": "2024-08-31", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Nanjing Bioheng Biotech Co., Ltd.", "conditions": ["SLE", "Sclerosis", "ANCA Associated Vasculitis", "IIM", "SS", "MS", "NMO Spectrum Disorder", "MG"], "cn_sites": [{"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06724809", "title": "Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-01-16", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 21, "sponsor": "Alexion Pharmaceuticals, Inc.", "conditions": ["NMOSD", "Neuromyelitis Optica Spectrum Disorders"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Dongguan", "status": ""}, {"facility": "Research Site", "city": "Jinan", "status": ""}, {"facility": "Research Site", "city": "Shanghai", "status": ""}, {"facility": "Research Site", "city": "Taiyuan", "status": ""}, {"facility": "Research Site", "city": "Wenzhou", "status": ""}, {"facility": "Research Site", "city": "Wuhan", "status": ""}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT06869278", "title": "A Study of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases", "status": "WITHDRAWN", "start": "2025-06-17", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": ["Multiple Sclerosis (MS)", "Neuromyelitis Optica Spectrum Disease (NMOSD)", "Anti-Myelin Oligodendrocyte Glycoprotein-IgG Associated Disorders (MOGAD)", "Myasthenia Gravis"], "cn_sites": [{"facility": "The Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": ""}, {"facility": "The First Affiliated Hospital of SOOCHOW University", "city": "Suzhou", "status": ""}, {"facility": "Union Hospital Tongji Medical College HUAZHONG University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07184840", "title": "Eculizumab For the Acute Attack of Neuromyelitis Optica Spectrum Disorder", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-09-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 110, "sponsor": "Tianjin Medical University General Hospital", "conditions": ["Neuromyelitis Optica Spectrum Disorder Attack"], "cn_sites": [{"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 73, "g_fetched": 39, "g_countries": [["United States", 14], ["France", 7], ["Germany", 4], ["Italy", 4], ["United Kingdom", 3], ["Greece", 1], ["Australia", 1], ["South Korea", 1], ["Israel", 1], ["Czechia", 1], ["Argentina", 1], ["Brazil", 1], ["Canada", 1], ["Netherlands", 1], ["Poland", 1], ["Serbia", 1], ["Spain", 1], ["Sweden", 1], ["Switzerland", 1], ["Martinique", 1], ["Austria", 1], ["United Arab Emirates", 1]], "g_trials": [{"nct": "NCT07595965", "title": "Evaluate the Safety and Tolerability of CE211NS21 in Patients With AQP4-IgG-positive NMOSD Relapse", "status": "NOT_YET_RECRUITING", "start": "2026-12-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Corestemchemon, Inc.", "countries": []}, {"nct": "NCT07818356", "title": "Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled Trial", "status": "NOT_YET_RECRUITING", "start": "2026-10-20", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Toulouse", "countries": ["France"]}, {"nct": "NCT05909761", "title": "Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy", "status": "RECRUITING", "start": "2026-10-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Amgen", "countries": ["United States"]}, {"nct": "NCT07804004", "title": "A Safety and Efficacy Study Evaluating CTX112 in Subjects With Refractory Neurologic Autoimmune Disease", "status": "NOT_YET_RECRUITING", "start": "2026-09-15", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "CRISPR Therapeutics", "countries": []}, {"nct": "NCT07704294", "title": "Early Prediction of Outcomes Following Optic Neuritis: Development and Acceptability of a Prognostic Tool", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "King's College London", "countries": ["United Kingdom"]}, {"nct": "NCT07573332", "title": "A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Patients", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "University of Texas Southwestern Medical Center", "countries": ["United States"]}, {"nct": "NCT07738952", "title": "Safety and Efficacy Study of Sivelestat in Neuromyelitis Optica Spectrum Disorder", "status": "NOT_YET_RECRUITING", "start": "2026-08-17", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Kyushu University", "countries": []}, {"nct": "NCT07010302", "title": "Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab in NMOSD", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Massachusetts General Hospital", "countries": ["Germany", "United States"]}, {"nct": "NCT07685678", "title": "Riptylimab for the Treatment of Optic Neuritis and Myelitis Spectrum Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-07-15", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Zhongming Qiu", "countries": []}, {"nct": "NCT07526298", "title": "Anticipating Irreversible Disability in Neuromyelitis Optica Spectrum Disorder: a Study to Assess Disease Activity in Apparently Stable Patients", "status": "NOT_YET_RECRUITING", "start": "2026-04-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS San Raffaele", "countries": ["Italy"]}, {"nct": "NCT07341828", "title": "A Study of C-CAR168 in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard Therapy", "status": "NOT_YET_RECRUITING", "start": "2026-02", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Huashan Hospital", "countries": []}, {"nct": "NCT07273292", "title": "Autonomic Dysfunction in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis : A Comparative Study", "status": "NOT_YET_RECRUITING", "start": "2026-01-20", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Mohamed Moshref abd alsattar", "countries": []}, {"nct": "NCT07304960", "title": "Multiple Sclerosis Versus Neuromyelitis Optica Spectrum Disorder", "status": "NOT_YET_RECRUITING", "start": "2026-01-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT06561009", "title": "Safety and Efficacy of BAFFR CART for Relapsed/ Refractory Neuromyelitis Optica Spectrum Disorder", "status": "NOT_YET_RECRUITING", "start": "2025-12-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Tianjin Medical University General Hospital", "countries": []}, {"nct": "NCT07182409", "title": "Efficacy and Safety of Monoclonal Antibody in Acute Phase of Neuromyelitis Optica Spectrum Disorder", "status": "NOT_YET_RECRUITING", "start": "2025-10-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "First Affiliated Hospital of Chongqing Medical University", "countries": []}, {"nct": "NCT07132398", "title": "Slow vs. Rapid Glucocorticoids Tapering With Inebilizumab in NMOSD", "status": "NOT_YET_RECRUITING", "start": "2025-09-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Tianjin Medical University General Hospital", "countries": []}, {"nct": "NCT06903130", "title": "Clinical Study to Evaluate the Effects of the Complement C5 Inhibitor Ravulizumab on Serum Neurofilament Light Chain (sNfL) and Glial Fibrillary Acidic Protein (sGFAP) Levels in Patients With Aquaporin-4-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD)", "status": "NOT_YET_RECRUITING", "start": "2025-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National and Kapodistrian University of Athens", "countries": ["Greece"]}, {"nct": "NCT07159893", "title": "Inectolizumab With Steroid Optimization in Newly Treated NMOSD", "status": "NOT_YET_RECRUITING", "start": "2025-09", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "First Affiliated Hospital of Wenzhou Medical University", "countries": []}, {"nct": "NCT06453694", "title": "Efgartigimod for the Treatment of Acute Optic Neuritis", "status": "RECRUITING", "start": "2025-08-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Anastasia Vishnevetsky, MD, MPH", "countries": ["United States"]}, {"nct": "NCT07202494", "title": "Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging", "status": "RECRUITING", "start": "2025-05-19", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique Hopitaux De Marseille", "countries": ["France"]}, {"nct": "NCT06680037", "title": "A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders", "status": "RECRUITING", "start": "2025-05-06", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "TG Therapeutics, Inc.", "countries": ["United States"]}, {"nct": "NCT06865274", "title": "Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte Myelin Protein Antibody Disease, and Multiple Sclerosis.", "status": "RECRUITING", "start": "2025-02-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Fondazione Policlinico Universitario Agostino Gemelli IRCCS", "countries": ["Italy"]}, {"nct": "NCT06780709", "title": "Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD", "status": "RECRUITING", "start": "2025-01-21", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Icahn School of Medicine at Mount Sinai", "countries": ["United States"]}, {"nct": "NCT06312644", "title": "Study of Ultomiris® (Ravulizumab) Safety in Pregnancy", "status": "RECRUITING", "start": "2024-12-16", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Alexion Pharmaceuticals, Inc.", "countries": ["Australia", "France", "Germany", "Italy", "South Korea", "United Kingdom", "United States"]}, {"nct": "NCT06633042", "title": "The Safety and Efficacy of Universal CAR-T Cells Targeting BCMA in the Treatment of Refractory NMOSD", "status": "NOT_YET_RECRUITING", "start": "2024-11-25", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Bioray Laboratories", "countries": []}]}, {"batch": 1, "no": 82, "name_zh": "尼曼匹克病", "query_terms": [{"term": "Niemann-Pick disease type C", "broad": false}, {"term": "Infantile neurovisceral acid sphingomyelinase deficiency", "broad": false}, {"term": "Chronic visceral acid sphingomyelinase deficiency", "broad": false}], "n_total": 2, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT03201627", "title": "Study of Lithium Carbonate to Treat Niemann-Pick Type C1 Disease", "status": "UNKNOWN", "start": "2017-07-05", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": ["Niemann-Pick Disease, Type C1"], "cn_sites": [{"facility": "Xin Hua Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03910621", "title": "Safety and Efficacy of Miglustat in Chinese NPC Patients", "status": "COMPLETED", "start": "2020-04-02", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 17, "sponsor": "Actelion", "conditions": ["Niemann-Pick Disease, Type C"], "cn_sites": [{"facility": "Peking University first Hospital", "city": "Beijing", "status": ""}, {"facility": "Xin Hua Hospital, Shanghai Jiao Tong University", "city": "Shanghai", "status": ""}], "cn_site_count": 2, "broad_only": false}], "g_total": 8, "g_fetched": 8, "g_countries": [["United States", 6], ["Brazil", 3], ["Australia", 3], ["Germany", 3], ["Italy", 3], ["Switzerland", 3], ["United Kingdom", 3], ["Argentina", 2], ["Canada", 2], ["India", 2], ["Mexico", 2], ["Pakistan", 2], ["Portugal", 2], ["Spain", 2], ["Turkey (Türkiye)", 2], ["France", 1], ["Sweden", 1], ["Czechia", 1], ["Netherlands", 1], ["Slovakia", 1]], "g_trials": [{"nct": "NCT07399704", "title": "A Study to Evaluate the Safety and Efficacy of Nizubaglustat (AZ-3102) in Patients With GM2 Gangliosidosis or Niemann-Pick Type C Disease", "status": "RECRUITING", "start": "2026-02-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Azafaros B.V.", "countries": ["Brazil"]}, {"nct": "NCT07082725", "title": "A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC)", "status": "RECRUITING", "start": "2025-06-30", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Azafaros B.V.", "countries": ["Argentina", "Australia", "Brazil", "Canada", "Germany", "India", "Italy", "Mexico", "Pakistan", "Portugal", "Spain", "Switzerland", "Turkey (Türkiye)", "United Kingdom", "United States"]}, {"nct": "NCT07054515", "title": "A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis", "status": "RECRUITING", "start": "2025-06-30", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Azafaros B.V.", "countries": ["Argentina", "Australia", "Brazil", "Canada", "France", "Germany", "India", "Italy", "Mexico", "Pakistan", "Portugal", "Spain", "Sweden", "Switzerland", "Turkey (Türkiye)", "United Kingdom", "United States"]}, {"nct": "NCT05588167", "title": "Establishment of Genomic and Phenotypic Database for Niemann-Pick Disease, Type C", "status": "RECRUITING", "start": "2022-11-28", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)", "countries": ["United States"]}, {"nct": "NCT05163288", "title": "A Pivotal Study of N-Acetyl-L-Leucine on Niemann-Pick Disease Type C", "status": "RECRUITING", "start": "2022-06-30", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "IntraBio Inc", "countries": ["Australia", "Czechia", "Germany", "Netherlands", "Slovakia", "Switzerland", "United Kingdom", "United States"]}, {"nct": "NCT04880356", "title": "Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.", "status": "RECRUITING", "start": "2021-03-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta", "countries": ["Italy"]}, {"nct": "NCT00344331", "title": "Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C", "status": "RECRUITING", "start": "2006-08-14", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)", "countries": ["United States"]}, {"nct": "NCT04316637", "title": "Early Access Program With Arimoclomol in US Patients With NPC", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "ZevraDenmark", "countries": ["United States"]}]}, {"batch": 1, "no": 83, "name_zh": "非综合征性耳聋", "query_terms": [{"term": "Rare non-syndromic genetic deafness", "broad": false}, {"term": "Non-Syndromic Deafness", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 2, "g_fetched": 2, "g_countries": [["France", 1], ["Australia", 1], ["United States", 1]], "g_trials": [{"nct": "NCT05402813", "title": "Natural History in Children up to 16 Years With Mild to Profound Hearing Loss Due to Mutations in GJB2 / OTOF Genes", "status": "RECRUITING", "start": "2022-11-18", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sensorion", "countries": ["France"]}, {"nct": "NCT01793168", "title": "Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford", "status": "RECRUITING", "start": "2010-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sanford Health", "countries": ["Australia", "United States"]}]}, {"batch": 1, "no": 84, "name_zh": "Noonan综合征", "query_terms": [{"term": "Noonan syndrome", "broad": false}], "n_total": 4, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT07336394", "title": "Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques", "status": "RECRUITING", "start": "2010-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "Chinese Academy of Medical Sciences, Fuwai Hospital", "conditions": ["Danon Disease", "Fabry Disease", "Cardiac Amyloidosis", "Noonan Syndrome", "Cardiac Sarcoidosis", "Glycogen Storage Disease", "Idiopathic Cardiomyopathy"], "cn_sites": [{"facility": "Fuwai Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03565003", "title": "A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China", "status": "COMPLETED", "start": "2018-11-20", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 126, "sponsor": "Jacobio Pharmaceuticals Co., Ltd.", "conditions": ["Non-small Cell Lung Cancer", "Head and Neck Cancer", "Esophageal Cancer", "Other Metastatic Solid Tumors"], "cn_sites": [{"facility": "Cancer Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Chinese PLA Central Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT04121286", "title": "A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China", "status": "COMPLETED", "start": "2020-07-14", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 17, "sponsor": "Allist Pharmaceuticals, Inc.", "conditions": ["Non-small Cell Lung Cancer", "Colorectal Cancer", "Pancreatic Ductal Carcinoma", "Esophageal Squamous Cell Carcinoma", "Head and Neck Squamous Cell Carcinoma", "Breast Cancer", "Other Solid Tumors"], "cn_sites": [{"facility": "Cancer Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical Collage Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}, {"facility": "Henan Provovential Cancer Hospital", "city": "Henan", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT05330325", "title": "A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-08-10", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 412, "sponsor": "Novo Nordisk A/S", "conditions": ["SGA, Turner Syndrome, Noonan Syndrome, ISS"], "cn_sites": [{"facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "Liuzhou Maternity and Child Healthcare Hospital-Child Healthcare", "city": "Liuzhou", "status": ""}, {"facility": "Sanya Central Hospital (Hainan Third People's Hospital)-Pediatric", "city": "Sanya", "status": ""}, {"facility": "Henan Children's Hospital Zhengzhou Children's Hospital-Endocrine Genetics and Metabolism", "city": "Zhengzhou", "status": ""}, {"facility": "Wuhan Children Hospital-Endocrine Genetics and Metabolism", "city": "Wuhan", "status": ""}, {"facility": "Wuhan Children Hospital", "city": "Wuhan", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical College of HUST-Pediatric", "city": "Wuhan", "status": ""}, {"facility": "Hunan Children's Hospital-Child Health Center", "city": "Changsha", "status": ""}, {"facility": "The First Bethune Hospital of Jilin University-Pediatric", "city": "Changchun", "status": ""}, {"facility": "Shandong Provincial Hospital-Pediatric", "city": "Jinan", "status": ""}, {"facility": "Shanghai Children's Hospital -Endocrine Genetics and Metabolism", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Children's Medical Center-Endocrine Genetics and Metabolism", "city": "Shanghai", "status": ""}, {"facility": "Chengdu Women's and Children's Central Hospital", "city": "Chengdu", "status": ""}], "cn_site_count": 14, "broad_only": false}], "g_total": 16, "g_fetched": 15, "g_countries": [["United States", 7], ["France", 5], ["Italy", 4], ["Germany", 2], ["Spain", 2], ["Romania", 1], ["South Korea", 1], ["Australia", 1], ["Canada", 1], ["Poland", 1], ["Netherlands", 1]], "g_trials": [{"nct": "NCT07817186", "title": "Clinical Trial of a MEK Inhibitor for RASopathy-Associated Severe Infantile Hypertrophic Cardiomyopathy: Baby MERIT", "status": "NOT_YET_RECRUITING", "start": "2027-08-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Carelon Research", "countries": []}, {"nct": "NCT07493239", "title": "A Decentralized Clinical Study Evaluating the Effectiveness of Two Different Doses of MyCondro™ on Physical Mobility and Joint Health", "status": "RECRUITING", "start": "2026-03-04", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Lesaffre International", "countries": ["United States"]}, {"nct": "NCT07259135", "title": "Link Between Abnormal Bleeding and Coagulation Disorders in Noonan Syndromes", "status": "NOT_YET_RECRUITING", "start": "2026-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Bordeaux", "countries": ["France"]}, {"nct": "NCT07221851", "title": "Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders", "status": "RECRUITING", "start": "2025-12-12", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Ascendis Pharma A/S", "countries": ["France", "Germany", "Italy", "Romania", "South Korea", "Spain", "United States"]}, {"nct": "NCT07464821", "title": "National Multicentre Study on Lipid Profile in Noonan Syndrome and Related Disorders: Trends by Age, Gender and Genotype", "status": "RECRUITING", "start": "2025-02-26", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS Azienda Ospedaliero-Universitaria di Bologna", "countries": ["Italy"]}, {"nct": "NCT06668805", "title": "A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment", "status": "RECRUITING", "start": "2024-11-22", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "BioMarin Pharmaceutical", "countries": ["Australia", "Canada", "France", "Germany", "Italy", "Spain", "United States"]}, {"nct": "NCT06147414", "title": "Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders", "status": "RECRUITING", "start": "2024-10-23", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT06555237", "title": "MEK Inhibitors for the Treatment of Hypertrophic Cardiomyopathy in Patients With RASopathies", "status": "RECRUITING", "start": "2024-08-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Medical University of Warsaw", "countries": ["Poland"]}, {"nct": "NCT05361811", "title": "Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial", "status": "RECRUITING", "start": "2024-01-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["United States"]}, {"nct": "NCT04888936", "title": "Clinical, Genetic, and Epidemiologic Study of Children and Adults With RASopathies", "status": "RECRUITING", "start": "2022-04-25", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["United States"]}, {"nct": "NCT05202210", "title": "Constitution of a Biological Collection to Study the Pathophysiology in Noonan Syndrome", "status": "RECRUITING", "start": "2022-01-26", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Toulouse", "countries": ["France"]}, {"nct": "NCT05761314", "title": "Solid Tumors in RASopathies", "status": "RECRUITING", "start": "2021-10-12", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Fondazione Policlinico Universitario Agostino Gemelli IRCCS", "countries": ["Italy"]}, {"nct": "NCT04463316", "title": "GROWing Up With Rare GENEtic Syndromes", "status": "RECRUITING", "start": "2018-10-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "dr. Laura C. G. de Graaff-Herder", "countries": ["Netherlands"]}, {"nct": "NCT04395495", "title": "RASopathy Biorepository", "status": "RECRUITING", "start": "2017-06-27", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Children's Hospital Medical Center, Cincinnati", "countries": ["United States"]}, {"nct": "NCT03050268", "title": "Familial Investigations of Childhood Cancer Predisposition", "status": "RECRUITING", "start": "2017-04-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "St. Jude Children's Research Hospital", "countries": ["United States"]}]}, {"batch": 1, "no": 85, "name_zh": "鸟氨酸氨甲酰基转移酶缺乏症", "query_terms": [{"term": "Ornithine transcarbamylase deficiency", "broad": false}], "n_total": 2, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT04573660", "title": "Abbott Vascular Medical Device Registry", "status": "RECRUITING", "start": "2020-10-25", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 3784, "sponsor": "Abbott Medical Devices", "conditions": ["Acute Myocardial Infarction", "Restenoses, Coronary", "Coronary Artery Lesions", "Venous Embolism", "Arterial Embolism"], "cn_sites": [{"facility": "The First Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "Jinhua Municipal Central Hospital", "city": "Jinhua", "status": "RECRUITING"}, {"facility": "Ningbo First Hospital", "city": "Ningbo", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT01663896", "title": "Observational Study of OCT in a Patients Undergoing FFR", "status": "COMPLETED", "start": "2012-12-11", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 418, "sponsor": "Abbott Medical Devices", "conditions": ["Coronary Artery Disease"], "cn_sites": [{"facility": "University of Hong Kong", "city": "Hong Kong", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 13, "g_fetched": 12, "g_countries": [["United States", 6], ["United Kingdom", 4], ["Australia", 2], ["Canada", 1], ["Spain", 1]], "g_trials": [{"nct": "NCT06735638", "title": "Outside the Cage (OTC) Robotic Esophagectomy", "status": "NOT_YET_RECRUITING", "start": "2027-01-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Centre hospitalier de l'Université de Montréal (CHUM)", "countries": ["Canada"]}, {"nct": "NCT07773246", "title": "Phase 1/2 Study of KRRO-121 in Healthy Volunteers and Patients With UCD", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Korro Bio, Inc.", "countries": ["Australia"]}, {"nct": "NCT07241845", "title": "Epiretinal Membrane in Patients With DR.", "status": "NOT_YET_RECRUITING", "start": "2026-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT06743906", "title": "Role of OCT & OCT Angiography in Patients With Posterior at the Uveitis Clinic of Assiut University Hospital.", "status": "NOT_YET_RECRUITING", "start": "2025-05-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT06805695", "title": "Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)", "status": "RECRUITING", "start": "2024-12-23", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "iECURE, Inc.", "countries": ["United Kingdom", "United States"]}, {"nct": "NCT06488313", "title": "A Study to Evaluate the Pharmacodynamics and Safety of ARCT-810 in Participants With OTCD", "status": "RECRUITING", "start": "2024-11-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Arcturus Therapeutics, Inc.", "countries": ["United States"]}, {"nct": "NCT06255782", "title": "An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC Deficiency", "status": "RECRUITING", "start": "2024-04-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "iECURE, Inc.", "countries": ["Australia", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT05092685", "title": "Halting Ornithine Transcarbamylase Deficiency With Recombinant AAV in ChildrEn", "status": "RECRUITING", "start": "2023-11-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University College, London", "countries": ["United Kingdom"]}, {"nct": "NCT04908319", "title": "Hepatic Histopathology in Urea Cycle Disorders", "status": "RECRUITING", "start": "2022-02-24", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Baylor College of Medicine", "countries": ["United States"]}, {"nct": "NCT04602325", "title": "Systemic Biomarkers of Brain Injury From Hyperammonemia", "status": "RECRUITING", "start": "2020-07-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Children's National Research Institute", "countries": ["United States"]}, {"nct": "NCT05299710", "title": "Ovarian Tissue Cryopreservation in Pre-Pubertal (OTC-Pre Pubertal)", "status": "RECRUITING", "start": "2018-05-29", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Erin Rowell", "countries": ["United States"]}, {"nct": "NCT02132741", "title": "Optical Coherence Tomography And NEphropathy: The OCTANE Study", "status": "RECRUITING", "start": "2014-05-16", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Edinburgh", "countries": ["United Kingdom"]}]}, {"batch": 1, "no": 86, "name_zh": "成骨不全症（脆骨病）", "query_terms": [{"term": "Osteogenesis imperfecta", "broad": false}], "n_total": 2, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT07557446", "title": "A Dose REgimen-Finding Study of AGA2115 in Chinese Patients With Osteogenesis ImpeRfecta (EIR)", "status": "RECRUITING", "start": "2026-06", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 48, "sponsor": "Angitia Biopharmaceuticals Guangzhou Limited", "conditions": ["Osteogenesis Imperfecta (OI)"], "cn_sites": [{"facility": "Chinese Academy of Medical Sciences, Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The University of Hong Kong-Shenzhen Hospital", "city": "Shenzhen", "status": "RECRUITING"}, {"facility": "Children's Hospital of Soochow University", "city": "Suzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Shanghai Sixth People's Hospital", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT05972551", "title": "Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-04-22", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 111, "sponsor": "Amgen", "conditions": ["Osteogenesis Imperfecta"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "The University of Hong Kong-Shenzhen Hospital", "city": "Shenzhen", "status": ""}, {"facility": "Tongji Hospital , Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Childrens Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "The First Bethune Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Shandong Provincial Hospital", "city": "Jinan", "status": ""}, {"facility": "West China Hospital Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Shanghai Sixth Peoples Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 8, "broad_only": false}], "g_total": 18, "g_fetched": 17, "g_countries": [["France", 4], ["United States", 4], ["Italy", 4], ["Belgium", 2], ["Canada", 2], ["Germany", 1], ["Japan", 1], ["Argentina", 1], ["Australia", 1], ["Denmark", 1], ["Netherlands", 1], ["United Kingdom", 1]], "g_trials": [{"nct": "NCT05559801", "title": "Mesenchymal Cell Therapy in Osteogenesis Imperfecta (OI)", "status": "NOT_YET_RECRUITING", "start": "2027-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Emory University", "countries": []}, {"nct": "NCT07666269", "title": "Morphology in Oral Rare Syndromes & Artificial Intelligence for Clinical Diagnosis", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Bordeaux", "countries": ["France"]}, {"nct": "NCT07594639", "title": "GRACE II (General Retrospective Analysis of Commercial Experience With AGN1 LOEP)", "status": "NOT_YET_RECRUITING", "start": "2026-06-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "AgNovos Healthcare, LLC", "countries": ["Belgium"]}, {"nct": "NCT07366086", "title": "Pediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis Imperfecta", "status": "RECRUITING", "start": "2026-03-18", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Amgen", "countries": ["Germany", "Japan", "United States"]}, {"nct": "NCT07062588", "title": "Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN)", "status": "RECRUITING", "start": "2025-12-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Angitia Incorporated Limited", "countries": ["Argentina", "Australia", "Canada", "Denmark", "France", "Netherlands", "United Kingdom", "United States"]}, {"nct": "NCT07412782", "title": "REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)", "status": "RECRUITING", "start": "2025-12-04", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Meyer Children's Hospital IRCCS", "countries": ["Italy"]}, {"nct": "NCT06874166", "title": "Social Cognition in Dystrophinopathies and Neurodevelopmental Disorders", "status": "NOT_YET_RECRUITING", "start": "2025-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS Eugenio Medea", "countries": []}, {"nct": "NCT07173010", "title": "Pediatric Arthropathy Beyond Inflammation: Clinical Spectrum and Diagnostic Approach at Assiut University Children Hospital", "status": "NOT_YET_RECRUITING", "start": "2025-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT07478224", "title": "An Interventional Study to Evaluate the Impact of Blood Flow Restriction Training on Muscle, Bone, and Quality of Life in Adults With Osteogenesis Imperfecta Type I", "status": "RECRUITING", "start": "2025-08-19", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Ghent", "countries": ["Belgium"]}, {"nct": "NCT07287241", "title": "Prospective Observational Cohort Study of Cardiac Structure and Function in Children and Adults With Osteogenesis Imperfecta", "status": "RECRUITING", "start": "2025-06-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Istituto Ortopedico Rizzoli", "countries": ["Italy"]}, {"nct": "NCT05927389", "title": "Adapted Physical Activity Program (APA) for Effort Rehabilitation of Children and Teenagers With Osteogenesis Imperfecta", "status": "RECRUITING", "start": "2024-02-26", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Toulouse", "countries": ["France"]}, {"nct": "NCT05258019", "title": "Site Preservation After Tooth Extraction", "status": "NOT_YET_RECRUITING", "start": "2023-11-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Nanfang Hospital, Southern Medical University", "countries": []}, {"nct": "NCT05419960", "title": "Audio-vestibular Evaluation of Children and Young Adults With Osteogenesis Imperfecta", "status": "RECRUITING", "start": "2022-12-22", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT05464498", "title": "Evaluation of Collagen-based Medical Device Treatment Combined With Physiotherapy in Subjects With Achilles Tendinopathy.", "status": "RECRUITING", "start": "2022-06-13", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Guna S.p.a", "countries": ["Italy"]}, {"nct": "NCT04152551", "title": "Effects of Bisphosphonates on OI-Related Hearing Loss", "status": "RECRUITING", "start": "2019-11-02", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Hospital for Special Surgery, New York", "countries": ["United States"]}, {"nct": "NCT02432625", "title": "BBD Longitudinal Study of Osteogenesis Imperfecta", "status": "RECRUITING", "start": "2015-06-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Baylor College of Medicine", "countries": ["Canada", "United States"]}, {"nct": "NCT04115774", "title": "Registry of Osteogenesis Imperfecta", "status": "RECRUITING", "start": "2013-06-28", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Luca Sangiorgi", "countries": ["Italy"]}]}, {"batch": 1, "no": 87, "name_zh": "帕金森病（青年型、早发型）", "query_terms": [{"term": "Young-onset Parkinson disease", "broad": false}, {"term": "Parkinson Disease (Young-onset , Early-onset)", "broad": true}], "n_total": 189, "n_open": 62, "n_open_precise": 4, "n_broad": 185, "trials": [{"nct": "NCT03508960", "title": "Chinese EOPD Registry", "status": "RECRUITING", "start": "2017-02-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 3000, "sponsor": "Xiangya Hospital of Central South University", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06608355", "title": "The Safety, Tolerability and Preliminary Efficacy of NouvNeu001 for Early-onset Parkinson's Disease", "status": "RECRUITING", "start": "2024-08-23", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "iRegene Therapeutics Co., Ltd.", "conditions": ["Early-onset Parkinson's Disease"], "cn_sites": [{"facility": "Tongji Hospital Affiliated to Tongji Medical College Hust", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07166757", "title": "Clinical Study to Evaluate XS411 in Treatment of Early-onset Parkinson's Disease", "status": "RECRUITING", "start": "2025-09-22", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.", "conditions": ["Parkinson Disease (PD)"], "cn_sites": [{"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07741045", "title": "Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's Disease", "status": "NOT_YET_RECRUITING", "start": "2026-08-03", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 300, "sponsor": "Hangzhou PhecdaMed Co., Ltd.", "conditions": ["Parkinson's Disease (PD)", "Parkinson Disease 6, Early-Onset"], "cn_sites": [{"facility": "Beijing Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Xuanwu Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "Guangdong Provincial People's Hospital", "city": "Guangzhou", "status": ""}, {"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "The Third Xiangya Hospital, Central South University", "city": "Changsha", "status": ""}, {"facility": "Xiangya Hospital, Central South University", "city": "Changsha", "status": ""}, {"facility": "General Hospital of Nuclear Industry (The Second Affiliated Hospital of Soochow University)", "city": "Suzhou", "status": ""}, {"facility": "Ruijin Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Sir Run Run Shaw Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "The Affiliated Hospital of Hangzhou Normal University", "city": "Hangzhou", "status": ""}, {"facility": "The Second Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Huzhou Central Hospital", "city": "Huzhou", "status": ""}, {"facility": "Jiaxing Second Hospital", "city": "Jiaxing", "status": ""}, {"facility": "Lishui Municipal People's Hospital", "city": "Lishui", "status": ""}, {"facility": "Taizhou Central Hospital", "city": "Taizhou", "status": ""}, {"facility": "Taizhou Hospital of Zhejiang Province", "city": "Taizhou", "status": ""}, {"facility": "Wenzhou Central Hospital", "city": "Wenzhou", "status": ""}], "cn_site_count": 21, "broad_only": false}, {"nct": "NCT03523104", "title": "Chinese PD-LRRK2 Registry", "status": "RECRUITING", "start": "2017-02-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "Xiangya Hospital of Central South University", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT03887663", "title": "Chinese PD Registry", "status": "RECRUITING", "start": "2017-02-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 3000, "sponsor": "Xiangya Hospital of Central South University", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Xiangya Hospital of Central South University", "city": "Changzhi", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT03523052", "title": "Chinese PD-SNCA Registry", "status": "RECRUITING", "start": "2017-02-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 3000, "sponsor": "Xiangya Hospital of Central South University", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT03508986", "title": "Chinese FPD Registry", "status": "RECRUITING", "start": "2017-02-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1500, "sponsor": "Xiangya Hospital of Central South University", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT03523065", "title": "Chinese PD-GBA Registry", "status": "RECRUITING", "start": "2017-02-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Xiangya Hospital of Central South University", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT05901818", "title": "Safety and Efficacy of Autologous iNSC-DAP in the Treatment of Parkinson's Disease", "status": "RECRUITING", "start": "2021-04-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Parkinson's Disease"], "cn_sites": [{"facility": "Xuanwu Hospital Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06129942", "title": "Light Therapy in Parkinson's Disease", "status": "RECRUITING", "start": "2021-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Second Affiliated Hospital of Soochow University", "conditions": ["Parkinson Disease", "Sleep Disorder", "Circadian Rhythm Disorders"], "cn_sites": [{"facility": "Department of Neurology, Second Affiliated Hospital of Soochow University", "city": "Suzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06295263", "title": "Application of AI Technology for the Diagnosis and Treatment of Geriatric Diseases", "status": "RECRUITING", "start": "2022-03-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 460, "sponsor": "Qilu Hospital of Shandong University", "conditions": ["Parkinson Disease", "Alzheimer Disease", "Nervous System Diseases", "Geriatric Diseases"], "cn_sites": [{"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06449404", "title": "7.0T Magnetic Resonance Imaging Study of Parkinson's Disease", "status": "RECRUITING", "start": "2022-03-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Chinese PLA General Hospital", "conditions": ["Parkinson's Diseases", "MRI"], "cn_sites": [{"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT05505461", "title": "Neoadjuvant Immunotherapy and Chemoradiotherapy for Locally Advanced Esophagogastric Junction Adenocarcinoma", "status": "NOT_YET_RECRUITING", "start": "2023-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 26, "sponsor": "Peking University People's Hospital", "conditions": ["Adenocarcinoma of Esophagogastric Junction"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT05319730", "title": "A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)", "status": "RECRUITING", "start": "2023-05-16", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 230, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Esophageal Squamous Cell Carcinoma"], "cn_sites": [{"facility": "Anhui Provincial Hospital ( Site 3501)", "city": "Hefei", "status": "RECRUITING"}, {"facility": "Beijing Cancer hospital-Digestive Oncology ( Site 3500)", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Xiamen University ( Site 3516)", "city": "Xiamen", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Xinxiang Medical University-Oncology ( Site 3510)", "city": "Xinxiang", "status": "RECRUITING"}, {"facility": "Henan Cancer Hospital ( Site 3518)", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "First Huai'an Hospital Affiliated to Nanjing Medical University ( Site 3506)", "city": "Huai'an", "status": "RECRUITING"}, {"facility": "Shanghai Chest Hospital-Esophageal surgery department ( Site 3513)", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Zhejiang Cancer Hospital-Thoracic oncology ( Site 3511)", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 8, "broad_only": true}, {"nct": "NCT05895019", "title": "Effects of Propofol on Brain Function in Patients With Parkinson's Disease", "status": "RECRUITING", "start": "2023-06-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 600, "sponsor": "Beijing Tiantan Hospital", "conditions": ["PD - Parkinson's Disease"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07392411", "title": "Study on Artificial Intelligence-Based Facial and Speech-Related Patterns in Parkinson's Disease and Their Digital Biomarkers", "status": "RECRUITING", "start": "2023-07-25", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 720, "sponsor": "Beijing Tiantan Hospital", "conditions": ["Parkinson's Disease", "Progressive Supranuclear Palsy(PSP)", "Multiple System Atrophy", "Healthy Control"], "cn_sites": [{"facility": "首都医科大学附属北京天坛医院", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06090682", "title": "Effect and Mechanism of Brain Stimulation for Parkinson's Disease With Cognitive Impairment", "status": "RECRUITING", "start": "2023-11-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Tianjin Huanhu Hospital", "conditions": ["Parkinson Disease", "Cognitive Impairment"], "cn_sites": [{"facility": "Tianjin Huanhu Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06685510", "title": "The Relation Between the Prognosis of Subthalamic Nucleus Deep Brain Stimulation Surgery by Microlesion Effect and Electrode Position", "status": "ENROLLING_BY_INVITATION", "start": "2023-11-06", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Second Affiliated Hospital of Nanchang University", "conditions": ["Parkinson&#39;s Disease (PD)", "Deep Brain Stimulation"], "cn_sites": [{"facility": "The Second Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06167681", "title": "The Safety, Tolerability and Efficacy of NouvNeu001 for Parkinson's Disease", "status": "RECRUITING", "start": "2024-01-17", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "iRegene Therapeutics Co., Ltd.", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Beijing Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Zhongnan Hospital of Wuhan University", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 2, "broad_only": true}, {"nct": "NCT06742450", "title": "Constant Current Versus Constant Voltage Subthalamic Nucleus Deep Brain Stimulation in Patients with Parkinson's Disease", "status": "RECRUITING", "start": "2024-01-27", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 180, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Parkinson&#39;s Disease (PD)"], "cn_sites": [{"facility": "Xuanwu Hospital of Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06304285", "title": "A Study Assessing the Effects of Acupuncture in Parkinson's Disease Patients With Chronic Appendicitis", "status": "RECRUITING", "start": "2024-03-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 84, "sponsor": "The First Affiliated Hospital of University of Science and Technology of China", "conditions": ["Parkinson's Disease", "Chronic Appendicitis", "Acupuncture"], "cn_sites": [{"facility": "The First Affiliated Hospital of University of Science and Technology of China", "city": "Hefei", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06390761", "title": "Efficacy of Acupuncture for the Treatment of Parkinson's Disease Related Constipation", "status": "RECRUITING", "start": "2024-04-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Xi'an No.3 Hospital", "conditions": ["Parkinson Disease", "Constipation", "Non-motor Symptom", "Randomized Controlled Trial"], "cn_sites": [{"facility": "Xi 'an No.3 Hospital", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06400017", "title": "Mechanism and Application of DBS in the Treatment of PD", "status": "RECRUITING", "start": "2024-07-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Beijing Tiantan Hospital", "conditions": ["Parkinson's Disease and Parkinsonism"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06874803", "title": "Acupuncture and Moxibustion for Motor Symptoms in Early Parkinson's Disease", "status": "RECRUITING", "start": "2024-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Jiani Wu", "conditions": ["Parkinson's Disease (PD)"], "cn_sites": [{"facility": "Guang'anmen Hospita, China Academy of Chinese Medical Sciences", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06837038", "title": "Clinical Study of Rhythmic Auditory Stimulation for Gait Disorders", "status": "ENROLLING_BY_INVITATION", "start": "2024-12-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "YiCheng Zhu", "conditions": ["Hemiplegia Due to Stroke", "Parkinson Disease", "Parkinsonian Syndrome"], "cn_sites": [{"facility": "Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06383247", "title": "The Efficacy and Safety of Precision REpetitive Transcranial Magnetic Stimulation in Alleviating Motor Symptom in Parkinson's Disease", "status": "RECRUITING", "start": "2024-12-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 290, "sponsor": "Anhui Medical University", "conditions": ["Parkinson Disease", "Transcranial Magenetic Stimualtion", "Supplementary Motor Area"], "cn_sites": [{"facility": "Cognitive Neuropsychology Lab Anhui Medical University", "city": "Hefei", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06665113", "title": "Neuroprotective Effects of Long-term TaVNS in Early Parkinson's Disease Patients", "status": "RECRUITING", "start": "2024-12-23", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Kezhong Zhang", "conditions": ["Parkinson Disease, Idiopathic"], "cn_sites": [{"facility": "The First Affiliated Hospital with Nanjing Medical University", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07176091", "title": "Clinical Efficacy of Intermittent Theta Burst Transcranial Magnetic Stimulation With Different Modes on Parkinson's Disease", "status": "ENROLLING_BY_INVITATION", "start": "2025-01-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "Second Affiliated Hospital of Soochow University", "conditions": ["Parkinsonism", "Transcranial Magnetic Stimilation", "Intermittent Theta Burst Stimulation", "Primary Motor Cortex", "Electroencephalography", "Neuromodulation"], "cn_sites": [{"facility": "The Second Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06388863", "title": "Evaluation of the Efficacy and Safety of Fecal Microbiota Transplantation for Constipation in Parkinson's Disease", "status": "RECRUITING", "start": "2025-02-21", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 76, "sponsor": "Shanghai Zhongshan Hospital", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "180 Fenglin Road", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06848192", "title": "The Parkinson's Disease Case-Control Study", "status": "RECRUITING", "start": "2025-03-05", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 40, "sponsor": "Westlake University", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "The First Affiliated Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06949670", "title": "Alpha-Synuclein PET/CT in Various α-Syn-Related Disease", "status": "RECRUITING", "start": "2025-04-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Tianjin Medical University", "conditions": ["Alpha Synuclein Pathology", "Alpha-Synuclein", "Parkinson Disease"], "cn_sites": [{"facility": "The First Affiliated Hospital of University of Science and Technology of China", "city": "Hefei", "status": "RECRUITING"}, {"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": "RECRUITING"}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": true}, {"nct": "NCT07018388", "title": "Intrapatient Comparison of STN and GPi tTIS in PD", "status": "ENROLLING_BY_INVITATION", "start": "2025-04-23", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Ruijin Hospital", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Ruijin Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06930742", "title": "Mindfulness-Enhanced Dual-Task Training in PD-MCI", "status": "NOT_YET_RECRUITING", "start": "2025-05-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "Nanjing Mingzhou Rehabilitation Hospital", "conditions": ["Mild Cognitive Impairment (MCI)", "Parkinson's Disease (PD)"], "cn_sites": [{"facility": "Nanjing Mingzhou Rehabilitation Hospital", "city": "Nanjing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06821529", "title": "Stereotactic Intracerebral Injection of IPSC-DAPs in Patients with Parkinson's Disease", "status": "NOT_YET_RECRUITING", "start": "2025-05-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "iCamuno Biotherapeutics Ltd.", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06952504", "title": "A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)", "status": "RECRUITING", "start": "2025-05-22", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1123, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Endometrial Cancer"], "cn_sites": [{"facility": "Anhui Provincial Hospital ( Site 0830)", "city": "Hefei", "status": "RECRUITING"}, {"facility": "Peking University Peoples Hospital ( Site 0845)", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Chongqing University Cancer Hospital ( Site 0838)", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "Fujian Province Cancer Hospital ( Site 0802)", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated hospital of Xiamen University ( Site 0822)", "city": "Xiamen", "status": "RECRUITING"}, {"facility": "Sun Yat-sen University Cancer Center ( Site 0846)", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Sun Yat-sen Memorial Hospital, Sun Yat-sen University ( Site 0801)", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Zhujiang Hospital of Southern Medical University ( Site 0829)", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Cancer Hospital of Shantou University Medical College ( Site 0827)", "city": "Shantou", "status": "RECRUITING"}, {"facility": "Affiliated Hospital of Guangdong Medical University ( Site 0823)", "city": "Zhanjiang", "status": "RECRUITING"}, {"facility": "Liuzhou People's Hospital ( Site 0831)", "city": "Liuzhou", "status": "RECRUITING"}, {"facility": "Guangxi Medical University Affiliated Tumor Hospital. ( Site 0825)", "city": "Nanning", "status": "RECRUITING"}, {"facility": "Harbin Medical University Cancer Hospital ( Site 0850)", "city": "Harbin", "status": "RECRUITING"}, {"facility": "Henan Cancer Hospital ( Site 0806)", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Zhengzhou University ( Site 0833)", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Wuhan Union Hospital Cancer Center ( Site 0824)", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Xiangya Hospital Central South University ( Site 0821)", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Hunan Cancer Hospital ( Site 0826)", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Nanjing First Hospital ( Site 0828)", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Jiangxi Maternal and Child Health Hospital ( Site 0807)", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "The First Hospital Of Jilin University ( Site 0815)", "city": "Changchun", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Xi'an Jiaotong University ( Site 0816)", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "Shandong Cancer Hospital ( Site 0803)", "city": "Jinan", "status": "RECRUITING"}, {"facility": "LinYi Cancer Hospital ( Site 0820)", "city": "Linyi", "status": "RECRUITING"}, {"facility": "Shanghai Tenth People's Hospital ( Site 0847)", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Obstetrics & Gynecology Hospital of Fudan University ( Site 0818)", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Shanxi Provincial Cancer Hospital ( Site 0843)", "city": "Taiyuan", "status": "RECRUITING"}, {"facility": "West China Second University Hospital, Sichuan University ( Site 0849)", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "The Second People's Hospital of Yibin ( Site 0840)", "city": "Yibin", "status": "RECRUITING"}, {"facility": "Yunnan Province Cancer Hospital ( Site 0811)", "city": "Kunming", "status": "RECRUITING"}, {"facility": "The Affiliated Women's Hospital of Zhejiang University ( Site 0834)", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Taizhou Hospital of Zhejiang Province ( Site 0809)", "city": "Linhai", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University ( Site 0805)", "city": "Wenzhou", "status": "RECRUITING"}], "cn_site_count": 33, "broad_only": true}, {"nct": "NCT06978946", "title": "Deep Cervical Lymphaticovenous Anastomosis Surgery for Moderate-to-Advanced Dementia Patients", "status": "NOT_YET_RECRUITING", "start": "2025-05-28", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 85, "sponsor": "RenJi Hospital", "conditions": ["Alzheimer Disease", "Lewy Body Dementia (LBD)", "Frontotemporal Dementia (FTD)", "Dementia", "Parkinsons Disease With Dementia (PDD)"], "cn_sites": [{"facility": "Renji Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07100171", "title": "Evaluation of GM101 Injection in Patients With Parkinson's Disease", "status": "RECRUITING", "start": "2025-05-29", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Genemagic Biosciences Co., Ltd", "conditions": ["Parkinson&#39;s Disease"], "cn_sites": [{"facility": "Xiangya Hospital, Central South University", "city": "Changsha", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07644013", "title": "Prospective Multicenter Registry Study of Multiple System Atrophy in China", "status": "RECRUITING", "start": "2025-06-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 214, "sponsor": "Peking University First Hospital", "conditions": ["Multiple System Atrophy", "Parkinson's Disease", "Atypical Parkinsonism"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06928519", "title": "Efficacy and Safety of Entacapone Combined With Madopar in the Treatment of Early Parkinson's Disease: An Observational, Multicenter, Case-Control Study", "status": "RECRUITING", "start": "2025-06-05", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 216, "sponsor": "Yousheng Xiao", "conditions": ["Parkinson Disease (PD)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06966700", "title": "A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)", "status": "RECRUITING", "start": "2025-06-30", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 2400, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Breast Neoplasms", "Triple Negative Breast Neoplasms", "HR Low-Positive/HER2-Negative Breast Neoplasms"], "cn_sites": [{"facility": "Anhui Provincial Cancer Hospital ( Site 2234)", "city": "Hefei", "status": "RECRUITING"}, {"facility": "Beijing Cancer Hospital ( Site 2201)", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The First Affiliated hospital of Xiamen University-Breast Surgery ( Site 2224)", "city": "Xiamen", "status": "RECRUITING"}, {"facility": "Guangdong Maternity and Child Health Care Hospital ( Site 2251)", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Jiangmen Central Hospital ( Site 2243)", "city": "Jiangmen", "status": "RECRUITING"}, {"facility": "Liuzhou People's Hospital ( Site 2259)", "city": "Liuzhou", "status": "RECRUITING"}, {"facility": "Guangxi Medical University Affiliated Tumor Hospital ( Site 2223)", "city": "Nanning", "status": "RECRUITING"}, {"facility": "Xingtai People's Hospital ( Site 2260)", "city": "Xingtai", "status": "RECRUITING"}, {"facility": "Harbin Medical University Cancer Hospital ( Site 2204)", "city": "Haerbin", "status": "RECRUITING"}, {"facility": "Henan Cancer Hospital ( Site 2238)", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Wuhan Union Hospital ( Site 2239)", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Renmin Hospital of Wuhan University ( Site 2236)", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Hunan Cancer Hospital ( Site 2232)", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Xiangya Hospital of Central South University ( Site 2225)", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Jiangsu Province Hospital ( Site 2216)", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Nanjing Drum Tower Hospital ( Site 2217)", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "The Third Hospital Of Nanchang ( Site 2218)", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "The First Hospital Of Jilin University ( Site 2207)", "city": "Changchun", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Xi'an Jiaotong University ( Site 2203)", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "Jinan Central Hospital ( Site 2249)", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Shandong Cancer Hospital ( Site 2205)", "city": "Jinan", "status": "RECRUITING"}, {"facility": "LinYi Cancer Hospital ( Site 2248)", "city": "Linyi", "status": "RECRUITING"}, {"facility": "Fudan University Shanghai Cancer Center ( Site 2209)", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Deyang City People's Hospital ( Site 2244)", "city": "Deyang", "status": "RECRUITING"}, {"facility": "The Second People's Hospital of Neijiang ( Site 2242)", "city": "Neijiang", "status": "RECRUITING"}, {"facility": "Xinjiang Medical University Cancer Hospital - Urumqi ( Site 2230)", "city": "Ürümqi", "status": "RECRUITING"}, {"facility": "Yunnan Province Cancer Hospital ( Site 2226)", "city": "Kunming", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine ( Site 2212)", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Zhejiang Cancer Hospital ( Site 2211)", "city": "Hangzhou", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Zhejiang Provincial People's Hospital ( Site 2215)", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 30, "broad_only": true}, {"nct": "NCT06607900", "title": "hUC-MSC-sEV-001 Nasal Drops for Neurodegenerative Diseases", "status": "NOT_YET_RECRUITING", "start": "2025-07-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Alzheimer Disease", "Parkinson Disease", "Lewy Body Dementia", "Multiple System Atrophy", "Fronto-temporal Dementia", "Amyotrophic Lateral Sclerosis"], "cn_sites": [{"facility": "Xuanwu Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07153692", "title": "Clinical Efficacy and Mechanism of tDCS for Dysphagia in PD", "status": "RECRUITING", "start": "2025-07-17", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 58, "sponsor": "Wang Ping", "conditions": ["Parkinson's Disease and Parkinsonism", "Dysphagia"], "cn_sites": [{"facility": "Second Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07080775", "title": "The Safety and Tolerability of XS411CN Injection in Treatment of Primary Parkinson's Disease", "status": "RECRUITING", "start": "2025-08-05", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.", "conditions": ["Parkinson's Disease"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07244640", "title": "Non-Invasive Fundus Retinal Detection Technology for Early Diagnosis of Parkinson's Disease", "status": "RECRUITING", "start": "2025-11", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Parkinson's Disease (PD)"], "cn_sites": [{"facility": "2nd Affiliated Hospital, School of Medicine, Zhejiang University", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07174310", "title": "A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease", "status": "RECRUITING", "start": "2025-11-24", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 900, "sponsor": "Hoffmann-La Roche", "conditions": ["Parkinson's Disease"], "cn_sites": [{"facility": "Beijing Friendship Hospital Affiliated of Capital University of Medical Science", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Xuanwu Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Tian Tan Hospital,Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Hospital of Ministry of Health", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": "RECRUITING"}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital, Chongqing Medical University", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Guangdong Provincial People's Hospital", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Nanjing Brain Hospital", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Ruijin Hospital Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Soochow University", "city": "Suzhou", "status": "RECRUITING"}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "First Affiliated Hospital of Medical College of Xi'an Jiaotong University", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "The Affiliated Hospital of Xuzhou Medical University", "city": "Xuzhou", "status": "RECRUITING"}], "cn_site_count": 21, "broad_only": true}, {"nct": "NCT07250685", "title": "Subthalamic Nucleus Versus Globus Pallidal Internus Deep Brain Stimulation for Parkinson Disease", "status": "NOT_YET_RECRUITING", "start": "2025-11-24", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 86, "sponsor": "Zhang Jianguo", "conditions": ["PD - Parkinson's Disease"], "cn_sites": [{"facility": "Beijing Tiantan Hospital Affiliated to Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Nanjing Brain Hospital", "city": "Nanjing", "status": ""}, {"facility": "The First Affiliated Hospital of Dalian Medical University", "city": "Dalian", "status": ""}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": ""}, {"facility": "Changhai Hospital of Shanghai", "city": "Shanghai", "status": ""}, {"facility": "Tianjin Huanhu Hospital", "city": "Tianjin", "status": ""}, {"facility": "The Second Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 8, "broad_only": true}, {"nct": "NCT07299240", "title": "Remote Ischemic Conditioning for Sleep Disturbances and Other Non-motor Symptoms in Parkinson's Disease", "status": "RECRUITING", "start": "2026-01-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 48, "sponsor": "Jiangsu Province Nanjing Brain Hospital", "conditions": ["Parkinson Disease (PD)", "Insomnia"], "cn_sites": [{"facility": "The Affiliated Brain Hospital of Nanjing Medical University, 264 Guangzhou Road", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07586501", "title": "China-NINE Cohort：Neuroimmune Network in Elderly / Neurodegeneration", "status": "ENROLLING_BY_INVITATION", "start": "2026-01-16", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 260, "sponsor": "Yantai Yuhuangding Hospital", "conditions": ["Cognitive Dysfunction", "Cognitive Dysfunction, Cognitive Disorder", "Parkinson's Disease (PD)"], "cn_sites": [{"facility": "Yantai Yuhuangding Hospital", "city": "Yantai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07212088", "title": "Stereotactic Intracerebral Injection of Allogenic IPSC-DAPs in Patients With Parkinson's Disease", "status": "NOT_YET_RECRUITING", "start": "2026-02-28", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "iCamuno Biotherapeutics Ltd.", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07518290", "title": "Remotely Supervised Home-based Transcranial Temporal Interference Stimulation on Motor Symptoms in Parkinson's Disease", "status": "RECRUITING", "start": "2026-04-04", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 68, "sponsor": "Shanghai University of Sport", "conditions": ["PARKINSON DISEASE (Disorder)", "Motor Symptoms"], "cn_sites": [{"facility": "Shanghai University of Sport", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07533591", "title": "Clinical Study of Chemogenetic Gene Therapy With AAV for Parkinson's Disease Using Stereotactic Surgery in the Subthalamic Nucleus", "status": "NOT_YET_RECRUITING", "start": "2026-05", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Parkinson's Disease (PD)"], "cn_sites": [{"facility": "Second Affiliated Hospital, School of Medicine,Zhejiang University", "city": "Zhejiang", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07635823", "title": "Adaptive DBS for PD", "status": "RECRUITING", "start": "2026-05-16", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Beijing Pins Medical Co., Ltd", "conditions": ["Parkinson Disease(PD)"], "cn_sites": [{"facility": "The First Affiliated Hospital of USTC (Anhui Provincial Hospital)", "city": "Hefei", "status": "NOT_YET_RECRUITING"}, {"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Xuanwu Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "First Affiliated Hospital, Sun Yat-Sen University", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Nanjing Brain Hospital", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": "NOT_YET_RECRUITING"}, {"facility": "West China Hospital", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 9, "broad_only": true}, {"nct": "NCT07625540", "title": "Subthalamic Nucleus-Targeted Transcranial Temporal Interference Stimulation for Motor and Non-Motor Symptoms in Parkinson's Disease", "status": "RECRUITING", "start": "2026-05-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 32, "sponsor": "Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": ["Parkinson's Disease (PD)"], "cn_sites": [{"facility": "Shanghai General Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07381751", "title": "Artificial Intelligence-assisted MDS-UPDRS Assessment for Parkinson's Disease", "status": "RECRUITING", "start": "2026-06-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Hong Kong University of Science and Technology", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Hong Kong University of Science and Technology", "city": "Hong Kong", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07604116", "title": "A Study to Evaluate Satety, Tolerability, Biodistribution, Radiation Dosimetry, and Pharmacokinetics of SST001 in Healthy Volunteers, Patients With PD and Patients With MSA", "status": "RECRUITING", "start": "2026-06-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Synusight Biotech (Shanghai) Co., Ltd.", "conditions": ["Multiple System Atrophy (MSA)", "Parkinson's Disease (PD)"], "cn_sites": [{"facility": "Affiliated Hospital of Jiangnan University", "city": "Wuxi", "status": "RECRUITING"}, {"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": true}, {"nct": "NCT07745673", "title": "Comparative Study of TIS Efficacy Across Different Targets", "status": "RECRUITING", "start": "2026-06-29", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Zhongnan Hospital", "conditions": ["PARKINSON DIS"], "cn_sites": [{"facility": "Zhongnan Hospital of Wuhan University", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07698236", "title": "Temporal Interference Noninvasive Deep Brain Stimulation for Idiopathic Parkinson's Disease and Parkinsonian Syndromes: Effects and Target Exploration", "status": "ENROLLING_BY_INVITATION", "start": "2026-07-03", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Ruijin Hospital", "conditions": ["Parkinson's Disease", "Parkinsonian Syndromes"], "cn_sites": [{"facility": "Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07685444", "title": "A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of Intracerebral Injection of LY-N001 Injection for the Treatment of Moderate to Advanced Parkinson's Disease With GBA1 Mutations", "status": "NOT_YET_RECRUITING", "start": "2026-07-07", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Lingyi Biotech Co., Ltd.", "conditions": ["Parkinson's Disease (PD)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07733349", "title": "Phase I/II Clinical Trial of UX-DA003 Injection for the Treatment of Patients With Parkinson's Disease", "status": "NOT_YET_RECRUITING", "start": "2026-08-03", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Shanghai UniXell Biotechnology Co., Ltd", "conditions": ["Parkinson's Disease"], "cn_sites": [{"facility": "Ruijin Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07384442", "title": "Effects of Targeted Temporal Interference Stimulation of Cerebellar Nuclei on Tremor and Gait Disturbance in Parkinson's Disease Patients", "status": "NOT_YET_RECRUITING", "start": "2026-08-19", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "YangPan", "conditions": ["Parkinson's Disease", "Movement Disorders"], "cn_sites": [{"facility": "Zhongnan hospital", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07718659", "title": "ZR001 Chemogenetics Gene Therapy Study in Patients With Parkinson's Disease", "status": "NOT_YET_RECRUITING", "start": "2026-12-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 8, "sponsor": "Qianfoshan Hospital", "conditions": ["Parkinson's Disease (PD)", "Parkinsonian Disorders"], "cn_sites": [{"facility": "The First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital)", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT00224263", "title": "Efficacy and Safety of Lingzhi in Patients With Early Parkinson's Disease", "status": "COMPLETED", "start": "2005-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 360, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Parkinson's Disease"], "cn_sites": [{"facility": "Xuanwu Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT00461942", "title": "Efficacy and Safety of Green Tea Polyphenol in De Novo Parkinson's Disease Patients", "status": "COMPLETED", "start": "2006-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 480, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Parkinson's Disease"], "cn_sites": [{"facility": "Beijing Institute of Geriatrics, Xuanwu Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT01416818", "title": "Treatment of Depression in Parkinson's Disease", "status": "UNKNOWN", "start": "2008-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Depression in Parkinson's Disease"], "cn_sites": [{"facility": "Xuanwu Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT00656253", "title": "Clinical Trial on the Effectiveness of Herbal Medicinal Mixture in Parkinson Disease", "status": "COMPLETED", "start": "2008-08", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 158, "sponsor": "Fudan University", "conditions": ["Parkinson's Disease"], "cn_sites": [{"facility": "Department of Neurology, Xuanwu hospital, Capital University of Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Department of Integrative Medicine, Zhongshan hospital, Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Department of Nuerology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine", "city": "Shanghai", "status": ""}, {"facility": "Tongji Hospital of Tongji University", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Chinese Medical Hospital", "city": "Shanghai", "status": ""}, {"facility": "Department of Nuerology, Xinhua Hospital, Affiliated to Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "The Sixth People's Hospital, Shanghai Jiaotong University", "city": "Shanghai", "status": ""}, {"facility": "Department of Neurology, Yueyang Hospital of Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine", "city": "Shanghai", "status": ""}, {"facility": "Department of Neurology, The second people's hospital of Wenzhou", "city": "Wenzhou", "status": ""}], "cn_site_count": 10, "broad_only": true}, {"nct": "NCT01154166", "title": "A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment With Ropinirole PR as Adjunctive Therapy in Patients With Parkinson's Disease Who Are Not Optimally Controlled on L-Dopa", "status": "COMPLETED", "start": "2010-02-15", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 347, "sponsor": "GlaxoSmithKline", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "GSK Investigational Site", "city": "Guangzhou", "status": ""}, {"facility": "GSK Investigational Site", "city": "Wuhan", "status": ""}, {"facility": "GSK Investigational Site", "city": "Suzhou", "status": ""}, {"facility": "GSK Investigational Site", "city": "Xi'an", "status": ""}, {"facility": "GSK Investigational Site", "city": "Chengdu", "status": ""}, {"facility": "GSK Investigational Site", "city": "Kunming", "status": ""}, {"facility": "GSK Investigational Site", "city": "Hangzhou", "status": ""}, {"facility": "GSK Investigational Site", "city": "Beijing", "status": ""}, {"facility": "GSK Investigational Site", "city": "Shanghai", "status": ""}, {"facility": "GSK Investigational Site", "city": "Tianjin", "status": ""}], "cn_site_count": 10, "broad_only": true}, {"nct": "NCT01435915", "title": "Ropinirole PR Pharmacokinetics Study Among Chinese Healthy Subjects", "status": "COMPLETED", "start": "2010-06-28", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "GlaxoSmithKline", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "GSK Investigational Site", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT01191944", "title": "Pramipexole Extended Release Versus Pramipexole Immediate Release for 18 Weeks in Chinese Parkinson's Disease (PD) Patients", "status": "COMPLETED", "start": "2010-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 475, "sponsor": "Boehringer Ingelheim", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "248.671.86004 Boehringer Ingelheim Investigational Site", "city": "Beijing", "status": ""}, {"facility": "248.671.86006 Boehringer Ingelheim Investigational Site", "city": "Beijing", "status": ""}, {"facility": "248.671.86007 Boehringer Ingelheim Investigational Site", "city": "Beijing", "status": ""}, {"facility": "248.671.86020 Boehringer Ingelheim Investigational Site", "city": "Beijing", "status": ""}, {"facility": "248.671.86012 Boehringer Ingelheim Investigational Site", "city": "Chengdu", "status": ""}, {"facility": "248.671.86013 Boehringer Ingelheim Investigational Site", "city": "Chongqing", "status": ""}, {"facility": "248.671.86014 Boehringer Ingelheim Investigational Site", "city": "Chongqing", "status": ""}, {"facility": "248.671.86008 Boehringer Ingelheim Investigational Site", "city": "Guangzhou", "status": ""}, {"facility": "248.671.86009 Boehringer Ingelheim Investigational Site", "city": "Guangzhou", "status": ""}, {"facility": "248.671.86017 Boehringer Ingelheim Investigational Site", "city": "Hangzhou", "status": ""}, {"facility": "248.671.86018 Boehringer Ingelheim Investigational Site", "city": "Hangzhou", "status": ""}, {"facility": "248.671.86005 Boehringer Ingelheim Investigational Site", "city": "Jinan", "status": ""}, {"facility": "248.671.86002 Boehringer Ingelheim Investigational Site", "city": "Nanjing", "status": ""}, {"facility": "248.671.86001 Boehringer Ingelheim Investigational Site", "city": "Shanghai", "status": ""}, {"facility": "248.671.86003 Boehringer Ingelheim Investigational Site", "city": "Shanghai", "status": ""}, {"facility": "248.671.86010 Boehringer Ingelheim Investigational Site", "city": "Shanghai", "status": ""}, {"facility": "248.671.86011 Boehringer Ingelheim Investigational Site", "city": "Shenyang", "status": ""}, {"facility": "248.671.86019 Boehringer Ingelheim Investigational Site", "city": "Suzhou", "status": ""}, {"facility": "248.671.86015 Boehringer Ingelheim Investigational Site", "city": "Wuhan", "status": ""}, {"facility": "248.671.86016 Boehringer Ingelheim Investigational Site", "city": "Wuhan", "status": ""}], "cn_site_count": 20, "broad_only": true}, {"nct": "NCT01536574", "title": "Open-Label Extension Study With REQUIP PR for Subjects From Study ROP111528", "status": "COMPLETED", "start": "2010-09-02", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 295, "sponsor": "GlaxoSmithKline", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "GSK Investigational Site", "city": "Guangzhou", "status": ""}, {"facility": "GSK Investigational Site", "city": "Wuhan", "status": ""}, {"facility": "GSK Investigational Site", "city": "Suzhou", "status": ""}, {"facility": "GSK Investigational Site", "city": "Xi'an", "status": ""}, {"facility": "GSK Investigational Site", "city": "Chengdu", "status": ""}, {"facility": "GSK Investigational Site", "city": "Kunming", "status": ""}, {"facility": "GSK Investigational Site", "city": "Hangzhou", "status": ""}, {"facility": "GSK Investigational Site", "city": "Beijing", "status": ""}, {"facility": "GSK Investigational Site", "city": "Shanghai", "status": ""}, {"facility": "GSK Investigational Site", "city": "Tianjin", "status": ""}], "cn_site_count": 10, "broad_only": true}, {"nct": "NCT01437189", "title": "The Effects of Sertraline on Depression in Parkinson's Disease", "status": "COMPLETED", "start": "2011-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 35, "sponsor": "Zhejiang University", "conditions": ["Depression", "Parkinson's Disease"], "cn_sites": [{"facility": "Department of Neurology, the Second Affiliated Hospital, School of Medicine, Zhejiang University", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT01736891", "title": "Clinical Trial of Rasagiline in Levodopa-Treated Parkinson's Disease Patients With Motor Fluctuations", "status": "COMPLETED", "start": "2011-11", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 268, "sponsor": "Chongqing Fortune Pharmaceutical Co., Ltd.", "conditions": ["Parkinson´s Disease"], "cn_sites": [{"facility": "CN002", "city": "Chengdu", "status": ""}, {"facility": "CN005", "city": "Chenzhou", "status": ""}, {"facility": "CN007", "city": "Chongqing", "status": ""}, {"facility": "CN003", "city": "Guilin", "status": ""}, {"facility": "CN004", "city": "Lanzhou", "status": ""}, {"facility": "CN006", "city": "Luzhou", "status": ""}, {"facility": "CN008", "city": "Nanjing", "status": ""}, {"facility": "CN001", "city": "Xi'an", "status": ""}], "cn_site_count": 8, "broad_only": true}, {"nct": "NCT01470859", "title": "The Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Early Parkinson's Disease", "status": "COMPLETED", "start": "2011-12", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Huashan Hospital", "conditions": ["Idiopathic Parkinson's Disease"], "cn_sites": [{"facility": "Huashan Hospital Affiliated to Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT01998204", "title": "Requirement of Propofol for Induction of Unconsciousness in Patients With Parkinson's Disease", "status": "COMPLETED", "start": "2012-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 62, "sponsor": "Changhai Hospital", "conditions": ["Parkinson's Disease"], "cn_sites": [{"facility": "Department of Anesthesiology, Changhai Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT01652313", "title": "Pharmacokinetic Properties of Rasagiline (Lu 00-773) in Healthy Young Chinese Men and Women", "status": "COMPLETED", "start": "2012-05", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "H. Lundbeck A/S", "conditions": ["Parkinson's Disease"], "cn_sites": [{"facility": "CN001", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT01953718", "title": "A Retrospective Study of the Effects of Different Parameters on Motor Symptoms of PD in Bilateral STN Stimulation", "status": "COMPLETED", "start": "2013-07", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 27, "sponsor": "First Affiliated Hospital, Sun Yat-Sen University", "conditions": ["Parkinson's Disease"], "cn_sites": [{"facility": "First Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT02071693", "title": "A Retrospective Study of the Relationship Between White Matter Hyperintensities(WMHs) Within the Cholinergic Pathways and the Cognition of PD Patients After Bilateral STN DBS", "status": "COMPLETED", "start": "2013-12", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 38, "sponsor": "First Affiliated Hospital, Sun Yat-Sen University", "conditions": ["Parkinson's Disease"], "cn_sites": [{"facility": "First Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT02601144", "title": "Variable Frequency Stimulation of Subthalamic Nucleus for Freezing of Gait in Parkinson's Disease", "status": "COMPLETED", "start": "2015-10", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 28, "sponsor": "Beijing Pins Medical Co., Ltd", "conditions": ["Parkinson's Disease"], "cn_sites": [{"facility": "Tsinghua University Yuquan Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Tian Tan Hospital,Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 2, "broad_only": true}, {"nct": "NCT03227250", "title": "Effects of Bilateral GPI DBS on Freezing of Gait in PD", "status": "COMPLETED", "start": "2015-11-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 46, "sponsor": "Haiyan Zhou", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04002596", "title": "Safety and Initial Effectiveness of Transcranial MR Guided Focused Ultrasound for the Treatment of Parkinson's Disease", "status": "COMPLETED", "start": "2017-02-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 26, "sponsor": "InSightec", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT03875092", "title": "A Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407)-China Extension Study", "status": "COMPLETED", "start": "2017-04-21", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 125, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Non-small Cell Lung Cancer"], "cn_sites": [{"facility": "Zhongshan Hospital Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT03119636", "title": "Safety and Efficacy Study of Human ESC-derived Neural Precursor Cells in the Treatment of Parkinson's Disease", "status": "UNKNOWN", "start": "2017-05", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Chinese Academy of Sciences", "conditions": ["Parkinson's Disease"], "cn_sites": [{"facility": "The first affiliated hospital of Zhengzhou university", "city": "Zhengzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT03230331", "title": "Follow Up Study for Treatment of Parkinson's Disease With Subthalamic Deep Brain Stimulation", "status": "COMPLETED", "start": "2017-07-24", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 20, "sponsor": "Ruijin Hospital", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT02937688", "title": "Deep Brain Stimulation (DBS) for Parkinson's Disease International Study", "status": "COMPLETED", "start": "2017-07-26", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 212, "sponsor": "MedtronicNeuro", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Xuanwu Hospital Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Huaxi Hospital", "city": "Chengdu", "status": ""}, {"facility": "The First Affiliated Hospital of Sun Yat-Sen University", "city": "Guangzhou", "status": ""}, {"facility": "Ruijin Hospital Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Huashan Hospital", "city": "Shanghai", "status": ""}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "Tangdu Hospital", "city": "Xi'an", "status": ""}], "cn_site_count": 7, "broad_only": true}, {"nct": "NCT03267550", "title": "The Safety of Remote DBS Programming System", "status": "WITHDRAWN", "start": "2017-08-08", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Ruijin Hospital", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Shanghai Ruijin Hospital Functional Neurosurgery", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04162275", "title": "A Single-dose Study to Investigate the Tolerance and Pharmacokinetics of Finamine Tablets in China", "status": "COMPLETED", "start": "2017-08-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 34, "sponsor": "Yiling Pharmaceutical Inc.", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Shijiazhuang Yiling Pharmaceutical Co. Ltd", "city": "Shijiazhuang", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT03053726", "title": "Evaluate the Effectiveness and Safety of Variable Frequency Stimulation Compared With Constant Frequency Stimulation for Patients With Idiopathic Parkinson's Disease", "status": "UNKNOWN", "start": "2017-08-18", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 106, "sponsor": "Beijing Pins Medical Co., Ltd", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Beijing Tiantan Hospital Affiliated to Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "General Hospital of PLA", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Dalian Medical University", "city": "Dalian", "status": "RECRUITING"}, {"facility": "Nanjing Brain Hospital Affiliated to Nanjing Medical University", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Changhai Hospital of Shanghai", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Huashan hospital, Fudan university", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "The General Hospital of Shenyang Military", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Second People's Hospital of Shenzhen", "city": "Shenzhen", "status": "RECRUITING"}], "cn_site_count": 9, "broad_only": true}, {"nct": "NCT03497884", "title": "Individualized Precise Localization of rTMS on Primary Motor Area", "status": "COMPLETED", "start": "2017-09-04", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 38, "sponsor": "Hangzhou Normal University", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Hangzhou Normal University,Center for Cognition and Brain Disorder", "city": "Hangzhou", "status": ""}, {"facility": "Hangzhou Normal University", "city": "Hangzhou", "status": ""}], "cn_site_count": 2, "broad_only": true}, {"nct": "NCT03221426", "title": "Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)", "status": "COMPLETED", "start": "2017-10-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1007, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Gastric Cancer", "Gastroesophageal Junction Cancer"], "cn_sites": [{"facility": "Beijing Cancer Hospital ( Site 0221)", "city": "Beijing", "status": ""}, {"facility": "Zhejiang Cancer Hospital ( Site 0231)", "city": "Hangzhou", "status": ""}, {"facility": "Sir Run Run Shaw Hospital ( Site 0233)", "city": "Hangzhou", "status": ""}], "cn_site_count": 3, "broad_only": true}, {"nct": "NCT04045678", "title": "A Multiple Ascending Dose Study With LY03003 in Patients With Early-stage Parkinson's Disease", "status": "COMPLETED", "start": "2017-10-10", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Luye Pharma Group Ltd.", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "Xuanwu Hospital Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Shengjing Hospital of China Medical University", "city": "Shenyang", "status": ""}], "cn_site_count": 3, "broad_only": true}, {"nct": "NCT03501004", "title": "The Study of Acupuncture on Vascular and Functional Neuroimaging in Parkinson's Disease Patients With Sleep Disorders", "status": "COMPLETED", "start": "2018-06-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Tsinghua University", "conditions": ["Acupuncture", "Parkinson's Disease", "Sleep Disorders", "Neuroimaging"], "cn_sites": [{"facility": "Tsinghua University Yuquan Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT03521635", "title": "The SUSTAIN Study Compares the Effects of Sustained and Immediate-release Pramipexole on the noctUrnal Symptoms of paTients With Advanced ParkInsoN's Disease Who Also Take L-Dopa", "status": "COMPLETED", "start": "2018-07-03", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 98, "sponsor": "Boehringer Ingelheim", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Hospital", "city": "Beijing", "status": ""}, {"facility": "West China Hospital", "city": "Chengdu", "status": ""}, {"facility": "The First Afiliated Hospital, Sun Yet-sen University", "city": "Guangzhou", "status": ""}, {"facility": "2nd Affiliated Hosp Zhejiang University College of Medical", "city": "Hangzhou", "status": ""}, {"facility": "Brain Hospital Affiliated to Nanjing Med University", "city": "Nanjing", "status": ""}, {"facility": "Ruijin Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "The First Hospital of Chinese Medical University", "city": "Shenyang", "status": ""}, {"facility": "The Second Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "Wuhan Union Hospital", "city": "Wuhan", "status": ""}, {"facility": "First Affiliated Hospital of Xi'an JiaoTong University", "city": "Xi'an", "status": ""}], "cn_site_count": 12, "broad_only": true}, {"nct": "NCT03594656", "title": "Effects of Lingzhi on Disease Progression in Patients With Untreated Early Parkinson's Disease", "status": "UNKNOWN", "start": "2018-07-15", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 288, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Xuanwu Hospital of Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04455555", "title": "Efficacy and Safety of Rotigotine in the Treatment of Patients With Early Stage of Primary Parkinson's Disease", "status": "COMPLETED", "start": "2018-08-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 294, "sponsor": "Peking University Third Hospital", "conditions": ["Parkinson's Disease"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT03655171", "title": "A Pilot Study to Evaluate the Severity of Motor Dysfunction in Parkinson's Disease Based on AI Video Analysis", "status": "COMPLETED", "start": "2018-08-20", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 30, "sponsor": "Huashan Hospital", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Huashan Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT03615326", "title": "Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)", "status": "COMPLETED", "start": "2018-10-05", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 738, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Gastric Neoplasms", "Gastroesophageal Junction Adenocarcinoma"], "cn_sites": [{"facility": "Shanghai General Hospital ( Site 2404)", "city": "Shanghai", "status": ""}, {"facility": "Peking Union Medical College Hospital ( Site 2419)", "city": "Beijing", "status": ""}, {"facility": "Fifth Medical Center of CPLA General Hospital ( Site 2415)", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer Hospital ( Site 2413)", "city": "Beijing", "status": ""}, {"facility": "Fujian Provincial Cancer Hospital ( Site 2418)", "city": "Fuzhou", "status": ""}, {"facility": "900 Hospital of the Joint ( Site 2420)", "city": "Fuzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Xiamen University ( Site 2431)", "city": "Xiamen", "status": ""}, {"facility": "Guangdong General Hospital ( Site 2433)", "city": "Guangzhou", "status": ""}, {"facility": "Harbin Medical University Cancer Hospital ( Site 2407)", "city": "Harbin", "status": ""}, {"facility": "Henan Cancer Hospital ( Site 2400)", "city": "Zhengzhou", "status": ""}, {"facility": "Xiangya Hospital Central-South University ( Site 2426)", "city": "Changsha", "status": ""}, {"facility": "Jiangsu Cancer Hospital ( Site 2432)", "city": "Nanjing", "status": ""}, {"facility": "The First Hospital Of Jilin University ( Site 2402)", "city": "Changchun", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center ( Site 2424)", "city": "Shanghai", "status": ""}, {"facility": "Zhongshan Hospital affiliated to Fudan University ( Site 2401)", "city": "Shanghai", "status": ""}, {"facility": "Cancer Hospital Affiliated to Xinjiang Medical University ( Site 2430)", "city": "Ürümqi", "status": ""}, {"facility": "The First Affiliated Hospital.Zhejiang University ( Site 2408)", "city": "Hangzhou", "status": ""}, {"facility": "Sir Run Run Shaw Hospital ( Site 2412)", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital ( Site 2409)", "city": "Hangzhou", "status": ""}], "cn_site_count": 19, "broad_only": true}, {"nct": "NCT04629404", "title": "A Clinical Trial to Evaluate the Pharmacodynamics/Pharmacokinetics and Safety of LY03003 in Early PD Patients", "status": "COMPLETED", "start": "2018-11-05", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 32, "sponsor": "Luye Pharma Group Ltd.", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Shengjing Hospital of China Medical University", "city": "Shenyang", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT03675737", "title": "Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)", "status": "COMPLETED", "start": "2018-11-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1579, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Stomach Neoplasms"], "cn_sites": [{"facility": "Cancer Hospital Chinese Academy of Medical Sciences ( Site 2421)", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital ( Site 2425)", "city": "Beijing", "status": ""}, {"facility": "Fujian Medical University Union Hospital ( Site 2410)", "city": "Fuzhou", "status": ""}, {"facility": "Fujian Provincial Cancer Hospital ( Site 2414)", "city": "Fuzhou", "status": ""}, {"facility": "900 Hospital of the Joint ( Site 2418)", "city": "Fuzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Xiamen University ( Site 2430)", "city": "Xiamen", "status": ""}, {"facility": "Zhongshan Hospital Xiamen University ( Site 2447)", "city": "Xiamen", "status": ""}, {"facility": "Guangdong General Hospital ( Site 2431)", "city": "Guangzhou", "status": ""}, {"facility": "Peking University Shenzhen Hospital ( Site 2442)", "city": "Shenzhen", "status": ""}, {"facility": "Fourth Hospital Of Hebei Medical University ( Site 2436)", "city": "Shijiazhuang", "status": ""}, {"facility": "Harbin Medical University Cancer Hospital ( Site 2401)", "city": "Harbin", "status": ""}, {"facility": "Henan Cancer Hospital ( Site 2415)", "city": "Zhengzhou", "status": ""}, {"facility": "Hubei Cancer Hospital ( Site 2434)", "city": "Wuhan", "status": ""}, {"facility": "Xiangya Hospital Central-South University ( Site 2419)", "city": "Changsha", "status": ""}, {"facility": "Hunan Cancer Hospital ( Site 2439)", "city": "Changsha", "status": ""}, {"facility": "Changzhou Cancer Hospital-Changzhou Fourth Peoples Hospital ( Site 2441)", "city": "Changzhou", "status": ""}, {"facility": "The 81st Hospital of PLA ( Site 2413)", "city": "Nanjing", "status": ""}, {"facility": "Jiangsu Cancer Hospital ( Site 2432)", "city": "Nanjing", "status": ""}, {"facility": "Yancheng First People s Hospital ( Site 2426)", "city": "Yancheng", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University ( Site 2440)", "city": "Nanchang", "status": ""}, {"facility": "The First Hospital of Jilin University ( Site 2416)", "city": "Changchun", "status": ""}, {"facility": "The Affiliated Hospital of Qingdao University ( Site 2405)", "city": "Qingdao", "status": ""}, {"facility": "Shanghai East Hospital ( Site 2403)", "city": "Shanghai", "status": ""}, {"facility": "Zhongshan Hospital affiliated to Fudan University ( Site 2407)", "city": "Shanghai", "status": ""}, {"facility": "1st Affil hosp of Med College of Xi'an Jiaotong University ( Site 2428)", "city": "XiAn", "status": ""}, {"facility": "Cancer Hospital Affiliated to Xinjiang Medical University ( Site 2420)", "city": "Ürümqi", "status": ""}, {"facility": "Zhejiang Provincial People's Hospital ( Site 2446)", "city": "Hangzhou", "status": ""}, {"facility": "Sir Run Run Show Hospital ( Site 2427)", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital ( Site 2417)", "city": "Hangzhou", "status": ""}], "cn_site_count": 29, "broad_only": true}, {"nct": "NCT04859582", "title": "Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)-China Extension", "status": "WITHDRAWN", "start": "2018-11-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Stomach Neoplasms"], "cn_sites": [{"facility": "Cancer Hospital Chinese Academy of Medical Sciences ( Site 2421)", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital ( Site 2425)", "city": "Beijing", "status": ""}, {"facility": "Fujian Medical University Union Hospital ( Site 2410)", "city": "Fuzhou", "status": ""}, {"facility": "Fujian Provincial Cancer Hospital ( Site 2414)", "city": "Fuzhou", "status": ""}, {"facility": "900 Hospital of the Joint ( Site 2418)", "city": "Fuzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Xiamen University ( Site 2430)", "city": "Xiamen", "status": ""}, {"facility": "Zhongshan Hospital Xiamen University ( Site 2447)", "city": "Xiamen", "status": ""}, {"facility": "Guangdong General Hospital ( Site 2431)", "city": "Guangzhou", "status": ""}, {"facility": "Peking University Shenzhen Hospital ( Site 2442)", "city": "Shenzhen", "status": ""}, {"facility": "Harbin Medical University Cancer Hospital ( Site 2401)", "city": "Harbin", "status": ""}, {"facility": "Henan Cancer Hospital ( Site 2415)", "city": "Zhengzhou", "status": ""}, {"facility": "Hubei Cancer Hospital ( Site 2434)", "city": "Wuhan", "status": ""}, {"facility": "Xiangya Hospital Central-South University ( Site 2419)", "city": "Changsha", "status": ""}, {"facility": "Hunan Cancer Hospital ( Site 2439)", "city": "Changsha", "status": ""}, {"facility": "Changzhou Cancer Hospital-Changzhou Fourth Peoples Hospital ( Site 2441)", "city": "Changzhou", "status": ""}, {"facility": "The 81st Hospital of PLA ( Site 2413)", "city": "Nanjing", "status": ""}, {"facility": "Jiangsu Cancer Hospital ( Site 2432)", "city": "Nanjing", "status": ""}, {"facility": "Yancheng First People s Hospital ( Site 2426)", "city": "Yancheng", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University ( Site 2440)", "city": "Nanchang", "status": ""}, {"facility": "The First Hospital of Jilin University ( Site 2416)", "city": "Changchun", "status": ""}, {"facility": "The Affiliated Hospital of Qingdao University ( Site 2405)", "city": "Qingdao", "status": ""}, {"facility": "Shanghai East Hospital ( Site 2403)", "city": "Shanghai", "status": ""}, {"facility": "Zhongshan Hospital affiliated to Fudan University ( Site 2407)", "city": "Shanghai", "status": ""}, {"facility": "1st Affil hosp of Med College of Xi'an Jiaotong University ( Site 2428)", "city": "XiAn", "status": ""}, {"facility": "Cancer Hospital Affiliated to Xinjiang Medical University ( Site 2420)", "city": "Ürümqi", "status": ""}, {"facility": "Zhejiang Provincial People's Hospital ( Site 2446)", "city": "Hangzhou", "status": ""}, {"facility": "Sir Run Run Show Hospital ( Site 2427)", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital ( Site 2417)", "city": "Hangzhou", "status": ""}], "cn_site_count": 28, "broad_only": true}, {"nct": "NCT06090929", "title": "STN-DBS and the Risk of Sialorrhea", "status": "COMPLETED", "start": "2019-01-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 234, "sponsor": "Qilu Hospital of Shandong University", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Chao Zhang", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT03829319", "title": "Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)", "status": "COMPLETED", "start": "2019-03-25", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 761, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Nonsquamous Non-small Cell Lung Cancer"], "cn_sites": [{"facility": "Peking Union Medical College Hospital ( Site 0108)", "city": "Beijing", "status": ""}, {"facility": "Cancer Hospital Chinese Academy of Medical Science ( Site 0117)", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer Hospital ( Site 0120)", "city": "Beijing", "status": ""}, {"facility": "The Second Hospital Affiliated to AMU ( Site 0119)", "city": "Chongqing", "status": ""}, {"facility": "First Affiliated Hospital of The Third Military Medical University ( Site 0118)", "city": "Chongqing", "status": ""}, {"facility": "Fujian Provincial Cancer Hospital ( Site 0102)", "city": "Fuzhou", "status": ""}, {"facility": "Southern Medical University Nanfang Hospital ( Site 0121)", "city": "Guangzhou", "status": ""}, {"facility": "The Third Affiliated Hospital of Harbin Medical University ( Site 0100)", "city": "Harbin", "status": ""}, {"facility": "Henan Cancer Hospital ( Site 0112)", "city": "Zhengzhou", "status": ""}, {"facility": "Wuhan Union Hospital Cancer Center-Cancer Center ( Site 0123)", "city": "Wuhan", "status": ""}, {"facility": "Hubei Cancer Hospital ( Site 0122)", "city": "Wuhan", "status": ""}, {"facility": "Jilin Cancer Hospital ( Site 0115)", "city": "Changchun", "status": ""}, {"facility": "Zhongshan Hospital Fudan University ( Site 0103)", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Pulmonary Hospital ( Site 0101)", "city": "Shanghai", "status": ""}, {"facility": "Tianjin Medical University Cancer Institute & Hospital ( Site 0111)", "city": "Tianjin", "status": ""}, {"facility": "Cancer Hospital Affiliated to Xinjiang Medical University ( Site 0110)", "city": "Urumuqi", "status": ""}, {"facility": "The First Affiliated Hospital Zhejiang University ( Site 0109)", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital ( Site 0113)", "city": "Hangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University ( Site 0124)", "city": "Wenzhou", "status": ""}], "cn_site_count": 19, "broad_only": true}, {"nct": "NCT03898180", "title": "Study of First-line Pembrolizumab (MK-3475) With Lenvatinib (MK-7902/E7080) in Urothelial Carcinoma Cisplatin-ineligible Participants Whose Tumors Express Programmed Cell Death-Ligand 1 and in Participants Ineligible for Platinum-containing Chemotherapy (MK-7902-011/E7080-G000-317/ LEAP-011)", "status": "COMPLETED", "start": "2019-05-06", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 505, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Urothelial Carcinoma"], "cn_sites": [{"facility": "Peking University First Hospital ( Site 0726)", "city": "Beijing", "status": ""}, {"facility": "Fifth Medical Center of CPLA General Hospital ( Site 0732)", "city": "Beijing", "status": ""}, {"facility": "Peking University Third Hospital ( Site 0727)", "city": "Beijing", "status": ""}, {"facility": "Chongqing Cancer Hospital ( Site 0741)", "city": "Chongging", "status": ""}, {"facility": "The First Affiliated Hospital of Xiamen University ( Site 0743)", "city": "Xiamen", "status": ""}, {"facility": "Sun Yat-Sen University Cancer Center ( Site 0752)", "city": "Guangdong", "status": ""}, {"facility": "The First Affiliated Hospital of Guangzhou Medical University ( Site 0749)", "city": "Guangzhou", "status": ""}, {"facility": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University ( Site 0746)", "city": "Guangzhou", "status": ""}, {"facility": "Harbin Medical University Cancer Hospital ( Site 0750)", "city": "Harbin", "status": ""}, {"facility": "Hubei Cancer Hospital ( Site 0744)", "city": "Wuhan", "status": ""}, {"facility": "Hunan Cancer Hospital ( Site 0745)", "city": "Changsha", "status": ""}, {"facility": "Nanjing Drum Tower Hospital ( Site 0737)", "city": "Nanjing", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center ( Site 0721)", "city": "Shanghai", "status": ""}, {"facility": "Zhongshan Hospital Fudan University ( Site 0725)", "city": "Shanghai", "status": ""}, {"facility": "The First Affiliated Hospital of Xi an Jiaotong University ( Site 0738)", "city": "Xian", "status": ""}, {"facility": "Cancer Hospital Affiliated to Xinjiang Medical University ( Site 0751)", "city": "Ürümqi", "status": ""}, {"facility": "Second Affiliated Hospital, Zhejiang University ( Site 0734)", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Provincial People's Hospital ( Site 0735)", "city": "Hangzhou", "status": ""}], "cn_site_count": 18, "broad_only": true}, {"nct": "NCT04048265", "title": "TMS Treatment in Parkinson's Disease With Pain.", "status": "COMPLETED", "start": "2019-05-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 52, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Transcranial Magnetic Stimulation", "Parkinson Disease", "Pain"], "cn_sites": [{"facility": "The Neurology Department of Xuanwu Hospital,Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT05901350", "title": "The Correlation of Reduction of Levodopa and Non-motor Symptoms of Parkinson's Disease After Deep Brain Stimulation", "status": "COMPLETED", "start": "2019-06-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 338, "sponsor": "Qilu Hospital of Shandong University", "conditions": ["Parkinson Disease", "Visual Impairment"], "cn_sites": [{"facility": "Chao Zhang", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04023201", "title": "Nocturnal Symptoms and Quality of Life in Patients With Parkinson's Disease in Shanghai", "status": "UNKNOWN", "start": "2019-07-03", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1500, "sponsor": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": ["Parkinson's Disease"], "cn_sites": [{"facility": "Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04000529", "title": "Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies", "status": "TERMINATED", "start": "2019-07-30", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 122, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Non-small Cell Lung Carcinoma", "Head and Neck Squamous Cell Carcinoma", "Esophageal SCC", "Gastrointestinal Stromal Tumors", "Colorectal Cancer"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Chengdu", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04137146", "title": "SNS for Treatment of PD Gait Disorder", "status": "UNKNOWN", "start": "2019-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Ruijin Hospital", "conditions": ["Parkinson Disease", "Gait Disorders, Neurologic"], "cn_sites": [{"facility": "Functional neurosurgery of Shanghai jiaotong university affiliated Ruijin hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04676412", "title": "Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Nonsmall Cell Lung Cancer (NSCLC) [MK-7902-007/E7080-G000-314/LEAP-007] - China Extension Study", "status": "COMPLETED", "start": "2019-10-23", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 107, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Non-small Cell Lung Cancer"], "cn_sites": [{"facility": "Anhui Provincial Hospital ( Site 0108)", "city": "Hefei", "status": ""}, {"facility": "The First Affiliated Hospital of Anhui Medical University ( Site 0113)", "city": "Hefei", "status": ""}, {"facility": "Peking Union Medical College Hospital ( Site 0105)", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer Hospital ( Site 0102)", "city": "Beijing", "status": ""}, {"facility": "Beijing Chest Hospital Capital Medical University ( Site 0111)", "city": "Beijing", "status": ""}, {"facility": "Xiangya Hospital of Central South University ( Site 0115)", "city": "Changsha", "status": ""}, {"facility": "Hunan Cancer Hospital ( Site 0104)", "city": "Changsha", "status": ""}, {"facility": "Zhongshan Hospital Fudan University ( Site 0100)", "city": "Shanghai", "status": ""}, {"facility": "Jiangsu Cancer Hospital ( Site 0101)", "city": "Nanjing", "status": ""}, {"facility": "The First Hospital of Jilin University ( Site 0110)", "city": "Changchun", "status": ""}, {"facility": "Shanghai Chest Hospital ( Site 0112)", "city": "Shanghai", "status": ""}, {"facility": "1st Affil Hosp of Med College of Xi'an Jiaotong University ( Site 0103)", "city": "XiAn", "status": ""}, {"facility": "West China Hospital of Sichuan University ( Site 0117)", "city": "Chengdu", "status": ""}, {"facility": "The First Affiliated Hospital Zhejiang University ( Site 0106)", "city": "Hangzhou", "status": ""}, {"facility": "Hangzhou First People's Hospital ( Site 0109)", "city": "Hangzhou", "status": ""}, {"facility": "2nd Affil Hosp of Zhejiang University College of Medicine ( Site 0114)", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital ( Site 0116)", "city": "Hangzhou", "status": ""}], "cn_site_count": 17, "broad_only": true}, {"nct": "NCT04716933", "title": "Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)-China Extension Study", "status": "COMPLETED", "start": "2019-11-05", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 201, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Nonsquamous Non-small Cell Lung Cancer"], "cn_sites": [{"facility": "Peking Union Medical College Hospital ( Site 0108)", "city": "Beijing", "status": ""}, {"facility": "Cancer Hospital Chinese Academy of Medical Science ( Site 0117)", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer Hospital ( Site 0120)", "city": "Beijing", "status": ""}, {"facility": "The Second Hospital Affiliated to AMU ( Site 0119)", "city": "Chongqing", "status": ""}, {"facility": "First Affiliated Hospital of The Third Military Medical University ( Site 0118)", "city": "Chongqing", "status": ""}, {"facility": "Fujian Provincial Cancer Hospital ( Site 0102)", "city": "Fuzhou", "status": ""}, {"facility": "Southern Medical University Nanfang Hospital ( Site 0121)", "city": "Guangzhou", "status": ""}, {"facility": "The Third Affiliated Hospital of Harbin Medical University ( Site 0100)", "city": "Harbin", "status": ""}, {"facility": "Henan Cancer Hospital ( Site 0112)", "city": "Zhengzhou", "status": ""}, {"facility": "Wuhan Union Hospital ( Site 0123)", "city": "Wuhan", "status": ""}, {"facility": "Hubei Cancer Hospital ( Site 0122)", "city": "Wuhan", "status": ""}, {"facility": "Zhongshan Hospital Fudan University ( Site 0103)", "city": "Shanghai", "status": ""}, {"facility": "Jilin Cancer Hospital ( Site 0115)", "city": "Changchun", "status": ""}, {"facility": "Shanghai Pulmonary Hospital ( Site 0101)", "city": "Shanghai", "status": ""}, {"facility": "Tianjin Medical University Cancer Institute & Hospital ( Site 0111)", "city": "Tianjin", "status": ""}, {"facility": "Cancer Hospital Affiliated to Xinjiang Medical University ( Site 0110)", "city": "Urumuqi", "status": ""}, {"facility": "The First Affiliated Hospital Zhejiang University ( Site 0109)", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital ( Site 0113)", "city": "Hangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University ( Site 0124)", "city": "Wenzhou", "status": ""}], "cn_site_count": 19, "broad_only": true}, {"nct": "NCT04804176", "title": "Study on the Mode and Mechanism of Ultra-low Frequency rTMS for Sleep Disorders in Patients With Parkinson's Disease", "status": "UNKNOWN", "start": "2019-12-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 99, "sponsor": "Qianfoshan Hospital", "conditions": ["Repetitive Transcranial Magnetic Stimulation", "Parkinson Disease", "Sleep Disorder"], "cn_sites": [{"facility": "The First Affiliated Hospital of Shandong First Medical University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04191096", "title": "Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991)", "status": "COMPLETED", "start": "2020-02-12", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1251, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Metastatic Hormone-Sensitive Prostate Cancer"], "cn_sites": [{"facility": "Peking University First Hospital ( Site 0800)", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer Hospital ( Site 0802)", "city": "Beijing", "status": ""}, {"facility": "Chongqing Cancer Hospital ( Site 0815)", "city": "Chongqing", "status": ""}, {"facility": "The First Affiliated Hospital of Xiamen University ( Site 0816)", "city": "Xiamen", "status": ""}, {"facility": "The First Affiliated Hospital of Guangzhou Medical University-Urology ( Site 0837)", "city": "Guangdong", "status": ""}, {"facility": "Sun Yat-Sen University Cancer Center ( Site 0825)", "city": "Guangzhou", "status": ""}, {"facility": "Sun Yat Sen Memorial Hospital ( Site 0819)", "city": "Guangzhou", "status": ""}, {"facility": "Southern Medical University Nanfang Hospital ( Site 0838)", "city": "Guangzhou", "status": ""}, {"facility": "Harbin Medical University Cancer Hospital ( Site 0822)", "city": "Harbin", "status": ""}, {"facility": "Henan Cancer Hospital ( Site 0818)", "city": "Zhengzhou", "status": ""}, {"facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 0829)", "city": "Wuhan", "status": ""}, {"facility": "Hubei Cancer Hospital ( Site 0833)", "city": "Wuhan", "status": ""}, {"facility": "Hunan Cancer Hospital ( Site 0817)", "city": "Changsha", "status": ""}, {"facility": "Nanjing Drum Tower Hospital ( Site 0811)", "city": "Nanjing", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University ( Site 0821)", "city": "Nanchang", "status": ""}, {"facility": "The Second Affiliated Hosp of Xi'an Jiaotong Univ College of Medicine ( Site 0831)", "city": "Xi'an", "status": ""}, {"facility": "Renji Hospital Shanghai Jiaotong University School of Medicine ( Site 0807)", "city": "Shanghai", "status": ""}, {"facility": "The first affiliated Hospital of Xi an Jiaotong University ( Site 0812)", "city": "Xi’an", "status": ""}, {"facility": "Tianjin Medical University Cancer Institute & Hospital ( Site 0804)", "city": "Tianjin", "status": ""}, {"facility": "2nd Affil Hosp of Zhejiang University College of Medicine ( Site 0808)", "city": "Hangzhou", "status": ""}, {"facility": "The 1st Affil Hosp of College of Medicine, Zhejiang Univ ( Site 0830)", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Provincial People's Hospital ( Site 0809)", "city": "Hangzhou", "status": ""}, {"facility": "Ningbo First Hospital-Urology ( Site 0835)", "city": "Ningbo", "status": ""}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University ( Site 0834)", "city": "Wenzhou", "status": ""}], "cn_site_count": 24, "broad_only": true}, {"nct": "NCT04255719", "title": "Unilateral GPi vs Unilateral STN DBS in the Same Patient With PD", "status": "COMPLETED", "start": "2020-03-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Ruijin Hospital", "conditions": ["Parkinson Disease", "Deep Brain Stimulation", "Globus Pallidus Interna", "Subthalamic Nucleus"], "cn_sites": [{"facility": "Functional neurosurgery of Shanghai jiaotong university affiliated Ruijin hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04870372", "title": "Selegiline for the Treatment of Excessive Daytime Sleepiness in Parkinson's Disease", "status": "COMPLETED", "start": "2020-03-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 141, "sponsor": "Second Affiliated Hospital of Soochow University", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Changshu Hospital Affiliated to Nanjing University of Chinese Medicine", "city": "Changshu", "status": ""}, {"facility": "Second Affiliated Hospital of Nantong University", "city": "Nantong", "status": ""}, {"facility": "Department of Neurology, Second Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "Jiang Yuan Hospital Affiliated to Jiangsu Institute of Nuclear Medicine", "city": "Wuxi", "status": ""}], "cn_site_count": 4, "broad_only": true}, {"nct": "NCT04571164", "title": "A Study to Evaluate the Effectiveness and Safety of LY03003 in Patients With Early Primary PD", "status": "COMPLETED", "start": "2020-05-11", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 294, "sponsor": "Luye Pharma Group Ltd.", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Xuanwu Hospital Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04246177", "title": "Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)", "status": "TERMINATED", "start": "2020-05-22", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 480, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Carcinoma, Hepatocellular"], "cn_sites": [{"facility": "Anhui Provincial Hospital ( Site 0092)", "city": "Heifei", "status": ""}, {"facility": "Beijing Cancer Hospital ( Site 0099)", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer Hospital ( Site 0105)", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital ( Site 0087)", "city": "Beijing", "status": ""}, {"facility": "Chinese People s Liberation Army Army Characteristic Medical Center ( Site 0117)", "city": "Chongqing", "status": ""}, {"facility": "Chongqing University Three Gorges Hospital ( Site 0859)", "city": "Chongqing", "status": ""}, {"facility": "Mengchao Hepatobiliary Hospital of Fujian Medical University ( Site 0121)", "city": "Fuzhou", "status": ""}, {"facility": "Fujian Provincial Cancer Hospital ( Site 0085)", "city": "Fuzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Fujian Medical University ( Site 0089)", "city": "Fuzhou", "status": ""}, {"facility": "Zhongshan Hospital Fudan University (Xiamen Branch) ( Site 0133)", "city": "Xiamen", "status": ""}, {"facility": "Zhujiang Hospital of Southern Medical University ( Site 0115)", "city": "Guangzhou", "status": ""}, {"facility": "Guangdong Provincial People s Hospital ( Site 0100)", "city": "Guangzhou", "status": ""}, {"facility": "NANFANG HOSPITAL SOUTHERN MEDICAL UNIVERSITY ( Site 0088)", "city": "Guangzhou", "status": ""}, {"facility": "SUN YAT-SEN UNIVERSITY CANCER CENTRE ( Site 0128)", "city": "Guangzhou", "status": ""}, {"facility": "Jinan University - Zhuhai People's Hospital-Intervention Department ( Site 0856)", "city": "Zhuhai", "status": ""}, {"facility": "Guangxi Medical University Affiliated Tumor Hospital-Hepatological surgery ( Site 0862)", "city": "Nanning", "status": ""}, {"facility": "Hainan General Hospital ( Site 0112)", "city": "Haikou", "status": ""}, {"facility": "Harbin Medical University Cancer Hospital ( Site 0090)", "city": "Harbin", "status": ""}, {"facility": "Henan Cancer Hospital ( Site 0114)", "city": "Zhengzhou", "status": ""}, {"facility": "Tongji Hospital Tongji Medical,Science & Technology ( Site 0126)", "city": "Wuhan", "status": ""}, {"facility": "Hubei Cancer Hospital ( Site 0101)", "city": "Wuhan", "status": ""}, {"facility": "Hunan Provincial People's Hospital ( Site 0113)", "city": "Changsha", "status": ""}, {"facility": "Hunan Cancer Hospital ( Site 0096)", "city": "Changsha", "status": ""}, {"facility": "The First Affiliated Hospital of Soochow University ( Site 0120)", "city": "Suzhou", "status": ""}, {"facility": "Jiangxi Provincial Cancer Hospital-Cancer Hospital ( Site 0134)", "city": "Nanchang", "status": ""}, {"facility": "Xi'an International Medical Center Hospital ( Site 0860)", "city": "Xi'an", "status": ""}, {"facility": "The Third Affiliated Hospital of the PLA Navy Medical University ( Site 0123)", "city": "Shanghai", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center ( Site 0106)", "city": "Shanghai", "status": ""}, {"facility": "Zhongshan Hospital Fudan University ( Site 0084)", "city": "Shanghai", "status": ""}, {"facility": "The First Affiliated Hospital of Xi an Jiaotong University ( Site 0108)", "city": "Xi’an", "status": ""}, {"facility": "West China Hospital of Sichuan University ( Site 0119)", "city": "Chengdu", "status": ""}, {"facility": "Suining Central Hospital ( Site 0857)", "city": "Suining", "status": ""}, {"facility": "Tianjin Medical University Cancer Institute & Hospital ( Site 0098)", "city": "Tianjin", "status": ""}, {"facility": "Tianjin Third Central Hospital ( Site 0861)", "city": "Tianjin", "status": ""}, {"facility": "The First Hospital of Kunming ( Site 0124)", "city": "Kunming", "status": ""}, {"facility": "2nd Affil Hosp of Zhejiang University College of Medicine ( Site 0110)", "city": "Hangzhou", "status": ""}, {"facility": "Sir Run Run Shaw Hospital ( Site 0094)", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital ( Site 0103)", "city": "Hangzhou", "status": ""}, {"facility": "Ningbo Medical Center LiHuili Hospital ( Site 0132)", "city": "Ningbo", "status": ""}], "cn_site_count": 39, "broad_only": true}, {"nct": "NCT04431570", "title": "Repetitive Transcranial Magnetic Stimulation for the Treatment of Freezing of Gait in Parkinson's Disease", "status": "UNKNOWN", "start": "2020-06-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 66, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Parkinson Disease", "Gait Disorders, Neurologic"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04934592", "title": "Correlation Between Non-motor Symptoms and Malnutrition in Patients With Parkinson's Disease", "status": "UNKNOWN", "start": "2020-06-30", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 85, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Second Affiliated Hospital of Medical College of Zhejiang University", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04926909", "title": "Study on Serum Cystatin C and PET-DAT in Patients With Parkinson's Disease", "status": "UNKNOWN", "start": "2020-07-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 121, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Parkinson's Disease"], "cn_sites": [{"facility": "Second Affiliated Hospital, College of Medicine, Zhejiang University", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04630860", "title": "A Study to Evaluate the Pharmacokinetics and Safety of LY03003 in Patients With Advanced-stage PD", "status": "COMPLETED", "start": "2020-07-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Luye Pharma Group Ltd.", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Xuanwu Hospital Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04924062", "title": "Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)-China Extension Study", "status": "COMPLETED", "start": "2020-07-10", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 158, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Biliary Tract Carcinoma"], "cn_sites": [{"facility": "Anhui Provincial Hospital ( Site 0140)", "city": "Hefei", "status": ""}, {"facility": "Beijing Cancer Hospital ( Site 0138)", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital ( Site 0150)", "city": "Beijing", "status": ""}, {"facility": "First Affiliated Hospital of The Third Military Medical University ( Site 0130)", "city": "Chongqing", "status": ""}, {"facility": "Fujian Provincial Cancer Hospital ( Site 0154)", "city": "Fuzhou", "status": ""}, {"facility": "900 Hospital of the Joint ( Site 0137)", "city": "Fuzhou", "status": ""}, {"facility": "Guangdong Provincial People s Hospital ( Site 0161)", "city": "Guangzhou", "status": ""}, {"facility": "Harbin Medical University Cancer Hospital ( Site 0133)", "city": "Harbin", "status": ""}, {"facility": "Hunan Provincial People Hospital ( Site 0142)", "city": "Changsha", "status": ""}, {"facility": "Hunan Cancer Hospital ( Site 0132)", "city": "Changsha", "status": ""}, {"facility": "The Third Xiangya Hospital of Central South University ( Site 0157)", "city": "Changsha", "status": ""}, {"facility": "The 81st Hospital of PLA ( Site 0128)", "city": "Nanjing", "status": ""}, {"facility": "The First Hospital of Jilin University ( Site 0131)", "city": "Changchun", "status": ""}, {"facility": "Zhongshan Hospital Fudan University ( Site 0129)", "city": "Shanghai", "status": ""}, {"facility": "Renji Hospital Shanghai Jiaotong University School of Medicine ( Site 0158)", "city": "Shanghai", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center ( Site 0160)", "city": "Shanghai", "status": ""}, {"facility": "Tangdu Hospital ( Site 0146)", "city": "Xi’an", "status": ""}, {"facility": "The First Affiliated Hospital of Xi an Jiaotong University ( Site 0145)", "city": "Xi’an", "status": ""}, {"facility": "West China Hospital of Sichuan University ( Site 0147)", "city": "Chengdu", "status": ""}, {"facility": "Tianjin Medical University Cancer Institute & Hospital ( Site 0155)", "city": "Tianjin", "status": ""}, {"facility": "The First Affiliated Hospital Zhejiang University ( Site 0136)", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital ( Site 0134)", "city": "Hangzhou", "status": ""}], "cn_site_count": 22, "broad_only": true}, {"nct": "NCT04483219", "title": "Tyrosine Kinase Inhibitor (TKI) + Anti-PD-1 Antibody in TKI-responded Microsatellite Stability/Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Adenocarcinoma.", "status": "UNKNOWN", "start": "2020-07-24", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 53, "sponsor": "China Medical University, China", "conditions": ["MSS", "pMMR", "Metastatic Colorectal Adenocarcinoma"], "cn_sites": [{"facility": "Cancer Hospital of China Medical University/Liaoning Cancer Hospital &Institute", "city": "Shenyang", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04882241", "title": "Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)-China Extension", "status": "COMPLETED", "start": "2020-07-29", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Gastric Cancer", "Gastroesophageal Junction Cancer"], "cn_sites": [{"facility": "Afflilated Hospital of Bengbu Medical College-Surgical Oncology (Site 0638)", "city": "Bengbu", "status": ""}, {"facility": "Beijing Friendship Hospital ( Site 0637)", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer Hospital ( Site 0221)", "city": "Beijing", "status": ""}, {"facility": "Fujian Provincial Cancer Hospital ( Site 0230)", "city": "Fuzhou", "status": ""}, {"facility": "Fujian Medical University Union Hospital-1 Bingfanglou-Gastric Surgery Department (Site 0632)", "city": "Fuzhou Fujian", "status": ""}, {"facility": "The First Affiliated Hospital, Sun Yat-sen University (Site 0635)", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Guangzhou Medical University ( Site 0224)", "city": "Guangzhou", "status": ""}, {"facility": "Fourth Hospital of Hebei Medical University ( Site 0633)", "city": "Shijiazhuang", "status": ""}, {"facility": "Henan Cancer Hospital (Site 0227)", "city": "Zhengzhou", "status": ""}, {"facility": "The Affiliated Hospital of Xuzhou Medical College-Oncology ( Site 0645)", "city": "Xuzhou", "status": ""}, {"facility": "The First Hospital of Jilin University-Gastrointestinal Surgery ( Site 0234)", "city": "Changchun", "status": ""}, {"facility": "Tangdu Hospital of Fourth Military Medical University of Chinese People's Liberation Army ( Site 0647)", "city": "Xi'an", "status": ""}, {"facility": "Shandong Provincial Hospital-Gastrointestinal Surgery ( Site 0640)", "city": "Jinan", "status": ""}, {"facility": "The Affiliated Hospital of Qingdao University ( Site 0636)", "city": "Qingdao", "status": ""}, {"facility": "Renji Hospital Shanghai Jiao Tong University School of Medicine ( Site 0642)", "city": "Shanghai", "status": ""}, {"facility": "Sichuan Cancer hospital", "city": "Chengdu", "status": ""}, {"facility": "Zhejiang Provincial People's Hospital-Oncology (Site 0656)", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital ( Site 0231)", "city": "Hangzhou", "status": ""}, {"facility": "Sir Run Run Shaw Hospital ( Site 0233)", "city": "Hangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University (Site 0652)", "city": "Wenzhou", "status": ""}], "cn_site_count": 20, "broad_only": true}, {"nct": "NCT04696978", "title": "Study for Perioperative Neurocognitive Disorders After Deep Brain Stimulation Surgery for Parkinson's Disease", "status": "UNKNOWN", "start": "2020-08-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 300, "sponsor": "wenbinlu", "conditions": ["Neurocognitive Disorders"], "cn_sites": [{"facility": "Changhai Hospital, Second Military Medical University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04528147", "title": "Yi Jin Jing Tiger Roaring Speech Rehabilitation With Real-Time Feedback Technique for PD", "status": "UNKNOWN", "start": "2020-10-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Ruijin Hospital", "conditions": ["Speech Disorders", "Parkinson Disease"], "cn_sites": [{"facility": "Functional neurosurgery of Shanghai jiaotong university affiliated Ruijin hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04414813", "title": "Stereotactic Transplantation of hAESCs for Parkinson's Disease", "status": "COMPLETED", "start": "2020-10-08", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 3, "sponsor": "Shanghai East Hospital", "conditions": ["Parkinson's Disease"], "cn_sites": [{"facility": "WU Jingwen", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04651140", "title": "Research on the Effect and Mechanism of Aerobic Exercise on PD", "status": "UNKNOWN", "start": "2020-10-13", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "The First Hospital of Jilin University", "conditions": ["Parkinson's Disease", "Physical Exercise"], "cn_sites": [{"facility": "FirstJilinU", "city": "Changchun", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04624204", "title": "Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)", "status": "ACTIVE_NOT_RECRUITING", "start": "2020-12-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 672, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Small Cell Lung Cancer"], "cn_sites": [{"facility": "Peking Union Medical College Hospital ( Site 3102)", "city": "Beijing", "status": ""}, {"facility": "Cancer Hospital Chinese Academy of Medical Sciences ( Site 3104)", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer hospital-Oncology Radiotherapy Department ( Site 3140)", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer Hospital ( Site 3127)", "city": "Beijing", "status": ""}, {"facility": "Chongqing Cancer Hospital ( Site 3135)", "city": "Chongqing", "status": ""}, {"facility": "Daping Hospital,Third Military Medical University ( Site 3136)", "city": "Chongqing", "status": ""}, {"facility": "Fujian Provincial Cancer Hospital ( Site 3126)", "city": "Fuzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Xiamen University ( Site 3121)", "city": "Xiamen", "status": ""}, {"facility": "Peking University Shenzhen Hospital ( Site 3118)", "city": "Shenzhen", "status": ""}, {"facility": "Cancer Hospital Chinese Academy Of Medical Sciences. Shenzhen Center ( Site 3113)", "city": "Shenzhen", "status": ""}, {"facility": "Henan Cancer Hospital ( Site 3105)", "city": "Zhengzhou", "status": ""}, {"facility": "Tongji Medical College Huazhong University of Science and Technology ( Site 3138)", "city": "Wuhan", "status": ""}, {"facility": "Union Hospital, Tongji Medical College of HUST ( Site 3123)", "city": "Wuhan", "status": ""}, {"facility": "Hubei Cancer Hospital ( Site 3120)", "city": "Wuhan", "status": ""}, {"facility": "Xiangya Hospital of Central South University ( Site 3137)", "city": "Changsha", "status": ""}, {"facility": "Second Xiangya Hospital of Central-South University ( Site 3128)", "city": "Changsha", "status": ""}, {"facility": "Hunan Cancer Hospital ( Site 3133)", "city": "Changsha", "status": ""}, {"facility": "Jiangsu Cancer Hospital ( Site 3139)", "city": "Nanjing", "status": ""}, {"facility": "The Second Affiliated Hospital of Nanchang University ( Site 3106)", "city": "Nanchang", "status": ""}, {"facility": "The First Hospital of Jilin University ( Site 3132)", "city": "Changchun", "status": ""}, {"facility": "Affiliated Cancer Hospital of Shandong First Medical University ( Site 3100)", "city": "Jinan", "status": ""}, {"facility": "Shanghai Chest Hospital ( Site 3107)", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Pulmonary Hospital ( Site 3101)", "city": "Shanghai", "status": ""}, {"facility": "West China Hospital of Sichuan University ( Site 3114)", "city": "Chengdu", "status": ""}, {"facility": "Tianjin Medical University Cancer Institute & Hospital ( Site 3103)", "city": "Tianjin", "status": ""}, {"facility": "Hangzhou Cancer Hospital ( Site 3129)", "city": "Hanghzou", "status": ""}, {"facility": "The 1st Affil Hosp of College of Medicine, Zhejiang Univ ( Site 3131)", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital ( Site 3108)", "city": "Hangzhou", "status": ""}], "cn_site_count": 28, "broad_only": true}, {"nct": "NCT06566313", "title": "An Open-label Study on the Clinical Efficacy of tDCS Intervention in PD", "status": "COMPLETED", "start": "2021-01-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 17, "sponsor": "Anhui Medical University", "conditions": ["Transcranial Direct Current Stimulation", "Parkinson Disease", "Primary Left Motor Cortex"], "cn_sites": [{"facility": "Cognitive Neuropsychology Lab Anhui Medical University", "city": "Hefei", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04721028", "title": "A Cross-sectional Study of Sarcopenia in Patients With Parkinson ' s Disease", "status": "UNKNOWN", "start": "2021-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 908, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Search MeSH, PubMed Database"], "cn_sites": [{"facility": "SAHZhejiangU", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04617873", "title": "DBS and SCS Therapy Improve Motor Function in Multiple System Atrophy With Predominant Parkinsonism", "status": "UNKNOWN", "start": "2021-01-05", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "zhangyuqing", "conditions": ["Multiple System Atrophy, Parkinson Variant (Disorder)"], "cn_sites": [{"facility": "Capital Medical University of Xuanwu Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04212897", "title": "fNIRS Studies of Music Intervention of Parkinson's Disease", "status": "UNKNOWN", "start": "2021-01-18", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 150, "sponsor": "The First Affiliated Hospital of Dalian Medical University", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "First Affiliated Hospital of Dalian Medical University", "city": "Dalian", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04625361", "title": "Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC122505MsOH Tablets in Healthy Adult Subjects", "status": "COMPLETED", "start": "2021-01-20", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 106, "sponsor": "Sunshine Lake Pharma Co., Ltd.", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Shanghai Xuhui Central Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04693039", "title": "Study on the Safety, Tolerance and Pharmacokinetics of Phenlarmide Tablets", "status": "COMPLETED", "start": "2021-02-23", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Shijiazhuang Yiling Pharmaceutical Co. Ltd", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Chen Biao", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04749394", "title": "A Study of Camrelizumab Plus Apatinib as Consolidation Therapy in Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy", "status": "UNKNOWN", "start": "2021-03-17", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 42, "sponsor": "Chinese Academy of Medical Sciences", "conditions": ["Locally Advanced Non-Small Cell Lung Cancer"], "cn_sites": [{"facility": "National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04776148", "title": "Study of Lenvatinib (MK-7902/E7080) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care in Participants With Metastatic Colorectal Cancer (MK-7902-017/E7080-G000-325/LEAP-017)", "status": "COMPLETED", "start": "2021-03-29", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 563, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Colorectal Neoplasms"], "cn_sites": [{"facility": "The First People's Hospital of Foshan-Gastrointestinal oncology ( Site 1604)", "city": "Foshan", "status": ""}, {"facility": "SUN YAT-SEN UNIVERSITY CANCER CENTRE ( Site 1600)", "city": "Guangzhou", "status": ""}, {"facility": "Sir Run Run Shaw Hospital-Medical Oncology ( Site 1606)", "city": "Hangzhou", "status": ""}], "cn_site_count": 3, "broad_only": true}, {"nct": "NCT04738487", "title": "Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab (MK-3475) Monotherapy for Programmed Cell Death 1 Ligand 1 (PD-L1) Positive Metastatic Non-Small Cell Lung Cancer (MK-7684A-003, KEYVIBE-003)", "status": "TERMINATED", "start": "2021-04-07", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1264, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Lung Neoplasms", "Non-Small-Cell Lung Carcinoma"], "cn_sites": [{"facility": "The First Affiliated Hospital of Anhui Medical University ( Site 2022)", "city": "Hefei", "status": ""}, {"facility": "Anhui Provincil Hospital South District-Respiratory Medicine Dept ( Site 2017)", "city": "Hefei", "status": ""}, {"facility": "Cancer Hospital Chinese Academy of Medical Science-Oncology ( Site 2030)", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer hospital-intrathoratic deparmtment II ( Site 2001)", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer hospital-Thoracic Cancer Department A ( Site 2003)", "city": "Beijing", "status": ""}, {"facility": "Beijing Peking Union Medical College Hospital-pneumology department ( Site 2009)", "city": "Beijing", "status": ""}, {"facility": "Beijing Chest Hospital,Capital Medical University ( Site 2020)", "city": "Beijing", "status": ""}, {"facility": "Chongqing Cancer Hospital-Medical Oncology ( Site 2028)", "city": "Chongqing", "status": ""}, {"facility": "Army Medical Center of People's Liberation Army-respiratory ( Site 2025)", "city": "Chongqing", "status": ""}, {"facility": "Fujian Provincial Cancer Hospital-oncology department ( Site 2023)", "city": "Fuzhou", "status": ""}, {"facility": "Fuzhou General hospital of Nanjing Military Command-Oncology Department ( Site 2029)", "city": "Fuzhou", "status": ""}, {"facility": "Southern Medical University Nanfang Hospital-Depatrment of Respiratory and Critical Care Medicine (", "city": "Guangzhou", "status": ""}, {"facility": "Harbin Medical University Cancer Hospital ( Site 2006)", "city": "Harbin", "status": ""}, {"facility": "Henan Cancer Hospital ( Site 2015)", "city": "Zhengzhou", "status": ""}, {"facility": "Wuhan Union Hospital-Medical Oncology ( Site 2019)", "city": "Wuhan", "status": ""}, {"facility": "Xiangya Hospital Central South University-Respiratory -Asthma&COPD ( Site 2026)", "city": "Changsha", "status": ""}, {"facility": "Hunan Cancer Hospital-thoracic oncology II ( Site 2013)", "city": "Changsha", "status": ""}, {"facility": "Northern Jiangsu People's Hospital-General Surgery Department ( Site 2016)", "city": "Yangzhou", "status": ""}, {"facility": "Jilin Cancer Hospital-oncology department ( Site 2000)", "city": "Changchun", "status": ""}, {"facility": "Tang Du Hospital ( Site 2004)", "city": "Xi'an", "status": ""}, {"facility": "The First Affiliated Hospital of Xian Jiaotong University wa-Oncology ( Site 2012)", "city": "Xi'an", "status": ""}, {"facility": "LinYi Cancer Hospital ( Site 2034)", "city": "Linyi", "status": ""}, {"facility": "Linyi People's Hospital-Oncology ( Site 2035)", "city": "Linyi", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center ( Site 2032)", "city": "Shanghai", "status": ""}, {"facility": "West China Hospital Sichuan University-respiratory ( Site 2018)", "city": "Chengdu", "status": ""}, {"facility": "Hangzhou Cancer Hospital-Medical Oncology ( Site 2039)", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital-Breast Oncology ( Site 2008)", "city": "Hangzhou", "status": ""}, {"facility": "The Second Affiliated hospital of Zhejiang University school of medicine-Respiratory Medicine ( Site", "city": "Hangzhou", "status": ""}, {"facility": "Taizhou Hospital of Zhejiang Province-Respiratory ( Site 2027)", "city": "Linhai", "status": ""}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University-Respiratory department ( Site 2031)", "city": "Wenzhou", "status": ""}], "cn_site_count": 30, "broad_only": true}, {"nct": "NCT04736706", "title": "A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-04-14", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1854, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Carcinoma, Renal Cell"], "cn_sites": [{"facility": "The First Afflilated Hospital of Bengbu Medical College-Urology Surgery ( Site 6041)", "city": "Bengbu", "status": ""}, {"facility": "Cancer Hospital Chinese Academy of Medical Science-Oncology ( Site 6026)", "city": "Beijing", "status": ""}, {"facility": "Peking University First Hospital ( Site 6011)", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer hospital-Renal carcinoma and melanoma ( Site 6000)", "city": "Beijing", "status": ""}, {"facility": "Chongqing University Cancer Hospital ( Site 6009)", "city": "Chongging", "status": ""}, {"facility": "The First Affiliated Hospital Of Fujian Medical University-Urology ( Site 6038)", "city": "Fuzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Xiamen University ( Site 6001)", "city": "Xiamen", "status": ""}, {"facility": "SUN YAT-SEN UNIVERSITY CANCER CENTRE ( Site 6003)", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Guangzhou Medical University ( Site 6036)", "city": "Guangzhou", "status": ""}, {"facility": "Guangzhou First People's Hospital ( Site 6007)", "city": "Guangzhou", "status": ""}, {"facility": "Sun Yat-sen Memorial Hospital, Sun Yat-sen University-Urology Surgery ( Site 6005)", "city": "Guangzhou", "status": ""}, {"facility": "Harbin Medical University Cancer Hospital-urology ( Site 6015)", "city": "Harbin", "status": ""}, {"facility": "Henan Cancer Hospital-Urology ( Site 6006)", "city": "Zhengzhou", "status": ""}, {"facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 6002)", "city": "Wuhan", "status": ""}, {"facility": "Xiangya Hospital Central South University ( Site 6034)", "city": "Changsha", "status": ""}, {"facility": "Hunan Cancer Hospital ( Site 6020)", "city": "Changsha", "status": ""}, {"facility": "Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Urology ( Site 6022)", "city": "Nanjing", "status": ""}, {"facility": "The Second Affiliated Hospital of Soochow University-Urology ( Site 6025)", "city": "Suzhou", "status": ""}, {"facility": "Jiangxi Provincial Cancer Hospital ( Site 6042)", "city": "Nanchang", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University ( Site 6019)", "city": "Nanchang", "status": ""}, {"facility": "The First Affiliated Hospital of Xi'an Jiaotong University ( Site 6014)", "city": "Xi'an", "status": ""}, {"facility": "Renji Hospital Shanghai Jiao Tong University School of Medicine ( Site 6017)", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Tenth People's Hospital ( Site 6023)", "city": "Shanghai", "status": ""}, {"facility": "West China Hospital Sichuan University-Urology Surgery ( Site 6016)", "city": "Chengdu", "status": ""}, {"facility": "Tianjin Medical University Cancer Institute and Hospital ( Site 6029)", "city": "Tianjin", "status": ""}, {"facility": "The Second Hospital of Tianjin Medical University ( Site 6032)", "city": "Tianjin", "status": ""}, {"facility": "The First Affiliated Hospital Zhejiang University School of Medicine ( Site 6024)", "city": "Hangzhou", "status": ""}, {"facility": "The First Hospital of Jiaxing ( Site 6033)", "city": "Jiaxing", "status": ""}, {"facility": "Ningbo First Hospital-Urology ( Site 6028)", "city": "Ningbo", "status": ""}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University-Urology Surgery ( Site 6021)", "city": "Wenzhou", "status": ""}], "cn_site_count": 30, "broad_only": true}, {"nct": "NCT04812002", "title": "Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy", "status": "UNKNOWN", "start": "2021-04-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Women's Hospital School Of Medicine Zhejiang University", "conditions": ["Gestational Trophoblastic Neoplasia"], "cn_sites": [{"facility": "Women's Hospital School of Medicine Zhejiang University", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04934722", "title": "Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991)-China Extension", "status": "COMPLETED", "start": "2021-05-25", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 186, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Metastatic Hormone-Sensitive Prostate Cancer"], "cn_sites": [{"facility": "Peking University First Hospital ( Site 0800)", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer Hospital ( Site 0802)", "city": "Beijing", "status": ""}, {"facility": "Chongqing Cancer Hospital ( Site 0815)", "city": "Chongqing", "status": ""}, {"facility": "The First Affiliated Hospital of Xiamen University (Site 0816)", "city": "Xiamen", "status": ""}, {"facility": "Sun Yat-Sen University Cancer Center ( Site 0825)", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Guangzhou Medical University-Urology ( Site 0638)", "city": "Guangzhou", "status": ""}, {"facility": "Sun Yat Sen Memorial Hospital (Site # 0819)", "city": "Guangzhou", "status": ""}, {"facility": "Southern Medical University Nanfang Hospital ( Site 0838)", "city": "Guangzhou", "status": ""}, {"facility": "Harbin Medical University Cancer Hospital ( Site 0822)", "city": "Harbin", "status": ""}, {"facility": "Henan Cancer Hospital ( Site 0818)", "city": "Zhengzhou", "status": ""}, {"facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 0829)", "city": "Wuhan", "status": ""}, {"facility": "Hubei Cancer Hospital ( Site 0833)", "city": "Wuhan", "status": ""}, {"facility": "Hunan Cancer Hospital ( Site 0817)", "city": "Changsha", "status": ""}, {"facility": "Nanjing Drum Tower Hospital ( Site 0811)", "city": "Nanjing", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University ( Site 0821)", "city": "Nanchang", "status": ""}, {"facility": "The Second Affiliated Hosp of Xi'an Jiaotong Univ College of Medicine ( Site 0831)", "city": "Xi'an", "status": ""}, {"facility": "Renji Hospital Shanghai Jiaotong University School of Medicine ( Site 0807 )", "city": "Shanghai", "status": ""}, {"facility": "The first affiliated Hospital of Xi an Jiaotong University ( Site # 0812)", "city": "Xi’an", "status": ""}, {"facility": "Tianjin Medical University Cancer Institute & Hospital ( Site 0804 )", "city": "Tianjin", "status": ""}, {"facility": "2nd Affil Hosp of Zhejiang University College of Medicine ( Site 0808)", "city": "Hangzhou", "status": ""}, {"facility": "The 1st Affil Hosp of College of Medicine, Zhejiang Univ ( Site 0830)", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Provincial People's Hospital ( Site 0809)", "city": "Hangzhou", "status": ""}, {"facility": "Ningbo First Hospital-Urology (0835)", "city": "Ningbo", "status": ""}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University ( Site 0834)", "city": "Wenzhou", "status": ""}], "cn_site_count": 24, "broad_only": true}, {"nct": "NCT04895358", "title": "Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-06-18", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 342, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Breast Neoplasms"], "cn_sites": [{"facility": "Anhui Cancer Hospital-medical oncology ( Site 2632)", "city": "Hefei", "status": ""}, {"facility": "Cancer Hospital Chinese Academy of Medical Science ( Site 2635)", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer hospital-Department of Breast Cancer ( Site 2605)", "city": "Beijing", "status": ""}, {"facility": "Beijing Peking Union Medical College Hospital-Medical Oncology ( Site 2610)", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated hospital of Xiamen University-Breast Surgery ( Site 2613)", "city": "Xiamen", "status": ""}, {"facility": "The First People's Hospital of Foshan-Oncology Department of Breast Cancer ( Site 2620)", "city": "Foshan", "status": ""}, {"facility": "SUN YAT-SEN UNIVERSITY CANCER CENTRE-oncology breast ( Site 2616)", "city": "Guangzhou", "status": ""}, {"facility": "Sun Yat-sen Memorial Hospital, Sun Yat-sen University-Breast Oncology Center ( Site 2641)", "city": "Guangzhou", "status": ""}, {"facility": "Peking University Shenzhen Hospital-Oncology Department ( Site 2601)", "city": "Shenzhen", "status": ""}, {"facility": "Guangxi Medical University Affiliated Tumor Hospital-Oncology Dept. of Breast and Bone Soft Tissue (", "city": "Nanning", "status": ""}, {"facility": "Henan Cancer Hospital-Galactophore Department ( Site 2615)", "city": "Zhengzhou", "status": ""}, {"facility": "Wuhan Union Hospital Cancer Center-Cancer Center ( Site 2629)", "city": "Wuhan", "status": ""}, {"facility": "Xiangya Hospital Central South University-Breast department ( Site 2621)", "city": "Changsha", "status": ""}, {"facility": "Hunan Cancer Hospital ( Site 2608)", "city": "Changsha", "status": ""}, {"facility": "Jiangsu provincial people's hospital-Oncology Department ( Site 2607)", "city": "Nanjing", "status": ""}, {"facility": "The Third Hospital of Nanchang-Oncology Dept ( Site 2628)", "city": "Nanchang", "status": ""}, {"facility": "Jilin Cancer Hospital-oncology department ( Site 2619)", "city": "Changchun", "status": ""}, {"facility": "The First Affiliated Hospital of Xian Jiaotong University wa-Oncology ( Site 2604)", "city": "Xi'an", "status": ""}, {"facility": "Shandong Cancer Hospital-Breast surgery ( Site 2623)", "city": "Jinan", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center-Oncology ( Site 2600)", "city": "Shanghai", "status": ""}, {"facility": "Renji Hospital Shanghai Jiao Tong University School of Medicine-Breast surgery ( Site 2626)", "city": "Shanghai", "status": ""}, {"facility": "West China Hospital Sichuan University-Head and Neck Oncology ( Site 2630)", "city": "Chengdu", "status": ""}, {"facility": "Tianjin Medical University Cancer Institute and Hospital-Department of Breast Cancer ( Site 2612)", "city": "Tianjin", "status": ""}, {"facility": "Xinjiang Medical University Cancer Hospital - Urumqi-galactophore department ( Site 2624)", "city": "Ürümqi", "status": ""}, {"facility": "Zhejiang Cancer Hospital-Breast Oncology ( Site 2622)", "city": "Hangzhou", "status": ""}, {"facility": "Taizhou Hospital of Zhejiang Province ( Site 2636)", "city": "Linhai", "status": ""}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University-Thyroid and breast surgery ( Site 2625)", "city": "Wenzhou", "status": ""}], "cn_site_count": 27, "broad_only": true}, {"nct": "NCT05992701", "title": "Effectiveness and Safety of Directional Deep Brain Stimulation for Parkinson's Disease", "status": "COMPLETED", "start": "2021-07-28", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 26, "sponsor": "Beijing Pins Medical Co., Ltd", "conditions": ["Parkinson's Disease"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University", "city": "Beijing", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "First Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}, {"facility": "Nanjing Brain Hospital Affiliated to Nanjing Medical University", "city": "Nanjing", "status": ""}, {"facility": "Changhai Hospital, the Second Military Medical University", "city": "Shanghai", "status": ""}, {"facility": "Shenzhen Second People's Hospital (the First Affiliated Hospital of Shenzhen University)", "city": "Shenzhen", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "Zhongnan Hospital of Wuhan University", "city": "Wuhan", "status": ""}], "cn_site_count": 9, "broad_only": true}, {"nct": "NCT04949256", "title": "Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014).", "status": "TERMINATED", "start": "2021-07-28", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 863, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Metastatic Esophageal Squamous Cell Carcinoma"], "cn_sites": [{"facility": "Anhui Provincial Cancer Hospital ( Site 8058)", "city": "Hefei", "status": ""}, {"facility": "The Second Affiliated Hospital of Anhui Medical University ( Site 8026)", "city": "Hefei", "status": ""}, {"facility": "Beijing Cancer Hospital ( Site 8001)", "city": "Beijing", "status": ""}, {"facility": "Fujian Provincial Cancer Hospital ( Site 8029)", "city": "Fuzhou", "status": ""}, {"facility": "Zhongshan Hospital Affiliated to Xiamen University ( Site 8055)", "city": "Xiamen", "status": ""}, {"facility": "The First Affiliated Hospital of Xiamen University ( Site 8003)", "city": "Xiamen City, Fujian Province", "status": ""}, {"facility": "The First Affiliated Hospital.Sun Yat-sen University ( Site 8047)", "city": "Guangzhou", "status": ""}, {"facility": "Southern Medical University Nanfang Hospital ( Site 8031)", "city": "Guangzhou", "status": ""}, {"facility": "The Third Xiangya Hospital of Central South University ( Site 8046)", "city": "Changsha", "status": ""}, {"facility": "The First Affiliated Hospital of Hainan Medical University ( Site 8042)", "city": "Haikou", "status": ""}, {"facility": "Affiliated Hospital of Chengde Medical Univeristy ( Site 8053)", "city": "Chengde", "status": ""}, {"facility": "Harbin Medical University Cancer Hospital ( Site 8009)", "city": "Harbin", "status": ""}, {"facility": "Anyang Cancer Hospital ( Site 8006)", "city": "Anyang", "status": ""}, {"facility": "The First Affiliated Hospital of Henan University of Science &Technology-Tumor ( Site 8036)", "city": "Luoyang", "status": ""}, {"facility": "The First Affiliated Hospital of Xinxiang Medical University ( Site 8018)", "city": "Xinxiang", "status": ""}, {"facility": "Tongji Medical College Huazhong Uinversity Of Science and Technology ( Site 8025)", "city": "Wuhan", "status": ""}, {"facility": "Hubei Cancer Hospital ( Site 8014)", "city": "Wuhan", "status": ""}, {"facility": "Affiliated hospital of Jiangnan university ( Site 8049)", "city": "Wuxi", "status": ""}, {"facility": "The Affiliated Hospital of Xuzhou Medical University ( Site 8015)", "city": "Xuzhou", "status": ""}, {"facility": "Jilin Cancer Hospital ( Site 8016)", "city": "Changchun", "status": ""}, {"facility": "Jinan Central Hospital ( Site 8052)", "city": "Jinan", "status": ""}, {"facility": "Shandong Cancer Hospital ( Site 8060)", "city": "Jinan", "status": ""}, {"facility": "Affiliated Hospital of Jining Medical University ( Site 8017)", "city": "Jining", "status": ""}, {"facility": "Linyi Cancer Hospital- Medical Oncology Department ( Site 8051)", "city": "Linyi", "status": ""}, {"facility": "Shanxi Provincial Cancer Hospital ( Site 8019)", "city": "Taiyuan", "status": ""}, {"facility": "West China Hospital of Sichuan University ( Site 8048)", "city": "Chengdu", "status": ""}, {"facility": "Tianjin Medical University Cancer Institute & Hospital ( Site 8035)", "city": "Tianjin", "status": ""}, {"facility": "The Affiliated Cancer Hospital of Xinjiang Medical University. ( Site 8041)", "city": "Ürümqi", "status": ""}, {"facility": "Sir Run Run Shaw Hospital ( Site 8021)", "city": "Hangzhou", "status": ""}], "cn_site_count": 29, "broad_only": true}, {"nct": "NCT04976569", "title": "Neuromodulation of Sleep Architecture by STN-DBS in Parkinsonian Patients", "status": "UNKNOWN", "start": "2021-08-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 5, "sponsor": "Tsinghua University", "conditions": ["Parkinson Disease", "Sleep Disorder"], "cn_sites": [{"facility": "National Engineering Laboratory for Neuromodulation", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07731841", "title": "Transcranial Magnetic Stimulation for Freezing of Gait in Parkinson's Disease", "status": "COMPLETED", "start": "2021-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 85, "sponsor": "The First Affiliated Hospital with Nanjing Medical University", "conditions": ["Parkinson Disease (PD)"], "cn_sites": [{"facility": "The First Affiliated Hospital with Nanjing Medical University", "city": "Nanjing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT05064059", "title": "A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)", "status": "COMPLETED", "start": "2021-11-10", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 441, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Colorectal Cancer"], "cn_sites": [{"facility": "The Second Affiliated Hospital of Anhui Medical University ( Site 1179)", "city": "Hefei", "status": ""}, {"facility": "Chongqing Cancer Hospital ( Site 1151)", "city": "Chongqing", "status": ""}, {"facility": "Fujian Province Cancer Hospital ( Site 1178)", "city": "Fuzhou", "status": ""}, {"facility": "Sun Yat-Sen University Cancer Center ( Site 1150)", "city": "Guangzhou", "status": ""}, {"facility": "Southern Medical University Nanfang Hospital ( Site 1154)", "city": "Guangzhou", "status": ""}, {"facility": "The Sixth Affiliated Hospital of Sun Yat-sen University ( Site 1159)", "city": "Guangzhou", "status": ""}, {"facility": "Guangxi Medical University Affiliated Tumor Hospital ( Site 1158)", "city": "Nanning", "status": ""}, {"facility": "Hainan General Hospital ( Site 1177)", "city": "Haikou", "status": ""}, {"facility": "Wuhan Union Hospital Cancer Center ( Site 1162)", "city": "Wuhan", "status": ""}, {"facility": "Hubei Cancer Hospital ( Site 1152)", "city": "Wuhan", "status": ""}, {"facility": "Xiangya Hospital Central South University ( Site 1171)", "city": "Changsha", "status": ""}, {"facility": "Hunan Cancer Hospital ( Site 1174)", "city": "Changsha", "status": ""}, {"facility": "The Third Xiangya Hospital of Central South University ( Site 1175)", "city": "Changsha", "status": ""}, {"facility": "Changzhou Cancer Hospital-Department of Oncology ( Site 1183)", "city": "Changzhou", "status": ""}, {"facility": "Affiliated Hospital of Jiangnan University(Wuxi Fourth People's Hospital ) ( Site 1185)", "city": "Wuxi", "status": ""}, {"facility": "Jilin Cancer Hospital ( Site 1163)", "city": "Changchun", "status": ""}, {"facility": "Jinan Central Hospital ( Site 1167)", "city": "Jinan", "status": ""}, {"facility": "Shanghai Tenth People's Hospital ( Site 1170)", "city": "Shanghai", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center ( Site 1176)", "city": "Shanghai", "status": ""}, {"facility": "West China Hospital Sichuan University ( Site 1172)", "city": "Chengdu", "status": ""}, {"facility": "Tianjin Medical University Cancer Institute and Hospital ( Site 1161)", "city": "Tianjin", "status": ""}, {"facility": "Yunnan Province Cancer Hospital-Colorectal surgery ( Site 1169)", "city": "Kunming", "status": ""}, {"facility": "Zhejiang Cancer Hospital ( Site 1180)", "city": "Hangzhou", "status": ""}, {"facility": "Sir Run Run Shaw Hospital-Medical Oncology ( Site 1173)", "city": "Hangzhou", "status": ""}], "cn_site_count": 24, "broad_only": true}, {"nct": "NCT04871464", "title": "Role and Mechanism of Probiotics in Improving Motor Symptoms in Mild to Moderate Parkinson's Disease", "status": "UNKNOWN", "start": "2021-11-11", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 240, "sponsor": "Beijing Friendship Hospital", "conditions": ["Parkinson Disease", "Parkinsonian Disorders", "Basal Ganglia Diseases", "Brain Diseases", "Movement Disorders", "Neurodegenerative Diseases", "Central Nervous System Diseases", "Nervous System Diseases"], "cn_sites": [{"facility": "China-Japan Friendship Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Beijing Friendship Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Xuanwu Hospital Capital Medical University", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Peking University Third Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Beijing Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Jinan Central Hospital", "city": "Jinan", "status": "NOT_YET_RECRUITING"}, {"facility": "Shanghai Changzheng Hospital", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 10, "broad_only": true}, {"nct": "NCT05116189", "title": "Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-12-13", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 643, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Ovarian Cancer", "Carcinoma, Ovarian Epithelial", "Fallopian Tube Neoplasms"], "cn_sites": [{"facility": "Anhui Provincial Hospital-Obstetrics and Gynecology ( Site 0709)", "city": "Hefei", "status": ""}, {"facility": "Beijing Cancer hospital ( Site 0711)", "city": "Beijing", "status": ""}, {"facility": "Beijing Peking Union Medical College Hospital-Gynecological center of tumor ( Site 0702)", "city": "Beijing", "status": ""}, {"facility": "Fujian Provincial Cancer Hospital ( Site 0713)", "city": "Fuzhou", "status": ""}, {"facility": "Lanzhou university second hospital ( Site 0734)", "city": "Lanzhou", "status": ""}, {"facility": "Zhujiang Hospital ( Site 0739)", "city": "Guangzhou", "status": ""}, {"facility": "Affiliated Hospital of Guangdong Medical University ( Site 0743)", "city": "Zhanjiang", "status": ""}, {"facility": "Guangxi Medical University Affiliated Tumor Hospital ( Site 0717)", "city": "Nanning", "status": ""}, {"facility": "Hainan General Hospital ( Site 0736)", "city": "Haikou", "status": ""}, {"facility": "Henan Cancer Hospital ( Site 0718)", "city": "Zhengzhou", "status": ""}, {"facility": "Wuhan Union Hospital-Medical Oncology ( Site 0735)", "city": "Wuhan", "status": ""}, {"facility": "Hubei Cancer Hospital-Hubei Cancer Hospital ( Site 0708)", "city": "Wuhan", "status": ""}, {"facility": "Xiangya Hospital Central South University-Gynecology ( Site 0705)", "city": "Changsha", "status": ""}, {"facility": "Hunan Cancer Hospital ( Site 0704)", "city": "Changsha", "status": ""}, {"facility": "Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Oncology (", "city": "Nanjing", "status": ""}, {"facility": "Zhongda Hospital Southeast University ( Site 0723)", "city": "Nanjing", "status": ""}, {"facility": "Jiangxi Maternal and Child Health Hospital-Oncology Department ( Site 0716)", "city": "Nanchang", "status": ""}, {"facility": "The First Hospital of Jilin University ( Site 0710)", "city": "Changchun", "status": ""}, {"facility": "Shandong Cancer Hospital-Oncology Department ( Site 0733)", "city": "Jinan", "status": ""}, {"facility": "LinYi Cancer Hospital ( Site 0731)", "city": "Linyi", "status": ""}, {"facility": "Obstetrics & Gynecology Hospital of Fudan University ( Site 0715)", "city": "Shanghai", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center-Gynecologic Oncology Department ( Site 0701)", "city": "Shanghai", "status": ""}, {"facility": "Shanghai First Maternity and Infant Hospital-Gynecology department ( Site 0744)", "city": "Shanghai", "status": ""}, {"facility": "West China Second University Hospital Sichuan University ( Site 0740)", "city": "Chengdu", "status": ""}, {"facility": "Tianjin Central Hosptial of Gynecology Obstetrics ( Site 0737)", "city": "Tianjin", "status": ""}, {"facility": "Tianjin Medical University Cancer Institute and Hospital ( Site 0720)", "city": "Tianjin", "status": ""}, {"facility": "Yunnan Province Cancer Hospital-Gynecology Department ( Site 0714)", "city": "Kunming", "status": ""}, {"facility": "The Affiliated Women's Hospital of Zhejiang University-Obstetrics and Gynecology ( Site 0741)", "city": "Hangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University-Gynecology ( Site 0706)", "city": "Wenzhou", "status": ""}], "cn_site_count": 29, "broad_only": true}, {"nct": "NCT05471713", "title": "MAPT Haploid H1b and the Damage of BBB in Dorsal Medulla Oblongata and Autonomic Dysfunction in PD", "status": "UNKNOWN", "start": "2022-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 80, "sponsor": "Zhujiang Hospital", "conditions": ["Parkinson's Disease"], "cn_sites": [{"facility": "Zhujiang Hospital of Southern Medical University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04952194", "title": "Clinical Study of Stalevo in the Treatment of Early Parkinson's Disease", "status": "UNKNOWN", "start": "2022-01-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 180, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Second Affilliated Hospital Zhejiang University", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06832358", "title": "Positive Psychological Intervention for Parkinson's Disease Patients", "status": "COMPLETED", "start": "2022-02-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "First Affiliated Hospital of Wenzhou Medical University", "conditions": ["Parkinson"], "cn_sites": [{"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT05173987", "title": "Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-02-03", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 280, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Endometrial Neoplasms"], "cn_sites": [{"facility": "Anhui Provincial Hospital-Obstetrics and Gynecology ( Site 0730)", "city": "Hefei", "status": ""}, {"facility": "Beijing Obstetrics and Gynecology Hospital Capital Medical University ( Site 0740)", "city": "Beijing", "status": ""}, {"facility": "Peking University First Hospital ( Site 0723)", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer hospital ( Site 0715)", "city": "Beijing", "status": ""}, {"facility": "Southwest Hospital of Third Military Medical University ( Site 0719)", "city": "Chongqing", "status": ""}, {"facility": "The Second Affiliated Hospital of Chongqing Medical University ( Site 0745)", "city": "Chongqing", "status": ""}, {"facility": "Fuling Central Hospital ( Site 0733)", "city": "Fulingqu", "status": ""}, {"facility": "Fujian Provincial Cancer Hospital ( Site 0720)", "city": "Fuzhou", "status": ""}, {"facility": "SUN YAT-SEN UNIVERSITY CANCER CENTRE ( Site 0710)", "city": "Guangzhou", "status": ""}, {"facility": "Cancer Hospital of Shantou University Medical College ( Site 0732)", "city": "Shantou", "status": ""}, {"facility": "Affiliated Hospital of Guangdong Medical University ( Site 0731)", "city": "Zhanjiang", "status": ""}, {"facility": "Guangxi Medical University Affiliated Tumor Hospital-Gynecological oncology ( Site 0704)", "city": "Nanning", "status": ""}, {"facility": "Hainan General Hospital ( Site 0703)", "city": "Haikou", "status": ""}, {"facility": "Harbin Medical University Cancer Hospital ( Site 0711)", "city": "Harbin", "status": ""}, {"facility": "Henan Cancer Hospital ( Site 0713)", "city": "Zhengzhou", "status": ""}, {"facility": "Wuhan Union Hospital-Medical Oncology ( Site 0716)", "city": "Wuhan", "status": ""}, {"facility": "Xiangya Hospital Central South University-Gynecology ( Site 0708)", "city": "Changsha", "status": ""}, {"facility": "Hunan Cancer Hospital ( Site 0709)", "city": "Changsha", "status": ""}, {"facility": "Jiangsu Province Hospital-Oncology Department ( Site 0707)", "city": "Nanjing", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University ( Site 0729)", "city": "Nanchang", "status": ""}, {"facility": "The First Hospital of Jilin University ( Site 0705)", "city": "Changchun", "status": ""}, {"facility": "Shaanxi Provincial Cancer Hospital ( Site 0714)", "city": "Xi'an", "status": ""}, {"facility": "Binzhou Medical University Hospital-Oncology department ( Site 0735)", "city": "Binzhou", "status": ""}, {"facility": "Obstetrics & Gynecology Hospital of Fudan University ( Site 0702)", "city": "Shanghai", "status": ""}, {"facility": "Shanghai First Maternity and Infant Hospital-Gynecology department ( Site 0717)", "city": "Shanghai", "status": ""}, {"facility": "West China Second University Hospital Sichuan University ( Site 0701)", "city": "Chengdu", "status": ""}, {"facility": "Tianjin Cancer Hospital (Tianjin Medical University Cancer institute & Hospital) ( Site 0706)", "city": "Tianjin", "status": ""}, {"facility": "Yunnan Province Cancer Hospital-Gynecology Department ( Site 0721)", "city": "Kunming", "status": ""}, {"facility": "The Affiliated Women's Hospital of Zhejiang University-Obstetrics and Gynecology ( Site 0726)", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital-Oncology ( Site 0700)", "city": "Hangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University-Gynecology ( Site 0725)", "city": "Wenzhou", "status": ""}], "cn_site_count": 31, "broad_only": true}, {"nct": "NCT05239741", "title": "Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66)", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-04-02", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Colorectal Neoplasms"], "cn_sites": [{"facility": "Beijing Cancer hospital-Digestive Oncology ( Site 0001)", "city": "Beijing", "status": ""}, {"facility": "Beijing Peking Union Medical College Hospital-Medical Oncology ( Site 0011)", "city": "Beijing", "status": ""}, {"facility": "Tianjin Medical University Cancer Institute and Hospital-Gastric oncology ( Site 0019)", "city": "Tianjin", "status": ""}, {"facility": "The First Affiliated Hospital of Chongqing Medical University ( Site 0051)", "city": "Chongqing", "status": ""}, {"facility": "Chongqing University Cancer Hospital-Medical Oncology ( Site 0012)", "city": "Chongqing", "status": ""}, {"facility": "Fujian Provincial Cancer Hospital ( Site 0009)", "city": "Fuzhou", "status": ""}, {"facility": "Sun Yat-sen University Cancer Center ( Site 0047)", "city": "Guangzhou", "status": ""}, {"facility": "Guangdong Provincial People's Hospital ( Site 0035)", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital, Sun Yat-sen University ( Site 0014)", "city": "Guangzhou", "status": ""}, {"facility": "The Sixth Affiliated Hospital of Sun Yat-sen University-Oncology ( Site 0048)", "city": "Guangzhou", "status": ""}, {"facility": "Cancer Hospital of Shantou University Medical College ( Site 0036)", "city": "Shantou", "status": ""}, {"facility": "Guangxi Medical University Affiliated Tumor Hospital ( Site 0039)", "city": "Nanning", "status": ""}, {"facility": "Harbin Medical University Cancer Hospital ( Site 0007)", "city": "Harbin", "status": ""}, {"facility": "Henan Cancer Hospital-henan cancer hospital ( Site 0015)", "city": "Zhengzhou", "status": ""}, {"facility": "Tongji Hospital Tongji Medical,Science & Technology-oncology ( Site 0018)", "city": "Wuhan", "status": ""}, {"facility": "Wuhan Union Hospital Cancer Center-Cancer Center ( Site 0008)", "city": "Wuhan", "status": ""}, {"facility": "The Third Xiangya Hospital of Central South University ( Site 0031)", "city": "Changsha", "status": ""}, {"facility": "The Affiliated Jiangyin Hospital of Southeast University Medical College ( Site 0037)", "city": "Jiangyin", "status": ""}, {"facility": "Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Oncology ( Site 0002)", "city": "Nanjing", "status": ""}, {"facility": "The first affiliated hospital of China medical university ( Site 0043)", "city": "Shemyang", "status": ""}, {"facility": "Tangdu Hospital of Fourth Military Medical University of Chi-General Surgery ( Site 0045)", "city": "Xi'an", "status": ""}, {"facility": "Jinan Central Hospital-oncology department ( Site 0021)", "city": "Jinan", "status": ""}, {"facility": "Shandong Cancer Hospital ( Site 0041)", "city": "Jinan", "status": ""}, {"facility": "Shanghai Changhai Hospital ( Site 0024)", "city": "Shanghai", "status": ""}, {"facility": "Shanghai East Hospital ( Site 0022)", "city": "Shanghai", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center-Oncology ( Site 0046)", "city": "Shanghai", "status": ""}, {"facility": "Shanxi Cancer Hospital ( Site 0032)", "city": "Taiyuan", "status": ""}, {"facility": "Sichuan Cancer Hospital. ( Site 0050)", "city": "Chengdu", "status": ""}, {"facility": "West China Hospital, Sichuan University ( Site 0044)", "city": "Chengdu", "status": ""}, {"facility": "The Affiliated Cancer Hospital of Xinjiang Medical University ( Site 0049)", "city": "Ürümqi", "status": ""}, {"facility": "Yunnan Province Cancer Hospital-Colorectal surgery ( Site 0006)", "city": "Kunming", "status": ""}, {"facility": "Zhejiang Cancer Hospital-oncology-abdominal neoplasms ( Site 0028)", "city": "Hangzhou", "status": ""}], "cn_site_count": 32, "broad_only": true}, {"nct": "NCT05353764", "title": "Effect of Scalp Nerve Block on the Recovery Quality of Parkinson's Patients After Deep Brain Stimulation", "status": "UNKNOWN", "start": "2022-04-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 88, "sponsor": "Changhai Hospital", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Changhai Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07792265", "title": "Anesthesia and Postoperative Delirium in Parkinson DBS", "status": "COMPLETED", "start": "2022-05-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 400, "sponsor": "Beijing Tiantan Hospital", "conditions": ["PARKINSON DISEASE (Disorder)", "Deep Brain Stimulation", "Postoperative Delirium"], "cn_sites": [{"facility": "Beijing Tian Tan Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06147713", "title": "Vibrotactile Foot Device for Freezing of Gait in Parkinson's Disease", "status": "UNKNOWN", "start": "2022-05-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 200, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Parkinson Disease", "Freezing of Gait"], "cn_sites": [{"facility": "Xuanwu Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT05445505", "title": "Neuroprotective Effects of iTBS in PD", "status": "UNKNOWN", "start": "2022-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Ruijin Hospital", "conditions": ["Neuroprotection", "Parkinson Disease", "Intermittent Theta Burst Stimulation"], "cn_sites": [{"facility": "Department of neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT05806736", "title": "Curative Effect and Mechanism of Transcutaneous Auricular Vagus Nerve Stimulation on Sleep Disorders of PD", "status": "COMPLETED", "start": "2022-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "The First Affiliated Hospital with Nanjing Medical University", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "the First Affiliated Hospital of Nanjing Medical University", "city": "Nanjing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT05505877", "title": "Phase I/IIa Study of BR790 in Combination With Tislelizumab in Adult Subjects With Advanced Solid Tumors", "status": "UNKNOWN", "start": "2022-09-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 160, "sponsor": "Shanghai Gopherwood Biotech Co., Ltd.", "conditions": ["Advanced Solid Tumor"], "cn_sites": [{"facility": "Sun Yat-Sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT05550714", "title": "Choice of Anesthesia in Microelectrode Recording Guided Deep Brain Stimulation for Parkinson's Disease", "status": "UNKNOWN", "start": "2022-10-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 188, "sponsor": "Beijing Tiantan Hospital", "conditions": ["PD - Parkinson's Disease", "Dexmedetomidine", "Desflurane", "Deep Brain Stimulation"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06010290", "title": "The Novel 18F-labeled MAO-B PET Tracer Study in Parkinsonism Patients", "status": "UNKNOWN", "start": "2022-11-30", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 80, "sponsor": "Anhui Provincial Hospital", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "The First Affiliated Hospital of China University of Science and Technology", "city": "Hefei", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT05626569", "title": "Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCC", "status": "UNKNOWN", "start": "2022-12-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Sun Yat-sen University", "conditions": ["Esophageal Squamous Cell Carcinoma", "Oligometastatic Disease"], "cn_sites": [{"facility": "Mian Xi", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06539260", "title": "Clinical Relationship Between Vitamin D-mediated Th17 and Treg Cells and Parkinson's Disease", "status": "COMPLETED", "start": "2023-01-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Suzhou Municipal Hospital of Anhui Province", "conditions": ["Neurology", "Immunology"], "cn_sites": [{"facility": "Suzhou Hospital of Anhui Medical University", "city": "Suzhou", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT05665595", "title": "A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010)", "status": "TERMINATED", "start": "2023-01-19", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1594, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Beijing Ji Shui Tan Hospital ( Site 1657)", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer hospital-Renal carcinoma and melanoma ( Site 1650)", "city": "Beijing", "status": ""}, {"facility": "Chongqing University Cancer Hospital ( Site 1651)", "city": "Chongqing", "status": ""}, {"facility": "Fujian Provincial Cancer Hospital ( Site 1659)", "city": "Fuzhou", "status": ""}, {"facility": "Sun Yat-sen University Cancer Center-melanoma ( Site 1655)", "city": "Guangzhou", "status": ""}, {"facility": "Guangxi Medical University Affiliated Tumor Hospital ( Site 1668)", "city": "Nanning", "status": ""}, {"facility": "Fourth Hospital of Hebei Medical University ( Site 1669)", "city": "Shijiazhuang", "status": ""}, {"facility": "The Third Hospital of Zhengzhou-Oncology ( Site 1653)", "city": "Zhengzhou", "status": ""}, {"facility": "Wuhan Union Hospital Cancer Center-Cancer Center ( Site 1664)", "city": "Wuhan", "status": ""}, {"facility": "The Second Xiangya Hospital of Central South University-Oncology ( Site 1673)", "city": "Changsha", "status": ""}, {"facility": "Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Oncology (", "city": "Nanjing", "status": ""}, {"facility": "Jiangsu Province Hospital-Oncology Department ( Site 1663)", "city": "Nanjing", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University ( Site 1652)", "city": "Nanchang", "status": ""}, {"facility": "The First Hospital of Jilin University-Oncology ( Site 1665)", "city": "Changchun", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center ( Site 1658)", "city": "Shanghai", "status": ""}, {"facility": "Shanxi Bethune Hospital ( Site 1660)", "city": "Taiyuan", "status": ""}, {"facility": "West China Hospital, Sichuan University-Head and Neck Oncology ( Site 1667)", "city": "Chengdu", "status": ""}, {"facility": "Tianjin Medical University Cancer Institute & Hospital-Biotherapy ( Site 1671)", "city": "Tianjin", "status": ""}, {"facility": "Xinjiang Medical University Cancer Hospital - Urumqi-Bone and Soft Tissue Department ( Site 1674)", "city": "Ürümqi", "status": ""}, {"facility": "Yunnan Province Cancer Hospital-Biotherapy Center ( Site 1666)", "city": "Kunming", "status": ""}, {"facility": "Zhejiang Cancer Hospital-Oncology ( Site 1661)", "city": "Hangzhou", "status": ""}], "cn_site_count": 21, "broad_only": true}, {"nct": "NCT05609968", "title": "Study of Pembrolizumab (MK-3475) Monotherapy Versus Sacituzumab Govitecan in Combination With Pembrolizumab for Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-3475-D46)", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-02-06", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 614, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Carcinoma, Non-Small-Cell Lung"], "cn_sites": [{"facility": "Second Affiliated hospital of Anhui Medical University ( Site 0126)", "city": "Hefei", "status": ""}, {"facility": "Anhui Provincial Hospital ( Site 0136)", "city": "Hefei", "status": ""}, {"facility": "Beijing Cancer hospital ( Site 0104)", "city": "Beijing", "status": ""}, {"facility": "Beijing Peking Union Medical College Hospital-pneumology department ( Site 0106)", "city": "Beijing", "status": ""}, {"facility": "Beijing Chest Hospital,Capital Medical University ( Site 0105)", "city": "Beijing", "status": ""}, {"facility": "Chongqing University Cancer Hospital-Medical Oncology ( Site 0130)", "city": "Chongqing", "status": ""}, {"facility": "Fujian Provincial Cancer Hospital ( Site 0131)", "city": "Fuzhou", "status": ""}, {"facility": "The First Affiliated hospital of Xiamen University ( Site 0132)", "city": "Xiamen", "status": ""}, {"facility": "Southern Medical University Nanfang Hospital-Depatrment of Respiratory and Critical Care Medicine ( Site 0125)", "city": "Guangzhou", "status": ""}, {"facility": "Affiliated Cancer Hospital of Guangxi Medical University ( Site 0113)", "city": "Nanning", "status": ""}, {"facility": "Harbin Medical University Cancer Hospital ( Site 0119)", "city": "Harbin", "status": ""}, {"facility": "Henan Cancer Hospital ( Site 0127)", "city": "Zhengzhou", "status": ""}, {"facility": "Tongji Hospital Tongji Medical,Science & Technology ( Site 0116)", "city": "Wuhan", "status": ""}, {"facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 0115)", "city": "Wuhan", "status": ""}, {"facility": "Hubei Cancer Hospital ( Site 0107)", "city": "Wuhan", "status": ""}, {"facility": "Xiangya Hospital Central South University ( Site 0124)", "city": "Changsha", "status": ""}, {"facility": "The Second Xiangya Hospital of Central South University ( Site 0135)", "city": "Changsha", "status": ""}, {"facility": "Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School ( Site 0112)", "city": "Nanjing", "status": ""}, {"facility": "Nantong Tumor Hospital-Medical Oncology ( Site 0122)", "city": "Nantong", "status": ""}, {"facility": "The First Affliated Hospital of Suzhou University ( Site 0114)", "city": "Suzhou", "status": ""}, {"facility": "The Second Affiliated Hospital of Nanchang University ( Site 0134)", "city": "Nanchang", "status": ""}, {"facility": "The First Hospital of Jilin University ( Site 0117)", "city": "Changchun", "status": ""}, {"facility": "Jilin Province Tumor Hospital-clinical research ( Site 0118)", "city": "Changchun", "status": ""}, {"facility": "The First Affiliated Hospital of Xi'an Jiaotong University-Oncology ( Site 0133)", "city": "Xi'an", "status": ""}, {"facility": "Jinan Central Hospital-oncology department ( Site 0121)", "city": "Jinan", "status": ""}, {"facility": "LinYi Cancer Hospital ( Site 0120)", "city": "Linyi", "status": ""}, {"facility": "Shanghai Chest Hospital ( Site 0101)", "city": "Shanghai", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center-Oncology ( Site 0102)", "city": "Shanghai", "status": ""}, {"facility": "Huashan Hospital, Fudan University ( Site 0103)", "city": "Shanghai", "status": ""}, {"facility": "West China Hospital of Sichuan University ( Site 0129)", "city": "Chengdu", "status": ""}, {"facility": "Sichuan Cancer hospital. ( Site 0128)", "city": "Chengdu", "status": ""}, {"facility": "The First Affiliated Hospital, Zhejiang University ( Site 0109)", "city": "Hangzhou", "status": ""}, {"facility": "The Second Affiliated hospital of Zhejiang University school of medicine ( Site 0110)", "city": "Hangzhou", "status": ""}, {"facility": "Sir Run Run Shaw Hospital-Medical Oncology ( Site 0111)", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital ( Site 0108)", "city": "Hangzhou", "status": ""}], "cn_site_count": 35, "broad_only": true}, {"nct": "NCT05678725", "title": "Transcranial Direct/ Alternating Current Stimulation for Parkinson's Disease Treatment", "status": "COMPLETED", "start": "2023-02-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Anhui Medical University", "conditions": ["tACS", "tDCS"], "cn_sites": [{"facility": "Anhui Medical University", "city": "Hefei", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT05281003", "title": "Pembrolizumab Plus Chemo in Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (Eastern Cooperative Thoracic Oncology Projects 2004, ECTOP-2004)", "status": "UNKNOWN", "start": "2023-02-20", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 128, "sponsor": "Fudan University", "conditions": ["Esophageal Squamous Cell Carcinoma"], "cn_sites": [{"facility": "Fudan University Cancer Center", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": true}, {"nct": "NCT06614153", "title": "Pharmacokinetics,Pharmacodynamics,Efficacy and Safety of HRG2010 in Parkinson's Disease Patients With Motor Fluctuations", "status": "COMPLETED", "start": "2023-05-16", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 61, "sponsor": "Jiangsu HengRui Medicine Co., Ltd.", "conditions": ["Parkinson's Disease"], "cn_sites": [{"facility": "Beijing Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT05905198", "title": "Programming Strategy of VFS for Gait Impairments in PD", "status": "UNKNOWN", "start": "2023-05-24", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Parkinson's Disease", "Deep Brain Stimulation", "Gait Disorders, Neurologic"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06734676", "title": "fMRI-guided Transcranial Magnetic Stimulation Treatment for Parkinson's Disease", "status": "COMPLETED", "start": "2023-05-29", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Changping Laboratory", "conditions": ["Parkinson&#39;s Disease"], "cn_sites": [{"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06009471", "title": "A Multicenter Clinical Study of rTMS for Parkinson's Disease", "status": "UNKNOWN", "start": "2023-07-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 200, "sponsor": "Affiliated Hospital of Nantong University", "conditions": ["Parkinson's Disease"], "cn_sites": [{"facility": "rTMS", "city": "Nantong", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT05997667", "title": "Study on the Efficacy and Safety of Rechargeable Implantable DBS System in the Treatment of Parkinson's Disease", "status": "UNKNOWN", "start": "2023-07-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Lepu Medical Technology (Beijing) Co., Ltd.", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Xuanwu Hospital Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "ZhuJiang Hospital of Southern Medical University", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Renmin Hospital of Wuhan University", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Affiliated Hospital of Air Force Medical University", "city": "Xi'an", "status": "NOT_YET_RECRUITING"}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 7, "broad_only": true}, {"nct": "NCT06319118", "title": "A Clinical Study of Dihydroergotine Mesylate Extended-release Tablets for the Treatment of Drooling in Parkinson's Disease.", "status": "COMPLETED", "start": "2023-10-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Second Affiliated Hospital of Soochow University", "conditions": ["Salivation in Parkinson's Disease"], "cn_sites": [{"facility": "The Second Arilliated Hospital of Soochow University", "city": "Suzhou", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT05637593", "title": "Rhythmic Auditory Stimulation on Upper-limb Movements in PD Patients", "status": "COMPLETED", "start": "2023-10-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 38, "sponsor": "The Hong Kong Polytechnic University", "conditions": ["Acoustic Stimulation", "Parkinson Disease", "Movement, Abnormal", "Bradykinesia", "Arm"], "cn_sites": [{"facility": "Wuhan Brain Hospital", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06175897", "title": "Effects of STN DBS on Cognition and Brain Networks in PD Patients Analyzed Based on EEG and fNIRS", "status": "UNKNOWN", "start": "2023-10-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 80, "sponsor": "Zhiqi Mao", "conditions": ["Parkinson's Disease", "Executive Function", "Electroencephalogram", "Functional Near - Infrared Spectroscopy"], "cn_sites": [{"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06195124", "title": "A Study on the Safety and Tolerability of RGL-193 in Patients With Advanced Parkinson's Disease", "status": "UNKNOWN", "start": "2023-12", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 8, "sponsor": "Second Affiliated Hospital of Soochow University", "conditions": ["Advanced Parkinson's Disease"], "cn_sites": [{"facility": "Department of Neurology, Second Affiliated Hospital of Soochow University", "city": "Suzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06396494", "title": "An Automated Navigation System for Deep Brain Electrode Implantation", "status": "UNKNOWN", "start": "2024-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 30, "sponsor": "Beijing Tiantan Hospital", "conditions": ["Advanced Parkinson's Disease", "Refractory Epilepsy", "Obsessive-compulsive Disorder"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06255756", "title": "Effect of Acupuncture Therapy on Dysphagic Parkinson's Patients", "status": "WITHDRAWN", "start": "2024-02-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Zeng Changhao", "conditions": ["Dysphagia"], "cn_sites": [{"facility": "Zheng Da yi Yuan Hospital", "city": "Zhenzhou", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06537050", "title": "A Randomized, Double-blind, Placebo-controlled Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JX2105 in Healthy Chinese Subjects", "status": "UNKNOWN", "start": "2024-07-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 52, "sponsor": "Zhejiang Jingxin Pharmaceutical Co., Ltd.", "conditions": ["Parkinson's Disease"], "cn_sites": [{"facility": "Beijing Ditan Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06641193", "title": "Clinical Trail of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Upper Limb Bradykinesia in Parkinson' Disease' Patients", "status": "UNKNOWN", "start": "2024-08-27", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": ["Parkinson&#39;s Disease (PD)", "Bradykinesia", "Upper Limb Function"], "cn_sites": [{"facility": "Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06542991", "title": "An Open-label Study on the Clinical Efficacy of rTMS Intervention in PD", "status": "UNKNOWN", "start": "2024-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Anhui Medical University", "conditions": ["Transcranial Magnetic Stimulation", "Parkinson Disease", "Supplementary Motor Area"], "cn_sites": [{"facility": "Cognitive Neuropsychology Lab Anhui Medical University", "city": "Hefei", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06480461", "title": "A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R09b in Patients With Parkinson's Disease", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-09-02", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 39, "sponsor": "Shanghai Vitalgen BioPharma Co., Ltd.", "conditions": ["Parkinson's Disease"], "cn_sites": [{"facility": "Shanghai", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04536857", "title": "Detection of A-synuclein Aggregate as Biomarker in Diagnosing Parkinson's Disease at Early Stage by Using Protein Misfolding Cyclic Amplification (PMCA)", "status": "WITHDRAWN", "start": "2024-10-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 0, "sponsor": "Huashan Hospital", "conditions": ["Parkinson's Disease"], "cn_sites": [{"facility": "Huashan Hospital Affiliated to Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06415682", "title": "The Efficacy and Mechanism of SMA+M1 Repetitive Transcranial Magnetic Stimulation on Freezing of Gait in PD", "status": "COMPLETED", "start": "2024-10-08", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 64, "sponsor": "The First Affiliated Hospital with Nanjing Medical University", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "The First Affiliated Hospital of Nanjing Medical University", "city": "Nanjing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06639945", "title": "Clinical Trail of Transcranial MR-guided Focused Ultrasound in the Treatment of Motor Symptoms in Patients With Parkinson' Disease", "status": "COMPLETED", "start": "2025-01-07", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": ["Parkinson Disease, Idiopathic"], "cn_sites": [{"facility": "Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06778265", "title": "An Exploratory Clinical Study of UX-DA001 in Subjects With Idiopathic Parkinson's Disease", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-03-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Shanghai UniXell Biotechnology Co., Ltd", "conditions": ["Parkinson Disease, Idiopathic"], "cn_sites": [{"facility": "Ruijin Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06980935", "title": "STN-tTIS Modulates Parkinson Motor Symptoms With and Without Medications", "status": "COMPLETED", "start": "2025-04-14", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Ruijin Hospital", "conditions": ["Parkinson Disease"], "cn_sites": [{"facility": "Ruijin Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07309198", "title": "Temporal Interference Stimulation on Motor Symptoms in Parkinson's Disease", "status": "COMPLETED", "start": "2025-12-29", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 37, "sponsor": "Shanghai University of Sport", "conditions": ["Parkinson's Disease"], "cn_sites": [{"facility": "Shanghai University of Sport", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07483398", "title": "EFficacy and safEty of cRisugabalin on nocipLastic paIn in Patients With Parkinson's Disease (RELIEF-PD): a Multicentre, Double-blind, Randomised Controlled Trial", "status": "ACTIVE_NOT_RECRUITING", "start": "2026-03-13", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 166, "sponsor": "Guangdong Provincial People's Hospital", "conditions": ["PARKINSON DISEASE (Disorder)"], "cn_sites": [{"facility": "No. 106 Zhongshan Er Road", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07572903", "title": "The Efficacy and Safety of Temporal Interference Stimulation on Motor Symptoms of Parkinson's Disease", "status": "COMPLETED", "start": "2026-05-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 96, "sponsor": "The First Affiliated Hospital of Anhui Medical University", "conditions": ["Parkinson s Disease"], "cn_sites": [{"facility": "The First Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": ""}], "cn_site_count": 1, "broad_only": true}], "g_total": 9, "g_fetched": 5, "g_countries": [["United States", 2], ["Portugal", 1], ["Italy", 1], ["United Kingdom", 1]], "g_trials": [{"nct": "NCT07267065", "title": "AAV2-hAADC for Parkinson's Disease (PDCS-01)", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Krzysztof Bankiewicz", "countries": ["United States"]}, {"nct": "NCT07310147", "title": "Empower Your Mind to Embrace Your Life: an Online ACT Intervention for Young-Onset Parkinson's Disease", "status": "RECRUITING", "start": "2025-04-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Coimbra", "countries": ["Portugal"]}, {"nct": "NCT07235111", "title": "Omics Sciences for the Identification of Pathogenetic Mechanisms and Biomarkers in Neurodegenerative Diseases", "status": "RECRUITING", "start": "2025-02-28", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Ospedale Policlinico San Martino", "countries": ["Italy"]}, {"nct": "NCT07752355", "title": "Young Onset Parkinson's Disease Subtypes and Pathogenic Mechanisms", "status": "RECRUITING", "start": "2024-02-28", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "NYU Langone Health", "countries": ["United States"]}, {"nct": "NCT02760108", "title": "Parkinson's Families Project", "status": "RECRUITING", "start": "2015-04", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University College, London", "countries": ["United Kingdom"]}]}, {"batch": 1, "no": 88, "name_zh": "阵发性睡眠性血红蛋白尿", "query_terms": [{"term": "Paroxysmal nocturnal hemoglobinuria", "broad": false}], "n_total": 51, "n_open": 19, "n_open_precise": 19, "n_broad": 0, "trials": [{"nct": "NCT04645199", "title": "National Longitudinal Cohort of Hematological Diseases", "status": "RECRUITING", "start": "2020-12-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2300, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Multiple Myeloma", "Acute Myeloid Leukemia", "Hemophilia", "Hemophilia A", "Hemophilia B", "Myelodysplastic Syndrome", "MDS", "Lymphoma", "Leukemia", "Aplastic Anemia", "Bleeding Disorder", "Bone Marrow Transplantation", "Blood Disease Infection", "Autoimmune Hemolytic Anemia, AIHA", "Essential Thrombocythemia, ET", "Large Granular Lymphocyte Leukemia, LGLL", "Paroxysmal Nocturnal Hemoglobinuria, PNH"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07256301", "title": "A Phase Ib, Multicenter, Open-Label Study of Multiple-Dose EA5 in Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH)", "status": "RECRUITING", "start": "2024-01-03", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Shanghai Lanyi Therapeutics Co., Ltd.", "conditions": ["PNH - Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "The Institute of Hematology & Blood Diseases Hospital (Chinese Academy of Medical Sciences)", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital, Zhejiang University School of Medicine, Chengzhan Campus", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06932744", "title": "Study of Safety and Efficacy of MY008211A in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Who Are Naive to Complement Inhibitor Therapy", "status": "RECRUITING", "start": "2024-08-30", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 66, "sponsor": "Wuhan Createrna Science and Technology Co., Ltd", "conditions": ["Paroxysmal Nocturnal Haemoglobinuria (PNH)"], "cn_sites": [{"facility": "Peking Union Medical College Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Chinese Academy of Medical Sciences Hematology Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06932471", "title": "Study of Safety and Efficacy of MY008211A in Patients With Residual Anemia Despite Anti-C5 Antibody Treatment", "status": "RECRUITING", "start": "2024-08-30", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Wuhan Createrna Science and Technology Co., Ltd", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "Peking Union Medical College Hospital (PUMCH).", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06933914", "title": "Long-term Safety and Tolerability of MY008211A Tablets in Patients With Paroxysmal Nocturnal Hemoglobinuria", "status": "RECRUITING", "start": "2024-11-30", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Wuhan Createrna Science and Technology Co., Ltd", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria (PNH)"], "cn_sites": [{"facility": "Chinese Academy of Medical Sciences Hematology Hospital (Institute of Hematology, Chinese Academy of Medical Sciences)", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06745622", "title": "Long-term Safety and Tolerability of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria", "status": "RECRUITING", "start": "2025-01-03", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 47, "sponsor": "Haisco Pharmaceutical Group Co., Ltd.", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "The First Affiliated Hospital of Nanjing Medical University", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06978699", "title": "A Phase II Study Evaluating the Efficacy and Safety of XH-S003 Capsules in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)", "status": "RECRUITING", "start": "2025-04-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "S-INFINITY Pharmaceuticals Co., Ltd", "conditions": ["PNH - Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "TianJin Medical University General Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07152288", "title": "Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HSK39297 in Subjects With Hepatic Impairment", "status": "RECRUITING", "start": "2025-05-29", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Haisco Pharmaceutical Group Co., Ltd.", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria (PNH)"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06931691", "title": "A Multi-center, Ambispective Cohort Study to Evaluate the Impact of Iptacopan for Adult Patients With PNH in China", "status": "RECRUITING", "start": "2025-06-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 80, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Hefei", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Shijiazhuang", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Nantong", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Changchun", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT07657052", "title": "A Multicenter, Open-label Study Evaluating the Long-term Safety and Efficacy of XH-S003 Capsules in Patients With Paroxysmal Nocturnal Hemoglobinuria", "status": "ENROLLING_BY_INVITATION", "start": "2025-08-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 26, "sponsor": "S-INFINITY Pharmaceuticals Co., Ltd", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "TianJin Medical University General Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07177859", "title": "A Phase III Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients", "status": "NOT_YET_RECRUITING", "start": "2025-11", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 78, "sponsor": "Nanjing Chia-tai Tianqing Pharmaceutical", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07266155", "title": "Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)", "status": "NOT_YET_RECRUITING", "start": "2025-12-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Longbio Pharma", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "The First Affiliated Hospital of Nanjing Medical University", "city": "Nanjing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07470762", "title": "Study of Safety and Efficacy of HS-10542 in Patients With Paroxysmal Nocturnal Hemoglobinuria", "status": "RECRUITING", "start": "2026-02-14", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Jiangsu Hansoh Pharmaceutical Co., Ltd.", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "The First Affiliated Hospital，Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07462780", "title": "A Phase I Clinical Trial to Evaluate CMS-D017 Following Single and Multiple Doses in Healthy Participants", "status": "RECRUITING", "start": "2026-03-05", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 88, "sponsor": "Shenzhen Kangzhe Biotechnology Co., Ltd.", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria, PNH", "Complement-mediated Kidney Disease"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07177872", "title": "A Long-term Efficacy and Safety of NTQ5082 Capsules", "status": "NOT_YET_RECRUITING", "start": "2026-06", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 78, "sponsor": "Nanjing Chia-tai Tianqing Pharmaceutical", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences ,", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07760467", "title": "To Evaluate Safety, Tolerability, PK/PD & Food Effect of Single/Multiple Oral TUL321 Capsules in Healthy Participants.", "status": "RECRUITING", "start": "2026-08-26", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 94, "sponsor": "Zhuhai United Laboratories Co., Ltd.", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria, PNH"], "cn_sites": [{"facility": "Third Xiangya Hospital of Central South University", "city": "Changsha", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07816237", "title": "A Multicenter, Randomized, Open-Label, Positive Controlled Phase III Study to Evaluate the Efficacy and Safety of VSA012 Injection in Participants With Paroxysmal Nocturnal Hemoglobinuria Who Are Naive to Complement Inhibitor Therapy", "status": "NOT_YET_RECRUITING", "start": "2026-10-29", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 70, "sponsor": "Bisirna Therapeutics (Suzhou) Co., Ltd.", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria, PNH"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Jilin", "city": "Jilin City", "status": ""}, {"facility": "Quanzhou", "city": "Quanzhou", "status": ""}, {"facility": "Guangzhou", "city": "Guangzhou", "status": ""}, {"facility": "Nanning", "city": "Nanning", "status": ""}, {"facility": "Ha'erbin", "city": "Harbin", "status": ""}, {"facility": "Zhengzhou", "city": "Zhengzhou", "status": ""}, {"facility": "Wuhan", "city": "Wuhan", "status": ""}, {"facility": "Changsha", "city": "Changsha", "status": ""}, {"facility": "Nantong", "city": "Nantong", "status": ""}, {"facility": "Xi'an", "city": "Xi’an", "status": ""}, {"facility": "Chengdu", "city": "Chengdu", "status": ""}, {"facility": "Institute of Hematology, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}, {"facility": "The First Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 14, "broad_only": false}, {"nct": "NCT07796256", "title": "Study of SGB-9768 in Patients With Paroxysmal Nocturnal Hemoglobinuria", "status": "NOT_YET_RECRUITING", "start": "2026-10-31", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Suzhou Sanegene Bio Inc.", "conditions": ["PNH - Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS)", "city": "Tianjin", "status": ""}, {"facility": "The First Affiliated Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07747090", "title": "A Study of the Efficacy and Safety of FXS6837 Capsules Compared to Eculizumab for 24 Weeks in Patients With PNH.", "status": "NOT_YET_RECRUITING", "start": "2026-12-10", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "TianJin Medical University General Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01642979", "title": "Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal Hemoglobinuria", "status": "UNKNOWN", "start": "2012-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria", "Hemoglobinuria", "Hemoglobinuria, Paroxysmal", "Proteinuria", "Urination Disorders", "Thrombosis", "Bone Marrow Failure", "Aplastic Anemia,", "Anemia, Hemolytic"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital,", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01760096", "title": "Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013)", "status": "UNKNOWN", "start": "2013-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria", "Hemoglobinuria", "Hemoglobinuria, Paroxysmal", "Proteinuria", "Urination Disorders", "Thrombosis", "Bone Marrow Failure", "Aplastic Anemia,", "Anemia, Hemolytic"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital,", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03866681", "title": "Sirolimus Combined With Low-dose Warfarin for the Treatment of Refractory PNH", "status": "UNKNOWN", "start": "2019-04-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "Peking union medical college hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04434092", "title": "A Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibitors", "status": "ACTIVE_NOT_RECRUITING", "start": "2020-10-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 210, "sponsor": "Hoffmann-La Roche", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Nanfang Hospital, Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital, Zhejiang University", "city": "Hangzhou", "status": ""}, {"facility": "Jiangsu Province Hospital", "city": "Nanjing", "status": ""}, {"facility": "Affiliated Hospital of Nantong University", "city": "Nantong", "status": ""}, {"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT04654468", "title": "A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibition", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-03-17", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 51, "sponsor": "Hoffmann-La Roche", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Guangdong General Hospital", "city": "Guangzhou", "status": ""}, {"facility": "Institute of Hematology and Hospital of Blood Disease", "city": "Tianjin", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT04820530", "title": "Study of Efficacy and Safety of Twice Daily Oral Iptacopan (LNP023) in Adult PNH Patients Who Are Naive to Complement Inhibitor Therapy", "status": "COMPLETED", "start": "2021-07-19", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria (PNH)"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Tianjin", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT04747613", "title": "Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-07-27", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 208, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Tianjin", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05125341", "title": "Natural History Study of Adult Patients With Paroxysmal Nocturnal Hemoglobinuria of High-risk Hemolysis in China", "status": "COMPLETED", "start": "2021-11-25", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 67, "sponsor": "CARE Pharma Shanghai Ltd.", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria, Natural History Study"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05642585", "title": "A Study of Single-dose MY008211A in Healthy Adults", "status": "COMPLETED", "start": "2022-05-27", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 63, "sponsor": "Wuhan Createrna Science and Technology Co., Ltd", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "The Third Hospital of Changsha", "city": "Changsha", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05133531", "title": "A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-08-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 202, "sponsor": "Regeneron Pharmaceuticals", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05828485", "title": "Effect of Food on Pharmacokinetics of MY008211A Tablets in Healthy Adult Subjects", "status": "COMPLETED", "start": "2022-09-26", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Wuhan Createrna Science and Technology Co., Ltd", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "The Third Hospital of Changsha", "city": "Changsha", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05476887", "title": "To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of KP104", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-11-25", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 35, "sponsor": "Kira Pharmacenticals (US), LLC.", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Jiangsu Province Hospital", "city": "Nanjing", "status": ""}, {"facility": "Chinese Academy of Medical Sciences Peking Union Medical College - Institute of Hematology Blood Diseases Hospital", "city": "Tianjin", "status": ""}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT05828472", "title": "A Study of Multiple Ascending Doses MY008211A in Healthy Adults", "status": "COMPLETED", "start": "2023-01-10", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Wuhan Createrna Science and Technology Co., Ltd", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "The Third Hospital of Changsha", "city": "Changsha", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05886244", "title": "Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) in China", "status": "COMPLETED", "start": "2023-07-05", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 25, "sponsor": "Alexion Pharmaceuticals, Inc.", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Hangzhou", "status": ""}, {"facility": "Research Site", "city": "Nantong", "status": ""}, {"facility": "Research Site", "city": "Shanghai", "status": ""}, {"facility": "Research Site", "city": "Tianjin", "status": ""}, {"facility": "Research Site", "city": "Wuhan", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT06050226", "title": "A Study of MY008211A in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)", "status": "COMPLETED", "start": "2023-07-06", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 34, "sponsor": "Wuhan Createrna Science and Technology Co., Ltd", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "Institute of Hematology & Blood Disease Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06154512", "title": "A Real-world, Multi-center, Prospective, Observational Study for PNH in China", "status": "COMPLETED", "start": "2023-11-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 724, "sponsor": "AstraZeneca", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "Research Site", "city": "Hefei", "status": ""}, {"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Guangzhou", "status": ""}, {"facility": "Research Site", "city": "Nanning", "status": ""}, {"facility": "Research Site", "city": "Guiyang", "status": ""}, {"facility": "Research Site", "city": "Shijiazhuang", "status": ""}, {"facility": "Research Site", "city": "Harbin", "status": ""}, {"facility": "Research Site", "city": "Zhengzhou", "status": ""}, {"facility": "Research Site", "city": "Wuhan", "status": ""}, {"facility": "Research Site", "city": "Changsha", "status": ""}, {"facility": "Research Site", "city": "Nanjing", "status": ""}, {"facility": "Research Site", "city": "Nantong", "status": ""}, {"facility": "Research Site", "city": "Xuzhou", "status": ""}, {"facility": "Research Site", "city": "Nanchang", "status": ""}, {"facility": "Research Site", "city": "Changchun", "status": ""}, {"facility": "Research Site", "city": "Shenyang", "status": ""}, {"facility": "Research Site", "city": "Jinan", "status": ""}, {"facility": "Research Site", "city": "Qingdao", "status": ""}, {"facility": "Research Site", "city": "Zibo", "status": ""}, {"facility": "Research Site", "city": "Linyi", "status": ""}, {"facility": "Research Site", "city": "Shanghai", "status": ""}, {"facility": "Research Site", "city": "Taiyuan", "status": ""}, {"facility": "Research Site", "city": "Xi’an", "status": ""}, {"facility": "Research Site", "city": "Chengdu", "status": ""}, {"facility": "Research Site", "city": "Tianjin", "status": ""}, {"facility": "Research Site", "city": "Kunming", "status": ""}, {"facility": "Research Site", "city": "Hangzhou", "status": ""}], "cn_site_count": 27, "broad_only": false}, {"nct": "NCT06051357", "title": "Proof of Concept Study to Assess the Efficacy, Safety of HRS-5965 in Patients With Paroxysmal Nocturnal Hemoglobinuria", "status": "COMPLETED", "start": "2023-11-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 26, "sponsor": "Chengdu Suncadia Medicine Co., Ltd.", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "Peking Union Medical College Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "The Blood Disease Hospital of the Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06294301", "title": "A Study of Single and Multiple Doses of LP-005 in Healthy Adult Participants", "status": "COMPLETED", "start": "2023-11-23", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 68, "sponsor": "Longbio Pharma", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria (PNH)"], "cn_sites": [{"facility": "Shanghai Public Health Clinical Center", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06238544", "title": "Long-term Safety and Tolerability of HRS-5965 in Patients With Paroxysmal Nocturnal Hemoglobinuria", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-02-06", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 132, "sponsor": "Chengdu Suncadia Medicine Co., Ltd.", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "Peking Union Medical College Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "The Blood Disease Hospital of the Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06490991", "title": "Comparison of HRS-5965 Capsules and Tablets in Healthy Subjects", "status": "COMPLETED", "start": "2024-07-17", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 16, "sponsor": "Chengdu Suncadia Medicine Co., Ltd.", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria，IgA Nephropathy"], "cn_sites": [{"facility": "ZhongShan Hospital FuDan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06561841", "title": "A Study to Evaluate the Efficacy and Safety of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria（PNH）", "status": "COMPLETED", "start": "2024-07-17", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 47, "sponsor": "Haisco Pharmaceutical Group Co., Ltd.", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria (PNH)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Nanjing Medical University", "city": "Nanjing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06543459", "title": "To Evaluate the Effect of Single Oral Dose of MY008211A Tablets on QTc Interval in Healthy Subjects", "status": "UNKNOWN", "start": "2024-08-10", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 16, "sponsor": "Wuhan Createrna Science and Technology Co., Ltd", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06852092", "title": "Study on Mass Balance of [14C]HSK39297 in Healthy Chinese Adult Male Subjects", "status": "COMPLETED", "start": "2024-09-09", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 7, "sponsor": "Haisco Pharmaceutical Group Co., Ltd.", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria (PNH)"], "cn_sites": [{"facility": "The Second Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06578949", "title": "Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Ravulizumab in Chinese Adults Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)", "status": "COMPLETED", "start": "2024-10-10", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Alexion Pharmaceuticals, Inc.", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria", "PNH"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Guangzhou", "status": ""}, {"facility": "Research Site", "city": "Hangzhou", "status": ""}, {"facility": "Research Site", "city": "Nantong", "status": ""}, {"facility": "Research Site", "city": "Shanghai", "status": ""}, {"facility": "Research Site", "city": "Tianjin", "status": ""}, {"facility": "Research Site", "city": "Wuhan", "status": ""}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT06593938", "title": "A Study to Evaluate the Efficacy and Safety of Oral HRS-5965 in Adult Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Who Are Naive to Complement Inhibitor Therapy", "status": "COMPLETED", "start": "2024-10-25", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 76, "sponsor": "Chengdu Suncadia Medicine Co., Ltd.", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "Peking Union Medical College Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "The Blood Disease Hospital of the Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07212426", "title": "Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients.", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-11-14", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Longbio Pharma", "conditions": ["PNH - Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "The First Affiliated Hospital of Nanjing Medical University", "city": "Nanjing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06715943", "title": "Efficacy and Safety of HRS-5965 in Patients With PNH Who Are Still Anemia After Anti-C5 Antibody Treatment", "status": "COMPLETED", "start": "2025-01-07", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 39, "sponsor": "Chengdu Suncadia Medicine Co., Ltd.", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "Hematology Hospital of Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06764303", "title": "A Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-01-23", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Nanjing Chia-tai Tianqing Pharmaceutical", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "Hematology Hospital of the Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}, {"facility": "The First Affiliated Hospital, College of Medicine, Zhejiang University", "city": "Hangzhou", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06799546", "title": "A Phase III Study to Evaluate the Efficacy and Safety of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria Who Are Naive to Complement Inhibitor Therapy", "status": "COMPLETED", "start": "2025-02-13", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 73, "sponsor": "Haisco Pharmaceutical Group Co., Ltd.", "conditions": ["PNH"], "cn_sites": [{"facility": "The First Affiliated Hospital of Nanjing Medical University", "city": "Nanjing", "status": ""}, {"facility": "The First Affiliated Hospital, College of Medicine, Zhejiang University", "city": "Hangzhou", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06848296", "title": "Phase Ib Clinical Study to Evaluate the Safety and Tolerability of VSA012 Injection in Paroxysmal Nocturnal Hemoglobinuria", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-04-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Bisirna Therapeutics Pte. Ltd.", "conditions": ["Paroxysmal Nocturnal Hemoglobinuria (PNH)"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07052838", "title": "Efficacy and Safety of HSK39297 in Anti-C5 Treated PNH Patients With Anemia", "status": "COMPLETED", "start": "2025-05-12", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Haisco Pharmaceutical Group Co., Ltd.", "conditions": ["Paroxysmal Nocturnal Haemoglobinuria (PNH)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Nanjing Medical University", "city": "Nanjing", "status": ""}, {"facility": "The First Affiliated Hospital, College of Medicine, Zhejiang University", "city": "Hangzhou", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07035665", "title": "A Clinical Study to Evaluate the Effect of Food on the Pharmacokinetic Profiles of HRS-5965 Capsules in Healthy Subjects", "status": "COMPLETED", "start": "2025-06-30", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 16, "sponsor": "Chengdu Suncadia Medicine Co., Ltd.", "conditions": ["IgA Nephropathy", "Paroxysmal Nocturnal Hemoglobinuria"], "cn_sites": [{"facility": "ZhongShan Hospital FuDan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 44, "g_fetched": 26, "g_countries": [["United States", 9], ["South Korea", 6], ["Italy", 6], ["United Kingdom", 6], ["Canada", 4], ["Spain", 3], ["France", 3], ["Brazil", 2], ["Poland", 2], ["Turkey (Türkiye)", 2], ["Colombia", 2], ["Germany", 2], ["Netherlands", 2], ["Australia", 2], ["Malaysia", 2], ["Thailand", 2], ["Hungary", 1], ["India", 1], ["Japan", 1], ["Jordan", 1], ["Peru", 1], ["Philippines", 1], ["Romania", 1], ["Singapore", 1], ["Taiwan", 1], ["Czechia", 1], ["Serbia", 1]], "g_trials": [{"nct": "NCT05646563", "title": "Study of NM8074 in Adult PNH Patients With Inadequate Response to Soliris", "status": "NOT_YET_RECRUITING", "start": "2027-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "NovelMed Therapeutics", "countries": []}, {"nct": "NCT07788105", "title": "Efficacy and Safety of Lanoracopan in the Treatment of PNH", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Peking Union Medical College Hospital", "countries": []}, {"nct": "NCT07416162", "title": "A Study of Iptacopan in Korean Patients With Paroxysmal Nocturnal Hemoglobinuria or C3 Glomerulopathy", "status": "RECRUITING", "start": "2026-06-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": ["South Korea"]}, {"nct": "NCT07154745", "title": "A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Whose Current Treatment is Not Working Efficiently", "status": "RECRUITING", "start": "2026-06-11", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Regeneron Pharmaceuticals", "countries": ["Brazil", "Canada", "Italy", "Poland", "South Korea", "Spain", "Turkey (Türkiye)"]}, {"nct": "NCT05731050", "title": "Study of NM8074 in Soliris-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)", "status": "NOT_YET_RECRUITING", "start": "2026-06", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "NovelMed Therapeutics", "countries": []}, {"nct": "NCT07457151", "title": "Danicopan PMS in Korea", "status": "RECRUITING", "start": "2026-04-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "AstraZeneca", "countries": ["South Korea"]}, {"nct": "NCT05646524", "title": "Study of Efficacy and Safety of NM8074 in Adult PNH Patients Who Are Naive to Complement Inhibitor Therapy", "status": "NOT_YET_RECRUITING", "start": "2026-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "NovelMed Therapeutics", "countries": []}, {"nct": "NCT07187401", "title": "A First-in-Human Safety and Efficacy Study of ALN-CFB, a Small Interfering RNA (siRNA) Targeting Complement Factor B, in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria With Persistent Anemia on a C5 Inhibitor", "status": "RECRUITING", "start": "2026-02-11", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Regeneron Pharmaceuticals", "countries": ["Canada", "South Korea", "United Kingdom"]}, {"nct": "NCT07387302", "title": "SLN12140 in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) in China", "status": "NOT_YET_RECRUITING", "start": "2026-02-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Linno Pharmaceuticals, Inc.", "countries": []}, {"nct": "NCT07229235", "title": "REAL-CARE: Real-world Effectiveness of Iptacopan in Italian Patients With Paroxysmal Nocturnal Hemoglobinuria", "status": "RECRUITING", "start": "2026-01-13", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": ["Italy"]}, {"nct": "NCT06134414", "title": "Study of Safety and Efficacy of MY008211A in in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)", "status": "NOT_YET_RECRUITING", "start": "2025-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Wuhan Createrna Science and Technology Co., Ltd", "countries": []}, {"nct": "NCT06934967", "title": "Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients", "status": "RECRUITING", "start": "2025-10-28", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": ["Brazil", "Colombia", "Germany", "Italy", "Netherlands", "United States"]}, {"nct": "NCT06449001", "title": "Study of Danicopan as Add-on Treatment to Ravulizumab or Eculizumab in Pediatric Participants With PNH Who Have Clinically Significant Extravascular Hemolysis", "status": "RECRUITING", "start": "2025-08-11", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Alexion Pharmaceuticals, Inc.", "countries": ["Canada", "France", "United Kingdom"]}, {"nct": "NCT07108023", "title": "Hematological Disorders in EHPVO Patients", "status": "NOT_YET_RECRUITING", "start": "2025-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Rahab Nady", "countries": []}, {"nct": "NCT06312644", "title": "Study of Ultomiris® (Ravulizumab) Safety in Pregnancy", "status": "RECRUITING", "start": "2024-12-16", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Alexion Pharmaceuticals, Inc.", "countries": ["Australia", "France", "Germany", "Italy", "South Korea", "United Kingdom", "United States"]}, {"nct": "NCT06411626", "title": "Home Reported Outcomes in PNH", "status": "RECRUITING", "start": "2024-06-11", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": ["United States"]}, {"nct": "NCT06412497", "title": "MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.", "status": "RECRUITING", "start": "2024-06-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Masonic Cancer Center, University of Minnesota", "countries": ["United States"]}, {"nct": "NCT06524726", "title": "The International PNH Interest Group PNH Registry", "status": "RECRUITING", "start": "2024-05-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "International PNH Interest Group", "countries": ["United States"]}, {"nct": "NCT05876312", "title": "Safety, Tolerability, PK and PD of ADX-038 in Healthy Participants and Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients", "status": "RECRUITING", "start": "2023-08-07", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "ADARx Pharmaceuticals, Inc.", "countries": ["Australia", "United Kingdom"]}, {"nct": "NCT05744921", "title": "A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works", "status": "RECRUITING", "start": "2023-03-07", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Regeneron Pharmaceuticals", "countries": ["Canada", "Colombia", "Hungary", "India", "Italy", "Japan", "Jordan", "Malaysia", "Peru", "Philippines", "Poland", "Romania", "Singapore", "South Korea", "Spain", "Taiwan", "Thailand", "Turkey (Türkiye)", "United Kingdom"]}, {"nct": "NCT05755867", "title": "Global PNH Patient Registry", "status": "RECRUITING", "start": "2021-05-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Aplastic Anemia and MDS International Foundation", "countries": ["United States"]}, {"nct": "NCT04901936", "title": "A Study of Pegcetacoplan in Pediatric Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)", "status": "RECRUITING", "start": "2021-02-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Apellis Pharmaceuticals, Inc.", "countries": ["Czechia", "France", "Malaysia", "Netherlands", "Serbia", "Spain", "Thailand", "United Kingdom", "United States"]}, {"nct": "NCT03520647", "title": "Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis", "status": "RECRUITING", "start": "2019-02-19", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "countries": ["United States"]}, {"nct": "NCT01174108", "title": "Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells", "status": "RECRUITING", "start": "2010-12-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "countries": ["United States"]}, {"nct": "NCT05982938", "title": "Danicopan Early Access Program", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "Alexion Pharmaceuticals, Inc.", "countries": ["Italy"]}]}, {"batch": 1, "no": 89, "name_zh": "黑斑息肉综合征", "query_terms": [{"term": "Peutz-Jeghers syndrome", "broad": false}], "n_total": 4, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT06722534", "title": "Celecoxib for Prevention of Progression in Peutz-Jeghers Syndrome", "status": "RECRUITING", "start": "2025-02-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 80, "sponsor": "Air Force Military Medical University, China", "conditions": ["Peutz-Jeghers Syndrome", "Celecoxib", "Small Bowel Polyp"], "cn_sites": [{"facility": "Xijing Hospital of Digestive Diseases, Air Force Military Medical University", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03806075", "title": "Study of Accurate Diagnosis and Treatment of Peutz-Jeghers Syndrome", "status": "UNKNOWN", "start": "2018-03-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 150, "sponsor": "Yiqi Du", "conditions": ["Peutz-Jeghers Syndrome"], "cn_sites": [{"facility": "Changhai Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03781050", "title": "Efficacy of Rapamycin (Sirolimus) in the Treatment of Peutz-Jeghers Syndrome", "status": "UNKNOWN", "start": "2018-09-16", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Peutz-Jeghers Syndrome"], "cn_sites": [{"facility": "Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06001476", "title": "Cold Snare Polypectomy for Small Bowel Polyps in Patients With Peutz-Jeghers Syndrome", "status": "UNKNOWN", "start": "2023-08-20", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Shandong University", "conditions": ["Peutz-Jeghers Syndrome", "Small Bowel Polyp"], "cn_sites": [{"facility": "Qilu Hospital, Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 5, "g_fetched": 4, "g_countries": [["United States", 3], ["Italy", 1]], "g_trials": [{"nct": "NCT04095195", "title": "Registry of Subjects at Risk of Pancreatic Cancer", "status": "RECRUITING", "start": "2019-08-20", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Associazione Italiana per lo Studio del Pancreas", "countries": ["Italy"]}, {"nct": "NCT03050268", "title": "Familial Investigations of Childhood Cancer Predisposition", "status": "RECRUITING", "start": "2017-04-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "St. Jude Children's Research Hospital", "countries": ["United States"]}, {"nct": "NCT02000089", "title": "The Cancer of the Pancreas Screening-5 CAPS5)Study", "status": "RECRUITING", "start": "2014-01-06", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Johns Hopkins University", "countries": ["United States"]}, {"nct": "NCT02775461", "title": "Pancreas Registry and High Risk Registry", "status": "RECRUITING", "start": "2013-03-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Icahn School of Medicine at Mount Sinai", "countries": ["United States"]}]}, {"batch": 1, "no": 90, "name_zh": "苯丙酮尿症", "query_terms": [{"term": "Phenylketonuria", "broad": false}], "n_total": 7, "n_open": 4, "n_open_precise": 4, "n_broad": 0, "trials": [{"nct": "NCT06687733", "title": "Safety and Efficacy Study of NGGT002 in Adult Patients With Phenylketonuria", "status": "RECRUITING", "start": "2024-07-16", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "NGGT (Suzhou) Biotechnology Co., Ltd.", "conditions": ["Phenylketonurias"], "cn_sites": [{"facility": "First Affiliated Hospital of Bengbu Medical College", "city": "Bengbu", "status": "RECRUITING"}, {"facility": "Xinhua Hospital Affifiated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07672756", "title": "A Clinical Study on the Safety and Tolerability of PL54 Injection in Adult Patients With Phenylketonuria (PKU)", "status": "RECRUITING", "start": "2025-07-20", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 48, "sponsor": "Chongqing Peg-Bio Biopharm Co., Ltd.", "conditions": ["Phenylketonuria (PKU)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07685210", "title": "GenSci144 Tablets Phase I Clinical Trial", "status": "RECRUITING", "start": "2026-06-22", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 48, "sponsor": "Changchun GeneScience Pharmaceutical Co., Ltd.", "conditions": ["Phenylketonuria"], "cn_sites": [{"facility": "The First Affiliated Hospital of Shandong First Medical University (Shandong Qianfoshan Hospital).", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07318909", "title": "To Evaluate the Safety and Efficacy of GS1168 Injection in Adult Phenylketonuria", "status": "NOT_YET_RECRUITING", "start": "2027-12-31", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Gritgen Therapeutics Co., Ltd.", "conditions": ["Phenylketonuria (PKU)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03864029", "title": "Retrospective Observational Safety Effectiveness With Kuvan in hpA", "status": "COMPLETED", "start": "2017-10-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 26, "sponsor": "BioMarin Pharmaceutical", "conditions": ["Tetrahydrobiopterin Deficiency"], "cn_sites": [{"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06061614", "title": "Safety and Efficacy Study of NGGT002 in PKU Adult Subjects", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-03-30", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "The First Affiliated Hospital of Bengbu Medical University", "conditions": ["Phenylketonurias"], "cn_sites": [{"facility": "The First Affiliated Hospital of Bengbu Medical College", "city": "Bengbu", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05948020", "title": "Efficacy and Safety of Orally Administered Engineered Probiotics (CBT102-A) for the Treatment of Children With Phenylketonuria", "status": "COMPLETED", "start": "2023-09-02", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Children's Hospital of Fudan University", "conditions": ["Phenylketonuria"], "cn_sites": [{"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 35, "g_fetched": 31, "g_countries": [["United States", 16], ["United Kingdom", 5], ["France", 5], ["Poland", 4], ["Australia", 4], ["Germany", 3], ["Canada", 2], ["Switzerland", 2], ["Italy", 2], ["Czechia", 1], ["Japan", 1], ["Netherlands", 1], ["Spain", 1], ["Denmark", 1], ["Egypt", 1], ["Ireland", 1], ["Taiwan", 1]], "g_trials": [{"nct": "NCT07802366", "title": "Acceptability and Tolerance Market Research of a Slow Release, Phenylalanine-free Protein Substitute for the Dietary Management of Phenylketonuria", "status": "NOT_YET_RECRUITING", "start": "2026-10-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "metaX Institut fuer Diatetik GmbH", "countries": ["United Kingdom"]}, {"nct": "NCT07825883", "title": "The Impact of Frequency of Home Phenylalanine Measurements on Metabolic Control in a Population of Patients With Classic Phenylketonuria", "status": "RECRUITING", "start": "2026-09-11", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Michał Kania", "countries": ["Poland"]}, {"nct": "NCT07551921", "title": "PheCheck™ Validation Study", "status": "RECRUITING", "start": "2026-08-20", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Aptatek BioSciences, Inc", "countries": ["United States"]}, {"nct": "NCT07713758", "title": "A Trial to Examine if Repinatrabit is Processed Differently in Adults With Reduced Liver or Kidney Function Compared to Adults With Normal Liver and Kidney Function", "status": "RECRUITING", "start": "2026-07-17", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "countries": ["United States"]}, {"nct": "NCT07671859", "title": "PKU Microtablets Case Studies", "status": "NOT_YET_RECRUITING", "start": "2026-07-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Nutricia UK Ltd", "countries": ["United Kingdom"]}, {"nct": "NCT07694440", "title": "A Study of MZE782 in Adults With PKU", "status": "RECRUITING", "start": "2026-06-23", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Maze Therapeutics", "countries": ["United States"]}, {"nct": "NCT07477691", "title": "Immune Modulation During Palynziq® Treatment in Adults (IMPALA)", "status": "RECRUITING", "start": "2026-05-29", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "BioMarin Pharmaceutical", "countries": ["United States"]}, {"nct": "NCT07241234", "title": "A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With Phenylketonuria", "status": "RECRUITING", "start": "2026-04-17", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Agios Pharmaceuticals, Inc.", "countries": ["Poland", "United States"]}, {"nct": "NCT07446400", "title": "A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together", "status": "RECRUITING", "start": "2026-03-31", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "countries": ["Australia"]}, {"nct": "NCT07484945", "title": "Multiomics Approach in Adult Patients With Phenylketonuria", "status": "RECRUITING", "start": "2026-03-23", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Tours", "countries": ["France"]}, {"nct": "NCT07406009", "title": "The Psychosocial Functioning of Adults With Phenylketonuria.", "status": "NOT_YET_RECRUITING", "start": "2026-01-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Central Hospital, Nancy, France", "countries": []}, {"nct": "NCT07220265", "title": "Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers", "status": "RECRUITING", "start": "2025-12-19", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Missouri-Columbia", "countries": ["United States"]}, {"nct": "NCT07698743", "title": "Eating Disorders in Patients With Phenylketonuria", "status": "RECRUITING", "start": "2025-12-04", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Central Hospital, Nancy, France", "countries": ["France"]}, {"nct": "NCT06971731", "title": "A Study of JNT-517 in Participants With Phenylketonuria (PKU)", "status": "RECRUITING", "start": "2025-10-20", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "countries": ["Australia", "Canada", "Czechia", "France", "Germany", "Japan", "Netherlands", "Poland", "Spain", "United States"]}, {"nct": "NCT07728032", "title": "Impact Of A Phe-Restricted Diet On Gut Health In Children With PKU", "status": "RECRUITING", "start": "2025-10-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Birmingham Women's and Children's NHS Foundation Trust", "countries": ["United Kingdom"]}, {"nct": "NCT06628128", "title": "A Long-Term Study of JNT-517 in Participants With Phenylketonuria", "status": "RECRUITING", "start": "2025-08-11", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "countries": ["Australia", "United States"]}, {"nct": "NCT06941532", "title": "GMP Powdered Substitutes in PKU and TYR", "status": "RECRUITING", "start": "2025-05-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Nutricia UK Ltd", "countries": ["United Kingdom"]}, {"nct": "NCT06969209", "title": "Brain Aging in Phenylketonuria", "status": "RECRUITING", "start": "2025-01-13", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Insel Gruppe AG, University Hospital Bern", "countries": ["Switzerland"]}, {"nct": "NCT06332807", "title": "AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)", "status": "RECRUITING", "start": "2025-01-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "NGGT INC.", "countries": ["United States"]}, {"nct": "NCT06337864", "title": "Effect of Large Neutral Amino Acids in Adults With Classical Phenylketonuria", "status": "RECRUITING", "start": "2024-11-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Rigshospitalet, Denmark", "countries": ["Denmark"]}, {"nct": "NCT06560736", "title": "Development of Novel Psychological Assessment Tools and Anxiety Intervention for Phenylketonuria", "status": "RECRUITING", "start": "2024-10-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Missouri-Columbia", "countries": ["United States"]}, {"nct": "NCT06718842", "title": "Walking Program in Fatty Liver Children With Phenylketonuria", "status": "RECRUITING", "start": "2024-09-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Cairo University", "countries": ["Egypt"]}, {"nct": "NCT06289348", "title": "Announcement of Rare Metabolic Diseases in Systematic Newborn Screening: the Phenylketonuria Experience.", "status": "RECRUITING", "start": "2024-05-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT06302348", "title": "A Study of Sepiapterin in Participants With Phenylketonuria (PKU)", "status": "RECRUITING", "start": "2024-03-04", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "PTC Therapeutics", "countries": ["Australia", "France", "Ireland", "Poland", "United Kingdom", "United States"]}, {"nct": "NCT06305234", "title": "A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)", "status": "RECRUITING", "start": "2024-01-20", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "BioMarin Pharmaceutical", "countries": ["United States"]}]}, {"batch": 1, "no": 91, "name_zh": "POEMS综合征", "query_terms": [{"term": "POEMS syndrome", "broad": false}], "n_total": 7, "n_open": 5, "n_open_precise": 5, "n_broad": 0, "trials": [{"nct": "NCT04561557", "title": "Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System", "status": "RECRUITING", "start": "2020-09-22", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Tongji Hospital", "conditions": ["Autoimmune Diseases", "Autoimmune Diseases of the Nervous System", "Neuromyelitis Optica Spectrum Disorder", "Myasthenia Gravis", "Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "Idiopathic Inflammatory Myopathies", "Multiple Sclerosis", "Autoimmune Encephalitis", "Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)", "POEMS Syndrome"], "cn_sites": [{"facility": "Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05283993", "title": "A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH", "status": "RECRUITING", "start": "2021-07-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2000, "sponsor": "Peking University First Hospital", "conditions": ["Multiple Myeloma", "Amyloidosis", "Cryoglobulinemia", "Castleman's Disease", "Light Chain Deposition Disease", "Heavy Chain Deposition Disease", "Polyneuropathy Organomegaly Endocrinopathy Monoclonal Gammopathy and Skin Changes", "Smoldering Multiple Myeloma", "Plasma Cell Leukemia", "Monoclonal Gammopathy of Undetermined Significance (MGUS)", "Monoclonal Gammopathy of Renal Significance (MGRS)", "Monoclonal Gammopathy of Neurological Significance (MGNS)"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06518876", "title": "A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory POEMS Syndrome", "status": "NOT_YET_RECRUITING", "start": "2024-08-31", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 21, "sponsor": "Novatim Immune Therapeutics (Zhejiang) Co., Ltd.", "conditions": ["POEMS Syndrome"], "cn_sites": [{"facility": "Chinese Academy of Medical Sciences & Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07115654", "title": "BCMA/CD3 BsAb Therapy for POEMS Syndrome", "status": "NOT_YET_RECRUITING", "start": "2025-08-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["POEMS Syndrome"], "cn_sites": [{"facility": "Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07652879", "title": "KCD (Carfilzomib/Cyclophosphamide/Dexamethasone) Regimen for the Treatment of Newly Diagnosed POEMS Syndrome", "status": "RECRUITING", "start": "2026-06-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Shanghai Changzheng Hospital", "conditions": ["POEMS Syndrome"], "cn_sites": [{"facility": "Shanghai Changzheng Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01816620", "title": "Study to Evaluate Lenalidomide Plus Dexamethasone in Patients With Newly Diagnosed POEMS Syndrome", "status": "COMPLETED", "start": "2014-03", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 41, "sponsor": "Peking Union Medical College Hospital", "conditions": ["POEMS Syndrome"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05263817", "title": "A Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia, and Vasculitis", "status": "UNKNOWN", "start": "2021-10-08", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 75, "sponsor": "Zhejiang University", "conditions": ["POEMS Syndrome", "Amyloidosis", "Autoimmune Hemolytic Anemia", "Vasculitis"], "cn_sites": [{"facility": "The first affiliated hospital of medical college of zhejiang university", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}], "g_total": 8, "g_fetched": 3, "g_countries": [["United States", 2], ["Italy", 1]], "g_trials": [{"nct": "NCT07448935", "title": "One Gene, Two Diseases: the Pathologic Role of IGLV1-44 in AL Amyloidosis and POEMS", "status": "RECRUITING", "start": "2025-11-28", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondazione IRCCS Policlinico San Matteo di Pavia", "countries": ["Italy"]}, {"nct": "NCT06252948", "title": "Gut Microbiome Studies in Patients With POEMS Syndrome and Other Plasma Cell Disorders", "status": "RECRUITING", "start": "2021-12-29", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Mayo Clinic", "countries": ["United States"]}, {"nct": "NCT03717844", "title": "Registry for Adults With Plasma Cell Disorders (PCD's)", "status": "RECRUITING", "start": "2018-02-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "UNC Lineberger Comprehensive Cancer Center", "countries": ["United States"]}]}, {"batch": 1, "no": 92, "name_zh": "卟啉病", "query_terms": [{"term": "Porphyria", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 8, "g_fetched": 8, "g_countries": [["United States", 7], ["Belgium", 2], ["France", 2], ["Italy", 2], ["Norway", 2], ["Spain", 2], ["United Kingdom", 2], ["Sweden", 2], ["Canada", 1], ["Turkey (Türkiye)", 1], ["Germany", 1], ["Switzerland", 1], ["Taiwan", 1]], "g_trials": [{"nct": "NCT07820085", "title": "A Study to Investigate PORT-77 Oral Dosing Compared With Placebo in Participants With Erythropoietic Protoporphyria (EPP) or X-linked Protoporphyria (XLP)", "status": "RECRUITING", "start": "2026-09", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Portal Therapeutics, Inc.", "countries": ["United States"]}, {"nct": "NCT07567131", "title": "Observational Study of Adults and Adolescents With Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP)", "status": "RECRUITING", "start": "2026-04-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Portal Therapeutics, Inc.", "countries": ["Belgium", "Canada", "France", "Italy", "Norway", "Spain", "Turkey (Türkiye)", "United Kingdom", "United States"]}, {"nct": "NCT07024316", "title": "A Study to Investigate the Improvement of Photosensitivity in Terms of Skin Lesions Associated With CEP Following Administration of Oral ATL-001 (Ciclopirox Oral Solution) in Participants Aged >18 Years of Age With CEP", "status": "RECRUITING", "start": "2026-01-29", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Atlas Molecular Pharma", "countries": ["United States"]}, {"nct": "NCT06273644", "title": "Clinical Research on Acute Intermittent Porphyria and the Use of Carbohydrate-Rich Diet as a Treatment", "status": "RECRUITING", "start": "2024-01-27", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Nordlandssykehuset HF", "countries": ["Norway", "Sweden"]}, {"nct": "NCT05502133", "title": "Identification of Acute Intermittent Porphyria Modifying Genes", "status": "RECRUITING", "start": "2022-09-23", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Icahn School of Medicine at Mount Sinai", "countries": ["United States"]}, {"nct": "NCT04883905", "title": "ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)", "status": "RECRUITING", "start": "2021-04-26", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Alnylam Pharmaceuticals", "countries": ["Belgium", "France", "Germany", "Italy", "Spain", "Sweden", "Switzerland", "Taiwan", "United Kingdom", "United States"]}, {"nct": "NCT01561157", "title": "Longitudinal Study of the Porphyrias", "status": "RECRUITING", "start": "2010-11-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "The American Porphyrias Expert Collaborative", "countries": ["United States"]}, {"nct": "NCT07603401", "title": "Expanded Access Program of Bitopertin For Participants With EPP or XLP", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "Disc Medicine, Inc", "countries": ["United States"]}]}, {"batch": 1, "no": 93, "name_zh": "Prader-Willi综合征", "query_terms": [{"term": "Prader-Willi syndrome", "broad": false}], "n_total": 2, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT05791604", "title": "The Intervention of Obesity in Children With Prader-Willi Syndrome Using Prebiotics and Probiotics", "status": "RECRUITING", "start": "2023-04-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Children's Hospital of Fudan University", "conditions": ["Prader-Willi Syndrome"], "cn_sites": [{"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03554031", "title": "A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone Injection in Patients With Prader-Willi Syndrome", "status": "UNKNOWN", "start": "2018-04-14", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Changchun GeneScience Pharmaceutical Co., Ltd.", "conditions": ["Prader-Willi Syndrome"], "cn_sites": [{"facility": "Tongji medical college huazhong university of science & technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "The Children's Hospital,Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking union medical college hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking university first hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 6, "broad_only": false}], "g_total": 19, "g_fetched": 18, "g_countries": [["United States", 8], ["France", 6], ["Australia", 2], ["Belgium", 2], ["Netherlands", 2], ["Argentina", 1], ["Canada", 1], ["Denmark", 1], ["Germany", 1], ["Italy", 1], ["Poland", 1], ["Romania", 1], ["Spain", 1], ["Sweden", 1], ["United Kingdom", 1]], "g_trials": [{"nct": "NCT07607730", "title": "Regulating Together for Prader-Willi Syndrome: A Group Behavioral Therapy for Emotion Dysregulation", "status": "RECRUITING", "start": "2027-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Children's Mercy Hospital Kansas City", "countries": ["United States"]}, {"nct": "NCT07348601", "title": "A Study of CSTI-500 in Patients With Prader-Willi Syndrome", "status": "RECRUITING", "start": "2026-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "ConSynance Therapeutics", "countries": ["United States"]}, {"nct": "NCT07266324", "title": "A 2-Part Study to Assess Efficacy, Safety and Tolerability of BMB-101 for the Treatment of Patients With Prader-Willi Syndrome.", "status": "NOT_YET_RECRUITING", "start": "2026-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Bright Minds Biosciences Pty Ltd", "countries": ["Australia"]}, {"nct": "NCT07006207", "title": "Brain Olfactory Pathways in Prader-Willi Syndrome", "status": "NOT_YET_RECRUITING", "start": "2025-06-23", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Toulouse", "countries": ["France"]}, {"nct": "NCT06901245", "title": "Tirzepatide in PWS, HO and GNSO", "status": "RECRUITING", "start": "2025-05-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Grace Kim", "countries": ["United States"]}, {"nct": "NCT06877715", "title": "Autistic Symptomatology and Sensory Profile in Children With Prader-Willi Syndrome", "status": "RECRUITING", "start": "2025-04-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Toulouse", "countries": ["France"]}, {"nct": "NCT06740162", "title": "Physical Activity and Community EmPOWERment Project", "status": "RECRUITING", "start": "2025-01-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of North Carolina, Chapel Hill", "countries": ["United States"]}, {"nct": "NCT06573723", "title": "Institutional Registry of Rare Diseases", "status": "RECRUITING", "start": "2024-07-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Hospital Italiano de Buenos Aires", "countries": ["Argentina"]}, {"nct": "NCT06366464", "title": "A Study of Pitolisant in Patients With Prader-Willi Syndrome", "status": "RECRUITING", "start": "2024-05-28", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Harmony Biosciences Management, Inc.", "countries": ["Australia", "Belgium", "Canada", "Denmark", "France", "Germany", "Italy", "Poland", "Romania", "Spain", "Sweden", "United Kingdom", "United States"]}, {"nct": "NCT07122505", "title": "Oromyofunctional Therapy: a Rehabilitation Program for OSA in Children With Down Syndrome and Prader-Willi Syndrome", "status": "RECRUITING", "start": "2024-04-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Ghent", "countries": ["Belgium"]}, {"nct": "NCT06239116", "title": "A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment", "status": "RECRUITING", "start": "2024-03-05", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Rhythm Pharmaceuticals, Inc.", "countries": ["United States"]}, {"nct": "NCT06720571", "title": "Effects of Transcutaneous Vagus Nerve Stimulation on Emotion Regulation and Executive Functioning in Prader-Willi Syndrome", "status": "RECRUITING", "start": "2023-11-22", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Bordeaux", "countries": ["France"]}, {"nct": "NCT05939453", "title": "Impact of Bright Light Therapy on Prader-Willi Syndrome", "status": "RECRUITING", "start": "2023-10-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Maimonides Medical Center", "countries": ["United States"]}, {"nct": "NCT05938543", "title": "Cerebellar TMS and Satiety in Prader-Willi Syndrome", "status": "RECRUITING", "start": "2023-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Brigham and Women's Hospital", "countries": ["United States"]}, {"nct": "NCT04484051", "title": "Growth Hormone Study in Adults With Prader-Willi Syndrome", "status": "NOT_YET_RECRUITING", "start": "2023-03-24", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Erasmus Medical Center", "countries": ["Netherlands"]}, {"nct": "NCT04463316", "title": "GROWing Up With Rare GENEtic Syndromes", "status": "RECRUITING", "start": "2018-10-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "dr. Laura C. G. de Graaff-Herder", "countries": ["Netherlands"]}, {"nct": "NCT05945576", "title": "IDMet (RaDiCo Cohort) (RaDiCo-IDMet)", "status": "RECRUITING", "start": "2017-03-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Institut National de la Santé Et de la Recherche Médicale, France", "countries": ["France"]}, {"nct": "NCT02829684", "title": "Register of Patients With Prader-Willi Syndrome", "status": "RECRUITING", "start": "2009-03", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Toulouse", "countries": ["France"]}]}, {"batch": 1, "no": 94, "name_zh": "原发性联合免疫缺陷", "query_terms": [{"term": "Severe combined immunodeficiency", "broad": false}, {"term": "Non-severe combined immunodeficiency", "broad": false}, {"term": "Primary Combined Immune Deficiency", "broad": false}], "n_total": 7, "n_open": 3, "n_open_precise": 3, "n_broad": 0, "trials": [{"nct": "NCT07371663", "title": "An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors", "status": "RECRUITING", "start": "2025-12-03", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 266, "sponsor": "Beijing Tide Pharmaceutical Co., Ltd", "conditions": ["Solid Cancers", "NSCLC (Advanced Non-small Cell Lung Cancer)", "Gastric (Stomach) Cancer", "Endometrial Cancer", "Malignant Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT03645460", "title": "Gene Therapy for ADA-SCID Using an Improved Lentiviral Vector (Ivlv-ADA)", "status": "NOT_YET_RECRUITING", "start": "2027-06-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": ["Adenosine DeAminase Severe Combined ImmunoDeficiency (ADA-SCID)"], "cn_sites": [{"facility": "Shenzhen Geno-immune Medical Institute", "city": "Shenzhen", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03217617", "title": "SCID-X1 Gene Therapy Via Intravenous Lentiviral (Ivlv-X1) Injection", "status": "NOT_YET_RECRUITING", "start": "2027-06-30", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": ["SCID, X-Linked"], "cn_sites": [{"facility": "Shenzhen Geno-immune Medical Institute", "city": "Shenzhen", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02231983", "title": "Clinical Characteristics and Genetic Profiles of Severe Combined Immunodeficiency in China", "status": "UNKNOWN", "start": "2014-09", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 50, "sponsor": "Shanghai Children's Medical Center", "conditions": ["Severe Combined Immunodeficiency"], "cn_sites": [{"facility": "Shanghai children's medical center", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02590328", "title": "Neonatal Screening of Severe Combined Immunodeficiencies", "status": "COMPLETED", "start": "2015-12", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 180000, "sponsor": "Children's Hospital of Fudan University", "conditions": ["Severe Combined Immunodeficiency", "Neonatal Screening"], "cn_sites": [{"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04172181", "title": "Multi-center Clinical Study of Cord Blood Stem Cell Transplantation for SCID", "status": "UNKNOWN", "start": "2019-12-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 50, "sponsor": "Children's Hospital of Fudan University", "conditions": ["Severe Combined Immunodeficiency Disease"], "cn_sites": [{"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04286815", "title": "Gene Therapy for X Linked Severe Combined Immunodeficiency", "status": "UNKNOWN", "start": "2020-05-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Children's Hospital of Chongqing Medical University", "conditions": ["Gene Therapy"], "cn_sites": [{"facility": "Children's Hospital of Chongqing Medical University", "city": "Chongqing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}], "g_total": 18, "g_fetched": 16, "g_countries": [["United States", 10], ["France", 4], ["Germany", 1], ["Italy", 1], ["Slovakia", 1], ["Switzerland", 1], ["United Kingdom", 1], ["Australia", 1], ["Canada", 1], ["Ireland", 1], ["Portugal", 1], ["South Korea", 1], ["Spain", 1]], "g_trials": [{"nct": "NCT07704281", "title": "Follow-up of the Cohort of Newborns Screened at Birth Using TREC Analysis", "status": "NOT_YET_RECRUITING", "start": "2026-11-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Nantes University Hospital", "countries": ["France"]}, {"nct": "NCT07284641", "title": "Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)", "status": "RECRUITING", "start": "2026-05-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Paul Szabolcs", "countries": ["United States"]}, {"nct": "NCT07474935", "title": "Targeting Real World Usage In Stroke Treatment", "status": "RECRUITING", "start": "2026-01-29", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Phenox GmbH", "countries": ["France", "Germany", "Italy", "Slovakia", "Switzerland"]}, {"nct": "NCT06659588", "title": "Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With Primary Immunodeficiency and Secondary Humoral Deficiency", "status": "RECRUITING", "start": "2024-10-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT05071222", "title": "Safety and Efficacy Study of Transplantation of Autologous CD34+ Cells Transduced With the G2ARTE Lentiviral Vector Expressing the DCLRE1C cDNA in Artemis (DCLRE1C) Deficient Severe Combined Immunodeficiency Patients (ARTEGENE)", "status": "RECRUITING", "start": "2023-07-19", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT05651113", "title": "The Experience of Screening for SCID", "status": "RECRUITING", "start": "2022-11-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "King's College London", "countries": ["United Kingdom"]}, {"nct": "NCT05086692", "title": "A Beta-only IL-2 ImmunoTherapY Study", "status": "RECRUITING", "start": "2021-08-27", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Medicenna Therapeutics, Inc.", "countries": ["Australia", "Canada", "Ireland", "Portugal", "South Korea", "Spain", "United States"]}, {"nct": "NCT04528355", "title": "Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC", "status": "RECRUITING", "start": "2020-08-20", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Paul Szabolcs", "countries": ["United States"]}, {"nct": "NCT03538899", "title": "Autologous Gene Therapy for Artemis-Deficient SCID", "status": "RECRUITING", "start": "2018-05-31", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University of California, San Francisco", "countries": ["United States"]}, {"nct": "NCT03394053", "title": "The Mechanistic Biology of Primary Immunodeficiency Disorders", "status": "RECRUITING", "start": "2018-05-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "countries": ["United States"]}, {"nct": "NCT03311503", "title": "Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning", "status": "RECRUITING", "start": "2018-02-26", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "David Williams", "countries": ["United States"]}, {"nct": "NCT01962415", "title": "Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT", "status": "RECRUITING", "start": "2014-02-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Paul Szabolcs", "countries": ["United States"]}, {"nct": "NCT01306019", "title": "Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)", "status": "RECRUITING", "start": "2012-09-25", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "countries": ["United States"]}, {"nct": "NCT00128973", "title": "Evaluation of Patients With Immune Function Abnormalities", "status": "RECRUITING", "start": "2005-09-19", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "countries": ["United States"]}, {"nct": "NCT00055172", "title": "Genetic Basis of Immunodeficiency", "status": "RECRUITING", "start": "2004-04-05", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "countries": ["United States"]}, {"nct": "NCT06731036", "title": "Expanded Access to CD34+ Selection Utilizing Miltenyi CliniMACS Prodigy® for Patients Receiving Peripheral Blood Stem Cell Transplantations and Stem Cell Boosts", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "University of Florida", "countries": []}]}, {"batch": 1, "no": 95, "name_zh": "原发性遗传性肌张力不全", "query_terms": [{"term": "Isolated dystonia", "broad": false}, {"term": "Primary Hereditary Dystonia", "broad": false}], "n_total": 1, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT04650958", "title": "SUNDYS: A Multicenter, Randomized, Double-blind, Sham-controlled, Parallel-group Trial", "status": "UNKNOWN", "start": "2021-01-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 38, "sponsor": "Ruijin Hospital", "conditions": ["Dystonia"], "cn_sites": [{"facility": "Shanghai Ruijin Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}], "g_total": 3, "g_fetched": 4, "g_countries": [["United States", 4]], "g_trials": [{"nct": "NCT06792500", "title": "A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)", "status": "NOT_YET_RECRUITING", "start": "2026-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "George Washington University", "countries": ["United States"]}, {"nct": "NCT07304089", "title": "A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia", "status": "RECRUITING", "start": "2026-02-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Vima Therapeutics", "countries": ["United States"]}, {"nct": "NCT07111663", "title": "An Observational Study of Individuals With Isolated Dystonia", "status": "RECRUITING", "start": "2025-06-17", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Vima Therapeutics", "countries": ["United States"]}, {"nct": "NCT05317390", "title": "Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia", "status": "RECRUITING", "start": "2022-06-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Massachusetts Eye and Ear Infirmary", "countries": ["United States"]}]}, {"batch": 1, "no": 96, "name_zh": "原发性轻链型淀粉样变", "query_terms": [{"term": "AL amyloidosis", "broad": false}, {"term": "Primary Light Chain Amyloidosis", "broad": false}], "n_total": 43, "n_open": 27, "n_open_precise": 27, "n_broad": 0, "trials": [{"nct": "NCT04210791", "title": "Autologous Stem Cell Transplantation for Patients With AL Amyloidosis", "status": "ENROLLING_BY_INVITATION", "start": "2010-07-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Nanjing University School of Medicine", "conditions": ["AL Amyloidosis", "Plasma Cell Dyscrasia"], "cn_sites": [{"facility": "National Clinical Research Center of Kidney Diseases, Jinling Hospital", "city": "Nanjing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04924998", "title": "Clinical Study for AL-CM", "status": "RECRUITING", "start": "2021-06-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 400, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Immunoglobulin Light Amyloidosis Cardiomyopathy"], "cn_sites": [{"facility": "2nd Affiliated Hospital, School of Medicine, Zhejiang University, China", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06376214", "title": "Daratumumab for Patients With Light Chain Amyloidosis", "status": "RECRUITING", "start": "2023-01-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Nanjing University School of Medicine", "conditions": ["Light Chain (AL) Amyloidosis"], "cn_sites": [{"facility": "National Clinical Research Center for Kidney Diseases, Jinling Hospital", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06192979", "title": "Optimize First-line Treatment for AL Amyloidosis With t (11; 14)", "status": "RECRUITING", "start": "2024-01-05", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 41, "sponsor": "Jin Lu, MD", "conditions": ["Amyloidosis; Systemic", "AL Amyloidosis"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Capital Medical University Affiliated Fuxing Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Anzhen Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Chinese PLA Eastern Theater General Hospital", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Qilu Hospital of Shandong University (QingDao)", "city": "Qingdao", "status": "RECRUITING"}, {"facility": "Qingdao Municipal Hospital", "city": "Qingdao", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Xi'an Jiao Tong University", "city": "Xi’an", "status": "RECRUITING"}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT06342466", "title": "Bortezomib, Pomalidomide, Dexamethasone for Systemic AL Amyloidosis", "status": "RECRUITING", "start": "2024-05-06", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Jin Lu, MD", "conditions": ["Systemic Amyloidosis"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06418477", "title": "Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone Therapy for Patients with MIDD", "status": "RECRUITING", "start": "2024-06-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Peking University People's Hospital", "conditions": ["Monoclonal Gammopathy of Renal Significance"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT06627309", "title": "Rapid dFLC Response Predict CHR in AL Amyloidosis", "status": "RECRUITING", "start": "2024-10-26", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 50, "sponsor": "Peking University People's Hospital", "conditions": ["Systemic AL Amyloidosis"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Fuxing Hospital affiliated to Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Anzhen Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "First Affiliated Hospital of Harbin Medical University", "city": "Harbin", "status": "RECRUITING"}, {"facility": "Chinese PLA Eastern Theater General Hospital", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Shengjing Hospital of China Medical University", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Xi'an Jiao Tong University", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT07626476", "title": "Autologous BCMA-targeted CAR-T Cell Injection for Relapsed/Refractory Light Chain Amyloidosis", "status": "RECRUITING", "start": "2024-12-16", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Beijing Boren Hospital", "conditions": ["Relapsed/Refractory Light Chain Amyloidosis", "AL Amyloidosis", "Systemic Light Chain Amyloidosis"], "cn_sites": [{"facility": "Beijing GoBroad Boren Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07103863", "title": "Multimodal Radiomics Model (18F-FAPI PET/CT + CMR) for AL Cardiac Amyloidosis Prognosis", "status": "ENROLLING_BY_INVITATION", "start": "2025-02-13", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 49, "sponsor": "Beijing Anzhen Hospital", "conditions": ["AL Amyloidosis (AL)", "Cardiac Amyloidosis"], "cn_sites": [{"facility": "Beijing Anzhen Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06983951", "title": "Exploratory Clinical Study on the Safety and Efficacy of Targeted BCMA Autologous CART Cell Injection in Subjects With Recurrent/Refractory Light Chain Amyloidosis", "status": "RECRUITING", "start": "2025-02-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Beijing Boren Hospital", "conditions": ["Light Chain Amyloidosis"], "cn_sites": [{"facility": "Beijing Gobroad Brond Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06998875", "title": "A Prospective Cohort Study on Primary Cutaneous Amyloidosis", "status": "RECRUITING", "start": "2025-03-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 56, "sponsor": "Army Medical University, China", "conditions": ["Primary Cutaneous Amyloidosis"], "cn_sites": [{"facility": "Department of Dermatology, Southwest Hospital, Third Military Medical University (Army Medical University)", "city": "Chongqing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06699394", "title": "Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis", "status": "RECRUITING", "start": "2025-03-29", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Peking University People's Hospital", "conditions": ["AL Amyloidosis"], "cn_sites": [{"facility": "Peking University Peoples Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Fuxing Hospital affiliated to Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06935162", "title": "Teclistamab in Previously Treated AL Amyloidosis", "status": "RECRUITING", "start": "2025-05-21", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Peking Union Medical College Hospital", "conditions": ["AL Amyloidosis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07085559", "title": "Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research", "status": "RECRUITING", "start": "2025-06-23", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Anhui Provincial Hospital", "conditions": ["Multiple Myeloma (MM)", "Plasma Cell Leukemia (PCL)", "AL Amyloidosis (AL)"], "cn_sites": [{"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07079423", "title": "Teclistamab in Newly Diagnosed Mayo Stage IIIB AL Amyloidosis", "status": "RECRUITING", "start": "2025-06-28", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 35, "sponsor": "Peking Union Medical College Hospital", "conditions": ["AL Amyloidosis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07232459", "title": "[18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis", "status": "RECRUITING", "start": "2025-07-21", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 25, "sponsor": "Tianjin Medical University", "conditions": ["Amyloid", "Cardiac Amyloidosis", "Amyloidosis", "Healthy Subjects"], "cn_sites": [{"facility": "The First Affiliated Hospital of University of Science and Technology of China", "city": "Hefei", "status": "RECRUITING"}, {"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": "RECRUITING"}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07039578", "title": "Study Evaluating the Efficacy and Safety of CM336 Injection in the Treatment of Light-Chain Amyloidosis", "status": "RECRUITING", "start": "2025-07-25", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "Keymed Biosciences Co.Ltd", "conditions": ["Primary Light-Chain Amyloidosis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07151690", "title": "BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis", "status": "RECRUITING", "start": "2025-09-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 21, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Systemic Light Chain Amyloidosis"], "cn_sites": [{"facility": "Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07250269", "title": "Study of GC012F, CAR-T Therapy Targeting CD19 and BCMA in Chinese Participants With Relapsed or Refractory AL Amyloidosis", "status": "RECRUITING", "start": "2025-10-29", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Gracell Biotechnologies (Shanghai) Co., Ltd.", "conditions": ["Relapsed/Refractory AL Amyloidosis"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Changchun", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Suzhou", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Wenzhou", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT07215494", "title": "A Clinical Study on Minimal Residual Disease in Patients With Systemic Light Chain Amyloidosis", "status": "RECRUITING", "start": "2025-12-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Peking University First Hospital", "conditions": ["Light Chain (AL) Amyloidosis", "MRD"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07266116", "title": "Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis Patients", "status": "RECRUITING", "start": "2025-12-26", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 70, "sponsor": "Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.", "conditions": ["Systemic Light Chain Amyloidosis"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Southwest Hospital, Third Military Medical University (Army Medical University)", "city": "Chongqing", "status": "NOT_YET_RECRUITING"}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Guangzhou First Municipal People's Hospital", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Peking University ShenZhen Hospital", "city": "Shenzhen", "status": "NOT_YET_RECRUITING"}, {"facility": "The Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": "NOT_YET_RECRUITING"}, {"facility": "Affiliated Hospital of Hebei University", "city": "Baoding", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Harbin Medical University", "city": "Harbin", "status": "NOT_YET_RECRUITING"}, {"facility": "Anyang People's Hospital", "city": "Anyang", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Jiangsu Province Hospital", "city": "Nanjing", "status": "NOT_YET_RECRUITING"}, {"facility": "The first hospital of Jilin University", "city": "Changchun", "status": "NOT_YET_RECRUITING"}, {"facility": "China-Japan Union Hospital of Jilin University", "city": "Changchun", "status": "NOT_YET_RECRUITING"}, {"facility": "The second Affiliated hospital of dalian medical university", "city": "Dalian", "status": "NOT_YET_RECRUITING"}, {"facility": "Shengjing Hospital of China Medical University", "city": "Shenyang", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Xi'an Jiao Tong University", "city": "Xi'an", "status": "NOT_YET_RECRUITING"}, {"facility": "Qingdao municipal hosptial (group)", "city": "Qingdao", "status": "NOT_YET_RECRUITING"}, {"facility": "Renji Hospital Shanghai Jiaotong University School Of Medicine", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}, {"facility": "Sichuan Provincial People's Hospital", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}, {"facility": "Chinese Academy of Medical Sciences Hematology Hospital", "city": "Tianjin", "status": "NOT_YET_RECRUITING"}, {"facility": "Hangzhou First People's Hospital", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Sir Run Run Shaw Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 25, "broad_only": false}, {"nct": "NCT07388602", "title": "A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis (NDSLCA)", "status": "RECRUITING", "start": "2026-01-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "Sinocelltech Ltd.", "conditions": ["Amyloidosis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07335887", "title": "Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With t(11;14) Primary AL Amyloidosis", "status": "RECRUITING", "start": "2026-02-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 39, "sponsor": "Peking University People's Hospital", "conditions": ["AL Amyloidosis (AL)", "t(11;14) Positive"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The first Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi'an", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07638683", "title": "A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL).", "status": "RECRUITING", "start": "2026-05-22", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Shanghai Zhongshan Hospital", "conditions": ["Multiple Myeloma", "AL Amyloidosis"], "cn_sites": [{"facility": "Zhongshan Hospital Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07751471", "title": "BCMA/GPRC5D Trispecific Antibody Treatment for Newly Diagnosed Amyloidosis (AL-004)", "status": "NOT_YET_RECRUITING", "start": "2026-07-20", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["AL Amyloidosis"], "cn_sites": [{"facility": "Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07765524", "title": "A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Primary AL Amyloidosis", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 32, "sponsor": "Shenzhen Fosun Kairos Biotechnology Co., Ltd.", "conditions": ["Primary Light Chain (AL) Amyloidosis"], "cn_sites": [{"facility": "The Frist Affiliated Hospital of Jinan University", "city": "Guangzhou", "status": ""}, {"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": ""}, {"facility": "The Frist Affiliated Hospital of Guangxi Medical university", "city": "Nanning", "status": ""}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Tongji Mecial college of HUST", "city": "Wuhan", "status": ""}, {"facility": "Jiangsu Province Hospital", "city": "Nanjing", "status": ""}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": ""}, {"facility": "Zhongshan Hospital Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Sichuan Provincial People's Hospital", "city": "Chengdu", "status": ""}, {"facility": "West China Hospital Sichuan Hospital", "city": "Chengdu", "status": ""}, {"facility": "The Second Affiliated Hospital Zhejiang University school of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 11, "broad_only": false}, {"nct": "NCT07687004", "title": "Sonrotoclax and BCMA Bispecific Antibody in Newly Diagnosed Systemic AL Amyloidosis Based on t(11;14) Genetic Stratification", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Multiple Myeloma (MM)"], "cn_sites": [{"facility": "Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01998503", "title": "Bortezomib and Dexamethasone Followed by ASCT Compared With ASCT Alone in Treating Patients With AL Amyloidosis", "status": "COMPLETED", "start": "2007-12", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 56, "sponsor": "Nanjing University School of Medicine", "conditions": ["Amyloidosis"], "cn_sites": [{"facility": "Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine", "city": "Nanjing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01273844", "title": "Study of Bortezomib +HSCT in Primary Systemic Amyloidosis (AL)", "status": "COMPLETED", "start": "2011-03-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 21, "sponsor": "Zhi-Hong Liu, M.D.", "conditions": ["Amyloidosis"], "cn_sites": [{"facility": "Soochow University", "city": "Suzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03201965", "title": "A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis", "status": "COMPLETED", "start": "2017-10-05", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 416, "sponsor": "Janssen Research & Development, LLC", "conditions": ["Amyloidosis"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University People s Hospital", "city": "Beijing", "status": ""}, {"facility": "First affiliated Hospital of Zhejiang University", "city": "Hangzhou", "status": ""}, {"facility": "Ruijin Hospital Shanghai Jiao Tong University", "city": "Shanghai", "status": ""}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT03401372", "title": "BCD With or Without Doxycycline in Mayo Stage II-III Light Chain Amyloidosis Patients", "status": "COMPLETED", "start": "2018-04-21", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 140, "sponsor": "Jian Li", "conditions": ["Amyloidosis; Systemic"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04006223", "title": "The Diagnostic Value of Hybrid PET/MR for Systemic Amyloidosis", "status": "UNKNOWN", "start": "2019-03-11", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 30, "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": ["Systemic Amyloidosis", "PET/MR"], "cn_sites": [{"facility": "China, Hubei Province", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04612582", "title": "Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis", "status": "UNKNOWN", "start": "2020-01-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 70, "sponsor": "Guangdong Provincial People's Hospital", "conditions": ["Immunoglobulin Light-Chain Amyloidosis"], "cn_sites": [{"facility": "Guangdong Provincial People'S Hospital", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04504825", "title": "A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)", "status": "ACTIVE_NOT_RECRUITING", "start": "2020-08-25", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 125, "sponsor": "Alexion Pharmaceuticals, Inc.", "conditions": ["AL Amyloidosis"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Guangzhou", "status": ""}, {"facility": "Research Site", "city": "Hangzhou", "status": ""}, {"facility": "Research Site", "city": "Wenzhou", "status": ""}, {"facility": "Research Site", "city": "Wuhan", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT04512235", "title": "A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)", "status": "ACTIVE_NOT_RECRUITING", "start": "2020-11-03", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 281, "sponsor": "Alexion Pharmaceuticals, Inc.", "conditions": ["AL Amyloidosis"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Guangzhou", "status": ""}, {"facility": "Research Site", "city": "Hangzhou", "status": ""}, {"facility": "Research Site", "city": "Shanghai", "status": ""}, {"facility": "Research Site", "city": "Suzhou", "status": ""}, {"facility": "Research Site", "city": "Wenzhou", "status": ""}, {"facility": "Research Site", "city": "Wuhan", "status": ""}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT04474938", "title": "Daratumumab Combined With Bortezomib and Dexamethasone in Mayo 04 Stage III Light Chain Amyloidosis", "status": "UNKNOWN", "start": "2021-05-24", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Amyloidosis; Systemic"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05250973", "title": "A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-03-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 151, "sponsor": "Janssen Research & Development, LLC", "conditions": ["Amyloidosis"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}, {"facility": "West China Hospital Si Chuan University", "city": "Chengdu", "status": ""}, {"facility": "First affiliated Hospital of Zhejiang University", "city": "Hangzhou", "status": ""}, {"facility": "Ruijin Hospital Shanghai Jiao Tong University", "city": "Shanghai", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT05277493", "title": "A Registry of Chinese AL Amyloidosis Patients Treated With Subcutaneous or Intravenous Daratumumab", "status": "UNKNOWN", "start": "2022-03-30", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Peking Union Medical College Hospital", "conditions": ["AL Amyloidosis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05978661", "title": "FKC288 for Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis", "status": "UNKNOWN", "start": "2023-08-29", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Nanjing University School of Medicine", "conditions": ["Light Chain Amyloidosis"], "cn_sites": [{"facility": "Jinling Hospital", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05996406", "title": "Venetoclax and Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis with Translocation (11;14)", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-09-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Light Chain (AL) Amyloidosis", "CCND1 Translocation", "Venetoclax"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06455748", "title": "Daratumumab/Daratumumab and Hyaluronidase-fihj in Combination With Pomalidomide and Dexamethasone for the Treatment of Patients With Newly Diagnosed AL Amyloidosis: a Prospective, Multicenter, Single-arm Study", "status": "UNKNOWN", "start": "2024-03-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Yongyong MA", "conditions": ["Amyloid Light-chain Amyloidosis"], "cn_sites": [{"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06803082", "title": "The Impact of Systemic Light Chain Amyloidosis on Eyes", "status": "UNKNOWN", "start": "2024-09-04", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 130, "sponsor": "Zhongshan Ophthalmic Center, Sun Yat-sen University", "conditions": ["Systemic Light Chain Amyloidosis", "Ocular Complications"], "cn_sites": [{"facility": "Zhongshan Opthalmic Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06629818", "title": "Daratumumab Combined With Venetoclax and Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis With Translocation (11;14)", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-10-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Light Chain (AL) Amyloidosis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 64, "g_fetched": 40, "g_countries": [["United States", 20], ["Italy", 8], ["Spain", 4], ["United Kingdom", 4], ["France", 3], ["Belgium", 3], ["Japan", 3], ["Netherlands", 3], ["Switzerland", 2], ["Australia", 2], ["Greece", 2], ["Germany", 2], ["Hungary", 1], ["Canada", 1], ["Israel", 1], ["Norway", 1], ["South Korea", 1], ["Taiwan", 1], ["Uruguay", 1], ["Portugal", 1]], "g_trials": [{"nct": "NCT07709715", "title": "A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of NXC-201 Compared With Daratumumab With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) in Newly Diagnosed Systemic AL Amyloidosis", "status": "NOT_YET_RECRUITING", "start": "2027-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Nexcella Inc.", "countries": []}, {"nct": "NCT07793422", "title": "Study to Evaluate Change in Disease Activity and Adverse Events of Subcutaneous Etentamig Compared With Daratumumab Plus Cyclophosphamide Plus Bortezomib Plus Dexamethasone (Dara-CyBorD) in Adults With Amyloid Light Chain (AL) Amyloidosis", "status": "NOT_YET_RECRUITING", "start": "2026-11-29", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "AbbVie", "countries": []}, {"nct": "NCT07624760", "title": "Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging", "status": "NOT_YET_RECRUITING", "start": "2026-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Zurich", "countries": ["Switzerland"]}, {"nct": "NCT07615270", "title": "A Pilot Study of Anselamimab in Patients With AL Amyloidoma and Measurable Tissue Involvement", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Stanford University", "countries": ["United States"]}, {"nct": "NCT07524634", "title": "Dose Schedule Study of BCMA Bispecific Antibody, Elranatamab, for Newly Diagnosed Immunoglobulin Light Chain (AL) Amyloidosis", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Case Comprehensive Cancer Center", "countries": ["United States"]}, {"nct": "NCT07224672", "title": "A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis", "status": "RECRUITING", "start": "2026-06-24", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "GlaxoSmithKline", "countries": ["Australia", "United States"]}, {"nct": "NCT06971848", "title": "Evaluation of Skin Tests in Biotherapy Allergies", "status": "RECRUITING", "start": "2026-06-17", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Angers", "countries": ["France"]}, {"nct": "NCT07521722", "title": "DIV-AD BARCELONA: Alzheimer's Blood-Based Biomakers for a Diverse Community", "status": "NOT_YET_RECRUITING", "start": "2026-04-27", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Barcelonabeta Brain Research Center, Pasqual Maragall Foundation", "countries": ["Spain"]}, {"nct": "NCT07689331", "title": "Hungarian National Systemic Amyloidosis Registry", "status": "RECRUITING", "start": "2026-03-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Semmelweis University", "countries": ["Hungary"]}, {"nct": "NCT07448935", "title": "One Gene, Two Diseases: the Pathologic Role of IGLV1-44 in AL Amyloidosis and POEMS", "status": "RECRUITING", "start": "2025-11-28", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondazione IRCCS Policlinico San Matteo di Pavia", "countries": ["Italy"]}, {"nct": "NCT07448779", "title": "Investigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and Treatment", "status": "RECRUITING", "start": "2025-11-17", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondazione IRCCS Policlinico San Matteo di Pavia", "countries": ["Italy"]}, {"nct": "NCT07110844", "title": "Teclistamab-Daratumumab in AL Amyloidosis", "status": "RECRUITING", "start": "2025-11-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Rajshekhar Chakraborty, MD", "countries": ["United States"]}, {"nct": "NCT07172243", "title": "BE.Amycon Biobank & Data Registry UZ Leuven", "status": "RECRUITING", "start": "2025-09-24", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Universitaire Ziekenhuizen KU Leuven", "countries": ["Belgium"]}, {"nct": "NCT07143864", "title": "Efficacy and Safety of Stapokibart for Primary Cutaneous Amyloidosis", "status": "NOT_YET_RECRUITING", "start": "2025-09-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "First Affiliated Hospital of Chongqing Medical University", "countries": []}, {"nct": "NCT07081646", "title": "A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.", "status": "RECRUITING", "start": "2025-08-18", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Alexion Pharmaceuticals, Inc.", "countries": ["Canada", "United Kingdom", "United States"]}, {"nct": "NCT07055724", "title": "Study of Eque-cel CAR-T Therapy in Newly Diagnosed Severe AL Amyloidosis", "status": "NOT_YET_RECRUITING", "start": "2025-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Nanjing IASO Biotechnology Co., Ltd.", "countries": []}, {"nct": "NCT06971380", "title": "Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis", "status": "RECRUITING", "start": "2025-03-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Polina Stepensky", "countries": ["Israel"]}, {"nct": "NCT06855121", "title": "The Norwegian Immunotherapy in Multiple Myeloma Study", "status": "RECRUITING", "start": "2025-01-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "St. Olavs Hospital", "countries": ["Norway"]}, {"nct": "NCT06569147", "title": "Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis", "status": "RECRUITING", "start": "2024-11-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Dana-Farber Cancer Institute", "countries": ["United States"]}, {"nct": "NCT06292780", "title": "A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)", "status": "RECRUITING", "start": "2024-08-07", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Regeneron Pharmaceuticals", "countries": ["Greece", "South Korea", "Spain", "Taiwan", "United Kingdom", "United States"]}, {"nct": "NCT06420167", "title": "DapagliFLOzin in Renal AL Amyloidosis (FLORAL)", "status": "RECRUITING", "start": "2024-07-11", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Barbara Ann Karmanos Cancer Institute", "countries": ["United States"]}, {"nct": "NCT06022939", "title": "Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis", "status": "RECRUITING", "start": "2024-07-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "SWOG Cancer Research Network", "countries": ["United States"]}, {"nct": "NCT06887283", "title": "Essen Amyloidosis Registry", "status": "RECRUITING", "start": "2024-05-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Essen", "countries": ["Germany"]}, {"nct": "NCT06365060", "title": "Screening for AL Amyloidosis in Smoldering Multiple Myeloma", "status": "RECRUITING", "start": "2024-05-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Tufts Medical Center", "countries": ["United States"]}, {"nct": "NCT06158854", "title": "A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion", "status": "RECRUITING", "start": "2024-04-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "AbbVie", "countries": ["Australia", "France", "Greece", "Italy", "Japan", "United States"]}]}, {"batch": 1, "no": 97, "name_zh": "进行性家族性肝内胆汁淤积症", "query_terms": [{"term": "Progressive familial intrahepatic cholestasis", "broad": false}], "n_total": 1, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT07588880", "title": "A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in China", "status": "RECRUITING", "start": "2026-04-16", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 20, "sponsor": "Ipsen", "conditions": ["Progressive Familial Intrahepatic Cholestasis"], "cn_sites": [{"facility": "Capital Children's Medical Center", "city": "Beijing", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Chongqing Medical University - Children's Hospital", "city": "Chongqing", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Hunan Children's Hospital", "city": "Hunan", "status": "RECRUITING"}, {"facility": "Nanjing Medical University-Nanjing Children's Hospital", "city": "Nanjing", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Children's Hospital of Fudan University Endocrinology and Metabolism", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Xiamen Children's Hospital", "city": "Xiamen", "status": "ACTIVE_NOT_RECRUITING"}], "cn_site_count": 6, "broad_only": false}], "g_total": 12, "g_fetched": 11, "g_countries": [["Italy", 4], ["France", 2], ["Netherlands", 2], ["United States", 2], ["Canada", 1], ["Japan", 1], ["South Korea", 1], ["Belgium", 1], ["Germany", 1], ["Greece", 1], ["Portugal", 1], ["Spain", 1], ["Australia", 1]], "g_trials": [{"nct": "NCT07411716", "title": "Pediatric Evaluation and Registry for Liver Cholestasis in Canada", "status": "RECRUITING", "start": "2026-04-21", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Children's Hospital of Eastern Ontario", "countries": ["Canada"]}, {"nct": "NCT06506734", "title": "Dental Dyschromia and Quality of Life in Early Prolonged Hyperbilirubinemia", "status": "RECRUITING", "start": "2026-04-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Toulouse", "countries": ["France"]}, {"nct": "NCT07293897", "title": "A Database Study of Maralixibat (TAK-625) in Participants With Alagille Syndrome (ALGS) and Progressive Familial Intrahepatic Cholestasis (PFIC)", "status": "RECRUITING", "start": "2026-01-13", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Takeda", "countries": ["Japan"]}, {"nct": "NCT07317193", "title": "DEFINING THE GENETIC DRIVERS OF ADULT-ONSET CHOLESTATIC LIVER DISEASE", "status": "RECRUITING", "start": "2025-11-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico", "countries": ["Italy"]}, {"nct": "NCT07185919", "title": "A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in South Korea", "status": "RECRUITING", "start": "2025-10-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Ipsen", "countries": ["South Korea"]}, {"nct": "NCT07290257", "title": "Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in Patients With Alagille Syndrome or Progressive Familial Intrahepatic Cholestasis in the European Union (LEAP-EU)", "status": "RECRUITING", "start": "2025-09-25", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Mirum Pharmaceuticals, Inc.", "countries": ["Belgium", "France", "Germany", "Greece", "Italy", "Netherlands", "Portugal", "Spain"]}, {"nct": "NCT06777914", "title": "Familial Intrahepatic Cholestasis-related Genes Associated with Disease Susceptibility in Hepato-biliary Cancers", "status": "RECRUITING", "start": "2024-10-22", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS Azienda Ospedaliero-Universitaria di Bologna", "countries": ["Italy"]}, {"nct": "NCT06781242", "title": "Genotype-phenotype Relationship Between Cryptogenic Cholestasis and Familial Intrahepatic Cholestasis", "status": "RECRUITING", "start": "2024-01-16", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS Azienda Ospedaliero-Universitaria di Bologna", "countries": ["Italy"]}, {"nct": "NCT06193928", "title": "Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)", "status": "RECRUITING", "start": "2023-09-21", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Mirum Pharmaceuticals, Inc.", "countries": ["United States"]}, {"nct": "NCT06778174", "title": "Prospective Analysis of the Treatment of Progressive Familial Intrahepatic Cholestasis (TreatFIC)", "status": "RECRUITING", "start": "2023-02-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Medical Center Groningen", "countries": ["Netherlands"]}, {"nct": "NCT01793168", "title": "Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford", "status": "RECRUITING", "start": "2010-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sanford Health", "countries": ["Australia", "United States"]}]}, {"batch": 1, "no": 98, "name_zh": "进行性肌营养不良", "query_terms": [{"term": "Progressive muscular dystrophy", "broad": false}], "n_total": 24, "n_open": 8, "n_open_precise": 8, "n_broad": 0, "trials": [{"nct": "NCT04369209", "title": "A Registered Cohort Study on FSHD1", "status": "RECRUITING", "start": "2001-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "Ning Wang, MD., PhD.", "conditions": ["Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1)"], "cn_sites": [{"facility": "First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04012671", "title": "A Registered Cohort Study on Duchenne Muscular Dystrophy", "status": "RECRUITING", "start": "2019-07-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2000, "sponsor": "Ning Wang, MD., PhD.", "conditions": ["Duchenne Muscular Dystrophy"], "cn_sites": [{"facility": "First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04989751", "title": "A Multicenter Phenotype-Genotype Analysis of LGMD Patients in China", "status": "ENROLLING_BY_INVITATION", "start": "2021-07-07", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 450, "sponsor": "Huashan Hospital", "conditions": ["LGMD", "LGMDR2", "LGMDR1"], "cn_sites": [{"facility": "Huashan Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06641895", "title": "Evaluation of the Safety and Efficacy of BBM-D101 to Treat Patients with Duchenne Muscular Dystrophy", "status": "RECRUITING", "start": "2024-07-25", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Shanghai Jiao Tong University School of Medicine", "conditions": ["Duchenne Muscular Dystrophy (DMD)"], "cn_sites": [{"facility": "Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06900049", "title": "Evaluation of the Safety, Tolerability, and Efficacy of LE051 in Patients With Duchenne Muscular Dystrophy", "status": "RECRUITING", "start": "2024-10-24", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Shanghai Jiao Tong University School of Medicine", "conditions": ["Duchenne Muscular Dystrophy (DMD)"], "cn_sites": [{"facility": "Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07058662", "title": "A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of BBM-D101 in the Treatment of Duchenne Muscular Dystrophy.", "status": "RECRUITING", "start": "2025-07-31", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Belief BioMed (Beijing) Co., Ltd", "conditions": ["DMD"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07188012", "title": "Safety and Dystrophin Expression of SPOT-03 in Duchenne Muscular Dystrophy (DMD) Patients", "status": "RECRUITING", "start": "2025-08-06", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Shanghai Siponuoyin Biotechnology Co Ltd", "conditions": ["Duchenne Muscular Dystrophy (DMD)"], "cn_sites": [{"facility": "Shanghai Children's Medical Center", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07511920", "title": "A Multicenter Cohort Study of Duchenne and Becker Muscular Dystrophy in Western Chinese Children", "status": "NOT_YET_RECRUITING", "start": "2026-04-20", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "West China Second University Hospital", "conditions": ["Muscular Dystrophy, Becker", "Muscular Dystrophy", "Muscular Dystrophy (DMD)", "Muscular Dystrophy, Duchenne"], "cn_sites": [{"facility": "West China Second University Hospital, Sichuan University", "city": "Chengdu", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01610440", "title": "Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy", "status": "UNKNOWN", "start": "2011-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Shenzhen Beike Bio-Technology Co., Ltd.", "conditions": ["Duchenne Muscular Dystrophy"], "cn_sites": [{"facility": "The Second Affiliated Hospital of Kunming Medical College", "city": "Kunming", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02285062", "title": "Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma", "status": "COMPLETED", "start": "2015-02-17", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 570, "sponsor": "Celgene", "conditions": ["Lymphoma, Large B-Cell, Diffuse"], "cn_sites": [{"facility": "Local Institution - 209", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 206", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 215", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 200", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 211", "city": "Changchun", "status": ""}, {"facility": "Local Institution - 210", "city": "Chengdu", "status": ""}, {"facility": "Local Institution - 213", "city": "Chongqing", "status": ""}, {"facility": "Local Institution - 202", "city": "Fuzhou", "status": ""}, {"facility": "Local Institution - 217", "city": "Guangzhou, Guangdong", "status": ""}, {"facility": "Local Institution - 204", "city": "Hangzhou", "status": ""}, {"facility": "Local Institution - 207", "city": "Harbin, Heilongjiang", "status": ""}, {"facility": "Local Institution - 212", "city": "Nanjing", "status": ""}, {"facility": "Local Institution - 205", "city": "Nanjing, Jiangsu", "status": ""}, {"facility": "Local Institution - 214", "city": "Shanghai", "status": ""}, {"facility": "Local Institution - 219", "city": "Suzhu", "status": ""}, {"facility": "Local Institution - 221", "city": "Tianjin", "status": ""}, {"facility": "Local Institution - 203", "city": "Wuhan", "status": ""}], "cn_site_count": 17, "broad_only": false}, {"nct": "NCT02614820", "title": "The Safety, Efficacy and Tolerability of Remote Ischemic Preconditioning as a Therapy to DMD", "status": "UNKNOWN", "start": "2015-11", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "General Hospital of Chinese Armed Police Forces", "conditions": ["Duchenne Muscular Dystrophy (DMD)"], "cn_sites": [{"facility": "Shiwen wu", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03179631", "title": "Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy", "status": "COMPLETED", "start": "2017-07-06", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 360, "sponsor": "PTC Therapeutics", "conditions": ["Muscular Dystrophy, Duchenne", "Muscular Dystrophies", "Muscular Disorders, Atrophic", "Muscular Diseases", "Musculoskeletal Disease", "Neuromuscular Diseases", "Nervous System Diseases", "Genetic Diseases, X-Linked", "Genetic Diseases, Inborn"], "cn_sites": [{"facility": "General Hospital of Chinese Armed Police Forces", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": ""}, {"facility": "Xiangya Hospital Central South University", "city": "Hunan", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT03779646", "title": "Bisoprolol in DMD Early Cardiomyopathy", "status": "UNKNOWN", "start": "2019-01-16", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 42, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Duchenne Muscular Dystrophy", "Cardiomyopathy, Dilated"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03760029", "title": "A Natural History Study In Chinese Male Patients With Duchenne Muscular Dystrophy", "status": "COMPLETED", "start": "2019-07-24", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 312, "sponsor": "Pfizer", "conditions": ["Duchenne Muscular Dystrophy"], "cn_sites": [{"facility": "Children's Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "Children's Hospital of Chongqing Medical University (Liangjiang Branch)", "city": "Chongqing", "status": ""}, {"facility": "The First Affiliated Hospital Of Fujian Medical University", "city": "Fuzhou", "status": ""}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Affiliated children's hospital of fudan university", "city": "Shanghai", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT04060199", "title": "Study to Assess the Efficacy and Safety of Viltolarsen in Ambulant Boys With DMD (RACER53)", "status": "COMPLETED", "start": "2020-04-14", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 77, "sponsor": "NS Pharma, Inc.", "conditions": ["Duchenne Muscular Dystrophy"], "cn_sites": [{"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "The Third Medical Center of PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "Hunan Children's Hospital", "city": "Changsha", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT04371666", "title": "Phase 3 Trial of Pamrevlumab or Placebo With Systemic Corticosteroids in Participants With Non-ambulatory Duchenne Muscular Dystrophy (DMD)", "status": "TERMINATED", "start": "2020-08-10", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 98, "sponsor": "Kyntra Bio", "conditions": ["Duchenne Muscular Dystrophy"], "cn_sites": [{"facility": "Children's Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "West China Second University Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Peking Union Medical College Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT04632940", "title": "Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Participants With Ambulatory DMD", "status": "TERMINATED", "start": "2021-03-03", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 73, "sponsor": "Kyntra Bio", "conditions": ["Duchenne Muscular Dystrophy"], "cn_sites": [{"facility": "Children's Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "The 1st Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": ""}, {"facility": "West China Second University Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Peking Union Medical College Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT04768062", "title": "Study to Assess the Safety and Efficacy of Viltolarsen in Ambulant Boys With DMD (RACER53-X)", "status": "UNKNOWN", "start": "2021-04-13", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 74, "sponsor": "NS Pharma, Inc.", "conditions": ["Duchenne Muscular Dystrophy"], "cn_sites": [{"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "Hunan Children's Hospital", "city": "Changsha", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT04956289", "title": "Study to Assess the Safety, Tolerability, and Efficacy of Viltolarsen in Ambulant and Non-Ambulant Boys With DMD (Galactic53)", "status": "COMPLETED", "start": "2021-07-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "NS Pharma, Inc.", "conditions": ["Duchenne Muscular Dystrophy"], "cn_sites": [{"facility": "The Third Medical Center of PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "Hunan Children's Hospital", "city": "Changsha", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06114056", "title": "A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of Single Intravenous Infusion of JWK007 in Patients With Duchenne Muscular Dystrophy (DMD)", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-01-31", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 3, "sponsor": "West China Hospital", "conditions": ["Duchenne Muscular Dystrophy"], "cn_sites": [{"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06517498", "title": "Disease Burden and Living Situation of Patients With Facioscapulohumeral Muscular Dystrophy", "status": "UNKNOWN", "start": "2024-03-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 300, "sponsor": "Xi'an Jiaotong University", "conditions": ["Muscular Dystrophy, Facioscapulohumeral"], "cn_sites": [{"facility": "Health Science Center of Xi'an Jiaotong University", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06392724", "title": "A Study to Evaluate the Safety and Tolerability of GEN6050X in Duchenne Muscular Dystrophy.", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-07-05", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 3, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Duchenne Muscular Dystrophy (DMD)"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06594094", "title": "An Open-label, Multidose Dose-escalation Study to Understand the Safety of CRISPR Gene-editing Therapy and Its Long-Lasting Effects in DMD Patients (MUSCLE)", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-11-06", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 4, "sponsor": "HuidaGene Therapeutics Co., Ltd.", "conditions": ["Duchenne Muscular Dystrophin (DMD)"], "cn_sites": [{"facility": "Shanghai Children s Medical Center Affiliated to Shanghai Jiao Tong University School of Medical", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07282652", "title": "A Study to Evaluate the Safety and Tolerability of RAG-18 in Pediatric Patients With Duchenne Muscular Dystrophy", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-12-12", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Duchenne Muscular Dystrophy (DMD)"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 139, "g_fetched": 132, "g_countries": [["United States", 63], ["Italy", 20], ["United Kingdom", 18], ["France", 16], ["Belgium", 16], ["Spain", 14], ["Netherlands", 11], ["Canada", 11], ["Germany", 8], ["Australia", 7], ["Turkey (Türkiye)", 5], ["Israel", 4], ["New Zealand", 3], ["Denmark", 3], ["Poland", 3], ["Serbia", 3], ["South Korea", 3], ["Pakistan", 2], ["Egypt", 2], ["Japan", 2], ["Czechia", 2], ["Greece", 1], ["Belarus", 1], ["Russia", 1], ["Norway", 1], ["Puerto Rico", 1], ["Sweden", 1], ["Jordan", 1], ["Hungary", 1], ["Romania", 1], ["Slovenia", 1], ["Switzerland", 1], ["Austria", 1], ["Mali", 1]], "g_trials": [{"nct": "NCT07821125", "title": "Urotherapy Education for Families of Children With Duchenne Muscular Dystrophy", "status": "NOT_YET_RECRUITING", "start": "2026-11-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Lokman Hekim University", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT05470478", "title": "iBCI Optimization for Veterans With Paralysis", "status": "NOT_YET_RECRUITING", "start": "2026-10-02", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "VA Office of Research and Development", "countries": ["United States"]}, {"nct": "NCT07787689", "title": "Intermittent vs Alternate Daily Regimen of Prednisolone in Ambulatory Boys With Duchenne Muscular Dystrophy", "status": "NOT_YET_RECRUITING", "start": "2026-09-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Muhammad Aamir Latif", "countries": ["Pakistan"]}, {"nct": "NCT07740057", "title": "Multimodal Study About Absence of Dp140 in Becker Muscular Dystrophy: Brain-muscle Imaging, Cognition and Muscle Function", "status": "NOT_YET_RECRUITING", "start": "2026-09-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Institut de Myologie, France", "countries": ["France"]}, {"nct": "NCT07704099", "title": "Safety and Efficacy of KER-065 in Participants With Duchenne Muscular Dystrophy", "status": "NOT_YET_RECRUITING", "start": "2026-09-14", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Keros Therapeutics, Inc.", "countries": []}, {"nct": "NCT07642635", "title": "Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular Dystrophy", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Vanderbilt University Medical Center", "countries": ["United States"]}, {"nct": "NCT07587242", "title": "A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping", "status": "RECRUITING", "start": "2026-09-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Avidity Biosciences, Inc.", "countries": ["Belgium", "France", "Germany", "Italy", "Spain", "United Kingdom"]}, {"nct": "NCT07521930", "title": "Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)", "status": "RECRUITING", "start": "2026-09", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Johns Hopkins University", "countries": ["United States"]}, {"nct": "NCT07700225", "title": "Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension", "status": "RECRUITING", "start": "2026-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Virginia Commonwealth University", "countries": ["United States"]}, {"nct": "NCT07798609", "title": "A Trial to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of SFL-0821 in Adults With FSHD", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Soufflé Therapeutics, Inc.", "countries": ["Australia", "New Zealand"]}, {"nct": "NCT07542314", "title": "Study to Evaluate the Safety and Effectiveness of ELEVIDYS in Participants With Duchenne Muscular Dystrophy Treated in a Post-Marketing Setting", "status": "NOT_YET_RECRUITING", "start": "2026-08-31", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Sarepta Therapeutics, Inc.", "countries": ["United States"]}, {"nct": "NCT07745218", "title": "Preclinical Assessment of an Engineered HMGB1 Protein as a Novel Companion Therapy for Muscular Dystrophies", "status": "RECRUITING", "start": "2026-08-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS San Raffaele", "countries": ["Italy"]}, {"nct": "NCT07682129", "title": "Long-Term Extension Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon Skipping to Evaluate the Safety and Efficacy of Endosomal Escape Vehicle Phosphorodiamidate Morpholino Oligomer Platform Products (ELEVATE-LTE)", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Entrada Therapeutics, Inc.", "countries": ["Belgium", "Italy", "Netherlands", "Spain", "United Kingdom"]}, {"nct": "NCT07664124", "title": "Digital Monitoring of Upper Limb Function in Non-Ambulant DMD", "status": "NOT_YET_RECRUITING", "start": "2026-07-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Centre Hospitalier Universitaire de Liege", "countries": ["Belgium"]}, {"nct": "NCT07435129", "title": "Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD", "status": "RECRUITING", "start": "2026-07-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Scholar Rock, Inc.", "countries": ["United States"]}, {"nct": "NCT07766980", "title": "Evaluating VM100 Nutritional Supplement for Improving Quality of Life in Duchenne Muscular Dystrophy Patients", "status": "RECRUITING", "start": "2026-07-27", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Florida", "countries": ["United States"]}, {"nct": "NCT07172971", "title": "Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy", "status": "RECRUITING", "start": "2026-07-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Vanderbilt University Medical Center", "countries": ["United States"]}, {"nct": "NCT07423026", "title": "A Remote Study Using Technology to Assess Outcomes in DMD", "status": "RECRUITING", "start": "2026-06-24", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Oxford", "countries": ["United Kingdom"]}, {"nct": "NCT06998134", "title": "Toward Ubiquitous Lower Limb Exoskeleton Use in Children and Young Adults", "status": "RECRUITING", "start": "2026-06-23", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Institutes of Health Clinical Center (CC)", "countries": ["United States"]}, {"nct": "NCT07092540", "title": "The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular Dystrophy", "status": "RECRUITING", "start": "2026-06-03", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Rochester", "countries": ["United States"]}, {"nct": "NCT07581743", "title": "How Can Different Forms of Strengthening Exercises Affect the Muscular Tissue and Its Chemical Markers in Children With Duchenne Muscular Dystrophy", "status": "NOT_YET_RECRUITING", "start": "2026-06-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Cairo University", "countries": ["Egypt"]}, {"nct": "NCT07608432", "title": "Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)", "status": "RECRUITING", "start": "2026-06", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Dyne Therapeutics", "countries": ["United States"]}, {"nct": "NCT07486934", "title": "Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1", "status": "RECRUITING", "start": "2026-05-14", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Dyne Therapeutics", "countries": ["Australia", "Belgium", "Denmark", "France", "Germany", "Italy", "Japan", "Netherlands", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT07368400", "title": "DMD and Gamified Physiotherapy", "status": "NOT_YET_RECRUITING", "start": "2026-05-08", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Başak Çağla Arslan", "countries": []}, {"nct": "NCT07429240", "title": "PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD)", "status": "RECRUITING", "start": "2026-04-24", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Precision BioSciences, Inc.", "countries": ["United States"]}]}, {"batch": 1, "no": 99, "name_zh": "丙酸血症", "query_terms": [{"term": "Propionic acidemia", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 9, "g_fetched": 9, "g_countries": [["United States", 7], ["France", 4], ["Spain", 4], ["United Kingdom", 4], ["Canada", 3], ["Japan", 3], ["Netherlands", 3], ["Australia", 2], ["Italy", 2], ["Saudi Arabia", 2], ["Germany", 1], ["Norway", 1], ["Sweden", 1]], "g_trials": [{"nct": "NCT07643844", "title": "AAVrh10-PCCA Gene Therapy for Propionic Acidemia", "status": "RECRUITING", "start": "2026-07-20", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Mayo Clinic", "countries": ["United States"]}, {"nct": "NCT06664840", "title": "MyRareDiet A Novel Diet Tracking Tool", "status": "NOT_YET_RECRUITING", "start": "2024-11-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Oregon Health and Science University", "countries": []}, {"nct": "NCT05769621", "title": "A Retrospective Study to Characterize Participants With Propionic Acidemia", "status": "RECRUITING", "start": "2023-06-16", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "ModernaTX, Inc.", "countries": ["Australia", "Canada", "France", "Italy", "Japan", "Netherlands", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT05040178", "title": "An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and Pediatrics", "status": "RECRUITING", "start": "2022-06-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "RECORDATI GROUP", "countries": ["United States"]}, {"nct": "NCT05130437", "title": "A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study", "status": "RECRUITING", "start": "2021-11-09", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "ModernaTX, Inc.", "countries": ["Canada", "France", "Japan", "Netherlands", "Saudi Arabia", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT04159103", "title": "Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia", "status": "RECRUITING", "start": "2021-04-15", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "ModernaTX, Inc.", "countries": ["Canada", "France", "Japan", "Netherlands", "Saudi Arabia", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT04176523", "title": "Understanding the Long-Term Management of Organic Acidemia Patients With CARBAGLU®: A Mixed Methods Approach", "status": "RECRUITING", "start": "2019-01-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "RECORDATI GROUP", "countries": ["France", "Germany", "Italy", "Norway", "Spain", "Sweden", "United Kingdom"]}, {"nct": "NCT02890342", "title": "Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia", "status": "RECRUITING", "start": "2016-11-29", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Human Genome Research Institute (NHGRI)", "countries": ["United States"]}, {"nct": "NCT01793168", "title": "Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford", "status": "RECRUITING", "start": "2010-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sanford Health", "countries": ["Australia", "United States"]}]}, {"batch": 1, "no": 100, "name_zh": "肺泡蛋白沉积症", "query_terms": [{"term": "Autoimmune pulmonary alveolar proteinosis", "broad": false}, {"term": "Hereditary pulmonary alveolar proteinosis", "broad": false}, {"term": "Secondary pulmonary alveolar proteinosis", "broad": false}], "n_total": 4, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT02243228", "title": "Inhalation of Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Autoimmune Pulmonary Alveolar Proteinosis (PAP)", "status": "UNKNOWN", "start": "2014-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 42, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Autoimmune Pulmonary Alveolar Proteinosis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03316651", "title": "Sequential Therapy With WLL/Inhaling GM-CSF for Autoimmune Pulmonary Alveolar Proteinosis", "status": "UNKNOWN", "start": "2016-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Dai Huaping", "conditions": ["Pulmonary Alveolar Proteinosis", "Treatment"], "cn_sites": [{"facility": "China Japan Friendship Hispital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05640687", "title": "The Study of Mesenchymal Stem Cells Treat Autoimmune Pulmonary Alveolar Proteinosis in Vitro", "status": "UNKNOWN", "start": "2021-03-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 26, "sponsor": "Guangzhou Institute of Respiratory Disease", "conditions": ["Pulmonary Alveolar Proteinosis(PAP)"], "cn_sites": [{"facility": "Guangzhou Institute of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06111846", "title": "Study of Human Bone Marrow Mesenchymal Stem Cells in APAP", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-12-25", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd.", "conditions": ["Autoimmune Pulmonary Alveolar Proteinosis"], "cn_sites": [{"facility": "JiuzhitangMakerBeijingCellTech", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 3, "g_fetched": 5, "g_countries": [["Germany", 2], ["United States", 2], ["Turkey (Türkiye)", 1], ["United Kingdom", 1]], "g_trials": [{"nct": "NCT06431776", "title": "Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP).", "status": "RECRUITING", "start": "2025-10-22", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Savara Inc.", "countries": ["Germany"]}, {"nct": "NCT06989333", "title": "Local Spraying of GM-CSF Via Bronchoscopy in the Treatment of Autoimmune Pulmonary Alveolar Proteinosis", "status": "NOT_YET_RECRUITING", "start": "2025-07-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Jiuwu Bai", "countries": []}, {"nct": "NCT05761899", "title": "Safety and Efficacy of PMT Therapy of hPAP", "status": "RECRUITING", "start": "2023-06-26", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Children's Hospital Medical Center, Cincinnati", "countries": ["United States"]}, {"nct": "NCT02852928", "title": "European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank", "status": "RECRUITING", "start": "2013-12", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Matthias Griese", "countries": ["Germany", "Turkey (Türkiye)", "United Kingdom"]}, {"nct": "NCT06546098", "title": "Molgramostim Nebulizer Solution Expanded Access Program Protocol", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "Savara Inc.", "countries": ["United States"]}]}, {"batch": 1, "no": 101, "name_zh": "肺囊性纤维化", "query_terms": [{"term": "Cystic fibrosis", "broad": false}, {"term": "Pulmonary Cystic Fibrosis", "broad": false}], "n_total": 25, "n_open": 8, "n_open_precise": 8, "n_broad": 0, "trials": [{"nct": "NCT05289245", "title": "A National Registry on Chinese Patients With Cystic Fibrosis", "status": "RECRUITING", "start": "2022-04-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Pulmonary Function"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06528418", "title": "Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath", "status": "RECRUITING", "start": "2024-06-30", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 10000, "sponsor": "ChromX Health", "conditions": ["Lung Cancer", "Lung Infection", "COPD", "Bronchitis", "Pulmonary Fibrosis", "Pulmonary Embolism", "Pulmonary Arterial Hypertension", "Pulmonary Tuberculosis", "Pulmonary Abscess", "Emphysema", "Lung Injury", "Cystic Fibrosis of the Lung", "Bronchial Asthma", "Bronchiectasis", "Interstitial Lung Disease", "Preserved Ratio Impaired Spirometry"], "cn_sites": [{"facility": "The First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06660992", "title": "A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis", "status": "RECRUITING", "start": "2024-09-30", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 669, "sponsor": "Haisco Pharmaceutical Group Co., Ltd.", "conditions": ["Non-cystic Fibrosis Bronchiectasis"], "cn_sites": [{"facility": "The First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Yixing People's Hospital", "city": "Yixingcun", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06715956", "title": "Observational Study of Sputum Inflammation Phenotypes and Clinical Outcomes in Non-Cystic Fibrosis Bronchiectasis", "status": "NOT_YET_RECRUITING", "start": "2024-12-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 400, "sponsor": "Guangzhou Institute of Respiratory Disease", "conditions": ["Non-cystic Fibrosis Bronchiectasis (NCFBE)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06775340", "title": "Study of RSS0343 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis", "status": "RECRUITING", "start": "2025-01-22", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 252, "sponsor": "Jiangsu HengRui Medicine Co., Ltd.", "conditions": ["Adolescent Asthma"], "cn_sites": [{"facility": "First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06981091", "title": "A Multicenter, Randomized, Double-blind, Placebo-controlled Parallel-group Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of XH-S004 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis", "status": "NOT_YET_RECRUITING", "start": "2025-05-16", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 231, "sponsor": "S-INFINITY Pharmaceuticals Co., Ltd", "conditions": ["Non-Cystic Fibrosis Bronchiectasis"], "cn_sites": [{"facility": "Huadong Hospital Affiliated to fudan univercity", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07616375", "title": "A Study to Assess the Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis", "status": "RECRUITING", "start": "2025-09-28", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 669, "sponsor": "Haisco Pharmaceutical Group Co., Ltd.", "conditions": ["Non-cystic Fibrosis Bronchiectasis"], "cn_sites": [{"facility": "Yixing People's Hospital, Yixing, Jiangxi Recruiting", "city": "Yixingcun", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07696091", "title": "Study on Drug Interactions Affecting the Pharmacokinetics of RSS0343 Tablet", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Reistone Biopharma Company Limited", "conditions": ["Non-cystic Fibrosis Bronchiectasis、Chronic Sinusitis Without Nasal Polyps、Chronic Obstructive Pulmonary Disease"], "cn_sites": [{"facility": "The First Affiliated Hospital of Guangzhou University of Chinese Medicine", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01116869", "title": "China CellSearch Study", "status": "COMPLETED", "start": "2010-03-25", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Johnson & Johnson Medical, China", "conditions": ["Metastatic Breast Cancer", "Benign Breast Disease"], "cn_sites": [{"facility": "307 Hosptial of PLA", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02782312", "title": "Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis Bronchiectasis", "status": "COMPLETED", "start": "2011-06", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Shanghai Pulmonary Hospital, Shanghai, China", "conditions": ["Bronchiectasis"], "cn_sites": [{"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01684683", "title": "The Effect of Theophylline in the Treatment of Bronchiectasis", "status": "COMPLETED", "start": "2012-11", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "The First Affiliated Hospital of Guangzhou Medical University", "conditions": ["Bronchiectasis"], "cn_sites": [{"facility": "State Key Laboratory of Respiratory Research Institute.", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01801657", "title": "The Role of Viral Infection in Acute Exacerbations of Non-cystic Fibrosis Bronchiectasis in Adults", "status": "UNKNOWN", "start": "2013-02", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "The First Affiliated Hospital of Guangzhou Medical University", "conditions": ["Bronchiectasis"], "cn_sites": [{"facility": "The First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02081963", "title": "Combined Administration of Nebulized Amikacin in Patients With Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis", "status": "COMPLETED", "start": "2014-03", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 178, "sponsor": "Qilu Hospital of Shandong University", "conditions": ["Non-Cystic Fibrosis Bronchiectasis"], "cn_sites": [{"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02088216", "title": "Effect of Long-term, High-dose N-acetylcysteine on Exacerbations of Bronchiectaisis", "status": "COMPLETED", "start": "2014-04-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 161, "sponsor": "Qilu Hospital of Shandong University", "conditions": ["Non-Cystic Fibrosis Bronchiectasis"], "cn_sites": [{"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02106832", "title": "Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)", "status": "COMPLETED", "start": "2014-04-30", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 521, "sponsor": "Bayer", "conditions": ["Bronchiectasis"], "cn_sites": [{"facility": "", "city": "Fuzhou", "status": ""}, {"facility": "", "city": "Guangzhou", "status": ""}, {"facility": "", "city": "Hohehot", "status": ""}, {"facility": "", "city": "Suzhou", "status": ""}, {"facility": "", "city": "Wuxi", "status": ""}, {"facility": "", "city": "Nanchang", "status": ""}, {"facility": "", "city": "Shenyang", "status": ""}, {"facility": "", "city": "Yinchuan", "status": ""}, {"facility": "", "city": "Chengdu", "status": ""}, {"facility": "", "city": "Beijing", "status": ""}, {"facility": "", "city": "Chongqing", "status": ""}, {"facility": "", "city": "Shanghai", "status": ""}], "cn_site_count": 12, "broad_only": false}, {"nct": "NCT02507843", "title": "Vitamin D as an Adjunctive Treatment in Patients With Non-Cystic Fibrosis Bronchiectasis", "status": "UNKNOWN", "start": "2015-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 200, "sponsor": "Shanghai Pulmonary Hospital, Shanghai, China", "conditions": ["Bronchiectasis"], "cn_sites": [{"facility": "Shanghai Pulmonary Hospital , Tongji University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02929420", "title": "A Clinical Study on the Efficacy and Safety of the Treatment of Hyperplasia of Mammary Glands With Xiaoru Sanjie Capsule", "status": "UNKNOWN", "start": "2016-10", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 600, "sponsor": "First Affiliated Hospital Xi'an Jiaotong University", "conditions": ["Fibrocystic Disease of Breast"], "cn_sites": [{"facility": "Yu Ren", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03843541", "title": "A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretions", "status": "COMPLETED", "start": "2019-06-25", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 333, "sponsor": "Zambon SpA", "conditions": ["Respiratory Tract Diseases", "Abnormal Mucus Secretions"], "cn_sites": [{"facility": "Wuxi Peoples' Hospital affiliated to Nanjing Medical University", "city": "Wuxi", "status": ""}, {"facility": "Inner Mongolia Baogang Hospital", "city": "Baotou", "status": ""}, {"facility": "Beijing Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Tongren Hospital", "city": "Beijing", "status": ""}, {"facility": "China-Japan Friendship Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University Shougang Hospital", "city": "Beijing", "status": ""}, {"facility": "Jilin Province People's Hospital", "city": "Changchun", "status": ""}, {"facility": "The First Bethune Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Chengdu Fifth People's Hospital", "city": "Chengdu", "status": ""}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "The First Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "Deyang People's Hospital", "city": "Deyang", "status": ""}, {"facility": "Inner Mongolia People's Hospital", "city": "Hohhot", "status": ""}, {"facility": "Jinhua city central hospital/Jinhua hospital ,School of Medicine,Zhejiang UNIVERSITY", "city": "Jinhua", "status": ""}, {"facility": "Nanchang University-The Second Affiliated Hospital", "city": "Nanchang", "status": ""}, {"facility": "Nanjing First Hospital", "city": "Nanjing", "status": ""}, {"facility": "Zhongda Hospital, Southeast University - Pulmonology", "city": "Nanjing", "status": ""}, {"facility": "Jiangxi Pingxiang People's Hospital", "city": "Pingxiang", "status": ""}, {"facility": "Qingdao Municipal Hospital", "city": "Qingdao", "status": ""}, {"facility": "Minhang District Central Hospital", "city": "Shanghai", "status": ""}, {"facility": "Ruijin Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Shanghai General Hospital", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": ""}, {"facility": "Suining Central Hospital", "city": "Suining", "status": ""}, {"facility": "First Hospital of Shanxi Medical University", "city": "Taiyuan", "status": ""}, {"facility": "The First Hospital of Shanxi Medical University", "city": "Taiyuan", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical College of Huazhong University Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Yangzhou First People's Hospital", "city": "Yangzhou", "status": ""}, {"facility": "General Hospital of Ningxia Medical University", "city": "Yinchuan", "status": ""}, {"facility": "Affiliated Hospital of Guangdong Medical University - Respiration", "city": "Zhanjiang", "status": ""}, {"facility": "The First People's Hospital of Zigong", "city": "Zigong", "status": ""}], "cn_site_count": 31, "broad_only": false}, {"nct": "NCT05006573", "title": "Efficacy and Safety of Benralizumab in Patients With Non-cystic Fibrosis Bronchiectasis", "status": "TERMINATED", "start": "2021-07-21", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "AstraZeneca", "conditions": ["Non-cystic Fibrosis Bronchiectasis"], "cn_sites": [{"facility": "Research Site", "city": "Guangzhou", "status": ""}, {"facility": "Research Site", "city": "Shanghai", "status": ""}, {"facility": "Research Site", "city": "Zhengzhou", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT05604495", "title": "Screening for Cystic Fibrosis and Cystic Fibrosis Related Disorders in Chinese Adults With Bronchiectasis", "status": "UNKNOWN", "start": "2022-09-07", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "Shanghai Pulmonary Hospital, Shanghai, China", "conditions": ["Cystic Fibrosis, Pulmonary"], "cn_sites": [{"facility": "Shanghai pulmonary hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05601778", "title": "A Study of HSK31858 in Participants with Non-Cystic Fibrosis Bronchiectasis", "status": "COMPLETED", "start": "2022-12-06", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 226, "sponsor": "Haisco Pharmaceutical Group Co., Ltd.", "conditions": ["Non-cystic Fibrosis Bronchiectasis (NCFBE)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06106789", "title": "A Study of the Clinical Benefit of Tobramycin Inhalation Solution", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-04-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1600, "sponsor": "Qianfoshan Hospital", "conditions": ["Bronchiectasis", "Cystic Fibrosis", "Lung Infection"], "cn_sites": [{"facility": "Rui Yang,MD", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06280391", "title": "A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis", "status": "COMPLETED", "start": "2024-02-20", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 312, "sponsor": "Sanofi", "conditions": ["Bronchiectasis"], "cn_sites": [{"facility": "Investigational Site Number : 1560005", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560008", "city": "Changchun", "status": ""}, {"facility": "Investigational Site Number : 1560004", "city": "Chengdu", "status": ""}, {"facility": "Investigational Site Number : 1560001", "city": "Guangzhou", "status": ""}, {"facility": "Investigational Site Number : 1560006", "city": "Shanghai", "status": ""}, {"facility": "Investigational Site Number : 1560002", "city": "Shanghai", "status": ""}, {"facility": "Investigational Site Number : 1560007", "city": "Shenyang", "status": ""}, {"facility": "Investigational Site Number : 1560003", "city": "Xuzhou", "status": ""}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT07245407", "title": "A Translational Study for Phenotyping and Endotyping Chinese Patients With NCFBE", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-10-27", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 251, "sponsor": "AstraZeneca", "conditions": ["Non-cystic Fibrosis Bronchiectasis"], "cn_sites": [{"facility": "Beijing Chaoyang Hospital Affiliated to Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Beijing Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}, {"facility": "The Second Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "The Second Affiliated Hospital of Fujian Medical University", "city": "Quanzhou", "status": ""}, {"facility": "Gansu Provincial Hospital", "city": "Lanzhou", "status": ""}, {"facility": "Shenzhen People's Hospital", "city": "Shenzhen", "status": ""}, {"facility": "Affiliated Hospital of Guangdong Medical University\"", "city": "Zhanjiang", "status": ""}, {"facility": "The First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": ""}, {"facility": "Guizhou Provincial People's Hospital", "city": "Guiyang", "status": ""}, {"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Zhengzhou People's Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Shiyan Taihe Hospital", "city": "Shiya", "status": ""}, {"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "The Affiliated Hospital of Xuzhou Medical University", "city": "Xuzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": ""}, {"facility": "The Second Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Weifang People's Hospital", "city": "Weifang", "status": ""}, {"facility": "Huadong Hospital Affiliated to Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Ruijin Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Fifth People's Hospital", "city": "Shanghai", "status": ""}, {"facility": "Shanghai General Hospital", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Tongji Hospital", "city": "Shanghai", "status": ""}, {"facility": "Zhongshan Hospital Affiliated to FuDan University\"", "city": "Shanghai", "status": ""}, {"facility": "Chengdu Fifth People's Hospital", "city": "Chengdu", "status": ""}, {"facility": "Sichuan Academy of Medical Sciences · Sichuan Provincial People's Hospital", "city": "Chengdu", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Anning First People's Hospital", "city": "Anning", "status": ""}, {"facility": "The First Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}, {"facility": "The Second Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Jiaxing Second Hospital", "city": "Jiaxing", "status": ""}, {"facility": "Ningbo Fenghua District People's Hospital", "city": "Ningbo", "status": ""}, {"facility": "The First Affiliated Hospital of Ningbo University", "city": "Ningbo", "status": ""}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": ""}, {"facility": "Huzhou Central Hospital", "city": "Huzhou", "status": ""}, {"facility": "Jiaxing First Hospital", "city": "Jiaxing", "status": ""}, {"facility": "The First Affiliated Hospital of Xinxiang Medical University", "city": "Xinxiang", "status": ""}], "cn_site_count": 38, "broad_only": false}, {"nct": "NCT07289464", "title": "A Clinical Study of RSS0343 in Healthy Subjects", "status": "COMPLETED", "start": "2026-01-08", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 48, "sponsor": "Reistone Biopharma Company Limited", "conditions": ["Non-cystic Fibrosis Bronchiectasis"], "cn_sites": [{"facility": "Zhongnan Hospital of Wuhan University", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 182, "g_fetched": 174, "g_countries": [["United States", 83], ["France", 22], ["United Kingdom", 14], ["Canada", 10], ["Germany", 8], ["Egypt", 7], ["Spain", 5], ["Italy", 5], ["Pakistan", 4], ["Greece", 2], ["Poland", 2], ["Turkey (Türkiye)", 2], ["Australia", 2], ["Belgium", 2], ["Sweden", 2], ["Switzerland", 2], ["Bulgaria", 1], ["Hungary", 1], ["Japan", 1], ["Portugal", 1], ["Reunion", 1], ["Norway", 1], ["Denmark", 1], ["New Zealand", 1], ["Hong Kong", 1], ["Czechia", 1], ["Jordan", 1]], "g_trials": [{"nct": "NCT07485010", "title": "Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial", "status": "NOT_YET_RECRUITING", "start": "2027-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "The University of Queensland", "countries": []}, {"nct": "NCT04940533", "title": "Pharmacokinetics of CFTR Modulators in Pregnant Individuals and in Postpartum Breastfeeding Mothers", "status": "NOT_YET_RECRUITING", "start": "2027-01-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Minnesota", "countries": ["United States"]}, {"nct": "NCT07083557", "title": "Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)", "status": "RECRUITING", "start": "2027-01-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Bettina Mittendorfer", "countries": ["United States"]}, {"nct": "NCT07696338", "title": "Rethinking Early Airway Clearence Therapies", "status": "NOT_YET_RECRUITING", "start": "2026-09-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Nicole Hamblett", "countries": ["Canada", "United States"]}, {"nct": "NCT07813039", "title": "A Phase 1 Relative Bioavailability Study of a VX-581 Tablet Formulation", "status": "NOT_YET_RECRUITING", "start": "2026-09-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Vertex Pharmaceuticals Incorporated", "countries": []}, {"nct": "NCT07223255", "title": "Gastrointestinal Response of Pediatric Cystic Fibrosis Patients on Mediterranean Diet", "status": "RECRUITING", "start": "2026-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Dartmouth-Hitchcock Medical Center", "countries": ["United States"]}, {"nct": "NCT07692594", "title": "Heart and Blood Vessels Health in People With Cystic Fibrosis", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Liverpool Heart and Chest Hospital NHS Foundation Trust", "countries": ["United Kingdom"]}, {"nct": "NCT07665203", "title": "Home Air Pollution in Children With Cystic Fibrosis Study", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Seattle Children's Hospital", "countries": []}, {"nct": "NCT07780344", "title": "MRI Parameters as Biomarkers in Cystic Fibrosis (FEMPTO)", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Nottingham", "countries": ["United Kingdom"]}, {"nct": "NCT07809867", "title": "Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Istituto Giannina Gaslini", "countries": []}, {"nct": "NCT07720375", "title": "A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Adult Study Participants With Non-Cystic Fibrosis Bronchiectasis", "status": "RECRUITING", "start": "2026-08-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "UCB Biopharma SRL", "countries": ["United States"]}, {"nct": "NCT07688070", "title": "Verapamil Effect in Cystic Fibrosis-related Dysglycemia", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Rhode Island Hospital", "countries": ["United States"]}, {"nct": "NCT07275905", "title": "Bacteriophages for Adults With Cystic Fibrosis and Chronic Achromobacter Lung Infection", "status": "RECRUITING", "start": "2026-08-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Ghady Haidar", "countries": ["United States"]}, {"nct": "NCT07414810", "title": "Novel Point-of-care Sweat Chloride Testing Device for Monitoring CFTR Function", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Emory University", "countries": ["United States"]}, {"nct": "NCT07709494", "title": "A Phase 1a/1b Study to Investigate the Safety, Tolerability, Microbiological Response, and Pharmacokinetics of Inhaled Rev-56 in Adult Healthy Volunteers and Adult Non-cystic Fibrosis Bronchiectasis (NCFB) Patients With Chronic P. Aeruginosa", "status": "RECRUITING", "start": "2026-07-13", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Revagenix, Inc.", "countries": ["United States"]}, {"nct": "NCT07722364", "title": "HFCWO in Children With Non-CF Bronchiectasis", "status": "NOT_YET_RECRUITING", "start": "2026-07-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Sphinx university", "countries": ["Egypt"]}, {"nct": "NCT07422870", "title": "GRAnulomatous MAstitis REGistry Study", "status": "RECRUITING", "start": "2026-07-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "European Breast Cancer Research Association of Surgical Trialists", "countries": ["Germany"]}, {"nct": "NCT07729787", "title": "Autogenic Drainage Versus Mechanical Percussion in Children With Cystic Fibrosis", "status": "RECRUITING", "start": "2026-06-14", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Riphah International University", "countries": ["Pakistan"]}, {"nct": "NCT07628530", "title": "Reference Equations and Normative Data for Isometric Quadriceps and Handgrip Muscles STrength in Southern European Populations - RESTart: a Multicentre Study", "status": "NOT_YET_RECRUITING", "start": "2026-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Alcala", "countries": ["Spain"]}, {"nct": "NCT07163078", "title": "Nutrition Supplement for Cystic Fibrosis", "status": "NOT_YET_RECRUITING", "start": "2026-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Ohio State University", "countries": ["United States"]}, {"nct": "NCT07608328", "title": "Azithromycin to Modify Bronchiectasis Exacerbation Risk", "status": "NOT_YET_RECRUITING", "start": "2026-05-21", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Assiut University", "countries": ["Egypt"]}, {"nct": "NCT07376187", "title": "Digital Physiotherapy for Pediatric Chronic Suppurative Lung Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-05-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Thessaly", "countries": ["Greece"]}, {"nct": "NCT07450547", "title": "Phase 2 Study to Assess the Safety and Efficacy of ANG003", "status": "RECRUITING", "start": "2026-04-24", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Anagram Therapeutics, Inc.", "countries": ["United States"]}, {"nct": "NCT07500493", "title": "Tele-Rehabilitation in Adults With Cystic Fibrosis", "status": "NOT_YET_RECRUITING", "start": "2026-04-17", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "King Saud University", "countries": []}, {"nct": "NCT07454681", "title": "MRI Assessment of Lung Airways in Cystic Fibrosis: Evaluate MRI's Ability to Detect Changes in Airway Structure .", "status": "NOT_YET_RECRUITING", "start": "2026-04-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "The Hospital for Sick Children", "countries": ["Canada"]}]}, {"batch": 1, "no": 102, "name_zh": "视网膜色素变性", "query_terms": [{"term": "Retinitis pigmentosa", "broad": false}], "n_total": 17, "n_open": 8, "n_open_precise": 8, "n_broad": 0, "trials": [{"nct": "NCT05874310", "title": "Gene Therapy for Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa", "status": "RECRUITING", "start": "2023-02-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Frontera Therapeutics", "conditions": ["X-Linked Retinitis Pigmentosa"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Eye & ENT hospital of Fudan university", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05853107", "title": "Pilot Study of AuTNA I", "status": "RECRUITING", "start": "2023-05-12", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 7, "sponsor": "Eye & ENT Hospital of Fudan University", "conditions": ["Retinitis Pigmentosa"], "cn_sites": [{"facility": "Chunhui Jiang", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06292650", "title": "Safety and Efficacy Study of Novel Gene Therapy ZM-02 for Retinitis Pigmentosa Patients", "status": "RECRUITING", "start": "2024-02-25", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Zhongmou Therapeutics", "conditions": ["Retinitis Pigmentosa"], "cn_sites": [{"facility": "Beijing Tongren Hospital of Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06936787", "title": "An Open-label, Dose-ascending Study of IGT001 for Retinitis Pigmentosa", "status": "RECRUITING", "start": "2025-04-20", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 21, "sponsor": "Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": ["Retinitis Pigmentosa"], "cn_sites": [{"facility": "Shanghai General Hospital, Shanghai Jiao Tong University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07082855", "title": "A Multicenter, Randomized, Double-Blind, Controlled Clinical Study of Minocycline for the Treatment of Retinitis Pigmentosa", "status": "NOT_YET_RECRUITING", "start": "2025-07-15", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 126, "sponsor": "Zhongshan Ophthalmic Center, Sun Yat-sen University", "conditions": ["Retinitis Pigmentosa", "Inherited Retinal Dystrophy", "Retina Disorder"], "cn_sites": [{"facility": "Zhongshan Ophthalmic Center, Sun Yat-sen University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06952842", "title": "Safety and Efficacy of ZVS203e in the Treatment of Retinitis Pigmentosa Caused by RHO Gene Mutation", "status": "RECRUITING", "start": "2025-08-04", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Chigenovo Co., Ltd", "conditions": ["Retinitis Pigmentosa"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07126470", "title": "Impact of Capsular Tension Ring on Intraocular Lens Position in Retinitis Pigmentosa Cataract Patients", "status": "RECRUITING", "start": "2025-08-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 88, "sponsor": "Zhongshan Ophthalmic Center, Sun Yat-sen University", "conditions": ["Cataract", "Retinitis Pigmentosa (RP)"], "cn_sites": [{"facility": "Zhongshan Ophthalmic Center, Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Shenzhen Eye Hospital", "city": "Shenzhen", "status": "NOT_YET_RECRUITING"}, {"facility": "Wuhan Aier Eye Hospital", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07311863", "title": "UGX202 Injection in Patients With Advanced Retinitis Pigmentosa", "status": "NOT_YET_RECRUITING", "start": "2026-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Suzhou UgeneX Therapeutics Co., Ltd.", "conditions": ["Retinitis Pigmentosa (RP)"], "cn_sites": [{"facility": "Eye & ENT Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00231010", "title": "Molecular Genetics of Retinal Degenerations", "status": "COMPLETED", "start": "2005-09-26", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 3549, "sponsor": "National Eye Institute (NEI)", "conditions": ["Retinal Degeneration", "Retinitis Pigmentosa"], "cn_sites": [{"facility": "Sun Yat-Sen University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02465749", "title": "Clinical Trials of Continuous Oxygen Therapy Combined With Blue Light Deprivation in the Treatment of Retinitis Pigmentosa", "status": "UNKNOWN", "start": "2015-05", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 404, "sponsor": "Sun Yat-sen University", "conditions": ["Retinitis Pigmentosa"], "cn_sites": [{"facility": "State Key Laboratory of Ophthalmology,Zhongshan Ophthalmic Center, Sun Yat-sen University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03566147", "title": "Treatment of RP and LCA by Primary RPE Transplantation", "status": "UNKNOWN", "start": "2018-08-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Eyecure Therapeutics Inc.", "conditions": ["Leber Congenital Amaurosis, Retinitis Pigmentosa"], "cn_sites": [{"facility": "Beijing Tongren Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04068207", "title": "Minocycline Treatment in Retinitis Pigmentosa", "status": "COMPLETED", "start": "2019-08-25", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 35, "sponsor": "Sun Yat-sen University", "conditions": ["Retinitis Pigmentosa", "Inherited Retinal Dystrophy", "Retina Disorder"], "cn_sites": [{"facility": "Zhongshan Ophthalmic Center, Sun Yat-sen University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04723160", "title": "Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph", "status": "COMPLETED", "start": "2020-08-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 748, "sponsor": "Visionary Intelligence Ltd.", "conditions": ["Diabetic Retinopathy", "Retinal Vein Occlusion", "Retinal Artery Occlusion", "Central Serous Chorioretinopathy", "Pathologic Myopia", "Retinitis Pigmentosa", "Epiretinal Membrane", "Macular Holes", "Nonexudative Age-related Macular Degeneration", "Exudative Age Related Macular Degeneration", "Suspect Glaucoma", "Optic Atrophy", "Retinal Detachment"], "cn_sites": [{"facility": "Peking Union Medical College Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "The Second Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Tianjin Medical University Eye Hospital", "city": "Tianjin", "status": ""}, {"facility": "Eye Hospital, WMU Zhejiang Eye Hospital", "city": "Wenzhou", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT03944239", "title": "Safety and Efficacy of Subretinal Transplantation of Clinical Human Embryonic Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Retinitis Pigmentosa", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-05-19", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 25, "sponsor": "Qi Zhou", "conditions": ["Retinitis Pigmentosa"], "cn_sites": [{"facility": "Beijing Tongren Hospitol,Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05805007", "title": "Safety and Tolerability Study of Gene Editing Drug ZVS203e in Participants With Retinitis Pigmentosa", "status": "UNKNOWN", "start": "2023-09-12", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Peking University Third Hospital", "conditions": ["Retinitis Pigmentosa"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06076720", "title": "Evaluation of New Head-mounted Visual Aids Among Patients With Low Vision", "status": "UNKNOWN", "start": "2023-10-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Zhongshan Ophthalmic Center, Sun Yat-sen University", "conditions": ["Glaucoma", "Age-related Macular Degeneration", "Retinitis Pigmentosa", "Diabetic Retinopathy"], "cn_sites": [{"facility": "Zhongshan Ophthalmic Center, Sun Yat-sen University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06492850", "title": "Gene Therapy for RPGR Gene Mutation-associated X-linked Retinitis Pigmentosa", "status": "UNKNOWN", "start": "2024-04-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 32, "sponsor": "Frontera Therapeutics", "conditions": ["X-Linked Retinitis Pigmentosa (XLRP)"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}], "g_total": 69, "g_fetched": 61, "g_countries": [["United States", 23], ["France", 8], ["Australia", 6], ["Germany", 6], ["Israel", 4], ["Italy", 4], ["Canada", 3], ["Indonesia", 2], ["Belgium", 2], ["United Kingdom", 2], ["Netherlands", 2], ["Austria", 2], ["Russia", 1], ["Ireland", 1], ["Egypt", 1], ["Thailand", 1], ["Brazil", 1], ["Finland", 1], ["Mexico", 1], ["Norway", 1], ["Switzerland", 1], ["Antigua and Barbuda", 1], ["Argentina", 1], ["United Arab Emirates", 1]], "g_trials": [{"nct": "NCT05914233", "title": "Non-invasive Ultrasound Retinal Stimulation for Vision Restoration", "status": "NOT_YET_RECRUITING", "start": "2027-01-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Southern California", "countries": []}, {"nct": "NCT07290530", "title": "24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome", "status": "NOT_YET_RECRUITING", "start": "2026-12", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Nacuity Pharmaceuticals, Inc.", "countries": []}, {"nct": "NCT07796646", "title": "Study to Evaluate the Long-Term Safety of Ultevursen in Participants With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene", "status": "NOT_YET_RECRUITING", "start": "2026-10-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Laboratoires Thea", "countries": []}, {"nct": "NCT07774975", "title": "Safety Evaluation Study of Pitavastatin PLGA Nano-particle for Retinitis Pigmentosa", "status": "NOT_YET_RECRUITING", "start": "2026-09-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Kyushu University", "countries": []}, {"nct": "NCT07710196", "title": "A 24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Nacuity Pharmaceuticals, Inc.", "countries": []}, {"nct": "NCT07341763", "title": "Brain Stimulation Effects on Orientation and Mobility Skills in Adults With Vision Impairment", "status": "RECRUITING", "start": "2026-07-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Waterloo", "countries": ["Canada"]}, {"nct": "NCT07282457", "title": "Prospective, Randomized, Sham-controlled, Dose-finding I/II Trial of Safety and Efficacy of Modified Optogenetic Gene Therapy (ZM-02 Injection)", "status": "NOT_YET_RECRUITING", "start": "2026-06-25", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Zhongmou Therapeutics", "countries": []}, {"nct": "NCT05909488", "title": "Role of UC-MSC and CM to Inhibit Vision Loss in Retinitis Pigmentosa Phase I/II", "status": "NOT_YET_RECRUITING", "start": "2026-05", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "PT. Prodia Stem Cell Indonesia", "countries": ["Indonesia"]}, {"nct": "NCT05786287", "title": "Long-term Safety of UC-MSC Transplantation in Patients With Retinitis Pigmentosa", "status": "NOT_YET_RECRUITING", "start": "2026-05", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "PT. Prodia Stem Cell Indonesia", "countries": ["Indonesia"]}, {"nct": "NCT07266584", "title": "Restoration of Central Vision With PRIMA in Patients With Photoreceptor Degeneration", "status": "RECRUITING", "start": "2026-04-22", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Science Corporation", "countries": ["Australia"]}, {"nct": "NCT07548944", "title": "Observational Study to Investigate the Short-term Effects of Transcorneal Electrical Stimulation on Visual Performance", "status": "RECRUITING", "start": "2026-04-20", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Okuvision GmbH", "countries": ["Germany"]}, {"nct": "NCT06891885", "title": "A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older With Retinitis Pigmentosa", "status": "RECRUITING", "start": "2026-04-16", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Sumitomo Pharma America, Inc.", "countries": ["United States"]}, {"nct": "NCT07408232", "title": "A Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP)", "status": "RECRUITING", "start": "2026-03-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Octant, Inc.", "countries": ["United States"]}, {"nct": "NCT02018692", "title": "The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions in Adolescent Patients With Retinitis Pigmentosa", "status": "NOT_YET_RECRUITING", "start": "2026-03-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Sheba Medical Center", "countries": ["Israel"]}, {"nct": "NCT07502664", "title": "Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD)", "status": "RECRUITING", "start": "2026-02-19", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Ray Therapeutics, Inc.", "countries": ["United States"]}, {"nct": "NCT07265895", "title": "Inherited Retinal Diseases: Natural History and Genotype-Phenotype Correlations", "status": "NOT_YET_RECRUITING", "start": "2026-01-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS San Raffaele", "countries": ["Italy"]}, {"nct": "NCT07298174", "title": "Wide Field OCTA in Ocular Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS San Raffaele", "countries": []}, {"nct": "NCT07292987", "title": "Implementation and Evaluation of a Post-Diagnostic Announcement Protocol at the CRMR RefeRet, Quinze-Vingts Hospital", "status": "RECRUITING", "start": "2025-12-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts", "countries": ["France"]}, {"nct": "NCT07228793", "title": "Natural History Study of Patients With EYS-Associated RP", "status": "RECRUITING", "start": "2025-11-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sensor Technology for Deafblind", "countries": ["Russia"]}, {"nct": "NCT07278843", "title": "Natural History of Photoreceptor Degeneration in USH1B: Clinical Parameters and Validation of Functional Vision Tests in MYO7A", "status": "RECRUITING", "start": "2025-10-13", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts", "countries": ["France"]}, {"nct": "NCT07807111", "title": "Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Gene Therapy (SPVN20) in Subjects With Rod-Cone Dystrophy", "status": "RECRUITING", "start": "2025-10-08", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "SparingVision", "countries": ["Belgium", "France", "Ireland"]}, {"nct": "NCT06628947", "title": "A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa", "status": "RECRUITING", "start": "2025-08-29", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Kiora Pharmaceuticals, Inc.", "countries": ["Australia"]}, {"nct": "NCT06319872", "title": "The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration", "status": "RECRUITING", "start": "2025-05-19", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "University of Rochester", "countries": ["United States"]}, {"nct": "NCT06982417", "title": "InsightRP2 Registry", "status": "RECRUITING", "start": "2025-05-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Göttingen", "countries": ["Germany"]}, {"nct": "NCT06846151", "title": "Retinal Investigation Using Optos OCT Device", "status": "NOT_YET_RECRUITING", "start": "2025-05", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Optos, PLC", "countries": []}]}, {"batch": 1, "no": 103, "name_zh": "视网膜母细胞瘤", "query_terms": [{"term": "Retinoblastoma", "broad": false}], "n_total": 14, "n_open": 6, "n_open_precise": 6, "n_broad": 0, "trials": [{"nct": "NCT05080010", "title": "Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma", "status": "RECRUITING", "start": "2020-11-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 500, "sponsor": "Sun Yat-sen University", "conditions": ["Retinoblastoma"], "cn_sites": [{"facility": "Zhongshan Ophthalmic Center, Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06369181", "title": "Neuroendocrine Transformation in RB1/TP53 Inactivated NSCLC", "status": "RECRUITING", "start": "2021-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 50, "sponsor": "Fudan University", "conditions": ["Neuroendocrine Carcinoma", "Non-small Cell Lung Cancer", "Histology Transformation"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04799002", "title": "Topotecan and Melphalan for Retinoblastoma", "status": "RECRUITING", "start": "2021-03-11", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Sun Yat-sen University", "conditions": ["Retinoblastoma", "Chemotherapy Effect"], "cn_sites": [{"facility": "Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04903678", "title": "Intrathecal Chemotherapy for Central Nervous System Metastasis in Retinoblastoma", "status": "RECRUITING", "start": "2021-05-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Eye & ENT Hospital of Fudan University", "conditions": ["Retinoblastoma, Extraocular"], "cn_sites": [{"facility": "Fudan Eye & ENT Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06424301", "title": "Targeting NUDT21 siRNA Drugs for Patients With Refractory Retinoblastoma", "status": "RECRUITING", "start": "2024-12-20", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 2, "sponsor": "Eye & ENT Hospital of Fudan University", "conditions": ["Retinoblastoma", "Refractory"], "cn_sites": [{"facility": "Fudan Eye & ENT Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06972602", "title": "High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed", "status": "RECRUITING", "start": "2025-04-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Eye & ENT Hospital of Fudan University", "conditions": ["Retinoblastoma", "Retinoblastoma, Recurrent"], "cn_sites": [{"facility": "Fudan Eye & ENT Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02137928", "title": "Carboplatin Periocular Injection for Retinoblastoma", "status": "UNKNOWN", "start": "2006-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Sun Yat-sen University", "conditions": ["Retinoblastoma"], "cn_sites": [{"facility": "Zhongshan Ophthalmic Center, Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04429139", "title": "Photodynamic Therapy With Visudyne for Human Retinoblastoma: A Preliminary Study", "status": "COMPLETED", "start": "2011-02-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 8, "sponsor": "Sun Yat-sen University", "conditions": ["Retinoblastoma"], "cn_sites": [{"facility": "Kunbei Lai", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03764930", "title": "Attention to Retinoblastoma Diagnosed in the Trauma Setting", "status": "COMPLETED", "start": "2013-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 10, "sponsor": "Sun Yat-sen University", "conditions": ["Retinoblastoma", "Wounds and Injury"], "cn_sites": [{"facility": "Zhongshan Ophthalmic Center, Sun Yat-sen University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01899066", "title": "Efficacy Study of Lucentis in the Treatment of Retinoblastoma", "status": "UNKNOWN", "start": "2013-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Sun Yat-sen University", "conditions": ["Retinoblastoma"], "cn_sites": [{"facility": "Zhongshan Ophthalmic Center, Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01906814", "title": "Adjuvant Chemotherapy for High-risk Retinoblastoma After Enucleation", "status": "UNKNOWN", "start": "2013-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 179, "sponsor": "Sun Yat-sen University", "conditions": ["Retinoblastoma"], "cn_sites": [{"facility": "Zhongshan Ophthalmic Center, Sun Yat-sen University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02933333", "title": "G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor", "status": "UNKNOWN", "start": "2016-09-27", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 405, "sponsor": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": ["Acute Myeloid Leukemia", "Acute Lymphoid Leukemia", "Lymphoma", "Neuroblastoma", "Hepatoblastoma", "Retinoblastoma"], "cn_sites": [{"facility": "The First Affiliated of Xiamen University", "city": "Xiamen", "status": "RECRUITING"}, {"facility": "Children's Hospital of Soochow University", "city": "Suzhou", "status": "RECRUITING"}, {"facility": "Shandong Province Qianfoshan Hospital", "city": "Jinan", "status": "RECRUITING"}, {"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": "RECRUITING"}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Xinhua Hospital affiliated to Shanghai Jiaotong University school of medicine", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Northwest Women's Hospital", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT05308043", "title": "Deep Learning in Retinoblastoma Detection and Monitoring.", "status": "UNKNOWN", "start": "2020-03-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Beijing Tongren Hospital", "conditions": ["Retinoblastoma"], "cn_sites": [{"facility": "Wen-Bin Wei", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04990271", "title": "A Clinical Study on the Efficacy and Safety of VEC Intravenous Chemotherapy Combined With Conbercept Intravitreal Injection in the Treatment of Retinoblastoma", "status": "UNKNOWN", "start": "2021-07-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 92, "sponsor": "Chengdu Kanghong Biotech Co., Ltd.", "conditions": ["Retinoblastoma"], "cn_sites": [{"facility": "Beijing Children's Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Henan Children's Hospital", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Renmin Hospital of Wuhan University", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Xiangya Hospital Of Central South University", "city": "Changsha", "status": "NOT_YET_RECRUITING"}, {"facility": "Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 5, "broad_only": false}], "g_total": 23, "g_fetched": 17, "g_countries": [["United States", 12], ["Canada", 3], ["France", 2], ["Netherlands", 1], ["Australia", 1], ["Burkina Faso", 1], ["Côte d’Ivoire", 1], ["Democratic Republic of the Congo", 1], ["Madagascar", 1], ["Mali", 1], ["Senegal", 1]], "g_trials": [{"nct": "NCT07633756", "title": "A Phase 1b, Open-Label Study Of REC-617, A Selective CDK7 Inhibitor, In Patients With Metastatic Or Unresectable RB1-Negative Leiomyosarcoma After Prior Systemic Therapy", "status": "RECRUITING", "start": "2026-10-19", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "M.D. Anderson Cancer Center", "countries": ["United States"]}, {"nct": "NCT07530458", "title": "Retinoblastoma Consolidation in Egyptians", "status": "NOT_YET_RECRUITING", "start": "2026-05-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT06498648", "title": "Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma", "status": "RECRUITING", "start": "2026-03-18", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["United States"]}, {"nct": "NCT06725173", "title": "Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.", "status": "RECRUITING", "start": "2026-03-16", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Washington", "countries": ["United States"]}, {"nct": "NCT06679634", "title": "Retinoblastoma Phase II Expanded Access Clinical Trial", "status": "RECRUITING", "start": "2025-02-21", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Targeted Therapy Technologies, LLC", "countries": ["United States"]}, {"nct": "NCT06367530", "title": "Trilateral Retinoblastoma: Incidence and Outcomes", "status": "RECRUITING", "start": "2024-01-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Amsterdam UMC, location VUmc", "countries": ["Netherlands"]}, {"nct": "NCT05504291", "title": "A Study to Give Treatment Inside the Eye to Treat Retinoblastoma", "status": "RECRUITING", "start": "2022-11-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Children's Oncology Group", "countries": ["Australia", "Canada", "United States"]}, {"nct": "NCT04681417", "title": "Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome", "status": "RECRUITING", "start": "2021-03-25", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Institut Curie", "countries": ["France"]}, {"nct": "NCT04425434", "title": "Therapeutic Recommendations For The Treatment Of Children With A Retinoblastoma", "status": "RECRUITING", "start": "2020-11-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "French Africa Pediatric Oncology Group", "countries": ["Burkina Faso", "Côte d’Ivoire", "Democratic Republic of the Congo", "Madagascar", "Mali", "Senegal"]}, {"nct": "NCT04040205", "title": "Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration", "status": "RECRUITING", "start": "2019-10-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Medical College of Wisconsin", "countries": ["United States"]}, {"nct": "NCT03932786", "title": "Studying Health Outcomes After Treatment in Patients With Retinoblastoma", "status": "RECRUITING", "start": "2019-01-24", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Vanderbilt-Ingram Cancer Center", "countries": ["Canada", "United States"]}, {"nct": "NCT03546387", "title": "Determining Whether Multiple Anesthesia Exposures Affect Cognitive Function for Retinoblastoma Patients", "status": "RECRUITING", "start": "2018-05-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Memorial Sloan Kettering Cancer Center", "countries": ["United States"]}, {"nct": "NCT03267459", "title": "Can Pretreatment MRI be Used to Predict Intra-arterial Chemotherapy Response in Retinoblastoma?", "status": "RECRUITING", "start": "2018-01-11", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondation Ophtalmologique Adolphe de Rothschild", "countries": ["France"]}, {"nct": "NCT03050268", "title": "Familial Investigations of Childhood Cancer Predisposition", "status": "RECRUITING", "start": "2017-04-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "St. Jude Children's Research Hospital", "countries": ["United States"]}, {"nct": "NCT04959097", "title": "Retinoblastoma Patient Clinical Database and Tissue Repository", "status": "RECRUITING", "start": "2017-01-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Children's Hospital Los Angeles", "countries": ["Canada", "United States"]}, {"nct": "NCT01109394", "title": "Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies", "status": "RECRUITING", "start": "2010-04-21", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["United States"]}, {"nct": "NCT01050296", "title": "Molecular Analysis Of Solid Tumors", "status": "RECRUITING", "start": "2010-02-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "St. Jude Children's Research Hospital", "countries": ["United States"]}]}, {"batch": 1, "no": 104, "name_zh": "重症先天性粒细胞缺乏症", "query_terms": [{"term": "Severe congenital neutropenia", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 5, "g_fetched": 5, "g_countries": [["United States", 5], ["Argentina", 1], ["Australia", 1], ["Belgium", 1], ["Canada", 1], ["Colombia", 1], ["Czechia", 1], ["France", 1], ["Georgia", 1], ["Germany", 1], ["Greece", 1], ["Hungary", 1], ["India", 1], ["Israel", 1], ["Italy", 1], ["Malaysia", 1], ["Portugal", 1], ["Romania", 1], ["Serbia", 1], ["Spain", 1], ["Switzerland", 1], ["Thailand", 1], ["Turkey (Türkiye)", 1], ["Ukraine", 1], ["United Kingdom", 1]], "g_trials": [{"nct": "NCT07066085", "title": "Serial Blood Count Study", "status": "RECRUITING", "start": "2024-10-17", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "University of Washington", "countries": ["United States"]}, {"nct": "NCT06056297", "title": "A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections", "status": "RECRUITING", "start": "2024-06-06", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "X4 Pharmaceuticals", "countries": ["Argentina", "Australia", "Belgium", "Canada", "Colombia", "Czechia", "France", "Georgia", "Germany", "Greece", "Hungary", "India", "Israel", "Italy", "Malaysia", "Portugal", "Romania", "Serbia", "Spain", "Switzerland", "Thailand", "Turkey (Türkiye)", "Ukraine", "United Kingdom", "United States"]}, {"nct": "NCT06999954", "title": "Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform", "status": "RECRUITING", "start": "2024-02-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Shwachman-Diamond Syndrome Alliance Inc", "countries": ["United States"]}, {"nct": "NCT04099966", "title": "AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion", "status": "RECRUITING", "start": "2021-04-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Mitchell Cairo", "countries": ["United States"]}, {"nct": "NCT02720679", "title": "Investigation of the Genetics of Hematologic Diseases", "status": "RECRUITING", "start": "2016-06-17", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "St. Jude Children's Research Hospital", "countries": ["United States"]}]}, {"batch": 1, "no": 105, "name_zh": "婴儿严重肌阵挛性癫痫(Dravet综合征)", "query_terms": [{"term": "Dravet syndrome", "broad": false}, {"term": "Severe Myoclonic Epilepsy in Infancy (Dravet Syndrome)", "broad": false}], "n_total": 10, "n_open": 3, "n_open_precise": 3, "n_broad": 0, "trials": [{"nct": "NCT06908226", "title": "A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)", "status": "ENROLLING_BY_INVITATION", "start": "2025-02-12", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 324, "sponsor": "Longboard Pharmaceuticals", "conditions": ["Developmental and Epileptic Encephalopathy"], "cn_sites": [{"facility": "Peking University First Hospital (Beida Hospital)", "city": "Beijing", "status": ""}, {"facility": "Capital Medical University-Beijing Children's Hospital", "city": "Beijing", "status": ""}, {"facility": "Guangzhou Medical University-The Second Affiliated Hospital", "city": "Guangzhou", "status": ""}, {"facility": "Wuhan Children's Hospital", "city": "Wuhan", "status": ""}, {"facility": "Fudan University - Children's Hospital", "city": "Shanghai Shi", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT06872125", "title": "A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome", "status": "RECRUITING", "start": "2025-06-04", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 170, "sponsor": "Stoke Therapeutics, Inc", "conditions": ["Dravet Syndrome"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Guangzhou Medical university", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Wuhan Children's Hospital", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07675746", "title": "A Study to Evaluate the Safety and Pharmacokinetics of RC001 in Children With Dravet Syndrome", "status": "RECRUITING", "start": "2025-12-22", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 8, "sponsor": "Second Affiliated Hospital of Guangzhou Medical University", "conditions": ["Dravet Syndrome (DS)"], "cn_sites": [{"facility": "The Second Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03635073", "title": "A Study of Soticlestat in Adults and Children With Rare Epilepsies", "status": "TERMINATED", "start": "2018-07-19", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 156, "sponsor": "Takeda", "conditions": ["Epilepsy", "Dravet Syndrome (DS)", "Lennox-Gastaut Syndrome (LGS)"], "cn_sites": [{"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Children's Hospital,Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": ""}, {"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT03650452", "title": "A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies", "status": "COMPLETED", "start": "2018-08-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 141, "sponsor": "Takeda", "conditions": ["Epilepsy", "Dravet Syndrome", "Lennox-Gastaut Syndrome"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Capital Medical University (CMU) - Beijing Children's Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Children's Hospital,Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT04940624", "title": "A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome", "status": "COMPLETED", "start": "2021-10-28", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 144, "sponsor": "Takeda", "conditions": ["Dravet Syndrome (DS)"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Children's Hospital,Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Children's Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "The Second Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": ""}, {"facility": "Wuhan Childrens hospital", "city": "Wuhan", "status": ""}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Children's Hospital of Shanghai", "city": "Shanghai", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT05163314", "title": "A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome", "status": "TERMINATED", "start": "2022-03-04", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 352, "sponsor": "Takeda", "conditions": ["Dravet Syndrome (DS)", "Lennox Gastaut Syndrome (LGS)"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Children's Hospital,Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Children's Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "The Second Affiliated Hospital of Guangzhou Medical Univeristy", "city": "Guangzhou", "status": ""}, {"facility": "Guangzhou Women And Children's Medical Center", "city": "Guangzhou", "status": ""}, {"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": ""}, {"facility": "Wuhan Childrens hospital", "city": "Wuhan", "status": ""}, {"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "Jiangxi Provincial Children's Hospital", "city": "Nanchang", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Children's Hospital of Shanghai", "city": "Shanghai", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 12, "broad_only": false}, {"nct": "NCT06447675", "title": "Efficacy and Safety Evaluation of Hyperthermic Baths in the Treatment of Seizures in CDKL5 Deficiency Disorder", "status": "COMPLETED", "start": "2024-09-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 8, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["CDKL5 Deficiency Disorder"], "cn_sites": [{"facility": "Xuanwu Hospital,Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06660394", "title": "A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-09-25", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 96, "sponsor": "Longboard Pharmaceuticals", "conditions": ["Dravet Syndrome"], "cn_sites": [{"facility": "Peking University First Hospital (Beida Hospital)", "city": "Beijing", "status": ""}, {"facility": "Capital Medical University-Beijing Children's Hospital", "city": "Beijing", "status": ""}, {"facility": "Guangzhou Medical University-The Second Affiliated Hospital", "city": "Guangzhou", "status": ""}, {"facility": "Shenzhen Children's Hospital", "city": "Shenzhen Shi", "status": ""}, {"facility": "Wuhan Children's Hospital", "city": "Wuhan", "status": ""}, {"facility": "Fudan University - Children's Hospital", "city": "Shanghai Shi", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT06663163", "title": "The Association Between Fever and CDKL5 Deficiency Disorder: a Nationwide Survey", "status": "COMPLETED", "start": "2024-10-29", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 131, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["CDKL5 Deficiency Disorder"], "cn_sites": [{"facility": "Xuanwu Hospital,Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 23, "g_fetched": 21, "g_countries": [["United States", 12], ["Canada", 4], ["Australia", 4], ["France", 3], ["United Kingdom", 2], ["Italy", 1], ["Argentina", 1], ["Brazil", 1], ["Georgia", 1], ["Hungary", 1], ["India", 1], ["Poland", 1], ["Spain", 1]], "g_trials": [{"nct": "NCT05249556", "title": "Double-blind, Randomized, Placebo-controlled Trial of Ganaxolone in CDKL5 Deficiency Patients 6 Months to Less Than 2 Years Old", "status": "NOT_YET_RECRUITING", "start": "2027-03", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Immedica Pharma AB", "countries": []}, {"nct": "NCT06924827", "title": "A Study to Investigate the Transition of Children From 'Artisanal\" Cannabidiol (CBD) to Epidiolex", "status": "NOT_YET_RECRUITING", "start": "2027-01-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Elizabeth Donner", "countries": ["Canada"]}, {"nct": "NCT07801404", "title": "Biomarkers of Neurodegeneration, Synaptic Plasticity and Neuroinflammation in Dravet Syndrome", "status": "NOT_YET_RECRUITING", "start": "2026-09-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondazione Policlinico Universitario Agostino Gemelli IRCCS", "countries": ["Italy"]}, {"nct": "NCT07602205", "title": "Efficacy and Safety of Daily Home-based Hyperthermic Baths for Reducing Epileptic Seizures in CDKL5 Deficiency Disorder: A PROBE Clinical Trial", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Xuanwu Hospital, Beijing", "countries": []}, {"nct": "NCT07531745", "title": "ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome", "status": "RECRUITING", "start": "2026-05-21", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Ionis Pharmaceuticals, Inc.", "countries": ["Canada", "United States"]}, {"nct": "NCT07013331", "title": "A PET-MRI Study of Serotoninergic Brainstem Pathway in Patients With Dravet Syndrome", "status": "RECRUITING", "start": "2026-05-04", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Hospices Civils de Lyon", "countries": ["France"]}, {"nct": "NCT07112365", "title": "The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project", "status": "RECRUITING", "start": "2026-04-27", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "The University of Texas Health Science Center, Houston", "countries": ["United States"]}, {"nct": "NCT07225231", "title": "Clinical Utility of Reduced EEG Home Monitoring in Fenfluramine Titration for Dravet and LGS", "status": "NOT_YET_RECRUITING", "start": "2025-12-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Byteflies", "countries": []}, {"nct": "NCT05126914", "title": "Multicentre Real-life Follow-up Study of Rare Epileptic Syndromes in Children and Adolescents", "status": "RECRUITING", "start": "2025-12-11", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT07251673", "title": "Longitudinal Study of Phenotypic and Developmental Severity in Patients With Dravet Syndrome With SCN1A Gene Mutation", "status": "RECRUITING", "start": "2025-09-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT06967727", "title": "Registry and Natural History of Epilepsy-Dyskinesia Syndromes", "status": "RECRUITING", "start": "2025-06-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Boston Children's Hospital", "countries": ["United States"]}, {"nct": "NCT06738732", "title": "CBD Delivery with the A-Synaptic GT4 Transdermal Delivery System in with Dravet Syndrome And/or Lennox-Gastaut Syndrome", "status": "NOT_YET_RECRUITING", "start": "2025-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Alexander Rotenberg", "countries": ["United States"]}, {"nct": "NCT06401538", "title": "BMB-101 in Absence Epilepsy and DEE", "status": "RECRUITING", "start": "2024-12-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Bright Minds Biosciences Pty Ltd", "countries": ["Australia"]}, {"nct": "NCT06598449", "title": "Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of Age", "status": "RECRUITING", "start": "2024-10-22", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "University of Colorado, Denver", "countries": ["United States"]}, {"nct": "NCT06585605", "title": "A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes", "status": "RECRUITING", "start": "2024-07-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Boston Children's Hospital", "countries": ["United States"]}, {"nct": "NCT05419492", "title": "A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome", "status": "RECRUITING", "start": "2024-05-14", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Encoded Therapeutics", "countries": ["Australia", "United Kingdom", "United States"]}, {"nct": "NCT05651204", "title": "GABA Biomarkers in Dravet Syndrome", "status": "RECRUITING", "start": "2022-09-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Cook Children's Health Care System", "countries": ["United States"]}, {"nct": "NCT05558371", "title": "International CDKL5 Clinical Research Network", "status": "RECRUITING", "start": "2021-02-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Colorado, Denver", "countries": ["Australia", "United States"]}, {"nct": "NCT04462770", "title": "A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome", "status": "RECRUITING", "start": "2020-09-15", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Epygenix", "countries": ["Argentina", "Brazil", "Canada", "Georgia", "Hungary", "India", "Poland", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT04457687", "title": "Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "Eisai Inc.", "countries": ["Canada", "United States"]}, {"nct": "NCT06149663", "title": "Intermediate-Size Expanded Access Protocol (EAP) for LP352", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "Longboard Pharmaceuticals", "countries": ["Australia", "United States"]}]}, {"batch": 1, "no": 106, "name_zh": "镰刀型细胞贫血病", "query_terms": [{"term": "Sickle cell disease", "broad": false}], "n_total": 7, "n_open": 4, "n_open_precise": 4, "n_broad": 0, "trials": [{"nct": "NCT06399107", "title": "Investigation Into the Use of BAH243 Lentiviral Vector for Gene Therapy in Treating Sickle Cell Disease", "status": "RECRUITING", "start": "2024-08-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 85, "sponsor": "Essen Biotech", "conditions": ["Sickle Cell Disease", "Sickle-Cell Disease With Crisis"], "cn_sites": [{"facility": "District One Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06565026", "title": "CS-206 in Patients With Sickle Cell Disease", "status": "RECRUITING", "start": "2024-09-02", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 5, "sponsor": "CorrectSequence Therapeutics Co., Ltd", "conditions": ["Sickle Cell Disease"], "cn_sites": [{"facility": "The First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07190001", "title": "YOLT-204 in Patients With Hemoglobinopathies", "status": "NOT_YET_RECRUITING", "start": "2025-09-30", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Guangzhou Women and Children's Medical Center", "conditions": ["Hemoglobinopathies (Transfusion-dependent β-thalassemia and Sickle Cell Disease)"], "cn_sites": [{"facility": "Guangzhou women and children's medical center", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07000318", "title": "CS-206 in Patients With Sickle Cell Disease", "status": "NOT_YET_RECRUITING", "start": "2026-09-30", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 5, "sponsor": "Children's Hospital of Fudan University", "conditions": ["Sickle Cell Disease"], "cn_sites": [{"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00171821", "title": "A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron Overload", "status": "COMPLETED", "start": "2005-04", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1784, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Transfusion-dependent Iron Overload"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Nanjing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT06300723", "title": "Clinical Study of BRL-101 in Severe SCD", "status": "UNKNOWN", "start": "2024-07-29", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 3, "sponsor": "Bioray Laboratories", "conditions": ["Sickle Cell Disease"], "cn_sites": [{"facility": "First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06581627", "title": "A Research Study Looking at a Single Dose of Etavopivat in Healthy Chinese Participants", "status": "COMPLETED", "start": "2024-08-26", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Novo Nordisk A/S", "conditions": ["Healthy Volunteers", "Sickle Cell Disease", "Thalassemia"], "cn_sites": [{"facility": "Beijing Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 217, "g_fetched": 196, "g_countries": [["United States", 119], ["France", 31], ["United Kingdom", 10], ["Canada", 9], ["Nigeria", 8], ["Italy", 8], ["Spain", 8], ["Germany", 7], ["Turkey (Türkiye)", 7], ["Uganda", 6], ["Belgium", 6], ["Egypt", 5], ["Brazil", 5], ["Kenya", 5], ["Saudi Arabia", 5], ["Ghana", 4], ["Greece", 4], ["Oman", 4], ["Lebanon", 4], ["Guadeloupe", 3], ["Netherlands", 3], ["Colombia", 3], ["India", 3], ["Dominican Republic", 2], ["Israel", 2], ["Tanzania", 2], ["Angola", 2], ["Iraq", 1], ["Côte d’Ivoire", 1], ["Ireland", 1], ["Australia", 1], ["French Guiana", 1], ["Jamaica", 1], ["Argentina", 1], ["Brunei", 1], ["Cyprus", 1], ["Democratic Republic of the Congo", 1], ["Denmark", 1], ["Malaysia", 1], ["Pakistan", 1], ["Portugal", 1], ["Zambia", 1], ["Austria", 1]], "g_trials": [{"nct": "NCT07540767", "title": "Development of a Provider-Focused Intervention to Improve Health Outcomes in Pediatric Sickle Cell Disease", "status": "NOT_YET_RECRUITING", "start": "2027-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Connecticut Children's Medical Center", "countries": ["United States"]}, {"nct": "NCT07797582", "title": "MBI for Pain and Sleep in Adolescents and Young Adults With Sickle Cell Disease", "status": "NOT_YET_RECRUITING", "start": "2027-02", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Illinois at Chicago", "countries": []}, {"nct": "NCT05605366", "title": "Minocycline In Neurocognitive Outcomes - Sickle Cell Disease", "status": "NOT_YET_RECRUITING", "start": "2026-12-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "University of Cincinnati", "countries": []}, {"nct": "NCT07530965", "title": "Omega-3-Fatty Acids in Children With Sickle Cell Disease", "status": "NOT_YET_RECRUITING", "start": "2026-12-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Alabama at Birmingham", "countries": []}, {"nct": "NCT07648043", "title": "Feasibility and Acceptability of Amani", "status": "NOT_YET_RECRUITING", "start": "2026-11-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Massachusetts General Hospital", "countries": ["United States"]}, {"nct": "NCT07826988", "title": "Adaptive Platform Trial for Pain Management in Sickle Cell Vaso-Occlusive Crisis", "status": "NOT_YET_RECRUITING", "start": "2026-10-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": []}, {"nct": "NCT07799571", "title": "Buprenorphine for the Management of Pain in Children With Sickle Cell Disease", "status": "NOT_YET_RECRUITING", "start": "2026-10", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Natasha Archer", "countries": ["United States"]}, {"nct": "NCT07774351", "title": "A Clinical Exploratory Study of YOLT-204 in the Treatment of Hemoglobinopathies", "status": "NOT_YET_RECRUITING", "start": "2026-09-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "countries": []}, {"nct": "NCT07369024", "title": "Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults", "status": "RECRUITING", "start": "2026-09-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Mohsen Saidinejad", "countries": ["United States"]}, {"nct": "NCT07703566", "title": "CPAP for Hypoxemic Acute Chest Syndrome in Sickle Cell Disease", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": []}, {"nct": "NCT07782489", "title": "Pleuropulmonary Ultrasound Imaging in Patients With Sickle Cell Disease in a Vaso-occlusive Crisis. \"ECHODREP\"", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": []}, {"nct": "NCT07217548", "title": "Solving Stigma Through POV Simulation: Enhancing Pharmacist Empathy-based Practices With Sickle Cell Disease Patients", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Ohio State University", "countries": ["United States"]}, {"nct": "NCT07802210", "title": "Effectiveness of Innovative Educational Methods in Empowering Children With Sickle Cell Disease", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Aula Ibrahim abd alrazak", "countries": ["Iraq"]}, {"nct": "NCT07752043", "title": "Standard of Care Comparative Arm of Phase 1/2 Gene Therapy Trial DREPAMIR\" in Severe Sickle Cell Disease Patients", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT07616154", "title": "Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease", "status": "RECRUITING", "start": "2026-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "St. Jude Children's Research Hospital", "countries": ["United States"]}, {"nct": "NCT07498309", "title": "Evaluation of the Efficacy of Iloprost in the Management of Vaso-occlusive Crises in Adult Patients With Sickle Cell Disease", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Rouen", "countries": ["France"]}, {"nct": "NCT07282210", "title": "Efficacy and Safety of SIL-8301 for Control of Hemolysis in a Uniform Sickle Cell Disease Endotype", "status": "RECRUITING", "start": "2026-08-13", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Biossil Inc.", "countries": ["Canada"]}, {"nct": "NCT07674277", "title": "Virtual Reality for SCD VOC", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Maryland, Baltimore", "countries": ["United States"]}, {"nct": "NCT05377372", "title": "Early Life Exposures Among Children With Sickle Cell Disease", "status": "RECRUITING", "start": "2026-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Alabama at Birmingham", "countries": ["United States"]}, {"nct": "NCT07682662", "title": "Low Dose Bolus Ketamine For Use In Sickle Cell Pain Crisis", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "University of Mississippi Medical Center", "countries": ["United States"]}, {"nct": "NCT07708350", "title": "Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Sickle Cell Disease", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Daniel Bauer", "countries": ["United States"]}, {"nct": "NCT07719972", "title": "Universal Newborn Screening For Sickle Cell Disease In Mozambique", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "St. Jude Children's Research Hospital", "countries": []}, {"nct": "NCT07566494", "title": "Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease", "status": "RECRUITING", "start": "2026-07-31", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "countries": ["United States"]}, {"nct": "NCT07656415", "title": "A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)", "status": "RECRUITING", "start": "2026-07-21", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Agios Pharmaceuticals, Inc.", "countries": ["United States"]}, {"nct": "NCT07639008", "title": "Epidemiology of Invasive Bacterial Infections in Children With Sickle Cell Disease in France Between 2020 and 2025", "status": "NOT_YET_RECRUITING", "start": "2026-07-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}]}, {"batch": 1, "no": 107, "name_zh": "Silver-Russell综合征", "query_terms": [{"term": "Silver-Russell syndrome", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 3, "g_fetched": 3, "g_countries": [["France", 2], ["Australia", 1], ["United States", 1]], "g_trials": [{"nct": "NCT06878716", "title": "Silver Russell Syndrome, Parental Fertility and Assisted Reproductive Technology", "status": "NOT_YET_RECRUITING", "start": "2025-03", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT05945576", "title": "IDMet (RaDiCo Cohort) (RaDiCo-IDMet)", "status": "RECRUITING", "start": "2017-03-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Institut National de la Santé Et de la Recherche Médicale, France", "countries": ["France"]}, {"nct": "NCT01793168", "title": "Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford", "status": "RECRUITING", "start": "2010-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sanford Health", "countries": ["Australia", "United States"]}]}, {"batch": 1, "no": 108, "name_zh": "谷固醇血症", "query_terms": [{"term": "Sitosterolemia", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 0, "g_fetched": 0, "g_countries": [], "g_trials": []}, {"batch": 1, "no": 109, "name_zh": "脊髓延髓肌萎缩症（肯尼迪病）", "query_terms": [{"term": "Kennedy disease", "broad": false}, {"term": "Spinal and Bulbar Muscular Atrophy (Kennedy Disease)", "broad": false}], "n_total": 25, "n_open": 8, "n_open_precise": 8, "n_broad": 0, "trials": [{"nct": "NCT06348264", "title": "Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma", "status": "RECRUITING", "start": "2024-10-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 37, "sponsor": "Peking University First Hospital", "conditions": ["Salivary Gland Neoplasm Duct"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking University School and Hospital of Stomatology", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06854250", "title": "Prostate Cryoablation Combined With Metronomic Cyclophosphamide for Metastatic Prostate Cancer", "status": "RECRUITING", "start": "2025-03-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 104, "sponsor": "Sun Yat-sen University", "conditions": ["Metastatic Prostate Cancer"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06838520", "title": "Effect of ADT and ARPI on Bone Loss of Patients with Prostate Cancer", "status": "NOT_YET_RECRUITING", "start": "2025-04-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "The First Affiliated Hospital with Nanjing Medical University", "conditions": ["Prostate Cancer (Adenocarcinoma)"], "cn_sites": [{"facility": "The Third Affiliated Hospital of Soochow University", "city": "Changzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Nanjing Medical University", "city": "Nanjing", "status": ""}, {"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "Northern Jiangsu People's Hospital", "city": "Yangzhou", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT06855277", "title": "Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC", "status": "RECRUITING", "start": "2025-07-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 940, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Prostate Cancer"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT07190300", "title": "TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)", "status": "RECRUITING", "start": "2026-01-13", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 181, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07336446", "title": "A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs", "status": "RECRUITING", "start": "2026-01-27", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 300, "sponsor": "AstraZeneca", "conditions": ["Prostate Cancer"], "cn_sites": [{"facility": "Research Site", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07311694", "title": "A Phase III Study Comparing HRS-4357 With Novel Androgen Receptor Pathway Inhibitors in Patients With Progressive, PSMA-Positive Metastatic Castration-Resistant Prostate Cancer", "status": "RECRUITING", "start": "2026-02-02", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 370, "sponsor": "Jiangsu HengRui Medicine Co., Ltd.", "conditions": ["PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07795177", "title": "A Prospective Study Based on Spatial Multi-omics to Predict the Efficacy of ADT Combined With Second-generation Novel Hormonal Agents in Metastatic Hormone-sensitive Prostate Cancer.", "status": "NOT_YET_RECRUITING", "start": "2026-10-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Anhui Medical University", "conditions": ["Metastatic Hormone-Sensitive Prostate Cancer"], "cn_sites": [{"facility": "Universitythe First Affiliatedhospital of Anhuimedical", "city": "Hefei", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02294461", "title": "An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants", "status": "COMPLETED", "start": "2014-04-23", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 395, "sponsor": "Astellas Pharma Inc", "conditions": ["Progressive Metastatic Prostate Cancer"], "cn_sites": [{"facility": "CN00103", "city": "Beijing", "status": ""}, {"facility": "CN00104", "city": "Beijing", "status": ""}, {"facility": "CN00106", "city": "Beijing", "status": ""}, {"facility": "CN00111", "city": "Beijing", "status": ""}, {"facility": "CN00112", "city": "Beijing", "status": ""}, {"facility": "CN00114", "city": "Beijing", "status": ""}, {"facility": "CN00115", "city": "Beijing", "status": ""}, {"facility": "CN00127", "city": "Beijing", "status": ""}, {"facility": "CN00121", "city": "Changsha", "status": ""}, {"facility": "CN00107", "city": "Hangzhou", "status": ""}, {"facility": "CN00110", "city": "Nanjing", "status": ""}, {"facility": "CN00117", "city": "Nanjing", "status": ""}, {"facility": "CN00102", "city": "Shanghai", "status": ""}, {"facility": "CN00105", "city": "Shanghai", "status": ""}, {"facility": "CN00108", "city": "Shanghai", "status": ""}, {"facility": "CN00113", "city": "Shanghai", "status": ""}, {"facility": "CN00126", "city": "Shanghai", "status": ""}, {"facility": "CN00119", "city": "Suzhou", "status": ""}, {"facility": "CN00125", "city": "Tianjin", "status": ""}, {"facility": "CN00118", "city": "Wenzhou", "status": ""}, {"facility": "CN00109", "city": "Wuhan", "status": ""}, {"facility": "CN00124", "city": "Xi'an", "status": ""}], "cn_site_count": 22, "broad_only": false}, {"nct": "NCT02348281", "title": "Bicalutamide as A Treatment in AR-positive Metastatic Triple-Negative Breast Cancer (mTNBC) Patients", "status": "TERMINATED", "start": "2015-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 1, "sponsor": "Fudan University", "conditions": ["Breast Cancer"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02910050", "title": "Bicalutamide Plus Aromatase Inhibitors in ER(+)/AR(+)/HER2(-) Metastatic Breast Cancer", "status": "UNKNOWN", "start": "2016-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 58, "sponsor": "Xu fei", "conditions": ["Breast Cancer"], "cn_sites": [{"facility": "State Key Laboratory of Oncology in South China,Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03055312", "title": "Bicalutamide in Treatment of Androgen Receptor (AR) Positive Metastatic Triple Negative Breast Cancer", "status": "TERMINATED", "start": "2016-12-20", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Sun Yat-sen University", "conditions": ["Metastatic Triple Negative Breast Cancer"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": ""}, {"facility": "Sun Yat-sen University, Cancer Center", "city": "Guangzhou", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT03520478", "title": "A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate Cancer", "status": "UNKNOWN", "start": "2018-05-30", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 654, "sponsor": "Jiangsu HengRui Medicine Co., Ltd.", "conditions": ["Prostate Cancer", "Hormone-Dependent Prostate Cancer"], "cn_sites": [{"facility": "Affiliated Hospital of Hebei University", "city": "Baoding", "status": ""}, {"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "The third hospital of Peking University", "city": "Beijing", "status": ""}, {"facility": "Tumor Hospital of the Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "China Japan Friendship Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "The first hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Hunan Cancer Hospital", "city": "Changsha", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Army characteristic medical center of the Chinese people's Liberation Army", "city": "Chongqing", "status": ""}, {"facility": "Chongqing Cancer Hospital", "city": "Chongqing", "status": ""}, {"facility": "The First Affiliated Hospital of Army Medical University", "city": "Chongqing", "status": ""}, {"facility": "The First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": ""}, {"facility": "Sun Yat-Sen hospital of Sun Yat-Sen University", "city": "Guangzhou", "status": ""}, {"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Zhejiang University Medicine college", "city": "Hangzhou", "status": ""}, {"facility": "The Second affiliated hospital of zhejiang university medical college", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Province People's Hospital", "city": "Hangzhou", "status": ""}, {"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": ""}, {"facility": "The First Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": ""}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": ""}, {"facility": "Yunnan Provincial Cancer Hospital", "city": "Kunming", "status": ""}, {"facility": "The second hospital of Lanzhou University", "city": "Lanzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": ""}, {"facility": "Gulou Hospital Affiliated to Medical College of Nanjing University", "city": "Nanjing", "status": ""}, {"facility": "Jiangsu Provincial Cancer Hospital", "city": "Nanjing", "status": ""}, {"facility": "Jiangsu Provincial People's Hospital", "city": "Nanjing", "status": ""}, {"facility": "Huadong Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Ruijin Hospital", "city": "Shanghai", "status": ""}, {"facility": "Shanghai General Hospital", "city": "Shanghai", "status": ""}, {"facility": "The Cancer Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Zhongshan Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Liaoning Provincial Cancer Hospital", "city": "Shenyang", "status": ""}, {"facility": "The fourth hospital of Hebei Medical University", "city": "Shijia Zhuang", "status": ""}, {"facility": "The second hospital of Tianjin Medical University", "city": "Tianjing", "status": ""}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": ""}, {"facility": "Hubei Provincial Cancer Hospital", "city": "Wuhan", "status": ""}, {"facility": "Tongji Hospital, Tongji medical college of HUST", "city": "Wuhan", "status": ""}, {"facility": "Union Hospital, Tongji Medical college of HUST", "city": "Wuhan", "status": ""}, {"facility": "Wuxi People's Hospital", "city": "Wuxi", "status": ""}, {"facility": "The First Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi'an", "status": ""}, {"facility": "The Second Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi'an", "status": ""}, {"facility": "The First Affiliated Hospital of Xiamen University", "city": "Xiamen", "status": ""}, {"facility": "Jiangsu Subei people's Hospital", "city": "Yangzhou", "status": ""}, {"facility": "Henan people's Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Henan Provincial Cancer Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": ""}], "cn_site_count": 49, "broad_only": false}, {"nct": "NCT03523442", "title": "A Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Resistant Prostate Cancer", "status": "ACTIVE_NOT_RECRUITING", "start": "2018-08-31", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 19, "sponsor": "Janssen Research & Development, LLC", "conditions": ["Prostatic Neoplasms"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer Hospital of Peking University", "city": "Beijing", "status": ""}, {"facility": "Jiangsu Cancer Hospital", "city": "Nanjing", "status": ""}, {"facility": "Fudan Cancer Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT04720157", "title": "An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-06-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1140, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Prostatic Neoplasms"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Nanjing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Xian", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Chengdu", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Tianjin", "status": ""}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT05674045", "title": "A Phase 2, Randomized, Placebo-controlled, Double-blind Study of EG017 in Female Patients With Stress Urinary Incontinence", "status": "COMPLETED", "start": "2022-01-06", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 51, "sponsor": "Changchun GeneScience Pharmaceutical Co., Ltd.", "conditions": ["Stress Urinary Incontinence"], "cn_sites": [{"facility": "People's Hospital of Peking University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05335876", "title": "Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-12-19", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Spinal Muscular Atrophy (SMA)"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Chongqing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Chengdu", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT05673109", "title": "A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer", "status": "TERMINATED", "start": "2023-02-22", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 8, "sponsor": "Accutar Biotechnology Inc", "conditions": ["Metastatic Castration Resistant Prostate Cancer"], "cn_sites": [{"facility": "Site 2001", "city": "Beijing", "status": ""}, {"facility": "Site 2003", "city": "Guangzhou", "status": ""}, {"facility": "Site 2004", "city": "Hunan", "status": ""}, {"facility": "Site 2005", "city": "Nanchang", "status": ""}, {"facility": "Site 2002", "city": "Shanghai", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT05673694", "title": "To Evaluate a Phase Ia/Ib Clinical Study of EG017 in Patients With Advanced Breast Cancer.", "status": "UNKNOWN", "start": "2023-03-08", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 70, "sponsor": "Changchun GeneScience Pharmaceutical Co., Ltd.", "conditions": ["Breast Cancer"], "cn_sites": [{"facility": "Cancer Hospital of CAMS", "city": "Beijing", "status": "RECRUITING"}, {"facility": "First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Wuhan Union Hospital", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Hunan Cancer Hospital", "city": "Changsha", "status": "RECRUITING"}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT05658003", "title": "A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate Cancer", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-05-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 63, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Metastatic Castration-Resistant Prostate Cancer (mCRPC)"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Wuhan", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Nanjing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shenyang", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Xian", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Chengdu", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Hangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Tianjin", "status": ""}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT05670106", "title": "A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPC", "status": "COMPLETED", "start": "2023-05-16", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 62, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Metastatic Castration-Resistant Prostate Cancer (mCRPC)"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Zhengzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Wuhan", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Nanjing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Xian", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Chengdu", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Tianjin", "status": ""}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT05953168", "title": "T-DXd in the First-Line Treatment of Locally Advanced or Metastatic TNBC-LAR HER2-low Patients", "status": "UNKNOWN", "start": "2023-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 69, "sponsor": "Fudan University", "conditions": ["Triple-Negative Breast Cancer"], "cn_sites": [{"facility": "Breast cancer institute of Fudan University Cancer Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05954442", "title": "Everolimus With Investigator's Choice of Chemotherapy in Advanced Triple-Negative Breast Cancer (TNBC) With Luminal Androgen Receptor (LAR) Subtype", "status": "UNKNOWN", "start": "2023-09-13", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 203, "sponsor": "Fudan University", "conditions": ["Triple Negative Breast Cancer", "Metastatic Breast Cancer", "Mutation"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06764485", "title": "A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-03-13", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 960, "sponsor": "Celgene", "conditions": ["Metastatic Castration-resistant Prostate Cancer"], "cn_sites": [{"facility": "Local Institution - 0232", "city": "Hefei", "status": ""}, {"facility": "Local Institution - 0192", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 0249", "city": "Fuzhou", "status": ""}, {"facility": "Local Institution - 0213", "city": "Xiamen", "status": ""}, {"facility": "Local Institution - 0226", "city": "Guangzhou", "status": ""}, {"facility": "Local Institution - 0180", "city": "Guangzhou", "status": ""}, {"facility": "Local Institution - 0415", "city": "Huizhou", "status": ""}, {"facility": "Local Institution - 0417", "city": "Changzhou", "status": ""}, {"facility": "Local Institution - 0233", "city": "Nanjing", "status": ""}, {"facility": "Local Institution - 0229", "city": "Nanjing", "status": ""}, {"facility": "Local Institution - 0219", "city": "Nanchang", "status": ""}, {"facility": "Local Institution - 0191", "city": "Jinan", "status": ""}, {"facility": "Local Institution - 0221", "city": "Yantai", "status": ""}, {"facility": "Local Institution - 0214", "city": "Shanghai", "status": ""}, {"facility": "Local Institution - 0240", "city": "Chengdu", "status": ""}, {"facility": "Local Institution - 0278", "city": "Chengdu", "status": ""}, {"facility": "Local Institution - 0283", "city": "Chengdu", "status": ""}, {"facility": "Local Institution - 0218", "city": "Ürümqi", "status": ""}, {"facility": "Local Institution - 0196", "city": "Hangzhou", "status": ""}, {"facility": "Local Institution - 0281", "city": "Linhai", "status": ""}], "cn_site_count": 20, "broad_only": false}, {"nct": "NCT07047118", "title": "A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-07-03", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 138, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Prostatic Cancer, Castration-Resistant"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 61, "g_fetched": 54, "g_countries": [["United States", 32], ["Australia", 8], ["Canada", 6], ["United Kingdom", 6], ["Italy", 5], ["Spain", 5], ["Japan", 3], ["Belgium", 3], ["France", 2], ["Germany", 2], ["Turkey (Türkiye)", 2], ["Switzerland", 2], ["Netherlands", 2], ["South Korea", 1], ["Mexico", 1], ["Uruguay", 1], ["New Zealand", 1], ["Ireland", 1], ["Martinique", 1], ["Romania", 1], ["Slovakia", 1], ["Sweden", 1], ["Egypt", 1], ["Israel", 1]], "g_trials": [{"nct": "NCT07760844", "title": "An Open-Label, Randomized Phase III Study of Trastuzumab Rezetecan With or Without Everolimus in First to Third Line LAR Subtype TNBC", "status": "NOT_YET_RECRUITING", "start": "2026-10-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Fudan University", "countries": []}, {"nct": "NCT07711002", "title": "Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)", "status": "NOT_YET_RECRUITING", "start": "2026-10-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "AstraZeneca", "countries": ["Canada"]}, {"nct": "NCT07226713", "title": "Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors", "status": "RECRUITING", "start": "2026-09-03", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Medical College of Wisconsin", "countries": ["United States"]}, {"nct": "NCT07751133", "title": "Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer", "status": "RECRUITING", "start": "2026-08-28", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "University College, London", "countries": ["United Kingdom"]}, {"nct": "NCT07650240", "title": "Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial", "status": "RECRUITING", "start": "2026-08-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Mayo Clinic", "countries": ["United States"]}, {"nct": "NCT07723248", "title": "A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)", "status": "RECRUITING", "start": "2026-08-03", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "ORIC Pharmaceuticals", "countries": ["United States"]}, {"nct": "NCT07223385", "title": "High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)", "status": "RECRUITING", "start": "2026-08-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Cedars-Sinai Medical Center", "countries": ["United States"]}, {"nct": "NCT07745361", "title": "Study of Oral MRT-2359 With Apalutamide in Prostate Cancer", "status": "RECRUITING", "start": "2026-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Monte Rosa Therapeutics, Inc", "countries": ["United States"]}, {"nct": "NCT07592910", "title": "A Study of Mevrometostat With Enzalutamide in People With Prostate Cancer Who Have Previously Received Androgen Receptor Pathway Inhibitor Therapy", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Prostate Cancer Clinical Trials Consortium", "countries": []}, {"nct": "NCT07677267", "title": "A Study of Real-World Characteristics, Treatment Patterns, and Outcomes Among mCRPC Patients Previously Treated With an Androgen Receptor Pathway Inhibitor, Taxane-Based Chemotherapy, and Lutetium-177 Vipivotide Tetraxetan", "status": "RECRUITING", "start": "2026-06-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": ["United States"]}, {"nct": "NCT07596277", "title": "Exploring Lived Experiences of Families of Children With Spinal Muscular Atrophy(SMA) Type 1 Regarding Feeding and Communication", "status": "NOT_YET_RECRUITING", "start": "2026-06-19", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Guy's and St Thomas' NHS Foundation Trust", "countries": ["United Kingdom"]}, {"nct": "NCT06836726", "title": "Clinical Trial to Test Efficacy of Targeting Hypoxia Combined With ARSI After First-line ARSI Therapy for Castrate Resistant Prostate Cancer", "status": "NOT_YET_RECRUITING", "start": "2026-05-27", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University Health Network, Toronto", "countries": ["Canada"]}, {"nct": "NCT07570979", "title": "A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer", "status": "RECRUITING", "start": "2026-05-25", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": ["Australia", "Canada", "Japan", "South Korea", "United States"]}, {"nct": "NCT06844383", "title": "A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide", "status": "RECRUITING", "start": "2026-05-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Prostate Cancer Clinical Trials Consortium", "countries": ["United States"]}, {"nct": "NCT06705686", "title": "Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer", "status": "RECRUITING", "start": "2026-03-13", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "TechnoGenesys, Inc.", "countries": ["United States"]}, {"nct": "NCT07142551", "title": "Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response", "status": "RECRUITING", "start": "2026-03-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins", "countries": ["United States"]}, {"nct": "NCT07226986", "title": "A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC", "status": "RECRUITING", "start": "2025-12-05", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": ["Australia", "France", "Germany", "Italy", "Japan", "Spain", "United States"]}, {"nct": "NCT07181122", "title": "Quality of Life, Functional and Cognitive Outcomes in Patients With Metastatic Hormone-Sensitive Prostate Cancer", "status": "RECRUITING", "start": "2025-10-22", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Ankara Etlik City Hospital", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT07223372", "title": "An Observational Study to Learn More About How Medicines That Block Male Hormones Are Used in People With Prostate Cancer in Australia", "status": "RECRUITING", "start": "2025-10-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Bayer", "countries": ["Australia"]}, {"nct": "NCT07140900", "title": "Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer", "status": "RECRUITING", "start": "2025-10-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Amgen", "countries": ["Australia", "Switzerland", "United States"]}, {"nct": "NCT06195163", "title": "TRAP Study: Testosterone for Androgen Receptor Polymorphism", "status": "NOT_YET_RECRUITING", "start": "2025-09-30", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Instituto Bernabeu", "countries": ["Spain"]}, {"nct": "NCT07016399", "title": "Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC", "status": "RECRUITING", "start": "2025-09-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Vandana Abramson", "countries": ["United States"]}, {"nct": "NCT07406282", "title": "A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics", "status": "RECRUITING", "start": "2025-07-22", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Bayer", "countries": ["United States"]}, {"nct": "NCT06592924", "title": "Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response", "status": "RECRUITING", "start": "2025-05-28", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Canadian Cancer Trials Group", "countries": ["Canada", "Mexico", "United States", "Uruguay"]}, {"nct": "NCT06862596", "title": "Clinical Trial of Mexiletine Hydrochloride for Spinal and Bulbar Muscular Atrophy", "status": "RECRUITING", "start": "2025-02-28", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Masahisa Katsuno", "countries": ["Japan"]}]}, {"batch": 1, "no": 110, "name_zh": "脊髓性肌萎缩症", "query_terms": [{"term": "Proximal spinal muscular atrophy", "broad": false}, {"term": "Spinal Muscular Atrophy", "broad": true}], "n_total": 39, "n_open": 13, "n_open_precise": 0, "n_broad": 39, "trials": [{"nct": "NCT04010604", "title": "A Registered Cohort Study on SMA", "status": "RECRUITING", "start": "2019-07-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2000, "sponsor": "Wan-Jin Chen", "conditions": ["Spinal Muscular Atrophy"], "cn_sites": [{"facility": "Department of Neurology, First Affiliated Hospital Fujian Medical University", "city": "Fuzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT05614531", "title": "Clinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients with Spinal Muscular Atrophy Type 1", "status": "ENROLLING_BY_INVITATION", "start": "2023-02-16", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Guangzhou Jiayin Biotech Ltd", "conditions": ["Spinal Muscular Atrophy Type I"], "cn_sites": [{"facility": "The Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "The Children'S Hospital Zhejiang University of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 2, "broad_only": true}, {"nct": "NCT05824169", "title": "Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 1 Patients", "status": "RECRUITING", "start": "2023-02-25", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "GeneCradle Inc", "conditions": ["Spinal Muscular Atrophy"], "cn_sites": [{"facility": "Peking University， First Hospital, Department of Pediatrics", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Bayi Children's Hospital, Seventh Medical Center, PLA general hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Shengjing Hospital of China Medical University", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Children's Hospital of Soochow University", "city": "Suzhou", "status": "RECRUITING"}], "cn_site_count": 4, "broad_only": true}, {"nct": "NCT06421831", "title": "Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 3 Patients", "status": "RECRUITING", "start": "2024-05-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 21, "sponsor": "GeneCradle Inc", "conditions": ["Spinal Muscular Atrophy Type 3"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06772402", "title": "GCB-001 in Treatment of Patients With Type II (SMA) Spinal Muscular Atrophy", "status": "ENROLLING_BY_INVITATION", "start": "2025-01-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Genecombio Ltd.", "conditions": ["Spinal Muscular Atrophy Type 2"], "cn_sites": [{"facility": "Children's Hospital ZheJiang Univisity School Of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06588803", "title": "A Long-term Follow-up Study Evaluating Intravenous Injection of EXG001-307 in Patients With Type 1 SMA", "status": "ENROLLING_BY_INVITATION", "start": "2025-03", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 18, "sponsor": "Guangzhou Jiayin Biotech Ltd", "conditions": ["Spinal Muscular Atrophy"], "cn_sites": [{"facility": "The Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06888661", "title": "Clinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients With Spinal Muscular Atrophy", "status": "ENROLLING_BY_INVITATION", "start": "2025-03-10", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 4, "sponsor": "Guangzhou Jiayin Biotech Ltd", "conditions": ["Spinal Muscular Atrophy (SMA)"], "cn_sites": [{"facility": "Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "The Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 2, "broad_only": true}, {"nct": "NCT06971094", "title": "Safety and Efficacy Evaluation of GC101 Gene Therapy Via Intrathecal (IT) Injectionin the Treatment of Patients With Type 2 Spinal Muscular Atrophy (SMA) - Phase III", "status": "RECRUITING", "start": "2025-05-27", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "GeneCradle Inc", "conditions": ["SMA - Spinal Muscular Atrophy"], "cn_sites": [{"facility": "The Seventh Medical Center of Chinese PLA General Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Children's Medical Center of Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "National Children's Medical Center，Shanghai Jiaotong University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": "RECRUITING"}, {"facility": "Children's Hospital of Soochow University", "city": "Suzhou", "status": "RECRUITING"}, {"facility": "Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 7, "broad_only": true}, {"nct": "NCT07190300", "title": "TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)", "status": "RECRUITING", "start": "2026-01-13", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 181, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07336446", "title": "A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs", "status": "RECRUITING", "start": "2026-01-27", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 300, "sponsor": "AstraZeneca", "conditions": ["Prostate Cancer"], "cn_sites": [{"facility": "Research Site", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07221669", "title": "A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)", "status": "RECRUITING", "start": "2026-04-28", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Biogen", "conditions": ["Muscular Atrophy, Spinal"], "cn_sites": [{"facility": "The Third Affiliated Hospital of Zhengzhou University - North Campus", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Guangzhou Woman and Children's Medical Center_Guangzhou", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Childrens Hospital of Fudan University_Shanghai", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": true}, {"nct": "NCT07554924", "title": "A Phase I/II Clinical Study to Evaluate SKG0201 Injection in Subjects With Spinal Muscular Atrophy Type I", "status": "RECRUITING", "start": "2026-07-15", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 11, "sponsor": "Lanyue Biotech (Hangzhou) Co., Ltd.", "conditions": ["Spinal Muscular Atrophy 1"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Children's Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": true}, {"nct": "NCT07822711", "title": "Effects of Different Stiffness Settings During Robotic Isokinetic Training in Children With SMA", "status": "NOT_YET_RECRUITING", "start": "2026-09-21", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 13, "sponsor": "Peking University Third Hospital", "conditions": ["Spinal Muscular Atrophy (SMA)"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT02294461", "title": "An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants", "status": "COMPLETED", "start": "2014-04-23", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 395, "sponsor": "Astellas Pharma Inc", "conditions": ["Progressive Metastatic Prostate Cancer"], "cn_sites": [{"facility": "CN00103", "city": "Beijing", "status": ""}, {"facility": "CN00104", "city": "Beijing", "status": ""}, {"facility": "CN00106", "city": "Beijing", "status": ""}, {"facility": "CN00111", "city": "Beijing", "status": ""}, {"facility": "CN00112", "city": "Beijing", "status": ""}, {"facility": "CN00114", "city": "Beijing", "status": ""}, {"facility": "CN00115", "city": "Beijing", "status": ""}, {"facility": "CN00127", "city": "Beijing", "status": ""}, {"facility": "CN00121", "city": "Changsha", "status": ""}, {"facility": "CN00107", "city": "Hangzhou", "status": ""}, {"facility": "CN00110", "city": "Nanjing", "status": ""}, {"facility": "CN00117", "city": "Nanjing", "status": ""}, {"facility": "CN00102", "city": "Shanghai", "status": ""}, {"facility": "CN00105", "city": "Shanghai", "status": ""}, {"facility": "CN00108", "city": "Shanghai", "status": ""}, {"facility": "CN00113", "city": "Shanghai", "status": ""}, {"facility": "CN00126", "city": "Shanghai", "status": ""}, {"facility": "CN00119", "city": "Suzhou", "status": ""}, {"facility": "CN00125", "city": "Tianjin", "status": ""}, {"facility": "CN00118", "city": "Wenzhou", "status": ""}, {"facility": "CN00109", "city": "Wuhan", "status": ""}, {"facility": "CN00124", "city": "Xi'an", "status": ""}], "cn_site_count": 22, "broad_only": true}, {"nct": "NCT02348281", "title": "Bicalutamide as A Treatment in AR-positive Metastatic Triple-Negative Breast Cancer (mTNBC) Patients", "status": "TERMINATED", "start": "2015-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 1, "sponsor": "Fudan University", "conditions": ["Breast Cancer"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT02910050", "title": "Bicalutamide Plus Aromatase Inhibitors in ER(+)/AR(+)/HER2(-) Metastatic Breast Cancer", "status": "UNKNOWN", "start": "2016-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 58, "sponsor": "Xu fei", "conditions": ["Breast Cancer"], "cn_sites": [{"facility": "State Key Laboratory of Oncology in South China,Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT02908685", "title": "A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Risdiplam (RO7034067) in Type 2 and 3 Spinal Muscular Atrophy (SMA) Participants", "status": "COMPLETED", "start": "2016-10-19", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 231, "sponsor": "Hoffmann-La Roche", "conditions": ["Muscular Atrophy, Spinal"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 2, "broad_only": true}, {"nct": "NCT02913482", "title": "Investigate Safety, Tolerability, PK, PD and Efficacy of Risdiplam (RO7034067) in Infants With Type1 Spinal Muscular Atrophy", "status": "COMPLETED", "start": "2016-12-23", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 62, "sponsor": "Hoffmann-La Roche", "conditions": ["Muscular Atrophy, Spinal"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 2, "broad_only": true}, {"nct": "NCT03902054", "title": "Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine.", "status": "COMPLETED", "start": "2017-12-28", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 600, "sponsor": "Jiangsu Province Centers for Disease Control and Prevention", "conditions": ["Polio and Post-Polio Syndrome"], "cn_sites": [{"facility": "Jiangsu Provincial Center for Diseases Control and Prevention", "city": "Nanjing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04089566", "title": "Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy", "status": "COMPLETED", "start": "2020-03-26", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 145, "sponsor": "Biogen", "conditions": ["Muscular Atrophy, Spinal"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "The Children's Hospital of Zhejiang University school of Med_Hangzhou", "city": "Hangzhou", "status": ""}, {"facility": "Guangzhou Woman and Children's Medical Center", "city": "Guangzhou", "status": ""}, {"facility": "Xiangya Hospital, Central South University", "city": "Changsha", "status": ""}], "cn_site_count": 4, "broad_only": true}, {"nct": "NCT04419233", "title": "Non-Interventional, Postmarketing Surveillance Study of Nusinersen Sodium Injection", "status": "COMPLETED", "start": "2020-11-18", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 50, "sponsor": "Biogen", "conditions": ["Muscular Atrophy, Spinal"], "cn_sites": [{"facility": "Research Site", "city": "Xicheng", "status": ""}, {"facility": "Research Site", "city": "Fuzhou", "status": ""}, {"facility": "Research Site", "city": "Guangzhou", "status": ""}, {"facility": "Research Site", "city": "Suzhou", "status": ""}, {"facility": "Research Site", "city": "Changchun", "status": ""}, {"facility": "Research Site", "city": "Minhang", "status": ""}, {"facility": "Research Site", "city": "Chengdu", "status": ""}, {"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Hangzhou", "status": ""}], "cn_site_count": 9, "broad_only": true}, {"nct": "NCT04729907", "title": "A Study to Learn About the Long-Term Safety of Higher Doses of Nusinersen (BIIB058) Given as Injections to Participants With Spinal Muscular Atrophy (SMA) Who Took Part in an Earlier Nusinersen Trial (ONWARD)", "status": "COMPLETED", "start": "2021-04-19", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 115, "sponsor": "Biogen", "conditions": ["Muscular Atrophy, Spinal"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Guangzhou Woman and Children's Medical Center", "city": "Guangzhou", "status": ""}, {"facility": "The Children's Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 3, "broad_only": true}, {"nct": "NCT05042921", "title": "Pediatric Spinal Muscular Atrophy (SMA) China Registry", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-11-18", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 600, "sponsor": "Biogen", "conditions": ["Muscular Atrophy, Spinal"], "cn_sites": [{"facility": "Anhui Children's Hospital", "city": "Hefei", "status": ""}, {"facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Children's Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Xiamen Maternal and Child Health Hospital", "city": "Xiamen", "status": ""}, {"facility": "The First Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": ""}, {"facility": "Maternity and Child Health Care of Guangxi Zhuang Autonomous Region", "city": "Nanning", "status": ""}, {"facility": "The Second Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "The Third Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": ""}, {"facility": "Hunan Children's Hospital", "city": "Changsha", "status": ""}, {"facility": "Xiangya Hospital, Central South University", "city": "Changsha", "status": ""}, {"facility": "Wuhan Children's Hospital, Tongji Medical College Huazhong University of Science & Technology", "city": "Wuhan", "status": ""}, {"facility": "The Affiliated Hospital of Inner Mongolia Medical University", "city": "Hohhot", "status": ""}, {"facility": "Xuzhou Central Hospital", "city": "Xuzhou", "status": ""}, {"facility": "Jiangxi Provincial Children's Hospital", "city": "Nanchang", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Children's Hospital Affiliated to Shandong University", "city": "Jinan", "status": ""}, {"facility": "Dalian Women and Children's Medical Group", "city": "Dalian", "status": ""}, {"facility": "Shengjing Hospital of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "People's Hospital of Ningxia Hui Autonomous Region", "city": "Yinchuan", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "The Second Affiliated Hospital of Xi'An Jiaotong University", "city": "Xi’an", "status": ""}, {"facility": "West China Second University Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "The Children's Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 25, "broad_only": true}, {"nct": "NCT05269693", "title": "A BHI to Increase Hope Level and Stress Level of Parents With a CMC", "status": "COMPLETED", "start": "2021-12-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "The Hong Kong Polytechnic University", "conditions": ["Child With Cancer", "Muscular Atrophy, Spinal", "Child With Cerebral Palsy", "Endocrine System Diseases"], "cn_sites": [{"facility": "School of Nursing, The Hong Kong Polytechnic University", "city": "Hong Kong", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT05187260", "title": "Antisense Oligonucleotide for Spinal Muscular Atrophy", "status": "UNKNOWN", "start": "2022-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "First Affiliated Hospital of Fujian Medical University", "conditions": ["Spinal Muscular Atrophy"], "cn_sites": [{"facility": "Department of Neurology, Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Department of Pediatrics, Fujian Medical University Union Hospital", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "Department of Neurology, First Affiliated Hospital Fujian Medical University", "city": "Fuzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 3, "broad_only": true}, {"nct": "NCT06576388", "title": "Clinical Trial to Evaluate the Safety and Efficacy of EXG001-307 in Patients With Spinal Muscular Atrophy Type I", "status": "COMPLETED", "start": "2022-01-21", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 2, "sponsor": "Guangzhou Jiayin Biotech Ltd", "conditions": ["Type I Spinal Muscular Atrophy"], "cn_sites": [{"facility": "Hangzhou Jiayin Biotechnology Co., Ltd", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT05089656", "title": "Efficacy and Safety of Intrathecal OAV101 (AVXS-101) in Pediatric Patients With Type 2 Spinal Muscular Atrophy (SMA)", "status": "COMPLETED", "start": "2022-02-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 126, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Type 2 Spinal Muscular Atrophy"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Chongqing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shenzhen", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Chengdu", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Hangzhou", "status": ""}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 7, "broad_only": true}, {"nct": "NCT05631418", "title": "Chinese Regional Spinal Muscular Atrophy Patient Registration Study", "status": "WITHDRAWN", "start": "2022-11", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 0, "sponsor": "The Children's Hospital of Zhejiang University School of Medicine", "conditions": ["Recruitment"], "cn_sites": [{"facility": "The Children's Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT05335876", "title": "Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-12-19", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Spinal Muscular Atrophy (SMA)"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Chongqing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Chengdu", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}], "cn_site_count": 4, "broad_only": true}, {"nct": "NCT05618379", "title": "Adult Spinal Muscular Atrophy (SMA) China Registry", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-01-06", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Biogen", "conditions": ["Muscular Atrophy, Spinal"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": ""}, {"facility": "The First Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "Peking University Shenzhen Hospital", "city": "Shenzhen", "status": ""}, {"facility": "The Second Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": ""}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": ""}, {"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": ""}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "The First People's Hospital of Yunnan Province", "city": "Kunming", "status": ""}], "cn_site_count": 12, "broad_only": true}, {"nct": "NCT05673109", "title": "A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer", "status": "TERMINATED", "start": "2023-02-22", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 8, "sponsor": "Accutar Biotechnology Inc", "conditions": ["Metastatic Castration Resistant Prostate Cancer"], "cn_sites": [{"facility": "Site 2001", "city": "Beijing", "status": ""}, {"facility": "Site 2003", "city": "Guangzhou", "status": ""}, {"facility": "Site 2004", "city": "Hunan", "status": ""}, {"facility": "Site 2005", "city": "Nanchang", "status": ""}, {"facility": "Site 2002", "city": "Shanghai", "status": ""}], "cn_site_count": 5, "broad_only": true}, {"nct": "NCT06191354", "title": "A Clinical Study Evaluating the Safety and Efficacy of SKG0201 Injection in Patients With Spinal Muscular Atrophy Type 1", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-06-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Kun Sun", "conditions": ["Spinal Muscular Atrophy 1"], "cn_sites": [{"facility": "West China Sencond Hospital, Sichuan University / West China women's and children's Hospital", "city": "Chengdu", "status": ""}, {"facility": "Xinhua Hospital Affiliated To Shanghai Jiao Tong University School Of Medicine", "city": "Shanghai", "status": ""}, {"facility": "National Children's Medical Center, Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 3, "broad_only": true}, {"nct": "NCT05901987", "title": "Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 2 Patients", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-08-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 33, "sponsor": "GeneCradle Inc", "conditions": ["SMA II"], "cn_sites": [{"facility": "Peking University， First Hospital, Department of Pediatrics", "city": "Beijing", "status": ""}, {"facility": "Bayi Children's Hospital, Seventh Medical Center, PLA general hospital", "city": "Beijing", "status": ""}, {"facility": "West China Second University Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Children's Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "Tongji Medical college of Huazhong University of Science&Technology, Affiliated Children's Hospital", "city": "Wuhan", "status": ""}], "cn_site_count": 5, "broad_only": true}, {"nct": "NCT07617779", "title": "A Study of the Safety and Preliminary Efficacy of NKG001 in Pediatric Patients With Type 1 or Type 2 Spinal Muscular Atrophy", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-04-21", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 21, "sponsor": "Nikegen Pharmaceutical (Hangzhou) Company Limited", "conditions": ["Spinal Muscular Atrophy (SMA)"], "cn_sites": [{"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06622356", "title": "Multivariate Analysis and Machine Learning Model Risk Prediction of Recurrent Pain After PLIF Surgery for Degenerative Lumbar Spine Disease At Long-term Follow-up", "status": "COMPLETED", "start": "2024-09-20", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 452, "sponsor": "Hao Liu", "conditions": ["Lumbar Disc Herniation", "Lumbar Degenerative Disease", "Sarcopenia"], "cn_sites": [{"facility": "Medical record system and imaging system of the First Affiliated Hospital of Suzhou University", "city": "Suzhou", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06628583", "title": "Multivariate Analysis and Risk Factors Were Used to Predict the Short-term Postoperative Pain of Degenerative Lumbar Spine", "status": "COMPLETED", "start": "2024-09-20", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 936, "sponsor": "Hao Liu", "conditions": ["Lumbar Disc Herniation", "Lumbar Degenerative Disease", "Sarcopenia"], "cn_sites": [{"facility": "Medical record system and imaging system of the First Affiliated Hospital of Suzhou University, China", "city": "Suzhou", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06288230", "title": "An Open Label Study of Gene Therapy Product (Vesemnogene Lantuparvovec) in Spinal Muscular Atrophy", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-10-20", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Lantu Biopharma", "conditions": ["Spinal Muscular Atrophy"], "cn_sites": [{"facility": "Kunming Hope of Health Hospital", "city": "Kunming", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06648486", "title": "Robot-assisted Training", "status": "COMPLETED", "start": "2025-02-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 13, "sponsor": "Peking University Third Hospital", "conditions": ["Spinal Muscular Atrophy (SMA)"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06764485", "title": "A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-03-13", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 960, "sponsor": "Celgene", "conditions": ["Metastatic Castration-resistant Prostate Cancer"], "cn_sites": [{"facility": "Local Institution - 0232", "city": "Hefei", "status": ""}, {"facility": "Local Institution - 0192", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 0249", "city": "Fuzhou", "status": ""}, {"facility": "Local Institution - 0213", "city": "Xiamen", "status": ""}, {"facility": "Local Institution - 0226", "city": "Guangzhou", "status": ""}, {"facility": "Local Institution - 0180", "city": "Guangzhou", "status": ""}, {"facility": "Local Institution - 0415", "city": "Huizhou", "status": ""}, {"facility": "Local Institution - 0417", "city": "Changzhou", "status": ""}, {"facility": "Local Institution - 0233", "city": "Nanjing", "status": ""}, {"facility": "Local Institution - 0229", "city": "Nanjing", "status": ""}, {"facility": "Local Institution - 0219", "city": "Nanchang", "status": ""}, {"facility": "Local Institution - 0191", "city": "Jinan", "status": ""}, {"facility": "Local Institution - 0221", "city": "Yantai", "status": ""}, {"facility": "Local Institution - 0214", "city": "Shanghai", "status": ""}, {"facility": "Local Institution - 0240", "city": "Chengdu", "status": ""}, {"facility": "Local Institution - 0278", "city": "Chengdu", "status": ""}, {"facility": "Local Institution - 0283", "city": "Chengdu", "status": ""}, {"facility": "Local Institution - 0218", "city": "Ürümqi", "status": ""}, {"facility": "Local Institution - 0196", "city": "Hangzhou", "status": ""}, {"facility": "Local Institution - 0281", "city": "Linhai", "status": ""}], "cn_site_count": 20, "broad_only": true}], "g_total": 1, "g_fetched": 1, "g_countries": [["France", 1]], "g_trials": [{"nct": "NCT06147414", "title": "Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders", "status": "RECRUITING", "start": "2024-10-23", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}]}, {"batch": 1, "no": 111, "name_zh": "脊髓小脑性共济失调", "query_terms": [{"term": "Autosomal dominant cerebellar ataxia", "broad": false}, {"term": "Spinocerebellar Ataxia", "broad": false}], "n_total": 11, "n_open": 3, "n_open_precise": 3, "n_broad": 0, "trials": [{"nct": "NCT07092358", "title": "Hereditary Ataxia Research on Multi-Omics and Neuroclinical Insights in the Yangtze Delta", "status": "RECRUITING", "start": "2025-06-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 5000, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Hereditary Ataxia"], "cn_sites": [{"facility": "Second Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07371663", "title": "An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors", "status": "RECRUITING", "start": "2025-12-03", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 266, "sponsor": "Beijing Tide Pharmaceutical Co., Ltd", "conditions": ["Solid Cancers", "NSCLC (Advanced Non-small Cell Lung Cancer)", "Gastric (Stomach) Cancer", "Endometrial Cancer", "Malignant Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07743866", "title": "Optimizing Parameters of Transcranial Temporal Interference Stimulation for Spinocerebellar Ataxia Type 3", "status": "NOT_YET_RECRUITING", "start": "2026-08-07", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "First Affiliated Hospital of Fujian Medical University", "conditions": ["Spinocerebellar Ataxia Type 3"], "cn_sites": [{"facility": "Department of Rehabilitation Medicine, The First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01360164", "title": "Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Hereditary Ataxia", "status": "UNKNOWN", "start": "2010-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Shenzhen Beike Bio-Technology Co., Ltd.", "conditions": ["Hereditary Ataxia"], "cn_sites": [{"facility": "Nanjing University Medical College Affiliated Drum Tower Hospital", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01489267", "title": "A New Method to Treat Hereditary Cerebellar Ataxia - Umbilical Cord Mesenchymal Stem Cells Transplantation", "status": "UNKNOWN", "start": "2011-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "General Hospital of Chinese Armed Police Forces", "conditions": ["Hereditary Cerebellar Ataxia."], "cn_sites": [{"facility": "Yihua An", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05502432", "title": "Repetitive Transcranial Magnetic Stimulation in SCA3 Patients", "status": "COMPLETED", "start": "2018-12-17", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 39, "sponsor": "Ning Wang, MD., PhD.", "conditions": ["Spinocerebellar Ataxia Type 3"], "cn_sites": [{"facility": "Department of Neurology ,First Affiliated Hospital Fujian Medical University", "city": "Fuzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03701399", "title": "Troriluzole in Adult Participants With Spinocerebellar Ataxia", "status": "ACTIVE_NOT_RECRUITING", "start": "2019-03-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 299, "sponsor": "Biohaven Pharmaceuticals, Inc.", "conditions": ["Spinocerebellar Ataxias", "Spinocerebellar Ataxia Type 1", "Spinocerebellar Ataxia Type 2", "Spinocerebellar Ataxia Type 3", "Spinocerebellar Ataxia Type 6", "Spinocerebellar Ataxia Type 7", "Spinocerebellar Ataxia Type 8", "Spinocerebellar Ataxia Type 10"], "cn_sites": [{"facility": "Central South University Xiangya Hospital", "city": "Changsha", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05160870", "title": "Genotype-phenotype Correlation and Pathogenic Mechanism in Hereditary Ataxia", "status": "UNKNOWN", "start": "2021-06-30", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Hereditary Ataxia"], "cn_sites": [{"facility": "Second Affiliated Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05160883", "title": "Neuroimaging Changes in Hereditary Ataxia", "status": "UNKNOWN", "start": "2021-06-30", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Hereditary Ataxia"], "cn_sites": [{"facility": "Second Affiliated Hospital,Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05557786", "title": "Treatment of Transcranial Alternating Current Stimulation（tACS）on Cerebellar Ataxia", "status": "COMPLETED", "start": "2022-08-07", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 164, "sponsor": "First Affiliated Hospital of Fujian Medical University", "conditions": ["Spinocerebellar Ataxia Type 3", "Multiple System Atrophy-cerebellar Type"], "cn_sites": [{"facility": "Department of Neurology, The First Affiliated Hospital Fujian Medical University", "city": "Fuzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06904716", "title": "The Study of Transcranial Magnetic Stimulation in the Regulation of Spinocerebellar Ataxia", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-05-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "First Affiliated Hospital of Chongqing Medical University", "conditions": ["Spinocerebellar Ataxia"], "cn_sites": [{"facility": "the First Affiliatted Hospital of Chongqing medical Uiversity", "city": "Chongqing", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 57, "g_fetched": 55, "g_countries": [["United States", 22], ["France", 14], ["Italy", 11], ["Germany", 10], ["Spain", 8], ["Austria", 7], ["United Kingdom", 7], ["Netherlands", 6], ["Belgium", 5], ["Canada", 5], ["Czechia", 5], ["Australia", 5], ["Brazil", 4], ["Poland", 3], ["Ireland", 3], ["Greece", 2], ["Denmark", 2], ["India", 2], ["Taiwan", 2], ["Israel", 2], ["Switzerland", 1], ["Saudi Arabia", 1], ["Turkey (Türkiye)", 1], ["New Zealand", 1], ["Hong Kong", 1], ["Hungary", 1]], "g_trials": [{"nct": "NCT03378414", "title": "Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia", "status": "NOT_YET_RECRUITING", "start": "2026-12-31", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Sclnow Biotechnology Co., Ltd.", "countries": []}, {"nct": "NCT06628687", "title": "A Study to Learn How BIIB141 (Omaveloxolone) Affects the Health of Participants With Friedrich's Ataxia Who Took it During Pregnancy and/or During Breastfeeding and About the Health of Their Babies", "status": "RECRUITING", "start": "2026-10-26", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Biogen", "countries": ["United States"]}, {"nct": "NCT07752095", "title": "Cerebellar DBS in SCA1 and SCA3 Study", "status": "NOT_YET_RECRUITING", "start": "2026-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Gordon H. Baltuch", "countries": ["United States"]}, {"nct": "NCT07709728", "title": "Biomarkers for Babies and Young Children With Ataxia Telangiectasia", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Nottingham", "countries": []}, {"nct": "NCT07221292", "title": "Pivotal Study of N-acetyl-L-leucine for CACNA1A", "status": "RECRUITING", "start": "2026-08-17", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "IntraBio Inc", "countries": ["Austria", "Germany", "Greece", "Italy", "Switzerland", "United Kingdom", "United States"]}, {"nct": "NCT07681713", "title": "Long-Term Efficacy Study of Vatiquinone for the Treatment of Friedreich's Ataxia (FA)", "status": "NOT_YET_RECRUITING", "start": "2026-08-15", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "PTC Therapeutics", "countries": ["Belgium", "Brazil", "Canada", "France", "Spain", "United States"]}, {"nct": "NCT07778836", "title": "A Study to Evaluate the Efficacy and Safety of Subcutaneous Nomlabofusp in Subjects With Friedreich's Ataxia", "status": "RECRUITING", "start": "2026-08-05", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Larimar Therapeutics, Inc.", "countries": ["United States"]}, {"nct": "NCT07215416", "title": "Safety and Efficacy of Mutation-targeted Precision Genetic Therapy for Ataxia-Telangiectasia (A-T)", "status": "RECRUITING", "start": "2026-08", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Timothy Yu", "countries": ["United States"]}, {"nct": "NCT07731971", "title": "Digital Outcome Assessment Using AI Active Gaming and Motion Capture in Friedreich Ataxia", "status": "NOT_YET_RECRUITING", "start": "2026-07-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Exeter", "countries": ["United Kingdom"]}, {"nct": "NCT07721025", "title": "Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy", "status": "RECRUITING", "start": "2026-06-25", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Lexeo Therapeutics", "countries": ["United States"]}, {"nct": "NCT07325487", "title": "Interposed Nucleus aDBS for Ataxia", "status": "RECRUITING", "start": "2026-06-02", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Florida", "countries": ["United States"]}, {"nct": "NCT07467733", "title": "Evaluation of the Safety and Preliminary Efficacy of Neuroinduced Mesenchymal Stem Cells and Exosome Therapy in Patients With Spinocerebellar Palsy", "status": "NOT_YET_RECRUITING", "start": "2026-06-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Biocells Medical", "countries": ["Poland"]}, {"nct": "NCT07288437", "title": "Deep Brain Stimulation for Spinocerebellar Ataxia", "status": "RECRUITING", "start": "2026-04-27", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of California, San Francisco", "countries": ["United States"]}, {"nct": "NCT07444333", "title": "Cardiac Output and Fatigue in Friedreich's Ataxia", "status": "NOT_YET_RECRUITING", "start": "2026-04-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Scott Barbuto", "countries": []}, {"nct": "NCT07200505", "title": "Telerehabilitation for Core Stability and Strength in Hereditary Ataxia", "status": "NOT_YET_RECRUITING", "start": "2026-02-09", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Universitat de Lleida", "countries": ["Spain"]}, {"nct": "NCT07099651", "title": "Autosomal Dominant Spinocerebellar Ataxias and Social Cognition", "status": "RECRUITING", "start": "2025-12-09", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Angers", "countries": ["France"]}, {"nct": "NCT07508631", "title": "Friedreich Ataxia Nerve Ultrasund", "status": "RECRUITING", "start": "2025-12-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Centre Hospitalier Universitaire de Nice", "countries": ["France"]}, {"nct": "NCT07180355", "title": "A Study of SGT-212 Gene Therapy in Friedreich's Ataxia", "status": "RECRUITING", "start": "2025-10-22", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Solid Biosciences Inc.", "countries": ["United States"]}, {"nct": "NCT07185347", "title": "A Randomized, Parallel-arm, Double Blind, Placebo-controlled Study to Assess the Efficacy of Fampridine for Patients With Spinocerebellar Ataxia SCA27B Caused by a GAA Expansion in the FGF14 Gene", "status": "RECRUITING", "start": "2025-10-21", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT07019558", "title": "Ophthalmological Disorders in Dominant Spinal-cerebellar Ataxias", "status": "RECRUITING", "start": "2025-10-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Montpellier", "countries": ["France"]}, {"nct": "NCT06865482", "title": "Clinical Course Of Disease In Participants With FA-CM", "status": "RECRUITING", "start": "2025-09-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Lexeo Therapeutics", "countries": ["Brazil", "Canada", "Czechia", "France", "Germany", "Italy", "Spain", "United States"]}, {"nct": "NCT07079332", "title": "Structural Validity and Inter-rater Reliabitiliy of the Ataxia Trunk, Lower And Upper Extremity Scale (ATLAS)", "status": "NOT_YET_RECRUITING", "start": "2025-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Haute Ecole de Santé Vaud", "countries": []}, {"nct": "NCT07095062", "title": "Electroencephalogram in Patients With Friedreich's Ataxia for the Study of the Structural and Functional Connectome.", "status": "RECRUITING", "start": "2025-07-07", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "IRCCS Eugenio Medea", "countries": ["Italy"]}, {"nct": "NCT06953583", "title": "A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Children and Teens With Friedreich's Ataxia", "status": "RECRUITING", "start": "2025-06-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Biogen", "countries": ["Australia", "Austria", "Brazil", "Canada", "Denmark", "France", "Germany", "India", "Ireland", "Italy", "Netherlands", "Saudi Arabia", "Spain", "Turkey (Türkiye)", "United Kingdom", "United States"]}, {"nct": "NCT06397274", "title": "Stemchymal® for Polyglutamine Spinocerebellar Ataxia", "status": "NOT_YET_RECRUITING", "start": "2025-06-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Steminent US, Inc.", "countries": []}]}, {"batch": 1, "no": 112, "name_zh": "系统性硬化症", "query_terms": [{"term": "Systemic sclerosis", "broad": false}], "n_total": 94, "n_open": 65, "n_open_precise": 65, "n_broad": 0, "trials": [{"nct": "NCT06417502", "title": "Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry", "status": "RECRUITING", "start": "2022-04-29", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 20000, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Autoimmune Diseases", "Autoinflammatory Diseases"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Third Hospital of Peking University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Chidren's Hospital of Chongqing Medical University", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": "RECRUITING"}, {"facility": "The University of Hong Kong Shenzhen Institute of Research and Innovation (HKU-SIRI)", "city": "Shenzhen", "status": "RECRUITING"}, {"facility": "The Second Xiangya Hospital of Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Children's Hospital of Nanjing Medical University", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Children's Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT05859997", "title": "Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases", "status": "ENROLLING_BY_INVITATION", "start": "2023-05-17", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Bioray Laboratories", "conditions": ["Systemic Lupus Erythematosus (SLE)", "Sjogren's Syndrome", "Systemic Sclerosis", "Inflammatory Myopathy", "ANCA Associated Systemic Vasculitis", "Antiphospholipid Syndrome"], "cn_sites": [{"facility": "Shanghai ChangZheng hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05878717", "title": "A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease", "status": "RECRUITING", "start": "2023-09-13", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 300, "sponsor": "GlaxoSmithKline", "conditions": ["Systemic Sclerosis Associated Interstitial Lung Disease", "Scleroderma, Systemic"], "cn_sites": [{"facility": "GSK Investigational Site", "city": "Beijing", "status": "RECRUITING"}, {"facility": "GSK Investigational Site", "city": "Changchun", "status": "RECRUITING"}, {"facility": "GSK Investigational Site", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "GSK Investigational Site", "city": "Luzhou", "status": "RECRUITING"}, {"facility": "GSK Investigational Site", "city": "Mianyang", "status": "RECRUITING"}, {"facility": "GSK Investigational Site", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "GSK Investigational Site", "city": "Nanning", "status": "RECRUITING"}, {"facility": "GSK Investigational Site", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "GSK Investigational Site", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "GSK Investigational Site", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "GSK Investigational Site", "city": "Zhuzhou", "status": "RECRUITING"}], "cn_site_count": 11, "broad_only": false}, {"nct": "NCT06058091", "title": "RY_SW01 Cell Injection Therapy in Systemic Sclerosis", "status": "RECRUITING", "start": "2023-09-22", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 81, "sponsor": "Jiangsu Renocell Biotech Company", "conditions": ["Systemic Sclerosis"], "cn_sites": [{"facility": "Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, the Affiliated Drum Tower Hospital of Nanjing University Medical School", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06189495", "title": "A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease", "status": "RECRUITING", "start": "2023-12-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Changchun GeneScience Pharmaceutical Co., Ltd.", "conditions": ["Systemic Sclerosis Associated Interstitial Lung Disease", "Rheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD)", "Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": "RECRUITING"}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT06249438", "title": "A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy", "status": "RECRUITING", "start": "2024-03-20", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "RenJi Hospital", "conditions": ["Systemic Lupus Erythematosus (SLE)", "Immune-mediated Necrotizing Myopathy (IMNM)", "Neuromyelitis Optica Spectrum Disorders (NMOSD)", "Multiple Sclerosis (MS)", "Myasthenia Gravis", "Systemic Sclerosis (SSc)"], "cn_sites": [{"facility": "Department of Rheumatology, RenJi Hospital, School of Medicine, Shanghai JiaoTong University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06503224", "title": "An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2024-04-09", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "The First Affiliated Hospital of University of Science and Technology of China", "conditions": ["Autoimmune Diseases"], "cn_sites": [{"facility": "Hunan Siweikang Therapeutic Co.Ltd", "city": "Changsha", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06420154", "title": "The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2024-05-27", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "First Affiliated Hospital of Wenzhou Medical University", "conditions": ["Systemic Lupus Erythematosus (SLE)", "Sjogren's Syndrome", "Systemic Sclerosis", "Inflammatory Myopathy", "ANCA Associated Vasculitis", "Antiphospholipid Syndrome"], "cn_sites": [{"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06414135", "title": "Relmacabtagene Autoleucel for the Treatment of Systemic Sclerosis", "status": "RECRUITING", "start": "2024-06-12", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Liangjing Lu", "conditions": ["Systemic Sclerosis"], "cn_sites": [{"facility": "Renji Hospital, Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06350110", "title": "Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)", "status": "RECRUITING", "start": "2024-07-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 75, "sponsor": "Essen Biotech", "conditions": ["Systemic Lupus Erythematosus", "Lupus Nephritis", "Autoimmune Diseases", "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis", "Granulomatous Polyangiitis", "Microscopic Polyangiitis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathies", "Sjogren's Syndrome"], "cn_sites": [{"facility": "District One Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06548607", "title": "Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases", "status": "RECRUITING", "start": "2024-09-14", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Nanjing Bioheng Biotech Co., Ltd.", "conditions": ["SLE (Systemic Lupus)", "Systemic Sclerosis", "ANCA Associated Vasculitis", "Idiopathic Inflammatory Myopathies", "Sjogren's Syndrome", "Autoimmune Diseases"], "cn_sites": [{"facility": "The Third the People's Hospital of Bengbu", "city": "Bengbu", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06470048", "title": "A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis", "status": "RECRUITING", "start": "2024-10-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 200, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Diffuse Cutaneous Systemic Sclerosis"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Nanning", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Changchun", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Ningbo", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT06888960", "title": "Safety Study of CC312 in Autoimmune Disease Patients", "status": "RECRUITING", "start": "2024-11-08", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "CytoCares Inc", "conditions": ["Systemic Lupus Erythematosus (SLE)", "Idiopathic Inflammatory Myopathy (IIM)", "Systemic Sclerosis (SSc)", "Rheumatoid Arthritis (RA)", "Primary Immune Thrombocytopenia (ITP)", "Autoimmune Hemolytic Anemia"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06716606", "title": "A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)", "status": "RECRUITING", "start": "2024-12-12", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 514, "sponsor": "GlaxoSmithKline", "conditions": ["Connective Tissue Diseases"], "cn_sites": [{"facility": "GSK Investigational Site", "city": "Beijing", "status": "RECRUITING"}, {"facility": "GSK Investigational Site", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "GSK Investigational Site", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "GSK Investigational Site", "city": "Mianyang", "status": "RECRUITING"}, {"facility": "GSK Investigational Site", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "GSK Investigational Site", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "GSK Investigational Site", "city": "Zhuzhou", "status": "RECRUITING"}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT06794008", "title": "BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2024-12-26", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Peking University People's Hospital", "conditions": ["Systemic Lupus Erythematosus", "Inflammatory Myopathy", "Systemic Sclerosis (SSc)", "ANCA-associated Vasculitis", "IgG4-Related Diseases", "Antiphospholipid Syndrome", "Acquired Thrombotic Thrombocytopenic Purpura", "Behcet Disease", "Sjogren Syndrome"], "cn_sites": [{"facility": "Department of Rheumatology and Immunology, Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06775912", "title": "Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases", "status": "RECRUITING", "start": "2025-01-03", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Nanjing Bioheng Biotech Co., Ltd.", "conditions": ["SLE", "Systemic Sclerosis", "IIM", "NMOSD", "MS", "MG", "ANCA Associated Vasculitis (AAV)"], "cn_sites": [{"facility": "The First People's Hospital of Lianyungang", "city": "Lianyungang", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06614270", "title": "Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases", "status": "RECRUITING", "start": "2025-01-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Systemic Sclerosis (SSc)", "ANCA Associated Vasculitis (AAV)", "Idiopathic Inflammatory Myopathy (IIM)", "Sjogren&#39;s Syndrome", "Antiphospholipid Syndrome", "Systemic Lupus Erythematosus"], "cn_sites": [{"facility": "the second affiliated hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06375005", "title": "Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis", "status": "RECRUITING", "start": "2025-01-06", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 38, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Diffuse Cutaneous Systemic Sclerosis"], "cn_sites": [{"facility": "Affiliated Hospital of Yangzhou University", "city": "Yangzhou", "status": "RECRUITING"}, {"facility": "Huashan Hospital of Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Hangzhou First People's Hospital", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Sir Run Run Shaw Hospital, Zhejiang University School Of Medicine", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Changxing People's Hospital", "city": "Huzhou", "status": "RECRUITING"}, {"facility": "The First Hospital of Jiaxing", "city": "Jiaxing", "status": "RECRUITING"}, {"facility": "Ningbo First Hospital", "city": "Ningbo", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": "RECRUITING"}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT06941129", "title": "CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2025-02-11", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Systemic Lupus Erythematosus", "Systemic Sclerosis (SSc)", "Inflammatory Myopathy", "ANCA-Associated Vasculitis (AAV)", "Connective Tissue Disease-Associated Thrombocytopenia", "SLE-ITP"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06822881", "title": "CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc)", "status": "RECRUITING", "start": "2025-02-20", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 27, "sponsor": "Beijing GoBroad Hospital", "conditions": ["Systemic Lupus Erythematosus (SLE)", "Systemic Sclerosis (SSc)"], "cn_sites": [{"facility": "Beijing GoBroad Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06801119", "title": "Efficacy and Safety of HN2301 in Autoimmune Diseases（AIDs）", "status": "RECRUITING", "start": "2025-03-16", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Shenzhen MagicRNA Biotechnology Co., Ltd", "conditions": ["Systemic Lupus Erythematosus", "Scleroderma", "Rheumatoid Arthritis"], "cn_sites": [{"facility": "The First Affiliated Hospital of University of Science and Technology of China", "city": "Hefei", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06871644", "title": "Clinical Study of CD7 CAR-T Cells for Relapsed/refractory Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2025-03-18", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "PersonGen BioTherapeutics (Suzhou) Co., Ltd.", "conditions": ["Systemic Sclerosis - 2013 ACR/EULAR Classification Criteria"], "cn_sites": [{"facility": "PersonGen.Anke Cellular Therapeutice Co. Ltd", "city": "Hefei", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06947460", "title": "CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH", "status": "RECRUITING", "start": "2025-04-18", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 45, "sponsor": "Beijing GoBroad Hospital", "conditions": ["Refractory Lupus Nephritis", "Systemic Sclerosis", "Primary Sjogren&#39;s Syndrome Combined With Pulmonary Hypertension", "Other Autoimmune Diseases (AID)"], "cn_sites": [{"facility": "北京高博医院", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06978738", "title": "UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2025-05", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Changzhou No.2 People's Hospital", "conditions": ["Systemic Lupus Erythematosus", "Autoimmune Hemolytic Anemia", "Myasthenia Gravis", "Systemic Sclerosis", "ANCA-Associated Vasculitis", "Inflammatory Myopathy", "IgG4-RD"], "cn_sites": [{"facility": "Changzhou No.2 People's Hospital", "city": "Changzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06970951", "title": "Early Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2025-05-18", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "PersonGen BioTherapeutics (Suzhou) Co., Ltd.", "conditions": ["Systemic Lupus Erythematosus", "Rheumatoid Arthritis", "Dry Syndrome", "Idiopathic Inflammatory Myopathies", "Systemic Sclerosis"], "cn_sites": [{"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06978647", "title": "A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases", "status": "RECRUITING", "start": "2025-05-19", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "China Immunotech (Beijing) Biotechnology Co., Ltd.", "conditions": ["Systemic Lupus Erythematosus (SLE)", "Systemic Sclerosis (SSc)", "Inflammatory Myopathy", "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis", "Antiphospholipid Syndrome (APS)", "Rheumatoid Arthritis (RA)", "IgG4-Related Diseases", "Sjogren&#39;s Syndrome"], "cn_sites": [{"facility": "The First Medical Center of Chinese PLA General Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07188285", "title": "Mass Spectrometry-based Immune Profiling in Autoimmune Diseases", "status": "ENROLLING_BY_INVITATION", "start": "2025-05-25", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Peking University People's Hospital", "conditions": ["Systemic Lupus Erthematosus", "Sjogren&#39;s Syndrome", "Inflammatory Myopathies", "Systemic Sclerosis (SSc)", "Vasculitis", "Rheumatoid Arthritis (RA)", "Ankylosing Spondylitis", "Osteoarthritis", "Gouty Arthritis (GA)", "Psoriatic Arthritis (PsA)", "Healthy Controls"], "cn_sites": [{"facility": "Peking university people's hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07000682", "title": "The Clinical Study on the Treatment of SSc With UTAA91 Injection.", "status": "RECRUITING", "start": "2025-05-30", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": ["Systemic Sclerosis (SSc)"], "cn_sites": [{"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06980597", "title": "A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2025-06", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 44, "sponsor": "Beijing GoBroad Hospital", "conditions": ["Systemic Lupus Erythematosus (SLE)", "Idiopathic Inflammatory Myopathy (IIM)", "Systemic Sclerosis (SSc)", "ANCA Associated Vasculitis (AAV)"], "cn_sites": [{"facility": "Beijing Boren Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing GoBroad Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06982534", "title": "Clinical Study on the Treatment of Systemic Sclerosis With UTAA91 Injection.", "status": "NOT_YET_RECRUITING", "start": "2025-06", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "PersonGen BioTherapeutics (Suzhou) Co., Ltd.", "conditions": ["Systemic Sclerosis (SSc)"], "cn_sites": [{"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06828042", "title": "Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2025-07-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Peking University Third Hospital", "conditions": ["Systemic Lupus Erthematosus", "Systemic Sclerosis (SSc)", "Sjogren Syndrome", "ANCA Associated Vasculitis (AAV)", "Inflammatory Myopathies", "Antiphospholipid Syndrome"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07052565", "title": "CAR-T Cells Therapy for Patients With Autoimmune Diseases", "status": "RECRUITING", "start": "2025-07-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Anhui Provincial Hospital", "conditions": ["Autoimmune Diseases"], "cn_sites": [{"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07104721", "title": "A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases", "status": "RECRUITING", "start": "2025-08-04", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "China Immunotech (Beijing) Biotechnology Co., Ltd.", "conditions": ["Systemic Lupus Erythematosus (SLE)", "Lupus Nephritis (LN)", "Systemic Sclerosis (SSc)", "Inflammatory Myopathy", "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis", "Antiphospholipid Syndrome (APS)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07121777", "title": "Anti CD19/BCMA CAR Gene Therapy for Autoimmune Diseases", "status": "RECRUITING", "start": "2025-08-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Anhui Provincial Hospital", "conditions": ["Autoimmune Diseases"], "cn_sites": [{"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07184450", "title": "Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases", "status": "RECRUITING", "start": "2025-09-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 11, "sponsor": "Chongqing Precision Biotech Co., Ltd", "conditions": ["Juvenile Dermatomyositis (JDM)", "Polyarticular Juvenile Idiopathic Arthritis", "Systemic Sclerosis (SSc)", "Primary Sjogren&#39;s Syndrome"], "cn_sites": [{"facility": "Children's Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07193810", "title": "A Study of CC312 for Relapsed/Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2025-09-23", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "CytoCares Inc", "conditions": ["SLE - Systemic Lupus Erythematosus", "IIM- Idiopathic Inflammatory Myopathies", "SSc-Systemic Sclerosis"], "cn_sites": [{"facility": "Deyang People's Hospital", "city": "Deyang", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07167537", "title": "A Study of OL-CD19-GDT in Relapsed/ Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2025-10", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 44, "sponsor": "Beijing GoBroad Hospital", "conditions": ["Systemic Sclerosis (SSc)", "Primary Sjogren&#39;s Syndrome"], "cn_sites": [{"facility": "Beijing GoBroad Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07641634", "title": "A Phase 1/2 Study of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis.", "status": "RECRUITING", "start": "2025-10-27", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 44, "sponsor": "Prolium Bioscience, Inc", "conditions": ["Healthy Volunteers", "Systemic Sclerosis (SSc)", "Scleroderma, Systemic", "Scleroderma"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Guangdong Provincial People's Hospital", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "The Third Affiliated Hospital of Sun Yat-Sen University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Pingxiang People's Hospital", "city": "Pingxiang", "status": "RECRUITING"}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT07361094", "title": "Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2025-11-06", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Beijing Boren Hospital", "conditions": ["Relapsed/Refractory Systemic Lupus Erythematosus", "Relapsed/Refractory Systemic Sclerosis", "Relapsed/Refractory Idiopathic Inflammatory Myopathies", "Relapsed/Refractory sjögren's Syndrome", "Relapsed/Refractory Autoimmune Hemolytic Anemia", "Relapsed/Refractory Multiple Sclerosis"], "cn_sites": [{"facility": "Beijing GoBroad Boren Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07236801", "title": "Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases", "status": "RECRUITING", "start": "2025-11-13", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "China Immunotech (Beijing) Biotechnology Co., Ltd.", "conditions": ["Systemic Lupus Erythematosus (SLE)", "Systemic Sclerosis", "Sjogren's Syndrome (SS)", "Inflammatory Myopathy", "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis", "Antiphospholipid Syndrome"], "cn_sites": [{"facility": "The Affiliated Hospital of Xuzhou Medical University", "city": "Xuzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07305116", "title": "CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease", "status": "RECRUITING", "start": "2025-12-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "The Children's Hospital of Zhejiang University School of Medicine", "conditions": ["Autoimmune Diseases", "Systemic Lupus Erthematosus (SLE)", "Multi-Drug Resistant Nephrotic Syndrome", "IgA Nephropathy (IgAN)", "Systemic Sclerosis (SSc)", "ANCA Associated Systemic Vasculitis"], "cn_sites": [{"facility": "Children's Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07360808", "title": "Safety and Efficacy of Adipose-Derived Regenerative Cells (ADRCs) for Improving Hand Dysfunction in Systemic Sclerosis", "status": "RECRUITING", "start": "2025-12-31", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 48, "sponsor": "Cytori Therapeutics", "conditions": ["Systemic Sclerosis (SSc)", "Hand Dysfunction"], "cn_sites": [{"facility": "NanFang Hospital of Southern Medical University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Huashan Hospital Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07315087", "title": "CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2026-01-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["SLE - Systemic Lupus Erythematosus", "SSc-Systemic Sclerosis", "IIM- Idiopathic Inflammatory Myopathies", "ANCA Associated Vasculitis (AAV)", "Connective Tissue Disease-Associated Thrombocytopenia", "SLE-ITP"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07355972", "title": "Safety, Efficacy and Cellular Metabolic Dynamics of CT1195E in Patients With Refractory / Progressive SSC", "status": "RECRUITING", "start": "2026-01-16", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": ["SSc-Systemic Sclerosis"], "cn_sites": [{"facility": "Wuhan Union Hospita", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07413341", "title": "A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2026-01-22", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Therorna", "conditions": ["Systemic Lupus Erythematosus (SLE)", "Sjogren's Syndrome (SS)", "Systemic Sclerosis (SSc)", "Inflammatory Myopathy", "ANCA Associated Systemic Vasculitis"], "cn_sites": [{"facility": "Shanghai Changzheng Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07212322", "title": "A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-01-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Systemic Lupus Erythematosus", "Idiopahic Inflammatory Myopathies", "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis", "Sjögren's Syndrome", "Antiphospholipid Syndrome", "Immune Thrombocytopenia", "Systemic Sclerosis"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07246096", "title": "Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2026-02-20", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Changhai Hospital", "conditions": ["Autoimmune Diseases", "Systemic Lupus Erythematosus", "Systemic Sclerosis", "Primary Sjögren Syndrome", "Rheumatoid Arthritis", "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis"], "cn_sites": [{"facility": "Changhai Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07439029", "title": "YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-03", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Children's Hospital of Fudan University", "conditions": ["Systemic Lupus Erythematosus (SLE)", "Diffuse Systemic Sclerosis", "Idiopathic Inflammatory Myopathies (IIMs)", "ANCA Associated Vasculitis (AAV)", "Antiphospholipid Syndrome (APS)", "Sjogren's Syndrome (SS)"], "cn_sites": [{"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07470151", "title": "Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2026-03-12", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": ["System Lupus Erythematosus(SLE)", "Scleroderma", "Myasthenia Gravis (MG)"], "cn_sites": [{"facility": "Union hospital Tongji medical college Huazhong university of science and technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06947473", "title": "Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.", "status": "RECRUITING", "start": "2026-03-18", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 45, "sponsor": "Beijing GoBroad Hospital", "conditions": ["Refractory Lupus Nephritis", "Systemic Sclerosis", "Primary Sjogren&#39;s Syndrome Combined With Pulmonary Hypertension"], "cn_sites": [{"facility": "Beijing GoBroad Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07526350", "title": "MTS109 in Patients With Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2026-03-24", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Shanghai Changzheng Hospital", "conditions": ["Systemic Lupus Erythematosus", "Idiopathic Inflammatory Myopathies", "Systemic Sclerosis (SSc)", "ANCA-Associated Vasculitis (AAV)", "Sjogren's Syndrome (SS)"], "cn_sites": [{"facility": "Shanghai ChangZheng Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07507201", "title": "Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease", "status": "RECRUITING", "start": "2026-04-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "The Children's Hospital of Zhejiang University School of Medicine", "conditions": ["Autoimmune Diseases", "Systemic Lupus Erthematosus (SLE)", "Multi-Drug Resistant Nephrotic Syndrome", "IgA Nephropathy (IgAN)", "Systemic Sclerosis (SSc)", "ANCA Associated Systemic Vasculitis"], "cn_sites": [{"facility": "Children's Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07583030", "title": "A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-04-20", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 44, "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": ["Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE)", "Relapsed/Refractory IgG4-Related Disease (r/r IgG4-RD)", "Progressive Multiple Sclerosis (PMS)", "Relapsed/Refractory Myasthenia Gravis(r/r MS)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": ""}, {"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Shanxi Bethune Hospital", "city": "Taiyuan", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT07502105", "title": "Efficacy and Safety of Firsekibart in the Treatment of Systemic Sclerosis", "status": "NOT_YET_RECRUITING", "start": "2026-05-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Tongji Hospital", "conditions": ["Systemic Scleroderma"], "cn_sites": [{"facility": "Tongji Hospital, Tong ji Medical Colledge", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07586267", "title": "CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease", "status": "RECRUITING", "start": "2026-05-08", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "The Children's Hospital of Zhejiang University School of Medicine", "conditions": ["Autoimmune Diseases", "Systemic Lupus Erthematosus (SLE)", "Multi-Drug Resistant Nephrotic Syndrome", "IgA Nephropathy (IgAN)", "Systemic Sclerosis (SSc)", "ANCA Associated Systemic Vasculitis"], "cn_sites": [{"facility": "Children's Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07558850", "title": "Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2026-05-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 72, "sponsor": "The First Affiliated Hospital with Nanjing Medical University", "conditions": ["Rheumatoid Arthritis", "Dermatomyositis", "Systemic Lupus Erythematosus", "Systemic Sclerosis"], "cn_sites": [{"facility": "The First Affiliated Hospital with Nanjing Medical University (Jiangsu Province Hospital)", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07593911", "title": "A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 75, "sponsor": "Beijing GoBroad Hospital", "conditions": ["Systemic Lupus Erthematosus (SLE)", "Lupus Nephritis (LN)", "Multiple Sclerosis", "Myasthenia Gravis (MG)", "IgG4-Related Diseases", "Rheumatoid Arthritis (RA)"], "cn_sites": [{"facility": "Beijing GoBroad Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07676266", "title": "A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "The Affiliated Hospital of Qingdao University", "conditions": ["Multiple Sclerosis (MS)", "Myasthenia Gravis (MG)", "Neuromyelitis Optica Spectrum Disorder", "Systemic Lupus Erythematosus", "Systemic Sclerosis", "Immune-Mediated Necrotizing Myopathy"], "cn_sites": [{"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07674147", "title": "RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "The Children's Hospital of Zhejiang University School of Medicine", "conditions": ["Autoimmune Diseases", "SLE - Systemic Lupus Erythematosus", "SSc-Systemic Sclerosis", "IIM- Idiopathic Inflammatory Myopathies", "IgAN - IgA Nephropathy", "Multi-Drug Resistant Nephrotic Syndrome"], "cn_sites": [{"facility": "Nanjing Children's Hospital", "city": "Nanjing", "status": ""}, {"facility": "Children's Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07497087", "title": "A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis", "status": "RECRUITING", "start": "2026-07-27", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 448, "sponsor": "Boehringer Ingelheim", "conditions": ["Systemic Sclerosis"], "cn_sites": [{"facility": "China-Japan Friendship Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": "NOT_YET_RECRUITING"}, {"facility": "Xiangya Hospital, Central South University", "city": "Changsha", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Xiangya Hospital Of Central South University", "city": "Changsha", "status": "NOT_YET_RECRUITING"}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}, {"facility": "Guangdong Provincial People's Hospital", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The third affiliated hospital of Sun Yat-Sen University", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Henan University of Science and Technology", "city": "Luoyang", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": "NOT_YET_RECRUITING"}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Ningbo University", "city": "Ningbo", "status": "RECRUITING"}, {"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Renji Hospital Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}, {"facility": "The Eighth Affiliated Hospital, Sun Yat-sen University", "city": "Shenzhen", "status": "NOT_YET_RECRUITING"}, {"facility": "People's Hospital of Sichuan Province", "city": "Sichuan", "status": "NOT_YET_RECRUITING"}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Tongji Hospital Affiliated Tongji Medical College Huazhong University of S & T", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}, {"facility": "First Affiliated Hospital of Xiamen University", "city": "Xiamen", "status": "NOT_YET_RECRUITING"}, {"facility": "The Affiliated Hospital of Xuzhou Medical College", "city": "Xuzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Zhuzhou Central Hospital", "city": "Zhuzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 25, "broad_only": false}, {"nct": "NCT07745725", "title": "A Phase II Study of TollB-001 Tablets in Systemic Sclerosis", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Toll Biotech Co. Ltd. (Beijing)", "conditions": ["Systemic Sclerosis (SSc)"], "cn_sites": [{"facility": "Toll Biotech, 2108-B007, No. 9 West Beisihuan Road, Haidian District, Beijing, People's Republic of China", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07732309", "title": "A Study of ATG-201 in Adult Participants With Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 149, "sponsor": "Antengene Biologics Limited", "conditions": ["Systemic Lupus Erythematosus", "Systemic Sclerosis (SSc)", "Sjogren's Disease"], "cn_sites": [{"facility": "The First Affiliated Hospital of Bengbu Medical University", "city": "Bengbu", "status": ""}, {"facility": "The First Affiliated Hospital of University of Science and Technology of China", "city": "Hefei", "status": ""}, {"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital of Xiamen University", "city": "Xiamen", "status": ""}, {"facility": "Nanfang Hospital of Southern Medical Universit", "city": "Guangzhou", "status": ""}, {"facility": "Sun Yat-sen Memorial Hospital, Sun Yat-sen Universit", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Guangzhou University of Chinese Medicine", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "The Third Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Henan University of Science and Technology", "city": "Luoyang", "status": ""}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": ""}, {"facility": "Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School", "city": "Nanjing", "status": ""}, {"facility": "Nuclear Industry General Hospital", "city": "Suzhou", "status": ""}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": ""}, {"facility": "Linyi People's Hospital", "city": "Linyi", "status": ""}, {"facility": "Huashan Hospital Affiliated to Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Renji Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "The First Hospital of Shanxi Medical University", "city": "Taiyuan", "status": ""}, {"facility": "The Second Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi’an", "status": ""}, {"facility": "The Second Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 22, "broad_only": false}, {"nct": "NCT07596680", "title": "CD19/BCMA-Targeted Universal CAR-T Cell Injection for the Treatment of Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Nanjing Bioheng Biotech Co., Ltd.", "conditions": ["SLE - Systemic Lupus Erythematosus", "Systemic Sclerosis", "ANCA Associated Vasculitis", "Idiopathic Inflammatory Myopathies", "Sjögren Syndrome"], "cn_sites": [{"facility": "Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07806045", "title": "Nebulized UC-EVs for Recurrent or Refractory IMIDs With Lung Involvement", "status": "NOT_YET_RECRUITING", "start": "2026-10-14", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Qiubai Li", "conditions": ["IgG4 Related Disease", "Systemic Sclerosis (SSc)"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07523282", "title": "Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-12-31", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Shenzhen MagicRNA Biotechnology Co., Ltd", "conditions": ["Autoimmune Disease", "Systemic Lupus Erythematosus", "Systemic Sclerosis (SSc)"], "cn_sites": [{"facility": "The First Affiliated Hospital of University of Science and Technology of China", "city": "Hefei", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00706082", "title": "Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc)", "status": "TERMINATED", "start": "2008-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 490, "sponsor": "Actelion", "conditions": ["Systemic Sclerosis", "Pulmonary Arterial Hypertension", "Pulmonary Hypertension"], "cn_sites": [{"facility": "Peking Union Medical College Hospital (West Campus) Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00962923", "title": "Allogeneic Mesenchymal Stem Cells Transplantation for Systemic Sclerosis (SSc)", "status": "UNKNOWN", "start": "2009-08", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School", "conditions": ["Systemic Sclerosis", "Mesenchymal Stem Cells"], "cn_sites": [{"facility": "the Affiliated Drum Tower Hospital of Nanjing University Medical School", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02597933", "title": "A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis", "status": "COMPLETED", "start": "2015-11-12", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 580, "sponsor": "Boehringer Ingelheim", "conditions": ["Scleroderma, Systemic"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Chao-Yang Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Hospital", "city": "Beijing", "status": ""}, {"facility": "First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "West China Hospital", "city": "Chengdu", "status": ""}, {"facility": "The First Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": ""}, {"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": ""}, {"facility": "The First Hospital of Chinese Medical University", "city": "Shenyang", "status": ""}, {"facility": "Zhuzhou Central Hospital", "city": "Zhuzhou", "status": ""}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT03068234", "title": "Pirfenidone as Treatment of Skin Fibrosis in Systemic Sclerosis", "status": "UNKNOWN", "start": "2017-05", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 72, "sponsor": "RenJi Hospital", "conditions": ["Systemic Sclerosis"], "cn_sites": [{"facility": "RenJi Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03446339", "title": "Pulmonary Hypertension Screening for Rheumatology Patients (SOPHIE)", "status": "UNKNOWN", "start": "2017-08-03", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1800, "sponsor": "The University of Hong Kong", "conditions": ["Connective Tissue Diseases", "Systemic Sclerosis", "Systemic Lupus Erythematosus"], "cn_sites": [{"facility": "The University of Hong Kong", "city": "Hong Kong", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03313180", "title": "A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis", "status": "COMPLETED", "start": "2017-11-27", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 444, "sponsor": "Boehringer Ingelheim", "conditions": ["Lung Diseases, Interstitial"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "West China Hospital", "city": "Chengdu", "status": ""}, {"facility": "The First Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": ""}, {"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": ""}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT03856853", "title": "Efficacy and Safety of Pirfenidone in Patient With Systemic Sclerosis-associated Interstitial Lung Disease", "status": "UNKNOWN", "start": "2018-06-15", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 144, "sponsor": "Beijing Continent Pharmaceutical Co, Ltd.", "conditions": ["Systemic Sclerosis-associated Interstitial Lung Disease (Ssc-ild)"], "cn_sites": [{"facility": "Zhang, Ling", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04928586", "title": "Immunosuppressant Combined With Pirfenidone in CTD-ILD", "status": "UNKNOWN", "start": "2019-08-16", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 200, "sponsor": "Qilu Hospital of Shandong University", "conditions": ["Pirfenidone", "Connective Tissue Diseases", "Interstitial Lung Disease"], "cn_sites": [{"facility": "Qilu Hospital", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05297474", "title": "Structural and Functional Impairment of Multiple Organs in Patients With Systemic Sclerosis: A MR Imaging Study", "status": "UNKNOWN", "start": "2021-07-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 95, "sponsor": "Tsinghua University", "conditions": ["Systemic Sclerosis", "Multisystem Disorder"], "cn_sites": [{"facility": "Huilin He", "city": "Beijing", "status": "RECRUITING"}, {"facility": "China Center for Biomedical Imaging Research, Department of Biomedical Engineering, Tsinghua University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05085444", "title": "A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Scleroderma", "status": "UNKNOWN", "start": "2021-10-08", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Zhejiang University", "conditions": ["Scleroderma", "Autoimmune Diseases"], "cn_sites": [{"facility": "The First Affiliated Hospital, College of Medicine, Zhejiang University", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05300932", "title": "A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-03-08", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Tongji Hospital", "conditions": ["Systemic Sclerosis"], "cn_sites": [{"facility": "Department of RheumatologyTongji Hospital", "city": "Wuhan", "status": ""}, {"facility": "Tongji Hospital", "city": "Wuhan", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05505409", "title": "Efficacy and Safety of Pirfenidone in CTD-ILD", "status": "UNKNOWN", "start": "2022-06-22", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Qilu Hospital of Shandong University", "conditions": ["Pirfenidone", "Connective Tissue Diseases", "Interstitial Lung Disease"], "cn_sites": [{"facility": "Qilu Hospital", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05559580", "title": "A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms", "status": "COMPLETED", "start": "2022-12-13", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 214, "sponsor": "Boehringer Ingelheim", "conditions": ["Scleroderma, Systemic"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital Of Bengbu Medical College", "city": "Bengbu", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Guangdong Provincial People's Hospital", "city": "Guangzhou", "status": ""}, {"facility": "The third affiliated hospital of Sun Yat-Sen University", "city": "Guangzhou", "status": ""}, {"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": ""}, {"facility": "The First Affiliated Hospital of Ningbo University", "city": "Ningbo", "status": ""}, {"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": ""}, {"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": ""}, {"facility": "Wuhan Union Hospital", "city": "Wuhan", "status": ""}, {"facility": "Tongji Hospital Affiliated Tongji Medical College Huazhong University of S & T", "city": "Wuhan", "status": ""}], "cn_site_count": 16, "broad_only": false}, {"nct": "NCT06056921", "title": "Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease", "status": "UNKNOWN", "start": "2023-08-31", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Chongqing Precision Biotech Co., Ltd", "conditions": ["SLE (Systemic Lupus)", "Sjogren's Syndrome", "Systemic Scleroderma", "Dermatomyositis", "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis"], "cn_sites": [{"facility": "Shanxi Bethune Hospital", "city": "Taiyuan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06025578", "title": "A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-10-25", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1057, "sponsor": "Bristol-Myers Squibb", "conditions": ["Progressive Pulmonary Fibrosis"], "cn_sites": [{"facility": "Local Institution - 0087", "city": "Hefei", "status": ""}, {"facility": "Local Institution - 0113", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 0086", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 0100", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 0322", "city": "Lanzhou", "status": ""}, {"facility": "Local Institution - 0431", "city": "Guangzhou", "status": ""}, {"facility": "Local Institution - 0308", "city": "Guangzhou", "status": ""}, {"facility": "Local Institution - 0494", "city": "Guangzhou", "status": ""}, {"facility": "Local Institution - 0085", "city": "Shenzhen", "status": ""}, {"facility": "Local Institution - 0510", "city": "Shenzhen Shi", "status": ""}, {"facility": "Local Institution - 0425", "city": "Zhengzhou", "status": ""}, {"facility": "Local Institution - 0309", "city": "Shijiazhuang", "status": ""}, {"facility": "Local Institution - 0495", "city": "Yichang Shi", "status": ""}, {"facility": "Local Institution - 0455", "city": "Zhengzhou", "status": ""}, {"facility": "Local Institution - 0312", "city": "Wuhan", "status": ""}, {"facility": "Local Institution - 0432", "city": "Wuhan", "status": ""}, {"facility": "Local Institution - 0458", "city": "Suzhou", "status": ""}, {"facility": "Local Institution - 0172", "city": "Wuxi", "status": ""}, {"facility": "Local Institution - 0327", "city": "Nanjing", "status": ""}, {"facility": "Local Institution - 0496", "city": "Xuzhou", "status": ""}, {"facility": "Local Institution - 0443", "city": "Nanchang", "status": ""}, {"facility": "Local Institution - 0323", "city": "Shenyang", "status": ""}, {"facility": "Local Institution - 0497", "city": "Shenyang", "status": ""}, {"facility": "Local Institution - 0311", "city": "Xi'an", "status": ""}, {"facility": "Local Institution - 0329", "city": "Shanghai", "status": ""}, {"facility": "Local Institution - 0386", "city": "Shanghai", "status": ""}, {"facility": "Local Institution - 0096", "city": "Shanghai", "status": ""}, {"facility": "Local Institution - 0098", "city": "Shanghai Shi", "status": ""}, {"facility": "Local Institution - 0083", "city": "Shanghai Shi", "status": ""}, {"facility": "Local Institution - 0088", "city": "Shanghai", "status": ""}, {"facility": "Local Institution - 0324", "city": "Shanghai", "status": ""}, {"facility": "Local Institution - 0318", "city": "Chengdu", "status": ""}, {"facility": "Local Institution - 0372", "city": "Tianjin", "status": ""}, {"facility": "Local Institution - 0326", "city": "Tianjin", "status": ""}, {"facility": "Local Institution - 0454", "city": "Ningxia", "status": ""}, {"facility": "Local Institution - 0508", "city": "Hangzhou", "status": ""}, {"facility": "Local Institution - 0319", "city": "Hangzhou", "status": ""}, {"facility": "Local Institution - 0298", "city": "Ningbo", "status": ""}, {"facility": "Local Institution - 0429", "city": "Hangzhou", "status": ""}, {"facility": "Local Institution - 0426", "city": "Changsha", "status": ""}, {"facility": "Local Institution - 0313", "city": "Chengdu", "status": ""}, {"facility": "Local Institution - 0084", "city": "Hefei", "status": ""}, {"facility": "Local Institution - 0105", "city": "Hohhot", "status": ""}, {"facility": "Local Institution - 0433", "city": "Jinan", "status": ""}, {"facility": "Local Institution - 0434", "city": "Shijiazhuang", "status": ""}], "cn_site_count": 45, "broad_only": false}, {"nct": "NCT06316076", "title": "Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases", "status": "UNKNOWN", "start": "2023-10-30", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 48, "sponsor": "RenJi Hospital", "conditions": ["Systemic Lupus Erythematosus", "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis", "Idiopathic Inflammatory Myopathies", "Systemic Sclerosis"], "cn_sites": [{"facility": "Department of Rheumatology, Ren Ji Hospital South Campus, School of Medicine, Shanghai JiaoTong University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05925803", "title": "Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-11-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 314, "sponsor": "AstraZeneca", "conditions": ["Systemic Sclerosis", "Scleroderma"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Guangzhou", "status": ""}, {"facility": "Research Site", "city": "Hangzhou", "status": ""}, {"facility": "Research Site", "city": "Lanzhou", "status": ""}, {"facility": "Research Site", "city": "Shanghai", "status": ""}, {"facility": "Research Site", "city": "Tianjin", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT06149260", "title": "Subcutaneous Semaglutide in Systemic Scleroderma", "status": "UNKNOWN", "start": "2024-02-29", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Second Xiangya Hospital of Central South University", "conditions": ["Scleroderma, Systemic", "Fibrosis", "Semaglutide"], "cn_sites": [{"facility": "the Second Xiangya Hospital", "city": "Changsha", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06361745", "title": "Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases", "status": "UNKNOWN", "start": "2024-04-02", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "PersonGen BioTherapeutics (Suzhou) Co., Ltd.", "conditions": ["Systemic Lupus Erythematosus", "Idiopathic Inflammatory Myopathies", "Systemic Sclerosis", "IgG4 Related Disease", "Primary Sjögren Syndrome"], "cn_sites": [{"facility": "PersonGen.Anke Cellular Therapeutice Co., Ltd", "city": "Hefei", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06373081", "title": "Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease", "status": "UNKNOWN", "start": "2024-04-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Shanghai Changzheng Hospital", "conditions": ["Systemic Lupus Erythematosus (SLE)", "Sjogren's Syndrome", "Systemic Sclerosis", "Inflammatory Myopathy", "ANCA Associated Vasculitis", "Antiphospholipid Syndrome"], "cn_sites": [{"facility": "Shanghai ChangZheng hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06379646", "title": "An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease", "status": "UNKNOWN", "start": "2024-04-24", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "China Immunotech (Beijing) Biotechnology Co., Ltd.", "conditions": ["Systemic Lupus Erythematosus", "Systemic Sclerosis", "Inflammatory Myopathy", "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis", "Antiphospholipid Syndrome", "Sjogren's Syndrome"], "cn_sites": [{"facility": "Shanghai Changzheng Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06546540", "title": "The Safety and Efficacy of Telitacicept in the Treatment of Systemic Sclerosis", "status": "UNKNOWN", "start": "2024-06-08", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Peking University Third Hospital", "conditions": ["Systemic Sclerosis"], "cn_sites": [{"facility": "Peking Third Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06548620", "title": "A Study of RD06-04 in Patients With Active Autoimmune Diseases", "status": "WITHDRAWN", "start": "2024-08-31", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Nanjing Bioheng Biotech Co., Ltd.", "conditions": ["SLE", "Sclerosis", "ANCA Associated Vasculitis", "IIM", "SS", "MS", "NMO Spectrum Disorder", "MG"], "cn_sites": [{"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06549296", "title": "Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune Diseases", "status": "SUSPENDED", "start": "2024-09-13", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Nanjing Bioheng Biotech Co., Ltd.", "conditions": ["Systemic Lupus Erythematosus", "Systemic Sclerosis", "ANCA Associated Vasculitis", "Idiopathic Inflammatory Myopathies", "Sjogren's Syndrome", "Autoimmune Diseases"], "cn_sites": [{"facility": "Xuzhou Medical University Affiliated Hospital", "city": "Xuzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07155369", "title": "UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-03-18", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "The Affiliated Hospital of Xuzhou Medical University", "conditions": ["Systemic Lupus Erythematosus", "Systemic Sclerosis"], "cn_sites": [{"facility": "The Affiliated Hospital of Xuzhou Medical University", "city": "Xuzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06866080", "title": "A Study of LCAR-AIO in Subjects With Relapsed/Refractory Autoimmune Diseases", "status": "WITHDRAWN", "start": "2025-06-17", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Nanjing Legend Biotech Co.", "conditions": ["Relapsed/Refractory Autoimmune Diseases"], "cn_sites": [{"facility": "The First Affiliated Hospital of USTC (anhui provincial hospital)", "city": "Hefei", "status": ""}, {"facility": "Jiangsu Province Hospital", "city": "Nanjing", "status": ""}, {"facility": "The 1st Affiliated Hospital of WHU", "city": "Wenzhou", "status": ""}, {"facility": "The Affiliated Hospital of XUZHOU Medical University", "city": "Xuzhou", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT07339540", "title": "the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-11-04", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 45, "sponsor": "Tongji Hospital", "conditions": ["Recurrent or Refractory Systemic Lupus Erythematosus", "Recurrent or Refractory IgG4 Related Diseases", "Recurrent or Refractory Systemic Sclerosis", "Recurrent or Refractory Idiopathic Inflammatory Myopathy", "Recurrent or Refractory ANCA Associated Vasculitis"], "cn_sites": [{"facility": "Tongji Hospital, Affiliated to Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06792344", "title": "Clinical Study of CD19 CAR-T in the Treatment of Refractory Systemic Sclerosis", "status": "SUSPENDED", "start": "2025-12-14", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "The Children's Hospital of Zhejiang University School of Medicine", "conditions": ["Systemic Sclerosis (SSc)"], "cn_sites": [{"facility": "Children's Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07527936", "title": "A Study of BEN301 Injection in theTreatment of Autoimmune Diseases", "status": "SUSPENDED", "start": "2026-04-20", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "RenJi Hospital", "conditions": ["Systemic Sclerosis (SSc)", "Rheumatoid Arthritis (RA)", "Sjogren's Syndrome (SS)", "Idiopathic Inflammatory Myopathies(IIM)"], "cn_sites": [{"facility": "Shanghai Jiaotong University School of Medicine, Renji Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 217, "g_fetched": 144, "g_countries": [["United States", 40], ["France", 36], ["Spain", 12], ["Turkey (Türkiye)", 11], ["Germany", 10], ["United Kingdom", 10], ["Canada", 9], ["Italy", 8], ["Romania", 7], ["Poland", 6], ["Australia", 6], ["Switzerland", 5], ["Israel", 5], ["Belgium", 4], ["Brazil", 4], ["Netherlands", 4], ["Sweden", 4], ["Bulgaria", 3], ["Greece", 3], ["Serbia", 3], ["Egypt", 3], ["Argentina", 3], ["Japan", 2], ["Austria", 2], ["Thailand", 2], ["Czechia", 2], ["Portugal", 2], ["Croatia", 2], ["Norway", 2], ["Puerto Rico", 2], ["India", 1], ["Philippines", 1], ["Slovakia", 1], ["South Korea", 1], ["Taiwan", 1], ["New Zealand", 1], ["Slovenia", 1], ["Chile", 1], ["Denmark", 1], ["Hungary", 1], ["Lithuania", 1], ["Mexico", 1], ["Bangladesh", 1], ["Antigua and Barbuda", 1], ["Colombia", 1]], "g_trials": [{"nct": "NCT07335562", "title": "A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis", "status": "NOT_YET_RECRUITING", "start": "2027-02-03", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Juno Therapeutics, Inc., a Bristol-Myers Squibb Company", "countries": ["Belgium", "Canada", "France", "Germany", "Italy", "Japan", "Spain", "Switzerland", "United Kingdom", "United States"]}, {"nct": "NCT07544225", "title": "Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-12-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Gustave Roussy, Cancer Campus, Grand Paris", "countries": ["France"]}, {"nct": "NCT07783269", "title": "A Basket Study of CTA313 in Participants With Active Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-12", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Imviva Bio", "countries": []}, {"nct": "NCT07821398", "title": "Hyperpolarized Xenon MRI in Adults With Pulmonary Hypertension in Interstitial Lung Disease and Systemic Sclerosis", "status": "NOT_YET_RECRUITING", "start": "2026-11-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Bastiaan Driehuys", "countries": []}, {"nct": "NCT07209644", "title": "Catestatin as a Novel Biomarker for Cardiovascular and Microvascular Involvement in Systemic Sclerosis", "status": "NOT_YET_RECRUITING", "start": "2026-11-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT07748000", "title": "A Study of LIQ861 (Inhaled Treprostinil) in Adults With Systemic Sclerosis Who Have Symptomatic Raynaud's Phenomenon Attacks", "status": "NOT_YET_RECRUITING", "start": "2026-10-26", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Liquidia Technologies, Inc.", "countries": []}, {"nct": "NCT07782450", "title": "A Study to Learn About a Medicine Called PF-08154225 in Participants With Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-10-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Pfizer", "countries": []}, {"nct": "NCT07729995", "title": "BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease", "status": "NOT_YET_RECRUITING", "start": "2026-10", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Luminary Therapeutics", "countries": ["United States"]}, {"nct": "NCT07827742", "title": "Rituximab vs Placebo for Maintenance in Systemic Sclerosis - Interstitial Lung Disease", "status": "NOT_YET_RECRUITING", "start": "2026-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT07800871", "title": "FT839 in Autoimmune Diseases", "status": "RECRUITING", "start": "2026-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Fate Therapeutics", "countries": ["United States"]}, {"nct": "NCT07649265", "title": "A Trial in Healthy Adult Participants and Adults With Autoimmune Disease to Test How HBM7020 is Tolerated and Absorbed in the Body", "status": "NOT_YET_RECRUITING", "start": "2026-09-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "countries": []}, {"nct": "NCT07642297", "title": "TL1A Inhibition in Systemic Sclerosis-Related Skin Fibrosis and Immunological Alterations: A Proof-of-Concept In Vitro Study (FIBROSTOP)", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondazione Policlinico Universitario Campus Bio-Medico", "countries": ["Italy"]}, {"nct": "NCT07697274", "title": "Hyaluronidase for Sclerodactyly in Systemic Sclerosis Trial", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Medical University of South Carolina", "countries": ["United States"]}, {"nct": "NCT07691970", "title": "Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "AstraZeneca", "countries": ["Austria", "Belgium", "Brazil", "Bulgaria", "France", "Greece", "India", "Israel", "Italy", "Japan", "Philippines", "Poland", "Romania", "Serbia", "Slovakia", "South Korea", "Spain", "Taiwan", "Thailand", "Turkey (Türkiye)", "United Kingdom", "United States"]}, {"nct": "NCT07717060", "title": "Extracellular Vesicle Dynamics Predicting Vascular Complications and Treatment Response in Systemic Sclerosis", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Fondazione Policlinico Universitario Agostino Gemelli IRCCS", "countries": []}, {"nct": "NCT07737470", "title": "Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": []}, {"nct": "NCT07778446", "title": "A Study to Test CRT-402 in Refractory Autoimmune Disease", "status": "NOT_YET_RECRUITING", "start": "2026-08-24", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Myeloid Therapeutics", "countries": ["Australia"]}, {"nct": "NCT07817160", "title": "Pelvic Floor Dysfunction in Pulmonary Systemic Sclerosis", "status": "RECRUITING", "start": "2026-08-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Biruni University", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT07759557", "title": "Efficacy of A Non-Invasive Botulinum Toxin Microneedle Pad for the Treatment of Secondary Raynaud's Phenomenon", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Khon Kaen University", "countries": []}, {"nct": "NCT07490275", "title": "Allogeneic CD19/BCMA-Targeted CAR-γδT Cell Therapy: Safety and Preliminary Pharmacodynamics in Relapsed/Refractory Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-07-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "countries": []}, {"nct": "NCT06708845", "title": "US Zamto-cel Autoimmune Diseases", "status": "RECRUITING", "start": "2026-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Miltenyi Biomedicine GmbH", "countries": ["United States"]}, {"nct": "NCT07515638", "title": "Immun4Cure Cohort of Autoimmune Diseases", "status": "RECRUITING", "start": "2026-06-23", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Montpellier", "countries": ["France"]}, {"nct": "NCT07543679", "title": "Objective Assessment of Skin Damage Using ADHELASKIN in Patients With Systemic Sclerosis", "status": "RECRUITING", "start": "2026-05-07", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Centre Hospitalier Universitaire de Saint Etienne", "countries": ["France"]}, {"nct": "NCT07575347", "title": "Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)", "status": "RECRUITING", "start": "2026-05-04", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Stefan Lujinschi", "countries": ["Romania"]}, {"nct": "NCT07287670", "title": "EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)", "status": "RECRUITING", "start": "2026-04-16", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Mediar Therapeutics", "countries": ["Australia", "France", "Italy", "Netherlands", "New Zealand", "Poland", "Romania", "Spain", "United Kingdom", "United States"]}]}, {"batch": 1, "no": 113, "name_zh": "四氢生物蝶呤缺乏症", "query_terms": [{"term": "Hyperphenylalaninemia due to tetrahydrobiopterin deficiency", "broad": false}, {"term": "Tetrahydrobiopterin Deficiency", "broad": true}], "n_total": 1, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT03864029", "title": "Retrospective Observational Safety Effectiveness With Kuvan in hpA", "status": "COMPLETED", "start": "2017-10-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 26, "sponsor": "BioMarin Pharmaceutical", "conditions": ["Tetrahydrobiopterin Deficiency"], "cn_sites": [{"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 0, "g_fetched": 0, "g_countries": [], "g_trials": []}, {"batch": 1, "no": 114, "name_zh": "结节性硬化症", "query_terms": [{"term": "Tuberous sclerosis complex", "broad": false}], "n_total": 9, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT07327164", "title": "Precision Medicine for Neurocutaneous Syndromes in Western China", "status": "COMPLETED", "start": "2000-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1200, "sponsor": "West China Hospital", "conditions": ["Neurocutaneous Syndromes", "Neurofibromatosis Type 1 (NF1)", "Tuberous Sclerosis Complex (TSC)", "Sturge-Weber Syndrome (SWS)", "Von Hippel-Lindau Disease"], "cn_sites": [{"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03363763", "title": "Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex", "status": "TERMINATED", "start": "2017-04-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Aucta Pharmaceuticals, Inc", "conditions": ["Angiofibroma of Face", "Tuberous Sclerosis"], "cn_sites": [{"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03356769", "title": "Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex", "status": "UNKNOWN", "start": "2017-11-20", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 98, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Tuberous Sclerosis Complex", "Aspirin", "Epilepsy", "Cognitive Decline", "Skin Lesions"], "cn_sites": [{"facility": "Department of Neurology, Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03650452", "title": "A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies", "status": "COMPLETED", "start": "2018-08-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 141, "sponsor": "Takeda", "conditions": ["Epilepsy", "Dravet Syndrome", "Lennox-Gastaut Syndrome"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Capital Medical University (CMU) - Beijing Children's Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Children's Hospital,Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT03525834", "title": "Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.", "status": "COMPLETED", "start": "2018-11-09", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Renal Angiomyolipoma"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Wuhan", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Chengdu", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT04198207", "title": "The Effectiveness and Safety of Vagus Nerve Stimulation for TRE", "status": "COMPLETED", "start": "2019-12-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 70, "sponsor": "Beijing Children's Hospital", "conditions": ["Tuberous Sclerosis Complex", "Epilepsy"], "cn_sites": [{"facility": "Beijing Children's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04198181", "title": "The Effectiveness and Safety of Resective Epilepsy Surgery for TRE", "status": "ACTIVE_NOT_RECRUITING", "start": "2019-12-12", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Beijing Children's Hospital", "conditions": ["Tuberous Sclerosis Complex", "Epilepsy"], "cn_sites": [{"facility": "Beijing Children's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05323734", "title": "Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy", "status": "COMPLETED", "start": "2022-04-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 129, "sponsor": "Marinus Pharmaceuticals", "conditions": ["Tuberous Sclerosis Complex"], "cn_sites": [{"facility": "First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Jiangxi Provincial Children's Hospital", "city": "Jiangxi", "status": ""}, {"facility": "Beijing Children Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "The Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": ""}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "Chengdu's Women and Children's Central Hospital", "city": "Chengdu", "status": ""}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT05604170", "title": "Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy", "status": "TERMINATED", "start": "2022-05-16", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 117, "sponsor": "Marinus Pharmaceuticals", "conditions": ["Tuberous Sclerosis Complex"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Children Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "The Affiliated Hospital of Guizhou Medical University", "city": "Beijing", "status": ""}, {"facility": "First Hospital of Jilin University", "city": "Jilin City", "status": ""}], "cn_site_count": 5, "broad_only": false}], "g_total": 25, "g_fetched": 25, "g_countries": [["United States", 10], ["Australia", 3], ["Italy", 2], ["Canada", 2], ["Netherlands", 2], ["Romania", 1], ["Ireland", 1], ["Spain", 1], ["Poland", 1], ["Mexico", 1], ["France", 1], ["United Kingdom", 1]], "g_trials": [{"nct": "NCT07680322", "title": "A Phase 2 Study of the Safety and Efficacy of AV078 in Participants With Tuberous Sclerosis Complex (TSC) Refractory Epilepsy", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Aeovian Pharmaceuticals, Inc.", "countries": []}, {"nct": "NCT07287202", "title": "Safety, Tolerability, and Pharmacokinetics of SVG103 (Paxalisib) in Focal Cortical Dysplasia Type II (FCD-II), Tuberous Sclerosis Complex (TSC) or Hemimegalencephaly (HME)", "status": "RECRUITING", "start": "2026-07-14", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Sovargen", "countries": ["Australia"]}, {"nct": "NCT07575347", "title": "Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)", "status": "RECRUITING", "start": "2026-05-04", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Stefan Lujinschi", "countries": ["Romania"]}, {"nct": "NCT07561957", "title": "A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines", "status": "RECRUITING", "start": "2026-01-14", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "St. James's Hospital, Ireland", "countries": ["Ireland"]}, {"nct": "NCT07369505", "title": "Sapu003 in Advanced mTOR-sensitive Solid Tumors", "status": "RECRUITING", "start": "2025-12-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "SAPU NANO (US) LLC", "countries": ["Australia"]}, {"nct": "NCT07304856", "title": "Role of Extracellular Vesicles as Biomarkers of Pulmonary Involvement in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex", "status": "RECRUITING", "start": "2025-04-16", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Milan", "countries": ["Italy"]}, {"nct": "NCT06081348", "title": "Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders", "status": "RECRUITING", "start": "2024-09-16", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Holland Bloorview Kids Rehabilitation Hospital", "countries": ["Canada"]}, {"nct": "NCT07403266", "title": "Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Complex (TSC)", "status": "RECRUITING", "start": "2024-06-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Oils4Cure", "countries": ["Spain"]}, {"nct": "NCT06330350", "title": "Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling", "status": "RECRUITING", "start": "2024-01-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Maastricht University Medical Center", "countries": ["Netherlands"]}, {"nct": "NCT06105736", "title": "Regulating Together in Tuberous Sclerosis Complex", "status": "RECRUITING", "start": "2023-12-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Children's Hospital Medical Center, Cincinnati", "countries": ["United States"]}, {"nct": "NCT06160310", "title": "Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)", "status": "RECRUITING", "start": "2023-07-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "David M. Ritter", "countries": ["United States"]}, {"nct": "NCT05534672", "title": "Placebo Controlled Study to Assess the Efficacy and Safety of Rapamycin in Drug Resistant Epilepsy Associated With Tuberous Sclerosis Complex", "status": "RECRUITING", "start": "2023-01-23", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Katarzyna Kotulska", "countries": ["Poland"]}, {"nct": "NCT06523582", "title": "Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients", "status": "RECRUITING", "start": "2022-08-03", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Universidad Nacional Autonoma de Mexico", "countries": ["Mexico"]}, {"nct": "NCT05469373", "title": "ESIS in Pediatric DRE", "status": "RECRUITING", "start": "2022-02-17", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sarah Katie Ihnen", "countries": ["United States"]}, {"nct": "NCT05104983", "title": "Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study", "status": "RECRUITING", "start": "2021-10-13", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Darcy Krueger", "countries": ["United States"]}, {"nct": "NCT06764602", "title": "Observational, Retrospective, Multicenter, Nonprofit Study on the Prevalence of Renal Involvement in Pediatric Patients With Tuberous Sclerosis", "status": "RECRUITING", "start": "2021-07-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS Azienda Ospedaliero-Universitaria di Bologna", "countries": ["Italy"]}, {"nct": "NCT04463316", "title": "GROWing Up With Rare GENEtic Syndromes", "status": "RECRUITING", "start": "2018-10-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "dr. Laura C. G. de Graaff-Herder", "countries": ["Netherlands"]}, {"nct": "NCT03050268", "title": "Familial Investigations of Childhood Cancer Predisposition", "status": "RECRUITING", "start": "2017-04-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "St. Jude Children's Research Hospital", "countries": ["United States"]}, {"nct": "NCT05676099", "title": "TSC Biosample Repository and Natural History Database", "status": "RECRUITING", "start": "2016-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Tuberous Sclerosis Association", "countries": ["Canada", "United States"]}, {"nct": "NCT02890641", "title": "Genetic and Electrophysiologic Study in Focal Drug-resistant Epilepsies", "status": "RECRUITING", "start": "2015-12-17", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondation Ophtalmologique Adolphe de Rothschild", "countries": ["France"]}, {"nct": "NCT06065852", "title": "National Registry of Rare Kidney Diseases", "status": "RECRUITING", "start": "2009-11-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "UK Kidney Association", "countries": ["United Kingdom"]}, {"nct": "NCT00001975", "title": "Study of Skin Tumors in Tuberous Sclerosis", "status": "RECRUITING", "start": "2000-01-26", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "countries": ["United States"]}, {"nct": "NCT00001532", "title": "Role of Genetic Factors in the Development of Lung Disease", "status": "RECRUITING", "start": "1996-09-13", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "countries": ["United States"]}, {"nct": "NCT00001465", "title": "Study of the Disease Process of Lymphangioleiomyomatosis", "status": "RECRUITING", "start": "1995-12-18", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "countries": ["United States"]}, {"nct": "NCT06149663", "title": "Intermediate-Size Expanded Access Protocol (EAP) for LP352", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "Longboard Pharmaceuticals", "countries": ["Australia", "United States"]}]}, {"batch": 1, "no": 115, "name_zh": "原发性酪氨酸血症", "query_terms": [{"term": "Tyrosinemia type 1", "broad": false}, {"term": "Tyrosinemia type 2", "broad": false}, {"term": "Tyrosinemia type 3", "broad": false}], "n_total": 1, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT06227429", "title": "A Non-interventional, Post-Marketing Study to Describe Outcome of Nitisinone Treatment in HT-1 Patients", "status": "WITHDRAWN", "start": "2025-09", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 0, "sponsor": "Swedish Orphan Biovitrum", "conditions": ["Hereditary Tyrosinemia, Type I"], "cn_sites": [{"facility": "Swedish Orphan Biovitrum Research Site", "city": "Beijing", "status": ""}, {"facility": "Swedish Orphan Biovitrum Research Site", "city": "Chongqing", "status": ""}, {"facility": "Swedish Orphan Biovitrum Research Site", "city": "Hefei", "status": ""}, {"facility": "Swedish Orphan Biovitrum Research Site", "city": "Wuhan", "status": ""}], "cn_site_count": 4, "broad_only": false}], "g_total": 1, "g_fetched": 1, "g_countries": [["United Kingdom", 1]], "g_trials": [{"nct": "NCT06941532", "title": "GMP Powdered Substitutes in PKU and TYR", "status": "RECRUITING", "start": "2025-05-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Nutricia UK Ltd", "countries": ["United Kingdom"]}]}, {"batch": 1, "no": 116, "name_zh": "极长链酰基辅酶A脱氢酶缺乏症", "query_terms": [{"term": "Very long chain acyl-CoA dehydrogenase deficiency", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 4, "g_fetched": 4, "g_countries": [["Israel", 1], ["United States", 1], ["Austria", 1], ["Germany", 1], ["Italy", 1]], "g_trials": [{"nct": "NCT06017869", "title": "Evaluate the Safety and Therapeutic Effects of a Single Intravenous Infusion (IV) of Autologous CD34+ Cells Enriched With Allogenic Placenta-derived Mitochondria in Patients With a Diagnosis of Pearson Syndrome (PS)", "status": "RECRUITING", "start": "2023-07-31", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Minovia Therapeutics Ltd.", "countries": ["Israel"]}, {"nct": "NCT04602325", "title": "Systemic Biomarkers of Brain Injury From Hyperammonemia", "status": "RECRUITING", "start": "2020-07-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Children's National Research Institute", "countries": ["United States"]}, {"nct": "NCT05554835", "title": "Global Registry and Natural History Study for Mitochondrial Disorders", "status": "RECRUITING", "start": "2009-02-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "LMU Klinikum", "countries": ["Austria", "Germany", "Italy"]}, {"nct": "NCT03773770", "title": "Expanded Access to Triheptanoin", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "Ultragenyx Pharmaceutical Inc", "countries": []}]}, {"batch": 1, "no": 117, "name_zh": "威廉姆斯综合征", "query_terms": [{"term": "Williams syndrome", "broad": false}], "n_total": 2, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT07509879", "title": "Research on the Molecular Mechanism of Cognitive Differences Between Williams Syndrome and Autism Spectrum Disorder", "status": "NOT_YET_RECRUITING", "start": "2026-04-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 75, "sponsor": "Qilu Hospital of Shandong University", "conditions": ["Williams Syndrome", "Autism Disorder"], "cn_sites": [{"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06315699", "title": "Clemastine Fumarate in the Treatment of Neurodevelopmental Delays in Williams Syndrome", "status": "COMPLETED", "start": "2024-03-20", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 28, "sponsor": "Qilu Hospital of Shandong University", "conditions": ["Williams Syndrome", "Child", "Neurodevelopmental Delay"], "cn_sites": [{"facility": "Qilu Hospital of Shandong University", "city": "Tainan", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 11, "g_fetched": 10, "g_countries": [["United States", 5], ["France", 2], ["Netherlands", 1], ["Australia", 1], ["Israel", 1]], "g_trials": [{"nct": "NCT07469566", "title": "Characterization of the Natural History of Microduplication Syndrome 7q11.23", "status": "RECRUITING", "start": "2026-07-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Hospices Civils de Lyon", "countries": ["France"]}, {"nct": "NCT07537374", "title": "A Case-Control Observational Study of Peripheral Blood-Derived iPSC Models to Investigate Oligodendrocyte Lineage Development in Children With Williams Syndrome and Healthy Controls", "status": "NOT_YET_RECRUITING", "start": "2026-04-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Qilu Hospital of Shandong University", "countries": []}, {"nct": "NCT07493096", "title": "Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders", "status": "RECRUITING", "start": "2026-03-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Healing Hope International", "countries": ["United States"]}, {"nct": "NCT06740162", "title": "Physical Activity and Community EmPOWERment Project", "status": "RECRUITING", "start": "2025-01-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of North Carolina, Chapel Hill", "countries": ["United States"]}, {"nct": "NCT06930417", "title": "Characterization and Natural History of Williams Syndrome and Other Chromosome 7q11.23 Variants", "status": "RECRUITING", "start": "2024-10-21", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Pennsylvania", "countries": ["United States"]}, {"nct": "NCT07285720", "title": "Phonological Constraints on Language Development in Individuals With Williams Syndrome", "status": "RECRUITING", "start": "2024-07-05", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Centre Hospitalier Universitaire, Amiens", "countries": ["France"]}, {"nct": "NCT04463316", "title": "GROWing Up With Rare GENEtic Syndromes", "status": "RECRUITING", "start": "2018-10-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "dr. Laura C. G. de Graaff-Herder", "countries": ["Netherlands"]}, {"nct": "NCT01132885", "title": "Defining the Brain Phenotype of Children With Williams Syndrome", "status": "RECRUITING", "start": "2011-01-23", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Institute of Mental Health (NIMH)", "countries": ["United States"]}, {"nct": "NCT01793168", "title": "Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford", "status": "RECRUITING", "start": "2010-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sanford Health", "countries": ["Australia", "United States"]}, {"nct": "NCT00768820", "title": "The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome", "status": "RECRUITING", "start": "2001-05", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "The Chaim Sheba Medical Center", "countries": ["Israel"]}]}, {"batch": 1, "no": 118, "name_zh": "湿疹血小板减少伴免疫缺陷综合征", "query_terms": [{"term": "Wiskott-Aldrich syndrome", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 2, "g_fetched": 2, "g_countries": [["United States", 2]], "g_trials": [{"nct": "NCT04528355", "title": "Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC", "status": "RECRUITING", "start": "2020-08-20", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Paul Szabolcs", "countries": ["United States"]}, {"nct": "NCT01962415", "title": "Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT", "status": "RECRUITING", "start": "2014-02-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Paul Szabolcs", "countries": ["United States"]}]}, {"batch": 1, "no": 119, "name_zh": "X-连锁无丙种球蛋白血症", "query_terms": [{"term": "X-linked agammaglobulinemia", "broad": false}], "n_total": 1, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT02234791", "title": "Mutation of the BTK Gene and Genotype-phenotype Correlation of Chinese Patients With X-Linked Agammaglobulinemia", "status": "UNKNOWN", "start": "2014-09", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Shanghai Children's Medical Center", "conditions": ["Agammaglobulinemia, BTK"], "cn_sites": [{"facility": "Shanghai Children'S Medical Center", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 2, "g_fetched": 2, "g_countries": [["Belgium", 1]], "g_trials": [{"nct": "NCT06150833", "title": "IVIG Boya: Safety, Efficacy, and Pharmacokinetics", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Azidus Brasil", "countries": []}, {"nct": "NCT07328178", "title": "Analysis of the Role of IgE Proteoforms in Health and Disease", "status": "RECRUITING", "start": "2025-01-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "KU Leuven", "countries": ["Belgium"]}]}, {"batch": 1, "no": 120, "name_zh": "X-连锁肾上腺脑白质营养不良", "query_terms": [{"term": "X-linked adrenoleukodystrophy", "broad": false}], "n_total": 5, "n_open": 3, "n_open_precise": 3, "n_broad": 0, "trials": [{"nct": "NCT05939232", "title": "Registry of X-linked Adrenoleukodystrophy", "status": "RECRUITING", "start": "2023-07-20", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Beijing Tiantan Hospital", "conditions": ["X-linked Adrenoleukodystrophy"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06796920", "title": "Epidural Spinal Cord Stimulation for Lower-limb Impairment in Adrenomyeloneuropathy", "status": "RECRUITING", "start": "2025-02-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Third Military Medical University", "conditions": ["Adrenomyeloneuropathy Without Cerebral Involvement"], "cn_sites": [{"facility": "Beijing TianTan Hospital", "city": "Beijing", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "The 958 Hospital of Chinese People's Liberation Army, The Jiangbei Campus of Southwest Hospital, The First Affiliated Hospital of Army Medical University", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "the Southwest hospital", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "Jingmen No.1 People's Hospital", "city": "Jingmen", "status": "ACTIVE_NOT_RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT03727555", "title": "IT and IV Lentiviral Gene Therapy for X-ALD", "status": "NOT_YET_RECRUITING", "start": "2027-06-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": ["X-linked Adrenoleukodystrophy"], "cn_sites": [{"facility": "Shenzhen Geno-immune Medical Institute", "city": "Shenzhen", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02559830", "title": "Autologous Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy and Adrenoleukodystrophy", "status": "UNKNOWN", "start": "2015-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Shenzhen Second People's Hospital", "conditions": ["Metachromatic Leukodystrophy", "Adrenoleukodystrophy"], "cn_sites": [{"facility": "Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University", "city": "Shenzhen", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03649919", "title": "Multi-center Clinical Study on the Diagnosis and Treatment Management of Rare Neurological Disease in Children", "status": "WITHDRAWN", "start": "2021-09-30", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 0, "sponsor": "Children's Hospital of Fudan University", "conditions": ["Xlsma", "DMD", "X-ALD", "TSC"], "cn_sites": [{"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 16, "g_fetched": 13, "g_countries": [["United States", 8], ["France", 2], ["Italy", 1], ["Germany", 1]], "g_trials": [{"nct": "NCT06224413", "title": "A Study of Participants With Cerebral Adrenoleukodystrophy (CALD) Treated With Elivaldogene Autotemcel", "status": "RECRUITING", "start": "2024-03-27", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Genetix Biotherapeutics Inc.", "countries": ["United States"]}, {"nct": "NCT06178120", "title": "Disease Progression in Women With X-linked Adrenoleukodystrophy", "status": "RECRUITING", "start": "2024-01-02", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Minoryx Therapeutics, S.L.", "countries": ["France"]}, {"nct": "NCT05911919", "title": "Validation of a Prognostic Biomarker Using Brain Diffusion MRI in X-linked Adrenoleukodystrophy", "status": "NOT_YET_RECRUITING", "start": "2023-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": []}, {"nct": "NCT05443906", "title": "Home Exercise for Individuals With Neurodegenerative Disease", "status": "RECRUITING", "start": "2023-02-13", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Hugo W. Moser Research Institute at Kennedy Krieger, Inc.", "countries": ["United States"]}, {"nct": "NCT04925349", "title": "Modeling Macrophages Activation Pattern in X-linked Adrenoleukodystrophy, Metachromatic Leukodystrophy and Adult Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia", "status": "RECRUITING", "start": "2021-08-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT04880356", "title": "Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.", "status": "RECRUITING", "start": "2021-03-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta", "countries": ["Italy"]}, {"nct": "NCT04528355", "title": "Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC", "status": "RECRUITING", "start": "2020-08-20", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Paul Szabolcs", "countries": ["United States"]}, {"nct": "NCT04675749", "title": "Quality of Life in Women With X-linked Adrenoleukodystrophy", "status": "RECRUITING", "start": "2019-12-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Leipzig University Medical Center", "countries": ["Germany"]}, {"nct": "NCT03789721", "title": "Adrenoleukodystrophy National Registry Study", "status": "RECRUITING", "start": "2019-05-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Masonic Cancer Center, University of Minnesota", "countries": ["United States"]}, {"nct": "NCT03047369", "title": "The Myelin Disorders Biorepository Project", "status": "RECRUITING", "start": "2016-12-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Children's Hospital of Philadelphia", "countries": ["United States"]}, {"nct": "NCT02254863", "title": "UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells", "status": "RECRUITING", "start": "2014-09", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Joanne Kurtzberg, MD", "countries": ["United States"]}, {"nct": "NCT01962415", "title": "Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT", "status": "RECRUITING", "start": "2014-02-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Paul Szabolcs", "countries": ["United States"]}, {"nct": "NCT01881334", "title": "Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "Joanne Kurtzberg, MD", "countries": ["United States"]}]}, {"batch": 1, "no": 121, "name_zh": "X-连锁淋巴增生症", "query_terms": [{"term": "X-linked lymphoproliferative disease", "broad": false}], "n_total": 1, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT04645199", "title": "National Longitudinal Cohort of Hematological Diseases", "status": "RECRUITING", "start": "2020-12-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2300, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Multiple Myeloma", "Acute Myeloid Leukemia", "Hemophilia", "Hemophilia A", "Hemophilia B", "Myelodysplastic Syndrome", "MDS", "Lymphoma", "Leukemia", "Aplastic Anemia", "Bleeding Disorder", "Bone Marrow Transplantation", "Blood Disease Infection", "Autoimmune Hemolytic Anemia, AIHA", "Essential Thrombocythemia, ET", "Large Granular Lymphocyte Leukemia, LGLL", "Paroxysmal Nocturnal Hemoglobinuria, PNH"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}], "g_total": 8, "g_fetched": 7, "g_countries": [["United States", 6], ["United Kingdom", 1]], "g_trials": [{"nct": "NCT06610019", "title": "Cardiovascular Multimodality Imaging Study", "status": "RECRUITING", "start": "2023-05-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Montefiore Medical Center", "countries": ["United States"]}, {"nct": "NCT04528355", "title": "Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC", "status": "RECRUITING", "start": "2020-08-20", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Paul Szabolcs", "countries": ["United States"]}, {"nct": "NCT03050268", "title": "Familial Investigations of Childhood Cancer Predisposition", "status": "RECRUITING", "start": "2017-04-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "St. Jude Children's Research Hospital", "countries": ["United States"]}, {"nct": "NCT01962415", "title": "Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT", "status": "RECRUITING", "start": "2014-02-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Paul Szabolcs", "countries": ["United States"]}, {"nct": "NCT06065852", "title": "National Registry of Rare Kidney Diseases", "status": "RECRUITING", "start": "2009-11-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "UK Kidney Association", "countries": ["United Kingdom"]}, {"nct": "NCT00001405", "title": "Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes", "status": "RECRUITING", "start": "1994-02-27", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "countries": ["United States"]}, {"nct": "NCT01881334", "title": "Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "Joanne Kurtzberg, MD", "countries": ["United States"]}]}, {"batch": 2, "no": 1, "name_zh": "软骨发育不全", "query_terms": [{"term": "Achondroplasia", "broad": false}], "n_total": 7, "n_open": 2, "n_open_precise": 2, "n_broad": 0, "trials": [{"nct": "NCT07301463", "title": "A Study in Children With Achondroplasia", "status": "RECRUITING", "start": "2025-06-20", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 260, "sponsor": "Abbisko Therapeutics Co, Ltd", "conditions": ["Achondroplasia"], "cn_sites": [{"facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Guangzhou Women and Childrens Medical Center", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Henan Children's Hospital, Zhengzhou Children's Hospital", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Xin Hua Hospital Affiliatod to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Chengdu Women's and Children's Central Hospital", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}, {"facility": "West China Second University Hospital, Sichuan University", "city": "Chengdu", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Children's Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT07297875", "title": "A Study of ABSK061 to Assess Safety, Tolerability, Pharmacokinetics, and Efficacy in Children With Achondroplasia", "status": "NOT_YET_RECRUITING", "start": "2025-12-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 110, "sponsor": "Abbisko Therapeutics Co, Ltd", "conditions": ["Achondroplasia"], "cn_sites": [{"facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Henan Children's Hospital, Zhengzhou Children's Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Chengdu Women's and Children's Central Hospital", "city": "Chengde", "status": ""}, {"facility": "West China Second University Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Children's Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT03794609", "title": "Observational Study Investigating Clinical & Anthropometric Characteristics of Children With Achondroplasia.", "status": "TERMINATED", "start": "2018-06-15", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 315, "sponsor": "Pfizer", "conditions": ["Achondroplasia"], "cn_sites": [{"facility": "The First Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT03875534", "title": "A Multi-center, Longitudinal, Observational Study of Children With Achondroplasia", "status": "COMPLETED", "start": "2019-06-19", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 260, "sponsor": "Ascendis Pharma A/S", "conditions": ["Achondroplasia"], "cn_sites": [{"facility": "Ascendis Pharma Investigational Site", "city": "Beijing", "status": ""}, {"facility": "Ascendis Pharma Investigational Site", "city": "Guangzhou", "status": ""}, {"facility": "Ascendis Pharma Investigational Site", "city": "Hangzhou", "status": ""}, {"facility": "Ascendis Pharma Investigational Site", "city": "Shanghai", "status": ""}, {"facility": "Ascendis Pharma Investigational Site", "city": "Shenzhen", "status": ""}, {"facility": "Ascendis Pharma Investigational Site", "city": "Wuhan", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT05246033", "title": "A Dose Escalation Trial Evaluating Safety, Efficacy, and Pharmacokinetics of Multiple Subcutaneous Doses of TransCon CNP Administered Once Weekly in Children With Achondroplasia", "status": "COMPLETED", "start": "2022-01-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Visen Pharmaceuticals (Shanghai) Co., Ltd.", "conditions": ["Achondroplasia"], "cn_sites": [{"facility": "Ascendis Pharma Investigational Site", "city": "Beijing", "status": ""}, {"facility": "Ascendis Pharma Investigational Site", "city": "Guangzhou", "status": ""}, {"facility": "Ascendis Pharma Investigational Site", "city": "Hangzhou", "status": ""}, {"facility": "Ascendis Pharma Investigational Site", "city": "Shanghai", "status": ""}, {"facility": "Ascendis Pharma Investigational Site", "city": "Wuhan", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT05353192", "title": "A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia", "status": "COMPLETED", "start": "2022-08-20", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 39, "sponsor": "Changchun GeneScience Pharmaceutical Co., Ltd.", "conditions": ["Achondroplasia"], "cn_sites": [{"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06067425", "title": "Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SAR442501 in Pediatric Participants With Achondroplasia", "status": "TERMINATED", "start": "2023-10-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 16, "sponsor": "Sanofi", "conditions": ["Osteochondrodysplasia"], "cn_sites": [{"facility": "Investigational Site Number : 1560002", "city": "Shanghai", "status": ""}, {"facility": "Investigational Site Number : 1560001", "city": "Wuhan", "status": ""}], "cn_site_count": 2, "broad_only": false}], "g_total": 12, "g_fetched": 10, "g_countries": [["United States", 6], ["Canada", 5], ["United Kingdom", 5], ["Australia", 4], ["France", 4], ["Italy", 3], ["Japan", 2], ["Norway", 2], ["Spain", 2], ["Sweden", 2], ["Denmark", 2], ["Ireland", 2], ["Poland", 1], ["Romania", 1], ["South Korea", 1], ["Singapore", 1], ["Netherlands", 1], ["Austria", 1], ["Finland", 1], ["Germany", 1], ["New Zealand", 1], ["Portugal", 1]], "g_trials": [{"nct": "NCT07441876", "title": "Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia", "status": "RECRUITING", "start": "2026-04-20", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "BioMarin Pharmaceutical", "countries": ["Australia", "Canada", "Italy", "Japan", "Poland", "Romania", "South Korea", "United Kingdom", "United States"]}, {"nct": "NCT07388966", "title": "Prospective Longitudinal Monocentric Study to Measure Limb Movement in Patients With FGFR3-related Skeletal Dysplasia", "status": "RECRUITING", "start": "2026-02-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "SYSNAV", "countries": ["France"]}, {"nct": "NCT07169279", "title": "Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH)", "status": "RECRUITING", "start": "2025-11-19", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "QED Therapeutics, a BridgeBio company", "countries": ["Australia", "Canada", "Norway", "Singapore", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT06842355", "title": "A Study of TYRA-300 in Children With Achondroplasia: BEACH301", "status": "RECRUITING", "start": "2025-03-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Tyra Biosciences, Inc", "countries": ["Australia", "Canada", "France", "Netherlands", "Spain", "Sweden", "United Kingdom", "United States"]}, {"nct": "NCT06732895", "title": "A Clinical Trial to Evaluate Efficacy and Safety of Navepegritide in Adolescents (12 - 18 Years of Age) With Achondroplasia.", "status": "RECRUITING", "start": "2024-12-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Ascendis Pharma A/S", "countries": ["Canada", "Denmark", "France", "Ireland", "United Kingdom"]}, {"nct": "NCT06926491", "title": "Evaluate the Efficacy and Safety of KK8398 in Patients With Achondroplasia（AOBA Study）", "status": "RECRUITING", "start": "2024-12-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Kyowa Kirin Co., Ltd.", "countries": ["Japan"]}, {"nct": "NCT06079398", "title": "A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Infants (0 to <2 Years of Age) With Achondroplasia", "status": "RECRUITING", "start": "2024-01-23", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Ascendis Pharma A/S", "countries": ["Australia", "Austria", "Canada", "Denmark", "Finland", "France", "Germany", "Ireland", "Italy", "New Zealand", "Norway", "Portugal", "Sweden", "United Kingdom", "United States"]}, {"nct": "NCT06168201", "title": "VIrtual STudy in Achondroplasia for the US (VISTA)", "status": "RECRUITING", "start": "2023-02-21", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "BioMarin Pharmaceutical", "countries": ["United States"]}, {"nct": "NCT05328050", "title": "Registry for Patients With Achondroplasia / Hypochondroplasia (OMPR-Ach/Hy)", "status": "RECRUITING", "start": "2021-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico", "countries": ["Italy"]}, {"nct": "NCT02597881", "title": "Achondroplasia Natural History Multicenter Clinical Study", "status": "RECRUITING", "start": "2016-04", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Johns Hopkins University", "countries": ["United States"]}]}, {"batch": 2, "no": 2, "name_zh": "获得性血友病", "query_terms": [{"term": "Acquired hemophilia A", "broad": false}, {"term": "Acquired hemophilia B", "broad": false}, {"term": "Acquired hemophilia", "broad": true}], "n_total": 6, "n_open": 3, "n_open_precise": 3, "n_broad": 0, "trials": [{"nct": "NCT05849740", "title": "An Exploratory Study of Cluster of Differentiation 38 (CD38) Monoclonal Antibody Combined Corticosteroid in Acquired Hemophilia A", "status": "RECRUITING", "start": "2023-05-22", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 25, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Acquired Hemophilia"], "cn_sites": [{"facility": "Chinese Academy of Medical Science and Blood Disease Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06727669", "title": "Longitudinal Cohort of Thrombosis and Hemostasis Diseases", "status": "RECRUITING", "start": "2024-11-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 3000, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia", "Thrombotic Thrombocytopenic Purpura", "Hemophilia A, Acquired", "Disseminated Intravascular Coagulation", "Thrombophilia", "Deep Vein Thrombosis", "Pulmonary Embolism", "Thrombotic Microangiopathies", "Coagulation Factor Deficiency", "Hemophilia A", "Hemophilia B", "Hemophilia B, Acquired", "Platelet Dysfunction", "Arterial Thromboembolism", "Bleeding Disorder", "Thrombosis"], "cn_sites": [{"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Department of Hematology, Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Department of Hematology, Beijing Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Xinqiao Hospital, Army Military Medical University", "city": "Chongqing", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT07789587", "title": "A Study of Bometase Alfa for Bleeding Control in Acquired Hemophilia A", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Acquired Hemophilia A"], "cn_sites": [{"facility": "Chinese Academy of Medical Science and Blood Disease Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00797381", "title": "Efficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia", "status": "UNKNOWN", "start": "2009-05", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Shanghai Public Health Clinical Center", "conditions": ["HIV Infection", "Hemophilia A"], "cn_sites": [{"facility": "Shanghai Public Health Clinical Center", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03384277", "title": "Trial of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab", "status": "COMPLETED", "start": "2017-12-29", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 66, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Acquired Hemophilia A"], "cn_sites": [{"facility": "Ethics Committee of Blood disease hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03700229", "title": "Study to Evaluate Rituximab and Bortezomib in Patients With Newly Diagnosed Acquired Hemophilia A", "status": "UNKNOWN", "start": "2018-10-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 22, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Acquired Hemophilia A"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}], "g_total": 5, "g_fetched": 2, "g_countries": [["South Korea", 1], ["Japan", 1]], "g_trials": [{"nct": "NCT06550882", "title": "A Study of OBIZUR in Adults With Acquired Hemophilia A (AHA) in South Korea", "status": "RECRUITING", "start": "2025-07-22", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Takeda", "countries": ["South Korea"]}, {"nct": "NCT06461533", "title": "A Survey of Susoctocog Alfa (Genetical Recombination) in Participants With Acquired Haemophilia A", "status": "RECRUITING", "start": "2024-06-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Takeda", "countries": ["Japan"]}]}, {"batch": 2, "no": 3, "name_zh": "肢端肥大症", "query_terms": [{"term": "Acromegaly", "broad": false}], "n_total": 13, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT03158090", "title": "The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research", "status": "RECRUITING", "start": "2017-12-15", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1965, "sponsor": "Ginkgo Leaf Center for Rare Disorders", "conditions": ["Acromegaly"], "cn_sites": [{"facility": "China Acromegaly Organization", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00993356", "title": "Preoperative Lanreotide Treatment in Acromegalic Patients With Macroadenomas", "status": "UNKNOWN", "start": "2004-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 96, "sponsor": "Shanghai Jiao Tong University School of Medicine", "conditions": ["Acromegaly"], "cn_sites": [{"facility": "Department of Neurosurgery, The First Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00600886", "title": "Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly", "status": "COMPLETED", "start": "2008-02-11", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 358, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Acromegaly"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT01368133", "title": "The Observational Study of Growth Hormone-secreting Pituitary Tumors", "status": "UNKNOWN", "start": "2011-05", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 60, "sponsor": "Huashan Hospital", "conditions": ["Acromegaly", "Pituitary Tumor"], "cn_sites": [{"facility": "Huashan Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02060383", "title": "Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly", "status": "COMPLETED", "start": "2014-05-23", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 249, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Cushing's Disease", "Acromegaly"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Chengdu", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT02493517", "title": "Efficacy and Safety of Lanreotide Autogel® 60, 90 or 120 mg With Lanreotide 40 mg Prolonged Release (PR) in Acromegaly", "status": "COMPLETED", "start": "2014-10", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 128, "sponsor": "Ipsen", "conditions": ["Acromegaly"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Fujian Provincial Hospital", "city": "Fuzhou", "status": ""}, {"facility": "The First Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "Affiliate Hospital of Guiyang Medical College", "city": "Guizhou", "status": ""}, {"facility": "Jiangsu Provincial People's Hospital", "city": "Nanjing", "status": ""}, {"facility": "Huashan Hospital Fudan University", "city": "Shanghai", "status": ""}, {"facility": "The Second Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "Tongji Medical College Huazhong University of Science & Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT02354508", "title": "Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues", "status": "COMPLETED", "start": "2015-03-31", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 123, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Acromegaly"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Chengdu", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT04520646", "title": "A Pilot Study of Empagliflozin in the Treatment of Acromegalic Cardiomyopathy", "status": "UNKNOWN", "start": "2020-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Huashan Hospital", "conditions": ["Acromegaly", "Cardiomyopathies"], "cn_sites": [{"facility": "Huashan Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05192382", "title": "A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2)", "status": "TERMINATED", "start": "2021-12-17", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 111, "sponsor": "Crinetics Pharmaceuticals Inc.", "conditions": ["Acromegaly"], "cn_sites": [{"facility": "Crinetics Study Site (b)", "city": "Beijing", "status": ""}, {"facility": "Crinetics Study Site", "city": "Guangzhou", "status": ""}, {"facility": "Crinetics Study Site", "city": "Shijiazhuang", "status": ""}, {"facility": "Crinetics Study Site", "city": "Zhengzhou", "status": ""}, {"facility": "Crinetics Study Site", "city": "Wuhan", "status": ""}, {"facility": "Crinetics Study Site", "city": "Changsha", "status": ""}, {"facility": "Crinetics Study Site", "city": "Jinan", "status": ""}, {"facility": "Crinetics Study Site", "city": "Xi’an", "status": ""}, {"facility": "Crinetics Study Site", "city": "Chengdu", "status": ""}, {"facility": "Crinetics Study Site", "city": "Hangzhou", "status": ""}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT05431803", "title": "Real-World Study (RWS) of Lanreotide Autogel (LAN) for the Treatment of Patients With Acromegaly in China", "status": "COMPLETED", "start": "2022-06-30", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 129, "sponsor": "Ipsen", "conditions": ["Acromegaly"], "cn_sites": [{"facility": "Peking Union Medical College Hospital (PUMCH)", "city": "Beijing", "status": ""}, {"facility": "Peking University Third Hospital (PUH3)", "city": "Beijing", "status": ""}, {"facility": "Xiangya Hospital Central South University (XYHCSU)", "city": "Changsha", "status": ""}, {"facility": "West China Hospital，Sichuan University (WCH)", "city": "Chengdu", "status": ""}, {"facility": "The First Affiliated Hospital,Sun Yat-sen University (FAHSYSU)", "city": "Guangzhou", "status": ""}, {"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine (SAHZU)", "city": "Hangzhou", "status": ""}, {"facility": "Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School (NJDTH)", "city": "Nanjing", "status": ""}, {"facility": "The First Hospital of China Medical University (CMU1H)", "city": "Shenyang", "status": ""}, {"facility": "The Second Hospital of Hebei Medical University (HB2H)", "city": "Shijiazhuang", "status": ""}, {"facility": "Affiliated Hospital of Wenzhou Medical University (FAHWMU)", "city": "Wenzhou", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology (TJH HUST)", "city": "Wuhan", "status": ""}, {"facility": "The First Affiliated Hospital of Zhengzhou University (FAHZZU)", "city": "Zhengzhou", "status": ""}], "cn_site_count": 12, "broad_only": false}, {"nct": "NCT05761431", "title": "A Single-dose Study of Octreotide Injection in Healthy Adult Subjects", "status": "COMPLETED", "start": "2023-03-02", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 56, "sponsor": "CSPC ZhongQi Pharmaceutical Technology Co., Ltd.", "conditions": ["Acromegaly"], "cn_sites": [{"facility": "Beijing Anzhen Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07814651", "title": "A Clinical Trial to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Octreotide Long-acting Injection in Patients With Acromegaly", "status": "COMPLETED", "start": "2024-04-16", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 78, "sponsor": "CSPC ZhongQi Pharmaceutical Technology Co., Ltd.", "conditions": ["Acromegaly"], "cn_sites": [{"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07663318", "title": "A Phase 1 Study to Evaluate the Relative Bioavailability of Octreotide Acetate Tablets(T25) Compared to MYCAPSSA® and The Food Effect on Pharmacokinetics Of Octreotide Acetate Tablets(T25)", "status": "COMPLETED", "start": "2026-06-25", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Triastek (Shanghai) Limited", "conditions": ["Acromegaly"], "cn_sites": [{"facility": "Zibo Central Hospital", "city": "Zibo", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 17, "g_fetched": 16, "g_countries": [["United States", 4], ["Italy", 4], ["United Kingdom", 3], ["Germany", 2], ["Turkey (Türkiye)", 1], ["Austria", 1], ["Belgium", 1], ["Brazil", 1], ["Bulgaria", 1], ["Denmark", 1], ["Estonia", 1], ["France", 1], ["Hungary", 1], ["Israel", 1], ["Latvia", 1], ["Lithuania", 1], ["Poland", 1], ["Romania", 1], ["Serbia", 1], ["Slovakia", 1], ["Spain", 1], ["Sweden", 1], ["Netherlands", 1], ["Taiwan", 1]], "g_trials": [{"nct": "NCT07813351", "title": "PRESTO: A Phase III Randomised Controlled Trial of Dose-escalated Proton Beam Therapy Versus Standard of Care Radiotherapy for Functioning Pituitary Tumours", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "University College, London", "countries": []}, {"nct": "NCT07641179", "title": "A Study to Evaluate MAR002 for Acromegaly", "status": "RECRUITING", "start": "2026-07-23", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Marea Therapeutics", "countries": ["United States"]}, {"nct": "NCT07659912", "title": "Direct Versus Video Laryngoscopy in Patients With Acromegaly", "status": "NOT_YET_RECRUITING", "start": "2026-07-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Muzaffer GENCER", "countries": []}, {"nct": "NCT07583563", "title": "An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly", "status": "RECRUITING", "start": "2026-06-05", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Camurus AB", "countries": ["Germany", "United Kingdom"]}, {"nct": "NCT07623824", "title": "A Phase III Clinical Trial to Evaluate the Efficacy and Safety of Octreotide Long-acting Injection in Patients With Acromegaly", "status": "NOT_YET_RECRUITING", "start": "2026-05-31", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "CSPC ZhongQi Pharmaceutical Technology Co., Ltd.", "countries": []}, {"nct": "NCT07306325", "title": "Ultrasound in Predicting Difficult Intubation in Acromegaly Patients", "status": "NOT_YET_RECRUITING", "start": "2025-12-25", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Başakşehir Çam & Sakura City Hospital", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT06930625", "title": "A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs", "status": "RECRUITING", "start": "2025-11-26", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Debiopharm International SA", "countries": ["Austria", "Belgium", "Brazil", "Bulgaria", "Denmark", "Estonia", "France", "Germany", "Hungary", "Israel", "Italy", "Latvia", "Lithuania", "Poland", "Romania", "Serbia", "Slovakia", "Spain", "Sweden", "United Kingdom", "United States"]}, {"nct": "NCT07179926", "title": "Effects of Pasireotide Lar Therapy on Bone Metabolism", "status": "RECRUITING", "start": "2025-09-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondazione Policlinico Universitario Agostino Gemelli IRCCS", "countries": ["Italy"]}, {"nct": "NCT07195175", "title": "Study of MAR002 in Healthy Men", "status": "RECRUITING", "start": "2025-08-11", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Marea Therapeutics", "countries": ["United States"]}, {"nct": "NCT06326853", "title": "Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models", "status": "NOT_YET_RECRUITING", "start": "2024-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS San Raffaele", "countries": []}, {"nct": "NCT06597383", "title": "The RApid Switch From 1st Generation Somatostatin Analogues to PaSireOtiDe In Acromegaly", "status": "RECRUITING", "start": "2023-11-24", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS San Raffaele", "countries": ["Italy"]}, {"nct": "NCT06949891", "title": "KETOgenic Diet Therapy in Patients With ACROmegaly", "status": "RECRUITING", "start": "2023-06-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Erasmus Medical Center", "countries": ["Netherlands"]}, {"nct": "NCT05964712", "title": "Effects of Therapies in the Acromegaly Disease: Acral Morpho-functional Study", "status": "RECRUITING", "start": "2019-06-18", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Istituto Auxologico Italiano", "countries": ["Italy"]}, {"nct": "NCT03042026", "title": "Developing a Simple Recognition System of Acromegaly", "status": "RECRUITING", "start": "2012-06-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Taiwan University Hospital", "countries": ["Taiwan"]}, {"nct": "NCT00461188", "title": "Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA", "status": "RECRUITING", "start": "2007-03-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Barts & The London NHS Trust", "countries": ["United Kingdom"]}, {"nct": "NCT00001595", "title": "An Investigation of Pituitary Tumors and Related Hypothalmic Disorders", "status": "RECRUITING", "start": "1997-04-21", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)", "countries": ["United States"]}]}, {"batch": 2, "no": 4, "name_zh": "成人斯蒂尔病", "query_terms": [{"term": "Adult-onset Still disease", "broad": false}], "n_total": 3, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT07191444", "title": "A Study of Firsekibart Versus Anakinra in Adult-Onset Still's Disease", "status": "RECRUITING", "start": "2025-09-24", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 20, "sponsor": "Ruijin Hospital", "conditions": ["Still&#39;s Disease, Adult-Onset"], "cn_sites": [{"facility": "Ruijin Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03651193", "title": "Multi-center Registration Study of Adult Onset Still's Disease in Chinese Population", "status": "UNKNOWN", "start": "2018-11-28", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 150, "sponsor": "Second Xiangya Hospital of Central South University", "conditions": ["Adult Onset Still Disease"], "cn_sites": [{"facility": "The Second Xiangya Hospital of Central South University", "city": "Hunan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07151157", "title": "Therapeutic Value of Sirolimus in Refractory Adult-Onset Still's Disease", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-08-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 3, "sponsor": "Ruijin Hospital", "conditions": ["Adult-Onset Still's Disease"], "cn_sites": [{"facility": "Ruiiin Hospital Shanghai JiaoTong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 7, "g_fetched": 6, "g_countries": [["United States", 3], ["France", 2], ["Switzerland", 1], ["Canada", 1], ["Germany", 1], ["Italy", 1], ["Netherlands", 1], ["Spain", 1], ["Turkey (Türkiye)", 1], ["Belgium", 1]], "g_trials": [{"nct": "NCT07517250", "title": "A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients", "status": "RECRUITING", "start": "2026-03-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": ["Switzerland"]}, {"nct": "NCT07203001", "title": "A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease", "status": "RECRUITING", "start": "2025-11-03", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": ["Canada", "France", "Germany", "Italy", "Netherlands", "Spain", "Turkey (Türkiye)", "United States"]}, {"nct": "NCT04402086", "title": "Rheumatology Patient Registry and Biorepository", "status": "RECRUITING", "start": "2020-08-04", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Yale University", "countries": ["United States"]}, {"nct": "NCT03510442", "title": "Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related Conditions", "status": "RECRUITING", "start": "2018-05-21", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)", "countries": ["United States"]}, {"nct": "NCT05927454", "title": "Acostill ( RaDiCo Cohort) (RaDiCo Acostill)", "status": "RECRUITING", "start": "2017-07-11", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Institut National de la Santé Et de la Recherche Médicale, France", "countries": ["France"]}, {"nct": "NCT02143986", "title": "Glycosylated Ferritin in Macrophagic Activation Syndromes", "status": "RECRUITING", "start": "2014-05", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Brugmann University Hospital", "countries": ["Belgium"]}]}, {"batch": 2, "no": 5, "name_zh": "Alagille综合征", "query_terms": [{"term": "Alagille syndrome", "broad": false}], "n_total": 1, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT05488067", "title": "Atorvastatin Therapy on Xanthoma in Alagille Syndrome", "status": "COMPLETED", "start": "2022-03-22", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Children's Hospital of Fudan University", "conditions": ["Alagille Syndrome", "Atorvastatin", "Xanthoma"], "cn_sites": [{"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 10, "g_fetched": 10, "g_countries": [["United States", 4], ["France", 3], ["Italy", 2], ["Spain", 2], ["Canada", 1], ["Japan", 1], ["Belgium", 1], ["Germany", 1], ["Greece", 1], ["Netherlands", 1], ["Portugal", 1], ["Australia", 1]], "g_trials": [{"nct": "NCT07335523", "title": "Determine the Prevalence of Exocrine Pancreatic Insufficiency (EPI) in Pediatric and Adult Participants With Alagille Syndrome After Liver Transplantation", "status": "RECRUITING", "start": "2026-08-03", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Digestive Care, Inc.", "countries": ["United States"]}, {"nct": "NCT07585097", "title": "A Study to Observe the Long-term Safety of Odevixibat in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment", "status": "RECRUITING", "start": "2026-07-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Ipsen", "countries": ["France", "Italy"]}, {"nct": "NCT07411716", "title": "Pediatric Evaluation and Registry for Liver Cholestasis in Canada", "status": "RECRUITING", "start": "2026-04-21", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Children's Hospital of Eastern Ontario", "countries": ["Canada"]}, {"nct": "NCT06506734", "title": "Dental Dyschromia and Quality of Life in Early Prolonged Hyperbilirubinemia", "status": "RECRUITING", "start": "2026-04-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Toulouse", "countries": ["France"]}, {"nct": "NCT07293897", "title": "A Database Study of Maralixibat (TAK-625) in Participants With Alagille Syndrome (ALGS) and Progressive Familial Intrahepatic Cholestasis (PFIC)", "status": "RECRUITING", "start": "2026-01-13", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Takeda", "countries": ["Japan"]}, {"nct": "NCT07290257", "title": "Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in Patients With Alagille Syndrome or Progressive Familial Intrahepatic Cholestasis in the European Union (LEAP-EU)", "status": "RECRUITING", "start": "2025-09-25", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Mirum Pharmaceuticals, Inc.", "countries": ["Belgium", "France", "Germany", "Greece", "Italy", "Netherlands", "Portugal", "Spain"]}, {"nct": "NCT06850038", "title": "A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment", "status": "RECRUITING", "start": "2025-04-22", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Ipsen", "countries": ["United States"]}, {"nct": "NCT06193928", "title": "Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)", "status": "RECRUITING", "start": "2023-09-21", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Mirum Pharmaceuticals, Inc.", "countries": ["United States"]}, {"nct": "NCT06767605", "title": "Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai)", "status": "RECRUITING", "start": "2016-01-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Asociación Española para el Estudio del Hígado", "countries": ["Spain"]}, {"nct": "NCT01793168", "title": "Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford", "status": "RECRUITING", "start": "2010-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sanford Health", "countries": ["Australia", "United States"]}]}, {"batch": 2, "no": 6, "name_zh": "α-１-抗胰蛋白酶缺乏症", "query_terms": [{"term": "Alpha-1-antitrypsin deficiency", "broad": false}], "n_total": 1, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT07193615", "title": "Study of YOLT-202 in the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-06-18", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "RenJi Hospital", "conditions": ["Alpha-1 Antitrypsin Deficiency (AATD)"], "cn_sites": [{"facility": "Ren Ji Hospital Affiliated to Shanghai Jiao Tong University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 24, "g_fetched": 24, "g_countries": [["United States", 14], ["United Kingdom", 6], ["Spain", 5], ["Germany", 4], ["Ireland", 4], ["Portugal", 4], ["Australia", 4], ["France", 4], ["Denmark", 3], ["Netherlands", 3], ["Poland", 3], ["Sweden", 3], ["Austria", 3], ["Belgium", 2], ["Canada", 2], ["Italy", 2], ["Switzerland", 2], ["Czechia", 2], ["Georgia", 1], ["Turkey (Türkiye)", 1], ["New Zealand", 1], ["The Gambia", 1], ["Brazil", 1]], "g_trials": [{"nct": "NCT07639996", "title": "Natural Course and Molecular Basis of Alpha 1- Antitrypsin Deficiency-associated Liver Disease.", "status": "NOT_YET_RECRUITING", "start": "2026-10-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT07326592", "title": "Phase 4, Double-blind Study Evaluating the Response on Computed Tomography (CT) Lung Density Decline Rates of Respreeza / Zemaira Weekly for 3 Years in Adults With alpha1 Antitrypsin Deficiency (AATD)", "status": "NOT_YET_RECRUITING", "start": "2026-07-20", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "CSL Behring", "countries": []}, {"nct": "NCT07707635", "title": "IBS-Oriented CDED Versus Low FODMAP Diet for Irritable Bowel Syndrome", "status": "NOT_YET_RECRUITING", "start": "2026-07-07", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Ariel University", "countries": []}, {"nct": "NCT07555483", "title": "A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)", "status": "RECRUITING", "start": "2026-05-05", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Grifols Therapeutics LLC", "countries": ["Denmark", "Germany", "Ireland", "Netherlands", "Poland", "Portugal", "Spain", "Sweden", "United States"]}, {"nct": "NCT07227207", "title": "A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD)", "status": "RECRUITING", "start": "2026-04-21", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Tessera Therapeutics, Inc.", "countries": ["Australia", "United Kingdom", "United States"]}, {"nct": "NCT07431112", "title": "A Study of AIR-001 in Adults With Alpha-1 Antitrypsin Deficiency (AATD)", "status": "RECRUITING", "start": "2026-03-17", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "AIRNA Corporation", "countries": ["Australia", "Georgia", "Portugal", "Spain", "United Kingdom"]}, {"nct": "NCT07715617", "title": "Development of a Prediction Score for the Occurrence of Death or Lung Transplantation in Patients With Emphysema Secondary to Alpha-1-anti-tripsin Deficiency", "status": "RECRUITING", "start": "2026-02-16", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Bordeaux", "countries": ["France"]}, {"nct": "NCT07145385", "title": "Prevalence of Alpha-1 Antitrypsin Deficiency in Non-Cirrhotic Liver Cancer", "status": "NOT_YET_RECRUITING", "start": "2026-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Bordeaux", "countries": ["France"]}, {"nct": "NCT07135427", "title": "Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency", "status": "RECRUITING", "start": "2025-09-03", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "University of Alabama at Birmingham", "countries": ["United States"]}, {"nct": "NCT07152834", "title": "Screening for Alpha-1 Antitrypsin Deficiency in Patients With Airway Obstruction", "status": "RECRUITING", "start": "2025-08-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Muğla Sıtkı Koçman University", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT06505603", "title": "PiMZ Longitudinal Cohort (PiMZ Logic)", "status": "RECRUITING", "start": "2025-05-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Columbia University", "countries": ["United States"]}, {"nct": "NCT06996756", "title": "Gene Therapy for Alpha 1- Antitrypsin Deficiency", "status": "RECRUITING", "start": "2025-02-26", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Weill Medical College of Cornell University", "countries": ["United States"]}, {"nct": "NCT06512454", "title": "A Study in Adults to Learn About Inherited Alpha-1 Antitrypsin Deficiency (AATD) and AATD Related Liver Problems", "status": "RECRUITING", "start": "2024-09-25", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Takeda", "countries": ["Austria", "Germany", "Ireland", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT06389877", "title": "A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)", "status": "RECRUITING", "start": "2024-06-19", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Beam Therapeutics Inc.", "countries": ["Australia", "Ireland", "Netherlands", "New Zealand", "United Kingdom", "United States"]}, {"nct": "NCT06165341", "title": "Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)", "status": "RECRUITING", "start": "2024-03-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Takeda", "countries": ["Austria", "Belgium", "Canada", "France", "Germany", "Italy", "Poland", "Portugal", "Spain", "Sweden", "Switzerland", "United Kingdom", "United States"]}, {"nct": "NCT06049082", "title": "A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency", "status": "RECRUITING", "start": "2024-02-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Krystal Biotech, Inc.", "countries": ["United States"]}, {"nct": "NCT06029543", "title": "Permian Health Women's Lung Health Study", "status": "NOT_YET_RECRUITING", "start": "2023-12", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Permian Health Lung Institute", "countries": ["The Gambia"]}, {"nct": "NCT05677971", "title": "Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein", "status": "RECRUITING", "start": "2023-03-06", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Takeda", "countries": ["Australia", "Austria", "Belgium", "Brazil", "Canada", "Czechia", "Denmark", "France", "Germany", "Ireland", "Italy", "Netherlands", "Poland", "Portugal", "Spain", "Sweden", "Switzerland", "United Kingdom", "United States"]}, {"nct": "NCT05335603", "title": "An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis", "status": "RECRUITING", "start": "2020-08-24", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Copenhagen", "countries": ["Denmark"]}, {"nct": "NCT04157049", "title": "Alpha-1 Research Registry", "status": "RECRUITING", "start": "2019-06-20", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Alpha-1 Foundation", "countries": ["United States"]}, {"nct": "NCT05178277", "title": "Czech AATD Registry", "status": "RECRUITING", "start": "2018-01-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Thomayer University Hospital", "countries": ["Czechia"]}, {"nct": "NCT01851642", "title": "Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs", "status": "RECRUITING", "start": "2007-08-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Florida", "countries": ["United States"]}, {"nct": "NCT00500123", "title": "The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study", "status": "RECRUITING", "start": "2001-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Florida", "countries": ["United States"]}, {"nct": "NCT00001532", "title": "Role of Genetic Factors in the Development of Lung Disease", "status": "RECRUITING", "start": "1996-09-13", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "countries": ["United States"]}]}, {"batch": 2, "no": 7, "name_zh": "ANCA相关性血管炎", "query_terms": [{"term": "Anti-neutrophil cytoplasmic antibody-associated vasculitis", "broad": false}, {"term": "ANCA-associated vasculitis", "broad": false}], "n_total": 64, "n_open": 40, "n_open_precise": 40, "n_broad": 0, "trials": [{"nct": "NCT05315141", "title": "Multicenter Cohort Study of AAV in Hunan of China", "status": "RECRUITING", "start": "2022-03-16", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Xiangya Hospital of Central South University", "conditions": ["ANCA Associated Vasculitis"], "cn_sites": [{"facility": "Xiangya hospital", "city": "Changsha", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05965284", "title": "Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM)", "status": "RECRUITING", "start": "2023-03-09", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Chinese SLE Treatment And Research Group", "conditions": ["ANCA-associated Vasculitis", "Maintenance Therapy"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05859997", "title": "Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases", "status": "ENROLLING_BY_INVITATION", "start": "2023-05-17", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Bioray Laboratories", "conditions": ["Systemic Lupus Erythematosus (SLE)", "Sjogren's Syndrome", "Systemic Sclerosis", "Inflammatory Myopathy", "ANCA Associated Systemic Vasculitis", "Antiphospholipid Syndrome"], "cn_sites": [{"facility": "Shanghai ChangZheng hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05962840", "title": "Efficacy and Safety for Rituximab Combined With Telitacicept in the Treatment of ANCA-associated Vasculitis (TTCAAVREM)", "status": "RECRUITING", "start": "2023-06-29", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Chinese SLE Treatment And Research Group", "conditions": ["ANCA Associated Vasculitis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05979051", "title": "A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （EGPA）", "status": "RECRUITING", "start": "2023-11-16", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 166, "sponsor": "Guangdong Hengrui Pharmaceutical Co., Ltd", "conditions": ["Eosinophilic Granulomatosis With Polyangiitis"], "cn_sites": [{"facility": "Beijing Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06277427", "title": "Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T Cells", "status": "RECRUITING", "start": "2024-02-05", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Lingli Dong", "conditions": ["Lupus Nephritis", "ANCA Associated Vasculitis"], "cn_sites": [{"facility": "Tongji Hospital", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06285279", "title": "The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases", "status": "RECRUITING", "start": "2024-03-04", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Nanjing University School of Medicine", "conditions": ["Lupus Nephritis", "ANCA-associated Vasculitis", "Membranous Nephropathy - PLA2R Induced", "IgG4-Related Diseases"], "cn_sites": [{"facility": "Jinling Hospital", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06420154", "title": "The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2024-05-27", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "First Affiliated Hospital of Wenzhou Medical University", "conditions": ["Systemic Lupus Erythematosus (SLE)", "Sjogren's Syndrome", "Systemic Sclerosis", "Inflammatory Myopathy", "ANCA Associated Vasculitis", "Antiphospholipid Syndrome"], "cn_sites": [{"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06350110", "title": "Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)", "status": "RECRUITING", "start": "2024-07-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 75, "sponsor": "Essen Biotech", "conditions": ["Systemic Lupus Erythematosus", "Lupus Nephritis", "Autoimmune Diseases", "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis", "Granulomatous Polyangiitis", "Microscopic Polyangiitis", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathies", "Sjogren's Syndrome"], "cn_sites": [{"facility": "District One Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06548607", "title": "Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases", "status": "RECRUITING", "start": "2024-09-14", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Nanjing Bioheng Biotech Co., Ltd.", "conditions": ["SLE (Systemic Lupus)", "Systemic Sclerosis", "ANCA Associated Vasculitis", "Idiopathic Inflammatory Myopathies", "Sjogren's Syndrome", "Autoimmune Diseases"], "cn_sites": [{"facility": "The Third the People's Hospital of Bengbu", "city": "Bengbu", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06794008", "title": "BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2024-12-26", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Peking University People's Hospital", "conditions": ["Systemic Lupus Erythematosus", "Inflammatory Myopathy", "Systemic Sclerosis (SSc)", "ANCA-associated Vasculitis", "IgG4-Related Diseases", "Antiphospholipid Syndrome", "Acquired Thrombotic Thrombocytopenic Purpura", "Behcet Disease", "Sjogren Syndrome"], "cn_sites": [{"facility": "Department of Rheumatology and Immunology, Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06775912", "title": "Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases", "status": "RECRUITING", "start": "2025-01-03", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Nanjing Bioheng Biotech Co., Ltd.", "conditions": ["SLE", "Systemic Sclerosis", "IIM", "NMOSD", "MS", "MG", "ANCA Associated Vasculitis (AAV)"], "cn_sites": [{"facility": "The First People's Hospital of Lianyungang", "city": "Lianyungang", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06614270", "title": "Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases", "status": "RECRUITING", "start": "2025-01-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Systemic Sclerosis (SSc)", "ANCA Associated Vasculitis (AAV)", "Idiopathic Inflammatory Myopathy (IIM)", "Sjogren&#39;s Syndrome", "Antiphospholipid Syndrome", "Systemic Lupus Erythematosus"], "cn_sites": [{"facility": "the second affiliated hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06941129", "title": "CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2025-02-11", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Systemic Lupus Erythematosus", "Systemic Sclerosis (SSc)", "Inflammatory Myopathy", "ANCA-Associated Vasculitis (AAV)", "Connective Tissue Disease-Associated Thrombocytopenia", "SLE-ITP"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06978738", "title": "UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2025-05", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Changzhou No.2 People's Hospital", "conditions": ["Systemic Lupus Erythematosus", "Autoimmune Hemolytic Anemia", "Myasthenia Gravis", "Systemic Sclerosis", "ANCA-Associated Vasculitis", "Inflammatory Myopathy", "IgG4-RD"], "cn_sites": [{"facility": "Changzhou No.2 People's Hospital", "city": "Changzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06978647", "title": "A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases", "status": "RECRUITING", "start": "2025-05-19", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "China Immunotech (Beijing) Biotechnology Co., Ltd.", "conditions": ["Systemic Lupus Erythematosus (SLE)", "Systemic Sclerosis (SSc)", "Inflammatory Myopathy", "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis", "Antiphospholipid Syndrome (APS)", "Rheumatoid Arthritis (RA)", "IgG4-Related Diseases", "Sjogren&#39;s Syndrome"], "cn_sites": [{"facility": "The First Medical Center of Chinese PLA General Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06980597", "title": "A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2025-06", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 44, "sponsor": "Beijing GoBroad Hospital", "conditions": ["Systemic Lupus Erythematosus (SLE)", "Idiopathic Inflammatory Myopathy (IIM)", "Systemic Sclerosis (SSc)", "ANCA Associated Vasculitis (AAV)"], "cn_sites": [{"facility": "Beijing Boren Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing GoBroad Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06986018", "title": "Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAV", "status": "NOT_YET_RECRUITING", "start": "2025-06-14", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Peking University People's Hospital", "conditions": ["Idiopathic Inflammatory Myopathies", "ANCA-Associated Vasculitis"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07033299", "title": "The Safety, Efficacy, and Cellular Metabolic Kinetics of CT1192 in Treating Patients With Anti Neutrophil Cytoplasmic Antibody Associated Vasculitis", "status": "NOT_YET_RECRUITING", "start": "2025-07-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": ["ANCA Associated Vasculitis (AAV)"], "cn_sites": [{"facility": "Wuhan Union Hospita", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06828042", "title": "Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2025-07-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Peking University Third Hospital", "conditions": ["Systemic Lupus Erthematosus", "Systemic Sclerosis (SSc)", "Sjogren Syndrome", "ANCA Associated Vasculitis (AAV)", "Inflammatory Myopathies", "Antiphospholipid Syndrome"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07203404", "title": "A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.", "status": "RECRUITING", "start": "2025-07-24", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 96, "sponsor": "Nanjing Bioheng Biotech Co., Ltd.", "conditions": ["SLE", "LN", "ANCA Associated Vasculitis", "ANCA-Associated Glomerulonephritis", "Anti-GBM Disease", "MN", "SSc", "IIM", "IgA Nephropathy"], "cn_sites": [{"facility": "Zhongshan Hospital, Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07104721", "title": "A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases", "status": "RECRUITING", "start": "2025-08-04", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "China Immunotech (Beijing) Biotechnology Co., Ltd.", "conditions": ["Systemic Lupus Erythematosus (SLE)", "Lupus Nephritis (LN)", "Systemic Sclerosis (SSc)", "Inflammatory Myopathy", "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis", "Antiphospholipid Syndrome (APS)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07123519", "title": "A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases", "status": "RECRUITING", "start": "2025-08-13", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "China Immunotech (Beijing) Biotechnology Co., Ltd.", "conditions": ["Systemic Lupus Erythematosus (SLE)", "Lupus Nephritis (LN)", "Sjogren&#39;s Syndrome (SS)", "Inflammatory Myopathy", "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis", "Antiphospholipid Syndrome (APS)"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital, China", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07151521", "title": "(68)Ga-FAPI PET/CT in Patients With ANCA-associated Vasculitis", "status": "RECRUITING", "start": "2025-09-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 30, "sponsor": "Ruijin Hospital", "conditions": ["ANCA-associated Vasculitis"], "cn_sites": [{"facility": "Ruiiin Hospital Shanghai JiaoTong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07168161", "title": "BDB-001 Phase III Trial in ANCA-Associated Vasculitis", "status": "RECRUITING", "start": "2025-11-10", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 300, "sponsor": "Staidson (Beijing) Biopharmaceuticals Co., Ltd", "conditions": ["ANCA Associated Vasculitis (AAV)"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Peking University People's Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Peking University Third Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Peking University International Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Beijing Tsinghua Changgung Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Xiamen University", "city": "Xiamen", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Hospital of Lanzhou University", "city": "Lanzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Guangdong General Hospital", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Sun Yat-sen Memorial Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Meizhou People's Hospital", "city": "Meizhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Yuebei People's Hospital", "city": "Shaoguan", "status": "NOT_YET_RECRUITING"}, {"facility": "Guangdong Provincial People's Hospital", "city": "Shenzhen", "status": "NOT_YET_RECRUITING"}, {"facility": "Peking university Shenzhen Hospital", "city": "Shenzhen", "status": "NOT_YET_RECRUITING"}, {"facility": "Liuzhou People's Hospital", "city": "Liuzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": "NOT_YET_RECRUITING"}, {"facility": "Guangxi Academy of Medical Sciences,The People's Hospital of Guangxi Zhuang Autonomous Region", "city": "Nanning", "status": "NOT_YET_RECRUITING"}, {"facility": "Guizhou Provincial People's Hospital", "city": "Guiyang", "status": "NOT_YET_RECRUITING"}, {"facility": "Cangzhou City People's Hospital", "city": "Cangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Hospital of Hebei Medical University City:Shijiazhuang", "city": "Shijiazhuang", "status": "NOT_YET_RECRUITING"}, {"facility": "Kailuan General Hospital", "city": "Tangshan", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Affiliated Hospital of Harbin", "city": "Harbin", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Henan University of science and Technology", "city": "Luoyang", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Tongji Hospital,Tongji Medical college of Hust", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}, {"facility": "Yichang Central People's Hospital", "city": "Yichang", "status": "NOT_YET_RECRUITING"}, {"facility": "General Hospital of Hunan University of Medicine", "city": "Changde", "status": "NOT_YET_RECRUITING"}, {"facility": "Hunan Provincial People's Hospital", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Xiangya Hospital Central South University (Nephrology Department)", "city": "Changsha", "status": "NOT_YET_RECRUITING"}, {"facility": "Xiangya Hospital Central South University(Rheumatism Immunity Branch)", "city": "Changsha", "status": "NOT_YET_RECRUITING"}, {"facility": "General Hospital of Hunan University of Medicine", "city": "Huaihua", "status": "NOT_YET_RECRUITING"}, {"facility": "Zhuzhou Central Hospital", "city": "Zhuzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Nanjing Gulou Hospital", "city": "Nanjing", "status": "NOT_YET_RECRUITING"}, {"facility": "Nanjing University School of Medicine Affiliated Gulou Hospital", "city": "Nanjing", "status": "NOT_YET_RECRUITING"}, {"facility": "Jiang Su Province Hospital", "city": "Nanjing", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Affiliated Hospital of Soochow University", "city": "Suzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The Affiliated Hospital of Xuzhou Medical University", "city": "Xuzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Jiangxi Provincial People's Hospital", "city": "Nanchang", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Hospital of Jilin University", "city": "Changchun", "status": "NOT_YET_RECRUITING"}, {"facility": "Affiliated Hospital of Yanbian University (Yanbian Hospital)", "city": "Yanbian", "status": "NOT_YET_RECRUITING"}, {"facility": "Shengjing Hospital of China Medical University", "city": "Shengyang", "status": "NOT_YET_RECRUITING"}, {"facility": "Affiliated Hospital of Inner Mongolia Medical University", "city": "Hohhot", "status": "NOT_YET_RECRUITING"}, {"facility": "Shandong Provincial Hospital", "city": "Jinan", "status": "NOT_YET_RECRUITING"}, {"facility": "Weifang People's Hospital", "city": "Weifang", "status": "NOT_YET_RECRUITING"}, {"facility": "Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}, {"facility": "Zhongshan hospital,Fudan University", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}, {"facility": "Shanxi Bethune Hospital", "city": "Taiyuan", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Hospital of Shanxi Medical University", "city": "Taiyuan", "status": "NOT_YET_RECRUITING"}, {"facility": "Xijing Hospital", "city": "Xi’an", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Xi'an Jiao Tong University", "city": "Xi’an", "status": "NOT_YET_RECRUITING"}, {"facility": "The Third People's Hospital of Chengdu", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}, {"facility": "Sichuan Provincial People's Hospital", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Xinjiang Medical University", "city": "Ürümqi", "status": "NOT_YET_RECRUITING"}, {"facility": "The First People's Hospital of Yunnan Province", "city": "Kunming", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital, College of Medicine, Zhejiang University", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Affiliated Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Zhejiang Provincial People's Hospital", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "People's Hospital of Lishui", "city": "Lishui", "status": "NOT_YET_RECRUITING"}, {"facility": "The Affiliated Hospital of the Medical School of Ningbo University", "city": "Ningbo", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 64, "broad_only": false}, {"nct": "NCT07236801", "title": "Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases", "status": "RECRUITING", "start": "2025-11-13", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "China Immunotech (Beijing) Biotechnology Co., Ltd.", "conditions": ["Systemic Lupus Erythematosus (SLE)", "Systemic Sclerosis", "Sjogren's Syndrome (SS)", "Inflammatory Myopathy", "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis", "Antiphospholipid Syndrome"], "cn_sites": [{"facility": "The Affiliated Hospital of Xuzhou Medical University", "city": "Xuzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07236762", "title": "An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases", "status": "RECRUITING", "start": "2025-11-24", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "China Immunotech (Beijing) Biotechnology Co., Ltd.", "conditions": ["Systemic Lupus Erythematosus", "Lupus Nephritis (LN)", "Sjogren's Syndrome", "Inflammatory Myopathy", "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis", "Antiphospholipid Syndrome"], "cn_sites": [{"facility": "The third people's Hospital of Bengbu", "city": "Bengbu", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07160608", "title": "Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis", "status": "RECRUITING", "start": "2025-11-26", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 75, "sponsor": "Alexion Pharmaceuticals, Inc.", "conditions": ["Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis"], "cn_sites": [{"facility": "Research Site", "city": "Baotou", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Shenzhen", "status": "RECRUITING"}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT07305116", "title": "CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease", "status": "RECRUITING", "start": "2025-12-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "The Children's Hospital of Zhejiang University School of Medicine", "conditions": ["Autoimmune Diseases", "Systemic Lupus Erthematosus (SLE)", "Multi-Drug Resistant Nephrotic Syndrome", "IgA Nephropathy (IgAN)", "Systemic Sclerosis (SSc)", "ANCA Associated Systemic Vasculitis"], "cn_sites": [{"facility": "Children's Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07315087", "title": "CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2026-01-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["SLE - Systemic Lupus Erythematosus", "SSc-Systemic Sclerosis", "IIM- Idiopathic Inflammatory Myopathies", "ANCA Associated Vasculitis (AAV)", "Connective Tissue Disease-Associated Thrombocytopenia", "SLE-ITP"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07413341", "title": "A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2026-01-22", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Therorna", "conditions": ["Systemic Lupus Erythematosus (SLE)", "Sjogren's Syndrome (SS)", "Systemic Sclerosis (SSc)", "Inflammatory Myopathy", "ANCA Associated Systemic Vasculitis"], "cn_sites": [{"facility": "Shanghai Changzheng Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07212322", "title": "A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-01-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Systemic Lupus Erythematosus", "Idiopahic Inflammatory Myopathies", "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis", "Sjögren's Syndrome", "Antiphospholipid Syndrome", "Immune Thrombocytopenia", "Systemic Sclerosis"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07246096", "title": "Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2026-02-20", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Changhai Hospital", "conditions": ["Autoimmune Diseases", "Systemic Lupus Erythematosus", "Systemic Sclerosis", "Primary Sjögren Syndrome", "Rheumatoid Arthritis", "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis"], "cn_sites": [{"facility": "Changhai Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07439029", "title": "YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-03", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Children's Hospital of Fudan University", "conditions": ["Systemic Lupus Erythematosus (SLE)", "Diffuse Systemic Sclerosis", "Idiopathic Inflammatory Myopathies (IIMs)", "ANCA Associated Vasculitis (AAV)", "Antiphospholipid Syndrome (APS)", "Sjogren's Syndrome (SS)"], "cn_sites": [{"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07526350", "title": "MTS109 in Patients With Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2026-03-24", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Shanghai Changzheng Hospital", "conditions": ["Systemic Lupus Erythematosus", "Idiopathic Inflammatory Myopathies", "Systemic Sclerosis (SSc)", "ANCA-Associated Vasculitis (AAV)", "Sjogren's Syndrome (SS)"], "cn_sites": [{"facility": "Shanghai ChangZheng Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07507201", "title": "Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease", "status": "RECRUITING", "start": "2026-04-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "The Children's Hospital of Zhejiang University School of Medicine", "conditions": ["Autoimmune Diseases", "Systemic Lupus Erthematosus (SLE)", "Multi-Drug Resistant Nephrotic Syndrome", "IgA Nephropathy (IgAN)", "Systemic Sclerosis (SSc)", "ANCA Associated Systemic Vasculitis"], "cn_sites": [{"facility": "Children's Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07586267", "title": "CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease", "status": "RECRUITING", "start": "2026-05-08", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "The Children's Hospital of Zhejiang University School of Medicine", "conditions": ["Autoimmune Diseases", "Systemic Lupus Erthematosus (SLE)", "Multi-Drug Resistant Nephrotic Syndrome", "IgA Nephropathy (IgAN)", "Systemic Sclerosis (SSc)", "ANCA Associated Systemic Vasculitis"], "cn_sites": [{"facility": "Children's Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07746180", "title": "Obinutuzumab Beta Combined With Low-dose Glucocorticoid in New-onset ANCA-Associated Glomerulonephritis", "status": "RECRUITING", "start": "2026-08-21", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Chinese PLA General Hospital", "conditions": ["ANCA-Associated Glomerulonephritis (AAGN)", "ANCA-Associated Vasculitis (AAV)"], "cn_sites": [{"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07596680", "title": "CD19/BCMA-Targeted Universal CAR-T Cell Injection for the Treatment of Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Nanjing Bioheng Biotech Co., Ltd.", "conditions": ["SLE - Systemic Lupus Erythematosus", "Systemic Sclerosis", "ANCA Associated Vasculitis", "Idiopathic Inflammatory Myopathies", "Sjögren Syndrome"], "cn_sites": [{"facility": "Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07389499", "title": "A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney Diseases", "status": "NOT_YET_RECRUITING", "start": "2027-08", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Grit Biotechnology", "conditions": ["IgA Nephropathy (IgAN)", "Membranous Nephropathy", "ANCA-associated Vasculitis (AAV)/ANCA-associated Glomerulonephritis (AAGN)", "Refractory Podocytopathy", "Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits"], "cn_sites": [{"facility": "Zhongshan Hospital Affiliated to Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00301652", "title": "MMF Versus CTX in the Induction Treatment of ANCA Associated Vasculitis", "status": "COMPLETED", "start": "2003-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Nanjing University School of Medicine", "conditions": ["Vasculitis", "Anti-Neutrophil Cytoplasmic Antibody"], "cn_sites": [{"facility": "Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine", "city": "Nanjing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01066208", "title": "American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis", "status": "UNKNOWN", "start": "2011-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 3588, "sponsor": "University of Oxford", "conditions": ["Wegener's Granulomatosis", "Microscopic Polyangiitis", "Churg Strauss Syndrome", "Polyarteritis Nodosa", "Giant Cell Arteritis", "Takayasu Arteritis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital, Beijing", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04413149", "title": "Anti-neutrophil Cytoplasmic Antibody in Interstitial Lung Disease.", "status": "COMPLETED", "start": "2014-04-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 80, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Interstitial Lung Disease", "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02126098", "title": "Observation Study of Clinical Manifestation and Outcome in Chinese Patients With Pulmonary Vasculitis", "status": "UNKNOWN", "start": "2014-05", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Peking Union Medical College Hospital", "conditions": ["ANCA-associated Vasculitis", "Granulomatosis With Polyangiitis", "Microscopic Polyangiitis", "EosinphilicGranulomatosis With Polyangiitis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02294344", "title": "The Clinical Efficacy of DFPP in Patients With AAGN", "status": "TERMINATED", "start": "2014-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 14, "sponsor": "Zhi-Hong Liu, M.D.", "conditions": ["Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis"], "cn_sites": [{"facility": "Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine", "city": "Nanjing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04973033", "title": "Effect of Tofacitinib in Treating ANCA-associated Vasculitis", "status": "COMPLETED", "start": "2019-12-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Shanghai Zhongshan Hospital", "conditions": ["ANCA Associated Vasculitis", "Drug Use", "JAK-STAT Pathway Deregulation"], "cn_sites": [{"facility": "Department of Rheumatology in Zhongshan hospital, Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04737343", "title": "Comparison of the Efficacy of Leflunomide and Azathioprine for the Maintenance Therapy of ANCA Associated Vasculitis", "status": "UNKNOWN", "start": "2021-06-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 114, "sponsor": "Chinese SLE Treatment And Research Group", "conditions": ["ANCA Associated Vasculitis", "Maintenance Therapy"], "cn_sites": [{"facility": "AnHui provincial hospital", "city": "Hefei", "status": "NOT_YET_RECRUITING"}, {"facility": "the Affiliated Hospital of Inner Mongolia Medical University", "city": "Hohhot", "status": "NOT_YET_RECRUITING"}, {"facility": "the Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": "NOT_YET_RECRUITING"}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT04923074", "title": "the Application of Diffusion Tensor Imaging in the Evaluation of Peripheral Neuropathy in ANCA Associated Vasculitis", "status": "UNKNOWN", "start": "2021-07", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 50, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["ANCA Associated Vasculitis"], "cn_sites": [{"facility": "2nd affiliated hospital of Zhejiang University, School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04944524", "title": "Comparison of Tofacitinib and Methotrexate in the Maintained Treatment of GPA", "status": "UNKNOWN", "start": "2021-07-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 66, "sponsor": "Shanghai Zhongshan Hospital", "conditions": ["Granulomatosis With Polyangiitis"], "cn_sites": [{"facility": "Department of Rheumatology in Zhongshan hospital, Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05197842", "title": "Efficacy and Safety of Substitution of Glucocorticoid for BDB-001 Injection in Patients With Anti-neutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis", "status": "COMPLETED", "start": "2022-02-22", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 93, "sponsor": "Staidson (Beijing) Biopharmaceuticals Co., Ltd", "conditions": ["ANCA-associated Vasculitis"], "cn_sites": [{"facility": "The Second hospital Of Anhui Medical University", "city": "Hefei", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University International Hospital", "city": "Beijing", "status": ""}, {"facility": "Guangxi Academy of Medical Sciences,The People's Hospital of Guangxi Zhuang Autonomous Region", "city": "Nanning", "status": ""}, {"facility": "The Second hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "The Third hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "The First Affiliated Hospital of Henan University of science and Technology", "city": "Luoyang", "status": ""}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": ""}, {"facility": "Tongji Hospital,Tongji Medical college of Hust", "city": "Wuhan", "status": ""}, {"facility": "Xiangya Hospital Central South University (Nephrology Department)", "city": "Changsha", "status": ""}, {"facility": "Xiangya Hospital Central South University(Rheumatism Immunity Branch)", "city": "Changsha", "status": ""}, {"facility": "The Third Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": ""}, {"facility": "Shengjing Hospital of China Medical University", "city": "Shengyang", "status": ""}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "General Hospital of Ningxia Medical University", "city": "Yinchuan", "status": ""}, {"facility": "Zhongshan hospital,Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Xijing Hospital", "city": "Xi’an", "status": ""}, {"facility": "The First Affiliated Hospital of Xi'an Jiao Tong University", "city": "Xi’an", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "The First Affiliated Hospital, College of Medicine, Zhejiang University", "city": "Hangzhou", "status": ""}], "cn_site_count": 22, "broad_only": false}, {"nct": "NCT05353179", "title": "Study on Pharmacokinetics of Meperizumab Injection and NUCALA® in Healthy Male Volunteers", "status": "UNKNOWN", "start": "2022-06", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 88, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Granulomatosis With Polyangiitis", "Hemophagocytic Syndrome"], "cn_sites": [{"facility": "Affiliated Hospital of Changchun University of Traditional Chinese Medicine", "city": "Changchun", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05263934", "title": "Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-07-14", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 163, "sponsor": "GlaxoSmithKline", "conditions": ["Eosinophilic Granulomatosis With Polyangiitis"], "cn_sites": [{"facility": "GSK Investigational Site", "city": "Beijing", "status": ""}, {"facility": "GSK Investigational Site", "city": "Guangzhou", "status": ""}, {"facility": "GSK Investigational Site", "city": "Hefei", "status": ""}, {"facility": "GSK Investigational Site", "city": "Nanjing", "status": ""}, {"facility": "GSK Investigational Site", "city": "Qingdao", "status": ""}, {"facility": "GSK Investigational Site", "city": "Shanghai", "status": ""}, {"facility": "GSK Investigational Site", "city": "Shenzhen", "status": ""}, {"facility": "GSK Investigational Site", "city": "Wenzhou", "status": ""}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT05969522", "title": "Stratified Therapy on Pediatric AAGN", "status": "UNKNOWN", "start": "2023-01-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 200, "sponsor": "Wang Mo", "conditions": ["Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis", "ANCA-Associated Glomerulonephritis"], "cn_sites": [{"facility": "Children's Hospital of Chongqing Medical University", "city": "Chongqing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06056921", "title": "Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease", "status": "UNKNOWN", "start": "2023-08-31", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Chongqing Precision Biotech Co., Ltd", "conditions": ["SLE (Systemic Lupus)", "Sjogren's Syndrome", "Systemic Scleroderma", "Dermatomyositis", "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis"], "cn_sites": [{"facility": "Shanxi Bethune Hospital", "city": "Taiyuan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06316076", "title": "Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases", "status": "UNKNOWN", "start": "2023-10-30", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 48, "sponsor": "RenJi Hospital", "conditions": ["Systemic Lupus Erythematosus", "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis", "Idiopathic Inflammatory Myopathies", "Systemic Sclerosis"], "cn_sites": [{"facility": "Department of Rheumatology, Ren Ji Hospital South Campus, School of Medicine, Shanghai JiaoTong University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06373081", "title": "Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease", "status": "UNKNOWN", "start": "2024-04-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Shanghai Changzheng Hospital", "conditions": ["Systemic Lupus Erythematosus (SLE)", "Sjogren's Syndrome", "Systemic Sclerosis", "Inflammatory Myopathy", "ANCA Associated Vasculitis", "Antiphospholipid Syndrome"], "cn_sites": [{"facility": "Shanghai ChangZheng hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06379646", "title": "An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease", "status": "UNKNOWN", "start": "2024-04-24", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "China Immunotech (Beijing) Biotechnology Co., Ltd.", "conditions": ["Systemic Lupus Erythematosus", "Systemic Sclerosis", "Inflammatory Myopathy", "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis", "Antiphospholipid Syndrome", "Sjogren's Syndrome"], "cn_sites": [{"facility": "Shanghai Changzheng Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06462144", "title": "IMPT-514 in Systemic Lupus Erythematosus, Anca-associated Vasculitis, and Idiopathic Inflammatory Myopathy", "status": "TERMINATED", "start": "2024-06-13", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 3, "sponsor": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School", "conditions": ["Systemic Lupus Erythematosus (SLE)", "ANCA Associated Vasculitis (AAV)", "Idiopathic Inflammatory Myopathy (IIM)"], "cn_sites": [{"facility": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School", "city": "Nanjing", "status": ""}, {"facility": "The Affiliated Hospital Of Xuzhou Medical University", "city": "Xuzhou", "status": ""}, {"facility": "Zhongshan Hospital Fudan University.", "city": "Shanghai", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT06388941", "title": "Iptacopan in Patients With ANCA Associated Vasculitis", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-08-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 84, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Anti-Neutrophil Cytoplasm Antibodies (ANCA) Associated Vasculitis"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Shijiazhuang", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Zhengzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT06548620", "title": "A Study of RD06-04 in Patients With Active Autoimmune Diseases", "status": "WITHDRAWN", "start": "2024-08-31", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Nanjing Bioheng Biotech Co., Ltd.", "conditions": ["SLE", "Sclerosis", "ANCA Associated Vasculitis", "IIM", "SS", "MS", "NMO Spectrum Disorder", "MG"], "cn_sites": [{"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06549296", "title": "Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune Diseases", "status": "SUSPENDED", "start": "2024-09-13", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Nanjing Bioheng Biotech Co., Ltd.", "conditions": ["Systemic Lupus Erythematosus", "Systemic Sclerosis", "ANCA Associated Vasculitis", "Idiopathic Inflammatory Myopathies", "Sjogren's Syndrome", "Autoimmune Diseases"], "cn_sites": [{"facility": "Xuzhou Medical University Affiliated Hospital", "city": "Xuzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06656962", "title": "The Efficacy and Safety of Treatment with Telitacicept in Antineutrophil Cytoplasmic Antibody-associated Nephritis (AAGN)", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-10-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Renmin Hospital of Wuhan University", "conditions": ["Antineutrophil Cytoplasmic Antibody (ANCA)-associated Nephritis (AAGN)"], "cn_sites": [{"facility": "Renmin hospital of Wuhan University", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06866080", "title": "A Study of LCAR-AIO in Subjects With Relapsed/Refractory Autoimmune Diseases", "status": "WITHDRAWN", "start": "2025-06-17", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Nanjing Legend Biotech Co.", "conditions": ["Relapsed/Refractory Autoimmune Diseases"], "cn_sites": [{"facility": "The First Affiliated Hospital of USTC (anhui provincial hospital)", "city": "Hefei", "status": ""}, {"facility": "Jiangsu Province Hospital", "city": "Nanjing", "status": ""}, {"facility": "The 1st Affiliated Hospital of WHU", "city": "Wenzhou", "status": ""}, {"facility": "The Affiliated Hospital of XUZHOU Medical University", "city": "Xuzhou", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT07339540", "title": "the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-11-04", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 45, "sponsor": "Tongji Hospital", "conditions": ["Recurrent or Refractory Systemic Lupus Erythematosus", "Recurrent or Refractory IgG4 Related Diseases", "Recurrent or Refractory Systemic Sclerosis", "Recurrent or Refractory Idiopathic Inflammatory Myopathy", "Recurrent or Refractory ANCA Associated Vasculitis"], "cn_sites": [{"facility": "Tongji Hospital, Affiliated to Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 92, "g_fetched": 53, "g_countries": [["United States", 17], ["France", 16], ["Canada", 7], ["Italy", 6], ["United Kingdom", 6], ["Netherlands", 4], ["Poland", 4], ["Turkey (Türkiye)", 4], ["Germany", 4], ["Austria", 2], ["India", 2], ["Israel", 2], ["Brazil", 2], ["Japan", 2], ["Sweden", 2], ["Czechia", 2], ["Denmark", 2], ["Argentina", 1], ["Belgium", 1], ["South Korea", 1], ["Mexico", 1], ["Australia", 1], ["Puerto Rico", 1], ["Greece", 1], ["Hungary", 1], ["Romania", 1], ["Spain", 1], ["Switzerland", 1]], "g_trials": [{"nct": "NCT07800871", "title": "FT839 in Autoimmune Diseases", "status": "RECRUITING", "start": "2026-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Fate Therapeutics", "countries": ["United States"]}, {"nct": "NCT07636655", "title": "Immune Monitoring Following B-cell Depletion in ANCA-associated Vasculitis", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Nantes University Hospital", "countries": ["France"]}, {"nct": "NCT07737470", "title": "Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": []}, {"nct": "NCT07556484", "title": "Pharmacokinetics Of Emulsified Avacopan Applied By NG Tube", "status": "RECRUITING", "start": "2026-08-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Mayo Clinic", "countries": ["United States"]}, {"nct": "NCT07444567", "title": "Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment", "status": "RECRUITING", "start": "2026-07-24", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "AstraZeneca", "countries": ["Argentina", "Austria", "Belgium", "Canada", "France", "India", "Israel", "Italy", "Netherlands", "Poland", "South Korea", "Turkey (Türkiye)", "United Kingdom", "United States"]}, {"nct": "NCT07490275", "title": "Allogeneic CD19/BCMA-Targeted CAR-γδT Cell Therapy: Safety and Preliminary Pharmacodynamics in Relapsed/Refractory Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-07-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "countries": []}, {"nct": "NCT06226662", "title": "Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)", "status": "NOT_YET_RECRUITING", "start": "2026-06", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "NovelMed Therapeutics", "countries": []}, {"nct": "NCT07176546", "title": "TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis", "status": "RECRUITING", "start": "2026-05-22", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Robert Spiera, MD", "countries": ["United States"]}, {"nct": "NCT07087912", "title": "Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases", "status": "RECRUITING", "start": "2026-03-16", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "University of Sao Paulo General Hospital", "countries": ["Brazil"]}, {"nct": "NCT07373262", "title": "Avacopan Added to Standard-of-care Therapy in ANCA-associated Vasculitis With Severe Kidney Involvement", "status": "NOT_YET_RECRUITING", "start": "2026-03-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Toulouse", "countries": ["France"]}, {"nct": "NCT07815886", "title": "Benralizumab Effectiveness in EGPA", "status": "RECRUITING", "start": "2026-02-11", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "European EGPA Study Group", "countries": ["Italy"]}, {"nct": "NCT07451847", "title": "Comparison of a Strategy Based on Clinico-biological Monitoring Versus Pre-emptive Rituximab Treatment in Cases of ANCA Reappearance in Granulomatosis With Polyangiitis and Microscopic Polyangiitis.", "status": "NOT_YET_RECRUITING", "start": "2026-02", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT07258524", "title": "PET Assessment of Disease Activity and Cardiovascular Disease Risk in ANCA-associated Vasculitis", "status": "RECRUITING", "start": "2026-01-28", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Edinburgh", "countries": ["United Kingdom"]}, {"nct": "NCT07251179", "title": "Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies", "status": "RECRUITING", "start": "2026-01-20", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Strasbourg, France", "countries": ["France"]}, {"nct": "NCT07089121", "title": "Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders", "status": "RECRUITING", "start": "2026-01-14", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Cartesian Therapeutics", "countries": ["United States"]}, {"nct": "NCT06940661", "title": "Obinutuzumab for Remission Induction in Patients With Relapsing PR3-ANCA Granulomatosis With Polyangiitis", "status": "RECRUITING", "start": "2025-12-19", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT07138898", "title": "Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty", "status": "RECRUITING", "start": "2025-12-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "NYU Langone Health", "countries": ["United States"]}, {"nct": "NCT07301164", "title": "Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2025-12-11", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Peking University Third Hospital", "countries": []}, {"nct": "NCT07077304", "title": "EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases", "status": "RECRUITING", "start": "2025-11-19", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT06983821", "title": "Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW)", "status": "RECRUITING", "start": "2025-11-10", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Ottawa Hospital Research Institute", "countries": ["Canada"]}, {"nct": "NCT07010250", "title": "Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis", "status": "RECRUITING", "start": "2025-11-03", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT07035834", "title": "SGLT-2 Inhibitors on Albuminuria in Chronic Kidney Disease Patients With Lupus Nephritis and ANCA- Associated Vasculitis", "status": "NOT_YET_RECRUITING", "start": "2025-09", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Federico II University", "countries": []}, {"nct": "NCT04871191", "title": "Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis", "status": "RECRUITING", "start": "2025-06-06", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT07275190", "title": "The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome", "status": "RECRUITING", "start": "2025-06-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Fondazione IRCCS Policlinico San Matteo di Pavia", "countries": ["Italy"]}, {"nct": "NCT06512883", "title": "A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases", "status": "RECRUITING", "start": "2025-04-17", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "AstraZeneca", "countries": ["Brazil", "Canada", "France", "India", "Israel", "Mexico", "Netherlands", "Poland", "Turkey (Türkiye)", "United States"]}]}, {"batch": 2, "no": 8, "name_zh": "Bardet-Biedl 综合征", "query_terms": [{"term": "Bardet-Biedl syndrome", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 8, "g_fetched": 8, "g_countries": [["United States", 3], ["United Kingdom", 1], ["Germany", 1], ["France", 1], ["Netherlands", 1]], "g_trials": [{"nct": "NCT07269665", "title": "First-in-Human, Dose Escalation Trial of AXV-101 in BBS1-Related Retinal Degeneration", "status": "RECRUITING", "start": "2026-06-26", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Axovia Therapeutics", "countries": ["United Kingdom"]}, {"nct": "NCT06615011", "title": "Bardet Beidle Syndrome in a Syrian Adolescent : a Rare Case Report", "status": "NOT_YET_RECRUITING", "start": "2024-10-12", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Al Baath University", "countries": []}, {"nct": "NCT07674290", "title": "Real-World Effects of MC4R Agonist Therapy in BBS and Severe Genetic Obesity", "status": "RECRUITING", "start": "2023-01-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Tom Hühne", "countries": ["Germany"]}, {"nct": "NCT04461444", "title": "COhort for Bardet-Bield Syndrome and Alström Syndrome for Translational Research Monocentric Interventional Study", "status": "RECRUITING", "start": "2020-06-16", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Strasbourg, France", "countries": ["France"]}, {"nct": "NCT04463316", "title": "GROWing Up With Rare GENEtic Syndromes", "status": "RECRUITING", "start": "2018-10-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "dr. Laura C. G. de Graaff-Herder", "countries": ["Netherlands"]}, {"nct": "NCT02435940", "title": "Inherited Retinal Degenerative Disease Registry", "status": "RECRUITING", "start": "2014-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Foundation Fighting Blindness", "countries": ["United States"]}, {"nct": "NCT02329210", "title": "Clinical Registry Investigating Bardet-Biedl Syndrome", "status": "RECRUITING", "start": "2014-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Marshfield Clinic Research Foundation", "countries": ["United States"]}, {"nct": "NCT01401998", "title": "ARPKD Database Study", "status": "RECRUITING", "start": "2011-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Children's Hospital of Philadelphia", "countries": ["United States"]}]}, {"batch": 2, "no": 9, "name_zh": "白塞病/贝赫切特综合征", "query_terms": [{"term": "Behçet disease", "broad": false}, {"term": "Behçet's disease", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 0, "g_fetched": 0, "g_countries": [], "g_trials": []}, {"batch": 2, "no": 10, "name_zh": "蓝色橡皮疱样痣", "query_terms": [{"term": "Blue rubber bleb nevus syndrome", "broad": false}, {"term": "Blue rubber bleb nevus", "broad": true}], "n_total": 1, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT03767660", "title": "Efficacy of Rapamycin (Sirolimus) in the Treatment of BRBNS, Hereditary or Sporadic Venous Malformation", "status": "UNKNOWN", "start": "2018-07-31", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Blue Rubber Bleb Nevus Syndrome", "Venous Malformation"], "cn_sites": [{"facility": "Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}], "g_total": 1, "g_fetched": 1, "g_countries": [["United States", 1]], "g_trials": [{"nct": "NCT02399527", "title": "Lymphatic Anomalies Registry for the Assessment of Outcome Data", "status": "RECRUITING", "start": "2013-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Boston Children's Hospital", "countries": ["United States"]}]}, {"batch": 2, "no": 11, "name_zh": "CDKL5缺乏症", "query_terms": [{"term": "CDKL5-deficiency disorder", "broad": false}], "n_total": 4, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT03635073", "title": "A Study of Soticlestat in Adults and Children With Rare Epilepsies", "status": "TERMINATED", "start": "2018-07-19", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 156, "sponsor": "Takeda", "conditions": ["Epilepsy", "Dravet Syndrome (DS)", "Lennox-Gastaut Syndrome (LGS)"], "cn_sites": [{"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Children's Hospital,Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": ""}, {"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT03650452", "title": "A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies", "status": "COMPLETED", "start": "2018-08-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 141, "sponsor": "Takeda", "conditions": ["Epilepsy", "Dravet Syndrome", "Lennox-Gastaut Syndrome"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Capital Medical University (CMU) - Beijing Children's Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Children's Hospital,Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT06447675", "title": "Efficacy and Safety Evaluation of Hyperthermic Baths in the Treatment of Seizures in CDKL5 Deficiency Disorder", "status": "COMPLETED", "start": "2024-09-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 8, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["CDKL5 Deficiency Disorder"], "cn_sites": [{"facility": "Xuanwu Hospital,Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06663163", "title": "The Association Between Fever and CDKL5 Deficiency Disorder: a Nationwide Survey", "status": "COMPLETED", "start": "2024-10-29", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 131, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["CDKL5 Deficiency Disorder"], "cn_sites": [{"facility": "Xuanwu Hospital,Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 6, "g_fetched": 6, "g_countries": [["United States", 4], ["Australia", 2]], "g_trials": [{"nct": "NCT05249556", "title": "Double-blind, Randomized, Placebo-controlled Trial of Ganaxolone in CDKL5 Deficiency Patients 6 Months to Less Than 2 Years Old", "status": "NOT_YET_RECRUITING", "start": "2027-03", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Immedica Pharma AB", "countries": []}, {"nct": "NCT07602205", "title": "Efficacy and Safety of Daily Home-based Hyperthermic Baths for Reducing Epileptic Seizures in CDKL5 Deficiency Disorder: A PROBE Clinical Trial", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Xuanwu Hospital, Beijing", "countries": []}, {"nct": "NCT06967727", "title": "Registry and Natural History of Epilepsy-Dyskinesia Syndromes", "status": "RECRUITING", "start": "2025-06-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Boston Children's Hospital", "countries": ["United States"]}, {"nct": "NCT06585605", "title": "A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes", "status": "RECRUITING", "start": "2024-07-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Boston Children's Hospital", "countries": ["United States"]}, {"nct": "NCT05558371", "title": "International CDKL5 Clinical Research Network", "status": "RECRUITING", "start": "2021-02-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Colorado, Denver", "countries": ["Australia", "United States"]}, {"nct": "NCT06149663", "title": "Intermediate-Size Expanded Access Protocol (EAP) for LP352", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "Longboard Pharmaceuticals", "countries": ["Australia", "United States"]}]}, {"batch": 2, "no": 12, "name_zh": "无脉络膜症", "query_terms": [{"term": "Choroideremia", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 4, "g_fetched": 4, "g_countries": [["United States", 3], ["Belgium", 1]], "g_trials": [{"nct": "NCT06375239", "title": "Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration", "status": "RECRUITING", "start": "2024-04-05", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Ray Therapeutics, Inc.", "countries": ["United States"]}, {"nct": "NCT07377162", "title": "HYPER MIND - Hyperoxia Effects on Cerebral Hemodynamics", "status": "RECRUITING", "start": "2024-01-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Erasme University Hospital", "countries": ["Belgium"]}, {"nct": "NCT02435940", "title": "Inherited Retinal Degenerative Disease Registry", "status": "RECRUITING", "start": "2014-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Foundation Fighting Blindness", "countries": ["United States"]}, {"nct": "NCT01866371", "title": "High Resolution Retinal Imaging", "status": "RECRUITING", "start": "2013-05", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Pennsylvania", "countries": ["United States"]}]}, {"batch": 2, "no": 13, "name_zh": "慢性炎性脱髓鞘性多发性神经根神经病", "query_terms": [{"term": "Chronic inflammatory demyelinating polyneuropathy", "broad": false}], "n_total": 19, "n_open": 13, "n_open_precise": 13, "n_broad": 0, "trials": [{"nct": "NCT04561557", "title": "Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System", "status": "RECRUITING", "start": "2020-09-22", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Tongji Hospital", "conditions": ["Autoimmune Diseases", "Autoimmune Diseases of the Nervous System", "Neuromyelitis Optica Spectrum Disorder", "Myasthenia Gravis", "Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "Idiopathic Inflammatory Myopathies", "Multiple Sclerosis", "Autoimmune Encephalitis", "Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)", "POEMS Syndrome"], "cn_sites": [{"facility": "Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05327114", "title": "Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)", "status": "RECRUITING", "start": "2022-09-23", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 201, "sponsor": "Janssen Research & Development, LLC", "conditions": ["Polyradiculoneuropathy, Chronic Inflammatory Demyelinating"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Xuanwu Hospital ,Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": "RECRUITING"}, {"facility": "The Third Xiangya Hospital of Central Sourth University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Sichuan Provincial Peoples Hospital", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Chifeng Municipal Hospital", "city": "Chifeng", "status": "RECRUITING"}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital Sun Yat sen University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Qianfoshan hospital of Shandong Province", "city": "Jinan", "status": "COMPLETED"}, {"facility": "The First Affiliated Hospital of NanChang University", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Huashan Hospital Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Tong Ren Hospital Shanghai Jiao Tong University school of medicine", "city": "Shanghai", "status": "COMPLETED"}, {"facility": "Renmin Hospital of Wuhan University", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Tangdu hospital the Fourth Military Medical", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "Xi 'an GaoXin Hospital", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 19, "broad_only": false}, {"nct": "NCT06502015", "title": "Biomarkers in Autoimmune Disease of Nervous System", "status": "RECRUITING", "start": "2024-07-31", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 50000, "sponsor": "Tongji Hospital", "conditions": ["Autoimmune Diseases of the Nervous System", "Neuromyelitis Optica Spectrum Disorder", "Multiple Sclerosis", "Guillain-Barre Syndrome", "Acute Disseminated Encephalomyelitis", "Autoimmune Encephalitis", "Stiff-Person Syndrome", "Myasthenia Gravis", "Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "Idiopathic Inflammatory Myopathies", "Autoimmune Diseases"], "cn_sites": [{"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06290141", "title": "A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)", "status": "RECRUITING", "start": "2024-08-21", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 160, "sponsor": "Sanofi", "conditions": ["Chronic Inflammatory Demyelinating Polyneuropathy"], "cn_sites": [{"facility": "Investigational Site Number : 1560013", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560010", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560005", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560017", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560009", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560011", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560002", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560012", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560007", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560014", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560016", "city": "Jiazhuang", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560008", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560015", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560001", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560003", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560006", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560004", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 17, "broad_only": false}, {"nct": "NCT06858579", "title": "A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)", "status": "RECRUITING", "start": "2025-02-10", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 256, "sponsor": "Dianthus Therapeutics", "conditions": ["Chronic Inflammatory Demyelinating Polyneuropathy"], "cn_sites": [{"facility": "Clinical Study Site", "city": "Hefei", "status": "RECRUITING"}, {"facility": "Clinical Study Site", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Clinical Study Site", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Clinical Study Site", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Clinical Study Site", "city": "Chifeng", "status": "RECRUITING"}, {"facility": "Clinical Study Site", "city": "Suzhou", "status": "RECRUITING"}, {"facility": "Clinical Study Site", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Clinical Study Site", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Clinical Study Site", "city": "Fujian", "status": "RECRUITING"}, {"facility": "Clinical Study Site", "city": "Guangdong", "status": "RECRUITING"}, {"facility": "Clinical Study Site", "city": "Jilin City", "status": "RECRUITING"}, {"facility": "Clinical Study Site", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Clinical Study Site", "city": "Sichuan", "status": "RECRUITING"}, {"facility": "Clinical Study Site", "city": "Taiyuan", "status": "RECRUITING"}], "cn_site_count": 14, "broad_only": false}, {"nct": "NCT06485232", "title": "Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.", "status": "NOT_YET_RECRUITING", "start": "2025-02-28", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 25, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Neuromyelitis Optica Spectrum Disorders", "Myasthenia Gravis, Generalized", "Multiple Sclerosis", "Chronic Inflammatory Demyelinating Polyradiculoneuropathy"], "cn_sites": [{"facility": "Xuanwu Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06859099", "title": "Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP", "status": "ENROLLING_BY_INVITATION", "start": "2025-04-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 300, "sponsor": "Sanofi", "conditions": ["Polyneuropathy, Inflammatory Demyelinating, Chronic"], "cn_sites": [{"facility": "Investigational Site Number : 1560013", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560005", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560009", "city": "Changsha", "status": ""}, {"facility": "Investigational Site Number : 1560011", "city": "Chengdu", "status": ""}, {"facility": "Investigational Site Number : 1560002", "city": "Fuzhou", "status": ""}, {"facility": "Investigational Site Number : 1560012", "city": "Guangzhou", "status": ""}, {"facility": "Investigational Site Number : 1560014", "city": "Hangzhou", "status": ""}, {"facility": "Investigational Site Number : 1560001", "city": "Shanghai", "status": ""}, {"facility": "Investigational Site Number : 1560003", "city": "Wuhan", "status": ""}, {"facility": "Investigational Site Number : 1560006", "city": "Wuhan", "status": ""}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT07022197", "title": "Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases", "status": "RECRUITING", "start": "2025-04-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 27, "sponsor": "Tianjin Medical University General Hospital", "conditions": ["Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "NMO Spectrum Disorder", "Myasthenia Gravis", "Idiopathic Inflammatory Myopathies"], "cn_sites": [{"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06939166", "title": "Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases", "status": "RECRUITING", "start": "2025-06-17", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Tianjin Huanhu Hospital", "conditions": ["Neuromyelitis Optica Spectrum Disorders", "Myasthenia Gravis", "Multiple Sclerosis", "Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "Autoimmune Encephalitis"], "cn_sites": [{"facility": "Tianjin Huanhu Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07091630", "title": "A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP", "status": "RECRUITING", "start": "2025-09-16", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 160, "sponsor": "argenx", "conditions": ["Chronic Inflammatory Demyelinating Polyneuropathy", "CIDP", "Chronic Inflammatory Demyelinating Polyradiculoneuropathy"], "cn_sites": [{"facility": "Fujian Medical University Union Hospital - Yushan Campus", "city": "Fuzhou", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "The People's Hospital of Baiyun District Guangzhou", "city": "Guangzhou", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Peking University First Hospital - Changqiao Campus", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Guangdong Provincial Hospital of Chinese Medicine", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Nanfang Hospital Southern Medical University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Xi'an Gaoxin Hospital", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT07337785", "title": "CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases", "status": "RECRUITING", "start": "2025-12-12", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Tongji Hospital", "conditions": ["Relapsing or Refractory Multiple Sclerosis (MS)", "Myasthenia Gravis (MG)", "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)", "Autoimmune Encephalitis (AE)"], "cn_sites": [{"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07333196", "title": "Tongji NADs Cohort", "status": "NOT_YET_RECRUITING", "start": "2026-03-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1550, "sponsor": "Tongji Hospital", "conditions": ["Multiple Sclerosis", "NMO Spectrum Disorder", "Autoimmune Encephalitis", "Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease", "Autoimmune Nodopathy", "Acute Inflammatory Demyelinating Polyradiculoneuropathy", "Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "Myasthenia Gravis", "Idiopathic Inflammatory Myopathies"], "cn_sites": [{"facility": "Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07526493", "title": "Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.", "status": "RECRUITING", "start": "2026-04-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Tongji Hospital", "conditions": ["Multiple Sclerosis (MS)", "Neuromyelitis Optica Spectrum Disorder (NMOSD)", "Autoimmune Encephalitis (AE)", "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)", "Myasthenia Gravis (MG)", "Anti-Myelin Oligodendrocyte Glycoprotein Immunoglobulin G Antibody-Associated Disease (MOGAD)", "Idiopathic Inflammatory Myopathies (IIM)"], "cn_sites": [{"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04292834", "title": "A Registered Cohort Study of Immune-Mediated Neuropathies", "status": "UNKNOWN", "start": "2020-02-29", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "First Affiliated Hospital of Fujian Medical University", "conditions": ["Chronic Inflammatory Demyelinating Polyneuropathy"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Department of Neurology,First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT04281472", "title": "A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)", "status": "COMPLETED", "start": "2020-04-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 322, "sponsor": "argenx", "conditions": ["Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)"], "cn_sites": [{"facility": "Investigator site 0860033", "city": "Beijing", "status": ""}, {"facility": "Investigator site 0860030", "city": "Changchun", "status": ""}, {"facility": "Investigator site 0860041", "city": "Changsha", "status": ""}, {"facility": "Investigator site 0860036", "city": "Chengdu", "status": ""}, {"facility": "Investigator site 0860049", "city": "Chifeng", "status": ""}, {"facility": "Investigator site 0860038", "city": "Fuzhou", "status": ""}, {"facility": "Investigator site 0860050", "city": "Guanzhou", "status": ""}, {"facility": "Investigator site 0860032", "city": "Guanzhou", "status": ""}, {"facility": "Investigator site 0860045", "city": "Guiyang", "status": ""}, {"facility": "Investigator site 0860046", "city": "Hangzhou", "status": ""}, {"facility": "Investigator site 0860035", "city": "Hanzhou", "status": ""}, {"facility": "Investigator site 0860031", "city": "Jinan", "status": ""}, {"facility": "Investigator site 0860063", "city": "Jining", "status": ""}, {"facility": "Investigator site 0860044", "city": "Nanchang", "status": ""}, {"facility": "Investigator Site 0860040", "city": "Nanchang", "status": ""}, {"facility": "Investigator site 0860051", "city": "Nanchang", "status": ""}, {"facility": "Investigator site 0860043", "city": "Nanjing", "status": ""}, {"facility": "Investigator site 0860047", "city": "Shanghai", "status": ""}, {"facility": "Investigator site 0860028", "city": "Shanghai", "status": ""}, {"facility": "Investigator site 0860052", "city": "Shanghai", "status": ""}, {"facility": "Investigator site 0860042", "city": "Taiyuan", "status": ""}, {"facility": "Investigator site 0860029", "city": "Wuhan", "status": ""}, {"facility": "Investigator site 0860034", "city": "Wuhan", "status": ""}, {"facility": "Investigator site 0860048", "city": "Xi'an", "status": ""}, {"facility": "Investigator site 0860037", "city": "Xi'an", "status": ""}, {"facility": "Investigator site 0860054", "city": "Xiangyang", "status": ""}], "cn_site_count": 26, "broad_only": false}, {"nct": "NCT04280718", "title": "A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)", "status": "ACTIVE_NOT_RECRUITING", "start": "2020-09-18", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 229, "sponsor": "argenx", "conditions": ["Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)"], "cn_sites": [{"facility": "Investigator site 0860033", "city": "Beijing", "status": ""}, {"facility": "Investigator site 860041", "city": "Changsha", "status": ""}, {"facility": "Investigator site 0860036", "city": "Chengdu", "status": ""}, {"facility": "Investigator site 860049", "city": "Chifeng", "status": ""}, {"facility": "Investigator site 0860038", "city": "Fuzhou", "status": ""}, {"facility": "Investigator site 0860050", "city": "Guangzhou", "status": ""}, {"facility": "Investigator site 0860032", "city": "Guanzhou", "status": ""}, {"facility": "Investigator site 0860045", "city": "Guiyang", "status": ""}, {"facility": "Investigator site 0860035", "city": "Hangzhou", "status": ""}, {"facility": "Investigator site 0860031", "city": "Jinan", "status": ""}, {"facility": "Investigator site 0860040", "city": "Nanchang", "status": ""}, {"facility": "Investigator site 0860043", "city": "Nanjing", "status": ""}, {"facility": "Investigator site 0860028", "city": "Shanghai", "status": ""}, {"facility": "Investigator site 860047", "city": "Shanghai", "status": ""}, {"facility": "Investigator site 0860042", "city": "Tianjin", "status": ""}, {"facility": "Investigator site 0860034", "city": "Wuhan", "status": ""}, {"facility": "Investigator site 0860029", "city": "Wuhan", "status": ""}, {"facility": "Investigator site 0860048", "city": "Xi'an", "status": ""}, {"facility": "Investigator site 0860054", "city": "Xianyang", "status": ""}], "cn_site_count": 19, "broad_only": false}, {"nct": "NCT04658472", "title": "Proof-of-concept Study for SAR445088 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)", "status": "COMPLETED", "start": "2021-04-28", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 98, "sponsor": "Bioverativ, a Sanofi company", "conditions": ["Chronic Inflammatory Demyelinating Polyradiculoneuropathy"], "cn_sites": [{"facility": "Investigational Site Number : 1560002", "city": "Fuzhou", "status": ""}, {"facility": "Investigational Site Number : 1560001", "city": "Shanghai", "status": ""}, {"facility": "Investigational Site Number : 1560004", "city": "Wuhan", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT06290128", "title": "A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-07-12", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 109, "sponsor": "Sanofi", "conditions": ["Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "Polyneuropathy, Inflammatory Demyelinating, Chronic"], "cn_sites": [{"facility": "Investigational Site Number : 1560013", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560010", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560005", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560016", "city": "Beijing", "status": ""}, {"facility": "Investigational Site Number : 1560009", "city": "Changsha", "status": ""}, {"facility": "Investigational Site Number : 1560011", "city": "Chengdu", "status": ""}, {"facility": "Investigational Site Number : 1560002", "city": "Fuzhou", "status": ""}, {"facility": "Investigational Site Number : 1560012", "city": "Guangzhou", "status": ""}, {"facility": "Investigational Site Number : 1560007", "city": "Guangzhou", "status": ""}, {"facility": "Investigational Site Number : 1560014", "city": "Hangzhou", "status": ""}, {"facility": "Investigational Site Number : 1560008", "city": "Jinan", "status": ""}, {"facility": "Investigational Site Number : 1560015", "city": "Nanchang", "status": ""}, {"facility": "Investigational Site Number : 1560001", "city": "Shanghai", "status": ""}, {"facility": "Investigational Site Number : 1560003", "city": "Wuhan", "status": ""}, {"facility": "Investigational Site Number : 1560006", "city": "Wuhan", "status": ""}, {"facility": "Investigational Site Number : 1560004", "city": "Xi'an", "status": ""}], "cn_site_count": 16, "broad_only": false}, {"nct": "NCT07597733", "title": "Telitacicept for Refractory Chronic Inflammatory Demyelinating Polyneuropathy", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-09-26", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 76, "sponsor": "Sichuan Academy of Medical Sciences", "conditions": ["Refractory Chronic Inflammatory Demyelinating Polyneuropathy"], "cn_sites": [{"facility": "Sichuan Provincial People's Hospital", "city": "Chengdu", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 48, "g_fetched": 36, "g_countries": [["United States", 18], ["Germany", 9], ["Italy", 6], ["Australia", 4], ["Poland", 4], ["Spain", 4], ["Denmark", 4], ["Canada", 3], ["Czechia", 3], ["Argentina", 3], ["Colombia", 3], ["Greece", 3], ["Netherlands", 3], ["Austria", 2], ["Brazil", 2], ["Estonia", 2], ["France", 2], ["Hungary", 2], ["Japan", 2], ["Norway", 2], ["Portugal", 2], ["Romania", 2], ["Serbia", 2], ["Slovakia", 2], ["Slovenia", 2], ["Sweden", 2], ["Turkey (Türkiye)", 2], ["United Kingdom", 2], ["Belgium", 2], ["Israel", 1], ["Singapore", 1], ["South Korea", 1], ["Switzerland", 1], ["Bosnia and Herzegovina", 1], ["Bulgaria", 1], ["Finland", 1], ["Ireland", 1], ["Mexico", 1], ["Peru", 1], ["Egypt", 1]], "g_trials": [{"nct": "NCT06752356", "title": "A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)", "status": "RECRUITING", "start": "2026-10", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Kedrion S.p.A.", "countries": ["United States"]}, {"nct": "NCT07719153", "title": "Ultrasound-driven Stratification in CIDP", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Centre Hospitalier Universitaire de Nice", "countries": []}, {"nct": "NCT07638566", "title": "A Study to Assess the Correct Dose, Safety and Efficacy of Empasiprubart in Adolescent Participants Aged 12 to Less Than 18 Years With Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "argenx", "countries": []}, {"nct": "NCT07696377", "title": "An Exploratory Study of Obinutuzumab β in the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "status": "NOT_YET_RECRUITING", "start": "2026-07-15", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Zhongming Qiu", "countries": []}, {"nct": "NCT07304154", "title": "A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases", "status": "RECRUITING", "start": "2026-04-10", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Kite, A Gilead Company", "countries": ["Australia", "Canada", "United States"]}, {"nct": "NCT07540221", "title": "A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy", "status": "RECRUITING", "start": "2026-04-02", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Grifols Therapeutics LLC", "countries": ["Czechia", "Poland", "United States"]}, {"nct": "NCT07478172", "title": "Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease", "status": "RECRUITING", "start": "2026-03-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Missouri-Columbia", "countries": ["United States"]}, {"nct": "NCT07273903", "title": "Subcutaneous Immunoglobulin Therapy Effectiveness Monitoring in CIDP Patients Using Smart Devices", "status": "RECRUITING", "start": "2026-01-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Heinrich-Heine University, Duesseldorf", "countries": ["Germany"]}, {"nct": "NCT07154524", "title": "Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)", "status": "RECRUITING", "start": "2025-08-27", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Ulm", "countries": ["Germany"]}, {"nct": "NCT06920004", "title": "A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP", "status": "RECRUITING", "start": "2025-08-22", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "argenx", "countries": ["Argentina", "Australia", "Austria", "Brazil", "Canada", "Colombia", "Czechia", "Estonia", "France", "Germany", "Greece", "Hungary", "Israel", "Italy", "Japan", "Netherlands", "Norway", "Poland", "Portugal", "Romania", "Serbia", "Singapore", "Slovakia", "Slovenia", "South Korea", "Spain", "Sweden", "Switzerland", "Turkey (Türkiye)", "United Kingdom", "United States"]}, {"nct": "NCT07264426", "title": "Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study", "status": "RECRUITING", "start": "2025-08-11", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "argenx", "countries": ["Germany", "United States"]}, {"nct": "NCT07121985", "title": "Multispectral Optoacoustic Imaging for the Detection of Inflammation and Damage of Peripheral Nerves in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy", "status": "NOT_YET_RECRUITING", "start": "2025-08-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Erlangen-Nürnberg Medical School", "countries": []}, {"nct": "NCT07006597", "title": "Vitaccess Real CIDP Registry", "status": "NOT_YET_RECRUITING", "start": "2025-07-31", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Vitaccess Ltd", "countries": []}, {"nct": "NCT06798012", "title": "A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)", "status": "RECRUITING", "start": "2025-05-14", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Takeda", "countries": ["Canada", "Colombia", "United States"]}, {"nct": "NCT06680037", "title": "A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders", "status": "RECRUITING", "start": "2025-05-06", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "TG Therapeutics, Inc.", "countries": ["United States"]}, {"nct": "NCT06747351", "title": "A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)", "status": "RECRUITING", "start": "2025-05-06", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Takeda", "countries": ["Argentina", "Czechia", "Denmark", "Germany", "Greece", "Italy", "Japan", "Poland", "Spain", "Sweden", "United States"]}, {"nct": "NCT06538064", "title": "A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care", "status": "RECRUITING", "start": "2025-04-29", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Takeda", "countries": ["Denmark", "Germany", "United States"]}, {"nct": "NCT06881979", "title": "High-Tech Rehabilitation Pathway for Chronic Adult Neuromuscular Diseases - Fit4MedRob-Chronic MND Project", "status": "RECRUITING", "start": "2025-04-28", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Istituti Clinici Scientifici Maugeri SpA", "countries": ["Italy"]}, {"nct": "NCT06968975", "title": "Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)", "status": "RECRUITING", "start": "2025-04-11", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sanofi", "countries": ["United States"]}, {"nct": "NCT07032662", "title": "Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)", "status": "RECRUITING", "start": "2025-03-18", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Immunovant Sciences GmbH", "countries": ["Argentina", "Australia", "Austria", "Belgium", "Bosnia and Herzegovina", "Brazil", "Bulgaria", "Colombia", "Denmark", "Estonia", "Finland", "Germany", "Greece", "Hungary", "Ireland", "Italy", "Mexico", "Netherlands", "Norway", "Peru", "Poland", "Portugal", "Romania", "Serbia", "Slovakia", "Slovenia", "Spain", "Turkey (Türkiye)", "United Kingdom", "United States"]}, {"nct": "NCT06858722", "title": "Ripertamab for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy", "status": "NOT_YET_RECRUITING", "start": "2025-03-15", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Zhongming Qiu", "countries": []}, {"nct": "NCT07461896", "title": "Studying Nerve Function and Structure in Charcot-Marie-Tooth Disease, Anti-MAG Neuropathy and CIDP", "status": "RECRUITING", "start": "2025-03-03", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta", "countries": ["Italy"]}, {"nct": "NCT06714838", "title": "Rituximab Induced Remission in Patients With Chronic Inflammatory Demyelinating Polyneuropathy", "status": "RECRUITING", "start": "2024-10-16", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Amsterdam University Medical Center (UMC), Location Academic Medical Center (AMC)", "countries": ["Netherlands"]}, {"nct": "NCT06615622", "title": "Our Study Aims to Determine if Nerve Alterations in Acute GBS and CIDP Detectable by Ultrasound Match Electrodiagnostic Findings and if This Method Aids Early Diagnosis, Predict Their Outcomes and Differentiate Between Axonal and Demyelinating Subtypes.", "status": "RECRUITING", "start": "2024-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": ["Egypt"]}, {"nct": "NCT06299748", "title": "A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.", "status": "RECRUITING", "start": "2023-11-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "argenx", "countries": ["Germany", "Italy", "Spain", "United States"]}]}, {"batch": 2, "no": 14, "name_zh": "肾透明细胞肉瘤", "query_terms": [{"term": "Clear cell sarcoma of kidney", "broad": false}], "n_total": 1, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT06683846", "title": "Ivonescimab in the Treatment of Multiple Advanced Tumors", "status": "RECRUITING", "start": "2024-11-20", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 400, "sponsor": "Fudan University", "conditions": ["Pheochromocytoma/Paraganglioma", "Rhabdomyosarcoma", "Paget Disease, Extramammary", "Renal Angiomyolipoma", "Perivascular Epithelioid Cell Tumor, Malignant", "Sarcoma", "Urachal Cancer", "Neuroendocrine Cancer", "Basal Cell Carcinomas", "Sarcomatoid Carcinoma", "Penile Cancer", "Adrenal Cortical Cancer", "Germ Cell Cancer Metastatic", "Non-Clear Cell Renal Cell Carcinoma", "Prostate Cancers", "Clear Cell Renal Cancer", "Urothelial Carcinoma", "Kidney Cancer", "Rare Tumors"], "cn_sites": [{"facility": "Fudan University Cancer Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}], "g_total": 4, "g_fetched": 3, "g_countries": [["Uganda", 1], ["Brazil", 1], ["Australia", 1], ["United Kingdom", 1], ["United States", 1]], "g_trials": [{"nct": "NCT07576725", "title": "Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial", "status": "NOT_YET_RECRUITING", "start": "2026-12-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Fred Hutchinson Cancer Center", "countries": ["Uganda"]}, {"nct": "NCT06638931", "title": "Agnostic Therapy in Rare Solid Tumors", "status": "RECRUITING", "start": "2024-07-16", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Instituto do Cancer do Estado de São Paulo", "countries": ["Brazil"]}, {"nct": "NCT06242470", "title": "A Study of MGC026 in Participants With Advanced Solid Tumors", "status": "RECRUITING", "start": "2024-03-06", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "MacroGenics", "countries": ["Australia", "United Kingdom", "United States"]}]}, {"batch": 2, "no": 15, "name_zh": "冷凝集素病", "query_terms": [{"term": "Cold agglutinin disease", "broad": false}], "n_total": 2, "n_open": 2, "n_open_precise": 2, "n_broad": 0, "trials": [{"nct": "NCT07019038", "title": "National Longitudinal Cohort of Hematological Diseases- Autoimmune Hemolytic Anemia", "status": "RECRUITING", "start": "2001-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 9999, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["AIHA - Warm Autoimmune Hemolytic Anemia", "AIHA - Cold Autoimmune Hemolytic Anemia", "Autoimmune Hemolytic Anemia Mixed Type"], "cn_sites": [{"facility": "Red Blood Cell Diseases Center and Regenerative Medicine Center", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06847607", "title": "A Multicenter Prospective Study of Iptacopan in the Treatment of Refractory/Relapsed Autoimmune Hemolytic Anemia (AIHA)", "status": "NOT_YET_RECRUITING", "start": "2025-03-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Bing Han", "conditions": ["AIHA - Warm Autoimmune Hemolytic Anemia", "AIHA - Cold Autoimmune Hemolytic Anemia"], "cn_sites": [{"facility": "Bing Han", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 6, "g_fetched": 4, "g_countries": [["Australia", 1], ["United States", 1], ["United Kingdom", 1], ["Italy", 1]], "g_trials": [{"nct": "NCT07091370", "title": "Inaticabtagene Autoleucel Injection in the Treatment of Autoimmune Hemolytic Anemia After Three or More Lines of Therapy", "status": "NOT_YET_RECRUITING", "start": "2025-12-27", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Juventas Cell Therapy Ltd.", "countries": []}, {"nct": "NCT07083960", "title": "OM336 in Autoimmune Cytopenias", "status": "RECRUITING", "start": "2025-08-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Lakefront Biotherapeutics West LLC", "countries": ["Australia", "United States"]}, {"nct": "NCT05318534", "title": "Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Male and Female Subjects and Safety, Tolerability, Pharmacokinetics, and Pilot Efficacy Biomarkers in Subjects With Cold Agglutinin Disease", "status": "RECRUITING", "start": "2022-04-08", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Gliknik Inc.", "countries": ["United Kingdom"]}, {"nct": "NCT05931718", "title": "Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia", "status": "RECRUITING", "start": "2019-06-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico", "countries": ["Italy"]}]}, {"batch": 2, "no": 16, "name_zh": "先天性胆道闭锁", "query_terms": [{"term": "Biliary atresia and associated disorders", "broad": false}, {"term": "Congenital biliary atresia", "broad": false}], "n_total": 20, "n_open": 4, "n_open_precise": 4, "n_broad": 0, "trials": [{"nct": "NCT05072626", "title": "High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia", "status": "RECRUITING", "start": "2021-10-11", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 300, "sponsor": "Children's Hospital of Fudan University", "conditions": ["Biliary Atresia", "Infant", "Nutrition Support", "Medium-chain Triglyceride"], "cn_sites": [{"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05925309", "title": "Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy", "status": "RECRUITING", "start": "2023-07-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 356, "sponsor": "Children's Hospital of Fudan University", "conditions": ["Biliary Atresia", "Cholangitis", "Anti-Bacterial Agents"], "cn_sites": [{"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05848310", "title": "Preoperative Serum FGF19 in the Prognosis of Biliary Atresia", "status": "RECRUITING", "start": "2023-10-15", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Children's Hospital of Fudan University", "conditions": ["Biliary Atresia", "Prognosis"], "cn_sites": [{"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06764082", "title": "Nutritional Intervention for Biliary Atresia", "status": "RECRUITING", "start": "2025-02-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Tongji Hospital", "conditions": ["Nutrition Disorder, Infant", "Biliary Atresia"], "cn_sites": [{"facility": "Tongji Hospital", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03842150", "title": "Development and Validation of a Screening Score for the Biliary Atresia in Infantile Cholestasis: A Prospective Study", "status": "UNKNOWN", "start": "2014-06-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 400, "sponsor": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": ["Biliary Atresia", "Neonatal Cholestasis", "Infantile Hepatitis Syndrome"], "cn_sites": [{"facility": "Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02503384", "title": "Clinical and Basic Study for Pediatric Liver Transplantation", "status": "UNKNOWN", "start": "2015-07", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 180, "sponsor": "RenJi Hospital", "conditions": ["Biliary Atresia", "Metabolic Disorders", "Fulminant Liver Failure", "Hepatic Tumors"], "cn_sites": [{"facility": "Deparment of Liver Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05909033", "title": "Early Predictors for the Short Term Native Liver Survival in Patients With Biliary Atresia After Kasai Procedure", "status": "UNKNOWN", "start": "2017-05-20", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 150, "sponsor": "Weibing Tang", "conditions": ["Biliary Atresia"], "cn_sites": [{"facility": "Children's Hospital of Nanjing Medical University", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03563378", "title": "Effects of Intraoperative Normal Saline vs Lactated Ringer on Outcomes in Pediatric Liver Transplantation", "status": "UNKNOWN", "start": "2018-07-28", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 200, "sponsor": "RenJi Hospital", "conditions": ["Biliary Atresia Intrahepatic Syndromic Form"], "cn_sites": [{"facility": "Renji Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03898765", "title": "Dry Blood Spot Screening Test for Biliary Atresia（DBS-SCReBA）", "status": "WITHDRAWN", "start": "2019-04-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": ["Hepatobiliary Disease", "Biliary Atresia", "Neonatal Cholestasis"], "cn_sites": [{"facility": "Shanghai Xinhua Hospital, affiliated to Shanghai Jiao Tong University, School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04336722", "title": "Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)", "status": "COMPLETED", "start": "2020-07-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 254, "sponsor": "Albireo, an Ipsen Company", "conditions": ["Biliary Atresia"], "cn_sites": [{"facility": "Guangzhou Women and Children's Medical Center", "city": "Guangzhou", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05181332", "title": "Predictive Models of Hepatic Decompensation and Survival Outcomes in Pediatric Patients With Cirrhosis", "status": "UNKNOWN", "start": "2021-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 400, "sponsor": "West China Hospital", "conditions": ["Cirrhosis", "Biliary Atresia", "Choledochal Cyst", "Primary Sclerosing Cholangitis", "HBV", "HCV", "Autoimmune Hepatitis"], "cn_sites": [{"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04370145", "title": "Antibiotics Treatment of Cholangitis Post-Kasai Portoenterostomy", "status": "COMPLETED", "start": "2021-05-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 160, "sponsor": "Tongji Hospital", "conditions": ["Cholangitis, Secondary Biliary", "Treatment Compliance", "Antibodies Drug Specific"], "cn_sites": [{"facility": "Tongji hospital affiliated to tongji medical college of huazhong university of science and technology", "city": "Wuhan", "status": ""}, {"facility": "TongjiHospital", "city": "Wuhan", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT04524390", "title": "Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai", "status": "COMPLETED", "start": "2021-07-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 75, "sponsor": "Mirum Pharmaceuticals, Inc.", "conditions": ["Biliary Atresia"], "cn_sites": [{"facility": "Beijing Pediatric Research Institute", "city": "Beijing", "status": ""}, {"facility": "Guangzhou Women and Children's Medical Center", "city": "Guangzhou", "status": ""}, {"facility": "The Children's Hospital, Zhejiang University School of Medicine", "city": "Hanzhou", "status": ""}, {"facility": "Children's hospital of Shanghai", "city": "Shanghai", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT05426733", "title": "An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary Atresia", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-07-05", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 180, "sponsor": "Albireo, an Ipsen Company", "conditions": ["Biliary Atresia"], "cn_sites": [{"facility": "Guangzhou Women And Childrens Medical Center", "city": "Guangdong", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05464303", "title": "Definition for Biliary Atresia Associated Cholangitis After Surgery", "status": "UNKNOWN", "start": "2022-07-15", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Nanjing Children's Hospital", "conditions": ["Biliary Atresia", "Cholangitis"], "cn_sites": [{"facility": "NJMU", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05503394", "title": "A Peer Support Network System Construction for the Primary Caregivers of Children With Biliary Atresia", "status": "COMPLETED", "start": "2022-08-31", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 45, "sponsor": "Children's Hospital of Fudan University", "conditions": ["Biliary Atresia Congenital Type 3"], "cn_sites": [{"facility": "Children's hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05783518", "title": "Effect of Desflurane on Pediatric Acute Respiratory Distress Syndrome After Living Donor Liver Transplant Recipients", "status": "UNKNOWN", "start": "2023-03-27", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 165, "sponsor": "Tianjin First Central Hospital", "conditions": ["Pediatric Acute Respiratory Distress Syndrome", "Desflurane", "Biliary Atresia"], "cn_sites": [{"facility": "TianjinFCH", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06219993", "title": "Robot-assisted Modified Kasai Portoenterostomy Versus Open Kasai Portoenterostomy for Biliary Atresia", "status": "UNKNOWN", "start": "2023-12-21", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 60, "sponsor": "Zunyi Medical College", "conditions": ["Biliary Atresia", "Kasai Operation", "Robotic Surgery", "Open Surgery"], "cn_sites": [{"facility": "Affiliated Hospital of Zunyi Medical University", "city": "Zunyi", "status": ""}, {"facility": "Affiliated hospital of zunyi medical university", "city": "Zunyi", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06121375", "title": "Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Obeticholic Acid (OCA) Compared to Placebo in Pediatric Participants With Biliary Atresia, Post-hepatoportoenterostomy", "status": "TERMINATED", "start": "2024-09-02", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 28, "sponsor": "Intercept Pharmaceuticals", "conditions": ["Biliary Atresia"], "cn_sites": [{"facility": "Children's Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Guangzhou Women And Childrens Medical Center", "city": "Guangzhou", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Childrens Hospital of Shanghai", "city": "Shanghai", "status": ""}, {"facility": "Children's Hospital of Shanxi", "city": "Taiyuan", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT07328204", "title": "Kasai Portoenterostomy Timing and Outcomes in Biliary Atresia", "status": "COMPLETED", "start": "2025-12-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "The Children's Hospital of Zhejiang University School of Medicine", "conditions": ["Biliary Atresia"], "cn_sites": [{"facility": "Children's Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 22, "g_fetched": 18, "g_countries": [["United States", 7], ["Indonesia", 2], ["France", 2], ["Canada", 2], ["Switzerland", 1], ["United Kingdom", 1], ["Egypt", 1], ["Pakistan", 1], ["Denmark", 1], ["Australia", 1]], "g_trials": [{"nct": "NCT06260566", "title": "Tolerability of Enteral NAC in Infants", "status": "NOT_YET_RECRUITING", "start": "2026-10", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Sanjiv Harpavat", "countries": []}, {"nct": "NCT07797673", "title": "Umbilical Cord Mesenchymal Stem Cell Therapy for Biliary Atresia", "status": "RECRUITING", "start": "2026-09-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Dr Cipto Mangunkusumo General Hospital", "countries": ["Indonesia"]}, {"nct": "NCT06506734", "title": "Dental Dyschromia and Quality of Life in Early Prolonged Hyperbilirubinemia", "status": "RECRUITING", "start": "2026-04-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Toulouse", "countries": ["France"]}, {"nct": "NCT07250854", "title": "The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal Cholestasis", "status": "RECRUITING", "start": "2026-01-23", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "University of Alabama at Birmingham", "countries": ["United States"]}, {"nct": "NCT07129655", "title": "Cholangitis Definition and Treatment After Kasai Hepatoportoenterostomy for Biliary Atresia: TRACK-BA Study (TRacking Cholangitis Post Kasai in Biliary Atresia)", "status": "NOT_YET_RECRUITING", "start": "2025-10-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Geneva", "countries": ["Switzerland"]}, {"nct": "NCT07139717", "title": "Stool Card in Biliary Atresia", "status": "NOT_YET_RECRUITING", "start": "2025-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT07011199", "title": "Clinical Outcomes of Early Kasai Surgery With Umbilical Cord MSCs in Biliary Atresia", "status": "NOT_YET_RECRUITING", "start": "2025-06-17", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Universitas Diponegoro", "countries": ["Indonesia"]}, {"nct": "NCT07697872", "title": "The Dirty Nappy Study", "status": "RECRUITING", "start": "2025-04-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Birmingham Women's and Children's NHS Foundation Trust", "countries": ["United Kingdom"]}, {"nct": "NCT06708572", "title": "Evaluation of the Use of Granulocyte Colony Stimulating Factor (GCSF) in Post Kasai Type 3 Biliary Atresia", "status": "RECRUITING", "start": "2024-12", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "National Liver Institute, Egypt", "countries": ["Egypt"]}, {"nct": "NCT07513038", "title": "Use of Indocyanine Green (ICG) for the Diagnosis of Biliary Atresia", "status": "RECRUITING", "start": "2024-08-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Boston Children's Hospital", "countries": ["United States"]}, {"nct": "NCT07709702", "title": "ERAS in Choledochal Cyst & Biliary Atresia", "status": "RECRUITING", "start": "2024-07-27", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Muhammad Zubair Shoukat", "countries": ["Pakistan"]}, {"nct": "NCT04272515", "title": "Molecular Characterization for Understanding Biliary Atresia", "status": "RECRUITING", "start": "2021-02-07", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Institut National de la Santé Et de la Recherche Médicale, France", "countries": ["France"]}, {"nct": "NCT05399745", "title": "BILACO Trial: Biliary Atresia - a Severe Complex Congenital Liver Disease", "status": "RECRUITING", "start": "2020-03-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Rigshospitalet, Denmark", "countries": ["Denmark"]}, {"nct": "NCT03273049", "title": "Mapping Disease Pathways for Biliary Atresia", "status": "RECRUITING", "start": "2016-07-21", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Pittsburgh", "countries": ["United States"]}, {"nct": "NCT01793168", "title": "Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford", "status": "RECRUITING", "start": "2010-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sanford Health", "countries": ["Australia", "United States"]}, {"nct": "NCT02137668", "title": "Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin", "status": "RECRUITING", "start": "2010-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Sacramento Pediatric Gastroenterology", "countries": ["United States"]}, {"nct": "NCT00345553", "title": "Biliary Atresia Study in Infants and Children", "status": "RECRUITING", "start": "2006-05-16", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Arbor Research Collaborative for Health", "countries": ["Canada", "United States"]}, {"nct": "NCT00061828", "title": "A Prospective Database of Infants With Cholestasis", "status": "RECRUITING", "start": "2004-04-21", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Arbor Research Collaborative for Health", "countries": ["Canada", "United States"]}]}, {"batch": 2, "no": 17, "name_zh": "先天性凝血因子VII缺乏症", "query_terms": [{"term": "Congenital factor VII deficiency", "broad": false}], "n_total": 3, "n_open": 2, "n_open_precise": 2, "n_broad": 0, "trials": [{"nct": "NCT07644832", "title": "An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII Deficiency", "status": "RECRUITING", "start": "2024-05-31", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 76, "sponsor": "Shanghai RAAS Blood Products Co., Ltd.", "conditions": ["Hemophilia A", "Hemophilia B", "Factor VII Deficiency"], "cn_sites": [{"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of University of Science and Technology of China", "city": "Hefei", "status": "RECRUITING"}, {"facility": "Jinan Central Hospital", "city": "Jinan", "status": "RECRUITING"}, {"facility": "The First Hospital of Lanzhou University", "city": "Lanzhou", "status": "RECRUITING"}, {"facility": "Ruijin Hospital Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": "COMPLETED"}, {"facility": "The Second Hospital of Shanxi Medical University", "city": "Taiyuan", "status": "RECRUITING"}, {"facility": "Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": "COMPLETED"}, {"facility": "Xian Central Hospital", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "Zhengzhou People's Hospital", "city": "Zhengzhou", "status": "RECRUITING"}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT07711158", "title": "A Phase II Exploratory Study of SR604 Injection Evaluating the Safety and Efficacy in the Treatment of Congenital Coagulation Factor VII Deficiency", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Shanghai RAAS Blood Products Co., Ltd.", "conditions": ["Factor VII Deficiency"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05651061", "title": "A Phase I of SS109 in Hemophilia A or and B With Inhibitors", "status": "COMPLETED", "start": "2022-12-14", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 27, "sponsor": "Hangzhou Gensciences Biopharmaceutical Co., Ltd.", "conditions": ["Hemophilia A With Inhibitor", "Hemophilia B With Inhibitor", "Factor VII Deficiency"], "cn_sites": [{"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": ""}, {"facility": "Henan Provincial Cancer Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Xiangya Hospital, Central South University", "city": "Changsha", "status": ""}, {"facility": "Affiliated Hospital of Xuzhou Medical University", "city": "Xuzhou", "status": ""}, {"facility": "Jiangxi Provincial People's Hospital", "city": "Nanchang", "status": ""}, {"facility": "The First Affiliated Hospital of Shandong First Medical University", "city": "Jinan", "status": ""}, {"facility": "The Second Hospital of Shanxi Medical University", "city": "Taiyuan", "status": ""}, {"facility": "Xi'an Central Hospital", "city": "Xi’an", "status": ""}, {"facility": "Hematology Hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}, {"facility": "The Second Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}], "cn_site_count": 10, "broad_only": false}], "g_total": 4, "g_fetched": 2, "g_countries": [["United Kingdom", 1], ["Canada", 1], ["United States", 1]], "g_trials": [{"nct": "NCT07347249", "title": "A Clinical Study to Assess Sutacimig in Participants With Congenital Factor VII Deficiency", "status": "RECRUITING", "start": "2026-03-11", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Hemab ApS", "countries": ["United Kingdom"]}, {"nct": "NCT06349473", "title": "A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)", "status": "RECRUITING", "start": "2024-05-10", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Equilibra Bioscience LLC", "countries": ["Canada", "United States"]}]}, {"batch": 2, "no": 18, "name_zh": "冷吡啉（冷炎素）相关周期性综合征/ NLRP3相关自身炎症性疾病", "query_terms": [{"term": "NLRP3-associated autoinflammatory disease", "broad": false}, {"term": "Cryopyrin associated periodic syndrome/ NLRP3-associated systemic autoinflammatory disease", "broad": false}], "n_total": 2, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT03566615", "title": "Does the Cap Increase the Finding of Polyps When Water Exchange Colonoscopy is Used", "status": "UNKNOWN", "start": "2018-07-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 1630, "sponsor": "VA Greater Los Angeles Healthcare System", "conditions": ["Colonoscopy", "Polyp of Colon"], "cn_sites": [{"facility": "Xijing Hospital of Digestive Diseases", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03923140", "title": "A Clinical Study of Tranilast in the Treatment of Cryopyrin-Associated Periodic Syndrome (CAPS)", "status": "UNKNOWN", "start": "2019-05-23", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 71, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Cryopyrin-Associated Periodic Syndromes"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}], "g_total": 6, "g_fetched": 6, "g_countries": [["France", 2], ["United States", 2], ["Canada", 1], ["South Korea", 1]], "g_trials": [{"nct": "NCT06544018", "title": "Circadian Rhythm Deregulation in Patients With CAPS", "status": "RECRUITING", "start": "2026-02-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Hospices Civils de Lyon", "countries": ["France"]}, {"nct": "NCT07247266", "title": "Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of JTE-162 in Subjects With Cryopyrin-Associated Periodic Syndrome (CAPS)", "status": "RECRUITING", "start": "2026-02-02", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Akros Pharma Inc.", "countries": ["Canada"]}, {"nct": "NCT06974877", "title": "Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load", "status": "RECRUITING", "start": "2025-09-10", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "countries": ["United States"]}, {"nct": "NCT06838143", "title": "Ilaris NIS in Korea", "status": "RECRUITING", "start": "2025-03-29", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": ["South Korea"]}, {"nct": "NCT05292768", "title": "Are Mast Cells Involved in Autoinflammatory Diseases", "status": "NOT_YET_RECRUITING", "start": "2022-03", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT02974595", "title": "Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still'S-like Diseases, and Other Undifferentiated Autoinflammatory Diseases)", "status": "RECRUITING", "start": "2016-12-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "countries": ["United States"]}]}, {"batch": 2, "no": 19, "name_zh": "皮肤神经内分泌癌（梅克尔细胞癌）", "query_terms": [{"term": "Cutaneous neuroendocrine carcinoma", "broad": false}], "n_total": 3, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT07070232", "title": "A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors", "status": "RECRUITING", "start": "2025-08-12", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 1438, "sponsor": "BioNTech SE", "conditions": ["Advanced Solid Tumor"], "cn_sites": [{"facility": "Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Tianjin Medical University Cancer Institute & Hospital", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "Hubei Cancer Hospital", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT05544929", "title": "A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-10-26", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 126, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Carcinoma, Non-Small-Cell Lung", "Cutaneous Melanoma", "Carcinoma, Renal Cell", "Carcinoma, Ovarian Epithelial", "Nasopharyngeal Carcinoma", "Carcinoma, Thymic", "Anal Cancer", "Mesothelioma", "Esophagogastric Cancer", "High Microsatellite Instability Colorectal Carcinoma", "Squamous Cell Carcinoma of Head and Neck", "Triple Negative Breast Neoplasms"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05879822", "title": "A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-10-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 73, "sponsor": "Incyte Corporation", "conditions": ["Advanced Solid Tumor"], "cn_sites": [{"facility": "The People'S Hospital of Guangxi Zhuang Autonomous Region", "city": "Nanning", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 61, "g_fetched": 60, "g_countries": [["United States", 44], ["Australia", 9], ["France", 6], ["Italy", 5], ["Germany", 4], ["South Korea", 4], ["Spain", 4], ["Japan", 3], ["Canada", 3], ["Ireland", 2], ["Portugal", 2], ["Uganda", 1], ["Russia", 1], ["Argentina", 1], ["Belgium", 1], ["Brazil", 1], ["Chile", 1], ["Mexico", 1], ["Netherlands", 1], ["Poland", 1], ["Taiwan", 1], ["Turkey (Türkiye)", 1]], "g_trials": [{"nct": "NCT07576725", "title": "Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial", "status": "NOT_YET_RECRUITING", "start": "2026-12-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Fred Hutchinson Cancer Center", "countries": ["Uganda"]}, {"nct": "NCT07472322", "title": "ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University of Wisconsin, Madison", "countries": ["United States"]}, {"nct": "NCT07749586", "title": "A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors", "status": "RECRUITING", "start": "2026-07-29", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Arvinas Inc.", "countries": ["United States"]}, {"nct": "NCT07600476", "title": "A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors", "status": "RECRUITING", "start": "2026-07-03", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Kupando GmbH", "countries": ["Germany"]}, {"nct": "NCT07302347", "title": "A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21)", "status": "RECRUITING", "start": "2026-06-23", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Merck Sharp & Dohme LLC", "countries": ["Japan"]}, {"nct": "NCT07387198", "title": "Neoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab", "status": "RECRUITING", "start": "2026-05-29", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest", "countries": ["Germany"]}, {"nct": "NCT07339176", "title": "Intratumoral N17350 in Advanced Solid Tumors", "status": "RECRUITING", "start": "2026-05-25", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Onchilles Pharma Inc", "countries": ["Australia", "United States"]}, {"nct": "NCT07288073", "title": "TIL Therapy in cSCC and MCC", "status": "RECRUITING", "start": "2026-02-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Karam Khaddour, MD, MS", "countries": ["United States"]}, {"nct": "NCT07215988", "title": "Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a \"Filter\" Observational Study", "status": "RECRUITING", "start": "2026-02-04", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Ohio State University Comprehensive Cancer Center", "countries": ["United States"]}, {"nct": "NCT07285044", "title": "The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas", "status": "RECRUITING", "start": "2025-12-18", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Mayo Clinic", "countries": ["United States"]}, {"nct": "NCT06887348", "title": "A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3", "status": "RECRUITING", "start": "2025-12-12", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Replimune, Inc.", "countries": ["Australia", "United States"]}, {"nct": "NCT06947928", "title": "Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma", "status": "RECRUITING", "start": "2025-12-11", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "TuHURA Biosciences, Inc.", "countries": ["United States"]}, {"nct": "NCT07006727", "title": "Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors", "status": "RECRUITING", "start": "2025-10-16", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": ["Canada", "South Korea", "United States"]}, {"nct": "NCT04119024", "title": "Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors", "status": "RECRUITING", "start": "2025-10-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Anusha Kalbasi", "countries": ["United States"]}, {"nct": "NCT06940440", "title": "IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)", "status": "RECRUITING", "start": "2025-10", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "TuHURA Biosciences, Inc.", "countries": ["United States"]}, {"nct": "NCT06814496", "title": "Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors", "status": "RECRUITING", "start": "2025-09-08", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University of Arizona", "countries": ["United States"]}, {"nct": "NCT07130032", "title": "Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint Blockade", "status": "RECRUITING", "start": "2025-08-14", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "EuroCityClinic LLC", "countries": ["Russia"]}, {"nct": "NCT07115043", "title": "A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors", "status": "RECRUITING", "start": "2025-07-29", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "AstraZeneca", "countries": ["Australia", "Japan", "South Korea", "United States"]}, {"nct": "NCT06753136", "title": "Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype", "status": "RECRUITING", "start": "2025-07-23", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Istituto Oncologico Veneto IRCCS", "countries": ["Italy"]}, {"nct": "NCT06967961", "title": "Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers", "status": "RECRUITING", "start": "2025-07-23", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Institut Claudius Regaud", "countries": ["France"]}, {"nct": "NCT06780475", "title": "Validation of in Vitro Method for Anti-MCPyV Immunotherapy on Patients With Cutaneous Merkel Cell Carcinoma", "status": "RECRUITING", "start": "2025-05-27", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT07080242", "title": "Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors", "status": "RECRUITING", "start": "2025-04-28", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "SystImmune Inc.", "countries": ["United States"]}, {"nct": "NCT06039033", "title": "Exploring Merkel Cell Carcinoma Clinical Trial Engagement Patterns", "status": "NOT_YET_RECRUITING", "start": "2024-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Power Life Sciences Inc.", "countries": ["United States"]}, {"nct": "NCT06444815", "title": "A Study of VET3-TGI in Patients With Solid Tumors", "status": "RECRUITING", "start": "2024-09-16", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "KaliVir Immunotherapeutics", "countries": ["United States"]}, {"nct": "NCT05896839", "title": "Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer", "status": "RECRUITING", "start": "2024-07-24", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["United States"]}]}, {"batch": 2, "no": 20, "name_zh": "皮肤T细胞淋巴瘤", "query_terms": [{"term": "Primary cutaneous T-cell lymphoma", "broad": false}, {"term": "Cutaneous T-cell lymphomas", "broad": false}], "n_total": 19, "n_open": 10, "n_open_precise": 10, "n_broad": 0, "trials": [{"nct": "NCT02848274", "title": "ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome", "status": "RECRUITING", "start": "2016-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2000, "sponsor": "Stanford University", "conditions": ["Mycosis Fungoides", "Non-Hodgkin's Lymphoma"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05518851", "title": "TreAtments and outComes in paTients With prImary CutAneous Lymphoma", "status": "RECRUITING", "start": "2022-08-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 3000, "sponsor": "Peking University First Hospital", "conditions": ["Primary Cutaneous Lymphoma"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "SUN YAI-SEN Memorial Hospital, SUN YAI-SEN University", "city": "Guandong", "status": "RECRUITING"}, {"facility": "Hospital for Skin Disease, Institute of Dermatology, Chinese Academy of Medical Sciences, Peking Union Medical College", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT06436677", "title": "A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma", "status": "RECRUITING", "start": "2024-05-09", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Peking University First Hospital", "conditions": ["Cutaneous T-Cell Lymphoma/Mycosis Fungoides", "Cutaneous T Cell Lymphoma"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT06716658", "title": "JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas", "status": "RECRUITING", "start": "2024-12-25", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 48, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Lymphoma, T-Cell", "NK-LGL Leukemia", "T-LGL Leukemia", "Cutaneous T Cell Lymphoma", "Cutaneous T Cell Lymphoma (CTCL)", "Large Granular Lymphocyte Leukemia", "Large Granular Lymphocytic Leukemia", "Indolent T-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract", "Primary Cutaneous Acral CD8-Positive T-Cell Lymphoma", "Mycosis Fungoides"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital, China", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06914037", "title": "A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological Malignancies", "status": "RECRUITING", "start": "2025-03-31", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Tianjin Medical University Cancer Institute and Hospital", "conditions": ["Peripheral T-cell Lymphoma", "Cutaneous T-cell Lymphoma (CTCL)", "NHL (Non-Hodgkin Lymphoma)"], "cn_sites": [{"facility": "Tianjin Medical University Cancer Institute & Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06925464", "title": "CD7 CAR T-Cell Therapy for r/r T-cell Lymphomas", "status": "RECRUITING", "start": "2025-04-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Beijing GoBroad Hospital", "conditions": ["T-Cell Non-Hodgkin Lymphoma", "T-cell Lymphoma (PTCL and CTCL)"], "cn_sites": [{"facility": "Beijing GoBroad Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "湛江中心人民医院", "city": "Zhanjiang", "status": "RECRUITING"}, {"facility": "Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Shanghai Liquan Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT07022964", "title": "CD5 CAR T-Cell Therapy for r/r T-cell Lymphomas", "status": "RECRUITING", "start": "2025-06-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Beijing GoBroad Hospital", "conditions": ["T-Cell Non-Hodgkin Lymphoma", "T-cell Lymphoma (PTCL and CTCL)"], "cn_sites": [{"facility": "Beijing GoBroad Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Shanghai Liquan Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07754890", "title": "Golidocitinib and Chidamide for Cutaneous T-Cell Lymphoma", "status": "RECRUITING", "start": "2025-08-26", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 65, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Cutaneous T-cell Lymphoma (CTCL)"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07535710", "title": "Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma", "status": "NOT_YET_RECRUITING", "start": "2026-03-30", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 37, "sponsor": "Shanghai Jiao Tong University School of Medicine", "conditions": ["Cutaneous T-Cell Lymphoma Refractory", "Cutaneous T-Cell Lymphoma, Relapsed", "Sezary Syndrome", "Cutaneous T Cell Lymphoma (CTCL)"], "cn_sites": [{"facility": "Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai", "city": "Shanghai", "status": ""}, {"facility": "Ruijin Hospital Wuxi Branch", "city": "Wuxi", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07717580", "title": "Efficacy and Safety of Brentuximab Vedotin Combined With Lisaftoclax in CD30+ Cutaneous T-cell Lymphoma (CTCL)", "status": "NOT_YET_RECRUITING", "start": "2026-07-31", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 46, "sponsor": "Peking University First Hospital", "conditions": ["Cutaneous T-Cell Lymphoma/Mycosis Fungoides", "Primary Cutaneous Anaplastic Large Cell Lymphoma"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02597153", "title": "Phase II Clinical Study of PLM60 for the Treatment of Cutaneous T Cell Lymphomas", "status": "TERMINATED", "start": "2015-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 1, "sponsor": "CSPC ZhongQi Pharmaceutical Technology Co., Ltd.", "conditions": ["Relapsed Cutaneous T Cell Lymphom"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03493451", "title": "Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms", "status": "COMPLETED", "start": "2018-04-13", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 77, "sponsor": "BeiGene", "conditions": ["Peripheral T Cell Lymphoma", "PTCL", "Extranodal NK/T-cell Lymphoma", "Extranodal NK/T-cell Lymphoma, Nasal Type", "Extranodal NK T Cell Lymphoma", "Extranodal NK T Cell Lymphoma, Nasal", "Adult Nasal Type Extranodal NK/T-cell Lymphoma", "Angioimmunoblastic T-cell Lymphoma", "Angioimmunoblastic T-Cell Lymphoma Recurrent", "Angioimmunoblastic T-Cell Lymphoma Refractory", "Peripheral T-cell Lymphoma NOS", "Peripheral T-Cell Lymphoma, Not Otherwise Specified", "Peripheral T-Cell Lymphoma Refractory", "Anaplastic Large Cell Lymphoma", "Anaplastic Large Cell Lymphoma, ALK-Positive", "Anaplastic Large Cell Lymphoma, ALK-negative", "ALK-negative Anaplastic Large Cell Lymphoma", "ALK-Positive Anaplastic Large Cell Lymphoma", "Cutaneous T-cell Lymphoma"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Sun Yat Sen University Cancer Center", "city": "Guangzhou", "status": ""}, {"facility": "Harbin Medical University Cancer Hospital", "city": "Harbin", "status": ""}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "The Affiliated Hospital of Xuzhou Medical University", "city": "Xuzhou", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}, {"facility": "Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Tianjin Medical University Cancer Institute and Hospital", "city": "Tianjin", "status": ""}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": ""}], "cn_site_count": 13, "broad_only": false}, {"nct": "NCT03999697", "title": "A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies", "status": "UNKNOWN", "start": "2018-12-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "PersonGen BioTherapeutics (Suzhou) Co., Ltd.", "conditions": ["Diffuse Large B Cell Lymphoma", "Follicular Lymphoma", "Primary Cutaneous Follicle Centre Lymphoma", "Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue", "Mantle Cell Lymphoma", "Plasma Cell Neoplasm", "B Cell Lymphoma"], "cn_sites": [{"facility": "PersonGen·Anke cellular therapeutics Co., Ltd", "city": "Hefei", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04296786", "title": "Sintilimab Plus Chidamide in the Treatment of Relapsed and Refractory Cutaneous T-cell Lymphoma: a Multicenter Phase II Study", "status": "UNKNOWN", "start": "2019-11-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 52, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Cutaneous T-cell Lymphoma"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05781386", "title": "A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors", "status": "UNKNOWN", "start": "2022-03-06", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 255, "sponsor": "Jiangsu Simcere Biologics Co., Ltd", "conditions": ["Advanced Solid Tumor", "Cutaneous T Cell Lymphoma"], "cn_sites": [{"facility": "Sun Yat-Sen University Cancer Center", "city": "Guanzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05442554", "title": "A Study of Brentuximab Vedotin Treatment in Chinese Adults With CD30-Positive Cutaneous T-Cell Lymphoma", "status": "COMPLETED", "start": "2022-11-28", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Takeda", "conditions": ["T-Cell Lymphoma"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}, {"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": ""}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT06285370", "title": "A Study to Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or Sézary Syndrome Previously Treated With Systemic Therapy", "status": "COMPLETED", "start": "2023-05-29", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 23, "sponsor": "Kyowa Kirin China Pharmaceutical Co., Ltd.", "conditions": ["Cutaneous T-Cell Lymphoma"], "cn_sites": [{"facility": "Peking University First Hospital, Department of Dermatology and Venereology", "city": "Beijing", "status": ""}, {"facility": "Sun Yat-sen University Cancer Center, Department of Medical Oncology", "city": "Guangzhou", "status": ""}, {"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "The Affiliated Hospital of Inner Mongolia Medical University", "city": "Hohhot", "status": ""}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "ZheJiang Cancer Hospital", "city": "Hangzhou", "status": ""}, {"facility": "First Affiliated Hospital of Zhengzhou University", "city": "Henan", "status": ""}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT06037239", "title": "Phase I/II Study of Linperlisib Plus Chidamide for R/R Cutaneous T-cell Lymphoma: a Prospective, Single-center Study", "status": "UNKNOWN", "start": "2023-07-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 53, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Cutaneous T-cell Lymphoma"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06485219", "title": "A Phase IIa Clinical Study of Purinostat Mesylate for Injection in Patients With Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-04-14", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Chengdu Zenitar Biomedical Technology Co., Ltd", "conditions": ["Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)", "Cutaneous T-cell Lymphoma (CTCL)"], "cn_sites": [{"facility": "Ruijin Hospital, Shanghai Jiaotong University School Of Medicine", "city": "Shanghai", "status": ""}, {"facility": "West China Hospital Sichuan University", "city": "Chengdu", "status": ""}], "cn_site_count": 2, "broad_only": false}], "g_total": 82, "g_fetched": 72, "g_countries": [["United States", 51], ["Italy", 9], ["Spain", 5], ["France", 5], ["Australia", 3], ["Denmark", 2], ["South Korea", 2], ["Germany", 2], ["Costa Rica", 1], ["Belgium", 1], ["Netherlands", 1], ["Moldova", 1], ["Poland", 1], ["Romania", 1], ["Ukraine", 1], ["Greece", 1], ["United Kingdom", 1], ["Hong Kong", 1], ["Taiwan", 1], ["Sweden", 1]], "g_trials": [{"nct": "NCT07608549", "title": "FLASH Pilot Phase 1 Safety Study", "status": "NOT_YET_RECRUITING", "start": "2029-10-31", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Lesley A. Jarvis", "countries": []}, {"nct": "NCT07691450", "title": "Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma", "status": "NOT_YET_RECRUITING", "start": "2027-01-03", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "City of Hope Medical Center", "countries": ["United States"]}, {"nct": "NCT07714187", "title": "A Study of Topical Duvelisib in Participants With Early-stage Mycosis Fungoides", "status": "NOT_YET_RECRUITING", "start": "2027-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "SecuraBio", "countries": ["United States"]}, {"nct": "NCT05728879", "title": "Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray Solution", "status": "NOT_YET_RECRUITING", "start": "2027-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Northwestern University", "countries": ["United States"]}, {"nct": "NCT07710781", "title": "Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies", "status": "NOT_YET_RECRUITING", "start": "2026-12-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Ossium Health, Inc.", "countries": []}, {"nct": "NCT07682792", "title": "Golidocitinib in Patients With Mycosis Fungoides/Sézary Syndrome and T-Cell Large Granular Lymphocytic Leukemia", "status": "NOT_YET_RECRUITING", "start": "2026-09-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Washington University School of Medicine", "countries": ["United States"]}, {"nct": "NCT07781449", "title": "Topical JAK-Inhibition of Early-Stage CTCL", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Aarhus University Hospital", "countries": []}, {"nct": "NCT07192471", "title": "A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma", "status": "RECRUITING", "start": "2026-09", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Kyowa Kirin, Inc.", "countries": ["Italy", "Spain", "United States"]}, {"nct": "NCT07529405", "title": "A Study of VG712 in Patients With Mycosis Fungoides", "status": "NOT_YET_RECRUITING", "start": "2026-07-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Virogen Biotechnology Inc.", "countries": ["United States"]}, {"nct": "NCT07658924", "title": "Efficacy and Safety of Benvitimod Cream in Cutaneous T-Cell Lymphoma", "status": "NOT_YET_RECRUITING", "start": "2026-07-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Peking University First Hospital", "countries": []}, {"nct": "NCT07538960", "title": "Epidemiology and Management of Cutaneous T-Cell Lymphoma at Hospital México, Costa Rica.", "status": "NOT_YET_RECRUITING", "start": "2026-05", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Caja Costarricense de Seguro Social", "countries": ["Costa Rica"]}, {"nct": "NCT07477769", "title": "Lymphocyte Phenotype of Autosomal Recessive Congenital Ichthyoses Mutated NIPAL4 (Nipal4-nEDD)", "status": "NOT_YET_RECRUITING", "start": "2026-04-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": []}, {"nct": "NCT05544968", "title": "Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies", "status": "RECRUITING", "start": "2026-03-04", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Medical College of Wisconsin", "countries": ["United States"]}, {"nct": "NCT07356245", "title": "Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma", "status": "RECRUITING", "start": "2026-02-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Jonathan Brammer", "countries": ["United States"]}, {"nct": "NCT07195916", "title": "A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies", "status": "RECRUITING", "start": "2026-01-08", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Incyte Corporation", "countries": ["Australia", "Belgium", "Denmark", "Italy", "United States"]}, {"nct": "NCT07213882", "title": "A Phase 1, Multicenter, Open-label, Prospective, First-in-human Dose-escalation Clinical Trial of Domain Therapeutics' Anti-CCR8 Monoclonal Antibody (DT-7012) in Patients With Relapsed or Refractory Cutaneous T-cell Lymphomas (CTCL)", "status": "NOT_YET_RECRUITING", "start": "2026-01-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": []}, {"nct": "NCT07283822", "title": "Amping up With PemJAK", "status": "RECRUITING", "start": "2025-12-03", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Seda S. Tolu", "countries": ["United States"]}, {"nct": "NCT07178457", "title": "Brentuximab Vedotin in CutAneous T-cell Lymphomas (CTCL): Post-allogeneic Hematopoietic Stem Cell Transplant Maintenance", "status": "NOT_YET_RECRUITING", "start": "2025-11-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": []}, {"nct": "NCT07055477", "title": "A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)", "status": "RECRUITING", "start": "2025-09-29", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["United States"]}, {"nct": "NCT07046663", "title": "Long-term Assessment of Chlormethine Gel in Mycosis Fungoides", "status": "NOT_YET_RECRUITING", "start": "2025-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondazione Italiana Linfomi - ETS", "countries": ["Italy"]}, {"nct": "NCT07047885", "title": "Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL)", "status": "RECRUITING", "start": "2025-08-27", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "H. Lee Moffitt Cancer Center and Research Institute", "countries": ["United States"]}, {"nct": "NCT06712810", "title": "Q702 for the Treatment of Patients With Hematologic Malignancies", "status": "RECRUITING", "start": "2025-08-27", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Mayo Clinic", "countries": ["United States"]}, {"nct": "NCT06385522", "title": "A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System", "status": "NOT_YET_RECRUITING", "start": "2025-08", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Boston Immune Technologies and Therapeutics", "countries": []}, {"nct": "NCT07021495", "title": "SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)", "status": "RECRUITING", "start": "2025-07-29", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Leiden University Medical Center", "countries": ["Netherlands"]}, {"nct": "NCT06860880", "title": "Combating Cancer-Related Fatigue: A Personalized Supportive Care Program", "status": "RECRUITING", "start": "2025-06-03", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "UNC Lineberger Comprehensive Cancer Center", "countries": ["United States"]}]}, {"batch": 2, "no": 21, "name_zh": "胱氨酸贮积症", "query_terms": [{"term": "Cystinosis", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 11, "g_fetched": 11, "g_countries": [["France", 4], ["United States", 4], ["Spain", 1], ["Germany", 1], ["Italy", 1], ["Turkey (Türkiye)", 1], ["Australia", 1], ["United Kingdom", 1]], "g_trials": [{"nct": "NCT07680751", "title": "European Cystinosis Cohort 2", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Institut National de la Santé Et de la Recherche Médicale, France", "countries": ["France"]}, {"nct": "NCT07242261", "title": "Non-invasive Characterisation of Oral Carcinomas in Patients With Fanconi Anaemia", "status": "NOT_YET_RECRUITING", "start": "2026-04-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Institut Jean-Godinot", "countries": []}, {"nct": "NCT07319091", "title": "Cystinosis and Mitochondrial Metabolism", "status": "RECRUITING", "start": "2025-12-08", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Hospices Civils de Lyon", "countries": ["France"]}, {"nct": "NCT06910813", "title": "DFT383 in Pediatric Participants With Nephropathic Cystinosis", "status": "RECRUITING", "start": "2025-06-02", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": ["United States"]}, {"nct": "NCT05508009", "title": "Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor", "status": "RECRUITING", "start": "2023-01-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Alice Bertaina", "countries": ["United States"]}, {"nct": "NCT06213402", "title": "RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)", "status": "RECRUITING", "start": "2021-11-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Hospital Universitari Vall d'Hebron Research Institute", "countries": ["Spain"]}, {"nct": "NCT03919981", "title": "CYSTEA-BONE Clinical Study", "status": "RECRUITING", "start": "2019-04-05", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Hospices Civils de Lyon", "countries": ["France", "Germany", "Italy", "Turkey (Türkiye)"]}, {"nct": "NCT05901077", "title": "European Cystinosis Cohort", "status": "RECRUITING", "start": "2017-04-20", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Institut National de la Santé Et de la Recherche Médicale, France", "countries": ["France"]}, {"nct": "NCT01793168", "title": "Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford", "status": "RECRUITING", "start": "2010-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sanford Health", "countries": ["Australia", "United States"]}, {"nct": "NCT06065852", "title": "National Registry of Rare Kidney Diseases", "status": "RECRUITING", "start": "2009-11-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "UK Kidney Association", "countries": ["United Kingdom"]}, {"nct": "NCT00359684", "title": "Use of Cysteamine in the Treatment of Cystinosis", "status": "RECRUITING", "start": "1979-01-04", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Human Genome Research Institute (NHGRI)", "countries": ["United States"]}]}, {"batch": 2, "no": 22, "name_zh": "隆突性皮肤纤维肉瘤", "query_terms": [{"term": "Dermatofibrosarcoma protuberans", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 9, "g_fetched": 9, "g_countries": [["United States", 4], ["Norway", 2], ["Australia", 1], ["United Kingdom", 1]], "g_trials": [{"nct": "NCT07646080", "title": "Exploratory Study on Toripalimab and Anlotinib Combined With Standard Chemotherapy for Refractory Dermatofibrosarcoma Protuberans", "status": "NOT_YET_RECRUITING", "start": "2026-06-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Yanjie Zhang, MD", "countries": []}, {"nct": "NCT07173972", "title": "Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma.", "status": "RECRUITING", "start": "2026-01-26", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Oslo University Hospital", "countries": ["Norway"]}, {"nct": "NCT07169344", "title": "Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma", "status": "RECRUITING", "start": "2026-01-26", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Oslo University Hospital", "countries": ["Norway"]}, {"nct": "NCT06526897", "title": "Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma", "status": "NOT_YET_RECRUITING", "start": "2025-01-28", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "ECOG-ACRIN Cancer Research Group", "countries": []}, {"nct": "NCT06789172", "title": "A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors", "status": "RECRUITING", "start": "2025-01-23", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Epkin", "countries": ["Australia", "United Kingdom", "United States"]}, {"nct": "NCT06610071", "title": "NIFR Image-guided Surgery for Malignant Soft Tissue Tumor With Low-dose SWIG Technique", "status": "NOT_YET_RECRUITING", "start": "2024-10-30", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "The Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College", "countries": []}, {"nct": "NCT06239272", "title": "NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)", "status": "RECRUITING", "start": "2024-03-27", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "St. Jude Children's Research Hospital", "countries": ["United States"]}, {"nct": "NCT05711615", "title": "Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma", "status": "RECRUITING", "start": "2024-02-06", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["United States"]}, {"nct": "NCT04332874", "title": "A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg", "status": "RECRUITING", "start": "2020-04-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Memorial Sloan Kettering Cancer Center", "countries": ["United States"]}]}, {"batch": 2, "no": 23, "name_zh": "嗜酸性粒细胞性胃肠炎", "query_terms": [{"term": "Eosinophilic gastroenteritis", "broad": false}], "n_total": 2, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT07257835", "title": "Dupilumab Therapy for EGIDs", "status": "RECRUITING", "start": "2025-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 20, "sponsor": "Children's Hospital of Fudan University", "conditions": ["Eosinophilic Gastrointestinal Disorders (EGIDs)"], "cn_sites": [{"facility": "201102", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05583227", "title": "Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-11-10", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 368, "sponsor": "AstraZeneca", "conditions": ["Eosinophilic Esophagitis"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Guangzhou", "status": ""}, {"facility": "Research Site", "city": "Hangzhou", "status": ""}, {"facility": "Research Site", "city": "Nanjing", "status": ""}, {"facility": "Research Site", "city": "Shanghai", "status": ""}, {"facility": "Research Site", "city": "Shenyang", "status": ""}, {"facility": "Research Site", "city": "Tianjin", "status": ""}, {"facility": "Research Site", "city": "Wuhan", "status": ""}], "cn_site_count": 8, "broad_only": false}], "g_total": 43, "g_fetched": 42, "g_countries": [["United States", 22], ["Italy", 5], ["France", 3], ["Netherlands", 3], ["Australia", 2], ["Mali", 1], ["Turkey (Türkiye)", 1], ["Germany", 1], ["Argentina", 1], ["Belgium", 1], ["Norway", 1], ["Canada", 1], ["New Zealand", 1], ["Switzerland", 1], ["United Kingdom", 1], ["Israel", 1]], "g_trials": [{"nct": "NCT07023380", "title": "EoE Food Test Pilot Study", "status": "NOT_YET_RECRUITING", "start": "2027-01-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Children's Hospital of Philadelphia", "countries": ["United States"]}, {"nct": "NCT07588568", "title": "A Trial of Upadacitinib for Non-responsive Eosinophilic Esophagitis", "status": "NOT_YET_RECRUITING", "start": "2026-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University of North Carolina, Chapel Hill", "countries": ["United States"]}, {"nct": "NCT07027826", "title": "The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States", "status": "RECRUITING", "start": "2026-09-23", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "countries": ["Mali", "United States"]}, {"nct": "NCT07780981", "title": "Impact of Body Positioning on EndoFLIP Measurements: A Comparative Study of Supine and Left Lateral Decubitus Positions", "status": "RECRUITING", "start": "2026-07-24", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Johns Hopkins University", "countries": ["United States"]}, {"nct": "NCT07779772", "title": "Elimination Diet Strategies and Histologic Remission in Children With Eosinophilic Gastrointestinal Disorders", "status": "RECRUITING", "start": "2026-07-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Cukurova University", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT07234825", "title": "Trial of Partial Enteral Nutrition With Dairy Free Diet in Eosinophilic Esophagitis", "status": "RECRUITING", "start": "2026-03-18", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Kate Farms Inc", "countries": ["United States"]}, {"nct": "NCT07506746", "title": "PRospective Registry of Esophageal Motility", "status": "RECRUITING", "start": "2026-03-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS San Raffaele", "countries": ["Italy"]}, {"nct": "NCT07227506", "title": "Utility of Mucosal Impedance Device in Chronic Esophageal Disorders:", "status": "RECRUITING", "start": "2025-11-20", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Medical College of Wisconsin", "countries": ["United States"]}, {"nct": "NCT07112378", "title": "A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis", "status": "RECRUITING", "start": "2025-11-10", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Regeneron Pharmaceuticals", "countries": ["United States"]}, {"nct": "NCT07614633", "title": "Natural History of Eosinophilic Esophagitis in Adult and Pediatric Population", "status": "RECRUITING", "start": "2025-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondazione IRCCS Policlinico San Matteo di Pavia", "countries": ["Italy"]}, {"nct": "NCT07057986", "title": "Trans-Cervical and Trans-abdominal Ultrasound for Monitoring Esophageal Thickness in Eosinophilic Esophagitis", "status": "NOT_YET_RECRUITING", "start": "2025-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Sheba Medical Center", "countries": []}, {"nct": "NCT06972147", "title": "Prevalence and Description of FIRE (Food Induced Immediate Response of the Esophagus) in the Pediatric Population With Eosinophilic Esophagitis", "status": "RECRUITING", "start": "2025-07-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Angers", "countries": ["France"]}, {"nct": "NCT07012928", "title": "Local Clinical and Immunological Responses in Eosinophilic Esophagitis (EoE) Patients, Role of Mucosal Barrier Function and Type II Inflammation", "status": "RECRUITING", "start": "2025-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)", "countries": ["Netherlands"]}, {"nct": "NCT06995274", "title": "Umbilical Cord Blood Therapy in a Child With Eosinophilic Duodenitis and Autism Spectrum Disorder: a Case Study", "status": "NOT_YET_RECRUITING", "start": "2025-06-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Bundang CHA Hospital", "countries": []}, {"nct": "NCT06695897", "title": "A Non-interventional Observational Study to Assess Long-term Efficacy and Safety of Dupilumab for the Treatment of Patients (>= 12 Years) With Eosinophilic Esophagitis Under Real-world-conditions in Germany", "status": "RECRUITING", "start": "2025-05-28", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sanofi", "countries": ["Germany"]}, {"nct": "NCT05485155", "title": "Zemaira Eosinophilic Esophagitis Pilot Study", "status": "RECRUITING", "start": "2025-05-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Children's Hospital Medical Center, Cincinnati", "countries": ["United States"]}, {"nct": "NCT06817213", "title": "Patient-Centered Decision Support for Eosinophilic Esophagitis", "status": "RECRUITING", "start": "2025-04-16", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Michigan", "countries": ["United States"]}, {"nct": "NCT06705387", "title": "Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoE", "status": "RECRUITING", "start": "2024-12-23", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University of Colorado, Denver", "countries": ["United States"]}, {"nct": "NCT06665971", "title": "Effect of Dupilumab on the Muscle Function of the Esophagus (food Pipe) in Participants with Eosinophilic Esophagitis (EoE)", "status": "RECRUITING", "start": "2024-11-10", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "University of California, San Diego", "countries": ["United States"]}, {"nct": "NCT06573723", "title": "Institutional Registry of Rare Diseases", "status": "RECRUITING", "start": "2024-07-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Hospital Italiano de Buenos Aires", "countries": ["Argentina"]}, {"nct": "NCT06443346", "title": "Prospective Registry of EoSinophilic esOphagitis", "status": "RECRUITING", "start": "2024-06-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS San Raffaele", "countries": ["Italy"]}, {"nct": "NCT06387030", "title": "EDN and Eosinophilic Esophagitis", "status": "RECRUITING", "start": "2024-04-19", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT06389994", "title": "Esophageal String Test Monitoring to Monitor Eosinophilic Esophagitis During Oral Immunotherapy", "status": "RECRUITING", "start": "2024-04-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Children's Hospital of Philadelphia", "countries": ["United States"]}, {"nct": "NCT06190080", "title": "Outcome of Children With Eosinophilic Esophagitis", "status": "NOT_YET_RECRUITING", "start": "2024-03", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Fondation Lenval", "countries": ["France"]}, {"nct": "NCT06381219", "title": "Pediatric Eosinophilic Esophagitis (pedEoE): Effect of Allergen Heat Denaturation on EoE Remission: a Pilot Trial", "status": "RECRUITING", "start": "2023-12-19", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Universitaire Ziekenhuizen KU Leuven", "countries": ["Belgium"]}]}, {"batch": 2, "no": 24, "name_zh": "上皮样肉瘤", "query_terms": [{"term": "Epithelioid sarcoma", "broad": false}], "n_total": 4, "n_open": 3, "n_open_precise": 3, "n_broad": 0, "trials": [{"nct": "NCT04390737", "title": "Evaluate the Safety and Clinical Activity of HH2853", "status": "RECRUITING", "start": "2020-09-08", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 254, "sponsor": "Haihe Biopharma Co., Ltd.", "conditions": ["FL Lymphoma", "Epithelioid Sarcoma", "Peripheral T Cell Lymphoma", "Advanced Solid Tumor"], "cn_sites": [{"facility": "The First Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": "RECRUITING"}, {"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Jishuitan Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Sun Yat-Sen University Cancer Hospital", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Affiliated Tumor Hospital of Guangxi Medical University", "city": "Nanning", "status": "RECRUITING"}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Hunan Cancer Hospital", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Affiliated Drum Tower Hospital, Medical School of Nanjing University", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Liaoning Cancer Hospital&Institute", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Shengjing Hospital Of China Medical University", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Linyi Tumor Hospital", "city": "Linyi", "status": "RECRUITING"}, {"facility": "Shanghai Sixth People's Hospital", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Zhongshan Hospital Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Shanxi Cancer Hospital", "city": "Taiyuan", "status": "RECRUITING"}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Tianjin Cancer Hospital", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 18, "broad_only": false}, {"nct": "NCT06277154", "title": "MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma", "status": "RECRUITING", "start": "2024-02-21", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 148, "sponsor": "HRYZ Biotech Co.", "conditions": ["Leiomyosarcoma", "Liposarcoma", "Synovial Sarcoma", "Angiosarcoma", "Undifferentiated Pleomorphic Sarcoma", "Epithelioid Sarcoma", "Malignant Peripheral Nerve Sheath Tumors", "Fibrosarcoma", "Pleomorphic Rhabdomyosarcoma", "Endometrial Stromal Sarcoma", "Desmoplastic Small Round Cell Tumor"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06683846", "title": "Ivonescimab in the Treatment of Multiple Advanced Tumors", "status": "RECRUITING", "start": "2024-11-20", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 400, "sponsor": "Fudan University", "conditions": ["Pheochromocytoma/Paraganglioma", "Rhabdomyosarcoma", "Paget Disease, Extramammary", "Renal Angiomyolipoma", "Perivascular Epithelioid Cell Tumor, Malignant", "Sarcoma", "Urachal Cancer", "Neuroendocrine Cancer", "Basal Cell Carcinomas", "Sarcomatoid Carcinoma", "Penile Cancer", "Adrenal Cortical Cancer", "Germ Cell Cancer Metastatic", "Non-Clear Cell Renal Cell Carcinoma", "Prostate Cancers", "Clear Cell Renal Cancer", "Urothelial Carcinoma", "Kidney Cancer", "Rare Tumors"], "cn_sites": [{"facility": "Fudan University Cancer Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05656222", "title": "Irinotecan and Anlotinib for Epithelioid Sarcoma", "status": "WITHDRAWN", "start": "2021-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Peking University People's Hospital", "conditions": ["Objective Response", "Overall Survival"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 15, "g_fetched": 12, "g_countries": [["United States", 5], ["France", 2], ["Italy", 2], ["Japan", 1], ["Armenia", 1], ["Austria", 1], ["Denmark", 1], ["Germany", 1], ["Poland", 1], ["Portugal", 1], ["Spain", 1], ["Sweden", 1], ["United Kingdom", 1], ["Switzerland", 1]], "g_trials": [{"nct": "NCT07734116", "title": "A Study of ONO-4538HSC in Pediatric Patients With Malignant Solid Tumors and in Patients With Epithelioid Sarcoma.", "status": "RECRUITING", "start": "2026-08-18", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Ono Pharmaceutical Co., Ltd.", "countries": ["Japan"]}, {"nct": "NCT07467772", "title": "Ph 2 Elacestrant in ER Positive Uterine Sarcomas", "status": "RECRUITING", "start": "2026-03-25", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Dana-Farber Cancer Institute", "countries": ["United States"]}, {"nct": "NCT06625190", "title": "Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors", "status": "RECRUITING", "start": "2026-02-11", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University of Florida", "countries": ["United States"]}, {"nct": "NCT07089992", "title": "A Study of Pembrolizumab in People With Ultra-Rare Sarcomas", "status": "RECRUITING", "start": "2025-12-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Memorial Sloan Kettering Cancer Center", "countries": ["United States"]}, {"nct": "NCT06715579", "title": "Cardiac Angiosarcoma International Registry", "status": "RECRUITING", "start": "2025-05-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Immune Oncology Research Institute", "countries": ["Armenia"]}, {"nct": "NCT07675967", "title": "Clonal Hematopoiesis Chemotherapy and Radiation Effects Study", "status": "RECRUITING", "start": "2025-04-04", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Dana-Farber Cancer Institute", "countries": ["United States"]}, {"nct": "NCT06239272", "title": "NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)", "status": "RECRUITING", "start": "2024-03-27", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "St. Jude Children's Research Hospital", "countries": ["United States"]}, {"nct": "NCT06408441", "title": "The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)", "status": "RECRUITING", "start": "2023-12-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondazione IRCCS Istituto Nazionale dei Tumori, Milano", "countries": ["Austria", "Denmark", "France", "Germany", "Italy", "Poland", "Portugal", "Spain", "Sweden", "United Kingdom"]}, {"nct": "NCT03967834", "title": "Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group", "status": "RECRUITING", "start": "2021-04-26", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Institut Claudius Regaud", "countries": ["France"]}, {"nct": "NCT04300257", "title": "Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care", "status": "RECRUITING", "start": "2019-10-19", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Kantonsspital Winterthur KSW", "countries": ["Switzerland"]}, {"nct": "NCT03099681", "title": "An Observational Study on Epithelioid Sarcoma", "status": "RECRUITING", "start": "2017-08-22", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Italian Sarcoma Group", "countries": ["Italy"]}, {"nct": "NCT07502716", "title": "Compassionate Use of Ubamatamab", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "Regeneron Pharmaceuticals", "countries": []}]}, {"batch": 2, "no": 25, "name_zh": "面肩肱型肌营养不良症", "query_terms": [{"term": "Facioscapulohumeral dystrophy", "broad": false}, {"term": "Facioscapulohumeral muscular dystrophy", "broad": false}], "n_total": 2, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT04369209", "title": "A Registered Cohort Study on FSHD1", "status": "RECRUITING", "start": "2001-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "Ning Wang, MD., PhD.", "conditions": ["Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1)"], "cn_sites": [{"facility": "First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06517498", "title": "Disease Burden and Living Situation of Patients With Facioscapulohumeral Muscular Dystrophy", "status": "UNKNOWN", "start": "2024-03-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 300, "sponsor": "Xi'an Jiaotong University", "conditions": ["Muscular Dystrophy, Facioscapulohumeral"], "cn_sites": [{"facility": "Health Science Center of Xi'an Jiaotong University", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}], "g_total": 23, "g_fetched": 22, "g_countries": [["United States", 9], ["Italy", 5], ["Netherlands", 5], ["Australia", 3], ["France", 3], ["Spain", 3], ["Belgium", 3], ["New Zealand", 2], ["Canada", 2], ["Germany", 2], ["United Kingdom", 2], ["Denmark", 1], ["Japan", 1], ["Norway", 1], ["Czechia", 1], ["Egypt", 1], ["Hungary", 1], ["Poland", 1], ["Romania", 1], ["Slovenia", 1]], "g_trials": [{"nct": "NCT07798609", "title": "A Trial to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of SFL-0821 in Adults With FSHD", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Soufflé Therapeutics, Inc.", "countries": ["Australia", "New Zealand"]}, {"nct": "NCT07435129", "title": "Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD", "status": "RECRUITING", "start": "2026-07-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Scholar Rock, Inc.", "countries": ["United States"]}, {"nct": "NCT07543016", "title": "Amino Acids and Exercise in FSHD", "status": "RECRUITING", "start": "2026-04-08", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Pavia", "countries": ["Italy"]}, {"nct": "NCT07478172", "title": "Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease", "status": "RECRUITING", "start": "2026-03-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Missouri-Columbia", "countries": ["United States"]}, {"nct": "NCT07086521", "title": "Safety and Preliminary Efficacy of ULSC in Facioscapulohumeral Muscular Dystrophy (FSHD)", "status": "RECRUITING", "start": "2025-12-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Restem, LLC.", "countries": ["United States"]}, {"nct": "NCT06721299", "title": "Clenbuterol to Target DUX4 in FSHD", "status": "RECRUITING", "start": "2025-06-25", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Jeffrey Statland", "countries": ["United States"]}, {"nct": "NCT07038200", "title": "A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD", "status": "RECRUITING", "start": "2025-06-10", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Avidity Biosciences, Inc.", "countries": ["Canada", "Denmark", "France", "Germany", "Italy", "Japan", "Netherlands", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT06847282", "title": "Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)", "status": "RECRUITING", "start": "2025-05-22", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Kansas Medical Center", "countries": ["Australia", "United States"]}, {"nct": "NCT06917430", "title": "Muscle MRI Outlining of Neuromuscular Diseases Using Artificial Intelligence", "status": "NOT_YET_RECRUITING", "start": "2025-05-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Rigshospitalet, Denmark", "countries": []}, {"nct": "NCT06708468", "title": "Personalized Training for People With Rare Neuromuscular Disorders", "status": "RECRUITING", "start": "2024-12-13", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Oslo University Hospital", "countries": ["Norway"]}, {"nct": "NCT06911190", "title": "Ten Year Follow-up in FSHD: the FOCUS 3 Study", "status": "RECRUITING", "start": "2024-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Radboud University Medical Center", "countries": ["Netherlands"]}, {"nct": "NCT07409142", "title": "BetterLife FSHD: A Patient-driven Health and Research Platform", "status": "RECRUITING", "start": "2024-08-02", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "FSHD Society", "countries": ["United States"]}, {"nct": "NCT06131983", "title": "Study of SRP-1001 in Adult and Adolescent Participants With Facioscapulohumeral Muscular Dystrophy Type 1", "status": "RECRUITING", "start": "2024-06-19", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Sarepta Therapeutics, Inc.", "countries": ["Australia", "Canada", "Germany", "Italy", "Netherlands", "New Zealand", "Spain"]}, {"nct": "NCT06227182", "title": "Magnetic Resonance Imaging and Ultrasound Comparison With Load Evaluation", "status": "RECRUITING", "start": "2024-04-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Radboud University Medical Center", "countries": ["Netherlands"]}, {"nct": "NCT06600308", "title": "Walking ANalysis Interest in Persons wiTh facioscapulohumEral Muscular Dystrophies", "status": "RECRUITING", "start": "2024-04-03", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Centre Hospitalier Universitaire Dijon", "countries": ["France"]}, {"nct": "NCT07136844", "title": "Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology", "status": "RECRUITING", "start": "2024-03-29", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Centre Hospitalier Universitaire de Liege", "countries": ["Belgium"]}, {"nct": "NCT06079567", "title": "An 18-month Prospective Natural History Study to Gain Insight Into FSHD2 Pathophysiology and Disease Progression", "status": "RECRUITING", "start": "2023-10-03", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Centre Hospitalier Universitaire de Nice", "countries": ["Belgium", "France", "Italy", "Netherlands", "Spain"]}, {"nct": "NCT06078852", "title": "Longitudinal Study on Diaframmatic Ultrasound in FSHD Patients", "status": "RECRUITING", "start": "2023-07-18", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Fondazione Policlinico Universitario Agostino Gemelli IRCCS", "countries": ["Italy"]}, {"nct": "NCT05982119", "title": "Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study", "status": "RECRUITING", "start": "2020-07-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Centre Hospitalier Universitaire de Liege", "countries": ["Belgium", "Czechia", "Egypt", "Hungary", "Poland", "Romania", "Slovenia"]}, {"nct": "NCT05019625", "title": "Biomarker Development for Muscular Dystrophies", "status": "RECRUITING", "start": "2015-02-20", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Massachusetts General Hospital", "countries": ["United States"]}, {"nct": "NCT04001582", "title": "The United Kingdom Facioscapulohumeral Muscular Dystrophy Patient Registry", "status": "RECRUITING", "start": "2013-05", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Newcastle University", "countries": ["United Kingdom"]}, {"nct": "NCT00082108", "title": "Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry", "status": "RECRUITING", "start": "2000-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Rochester", "countries": ["United States"]}]}, {"batch": 2, "no": 26, "name_zh": "家族性噬血细胞淋巴组织细胞增生症", "query_terms": [{"term": "Familial hemophagocytic lymphohistiocytosis", "broad": false}], "n_total": 1, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT05744063", "title": "A Post-authorization Study to Describe the Safety and Efficacy of Emapalumab for the Treatment of pHLH in Treatment Experienced Chinese Patients", "status": "COMPLETED", "start": "2023-02-03", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 13, "sponsor": "Swedish Orphan Biovitrum", "conditions": ["Primary Hemophagocytic Lymphohistiocytosis"], "cn_sites": [{"facility": "Swedish Orphan Biovitrum Research site", "city": "Shanghai", "status": ""}, {"facility": "Swedish Orphan Biovitrum Research site", "city": "Beijing", "status": ""}, {"facility": "Swedish Orphan Biovitrum Research site", "city": "Chongqing", "status": ""}, {"facility": "Swedish Orphan Biovitrum Research site", "city": "Guangzhou", "status": ""}, {"facility": "Swedish Orphan Biovitrum Research site", "city": "Nanjing", "status": ""}, {"facility": "Swedish Orphan Biovitrum Research site", "city": "Zhengzhou", "status": ""}], "cn_site_count": 6, "broad_only": false}], "g_total": 4, "g_fetched": 4, "g_countries": [["France", 3], ["Australia", 1], ["United States", 1]], "g_trials": [{"nct": "NCT07741747", "title": "Impact of Ultra-fast Genetic Diagnosis of Familial Lymphohistiocytosis on the Time to Bone Marrow Transplantation and Overall Survival", "status": "NOT_YET_RECRUITING", "start": "2026-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique Hopitaux De Marseille", "countries": ["France"]}, {"nct": "NCT06736080", "title": "Safety and Efficacy of Gene Therapy of FHL Type 3 Caused by Mutations in the Human UNC13D Gene by Transplantation of a Single Dose of Autologous CD34+ Cells Transduced ex Vivo With the UNC13D LV Vector Expressing the UNC13D cDNA", "status": "NOT_YET_RECRUITING", "start": "2026-05", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT05762640", "title": "Ruxolitinib as First Line Treatment in Primary Haemophagocytic Lymphohistiocytosis (R-HLH)", "status": "RECRUITING", "start": "2024-11-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT01793168", "title": "Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford", "status": "RECRUITING", "start": "2010-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sanford Health", "countries": ["Australia", "United States"]}]}, {"batch": 2, "no": 27, "name_zh": "家族性腺瘤性息肉病", "query_terms": [{"term": "Familial adenomatous polyposis", "broad": false}], "n_total": 4, "n_open": 2, "n_open_precise": 2, "n_broad": 0, "trials": [{"nct": "NCT04531930", "title": "Colorectal Adenoma Canceration in FAP", "status": "NOT_YET_RECRUITING", "start": "2020-10-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 124, "sponsor": "Changhai Hospital", "conditions": ["Familial Adenomatous Polyposis"], "cn_sites": [{"facility": "Changhai Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06649825", "title": "Efficacy of Vitamin B1 in Familial Adenomatous Polyposis Patients.", "status": "ENROLLING_BY_INVITATION", "start": "2024-01-08", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Shanghai Zhongshan Hospital", "conditions": ["Familial Adenomatous Polyposis (FAP)"], "cn_sites": [{"facility": "Shanghai Zhongshan Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03333265", "title": "Primary Chemoprevention of Familial Adenomatous Polyposis With Berberine Hydrochloride", "status": "COMPLETED", "start": "2017-09-01", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Xijing Hospital of Digestive Diseases", "conditions": ["Colorectal Adenomas"], "cn_sites": [{"facility": "Li", "city": "Xi'an", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05687318", "title": "A Clinical Trial of the Effectiveness and Safety of Software Assisting Diagnose the Intestinal Polyp Digestive Endoscopy by Analysis of Colonoscopy Medical Images From Electronic Digestive Endoscopy Equipment", "status": "COMPLETED", "start": "2022-09-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 337, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Artificial Intelligence", "Enteroscope", "Intestinal Polyposis, Adenomatous"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 22, "g_fetched": 21, "g_countries": [["United States", 11], ["France", 3], ["Netherlands", 3], ["Denmark", 2], ["Italy", 2], ["Australia", 2], ["United Kingdom", 1], ["Germany", 1], ["Puerto Rico", 1], ["Spain", 1], ["Brazil", 1]], "g_trials": [{"nct": "NCT07729371", "title": "A Safety Study of ST316 in Participants With Familial Adenomatous Polyposis (FAP).", "status": "NOT_YET_RECRUITING", "start": "2027-01-04", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Sapience Therapeutics", "countries": []}, {"nct": "NCT06308445", "title": "Safety Study for the Use of Rapamycin in Children With Familial Adenomatous Polyposis", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Toulouse", "countries": ["France"]}, {"nct": "NCT07726771", "title": "Evaluation of the Ileo-anal Pouch in FAP (ENDOPOL)", "status": "RECRUITING", "start": "2026-07-09", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "London North West Healthcare NHS Trust", "countries": ["United Kingdom"]}, {"nct": "NCT06641310", "title": "Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)", "status": "RECRUITING", "start": "2026-05-13", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Michigan Rogel Cancer Center", "countries": ["United States"]}, {"nct": "NCT06557733", "title": "An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis", "status": "RECRUITING", "start": "2026-03-31", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["United States"]}, {"nct": "NCT06881303", "title": "Impact of Prior Identification and Education of Patients Requiring a Digestive Stoma for Fecal Diversion", "status": "NOT_YET_RECRUITING", "start": "2026-03-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique Hopitaux De Marseille", "countries": ["France"]}, {"nct": "NCT07463599", "title": "Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma", "status": "RECRUITING", "start": "2026-02-17", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "HonorHealth Research Institute", "countries": ["United States"]}, {"nct": "NCT05630794", "title": "Testing for Safety and Colorectal Cancer Preventive Effects of ONC201", "status": "RECRUITING", "start": "2025-10-06", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["United States"]}, {"nct": "NCT06950385", "title": "Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis", "status": "RECRUITING", "start": "2025-07-18", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Rapamycin Holdings Inc.", "countries": ["Denmark", "Germany", "Italy", "Netherlands", "Puerto Rico", "Spain", "United States"]}, {"nct": "NCT06538402", "title": "Ten Versus Fifteen Centimeter Pouch in IPAA Surgery", "status": "RECRUITING", "start": "2025-07-03", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Odense University Hospital", "countries": ["Denmark"]}, {"nct": "NCT07066046", "title": "Artificial Intelligence-assisted Colonoscopy in the Detection and Characterization of Colorectal Lesions", "status": "RECRUITING", "start": "2025-02-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Instituto do Cancer do Estado de São Paulo", "countries": ["Brazil"]}, {"nct": "NCT06614738", "title": "Microbial and Environmental Factors Associated With Polyps Development in Familial Adenomatous Polyposis (MicrobEnvironment in FAP)", "status": "RECRUITING", "start": "2024-12-17", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Hospices Civils de Lyon", "countries": ["France"]}, {"nct": "NCT05552755", "title": "Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)", "status": "RECRUITING", "start": "2023-07-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Recursion Pharmaceuticals Inc.", "countries": ["United States"]}, {"nct": "NCT05919264", "title": "FOG-001 in Locally Advanced or Metastatic Solid Tumors", "status": "RECRUITING", "start": "2023-05-23", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Parabilis Medicines, Inc.", "countries": ["Australia", "United States"]}, {"nct": "NCT04678011", "title": "A Personalized Surveillance and Intervention Protocol for Patients With Familial Adenomatous Polyposis That Have Undergone (Procto)Colectomy", "status": "RECRUITING", "start": "2021-11-24", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)", "countries": ["Netherlands", "United States"]}, {"nct": "NCT04677998", "title": "A Personalized Surveillance and Intervention Protocol for Duodenal and Gastric Polyposis in Patients With Familial Adenomatous Polyposis", "status": "RECRUITING", "start": "2020-11-24", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)", "countries": ["Netherlands", "United States"]}, {"nct": "NCT07199127", "title": "Duodenal Polyposis Classification in FAP", "status": "RECRUITING", "start": "2018-02-02", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondazione IRCCS Istituto Nazionale dei Tumori, Milano", "countries": ["Italy"]}, {"nct": "NCT03471403", "title": "Cold Snare Polypectomy for Duodenal Adenomas in Familial Adenomatous Polyposis", "status": "RECRUITING", "start": "2017-10-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Western Sydney Local Health District", "countries": ["Australia"]}, {"nct": "NCT03050268", "title": "Familial Investigations of Childhood Cancer Predisposition", "status": "RECRUITING", "start": "2017-04-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "St. Jude Children's Research Hospital", "countries": ["United States"]}, {"nct": "NCT02012699", "title": "Integrated Cancer Repository for Cancer Research", "status": "RECRUITING", "start": "2013-11-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Nebraska", "countries": ["United States"]}, {"nct": "NCT07689942", "title": "Expanded Access to 0.5 mg eRapa for Familial Adenomatous Polyposis", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "Biodexa Pharmaceuticals", "countries": []}]}, {"batch": 2, "no": 28, "name_zh": "进行性骨化性纤维发育不良", "query_terms": [{"term": "Fibrodysplasia ossificans progressiva", "broad": false}], "n_total": 3, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT05090891", "title": "To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva", "status": "RECRUITING", "start": "2022-05-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 98, "sponsor": "Incyte Corporation", "conditions": ["Fibrodysplasia Ossificans Progressiva (FOP)"], "cn_sites": [{"facility": "Beijing Childrens Hospital Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Tongji Hospital of Tongji University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Shanghai Childrens Medical Center", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Childrens Hospital of Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT05039515", "title": "A Study to Assess the Effectiveness and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP).", "status": "TERMINATED", "start": "2021-12-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 113, "sponsor": "Clementia Pharmaceuticals Inc.", "conditions": ["Fibrodysplasia Ossificans Progressiva"], "cn_sites": [{"facility": "Children's Hospital Capital Institute of Pediatrics (CIP)", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Shangai Children Medical Center", "city": "Shanghai", "status": ""}, {"facility": "Tongi University - Tongi Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT05394116", "title": "A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP)", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-11-21", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 63, "sponsor": "Regeneron Pharmaceuticals", "conditions": ["Fibrodysplasia Ossificans Progressiva"], "cn_sites": [{"facility": "Tongji Hospital of Tongji University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 5, "g_fetched": 4, "g_countries": [["United States", 3], ["Canada", 1]], "g_trials": [{"nct": "NCT07559513", "title": "A Study to Investigate the Safety, Pharmacokinetics (PK), and Efficacy of Garetosmab in Children and Adolescents With Fibrodysplasia Ossificans Progressiva (FOP)", "status": "NOT_YET_RECRUITING", "start": "2027-02-02", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Regeneron Pharmaceuticals", "countries": []}, {"nct": "NCT06724562", "title": "IL1 Inhibition in FOP", "status": "RECRUITING", "start": "2025-04-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of California, San Francisco", "countries": ["United States"]}, {"nct": "NCT06089616", "title": "A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP)", "status": "RECRUITING", "start": "2024-12-05", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Ipsen", "countries": ["Canada", "United States"]}, {"nct": "NCT02745158", "title": "The Fibrodysplasia Ossificans Progressiva (FOP) Registry", "status": "RECRUITING", "start": "2015-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "The International FOP Association", "countries": ["United States"]}]}, {"batch": 2, "no": 29, "name_zh": "脆性X综合征", "query_terms": [{"term": "Fragile X syndrome", "broad": false}], "n_total": 1, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT05120505", "title": "Metformin in Children With Fragile X Syndrome", "status": "COMPLETED", "start": "2021-12-29", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 37, "sponsor": "Children's Hospital of Fudan University", "conditions": ["Fragile X Syndrome", "Metformin"], "cn_sites": [{"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 19, "g_fetched": 19, "g_countries": [["United States", 9], ["France", 3], ["Canada", 2], ["Spain", 1], ["Italy", 1], ["Australia", 1], ["Israel", 1]], "g_trials": [{"nct": "NCT07434037", "title": "The Neurocognitive Bases of Trust in Intellectual Disability", "status": "RECRUITING", "start": "2026-07-17", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Hospices Civils de Lyon", "countries": ["France"]}, {"nct": "NCT07654114", "title": "Safety, Tolerability, and Preliminary Effectiveness of CTH120 in Fragile X Syndrome", "status": "RECRUITING", "start": "2026-05-21", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Connecta Therapeutics, S.L.", "countries": ["Spain"]}, {"nct": "NCT06868979", "title": "Optical Imaging in X-linked Disorders.", "status": "RECRUITING", "start": "2026-03-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Hospices Civils de Lyon", "countries": ["France"]}, {"nct": "NCT07493096", "title": "Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders", "status": "RECRUITING", "start": "2026-03-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Healing Hope International", "countries": ["United States"]}, {"nct": "NCT07439510", "title": "A Study to Investigate the Effects and Safety of SPG601 for the Treatment of Fragile X Syndrome in Male Participants", "status": "NOT_YET_RECRUITING", "start": "2026-03-01", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Spinogenix", "countries": []}, {"nct": "NCT07328529", "title": "Inhibition of Aggressive Behavior in Participants With Fragile X Syndrome", "status": "NOT_YET_RECRUITING", "start": "2026-03", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Azevan Pharmaceuticals", "countries": ["United States"]}, {"nct": "NCT07209462", "title": "Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)", "status": "RECRUITING", "start": "2025-11-22", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Mirum Pharmaceuticals, Inc.", "countries": ["United States"]}, {"nct": "NCT06261502", "title": "Effect of CANnabidiol on Anxiety and GABAergic Function in Individuals With Fragile-X Syndrome", "status": "RECRUITING", "start": "2025-09-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Université de Sherbrooke", "countries": ["Canada"]}, {"nct": "NCT06261450", "title": "Effect of CBD on the Brain", "status": "NOT_YET_RECRUITING", "start": "2025-05-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Université de Sherbrooke", "countries": []}, {"nct": "NCT06740162", "title": "Physical Activity and Community EmPOWERment Project", "status": "RECRUITING", "start": "2025-01-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of North Carolina, Chapel Hill", "countries": ["United States"]}, {"nct": "NCT06147414", "title": "Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders", "status": "RECRUITING", "start": "2024-10-23", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT06081348", "title": "Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders", "status": "RECRUITING", "start": "2024-09-16", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Holland Bloorview Kids Rehabilitation Hospital", "countries": ["Canada"]}, {"nct": "NCT06088589", "title": "Speech-in-noise Perception in Autism and Fragile X", "status": "RECRUITING", "start": "2023-11-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Children's Hospital Medical Center, Cincinnati", "countries": ["United States"]}, {"nct": "NCT06227780", "title": "Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental Disorders", "status": "RECRUITING", "start": "2023-05-24", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Children's Hospital Medical Center, Cincinnati", "countries": ["United States"]}, {"nct": "NCT06560242", "title": "Tracking Early Emergence of Sound Perception Impairments in FXS With Multimodal fNIRS/EEG- Infant", "status": "RECRUITING", "start": "2022-10-31", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Children's Hospital Medical Center, Cincinnati", "countries": ["United States"]}, {"nct": "NCT05957549", "title": "Tracking Early Emergence of Sound Perception Impairments in FXS With Multimodal fNIRS/EEG-Preschool Age", "status": "RECRUITING", "start": "2022-10-04", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Children's Hospital Medical Center, Cincinnati", "countries": ["United States"]}, {"nct": "NCT06677866", "title": "Group CBT in Adolescents With Fragile X Syndrome and in Adolescents With Autism Spectrum Disorder", "status": "RECRUITING", "start": "2022-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Bambino Gesù Hospital and Research Institute", "countries": ["Italy"]}, {"nct": "NCT01793168", "title": "Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford", "status": "RECRUITING", "start": "2010-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sanford Health", "countries": ["Australia", "United States"]}, {"nct": "NCT00768820", "title": "The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome", "status": "RECRUITING", "start": "2001-05", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "The Chaim Sheba Medical Center", "countries": ["Israel"]}]}, {"batch": 2, "no": 30, "name_zh": "神经节苷脂贮积症", "query_terms": [{"term": "Gangliosidosis", "broad": false}], "n_total": 1, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT04395339", "title": "GM1 Prophylaxis for WBRT Related Cognitive Dysfunction", "status": "TERMINATED", "start": "2020-05-15", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 51, "sponsor": "Sun Yat-sen University", "conditions": ["Brain Metastases", "Radiotherapy Side Effect", "Cognitive Impairment", "Gangliosidosis, GM1", "Breast Cancer"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 12, "g_fetched": 12, "g_countries": [["United States", 8], ["Brazil", 3], ["France", 2], ["Argentina", 2], ["Australia", 2], ["Canada", 2], ["Germany", 2], ["India", 2], ["Italy", 2], ["Mexico", 2], ["Pakistan", 2], ["Portugal", 2], ["Spain", 2], ["Switzerland", 2], ["Turkey (Türkiye)", 2], ["United Kingdom", 2], ["Sweden", 1]], "g_trials": [{"nct": "NCT07479953", "title": "Prenatal Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis Clinical Trial", "status": "NOT_YET_RECRUITING", "start": "2027-01-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Tippi Mackenzie", "countries": []}, {"nct": "NCT07740512", "title": "Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of PLX-200 in Pediatric Patients (Master Protocol)", "status": "NOT_YET_RECRUITING", "start": "2026-12-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Polaryx Therapeutics, Inc.", "countries": []}, {"nct": "NCT07445490", "title": "Translational Potential of ex Vivo Gene Therapy in GM2 Gangliosidosis", "status": "NOT_YET_RECRUITING", "start": "2026-05", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT07399704", "title": "A Study to Evaluate the Safety and Efficacy of Nizubaglustat (AZ-3102) in Patients With GM2 Gangliosidosis or Niemann-Pick Type C Disease", "status": "RECRUITING", "start": "2026-02-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Azafaros B.V.", "countries": ["Brazil"]}, {"nct": "NCT07082725", "title": "A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC)", "status": "RECRUITING", "start": "2025-06-30", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Azafaros B.V.", "countries": ["Argentina", "Australia", "Brazil", "Canada", "Germany", "India", "Italy", "Mexico", "Pakistan", "Portugal", "Spain", "Switzerland", "Turkey (Türkiye)", "United Kingdom", "United States"]}, {"nct": "NCT07054515", "title": "A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis", "status": "RECRUITING", "start": "2025-06-30", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Azafaros B.V.", "countries": ["Argentina", "Australia", "Brazil", "Canada", "France", "Germany", "India", "Italy", "Mexico", "Pakistan", "Portugal", "Spain", "Sweden", "Switzerland", "Turkey (Türkiye)", "United Kingdom", "United States"]}, {"nct": "NCT03952637", "title": "A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis", "status": "RECRUITING", "start": "2019-08-19", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "National Human Genome Research Institute (NHGRI)", "countries": ["United States"]}, {"nct": "NCT03047369", "title": "The Myelin Disorders Biorepository Project", "status": "RECRUITING", "start": "2016-12-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Children's Hospital of Philadelphia", "countries": ["United States"]}, {"nct": "NCT02254863", "title": "UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells", "status": "RECRUITING", "start": "2014-09", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Joanne Kurtzberg, MD", "countries": ["United States"]}, {"nct": "NCT03333200", "title": "Longitudinal Study of Neurodegenerative Disorders", "status": "RECRUITING", "start": "2012-01-11", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Pittsburgh", "countries": ["United States"]}, {"nct": "NCT00668187", "title": "A Natural History Study of the Gangliosidoses", "status": "RECRUITING", "start": "2010-12", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Minnesota", "countries": ["United States"]}, {"nct": "NCT00029965", "title": "Natural History of Glycosphingolipid Storage Disorders and Glycoprotein Disorders", "status": "RECRUITING", "start": "2002-02-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Human Genome Research Institute (NHGRI)", "countries": ["United States"]}]}, {"batch": 2, "no": 31, "name_zh": "胃肠胰神经内分泌肿瘤", "query_terms": [{"term": "Gastroenteropancreatic neuroendocrine neoplasm", "broad": false}], "n_total": 12, "n_open": 4, "n_open_precise": 4, "n_broad": 0, "trials": [{"nct": "NCT05884255", "title": "An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors.", "status": "RECRUITING", "start": "2023-07-06", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 220, "sponsor": "Jiangsu HengRui Medicine Co., Ltd.", "conditions": ["Advanced Gastroenteropancreatic Neuroendocrine Tumor"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Tianjin University Cancer Institute and Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06840821", "title": "Evaluating the Safety, Tolerability, and Preliminary Anti-tumor Activity of MB0151 in Adult Subjects With Advanced Solid Tumors Expressing Somatostatin Receptors", "status": "RECRUITING", "start": "2025-05-08", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 156, "sponsor": "Mainline Biosciences (Shanghai) Co., Ltd", "conditions": ["Advanced Solid Tumors"], "cn_sites": [{"facility": "Cancer Hospital Affiliated to Shandong First Medical University", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06784752", "title": "Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET", "status": "RECRUITING", "start": "2025-05-30", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 240, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Somatostatin Receptor Positive (SSTR+)", "Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07165886", "title": "Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors", "status": "RECRUITING", "start": "2025-08-29", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 298, "sponsor": "CSPC ZhongQi Pharmaceutical Technology Co., Ltd.", "conditions": ["Gastroenteropancreatic Neuroendocrine Tumors"], "cn_sites": [{"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01994213", "title": "A Study of Famitinib in Patients With Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumor", "status": "TERMINATED", "start": "2011-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 53, "sponsor": "Jiangsu HengRui Medicine Co., Ltd.", "conditions": ["Gastroenteropancreatic Neuroendocrine Tumor"], "cn_sites": [{"facility": "Cancer Institute and Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03457844", "title": "A Study of Anlotinib in Patients With Gastroenteropancreatic Neuroendocrine Tumor G3", "status": "UNKNOWN", "start": "2018-01-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Gastroenteropancreatic Neuroendocrine Tumor G3"], "cn_sites": [{"facility": "Yihebali Chi", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04852679", "title": "Study to Assess the Efficacy and Safety of Lanreotide Autogel® in Chinese Participants With GEP-NETs", "status": "COMPLETED", "start": "2021-05-24", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 43, "sponsor": "Ipsen", "conditions": ["Gastroenteropancreatic Neuroendocrine Tumor"], "cn_sites": [{"facility": "Cancer Hospital Chinese Academy of Sciences", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital, Sun Yat-Sen University", "city": "Guangzhou", "status": ""}, {"facility": "Harbin Medical University Cancer Hospital", "city": "Harbin", "status": ""}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology", "city": "Wuhan", "status": ""}, {"facility": "Qilu Hospital Of Shandong University", "city": "Jinan", "status": ""}, {"facility": "Zhongshan Hospital Affiliated to Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Fudan University Shanghai Cancer Centre", "city": "Shanghai", "status": ""}, {"facility": "The First Affiliated Hospital Of Xi'an Jiaotong University", "city": "Xi’an", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "The second affiliated hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of College of Medicine, Zhejiang University", "city": "Hangzhou", "status": ""}], "cn_site_count": 14, "broad_only": false}, {"nct": "NCT04919226", "title": "Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-12-21", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 259, "sponsor": "ITM Solucin GmbH", "conditions": ["Neuroendocrine Tumors"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}, {"facility": "Affiliated Hospital of Jiangnan University", "city": "Wuxi", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05459844", "title": "A Study Comparing Treatment With Lutetium[177Lu] Oxodotreotide Injection to Octreotide LAR in Patients With GEP-NETs", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-08-31", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 196, "sponsor": "Sinotau Pharmaceutical Group", "conditions": ["Neuroendocrine Tumors"], "cn_sites": [{"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "The First Afilliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Xiamen University", "city": "Xiamen", "status": ""}, {"facility": "The First Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Jinan University", "city": "Guangzhou", "status": ""}, {"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": ""}, {"facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology", "city": "Wuhan", "status": ""}, {"facility": "Nanjing First Hospital", "city": "Nanjing", "status": ""}, {"facility": "The first hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "The First Affiliated Hospital of AFMU", "city": "Xi'an", "status": ""}, {"facility": "The First Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi'an", "status": ""}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}, {"facility": "Zhongshan Hospital, Fudan University", "city": "Shanghai", "status": ""}, {"facility": "The First Affiliated Hospital of Shanxi Medical University", "city": "Taiyuan", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Affiliated Hospital of Southwest Medical University", "city": "Luzhou", "status": ""}, {"facility": "Mianyang Central Hospital", "city": "Mianyang", "status": ""}, {"facility": "Tianjin Medical University Cancer Institute & Hospital", "city": "Tianjin", "status": ""}, {"facility": "The First Affiliated Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": ""}], "cn_site_count": 23, "broad_only": false}, {"nct": "NCT05894486", "title": "Phase II Study to Evaluate the Efficacy and Safety of 177Lu-Dotatate in the First-line Treatment of Patients With Locally Advanced or Metastatic, Somatostatin Receptor-positive G2 or G3 Gastroenteropancreatic Neuroendocrine Tumors", "status": "UNKNOWN", "start": "2023-06-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Peking University", "conditions": ["Neuroendocrine Tumors"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06091748", "title": "Gallium (68Ga) Edotreotide PET/CT for Imaging Patients With Gastrointestinal Pancreatic Neuroendocrine Tumors", "status": "COMPLETED", "start": "2024-02-22", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 69, "sponsor": "Jiangsu HengRui Medicine Co., Ltd.", "conditions": ["Advanced Gastroenteropancreatic Neuroendocrine Tumor"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06983106", "title": "Correlation Between Body Composition and Pathologic Grade/Prognosis in GEP-NENs: A Retrospective Study", "status": "COMPLETED", "start": "2024-11-04", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 633, "sponsor": "Tongji Hospital", "conditions": ["Neuroendocrine Tumors"], "cn_sites": [{"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 27, "g_fetched": 23, "g_countries": [["United States", 14], ["France", 6], ["Canada", 4], ["South Korea", 2], ["Belgium", 2], ["Netherlands", 2], ["Brazil", 1], ["Spain", 1], ["Taiwan", 1], ["Italy", 1], ["India", 1]], "g_trials": [{"nct": "NCT07661420", "title": "211At-MABG in Adults With Advanced Neuroendocrine Cancers", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "University of Pennsylvania", "countries": ["United States"]}, {"nct": "NCT07488923", "title": "A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)", "status": "RECRUITING", "start": "2026-06-23", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Moonlight Bio, Inc", "countries": ["United States"]}, {"nct": "NCT07635316", "title": "A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients", "status": "RECRUITING", "start": "2026-06-12", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": ["United States"]}, {"nct": "NCT07278479", "title": "Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors", "status": "RECRUITING", "start": "2026-05-18", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Molecular Partners AG", "countries": ["United States"]}, {"nct": "NCT06937905", "title": "Tarlatamab vs Standard of Care Chemotherapy in Patients With Pre-treated Advanced, Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinomas (NECs)", "status": "RECRUITING", "start": "2026-02-06", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Intergroupe Francophone de Cancerologie Thoracique", "countries": ["France"]}, {"nct": "NCT07165132", "title": "Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.", "status": "RECRUITING", "start": "2025-12-03", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "RayzeBio, Inc.", "countries": ["Canada", "United States"]}, {"nct": "NCT07006727", "title": "Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors", "status": "RECRUITING", "start": "2025-10-16", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": ["Canada", "South Korea", "United States"]}, {"nct": "NCT07150546", "title": "Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors.", "status": "RECRUITING", "start": "2025-10-14", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Emory University", "countries": ["United States"]}, {"nct": "NCT07080242", "title": "Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors", "status": "RECRUITING", "start": "2025-04-28", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "SystImmune Inc.", "countries": ["United States"]}, {"nct": "NCT07302100", "title": "Nutritional Status Assessment in Adult Patients Followed for Gastroenteropancreatic Neuroendocrine Tumors at Strasbourg University Hospital", "status": "RECRUITING", "start": "2024-12-12", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Strasbourg, France", "countries": ["France"]}, {"nct": "NCT06016855", "title": "Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors", "status": "RECRUITING", "start": "2024-05-31", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Vanderbilt-Ingram Cancer Center", "countries": ["United States"]}, {"nct": "NCT04090034", "title": "Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors", "status": "RECRUITING", "start": "2024-03-28", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Methodist Health System", "countries": ["United States"]}, {"nct": "NCT06256705", "title": "Multi-modal Characterisation of Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort", "status": "RECRUITING", "start": "2024-03-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT05773274", "title": "Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial", "status": "RECRUITING", "start": "2024-01-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["Canada", "United States"]}, {"nct": "NCT05636618", "title": "Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors", "status": "RECRUITING", "start": "2023-09-27", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Perspective Therapeutics", "countries": ["United States"]}, {"nct": "NCT05652686", "title": "A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)", "status": "RECRUITING", "start": "2023-09-05", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Phanes Therapeutics", "countries": ["United States"]}, {"nct": "NCT05701241", "title": "Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients", "status": "RECRUITING", "start": "2023-06-28", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Antwerp", "countries": ["Belgium", "Netherlands"]}, {"nct": "NCT05477576", "title": "Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy", "status": "RECRUITING", "start": "2022-03-24", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "RayzeBio, Inc.", "countries": ["Belgium", "Brazil", "Canada", "France", "Netherlands", "South Korea", "Spain", "United States"]}, {"nct": "NCT04837885", "title": "Intra-arterial Hepatic (IAH) Infusion of Radiolabelled Somatostatin Analogs in GEP-NET Patients With Dominant Liver Metastases", "status": "RECRUITING", "start": "2021-09-24", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Bordeaux", "countries": ["France"]}, {"nct": "NCT05048901", "title": "Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors", "status": "RECRUITING", "start": "2021-09-17", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "National Health Research Institutes, Taiwan", "countries": ["Taiwan"]}, {"nct": "NCT04325425", "title": "Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary", "status": "RECRUITING", "start": "2020-09-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Centre Hospitalier Universitaire Dijon", "countries": ["France"]}, {"nct": "NCT06155318", "title": "68Ga-DOTATOC PET for the Evaluation of Gastroenteropancreatic Neuroendocrine Tumours", "status": "RECRUITING", "start": "2019-09-05", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS San Raffaele", "countries": ["Italy"]}, {"nct": "NCT07185672", "title": "PRRT Versus PRRT Plus Chemotherapy in GEP NET (PReCedeNT Trial)", "status": "RECRUITING", "start": "2019-08-07", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Tata Memorial Hospital", "countries": ["India"]}]}, {"batch": 2, "no": 32, "name_zh": "胃肠间质瘤", "query_terms": [{"term": "Gastrointestinal stromal tumor", "broad": false}], "n_total": 75, "n_open": 26, "n_open_precise": 26, "n_broad": 0, "trials": [{"nct": "NCT03594422", "title": "A Study of HQP1351 in Patients With GIST or Other Solid Tumors", "status": "RECRUITING", "start": "2018-07-11", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Ascentage Pharma Group Inc.", "conditions": ["Gastrointestinal Stromal Tumor (GIST)", "Solid Tumor, Adult"], "cn_sites": [{"facility": "Sun-Yat Sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Guangdong general hospital", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Henan cancer hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Union Hospital Tongji Medical College of Huazhong University of Science ang Technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Chinese PLA general hospital, Beijing, China", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT03716089", "title": "Comparison of Tumor Efficacy Safety in Laparoscopic Resection of Gastrointestinal Stromal Tumors Between Favorable and Unfavorable Site", "status": "RECRUITING", "start": "2018-10-11", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 250, "sponsor": "Fujian Medical University", "conditions": ["GIST of Stomach", "Gastric Cancer", "Surgery", "Complication"], "cn_sites": [{"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04924075", "title": "Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)", "status": "RECRUITING", "start": "2021-08-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 355, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Pheochromocytoma/Paraganglioma", "Pancreatic Neuroendocrine Tumor", "Von Hippel-Lindau Disease", "Advanced Gastrointestinal Stromal Tumor", "HIF-2α Mutated Cancers"], "cn_sites": [{"facility": "Peking University First Hospital-Urology ( Site 1900)", "city": "Beijing", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Sun Yat-sen University Cancer Center ( Site 1905)", "city": "Guangzhou", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Renji Hospital Shanghai Jiao Tong University School of Medicine ( Site 1904)", "city": "Shanghai", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "West China Hospital of Sichuan University ( Site 1906)", "city": "Chengdu", "status": "COMPLETED"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT04933669", "title": "Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors", "status": "RECRUITING", "start": "2021-09-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 122, "sponsor": "First Affiliated Hospital of Zhejiang University", "conditions": ["Progression-free Survival", "Gastrointestinal Stromal Tumor", "Neoadjuvant"], "cn_sites": [{"facility": "The First Affiliated Hospital, College of Medicine, Zhejiang University", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05408897", "title": "Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD", "status": "RECRUITING", "start": "2022-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 45, "sponsor": "Peking University People's Hospital", "conditions": ["Gastrointestinal Stromal Tumors", "Minimal Residual Disease"], "cn_sites": [{"facility": "Peking University People'S Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05464875", "title": "A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors", "status": "RECRUITING", "start": "2022-07-09", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 74, "sponsor": "Xinhua Zhang, MD", "conditions": ["Gastrointestinal Stromal Tumors", "Unresectable Solid Tumor", "Recurrent Metastatic Malignant Neoplasm"], "cn_sites": [{"facility": "The First Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05461664", "title": "Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA", "status": "RECRUITING", "start": "2022-07-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 74, "sponsor": "Xinhua Zhang, MD", "conditions": ["Gastrointestinal Stromal Tumors", "Unresectable Solid Tumor", "Recurrent Metastatic Malignant Neoplasm"], "cn_sites": [{"facility": "The First Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05751733", "title": "Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST", "status": "RECRUITING", "start": "2023-02-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 258, "sponsor": "Xiangya Hospital of Central South University", "conditions": ["Gastrointestinal Stromal Tumors"], "cn_sites": [{"facility": "Xiangya Hospital, Central South University", "city": "Changsha", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05938309", "title": "A Cohort Study on the Safety of Laparoscopic Resection of 5cm or Larger Gastric Gastrointestinal Stromal Tumors", "status": "RECRUITING", "start": "2023-05-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 194, "sponsor": "Fujian Medical University", "conditions": ["Gastrointestinal Stromal Tumors"], "cn_sites": [{"facility": "Department of Gastric Surgery， Fujian Medical University Union Hospital", "city": "Fuzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05970900", "title": "Preoperative Imatinib Mesylate Combined With Rectal-sparing Surgery in Patients With c-KIT Gene-mutant Rectal GIST", "status": "NOT_YET_RECRUITING", "start": "2023-10-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 23, "sponsor": "Fujian Medical University Union Hospital", "conditions": ["Gastrointestinal Stromal Tumor of Rectum"], "cn_sites": [{"facility": "Weizhong Jiang", "city": "Fuzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06748690", "title": "MCB vs EUS-FNA for Preoperative Pathological Evaluation of Gastric SMT", "status": "RECRUITING", "start": "2024-01-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 96, "sponsor": "Peking University People's Hospital", "conditions": ["Gastrointestinal Stromal Tumor of Stomach", "Submucosal Tumor of Stomach"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06507683", "title": "Evaluate the Efficacy and Safety of Radiotherapy Combined With Ripretinib in the Treatment of Unresectable Advanced GIST", "status": "RECRUITING", "start": "2024-05-28", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 32, "sponsor": "First Affiliated Hospital of Chongqing Medical University", "conditions": ["Gastrointestinal Stromal Tumors"], "cn_sites": [{"facility": "The First Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06640361", "title": "A Study of Olverembatinib in SDH-deficient GIST.", "status": "RECRUITING", "start": "2024-11-11", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Ascentage Pharma Group Inc.", "conditions": ["GIST"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07411118", "title": "RCT of EFTR Versus STER for GIST Treatment", "status": "RECRUITING", "start": "2025-02-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 136, "sponsor": "Chinese University of Hong Kong", "conditions": ["Small Size Gastrointestinal Stromal Tumors", "GIST"], "cn_sites": [{"facility": "Department of Gastroenterology, Zhongshan Hospital of Fudan University", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06760819", "title": "A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)", "status": "RECRUITING", "start": "2025-02-13", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 111, "sponsor": "Bayer", "conditions": ["Advanced Solid Tumors", "HER2 Mutation"], "cn_sites": [{"facility": "Peking University First Hospital - Oncology Department", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Cancer Hospital - Oncology Department", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Hunan Cancer Hospital - Oncology Department", "city": "Changsha", "status": "NOT_YET_RECRUITING"}, {"facility": "Fudan University Shanghai Cancer Center - Oncology Department", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Zhongshan Hospital, Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Sir Run Run Shaw Hospital, Zhejiang Univ. School of Medicine - Oncology Department", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT06926374", "title": "Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery", "status": "RECRUITING", "start": "2025-03-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "Chinese University of Hong Kong", "conditions": ["Colorectal Carcinoma", "Rectal Prolapse", "Prostate Cancer (Adenocarcinoma)", "Bladder Cancer", "Kidney Cancer", "Hiatal Hernia With Gastroesophageal Reflux Disease", "GIST - Gastrointestinal Stromal Tumor", "Esophageal Cancer", "Gallstones", "Gastric Cancer"], "cn_sites": [{"facility": "Prince of Wales Hospital, The Chinese University of Hong Kong", "city": "Hong Kong", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07559864", "title": "Comparing Regorafenib Combined With Envafolimab to Physician's Choice in Patients With Metastatic Gastrointestinal Stromal Tumors Harboring KIT Exon 17 Mutations Refractory to Standard Treatment", "status": "RECRUITING", "start": "2025-07-14", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Jian Li", "conditions": ["GIST - Gastrointestinal Stromal Tumor", "KIT Gene Mutation"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07078136", "title": "Multicenter Observational Study of Multimodal AI for Upper GI Mesenchymal Tumor Diagnosis", "status": "RECRUITING", "start": "2025-07-28", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 130, "sponsor": "Huazhong University of Science and Technology", "conditions": ["Submucosal Tumor", "Gastrointestinal Stromal Tumor (GIST)", "Leiomyoma", "Schwannoma"], "cn_sites": [{"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06772233", "title": "A Study of Regorafenib Combined With Envafolimab for Metastatic Gastrointestinal Stromal Tumors With Kit Gene Exon 17 Mutation That Failed Standard Treatment", "status": "NOT_YET_RECRUITING", "start": "2025-07-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Peking University", "conditions": ["Metastatic Gastrointestinal Stromal Tumors (GIST)"], "cn_sites": [{"facility": "Beijing Cancer Hospital, 52 Fucheng Road", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07106411", "title": "CEH-EUS for Differentiating GISTs and Leiomyomas: A Multicenter Prospective Self-Controlled Study", "status": "NOT_YET_RECRUITING", "start": "2025-08", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 288, "sponsor": "Huazhong University of Science and Technology", "conditions": ["Submucosal Tumor", "Gastrointestinal Stromal Tumor (GIST)", "Leiomyoma"], "cn_sites": [{"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07218926", "title": "A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy", "status": "RECRUITING", "start": "2025-12-03", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 450, "sponsor": "GlaxoSmithKline", "conditions": ["Gastrointestinal Neoplasms"], "cn_sites": [{"facility": "GSK Investigational Site", "city": "Shijiazhuang", "status": "RECRUITING"}, {"facility": "GSK Investigational Site", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "GSK Investigational Site", "city": "Beijing", "status": "RECRUITING"}, {"facility": "GSK Investigational Site", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "GSK Investigational Site", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "GSK Investigational Site", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "GSK Investigational Site", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "GSK Investigational Site", "city": "Jinan", "status": "RECRUITING"}, {"facility": "GSK Investigational Site", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT07405125", "title": "Safety of Robotic Surgery for GISTs at Special Anatomic Sites", "status": "RECRUITING", "start": "2026-02-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 182, "sponsor": "The First Affiliated Hospital with Nanjing Medical University", "conditions": ["Gastrointenstinal Stromal Tumor (GIST)"], "cn_sites": [{"facility": "The First Affiliated Hospital with Nanjing Medical University (Jiangsu Province Hospital)", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07550582", "title": "Mesenteric Vascular Preconditioning Combined With Laparoscopic and Endoscopic Cooperative Surgery for Submucosal Tumor at the Gastroesophageal Junction", "status": "ENROLLING_BY_INVITATION", "start": "2026-04-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Peking University People's Hospital", "conditions": ["Submucosal Tumor of Gastrointestinal Tract", "Gastrointestinal Stromal Tumor (GIST)"], "cn_sites": [{"facility": "Peking University People' Hosptial", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07581977", "title": "A Novel Two-Tooth Clip for ESD and EFTR of GIST", "status": "RECRUITING", "start": "2026-04-24", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Affiliated Hospital to Academy of Military Medical Sciences", "conditions": ["GIST - Gastrointestinal Stromal Tumor"], "cn_sites": [{"facility": "The Fifth Medical Center of Chinese PLA General Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07379047", "title": "Efficacy and Safety of NB003 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)", "status": "RECRUITING", "start": "2026-05-11", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 255, "sponsor": "Ningbo Newbay Technology Development Co., Ltd", "conditions": ["GIST - Gastrointestinal Stromal Tumor", "Advanced"], "cn_sites": [{"facility": "The First Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Hospital of Anhui Medical University", "city": "Hefei", "status": "RECRUITING"}, {"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Guangxi Medical University Affiliated Cancer Hospital", "city": "Nanning", "status": "NOT_YET_RECRUITING"}, {"facility": "The Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": "NOT_YET_RECRUITING"}, {"facility": "The Fourth Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": "NOT_YET_RECRUITING"}, {"facility": "Cancer Hospital Affiliated to Harbin Medical University", "city": "Harbin", "status": "NOT_YET_RECRUITING"}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Hubei Cancer Hospital", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}, {"facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Xiangya Hospital, Central South University", "city": "Changsha", "status": "NOT_YET_RECRUITING"}, {"facility": "Jiangsu Cancer Hospital", "city": "Nanjing", "status": "NOT_YET_RECRUITING"}, {"facility": "Jiangsu Province Hospital", "city": "Nanjing", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": "NOT_YET_RECRUITING"}, {"facility": "Jilin Cancer Hospital", "city": "Changchun", "status": "NOT_YET_RECRUITING"}, {"facility": "Shandong Cancer Hospital", "city": "Jinan", "status": "NOT_YET_RECRUITING"}, {"facility": "Shandong Provincial Hospital", "city": "Jinan", "status": "NOT_YET_RECRUITING"}, {"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": "RECRUITING"}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}, {"facility": "Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}, {"facility": "Shanxi Cancer Hospital", "city": "Taiyuan", "status": "NOT_YET_RECRUITING"}, {"facility": "Sichuan Cancer Hospital", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}, {"facility": "Sir Run Run Shaw Hospital , affiliated with the Zhejiang University School of Medicine", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 30, "broad_only": false}, {"nct": "NCT07585266", "title": "A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)", "status": "RECRUITING", "start": "2026-07-27", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 800, "sponsor": "GlaxoSmithKline", "conditions": ["Gastrointestinal Stromal Neoplasms"], "cn_sites": [{"facility": "GSK Investigational Site", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01613053", "title": "Continuation of Drug Supply in Chinese Patients After CAMN107DBR01study Termination", "status": "NO_LONGER_AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "enrollment": null, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Gastrointestinal Stromal Tumor"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Chengdu", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT06038552", "title": "Comparison of Clinical Efficacy of Liver Resection, RFA, TACE, and Drug Therapy in Patients with GIST LM", "status": "COMPLETED", "start": "2002-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 238, "sponsor": "First Affiliated Hospital, Sun Yat-Sen University", "conditions": ["GIST, Malignant", "Liver Metastases"], "cn_sites": [{"facility": "The First Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00793871", "title": "Safety And Efficacy Study Of Sunitinib Malate In Chinese Patients With Imatinib Resistant Or Intolerant Malignant Gastrointestinal Stromal Tumor", "status": "COMPLETED", "start": "2008-11", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Pfizer", "conditions": ["Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors"], "cn_sites": [{"facility": "Nanjing Bayi Hospital", "city": "Nanjing", "status": ""}, {"facility": "Cancer Institute & Hospital Chinese Academy of Medical Sciences and PUMC", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "307 Hospital of PLA", "city": "Beijing", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT00785785", "title": "A Study of Nilotinib Versus Imatinib in GIST Patients", "status": "COMPLETED", "start": "2009-03", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 644, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Gastrointestinal Stromal Tumor (GIST)"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Nanjing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT00751036", "title": "Nilotinib 800 Mg And Imatinib 800 Mg For The Treatment Of Patients With Gastrointestinal Stromal Tumors (Gist) Refractory To Imatinib 400 Mg", "status": "TERMINATED", "start": "2009-06", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 94, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Gastrointestinal Stromal Tumors"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Chengdu", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT01267695", "title": "Perioperative Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor", "status": "COMPLETED", "start": "2010-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Peking University", "conditions": ["Gastrointestinal Stromal Tumor"], "cn_sites": [{"facility": "Peking University School of Oncology", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01271712", "title": "Study of Regorafenib as a 3rd-line or Beyond Treatment for Gastrointestinal Stromal Tumors (GIST)", "status": "COMPLETED", "start": "2011-01-04", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 199, "sponsor": "Bayer", "conditions": ["Gastrointestinal Stromal Tumors"], "cn_sites": [{"facility": "", "city": "Guangzhou", "status": ""}, {"facility": "", "city": "Nanjing", "status": ""}, {"facility": "", "city": "Beijing", "status": ""}, {"facility": "", "city": "Shanghai", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT01768104", "title": "ESTD vs. VATS for Upper Gastrointestinal Submucosal Tumors", "status": "UNKNOWN", "start": "2011-12", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 200, "sponsor": "Nanfang Hospital, Southern Medical University", "conditions": ["Upper Gastrointestinal Submucosal Tumors (SMTs)", "Gastrointestinal Stromal Tumors (GISTs)", "Leiomyoma"], "cn_sites": [{"facility": "Nanfang Hospital of Southern Medical University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02336724", "title": "A Study of Famitinib in Patients With Gastrointestinal Stromal Tumor", "status": "UNKNOWN", "start": "2012-03", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 88, "sponsor": "Jiangsu HengRui Medicine Co., Ltd.", "conditions": ["Gastrointestinal Stromal Tumor"], "cn_sites": [{"facility": "Nanjing Bayi Hospital", "city": "Nanjing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01742299", "title": "Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator", "status": "COMPLETED", "start": "2013-03-26", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 155, "sponsor": "Novartis Pharmaceuticals", "conditions": ["GIST and CML"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Nanjing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT02353052", "title": "Prospective Cohort Study of the Clinical Applications for the Pathologic Type, Staging, and Grading of GIST", "status": "UNKNOWN", "start": "2013-07", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 900, "sponsor": "Shanghai Zhongshan Hospital", "conditions": ["Gastrointestinal Stromal Tumor"], "cn_sites": [{"facility": "180 Fenglin Road", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03238820", "title": "Robotic Resection for Patients With Gastric Gastrointestinal Stromal Tumors: a Single-center Study", "status": "COMPLETED", "start": "2014-01-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "JIANG Zhi-Wei", "conditions": ["Gastrointestinal Stromal Tumor of Stomach"], "cn_sites": [{"facility": "Jinling Hospital, Medical School of Nanjing University", "city": "Nanjing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03092128", "title": "A Retrospective Pharmacokinetics and Pharmacogenomics Research of Imatinib in Gastrointestinal Stromal Tumor Treatment", "status": "UNKNOWN", "start": "2014-06", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Xueding Wang", "conditions": ["Gastrointestinal Stromal Tumors", "Germline Mutation", "Somatic Mutation", "Plasma Concentration"], "cn_sites": [{"facility": "Institute of Clinical Pharmacology, Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04198337", "title": "Endoscopic Full Thickness Resection for Gastric GIST", "status": "UNKNOWN", "start": "2014-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Chinese University of Hong Kong", "conditions": ["Gastric GIST"], "cn_sites": [{"facility": "Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong", "city": "Hong Kong", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05565066", "title": "A Real-world Comparison of FNB and FNA in IHC-required Lesions.", "status": "COMPLETED", "start": "2014-12-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 439, "sponsor": "Huazhong University of Science and Technology", "conditions": ["Neuroendocrine Tumors", "Autoimmune Pancreatitis", "Gastrointestinal Stromal Tumors"], "cn_sites": [{"facility": "Tongji Hospital, Tongji Medical College, HUST", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02426762", "title": "Quick Skin Sealant in Closure of Surgical Wound After Laparoscopic Surgery", "status": "UNKNOWN", "start": "2015-02", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "First Affiliated Hospital, Sun Yat-Sen University", "conditions": ["Complications of Surgical Procedures", "Surgical Site Infection", "Gastric Cancer", "Colorectal Cancer", "Gastrointestinal Stromal Tumor", "Inflammatory Bowel Disease", "Diverticula"], "cn_sites": [{"facility": "The First Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02776878", "title": "A Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in Refractory Metastatic GIST", "status": "UNKNOWN", "start": "2016-05", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 57, "sponsor": "Peking University Cancer Hospital & Institute", "conditions": ["Gastrointestinal Stromal Tumor"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital,Sun Yat-sen University", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "No.81 Hospital of Chinese People's Liberation Army", "city": "Nanjing", "status": "NOT_YET_RECRUITING"}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}, {"facility": "Shanxi Cancer Hospital", "city": "Taiyuan", "status": "NOT_YET_RECRUITING"}, {"facility": "West China Hospital , Sichuan University", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT02763748", "title": "the Laparoscopic and Endoscopic Cooperative Surgery of Gastrointestinal Stromal Tumor", "status": "UNKNOWN", "start": "2016-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "First Affiliated Hospital Xi'an Jiaotong University", "conditions": ["Gastrointestinal Stromal Tumor"], "cn_sites": [{"facility": "First Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02931981", "title": "Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal Tumor", "status": "UNKNOWN", "start": "2016-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 50, "sponsor": "RenJi Hospital", "conditions": ["Gastrointestinal Stromal Tumor"], "cn_sites": [{"facility": "Ethics Committee of Renji Hospital, School of Medicine,Shanghai Jiaotong University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06628739", "title": "Correlation Between Imatinib Trough Concentration and Efficacy in Advanced GIST Patients with Different Genotypes", "status": "COMPLETED", "start": "2017-07-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 168, "sponsor": "First Affiliated Hospital, Sun Yat-Sen University", "conditions": ["Gastrointestinal Stromal Tumor, Malignant"], "cn_sites": [{"facility": "The First Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03471273", "title": "Comparison of Endoscopic and Laparoscopic Resection for Small Gastric Gastrointestinal Stromal Tumor", "status": "UNKNOWN", "start": "2017-09-18", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 900, "sponsor": "Nanfang Hospital, Southern Medical University", "conditions": ["Therapeutic Value of Endoscopic and Laparoscopic Resection for Small Gastric Gastrointestinal Stromal Tumor"], "cn_sites": [{"facility": "Nanfang Hospistal", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03465722", "title": "(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST", "status": "COMPLETED", "start": "2018-03-26", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 476, "sponsor": "Blueprint Medicines Corporation", "conditions": ["GIST"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "West China Hospital Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "The First Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "The Sixth Affiliated Hospital of Sun Yat-Sen University", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital, Zhejiang University", "city": "Hangzhou", "status": ""}, {"facility": "Harbin Medical University Cancer Hospital", "city": "Harbin", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang Medical University", "city": "Nanchang", "status": ""}, {"facility": "Guangxi Medical University Affiliated Tumor Hospital & Oncology Medical College", "city": "Nanning", "status": ""}, {"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}, {"facility": "Fudan University Zhongshan Hospital", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Jiaotong University School of Medicine, Renji Hospital", "city": "Shanghai", "status": ""}, {"facility": "Liaoning Cancer Hospital & Institute", "city": "Shenyang", "status": ""}, {"facility": "Tianjin Cancer Hospital", "city": "Tianjin", "status": ""}, {"facility": "Affiliated Cancer Hospital of Xinjiang Medical University", "city": "Ürümqi", "status": ""}, {"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 19, "broad_only": false}, {"nct": "NCT03601234", "title": "Laparoscopic Endoscopic Cooperative Surgery in the Treatment of Gastric Stromal Tumors", "status": "UNKNOWN", "start": "2018-04-16", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 80, "sponsor": "First Affiliated Hospital Xi'an Jiaotong University", "conditions": ["Gastrointestinal Stromal Tumors"], "cn_sites": [{"facility": "First Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04106024", "title": "Efficacy and Safety of Anlotinib in Patients With Advanced Gastrointestinal Stromal Tumor After Failure of Imatinib: a Prospective, Single Arm and Multicenter Trial", "status": "UNKNOWN", "start": "2018-10-23", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Cttq", "conditions": ["Gastrointestinal Stromal Tumors"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05800106", "title": "A Bioequivalence Study of Sunitinib Malate Capsules.", "status": "COMPLETED", "start": "2018-12-04", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Gastrointestinal Stromal Tumors", "Renal Cell Carcinoma", "Pancreatic Neuroendocrine Tumor"], "cn_sites": [{"facility": "Affiliated Hospital of Changchun University of Traditional Chinese Medicine", "city": "Changchun", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04000529", "title": "Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies", "status": "TERMINATED", "start": "2019-07-30", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 122, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Non-small Cell Lung Carcinoma", "Head and Neck Squamous Cell Carcinoma", "Esophageal SCC", "Gastrointestinal Stromal Tumors", "Colorectal Cancer"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Chengdu", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04254939", "title": "A Study of CS3007 in Subjects With Gastrointestinal Stromal Tumor", "status": "COMPLETED", "start": "2019-08-15", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 65, "sponsor": "CStone Pharmaceuticals", "conditions": ["Gastrointestinal Stromal Tumors"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Sun Yat-Sen University", "city": "Guangzhou", "status": ""}, {"facility": "The Sixth Affiliated Hospital of Sun Yat-Sen University", "city": "Guangzhou", "status": ""}, {"facility": "Harbin Medical University Cancer Hospital", "city": "Harbin", "status": ""}, {"facility": "Wuhan Union Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang Medical University", "city": "Nanchang", "status": ""}, {"facility": "Liaoning Cancer Hospital & Institute", "city": "Shenyang", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}, {"facility": "Fudan University Zhongshan Hospital (General Surgery Department)", "city": "Shanghai", "status": ""}, {"facility": "Fudan University Zhongshan Hospital (Internal Tumor Department)", "city": "Shanghai", "status": ""}, {"facility": "Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Xinjiang Medical University Cancer Hospital", "city": "Ürümqi", "status": ""}, {"facility": "The First Affiliated Hospital Zhe Jiang University", "city": "Hangzhou", "status": ""}], "cn_site_count": 16, "broad_only": false}, {"nct": "NCT04143048", "title": "A Study on Non-invasive Early Diagnosis of Gastrointestinal Stromal Tumors and Differentiation of Benign and Malignant Nodules", "status": "UNKNOWN", "start": "2019-09-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 300, "sponsor": "The First Affiliated Hospital with Nanjing Medical University", "conditions": ["Gastrointestinal Stromal Tumor"], "cn_sites": [{"facility": "First Affiliated Hospital of Nanjing Medical University", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04282980", "title": "A Study of DCC-2618 (Ripretinib) In Patients With With Advanced Gastrointestinal Stromal Tumors (GIST)", "status": "COMPLETED", "start": "2020-04-23", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 39, "sponsor": "Zai Lab (Shanghai) Co., Ltd.", "conditions": ["Gastrointestinal Stromal Tumors"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Chinese People's Liberation Army General Hospital", "city": "Beijing", "status": ""}, {"facility": "Union Medical College Hospital, Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "Union Medical College Hospital, Fujian Medical University", "city": "Fuzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "The Sixth Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "Fudan University Cancer Hospital", "city": "Shanghai", "status": ""}, {"facility": "Renji Hospital, Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT04409223", "title": "Efficacy and Safety of Famitinib Versus Sunitinib in the Treatment of Advanced Gastrointestinal Stromal Tumour Patients After Failure of Imatinib", "status": "TERMINATED", "start": "2020-09-12", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 185, "sponsor": "Jiangsu HengRui Medicine Co., Ltd.", "conditions": ["Gastrointestinal Stromal Tumors"], "cn_sites": [{"facility": "307 Hospital of PLA", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04584008", "title": "Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics", "status": "ACTIVE_NOT_RECRUITING", "start": "2020-09-23", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 600, "sponsor": "Peking University", "conditions": ["Biliary Tract Neoplasms", "Gastric Cancer", "Esophageal Squamous Cell Carcinoma", "Colorectal Cancer", "Gastrointestinal Stromal Tumors", "Pancreatic Cancer", "Neuroendocrine Tumors", "Unknown Primary Cancer", "Digestive Cancer"], "cn_sites": [{"facility": "Peking University Cancer Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05197933", "title": "Safety of Laparoscopic Resection for Gastrointestinal Stromal Tumor on Unfavorable Anatomic Site of Stomach", "status": "UNKNOWN", "start": "2020-10-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 182, "sponsor": "RenJi Hospital", "conditions": ["Gastrointestinal Stromal Tumors"], "cn_sites": [{"facility": "Renji hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04006769", "title": "Entacapone Combination With Imatinib for Treatment of GIST", "status": "COMPLETED", "start": "2020-10-30", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 5, "sponsor": "Xiangya Hospital of Central South University", "conditions": ["Gastrointestinal Stromal Tumor, Malignant"], "cn_sites": [{"facility": "Bin Li, MD", "city": "Changsha", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05400018", "title": "Clinical Evaluation of Genetron D842V PCR Kit in GIST Patients", "status": "COMPLETED", "start": "2020-11-20", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1041, "sponsor": "Genetron Health", "conditions": ["GIST", "Gastrointestinal Stromal Tumors"], "cn_sites": [{"facility": "Peking University Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Harbin Medical University Cancer Hospital", "city": "Harbin", "status": ""}, {"facility": "Shanghai Tenth People's Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT04633122", "title": "A Study to Assess DCC-2618 and Sunitinib in Patients With Advanced GIST After Treatment With Imatinib", "status": "COMPLETED", "start": "2020-11-25", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 108, "sponsor": "Zai Lab (Shanghai) Co., Ltd.", "conditions": ["Gastrointestinal Stromal Tumor(GIST)"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "The General Hospital of Peking University", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital of Chongqing Medical Universty", "city": "Chongqing", "status": ""}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": ""}, {"facility": "The Cancer Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "The sixth Affiliated hospital of Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "The 4th Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "The Affiliated Hospital of Haerbin MedicalUniversity", "city": "Harbin", "status": ""}, {"facility": "Union Hospital of HUST", "city": "Wuhan", "status": ""}, {"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": ""}, {"facility": "Fudan University Cancer Hospital", "city": "Shanghai", "status": ""}, {"facility": "Fudan University, Zhongshan Hospital", "city": "Shanghai", "status": ""}, {"facility": "Renji Hospital, Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "The Affiliated Hospital of Xinjiang Medical University", "city": "Ürümqi", "status": ""}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": ""}], "cn_site_count": 18, "broad_only": false}, {"nct": "NCT05001204", "title": "68Ga-NOTA-RM26 PET/CT for the Detection of Gastrointestinal Stromal Tumor", "status": "UNKNOWN", "start": "2021-05-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Gastrointestinal Stromal Tumors"], "cn_sites": [{"facility": "Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05697107", "title": "Ripretinib in Chinese Patients With Advanced GIST: a Real World Study", "status": "UNKNOWN", "start": "2021-05-20", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 308, "sponsor": "Peking University", "conditions": ["Gastrointestinal Stromal Tumors"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05132738", "title": "Ripretinib Used for Resectable Metastatic GIST After Failure of Imatinib Therapy", "status": "UNKNOWN", "start": "2021-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "RenJi Hospital", "conditions": ["Gastrointestinal Stromal Tumors"], "cn_sites": [{"facility": "Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05895942", "title": "Exploring the Molecular Mechanism Based on KIT Mutation", "status": "UNKNOWN", "start": "2021-09-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 190, "sponsor": "Xijing Hospital", "conditions": ["GIST"], "cn_sites": [{"facility": "Xijing Hospital of Air Force Military Medical University", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05354388", "title": "Ripretinib Combined With Surgery in Advanced GIST That Have Failed Imatinib Therapy: A Multicenter,Observational Study", "status": "UNKNOWN", "start": "2021-10-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 30, "sponsor": "Sichuan Provincial People's Hospital", "conditions": ["Gastrointestinal Stromal Tumor(GIST)"], "cn_sites": [{"facility": "Sichuan Provincial People's Hospital", "city": "Chengdu", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05245968", "title": "A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101)", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-12-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 78, "sponsor": "Taiho Pharmaceutical Co., Ltd.", "conditions": ["Gastrointestinal Stromal Tumors"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Fudan University, Shanghai Cancer Center", "city": "Shanghai", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05187416", "title": "Correlation Between Elastic Modulus of Ultrasonic Shear Wave and Tumor Stromal Component in Pancreatic Cancer", "status": "UNKNOWN", "start": "2022-02-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 50, "sponsor": "Xijing Hospital", "conditions": ["Pancreatic Neoplasms"], "cn_sites": [{"facility": "Xijing Hospital", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05665868", "title": "Study on Integrated Nursing Strategy for Patients With Gastrointestinal Stromal Tumors After Targeted Therapy", "status": "UNKNOWN", "start": "2022-04-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 62, "sponsor": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School", "conditions": ["Nursing Caries", "Gastrointestinal Stromal Tumors"], "cn_sites": [{"facility": "Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05440357", "title": "Second-line Pharmacotherapy Patterns and Outcomes of Advanced Gastrointestinal Stromal Tumor: A Real-world Study", "status": "UNKNOWN", "start": "2022-07-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Xinhua Zhang, MD", "conditions": ["Gastrointestinal Stromal Tumors"], "cn_sites": [{"facility": "Chongqing University Cancer Hospital", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "Nanfang Hospital of Southern Medical University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Sixth Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "The first affiliated hospital,Sun yat-sen university", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Peking University Shenzhen Hospital", "city": "Shenzhen", "status": "RECRUITING"}, {"facility": "Hainan Cancer Hospital", "city": "Haikou", "status": "RECRUITING"}, {"facility": "Second Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": "RECRUITING"}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT05489237", "title": "First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-08-03", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 276, "sponsor": "IDRX, Inc., a wholly owned subsidiary of GSK, LLC", "conditions": ["Gastrointestinal Neoplasms", "Gastrointestinal Stromal Tumor (GIST)", "Digestive System Disease", "Gastrointestinal Diseases", "Metastatic Cancer"], "cn_sites": [{"facility": "GSK Investigational Site", "city": "Beijing", "status": ""}, {"facility": "GSK Investigational Site", "city": "Guangzhou", "status": ""}, {"facility": "GSK Investigational Site", "city": "Wuhan", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT05381753", "title": "Safety and Efficacy of Avapritinib in Chinese Patients With Gastrointestinal Stromal Tumor (GIST) in the Real World", "status": "COMPLETED", "start": "2022-08-29", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 61, "sponsor": "CStone Pharmaceuticals", "conditions": ["Gastrointestinal Stromal Tumors"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05867901", "title": "A Prospective Study on Predicting Recurrence Risk of Postoperative High-risk GISTs in NED State Based on MRD Detection Via Liquid Biopsy", "status": "SUSPENDED", "start": "2023-06-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 66, "sponsor": "Peking University People's Hospital", "conditions": ["Gastrointestinal Stromal Tumors"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06431451", "title": "The Correlation Between Ripretinib Exposure and the Efficacy and Safety in Patients with Advanced GISTs", "status": "UNKNOWN", "start": "2024-06-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 60, "sponsor": "First Affiliated Hospital, Sun Yat-Sen University", "conditions": ["Gastrointestinal Stromal Tumors"], "cn_sites": [{"facility": "The First Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07454967", "title": "Development of a Multimodal AI System for GIST Management", "status": "COMPLETED", "start": "2026-03-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 300, "sponsor": "Qun Zhao", "conditions": ["Gastrointestinal Stromal Tumors", "Gastric Subepithelial Tumors", "Gastric Leiomyoma", "Artificial Intelligence (AI)", "Multimodal Imaging"], "cn_sites": [{"facility": "The Fifth Affiliated Hospital of Anhui Medical University", "city": "Fuyang", "status": ""}, {"facility": "Baoding Central Hospital", "city": "Baoding", "status": ""}, {"facility": "Cangzhou People's Hospital", "city": "Cangzhou", "status": ""}, {"facility": "Hengshui People's Hospital", "city": "Hengshui", "status": ""}, {"facility": "Shijiazhuang People's Hospital", "city": "Shijiazhuang", "status": ""}, {"facility": "The Second Affiliated Hospital of Xingtai Medical College", "city": "Xingtai", "status": ""}, {"facility": "Renmin Hospital of Wuhan University", "city": "Wuhan", "status": ""}, {"facility": "The First Affiliated Hospital of University of South China", "city": "Hengyang", "status": ""}, {"facility": "Jinling Hospital", "city": "Nanjing", "status": ""}], "cn_site_count": 9, "broad_only": false}], "g_total": 67, "g_fetched": 42, "g_countries": [["United States", 21], ["South Korea", 7], ["France", 7], ["Germany", 5], ["Italy", 5], ["United Kingdom", 4], ["Netherlands", 4], ["Spain", 4], ["Brazil", 3], ["Mexico", 3], ["Taiwan", 2], ["Japan", 2], ["Denmark", 2], ["Australia", 2], ["Canada", 2], ["Norway", 2], ["Sweden", 2], ["Argentina", 2], ["Portugal", 1], ["Switzerland", 1], ["Chile", 1], ["Czechia", 1], ["Hong Kong", 1], ["Hungary", 1], ["Poland", 1], ["Costa Rica", 1], ["Peru", 1]], "g_trials": [{"nct": "NCT07724626", "title": "Hyperpolarized MRI for GIST on Imatinib", "status": "NOT_YET_RECRUITING", "start": "2027-01-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Chang Gung Memorial Hospital", "countries": ["Taiwan"]}, {"nct": "NCT07689201", "title": "A Study of Velzatinib in Participants With Metastatic and/or Unresectable GIST After Imatinib, Sunitinib, Regorafenib, and Pimitespib", "status": "RECRUITING", "start": "2026-08-17", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "GlaxoSmithKline", "countries": ["Japan"]}, {"nct": "NCT07647068", "title": "Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal Tumors", "status": "NOT_YET_RECRUITING", "start": "2026-08-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Joal Beane", "countries": ["United States"]}, {"nct": "NCT07618377", "title": "Study of DCC-2618 in Patients With GIST After at Least 3 Prior Treatments", "status": "RECRUITING", "start": "2026-07-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Ono Pharmaceutical Co., Ltd.", "countries": ["Japan"]}, {"nct": "NCT07406633", "title": "KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)", "status": "RECRUITING", "start": "2026-06-23", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Kumquat Biosciences Inc.", "countries": ["United States"]}, {"nct": "NCT07434843", "title": "PH 2 Pemigatinib in SDH-deficient GIST", "status": "RECRUITING", "start": "2026-05-19", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Dana-Farber Cancer Institute", "countries": ["United States"]}, {"nct": "NCT07171203", "title": "Preoperative Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor", "status": "RECRUITING", "start": "2026-05-13", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "University of California, San Diego", "countries": ["United States"]}, {"nct": "NCT07273045", "title": "A Comprehensive, Multinational GIST Registry", "status": "NOT_YET_RECRUITING", "start": "2026-01-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Universität Duisburg-Essen", "countries": ["Germany"]}, {"nct": "NCT07096609", "title": "Lenvatinib After Progression on Imatinib, Sunitinib, and Regorafenib for GIST Patients", "status": "RECRUITING", "start": "2025-10-29", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Asan Medical Center", "countries": ["South Korea"]}, {"nct": "NCT07124000", "title": "DESTINY-PANTUMOUR04", "status": "RECRUITING", "start": "2025-09-18", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "AstraZeneca", "countries": ["United States"]}, {"nct": "NCT07109024", "title": "Resistance Profiling Using Functional Imaging and Next Generation Sequencing in Refractory Gastrointestinal Stomal Tumors (GIST)", "status": "NOT_YET_RECRUITING", "start": "2025-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Universität Duisburg-Essen", "countries": ["Germany"]}, {"nct": "NCT07673861", "title": "Clinical Utility of ctDNA in Detecting Resistance Mechanisms and Delivering Precision Medicine to Cancer Patients", "status": "RECRUITING", "start": "2025-05-23", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Royal Marsden NHS Foundation Trust", "countries": ["United Kingdom"]}, {"nct": "NCT07522762", "title": "Long-term Survivorship Challenges of Advanced/Metastatic GIST Patients Responding to Tyrosine Kinase Inhibitor Treatment: an Observational Study", "status": "RECRUITING", "start": "2025-05-21", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "The Netherlands Cancer Institute", "countries": ["Netherlands"]}, {"nct": "NCT06655246", "title": "A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)", "status": "RECRUITING", "start": "2025-03-27", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Kura Oncology, Inc.", "countries": ["United States"]}, {"nct": "NCT06805825", "title": "A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit", "status": "RECRUITING", "start": "2025-02-03", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Novelty Nobility, Inc.", "countries": ["United States"]}, {"nct": "NCT07072143", "title": "An International Study on Pediatric Patients With Rare Tumors.", "status": "RECRUITING", "start": "2025-01-25", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Azienda Ospedaliera di Padova", "countries": ["Italy"]}, {"nct": "NCT06630234", "title": "A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)", "status": "RECRUITING", "start": "2024-12-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Deciphera Pharmaceuticals, LLC", "countries": ["United States"]}, {"nct": "NCT06326346", "title": "GIST Oral Paclitaxel(Liporaxel)", "status": "RECRUITING", "start": "2024-11-20", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Asan Medical Center", "countries": ["South Korea"]}, {"nct": "NCT06638931", "title": "Agnostic Therapy in Rare Solid Tumors", "status": "RECRUITING", "start": "2024-07-16", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Instituto do Cancer do Estado de São Paulo", "countries": ["Brazil"]}, {"nct": "NCT06380816", "title": "A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer", "status": "RECRUITING", "start": "2024-07-09", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Cancer Research UK", "countries": ["United Kingdom"]}, {"nct": "NCT05493215", "title": "Imatinib TDM in GIST", "status": "RECRUITING", "start": "2024-03-26", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Reema A. Patel", "countries": ["United States"]}, {"nct": "NCT05500391", "title": "Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring", "status": "RECRUITING", "start": "2024-02-28", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Centre Oscar Lambret", "countries": ["France"]}, {"nct": "NCT05366816", "title": "ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST", "status": "RECRUITING", "start": "2023-10-17", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University of Miami", "countries": ["United States"]}, {"nct": "NCT05957367", "title": "A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies", "status": "RECRUITING", "start": "2023-09-28", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Deciphera Pharmaceuticals, LLC", "countries": ["Denmark", "France", "Germany", "Italy", "Netherlands", "Portugal", "Spain", "Switzerland", "United States"]}, {"nct": "NCT05905887", "title": "Rivoceranib Plus Paclitaxel in Patients With Gastrointestinal Stromal Tumor", "status": "RECRUITING", "start": "2023-09-06", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Asan Medical Center", "countries": ["South Korea"]}]}, {"batch": 2, "no": 33, "name_zh": "泛发性脓疱型银屑病", "query_terms": [{"term": "Generalized pustular psoriasis", "broad": false}], "n_total": 17, "n_open": 7, "n_open_precise": 7, "n_broad": 0, "trials": [{"nct": "NCT06231381", "title": "Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP)", "status": "RECRUITING", "start": "2024-02-29", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 33, "sponsor": "Shanghai Huaota Biopharmaceutical Co., Ltd.", "conditions": ["Generalized Pustular Psoriasis (GPP)"], "cn_sites": [{"facility": "Peking University People's Hospital (PKUPH)", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Shanghai Huaota Biopharmaceutical Co., Ltd", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06477536", "title": "Long-Term Safety and Efficacy of HB0034 in Subjects With Generalized Pustular Psoriasis", "status": "RECRUITING", "start": "2024-09-02", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 33, "sponsor": "Shanghai Huaota Biopharmaceutical Co., Ltd.", "conditions": ["Generalized Pustular Psoriasis"], "cn_sites": [{"facility": "Peking University People's Hospital (PKUPH)", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The Second affiliated Hospital zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07270003", "title": "A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar Pustulosis", "status": "RECRUITING", "start": "2025-10-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Xijing Hospital", "conditions": ["Palmoplantar Pustulosis (PPP)"], "cn_sites": [{"facility": "Xijing hospital", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07219420", "title": "A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis", "status": "RECRUITING", "start": "2025-11-14", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 320, "sponsor": "UCB Biopharma SRL", "conditions": ["Palmoplantar Pustulosis"], "cn_sites": [{"facility": "Ppp001 20357", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Ppp001 20137", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Ppp001 20352", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Ppp001 20350", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "Ppp001 20311", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Ppp001 20313", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Ppp001 20022", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Ppp001 20193", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Ppp001 20344", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Ppp001 20355", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Ppp001 20345", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Ppp001 20184", "city": "Shenzhen", "status": "RECRUITING"}, {"facility": "Ppp001 20136", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "Ppp001 20356", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "Ppp001 20353", "city": "Yinchuan", "status": "RECRUITING"}], "cn_site_count": 15, "broad_only": false}, {"nct": "NCT07503652", "title": "Clinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar Pustulosis", "status": "RECRUITING", "start": "2026-03", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "First Hospital of China Medical University", "conditions": ["Palmoplantar Pustulosis (PPP)"], "cn_sites": [{"facility": "First Hospital of China Medical University", "city": "Shenyang", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07552454", "title": "Picankibart in Palmoplantar Pustulosis", "status": "RECRUITING", "start": "2026-04-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Xijing Hospital", "conditions": ["Palmoplantar Pustulosis"], "cn_sites": [{"facility": "Department of Dermatology, Xijing Hospital, Fourth Military Medical University, No. 127 of West Changle Road, 710032, Xi'an, Shaanxi, China", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07530367", "title": "Tofacitinib Plus Imatinib in Moderate-to-Severe Palmoplantar Pustulosis", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 135, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Palmoplantar Pustulosis (PPP)"], "cn_sites": [{"facility": "Second Affiliated Hospital, School of Medicine, Zhejiang University", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03782792", "title": "Effisayil™ 1: A Study to Test Spesolimab (BI 655130) in Patients With a Flare-up of a Skin Disease Called Generalized Pustular Psoriasis", "status": "COMPLETED", "start": "2019-01-31", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 53, "sponsor": "Boehringer Ingelheim", "conditions": ["Generalized Pustular Psoriasis"], "cn_sites": [{"facility": "The First Hospital of Dalian Medical University", "city": "Dalian", "status": ""}, {"facility": "2nd Affiliated Hosp Zhejiang University College of Medical", "city": "Hangzhou", "status": ""}, {"facility": "Shanghai Skin Disease Hospital", "city": "Shanghai", "status": ""}, {"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT03886246", "title": "Effisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With Generalized Pustular Psoriasis Who Took Part in a Previous Study", "status": "ACTIVE_NOT_RECRUITING", "start": "2019-05-29", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 131, "sponsor": "LEO Pharma", "conditions": ["Generalized Pustular Psoriasis"], "cn_sites": [{"facility": "Sun yet-sen Memorial Hospital, Sun yet-sen Univesity", "city": "Guangzhou", "status": ""}, {"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Shanghai Skin Disease Hospital", "city": "Shanghai", "status": ""}, {"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Second Affiliated Hospital of Xi'an JiaoTong University", "city": "Xi'an", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT06391996", "title": "Biologic Therapy for Generalized Pustular Psoriasis", "status": "COMPLETED", "start": "2019-07-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 65, "sponsor": "Chao Ji", "conditions": ["Generalized Pustular Psoriasis"], "cn_sites": [{"facility": "First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04399837", "title": "A Study to Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular Psoriasis", "status": "COMPLETED", "start": "2020-06-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 123, "sponsor": "Boehringer Ingelheim", "conditions": ["Generalized Pustular Psoriasis"], "cn_sites": [{"facility": "Sun yet-sen Memorial Hospital, Sun yet-sen Univesity", "city": "Guangzhou", "status": ""}, {"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Shanghai Skin Disease Hospital", "city": "Shanghai", "status": ""}, {"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": ""}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital", "city": "Tianjin", "status": ""}, {"facility": "Second Affiliated Hospital of Xi'an JiaoTong University", "city": "Xi'an", "status": ""}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT05239039", "title": "An Expanded Access Program in China to Provide Spesolimab to People With a Flare-up in Generalized Pustular Psoriasis Who Have no Other Treatment Options", "status": "COMPLETED", "start": "2022-03-15", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 39, "sponsor": "Boehringer Ingelheim", "conditions": ["Generalized Pustular Psoriasis"], "cn_sites": [{"facility": "Beijing Friendship Hospital", "city": "Beijing", "status": ""}, {"facility": "West China Hospital", "city": "Chengdu", "status": ""}, {"facility": "Southern Medical University Dermatology Hospital", "city": "Guangzhou", "status": ""}, {"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Hangzhou Third People's Hospital", "city": "Hangzhou", "status": ""}, {"facility": "Shandong Provincial Hospital of Dermatology", "city": "Jinan", "status": ""}, {"facility": "Dermatology Hospital, Chinese Academy of Medical Sciences", "city": "Nanjing", "status": ""}, {"facility": "Shanghai Skin Disease Hospital", "city": "Shanghai", "status": ""}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "The University of Hong Kong-Shenzhen Hospital", "city": "Shenzhen", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "Wuhan Union Hospital", "city": "Wuhan", "status": ""}], "cn_site_count": 12, "broad_only": false}, {"nct": "NCT05512598", "title": "HB0034 in Patients With Generalized Pustular Psoriasis (GPP)", "status": "COMPLETED", "start": "2022-11-06", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Shanghai Huaota Biopharmaceutical Co., Ltd.", "conditions": ["Generalized Pustular Psoriasis"], "cn_sites": [{"facility": "Dermatology Hospital of Shandong First Medical University", "city": "Shandong", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06013969", "title": "A Study to Test Whether Spesolimab Helps People With Generalized Pustular Psoriasis (GPP) Who Need Treatment for Repeated Flares", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-10-22", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 42, "sponsor": "LEO Pharma", "conditions": ["Generalized Pustular Psoriasis"], "cn_sites": [{"facility": "Southern Medical University Dermatology Hospital", "city": "Guangzhou", "status": ""}, {"facility": "Shanghai Skin Disease Hospital", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Tenth People's Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT06433531", "title": "A Clinical Study of TQH2929 Injection in Treatment With Generalized Pustular Psoriasis (GPP)", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-06-19", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.", "conditions": ["Generalized Pustular Psoriasis"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Dermatology Hospital of Southern Medical Universitye", "city": "Guangzhou", "status": ""}, {"facility": "The First Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "The Second Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "Second People's Hospital of Chengdu", "city": "Chengdu", "status": ""}, {"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT07000630", "title": "Efficacy and Tolerability of Deucravacitinib in the Management of Palmoplantar Pustulosis", "status": "TERMINATED", "start": "2025-06-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 3, "sponsor": "Peking University First Hospital", "conditions": ["Palmoplantar Pustulosis"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07314060", "title": "A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized Pustular Psoriasis", "status": "TERMINATED", "start": "2026-03-19", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Generalized Pustular Psoriasis"], "cn_sites": [{"facility": "Peking University First Hospita", "city": "Beijing", "status": ""}, {"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": ""}, {"facility": "Southern Medical University Dermatology Hospital", "city": "Guangzhou", "status": ""}, {"facility": "Sun Yat-sen Memorial Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "The Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": ""}, {"facility": "The Second Hospital Of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "The Second Affiliated Hospital of Henan University of science and technology", "city": "Luoyang", "status": ""}, {"facility": "Zhengzhou Central Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "The fifth Affiliated hospital of zhengzhou university", "city": "Zhengzhou", "status": ""}, {"facility": "Shiyan Renmin Hospital", "city": "Shiyan", "status": ""}, {"facility": "Renmin Hospital of Wuhan University", "city": "Wuhan", "status": ""}, {"facility": "The First Hospital of Hunan University of Chinese Medicine", "city": "Changsha", "status": ""}, {"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "The General Hospital Of Hunan University Of Medicine", "city": "Huaihua", "status": ""}, {"facility": "The first hospital of jilin university", "city": "Changchun", "status": ""}, {"facility": "The first hospital of china medical university", "city": "Shenyang", "status": ""}, {"facility": "Shandong First Medical University Affiliated Dermatology Hospital", "city": "Jinan", "status": ""}, {"facility": "Shanghai Skin Disease Hospital", "city": "Shanghai", "status": ""}, {"facility": "The Second Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi’an", "status": ""}, {"facility": "Chengdu Second People's Hospital", "city": "Chengdu", "status": ""}, {"facility": "Sichuan Provincial People' s Hospital", "city": "Chengdu", "status": ""}, {"facility": "The Affiliated Hospital of Southwest Medical University", "city": "Luzhou", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital", "city": "Tianjin", "status": ""}, {"facility": "People's Hospital of Xinjiang Uygur Autonomous Region", "city": "Ürümqi", "status": ""}, {"facility": "The First Affiliated Hospital of Xinjiang Medical University", "city": "Ürümqi", "status": ""}, {"facility": "The First Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}, {"facility": "Jiaxing First Hospital", "city": "Jiaxing", "status": ""}, {"facility": "The first affiliated hospital of ningbo university", "city": "Ningbo", "status": ""}], "cn_site_count": 31, "broad_only": false}], "g_total": 13, "g_fetched": 6, "g_countries": [["Canada", 2], ["Germany", 2], ["United States", 2], ["Costa Rica", 1], ["Poland", 1], ["United Kingdom", 1], ["Italy", 1], ["Portugal", 1], ["Singapore", 1], ["Switzerland", 1], ["Turkey (Türkiye)", 1]], "g_trials": [{"nct": "NCT07448428", "title": "Generalized Pustular Psoriasis Registry in Costa Rica", "status": "NOT_YET_RECRUITING", "start": "2026-05", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Caja Costarricense de Seguro Social", "countries": ["Costa Rica"]}, {"nct": "NCT07013201", "title": "A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis", "status": "RECRUITING", "start": "2025-09-11", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "LEO Pharma", "countries": ["Canada", "Germany", "Poland", "United Kingdom", "United States"]}, {"nct": "NCT06790940", "title": "Construction of a Psoriasis and Psoriatic Arthritis Diagnostic Model Based on Multidimensional Nail Information", "status": "NOT_YET_RECRUITING", "start": "2025-01-20", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Shanghai Yueyang Integrated Medicine Hospital", "countries": []}, {"nct": "NCT05994976", "title": "Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers", "status": "RECRUITING", "start": "2023-10-17", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Innovaderm Research Inc.", "countries": ["Canada"]}, {"nct": "NCT06100991", "title": "CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry", "status": "RECRUITING", "start": "2023-09-19", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "CorEvitas", "countries": ["United States"]}, {"nct": "NCT04359394", "title": "International Rare And Severe Psoriasis Expert Network", "status": "RECRUITING", "start": "2021-09-22", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Basel, Switzerland", "countries": ["Germany", "Italy", "Portugal", "Singapore", "Switzerland", "Turkey (Türkiye)"]}]}, {"batch": 2, "no": 34, "name_zh": "遗传性甲状旁腺功能减退症", "query_terms": [{"term": "Genetic hypoparathyroidism", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 13, "g_fetched": 13, "g_countries": [["United States", 5], ["Netherlands", 2], ["Tunisia", 1], ["Italy", 1], ["Canada", 1], ["Switzerland", 1], ["France", 1], ["Israel", 1]], "g_trials": [{"nct": "NCT07083557", "title": "Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)", "status": "RECRUITING", "start": "2027-01-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Bettina Mittendorfer", "countries": ["United States"]}, {"nct": "NCT07284641", "title": "Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)", "status": "RECRUITING", "start": "2026-05-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Paul Szabolcs", "countries": ["United States"]}, {"nct": "NCT07493096", "title": "Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders", "status": "RECRUITING", "start": "2026-03-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Healing Hope International", "countries": ["United States"]}, {"nct": "NCT07643896", "title": "The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk Assessment", "status": "RECRUITING", "start": "2026-01-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "BillionToOne Inc.", "countries": ["United States"]}, {"nct": "NCT06445036", "title": "Tunisian Clinical Registry on Hypoparathyroidism and Pseudo-hypoparathyroidism", "status": "NOT_YET_RECRUITING", "start": "2025-02-27", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Dacima Consulting", "countries": ["Tunisia"]}, {"nct": "NCT06645899", "title": "Institution of an Italian Multicenter Database of Patients Affected by Hypoparathyroidism or Pseudohypoparathyroidism", "status": "RECRUITING", "start": "2024-11-04", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore", "countries": ["Italy"]}, {"nct": "NCT06081348", "title": "Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders", "status": "RECRUITING", "start": "2024-09-16", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Holland Bloorview Kids Rehabilitation Hospital", "countries": ["Canada"]}, {"nct": "NCT05664412", "title": "Using Transcranial Alternating Current Stimulation to Improve Executive Function in 22q11.2 Deletion Syndrome", "status": "RECRUITING", "start": "2023-10-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Stephan Eliez", "countries": ["Switzerland"]}, {"nct": "NCT05924347", "title": "Early Scoliotic Changes in Children at Increased Risk for Scoliosis Development", "status": "RECRUITING", "start": "2023-06-16", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "UMC Utrecht", "countries": ["Netherlands"]}, {"nct": "NCT04639388", "title": "Understanding of Psychotic Disorders in Children With 22q11.2DS", "status": "RECRUITING", "start": "2020-11-13", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Hôpital le Vinatier", "countries": ["France"]}, {"nct": "NCT04463316", "title": "GROWing Up With Rare GENEtic Syndromes", "status": "RECRUITING", "start": "2018-10-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "dr. Laura C. G. de Graaff-Herder", "countries": ["Netherlands"]}, {"nct": "NCT00556530", "title": "Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome", "status": "RECRUITING", "start": "2016-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Albert Einstein College of Medicine", "countries": ["United States"]}, {"nct": "NCT00768820", "title": "The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome", "status": "RECRUITING", "start": "2001-05", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "The Chaim Sheba Medical Center", "countries": ["Israel"]}]}, {"batch": 2, "no": 35, "name_zh": "巨细胞动脉炎", "query_terms": [{"term": "Giant cell arteritis", "broad": false}], "n_total": 4, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT06766552", "title": "A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.", "status": "NOT_YET_RECRUITING", "start": "2025-01-30", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 10000, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Ankylosing Spondylitis (AS)", "Psoriatic Arthritis (PsA)", "Nr-axSpA", "Polymyalgia Rheumatica (PMR)", "Takayasu Arteritis (TAK)", "Giant Cell Arteritis (GCA)", "Behcet&#39;s Disease", "Enthesitis-related Arthritis"], "cn_sites": [{"facility": "The Second Affiliated Hospital of Zhejiang University", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01066208", "title": "American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis", "status": "UNKNOWN", "start": "2011-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 3588, "sponsor": "University of Oxford", "conditions": ["Wegener's Granulomatosis", "Microscopic Polyangiitis", "Churg Strauss Syndrome", "Polyarteritis Nodosa", "Giant Cell Arteritis", "Takayasu Arteritis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital, Beijing", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04799262", "title": "Tofacitinib as a GC Sparing Agent for Polymyalgia Rheumatica", "status": "COMPLETED", "start": "2021-01-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 14, "sponsor": "RenJi Hospital", "conditions": ["Polymyalgia Rheumatica", "Effect of Drug", "Safety Issues"], "cn_sites": [{"facility": "Ren Ji Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06172361", "title": "Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With Polymyalgia Rheumatica", "status": "COMPLETED", "start": "2024-01-20", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 104, "sponsor": "Zhejiang University", "conditions": ["Polymyalgia Rheumatica"], "cn_sites": [{"facility": "Division of Rheumatology, the First Affiliated Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 55, "g_fetched": 54, "g_countries": [["France", 14], ["United States", 10], ["Canada", 7], ["Germany", 7], ["Denmark", 6], ["United Kingdom", 4], ["Switzerland", 3], ["Sweden", 1], ["Italy", 1], ["Armenia", 1], ["Turkey (Türkiye)", 1]], "g_trials": [{"nct": "NCT07269938", "title": "Mapping B-cell Biology Across the Cardiovascular Territories of Giant Cell Arteritis: Towards a New Therapeutic Approach (RituxiMAP GCA)", "status": "NOT_YET_RECRUITING", "start": "2026-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Edinburgh", "countries": ["United Kingdom"]}, {"nct": "NCT07737470", "title": "Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": []}, {"nct": "NCT07748195", "title": "DNA Methylation in PMR", "status": "NOT_YET_RECRUITING", "start": "2026-08-31", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Dartmouth-Hitchcock Medical Center", "countries": []}, {"nct": "NCT07749547", "title": "Using Personalized Rehabilitation to Reduce Disease and Increase Activity of Patients With Polymyalgia Rheumatica", "status": "NOT_YET_RECRUITING", "start": "2026-08-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Washington University School of Medicine", "countries": []}, {"nct": "NCT07132164", "title": "Justification of the Initial Diagnosis and Evaluation of the Overall Evolution of a Cohort of Recent Polymyalgia Rheumatica (JADORE)", "status": "NOT_YET_RECRUITING", "start": "2026-07-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Brest", "countries": ["France"]}, {"nct": "NCT07628075", "title": "Long-Axial Field of View (LAFOV) [18F]FDG PET/CT Imaging in Large Vessel Vasculitis (LVV): Protocol Optimisation Study.", "status": "NOT_YET_RECRUITING", "start": "2026-07-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Imperial College London", "countries": ["United Kingdom"]}, {"nct": "NCT06833411", "title": "Treatment for Giant Cell Arteritis With Tocilizumab and 8 as Compared to 26 Weeks of Prednisone", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Insel Gruppe AG, University Hospital Bern", "countries": ["Switzerland"]}, {"nct": "NCT07720804", "title": "Kinetics of C-Reactive Protein in Giant Cell Arteritis Following Glucocorticoid Initiation: A Pilot Study (GIDEON)", "status": "NOT_YET_RECRUITING", "start": "2026-06-22", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Limoges", "countries": []}, {"nct": "NCT06957002", "title": "Bosentan in the Treatment of Giant Cell Arteritis", "status": "NOT_YET_RECRUITING", "start": "2026-06", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT07286214", "title": "Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica", "status": "RECRUITING", "start": "2026-05-12", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Sanofi", "countries": ["Canada", "United States"]}, {"nct": "NCT07552636", "title": "Disease Activity Monitoring in Patients With Giant Cell Arteritis Study", "status": "RECRUITING", "start": "2026-05-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Aarhus", "countries": ["Denmark"]}, {"nct": "NCT07508514", "title": "Early Temporal Dynamics of Optic Nerve Sheath Diameter After Therapy in GCA", "status": "NOT_YET_RECRUITING", "start": "2026-05-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal", "countries": ["Canada"]}, {"nct": "NCT07354906", "title": "Upadacitinib in Giant Cell Arteritis (GCA) With Active Large-vessel Involvement.", "status": "NOT_YET_RECRUITING", "start": "2026-03-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Groupe français d'étude des Maladies Inflammatoires de loeil", "countries": ["France"]}, {"nct": "NCT07246577", "title": "The VGR GCA Cohort: Ultrasound, Biopsy and Biomarkers - Novel Methods for Diagnosis, Monitoring and Prognosis in Giant Cell Arteritis.", "status": "RECRUITING", "start": "2026-03-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Vastra Gotaland Region", "countries": ["Sweden"]}, {"nct": "NCT07060274", "title": "Halo Sign Vanishing Time After Steroids Outbreak in GCA Patients", "status": "RECRUITING", "start": "2026-02-27", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Centre Hospitalier le Mans", "countries": ["France"]}, {"nct": "NCT07394478", "title": "Study of the Association Between Sacroiliitis/Axial Spondylarthritis and Giant Cell Arteritis/ Polymyalgia Rheumatica", "status": "NOT_YET_RECRUITING", "start": "2026-02-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Hôpital NOVO", "countries": ["France"]}, {"nct": "NCT07266168", "title": "Efficacy and Safety of Ivarmacitinib in the Treatment of Patients With Polymyalgia Rheumatica", "status": "NOT_YET_RECRUITING", "start": "2026-01-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "countries": []}, {"nct": "NCT07206238", "title": "Orbital Vascular Inflammation in Ischemic Optic Neuropathy and Giant Cell Arteritis", "status": "RECRUITING", "start": "2026-01-14", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Rigshospitalet, Denmark", "countries": ["Denmark"]}, {"nct": "NCT07108387", "title": "Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis", "status": "RECRUITING", "start": "2026-01-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "countries": ["United States"]}, {"nct": "NCT07279688", "title": "Justification And Evaluation of Baricitinib Plus Corticosteroids Versus corticosteroiDs Alone in pOlymyalgia RhEumatica", "status": "RECRUITING", "start": "2025-12-18", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Brest", "countries": ["France"]}, {"nct": "NCT07138898", "title": "Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty", "status": "RECRUITING", "start": "2025-12-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "NYU Langone Health", "countries": ["United States"]}, {"nct": "NCT07084480", "title": "Giant Cell Arteritis - Ways to Precision Medicine", "status": "RECRUITING", "start": "2025-11-14", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Wuerzburg University Hospital", "countries": ["Germany"]}, {"nct": "NCT07001059", "title": "oPtic Nerve Sheath Evaluation in gianT Cell aRtheritis by UltraSound", "status": "RECRUITING", "start": "2025-09-04", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Hôpital NOVO", "countries": ["France"]}, {"nct": "NCT07010484", "title": "Using Novel Imaging to Rethink Diagnostic and Treatment Strategies for Polymyalgia Rheumatica", "status": "RECRUITING", "start": "2025-08-21", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Kresten Krarup Keller", "countries": ["Denmark"]}, {"nct": "NCT06894602", "title": "Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell Arteritis", "status": "RECRUITING", "start": "2025-08-05", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Brest", "countries": ["France"]}]}, {"batch": 2, "no": 36, "name_zh": "骨巨细胞瘤", "query_terms": [{"term": "Giant cell tumor of bone", "broad": false}], "n_total": 11, "n_open": 5, "n_open_precise": 5, "n_broad": 0, "trials": [{"nct": "NCT05595603", "title": "Zoledronic Acid-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Bone Tumor After Intralesional Curettage", "status": "RECRUITING", "start": "2023-03", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 153, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Giant Cell Tumor of Bone"], "cn_sites": [{"facility": "The Second Affiliated Hospital of Zhejiang University", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05813665", "title": "A Study to Evaluate the Efficacy and Safety of Narlumosbart (JMT103) in Patients With Giant Cell Tumor of Bone", "status": "NOT_YET_RECRUITING", "start": "2023-04", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 146, "sponsor": "Shanghai JMT-Bio Inc.", "conditions": ["Giant Cell Tumor of Bone"], "cn_sites": [{"facility": "Beijing Ji Shui Tan Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06302465", "title": "Narlumosbartmab Combined With Neoadjuvant Chemotherapy in Bone-derived Malignancies With Osteolytic Lesions and Multinucleated Giant Cells", "status": "RECRUITING", "start": "2024-05-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Peking University People's Hospital", "conditions": ["Malignant Bone Tumor"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06647901", "title": "Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study", "status": "RECRUITING", "start": "2024-08-23", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 45, "sponsor": "Tang Xiaodong", "conditions": ["Giant Cell Tumor of Bone"], "cn_sites": [{"facility": "Peking University People&amp;#39;s Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07315828", "title": "Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Giant Cell Tumor of Bone Surgery", "status": "RECRUITING", "start": "2026-01-02", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Shanghai Jiao Tong University Affiliated Sixth People's Hospital", "conditions": ["Giant Cell Tumor of Bone"], "cn_sites": [{"facility": "Shanghai Sixth People's Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06331104", "title": "Network Pharmacology Prediction: Mechanism Study of Puerarin in the Treatment of Giant Cell Tumors of Bone", "status": "COMPLETED", "start": "2012-06-14", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 145, "sponsor": "Changye Zou", "conditions": ["Giant Cell Tumors"], "cn_sites": [{"facility": "Churong Yan", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03259152", "title": "Characteristics and Mechanism of Denosumab-treated Giant Cell Tumor of Bone", "status": "UNKNOWN", "start": "2016-05-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Hebei Medical University Third Hospital", "conditions": ["Giant Cell Tumor of Bone"], "cn_sites": [{"facility": "Zhuang Zhou", "city": "Shijiazhuang", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04255576", "title": "Efficacy and Safety of JMT103 in Patients With Giant Cell Tumor of Bone", "status": "UNKNOWN", "start": "2019-10-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 139, "sponsor": "Shanghai JMT-Bio Inc.", "conditions": ["Giant Cell Tumor of Bone"], "cn_sites": [{"facility": "Beijing Ji Shui Tan Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04952818", "title": "The Value of Preoperative Diagnosis and Prognostic Prediction Based on Radiomics of Giant Cell Tumor of Spine", "status": "COMPLETED", "start": "2020-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Peking University Third Hospital", "conditions": ["Spinal Tumor"], "cn_sites": [{"facility": "Peking University third hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05402865", "title": "A Real-world Study on Patients of Unresectable Giant Cell Tumor of Bone", "status": "COMPLETED", "start": "2021-11-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 301, "sponsor": "Shanghai JMT-Bio Inc.", "conditions": ["Giant Cell Tumor of Bone"], "cn_sites": [{"facility": "Beijing Jishuitan Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Beijing", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT04586660", "title": "Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-08-17", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Amgen", "conditions": ["Giant Cell Tumor of Bone"], "cn_sites": [{"facility": "Beijing Jishuitan Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University Peoples Hospital", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": ""}, {"facility": "The Third Affiliated Hospital Of Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": ""}, {"facility": "Harbin Meidical University Cancer Hospital", "city": "Harbin", "status": ""}, {"facility": "Tangdu Hospital of Air Force Medical University", "city": "Xi'an", "status": ""}, {"facility": "The Second Affiliated hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 8, "broad_only": false}], "g_total": 10, "g_fetched": 5, "g_countries": [["United States", 4], ["Canada", 2], ["Czechia", 1], ["India", 1]], "g_trials": [{"nct": "NCT07609277", "title": "TRACP-5b for Diagnosis and Follow-up of Giant Cell Tumor of Bone", "status": "RECRUITING", "start": "2026-01-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "St. Anne's University Hospital Brno, Czech Republic", "countries": ["Czechia"]}, {"nct": "NCT07227961", "title": "PROMIS and Mobility Evaluation in Sarcoma Patients", "status": "RECRUITING", "start": "2025-07-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Calgary", "countries": ["Canada", "United States"]}, {"nct": "NCT06239272", "title": "NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)", "status": "RECRUITING", "start": "2024-03-27", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "St. Jude Children's Research Hospital", "countries": ["United States"]}, {"nct": "NCT05463796", "title": "InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer", "status": "RECRUITING", "start": "2023-04-25", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Dana-Farber Cancer Institute", "countries": ["United States"]}, {"nct": "NCT03295981", "title": "Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone", "status": "RECRUITING", "start": "2018-05-03", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "St. Louis University", "countries": ["Canada", "India", "United States"]}]}, {"batch": 2, "no": 37, "name_zh": "血小板无力症", "query_terms": [{"term": "Glanzmann thrombasthenia", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 5, "g_fetched": 5, "g_countries": [["United States", 3], ["France", 1]], "g_trials": [{"nct": "NCT07136857", "title": "Eptacog Beta in Glanzmann's (HeT_LFB-Strength-Study_FID531)", "status": "RECRUITING", "start": "2025-10-02", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Emory University", "countries": ["United States"]}, {"nct": "NCT06820515", "title": "ATHNdataset Registry", "status": "RECRUITING", "start": "2024-10-25", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "American Thrombosis and Hemostasis Network", "countries": ["United States"]}, {"nct": "NCT06204042", "title": "Multinational Glanzmann Study", "status": "NOT_YET_RECRUITING", "start": "2024-03-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "UMC Utrecht", "countries": []}, {"nct": "NCT04119908", "title": "Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases", "status": "RECRUITING", "start": "2023-05-24", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Lille", "countries": ["France"]}, {"nct": "NCT00230165", "title": "The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders.", "status": "RECRUITING", "start": "2005-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Rockefeller University", "countries": ["United States"]}]}, {"batch": 2, "no": 38, "name_zh": "胶质母细胞瘤", "query_terms": [{"term": "Glioblastoma", "broad": false}], "n_total": 147, "n_open": 56, "n_open_precise": 56, "n_broad": 0, "trials": [{"nct": "NCT03005132", "title": "Integrative Analysis of Human Glioblastoma Multiforme", "status": "RECRUITING", "start": "2016-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "Shanghai 10th People's Hospital", "conditions": ["GBM"], "cn_sites": [{"facility": "Shanghai Tenth People's Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05990244", "title": "Magnetic Resonance Elastography in Glioma: Exploring Tumor Stiffness and Adhesion", "status": "RECRUITING", "start": "2017-01-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Shengjing Hospital", "conditions": ["Glioma"], "cn_sites": [{"facility": "Shengjing Hospital", "city": "Shenyang", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04267978", "title": "Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas", "status": "RECRUITING", "start": "2020-02-13", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 109, "sponsor": "Beijing Sanbo Brain Hospital", "conditions": ["Glioblastoma, Recurrent", "Lower Grade Glioma, Recurrent"], "cn_sites": [{"facility": "Beijing Sanbo Brain Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06595186", "title": "JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)", "status": "RECRUITING", "start": "2022-10-31", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 25, "sponsor": "JenKem Technology Co., Ltd.", "conditions": ["Glioblastoma Multiforme (GBM)"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05541042", "title": "Radiogenomics in Glioblastoma: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers", "status": "NOT_YET_RECRUITING", "start": "2022-12-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 50, "sponsor": "Henan Provincial People's Hospital", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05502991", "title": "Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNA-level-relapse and Clinical-relapse Glioblastoma", "status": "NOT_YET_RECRUITING", "start": "2022-12-11", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Henan Provincial People's Hospital", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05957679", "title": "MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment", "status": "RECRUITING", "start": "2023-01-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Shengjing Hospital", "conditions": ["Spinal Cord Tumors"], "cn_sites": [{"facility": "Shengjing Hospital", "city": "Shenyang", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05842746", "title": "Elemene Plus Stupp Protocol Versus Stupp Protocol Alone for Newly-diagnosed Glioblastoma", "status": "NOT_YET_RECRUITING", "start": "2023-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 74, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Glioblastoma, IDH-wildtype"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05303519", "title": "SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)", "status": "RECRUITING", "start": "2023-06-05", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 365, "sponsor": "Nuvation Bio Inc.", "conditions": ["Glioma", "Astrocytoma, Grade IV", "IDH1-mutant Glioma", "Astrocytoma, IDH-Mutant, Grade 3", "Astrocytoma, IDH-Mutant, Grade 4", "Astrocytoma, IDH-Mutant, Grade 2", "Oligodendroglioma", "Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Sanbo Brain Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Xuanwu Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Huashan Hospital Affiliated to Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": "RECRUITING"}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT05577091", "title": "Tris-CAR-T Cell Therapy for Recurrent Glioblastoma", "status": "RECRUITING", "start": "2023-09-30", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Beijing Tiantan Hospital", "conditions": ["Recurrent Glioblastoma"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05540275", "title": "Tislelizumab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for Bevacizumab Refractory Recurrent Glioblastoma", "status": "NOT_YET_RECRUITING", "start": "2023-10-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Henan Provincial People's Hospital", "conditions": ["Recurrent Glioblastoma"], "cn_sites": [{"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07145047", "title": "Clinical Study of Oncolytic Virus in Glioblastoma", "status": "RECRUITING", "start": "2023-11-02", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Mianyang Central Hospital", "conditions": ["Glioblastoma (GBM)"], "cn_sites": [{"facility": "Mianyang Central Hospital", "city": "Mianyang", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06616727", "title": "The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM", "status": "ENROLLING_BY_INVITATION", "start": "2023-12-26", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Shanghai Simnova Biotechnology Co.,Ltd.", "conditions": ["Recurrent Glioblastoma Multiforme (GBM)"], "cn_sites": [{"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06220552", "title": "The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma", "status": "RECRUITING", "start": "2023-12-27", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Fifth Affiliated Hospital, Sun Yat-Sen University", "conditions": ["Recurrent Glioblastoma"], "cn_sites": [{"facility": "Yingpeng Peng", "city": "Zhuhai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06690216", "title": "Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors", "status": "ENROLLING_BY_INVITATION", "start": "2024-03-30", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Man Hu", "conditions": ["Glioblastoma (GBM)", "Head and Neck Squamous Cell Carcinoma", "Non-Small Cell Lung Cancer", "Esophageal Cancer"], "cn_sites": [{"facility": "Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06327451", "title": "Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma", "status": "RECRUITING", "start": "2024-04-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Tianjin Medical University General Hospital", "conditions": ["Glioblastoma, IDH-wildtype"], "cn_sites": [{"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06368934", "title": "Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma", "status": "NOT_YET_RECRUITING", "start": "2024-04-08", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 326, "sponsor": "Huashan Hospital", "conditions": ["Glioma", "Glioblastoma"], "cn_sites": [{"facility": "Hushan Hospital, Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05990556", "title": "Research on the Safety and Efficacy of Blocking Dural Blood Supply in Glioblastoma Patients", "status": "RECRUITING", "start": "2024-05-11", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "First Affiliated Hospital, Sun Yat-Sen University", "conditions": ["Glioblastoma", "Meningeal Arteries"], "cn_sites": [{"facility": "the First Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06740955", "title": "Hypofractionated Radiotherapy", "status": "RECRUITING", "start": "2024-08-13", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 420, "sponsor": "The First Hospital of Jilin University", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07130149", "title": "Sonodynamic-Chemoradiotherapy Integration in Glioblastoma", "status": "ENROLLING_BY_INVITATION", "start": "2024-10-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 230, "sponsor": "Yingjuan Zheng", "conditions": ["Glioblastoma (GBM)"], "cn_sites": [{"facility": "First H A Zhengzhou U", "city": "Zhengzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06598787", "title": "A Study of BL-B01D1 in Patients With Recurrent Glioblastoma", "status": "RECRUITING", "start": "2024-10-17", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Sichuan Baili Pharmaceutical Co., Ltd.", "conditions": ["Recurrent Glioblastoma"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06640582", "title": "TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas", "status": "RECRUITING", "start": "2024-10-20", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 85, "sponsor": "Essen Biotech", "conditions": ["Brain Tumor", "Brain Metastases", "Brain Cancer", "Glioma", "Gliomas, Malignant", "Glioblastoma", "Meningioma"], "cn_sites": [{"facility": "District One Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06757153", "title": "Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients", "status": "RECRUITING", "start": "2024-12-19", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Zhongnan Hospital", "conditions": ["Glioblastoma (GBM)"], "cn_sites": [{"facility": "Zhongnan Hospital of Wuhan University", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06936046", "title": "Enhanced Adjuvant Therapy for Newly Diagnosed GBM With Partial Surgical Resection or Short-term Progression", "status": "RECRUITING", "start": "2025-01-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 200, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "2nd Affiliated Hospital, School of Medicine, Zhejiang University, China", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07538128", "title": "Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent Glioblastoma", "status": "RECRUITING", "start": "2025-01-09", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Huashan Hospital", "conditions": ["Recurrent Glioblastoma"], "cn_sites": [{"facility": "Huashan Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06914128", "title": "A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors", "status": "RECRUITING", "start": "2025-03-21", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 450, "sponsor": "Bayer", "conditions": ["MTAP-deleted Solid Tumors"], "cn_sites": [{"facility": "Beijing Cancer Hospital - Oncology Department", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing chest hospital, Capital Medical University", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Tongji Hosp. of Tongji Med Coll, Huazhong Uni of Sci & Tech.", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Jiangsu Provincial People's Hospital - The First Affiliated Hospital of Nanjing Medical University", "city": "Nanjing", "status": "NOT_YET_RECRUITING"}, {"facility": "Sir Run Run Shaw Hospital, Zhejiang Univ. School of Medicine - Oncology Department", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT07144735", "title": "Allogeneic γδT Cells in Glioblastoma", "status": "RECRUITING", "start": "2025-04-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Peking University Third Hospital", "conditions": ["Glioblastoma (GBM)", "Glioblastoma Multiforme (GBM)"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Zhengzhou Second Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Henan Academy of Innovations in Medical Science", "city": "Zhengzhou", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07193654", "title": "Stupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced Spread", "status": "RECRUITING", "start": "2025-04-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 38, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Glioblastoma (GBM)"], "cn_sites": [{"facility": "2nd Affiliated Hospital, School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06773481", "title": "BC008-1A Injection for Recurrent CNS WHO G4 Glioma", "status": "RECRUITING", "start": "2025-04-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.", "conditions": ["Glioma", "Glioma Tumor Recurrence", "Glioma, Recurrent High Grade", "Glioblastomas (GBM)", "Glioblastoma WHO Grade IV"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06902350", "title": "Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors", "status": "RECRUITING", "start": "2025-05-21", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 102, "sponsor": "Chipscreen Biosciences, Ltd.", "conditions": ["Neoplasms", "Glioblastoma, Adult", "Small Cell Lung Carcinoma (SCLC)"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Jilin Cancer Hospital", "city": "Changchun", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06939400", "title": "Photodynamic Therapy for Glioblastoma Multiforme Based on Metaverse and Yellow Fluorescence", "status": "NOT_YET_RECRUITING", "start": "2025-06-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Zhejiang Provincial People's Hospital", "conditions": ["Glioblastoma Multiforme (GBM)"], "cn_sites": [{"facility": "Zhejiang Provincial People's Hospital", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07067905", "title": "Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma", "status": "RECRUITING", "start": "2025-06-27", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Chinese PLA General Hospital", "conditions": ["Clear Cell Renal Cell Carcinoma and Glioblastoma"], "cn_sites": [{"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07093814", "title": "A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma", "status": "RECRUITING", "start": "2025-09-02", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 42, "sponsor": "Guangzhou Virotech Pharmaceutical Co., Ltd.", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "The First Affiliated Hospital of USTC", "city": "Hefei", "status": "NOT_YET_RECRUITING"}, {"facility": "Sanbo Brain Hospital Capital Medical University", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "The Cancer Hospital Affiliated to Chongqing University", "city": "Chongqing", "status": "NOT_YET_RECRUITING"}, {"facility": "Nanfang Hospital, Southern Medical University", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Shenzhen Second People's Hospital", "city": "Shenzhen", "status": "RECRUITING"}, {"facility": "The Fifth Affiliated Hospital of Sun Yat-sen University", "city": "Zhuhai", "status": "RECRUITING"}, {"facility": "Guangxi Medical University Cancer Hospital", "city": "Nanning", "status": "RECRUITING"}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": "NOT_YET_RECRUITING"}, {"facility": "Tangdu Hospital of Air Force Medical University of the PLA", "city": "Xi’an", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 11, "broad_only": false}, {"nct": "NCT07520214", "title": "Clinical Study on the Safety and Immunogenicity of Specific Cancer Vaccines in Preventing Recurrence of Glioblastoma", "status": "ENROLLING_BY_INVITATION", "start": "2025-09-10", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Beijing Neurosurgical Institute", "conditions": ["Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype", "Glioblastom WHO Grade 4"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07193628", "title": "B7H3/IL13Ra2 Bispecific Armored Chimeric Antigen Receptor T-Cell Therapy Study for Recurrent/Refractory Glioblastoma", "status": "RECRUITING", "start": "2025-09-26", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 14, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Refractory Glioblastoma", "Recurrent Glioblastoma"], "cn_sites": [{"facility": "the Second Affiliated Hospital, School of Medicine, Zhejiang University", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07244835", "title": "A Study of DEG6498 in Participants With Solid Tumors", "status": "RECRUITING", "start": "2025-11-13", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Degron Therapeutics Co.", "conditions": ["Malignant Neoplasms"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing GoBroad Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Sun Yat-Sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07244666", "title": "Safety and Preliminary Efficacy of a Metabolically Armed Chimeric Antigen Receptor T Cell Therapy Targeting EGFRvIII for Recurrent Glioblastoma", "status": "NOT_YET_RECRUITING", "start": "2025-11-15", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Glioblastoma (GBM)"], "cn_sites": [{"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07670026", "title": "Intensified Adjuvant Therapy for High-Risk Newly Diagnosed Glioblastoma With Subtotal Resection or Short-Term Progression", "status": "RECRUITING", "start": "2025-12-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 31, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "The Second Affiliated Hospital,School of Medicine,Zhejiang University", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07511725", "title": "Prophylactic Regimen With Intrathecal Thiotepa in SVZ-positive or Meningeal-risk Glioblastoma", "status": "RECRUITING", "start": "2026-01-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 38, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Glioblastoma (GBM)"], "cn_sites": [{"facility": "2nd Affiliated Hospital, School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07318818", "title": "A Clinical Trial of P134 Cells in Recurrent Glioblastoma", "status": "RECRUITING", "start": "2026-01-05", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 26, "sponsor": "Tasly Pharmaceutical Group Co., Ltd", "conditions": ["Recurrent Glioblastoma IDH Wildtype"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07297212", "title": "A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma", "status": "RECRUITING", "start": "2026-01-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 75, "sponsor": "BioNTech SE", "conditions": ["Recurrent Glioblastoma"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Affiliated Tumor Hospital of Chongqing Medical University", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "Affiliated Cancer Hospital of Shandong First Medical University", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Shenzhen Second People's Hospital", "city": "Shenzhen", "status": "RECRUITING"}, {"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT07410494", "title": "Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors", "status": "RECRUITING", "start": "2026-02-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 85, "sponsor": "Essen Biotech", "conditions": ["Cancer", "Breast Cancer", "Non-Small Cell Lung Cancer (NSCLC)", "Colorectal Cancer (Locally Advanced or Metastatic)", "Prostate Cancer - Recurrent", "Pancreatic Ductal Adenocarcinoma (PDAC)", "Ovarian Cancer", "Glioblastoma", "Melanoma (Skin Cancer)", "Acute Myeloid Leukemia (AML)", "Non Hodgkin Lymphoma", "Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma", "Liver Cancer"], "cn_sites": [{"facility": "District One Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07410676", "title": "EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors", "status": "RECRUITING", "start": "2026-02-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 83, "sponsor": "Essen Biotech", "conditions": ["Cancer", "Sarcoma", "Leukaemia", "Breast Cancer (Locally Advanced or Metastatic)", "Lung Cancer (Diagnosis)", "Colorectal Cancer", "Melanoma (Skin Cancer)", "Bladder Cancer", "Kidney Cancer", "Pancreatic Cancer Metastatic", "Liver Cancer (Primary and Metastatic)", "Ovarian Cancer", "Esophageal Cancer", "Glioblastoma", "Non-Melanoma Skin Cancer"], "cn_sites": [{"facility": "District One Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07480941", "title": "Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma", "status": "RECRUITING", "start": "2026-02-02", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Beijing Biotech", "conditions": ["Glioblastoma", "High-grade Glioma", "Malignant Glioma", "Recurrent Glioblastoma", "Recurrent High-grade Glioma"], "cn_sites": [{"facility": "Peking University Shenzhen Hospital", "city": "Shenzhen", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07455045", "title": "A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG)", "status": "NOT_YET_RECRUITING", "start": "2026-03-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.", "conditions": ["High Grade Glioma (III or IV)", "Diffuse Midline Glioma (DMG)", "Glioblastoma (GBM)"], "cn_sites": [{"facility": "Sun Yat-Sen University Cancer Center", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07523529", "title": "Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors", "status": "RECRUITING", "start": "2026-03-02", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 72, "sponsor": "Beijing Biotech", "conditions": ["Advanced Unresectable", "Metastatic"], "cn_sites": [{"facility": "Peking University Shenzhen Hospital", "city": "Shenzhen", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07551336", "title": "Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma", "status": "RECRUITING", "start": "2026-03-02", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Beijing Biotech", "conditions": ["Malignant Glioma", "High-Grade Gliomas", "Glioblastoma", "Recurrent High-Grade Gliomas", "Recurrent Glioblastoma"], "cn_sites": [{"facility": "Peking University Shenzhen Hospital", "city": "Shenzhen", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07552233", "title": "NK Cell Therapy for Malignant Solid Brain Tumors", "status": "RECRUITING", "start": "2026-04", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 27, "sponsor": "Peking University Third Hospital", "conditions": ["Malignant Solid Brain Tumors", "Glioblastoma (GBM)", "Glioblastoma Multiforme (GBM)", "Brain Metastasis", "Malignant Meningioma"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Qinhuangdao Runze Hospital", "city": "Qinhuangdao", "status": "NOT_YET_RECRUITING"}, {"facility": "Zhengzhou Second Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Henan Academy of Innovations in Medical Science", "city": "Zhengzhou", "status": "RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT07552467", "title": "Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors", "status": "RECRUITING", "start": "2026-04-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 26, "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": ["Pancreatic Cancer", "Breast Cancer", "Lung Cancer", "Sarcoma", "Head and Neck Tumors", "Glioblastoma", "Colorectal Cancer", "Melanoma"], "cn_sites": [{"facility": "Wuhan Union Hospital, China", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07608003", "title": "Multicenter Prospective Study on MRI AI Model for Midline Glioma Subtyping and Prognosis:", "status": "RECRUITING", "start": "2026-05-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Xiangya Hospital of Central South University", "conditions": ["Gliomas Harboring IDH1 and/or IDH2 Mutations", "Glioma Glioblastoma Multiforme", "Glioma of Brainstem", "Glioma, Diffuse Midline, H3K27M-mutant", "Glioma : Oligodendroglioma or Astrocytoma", "Gliomas"], "cn_sites": [{"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07655869", "title": "[177Lu]Lu-DOTA-EB-RGD2 Therapy in Patients With Recurrent High-grade Glioma", "status": "RECRUITING", "start": "2026-06-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Beijing Tiantan Hospital", "conditions": ["Recurrent High-Grade Gliomas", "Recurrent Glioblastoma IDH Wildtype"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07501559", "title": "A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)", "status": "RECRUITING", "start": "2026-06-17", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Jecho Biopharmaceuticals Co., Ltd.", "conditions": ["Recurrent Glioblastoma Multiforme(GBM)"], "cn_sites": [{"facility": "Huashan Hospital, Shanghai Medical College, Fudan University & Beijing TianTan Hospital,Capital Medical University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07648823", "title": "Dosimetry, Safety, and Efficacy Study of [177Lu]Lu-XT771 in Patients With Recurrent Glioblastoma", "status": "RECRUITING", "start": "2026-06-20", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 5, "sponsor": "Beijing Tiantan Hospital", "conditions": ["Recurrent Glioblastoma (WHO-Grade IV Glioma)", "Recurrent Glioblastoma", "Glioblastoma (GBM)", "Recurrent Glioblastoma IDH Wildtype"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07758062", "title": "Levetiracetam Extended-Release Plus Stupp Protocol for Hypoxic IDH-Wildtype Glioblastoma", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 140, "sponsor": "Tianjin Medical University General Hospital", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03914768", "title": "Immune Modulatory DC Vaccine Against Brain Tumor", "status": "NOT_YET_RECRUITING", "start": "2026-12-31", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": ["Diffuse Intrinsic Pontine Glioma or Glioblastoma"], "cn_sites": [{"facility": "Shenzhen Geno-immune Medical Institute", "city": "Shenzhen", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07180927", "title": "DLL3 CAR-T Therapy Targeting Brain Tumors", "status": "NOT_YET_RECRUITING", "start": "2027-06-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": ["Glioblastoma of Cerebellum"], "cn_sites": [{"facility": "Shenzhen Geno-immuno Medical Institute", "city": "Shenzhen", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00870181", "title": "ADV-TK Improves Outcome of Recurrent High-Grade Glioma", "status": "COMPLETED", "start": "2008-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 47, "sponsor": "Huazhong University of Science and Technology", "conditions": ["Malignant Glioma of Brain", "Glioblastoma"], "cn_sites": [{"facility": "Beijing YouAn Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03388372", "title": "Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma", "status": "COMPLETED", "start": "2010-08-18", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 39, "sponsor": "Biotech Pharmaceutical Co., Ltd.", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": ""}, {"facility": "Guangdong Brain Hospital", "city": "Guangdong", "status": ""}, {"facility": "The First Affiliated Hospital/School of Clinical Medicine of Guangdong", "city": "Guangdong", "status": ""}, {"facility": "The First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Shenzhen People's Hospital", "city": "Shenzhen", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT01567202", "title": "Study of DC Vaccination Against Glioblastoma", "status": "UNKNOWN", "start": "2012-03", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Huashan Hospital", "conditions": ["Glioma", "Glioblastoma Multiforme", "Neoplasms"], "cn_sites": [{"facility": "Huashan hospital, Fudan university", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01637753", "title": "Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma", "status": "UNKNOWN", "start": "2012-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 212, "sponsor": "Shandong Lanjin Pharmaceuticals Co.,Ltd", "conditions": ["Anaplastic Astrocytoma", "Anaplastic Oligodendroglioma", "Anaplastic Oligoastrocytoma", "Glioblastoma"], "cn_sites": [{"facility": "Sun Yat-Sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01656980", "title": "Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma", "status": "UNKNOWN", "start": "2012-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 236, "sponsor": "Shandong Lanjin Pharmaceuticals Co.,Ltd", "conditions": ["Anaplastic Astrocytoma", "Anaplastic Oligodendroglioma", "Anaplastic Oligoastrocytoma", "Glioblastoma"], "cn_sites": [{"facility": "Beijing Tiantan Hospital Affiliated to Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01765088", "title": "A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas", "status": "UNKNOWN", "start": "2012-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 300, "sponsor": "Sun Yat-sen University", "conditions": ["Anaplastic Oligoastrocytoma", "Anaplastic Astrocytoma", "Glioblastoma"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02122822", "title": "Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96", "status": "COMPLETED", "start": "2013-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Cure&Sure Biotech Co., LTD", "conditions": ["Glioma"], "cn_sites": [{"facility": "Beijing Tiantan Hospital Affiliated to Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01939574", "title": "A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma", "status": "UNKNOWN", "start": "2013-08", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Shandong Cancer Hospital and Institute", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "Shandong Cancer Hospital and Institute", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02047058", "title": "Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological Characteristics", "status": "UNKNOWN", "start": "2014-03", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 240, "sponsor": "Nanfang Hospital, Southern Medical University", "conditions": ["Glioblastoma", "Malignant Glioma"], "cn_sites": [{"facility": "Nanfang Glioma Centre", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02520635", "title": "Supra-early Post-Surgery Chemotherapy in the Treatment on GBM Patients", "status": "UNKNOWN", "start": "2015-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 180, "sponsor": "Beijing Tiantan Hospital", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02573324", "title": "A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification", "status": "COMPLETED", "start": "2015-01-04", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 691, "sponsor": "AbbVie", "conditions": ["Glioblastoma", "Gliosarcoma"], "cn_sites": [{"facility": "Anhui Provincial Hospital /ID# 166320", "city": "Hefei", "status": ""}, {"facility": "SanboBrain Hospital Capital Medical University /ID# 166422", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital /ID# 157430", "city": "Beijing", "status": ""}, {"facility": "Sun Yat-Sen University Cancer Center /ID# 143919", "city": "Guangzhou", "status": ""}, {"facility": "Tongji Hospital Tongji Medical College of HUST /ID# 163820", "city": "Wuhan", "status": ""}, {"facility": "Duplicate_Xiangya Hospital Central South University /ID# 166791", "city": "Changsha", "status": ""}, {"facility": "The First Affiliated Hospital of Soochow University /ID# 165596", "city": "Suzhou", "status": ""}, {"facility": "Duplicate_Tangdu Hospital /ID# 143920", "city": "Xi'an", "status": ""}, {"facility": "Duplicate_Huashan Hospital of Fudan University /ID# 159999", "city": "Shanghai", "status": ""}, {"facility": "Duplicate_The Second Affiliated Hospital of ZUSM /ID# 165593", "city": "Hangzhou", "status": ""}, {"facility": "Beijing Tian Tan Hospital, Capital Medical University /ID# 167160", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital of Fujian Medical University /ID# 159166", "city": "Fuzhou", "status": ""}, {"facility": "Duplicate_Shengjing Hospital of China Medical University /ID# 167016", "city": "Shenyang", "status": ""}, {"facility": "Duplicate_Tianjin Med Univ General Hosp /ID# 143923", "city": "Tianjin", "status": ""}], "cn_site_count": 14, "broad_only": false}, {"nct": "NCT02629757", "title": "A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas", "status": "UNKNOWN", "start": "2015-04", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Sun Yat-sen University", "conditions": ["Anaplastic Oligoastrocytoma", "Anaplastic Astrocytoma", "Glioblastoma"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02698280", "title": "Bevacizumab and Nimustine in Patients With Recurrent High Grade Glioma", "status": "COMPLETED", "start": "2015-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 23, "sponsor": "Huashan Hospital", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "Huashan hospital, Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02910804", "title": "IRDye800CW-BBN PET-NIRF Imaging Guiding Surgery in Patients With Glioblastoma", "status": "UNKNOWN", "start": "2015-11", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Beijing Tiantan Hospital", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05600491", "title": "A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme", "status": "UNKNOWN", "start": "2015-11-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 78, "sponsor": "Sun Yat-sen University", "conditions": ["Anaplastic Oligoastrocytoma", "Glioblastoma"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02663440", "title": "Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma Multiforme", "status": "UNKNOWN", "start": "2016-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 41, "sponsor": "Zhejiang Cancer Hospital", "conditions": ["Glioblastoma Multiforme"], "cn_sites": [{"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02808364", "title": "Personalized Cellular Vaccine for Recurrent Glioblastoma (PERCELLVAC2)", "status": "COMPLETED", "start": "2016-03-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Guangdong 999 Brain Hospital", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "Guangdong 999 Brain Hospital", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02709616", "title": "Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC)", "status": "COMPLETED", "start": "2016-03-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Guangdong 999 Brain Hospital", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "Guangdong 999 Brain Hospital", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03660761", "title": "Apatinib in Recurrent or Refractory Intracranial Central Nervous System Malignant Tumors", "status": "COMPLETED", "start": "2016-03-03", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 25, "sponsor": "Rongjie Tao", "conditions": ["Efficacy and Safety"], "cn_sites": [{"facility": "Neurosurgery, Shandong Cancer Hospital and Institute", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02728349", "title": "Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma", "status": "COMPLETED", "start": "2016-04-12", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 26, "sponsor": "Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "Beijing Shijitan Hospital,Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02937844", "title": "Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma Multiforme", "status": "UNKNOWN", "start": "2016-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Beijing Sanbo Brain Hospital", "conditions": ["Glioblastoma Multiforme"], "cn_sites": [{"facility": "Sanbo Brain Hospital Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02844062", "title": "Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme", "status": "UNKNOWN", "start": "2016-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Beijing Sanbo Brain Hospital", "conditions": ["Glioblastoma Multiforme"], "cn_sites": [{"facility": "Sanbo Brain Hospital Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02939378", "title": "Ketogenic Diet Adjunctive to Salvage Chemotherapy for Recurrent Glioblastoma:a Pilot Study", "status": "UNKNOWN", "start": "2016-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Song Lin", "conditions": ["Glioblastoma Multiforme"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02685605", "title": "Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme", "status": "ACTIVE_NOT_RECRUITING", "start": "2016-12-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 314, "sponsor": "Universitätsmedizin Mannheim", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "Beijing Tian Tan Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03347097", "title": "Adoptive Cell Therapy of Autologous TIL and PD1-TIL Cells for Patients With Glioblastoma Multiforme", "status": "UNKNOWN", "start": "2017-01-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Huashan Hospital", "conditions": ["Glioblastoma Multiforme"], "cn_sites": [{"facility": "Huashan hospital, Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05476341", "title": "A Phase I Clinical Trial of Bevacizumab Injection", "status": "COMPLETED", "start": "2017-04-06", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 98, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Rectal Cancer", "Lung Cancer", "Ovarian Cancer", "Cervical Cancer", "Glioblastoma"], "cn_sites": [{"facility": "Affiliated Hospital of Changchun University of Traditional Chinese Medicine", "city": "Changchun", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03170141", "title": "Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme", "status": "TERMINATED", "start": "2017-05-31", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": ["Glioblastoma Multiforme of Brain", "Brain Cancer"], "cn_sites": [{"facility": "Shenzhen Geno-immune Medical Institute", "city": "Shenzhen", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03567135", "title": "Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy as a Treatment for Glioblastoma", "status": "UNKNOWN", "start": "2017-10-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 60, "sponsor": "Fuzhou General Hospital", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "Fuzhou General Hospital", "city": "Fuzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03050736", "title": "Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression", "status": "COMPLETED", "start": "2017-12-17", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 29, "sponsor": "Kintara Therapeutics, Inc.", "conditions": ["Glioma", "Glioblastoma", "Glioblastoma Multiforme", "GBM", "Brain Cancer"], "cn_sites": [{"facility": "Sun Yat-Sen University Cancer Center", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03231501", "title": "HMPL-813 in Treating Patients With Glioblastoma", "status": "UNKNOWN", "start": "2018-01-26", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 29, "sponsor": "Hutchison Medipharma Limited", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "Huashan Hospital", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "The second hospital affiliated to Zhejiang University Medical School", "city": "Hanzhou", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT03160599", "title": "Restricted Calorie Ketogenic Diet as a Treatment in Malignant Tumors", "status": "UNKNOWN", "start": "2018-03-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Second Affiliated Hospital of Guangzhou Medical University", "conditions": ["Malignant Tumors"], "cn_sites": [{"facility": "the Second Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03392545", "title": "Combination of Immunization and Radiotherapy for Malignant Gliomas (InSituVac1)", "status": "UNKNOWN", "start": "2018-04-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Beijing Tiantan Hospital", "conditions": ["High Grade Glioma", "Glioblastoma", "Glioma of Brainstem", "Glioma, Malignant"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06562621", "title": "Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma", "status": "COMPLETED", "start": "2018-08-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 38, "sponsor": "Beijing Neurosurgical Institute", "conditions": ["Glioblastoma Multiforme", "Gliomas, Malignant"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06105619", "title": "A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN).", "status": "ACTIVE_NOT_RECRUITING", "start": "2018-10-08", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 84, "sponsor": "Beijing Pearl Biotechnology Limited Liability Company", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "Beijing Tiantan Hospital,Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03734913", "title": "A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors", "status": "UNKNOWN", "start": "2019-01-25", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 65, "sponsor": "Guangdong Zhongsheng Pharmaceutical Co., Ltd.", "conditions": ["Basal Cell Carcinoma", "Medulloblastoma", "Adenocarcinoma of Esophagogastric Junction", "Small Cell Lung Cancer", "Neuroendocrine Neoplasm", "Glioblastoma"], "cn_sites": [{"facility": "Jilin Cancer Hospital", "city": "Changchun", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04119674", "title": "Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma", "status": "COMPLETED", "start": "2019-03-19", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 33, "sponsor": "Zhejiang Cancer Hospital", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "Zhejiang cancer hospital", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04045847", "title": "CD147-CART Cells in Patients With Recurrent Malignant Glioma.", "status": "UNKNOWN", "start": "2019-05-30", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 31, "sponsor": "Xijing Hospital", "conditions": ["Recurrent Glioblastoma", "CD147 Positive"], "cn_sites": [{"facility": "National Translational Science Center for Molecular Medicine & Department of Cell Biology", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04004975", "title": "Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib", "status": "UNKNOWN", "start": "2019-06-25", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Shandong Cancer Hospital and Institute", "conditions": ["Recurrent Glioblastoma"], "cn_sites": [{"facility": "Shandong cancer hospital", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03650257", "title": "A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96", "status": "UNKNOWN", "start": "2019-08-21", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 150, "sponsor": "Cure&Sure Biotech Co., LTD", "conditions": ["Glioma of Brain"], "cn_sites": [{"facility": "Beijing Tiantan Hospital Affiliated to Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04157478", "title": "Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma", "status": "UNKNOWN", "start": "2020-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 464, "sponsor": "People's Hospital of Guangxi Zhuang Autonomous Region", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "Nanxishan Hospital of Guangxi Zhuang Autonomous Region", "city": "Guilin", "status": ""}, {"facility": "Liuzhou Worker's Hospital", "city": "Liuzhou", "status": ""}, {"facility": "Liuzhou People's Hospital", "city": "Liuzhou", "status": ""}, {"facility": "Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": ""}, {"facility": "Affiliated Tumor Hospital of Guangxi Medical University", "city": "Nanning", "status": ""}, {"facility": "People's Hospital of Guangxi Zhuang Autonomous Region", "city": "Nanning", "status": ""}, {"facility": "Yulin First Hospital", "city": "Yulin", "status": ""}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT04270461", "title": "NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors", "status": "WITHDRAWN", "start": "2020-03-17", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Jiujiang University Affiliated Hospital", "conditions": ["Hepatocellular Carcinoma", "Glioblastoma", "Medulloblastoma", "Colon Cancer"], "cn_sites": [{"facility": "Affiliated hospital of jiujiang university", "city": "Jiujiang", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04689087", "title": "A Prospective, Open-label, Single-arm Clinical Study", "status": "UNKNOWN", "start": "2020-04-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Sun Yat-sen University", "conditions": ["Recurrent Glioblastoma Multiforme"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04417933", "title": "Tumor Electric Fields Treatment System for Glioblastoma", "status": "UNKNOWN", "start": "2020-04-07", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 5, "sponsor": "Xiangya Hospital of Central South University", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04547621", "title": "HSRT and IMRT Chemoradiotherapy for Newly Diagnosed GBM", "status": "UNKNOWN", "start": "2020-09-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Huashan Hospital", "conditions": ["Glioma, Malignant"], "cn_sites": [{"facility": "CyberKnife Center, Department of Neurosurgery, Huashan Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04547855", "title": "Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP Regimen", "status": "UNKNOWN", "start": "2020-09-11", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 54, "sponsor": "Yonggao Mou", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04536649", "title": "Proton and Heavy Ion Beam Radiation vs. Photon Beam Radiation for Newly Diagnosed Glioblastoma.", "status": "UNKNOWN", "start": "2020-10-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 369, "sponsor": "Shanghai Proton and Heavy Ion Center", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "Shanghai Proton and Heavy Ion Center", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04829097", "title": "Neoadjuvant Temozolomide Combined With Simultaneous IMRT for Treatment of Glioblastoma", "status": "UNKNOWN", "start": "2020-11-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 80, "sponsor": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "The Affiliated Hospital of Nanjing University Medical School", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04583020", "title": "Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma", "status": "UNKNOWN", "start": "2020-11-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 42, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04388033", "title": "Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.", "status": "UNKNOWN", "start": "2020-12", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Glioblastoma", "Glioma", "Neoplasms, Neuroepithelial", "Neuroectodermal Tumors", "Neoplasms", "Neoplasms, Nerve Tissue", "Vaccines", "Immunologic Factors"], "cn_sites": [{"facility": "The Second Affiliated hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT03776071", "title": "A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1", "status": "COMPLETED", "start": "2020-12-16", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 260, "sponsor": "Denovo Biopharma LLC", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "First Affiliated Hospital of USTC - Anhui Provincial Hospital", "city": "Hefei", "status": ""}, {"facility": "Beijing Tian Tan Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Sanbo Brain Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Sun Yat-Sen University Cancer Center", "city": "Guangzhou", "status": ""}, {"facility": "Shenzhen Second People's Hospital", "city": "Shenzhen", "status": ""}, {"facility": "Tongji Hospital", "city": "Wuhan", "status": ""}, {"facility": "Shengjing Hospital - Nanhu Campus", "city": "Shenyang", "status": ""}, {"facility": "Tangdu Hospital", "city": "Xi'an", "status": ""}, {"facility": "Huashan Hospital Affiliated to Fudan University", "city": "Shanghai", "status": ""}, {"facility": "General Hospital of Tianjin Medical University", "city": "Tianjin", "status": ""}, {"facility": "Tianjin Huanhu Hospital", "city": "Xianshuigu", "status": ""}], "cn_site_count": 12, "broad_only": false}, {"nct": "NCT04600817", "title": "A Study to Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent Chemoradiotherapy (CCRT)", "status": "UNKNOWN", "start": "2020-12-31", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 160, "sponsor": "TJ Biopharma Co., Ltd.", "conditions": ["Newly Diagnosed Glioblastoma"], "cn_sites": [{"facility": "Shenzhen Second People's Hospital", "city": "Shenzhen", "status": ""}, {"facility": "Harbin Medical University Cancer Hospital", "city": "Harbin", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical College of HUST", "city": "Wuhan", "status": ""}, {"facility": "Jiangsu Province Hospital", "city": "Nanjing", "status": ""}, {"facility": "The Second Affiliated Hospital Of Nanchang University", "city": "Nanchang", "status": ""}, {"facility": "Liaoning Cancer Hospital & Institute", "city": "Shenyang", "status": ""}, {"facility": "Shengjing Hospital of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "General Hospital of Ningxia Medical University", "city": "Yinchuan", "status": ""}, {"facility": "Tangdu Hospital of The Fourth Military Medical University of Chinese PLA", "city": "Xi'an", "status": ""}, {"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Chongqiong Cancer Hospital", "city": "Chongqing", "status": ""}, {"facility": "Huashan Hospital Affiliated to Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Tianjin Huanhu Hospital", "city": "Tianjin", "status": ""}, {"facility": "Tianjin Medical University Cancer Institute & Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 15, "broad_only": false}, {"nct": "NCT04715620", "title": "Niraparib Combined With Radiotherapy in rGBM", "status": "UNKNOWN", "start": "2021-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Tianjin Huanhu Hospital", "conditions": ["Recurrent Glioblastoma"], "cn_sites": [{"facility": "Tianjin Huanhu Hosptal", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04725214", "title": "Anlotinib Combined With STUPP for MGMT Nonmethylated Glioblastoma", "status": "UNKNOWN", "start": "2021-01-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 33, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["MGMT-Unmethylated Glioblastoma"], "cn_sites": [{"facility": "The Second Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05131763", "title": "NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors", "status": "UNKNOWN", "start": "2021-03-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 3, "sponsor": "Fudan University", "conditions": ["Hepatocellular Carcinoma", "Glioblastoma", "Medulloblastoma", "Colon Cancer"], "cn_sites": [{"facility": "Xunyang Changchun Shihua Hospital", "city": "Jiujiang", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04814329", "title": "Glioblastoma Response Prediction to Apatinib", "status": "COMPLETED", "start": "2021-04-22", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 18, "sponsor": "Beijing Sanbo Brain Hospital", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "Capital Medical University Sanbo Brain Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04674527", "title": "Pilot Study of Elemene in Treating Patients With Refractory Glioblastoma", "status": "UNKNOWN", "start": "2021-06-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Refractory Glioblastoma"], "cn_sites": [{"facility": "Second Affiliated Hospital, School of Medicine, Zhejiang University", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04902586", "title": "Effect of Radiotherapy Concurrent of TTFields in Patients With Glioblastoma", "status": "UNKNOWN", "start": "2021-06-19", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Zhongnan Hospital", "conditions": ["Glioma", "Glioblastoma"], "cn_sites": [{"facility": "Zhongnan hospital", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04952571", "title": "Combined Treatment of Camrelizumab and Bevacizumab for Adult Patients with Recurrent Glioblastoma (GBM)", "status": "TERMINATED", "start": "2021-06-27", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 3, "sponsor": "Beijing Sanbo Brain Hospital", "conditions": ["Recurrent Glioblastoma"], "cn_sites": [{"facility": "Beijing Sanbo Brain Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04959500", "title": "Newly Diagnosed Glioblastoma", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-07-21", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 150, "sponsor": "Sun Yat-sen University", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "The First Affiliated Hospital of Bengbu Medical College", "city": "Bengbu", "status": ""}, {"facility": "Beijing TianTan Hospital,Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "The Sixth Madical Center of PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "The General Hospital of the People's Liberation Army (PLAGH)", "city": "Beijing", "status": ""}, {"facility": "Chongqing University Cancer Hospital", "city": "Chongqing", "status": ""}, {"facility": "Fujian Provincial Cancer Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Lanzhou University Second Hospital", "city": "Lanzhou", "status": ""}, {"facility": "The First Hospital of Lanzhou University", "city": "Lanzhou", "status": ""}, {"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": ""}, {"facility": "Shenzhen People's Hospital", "city": "Shenzhen", "status": ""}, {"facility": "The Fifth Affiliated Hospital Sun Yat-sen University", "city": "Zhuhai", "status": ""}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "The affiliated hospital of xuzhou medical university", "city": "Xuzhou", "status": ""}, {"facility": "The First Affiliated Hospital of NanChang University", "city": "Nanchang", "status": ""}, {"facility": "Jiangxi Cancer Hospital", "city": "Nanchang", "status": ""}, {"facility": "Gansu Provincial Hospital", "city": "Gansu", "status": ""}, {"facility": "Liaoning Cancer Hospital & Institute", "city": "Shenyang", "status": ""}, {"facility": "Fudan University shabghai cancer center", "city": "Shanghai", "status": ""}, {"facility": "The Second Affiliated Hospital of PLA Air Force Medical University", "city": "Xian", "status": ""}, {"facility": "West China Hospital，Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": ""}], "cn_site_count": 22, "broad_only": false}, {"nct": "NCT04968366", "title": "Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery", "status": "COMPLETED", "start": "2021-07-30", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 11, "sponsor": "Beijing Tiantan Hospital", "conditions": ["Glioblastoma Multiforme of Brain"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05033587", "title": "Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma.", "status": "UNKNOWN", "start": "2021-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 28, "sponsor": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School", "conditions": ["MGMT-Unmethylated Glioblastoma"], "cn_sites": [{"facility": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05447195", "title": "Phase 2 Study of CAN008 in Subjects With GBM", "status": "UNKNOWN", "start": "2021-10-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 117, "sponsor": "CANbridge Life Sciences Ltd.", "conditions": ["Newly-diagnosed Glioblastoma"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04888611", "title": "Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma", "status": "UNKNOWN", "start": "2021-10-26", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Huashan Hospital", "conditions": ["Recurrent Glioblastoma"], "cn_sites": [{"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05131711", "title": "Combination of Stereotactic Radiosurgery and Enhanced Immunotherapy for Recurrent Glioblastomas(inSituVac2)(CSREIG)", "status": "UNKNOWN", "start": "2021-11-16", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Beijing Tiantan Hospital", "conditions": ["Recurrent Glioblastoma"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05201326", "title": "Irinotecan And Bevacizumab Combined With Re-radiotherapy in Recurrent Glioblastoma", "status": "UNKNOWN", "start": "2021-12-22", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Ruijin Hospital", "conditions": ["Recurrent Glioblastoma"], "cn_sites": [{"facility": "Ruijin Hospital, Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05118776", "title": "Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBM", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-01-21", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 136, "sponsor": "Ascletis Pharmaceuticals Co., Ltd.", "conditions": ["Recurrent Glioblastoma"], "cn_sites": [{"facility": "Beijing Tiantan Hospital，Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05241392", "title": "Safety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-01-27", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Beijing Tiantan Hospital", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05333588", "title": "The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme.", "status": "UNKNOWN", "start": "2022-02-15", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Hebei Senlang Biotechnology Inc., Ltd.", "conditions": ["Glioblastoma Multiforme, Adult"], "cn_sites": [{"facility": "The Second Hospital of HeBei Medical University", "city": "Shijiazhuang", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05868083", "title": "The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the Recurrent Glioblastoma", "status": "UNKNOWN", "start": "2022-06-24", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 16, "sponsor": "Shanghai Simnova Biotechnology Co.,Ltd.", "conditions": ["Recurrent Glioblastoma Multiforme"], "cn_sites": [{"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06279767", "title": "Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma", "status": "UNKNOWN", "start": "2022-07-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 27, "sponsor": "The First Affiliated Hospital with Nanjing Medical University", "conditions": ["Glioblastoma", "Cancer", "Temozolomide"], "cn_sites": [{"facility": "Department of Neurosurgery of The First Affiliated Hospital of Nanjing Medical University", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05557240", "title": "Neoantigens Phase I Trial in Newly Diagnosed Glioblastoma Patients", "status": "UNKNOWN", "start": "2022-09-13", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Shanghai 10th People's Hospital", "conditions": ["Glioma, Malignant", "Antigen-specific Vaccines", "Individualized Treatment"], "cn_sites": [{"facility": "Shanghai 10th People's Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07635173", "title": "SM-1 Combined With Temozolomide in Subjects With Refractory or Recurrent High-Grade Gliomas", "status": "COMPLETED", "start": "2022-09-19", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 35, "sponsor": "Shenzhen Zhenxing Medical Technology Co., Ltd", "conditions": ["Glioma", "Glioblastomas (GBM)", "High Grade Gliomas"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05589961", "title": "Safety and Efficacy of TRPP Therapy in Glioblastoma Multiforme", "status": "UNKNOWN", "start": "2022-10", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "The Second Hospital of Hebei Medical University", "conditions": ["Glioblastoma Multiforme"], "cn_sites": [{"facility": "the Second Hospital of HeBei Medical University", "city": "Shijiazhuang", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06600399", "title": "Correlation Between Prostate-specific Membrane Antigen Positron Emission Tomography and Arterial Spin Labeling Perfusion Imaging in Glioblastoma", "status": "COMPLETED", "start": "2022-10-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 26, "sponsor": "Lanzhou University Second Hospital", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "The Second Hospital of Lanzhou University", "city": "Lanzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05611645", "title": "Low-dose Bevacizumab With HSRT vs BVZ Alone for GBM at First Recurrence", "status": "UNKNOWN", "start": "2022-10-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 42, "sponsor": "Huashan Hospital", "conditions": ["Glioma", "Recurrent Glioma"], "cn_sites": [{"facility": "CyberKnife Center, Department of Neurosurgery, Huashan Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07497373", "title": "A Phase I Study to Evaluate the Safety and Tolerability of JL15003 Injection in Patients With Recurrent Glioblastoma", "status": "COMPLETED", "start": "2022-11-16", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 17, "sponsor": "Jecho Biopharmaceuticals Co., Ltd.", "conditions": ["Recurrent Glioblastoma Multiforme(GBM)"], "cn_sites": [{"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Beijing Tsinghua Changgung Hospital", "city": "Beijing", "status": ""}, {"facility": "Huashan Hospital, Shanghai Medical College, Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT05624736", "title": "Hierarchical Diagnosis for Adult Diffuse Glioma Based on Deep Learning", "status": "UNKNOWN", "start": "2022-11-20", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School", "conditions": ["Astrocytoma", "Glioblastoma Multiforme", "Oligodendroglioma"], "cn_sites": [{"facility": "Department of Radiology, the Affiliated Drum Tower Hospital of Nanjing University", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06346821", "title": "Tumor Treating Fields for Newly Diagnosed Glioblastoma: Two Emulated Trials With Chinese Multi-Hospital Based Real-World Data", "status": "COMPLETED", "start": "2022-11-22", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 181, "sponsor": "Sichuan University", "conditions": ["Glioblastoma Multiforme"], "cn_sites": [{"facility": "West China Hospital", "city": "Chengdu", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05663125", "title": "LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas", "status": "UNKNOWN", "start": "2022-12-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Beijing Tiantan Hospital", "conditions": ["Recurrent Glioblastoma"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05539339", "title": "Personalized Trial in ctDNA-level-relapse Glioblastoma", "status": "UNKNOWN", "start": "2022-12-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Henan Provincial People's Hospital", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04385173", "title": "Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma", "status": "UNKNOWN", "start": "2022-12-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Recurrent Glioblastoma", "Refractory Glioblastoma"], "cn_sites": [{"facility": "the Second Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05515133", "title": "Correlation Between Psychological Stress and Disease Progression in Newly Diagnosed Glioblastoma Patients", "status": "UNKNOWN", "start": "2022-12-15", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 60, "sponsor": "Henan Provincial People's Hospital", "conditions": ["Glioblastoma"], "cn_sites": [{"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05638451", "title": "Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients", "status": "UNKNOWN", "start": "2023-05-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Zhujiang Hospital", "conditions": ["Recurrent Glioblastoma"], "cn_sites": [{"facility": "southern medical university affiliated Zhujiang Hospital", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04077866", "title": "B7-H3 CAR-T for Recurrent or Refractory Glioblastoma", "status": "UNKNOWN", "start": "2023-06-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Recurrent Glioblastoma", "Refractory Glioblastoma"], "cn_sites": [{"facility": "the Second Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Huzhou Central Hospital", "city": "Huzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Ningbo Yinzhou People's Hospital", "city": "Ningbo", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT05914935", "title": "Safety and Tolerability Study of Recombinant L-IFN Adenovirus Injection in Patients With Recurrent Glioblastoma", "status": "UNKNOWN", "start": "2023-06-27", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Binhai Hospital of Fujian Medical University", "conditions": ["Recurring Glioblastoma"], "cn_sites": [{"facility": "Binhai Hospital of Fujian Medical University", "city": "Fujian", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06043232", "title": "MMR/MSI Phenotypes in Prediction of Tumor Vaccine Benefit for Gliomas", "status": "UNKNOWN", "start": "2023-09", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 360, "sponsor": "Huashan Hospital", "conditions": ["Glioma"], "cn_sites": [{"facility": "Huashan Hospital，Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06193538", "title": "The Safety and Effectiveness of NV-A01 in Glioma Patients", "status": "UNKNOWN", "start": "2023-09-14", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "First Affiliated Hospital of Wannan Medical College", "conditions": ["Advanced Glioblastoma Patients"], "cn_sites": [{"facility": "Wannan medical college hospital", "city": "Wuhu", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06147505", "title": "XS005 Injection Combined With Stupp Regimen for Adjuvant Chemotherapy in Subjects With Primary Glioblastoma(GBM)", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-10-29", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 13, "sponsor": "Dushu Lake Hospital Affiliated to Soochow University", "conditions": ["Tumor"], "cn_sites": [{"facility": "Dushu Lake Hospital Affiliated to Soochow University", "city": "Suzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06353360", "title": "TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.", "status": "UNKNOWN", "start": "2024-04-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Jiangsu Healthy Life Innovation Medical Technology Co., Ltd", "conditions": ["Glioblastoma Multiforme"], "cn_sites": [{"facility": "Huashan Hospital affiliated to Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06585527", "title": "Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma", "status": "UNKNOWN", "start": "2024-08-29", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Beijing Neurosurgical Institute", "conditions": ["Glioblastoma Multiforme", "Glioma, Malignant"], "cn_sites": [{"facility": "Beijing Tiantan Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07651020", "title": "The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors", "status": "COMPLETED", "start": "2025-03-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1, "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": ["Pancreatic Cancer", "Breast Cancer", "Lung Cancer", "Sarcoma", "Head and Neck Cancers", "Glioblastoma", "Colorectal Cancer", "Melanoma", "Ovarian Cancer"], "cn_sites": [{"facility": "Wuhan Union Hospital, China", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 432, "g_fetched": 174, "g_countries": [["United States", 96], ["France", 14], ["Germany", 13], ["United Kingdom", 11], ["Switzerland", 10], ["Italy", 10], ["Netherlands", 10], ["Canada", 9], ["Belgium", 7], ["Australia", 6], ["Taiwan", 6], ["Poland", 6], ["Spain", 6], ["Denmark", 5], ["Greece", 3], ["Austria", 3], ["Sweden", 3], ["Israel", 2], ["Japan", 2], ["South Korea", 2], ["Singapore", 2], ["Czechia", 1], ["Norway", 1], ["New Zealand", 1], ["India", 1], ["Puerto Rico", 1], ["Hungary", 1], ["Russia", 1], ["Portugal", 1]], "g_trials": [{"nct": "NCT07349693", "title": "Comparison of Cerebraca Wafer Plus Temozolomide Versus Temozolomide Alone in Recurrent Glioblastoma", "status": "NOT_YET_RECRUITING", "start": "2027-04-01", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Everfront Biotech Co., Ltd.", "countries": ["United States"]}, {"nct": "NCT07791264", "title": "FPS-ZM1 With or Without Dexamethasone for Controlling Post Operative Cerebral Edema in Patients With Glioblastoma", "status": "NOT_YET_RECRUITING", "start": "2027-02-17", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "City of Hope Medical Center", "countries": ["United States"]}, {"nct": "NCT07546669", "title": "Efficacy of Zoster Vaccination in Glioblastoma Patients", "status": "NOT_YET_RECRUITING", "start": "2027-01-02", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Essen", "countries": []}, {"nct": "NCT07689721", "title": "ctDNA-Guided Intraventricular Therapy for CNS Malignancies", "status": "NOT_YET_RECRUITING", "start": "2027-01-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Alireza Mansouri", "countries": []}, {"nct": "NCT04373785", "title": "NG101m Adjuvant Therapy in Glioblastoma Patients", "status": "NOT_YET_RECRUITING", "start": "2027-01-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "NeuGATE Theranostics", "countries": ["United States"]}, {"nct": "NCT01777919", "title": "Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform", "status": "NOT_YET_RECRUITING", "start": "2027-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Olympion Medical Center", "countries": ["Greece"]}, {"nct": "NCT07775534", "title": "Tear Fluid for the Detection of Tumor-associated Extracellular Vesicles in Glioblastoma Patients", "status": "NOT_YET_RECRUITING", "start": "2026-12-09", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "City of Hope Medical Center", "countries": ["United States"]}, {"nct": "NCT06448286", "title": "PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma", "status": "NOT_YET_RECRUITING", "start": "2026-12-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Jonsson Comprehensive Cancer Center", "countries": ["United States"]}, {"nct": "NCT07590726", "title": "PIRe 2.0: A Stepped-Care Model for Involving Relatives Across Sectors", "status": "NOT_YET_RECRUITING", "start": "2026-10-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Rigshospitalet, Denmark", "countries": ["Denmark"]}, {"nct": "NCT07712770", "title": "Pilot Radioembolisation Clinical Trial Assessing Safety and Efficacy in Recurrent Glioma", "status": "NOT_YET_RECRUITING", "start": "2026-10", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Olivia Newton-John Cancer Research Institute", "countries": ["Australia"]}, {"nct": "NCT07089758", "title": "A Study for Cerebral Open Flow Microperfusion", "status": "NOT_YET_RECRUITING", "start": "2026-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Mayo Clinic", "countries": ["United States"]}, {"nct": "NCT07781852", "title": "Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Lumina Pharmaceuticals Inc", "countries": ["United States"]}, {"nct": "NCT07670455", "title": "Brain Radiotherapy Imaging for High-grade Glioma Using Hypoxia Targeting Through Oxygen-Enhanced Response", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "The Leeds Teaching Hospitals NHS Trust", "countries": []}, {"nct": "NCT07769918", "title": "Hypoxia-targeted Radiotherapy Boost for GBM", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "NYU Langone Health", "countries": ["United States"]}, {"nct": "NCT07422896", "title": "A Phase I First-in-human Trial of Bvax (B-cell Vaccination) in Addition to Standard of Care Chemoradiotherapy for Newly Diagnosed Glioblastoma", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Catalina Lee Chang", "countries": ["United States"]}, {"nct": "NCT07762716", "title": "Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "BreakBio Corp", "countries": ["United States"]}, {"nct": "NCT07735819", "title": "Positron Emission Tomography/Computed Tomography (PET/CT) Imaging in Patients Diagnosed With a Glioma", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Barbara Ann Karmanos Cancer Institute", "countries": ["United States"]}, {"nct": "NCT07708961", "title": "Temozolomide, With or Without WSD0922-FU, for the Treatment of EGFR-Mutant, IDH-Wildtype Glioblastoma", "status": "RECRUITING", "start": "2026-08-28", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Mayo Clinic", "countries": ["United States"]}, {"nct": "NCT07579208", "title": "A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma", "status": "RECRUITING", "start": "2026-08-21", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "M.D. Anderson Cancer Center", "countries": ["United States"]}, {"nct": "NCT07356973", "title": "Irinotecan-ChemoSeed in Surgically Resectable Glioblastoma", "status": "RECRUITING", "start": "2026-08-20", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "CRISM Therapeutics LTD", "countries": ["United Kingdom"]}, {"nct": "NCT04903795", "title": "BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma", "status": "RECRUITING", "start": "2026-08-17", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Mustafa Khasraw, MBChB, MD, FRCP, FRACP", "countries": ["United States"]}, {"nct": "NCT07628062", "title": "Phase 2 Study of NAI, HPV Vaccine, and Nab-Paclitaxel in HPV-Positive Oropharyngeal Cancer Followed by De-Intensified Radiation Compared With Standard Chemoradiation", "status": "NOT_YET_RECRUITING", "start": "2026-07-22", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "ImmunityBio, Inc.", "countries": []}, {"nct": "NCT07452458", "title": "Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma", "status": "RECRUITING", "start": "2026-07-16", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "NRG Oncology", "countries": ["United States"]}, {"nct": "NCT07416188", "title": "Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma", "status": "RECRUITING", "start": "2026-07-15", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "National Institute of Neurological Disorders and Stroke (NINDS)", "countries": ["United States"]}, {"nct": "NCT07678138", "title": "Exploratory Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of Tumor Neoantigen-pulsed Autologous Dendritic Cell Injection (YS247, Beijing YSCell Biotech Co., Ltd. [Abbreviated as YS])in Patients With Recurrent or Progressive Glioblastoma", "status": "NOT_YET_RECRUITING", "start": "2026-06-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Huanhu Hospital Affiliated to Tianjin Medical University", "countries": []}]}, {"batch": 2, "no": 39, "name_zh": "高林综合征", "query_terms": [{"term": "Gorlin syndrome", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 5, "g_fetched": 5, "g_countries": [["United States", 3], ["Netherlands", 2]], "g_trials": [{"nct": "NCT06623201", "title": "Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas", "status": "RECRUITING", "start": "2024-10-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Nathalie Zeitouni", "countries": ["United States"]}, {"nct": "NCT06330350", "title": "Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling", "status": "RECRUITING", "start": "2024-01-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Maastricht University Medical Center", "countries": ["Netherlands"]}, {"nct": "NCT05463757", "title": "Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study", "status": "RECRUITING", "start": "2021-11-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Maastricht University Medical Center", "countries": ["Netherlands"]}, {"nct": "NCT03050268", "title": "Familial Investigations of Childhood Cancer Predisposition", "status": "RECRUITING", "start": "2017-04-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "St. Jude Children's Research Hospital", "countries": ["United States"]}, {"nct": "NCT04569149", "title": "Primordial Dwarfism Registry", "status": "RECRUITING", "start": "2008-03-11", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Nemours Children's Clinic", "countries": ["United States"]}]}, {"batch": 2, "no": 40, "name_zh": "化脓性汗腺炎", "query_terms": [{"term": "Hidradenitis suppurativa", "broad": false}], "n_total": 21, "n_open": 13, "n_open_precise": 13, "n_broad": 0, "trials": [{"nct": "NCT06926192", "title": "Efficacy and Safety of Secukinumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa", "status": "RECRUITING", "start": "2020-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Peking Union Medical College", "conditions": ["Hidradenitis Suppurativa (HS)", "Hidradenitis Suppurativa (Acne Inversa)", "Secukinumab"], "cn_sites": [{"facility": "Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Science and Peking Union Medical College", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06707246", "title": "A Randomized Trial Comparing the Efficacy and Safety of Secukinumab with Tofacitinib in the Treatment of Moderate to Severe Hidradenitis Suppurativa in Chinese Patients", "status": "RECRUITING", "start": "2024-12-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Hidradenitis Suppurativa"], "cn_sites": [{"facility": "Jiaqi Chen", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06895499", "title": "Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients.", "status": "RECRUITING", "start": "2025-03-19", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Shanghai Huaota Biopharmaceutical Co., Ltd.", "conditions": ["Hidradenitis Suppurativa"], "cn_sites": [{"facility": "Dermatology Hospital affiliated to Shandong First Medical University", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06946641", "title": "A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients", "status": "RECRUITING", "start": "2025-03-31", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 102, "sponsor": "Shanghai Qilu Pharmaceutical Research and Development Center LTD", "conditions": ["Atopic Dermatitis", "Hidradenitis Suppurativa (HS)", "Rheumatoid Arthritis (RA)"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07109765", "title": "Secukinumab Treatment for Moderate to Severe Hidradenitis Suppurativa", "status": "RECRUITING", "start": "2025-06-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 50, "sponsor": "Peking Union Medical College", "conditions": ["Hidradenitis Suppurativa (HS)"], "cn_sites": [{"facility": "No. 1 Shuai Fu Yuan, Dongcheng District, Beijing", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06932003", "title": "A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Patients With Hidradenitis Suppurativa", "status": "RECRUITING", "start": "2025-07-08", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.", "conditions": ["Hidradenitis Suppurativa (HS)"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07170917", "title": "Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa", "status": "RECRUITING", "start": "2025-11-06", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 208, "sponsor": "Sanofi", "conditions": ["Hidradenitis Suppurativa"], "cn_sites": [{"facility": "Investigational Site Number : 1560002", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560001", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560004", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560005", "city": "Ürümqi", "status": "RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT07261072", "title": "Comparison of the Clinical Efficacy and Safety of Topical and Subcutaneous Injection of Secukinumab in HS", "status": "NOT_YET_RECRUITING", "start": "2025-12-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Peking Union Medical College", "conditions": ["Hidradenitis Suppurativa (HS)", "Hidradenitis Suppurativa (Acne Inversa)", "Secukinumab"], "cn_sites": [{"facility": "Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Science and Peking Union Medical College, Nanjing, Jiangsu 210042", "city": "Nanjing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07225569", "title": "A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa", "status": "RECRUITING", "start": "2025-12-29", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 144, "sponsor": "Sanofi", "conditions": ["Hidradenitis Suppurativa"], "cn_sites": [{"facility": "Investigational Site Number : 1560001", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560003", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560004", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Investigational Site Number : 1560002", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT07755670", "title": "Exploration of Brain Functional Networks in Patients With Hidradenitis Suppurativa Using fMRI", "status": "RECRUITING", "start": "2026-01-03", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 80, "sponsor": "Second Xiangya Hospital of Central South University", "conditions": ["Hidradenitis Suppurativa (HS)"], "cn_sites": [{"facility": "Second Xiangya Hospital of Central South University", "city": "Changsha", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07244263", "title": "A Study of Zasocitinib in Adults With Hidradenitis Suppurativa", "status": "RECRUITING", "start": "2026-01-26", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "Takeda", "conditions": ["Hidradenitis Suppurativa"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Southern Medical Universtiy - Dermatology Hospital (SMUDH) (Guangdong Provincial Dermatology Hospital)", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Union Hospital Tongji Medical College of Huazhong University of Science and Technology (HUST)", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}, {"facility": "Huashan Hospital, Fudan University, Shanghai", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT07554014", "title": "A Single-center, Prospective, Self-controlled, Observational Real-world Study of the Efficacy and Safety of Anti-IL-17A/F Monoclonal Antibody Combined With Non-ablative Dot Laser for the Treatment of Mild to Moderate Hidradenitis Suppurativa", "status": "NOT_YET_RECRUITING", "start": "2026-04-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Hidradenitis Suppurativa (HS)"], "cn_sites": [{"facility": "2nd Affiliated Hospital, School of Medicine, Zhejiang University, China", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07489573", "title": "Study of Efficacy and Safety of Secukinumab in Chinese Adult Patients With Moderate to Severe Hidradenitis Suppurativa", "status": "RECRUITING", "start": "2026-06-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Hidradenitis Suppurativa (HS)"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Shijiazhuang", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Ningbo", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Wenzhou", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT06568224", "title": "Therapeutic Effect of Methalazine on 27 Cases of Suppurative Hidradenitis", "status": "COMPLETED", "start": "2020-05-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 27, "sponsor": "The First Affiliated Hospital with Nanjing Medical University", "conditions": ["Hidradenitis Suppurativa"], "cn_sites": [{"facility": "Jiangsu Provincial People's Hospital", "city": "Nanjing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05103423", "title": "Safety and Efficacy Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)", "status": "COMPLETED", "start": "2021-06-24", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Staidson (Beijing) Biopharmaceuticals Co., Ltd", "conditions": ["Hidradenitis Suppurativa"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Plastic Surgery Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College", "city": "Beijing", "status": ""}, {"facility": "The Third Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "Union Hospital Tongji Medical College Huazong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Xiangya Hospital, Central South University", "city": "Changsha", "status": ""}, {"facility": "Chinese Academy of Medical Sciences and Peking Union Medical College", "city": "Nanjing", "status": ""}, {"facility": "The First Hospital of Jilin Universitv", "city": "Changchun", "status": ""}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "The First Affiliated Hospital of Air Force Medical University", "city": "Xi'an", "status": ""}, {"facility": "The Second Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi'an", "status": ""}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": ""}, {"facility": "Huashan Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Skin Disease Hospital", "city": "Shanghai", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}], "cn_site_count": 15, "broad_only": false}, {"nct": "NCT05093855", "title": "Efficacy and Safety Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)", "status": "COMPLETED", "start": "2021-08-18", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 41, "sponsor": "Staidson (Beijing) Biopharmaceuticals Co., Ltd", "conditions": ["Hidradenitis Suppurativa"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College", "city": "Beijing", "status": ""}, {"facility": "The Third Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "Union Hospital Tongji Medical College Huazong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Xiangya Hospital, Central South University", "city": "Changsha", "status": ""}, {"facility": "Chinese Academy of Medical Sciences and Peking Union Medical College", "city": "Nanjing", "status": ""}, {"facility": "The First Hospital of Jilin Universitv", "city": "Changchun", "status": ""}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "The Second Affiliated Hospital of Air Force Medical University", "city": "Xi'an", "status": ""}, {"facility": "The Second Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi'an", "status": ""}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": ""}, {"facility": "Huashan Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Skin Disease Hospital", "city": "Shanghai", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}], "cn_site_count": 15, "broad_only": false}, {"nct": "NCT05819398", "title": "Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa", "status": "COMPLETED", "start": "2023-04-17", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 209, "sponsor": "Boehringer Ingelheim", "conditions": ["Hidradenitis Suppurativa"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "The Second Xiangya Hospital Of Central South University", "city": "Changsha", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Southern Medical University Dermatology Hospital", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital, Zhejiang University", "city": "Hangzhou", "status": ""}, {"facility": "Shanghai Skin Disease Hospital", "city": "Shanghai", "status": ""}, {"facility": "Xinjiang Uygur Autonomous Region People's Hospital", "city": "Ürümqi", "status": ""}, {"facility": "Wuhan Union Hospital", "city": "Wuhan", "status": ""}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT06082323", "title": "A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers", "status": "COMPLETED", "start": "2024-06-13", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 150, "sponsor": "Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.", "conditions": ["Healthy Volunteer", "Hidradenitis Suppurativa", "Atopic Dermatitis"], "cn_sites": [{"facility": "Shanghai Xuhui Distric Central Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06799000", "title": "A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-01-31", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 588, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Hidradenitis Suppurativa"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Fuzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Wuhan", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Changsha", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Changchun", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shenyang", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Xian", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Chengdu", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Ürümqi", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Ningbo", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Jinan", "status": ""}], "cn_site_count": 12, "broad_only": false}, {"nct": "NCT06956235", "title": "Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012)", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-06-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 149, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Hidradenitis Suppurativa"], "cn_sites": [{"facility": "Dermatology Hospital of Southern Medical University ( Site 1504)", "city": "Guangzhou", "status": ""}, {"facility": "The Second Xiangya Hospital of Central South University ( Site 1505)", "city": "Changsha", "status": ""}, {"facility": "The First Hospital of Jilin University ( Site 1502)", "city": "Changchun", "status": ""}, {"facility": "Ruijin Hospital Shanghai Jiaotong University School of Medicine ( Site 1515)", "city": "Shanghai", "status": ""}, {"facility": "Huashan Hospital of Fudan University ( Site 1506)", "city": "Shanghai", "status": ""}, {"facility": "PEOPLE'S HOSPITAL OF XINJIANG UYGUR AUTONOMOUS REGION ( Site 1509)", "city": "Ürümqi", "status": ""}, {"facility": "The first Affiliated Hospital, Zhejiang University School of Medicine ( Site 1501)", "city": "Hangzhou", "status": ""}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT07727889", "title": "A 24-Week Real-World Study of Upadacitinib in Moderate-to-Severe Hidradenitis Suppurativa", "status": "ACTIVE_NOT_RECRUITING", "start": "2026-07-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Peking Union Medical College", "conditions": ["Hidradenitis Suppurativa (Acne Inversa)"], "cn_sites": [{"facility": "No. 1 Shuai Fu Yuan, Dongcheng District, Beijing", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 80, "g_fetched": 67, "g_countries": [["United States", 32], ["Canada", 10], ["France", 9], ["Germany", 7], ["Netherlands", 6], ["Spain", 6], ["Poland", 5], ["Italy", 4], ["Switzerland", 4], ["Argentina", 3], ["Bulgaria", 3], ["South Korea", 3], ["Czechia", 3], ["United Kingdom", 3], ["Australia", 2], ["Hungary", 2], ["Romania", 2], ["Greece", 2], ["Georgia", 1], ["Turkey (Türkiye)", 1], ["Colombia", 1], ["Estonia", 1], ["Japan", 1], ["Latvia", 1], ["Puerto Rico", 1], ["Taiwan", 1], ["Saudi Arabia", 1], ["Austria", 1], ["Belgium", 1], ["Chile", 1]], "g_trials": [{"nct": "NCT07690319", "title": "A Study of Early Secukinumab Treatment in Moderate to Severe Hidradenitis Suppurativa Patients", "status": "NOT_YET_RECRUITING", "start": "2026-10-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": []}, {"nct": "NCT07812116", "title": "A Study to Investigate Efficacy and Safety of Duvakitug in Adult Participants With Moderate to Severe Hidradenitis Suppurativa", "status": "NOT_YET_RECRUITING", "start": "2026-10-13", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Sanofi", "countries": []}, {"nct": "NCT07804134", "title": "Skin-in-Sight: a Longitudinal Cohort Infrastructure for Standardized Remote Monitoring and the Evaluation of Digital Care Innovations in Chronic Skin Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-10-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Medisch Spectrum Twente", "countries": ["Netherlands"]}, {"nct": "NCT07756346", "title": "Botulinum Toxin Blockade of Neuronal Signals to Immune Cells as a Novel Treatment for Hidradenitis Suppurativa", "status": "NOT_YET_RECRUITING", "start": "2026-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University of Massachusetts, Worcester", "countries": ["United States"]}, {"nct": "NCT07454889", "title": "A Real-world Study of Patients With Hidradenitis Suppurativa and High Cardiovascular Risk or Established Coronary Plaque Treated With Secukinumab", "status": "NOT_YET_RECRUITING", "start": "2026-09-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": []}, {"nct": "NCT07263230", "title": "The Safety and Efficacy of Roflumilast Foam in HS", "status": "RECRUITING", "start": "2026-09-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Beth Israel Deaconess Medical Center", "countries": ["United States"]}, {"nct": "NCT07800416", "title": "Mediterranean Dietary Intervention for HS", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of North Carolina, Chapel Hill", "countries": ["United States"]}, {"nct": "NCT07828860", "title": "Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Corvus Pharmaceuticals, Inc.", "countries": ["United States"]}, {"nct": "NCT07766005", "title": "A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Spyre Therapeutics, Inc.", "countries": ["United States"]}, {"nct": "NCT07748169", "title": "An Observational Study of Patients With Dermatologic Disease", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Target PharmaSolutions, Inc.", "countries": ["United States"]}, {"nct": "NCT07805798", "title": "Urinary Bladder Matrix (UBM) Registry", "status": "NOT_YET_RECRUITING", "start": "2026-08-31", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Integra LifeSciences Corporation", "countries": []}, {"nct": "NCT07783542", "title": "ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa", "status": "RECRUITING", "start": "2026-08-20", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Oruka Therapeutics, Inc.", "countries": ["United States"]}, {"nct": "NCT07689188", "title": "Safety and Efficacy of Roflumilast Foam 0.3% in Adolescent and Adult Subjects With Hidradenitis Suppurativa", "status": "NOT_YET_RECRUITING", "start": "2026-08-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Harrison Dermatology", "countries": ["United States"]}, {"nct": "NCT07665437", "title": "An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS", "status": "RECRUITING", "start": "2026-07-10", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": ["Argentina", "Australia", "Canada", "United States"]}, {"nct": "NCT06960447", "title": "Nd:YAG vs Alexandrite Laser Treatment in Hidradenitis Suppurativa", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Geisinger Clinic", "countries": []}, {"nct": "NCT07668713", "title": "FEcal tranSplantation in HidradeniTIs suppuratiVA : a piLot Study", "status": "NOT_YET_RECRUITING", "start": "2026-06-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Clermont-Ferrand", "countries": ["France"]}, {"nct": "NCT07629336", "title": "SAR447971 First-in-human Study", "status": "RECRUITING", "start": "2026-05-26", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Sanofi", "countries": ["Netherlands"]}, {"nct": "NCT07547813", "title": "A Proof-of-Concept Study of LAD328 in Adults With Hidradenitis Suppurativa", "status": "RECRUITING", "start": "2026-05-13", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Almirall, S.A.", "countries": ["Poland"]}, {"nct": "NCT07414550", "title": "Radiotherapy for Refractory Hidradenitis Suppurativa", "status": "RECRUITING", "start": "2026-05-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Thomas Jefferson University", "countries": ["United States"]}, {"nct": "NCT07417917", "title": "QLS12010 Capsules in Adults With Moderate to Severe Hidradenitis Suppurativa", "status": "NOT_YET_RECRUITING", "start": "2026-04-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Qilu Pharmaceutical Co., Ltd.", "countries": []}, {"nct": "NCT07213973", "title": "Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa", "status": "RECRUITING", "start": "2026-02-02", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Incyte Corporation", "countries": ["Canada", "United States"]}, {"nct": "NCT07388446", "title": "MAIT Cells in Hidradenitis Suppurativa", "status": "NOT_YET_RECRUITING", "start": "2026-02-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Hospices Civils de Lyon", "countries": ["France"]}, {"nct": "NCT07384975", "title": "A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa", "status": "RECRUITING", "start": "2026-01-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Navigator Medicines, Inc.", "countries": ["Bulgaria", "Canada", "Georgia", "Germany", "Hungary", "Poland", "Romania", "United States"]}, {"nct": "NCT07336641", "title": "LANDSCAPE: Demographics and Treatment Patterns of Patients With Immune-Mediated Inflammatory Skin Diseases in Italian Clinical Practice", "status": "NOT_YET_RECRUITING", "start": "2026-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondazione ISIDE", "countries": ["Italy"]}, {"nct": "NCT07291193", "title": "Impact of Sex Hormones on Human Skin Immunity in Health and Hidradenitis Suppurativa (SIAP)", "status": "NOT_YET_RECRUITING", "start": "2026-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Institut Pasteur", "countries": []}]}, {"batch": 2, "no": 41, "name_zh": "早老症", "query_terms": [{"term": "Hutchinson-Gilford progeria syndrome", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 1, "g_fetched": 1, "g_countries": [], "g_trials": [{"nct": "NCT07803432", "title": "Creating Stem Cells From a Progeria Patient's Blood to Test Candidate Treatments in the Lab", "status": "NOT_YET_RECRUITING", "start": "2026-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Bundang CHA Hospital", "countries": []}]}, {"batch": 2, "no": 42, "name_zh": "炎性肌纤维母细胞瘤", "query_terms": [{"term": "Inflammatory myofibroblastic tumor", "broad": false}], "n_total": 3, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT02971176", "title": "Low-dose Protocol for Computed Tomography-guided Lung Biopsy", "status": "COMPLETED", "start": "2016-11-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 280, "sponsor": "Xuzhou Central Hospital", "conditions": ["Lung Cancer, Adenocarcinoma", "Lung Inflammatory Pseudotumor"], "cn_sites": [{"facility": "Xuzhou Central Hospital", "city": "Xuzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04572594", "title": "Molecular Profiling and Molecular Labeling of Inflammatory Myofibroblastic Tumor", "status": "UNKNOWN", "start": "2020-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 29, "sponsor": "Sun Yat-sen University", "conditions": ["Inflammatory Myofibroblatic Tumor"], "cn_sites": [{"facility": "Cancer center of SunYat-sen University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05160922", "title": "Crizotinib Continuation Clinical Study", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-12-27", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 27, "sponsor": "Pfizer", "conditions": ["NSCLC", "ALCL", "IMT"], "cn_sites": [{"facility": "Cancer Hospital Chinese Academy of Medical Science", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Fujian Province Oncology Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Sun Yat-Sen University Cancer center", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Guangzhou Medical University.", "city": "Guangzhou", "status": ""}, {"facility": "Jilin Cancer Hospital", "city": "Changchun", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Wuhou District", "status": ""}, {"facility": "The First Affiliated Hospital of College of Medicine,Zhejiang University", "city": "Hangzhou", "status": ""}, {"facility": "Shanghai Chest Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 9, "broad_only": false}], "g_total": 3, "g_fetched": 3, "g_countries": [["United States", 2], ["France", 2], ["Netherlands", 1], ["Australia", 1], ["Canada", 1], ["Denmark", 1], ["Italy", 1], ["Singapore", 1], ["South Korea", 1], ["Spain", 1], ["Taiwan", 1], ["United Kingdom", 1]], "g_trials": [{"nct": "NCT06239272", "title": "NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)", "status": "RECRUITING", "start": "2024-03-27", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "St. Jude Children's Research Hospital", "countries": ["United States"]}, {"nct": "NCT04925609", "title": "Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors", "status": "RECRUITING", "start": "2022-08-18", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Princess Maxima Center for Pediatric Oncology", "countries": ["France", "Netherlands"]}, {"nct": "NCT04094610", "title": "A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations", "status": "RECRUITING", "start": "2020-03-12", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Turning Point Therapeutics, Inc.", "countries": ["Australia", "Canada", "Denmark", "France", "Italy", "Singapore", "South Korea", "Spain", "Taiwan", "United Kingdom", "United States"]}]}, {"batch": 2, "no": 43, "name_zh": "Leber先天性黑矇", "query_terms": [{"term": "Leber congenital amaurosis", "broad": false}], "n_total": 3, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT05906953", "title": "Safety and Efficacy Trial of HG004 for Leber Congenital Amaurosis Related to Rpe65 Gene Mutations (STAR)", "status": "RECRUITING", "start": "2023-10-31", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "HuidaGene Therapeutics Co., Ltd.", "conditions": ["Leber Congenital Amaurosis", "Inherited Retinal Diseases Caused by RPE65 Mutations"], "cn_sites": [{"facility": "Research Site", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03566147", "title": "Treatment of RP and LCA by Primary RPE Transplantation", "status": "UNKNOWN", "start": "2018-08-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Eyecure Therapeutics Inc.", "conditions": ["Leber Congenital Amaurosis, Retinitis Pigmentosa"], "cn_sites": [{"facility": "Beijing Tongren Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06088992", "title": "Leber Congenital Amaurosis Inherited Blindness of Gene Therapy Trial(LIGHT)", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-01-10", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": ["Leber Congenital Amaurosis"], "cn_sites": [{"facility": "Xinhua Hospital affiliated with Shanghai Jiao Tong UniversitySchool of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 6, "g_fetched": 5, "g_countries": [["United States", 4], ["Belgium", 1], ["Brazil", 1], ["Canada", 1], ["France", 1], ["Germany", 1], ["Netherlands", 1], ["Spain", 1], ["United Kingdom", 1], ["Australia", 1]], "g_trials": [{"nct": "NCT07681778", "title": "Safety and Tolerability of Subretinal OPGx-RDH12-1001 for LCA-Associated Inherited Retinal Degeneration (LCA-IRD)", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Opus Genetics, Inc", "countries": ["United States"]}, {"nct": "NCT06891443", "title": "Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)", "status": "RECRUITING", "start": "2025-06-04", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Laboratoires Thea", "countries": ["Belgium", "Brazil", "Canada", "France", "Germany", "Netherlands", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT06024057", "title": "An Expanded Clinical Study Evaluating the AAV2-RPE65 Gene Therapy(LX101) in Patients With LCA", "status": "NOT_YET_RECRUITING", "start": "2023-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine", "countries": []}, {"nct": "NCT02435940", "title": "Inherited Retinal Degenerative Disease Registry", "status": "RECRUITING", "start": "2014-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Foundation Fighting Blindness", "countries": ["United States"]}, {"nct": "NCT01793168", "title": "Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford", "status": "RECRUITING", "start": "2010-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sanford Health", "countries": ["Australia", "United States"]}]}, {"batch": 2, "no": 44, "name_zh": "Lennox-Gastaut 综合征", "query_terms": [{"term": "Lennox-Gastaut syndrome", "broad": false}], "n_total": 9, "n_open": 2, "n_open_precise": 2, "n_broad": 0, "trials": [{"nct": "NCT06908226", "title": "A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)", "status": "ENROLLING_BY_INVITATION", "start": "2025-02-12", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 324, "sponsor": "Longboard Pharmaceuticals", "conditions": ["Developmental and Epileptic Encephalopathy"], "cn_sites": [{"facility": "Peking University First Hospital (Beida Hospital)", "city": "Beijing", "status": ""}, {"facility": "Capital Medical University-Beijing Children's Hospital", "city": "Beijing", "status": ""}, {"facility": "Guangzhou Medical University-The Second Affiliated Hospital", "city": "Guangzhou", "status": ""}, {"facility": "Wuhan Children's Hospital", "city": "Wuhan", "status": ""}, {"facility": "Fudan University - Children's Hospital", "city": "Shanghai Shi", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT05066217", "title": "An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome", "status": "RECRUITING", "start": "2025-04-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 260, "sponsor": "Epygenix", "conditions": ["Lennox Gastaut Syndrome"], "cn_sites": [{"facility": "Peking University First Hospital - Changqiao Campus", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking University First Hospital - Daxing Campus", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Children's Hospital, Capital Medical University - PIN", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": "RECRUITING"}, {"facility": "Hunan Children's Hospital", "city": "Changsha", "status": "RECRUITING"}, {"facility": "West China Second University Hospital, Sichuan University - Huaxi Campus", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Chengdu Women's and Children's Central Hospital", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Children's Hospital of Chongqing Medical University", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "The Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": "RECRUITING"}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Jiangxi Provincial Children's Hospital", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": "RECRUITING"}, {"facility": "Wuhan Children's Hospital", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "Xuzhou Children's Hospital", "city": "Xuzhou", "status": "RECRUITING"}], "cn_site_count": 16, "broad_only": false}, {"nct": "NCT02632149", "title": "Trial to Assess Vagus Nerve Stimulation Therapy in Children With Lennox-Gastaut Syndrome", "status": "UNKNOWN", "start": "2016-10", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 31, "sponsor": "Beijing Pins Medical Co., Ltd", "conditions": ["Lennox-Gastaut Syndrome"], "cn_sites": [{"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": "RECRUITING"}, {"facility": "JiNing First People's Hospital", "city": "Jining", "status": "NOT_YET_RECRUITING"}, {"facility": "Linyi People's Hospital", "city": "Linyi", "status": "NOT_YET_RECRUITING"}, {"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": "NOT_YET_RECRUITING"}, {"facility": "Yantai Yuhuangding Hospital", "city": "Yantai", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT03635073", "title": "A Study of Soticlestat in Adults and Children With Rare Epilepsies", "status": "TERMINATED", "start": "2018-07-19", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 156, "sponsor": "Takeda", "conditions": ["Epilepsy", "Dravet Syndrome (DS)", "Lennox-Gastaut Syndrome (LGS)"], "cn_sites": [{"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Children's Hospital,Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": ""}, {"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT03650452", "title": "A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies", "status": "COMPLETED", "start": "2018-08-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 141, "sponsor": "Takeda", "conditions": ["Epilepsy", "Dravet Syndrome", "Lennox-Gastaut Syndrome"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Capital Medical University (CMU) - Beijing Children's Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Children's Hospital,Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT04938427", "title": "A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome", "status": "COMPLETED", "start": "2021-11-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 270, "sponsor": "Takeda", "conditions": ["Lennox Gastaut Syndrome (LGS)"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Children's Hospital,Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Children's Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "The Second Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Guangzhou Women And Children's Medical Center", "city": "Guangzhou", "status": ""}, {"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": ""}, {"facility": "Wuhan Childrens hospital", "city": "Wuhan", "status": ""}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": ""}, {"facility": "Jiangxi Provincial Children's Hospital", "city": "Nanchang", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Children's Hospital of Shanghai", "city": "Shanghai", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 12, "broad_only": false}, {"nct": "NCT05163314", "title": "A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome", "status": "TERMINATED", "start": "2022-03-04", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 352, "sponsor": "Takeda", "conditions": ["Dravet Syndrome (DS)", "Lennox Gastaut Syndrome (LGS)"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Children's Hospital,Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Children's Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "The Second Affiliated Hospital of Guangzhou Medical Univeristy", "city": "Guangzhou", "status": ""}, {"facility": "Guangzhou Women And Children's Medical Center", "city": "Guangzhou", "status": ""}, {"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": ""}, {"facility": "Wuhan Childrens hospital", "city": "Wuhan", "status": ""}, {"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "Jiangxi Provincial Children's Hospital", "city": "Nanchang", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Children's Hospital of Shanghai", "city": "Shanghai", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 12, "broad_only": false}, {"nct": "NCT06464653", "title": "Pallidothalamic Tracts Electrical Stimulation for Lennox-Gastaut Syndrome", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-05-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 5, "sponsor": "Liankun_Ren", "conditions": ["Lennox Gastaut Syndrome"], "cn_sites": [{"facility": "Xuanwu Hospital,Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06719141", "title": "A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-11-11", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 367, "sponsor": "Longboard Pharmaceuticals", "conditions": ["Developmental and Epileptic Encephalopathy"], "cn_sites": [{"facility": "Peking University First Hospital (Beida Hospital)", "city": "Beijing", "status": ""}, {"facility": "Capital Medical University-Beijing Children's Hospital", "city": "Beijing", "status": ""}, {"facility": "Guangzhou Medical University-The Second Affiliated Hospital", "city": "Guangzhou", "status": ""}, {"facility": "Shenzhen Children's Hospital", "city": "Shenzhen Shi", "status": ""}, {"facility": "Wuhan Children's Hospital", "city": "Wuhan", "status": ""}, {"facility": "Fudan University - Children's Hospital", "city": "Shanghai Shi", "status": ""}], "cn_site_count": 6, "broad_only": false}], "g_total": 12, "g_fetched": 11, "g_countries": [["United States", 5], ["Australia", 3], ["Poland", 2], ["Canada", 1], ["United Kingdom", 1], ["Argentina", 1], ["Colombia", 1], ["Germany", 1], ["Greece", 1], ["Hungary", 1], ["Israel", 1], ["Italy", 1], ["Mexico", 1], ["Portugal", 1], ["Serbia", 1], ["South Korea", 1], ["Spain", 1], ["Taiwan", 1]], "g_trials": [{"nct": "NCT06924827", "title": "A Study to Investigate the Transition of Children From 'Artisanal\" Cannabidiol (CBD) to Epidiolex", "status": "NOT_YET_RECRUITING", "start": "2027-01-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Elizabeth Donner", "countries": ["Canada"]}, {"nct": "NCT07728097", "title": "A Study to Investigate the Effect of Gradual Titration to Optimize Cannabidiol Treatment in Adults With LGS", "status": "NOT_YET_RECRUITING", "start": "2026-11-18", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Jazz Pharmaceuticals", "countries": ["United States"]}, {"nct": "NCT07568860", "title": "Sleep-Driven Adaptive Neuromodulation in Lennox-Gastaut Syndrome", "status": "NOT_YET_RECRUITING", "start": "2026-10-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Minnesota", "countries": []}, {"nct": "NCT06924086", "title": "The Children's Adaptive Deep Brain Stimulation for Epilepsy Trial", "status": "RECRUITING", "start": "2026-03-24", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University College, London", "countries": ["United Kingdom"]}, {"nct": "NCT07225231", "title": "Clinical Utility of Reduced EEG Home Monitoring in Fenfluramine Titration for Dravet and LGS", "status": "NOT_YET_RECRUITING", "start": "2025-12-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Byteflies", "countries": []}, {"nct": "NCT06738732", "title": "CBD Delivery with the A-Synaptic GT4 Transdermal Delivery System in with Dravet Syndrome And/or Lennox-Gastaut Syndrome", "status": "NOT_YET_RECRUITING", "start": "2025-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Alexander Rotenberg", "countries": ["United States"]}, {"nct": "NCT06401538", "title": "BMB-101 in Absence Epilepsy and DEE", "status": "RECRUITING", "start": "2024-12-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Bright Minds Biosciences Pty Ltd", "countries": ["Australia"]}, {"nct": "NCT05219617", "title": "Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults", "status": "RECRUITING", "start": "2022-04-28", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "SK Life Science, Inc.", "countries": ["Argentina", "Australia", "Colombia", "Germany", "Greece", "Hungary", "Israel", "Italy", "Mexico", "Poland", "Portugal", "Serbia", "South Korea", "Spain", "Taiwan", "United States"]}, {"nct": "NCT05374824", "title": "Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome", "status": "RECRUITING", "start": "2022-04-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Ann & Robert H Lurie Children's Hospital of Chicago", "countries": ["United States"]}, {"nct": "NCT06149663", "title": "Intermediate-Size Expanded Access Protocol (EAP) for LP352", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "Longboard Pharmaceuticals", "countries": ["Australia", "United States"]}, {"nct": "NCT03778424", "title": "An Extended Access Program (EAP) for Participants Who Have Completed Rufinamide Study E2080-G000-303", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "Eisai Inc.", "countries": ["Poland"]}]}, {"batch": 2, "no": 45, "name_zh": "角膜缘干细胞缺乏症", "query_terms": [{"term": "Limbal stem cell deficiency", "broad": false}], "n_total": 2, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [{"nct": "NCT03217487", "title": "Corneal Epithelial Autograft for LSCD", "status": "UNKNOWN", "start": "2017-07-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Chunxiao Wang", "conditions": ["Limbal Stem Cell Deficiency"], "cn_sites": [{"facility": "Zhongshan Ophthalmic Center, Sun Yat-sen Univerisity", "city": "Guanzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03217435", "title": "Corneal Epithelial Allograft From Living-related Donor for LSCD", "status": "COMPLETED", "start": "2017-07-27", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Chunxiao Wang", "conditions": ["Limbal Stem Cell Deficiency"], "cn_sites": [{"facility": "Zhongshan Ophthalmic Center, Sun Yat-sen Univerisity", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 12, "g_fetched": 12, "g_countries": [["United States", 4], ["France", 2], ["Italy", 1], ["Spain", 1], ["Taiwan", 1], ["South Korea", 1], ["Canada", 1]], "g_trials": [{"nct": "NCT07694817", "title": "Clinical Predictors of Visual Outcome in Patients Affected With Ocular Surface Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS San Raffaele", "countries": ["Italy"]}, {"nct": "NCT07636590", "title": "Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency", "status": "RECRUITING", "start": "2026-05-22", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Claris Biotherapeutics, Inc.", "countries": ["United States"]}, {"nct": "NCT03884569", "title": "Cultivated Limbal Epithelial Transplantation (CLET) for Limbal Stem Cell Deficiency (LSCD)", "status": "NOT_YET_RECRUITING", "start": "2025-11", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA", "countries": ["Spain"]}, {"nct": "NCT06919081", "title": "Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease", "status": "RECRUITING", "start": "2025-08-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University of Illinois at Chicago", "countries": ["United States"]}, {"nct": "NCT07119580", "title": "Association Between Limbal Function and Tear Proteomics in Chronic Ocular Diseases: Focusing on Glaucoma", "status": "RECRUITING", "start": "2025-07-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Taiwan University Hospital", "countries": ["Taiwan"]}, {"nct": "NCT06700655", "title": "A Clinical Study on Co-transplantation of Autologous Limbal Stem Cells and Corneal Stromal Stem Cells to Repair Corneal Injury", "status": "NOT_YET_RECRUITING", "start": "2024-12-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Zhongshan Ophthalmic Center, Sun Yat-sen University", "countries": []}, {"nct": "NCT06452316", "title": "Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiency", "status": "RECRUITING", "start": "2024-05-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Claris Biotherapeutics, Inc.", "countries": ["United States"]}, {"nct": "NCT03949881", "title": "Cultured Autologous Oral Mucosa Epithelial Sheet for the Treatment of Bilateral Limbal Stem Cell Deficiency", "status": "RECRUITING", "start": "2020-11-13", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Hospices Civils de Lyon", "countries": ["France"]}, {"nct": "NCT02886611", "title": "Limbal Stem Cell Deficiency of Genetic Origin: Genotype-phenotype Correlation", "status": "RECRUITING", "start": "2015-12-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondation Ophtalmologique Adolphe de Rothschild", "countries": ["France"]}, {"nct": "NCT02149732", "title": "Clinical Trial on the Effect of Autologous Oral Mucosal Epithelial Sheet Transplantation", "status": "AVAILABLE", "start": "2014-05", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "Seoul National University Hospital", "countries": ["South Korea"]}, {"nct": "NCT01756365", "title": "Autologous Cultured Corneal Epithelium (CECA) for the Treatment of Limbal Stem Cell Deficiency", "status": "RECRUITING", "start": "2012-12", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "CHU de Quebec-Universite Laval", "countries": ["Canada"]}, {"nct": "NCT07422389", "title": "BRM421 Ophthalmic Solution in Patients With Limbal Stem Cell Deficiency", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "BRIM Biotechnology Inc.", "countries": ["United States"]}]}, {"batch": 2, "no": 46, "name_zh": "恶性高热", "query_terms": [{"term": "Malignant hyperthermia of anesthesia", "broad": false}, {"term": "Malignant hyperthermia", "broad": true}], "n_total": 11, "n_open": 3, "n_open_precise": 1, "n_broad": 9, "trials": [{"nct": "NCT05402839", "title": "Screening of Malignant Hyperthermia Susceptible Individuals", "status": "RECRUITING", "start": "2022-02-22", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 50, "sponsor": "Peking University Third Hospital", "conditions": ["Malignant Hyperthermia"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04474860", "title": "Gene Mutation Spectrum of Malignant Hyperthermia in China", "status": "UNKNOWN", "start": "2019-01-15", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "West China Hospital", "conditions": ["Malignant Hyperthermia"], "cn_sites": [{"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07724756", "title": "Phase II Study of QLC2519 in Pediatric Solid Tumor Participants", "status": "RECRUITING", "start": "2026-06-26", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Qilu Pharmaceutical Co., Ltd.", "conditions": ["Pediatric Malignant Solid Tumor", "Febrile Neutropenia (FN)", "Neutropenia"], "cn_sites": [{"facility": "Beijing Children's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07829276", "title": "Study on the Efficacy and Safety of Different Doses of PEG-rhG-CSF for Primary Prevention of Febrile Neutropenia", "status": "ENROLLING_BY_INVITATION", "start": "2026-11-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 350, "sponsor": "Zhejiang Provincial People's Hospital", "conditions": ["Malignant Tumor"], "cn_sites": [{"facility": "Zhejiang Provincial People's Hospital", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT01838538", "title": "Clinical Study in Treatment of Malignant Ascites of Ovarian Cancer With Intraperitoneal Injection Bevacizumab Combined With Intraperitoneal Hyperthermic Perfusion Chemotherapy", "status": "UNKNOWN", "start": "2011-06", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 54, "sponsor": "Chinese PLA General Hospital", "conditions": ["Ovarian Cancer With Malignant Ascites"], "cn_sites": [{"facility": "First Hospital Affiliated to the PLA General Hospital, Beijing,China", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT02638051", "title": "Local mEHT + TCM Versus Intraperitoneal Chemoinfusion in Treatment of Malignant Ascites: Phase II RCT", "status": "COMPLETED", "start": "2014-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 260, "sponsor": "Galenic Research Institute Ltd", "conditions": ["Peritoneal Neoplasms", "Ascites", "Yang Deficiency", "Yin Deficiency"], "cn_sites": [{"facility": "Clifford Hospital", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT02179489", "title": "Surgery With HIPEC in Treating Patients With a High Risk of Developing Colorectal Peritoneal Carcinomatosis", "status": "COMPLETED", "start": "2014-11-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 271, "sponsor": "Zhejiang University", "conditions": ["Malignant Neoplasm of Large Intestine TNM Staging Primary Tumor (T) T4", "Peritoneal Carcinomatosis"], "cn_sites": [{"facility": "Union Hospital Fujian Medical University", "city": "Fuzhou", "status": ""}, {"facility": "Liaoning Cancer Hospital", "city": "Shenyang", "status": ""}, {"facility": "Zhongshan Hospital Fudan University", "city": "Shanghai", "status": ""}, {"facility": "The First Affiliated Hospital of College of Medicine Zhejiang University", "city": "Hangzhou", "status": ""}, {"facility": "Second Affiliated Hospitalof Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Sir Run Run Shaw Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Jinhua People's Hospital", "city": "Jinhua", "status": ""}, {"facility": "People's Hospital of Shaoxing", "city": "Shaoxing", "status": ""}, {"facility": "Yuyao People's Hospital", "city": "Yuyao", "status": ""}], "cn_site_count": 9, "broad_only": true}, {"nct": "NCT02528110", "title": "Radical Gastrectomy and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer", "status": "COMPLETED", "start": "2015-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Wuhan University", "conditions": ["Malignant Neoplasm of Stomach"], "cn_sites": [{"facility": "Zhongnan Hospital of Wuhan University", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT02830139", "title": "Radical Colorectal Resection and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Colorectal Cancer", "status": "COMPLETED", "start": "2016-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Wuhan University", "conditions": ["Malignant Neoplasm of Colorectum"], "cn_sites": [{"facility": "Zhongnan Hospital of Wuhan University", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT03393858", "title": "Combination of Immunotherapy and Hyperthermia in Advanced Malignant Mesothelioma", "status": "TERMINATED", "start": "2017-12-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Capital Medical University", "conditions": ["Cancer", "Mesothelioma, Malignant"], "cn_sites": [{"facility": "Capital Medical Unvierstiy Cancer Center/ Beijing Shijitan Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04345770", "title": "Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer", "status": "UNKNOWN", "start": "2020-04-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Wuhan University", "conditions": ["Malignant Neoplasm of Stomach"], "cn_sites": [{"facility": "Wuhan University", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}], "g_total": 2, "g_fetched": 1, "g_countries": [["United Kingdom", 1]], "g_trials": [{"nct": "NCT06791369", "title": "The Prevalence of RYR1-related Disease", "status": "NOT_YET_RECRUITING", "start": "2025-02", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "King's College London", "countries": ["United Kingdom"]}]}, {"batch": 2, "no": 47, "name_zh": "恶性胸膜间皮瘤", "query_terms": [{"term": "Pleural mesothelioma", "broad": false}, {"term": "Malignant pleural mesothelioma", "broad": false}], "n_total": 20, "n_open": 8, "n_open_precise": 8, "n_broad": 0, "trials": [{"nct": "NCT03917043", "title": "APG-2449 in Patients With Advanced Solid Tumors", "status": "RECRUITING", "start": "2019-05-27", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 165, "sponsor": "Ascentage Pharma Group Inc.", "conditions": ["Advanced Solid Cancer", "Non Small Cell Lung Cancer", "Esophageal Cancer", "Ovarian Cancer", "Malignant Pleural Mesothelioma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Fujian Cancer Hospital", "city": "Fuzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Sun-Yat Sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "The First affiliated hospital, Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Henan Provincial Oncology Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Union Hospital medical college Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Hunan Provincial Oncology Hospital", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Zhejiang Provincial Oncology Hospital", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT06726564", "title": "A Study of MT027 in Patients with Pleural Malignant Tumors", "status": "RECRUITING", "start": "2024-05-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Suzhou Maximum Bio-tech Co., Ltd.", "conditions": ["Advanced Malignant Solid Tumor", "Malignant Pleural Effusion", "Pleura Carcinoma", "Pleural Mesothelioma", "Pleural Malignant Mesothelioma", "Pleural Metastases"], "cn_sites": [{"facility": "Cancer Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06535607", "title": "Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors", "status": "RECRUITING", "start": "2024-08-22", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 257, "sponsor": "AstraZeneca", "conditions": ["Sub-study 1 Cervical Cancer (Volrustomig Monotherapy)", "Sub-study 2 Head and Neck Squamous Cell Carcinoma (Volrustomig Monotherapy)", "Sub-study 3 Head and Neck Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy)", "Sub-study 4 Esophageal Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy)", "Sub-study 5 Unresectable Pleural Mesothelioma (Volrustomig Monotherapy)"], "cn_sites": [{"facility": "Research Site", "city": "Anyang", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Bengbu", "status": "WITHDRAWN"}, {"facility": "Research Site", "city": "Changchun", "status": "WITHDRAWN"}, {"facility": "Research Site", "city": "Changsha", "status": "COMPLETED"}, {"facility": "Research Site", "city": "Chengdu", "status": "COMPLETED"}, {"facility": "Research Site", "city": "Chongqing", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Research Site", "city": "Dongguan", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Research Site", "city": "Fuzhou", "status": "COMPLETED"}, {"facility": "Research Site", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Hangzhou", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Research Site", "city": "Harbin", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Hefei", "status": "WITHDRAWN"}, {"facility": "Research Site", "city": "Jining", "status": "COMPLETED"}, {"facility": "Research Site", "city": "Kunming", "status": "COMPLETED"}, {"facility": "Research Site", "city": "Nanchang", "status": "TERMINATED"}, {"facility": "Research Site", "city": "Nanjing", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Nanning", "status": "COMPLETED"}, {"facility": "Research Site", "city": "Shandong", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Shanghai", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Research Site", "city": "Shenyang", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Research Site", "city": "Tianjin", "status": "COMPLETED"}, {"facility": "Research Site", "city": "Wuhan", "status": "COMPLETED"}, {"facility": "Research Site", "city": "Wuhou District", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 25, "broad_only": false}, {"nct": "NCT05188859", "title": "First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma", "status": "RECRUITING", "start": "2024-09-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 29, "sponsor": "Cancer Institute and Hospital, Chinese Academy of Medical Sciences", "conditions": ["Mesothelioma, Malignant", "Mesothelioma, Malignant Pleural", "Mesothelioma Malignant Advanced"], "cn_sites": [{"facility": "Shanxi Provincial Cancer Hospital/ Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University", "city": "Taiyuan", "status": "RECRUITING"}, {"facility": "Cancer Hospital Chinese Academy of Medical Sciences", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06566079", "title": "Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors", "status": "RECRUITING", "start": "2024-12-27", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 160, "sponsor": "InSilico Medicine Hong Kong Limited", "conditions": ["Malignant Mesothelioma", "Metastatic Malignant Solid Tumor", "Advanced Solid Tumor"], "cn_sites": [{"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Cancer Hospital Chinese Academy of Medical Sciences", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Sun Yat-Sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT06875076", "title": "Multicenter Single-Arm Study of Ivonescimab (AK112) Combined with Chemotherapy in Pretreated Pleural Mesothelioma", "status": "RECRUITING", "start": "2025-03-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 25, "sponsor": "The First Hospital of Jilin University", "conditions": ["Pretreated Pleural Mesothelioma"], "cn_sites": [{"facility": "Cancer center, First Hospital of Jilin University", "city": "Changchun", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07282873", "title": "Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors", "status": "NOT_YET_RECRUITING", "start": "2026-01-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 219, "sponsor": "TYK Medicines, Inc", "conditions": ["Solid Tumor Malignancies", "Malignant Mesothelioma (MM)"], "cn_sites": [{"facility": "Shanghai Chest Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07510815", "title": "Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma", "status": "RECRUITING", "start": "2026-03-02", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Beijing Biotech", "conditions": ["Malignant Pleural Mesotheliomas"], "cn_sites": [{"facility": "Peking University Shenzhen Hospital", "city": "Shenzhen", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02580747", "title": "Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso", "status": "UNKNOWN", "start": "2015-10", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Chinese PLA General Hospital", "conditions": ["Malignant Mesothelioma", "Pancreatic Cancer", "Ovarian Tumor", "Triple Negative Breast Cancer", "Endometrial Cancer", "Other Mesothelin Positive Tumors"], "cn_sites": [{"facility": "Biotherapeutic Department and Pediatrics Department of Chinese PLA General Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02899299", "title": "Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients", "status": "COMPLETED", "start": "2016-11-29", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 605, "sponsor": "Bristol-Myers Squibb", "conditions": ["Mesothelioma"], "cn_sites": [{"facility": "Local Institution - 0133", "city": "Harbin", "status": ""}, {"facility": "Local Institution", "city": "Changchun", "status": ""}, {"facility": "Local Institution", "city": "Shenyang", "status": ""}, {"facility": "Local Institution - 0124", "city": "Kunming", "status": ""}, {"facility": "Local Institution - 0120", "city": "Shanghai", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT03393858", "title": "Combination of Immunotherapy and Hyperthermia in Advanced Malignant Mesothelioma", "status": "TERMINATED", "start": "2017-12-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Capital Medical University", "conditions": ["Cancer", "Mesothelioma, Malignant"], "cn_sites": [{"facility": "Capital Medical Unvierstiy Cancer Center/ Beijing Shijitan Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03852823", "title": "Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours", "status": "UNKNOWN", "start": "2019-05-23", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 192, "sponsor": "CSPC ZhongQi Pharmaceutical Technology Co., Ltd.", "conditions": ["Advanced Solid Tumours", "Cervical Cancer", "Malignant Mesothelioma", "Lymphoma", "Non-Small-Cell Lung Cancer"], "cn_sites": [{"facility": "Shanghai East Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05042557", "title": "Real World Study of MPM in China", "status": "UNKNOWN", "start": "2021-06-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Chinese Academy of Medical Sciences", "conditions": ["Malignant Pleural Mesothelioma", "Diagnoses Disease", "Treatments", "Prognosis"], "cn_sites": [{"facility": "National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05136677", "title": "A Study to Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants", "status": "COMPLETED", "start": "2022-01-25", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 102, "sponsor": "Bristol-Myers Squibb", "conditions": ["Mesothelioma, Malignant"], "cn_sites": [{"facility": "Local Institution - 0009", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 0013", "city": "Harbin", "status": ""}, {"facility": "Local Institution - 0006", "city": "Zhengzhou", "status": ""}, {"facility": "Local Institution - 0005", "city": "Changsha", "status": ""}, {"facility": "Local Institution - 0023", "city": "Wuhan", "status": ""}, {"facility": "Local Institution - 0015", "city": "Yangzhou", "status": ""}, {"facility": "Local Institution - 0003", "city": "Changchun", "status": ""}, {"facility": "Local Institution - 0004", "city": "Shenyang", "status": ""}, {"facility": "Local Institution - 0021", "city": "Shenyang", "status": ""}, {"facility": "Local Institution - 0037", "city": "Jinan", "status": ""}, {"facility": "Local Institution - 0030", "city": "Qingdao", "status": ""}, {"facility": "Local Institution - 0001", "city": "Shanghai", "status": ""}, {"facility": "Local Institution - 0033", "city": "Taiyuan", "status": ""}, {"facility": "Local Institution - 0029", "city": "Chengdu", "status": ""}, {"facility": "Local Institution - 0007", "city": "Tianjin", "status": ""}, {"facility": "Local Institution - 0018", "city": "Tianjin", "status": ""}, {"facility": "Local Institution - 0010", "city": "Kunming", "status": ""}, {"facility": "Local Institution - 0014", "city": "Hangzhou", "status": ""}, {"facility": "Local Institution - 0020", "city": "Hangzhou", "status": ""}, {"facility": "Local Institution - 0012", "city": "Ningbo", "status": ""}, {"facility": "Local Institution - 0016", "city": "Ningbo", "status": ""}], "cn_site_count": 21, "broad_only": false}, {"nct": "NCT05598268", "title": "A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.", "status": "UNKNOWN", "start": "2022-03-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 74, "sponsor": "ImmVira Pharma Co. Ltd", "conditions": ["Advanced Solid Tumor", "Lung Cancer", "Liver Cancer", "Lymphoma", "Mesothelioma of Pleura"], "cn_sites": [{"facility": "The First Affiliated Hospital of Bengbu Medicial College", "city": "Bengbu", "status": "RECRUITING"}, {"facility": "Zhujiang Hospital of Southern Medical University", "city": "Guanzhou", "status": "RECRUITING"}, {"facility": "the First Affiliated Hospital of Henan University of Science and Technology", "city": "Luoyang", "status": "RECRUITING"}, {"facility": "Henan Cancer Hosptial", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Beijing Chest Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Shanghai Chest Hosptial", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT05498597", "title": "AMT-151 in Patients With Selected Advanced Solid Tumours", "status": "UNKNOWN", "start": "2023-01-25", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Multitude Therapeutics Inc.", "conditions": ["Advanced Solid Tumor", "Advanced Cancer", "Advanced Carcinoma", "Ovarian Cancer", "Ovarian Carcinoma", "Ovarian Epithelial Cancer", "Ovarian Endometrioid Adenocarcinoma", "Endometrial Cancer", "Endometrial Adenocarcinoma", "Endometrial Serous Adenocarcinoma", "Endometrial Endometrioid Adenocarcinoma", "Endometrial Clear Cell Adenocarcinoma", "Lung Adenocarcinoma", "Triple Negative Breast Cancer", "Pancreatic Ductal Adenocarcinoma", "Malignant Pleural Mesothelioma", "Ovarian Clear Cell Carcinoma", "Ovarian Clear Cell Adenocarcinoma", "Ovarian Mucinous Adenocarcinoma"], "cn_sites": [{"facility": "Fujian Provincial Cancer Hospital", "city": "Fuzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Hunan Cancer Hospital", "city": "Changsha", "status": "NOT_YET_RECRUITING"}, {"facility": "Shanghai Tumor Hospital", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT06031636", "title": "Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in Patients With Advanced Malignant Pleural Mesothelioma", "status": "UNKNOWN", "start": "2023-07-20", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 15, "sponsor": "Tianjin Medical University Second Hospital", "conditions": ["Malignant Pleural Mesothelioma, Advanced"], "cn_sites": [{"facility": "Tianjin Medical Unversity Second Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05930665", "title": "Study of Cadonilimab Combined With Bevacizumab and Standard Chemotherapy as First Line Therapy in Unresectable Pleural Mesothelioma", "status": "UNKNOWN", "start": "2023-11-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 38, "sponsor": "Sun Yat-sen University", "conditions": ["Pleural Mesothelioma"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06097728", "title": "MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-11-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 863, "sponsor": "AstraZeneca", "conditions": ["Unresectable Pleural Mesothelioma"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Changsha", "status": ""}, {"facility": "Research Site", "city": "Chengdu", "status": ""}, {"facility": "Research Site", "city": "Guangzhou", "status": ""}, {"facility": "Research Site", "city": "Hangzhou", "status": ""}, {"facility": "Research Site", "city": "Harbin", "status": ""}, {"facility": "Research Site", "city": "Kunming", "status": ""}, {"facility": "Research Site", "city": "Lanzhou", "status": ""}, {"facility": "Research Site", "city": "Ningbo", "status": ""}, {"facility": "Research Site", "city": "Qingdao", "status": ""}, {"facility": "Research Site", "city": "Shandong", "status": ""}, {"facility": "Research Site", "city": "Shanghai", "status": ""}, {"facility": "Research Site", "city": "Shenyang", "status": ""}, {"facility": "Research Site", "city": "Taiyuan", "status": ""}, {"facility": "Research Site", "city": "Tianjin", "status": ""}, {"facility": "Research Site", "city": "Wuhan", "status": ""}, {"facility": "Research Site", "city": "Xi'an", "status": ""}, {"facility": "Research Site", "city": "Zhengzhou", "status": ""}], "cn_site_count": 18, "broad_only": false}, {"nct": "NCT06256055", "title": "Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors", "status": "UNKNOWN", "start": "2024-03-05", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "UTC Therapeutics Inc.", "conditions": ["Malignant Mesothelioma", "Colorectal Cancer", "Bile Duct Cancer", "Rectal Cancer", "Ovary Cancer", "Pancreatic Cancer", "Breast Cancer Female"], "cn_sites": [{"facility": "Peking University Cancer Hospital & Institute", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}], "g_total": 61, "g_fetched": 53, "g_countries": [["United States", 27], ["Italy", 8], ["France", 5], ["United Kingdom", 5], ["Australia", 2], ["Belgium", 2], ["Netherlands", 2], ["South Korea", 2], ["Spain", 2], ["Denmark", 1], ["Egypt", 1], ["Germany", 1], ["Greece", 1], ["Canada", 1], ["Ireland", 1], ["Portugal", 1], ["Poland", 1]], "g_trials": [{"nct": "NCT07824986", "title": "A Phase 3 Trial in Advanced Epithelioid Mesothelioma", "status": "NOT_YET_RECRUITING", "start": "2026-12-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Vivace Therapeutics, Inc", "countries": []}, {"nct": "NCT07713732", "title": "TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors", "status": "NOT_YET_RECRUITING", "start": "2026-07-25", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Treeline Biosciences, Inc.", "countries": ["Australia"]}, {"nct": "NCT06971848", "title": "Evaluation of Skin Tests in Biotherapy Allergies", "status": "RECRUITING", "start": "2026-06-17", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Angers", "countries": ["France"]}, {"nct": "NCT07192900", "title": "Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease", "status": "RECRUITING", "start": "2026-06-03", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "David Bartlett, MD", "countries": ["United States"]}, {"nct": "NCT07443020", "title": "Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors", "status": "RECRUITING", "start": "2026-05", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)", "countries": ["United States"]}, {"nct": "NCT07532902", "title": "A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer", "status": "RECRUITING", "start": "2026-04-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Memorial Sloan Kettering Cancer Center", "countries": ["United States"]}, {"nct": "NCT07234058", "title": "Trial Assessing Fianlimab Plus Cemiplimab Plus Chemotherapy or Cemiplimab Plus Chemotherapy in Patients With Pleural Mesothelioma", "status": "RECRUITING", "start": "2026-04-02", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Intergroupe Francophone de Cancerologie Thoracique", "countries": ["France"]}, {"nct": "NCT07550049", "title": "Comprehensive Oncogenomic Mapping and Exploration in Thoracic and Head & Neck Oncology", "status": "NOT_YET_RECRUITING", "start": "2026-04", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Kansas Medical Center", "countries": []}, {"nct": "NCT07277413", "title": "A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors", "status": "RECRUITING", "start": "2026-03-04", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "IDEAYA Biosciences", "countries": ["United States"]}, {"nct": "NCT07126509", "title": "Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma", "status": "RECRUITING", "start": "2025-12-02", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Chicago", "countries": ["United States"]}, {"nct": "NCT07131345", "title": "Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma", "status": "NOT_YET_RECRUITING", "start": "2025-09-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "National Cancer Center, China", "countries": []}, {"nct": "NCT07121374", "title": "NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study", "status": "RECRUITING", "start": "2025-07-22", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Antwerp", "countries": ["Belgium"]}, {"nct": "NCT06840834", "title": "Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy", "status": "RECRUITING", "start": "2025-06-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Intergroupe Francophone de Cancerologie Thoracique", "countries": ["France"]}, {"nct": "NCT05425576", "title": "OT-101 in Combination With Pembrolizumab in Subjects With Malignant Pleural Mesothelioma Failing to Respond to Checkpoint Inhibition", "status": "NOT_YET_RECRUITING", "start": "2025-06", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Oncotelic Inc.", "countries": ["United States"]}, {"nct": "NCT06756035", "title": "CT-95 in Advanced Cancers Associated With Mesothelin Expression", "status": "RECRUITING", "start": "2025-03-31", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Context Therapeutics Inc.", "countries": ["United States"]}, {"nct": "NCT06790082", "title": "The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma", "status": "RECRUITING", "start": "2025-01-29", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Aalborg University Hospital", "countries": ["Denmark"]}, {"nct": "NCT05647265", "title": "Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma", "status": "RECRUITING", "start": "2024-11-27", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Alliance for Clinical Trials in Oncology", "countries": ["United States"]}, {"nct": "NCT06910449", "title": "Hemithoracic Arc Radiotherapy Post Pleural Decortication", "status": "RECRUITING", "start": "2024-11-11", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Cairo University", "countries": ["Egypt"]}, {"nct": "NCT07561190", "title": "Multidimensional Omics Analysis in Malignant Pleural Mesothelioma", "status": "RECRUITING", "start": "2024-08-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Azienda USL Reggio Emilia - IRCCS", "countries": ["Italy"]}, {"nct": "NCT06362369", "title": "A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy", "status": "RECRUITING", "start": "2024-08-23", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "7 Hills Pharma, LLC", "countries": ["United States"]}, {"nct": "NCT06251310", "title": "SW-682 in Advanced Solid Tumors", "status": "RECRUITING", "start": "2024-07-31", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany", "countries": ["United States"]}, {"nct": "NCT05932199", "title": "Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma", "status": "RECRUITING", "start": "2024-07-03", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Baylor College of Medicine", "countries": ["United States"]}, {"nct": "NCT06477419", "title": "A Study of Sacituzumab Govitecan in People With Mesothelioma", "status": "RECRUITING", "start": "2024-06-21", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Memorial Sloan Kettering Cancer Center", "countries": ["United States"]}, {"nct": "NCT06416930", "title": "Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural Mesothelioma", "status": "NOT_YET_RECRUITING", "start": "2024-06-20", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Cancer Institute and Hospital, Chinese Academy of Medical Sciences", "countries": []}, {"nct": "NCT06051695", "title": "A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression", "status": "RECRUITING", "start": "2024-04-03", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "A2 Biotherapeutics Inc.", "countries": ["United States"]}]}, {"batch": 2, "no": 48, "name_zh": "黑色素瘤", "query_terms": [{"term": "Melanoma", "broad": false}], "n_total": 195, "n_open": 66, "n_open_precise": 66, "n_broad": 0, "trials": [{"nct": "NCT03340506", "title": "Dabrafenib and/or Trametinib Rollover Study", "status": "RECRUITING", "start": "2018-01-26", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Melanoma", "Non Small Cell Lung Cancer", "Solid Tumor", "Rare Cancers", "High Grade Glioma"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Beijing", "status": "COMPLETED"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03755739", "title": "Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors", "status": "RECRUITING", "start": "2018-11-01", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 200, "sponsor": "Second Affiliated Hospital of Guangzhou Medical University", "conditions": ["Hepatocarcinoma", "Lung Cancer", "Melanoma", "Renal Cancer", "Head and Neck Cancer", "Pancreas Cancer", "Ovarian Cancer", "Colo-rectal Cancer", "Cervical Cancer", "Breast Cancer"], "cn_sites": [{"facility": "The Second Affiliated Hospital of Guangzhou Medical University", "city": "Guanzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04616443", "title": "OH2 Injection in Combination With HX008 for Melanoma.", "status": "RECRUITING", "start": "2020-12-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Binhui Biopharmaceutical Co., Ltd.", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Peking University Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04331093", "title": "Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma", "status": "RECRUITING", "start": "2021-03-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Di Wu", "conditions": ["Acral Melanoma"], "cn_sites": [{"facility": "The first hospital of Jilin University", "city": "Changchun", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04913285", "title": "A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors", "status": "RECRUITING", "start": "2021-08-04", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 400, "sponsor": "Pierre Fabre Medicament", "conditions": ["Solid Tumor, Adult", "Non-small Cell Lung Cancer", "Melanoma"], "cn_sites": [{"facility": "Harbin Medical University Cancer Hospital", "city": "Haerbin", "status": "RECRUITING"}, {"facility": "Linyi Cancer Hospital", "city": "Linyi", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Beijing University Cancer Hospital", "city": "Beijing", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "The Shanghai Pulmonary Hospital", "city": "Shanghai", "status": "ACTIVE_NOT_RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT05098184", "title": "A Study of GC101 TIL in Advanced Melanoma (10hospital)", "status": "RECRUITING", "start": "2021-09-26", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Shanghai Juncell Therapeutics", "conditions": ["Advanced Melanoma", "Tumor Infiltrating Lymphocyte", "Treatment Side Effects", "Effects of Immunotherapy"], "cn_sites": [{"facility": "Shanghai Tenth People's Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05366478", "title": "A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors", "status": "RECRUITING", "start": "2022-05-30", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Suzhou BlueHorse Therapeutics Co., Ltd.", "conditions": ["Melanoma", "Non Small Cell Lung Cancer", "Cervical Carcinoma"], "cn_sites": [{"facility": "Tianjin Beichen Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05512481", "title": "Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma", "status": "RECRUITING", "start": "2022-09-13", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Peking University Cancer Hospital & Institute", "conditions": ["Melanoma", "Acral Melanoma", "Temozolomide", "Apatinib", "Camrelizumab", "Neoadjuvant", "Pathological Response"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05539118", "title": "Interferon-α1b Combined With Toripalimab and Anlotinib Hydrochloride in Advanced Unresectable Melanoma", "status": "NOT_YET_RECRUITING", "start": "2022-09-30", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 48, "sponsor": "Xijing Hospital", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Air Force Military Medical University/ Fourth Military Medical University", "city": "Xi'an", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05868707", "title": "OH2 Injection in Melanoma", "status": "RECRUITING", "start": "2023-03-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 340, "sponsor": "Binhui Biopharmaceutical Co., Ltd.", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Peking University Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Chongqing University Cancer Hospital", "city": "Chongqing", "status": "NOT_YET_RECRUITING"}, {"facility": "Fujian Cancer Hosptial", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "Dermatology Hospital of Southern Medical University", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Guangxi Medical University Cancer Hospital", "city": "Nanning", "status": "NOT_YET_RECRUITING"}, {"facility": "Hainan Cancer Hospital", "city": "Haikou", "status": "NOT_YET_RECRUITING"}, {"facility": "The Fourth Hospital of Hebei Medical University and Hebei Tumor Hospital", "city": "Shijiazhuang", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Harbin Medical University", "city": "Harbin", "status": "NOT_YET_RECRUITING"}, {"facility": "The Third People's Hospital of Zhengzhou", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Hubei Cancer Hospital", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}, {"facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}, {"facility": "Hunan Cancer Hospital", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": "NOT_YET_RECRUITING"}, {"facility": "Jilin Cancer Hospital", "city": "Changchun", "status": "RECRUITING"}, {"facility": "The first hospital of Jilin University", "city": "Changchun", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Dalian Medical University", "city": "Dalian", "status": "NOT_YET_RECRUITING"}, {"facility": "Liaoning Cancer Hospital ＆ Institute", "city": "Shenyang", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi'an", "status": "NOT_YET_RECRUITING"}, {"facility": "The Affiliated Cancer Hospital of Shandong First Medical University", "city": "Jinan", "status": "NOT_YET_RECRUITING"}, {"facility": "Weifang People's Hospital", "city": "Weifang", "status": "RECRUITING"}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Shanxi Bethune Hospital", "city": "Taiyuan", "status": "NOT_YET_RECRUITING"}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Tianjin Medical University Cancer Institute ＆ Hospital", "city": "Tianjin", "status": "NOT_YET_RECRUITING"}, {"facility": "The Affiliated Cancer Hospital, Xinjiang Medical University", "city": "Ürümqi", "status": "NOT_YET_RECRUITING"}, {"facility": "Yunnan Cancer Hospital", "city": "Kunming", "status": "NOT_YET_RECRUITING"}, {"facility": "Cancer Hospital Of The University Of Chinese Academy Of Sciences Zhejiang Cancer Hospital", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Sir Run Run Shaw Hospital", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 30, "broad_only": false}, {"nct": "NCT05789043", "title": "Camrelizumab in Combination With Apatinib and Temozolomide as First-line Treatment in Advanced Acral Melanoma", "status": "RECRUITING", "start": "2023-03-21", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 140, "sponsor": "Peking University Cancer Hospital & Institute", "conditions": ["Acral Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07644897", "title": "Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma", "status": "RECRUITING", "start": "2023-05-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 55, "sponsor": "Sun Yat-sen University", "conditions": ["Melanoma", "Immune-related Adverse Event", "Immune Checkpoint Inhibitor"], "cn_sites": [{"facility": "Sun yat-sen uniersity", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Nanshan hospital", "city": "Shenzhen", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05983237", "title": "Fluzoparib in Combination With Camrelizumab and Temozolomide in Advanced Melanoma", "status": "RECRUITING", "start": "2023-08-15", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Jun Guo", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05914116", "title": "A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors", "status": "RECRUITING", "start": "2023-08-17", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 862, "sponsor": "DualityBio Inc.", "conditions": ["Advanced Solid Tumors"], "cn_sites": [{"facility": "Research Site 319", "city": "Hefei", "status": "RECRUITING"}, {"facility": "Research Site 365", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Research Site 310", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Research Site 337", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Research Site 327", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "Research Site 345", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "Research Site 353", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "Research Site 356", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "Research Site 313", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "Research Site 314", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Research Site 322", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Research site 367", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Research Site 346", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Research Site 348", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Research Site 350", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Research Site 360", "city": "Nanning", "status": "RECRUITING"}, {"facility": "Research Site 334", "city": "Baoding", "status": "RECRUITING"}, {"facility": "Research Site 315", "city": "Harbin", "status": "RECRUITING"}, {"facility": "Research Site 316", "city": "Luoyang", "status": "RECRUITING"}, {"facility": "Research Site 317", "city": "Xinxiang", "status": "RECRUITING"}, {"facility": "Research Site 306", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Research Site 304", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Research Site 321", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Research Site 311", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Research Site 309", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Research Site 323", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Research Site 344", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Research Site 305", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Research Site 307", "city": "Ganzhou", "status": "RECRUITING"}, {"facility": "Research Site 349", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Research Site 361", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Research Site 328", "city": "Changchun", "status": "RECRUITING"}, {"facility": "Research Site 301", "city": "Changchun", "status": "RECRUITING"}, {"facility": "Research Site 320", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Research Site 352", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Research Site 363", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Research Site 340", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Research Site 308", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Research Site 333", "city": "Linyi", "status": "RECRUITING"}, {"facility": "Research Site 302", "city": "Linyi", "status": "RECRUITING"}, {"facility": "Research Site 335", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Research Site 326", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Research Site 355", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Research Site 332", "city": "Xi’an", "status": "RECRUITING"}, {"facility": "Research Site 312", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Research Site 330", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Research Site 366", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Research Site 325", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Research Site 347", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "Research Site 318", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "Research site 368", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "Research Site 324", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Research Site 329", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Research Site 331", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Research Site 359", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Research site 369", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Research Site 303", "city": "Taizhou", "status": "RECRUITING"}], "cn_site_count": 57, "broad_only": false}, {"nct": "NCT06081920", "title": "A Study of IBI363 in Subjects With Advanced Melanoma", "status": "RECRUITING", "start": "2023-10-19", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 180, "sponsor": "Innovent Biologics (Suzhou) Co. Ltd.", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking University Cancer Hospital & Institute, Beijing, China,", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Fujian Cancer Hospital", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "The Third people's hospital of Zhengzhou", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Hunan Cancer Hospital", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "The first affiliated hospital of Nanchang university", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Jilin Cancer Hospital", "city": "Changchun", "status": "RECRUITING"}, {"facility": "The first hospital of Jilin University", "city": "Changchun", "status": "RECRUITING"}, {"facility": "Qilu Hospital of Shandong university", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Shanxi Bethune Hospital", "city": "Taiyuan", "status": "RECRUITING"}, {"facility": "Yunan Cancer Hospital", "city": "Kunming", "status": "RECRUITING"}], "cn_site_count": 12, "broad_only": false}, {"nct": "NCT06008106", "title": "Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma", "status": "RECRUITING", "start": "2023-11-02", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 165, "sponsor": "Shanghai Kechow Pharma, Inc.", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06359860", "title": "A Study of ST-1898 for Unresectable or Metastatic Melanoma", "status": "RECRUITING", "start": "2023-11-07", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 64, "sponsor": "Beijing Scitech-Mq Pharmaceuticals Limited", "conditions": ["Unresectable or Metastatic Melanoma"], "cn_sites": [{"facility": "Peking University Cancer Hospital & Institute", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06183736", "title": "CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency", "status": "NOT_YET_RECRUITING", "start": "2023-12-20", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 98, "sponsor": "Convalife (Shanghai) Co., Ltd.", "conditions": ["Advanced Solid Tumors"], "cn_sites": [{"facility": "Li Ning", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06203249", "title": "Microecology and Immunity in Patients With Anti-MDA5 Antibody Positive Dermatomyositis and Interstitial Lung Disease", "status": "RECRUITING", "start": "2024-01-20", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 50, "sponsor": "Chinese PLA General Hospital", "conditions": ["Microbiome", "Immune Function", "Anti-MDA5 Antibody Positive Dermatomyositis"], "cn_sites": [{"facility": "PLA", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06214156", "title": "A Clinical Study of T3011 in Subjects With Advanced Melanoma", "status": "RECRUITING", "start": "2024-01-26", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 42, "sponsor": "Shanghai Pharmaceuticals Holding Co., Ltd", "conditions": ["Advanced Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Bengbu Medical College", "city": "Bengbu", "status": "RECRUITING"}, {"facility": "Jilin Cancer Hospital", "city": "Changchun", "status": "RECRUITING"}, {"facility": "Chengdu Shangjin Nanfu Hospital", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Fujian Cancer Hospital", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "The Third People's Hospital of Zhengzhou", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Sun Yat-sen University Cancer Center", "city": "Zhongshan", "status": "RECRUITING"}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT06209580", "title": "AMT-253 in Patients With Advanced Solid Tumours", "status": "RECRUITING", "start": "2024-01-31", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 96, "sponsor": "Multitude Therapeutics Inc.", "conditions": ["Malignant Melanoma", "Advanced Solid Tumors"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06172478", "title": "A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors", "status": "RECRUITING", "start": "2024-02-26", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 740, "sponsor": "Daiichi Sankyo", "conditions": ["Advanced Solid Tumor", "Melanoma", "Head and Neck Cancer", "Gastric Cancer", "Ovarian Carcinoma", "Cervical Cancer", "Endometrial Cancer", "Bladder Cancer", "Esophageal Cancer", "Pancreatic Carcinoma", "Prostate Cancer", "Non-small Cell Lung Cancer (NSCLC)", "Lung Cancer", "Breast Cancer"], "cn_sites": [{"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06424626", "title": "A Trial of AK104 or AK112 in Combination With Axitinib in Patients With Metastatic Mucosal Melanoma", "status": "ENROLLING_BY_INVITATION", "start": "2024-05-28", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Peking University Cancer Hospital & Institute", "conditions": ["Melanoma", "Mucosal Melanoma", "Metastatic Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06500091", "title": "TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors", "status": "NOT_YET_RECRUITING", "start": "2024-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 54, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Soft Tissue Sarcoma", "Melanoma"], "cn_sites": [{"facility": "Cancer Hospital Chinese Academy of Medical Science", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Henan Cancer Hospital Affiliated Cancer Hospital of Zhengzhou University", "city": "Zhengzhou", "status": ""}, {"facility": "Hunan Cancer Hospital", "city": "Changsha", "status": ""}, {"facility": "Jilin Cancer Hospital", "city": "Changchun", "status": ""}, {"facility": "Cancer Hospital Affiliated to Shandong First Medical University", "city": "Jinan", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}, {"facility": "Shanxi Cancer Hospital", "city": "Taiyuan", "status": ""}, {"facility": "Tianjin Medical University Cancer Institute and Hospital", "city": "Tianjin", "status": ""}, {"facility": "Xinjiang Medical University Affiliated Cancer Hospital", "city": "Ürümqi", "status": ""}, {"facility": "Zhe Jiang Cancer Hospital", "city": "Hangzhou", "status": ""}], "cn_site_count": 11, "broad_only": false}, {"nct": "NCT07586891", "title": "Exploratory Study With Parallel Controls on the Safety and Efficacy of Neoadjuvant Low Branched-Chain Amino Acid Diet in Combination With Anti-PD-1 Monoclonal Antibody for Stage III Melanoma", "status": "RECRUITING", "start": "2024-07-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 80, "sponsor": "Xijing Hospital", "conditions": ["Melanoma (Skin Cancer)"], "cn_sites": [{"facility": "Xijing Hospital, Air Force Medical University", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06596915", "title": "Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors", "status": "RECRUITING", "start": "2024-09-11", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 167, "sponsor": "Shandong Boan Biotechnology Co., Ltd", "conditions": ["Non-Small Cell Lung Cancer", "Pancreatic Adenocarcinoma", "Breast Cancer", "Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06670300", "title": "Clinical Observation on the Safety and Efficacy of Cardonilmab in the Treatment of Second-line and Above Advanced Melanoma and Advanced Renal Cancer", "status": "NOT_YET_RECRUITING", "start": "2024-12-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "YongZhang", "conditions": ["Participants Who Had Received Second-line or Higher Advanced Melanoma and Advanced Renal Cancer"], "cn_sites": [{"facility": "the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06703398", "title": "A Study of GC101 TIL in Advanced Melanoma", "status": "RECRUITING", "start": "2024-12-20", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 98, "sponsor": "Shanghai Juncell Therapeutics", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06965231", "title": "Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial", "status": "RECRUITING", "start": "2025-01-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 58, "sponsor": "Fudan University", "conditions": ["Melanoma of Skin", "Acral Melanoma", "Stage II Melanoma"], "cn_sites": [{"facility": "Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Cancer center, Shanghai 411 hospital, China RongTong Medical Healthcare Group Co.Ltd./411 Hospital, Shanghai University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Department of Surgical Oncology, Fudan University Shanghai Cancer Center Minhang Branch Hospital", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Department of Oncology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT06708663", "title": "HX009+ IN10018 With or Without Standard Chemotherapy for Advanced Solid Tumours", "status": "RECRUITING", "start": "2025-01-17", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 124, "sponsor": "Hangzhou Hanx Biopharmaceuticals, Ltd.", "conditions": ["Biliary Tract Cancer", "Melanoma"], "cn_sites": [{"facility": "Peking University Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06839105", "title": "A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies", "status": "RECRUITING", "start": "2025-02-21", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 214, "sponsor": "Shanghai Junshi Bioscience Co., Ltd.", "conditions": ["Non-Small Cell Lung Cancer, Colorectal Cancer, Renal Cell Carcinoma, Melanoma and Other Solid Tumor"], "cn_sites": [{"facility": "Fujian Cancer Hospital", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Harbin Medical University Cancer Hospital", "city": "Harbin", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Henan University of Science & Technology", "city": "Luoyang", "status": "NOT_YET_RECRUITING"}, {"facility": "Hubei Cancer Hospital", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Hunan Cancer Hospital", "city": "Changsha", "status": "RECRUITING"}, {"facility": "First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": "NOT_YET_RECRUITING"}, {"facility": "Liaoning Cancer Hospital & Institute", "city": "Shenyang", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Shanghai Chest Hospital", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Yunnan Cancer Hospital", "city": "Kunming", "status": "NOT_YET_RECRUITING"}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 13, "broad_only": false}, {"nct": "NCT06797297", "title": "A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic Therapy", "status": "RECRUITING", "start": "2025-02-24", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 180, "sponsor": "Innovent Biologics (Suzhou) Co. Ltd.", "conditions": ["Melanoma"], "cn_sites": [{"facility": "First Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": "RECRUITING"}, {"facility": "Beijing Jishuitan Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking University Cancer Hospital & Institute, Beijing, China,", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Chongqing University Cancer Hospital", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "Fujian Cancer Hospital", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Affiliated Tumor Hospital of Guangxi Medical University", "city": "Nanning", "status": "RECRUITING"}, {"facility": "Fourth Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": "RECRUITING"}, {"facility": "Harbin Medical University Cancer Hospital", "city": "Harbin", "status": "RECRUITING"}, {"facility": "The Third people's hospital of Zhengzhou", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Xiangya Second Hospital of Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Hunan Cancer Hospital", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Baotou Cancer Hospital", "city": "Baotou", "status": "RECRUITING"}, {"facility": "Jiangsu Provincial People's Hospital", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Jiangxi Provincial Cancer Hospital", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Jilin Cancer Hospital", "city": "Changchun", "status": "RECRUITING"}, {"facility": "The first hospital of Jilin University", "city": "Changchun", "status": "RECRUITING"}, {"facility": "Liaoning Cancer Hospital", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Shandong First Medical University Affiliated Cancer Hospital", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Shanxi Bethune Hospital", "city": "Taiyuan", "status": "RECRUITING"}, {"facility": "Second Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi’an", "status": "RECRUITING"}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Tianjin Cancer Hospital", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "The Affiliated Cancer Hospital of Xinjiang Medical University", "city": "Ürümqi", "status": "RECRUITING"}, {"facility": "Yunnan Cancer Hospital", "city": "Kunming", "status": "RECRUITING"}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 31, "broad_only": false}, {"nct": "NCT07336979", "title": "Paclitaxel Polymersomes + Carboplatin + Adebelimab: Neoadjuvant Phase Ⅱ Single-Arm Study for Resectable Mucosal Melanoma", "status": "RECRUITING", "start": "2025-03-20", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 32, "sponsor": "Sun Yat-sen University", "conditions": ["Resectable Mucosal Melanoma"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07586904", "title": "Efficacy and Safety of Neoadjuvant Cadonilimab Plus High-Dose Recombinant Human Interferon α1b in Stage III/IV Melanoma.", "status": "RECRUITING", "start": "2025-05-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Xijing Hospital", "conditions": ["Melanoma (Skin Cancer)"], "cn_sites": [{"facility": "Xijing Hospital, Air Force Medical University Xi'an, Shaanxi, China", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06942143", "title": "An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors", "status": "RECRUITING", "start": "2025-05-22", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Guangzhou FineImmune Biotechnology Co., LTD.", "conditions": ["Sarcoma", "Lung Cancers", "Melanoma"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07376707", "title": "A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors", "status": "RECRUITING", "start": "2025-06-12", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 194, "sponsor": "Hefei TG ImmunoPharma Co., Ltd.", "conditions": ["CRC (Colorectal Cancer)", "Melanoma (Skin Cancer)", "HCC - Hepatocellular Carcinoma", "NSCLC (Non-small Cell Lung Cancer)"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07584291", "title": "Liquid Biopsy Multi-Omics and Biomarker Development in Melanoma", "status": "RECRUITING", "start": "2025-07-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Xijing Hospital", "conditions": ["Melanoma (Skin Cancer)"], "cn_sites": [{"facility": "Xijing Hospital, Air Force Medical University", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07004335", "title": "Efficacy and Safety of Iparomlimab and Tuvonralimab Injection in Combination With Bevacizumab After Progression on Anti-PD-(L)1 Therapy in Advanced Melanoma: A Prospective, Single-Arm, Exploratory Clinical Study", "status": "NOT_YET_RECRUITING", "start": "2025-07-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Hebei Medical University Fourth Hospital", "conditions": ["PD-(L)1", "CTLA-4", "Advanced Melanoma", "Iparomlimab", "Tuvonralimab", "Bevacizumab"], "cn_sites": [{"facility": "The Fourth Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06941818", "title": "HS-IT101 Injection in the Treatment of Advanced Melanoma", "status": "ENROLLING_BY_INVITATION", "start": "2025-07-10", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Qingdao Sino-Cell Biomedicine Co., Ltd.", "conditions": ["Advanced Melanoma"], "cn_sites": [{"facility": "Peking University Cancer Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07070518", "title": "Study of GV20-0251 in Participants With Solid Tumor Malignancies", "status": "RECRUITING", "start": "2025-07-11", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 350, "sponsor": "GV20 Therapeutics", "conditions": ["Solid Tumor Cancer", "Adult Refractory Cancer", "Endometrial Carcinoma (EC)", "Squamous Head and Neck Carcinoma", "pMMR/MSS Adenocarcinoma of the Colon or Rectum", "Non-Small Cell Lung Cancer", "Melanoma", "HCC - Hepatocellular Carcinoma", "Small Cell Lung Cancer"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Cancer Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT06953089", "title": "DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors", "status": "RECRUITING", "start": "2025-07-18", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 450, "sponsor": "DualityBio Inc.", "conditions": ["Solid Tumors"], "cn_sites": [{"facility": "CHN02-0", "city": "Beijing", "status": "RECRUITING"}, {"facility": "CHN13-0", "city": "Beijing", "status": "RECRUITING"}, {"facility": "CHN23-0", "city": "Beijing", "status": "RECRUITING"}, {"facility": "CHN17-0", "city": "Dongguan", "status": "RECRUITING"}, {"facility": "CHN06-0", "city": "Henan", "status": "RECRUITING"}, {"facility": "CHN12-0", "city": "Xinxiang", "status": "RECRUITING"}, {"facility": "CHN04-0", "city": "Hubei", "status": "RECRUITING"}, {"facility": "CHN26-0", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "CHN34-0", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "CHN11-0", "city": "Changsha", "status": "RECRUITING"}, {"facility": "CHN16-0", "city": "Xuzhou", "status": "RECRUITING"}, {"facility": "CHN35-0", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "CHN25-0", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "CHN04-0", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "CHN01-0", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "CHN24-0", "city": "Chengdu", "status": "RECRUITING"}], "cn_site_count": 16, "broad_only": false}, {"nct": "NCT07070232", "title": "A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors", "status": "RECRUITING", "start": "2025-08-12", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 1438, "sponsor": "BioNTech SE", "conditions": ["Advanced Solid Tumor"], "cn_sites": [{"facility": "Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Tianjin Medical University Cancer Institute & Hospital", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "Hubei Cancer Hospital", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT07106827", "title": "A Study of GV20-0251 in Advanced or Refractory Solid Tumors", "status": "RECRUITING", "start": "2025-09-04", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "West China Hospital", "conditions": ["HCC - Hepatocellular Carcinoma", "Cholangiocarcinoma", "Melanoma", "NSCLC (Non-small Cell Lung Cancer)", "Pancreatic Ductal Adenocarcinoma", "HNSCC", "Endometrial Cancer", "Testicular Cancer"], "cn_sites": [{"facility": "West China Hospital", "city": "Chengdu", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07099430", "title": "A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanoma", "status": "RECRUITING", "start": "2025-09-05", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 200, "sponsor": "Nanjing Leads Biolabs Co.,Ltd", "conditions": ["Advanced Melanoma"], "cn_sites": [{"facility": "Fujian Cancer Hospital", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Dermatology Hospital of Southern Medical University", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Guangxi Medical University Cancer Hospital", "city": "Nanning", "status": "RECRUITING"}, {"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": "NOT_YET_RECRUITING"}, {"facility": "Shandong Cancer Hospital", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}, {"facility": "Shanxi Bethune Hospital", "city": "Taiyuan", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi’an", "status": "NOT_YET_RECRUITING"}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Tianjin Medical University Cancer Institute &Hospital", "city": "Tianjin", "status": "NOT_YET_RECRUITING"}, {"facility": "Yunnan Cancer Hospital", "city": "Kunming", "status": "RECRUITING"}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 15, "broad_only": false}, {"nct": "NCT07260591", "title": "VSV-02 Compassionate Use in Advanced Solid Tumors", "status": "RECRUITING", "start": "2025-09-22", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "The First Affiliated Hospital of Xinxiang Medical College", "conditions": ["Advanced Solid Tumor", "Melanoma", "Breast Cancer", "Lung Cancer", "Cancer Treatment", "Immunotherapy"], "cn_sites": [{"facility": "The First Affiliated Hospital of Xinxiang Medical University", "city": "Xinxiang", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07244835", "title": "A Study of DEG6498 in Participants With Solid Tumors", "status": "RECRUITING", "start": "2025-11-13", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Degron Therapeutics Co.", "conditions": ["Malignant Neoplasms"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing GoBroad Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Sun Yat-Sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07371663", "title": "An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors", "status": "RECRUITING", "start": "2025-12-03", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 266, "sponsor": "Beijing Tide Pharmaceutical Co., Ltd", "conditions": ["Solid Cancers", "NSCLC (Advanced Non-small Cell Lung Cancer)", "Gastric (Stomach) Cancer", "Endometrial Cancer", "Malignant Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07310784", "title": "A Phase II Trial of LM103 in Advanced Melanoma", "status": "RECRUITING", "start": "2025-12-16", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 92, "sponsor": "Suzhou BlueHorse Therapeutics Co., Ltd.", "conditions": ["Advanced Melanoma"], "cn_sites": [{"facility": "Beijing Go Broad Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Fujian Cancer Hospital", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "Sun Yat-Sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Guangxi Medical University Cancer Hospital", "city": "Nanning", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": "RECRUITING"}, {"facility": "The Third People's Hospital of Zhengzhou", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Jilin Cancer Hospital", "city": "Changchun", "status": "RECRUITING"}, {"facility": "The first hospital of Jilin University", "city": "Changchun", "status": "RECRUITING"}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi’an", "status": "RECRUITING"}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Tianjin Medical University Cancer Institute & Hospital", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 16, "broad_only": false}, {"nct": "NCT07280832", "title": "Phase I/II Clinical Study of JMT108 Injection for the Treatment of Advanced Malignant Melanoma and Urinary Tract Tumors", "status": "RECRUITING", "start": "2025-12-17", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 500, "sponsor": "Shanghai JMT-Bio Inc.", "conditions": ["Unresectable Locally Advanced or Metastatic Melanoma", "Unresectable Locally Advanced or Metastatic Urinary Tract Tumors"], "cn_sites": [{"facility": "BeiJing Cancer Hospital EC", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07353073", "title": "A Prospective, Single-Arm, Phase II Clinical Study of Neoadjuvant Therapy With Pucotenlimab, Lenvatinib, and Temozolomide for Resectable Head and Neck Mucosal Melanoma (PLT-NAT-HNMM-II)", "status": "NOT_YET_RECRUITING", "start": "2026-01-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University", "conditions": ["Head and Neck Mucosal Melanomas"], "cn_sites": [{"facility": "Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07307534", "title": "Nevus Removal vs. Conservative Treatment in Halo Nevus With Vitiligo: A Randomized Study", "status": "NOT_YET_RECRUITING", "start": "2026-01-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Xijing Hospital", "conditions": ["Vitiligo", "Halo Nevus"], "cn_sites": [{"facility": "Xijing Hospital", "city": "Xi'an", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07445022", "title": "RWS of Tunlametinib in NRAS-Mutant Advanced Melanoma", "status": "RECRUITING", "start": "2026-01-28", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 110, "sponsor": "Fudan University", "conditions": ["Melanoma Advanced"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07347444", "title": "Iparomlimab and Tuvoraleimab Injection in Combination With Bevacizumab, Albumin-bound Paclitaxel, and Carboplatin as First- or Second-line Treatment for Patients With Advanced Acral and Mucosal Melanoma", "status": "NOT_YET_RECRUITING", "start": "2026-02", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 48, "sponsor": "Fudan University", "conditions": ["Acral Melanoma", "Mucosal Melanoma"], "cn_sites": [{"facility": "Fudan university cancer hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07410494", "title": "Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors", "status": "RECRUITING", "start": "2026-02-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 85, "sponsor": "Essen Biotech", "conditions": ["Cancer", "Breast Cancer", "Non-Small Cell Lung Cancer (NSCLC)", "Colorectal Cancer (Locally Advanced or Metastatic)", "Prostate Cancer - Recurrent", "Pancreatic Ductal Adenocarcinoma (PDAC)", "Ovarian Cancer", "Glioblastoma", "Melanoma (Skin Cancer)", "Acute Myeloid Leukemia (AML)", "Non Hodgkin Lymphoma", "Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma", "Liver Cancer"], "cn_sites": [{"facility": "District One Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07410676", "title": "EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors", "status": "RECRUITING", "start": "2026-02-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 83, "sponsor": "Essen Biotech", "conditions": ["Cancer", "Sarcoma", "Leukaemia", "Breast Cancer (Locally Advanced or Metastatic)", "Lung Cancer (Diagnosis)", "Colorectal Cancer", "Melanoma (Skin Cancer)", "Bladder Cancer", "Kidney Cancer", "Pancreatic Cancer Metastatic", "Liver Cancer (Primary and Metastatic)", "Ovarian Cancer", "Esophageal Cancer", "Glioblastoma", "Non-Melanoma Skin Cancer"], "cn_sites": [{"facility": "District One Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07627698", "title": "Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced Melanoma", "status": "RECRUITING", "start": "2026-03-02", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Beijing Biotech", "conditions": ["Unresectable Melanoma", "Metastatic Cutaneous Melanoma", "Metastatic Uveal Melanoma"], "cn_sites": [{"facility": "Peking University Shenzhen Hospital", "city": "Shenzhen", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07177937", "title": "A Study of DXC014 in Patients With Advanced Solid Tumors.", "status": "RECRUITING", "start": "2026-03-03", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 150, "sponsor": "Hangzhou DAC Biotechnology Co., Ltd.", "conditions": ["Small Cell Lung Cancer", "Melanoma", "Prostate Cancer", "Other Advanced Solid Tumors"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Hunan Cancer Hospital", "city": "Changsha", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": "RECRUITING"}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT06889610", "title": "A Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors.", "status": "RECRUITING", "start": "2026-03-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 95, "sponsor": "Fudan University", "conditions": ["Triple Negative Breast Cancer Metastatic", "Melanoma Metastatic", "Colorectal Cancer Metastatic"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07750067", "title": "Tunlametinib in Combination With Pucotenlimab and Hydroxychloroquine in NRAS Mutant Melanoma", "status": "RECRUITING", "start": "2026-04-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 37, "sponsor": "Sun Yat-sen University", "conditions": ["Melanoma Metastatic", "NRAS Mutation"], "cn_sites": [{"facility": "Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07400302", "title": "Sintilimab Combined With Chemotherapy for Adjuvant Treatment of Mucosal Melanoma After Surgery", "status": "RECRUITING", "start": "2026-04-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 220, "sponsor": "The First Hospital of Jilin University", "conditions": ["Mucosal Melanoma", "PD-L1 Positive"], "cn_sites": [{"facility": "The first hospital of Jilin University", "city": "Changchun", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07562841", "title": "Au-TMP and Radiotherapy for Advanced Melanoma With Anti-PD-1 Therapy", "status": "RECRUITING", "start": "2026-04-28", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "West China Hospital", "conditions": ["Advanced Melanoma"], "cn_sites": [{"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07518043", "title": "A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors", "status": "RECRUITING", "start": "2026-07-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 174, "sponsor": "Shanghai Henlius Biotech", "conditions": ["Esophageal and/or Cardia Cancer", "Melanoma", "Urothelial Carcinoma (UC)"], "cn_sites": [{"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital Zhejiang University School Of Medicine", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Henan University of Science & Technology", "city": "Luoyang", "status": "RECRUITING"}, {"facility": "The Second Hospital of Tianjin Medical University", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": "RECRUITING"}, {"facility": "Union Hospital, Tongji Medical College,Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT07760012", "title": "68Ga-SorB PET/CT Imaging in Patients With Solid Tumors", "status": "RECRUITING", "start": "2026-07-24", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Peking University Third Hospital", "conditions": ["Melanoma (Skin Cancer)", "Hepatocellular Carcinoma", "Lung Cancer", "Breast Cancer", "Pancreatic Cancer", "Ovarian Cancer"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07492680", "title": "A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)", "status": "RECRUITING", "start": "2026-07-27", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 260, "sponsor": "Bristol-Myers Squibb", "conditions": ["Solid Tumors"], "cn_sites": [{"facility": "Local Institution - 0155", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Local Institution - 0185", "city": "Chongqing", "status": "NOT_YET_RECRUITING"}, {"facility": "Local Institution - 0184", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Henan Medical University", "city": "Xinxiang", "status": "RECRUITING"}, {"facility": "Shanghai GoBroad Cancer Hospital China Pharmaceutical University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT06739226", "title": "Combination Immunotherapy Targeting Melanoma", "status": "NOT_YET_RECRUITING", "start": "2027-06-30", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Shenzhen Geno-Immune Medical Institute", "city": "Shenzhen", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07170293", "title": "Phase II Trial of Tunlametinib in Patients With NRAS Mutant Non-melanoma Refractory Solid Tumors", "status": "RECRUITING", "start": "2027-08-31", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Tianjin Medical University Second Hospital", "conditions": ["Solid Cancers"], "cn_sites": [{"facility": "Tianjin Medical Unversity Second Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00813449", "title": "Safety Study of Combined Chemotherapy and Endostar to Untreated Patients With Advanced Melanoma", "status": "UNKNOWN", "start": "2008-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 140, "sponsor": "Simcere Pharmaceutical Co., Ltd", "conditions": ["Advanced Melanoma", "Untreated Patients"], "cn_sites": [{"facility": "Beijing tumor hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02372708", "title": "Clinical Research on the Treatments on Advanced Malignant Melanoma by Combining in Situ Immunotherapy and Laser Therapy", "status": "COMPLETED", "start": "2008-08", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 72, "sponsor": "Chinese PLA General Hospital", "conditions": ["Melanoma"], "cn_sites": [{"facility": "First Affiliated Hospital, Chinese PLA General Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00881049", "title": "Trial of Imatinib (Gleevec®) in Selected Patients With Metastatic Melanoma", "status": "COMPLETED", "start": "2008-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 1, "sponsor": "Peking University", "conditions": ["Metastatic Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01028222", "title": "A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation", "status": "COMPLETED", "start": "2010-06", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 55, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03138642", "title": "Mucosal Melanoma of Head and Neck in Intensity-modulated Radiotherapy Era", "status": "UNKNOWN", "start": "2010-07-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Sun Yat-sen University", "conditions": ["Mucosal Melanoma"], "cn_sites": [{"facility": "LiXia Lu", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02809001", "title": "The Effects of Autologous Fat Transfer on Preventing Expanded Skin From Expansion Failure", "status": "COMPLETED", "start": "2011-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 80, "sponsor": "Shanghai Jiao Tong University School of Medicine", "conditions": ["Scar", "Nevus"], "cn_sites": [{"facility": "Shanghai Ninth People's Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01782508", "title": "A Phase II Study of Imatinib Versus Interferon as Adjuvant Therapy in KIT-mutated Melanoma", "status": "UNKNOWN", "start": "2012-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Peking University Cancer Hospital & Institute", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01910181", "title": "A Study of Vemurafenib (Zelboraf) in Chinese Participants With BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma", "status": "COMPLETED", "start": "2013-08-17", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 46, "sponsor": "Hoffmann-La Roche", "conditions": ["Malignant Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Sun Yet-sen University Cancer Center", "city": "Guangzhou", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT02023710", "title": "Bevacizumab Combined With Carboplatin Plus Paclitaxel Chemotherapy to Treat Metastatic Mucosal Melanoma", "status": "UNKNOWN", "start": "2013-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 182, "sponsor": "Peking University Cancer Hospital & Institute", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Yunan Tumor Hospital", "city": "Kunming", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT03435302", "title": "HDI Versus Chemotherapy as Systemic Adjuvant Therapy for Resected Mucosal Melanoma", "status": "UNKNOWN", "start": "2014-02", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 204, "sponsor": "Peking University Cancer Hospital & Institute", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02083354", "title": "Study to Investigate the Objective Response Rate of Dabrafenib in Combination With Trametinib in Subjects With BRAF V600 Mutation-Positive Melanoma", "status": "COMPLETED", "start": "2014-03-18", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 77, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Cancer", "Melanoma"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Kunming", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Hangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT02457650", "title": "T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies", "status": "UNKNOWN", "start": "2015-04", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Shenzhen Second People's Hospital", "conditions": ["Bladder Carcinoma", "Breast Cancer", "Esophagus Carcinoma", "Lung Cancer", "Melanoma", "Multiple Myeloma", "Neuroblastoma", "Ovarian Cancer", "Synovial Sarcoma", "Other Metastatic Solid Cancers"], "cn_sites": [{"facility": "Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University", "city": "Shenzhen", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02576431", "title": "A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors", "status": "COMPLETED", "start": "2015-09-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 215, "sponsor": "Bayer", "conditions": ["Solid Tumors Harboring NTRK Fusion"], "cn_sites": [{"facility": "Beijing Cancer Hospital - Oncology Department", "city": "Beijing", "status": ""}, {"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": ""}, {"facility": "Sichuan University West China Hospital", "city": "Chengdu", "status": ""}, {"facility": "Zhongshan Hospital, Fudan University - Oncology Department", "city": "Shanghai", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT02619058", "title": "A Clinical Trial of Adoptive Transfer With Autologous NKT Cells in Metastatic Melanoma Patients", "status": "UNKNOWN", "start": "2015-10", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Peking University Cancer Hospital & Institute", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02516527", "title": "A Phase 1 Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Ipilimumab in Chinese Subjects With Select Advanced Solid Tumors", "status": "COMPLETED", "start": "2015-10-16", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 25, "sponsor": "Bristol-Myers Squibb", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Local Institution", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02545075", "title": "A Comparative Study in Chinese Subjects With Chemotherapy Naïve Stage IV Melanoma Receiving Ipilimumab (3 mg/kg) vs. Dacarbazine", "status": "COMPLETED", "start": "2015-10-31", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 182, "sponsor": "Bristol-Myers Squibb", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Local Institution", "city": "Nanjing", "status": ""}, {"facility": "Local Institution", "city": "Changchun", "status": ""}, {"facility": "Local Institution", "city": "Xi’an", "status": ""}, {"facility": "Local Institution", "city": "Tianjin", "status": ""}, {"facility": "Local Institution", "city": "Hanghzou", "status": ""}, {"facility": "Local Institution", "city": "Beijing", "status": ""}, {"facility": "Local Institution", "city": "Kunming", "status": ""}, {"facility": "Local Institution", "city": "Shanghai", "status": ""}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT02568267", "title": "Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)", "status": "ACTIVE_NOT_RECRUITING", "start": "2015-11-19", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 534, "sponsor": "Hoffmann-La Roche", "conditions": ["Breast Cancer", "Cholangiocarcinoma", "Colorectal Cancer", "Head and Neck Neoplasms", "Lymphoma, Large-Cell, Anaplastic", "Melanoma", "Neuroendocrine Tumors", "Non-Small Cell Lung Cancer", "Ovarian Cancer", "Pancreatic Cancer", "Papillary Thyroid Cancer", "Primary Brain Tumors", "Renal Cell Carcinoma", "Sarcomas", "Salivary Gland Cancers", "Adult Solid Tumor"], "cn_sites": [{"facility": "Harbin Medical University Cancer Hospital", "city": "Harbin", "status": ""}, {"facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Sichuan Cancer Hospital", "city": "Chengdu", "status": ""}, {"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Cancer Center of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": ""}, {"facility": "Shanghai chest hospital", "city": "Shanghai", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}, {"facility": "Shenzhen People's Hospital", "city": "Shenzhen", "status": ""}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT02702973", "title": "Characteristic Analysis of Retinopathy Associated With High Doses of Interferon α-2b Therapy", "status": "UNKNOWN", "start": "2015-12", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1, "sponsor": "The First Hospital of Jilin University", "conditions": ["Retinopathy"], "cn_sites": [{"facility": "Jilin University,No.1 Hospital", "city": "Changchun", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02671513", "title": "A Tolerability and Pharmacokinetics Study of SHR6390 in Advanced Melanoma Patients", "status": "UNKNOWN", "start": "2016-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Jiangsu HengRui Medicine Co., Ltd.", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03048253", "title": "A Phase I-c Study of Recombinant GM-CSF Herpes Simplex Virus to TreatⅣ M1c", "status": "UNKNOWN", "start": "2016-03-29", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 30, "sponsor": "OrienGene Biotechnology Ltd.", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Beijing cancer hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02738489", "title": "A Study to Evaluate the Safety and Tolerability of Using the SHR-1210 in Patients With Advanced Melanoma", "status": "COMPLETED", "start": "2016-04-13", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Jiangsu HengRui Medicine Co., Ltd.", "conditions": ["Advanced Melanoma"], "cn_sites": [{"facility": "Cancer Hospital Affiliated to Beijing University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03095079", "title": "Rh-endostatin in Combination With Dacarbazine and Cisplatin as the First Line Therapy for Metastatic Melanoma", "status": "UNKNOWN", "start": "2016-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 70, "sponsor": "Peking University Cancer Hospital & Institute", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03007823", "title": "High-activity Natural Killer Immunotherapy for Small Metastases of Melanoma", "status": "COMPLETED", "start": "2016-12-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Fuda Cancer Hospital, Guangzhou", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Fuda cancer institute of Fuda cancer hospital", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02975700", "title": "A Study of PLX3397 in Patients With Unresectable or Metastatic KIT-mutated Melanoma", "status": "COMPLETED", "start": "2017-01-31", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Daiichi Sankyo Co., Ltd.", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Sun Yat-sen Hospital", "city": "Guangzhou", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT03086174", "title": "Tolerability and Pharmacokinetics of Toripalimab in Combination With Axitinib in Patients With Kidney Cancer and Melanoma", "status": "UNKNOWN", "start": "2017-03-31", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Shanghai Junshi Bioscience Co., Ltd.", "conditions": ["Kidney Cancer Stage Iv", "Advanced Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03178123", "title": "The Study of JS001 Compared to High-Dose Interferon In Patients With Mucosal Melanoma That Has Been Removed by Surgery", "status": "TERMINATED", "start": "2017-05-31", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Shanghai Junshi Bioscience Co., Ltd.", "conditions": ["Mucosal Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04200040", "title": "A Clinical Study to Evaluate the Safety and Efficacy of OrienX010 in Unresectable Malignant Melanoma Patients", "status": "UNKNOWN", "start": "2017-08-27", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 165, "sponsor": "OrienGene Biotechnology Ltd.", "conditions": ["Melanoma (Skin)"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03973151", "title": "Study of HL-085 in NRAS Mutant Advanced Melanoma", "status": "COMPLETED", "start": "2017-09-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 42, "sponsor": "Shanghai Kechow Pharma, Inc.", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT03383237", "title": "Clinical Study of Apatinib as the Second-line Therapy in Malignant Melanoma", "status": "UNKNOWN", "start": "2017-11-29", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Henan Cancer Hospital", "conditions": ["Malignant Melanoma"], "cn_sites": [{"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03033485", "title": "18F-Labeled Picolinamide PET Imaging of Melanoma Diagnosis", "status": "UNKNOWN", "start": "2017-12", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Xijing Hospital", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Xijing Hospital Nuclear Medicine Department", "city": "Xi'an", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03422445", "title": "A Study of Apatinib Combined With Temozolomide in Patients Witn Advanced Melanoma", "status": "UNKNOWN", "start": "2018-01-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Peking University Cancer Hospital & Institute", "conditions": ["Advanced Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03430297", "title": "A Randomized, Controlled, Multi-center, Phase III Clinical Study to Investigate Recombinant Humanized PD-1 Monoclonal Antibody Injection (JS001) Versus Dacarbazine as the 1st-line Therapy for Unresectable or Metastatic Melanoma", "status": "COMPLETED", "start": "2018-02-02", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 256, "sponsor": "Shanghai Junshi Bioscience Co., Ltd.", "conditions": ["Metastatic Melanoma", "Unresectable Melanoma"], "cn_sites": [{"facility": "Hefei Binhu Hospital", "city": "Hefei", "status": ""}, {"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Fujian Cancer Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": ""}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Wuhan Union Hospital", "city": "Wuhan", "status": ""}, {"facility": "Hunan Cancer Hospital", "city": "Changsha", "status": ""}, {"facility": "The First Hospital Of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Shandong Cancer Hospital", "city": "Jinan", "status": ""}, {"facility": "Yunnan Cancer Hospital", "city": "Kunming", "status": ""}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": ""}], "cn_site_count": 11, "broad_only": false}, {"nct": "NCT03638206", "title": "Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies", "status": "UNKNOWN", "start": "2018-03-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 73, "sponsor": "Shenzhen BinDeBio Ltd.", "conditions": ["B-cell Acute Lymphoblastic Leukemia", "Lymphoma", "Myeloid Leukemia", "Multiple Myeloma", "Hepatoma", "Gastric Cancer", "Pancreatic Cancer", "Mesothelioma", "Colorectal Cancer", "Esophagus Cancer", "Lung Cancer", "Glioma", "Melanoma", "Synovial Sarcoma", "Ovarian Cancer", "Renal Carcinoma"], "cn_sites": [{"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03966456", "title": "Real World Study of Four PD-1 Agents in China", "status": "UNKNOWN", "start": "2018-06-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "The Affiliated Hospital of Qingdao University", "conditions": ["Thoracic Cancer", "Gynecologic Cancer", "Abdomen Tumors", "Malignant Melanoma"], "cn_sites": [{"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03602547", "title": "Study of the Combination of CM082 With JS001 in Patients With Advanced Mucosal Melanoma.", "status": "UNKNOWN", "start": "2018-07-31", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "AnewPharma", "conditions": ["Mucosal Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03649529", "title": "Treatment of Malignant Melanoma With GPA-TriMAR-T Cell Therapy", "status": "UNKNOWN", "start": "2018-09-27", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Timmune Biotech Inc.", "conditions": ["Malignant Melanoma"], "cn_sites": [{"facility": "Hainan Cancer Hospital", "city": "Haikou", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Hainan Medical University", "city": "Haikou", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT04749485", "title": "A Study of HX008 for the Treatment of Patients With Malignant Melanoma", "status": "UNKNOWN", "start": "2018-11-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 119, "sponsor": "Taizhou Hanzhong biomedical co. LTD", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Peking University Cancer Hospital and Research Institute", "city": "Beijing", "status": ""}, {"facility": "Fujian Cancer Hospital", "city": "Fuzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Jinan University", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": ""}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": ""}, {"facility": "The first Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Fudan Universtiy Shanghai Cancer Center", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Tenth People's Hospital", "city": "Shanghai", "status": ""}, {"facility": "West China Hospital Sichuan Universtiy", "city": "Chengdu", "status": ""}, {"facility": "The Affiliated Cancer Hospital of Xinjiang Medical University", "city": "Ürümqi", "status": ""}, {"facility": "Zhejiang University School of Medicine Sir Run Run Shaw Hospital", "city": "Hangzhou", "status": ""}], "cn_site_count": 11, "broad_only": false}, {"nct": "NCT04386967", "title": "OH2 Injection in Solid Tumors", "status": "COMPLETED", "start": "2018-11-22", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 44, "sponsor": "Binhui Biopharmaceutical Co., Ltd.", "conditions": ["Solid Tumor", "Melanoma"], "cn_sites": [{"facility": "Peking University Cancer Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03955354", "title": "PD-1 Antibody SHR-1210 Combined With Apatinib of First-line Treatment of Advanced Acral Melanoma", "status": "UNKNOWN", "start": "2019-03-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Peking University Cancer Hospital & Institute", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Guo Jun", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT03820986", "title": "Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advance Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)", "status": "COMPLETED", "start": "2019-03-12", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 674, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Malignant Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital ( Site 0601)", "city": "Beijing", "status": ""}, {"facility": "Fujian Provincial Cancer Hospital ( Site 0612)", "city": "Fuzhou", "status": ""}, {"facility": "Sun Yat-Sen University Cancer Center ( Site 0602)", "city": "Guangzhou", "status": ""}, {"facility": "Henan Cancer Hospital ( Site 0610)", "city": "Zhengzhou", "status": ""}, {"facility": "Nanjing Drum Tower Hospital ( Site 0609)", "city": "Nanjing", "status": ""}, {"facility": "The First Hospital Of Jilin University ( Site 0603)", "city": "Changchun", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center ( Site 0607)", "city": "Shanghai", "status": ""}, {"facility": "Tianjin Medical University Cancer Institute & Hospital ( Site 0606)", "city": "Tianjin", "status": ""}, {"facility": "Yunnan Cancer Hospital ( Site 0604)", "city": "Kunming", "status": ""}, {"facility": "Sir Run Run Shaw Hospital ( Site 0605)", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital ( Site 0608)", "city": "Hangzhou", "status": ""}], "cn_site_count": 11, "broad_only": false}, {"nct": "NCT03932253", "title": "MEK Inhibitor FCN-159 To Treat Advanced Melanoma With NRAS-aberrant (Ia) and NRAS-mutant (Ib)or NF1-mutant(1b)", "status": "SUSPENDED", "start": "2019-03-21", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 79, "sponsor": "Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03917069", "title": "Nab-PCE vs PC for MM After Failure of Anti-PD-1", "status": "UNKNOWN", "start": "2019-03-23", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 145, "sponsor": "Peking University Cancer Hospital & Institute", "conditions": ["Advanced Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04206358", "title": "Study to Evaluate OrienX010 in Combination With JS001 in the Treatment of Stage IV (M1c) Liver Metastasis From Melanoma", "status": "UNKNOWN", "start": "2019-05-13", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Peking University Cancer Hospital & Institute", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04197882", "title": "Clinical Study to Evaluate OrienX010 in Combination With Toripalimab as Neoadjuvant Treatment in Advanced Melanoma", "status": "UNKNOWN", "start": "2019-05-27", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 33, "sponsor": "Peking University Cancer Hospital & Institute", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03986515", "title": "Apatinib Plus SHR1210 in Advanced Mucosal Melanoma", "status": "UNKNOWN", "start": "2019-06-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Henan Cancer Hospital", "conditions": ["Mucosal Melanoma", "Advanced Cancer", "Apatinib", "SHR-1210"], "cn_sites": [{"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03991975", "title": "Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Acral Malignant Melanoma", "status": "UNKNOWN", "start": "2019-06-11", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 42, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Advanced Acral Malignant Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04248387", "title": "Toripalimab in the Neoadjuvant Treatment of BRAF V600 Wild Type Melanoma", "status": "UNKNOWN", "start": "2019-06-17", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Fudan University", "conditions": ["Melanoma Stage IIIB-IV"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04180995", "title": "Toripalimab in Combination With Axitinib in Patients With Localized Mucosal Melanoma", "status": "UNKNOWN", "start": "2019-08-06", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Peking University Cancer Hospital & Institute", "conditions": ["Mucosal Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03941795", "title": "Phase II Study in the Treatment of Patients With Advanced Mucinous Melanoma", "status": "UNKNOWN", "start": "2019-11-11", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 99, "sponsor": "Peking University Cancer Hospital & Institute", "conditions": ["Advanced Mucosal Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Baishen First Hospital of Jilin University", "city": "Shengyang", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT04091217", "title": "Atezolizumab in Combination With Bevacizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma", "status": "COMPLETED", "start": "2019-11-25", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 43, "sponsor": "Hoffmann-La Roche", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Center; Renal Cancer And Melanoma Department.", "city": "Beijing", "status": ""}, {"facility": "Fujian Provincial Cancer Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital", "city": "Zhejiang", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT04172454", "title": "Safety and Efficacy of AK104, a PD-1/CTLA-4 Bispecific Antibody, in Selected Advanced Solid Tumors", "status": "COMPLETED", "start": "2019-12-20", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 68, "sponsor": "Akeso", "conditions": ["Advanced Solid Tumors", "Melanoma"], "cn_sites": [{"facility": "Sun Yat-Sen University Cancer Center", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04198818", "title": "A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors", "status": "TERMINATED", "start": "2020-01-07", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 37, "sponsor": "Haihe Biopharma Co., Ltd.", "conditions": ["Advanced Tumors", "Melanoma", "Non-Small-Cell Lung Cancer", "Erdheim-Chester Disease", "Other RAS/RAF/MEK/ERK Mutated Tumors"], "cn_sites": [{"facility": "Shanghai East hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04234620", "title": "Intensive Medicines Monitoring Study of Toripalimab Monoclonal Injection (Tuoyi) .", "status": "UNKNOWN", "start": "2020-02-15", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 800, "sponsor": "Shanghai Junshi Bioscience Co., Ltd.", "conditions": ["Melanoma", "Lung Cance", "Breast Cancer"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Cancer Hospital Chinese Academy of Medical Science", "city": "Beijing", "status": ""}, {"facility": "The first affiliated Hospital of Jinlin Universtiy", "city": "Changchun", "status": ""}, {"facility": "Hunan cancer hospital", "city": "Changsha", "status": ""}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": ""}, {"facility": "Chongqing Haijiya Cancer Hospital", "city": "Chongqing", "status": ""}, {"facility": "Fujian province cancer hospital", "city": "Fuzhou", "status": ""}, {"facility": "Zhejiang cancer hospital", "city": "Hangzhou", "status": ""}, {"facility": "Harbin Medical University Cancer Hospital", "city": "Harbin", "status": ""}, {"facility": "Qilu Hospital of Shandong university", "city": "Jinan", "status": ""}, {"facility": "Shandong province cancer hospital", "city": "Jinan", "status": ""}, {"facility": "Affiliated Cancer Hospital of Guangxi Medical university", "city": "Nanjing", "status": ""}, {"facility": "Najing Drum Tower Hospital", "city": "Nanjing", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}, {"facility": "Shanxi Bethune Hopital", "city": "Shanxi", "status": ""}, {"facility": "The fouth Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "The Second affiliated Hospital of Suzhou Universtiy", "city": "Suzhou", "status": ""}, {"facility": "Tianjin Medical University cancer institute & Hospital", "city": "Tianjin", "status": ""}, {"facility": "Hubei cancer hospital", "city": "Wuhan", "status": ""}, {"facility": "Tongji Medical College of Huazhong University of Science & Technology", "city": "Wuhan", "status": ""}, {"facility": "Wuhan Union Hospital", "city": "Wuhan", "status": ""}, {"facility": "The first affiliated Hospital of Xiamen Universtiy", "city": "Xiamen", "status": ""}, {"facility": "Yinchuan Lingke Internet Hosipital", "city": "Yinchuan", "status": ""}, {"facility": "Affiliated Hopital of Guangdong Medical University", "city": "Zhanjiang", "status": ""}, {"facility": "Henan cancer hospital", "city": "Zhengzhou", "status": ""}], "cn_site_count": 25, "broad_only": false}, {"nct": "NCT05907512", "title": "Endostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous Melanoma", "status": "UNKNOWN", "start": "2020-04-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 43, "sponsor": "Fudan University", "conditions": ["Clinical Stage III Cutaneous Melanoma AJCC v8", "Clinical Stage IV Cutaneous Melanoma AJCC v8"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04277663", "title": "The Study of IBI310 in Combination With IBI308 Compared to High-Dose Interferon In Patients With Acral Melanoma That Has Been Removed by Surgery", "status": "TERMINATED", "start": "2020-04-17", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 136, "sponsor": "Innovent Biologics (Suzhou) Co. Ltd.", "conditions": ["Acral Melanoma That Has Been Removed by Surgery"], "cn_sites": [{"facility": "Beijing cancer hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05602792", "title": "A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors", "status": "UNKNOWN", "start": "2020-04-21", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 233, "sponsor": "ImmVira Pharma Co. Ltd", "conditions": ["Advanced Solid Tumor", "Sarcoma", "HNSCC", "Breast Cancer", "Esophagus Cancer", "NSCLC", "Non-melanoma Skin Cancer"], "cn_sites": [{"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": "RECRUITING"}, {"facility": "The Second Hospital of Anhui Medical University", "city": "Hefei", "status": "RECRUITING"}, {"facility": "The Fifth Affiliated Hospital of Sun Yat-sen University", "city": "Guanzhou", "status": "RECRUITING"}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Wuhan Union Hospital", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Hunan Cancer Hospital", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Jiangxi Cancer Hospital", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Liaoning Cancer Hospital", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Zhejiang University Medical College", "city": "Hanzhou", "status": "RECRUITING"}, {"facility": "Zhejiang Provincial People's Hospital", "city": "Hanzhou", "status": "RECRUITING"}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Jishuitan Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Ninth People's Hospital,Shanghai Jiao Tong University School to Medicine", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Fudan University Cancer Hospital", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Zhongshan Hospital", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Shanghai Sixth People's Hospital", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second People's Hospital of Shenzhen", "city": "Shenzhen", "status": "RECRUITING"}], "cn_site_count": 19, "broad_only": false}, {"nct": "NCT04072900", "title": "A Personalized NeoAntigen Cancer Vaccine Combined With Anti-PD-1 in Melanoma", "status": "UNKNOWN", "start": "2020-04-21", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Xiangya Hospital of Central South University", "conditions": ["Melanoma (Skin)"], "cn_sites": [{"facility": "Xiangya Hospital, Central South University", "city": "Changsha", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04357509", "title": "The Tolerance,Pharmacokinetic Characteristics,Safety and Efficacy of ScTIL210 in the Treatment of Melanoma", "status": "UNKNOWN", "start": "2020-05", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 32, "sponsor": "Peking University Cancer Hospital & Institute", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04640545", "title": "A Study to Assess LBL-007 in Combination With Toripalimab and Axitinib Tablets Subjects With Advanced Melanoma", "status": "COMPLETED", "start": "2020-05-12", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 79, "sponsor": "Nanjing Leads Biolabs Co.,Ltd", "conditions": ["Advanced Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Fujian Cancer Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Hunan Cancer Hospital", "city": "Changsha", "status": ""}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": ""}, {"facility": "Jilin Cancer Hospital", "city": "Changchun", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT04462965", "title": "Postoperative Adjuvant Treatment of Completely Resected Mucosal Melanoma Phase II Study", "status": "UNKNOWN", "start": "2020-05-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 294, "sponsor": "Peking University Cancer Hospital & Institute", "conditions": ["Mucosal Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04472806", "title": "Maintenance Treatment of Toripalimab(JS001) in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma", "status": "UNKNOWN", "start": "2020-06-20", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 31, "sponsor": "Fudan University", "conditions": ["Mucosal Melanoma"], "cn_sites": [{"facility": "Zhiguo Luo", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04889118", "title": "Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advanced Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)-China Extension Study", "status": "COMPLETED", "start": "2020-07-14", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 131, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Malignant Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital (0601)", "city": "Beijing", "status": ""}, {"facility": "Fujian Provincial Cancer Hospital ( Site 0612)", "city": "Fuzhou", "status": ""}, {"facility": "Sun Yat-Sen University Cancer Center (0602)", "city": "Guangzhou", "status": ""}, {"facility": "Henan Cancer Hospital ( Site 0610)", "city": "Zhengzhou", "status": ""}, {"facility": "Nanjing Drum Tower Hospital (0609)", "city": "Nanjing", "status": ""}, {"facility": "The First Hospital Of Jilin University (0603)", "city": "Changchun", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center ( Site 0607)", "city": "Shanghai", "status": ""}, {"facility": "Tianjin Medical University Cancer Institute & Hospital (0606)", "city": "Tianjin", "status": ""}, {"facility": "Yunnan Cancer Hospital (0604)", "city": "Kunming", "status": ""}, {"facility": "Sir Run Run Shaw Hospital (0605)", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital ( Site 0608)", "city": "Hangzhou", "status": ""}], "cn_site_count": 11, "broad_only": false}, {"nct": "NCT04593485", "title": "Anti-PD-1 Antibody in the Treatment of Patients With Malignant Melanoma of the Female Genital Tract", "status": "UNKNOWN", "start": "2020-10-28", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Fudan University", "conditions": ["Malignant Melanoma"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04653038", "title": "A Study to Evaluate the Safety and Efficacy of MGD013 in Patients With Melanoma", "status": "TERMINATED", "start": "2020-10-29", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 92, "sponsor": "Zai Lab (Shanghai) Co., Ltd.", "conditions": ["Unresectable, Recurrent or Metastatic Melanoma", "Untreated Mucosal or Acral Lentiginous Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Fujian Cancer Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Hunan Cancer Hospital", "city": "Changsha", "status": ""}, {"facility": "Jiangsu Province Hospital", "city": "Nanjing", "status": ""}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": ""}, {"facility": "Jilin Cancer Hospital", "city": "Changchun", "status": ""}, {"facility": "The first hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}, {"facility": "Tangdu Hospital", "city": "Xi’an", "status": ""}, {"facility": "Tianjin Cancer Hospital", "city": "Tianjin", "status": ""}, {"facility": "Sir Run Shaw Hospital, School Of Medicine ,Zhejiang University", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": ""}], "cn_site_count": 13, "broad_only": false}, {"nct": "NCT05217303", "title": "HL-085 in NRAS-mutated Advanced Melanoma", "status": "COMPLETED", "start": "2020-11-02", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Shanghai Kechow Pharma, Inc.", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Oncology Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT04606472", "title": "A Study of SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid Tumors", "status": "ACTIVE_NOT_RECRUITING", "start": "2020-11-10", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Sichuan Baili Pharmaceutical Co., Ltd.", "conditions": ["Solid Tumor"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Chongqing University Cancer Hospital", "city": "Chongqing", "status": ""}, {"facility": "The First Affiliated Hospital of Xiamen University", "city": "Xiamen", "status": ""}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Hubei Cancer Hospital", "city": "Wuhan", "status": ""}, {"facility": "Union Hospital Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Shanghai Central Hospital", "city": "Shanghai", "status": ""}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": ""}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT04666272", "title": "Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete Resection", "status": "ACTIVE_NOT_RECRUITING", "start": "2020-12-31", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 78, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Fuzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Zhengzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Wuhan", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Changsha", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Nanjing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Kunming", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Hangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT07506447", "title": "The Value of [18F]FDG PET/CT Imaging in Prognostic Evaluation of Mucosal Melanoma", "status": "COMPLETED", "start": "2021-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 68, "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": ["FDG PET", "Mucosal Melanoma"], "cn_sites": [{"facility": "Wuhan Union Hospital", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04747561", "title": "Clinical Application of 18F-PEG3-FPN PET Imaging in Diagnosis and Staging of Malignant Melanoma", "status": "UNKNOWN", "start": "2021-01-12", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": ["Melanoma"], "cn_sites": [{"facility": "China, Hubei Province", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05274438", "title": "Imatinib and Toripalimab in Patients With Locally Advanced/Metastatic Melanoma Harbored With CKIT Mut", "status": "UNKNOWN", "start": "2021-01-26", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 37, "sponsor": "Peking University Cancer Hospital & Institute", "conditions": ["Advanced Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04871334", "title": "Safety, Tolerability and Pharmacokinetics of TWP-101 in Patients With Advanced Melanoma and Urothelial Carcinoma", "status": "UNKNOWN", "start": "2021-02-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 76, "sponsor": "Shandong TheraWisdom Biopharma Co., Ltd.", "conditions": ["Advanced Melanoma", "Advanced Urothelial Carcinoma"], "cn_sites": [{"facility": "Peking University Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04884997", "title": "A Study of Toripalimab or Combining With Temozolomide（iv） in the Treatment of Advanced/Metastatic Malignant Melanoma", "status": "UNKNOWN", "start": "2021-03-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "First Affiliated Hospital of Zhejiang University", "conditions": ["Malignant Melanoma"], "cn_sites": [{"facility": "Department of Medical Onocology, First Affiliated Hospital of Zhejiang University", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04773951", "title": "A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid Tumors", "status": "COMPLETED", "start": "2021-04-12", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 47, "sponsor": "Shanghai Junshi Bioscience Co., Ltd.", "conditions": ["Melanoma", "Renal Carcinoma", "Urothelial Carcinoma"], "cn_sites": [{"facility": "Fujian Provincial Cancer Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Tumor Hospital affiliated to Harbin Medical University", "city": "Harbin", "status": ""}, {"facility": "Hunan Cancer Hospital", "city": "Changsha", "status": ""}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": ""}, {"facility": "First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Run Run Shaw Hospital affiliated to Zhejiang University Medical College", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": ""}, {"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}, {"facility": "Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 11, "broad_only": false}, {"nct": "NCT05190185", "title": "A Clinical Trial of TAA06 Injection in Advanced Solid Tumors", "status": "UNKNOWN", "start": "2021-06-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "PersonGen BioTherapeutics (Suzhou) Co., Ltd.", "conditions": ["Malignant Melanoma, Lung Cancer, or Colorectal Cancer"], "cn_sites": [{"facility": "PersonGen BioTherapeutics(Suzhou) Co., Ltd.", "city": "Suzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04924413", "title": "L-TIL Plus Tislelizumab as First-line Treatment in Advanced Malignant Melanoma", "status": "TERMINATED", "start": "2021-07-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Quanli Gao", "conditions": ["Malignant Melanoma"], "cn_sites": [{"facility": "Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04979585", "title": "Camrelizumab Plus Amlotinib and Chemotherapy in the First-line Treatment of Melanoma", "status": "UNKNOWN", "start": "2021-07-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 66, "sponsor": "Di Wu", "conditions": ["Melanoma"], "cn_sites": [{"facility": "The first hospital of Jilin University", "city": "Changchun", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05009446", "title": "Single Arm Study of Induction Chemoradiotherapy Combined With Surgery in the Treatment of Locally Advanced SNMM", "status": "UNKNOWN", "start": "2021-08-10", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 28, "sponsor": "Eye & ENT Hospital of Fudan University", "conditions": ["Mucosal Melanoma", "Sinonasal Melanoma"], "cn_sites": [{"facility": "Eye& ENT Hospital, Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04849260", "title": "Phase Ib/II Clinical Study of Pexa-Vec (Vaccinia GM CSF / Thymidine Kinase-Deactivated Virus) Combined With Recombinant Whole Human Anti-PD-L1 Monoclonal Antibody (ZKAB001) in Metastatic Melanoma", "status": "UNKNOWN", "start": "2021-08-26", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 54, "sponsor": "Lee's Pharmaceutical Limited", "conditions": ["Local Progression or Metastatic Melanoma With Failed First-line Treatment"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05148325", "title": "Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT4706 in Advanced Solid Tumors", "status": "COMPLETED", "start": "2021-09-02", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 28, "sponsor": "Bio-Thera Solutions", "conditions": ["Advanced Solid Tumor", "Melanoma"], "cn_sites": [{"facility": "Beijing cancer hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05263453", "title": "HL-085+Vemurafenib to Treat Advanced Melanoma Patients With BRAF V600E/K Mutation", "status": "UNKNOWN", "start": "2021-09-06", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 104, "sponsor": "Shanghai Kechow Pharma, Inc.", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05003622", "title": "Phase 1 Safety Study of Encorafenib in Chinese Patients With Advanced Metastatic BRAF V600E Mutant Solid Tumors", "status": "COMPLETED", "start": "2021-09-27", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 3, "sponsor": "Pierre Fabre Medicament", "conditions": ["BRAF V600E Unresectable or Metastatic Melanoma", "BRAF V600E Metastatic NSCLC", "Melanoma"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05051865", "title": "To Explore the Efficacy and Safety of Camrelizumab Combined With SHR1020 in the Treatment of Advanced Melanoma", "status": "UNKNOWN", "start": "2021-10-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Peking University Cancer Hospital & Institute", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05002569", "title": "A Study to Assess Adjuvant Immunotherapy With Nivolumab Plus Relatlimab Versus Nivolumab Alone After Complete Resection of Stage III-IV Melanoma", "status": "TERMINATED", "start": "2021-10-19", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1093, "sponsor": "Bristol-Myers Squibb", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Local Institution - 0221", "city": "Hefei", "status": ""}, {"facility": "Local Institution - 0259", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 0261", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 0214", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 0241", "city": "Chongqing", "status": ""}, {"facility": "Local Institution - 0245", "city": "Fuzhou", "status": ""}, {"facility": "Local Institution - 0217", "city": "Guangzhou", "status": ""}, {"facility": "Local Institution - 0226", "city": "Zhengzhou", "status": ""}, {"facility": "Local Institution - 0237", "city": "Wuhan", "status": ""}, {"facility": "Local Institution - 0239", "city": "Wuhan", "status": ""}, {"facility": "Local Institution - 0234", "city": "Changsha Shi", "status": ""}, {"facility": "Local Institution - 0215", "city": "Nanjing", "status": ""}, {"facility": "Local Institution - 0225", "city": "Nanjing", "status": ""}, {"facility": "Local Institution - 0224", "city": "Nanchang", "status": ""}, {"facility": "Local Institution - 0219", "city": "Changchun", "status": ""}, {"facility": "Local Institution - 0242", "city": "Shenyang", "status": ""}, {"facility": "Local Institution - 0230", "city": "Chengdu", "status": ""}, {"facility": "Local Institution - 0263", "city": "Tianjin", "status": ""}, {"facility": "Local Institution - 0228", "city": "Ürümqi", "status": ""}, {"facility": "Local Institution - 0222", "city": "Kunming", "status": ""}, {"facility": "Local Institution - 0220", "city": "Hangzhou", "status": ""}, {"facility": "Local Institution - 0216", "city": "Hangzhou", "status": ""}, {"facility": "Local Institution - 0244", "city": "Taiyuan", "status": ""}], "cn_site_count": 23, "broad_only": false}, {"nct": "NCT05104801", "title": "Sitravatinib With or Without Tislelizumab in Patients With Unresectable or Metastatic Melanoma", "status": "UNKNOWN", "start": "2021-11", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 37, "sponsor": "Peking University Cancer Hospital & Institute", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05087602", "title": "Toripalimab Combined With Anlotinib in Unresectable Locally Advanced or Metastatic Acral Malignant Melanoma", "status": "UNKNOWN", "start": "2021-11-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 29, "sponsor": "Qilu Hospital of Shandong University", "conditions": ["Locally Advanced or Metastatic Acral Malignant Melanoma"], "cn_sites": [{"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05180851", "title": "Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study", "status": "UNKNOWN", "start": "2021-11-30", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 28, "sponsor": "Shanghai Fengxian District Central Hospital", "conditions": ["Head and Neck Cancer", "Melanoma", "Breast Cancer", "Bladder Cancer", "Ovarian Carcinoma", "Cervical Carcinoma", "Lung Cancer"], "cn_sites": [{"facility": "Shanghai Fengxian District Central Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05156515", "title": "PD-L1 Targeting Nanobody Probe for PET Imaging of Solid Tumor", "status": "UNKNOWN", "start": "2021-12-09", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Peking University Cancer Hospital & Institute", "conditions": ["Lung Cancer", "Melanoma", "PD-L1", "PET/CT"], "cn_sites": [{"facility": "Beijing cancer hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05117138", "title": "Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors", "status": "UNKNOWN", "start": "2022-01-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 39, "sponsor": "Beijing Immunochina Medical Science & Technology Co., Ltd.", "conditions": ["Melanoma", "Non-small Cell Lung Cancer", "Head and Neck Squamous Cell Carcinoma"], "cn_sites": [{"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05106023", "title": "To Explore the Efficacy and Safety of SHR-1701 Combined With Temozolomide in the Treatment of Advanced Melanoma", "status": "UNKNOWN", "start": "2022-01-21", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 31, "sponsor": "Yong Chen", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05235607", "title": "Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors", "status": "UNKNOWN", "start": "2022-03-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Sichuan University", "conditions": ["Carcinoma", "Melanoma", "Bladder Cancer", "Colorectal Cancer"], "cn_sites": [{"facility": "West China Hospital", "city": "Chengdu", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05114603", "title": "A Phase II Clinical Trial to Evaluate HLX208 in Advanced Melanoma Patients With BRAF V600 Mutation", "status": "UNKNOWN", "start": "2022-03-21", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Shanghai Henlius Biotech", "conditions": ["Advanced Melanoma"], "cn_sites": [{"facility": "Peking University Cancer Hospita", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Hunan cancer hospital", "city": "Changsha", "status": "RECRUITING"}, {"facility": "West China Hospital of Sichuan University", "city": "Chendu", "status": "NOT_YET_RECRUITING"}, {"facility": "Fujian cancer hospital", "city": "Fujian", "status": "NOT_YET_RECRUITING"}, {"facility": "Shangxi Bethune Hospita", "city": "Taiyuan", "status": "NOT_YET_RECRUITING"}, {"facility": "union Hospital Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}, {"facility": "Henan cancer hospital", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT06239623", "title": "ERK Inhibitor JSI-1187 in Advanced Solid Tumors", "status": "UNKNOWN", "start": "2022-04-02", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "JS InnoPharm, LLC", "conditions": ["Solid Tumor", "NSCLC", "Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05135715", "title": "A Study of RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression)", "status": "UNKNOWN", "start": "2022-04-19", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "RemeGen Co., Ltd.", "conditions": ["Melanoma, Stage II", "HER2-positive", "Advanced Melanoma"], "cn_sites": [{"facility": "Fujian cancer hospital", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": "RECRUITING"}, {"facility": "Zhejiang cancer hospital", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT06337617", "title": "A Multi-center Retrospective Study With Secondary Use of Data of Tafinlar (Dabrafenib) Plus Mekinist (Trametinib) in Chinese Patients With BRAF V600 Mutation Positive Melanoma", "status": "COMPLETED", "start": "2022-05-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 90, "sponsor": "Novartis Pharmaceuticals", "conditions": ["BRAF V600 Mutation Positive Melanoma"], "cn_sites": [{"facility": "Novartis", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05420324", "title": "A Study to Assess YH003 in Combination with Pebolizumab and Albumin Paclitaxel Injection in Subjects with Unresectable/metastatic Mucosal Melanoma", "status": "COMPLETED", "start": "2022-06-13", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Eucure (Beijing) Biopharma Co., Ltd", "conditions": ["Mucosal Melanoma"], "cn_sites": [{"facility": "Cancer Hospital of Fujian", "city": "Fuzhou", "status": ""}, {"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": ""}, {"facility": "Cancer Hospital of Zhenzhou", "city": "Zhengzhou", "status": ""}, {"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Hunan Cancer Hospital", "city": "Changsha", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Jilin City", "status": ""}, {"facility": "The First affiliated Hospital of Dalian Medical University", "city": "Dalian", "status": ""}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Tianjin Medical University Cancer Institute and Hospital", "city": "Tianjin", "status": ""}, {"facility": "Yunnan Cancer Hospital", "city": "Kunming", "status": ""}, {"facility": "Cancer Hospital of The University of Chinese Academy of Sciences", "city": "Hangzhou", "status": ""}], "cn_site_count": 12, "broad_only": false}, {"nct": "NCT05406466", "title": "Cryoablation Combined With Tislelizumab Plus Lenvatinib in Patients With Melanoma Liver Metastasis", "status": "UNKNOWN", "start": "2022-07-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 25, "sponsor": "Fudan University", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05451407", "title": "Efficacy and Safety of TQB2618 Injection Combined With Toripalimab Injection in Patients With Advanced Melanoma", "status": "UNKNOWN", "start": "2022-08-09", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Peking University Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05498805", "title": "PD-1 Inhibitors With or Without Radiation in Advanced Melanoma", "status": "UNKNOWN", "start": "2022-08-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 92, "sponsor": "Fudan University", "conditions": ["the Efficacy and Safety of PD-1 Inhibitors With or Without Radiotherapy in Patients With Advanced Melanoma"], "cn_sites": [{"facility": "Fudan University Shanghai Cencer Center", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05501912", "title": "A Study of ABM-1310 in Patients With BRAF V600-Mutant Advanced Solid Tumors", "status": "TERMINATED", "start": "2022-09-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "ABM Therapeutics Shanghai Company Limited", "conditions": ["Advanced Solid Tumor", "BRAF V600 Mutation"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Tsinghua Changgeng Hospital", "city": "Beijing", "status": ""}, {"facility": "Xuzhou Medical University Affiliated Hospital", "city": "Xuzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": ""}, {"facility": "Jilin Cancer Hospital", "city": "Changchun", "status": ""}, {"facility": "Affiliated Cancer Hospital of Shandong First Medical University (Shandong Cancer Institute, Shandong Cancer Hospital)", "city": "Jinan", "status": ""}, {"facility": "Shanghai Chest Hospital", "city": "Shanghai", "status": ""}, {"facility": "Zhongshan Hospital Affiliated to Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Huashan Hospital Affiliated to Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shanghai East Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT05798546", "title": "Treatment of Advanced Solid Tumors With Neo-T(GI-NeoT-02)", "status": "UNKNOWN", "start": "2022-09-28", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 21, "sponsor": "BGI, China", "conditions": ["Solid Tumor"], "cn_sites": [{"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05537740", "title": "A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-10-11", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 129, "sponsor": "Bayer", "conditions": ["Advanced Solid Tumors"], "cn_sites": [{"facility": "Guangdong Provincial People's Hospital", "city": "Guangzhou", "status": ""}, {"facility": "The Sixth Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "Jilin Cancer Hospital", "city": "Changchun", "status": ""}, {"facility": "LinYi Cancer Hospital (Linyi Tumor Hospital)", "city": "Linyi", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT05544929", "title": "A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-10-26", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 126, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Carcinoma, Non-Small-Cell Lung", "Cutaneous Melanoma", "Carcinoma, Renal Cell", "Carcinoma, Ovarian Epithelial", "Nasopharyngeal Carcinoma", "Carcinoma, Thymic", "Anal Cancer", "Mesothelioma", "Esophagogastric Cancer", "High Microsatellite Instability Colorectal Carcinoma", "Squamous Cell Carcinoma of Head and Neck", "Triple Negative Breast Neoplasms"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05478473", "title": "Clinical Study of Chidamide Combined With Toripalimab in the Treatment of Advanced Melanoma", "status": "UNKNOWN", "start": "2022-10-27", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 43, "sponsor": "Peking University Cancer Hospital & Institute", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05928962", "title": "An Exploratory Single-arm Study: PD-1 With Recombinant Human Adenovirus Type 5 Injection for Malignant Melanomas", "status": "UNKNOWN", "start": "2022-10-27", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Fujian Cancer Hospital", "conditions": ["Malignant Melanomas"], "cn_sites": [{"facility": "Fujian Cancer Hospital, Department of Internal Medicine, Ward 19", "city": "Fuzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06206681", "title": "Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid Tumors", "status": "UNKNOWN", "start": "2022-11-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "Sun Yat-sen University", "conditions": ["Eyelid Tumor", "Xanthelasma Palpebrarum", "Pigmented Nevi", "Keratosis"], "cn_sites": [{"facility": "Sun Yat-sen University", "city": "Guanzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05614102", "title": "A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-11-04", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 284, "sponsor": "Bayer", "conditions": ["Advanced Solid Tumors"], "cn_sites": [{"facility": "Cancer Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center", "city": "Shenzhen", "status": ""}, {"facility": "Sir Run Run Shaw Hospital, Zhejiang Univ. School of Medicine - Oncology Department", "city": "Hangzhou", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT05538130", "title": "A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-11-30", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 148, "sponsor": "Pfizer", "conditions": ["Melanoma", "Glioma", "Thyroid Cancer", "Non-Small Cell Lung Cancer", "Malignant Neoplasms", "Brain Neoplasms", "Advanced or Metastatic Solid Tumors", "HGG", "LGG", "Low Grade Glioma", "High Grade Glioma", "Differentiated Thyroid Cancer", "NSCLC (Non-small Cell Lung Cancer)"], "cn_sites": [{"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05466474", "title": "PD-1 Antibody Tislelizumab Combined With Dacarbazine in the Treatment of Advanced Melanoma", "status": "UNKNOWN", "start": "2022-12-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Henan Cancer Hospital", "conditions": ["Advanced Melanoma"], "cn_sites": [{"facility": "Department of Bone and Soft Tissue ,Henan Cancer Hospital", "city": "Zhengzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05647954", "title": "A Study of HX008 Plus Transcatheter Arterial Chemoembolization (TACE) in the First-Line Treatment of Subjects With Stage IV (M1c) Melanoma That is Metastatic to the Liver", "status": "UNKNOWN", "start": "2022-12-31", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 350, "sponsor": "Taizhou Hanzhong biomedical co. LTD", "conditions": ["Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms"], "cn_sites": [{"facility": "Beijing Cancer hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05661955", "title": "A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors.", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-01-09", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 113, "sponsor": "BeiGene", "conditions": ["Urothelial Carcinoma", "Renal Cell Carcinoma", "Melanoma", "Non-mucosal Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Fujian Cancer Hospital", "city": "Fuzhou", "status": ""}, {"facility": "The Second Hospital and Clinical Medical School, Lanzhou University", "city": "Lanzhou", "status": ""}, {"facility": "Zhujiang Hospital of Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Sun Yat Sen University Cancer Center", "city": "Guangzhou", "status": ""}, {"facility": "Guangxi Medical University Cancer Hospital", "city": "Nanning", "status": ""}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": ""}, {"facility": "Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "The Second Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "Nanjing Drum Tower Hospital,the Affiliated Hospital of Nanjing University Medical School", "city": "Nanjing", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Liaoning Cancer Hospital and Institute", "city": "Shenyang", "status": ""}, {"facility": "Shandong Cancer Hospital", "city": "Jinan", "status": ""}, {"facility": "Jining No1 Peoples Hospital West Branch", "city": "Jining", "status": ""}, {"facility": "Shanxi Provincial Cancer Hospital", "city": "Taiyuan", "status": ""}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Tianjin Medical University Cancer Institute and Hospital", "city": "Tianjin", "status": ""}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": ""}], "cn_site_count": 18, "broad_only": false}, {"nct": "NCT05798533", "title": "Neo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03)", "status": "UNKNOWN", "start": "2023-01-10", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "BGI, China", "conditions": ["Solid Tumor"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Shanghai Tenth People's Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05665595", "title": "A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010)", "status": "TERMINATED", "start": "2023-01-19", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1594, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Beijing Ji Shui Tan Hospital ( Site 1657)", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer hospital-Renal carcinoma and melanoma ( Site 1650)", "city": "Beijing", "status": ""}, {"facility": "Chongqing University Cancer Hospital ( Site 1651)", "city": "Chongqing", "status": ""}, {"facility": "Fujian Provincial Cancer Hospital ( Site 1659)", "city": "Fuzhou", "status": ""}, {"facility": "Sun Yat-sen University Cancer Center-melanoma ( Site 1655)", "city": "Guangzhou", "status": ""}, {"facility": "Guangxi Medical University Affiliated Tumor Hospital ( Site 1668)", "city": "Nanning", "status": ""}, {"facility": "Fourth Hospital of Hebei Medical University ( Site 1669)", "city": "Shijiazhuang", "status": ""}, {"facility": "The Third Hospital of Zhengzhou-Oncology ( Site 1653)", "city": "Zhengzhou", "status": ""}, {"facility": "Wuhan Union Hospital Cancer Center-Cancer Center ( Site 1664)", "city": "Wuhan", "status": ""}, {"facility": "The Second Xiangya Hospital of Central South University-Oncology ( Site 1673)", "city": "Changsha", "status": ""}, {"facility": "Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Oncology (", "city": "Nanjing", "status": ""}, {"facility": "Jiangsu Province Hospital-Oncology Department ( Site 1663)", "city": "Nanjing", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University ( Site 1652)", "city": "Nanchang", "status": ""}, {"facility": "The First Hospital of Jilin University-Oncology ( Site 1665)", "city": "Changchun", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center ( Site 1658)", "city": "Shanghai", "status": ""}, {"facility": "Shanxi Bethune Hospital ( Site 1660)", "city": "Taiyuan", "status": ""}, {"facility": "West China Hospital, Sichuan University-Head and Neck Oncology ( Site 1667)", "city": "Chengdu", "status": ""}, {"facility": "Tianjin Medical University Cancer Institute & Hospital-Biotherapy ( Site 1671)", "city": "Tianjin", "status": ""}, {"facility": "Xinjiang Medical University Cancer Hospital - Urumqi-Bone and Soft Tissue Department ( Site 1674)", "city": "Ürümqi", "status": ""}, {"facility": "Yunnan Province Cancer Hospital-Biotherapy Center ( Site 1666)", "city": "Kunming", "status": ""}, {"facility": "Zhejiang Cancer Hospital-Oncology ( Site 1661)", "city": "Hangzhou", "status": ""}], "cn_site_count": 21, "broad_only": false}, {"nct": "NCT05723432", "title": "KD6001 in Combination With Anti-PD-1 Antibody in Patients With Advanced Melanoma", "status": "UNKNOWN", "start": "2023-03-22", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 84, "sponsor": "Shanghai Kanda Biotechnology Co., Ltd.", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05823246", "title": "Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma", "status": "UNKNOWN", "start": "2023-04-24", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 66, "sponsor": "Qilu Pharmaceutical Co., Ltd.", "conditions": ["Melanoma", "Urothelial Carcinoma"], "cn_sites": [{"facility": "Peking University Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Fujian Cancer Hospital", "city": "Fuzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Xiangya Hospital of Central South University", "city": "Changsha", "status": "NOT_YET_RECRUITING"}, {"facility": "Jilin Cancer Hospital", "city": "Changchun", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": "NOT_YET_RECRUITING"}, {"facility": "West China Hospital", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT05827770", "title": "The Efficacy and Safety of Neoadjuvant Toripalimab Combined With Temozolomide in Resectable Stage III Melanoma", "status": "UNKNOWN", "start": "2023-05-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Yong Chen", "conditions": ["Melanoma Stage III"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07614828", "title": "Exploratory Clinical Study of Neoadjuvant Immunotherapy Combined With Chemotherapy in Malignant Melanoma of Nasal and Paranasal Mucosa", "status": "WITHDRAWN", "start": "2023-06-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Eye & ENT Hospital of Fudan University", "conditions": ["Mucosal Melanoma of the Head and Neck"], "cn_sites": [{"facility": "Eye & ENT Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05867303", "title": "A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors", "status": "UNKNOWN", "start": "2023-06-05", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 48, "sponsor": "RemeGen Co., Ltd.", "conditions": ["Melanoma", "Urothelial Carcinoma", "Renal Cell Carcinoma", "Non-small Cell Lung Cancer", "Head and Neck Squamous Cell Carcinoma", "Colorectal Carcinoma"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": ""}, {"facility": "Zhongnan Hospital of Wuhan University", "city": "Wuhan", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05955105", "title": "A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies", "status": "UNKNOWN", "start": "2023-07-25", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 200, "sponsor": "Innolake Biopharm", "conditions": ["Head and Neck Cancer", "Cervical Cancer", "Endometrial Cancer", "Triple Negative Breast Cancer", "Ovarian Cancer", "Soft Tissue Sarcoma", "Melanoma", "Nasopharyngeal Carcinoma", "Non Small Cell Lung Cancer", "Classic Hodgkin Lymphoma"], "cn_sites": [{"facility": "Shandong Cancer Hospital", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06291753", "title": "Characteristics and Tumor Staging Proposal for Primary Malignant Melanoma of the Esophagus", "status": "COMPLETED", "start": "2023-09-22", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 25, "sponsor": "Sun Yat-sen University", "conditions": ["Primary Malignant Melanoma of the Esophagus"], "cn_sites": [{"facility": "Qianwen Liu", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05879822", "title": "A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-10-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 73, "sponsor": "Incyte Corporation", "conditions": ["Advanced Solid Tumor"], "cn_sites": [{"facility": "The People'S Hospital of Guangxi Zhuang Autonomous Region", "city": "Nanning", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06120712", "title": "A Study of GC101 TIL in Advanced Melanoma (BZ)", "status": "COMPLETED", "start": "2023-11-08", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Shanghai Juncell Therapeutics", "conditions": ["Tumor Infiltrating Lymphocytes", "Safety", "Melanoma", "Efficacy", "Adverse Drug Event"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05338580", "title": "Clinical Trial of TJ271 Injection Combined With Pembrolizumab in the Treatment of Advanced Solid Tumors", "status": "WITHDRAWN", "start": "2023-12-31", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "TJ Biopharma Co., Ltd.", "conditions": ["First-line Non-small-cell Lung Cancer", "First-line Urothelial Carcinoma", "Second-line Urothelial Carcinoma", "Second-line Melanoma"], "cn_sites": [{"facility": "Shanghai Chest Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07670403", "title": "Digital Phenotyping of Psychological Distress in Skin Cancer Patients", "status": "COMPLETED", "start": "2024-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "West China Hospital", "conditions": ["Skin Cancer", "Melanoma (Skin Cancer)", "Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)", "Basal Cell Carcinoma of Skin"], "cn_sites": [{"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06583369", "title": "The Efficacy and Safety of Liangxue Ointment in the Treatment of Hand-foot Syndrome Caused by VEGFR-TKI Drugs", "status": "UNKNOWN", "start": "2024-03-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 220, "sponsor": "Peking University Cancer Hospital & Institute", "conditions": ["Hand-Foot Syndrome"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07651020", "title": "The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors", "status": "COMPLETED", "start": "2025-03-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1, "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": ["Pancreatic Cancer", "Breast Cancer", "Lung Cancer", "Sarcoma", "Head and Neck Cancers", "Glioblastoma", "Colorectal Cancer", "Melanoma", "Ovarian Cancer"], "cn_sites": [{"facility": "Wuhan Union Hospital, China", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07384299", "title": "Impact of Skin Type on Wonud Healing and Scarring Following Facial Skin Surgery", "status": "COMPLETED", "start": "2025-06-15", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 173, "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": ["Nevus", "Seborrheic Keratosis (SK)", "Cyst", "Lipoma", "Scar"], "cn_sites": [{"facility": "Not Appicable", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07441538", "title": "Optimizing the Timing for Facial Surgical Dressing Removal", "status": "COMPLETED", "start": "2025-06-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 144, "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": ["Nevus", "Seborrheic Keratosis (SK)", "Cyst", "Lipoma", "Scar"], "cn_sites": [{"facility": "Not Appicable", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07193966", "title": "NG2 and DLL3 CAR-T Cells Targeting Melanoma", "status": "TERMINATED", "start": "2025-09-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Shenzhen Geno-immune Medical Institute", "city": "Shenzhen", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07160335", "title": "A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-09-26", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 174, "sponsor": "Shanghai Henlius Biotech", "conditions": ["Non-small Cell Lung Cancer", "Melanoma", "Renal Cell Carcinoma"], "cn_sites": [{"facility": "The First Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": ""}, {"facility": "The First Affiliated Hospital of Wannan Medical College", "city": "Wuhu", "status": ""}, {"facility": "Beijing Chest Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Hunan Provincial Cancer Hospital", "city": "Hunan", "status": ""}, {"facility": "Fujian Cancer Hospital", "city": "Fuzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Xiamen University", "city": "Xiamen", "status": ""}, {"facility": "The Second Hospital of Lanzhou University", "city": "Lanzhou", "status": ""}, {"facility": "Cangzhou Central Hospital", "city": "Cangzhou", "status": ""}, {"facility": "The Fourth Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "The First Affiliated Hospital of Xinxiang Medical University", "city": "Xinxiang", "status": ""}, {"facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Zhongnan Hospital of Wuhan University", "city": "Wuhan", "status": ""}, {"facility": "Hubei Cancer Hospital", "city": "Wuhan", "status": ""}, {"facility": "The Third Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "The First Affiliated Hospital of University of South China", "city": "Hengyang", "status": ""}, {"facility": "The Affiliated Hospital of Xuzhou Medical University", "city": "Xuzhou", "status": ""}, {"facility": "Jiangxi Cancer Hospital", "city": "Nanchang", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Liaoning Cancer Hospital and Institute", "city": "Shenyang", "status": ""}, {"facility": "Guangxi Medical University Cancer Center", "city": "Guangxi", "status": ""}, {"facility": "Binzhou Medical University Hospital", "city": "Binzhou", "status": ""}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": ""}, {"facility": "Cancer Hospital of Shandong First Medical University", "city": "Jinan", "status": ""}, {"facility": "Linyi Cancer Hospital", "city": "Linyi", "status": ""}, {"facility": "ShangHai Pulmonary Hospital", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Chest Hospital", "city": "Shanghai", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}, {"facility": "Zhongshan Hospital, Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shanxi Bethune Hospital", "city": "Taiyuan", "status": ""}, {"facility": "The First Affiliated Hospital of Xi'an Jiao Tong University", "city": "Xi’an", "status": ""}, {"facility": "Yuebei People's Hospital", "city": "Guangdong", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Sichuan Cancer Hospital", "city": "Chengdu", "status": ""}, {"facility": "Yunnan Cancer Hospital", "city": "Kunming", "status": ""}, {"facility": "The First Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": ""}, {"facility": "Taizhou Hospital of Zhejiang Province", "city": "Taizhou", "status": ""}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Bengbu Medical College", "city": "Bengbu", "status": ""}], "cn_site_count": 41, "broad_only": false}], "g_total": 584, "g_fetched": 177, "g_countries": [["United States", 88], ["Australia", 19], ["France", 18], ["Italy", 16], ["Canada", 14], ["Germany", 14], ["Spain", 12], ["Netherlands", 7], ["United Kingdom", 6], ["Denmark", 5], ["South Korea", 5], ["Israel", 5], ["Sweden", 5], ["Japan", 3], ["Puerto Rico", 3], ["Switzerland", 3], ["Slovenia", 3], ["Singapore", 3], ["Belgium", 2], ["Greece", 2], ["New Zealand", 2], ["Poland", 2], ["Uganda", 1], ["Kazakhstan", 1], ["Czechia", 1], ["Brazil", 1], ["Portugal", 1], ["Finland", 1], ["Taiwan", 1], ["Norway", 1], ["Saudi Arabia", 1], ["Russia", 1]], "g_trials": [{"nct": "NCT06708455", "title": "Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma", "status": "NOT_YET_RECRUITING", "start": "2027-03-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Rapa Therapeutics LLC", "countries": ["United States"]}, {"nct": "NCT05903937", "title": "Locoregional Administration of TIL and Lymphodepletion in Patients With Melanoma and Liver Metastases", "status": "NOT_YET_RECRUITING", "start": "2027-01-31", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Vastra Gotaland Region", "countries": []}, {"nct": "NCT07183852", "title": "Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma", "status": "NOT_YET_RECRUITING", "start": "2027-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Vastra Gotaland Region", "countries": []}, {"nct": "NCT07704918", "title": "Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma", "status": "RECRUITING", "start": "2026-12-31", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Colorado, Denver", "countries": ["United States"]}, {"nct": "NCT07576725", "title": "Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial", "status": "NOT_YET_RECRUITING", "start": "2026-12-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Fred Hutchinson Cancer Center", "countries": ["Uganda"]}, {"nct": "NCT07032701", "title": "A Disposable Negative Pressure Wound Therapy Device (SNaP) to Promote Wound Healing in the Lower Limbs Following Mohs Micrographic Surgery for Non-melanoma Skin Cancer", "status": "NOT_YET_RECRUITING", "start": "2026-12", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Jonsson Comprehensive Cancer Center", "countries": ["United States"]}, {"nct": "NCT07803562", "title": "Low Dose Dexamethasone for the Prevention of Cytokine Release Syndrome Associated With Tebentafusp", "status": "NOT_YET_RECRUITING", "start": "2026-11", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University of California, San Diego", "countries": ["United States"]}, {"nct": "NCT07808515", "title": "A Study Comparing Cemiplimab-based Treatments for Adult Participants With Locally Advanced Basal Cell Skin Cancer (laBCC)", "status": "NOT_YET_RECRUITING", "start": "2026-10-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Regeneron Pharmaceuticals", "countries": []}, {"nct": "NCT07340619", "title": "Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs.", "status": "NOT_YET_RECRUITING", "start": "2026-09-18", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "UNICANCER", "countries": ["France"]}, {"nct": "NCT07820033", "title": "Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled Trial", "status": "NOT_YET_RECRUITING", "start": "2026-09-14", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University Health Network, Toronto", "countries": ["Canada"]}, {"nct": "NCT07720726", "title": "Impact of Dysport on PMFF Donor Scar", "status": "NOT_YET_RECRUITING", "start": "2026-09-14", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Vanderbilt University Medical Center", "countries": ["United States"]}, {"nct": "NCT07281924", "title": "Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis", "status": "RECRUITING", "start": "2026-09", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University of Wisconsin, Madison", "countries": ["United States"]}, {"nct": "NCT07707986", "title": "Safety of Topical Exosome-Containing Liquid in Healthy Volunteers for Future Surgical Wound Use", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "West Kazakhstan Marat Ospanov Medical University", "countries": ["Kazakhstan"]}, {"nct": "NCT07414979", "title": "Phase 1 Study Of Intrathecal Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells For Patients With Leptomeningeal Melanoma", "status": "NOT_YET_RECRUITING", "start": "2026-08-31", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "M.D. Anderson Cancer Center", "countries": ["United States"]}, {"nct": "NCT07691255", "title": "MELanoma Brain Metastasis Treated With CYberknife", "status": "RECRUITING", "start": "2026-08-25", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "European Institute of Oncology", "countries": ["Italy"]}, {"nct": "NCT07740941", "title": "NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma", "status": "NOT_YET_RECRUITING", "start": "2026-08-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "UNC Lineberger Comprehensive Cancer Center", "countries": ["United States"]}, {"nct": "NCT07694414", "title": "Rituximab for Treatment of Checkpoint Inhibitor Induced Immune-related Adverse Events", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Inge Marie Svane", "countries": ["Denmark"]}, {"nct": "NCT07686835", "title": "Dietary Fiber to Induce Gut Microbiota-mediated Response to Immunotherapy in Melanoma.", "status": "RECRUITING", "start": "2026-07-31", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Radboud University Medical Center", "countries": ["Netherlands"]}, {"nct": "NCT07749586", "title": "A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors", "status": "RECRUITING", "start": "2026-07-29", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Arvinas Inc.", "countries": ["United States"]}, {"nct": "NCT07680452", "title": "Clinical Study on High-fiber Diet and Short-term Fasting in Melanoma Under Immunotherapy With Checkpoint Inhibition", "status": "RECRUITING", "start": "2026-07-28", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Charite University, Berlin, Germany", "countries": ["Germany"]}, {"nct": "NCT07615881", "title": "Comparing Intravenous or Intradermal Administration of Anti-CTLA-4 in Combination With Anti-PD1 Treatment in Patients With Melanoma", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Amsterdam UMC, location VUmc", "countries": []}, {"nct": "NCT07529080", "title": "Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Michigan Rogel Cancer Center", "countries": ["United States"]}, {"nct": "NCT07645742", "title": "Pilot Study of Intermittent Fasting With Immune Checkpoint Inhibitors", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "West Virginia University", "countries": []}, {"nct": "NCT06971848", "title": "Evaluation of Skin Tests in Biotherapy Allergies", "status": "RECRUITING", "start": "2026-06-17", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Angers", "countries": ["France"]}, {"nct": "NCT07288112", "title": "DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma", "status": "RECRUITING", "start": "2026-04-06", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Diakonos Oncology Corporation", "countries": ["United States"]}]}, {"batch": 2, "no": 49, "name_zh": "异染性脑白质营养不良", "query_terms": [{"term": "Metachromatic leukodystrophy", "broad": false}], "n_total": 3, "n_open": 2, "n_open_precise": 2, "n_broad": 0, "trials": [{"nct": "NCT03725670", "title": "Direct Lentiviral Injection Gene Therapy for MLD", "status": "NOT_YET_RECRUITING", "start": "2027-05-31", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": ["Metachromatic Leukodystrophy (MLD)"], "cn_sites": [{"facility": "Lung-Ji Chang", "city": "Shenzhen", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07046338", "title": "Lentiviral Hematopoietic Stem Cell Gene Therapy for MLD", "status": "NOT_YET_RECRUITING", "start": "2027-06-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": ["Metachromatic Leukodystrophy (MLD)"], "cn_sites": [{"facility": "Shenzhen Geno-Immune Medical Institute", "city": "Shenzhen", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02559830", "title": "Autologous Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy and Adrenoleukodystrophy", "status": "UNKNOWN", "start": "2015-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Shenzhen Second People's Hospital", "conditions": ["Metachromatic Leukodystrophy", "Adrenoleukodystrophy"], "cn_sites": [{"facility": "Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University", "city": "Shenzhen", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}], "g_total": 9, "g_fetched": 7, "g_countries": [["United States", 5], ["France", 1], ["Italy", 1], ["Australia", 1]], "g_trials": [{"nct": "NCT04925349", "title": "Modeling Macrophages Activation Pattern in X-linked Adrenoleukodystrophy, Metachromatic Leukodystrophy and Adult Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia", "status": "RECRUITING", "start": "2021-08-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT04880356", "title": "Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.", "status": "RECRUITING", "start": "2021-03-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta", "countries": ["Italy"]}, {"nct": "NCT04528355", "title": "Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC", "status": "RECRUITING", "start": "2020-08-20", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Paul Szabolcs", "countries": ["United States"]}, {"nct": "NCT03047369", "title": "The Myelin Disorders Biorepository Project", "status": "RECRUITING", "start": "2016-12-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Children's Hospital of Philadelphia", "countries": ["United States"]}, {"nct": "NCT02254863", "title": "UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells", "status": "RECRUITING", "start": "2014-09", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Joanne Kurtzberg, MD", "countries": ["United States"]}, {"nct": "NCT01962415", "title": "Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT", "status": "RECRUITING", "start": "2014-02-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Paul Szabolcs", "countries": ["United States"]}, {"nct": "NCT01793168", "title": "Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford", "status": "RECRUITING", "start": "2010-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sanford Health", "countries": ["Australia", "United States"]}]}, {"batch": 2, "no": 50, "name_zh": "单基因非综合征性肥胖", "query_terms": [{"term": "Genetic non-syndromic obesity", "broad": false}, {"term": "Monogenic non-syndromic obesity", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 2, "g_fetched": 2, "g_countries": [["United States", 2], ["Australia", 1]], "g_trials": [{"nct": "NCT06901245", "title": "Tirzepatide in PWS, HO and GNSO", "status": "RECRUITING", "start": "2025-05-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Grace Kim", "countries": ["United States"]}, {"nct": "NCT01793168", "title": "Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford", "status": "RECRUITING", "start": "2010-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sanford Health", "countries": ["Australia", "United States"]}]}, {"batch": 2, "no": 51, "name_zh": "多发性内分泌腺瘤病", "query_terms": [{"term": "Multiple endocrine neoplasia", "broad": false}], "n_total": 138, "n_open": 49, "n_open_precise": 49, "n_broad": 0, "trials": [{"nct": "NCT03093116", "title": "A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements", "status": "RECRUITING", "start": "2017-03-07", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 500, "sponsor": "Turning Point Therapeutics, Inc.", "conditions": ["Locally Advanced Solid Tumors", "Metastatic Solid Tumors"], "cn_sites": [{"facility": "Local Institution - 6702", "city": "Beijing", "status": "COMPLETED"}, {"facility": "Beijing Cancer hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Daping Hospital, the Third Affiliated Hospital of Third Military Medical University /Cancer Center", "city": "Daping", "status": "RECRUITING"}, {"facility": "Local Institution - 6719", "city": "Fuzhou", "status": "COMPLETED"}, {"facility": "The First Affiliated hospital of Xiamen University-oncology", "city": "Xiamen", "status": "RECRUITING"}, {"facility": "Guangdong Provincial People'S Hospital", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Local Institution - 6733", "city": "Guangzhou", "status": "COMPLETED"}, {"facility": "Local Institution - 6505", "city": "Shenzhen", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "The Affiliated Tumor Hospital of Harbin Medical University", "city": "Harbin", "status": "RECRUITING"}, {"facility": "Local Institution - 6504", "city": "Shatin", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Local Institution - 6710", "city": "Wuhan", "status": "COMPLETED"}, {"facility": "Local Institution - 6705", "city": "Changsha", "status": "COMPLETED"}, {"facility": "Hunan Cancer Hospital-thoracic oncology II", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Local Institution - 6748", "city": "Nanjing", "status": "COMPLETED"}, {"facility": "XuZhou Central Hospital/Oncology Department", "city": "Xuzhou", "status": "RECRUITING"}, {"facility": "Jilin Cancer Hospital/Medical Oncology Department", "city": "Changchun", "status": "RECRUITING"}, {"facility": "The first hospital of Jilin university-Oncology Department", "city": "Changchun", "status": "RECRUITING"}, {"facility": "Liaoning Cancer Hospital", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Tangdu Hospital", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "Shanxi Bethune Hospital", "city": "Taiyuan", "status": "RECRUITING"}, {"facility": "Sichuan Cancer Hospital/Medical Oncology Department", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "The First Hospital Affiliated To AMU - Southwest Hospital", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "Local Institution - 6725", "city": "Hangzhou", "status": "COMPLETED"}, {"facility": "Zhejiang Cancer Hospital-Oncology", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "The Third Xiangya Hospital of Central South University/Department of Respiratory and Critical Care Medicine", "city": "Changsha", "status": "RECRUITING"}, {"facility": "West China Hospital Sichuan University/Lung cancer center", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital - Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": "RECRUITING"}, {"facility": "Shanghai Chest Hospital", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Weifang People's Hospital/Medical Oncology Department", "city": "Weifang", "status": "RECRUITING"}, {"facility": "Henan Cancer Hospital/The 1st pneumology department", "city": "Zhengzhou", "status": "RECRUITING"}], "cn_site_count": 31, "broad_only": false}, {"nct": "NCT05406999", "title": "Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer", "status": "RECRUITING", "start": "2020-02-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 900, "sponsor": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School", "conditions": ["Neoadjuvant Therapy", "High Risk Prostate Cancer", "Locally Advanced Prostate Cancer", "Intense Endocrine Therapy"], "cn_sites": [{"facility": "Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04686682", "title": "A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors", "status": "RECRUITING", "start": "2021-05-07", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 152, "sponsor": "Jacobio Pharmaceuticals Co., Ltd.", "conditions": ["NSCLC", "SCLC", "CRPC", "ESCC", "Ovarian Carcinoma", "AML", "MF", "Malignant Tumor"], "cn_sites": [{"facility": "Tianjin", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04924075", "title": "Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)", "status": "RECRUITING", "start": "2021-08-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 355, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Pheochromocytoma/Paraganglioma", "Pancreatic Neuroendocrine Tumor", "Von Hippel-Lindau Disease", "Advanced Gastrointestinal Stromal Tumor", "HIF-2α Mutated Cancers"], "cn_sites": [{"facility": "Peking University First Hospital-Urology ( Site 1900)", "city": "Beijing", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Sun Yat-sen University Cancer Center ( Site 1905)", "city": "Guangzhou", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Renji Hospital Shanghai Jiao Tong University School of Medicine ( Site 1904)", "city": "Shanghai", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "West China Hospital of Sichuan University ( Site 1906)", "city": "Chengdu", "status": "COMPLETED"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT04520074", "title": "Adjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer (ACTS-2)", "status": "RECRUITING", "start": "2021-10-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 590, "sponsor": "Fudan University", "conditions": ["Ovarian Cancer"], "cn_sites": [{"facility": "Wu Xiaohua", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05123482", "title": "A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies", "status": "RECRUITING", "start": "2021-10-18", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 460, "sponsor": "AstraZeneca", "conditions": ["Breast Cancer", "Biliary Tract Carcinoma", "Ovarian Cancer", "Endometrial Cancer", "Squamous Non-Small Cell Lung Cancer"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": "COMPLETED"}, {"facility": "Research Site", "city": "Changsha", "status": "TERMINATED"}, {"facility": "Research Site", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Guangzhou", "status": "COMPLETED"}, {"facility": "Research Site", "city": "Kunming", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Shandong", "status": "RECRUITING"}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT04921527", "title": "Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer", "status": "RECRUITING", "start": "2021-12-20", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 454, "sponsor": "Chipscreen Biosciences, Ltd.", "conditions": ["Ovarian Cancer", "Relapsed or Refractory", "Chiauranib", "Paclitaxel"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05251883", "title": "A Study to Analyze Data on Metastatic Ovarian Cancer Using Multi-omics", "status": "RECRUITING", "start": "2022-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University", "conditions": ["Ovarian Cancer"], "cn_sites": [{"facility": "The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen Universit", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05236686", "title": "Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer", "status": "RECRUITING", "start": "2022-02-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 94, "sponsor": "Shanghai Gynecologic Oncology Group", "conditions": ["Epithelial Ovarian Cancer", "Fallopian Tube Cancer", "Primary Peritoneal Carcinoma"], "cn_sites": [{"facility": "Zhongshan Hospital, Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06286631", "title": "Prediction of Lymph Node Metastasis in Patients With Thyroid Malignancy by a New Scale", "status": "RECRUITING", "start": "2023-05-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 800, "sponsor": "Second Affiliated Hospital of Xi'an Jiaotong University", "conditions": ["Papillary Thyroid Cancer"], "cn_sites": [{"facility": "The Second Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05803018", "title": "A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies", "status": "RECRUITING", "start": "2023-06-25", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 38, "sponsor": "Sichuan Baili Pharmaceutical Co., Ltd.", "conditions": ["Gynecological Malignant Tumor", "Solid Tumor"], "cn_sites": [{"facility": "Fudan University ShangHai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06249308", "title": "Liquid Biopsy-based Early Detection of Ovarian Cancer: a Proof-of-concept Study ( PROFOUND-OC )", "status": "RECRUITING", "start": "2023-12-18", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 168, "sponsor": "Fudan University", "conditions": ["Ovarian Cancer"], "cn_sites": [{"facility": "Sun Yat-sen Memorial Hospital", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Liaoning Cancer Hospital & Institute", "city": "Shenyang", "status": "NOT_YET_RECRUITING"}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT06587789", "title": "Ribociclib in Combination With Adjuvant Endocrine Therapy for Patients With Early High-risk HR+HER2- Breast Cancer", "status": "RECRUITING", "start": "2024-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 286, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Breast Cancer"], "cn_sites": [{"facility": "Second Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06662006", "title": "Nal-IRI/5-FU/LV Chemotherapy Combined With PD-L1 Inhibitor and Multi-target Anti-angiogenic Small Molecule±SBRT as Second-line Therapy in Metastatic Pancreatic Cancer Patients", "status": "RECRUITING", "start": "2024-03-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 56, "sponsor": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School", "conditions": ["Advanced Metastatic Pancreatic Cancer"], "cn_sites": [{"facility": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06767813", "title": "Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic Neoplasms", "status": "RECRUITING", "start": "2024-03-19", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 80, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.", "conditions": ["Pancreatic Neoplasms"], "cn_sites": [{"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Jiangsu Provincial People's Hospital", "city": "Nanjing", "status": "NOT_YET_RECRUITING"}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT06386146", "title": "JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation", "status": "RECRUITING", "start": "2024-07-24", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 144, "sponsor": "Jacobio Pharmaceuticals Co., Ltd.", "conditions": ["Solid Tumors"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT06495749", "title": "Early Diagnosis of Pancreatic Cancer Via Deciphering Multi-modal Immunological Signatures", "status": "NOT_YET_RECRUITING", "start": "2024-08-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 3000, "sponsor": "Zhejiang University", "conditions": ["Pancreatic Cancer Resectable"], "cn_sites": [{"facility": "First Affiliated Hospital, Medical College of Zhejiang University", "city": "Hangzhou", "status": ""}, {"facility": "the First Affiliated Hospital, School of Medicine, Zhejiang University", "city": "Hangzhou", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06531291", "title": "Surufatinib Combined With Serplulimab and Standard Chemotherapy as First-line Treatment in Advanced Solid Tumors With Neuroendocrine Differentiation", "status": "NOT_YET_RECRUITING", "start": "2024-08-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 80, "sponsor": "RenJi Hospital", "conditions": ["ESCC", "Biliary Tract Cancer", "Gastric Cancer", "Pancreas Cancer"], "cn_sites": [{"facility": "Renji hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06632886", "title": "AI-Assisted Non-Contrast CT for Multi-Cancer Screening", "status": "RECRUITING", "start": "2024-10-07", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 1000000, "sponsor": "Guo ShiWei", "conditions": ["Lung Cancers", "Liver Cancer", "Gastric Cancers", "Colorectal, Cancer", "Esophageal Cancer", "Pancreatic Cancer", "Breast Cancer"], "cn_sites": [{"facility": "Changhai Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07433283", "title": "Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor", "status": "RECRUITING", "start": "2024-11-12", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 54, "sponsor": "Sichuan Enray Pharmaceutical Sciences Company", "conditions": ["Tumor, Solid", "Lung Cancer", "Pancreas Cancer", "Thyroid Cancer", "Colorectal Cancer", "Cervical Cancer", "Vulva Cancer"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Hunan Provincial Tumor Hospital", "city": "Hunan", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "Fujian provincial cancer hospital", "city": "Fuzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Second Affiliated Hospital of Hainan Medical University", "city": "Haikou", "status": "RECRUITING"}, {"facility": "Harbin medical university cancer hospital", "city": "Heilongjiang", "status": "NOT_YET_RECRUITING"}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Henan", "status": "RECRUITING"}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT06560112", "title": "An Exploratory, Multi-cohort Phase II Study of Combination Therapy With AK104 and AK112 for Recurrent Ovarian Cancer", "status": "RECRUITING", "start": "2024-11-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 172, "sponsor": "Akeso", "conditions": ["Recurrent Ovarian Cancer"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06735326", "title": "Fluzoparib With or Without Bevacizumab for Neoadjuvant Therapy in Advanced Ovarian Cancer", "status": "RECRUITING", "start": "2024-11-27", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 105, "sponsor": "Qilu Hospital of Shandong University", "conditions": ["Ovarian Cancer", "Fallopian Tube Cancer", "Peritoneal Cancer"], "cn_sites": [{"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06684327", "title": "Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors", "status": "RECRUITING", "start": "2024-11-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Fudan University", "conditions": ["Paget Disease, Extramammary", "Rhabdomyosarcoma", "Testicular Cancer", "Penile Cancer", "Urachal Cancer"], "cn_sites": [{"facility": "Fudan University Cancer Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06759090", "title": "Metronomic Capecitabine with Camrelizumab and Apatinib Mesylate for Treatment of Advanced Pancreatic Cancer", "status": "NOT_YET_RECRUITING", "start": "2025-01-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 43, "sponsor": "Zhejiang University", "conditions": ["Metastatic Pancreatic Carcinoma"], "cn_sites": [{"facility": "The First Affiliated Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07571096", "title": "Construction of a Multi-dimensional Risk Assessment System: a Clinical Study of Polycystic Ovary Syndrome Complicated With Thrombophilia", "status": "RECRUITING", "start": "2025-03-04", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Guangdong Women and Children Hospital", "conditions": ["Polycystic Ovary Syndrome (PCOS)", "Thrombophilia"], "cn_sites": [{"facility": "Guangdong Women and Children Hospital", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06738966", "title": "A Study of BL0175 Injection in Postmenopausal Female Adults With HR-positive, Locally Advanced or Metastatic Cancer", "status": "RECRUITING", "start": "2025-03-10", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Shanghai Best-Link Bioscience, LLC", "conditions": ["Breast Cancer", "Ovarian Cancer", "Endometrial Cancer"], "cn_sites": [{"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": "RECRUITING"}, {"facility": "Jinan Central Hospital", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06855069", "title": "HS-20089 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer", "status": "RECRUITING", "start": "2025-03-13", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 468, "sponsor": "Hansoh BioMedical R&D Company", "conditions": ["Ovarian Cancer"], "cn_sites": [{"facility": "Cancer Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06726148", "title": "Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors", "status": "RECRUITING", "start": "2025-04-03", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 280, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Advanced HR+/HER2- Breast Cancer", "Advanced CCNE1-amplified Solid Tumors", "Extensive-stage Small Cell Lung Cancer"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Xian", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06842524", "title": "Dihydroartemisinin for the Treatment of Polycystic Ovary Syndrome", "status": "RECRUITING", "start": "2025-04-16", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 150, "sponsor": "Shanghai Zhongshan Hospital", "conditions": ["Polycystic Ovary Syndrome (PCOS)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Xiamen University", "city": "Xiamen", "status": "RECRUITING"}, {"facility": "Women and Children's Hospital, School of Medicine, Xiamen University", "city": "Xiamen", "status": "RECRUITING"}, {"facility": "Zhongshan Hospital Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": "RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT06990516", "title": "SHR - A1811 Injection in the Treatment of Platinum-sensitive Recurrent Ovarian Cancer", "status": "NOT_YET_RECRUITING", "start": "2025-06-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "Tongji Hospital", "conditions": ["Ovarian Cancer"], "cn_sites": [{"facility": "Tongji Hospital", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06953999", "title": "A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer", "status": "RECRUITING", "start": "2025-06-11", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 999, "sponsor": "Akeso", "conditions": ["Pancreatic Cancer"], "cn_sites": [{"facility": "Harbin Medical University Cancer Hospital", "city": "Harbin", "status": "RECRUITING"}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07612891", "title": "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Advanced/Metastatic Breast Cancer or Locally Advanced/Metastatic Solid Tumor", "status": "RECRUITING", "start": "2025-07-04", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 201, "sponsor": "Shenzhen Ionova Life Sciences Co., Ltd.", "conditions": ["Breast Cancer (Locally Advanced or Metastatic)", "Advanced Solid Cancers", "Metastatic (Stage IV) Breast Cancer", "Ovarian Cancer", "Endometrial Cancer"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07066657", "title": "A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors", "status": "RECRUITING", "start": "2025-07-25", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 572, "sponsor": "ArriVent BioPharma, Inc.", "conditions": ["Locally Advanced or Metastatic Solid Tumors", "Colorectal Cancer", "Gastric Cancer", "Pancreatic Cancer"], "cn_sites": [{"facility": "Peking University Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Gobroad Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Chongqing Daping Hospital", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "Sir Run Run Shaw Hospital, Zhejiang University School of Medicine", "city": "Zhejiang", "status": "RECRUITING"}, {"facility": "Harbin Medical University Cancer Hospital", "city": "Heilongjiang", "status": "RECRUITING"}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Hunan Cancer Hospital", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Cancer Hospital of Shandong First Medical University", "city": "Shandong", "status": "RECRUITING"}, {"facility": "Renji Hospital Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Zhongshan Hospital Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 11, "broad_only": false}, {"nct": "NCT07600268", "title": "Efficacy of Stereotactic Body Radiotherapy (SBRT) Combined With Maintenance Therapy Compared to Maintenance Therapy Alone in Advanced Pancreatic Cancer", "status": "RECRUITING", "start": "2025-08-14", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Shandong Cancer Hospital and Institute", "conditions": ["Pancreatic Cancer Non-resectable"], "cn_sites": [{"facility": "Shandong Cancer Hospital and Institute", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07079228", "title": "A Study to Compare QLS31905 and Chemotherapy With Placebo and Chemotherapy in Participants With Pancreatic Cancer", "status": "RECRUITING", "start": "2025-09-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 602, "sponsor": "Qilu Pharmaceutical Co., Ltd.", "conditions": ["Pancreatic Cancer"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07042802", "title": "A Study of LBL-024 in Combination With Paclitaxel ± Bevacizumab for the Treatment of Platinum-resistant Ovarian Cancer", "status": "RECRUITING", "start": "2025-12-02", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 180, "sponsor": "Nanjing Leads Biolabs Co.,Ltd", "conditions": ["Ovarian Cancer"], "cn_sites": [{"facility": "Cancer Institute and Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Obstetrics and Gynecology Hospital Capital Medical University", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Fujian Cancer Hospital", "city": "Fuzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Harbin Medical University Cancer Hospital", "city": "Harbin", "status": "NOT_YET_RECRUITING"}, {"facility": "AnYang Tumor Hospital", "city": "Anyang", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The Affiliated Hospital of Xuzhou Medical University", "city": "Xuzhou", "status": "RECRUITING"}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Shandong Cancer Hospital", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Tianjin Medical University Cancer Institute &Hospital", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "Yunnan Cancer Hospital", "city": "Kunming", "status": "RECRUITING"}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 13, "broad_only": false}, {"nct": "NCT07255404", "title": "A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer", "status": "RECRUITING", "start": "2025-12-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 105, "sponsor": "BioNTech SE", "conditions": ["Pancreatic Ductal Adenocarcinoma (PDAC)"], "cn_sites": [{"facility": "Tsinghua Changgung Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Jilin Cancer Hospital", "city": "Changchun", "status": "NOT_YET_RECRUITING"}, {"facility": "Sichuan Cancer Hospital", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Zhongshan Hospital Affiliated with Dalian University", "city": "Dalian", "status": "NOT_YET_RECRUITING"}, {"facility": "Sun Yat-sen Memorial Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Zhejiang Provincial People's Hospital", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Shandong University Cancer Hospital", "city": "Jinan", "status": "NOT_YET_RECRUITING"}, {"facility": "Yunnan Cancer Hospital", "city": "Kunming", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "The Affiliated Cancer Hospital of Guangxi Medical University", "city": "Nanning", "status": "RECRUITING"}, {"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of China Medical University", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "RECRUITING"}], "cn_site_count": 15, "broad_only": false}, {"nct": "NCT07438847", "title": "177Lu-CTR-FAPI for the Treatment of Thyroid Cancer", "status": "RECRUITING", "start": "2026-01-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "SHAOYAN LIU", "conditions": ["Thyroid Cancer"], "cn_sites": [{"facility": "National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07410494", "title": "Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors", "status": "RECRUITING", "start": "2026-02-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 85, "sponsor": "Essen Biotech", "conditions": ["Cancer", "Breast Cancer", "Non-Small Cell Lung Cancer (NSCLC)", "Colorectal Cancer (Locally Advanced or Metastatic)", "Prostate Cancer - Recurrent", "Pancreatic Ductal Adenocarcinoma (PDAC)", "Ovarian Cancer", "Glioblastoma", "Melanoma (Skin Cancer)", "Acute Myeloid Leukemia (AML)", "Non Hodgkin Lymphoma", "Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma", "Liver Cancer"], "cn_sites": [{"facility": "District One Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07304128", "title": "A Study of PLB-002 in Advanced Solid Tumors", "status": "RECRUITING", "start": "2026-02-06", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Primelink BioTherapeitics(ShenZhen) Limited", "conditions": ["Advanced Solid Tumor"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center- Gynecology Onc", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Fudan University Shanghai Cancer Center- Phase 1", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07448376", "title": "EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases", "status": "NOT_YET_RECRUITING", "start": "2026-03-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 20, "sponsor": "Huazhong University of Science and Technology", "conditions": ["CTCs", "Pancreatic Cancer", "Liver Metastases", "Relapse", "Borderline Resectable Pancreatic Cancer", "Resectable Pancreatic Cancers", "EUS"], "cn_sites": [{"facility": "Tongji Hospital, Tongji Medical College, HUST", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07670286", "title": "Spatial Multi-omics and Intelligent Early Warning of Pancreatic Cancer Cachexia", "status": "RECRUITING", "start": "2026-04-24", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Pancreatic Cancer", "Cachexia; Cancer; Sarcopenia"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07557225", "title": "18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors", "status": "RECRUITING", "start": "2026-04-27", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 200, "sponsor": "Peking University First Hospital", "conditions": ["Clear Cell Renal Cell Cancer (ccRCC)", "Urothelial Carcinoma (UC)", "Colorectal Cancer", "Cervical Cancer", "Ovarian Cancer", "Head and Neck Cancer", "Hepatocellular Carcinoma (HCC)", "Cholangiocarcinoma", "Non Small Cell Lung Cancer", "Small Cell Lung Cancer", "Breast Cancer", "Pancreatic Cancer", "Endometrial Cancer", "Von Hippel Lindau Disease"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07610798", "title": "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations", "status": "RECRUITING", "start": "2026-06-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 178, "sponsor": "Shenzhen Ionova Life Sciences Co., Ltd.", "conditions": ["Advance Solid Tumors", "Colon and Rectal Cancer", "Non - Small Cell Lung Cancer NSCLC", "Pancreatic Adenocarcinoma Advanced or Metastatic", "Ovarian Cancer", "Endometrial Cancer", "Biliary Cancers"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07492680", "title": "A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)", "status": "RECRUITING", "start": "2026-07-27", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 260, "sponsor": "Bristol-Myers Squibb", "conditions": ["Solid Tumors"], "cn_sites": [{"facility": "Local Institution - 0155", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Local Institution - 0185", "city": "Chongqing", "status": "NOT_YET_RECRUITING"}, {"facility": "Local Institution - 0184", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Henan Medical University", "city": "Xinxiang", "status": "RECRUITING"}, {"facility": "Shanghai GoBroad Cancer Hospital China Pharmaceutical University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT07791550", "title": "Baduanjin for Quality of Life in Pancreatic Cancer Chemotherapy", "status": "NOT_YET_RECRUITING", "start": "2026-08-28", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 96, "sponsor": "Tianjin Medical University Cancer Institute and Hospital", "conditions": ["Pancreatic Neoplasms", "Pancreatic Cancer", "Drug-Related Side Effects and Adverse Reactions (MeSH Term)"], "cn_sites": [{"facility": "Tianjin Medical University Cancer Institute & Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07828756", "title": "Albumin-bound Paclitaxel (Ⅱ)-Combined Regimens for Pancreatic Cancer", "status": "NOT_YET_RECRUITING", "start": "2026-09-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 147, "sponsor": "Tianjin Medical University Cancer Institute and Hospital", "conditions": ["Pancreatic Cancer"], "cn_sites": [{"facility": "Tianjin Medical University Cancer Institute & Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07795177", "title": "A Prospective Study Based on Spatial Multi-omics to Predict the Efficacy of ADT Combined With Second-generation Novel Hormonal Agents in Metastatic Hormone-sensitive Prostate Cancer.", "status": "NOT_YET_RECRUITING", "start": "2026-10-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Anhui Medical University", "conditions": ["Metastatic Hormone-Sensitive Prostate Cancer"], "cn_sites": [{"facility": "Universitythe First Affiliatedhospital of Anhuimedical", "city": "Hefei", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07138846", "title": "A Study Comparing MRG004A Plus Best Supportive Care Versus Placebo and Best Supportive Care in the Treatment of Patients With Advanced Pancreatic Cancer", "status": "NOT_YET_RECRUITING", "start": "2027-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 231, "sponsor": "Lepu Biopharma Co., Ltd.", "conditions": ["Advanced Pancreatic Cancer"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00902122", "title": "rAd-p53 Gene Therapy for Advanced Malignant Thyroid Tumors", "status": "UNKNOWN", "start": "2009-05", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 600, "sponsor": "Shenzhen SiBiono GeneTech Co.,Ltd", "conditions": ["Advanced Malignant Thyroid Tumors"], "cn_sites": [{"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01368133", "title": "The Observational Study of Growth Hormone-secreting Pituitary Tumors", "status": "UNKNOWN", "start": "2011-05", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 60, "sponsor": "Huashan Hospital", "conditions": ["Acromegaly", "Pituitary Tumor"], "cn_sites": [{"facility": "Huashan Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01525550", "title": "A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors", "status": "COMPLETED", "start": "2012-06-06", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 106, "sponsor": "Pfizer", "conditions": ["Well-differentiated Pancreatic Neuroendocrine Tumor"], "cn_sites": [{"facility": "China-Japan Friendship Hospital", "city": "Beijing", "status": ""}, {"facility": "307 Hospital of PLA", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Nanjing Bayi Hospital", "city": "Nanjing", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}, {"facility": "Zhongshan Hospital Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT01738269", "title": "Elecsys HE4 Chinese Reference Value Study", "status": "COMPLETED", "start": "2012-11", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2351, "sponsor": "Chinese PLA General Hospital", "conditions": ["Ovarian Cancer"], "cn_sites": [{"facility": "China PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": ""}, {"facility": "Sun Yat-Sen University Cancer Center", "city": "Guangzhou", "status": ""}, {"facility": "Shandong University Qilu Hospital", "city": "Jinan", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}, {"facility": "Tianjin Cancer Hospital", "city": "Tianjin", "status": ""}, {"facility": "Xinjiang Medical University Cancer Center", "city": "Ürümqi", "status": ""}, {"facility": "Tongji Hospital Tongji Medical Colege of HUST", "city": "Wuhan", "status": ""}, {"facility": "Zhongshan Hospital Xiamen University", "city": "Xiamen", "status": ""}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT01774019", "title": "Preoperative Biliary Drainage in Resectable Pancreatic or Periampullary Cancer", "status": "COMPLETED", "start": "2013-02-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 284, "sponsor": "Boston Scientific Corporation", "conditions": ["Pancreatic Carcinoma"], "cn_sites": [{"facility": "Beijing Friendship Hospital", "city": "Beijing", "status": ""}, {"facility": "Xijing Hospital of Digestive Diseases Fourth Military Medical University", "city": "Xi'an", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT01841528", "title": "Live Birth After Fresh Embryo Transfer Vs Frozen-thawed Embryo Transfer in Women With Polycystic Ovary Syndrome", "status": "UNKNOWN", "start": "2013-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 1180, "sponsor": "Zi-jiang Chen", "conditions": ["Polycystic Ovary Syndrome", "Infertility"], "cn_sites": [{"facility": "The First Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": ""}, {"facility": "The First Affiliated Hospital of Lanzhou University", "city": "Lanzhou", "status": ""}, {"facility": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University", "city": "Guangzhou", "status": ""}, {"facility": "The sixth Affiliated Hospital of Sun Yat-Sen University", "city": "Guangzhou", "status": ""}, {"facility": "Guangxi Maternal and Child Health Hospital", "city": "Nanning", "status": ""}, {"facility": "Renmin Hospital of Wuhan University", "city": "Wuhan", "status": ""}, {"facility": "Jiangsu Province Hospital", "city": "Nanjing", "status": ""}, {"facility": "Jiangxi Maternal and Child Health Hospital", "city": "Nanchang", "status": ""}, {"facility": "Reproductive Medicine Center in Shenyang City", "city": "Shenyang", "status": ""}, {"facility": "Reproductive medical hospital affiliated to Shandong University", "city": "Jinan", "status": ""}, {"facility": "Yuhuangding Hospital in Yantai", "city": "Yantai", "status": ""}, {"facility": "Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Shanxi Provincial Maternity and Children's Hospital", "city": "Xi’an", "status": ""}, {"facility": "Sir Run Run Shaw Hospital", "city": "Hangzhou", "status": ""}], "cn_site_count": 14, "broad_only": false}, {"nct": "NCT01629225", "title": "GRK4 Polymorphisms Blood Pressure Response to Candesartan", "status": "UNKNOWN", "start": "2013-07", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 500, "sponsor": "Third Military Medical University", "conditions": ["Essential Hypertension"], "cn_sites": [{"facility": "Department of Cardiology, Daping Hospital, The Third Military Medical University", "city": "Chongqing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02017015", "title": "Safety and Efficacy Study of Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Metastatic Pancreatic Cancer", "status": "COMPLETED", "start": "2013-12-24", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 83, "sponsor": "Celgene", "conditions": ["Pancreatic Neoplasms"], "cn_sites": [{"facility": "307 Hospital of Chinese PLA", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer Hospital", "city": "Beijing, PR", "status": ""}, {"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": ""}, {"facility": "Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University", "city": "Hangzhou, Zhejiang", "status": ""}, {"facility": "The First Affiliated Hospital of Medical School of Zhejiang University", "city": "Hangzhou, Zhejiang", "status": ""}, {"facility": "Harbin Medical University Tumor Hospital", "city": "Harbin, Heilongjiang", "status": ""}, {"facility": "Jiangsu Province Hospital The First Hospital affiliated with Nanjing Medical University", "city": "Nanjing", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}, {"facility": "Shanghai First People's Hospital", "city": "Shanghai", "status": ""}, {"facility": "Tianjin Medical University Cancer Institute and Hospital", "city": "Tianjin", "status": ""}, {"facility": "Xijing Hospital", "city": "Xi'an", "status": ""}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}], "cn_site_count": 15, "broad_only": false}, {"nct": "NCT02121366", "title": "EUS-guided Ethanol Ablation of an Insulinoma", "status": "UNKNOWN", "start": "2014-03", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Guangxi Medical University", "conditions": ["Insulinoma"], "cn_sites": [{"facility": "First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02327065", "title": "Prospective Multi-center, Single Blinded, Randomized, Controlled Trial of EUS-FNB and EUS-FNA on Solid Occupying Lesion", "status": "UNKNOWN", "start": "2014-12", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 408, "sponsor": "Huazhong University of Science and Technology", "conditions": ["Pancreas Neoplasms", "Lymphatic Metastasis", "Neoplasm Metastases", "Unknown Primary Neoplasm Metastasis"], "cn_sites": [{"facility": "Tongji hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02395016", "title": "A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer", "status": "COMPLETED", "start": "2015-04", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "Biotech Pharmaceutical Co., Ltd.", "conditions": ["Pancreatic Cancer"], "cn_sites": [{"facility": "First Affiliated Hospital of Bengbu Medical College", "city": "Bengbu", "status": ""}, {"facility": "Second Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": ""}, {"facility": "Beijing Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Chinese Academy of Medical Sciences Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "PLA General Hospital (301 Hospital)", "city": "Beijing", "status": ""}, {"facility": "Affiliated Hospital of Military Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Fuzhou General Hospital of Nanjing Military Region", "city": "Fuzhou", "status": ""}, {"facility": "Fujian Provincial Tumor Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Cancer Hospital of Harbin Medical University", "city": "Harbin", "status": ""}, {"facility": "Jiangyin City People's Hospital", "city": "Jiangyin", "status": ""}, {"facility": "Jiangsu Province Tumor Hospital", "city": "Nanjing", "status": ""}, {"facility": "Second Affiliated Hospital of Dalian Medical University", "city": "Dalian", "status": ""}, {"facility": "Shanghai Jiaotong University Affiliated Ruijin Hospital", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Fudan University Cancer Hospital", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Zhongshan Hospital, Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Huashan Hospital, Fudan University", "city": "Shanghai", "status": ""}, {"facility": "First People's Hospital Cancer Center, Shanghai Jiaotong University", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Changhai Hospital", "city": "Shanghai", "status": ""}, {"facility": "Affiliated Xijing Hospital, Fourth Military Medical University", "city": "Xi’an", "status": ""}, {"facility": "General Hospital of Chengdu Military Region", "city": "Chengdu", "status": ""}, {"facility": "First Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Second Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Sir Run Run Shaw Hospital", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": ""}], "cn_site_count": 25, "broad_only": false}, {"nct": "NCT02457650", "title": "T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies", "status": "UNKNOWN", "start": "2015-04", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Shenzhen Second People's Hospital", "conditions": ["Bladder Carcinoma", "Breast Cancer", "Esophagus Carcinoma", "Lung Cancer", "Melanoma", "Multiple Myeloma", "Neuroblastoma", "Ovarian Cancer", "Synovial Sarcoma", "Other Metastatic Solid Cancers"], "cn_sites": [{"facility": "Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University", "city": "Shenzhen", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02575651", "title": "A Phase I Study of Fluzoparib in Patient With Advanced Solid Malignancies", "status": "COMPLETED", "start": "2015-04", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 79, "sponsor": "Jiangsu HengRui Medicine Co., Ltd.", "conditions": ["Advanced Solid Malignancies"], "cn_sites": [{"facility": "No.307 Hospital, Academy of Military Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT02506842", "title": "Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection", "status": "UNKNOWN", "start": "2015-06", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 300, "sponsor": "Fudan University", "conditions": ["Stage ⅠA Pancreatic Cancer", "Stage ⅠB Pancreatic Cancer", "Stage ⅡA Pancreatic Cancer", "Stage ⅡB Pancreatic Cancer"], "cn_sites": [{"facility": "Department of Hepatobiliary Surgery, Sun Yat-Sen University Cancer Center,Sun Yat-Sen University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Department of Biliary Pancreatic Surgery, Shanghai Changzheng Hospital, The Second Military Medical University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Department of Biliary Pancreatic Surgery, Huadong Hospital, Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Department of Pancreatic Surgery, Huashan Hospital, Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Department of Pancreatic Surgery, Cancer Institute & Hospital, Tianjin Medical University", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "Department of General Surgery,Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT05554744", "title": "EUS-FNI for MEN1-related Pancreatic Neuroendocrine Tumors", "status": "UNKNOWN", "start": "2015-06-18", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Guangxi Medical University", "conditions": ["Multiple Endocrine Neoplasia Type 1", "Pancreatic Neuroendocrine Tumor"], "cn_sites": [{"facility": "First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02615223", "title": "Endocrine Therapy With or Without Cryoablation for Stage IV Prostate Cancer", "status": "UNKNOWN", "start": "2015-11", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Tianjin Medical University Cancer Institute and Hospital", "conditions": ["Stage IV Prostate Cancer"], "cn_sites": [{"facility": "Tianjin Medical University Cancer Institute and Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02646735", "title": "Fulvestrant 500mg With Exemestane Endocrine Therapy for Postmenopausal Advanced Breast Cancer Patients", "status": "UNKNOWN", "start": "2015-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 148, "sponsor": "Chinese Academy of Medical Sciences", "conditions": ["Breast Cancer"], "cn_sites": [{"facility": "National Cancer Institute, Cancer Hospital Chinese Academy of Medical Sciences", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06697613", "title": "Development and Validation of a Prediction Model for AKI Following Cisplatin-Based HIPEC in Patients With Ovarian Cancer", "status": "COMPLETED", "start": "2016-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 150, "sponsor": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University", "conditions": ["Ovarian Cancer", "AKI - Acute Kidney Injury"], "cn_sites": [{"facility": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02614495", "title": "Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma", "status": "COMPLETED", "start": "2016-02-24", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 66, "sponsor": "Hutchison Medipharma Limited", "conditions": ["Thyroid Carcinoma"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT02789371", "title": "Comparing of Modified Wet Suction Technique and Dry Suction Technique for EUS-FNA of Solid Occupying Lesions", "status": "UNKNOWN", "start": "2016-05", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 296, "sponsor": "Bin Cheng", "conditions": ["Pancreas Neoplasms", "Lymphatic Metastasis", "Neoplasm Metastases", "Unknown Primary Neoplasm Metastasis", "Infection", "Inflammation", "Sarcoid", "Lymphadenopathy"], "cn_sites": [{"facility": "Tongji hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03075462", "title": "A Study of Fluzoparib Given in Combination With Apatinib in Ovarian or Breast Cancer Patients", "status": "COMPLETED", "start": "2017-03-09", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 98, "sponsor": "Jiangsu HengRui Medicine Co., Ltd.", "conditions": ["Ovarian Cancer", "Triple Negative Breast Cancer"], "cn_sites": [{"facility": "Beijing Cancer Hosptial", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03037385", "title": "Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors", "status": "COMPLETED", "start": "2017-03-17", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 590, "sponsor": "Hoffmann-La Roche", "conditions": ["RET-altered Non Small Cell Lung Cancer", "Medullary Thyroid Cancer", "RET-altered Papillary Thyroid Cancer", "RET-altered Colon Cancer", "RET-altered Solid Tumors", "Lung Neoplasm", "Carcinoma, Non-Small-Cell Lung", "Thyroid Diseases", "Thyroid Neoplasm", "Thyroid Cancer, Papillary", "Carcinoma, Neuroendocrine", "Respiratory Tract Neoplasms", "Thoracic Neoplasms", "Neoplasms by Site", "Neoplasms", "Lung Diseases", "Respiratory Tract Disease", "Carcinoma, Bronchogenic", "Bronchial Neoplasms", "Endocrine System Diseases", "Endocrine Gland Neoplasm", "Head and Neck Neoplasms", "Adenocarcinoma, Papillary", "Adenocarcinoma", "Carcinoma", "Neoplasms, Glandular and Epithelial", "Neoplasms by Histologic Type", "Neuroendocrine Tumors", "Neuroectodermal Tumors", "Neoplasms, Germ Cell and Embryonal", "Neoplasms, Nerve Tissue", "Colonic Neoplasms", "Colorectal Neoplasms", "Intestinal Neoplasms", "Gastrointestinal Neoplasms", "Digestive System Neoplasm", "Digestive System Disease", "Gastrointestinal Disease", "Colonic Diseases", "Intestinal Disease"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "The affiliated Cancer Hospital, School of Medicine, UESTC", "city": "Chengdu", "status": ""}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Chongqing Cancer Hospital", "city": "Chongqing", "status": ""}, {"facility": "Fujian Provincial Cancer Hospital", "city": "Fuzhou", "status": ""}, {"facility": "First Affiliated Hospital of Gannan Medical University", "city": "Ganzhou", "status": ""}, {"facility": "Sun Yet-sen University Cancer Center", "city": "Guangzhou", "status": ""}, {"facility": "Guangdong General Hospital", "city": "Guangzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": ""}, {"facility": "Jinan Central Hospital", "city": "Jinan", "status": ""}, {"facility": "Gansu Cancer Hospital", "city": "Lanzhou", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}, {"facility": "Tianjin Medical University Cancer Institute & Hospital", "city": "Tianjing", "status": ""}, {"facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}], "cn_site_count": 15, "broad_only": false}, {"nct": "NCT07235553", "title": "Non-inferiority Investigation to Evaluate the Efficacy and Safety of the Ultrasonic Surgical System", "status": "COMPLETED", "start": "2017-03-28", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 136, "sponsor": "Ezisurg Medical Co. Ltd.", "conditions": ["Thyroid Cancer"], "cn_sites": [{"facility": "Beijing Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03123406", "title": "Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT", "status": "COMPLETED", "start": "2017-04-19", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 750, "sponsor": "Kyowa Kirin China Pharmaceutical Co., Ltd.", "conditions": ["Hyperparathyroidism; Secondary, Renal"], "cn_sites": [{"facility": "Nanjing Jinling Hospital", "city": "Nanjing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04183478", "title": "The Efficacy and Safety of K-001 in the Treatment of Advanced Pancreatic Cancer", "status": "UNKNOWN", "start": "2017-09-26", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 600, "sponsor": "RenJi Hospital", "conditions": ["Pancreatic Cancer"], "cn_sites": [{"facility": "RenJiH", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03166891", "title": "Phase Ib Study of Chiauranib in Patients With Ovarian Cancer", "status": "COMPLETED", "start": "2017-12-15", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 25, "sponsor": "Chipscreen Biosciences, Ltd.", "conditions": ["Ovarian Cancer"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03245346", "title": "Effects of Epidural Anesthesia and Analgesia on the Prognosis in Patients Undergoing Pancreatic Cancer Surgery", "status": "COMPLETED", "start": "2017-12-19", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 540, "sponsor": "Fudan University", "conditions": ["Cancer of Pancreas"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}, {"facility": "Fudan University Zhongshan Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT03638206", "title": "Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies", "status": "UNKNOWN", "start": "2018-03-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 73, "sponsor": "Shenzhen BinDeBio Ltd.", "conditions": ["B-cell Acute Lymphoblastic Leukemia", "Lymphoma", "Myeloid Leukemia", "Multiple Myeloma", "Hepatoma", "Gastric Cancer", "Pancreatic Cancer", "Mesothelioma", "Colorectal Cancer", "Esophagus Cancer", "Lung Cancer", "Glioma", "Melanoma", "Synovial Sarcoma", "Ovarian Cancer", "Renal Carcinoma"], "cn_sites": [{"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03709316", "title": "A Study of ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer", "status": "UNKNOWN", "start": "2018-06-30", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 384, "sponsor": "Zai Lab (Shanghai) Co., Ltd.", "conditions": ["Ovarian Cancer"], "cn_sites": [{"facility": "Anhui Provincal Hospital", "city": "Hefei", "status": ""}, {"facility": "Chongqing Cancer Hospital", "city": "Chongqing", "status": ""}, {"facility": "Fujian Cancer Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": ""}, {"facility": "The first affiliated hospital, Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "Guizhou Cancer hospital", "city": "Guiyang", "status": ""}, {"facility": "Harbin Medical University Cancer Hospital", "city": "Harbin", "status": ""}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Hubei Cancer Hospital", "city": "Wuhan", "status": ""}, {"facility": "Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Zhongnan hospital of wuhan university", "city": "Wuhan", "status": ""}, {"facility": "Hunan Cancer Hospital", "city": "Changsha", "status": ""}, {"facility": "Xiangya Hospital Central South Hospital", "city": "Changsha", "status": ""}, {"facility": "Jiangsu Cancer Hospital", "city": "Nanjing", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Liaoning Cancer Hospital & Institute", "city": "Shenyang", "status": ""}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": ""}, {"facility": "second hospital of Shanxi medical university", "city": "Taiyuan", "status": ""}, {"facility": "West China second university hospital", "city": "Chengdu", "status": ""}, {"facility": "Tianjin Central Hospital of Gynecology Obstetrics", "city": "Tianjin", "status": ""}, {"facility": "Affiliate Cancer Hospital Xinjiang Medical University", "city": "Ürümqi", "status": ""}, {"facility": "Yunnan Cancer Hospital", "city": "Kunming", "status": ""}, {"facility": "Woman's hospital School of medicine Zhejiang University", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": ""}, {"facility": "the First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": ""}, {"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Cancer Hospital of Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University People's hospital", "city": "Beijing", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}, {"facility": "Tianjin Tumour Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 31, "broad_only": false}, {"nct": "NCT03659292", "title": "Effects of Epidural Block on the Prognosis in Patients With Pancreatic Cancer Undergoing Distal Pancreatectomy", "status": "UNKNOWN", "start": "2018-09", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 540, "sponsor": "Fudan University", "conditions": ["Cancer of Pancreas"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}, {"facility": "Fudan University Zhongshan Hospital", "city": "Shanghai", "status": ""}, {"facility": "Fudan University Huashan Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT03742856", "title": "A Multi-omics Study of Epithelial Ovarian Cancer", "status": "UNKNOWN", "start": "2018-11-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 80, "sponsor": "Lei Li", "conditions": ["Epithelial Ovarian Cancer", "Tumor Invasiveness", "Whole Exome Sequencing", "Transcriptomics", "Metabolomics", "Tumorigenesis"], "cn_sites": [{"facility": "Lei Li", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03773263", "title": "New Application of Sequential in Vitro Muturation System for Infertility Patients With Polycystic Ovary Syndrome", "status": "UNKNOWN", "start": "2018-12", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 300, "sponsor": "Sun Yat-sen University", "conditions": ["Polycystic Ovary Syndrome", "Infertility"], "cn_sites": [{"facility": "The Sixth Affiliated Hospital, Sun Yat-Sen University", "city": "Guangzhou", "status": ""}, {"facility": "Jiangsu Province Hospital", "city": "Nanjing", "status": ""}, {"facility": "Reproductive medical hospital affiliated to Shandong University", "city": "Jinan", "status": ""}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": ""}, {"facility": "Tenth People's Hospital of Tongji University", "city": "Shanghai", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT03701334", "title": "A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer", "status": "ACTIVE_NOT_RECRUITING", "start": "2018-12-07", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 5101, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Early Breast Cancer"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shijiazhuang", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Harbin", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Zhengzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Wuhan", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Nanjing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Suzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Changchun", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Chengdu", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Hangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Chongqing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Tianjin", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Zhenjiang", "status": ""}], "cn_site_count": 15, "broad_only": false}, {"nct": "NCT05734911", "title": "Effectiveness and Safety of Niraparib as First-line Maintenance Therapy for Ovarian Cancer: a Real-world Study", "status": "COMPLETED", "start": "2019-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 199, "sponsor": "Zhongda Hospital", "conditions": ["Ovarian Neoplasms"], "cn_sites": [{"facility": "Zhongda hospital", "city": "Nanjing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03887611", "title": "Application of Ultrasound Artificial Intelligence and Elastography in Differential Diagnosis of Thyroid Nodules", "status": "UNKNOWN", "start": "2019-01-18", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2000, "sponsor": "Xin-Wu Cui", "conditions": ["Thyroid Nodule"], "cn_sites": [{"facility": "Xin-Wu Cui", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03803930", "title": "Comparing of a 22G EUS Procore Fine Needle Biopsy Device and a 20G EUS Procore Fine Needle Biopsy Device", "status": "UNKNOWN", "start": "2019-03-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 1224, "sponsor": "Huazhong University of Science and Technology", "conditions": ["Pancreas Neoplasms"], "cn_sites": [{"facility": "Bin Cheng", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05468476", "title": "Multi-omics Analysis of Women With PCOS and Obesity Compared With Non-PCOS Obese Controls", "status": "COMPLETED", "start": "2019-05-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 121, "sponsor": "Zhang Manna", "conditions": ["Polycystic Ovary Syndrome"], "cn_sites": [{"facility": "Department of Endocrinology, Shanghai Tenth People's Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03772353", "title": "Pyrotinib, Dalpiciclib(SHR6390) and Endocrine Therapy in Subjects With Dual-receptor Positive(ER+/HER2+) Advanced Breast Cancer", "status": "UNKNOWN", "start": "2019-05-12", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 59, "sponsor": "Fudan University", "conditions": ["Breast Cancer"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03901118", "title": "Chiauranib in Combination With Chemotherapy in Patients With Ovarian Cancer", "status": "COMPLETED", "start": "2019-07-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 47, "sponsor": "Chipscreen Biosciences, Ltd.", "conditions": ["Ovarian Cancer"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04131192", "title": "Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic Cancer", "status": "TERMINATED", "start": "2019-11-11", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 13, "sponsor": "Sunshine Lake Pharma Co., Ltd.", "conditions": ["Pancreatic Cancer"], "cn_sites": [{"facility": "Jiangsu Province Hospital", "city": "Nanjing", "status": ""}, {"facility": "shandong Cancer Hospital", "city": "Jinan", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT04120597", "title": "Clinical and Basic Research on the Treatment of Polycystic Ovary Syndrome", "status": "COMPLETED", "start": "2019-12-23", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 126, "sponsor": "Jiangxi University of Traditional Chinese Medicine", "conditions": ["Polycystic Ovary Syndrome"], "cn_sites": [{"facility": "The Second Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine", "city": "Nanchang", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04521348", "title": "Multiple Target Kinase Inhibitor and Anti-Programmed Death-1 Antibody in Patients With Advanced Thyroid Cancer", "status": "COMPLETED", "start": "2019-12-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 103, "sponsor": "Fudan University", "conditions": ["Thyroid Cancer"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03959150", "title": "Metronomic Chemotherapy With Capecitabine for Pancreatic Cancer", "status": "UNKNOWN", "start": "2020-01-05", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 231, "sponsor": "Ruijin Hospital", "conditions": ["Pancreatic Cancer"], "cn_sites": [{"facility": "Department of Oncology, Ruijin Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04229615", "title": "A Study of Fluzoparib±Apatinib Versus Placebo Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on First-Line Platinum-Based Chemotherapy", "status": "UNKNOWN", "start": "2020-06-02", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 690, "sponsor": "Jiangsu HengRui Medicine Co., Ltd.", "conditions": ["Ovarian Cancer", "Fallopian Tube Cancer", "Primary Peritoneal Carcinoma"], "cn_sites": [{"facility": "Cancer Hospital Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06540937", "title": "Phase II Clinical Study of Leflunomide in the Treatment of MEN-1 Neuroendocrine Tumor", "status": "UNKNOWN", "start": "2020-07-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Cancer Institute and Hospital, Chinese Academy of Medical Sciences", "conditions": ["Neuroendocrine Tumors"], "cn_sites": [{"facility": "National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04121286", "title": "A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China", "status": "COMPLETED", "start": "2020-07-14", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 17, "sponsor": "Allist Pharmaceuticals, Inc.", "conditions": ["Non-small Cell Lung Cancer", "Colorectal Cancer", "Pancreatic Ductal Carcinoma", "Esophageal Squamous Cell Carcinoma", "Head and Neck Squamous Cell Carcinoma", "Breast Cancer", "Other Solid Tumors"], "cn_sites": [{"facility": "Cancer Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical Collage Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}, {"facility": "Henan Provovential Cancer Hospital", "city": "Henan", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT04494425", "title": "Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer", "status": "ACTIVE_NOT_RECRUITING", "start": "2020-07-24", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 866, "sponsor": "AstraZeneca", "conditions": ["Advanced or Metastatic Breast Cancer"], "cn_sites": [{"facility": "Research Site", "city": "Baoding", "status": ""}, {"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Changchun", "status": ""}, {"facility": "Research Site", "city": "Changsha", "status": ""}, {"facility": "Research Site", "city": "Dalian", "status": ""}, {"facility": "Research Site", "city": "Foshan", "status": ""}, {"facility": "Research Site", "city": "Fuzhou", "status": ""}, {"facility": "Research Site", "city": "Guangzhou", "status": ""}, {"facility": "Research Site", "city": "Hangzhou", "status": ""}, {"facility": "Research Site", "city": "Harbin", "status": ""}, {"facility": "Research Site", "city": "Hefei", "status": ""}, {"facility": "Research Site", "city": "Jinan", "status": ""}, {"facility": "Research Site", "city": "Linyi", "status": ""}, {"facility": "Research Site", "city": "Nanchang", "status": ""}, {"facility": "Research Site", "city": "Nanjing", "status": ""}, {"facility": "Research Site", "city": "Nanning", "status": ""}, {"facility": "Research Site", "city": "Shanghai", "status": ""}, {"facility": "Research Site", "city": "Shenyang", "status": ""}, {"facility": "Research Site", "city": "Tianjin", "status": ""}, {"facility": "Research Site", "city": "Ürümqi", "status": ""}, {"facility": "Research Site", "city": "Wuhan", "status": ""}, {"facility": "Research Site", "city": "Xi'an", "status": ""}, {"facility": "Research Site", "city": "Zhengzhou", "status": ""}], "cn_site_count": 23, "broad_only": false}, {"nct": "NCT04477798", "title": "Protein Classifier for Thyroid Indeterminate Nodules", "status": "UNKNOWN", "start": "2020-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 320, "sponsor": "Luo Dingcun", "conditions": ["Thyroid Nodule"], "cn_sites": [{"facility": "Hangzhou First People's Hospital Affiliated to Zhejiang University Medical College", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04517357", "title": "A Phase 2 Trial of Fluzoparib Combined With Apatinib Versus Fluzoparib Monotherapy in Treatment With Relapsed Ovarian Cancer Patients", "status": "COMPLETED", "start": "2020-10-16", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Jiangsu HengRui Medicine Co., Ltd.", "conditions": ["Relapsed Ovarian Cancer"], "cn_sites": [{"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04768868", "title": "The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors", "status": "UNKNOWN", "start": "2021-02-25", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 350, "sponsor": "Impact Therapeutics, Inc.", "conditions": ["Advanced Solid Tumors"], "cn_sites": [{"facility": "Wuhan Union Hospital", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "West China 2nd University Hospital", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT04719572", "title": "Intervention Study of Drugs in Patients Osteopenia and Osteoporosis", "status": "UNKNOWN", "start": "2021-03", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 180, "sponsor": "Chinese PLA General Hospital", "conditions": ["Osteoporosis", "Osteopenia, Osteoporosis"], "cn_sites": [{"facility": "PLA General Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04674956", "title": "A Prospective, Randomized, Double-blinded, Multi-center Clinical Trial to Evaluate the Efficiency and Safety of Anti-PD1 Antibody (Camrelizumab) Combined With Paclitaxel(Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer", "status": "UNKNOWN", "start": "2021-03-04", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 401, "sponsor": "RenJi Hospital", "conditions": ["Pancreatic Cancer Stage IV", "Pancreatic Cancer Metastatic"], "cn_sites": [{"facility": "Ruijin hospital", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Shanghai Cancer Center", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Zhongshan Hospital", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Shanghai General Hospital", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Renji hospital", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Changhai Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT04560452", "title": "Drug Intensive Monitoring Study of Olaparib in Clinical Practice Among Chinese Patients", "status": "COMPLETED", "start": "2021-03-15", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1018, "sponsor": "AstraZeneca", "conditions": ["Ovarian Cancer", "Prostate Cancer"], "cn_sites": [{"facility": "Research Site", "city": "Anhui", "status": ""}, {"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Changsha", "status": ""}, {"facility": "Research Site", "city": "Chengdu", "status": ""}, {"facility": "Research Site", "city": "Chongqing", "status": ""}, {"facility": "Research Site", "city": "Dongguan", "status": ""}, {"facility": "Research Site", "city": "Foshan", "status": ""}, {"facility": "Research Site", "city": "Fujian", "status": ""}, {"facility": "Research Site", "city": "Guangdong", "status": ""}, {"facility": "Research Site", "city": "Guangzhou", "status": ""}, {"facility": "Research Site", "city": "Guangzho", "status": ""}, {"facility": "Research Site", "city": "Guizhou", "status": ""}, {"facility": "Research Site", "city": "Hangzhou", "status": ""}, {"facility": "Research Site", "city": "He'nan", "status": ""}, {"facility": "Research Site", "city": "Hebei", "status": ""}, {"facility": "Research Site", "city": "Heilongjiang", "status": ""}, {"facility": "Research Site", "city": "Henan", "status": ""}, {"facility": "Research Site", "city": "Huizhou", "status": ""}, {"facility": "Research Site", "city": "Jiangsu", "status": ""}, {"facility": "Research Site", "city": "Jiangxi", "status": ""}, {"facility": "Research Site", "city": "Jilin City", "status": ""}, {"facility": "Research Site", "city": "Jinghou", "status": ""}, {"facility": "Research Site", "city": "Liaoning", "status": ""}, {"facility": "Research Site", "city": "Luzhou", "status": ""}, {"facility": "Research Site", "city": "Nanjing", "status": ""}, {"facility": "Research Site", "city": "Nantong", "status": ""}, {"facility": "Research Site", "city": "Ningbo", "status": ""}, {"facility": "Research Site", "city": "Shandong", "status": ""}, {"facility": "Research Site", "city": "Shanghai", "status": ""}, {"facility": "Research Site", "city": "Shenyang", "status": ""}, {"facility": "Research Site", "city": "Sichuan", "status": ""}, {"facility": "Research Site", "city": "Taiyuan", "status": ""}, {"facility": "Research Site", "city": "Tianjin", "status": ""}, {"facility": "Research Site", "city": "Yichang", "status": ""}, {"facility": "Research Site", "city": "Yunan", "status": ""}, {"facility": "Research Site", "city": "Zhejiang", "status": ""}, {"facility": "Research Site", "city": "Zhengzhou", "status": ""}], "cn_site_count": 37, "broad_only": false}, {"nct": "NCT04643405", "title": "APG-1387 Plus Chemotherapy in Advanced Pancreatic Adenocarcinoma", "status": "TERMINATED", "start": "2021-03-17", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 21, "sponsor": "Ascentage Pharma Group Inc.", "conditions": ["Advanced Pancreatic Cancer"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04670978", "title": "Abraxane With Bevacizumab Biosimilar in Patients With Recurrent, Platinum-resistant Epithelial Ovarian Cancer", "status": "UNKNOWN", "start": "2021-03-31", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 96, "sponsor": "Shandong University", "conditions": ["Objective Response Rate"], "cn_sites": [{"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04718701", "title": "Anlotinib, Toripalimab and Nab-paclitaxel in Locally Advanced/Metastatic Pancreatic Cancer", "status": "UNKNOWN", "start": "2021-04-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 53, "sponsor": "The First Affiliated Hospital with Nanjing Medical University", "conditions": ["Pancreatic Neoplasm", "Metastatic Pancreatic Cancer", "Locally Advanced Pancreatic Adenocarcinoma"], "cn_sites": [{"facility": "The First Affiliated Hospital of Nanjing Medical University", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04892329", "title": "A Multi-center Study on the Efficacy and Safety of AI-assisted Navigation System for Biliopancreatic EUS", "status": "UNKNOWN", "start": "2021-05-12", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 285, "sponsor": "Renmin Hospital of Wuhan University", "conditions": ["Pancreatic Cancer"], "cn_sites": [{"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}, {"facility": "Renmin Hospital of Wuhan University", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT04718740", "title": "A Drug-drug Interaction Study Of Fluzoparib (SHR3162) on Patients With Recurrent Ovarian Cancer", "status": "COMPLETED", "start": "2021-06-25", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 33, "sponsor": "Jiangsu HengRui Medicine Co., Ltd.", "conditions": ["Recurrent Ovarian Cancer"], "cn_sites": [{"facility": "Hunan Cancer Hospital", "city": "Changsha", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04729387", "title": "Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected", "status": "TERMINATED", "start": "2021-07-22", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 358, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Ovarian Cancer"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Chengdu", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Jinan", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Tianjin", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT04998760", "title": "A Study to Evaluate Dual mTORC1/2 Inhibitor (ATG 008) or Selective Inhibitor of Nuclear Export Compound (ATG-010) in Combination With Chemotherapy in Patients With Relapsed or Metastatic Ovarian Cancer, Endometrial Cancer, and Cervical Cancer ( PORCH )", "status": "UNKNOWN", "start": "2021-08-03", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 96, "sponsor": "Qi Zhou", "conditions": ["1. Relapsed Ovarian Cancer 2. Metastatic Ovarian Cancer 3. Endometrial Cancer 4. Cervical Cancer"], "cn_sites": [{"facility": "Chongqing Cancer Hospital", "city": "Chongqing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05025046", "title": "NGS-based Thyroscan Genomic Classifier in the Diagnosis of Thyroid Nodules", "status": "COMPLETED", "start": "2021-09-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 250, "sponsor": "Rigen Biotech", "conditions": ["Thyroid Nodule", "Thyroid Cancer"], "cn_sites": [{"facility": "The First Peple's Hospital of Changzhou", "city": "Changzhou", "status": ""}, {"facility": "Zhejiang Provincial People's Hospital", "city": "Hangzhou", "status": ""}, {"facility": "Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Tianjin Medical University Center Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT05237193", "title": "A Prospective Study of UCAD for Diagnosing Benign or Malignant Biliary Obstruction and Follow-up", "status": "UNKNOWN", "start": "2021-09-03", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 400, "sponsor": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": ["Biliary Tract Neoplasms", "Pancreatic Carcinoma", "Gallbladder Cancer", "Pancreatic Head Carcinoma"], "cn_sites": [{"facility": "Xinhua Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04892342", "title": "Study of ESG401 in Adults With Solid Tumors", "status": "COMPLETED", "start": "2021-09-14", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 156, "sponsor": "Shanghai Escugen Biotechnology Co., Ltd", "conditions": ["Neoplasms, Breast", "Neoplasms, Lung", "Neoplasms,Colorectal", "Neoplasms, Bladder", "Neoplasm of Stomach", "Neoplasms,Ovarian"], "cn_sites": [{"facility": "Cancer Hospital Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "Tianjin Medical University Cancer Institute & Hospital", "city": "Tianjin", "status": ""}, {"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT05265091", "title": "A Study of KL590586 in Patients With Advanced Solid Tumors", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-09-15", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 414, "sponsor": "Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.", "conditions": ["Advanced Solid Tumor"], "cn_sites": [{"facility": "Sichuan Kelun Botai Biopharmaceutical Co.", "city": "Chengdu", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05310344", "title": "Albumin-bound Paclitaxel and Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer", "status": "UNKNOWN", "start": "2022-03-27", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Lei Li", "conditions": ["Ovarian Carcinoma", "Platinum-resistant Ovarian Cancer", "Recurrent Ovarian Carcinoma", "Albumin-bound Paclitaxel", "Bevacizumab", "Survival Outcomes", "Adverse Events"], "cn_sites": [{"facility": "Lei Li", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05381142", "title": "A Study to Learn More About How the Study Treatment Elinzanetant (or BAY3427080) Moves Into, Through and Out of the Body, How Safe it is and How it Affects the Body After Taking Single and Multiple Doses in Healthy Women Aged 40 to 65 Years", "status": "COMPLETED", "start": "2022-05-23", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 16, "sponsor": "Bayer", "conditions": ["Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men", "Hot Flashes", "Healthy Volunteers"], "cn_sites": [{"facility": "The First Affiliated Hospital of Guangzhou University of TCM", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05685524", "title": "Clinical Study of Pan-cancer DNA Methylation Test in Plasma", "status": "UNKNOWN", "start": "2022-07-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 3000, "sponsor": "Wuhan Ammunition Life-tech Co., Ltd", "conditions": ["Cancer"], "cn_sites": [{"facility": "The first affiliated hospital of Zhengzhou University", "city": "Zhengzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05627427", "title": "Multi-cohort Study of Surufatinib Plus Sintilimab in Metastatic NEN and Pancreatic Carcinoma Who Failed Standard Chemotherapy", "status": "UNKNOWN", "start": "2022-07-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Tianjin Medical University Cancer Institute and Hospital", "conditions": ["Neuroendocrine Tumor Grade 3", "Neuroendocrine Carcinoma", "Pancreatic Carcinoma"], "cn_sites": [{"facility": "Rui Liu", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05544929", "title": "A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-10-26", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 126, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Carcinoma, Non-Small-Cell Lung", "Cutaneous Melanoma", "Carcinoma, Renal Cell", "Carcinoma, Ovarian Epithelial", "Nasopharyngeal Carcinoma", "Carcinoma, Thymic", "Anal Cancer", "Mesothelioma", "Esophagogastric Cancer", "High Microsatellite Instability Colorectal Carcinoma", "Squamous Cell Carcinoma of Head and Neck", "Triple Negative Breast Neoplasms"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05523778", "title": "A Multi-center Study to Evaluate the Efficacy and Safety of Pancreatic Duct Stents Placement Before the Enucleation of Insulinoma Located in the Head and Neck of the Pancreas Near the Main Pancreatic Duct", "status": "UNKNOWN", "start": "2023-02-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 78, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Insulinoma"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05815862", "title": "Clinical Study of AL2846 Capsules in the Treatment of Advanced Lung Tumor and Advanced Ovarian Cancer", "status": "COMPLETED", "start": "2023-02-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 29, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Advanced Lung Cancer", "Ovarian Cancer"], "cn_sites": [{"facility": "Hunan Cancer Hospital", "city": "Changsha", "status": ""}, {"facility": "The Third Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "Northern Jiangsu People's Hospital", "city": "Yangzhou", "status": ""}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT05842187", "title": "In Vitro Organoid Drug Sensitivity-Guided Treatment for Metastatic Pancreatic and Gastric Cancer", "status": "UNKNOWN", "start": "2023-03-03", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Jianzhen Shan, MD", "conditions": ["Pancreatic Cancer", "Gastric Cancer"], "cn_sites": [{"facility": "The First Affiliated Hospital, Zhejiang University School of medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05830097", "title": "A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors", "status": "UNKNOWN", "start": "2023-03-14", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 260, "sponsor": "Coherent Biopharma (Hefei) Co., Ltd.", "conditions": ["Cancer, Breast", "Cancer, Lung", "Cancer of Pancreas", "Cancer of Esophagus", "Cancer Colorectal"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05816629", "title": "Multiparameter Ultrasound Based-AI for the Diagnosis of Thyroid Nodules", "status": "UNKNOWN", "start": "2023-03-20", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2000, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Thyroid Nodule"], "cn_sites": [{"facility": "SAHZJU", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05773716", "title": "Electroacupuncture and Pelvic Floor Muscle Training for Male Stress Urinary Incontinence", "status": "COMPLETED", "start": "2023-04-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "RenJi Hospital", "conditions": ["Stress Urinary Incontinence"], "cn_sites": [{"facility": "Renji Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06344780", "title": "Abemaciclib, Palbociclib or Dalpiciclib Combined with Endocrine Therapy As First-line Treatment in HR Positive, HER2 Negative Unresectable or Metastatic Breast Cancer", "status": "UNKNOWN", "start": "2023-05-20", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Fudan University", "conditions": ["Breast Cancer"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06344793", "title": "Initial CDK 4/6 Inhibitor Plus Endocrine Therapy Versus Initial Chemotherapy in HR Positive, HER2 Negative Unresectable or Metastatic Breast Cancer", "status": "COMPLETED", "start": "2023-05-20", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 608, "sponsor": "Fudan University", "conditions": ["Breast Cancer"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06224387", "title": "CTS2190 Phase I /II Clinical Study in Patients", "status": "UNKNOWN", "start": "2023-06-26", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 224, "sponsor": "CytosinLab Therapeutics Co., Ltd.", "conditions": ["Solid Tumors", "Pancreatic Cancer", "Non-small Cell Lung Cancer", "Triple-negative Breast Cancer"], "cn_sites": [{"facility": "The First Affiliated Hospital of Henan University of Science and Technology", "city": "Luoyang", "status": "RECRUITING"}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06090825", "title": "Cross-sectional Survey on Palliative Therapy for Pancreatic Cancer Patient", "status": "UNKNOWN", "start": "2023-09-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 450, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Pancreatic Cancer"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06134765", "title": "Bemalenograstim Alfa for the Prevention in Patients With Colorectal Cancer/Pancreatic Cancer", "status": "UNKNOWN", "start": "2023-11-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 89, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Colorectal Cancer", "Pancreatic Cancer"], "cn_sites": [{"facility": "the Second Affiliated Hospital of Medical College of Zhejiang University", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04536220", "title": "Establish Diagnostic Models Based on Portal Venous Blood for Pancreatic Cancer", "status": "UNKNOWN", "start": "2024-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 300, "sponsor": "Changhai Hospital", "conditions": ["Diagnoses Disease"], "cn_sites": [{"facility": "Changhai Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06018337", "title": "A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-01-18", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 541, "sponsor": "DualityBio Inc.", "conditions": ["Metastatic Breast Cancer"], "cn_sites": [{"facility": "Research Site 8640-0", "city": "Hefei", "status": ""}, {"facility": "Research Site 8614-0", "city": "Hefei", "status": ""}, {"facility": "Research Site 8601-0", "city": "Beijing", "status": ""}, {"facility": "Research Site 8625-0", "city": "Beijing", "status": ""}, {"facility": "Research Site 8653-0", "city": "Beijing", "status": ""}, {"facility": "Research Site 8627-0", "city": "Chongqing", "status": ""}, {"facility": "Research Site 8651-0", "city": "Fuzhou", "status": ""}, {"facility": "Research Site 8638-0", "city": "Xiamen", "status": ""}, {"facility": "Research Site 8630-0", "city": "Lanzhou", "status": ""}, {"facility": "Research Site 8604-0", "city": "Guangzhou", "status": ""}, {"facility": "Research Site 8628-0", "city": "Guangzhou", "status": ""}, {"facility": "Research Site 8621-0", "city": "Huizhou", "status": ""}, {"facility": "Research Site 8622-0", "city": "Zhuhai", "status": ""}, {"facility": "Research Site 8615-0", "city": "Nanning", "status": ""}, {"facility": "Research Site 8629-0", "city": "Baoding", "status": ""}, {"facility": "Research Site 8645-0", "city": "Shijiazhuang", "status": ""}, {"facility": "Research Site 8619-0", "city": "Harbin", "status": ""}, {"facility": "Research Site 8649-0", "city": "Anyang", "status": ""}, {"facility": "Research Site 8609-0", "city": "Luoyang", "status": ""}, {"facility": "Research Site 8648-0", "city": "Weihui", "status": ""}, {"facility": "Research Site 8605-0", "city": "Zhengzhou", "status": ""}, {"facility": "Research Site 8623-0", "city": "Zhengzhou", "status": ""}, {"facility": "Research Site 8637-0", "city": "Wuhan", "status": ""}, {"facility": "Research Site 8608-0", "city": "Wuhan", "status": ""}, {"facility": "Research Site 8633-0", "city": "Xiangyang", "status": ""}, {"facility": "Research Site 8635-0", "city": "Changsha", "status": ""}, {"facility": "Research Site 8654-0", "city": "Yongzhou", "status": ""}, {"facility": "Research Site 8646-0", "city": "Huai'an", "status": ""}, {"facility": "Research Site 8607-0", "city": "Nanjing", "status": ""}, {"facility": "Research Site 8624-0", "city": "Xuzhou", "status": ""}, {"facility": "Research Site 8631-0", "city": "Nanchang", "status": ""}, {"facility": "Research Site 8612-0", "city": "Changchun", "status": ""}, {"facility": "Research Site 8618-0", "city": "Changchun", "status": ""}, {"facility": "Research Site 8644-0", "city": "Changchun", "status": ""}, {"facility": "Research Site 8636-0", "city": "Dalian", "status": ""}, {"facility": "Research Site 8643-0", "city": "Shenyang", "status": ""}, {"facility": "Research Site 8642-0", "city": "Shenyang", "status": ""}, {"facility": "Research Site 8634-0", "city": "Jinan", "status": ""}, {"facility": "Research Site 8613-0", "city": "Jining", "status": ""}, {"facility": "Research Site 8610-0", "city": "Linyi", "status": ""}, {"facility": "Research Site 8650-0", "city": "Weihai", "status": ""}, {"facility": "Research Site 8603-0", "city": "Shanghai", "status": ""}, {"facility": "Research Site 8602-0", "city": "Shanghai", "status": ""}, {"facility": "Research Site 8611-0", "city": "Xi’an", "status": ""}, {"facility": "Research Site 8606-0", "city": "Chengdu", "status": ""}, {"facility": "Research Site 8626-0", "city": "Neijiang", "status": ""}, {"facility": "Research Site 8647-0", "city": "Zigong", "status": ""}, {"facility": "Research Site 8617-0", "city": "Tianjin", "status": ""}, {"facility": "Research Site 8616-0", "city": "Ürümqi", "status": ""}, {"facility": "Research Site 8632-0", "city": "Kunming", "status": ""}, {"facility": "Research Site 8652-0", "city": "Hangzhou", "status": ""}, {"facility": "Research Site 8620-0", "city": "Hangzhou", "status": ""}, {"facility": "Research Site 8641-0", "city": "Hangzhou", "status": ""}], "cn_site_count": 53, "broad_only": false}, {"nct": "NCT06363123", "title": "Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis", "status": "UNKNOWN", "start": "2024-03-29", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2700, "sponsor": "Beijing Friendship Hospital", "conditions": ["Lung Cancer", "Breast Cancer", "Colorectal Cancer", "Thyroid Cancer", "Gastric Cancer", "Cervical Cancer", "Liver Cancer", "Pancreatic Cancer", "Cholangiocarcinoma", "Prostate Cancer", "Esophageal Cancer", "Ovarian Cancer", "Renal Cell Carcinoma"], "cn_sites": [{"facility": "Cancer Hospital Chinese Academy of Medical Sciences", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Hebei Tumor Hospital", "city": "Shijiazhuang", "status": "RECRUITING"}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT06241092", "title": "AI-Based Multimodal Multi-tasks Analysis Reveals Tumor Molecular Heterogeneity, Predicts Preoperative Lymph Node Metastasis and Prognosis in Papillary Thyroid Carcinoma", "status": "UNKNOWN", "start": "2024-04-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 256, "sponsor": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University", "conditions": ["Papillary Thyroid Carcinoma; Molecular Heterogeneity; Multi-model Analysis; Artificial Intelligence; Lymph Node Metastases; Disease-free Survival"], "cn_sites": [{"facility": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06456281", "title": "Multi-omics Model for Pancreatic Cancer Screening Using cfDNA", "status": "UNKNOWN", "start": "2024-06-28", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 480, "sponsor": "Fudan University", "conditions": ["Pancreatic Cancer"], "cn_sites": [{"facility": "Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University; 270 Dong An Road, Shanghai 200032, China", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06440018", "title": "INSPIRE: a Multi-Cancer Early Detection Study", "status": "UNKNOWN", "start": "2024-07-20", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 5350, "sponsor": "Singlera Genomics Inc.", "conditions": ["Lung Cancer", "Gastric Cancer", "Liver Cancer", "Colorectal Cancer", "Pancreatic Cancer", "Esophageal Cancer", "Breast Cancer", "Cervical Cancer", "Ovarian Cancer", "Endometrial Cancer", "Bladder Cancer", "Prostate Cancer", "Cholangiocarcinoma"], "cn_sites": [{"facility": "Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06247995", "title": "A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-08-14", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Breast Cancer"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07750197", "title": "Exercise and Diet Responses in Adult Men With Obesity by MC4R Genotype and Metabolic Health", "status": "COMPLETED", "start": "2025-03-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Harbin Sport University", "conditions": ["Obesity", "Metabolically Healthy Obesity", "Metabolically Unhealthy Obesity"], "cn_sites": [{"facility": "Harbin Sport University", "city": "Harbin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07296575", "title": "Ultrasound Large-scale Model in Thyroid Field: A Multi-center Study on Medical-Engineering Integration", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-10-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2000, "sponsor": "Second Affiliated Hospital of Nanchang University", "conditions": ["Thyroid Abnormalities", "Thyroid", "Thyroid Cancer"], "cn_sites": [{"facility": "Second Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 159, "g_fetched": 110, "g_countries": [["United States", 51], ["United Kingdom", 11], ["South Korea", 11], ["Australia", 9], ["Italy", 9], ["Spain", 8], ["France", 7], ["Germany", 7], ["Canada", 6], ["Denmark", 4], ["Switzerland", 3], ["Singapore", 3], ["Belgium", 3], ["Turkey (Türkiye)", 3], ["Sweden", 3], ["Japan", 2], ["Czechia", 2], ["Taiwan", 2], ["Poland", 2], ["Netherlands", 2], ["Brazil", 1], ["New Zealand", 1], ["Argentina", 1], ["Ireland", 1], ["South Africa", 1], ["Mexico", 1], ["Hungary", 1], ["Puerto Rico", 1], ["Hong Kong", 1], ["Finland", 1]], "g_trials": [{"nct": "NCT07804017", "title": "Exhaled Breath Electronic Nose for Multi-Disease Risk Prescreening", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "The First Affiliated Hospital of Guangzhou Medical University", "countries": []}, {"nct": "NCT07671937", "title": "INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Alabama at Birmingham", "countries": ["United States"]}, {"nct": "NCT07689955", "title": "A Phase-II Clinical Trial of Radiotherapy to the Coeliac Plexus to Help Pain in Advanced Pancreatic Cancer", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Royal Marsden NHS Foundation Trust", "countries": []}, {"nct": "NCT07665515", "title": "Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer", "status": "RECRUITING", "start": "2026-09", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Epitopea Ltd", "countries": ["United Kingdom"]}, {"nct": "NCT07814872", "title": "A Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial Enrollment", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Harvard Medical School (HMS and HSDM)", "countries": ["United States"]}, {"nct": "NCT07787156", "title": "Reach and Engagement of GENetic Education, Risk Assessment, and TEsting Feasibility Trial", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Brigham and Women's Hospital", "countries": ["United States"]}, {"nct": "NCT07764744", "title": "Ovarian Cancer Liquid Biopsy for Early Assessment & Detection in Individuals With BRCA1/2 Pathogenic Variants", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Weill Medical College of Cornell University", "countries": ["United States"]}, {"nct": "NCT07469202", "title": "CYTALUX Dose Extension Study", "status": "NOT_YET_RECRUITING", "start": "2026-08-15", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "On Target Laboratories, LLC", "countries": []}, {"nct": "NCT07532356", "title": "Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk Stratification and Post-Treatment Surveillance in Fresh Thyroid Cancer Patients", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Taiwan University Hospital", "countries": []}, {"nct": "NCT07687264", "title": "Assessment of Metabolic Changes in Response to Glcuose Intake in Women With Polyendocrine Metabolic Ovarian Syndrome (PMOS)", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Zurich", "countries": ["Switzerland"]}, {"nct": "NCT07734948", "title": "Cardiovascular Effects of Purple-Fleshed Potatoes", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Instituto de Investigacion Nutricional, Peru", "countries": []}, {"nct": "NCT07705074", "title": "FAPI PET Imaging - An Exploratory Study", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Martin Huellner", "countries": ["Switzerland"]}, {"nct": "NCT06549751", "title": "MT-601 Administered To Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer", "status": "NOT_YET_RECRUITING", "start": "2026-07-16", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Marker Therapeutics, Inc.", "countries": ["United States"]}, {"nct": "NCT07670312", "title": "Evaluation of XYA02 in Patients With Advanced Solid Tumors", "status": "NOT_YET_RECRUITING", "start": "2026-07-15", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "XYone Therapeutics, Inc", "countries": ["Australia"]}, {"nct": "NCT06822751", "title": "FOsfomycin for Male Urinary Tract Infection", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Rouen", "countries": ["France"]}, {"nct": "NCT07693894", "title": "DISARM Clinical Study B: Evaluation of Innovative Ovarian Cancer Biomarker Assays", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National and Kapodistrian University of Athens", "countries": []}, {"nct": "NCT06801899", "title": "ToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary Cancer", "status": "RECRUITING", "start": "2026-06-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Insel Gruppe AG, University Hospital Bern", "countries": ["Germany", "Switzerland"]}, {"nct": "NCT07604571", "title": "Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer", "status": "RECRUITING", "start": "2026-05-28", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": ["Canada", "Japan", "Singapore", "South Korea", "United States"]}, {"nct": "NCT07371104", "title": "Bioequivalence Study of DWZ2501 in Patients With Advanced BRCA-mutated High-grade Ovarian Cancer", "status": "RECRUITING", "start": "2026-04-22", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Daewoong Pharmaceutical Co. LTD.", "countries": ["South Korea"]}, {"nct": "NCT07444723", "title": "Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors", "status": "RECRUITING", "start": "2026-04-16", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", "countries": ["United States"]}, {"nct": "NCT07382479", "title": "NeoAdjuvant ChemoTherapy With KELIM Guided Interval vs. Delayed Interval Debulking Surgery", "status": "NOT_YET_RECRUITING", "start": "2026-04-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Aristotle University Of Thessaloniki", "countries": []}, {"nct": "NCT07440290", "title": "DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.", "status": "RECRUITING", "start": "2026-04-01", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Cancer Research UK", "countries": ["United Kingdom"]}, {"nct": "NCT07704658", "title": "Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors", "status": "RECRUITING", "start": "2026-03-04", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Rigel Pharmaceuticals", "countries": ["Spain"]}, {"nct": "NCT07290309", "title": "Survivors Uniting for Remote Guided Exercise", "status": "RECRUITING", "start": "2026-02-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Colorado State University", "countries": ["United States"]}, {"nct": "NCT07303894", "title": "A Study of Isoquercetin in People With Ovarian Cancer", "status": "RECRUITING", "start": "2026-01-22", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Memorial Sloan Kettering Cancer Center", "countries": ["United States"]}]}, {"batch": 2, "no": 52, "name_zh": "发作性睡病", "query_terms": [{"term": "Narcolepsy", "broad": false}], "n_total": 14, "n_open": 7, "n_open_precise": 7, "n_broad": 0, "trials": [{"nct": "NCT06279247", "title": "Proteomics and Metabolomics of Body Fluid in Patients With Narcolepsy", "status": "RECRUITING", "start": "2022-09-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 60, "sponsor": "Qilu Hospital of Shandong University", "conditions": ["Narcolepsy"], "cn_sites": [{"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06797284", "title": "The Impact of Light, Electrical, and Magnetic Neuroregulation Interventions on Sleep-wake Disorders", "status": "RECRUITING", "start": "2025-02-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Second Affiliated Hospital of Soochow University", "conditions": ["Insomnia Chronic", "Narcolepsy", "REM Sleep Behavior Disorder"], "cn_sites": [{"facility": "Department of Neurology, Second Affiliated Hospital of Soochow University", "city": "Suzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06952699", "title": "A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)", "status": "RECRUITING", "start": "2025-05-06", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 88, "sponsor": "Takeda", "conditions": ["Narcolepsy Type 2"], "cn_sites": [{"facility": "Takeda Site 28", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Takeda Site 29", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Takeda Site 51", "city": "Changchun", "status": "RECRUITING"}, {"facility": "Takeda Site 27", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT07493265", "title": "A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy", "status": "RECRUITING", "start": "2026-03-26", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 64, "sponsor": "Eisai Inc.", "conditions": ["Narcolepsy"], "cn_sites": [{"facility": "Xuanwu Hospital Capital Medical University", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": "NOT_YET_RECRUITING"}, {"facility": "Nanfang Hospital Southern Medical University", "city": "Guangdong", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Jinan University (Guangzhou Overseas Chinese Hospital)", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Shandong Provincial Qianfoshan Hospital", "city": "Jinan", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Affiliated Hospital of Nanchang University - Donghu Campus", "city": "Nanchang", "status": "NOT_YET_RECRUITING"}, {"facility": "Huashan Hospital Fudan University", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}, {"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT07633301", "title": "A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)", "status": "RECRUITING", "start": "2026-06-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 92, "sponsor": "Takeda", "conditions": ["Narcolepsy Type 1"], "cn_sites": [{"facility": "Takeda Site 4", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Takeda Site 3", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Takeda Site 5", "city": "Zhengzhou", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07646678", "title": "A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia", "status": "RECRUITING", "start": "2026-06-11", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 500, "sponsor": "Takeda", "conditions": ["Idiopathic Hypersomnia", "Narcolepsy Type 1", "Narcolepsy Type 2"], "cn_sites": [{"facility": "Takeda Site 12", "city": "Xicheng", "status": "RECRUITING"}, {"facility": "Takeda Site 5", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Takeda Site 16", "city": "Zhenzhou", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07727239", "title": "Temporal Interference Stimulation of Hypothalamus in Patients With Narcolepsy Type 1", "status": "RECRUITING", "start": "2026-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Xijing Hospital", "conditions": ["Narcolepsy Type 1"], "cn_sites": [{"facility": "Xijing Hospital", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00061022", "title": "Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke", "status": "COMPLETED", "start": "2003-05", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 3200, "sponsor": "AstraZeneca", "conditions": ["Cerebral Stroke", "Stroke, Acute", "Cerebrovascular Stroke", "Ischemic Attack, Transient"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Guangzhou", "status": ""}, {"facility": "Research Site", "city": "Shanghai", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT03376568", "title": "Investigation of Clinical Feature and Brain Function in Narcoleptic Patients", "status": "UNKNOWN", "start": "2016-01-28", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Tang-Du Hospital", "conditions": ["Narcolepsy", "REM Sleep Behavior Disorder"], "cn_sites": [{"facility": "Tangdu Hospital", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04096560", "title": "A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy", "status": "TERMINATED", "start": "2020-05-27", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 97, "sponsor": "Takeda", "conditions": ["Narcolepsy Type 1 (NT1)", "Narcolepsy Type 2 (NT2)"], "cn_sites": [{"facility": "Xuanwu Hospital Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital of Jinan University", "city": "Tianhe", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT04940806", "title": "The Value of Combined Detection of Orexin-A, HLA Gene, PSG and MSLT in the Evaluation of Patients With Narcolepsy", "status": "UNKNOWN", "start": "2021-05-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 120, "sponsor": "Qianfoshan Hospital", "conditions": ["Narcolepsy"], "cn_sites": [{"facility": "The First Affiliated Hospital of Shandong First Medical University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06241911", "title": "Transcutaneous Auricular Vagus Nerve Stimulation in Patients With Narcolepsy Type 1", "status": "COMPLETED", "start": "2022-04-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Liu Yonghong", "conditions": ["Narcolepsy Type 1", "Fmri"], "cn_sites": [{"facility": "Liu Yonghong", "city": "Xi'an", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06505031", "title": "A Study of TAK-861 in People With Narcolepsy Type 1", "status": "COMPLETED", "start": "2024-10-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 105, "sponsor": "Takeda", "conditions": ["Narcolepsy Type 1"], "cn_sites": [{"facility": "Takeda Site 4", "city": "Beijing", "status": ""}, {"facility": "Takeda Site 27", "city": "Zhengzhou", "status": ""}, {"facility": "Takeda Site 28", "city": "Shanghai", "status": ""}, {"facility": "Takeda Site 26", "city": "Guangdong", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT07654803", "title": "Radar Sleep Monitoring in Type 1 Narcolepsy: Feasibility", "status": "ACTIVE_NOT_RECRUITING", "start": "2026-05-07", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1, "sponsor": "Xijing Hospital", "conditions": ["Narcolepsy Type 1 (NT 1)", "Hypersomnolence Disorder"], "cn_sites": [{"facility": "First Affiliated Hospital of PLA Air Force Medical University", "city": "Xi'an", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 36, "g_fetched": 29, "g_countries": [["United States", 18], ["France", 13], ["Canada", 6], ["Australia", 6], ["Italy", 6], ["Spain", 6], ["Netherlands", 4], ["Belgium", 3], ["Japan", 3], ["Finland", 2], ["Germany", 2], ["Poland", 1], ["Czechia", 1], ["Norway", 1], ["Sweden", 1], ["Switzerland", 1]], "g_trials": [{"nct": "NCT07766343", "title": "Hypersomnia in the Paediatric Population", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Montpellier", "countries": ["France"]}, {"nct": "NCT07540364", "title": "A Phase 3 Study to Evaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsy (AWAKE)", "status": "RECRUITING", "start": "2026-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Suven Life Sciences Limited", "countries": ["United States"]}, {"nct": "NCT07540897", "title": "A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)", "status": "RECRUITING", "start": "2026-08-13", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Alkermes, Inc.", "countries": ["Canada", "Poland", "United States"]}, {"nct": "NCT07625280", "title": "A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH", "status": "RECRUITING", "start": "2026-07-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Jazz Pharmaceuticals", "countries": ["United States"]}, {"nct": "NCT06383806", "title": "Decreasing Nightmares in Adults With Narcolepsy", "status": "RECRUITING", "start": "2026-07-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Utah", "countries": ["United States"]}, {"nct": "NCT07675135", "title": "A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy", "status": "RECRUITING", "start": "2026-06-04", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Harmony Biosciences Management, Inc.", "countries": ["Canada", "United States"]}, {"nct": "NCT07598708", "title": "A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence", "status": "RECRUITING", "start": "2026-05-29", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Centessa Pharmaceuticals (UK) Limited", "countries": ["United States"]}, {"nct": "NCT07584434", "title": "A Phase 1, First-in-human Study of VX-433", "status": "RECRUITING", "start": "2026-05-21", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Vertex Pharmaceuticals Incorporated", "countries": ["United States"]}, {"nct": "NCT07502443", "title": "A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2", "status": "RECRUITING", "start": "2026-04-22", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Alkermes, Inc.", "countries": ["Australia", "Belgium", "Canada", "France", "Italy", "Japan", "Netherlands", "Spain", "United States"]}, {"nct": "NCT07455383", "title": "A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1", "status": "RECRUITING", "start": "2026-04-06", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Alkermes, Inc.", "countries": ["Australia", "Belgium", "Canada", "France", "Italy", "Japan", "Netherlands", "Spain", "United States"]}, {"nct": "NCT07365566", "title": "Pain Assessment in Patients With Idiopathic Rapid Eye Movement (REM) Sleep Behaviour Disorder", "status": "RECRUITING", "start": "2026-02-24", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Toulouse", "countries": ["France"]}, {"nct": "NCT06809803", "title": "Extended-release Sodium Oxybate in Children", "status": "RECRUITING", "start": "2025-10-27", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Stanford University", "countries": ["United States"]}, {"nct": "NCT07096674", "title": "A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia", "status": "RECRUITING", "start": "2025-08-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Centessa Pharmaceuticals (UK) Limited", "countries": ["Canada", "Italy", "Spain", "United States"]}, {"nct": "NCT07006233", "title": "A Novel Approach to Manage Symptoms of Narcolepsy and Idiopathic Hypersomnia", "status": "RECRUITING", "start": "2025-06-23", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Sydney", "countries": ["Australia"]}, {"nct": "NCT07613710", "title": "A Trial to Test the Safety and Tolerability of Lu AH69593 in Adults That Are Healthy or Have Narcolepsy", "status": "RECRUITING", "start": "2025-06-13", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "H. Lundbeck A/S", "countries": ["Finland"]}, {"nct": "NCT06292598", "title": "Bacterial Translocation and Gut Microbiota in Type 1 Narcolepsy Patients Versus a Control Population", "status": "RECRUITING", "start": "2025-03-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Centre Hospitalier Universitaire de Nīmes", "countries": ["France"]}, {"nct": "NCT06786377", "title": "Genetic and Clinical Characterization of Type 1 and 2 Narcolepsy in Adult and Pediatric Black and North African Populations", "status": "NOT_YET_RECRUITING", "start": "2025-01-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT06767683", "title": "A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia", "status": "RECRUITING", "start": "2025-01-27", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Alkermes, Inc.", "countries": ["Australia", "Belgium", "Czechia", "France", "Italy", "Netherlands", "Spain", "United States"]}, {"nct": "NCT06752668", "title": "A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia", "status": "RECRUITING", "start": "2024-12-23", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Centessa Pharmaceuticals (UK) Limited", "countries": ["Canada", "France", "Italy", "Spain", "United States"]}, {"nct": "NCT06457945", "title": "Mind-wandering and Predictive Processes in Narcolepsy: a Putative Mechanism Through Covert REM Intrusions", "status": "RECRUITING", "start": "2024-12-03", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Hospices Civils de Lyon", "countries": ["France"]}, {"nct": "NCT06484348", "title": "Deciphering the Interactions Between Food Intake, Sleepiness, and Nighttime Sleep Quality in Patients With Type 1 Narcolepsy and Idiopathic Hypersomnia", "status": "RECRUITING", "start": "2024-10-16", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Hospices Civils de Lyon", "countries": ["France"]}, {"nct": "NCT06336057", "title": "Mentalizating in Adults Suffering from Narcolepsy Type 1.", "status": "RECRUITING", "start": "2024-05-17", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Toulouse", "countries": ["France"]}, {"nct": "NCT04806620", "title": "Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research", "status": "RECRUITING", "start": "2023-07-05", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Brain Inflammation Collaborative", "countries": ["United States"]}, {"nct": "NCT05816382", "title": "A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions", "status": "RECRUITING", "start": "2023-04-05", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Takeda", "countries": ["Australia", "Finland", "France", "Germany", "Italy", "Japan", "Netherlands", "Norway", "Spain", "Sweden", "Switzerland", "United States"]}, {"nct": "NCT05773872", "title": "Evaluation of Social Cognition in Patient With Type 1 or Type 2 Narcolepsy Versus Patients With Idiopathic Hypersomnia", "status": "RECRUITING", "start": "2022-11-18", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Centre Hospitalier Universitaire, Amiens", "countries": ["France"]}]}, {"batch": 2, "no": 53, "name_zh": "神经母细胞瘤", "query_terms": [{"term": "Neuroblastoma", "broad": false}], "n_total": 44, "n_open": 26, "n_open_precise": 26, "n_broad": 0, "trials": [{"nct": "NCT05069220", "title": "18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor", "status": "RECRUITING", "start": "2021-09-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 150, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Neuroendocrine Tumor", "Neuroblastoma", "Pheochromocytoma", "Paraganglioma"], "cn_sites": [{"facility": "Peking union medical college hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07516678", "title": "Serial ctDNA and Molecular Residual Disease Monitoring in Neuroblastoma", "status": "RECRUITING", "start": "2022-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Sun Yat-sen University", "conditions": ["Neuroblastoma"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07064746", "title": "Clinical Application Study of [123I]Metaiodobenzylguanidine and Somatostatin Receptor-Targeted Imaging in the Diagnosis and Staging of Neuroblastoma", "status": "RECRUITING", "start": "2022-07-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 150, "sponsor": "Nanjing First Hospital, Nanjing Medical University", "conditions": ["Neuroblastoma (NB)"], "cn_sites": [{"facility": "Nanjing First Hospital", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05303727", "title": "Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma", "status": "NOT_YET_RECRUITING", "start": "2022-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 64, "sponsor": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University", "conditions": ["Neuroblastoma"], "cn_sites": [{"facility": "Sun Yat-sen Memorial Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05562024", "title": "TAA06 Injection in the Treatment of Patients With B7-H3-positive Relapsed/ Refractory Neuroblastoma", "status": "RECRUITING", "start": "2022-12-30", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "PersonGen BioTherapeutics (Suzhou) Co., Ltd.", "conditions": ["B7-H3-positive Relapsed/ Refractory Neuroblastoma"], "cn_sites": [{"facility": "Shandong Cancer Hospital and Institute", "city": "Jinan", "status": "NOT_YET_RECRUITING"}, {"facility": "Tianjin Medical University Cancer Institute and Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05701306", "title": "APG-115 Alone or in Combination With APG-2575 in Recurrent or Refractory Neuroblastoma or Solid Tumors", "status": "RECRUITING", "start": "2023-02-28", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Ascentage Pharma Group Inc.", "conditions": ["Neuroblastoma", "Solid Tumor"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Tongji Hospital, Huazhong University of Science and Technology (HUST)", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Tianjin Medical University Cancer Institute & Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT06013618", "title": "Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma", "status": "RECRUITING", "start": "2023-06-19", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Sun Yat-Sen University Cancer Center", "conditions": ["Neuroblastoma"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06255210", "title": "Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma (ESICON)", "status": "RECRUITING", "start": "2024-03-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 25, "sponsor": "Hongmeng Yu", "conditions": ["Olfactory Neuroblastoma"], "cn_sites": [{"facility": "Eye & ENT Hospital of Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06574698", "title": "Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma", "status": "RECRUITING", "start": "2024-05-06", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 64, "sponsor": "Guangzhou Women and Children's Medical Center", "conditions": ["Neuroblastoma", "GD2 Antibody (Naxitamab)"], "cn_sites": [{"facility": "Guangzhou Women And Children's Medical Center", "city": "Guanzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06818916", "title": "Hetrombopag in Promoting Platelet Engraftment After Auto-HSCT in Children With Neuroblastoma", "status": "RECRUITING", "start": "2024-06-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Beijing Children's Hospital", "conditions": ["Delayed Platelet Engraftment", "Neuroblastoma", "Autologous Hematopoietic Stem Cell Transplantation"], "cn_sites": [{"facility": "Department of Stem Cell Transplantation, Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06631391", "title": "Phase I Study of Umbilical Cord Blood Natural Killer (NK) Cell Therapy for Children With High-risk, R/R Neuroblastoma.", "status": "RECRUITING", "start": "2024-11-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Sun Yat-sen University", "conditions": ["Neuroblastoma"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06684639", "title": "A Study on the Efficacy of GD2-CAR T Cells in the Treatment of Neuroblastoma", "status": "RECRUITING", "start": "2024-12-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "The General Hospital of Western Theater Command", "conditions": ["Neuroblastoma"], "cn_sites": [{"facility": "The General Hospital of Western Theater Command", "city": "Chengdu", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06703944", "title": "Risk Model for Metastasis Detection of Neuroblastoma", "status": "ENROLLING_BY_INVITATION", "start": "2024-12-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": ["Neuroblastoma (NB)", "Prognosis", "Bone Marrow Metastasis", "Bone Metastases"], "cn_sites": [{"facility": "Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "The Children's Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT06836505", "title": "Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial.", "status": "RECRUITING", "start": "2024-12-12", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Sun Yat-Sen University Cancer Center", "conditions": ["Neuroblastoma (NB)", "Desmoplastic Small Round Cell Tumor (DSRCT)"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Dongguan Taixin Hospital", "city": "Dongguan", "status": "RECRUITING"}, {"facility": "Shanghai YaKe Biotechnology Ltd.", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07195500", "title": "Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Paraganglioma", "status": "RECRUITING", "start": "2024-12-25", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 30, "sponsor": "Nanjing First Hospital, Nanjing Medical University", "conditions": ["Neuroblastoma", "Pheochromocytoma", "Paraganglioma"], "cn_sites": [{"facility": "Nanjing First Hospital", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06751134", "title": "Chimeric Natural Killer Receptor-Universal T Cells for Relapsed or Refractory Neuroblastoma", "status": "RECRUITING", "start": "2024-12-28", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Nanjing Children's Hospital", "conditions": ["Neuroblastoma, Recurrent, Refractory"], "cn_sites": [{"facility": "Nanjing Children's Hospital", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Nanjing", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06852807", "title": "18F-mFBG PET Imaging in the Evaluation of Neuroblastoma", "status": "RECRUITING", "start": "2025-02-04", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "First Affiliated Hospital of Zhejiang University", "conditions": ["Neuroblastoma"], "cn_sites": [{"facility": "The First Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06873672", "title": "Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China", "status": "NOT_YET_RECRUITING", "start": "2025-04-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 360, "sponsor": "RenJi Hospital", "conditions": ["Quality of Life (QOL)", "Patient-Reported Outcome Measures (PROMs)", "Pneumonia Childhood", "Neuroblastoma (NB)", "Wilms Tumour", "Immune Thrombocytopenic Purpura ( ITP )"], "cn_sites": [{"facility": "Guizhou Medical University", "city": "Guiyang", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06933394", "title": "Arsenic Trioxide With MAPK Inhibitors and Chemotherapy for Stage 4/M Neuroblastoma", "status": "RECRUITING", "start": "2025-05-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 92, "sponsor": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University", "conditions": ["Neuroblastoma"], "cn_sites": [{"facility": "Sun Yat-sen Memorial Hospital", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07067346", "title": "Safety & Efficacy of IR-101 in Relapsed/Refractory Neuroblastoma", "status": "RECRUITING", "start": "2025-07-18", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Sichuan University", "conditions": ["Neuroblastoma"], "cn_sites": [{"facility": "West China Hospital", "city": "Chengdu", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07090538", "title": "GSL Synthetase Inhibitor Plus GM-CSF and/ or Immune Checkpoint Inhibitor in Previously Treated High-Risk Neuroblastoma.", "status": "NOT_YET_RECRUITING", "start": "2025-08-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Chinese PLA General Hospital", "conditions": ["Neuroblastoma"], "cn_sites": [{"facility": "Biotherapeutic Department and Hematology Department of Chinese PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "Department of Pediatrics, The First Medical Center, Chinese PLA General Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07318831", "title": "Phase II Study of Chidamide-Dinutuximab Beta-Irinotecan-Temozolomide for Refractory/Relapsed Neuroblastoma in Children", "status": "RECRUITING", "start": "2026-01-06", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 27, "sponsor": "Tianjin Medical University Cancer Institute and Hospital", "conditions": ["Neuroblastoma (NB)", "Neuroblastoma in Children"], "cn_sites": [{"facility": "Tianjin Medical University Cancer Institute & Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07502287", "title": "Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma", "status": "RECRUITING", "start": "2026-03-02", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Beijing Biotech", "conditions": ["Relapsed Neuroblastoma", "Refractory Neuroblastoma", "High-Risk Neuroblastoma", "Ganglioneuroblastoma"], "cn_sites": [{"facility": "Peking University Shenzhen Hospital", "city": "Shenzhen", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07584499", "title": "Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors", "status": "RECRUITING", "start": "2026-05-30", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 51, "sponsor": "Sun Yat-sen University", "conditions": ["Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)", "Nasopharyngeal Carcinoma", "Lymphoepithelial Carcinoma", "Rhabdomyosarcoma", "Neuroblastoma", "Medulloblastoma", "Wilms Tumor", "Atypical Teratoid/Rhabdoid Tumors", "Diffuse Intrinsic Pontine Gliomas", "Other EGFR-positive Pediatric Solid Tumors Deemed Eligible by the Investigator"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07767630", "title": "Safety, Tolerability, and Preliminary Efficacy of [211At]MABG in Patients With Relapsed or Refractory Neuroblastoma", "status": "RECRUITING", "start": "2026-07-21", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Sichuan University", "conditions": ["Neuroblastoma (NB)"], "cn_sites": [{"facility": "West China Hospital", "city": "Chengdu", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04637503", "title": "4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma", "status": "NOT_YET_RECRUITING", "start": "2026-12-31", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": ["Neuroblastoma"], "cn_sites": [{"facility": "Shenzhen Geno-Immune Medical Institute", "city": "Shenzhen", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01121588", "title": "Studying An Investigational Drug Crizotinib (PF-02341066) In Non Non-Small Cell Lung Cancer Tumors That Are Positive For Anaplastic Lymphoma Kinase (ALK)", "status": "TERMINATED", "start": "2011-03-22", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 44, "sponsor": "Pfizer", "conditions": ["Neoplasms Malignant"], "cn_sites": [{"facility": "Cancer Institute and Hospital, Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "SUN Yat-Sen University Cancer Center", "city": "Guangzhou", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT02457650", "title": "T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies", "status": "UNKNOWN", "start": "2015-04", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Shenzhen Second People's Hospital", "conditions": ["Bladder Carcinoma", "Breast Cancer", "Esophagus Carcinoma", "Lung Cancer", "Melanoma", "Multiple Myeloma", "Neuroblastoma", "Ovarian Cancer", "Synovial Sarcoma", "Other Metastatic Solid Cancers"], "cn_sites": [{"facility": "Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University", "city": "Shenzhen", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02615106", "title": "Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma", "status": "UNKNOWN", "start": "2015-11", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": ["Neuroblastoma"], "cn_sites": [{"facility": "The Department of Radiation Oncology, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02765243", "title": "Anti-GD2 4th Generation CART Cells Targeting Refractory and/or Recurrent Neuroblastoma", "status": "COMPLETED", "start": "2016-01-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Zhujiang Hospital", "conditions": ["Neuroblastoma", "Effects of Immunotherapy"], "cn_sites": [{"facility": "Zhujiang Hospital of Southern Medical University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02650401", "title": "Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options", "status": "ACTIVE_NOT_RECRUITING", "start": "2016-05-03", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 69, "sponsor": "Hoffmann-La Roche", "conditions": ["Solid Tumors", "CNS Tumors"], "cn_sites": [{"facility": "Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT02919046", "title": "Study Evaluating the Efficacy and Safety With CAR-T for Relapsed or Refractory Neuroblastoma in Children", "status": "UNKNOWN", "start": "2016-09", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 22, "sponsor": "Sinobioway Cell Therapy Co., Ltd.", "conditions": ["Relapsed or Refractory Neuroblastoma"], "cn_sites": [{"facility": "Nanjing Children's Hospital", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT02933333", "title": "G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor", "status": "UNKNOWN", "start": "2016-09-27", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 405, "sponsor": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": ["Acute Myeloid Leukemia", "Acute Lymphoid Leukemia", "Lymphoma", "Neuroblastoma", "Hepatoblastoma", "Retinoblastoma"], "cn_sites": [{"facility": "The First Affiliated of Xiamen University", "city": "Xiamen", "status": "RECRUITING"}, {"facility": "Children's Hospital of Soochow University", "city": "Suzhou", "status": "RECRUITING"}, {"facility": "Shandong Province Qianfoshan Hospital", "city": "Jinan", "status": "RECRUITING"}, {"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": "RECRUITING"}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Xinhua Hospital affiliated to Shanghai Jiaotong University school of medicine", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Northwest Women's Hospital", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT03503864", "title": "Phase II Study of Combined Chemotherapy With Arsenic Trioxide in Stage 4/M Neuroblastoma", "status": "ACTIVE_NOT_RECRUITING", "start": "2017-06-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 80, "sponsor": "Yang Li", "conditions": ["Neuroblastoma"], "cn_sites": [{"facility": "Sun Yat-sen Memorial Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04412408", "title": "Study on Sintilimab in Stage IV High Risk Neuroblastoma", "status": "UNKNOWN", "start": "2020-09-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Shanghai Children's Medical Center", "conditions": ["Recurrent Stage IV High Risk Neuroblastoma"], "cn_sites": [{"facility": "Shanghai Children's Medical Center Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05179850", "title": "Computer Aided Diagnostic Tool on Computed Tomography Images for Diagnosis of Retroperitoneal Tumor in Children", "status": "UNKNOWN", "start": "2021-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 400, "sponsor": "West China Hospital", "conditions": ["Wilms' Tumor", "Neuroblastoma", "Teratoma", "Lymphoma", "Sarcoma", "Germ Cell Tumor"], "cn_sites": [{"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06190574", "title": "Diagnostic Efficacy and Prognostic Value of 18F-FDG PET/CT (MR) in Pediatric Solid Blastoma", "status": "COMPLETED", "start": "2021-07-30", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 50, "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": ["18F-FDG", "Neuroblastoma", "Hepatoblastoma", "Wilms Tumor"], "cn_sites": [{"facility": "China, Hubei Province", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05027386", "title": "Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Neuroblastoma: A Single-arm, Phase I/II，Multi-center, Clinical Study.", "status": "COMPLETED", "start": "2021-08-26", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 125, "sponsor": "Sun Yat-sen University", "conditions": ["Neuroblastoma"], "cn_sites": [{"facility": "Yizhuo Zhang", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05338541", "title": "Tucidinostat Plus Etoposide in the Treatment of Neuroblastoma in Childhood.", "status": "UNKNOWN", "start": "2022-05-27", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Yizhuo Zhang", "conditions": ["Neuroblastoma in Children"], "cn_sites": [{"facility": "Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05373901", "title": "Evaluation of the Safety and Pharmacokinetics of Dinutuximab Beta As Maintenance Therapy in Chinese Participants With High-Risk Neuroblastoma", "status": "COMPLETED", "start": "2022-06-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 8, "sponsor": "BeiGene", "conditions": ["High-risk Neuroblastoma"], "cn_sites": [{"facility": "Xinhua Hospital Affiliated To Shanghai Jiao Tong University School Of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Tianjin Medical University Cancer Institute & Hospital", "city": "Tianjin", "status": ""}, {"facility": "The Children's Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT06502210", "title": "Identification of New Gene Spliceosomes in Neuroblastoma", "status": "UNKNOWN", "start": "2024-04-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 20, "sponsor": "Affiliated Hospital of Nantong University", "conditions": ["Neuroblastoma"], "cn_sites": [{"facility": "Affiliated Hospital of Nantong University", "city": "Nantong", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06822842", "title": "Accurate Diagnosis and Grading of Pediatric Solid Tumors Based on Pathological Large Models", "status": "COMPLETED", "start": "2025-01-22", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1229, "sponsor": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": ["Neuroblastoma", "Medulloblastoma", "Wilms Tumor", "Hepatoblastoma", "Rhabdomyosarcoma"], "cn_sites": [{"facility": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07278674", "title": "Clinical Study of Eflornithine After Immunotherapy for High-risk Neuroblastoma（CSHEIN）", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-04-08", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 20, "sponsor": "Shanghai Children's Hospital", "conditions": ["High Risk Neuroblastoma"], "cn_sites": [{"facility": "Ruijin Hospital Hainan Branch, affiliated with Shanghai Jiao Tong University School of Medicine and Children's Hospital of Shanghai, affiliated with Shanghai Jiao Tong University School of Medicine", "city": "Hainan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07549425", "title": "Construction and Validation of an Intelligent Ultrasound Diagnostic System for the Spectrum of Neuroblastoma in Children", "status": "ACTIVE_NOT_RECRUITING", "start": "2026-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 300, "sponsor": "The Children's Hospital of Zhejiang University School of Medicine", "conditions": ["Neuroblastic Tumors"], "cn_sites": [{"facility": "Anhui Provincial Children's Hospital", "city": "Hefei", "status": ""}, {"facility": "The Children's Hospital Affiliated to Soochow University", "city": "Suzhou", "status": ""}, {"facility": "Kunming Children's Hospital", "city": "Kunming", "status": ""}, {"facility": "The Children's Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": ""}, {"facility": "Wenling Institute of Medical Big Data and Artificial Intelligence", "city": "Wenling", "status": ""}], "cn_site_count": 6, "broad_only": false}], "g_total": 130, "g_fetched": 105, "g_countries": [["United States", 65], ["Canada", 13], ["France", 9], ["Spain", 7], ["United Kingdom", 7], ["Israel", 5], ["Netherlands", 5], ["Italy", 5], ["Australia", 5], ["Denmark", 5], ["Austria", 4], ["Belgium", 4], ["Czechia", 4], ["Sweden", 4], ["Norway", 4], ["Russia", 3], ["Brazil", 3], ["Germany", 3], ["Greece", 3], ["Slovakia", 3], ["Switzerland", 3], ["Poland", 3], ["Taiwan", 2], ["Japan", 2], ["New Zealand", 2], ["Hungary", 2], ["Puerto Rico", 2], ["Lithuania", 2], ["Slovenia", 2], ["Iran", 1], ["Chile", 1], ["Colombia", 1], ["South Korea", 1], ["Turkey (Türkiye)", 1], ["Hong Kong", 1], ["Finland", 1], ["Ireland", 1], ["Portugal", 1]], "g_trials": [{"nct": "NCT07819838", "title": "Testing the Addition of an Anti-Cancer Drug, Daraxonrasib, for Relapsed or Refractory Solid Tumors With RAS Mutations", "status": "NOT_YET_RECRUITING", "start": "2027-04-09", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Children's Oncology Group", "countries": []}, {"nct": "NCT07261241", "title": "NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + Dinutuximab", "status": "NOT_YET_RECRUITING", "start": "2026-12-31", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "New Approaches to Neuroblastoma Therapy Consortium", "countries": ["United States"]}, {"nct": "NCT07635056", "title": "Haploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Neuroblastoma", "status": "RECRUITING", "start": "2026-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Children's Hospital Medical Center, Cincinnati", "countries": ["United States"]}, {"nct": "NCT07437963", "title": "Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse", "status": "NOT_YET_RECRUITING", "start": "2026-10-28", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": []}, {"nct": "NCT07527169", "title": "A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory Neuroblastoma", "status": "NOT_YET_RECRUITING", "start": "2026-10-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "M.D. Anderson Cancer Center", "countries": ["United States"]}, {"nct": "NCT07358260", "title": "B7-H3.CD28Z.CART in Solid Tumors", "status": "RECRUITING", "start": "2026-08-24", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Robbie Majzner", "countries": ["United States"]}, {"nct": "NCT07211737", "title": "NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma", "status": "RECRUITING", "start": "2026-07-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Baylor College of Medicine", "countries": ["United States"]}, {"nct": "NCT07688252", "title": "Dinutuximab-beta and Chemotherapy in Newly Diagnosed High-Risk Neuroblastoma", "status": "NOT_YET_RECRUITING", "start": "2026-07-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Chang Gung Memorial Hospital", "countries": ["Taiwan"]}, {"nct": "NCT07537400", "title": "Patients Between the Ages of 12 Months to 21 Years With Newly-Diagnosed High-Risk Neuroblastoma Will Receive Children's Oncology Group (COG) Type Recommended Therapy With the Addition of Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) to Induction Cycles 1-5", "status": "RECRUITING", "start": "2026-06-23", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Shaare Zedek Medical Center", "countries": ["Israel"]}, {"nct": "NCT06465199", "title": "Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas", "status": "RECRUITING", "start": "2026-05-13", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Milton S. Hershey Medical Center", "countries": ["United States"]}, {"nct": "NCT07518654", "title": "Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or Neuroblastoma", "status": "NOT_YET_RECRUITING", "start": "2026-05-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Michel Duval", "countries": ["Canada"]}, {"nct": "NCT07549321", "title": "A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients", "status": "RECRUITING", "start": "2026-03-30", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Renaissance Pharma Ltd.", "countries": ["Canada", "Spain", "United States"]}, {"nct": "NCT07444918", "title": "Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid Tumors", "status": "NOT_YET_RECRUITING", "start": "2026-03-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Tianjin Medical University Cancer Institute and Hospital", "countries": []}, {"nct": "NCT07111117", "title": "Comparison of 18F Labeled Analog of MIBG (18F-MFBG) PET/CT and 123I-MIBG SPECT in Pediatric Patients With Neuroblastoma.", "status": "NOT_YET_RECRUITING", "start": "2026-03-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Institut Curie", "countries": ["France"]}, {"nct": "NCT06625190", "title": "Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors", "status": "RECRUITING", "start": "2026-02-11", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University of Florida", "countries": ["United States"]}, {"nct": "NCT07172958", "title": "Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)", "status": "RECRUITING", "start": "2026-01-27", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Children's National Research Institute", "countries": ["United States"]}, {"nct": "NCT07375563", "title": "Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma", "status": "RECRUITING", "start": "2025-11-19", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Federal Research Institute of Pediatric Hematology, Oncology and Immunology", "countries": ["Russia"]}, {"nct": "NCT07085338", "title": "A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma", "status": "RECRUITING", "start": "2025-11-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "St. Jude Children's Research Hospital", "countries": ["United States"]}, {"nct": "NCT07399821", "title": "An Imaging Study of Anti-GD2-800CW in Patients With Neuroblastoma", "status": "RECRUITING", "start": "2025-11-05", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Princess Maxima Center for Pediatric Oncology", "countries": ["Netherlands"]}, {"nct": "NCT06995872", "title": "Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma", "status": "RECRUITING", "start": "2025-10-21", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["United States"]}, {"nct": "NCT06798532", "title": "Interest of Preoperative Arteriography to Identify the Adamkiewicz Artery Before Surgery for Basi-thoracic Neuroblastic Tumors", "status": "NOT_YET_RECRUITING", "start": "2025-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT06942039", "title": "Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation", "status": "RECRUITING", "start": "2025-09-23", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "C17 Council", "countries": ["Canada"]}, {"nct": "NCT06814496", "title": "Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors", "status": "RECRUITING", "start": "2025-09-08", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University of Arizona", "countries": ["United States"]}, {"nct": "NCT07087002", "title": "GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults", "status": "RECRUITING", "start": "2025-08-28", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Stanford University", "countries": ["United States"]}, {"nct": "NCT06479811", "title": "[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers", "status": "RECRUITING", "start": "2025-08-19", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["United States"]}]}, {"batch": 2, "no": 54, "name_zh": "神经纤维瘤病", "query_terms": [{"term": "Neurofibromatosis/schwannomatosis", "broad": false}, {"term": "Neurofibromatosis", "broad": true}], "n_total": 21, "n_open": 8, "n_open_precise": 3, "n_broad": 17, "trials": [{"nct": "NCT07707947", "title": "Selumetinib for NF2-Related Schwannomatosis", "status": "NOT_YET_RECRUITING", "start": "2026-07-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Beijing Tiantan Hospital", "conditions": ["Neurofibromatosis Type 2", "NF2", "NF2-related Schwannomatosis", "Meningioma", "Ependymoma", "Vestibular Schwannoma"], "cn_sites": [{"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07713745", "title": "Platform Research for Innovative Medicines in NF2-SWN (PRIME-NF2)", "status": "NOT_YET_RECRUITING", "start": "2026-07-18", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 200, "sponsor": "Beijing Tiantan Hospital", "conditions": ["Neurofibromatosis Type 2", "Vestibular Schwannoma", "Non-vestibular Schwannoma", "Meningioma", "Ependymoma", "NF2-related Schwannomatosis", "NF2"], "cn_sites": [{"facility": "Xuanwu Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Shanghai General Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT07708285", "title": "Luvometinib in Combination With Serplulimab for NF2-Related Tumors", "status": "NOT_YET_RECRUITING", "start": "2026-07-31", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Beijing Tiantan Hospital", "conditions": ["NF2-related Schwannomatosis", "NF2", "Neurofibromatosis Type 2", "Vestibular Schwannoma", "Meningioma"], "cn_sites": [{"facility": "Xuanwu Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Shanghai General Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT04085159", "title": "Immunotherapy Based on Antigen-specific Immune Effector Cells Targeting Neurofibromatosis or Schwannomatosis", "status": "TERMINATED", "start": "2026-06-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": ["Cancer"], "cn_sites": [{"facility": "Shenzhen Geno-immune Medical Institute", "city": "Shenzhen", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05331105", "title": "HL-085 in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas", "status": "RECRUITING", "start": "2021-10-18", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 70, "sponsor": "Shanghai Kechow Pharma, Inc.", "conditions": ["Neurofibromatosis 1", "Plexiform Neurofibromas"], "cn_sites": [{"facility": "Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06763315", "title": "Low-dose Selumetinib for the Treatment of Plexiform Neurofibromas in Chinese Children", "status": "NOT_YET_RECRUITING", "start": "2025-01-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "West China Hospital", "conditions": ["Plexiform Neurofibromas (PN)"], "cn_sites": [{"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06834438", "title": "Gene Therapy for Neurofibromatosis Type 2 (NF2) with ST002", "status": "NOT_YET_RECRUITING", "start": "2025-02-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Cancer Institute and Hospital, Chinese Academy of Medical Sciences", "conditions": ["NF2 Deficiency"], "cn_sites": [{"facility": "Shuhang Wang", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07024394", "title": "Follow-up Study to Evaluate the Safety and Efficacy of FCN-159 in Pediatric Participants With Neurofibromatosis Type 1", "status": "NOT_YET_RECRUITING", "start": "2025-06-12", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 65, "sponsor": "Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.", "conditions": ["Neurofibromatosis 1", "Plexiform Neurofibroma", "NF1"], "cn_sites": [{"facility": "Shanghai Ninth People's Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07407803", "title": "Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform Neurofibromas", "status": "RECRUITING", "start": "2026-03-31", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 177, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Plexiform Neurofibroma"], "cn_sites": [{"facility": "The First Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": "NOT_YET_RECRUITING"}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Xuanwu Hospital Capital Medical University", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Beijing Tiantan Hospital, Capital Medical University", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Peking University Third Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "The Southwest Hospital of Amu", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Fujan Medical University", "city": "Fuzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Gansu Provincial Cancer Hospital", "city": "Lanzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Sun Yat-Sen University Cancer Center", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Dermatology Hospital of Southern Medical University (Guangdong Provincial Dermatology Hospital / Guangdong Center for the Prevention and Control of Sexually Transmitted Diseases and Leprosy", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Guangxi Medical University Cancer Hospital （ Guangxi Cancer InstituteGuangxi Cancer Hospital & Medical University Oncology School & Cancer Center）", "city": "Nanning", "status": "NOT_YET_RECRUITING"}, {"facility": "Guizhou Provincial People's Hospital", "city": "Guiyang", "status": "NOT_YET_RECRUITING"}, {"facility": "The second hospital of Hebei medical university", "city": "Shijiazhuang", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Affiliated Hospital of Henan University of Science and Technology", "city": "Luoyang", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital Of Zhengzhou University", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Renmin Hospital of Wuhan University(Hubei General Hospital)", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}, {"facility": "Hunan Children's Hospital", "city": "Changsha", "status": "NOT_YET_RECRUITING"}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of China Medical University", "city": "Shenyang", "status": "NOT_YET_RECRUITING"}, {"facility": "Xijing hospital", "city": "Xi'an", "status": "NOT_YET_RECRUITING"}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": "NOT_YET_RECRUITING"}, {"facility": "Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}, {"facility": "Shanxi Cancer Hospital", "city": "Taiyuan", "status": "RECRUITING"}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Sichuan Academy of Medical Science&Sichuan Provincial People' Hospital", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}, {"facility": "Tianjin Medical University Cancer Institute & Hospital", "city": "Tianjin", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital Of Kunming Medical University", "city": "Kunming", "status": "NOT_YET_RECRUITING"}, {"facility": "Zhejiang Provincial People'S Hospital", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 28, "broad_only": true}, {"nct": "NCT07327164", "title": "Precision Medicine for Neurocutaneous Syndromes in Western China", "status": "COMPLETED", "start": "2000-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1200, "sponsor": "West China Hospital", "conditions": ["Neurocutaneous Syndromes", "Neurofibromatosis Type 1 (NF1)", "Tuberous Sclerosis Complex (TSC)", "Sturge-Weber Syndrome (SWS)", "Von Hippel-Lindau Disease"], "cn_sites": [{"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT02104323", "title": "Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors", "status": "COMPLETED", "start": "2014-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Beijing Tiantan Hospital", "conditions": ["Vestibular Schwannoma", "Neurofibromatosis Type 2"], "cn_sites": [{"facility": "Beijing Tiantan Hospital Affiliated to Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT02934256", "title": "Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors", "status": "COMPLETED", "start": "2016-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Li Peng", "conditions": ["Vestibular Schwannoma", "Neurofibromatosis Type 2"], "cn_sites": [{"facility": "Beijing Tiantan Hospital Affiliated to Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06379230", "title": "A Retrospective Study on Epidemiological Characteristics of Chinese NF1 Patients in Real World (PROMISE)", "status": "UNKNOWN", "start": "2019-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2000, "sponsor": "Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University", "conditions": ["Neurofibromatosis 1", "Plexiform Neurofibroma"], "cn_sites": [{"facility": "Xuanwu Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": "RECRUITING"}], "cn_site_count": 5, "broad_only": true}, {"nct": "NCT03932253", "title": "MEK Inhibitor FCN-159 To Treat Advanced Melanoma With NRAS-aberrant (Ia) and NRAS-mutant (Ib)or NF1-mutant(1b)", "status": "SUSPENDED", "start": "2019-03-21", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 79, "sponsor": "Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.", "conditions": ["Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04590235", "title": "A Study of Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)", "status": "ACTIVE_NOT_RECRUITING", "start": "2020-12-16", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 32, "sponsor": "AstraZeneca", "conditions": ["Neurofibromatosis 1", "Neurofibroma Plexiform"], "cn_sites": [{"facility": "Research Site", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04954001", "title": "Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis Type 1", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-03-26", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 160, "sponsor": "Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.", "conditions": ["Neurofibromatosis 1", "Plexiform Neurofibroma", "NF1"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Guangzhou", "status": ""}, {"facility": "Research Site", "city": "Hangzhou", "status": ""}, {"facility": "Research Site", "city": "Shanghai", "status": ""}, {"facility": "Research Site", "city": "Shijiazhuang", "status": ""}, {"facility": "Research Site", "city": "Wuhan", "status": ""}], "cn_site_count": 6, "broad_only": true}, {"nct": "NCT05011019", "title": "A Clinical Trial to Evaluate the Safety and Efficacy of AL2846 Capsules in Chinese Patients With Type I Neurofibromatosis", "status": "TERMINATED", "start": "2021-09-07", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 22, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Neurofibromatosis and Malignant Peripheral Nerve Sheath Tumors"], "cn_sites": [{"facility": "Shanghai Ninth People's Hospital, School of Medicine, Shanghai JiaoTong University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT05107037", "title": "A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of TQ-B3234 in Patients With Type I Neurofibromatosis", "status": "UNKNOWN", "start": "2021-11", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Type I Neurofibromatosis"], "cn_sites": [{"facility": "Shanghai Ninth People's Hospital ，Shanghai JiaoTong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT04924608", "title": "Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-11-19", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 145, "sponsor": "AstraZeneca", "conditions": ["Neurofibromatosis 1", "Plexiform Neurofibroma (PN)"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Guangzhou", "status": ""}, {"facility": "Research Site", "city": "Shenyang", "status": ""}], "cn_site_count": 3, "broad_only": true}, {"nct": "NCT05913037", "title": "FCN-159 in Adult Patients With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-06-20", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 167, "sponsor": "Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.", "conditions": ["Neurofibromatosis 1", "Plexiform Neurofibroma", "NF1"], "cn_sites": [{"facility": "Cancer Hospital Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "Chinese Academy of Medical Sciences & Peking Union Medical College", "city": "Beijing", "status": ""}, {"facility": "Plastic Surgery Hospital,Chinese Academy of Medical Sciences", "city": "Beijing", "status": ""}, {"facility": "Nanfang Hospital, Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": ""}, {"facility": "Peking University Shenzhen Hospital", "city": "Shenzhen", "status": ""}, {"facility": "The Fourth Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "The Second Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "Renmin Hospital of Wuhan University", "city": "Wuhan", "status": ""}, {"facility": "TongJi Hospital，TongJi Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "The First Hospial of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "Fudan University Shanghai Cancer center", "city": "Shanghai", "status": ""}, {"facility": "West China Hospital，Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Hangzhou First People's Hospital", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Provincial People'S Hospital", "city": "Hanzhou", "status": ""}], "cn_site_count": 15, "broad_only": true}, {"nct": "NCT06175637", "title": "Observational Study to Evaluate the Effect and Safety of Selumetinib in Pediatric Patients With NF1-PNs", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-12-20", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 409, "sponsor": "AstraZeneca", "conditions": ["Neurofibroma, Plexiform"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Chongqing", "status": ""}, {"facility": "Research Site", "city": "Lanzhou", "status": ""}, {"facility": "Research Site", "city": "Guangzhou", "status": ""}, {"facility": "Research Site", "city": "Shenzhen", "status": ""}, {"facility": "Research Site", "city": "Nanning", "status": ""}, {"facility": "Research Site", "city": "Guiyang", "status": ""}, {"facility": "Research Site", "city": "Shijiazhuang", "status": ""}, {"facility": "Research Site", "city": "Zhengzhou", "status": ""}, {"facility": "Research Site", "city": "Wuhan", "status": ""}, {"facility": "Research Site", "city": "Changsha", "status": ""}, {"facility": "Research Site", "city": "Nanjing", "status": ""}, {"facility": "Research Site", "city": "Suzhou", "status": ""}, {"facility": "Research Site", "city": "Nanchang", "status": ""}, {"facility": "Research Site", "city": "Shenyang", "status": ""}, {"facility": "Research Site", "city": "Jinan", "status": ""}, {"facility": "Research Site", "city": "Shanghai", "status": ""}, {"facility": "Research Site", "city": "Taiyuan", "status": ""}, {"facility": "Research Site", "city": "Xi’an", "status": ""}, {"facility": "Research Site", "city": "Chengdu", "status": ""}, {"facility": "Research Site", "city": "Tianjin", "status": ""}, {"facility": "Research Site", "city": "Kunming", "status": ""}, {"facility": "Research Site", "city": "Hangzhou", "status": ""}, {"facility": "Research Site", "city": "Wenzhou", "status": ""}], "cn_site_count": 24, "broad_only": true}], "g_total": 6, "g_fetched": 3, "g_countries": [["United States", 2], ["United Kingdom", 1]], "g_trials": [{"nct": "NCT07818213", "title": "How Can the Experience of Hospital Outpatient Departments be Improved?", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "King's College London", "countries": ["United Kingdom"]}, {"nct": "NCT04374305", "title": "Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)", "status": "RECRUITING", "start": "2020-06-20", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Scott R. Plotkin, MD, PhD", "countries": ["United States"]}, {"nct": "NCT01885767", "title": "Neurofibromatosis (NF) Registry Portal", "status": "RECRUITING", "start": "2012-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "The Children's Tumor Foundation", "countries": ["United States"]}]}, {"batch": 2, "no": 55, "name_zh": "神经元蜡样脂褐质沉积症", "query_terms": [{"term": "Neuronal ceroid lipofuscinosis", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 13, "g_fetched": 13, "g_countries": [["United States", 9], ["Germany", 2], ["Jordan", 1], ["Italy", 1], ["United Kingdom", 1], ["Australia", 1]], "g_trials": [{"nct": "NCT07582484", "title": "Gene Therapy Trial for CLN6 Batten Disease", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "The Charlotte and Gwenyth Gray Foundation", "countries": ["United States"]}, {"nct": "NCT07178288", "title": "Assessment of Pressure Pain Threshold (PPT) and Conditioned Pain Modulation (CPM) After Effect in Patients With and Without Tennis Elbow (TE)", "status": "RECRUITING", "start": "2025-09-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "The Hashemite University", "countries": ["Jordan"]}, {"nct": "NCT06844877", "title": "Italian NCL Registry: a Registry for NCL as an Integration Tool for Future Therapeutic Strategies", "status": "RECRUITING", "start": "2024-07-19", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS Fondazione Stella Maris", "countries": ["Italy"]}, {"nct": "NCT05791864", "title": "A First-in-Human, Open-Label, Dose-Escalation Study to Evaluate the Safety and Tolerability of Gene Therapy With TTX-381 for the Ocular Manifestations Associated With Neuronal Ceroid Lipofuscinosis Type 2 (CLN2) Disease", "status": "RECRUITING", "start": "2023-05-17", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Tern Therapeutics, LLC", "countries": ["Germany", "United Kingdom"]}, {"nct": "NCT06203106", "title": "NYSCF Scientific Discovery Biobank", "status": "RECRUITING", "start": "2022-11-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "New York Stem Cell Foundation Research Institute", "countries": ["United States"]}, {"nct": "NCT05007990", "title": "Caregiving Networks Across Disease Context and the Life Course", "status": "RECRUITING", "start": "2022-09-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Human Genome Research Institute (NHGRI)", "countries": ["United States"]}, {"nct": "NCT04613089", "title": "Natural History and Longitudinal Clinical Assessments in NCL / Batten Disease, the International DEM-CHILD Database", "status": "RECRUITING", "start": "2020-04-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Universitätsklinikum Hamburg-Eppendorf", "countries": ["Germany"]}, {"nct": "NCT03307304", "title": "Investigations of Juvenile Neuronal Ceroid Lipofuscinosis", "status": "RECRUITING", "start": "2017-11-27", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)", "countries": ["United States"]}, {"nct": "NCT02254863", "title": "UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells", "status": "RECRUITING", "start": "2014-09", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Joanne Kurtzberg, MD", "countries": ["United States"]}, {"nct": "NCT02435940", "title": "Inherited Retinal Degenerative Disease Registry", "status": "RECRUITING", "start": "2014-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Foundation Fighting Blindness", "countries": ["United States"]}, {"nct": "NCT03333200", "title": "Longitudinal Study of Neurodegenerative Disorders", "status": "RECRUITING", "start": "2012-01-11", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Pittsburgh", "countries": ["United States"]}, {"nct": "NCT01793168", "title": "Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford", "status": "RECRUITING", "start": "2010-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sanford Health", "countries": ["Australia", "United States"]}, {"nct": "NCT01873924", "title": "Clinical and Neuropsychological Investigations in Batten Disease", "status": "RECRUITING", "start": "2004-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Rochester", "countries": ["United States"]}]}, {"batch": 2, "no": 56, "name_zh": "神经营养性角膜炎", "query_terms": [{"term": "Neurotrophic keratopathy", "broad": false}, {"term": "Neurotrophic keratitis", "broad": false}], "n_total": 3, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT06975748", "title": "A Phase II Study of STSP-0902 Ophthalmic Solution in Patients With Neurotrophic Keratitis", "status": "RECRUITING", "start": "2025-06-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 48, "sponsor": "Staidson (Beijing) Biopharmaceuticals Co., Ltd", "conditions": ["Neurotrophic Keratitis"], "cn_sites": [{"facility": "Shandong First Medical University Affiliated Eye Hospital", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07120308", "title": "To Evaluate the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects Caused by Neurotrophic Keratitis", "status": "COMPLETED", "start": "2021-09-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 28, "sponsor": "Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.", "conditions": ["Corneal Epithelial Defect"], "cn_sites": [{"facility": "Xiamen Eye Center of Xiamen University", "city": "Xiamen", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06597422", "title": "A Study of STSP-0902 Ophthalmic Solution in Healthy Subjects", "status": "COMPLETED", "start": "2024-10-20", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 82, "sponsor": "Staidson (Beijing) Biopharmaceuticals Co., Ltd", "conditions": ["Neurotrophic Keratitis"], "cn_sites": [{"facility": "Beijing Tongren Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 14, "g_fetched": 13, "g_countries": [["United States", 10], ["Italy", 3], ["Mexico", 2], ["Poland", 2], ["Spain", 2], ["Argentina", 1], ["Czechia", 1], ["France", 1], ["Germany", 1], ["Hungary", 1], ["Japan", 1], ["Netherlands", 1], ["South Korea", 1], ["United Kingdom", 1], ["Canada", 1]], "g_trials": [{"nct": "NCT07694817", "title": "Clinical Predictors of Visual Outcome in Patients Affected With Ocular Surface Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS San Raffaele", "countries": ["Italy"]}, {"nct": "NCT07519902", "title": "An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED", "status": "RECRUITING", "start": "2026-06-02", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Dompé Farmaceutici S.p.A", "countries": ["Argentina", "Czechia", "France", "Germany", "Hungary", "Italy", "Japan", "Mexico", "Netherlands", "Poland", "South Korea", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT07502378", "title": "Effect of Acoltremon Ophthalmic Solution 0.003% on Signs and Symptoms of Ocular Surface Disease in Stage I Neurotrophic Keratopathy Patients With Tear Deficiency", "status": "RECRUITING", "start": "2026-04-06", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "University of South Florida", "countries": ["United States"]}, {"nct": "NCT07566975", "title": "Real-World Assessment of VEVYE® for Short-Term Symptom and Sign Improvement of Dry Eye Disease in a Neuro-Ophthalmology Clinic: A 6-Month Prospective Observational Study", "status": "RECRUITING", "start": "2026-03-31", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Neuro-Ophthalmology of Texas", "countries": ["United States"]}, {"nct": "NCT07568730", "title": "A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep in Subjects With Neurotrophic Keratitis", "status": "RECRUITING", "start": "2026-02-19", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "TearSolutions, Inc.", "countries": ["United States"]}, {"nct": "NCT06919081", "title": "Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease", "status": "RECRUITING", "start": "2025-08-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University of Illinois at Chicago", "countries": ["United States"]}, {"nct": "NCT07073729", "title": "Corneal Neurotization vs. Cenergermin for Neurotrophic Keratitis: A Pilot Study", "status": "NOT_YET_RECRUITING", "start": "2025-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's", "countries": ["Canada"]}, {"nct": "NCT06999733", "title": "A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis", "status": "RECRUITING", "start": "2025-07-07", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Krystal Biotech, Inc.", "countries": ["United States"]}, {"nct": "NCT06964269", "title": "Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease", "status": "RECRUITING", "start": "2025-02-11", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Toyos Clinic", "countries": ["United States"]}, {"nct": "NCT05927428", "title": "Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis", "status": "RECRUITING", "start": "2024-07-31", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "BRIM Biotechnology Inc.", "countries": ["United States"]}, {"nct": "NCT05555589", "title": "Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2", "status": "RECRUITING", "start": "2023-04-11", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "ReGenTree, LLC", "countries": ["Italy", "Poland", "Spain", "United States"]}, {"nct": "NCT04700657", "title": "The Prevalence of Hypoesthesia Related Keratitis in Ocular Graft Vs. Host Disease (GVHD) Patients", "status": "RECRUITING", "start": "2020-12-17", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Indiana University", "countries": ["United States"]}, {"nct": "NCT04604834", "title": "Autologous Platelet-rich Plasma (APRP) in the Treatment of Neurotrophic Keratopathy", "status": "RECRUITING", "start": "2020-11-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Universidad Autonoma de Nuevo Leon", "countries": ["Mexico"]}]}, {"batch": 2, "no": 57, "name_zh": "骨肉瘤", "query_terms": [{"term": "Osteosarcoma", "broad": false}, {"term": "Bone sarcoma", "broad": false}], "n_total": 96, "n_open": 36, "n_open_precise": 36, "n_broad": 0, "trials": [{"nct": "NCT04072042", "title": "BIOmarker Driven Trial of VEGFR2 Inhibitor in Advanced or Metastatic Sarcoma", "status": "RECRUITING", "start": "2019-10-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Ruijin Hospital", "conditions": ["Sarcoma"], "cn_sites": [{"facility": "Ruijin Hospital Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04589741", "title": "Toripalimab Combined With CAV/IE Regimen", "status": "RECRUITING", "start": "2020-10-23", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 134, "sponsor": "Sun Yat-sen University", "conditions": ["Soft Tissue Sarcoma"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05590572", "title": "A Study of Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma", "status": "NOT_YET_RECRUITING", "start": "2023-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 148, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Osteosarcoma"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": ""}, {"facility": "Ruijin Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Department of Orthopaedic Surgery, Sixth People's Hospital, Shanghai Jiao Tong University,", "city": "Shanghai", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT05617859", "title": "Lenvatinib for Advanced Bone and Soft Tissue Sarcoma", "status": "RECRUITING", "start": "2023-04-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Henan Cancer Hospital", "conditions": ["Effectiveness", "Sexuality"], "cn_sites": [{"facility": "Department of Bone and Soft Tissue ,Henan Cancer Hospital", "city": "Zhengzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06074692", "title": "PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA)", "status": "RECRUITING", "start": "2023-06-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 86, "sponsor": "Ruijin Hospital", "conditions": ["Sarcoma", "Sarcoma,Soft Tissue", "Sarcoma of Bone"], "cn_sites": [{"facility": "Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06114225", "title": "Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical Trial", "status": "RECRUITING", "start": "2023-06-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 43, "sponsor": "Ruijin Hospital", "conditions": ["Osteosarcoma"], "cn_sites": [{"facility": "Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05830123", "title": "ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas", "status": "RECRUITING", "start": "2023-06-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 170, "sponsor": "Hansoh BioMedical R&D Company", "conditions": ["Osteosarcoma", "Sarcoma"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Hunan Cancer Hospital", "city": "Changsha", "status": "RECRUITING"}, {"facility": "First Affiliated Hospital, Sun Yat-Sen University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Second Affiliated Hospital, School of Medicine, Zhejiang University", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Chinese PLA General Hospital of Eastern Theater Command", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Shanghai 6th People's Hospital", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Shanghai General Hospital", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Tianjin Cancer Hospital", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "RECRUITING"}], "cn_site_count": 11, "broad_only": false}, {"nct": "NCT06126510", "title": "Clinical Study of VG161 in the Treatment of Advanced Bone and Soft Tissue Sarcoma", "status": "RECRUITING", "start": "2023-07-18", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "CNBG-Virogin Biotech (Shanghai) Ltd.", "conditions": ["Sarcoma"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06041490", "title": "Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation", "status": "NOT_YET_RECRUITING", "start": "2023-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 88, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Liver Transplant; Complications", "Hepatocarcinoma", "Recurrent Osteosarcoma", "High-Risk Cancer"], "cn_sites": [{"facility": "Chinese Academy of Medical Sciences & Peking Union Medical College Hospital (CAMS&PUMCH)", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06778603", "title": "B7-H3 NIR Imaging for Osteosarcoma Surgery", "status": "RECRUITING", "start": "2024-01-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 32, "sponsor": "Peking University People's Hospital", "conditions": ["Osteosarcoma", "Resection Margins", "B7-H3 Probe", "Local Recurrence"], "cn_sites": [{"facility": "Musculoskeletal Tumor Center", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06111612", "title": "Intensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvement", "status": "RECRUITING", "start": "2024-01-20", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 50, "sponsor": "Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": ["Acute Myeloid Leukemia", "Myelodysplastic Neoplasm", "Chronic Myelomonocytic Leukemia", "Myeloid Sarcoma", "Extramedullary Myeloid Tumor"], "cn_sites": [{"facility": "Shanghai General Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06340204", "title": "Weekly Irinotecan Liposomes in Recurrent or Refractory Ewing Sarcoma", "status": "RECRUITING", "start": "2024-03-25", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 44, "sponsor": "Peking University People's Hospital", "conditions": ["Ewing Sarcoma"], "cn_sites": [{"facility": "Shandong Cancer Hospital and Institute", "city": "Jina", "status": "NOT_YET_RECRUITING"}, {"facility": "Peking University People's Hospital", "city": "Beijin", "status": "RECRUITING"}, {"facility": "Peking University Shougang Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT06637007", "title": "Phase II Clinical Trial of Chidamide Combined With AK112 for Second-line and Advanced Bone and Soft Tissue Sarcoma", "status": "RECRUITING", "start": "2024-08-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Shanxi Province Cancer Hospital", "conditions": ["Sarcoma,Soft Tissue", "Sarcoma", "Sarcoma of Bone"], "cn_sites": [{"facility": "Shanxi Cancer Hospital", "city": "Taiyuan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06550765", "title": "Safety and Efficacy of Degradable Magnesium Metal Clips in Surgical Margins of Radical Surgery for Malignant Bone and Soft Tissue Tumors", "status": "NOT_YET_RECRUITING", "start": "2024-08-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 98, "sponsor": "Guangdong Provincial People's Hospital", "conditions": ["Sarcoma, Soft Tissue", "Sarcoma, Spindle Cell"], "cn_sites": [{"facility": "Guangdong provincial people's hospital", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07648069", "title": "Tumor Neoantigen Vaccine SarVac Combined With Tumor Specific Lymphocyte Reinfusion in the Treatment of Advanced Sarcoma", "status": "RECRUITING", "start": "2024-09-03", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 16, "sponsor": "Sun Yat-sen University", "conditions": ["Soft Tissue Sarcoma (STS)", "Osteosarcoma"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06564272", "title": "A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma", "status": "RECRUITING", "start": "2024-09-27", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Beijing Konruns Pharmaceutical Co., Ltd.", "conditions": ["Ewing Sarcoma"], "cn_sites": [{"facility": "Beijing Children's Hospital Affiliated to Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06699472", "title": "A Prospective, Randomized, Controlled Clinical Study on the Prevention of Chemotherapy Related Myelosuppression in Patients with Ewing's Sarcoma Using Trilaciclib", "status": "RECRUITING", "start": "2024-10-31", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 22, "sponsor": "Fudan University", "conditions": ["Ewing Sarcoma", "Myelosuppression"], "cn_sites": [{"facility": "Fudan University Shanghai Cencer Center,", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06714383", "title": "Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of Osteosarcoma", "status": "RECRUITING", "start": "2024-11-13", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Peking University People's Hospital", "conditions": ["Osteosarcoma"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07602049", "title": "Cryoablation Plus Camrelizumab for Advanced Soft Tissue Sarcoma", "status": "RECRUITING", "start": "2024-11-20", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 57, "sponsor": "Sun Yat-sen University", "conditions": ["Soft Tissue Sarcoma (STS)", "Osteosarcoma"], "cn_sites": [{"facility": "Sun Yat-Sen Univerisity", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06836765", "title": "The Relationship Between The Differential Expression Of FosB Protein In Laryngeal Cancer Tissues And Clinical Prognosis", "status": "NOT_YET_RECRUITING", "start": "2025-04-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Yang ji", "conditions": ["Laryngeal Carcinoma"], "cn_sites": [{"facility": "Cllinical Laboratory of Chuanbei Medical College", "city": "Nanchong", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06827717", "title": "Phase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma", "status": "RECRUITING", "start": "2025-04-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 29, "sponsor": "Sun Yat-sen University", "conditions": ["Ewing Sarcoma"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06926283", "title": "A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors", "status": "RECRUITING", "start": "2025-05-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 110, "sponsor": "Hangzhou DAC Biotechnology Co., Ltd.", "conditions": ["Prostate Cancer", "Other Solid Tumors", "Ewing Sarcoma"], "cn_sites": [{"facility": "Hunan Cancer Hospital", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Zhejiang Provincial People's Hospital", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT07066982", "title": "Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas", "status": "RECRUITING", "start": "2025-05-29", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Essen Biotech", "conditions": ["Sarcoma", "Sarcoma, Kaposi", "Sarcoma, Ewing", "Sarcoma,Soft Tissue", "Sarcoma of Bone and Connective Tissue", "Sarcoma, Synovial", "Sarcoma Metastatic", "Sarcomas, Germinoblastic", "Sarcoma of Bone"], "cn_sites": [{"facility": "District One Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07142863", "title": "Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable Osteosarcoma Patients", "status": "NOT_YET_RECRUITING", "start": "2025-08-25", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 23, "sponsor": "Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": ["Osteosarcoma", "Neoadjuvant Therapy", "Neoadjuvant Chemotherapy", "PD-L1 Antibody", "Envafolimab"], "cn_sites": [{"facility": "Shanghai First People's Hospital, 100 Haining Road, Hongkou District", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07725783", "title": "Prospective Evaluation of Dynamic Serum ProGRP for Treatment Response Monitoring in Ewing Sarcoma", "status": "RECRUITING", "start": "2025-09-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Peking University People's Hospital", "conditions": ["Ewing Sarcoma"], "cn_sites": [{"facility": "Peking University People's Hospital, Beijing, Beijing 100044", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06939855", "title": "QL1706 in the Treatment of Advanced Bone and Soft Tissue Sarcoma", "status": "RECRUITING", "start": "2025-09-28", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 45, "sponsor": "Sun Yat-sen University", "conditions": ["Bone and Soft Tissue Tumors"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07052383", "title": "Safety and Efficacy of DIT309 in Advanced Bone and Soft Tissue Sarcomas", "status": "RECRUITING", "start": "2025-11-06", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Tcelltech Inc.", "conditions": ["Osteosarcoma", "Soft Tissue Sarcoma"], "cn_sites": [{"facility": "Shanghai General Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07596693", "title": "KXV01 Injection in Patients With Advanced Solid Tumor (Including Osteosarcoma and Sarcoma)", "status": "RECRUITING", "start": "2025-12-19", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "TCRx Therapeutics Co.Ltd", "conditions": ["Advanced Solid Tumors"], "cn_sites": [{"facility": "Shanghai Sixth People's Hospital Affiliated to Shanghai Jiaotong University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07359053", "title": "MAGNATE-S: Paclitaxel Polymer Micelles Combo in Advanced Sarcoma", "status": "RECRUITING", "start": "2025-12-25", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 46, "sponsor": "Shanghai 6th People's Hospital", "conditions": ["Sarcoma"], "cn_sites": [{"facility": "Shanghai Sixth Peolple'S Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07479732", "title": "Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma", "status": "RECRUITING", "start": "2026-03-05", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 56, "sponsor": "Peking University People's Hospital", "conditions": ["Osteosarcoma", "Osteosarcoma Metastatic"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07774533", "title": "68Ga-B7-H3 Nanobody ImmunoPET in Osteosarcoma", "status": "RECRUITING", "start": "2026-04-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 16, "sponsor": "Peking University First Hospital", "conditions": ["Osteosarcoma", "Osteosarcoma, Recurrent, Refractory"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07620431", "title": "Neoadjuvant Radiotherapy and Surgery for High-Risk Localized Ewing Sarcoma", "status": "NOT_YET_RECRUITING", "start": "2026-06-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 55, "sponsor": "Peking University People's Hospital", "conditions": ["Ewing Sarcoma", "Bone Neoplasms"], "cn_sites": [{"facility": "Peking University People's Hospital, Beijing, Beijing 100044", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07669155", "title": "Acute Normovolemic Hemodilution in Bone Cancer Surgery", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 420, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Acute Normovolemic Hemodilution"], "cn_sites": [{"facility": "The Second Affiliated Hospital of Zhejiang University anesthesiology department", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07669103", "title": "Bone Cancer Surgery Prospective Database", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 400, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Bone Cancer Surgery"], "cn_sites": [{"facility": "The Second Affiliated Hospital of Zhejiang University anesthesiology department", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03356782", "title": "Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas", "status": "NOT_YET_RECRUITING", "start": "2027-06-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": ["Sarcoma", "Osteoid Sarcoma", "Ewing Sarcoma"], "cn_sites": [{"facility": "Shenzhen Geno-immune Medical Institute", "city": "Shenzhen", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04433221", "title": "Combination Immunotherapy Targeting Sarcomas", "status": "NOT_YET_RECRUITING", "start": "2027-07-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": ["Sarcoma", "Osteoid Sarcoma", "Ewing Sarcoma"], "cn_sites": [{"facility": "Shenzhen Geno-Immune Medical Institute", "city": "Shenzhen", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06162962", "title": "Oncological and Functional Outcomes in Lower Limb Osteosarcoma Pediatric Patient", "status": "COMPLETED", "start": "2000-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 345, "sponsor": "Changye Zou", "conditions": ["Osteosarcoma", "Pediatric", "Lower Limb Injury", "Outcome"], "cn_sites": [{"facility": "Changye Zou", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00568464", "title": "Study on VCD/IE in the Patients With Ewing's Sarcoma Family of Tumors (ESFT)", "status": "TERMINATED", "start": "2007-03", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Fudan University", "conditions": ["Ewing's Sarcoma"], "cn_sites": [{"facility": "Fudan University Cancer Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01002092", "title": "A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma", "status": "UNKNOWN", "start": "2009-02", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 160, "sponsor": "Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd", "conditions": ["Osteosarcoma"], "cn_sites": [{"facility": "Nanjing General Hospital of Nanjing Military Command", "city": "Nanjing", "status": ""}, {"facility": "General Hospital of Jinan Military Command", "city": "Jinan", "status": ""}, {"facility": "Xijing Hospital", "city": "Xi’an", "status": ""}, {"facility": "The Military General Hospital of Beijing PLA", "city": "Beijing", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT01669369", "title": "Clinical Trial of Lithium Carbonate Combined With Neo-adjuvant Chemotherapy to Treat Osteosarcoma", "status": "UNKNOWN", "start": "2013-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 400, "sponsor": "Sun Yat-sen University", "conditions": ["Osteosarcoma"], "cn_sites": [{"facility": "The first affiliated hospital,Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03491371", "title": "Apatinib for Advanced Sarcoma: Results From Multiple Institutions' Off-label Use", "status": "COMPLETED", "start": "2015-06-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 56, "sponsor": "Peking University People's Hospital", "conditions": ["Efficacy", "Toxicity"], "cn_sites": [{"facility": "Musculoskeletal Tumor Center of Peking University People's Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University Shougang Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05794594", "title": "3D Printed Personalized Extendable Prosthesis", "status": "COMPLETED", "start": "2015-10-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 25, "sponsor": "Yuxi Su", "conditions": ["Osteosarcoma in Children"], "cn_sites": [{"facility": "Children's Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02711007", "title": "Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy", "status": "COMPLETED", "start": "2016-03", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 37, "sponsor": "GUO WEI", "conditions": ["Osteosarcoma", "Metastasis"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02650401", "title": "Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options", "status": "ACTIVE_NOT_RECRUITING", "start": "2016-05-03", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 69, "sponsor": "Hoffmann-La Roche", "conditions": ["Solid Tumors", "CNS Tumors"], "cn_sites": [{"facility": "Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT03932071", "title": "Zoledronic Acid in Decrease the Lung Metastatic Rate of Osteosarcoma", "status": "UNKNOWN", "start": "2017-01-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 150, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Lung Metastases", "Tumor Necrosis"], "cn_sites": [{"facility": "2nd Affiliated Hospital of Zhejiang University", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03163381", "title": "Apatinib Second Line Treatment for Advanced Osteosarcoma and Soft Tissue Sarcomas ,Openting ,Single Center, One-armed Clinical Study.", "status": "UNKNOWN", "start": "2017-04-11", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Henan Cancer Hospital", "conditions": ["Osteosarcoma, Advanced"], "cn_sites": [{"facility": "Henan cancer hospital", "city": "Zhengzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03108677", "title": "Circulating Exosome RNA in Lung Metastases of Primary High-Grade Osteosarcoma", "status": "UNKNOWN", "start": "2017-05-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 90, "sponsor": "Ruijin Hospital", "conditions": ["Lung Metastases", "Osteosarcoma"], "cn_sites": [{"facility": "Ruijin Hospital Shanghai Jiao Tong University School of medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03742063", "title": "Clinical Evaluation of Neoadjuvant Chemotherapy for Primary Malignant Sarcomas That Originate in Bone", "status": "COMPLETED", "start": "2017-06-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 190, "sponsor": "Peking University People's Hospital", "conditions": ["Clinical Response", "Histopathological Response", "Prognosis"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University Shougang Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT03336554", "title": "Epigenetic Biomarker for Osteosarcoma", "status": "UNKNOWN", "start": "2017-09-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Peking University People's Hospital", "conditions": ["Histologic Response (Tumor Necrosis Rate)", "Objective Response Rate for Neoadjuvant Chemotherapy, ORR", "Progression-free Survival, PFS", "Overall Survival, OS"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03358992", "title": "Clinical Evaluation for Sarcoma Originated From Bone", "status": "UNKNOWN", "start": "2018-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 300, "sponsor": "Peking University People's Hospital", "conditions": ["Sensitivity", "Specificity", "Histological Response", "Survival"], "cn_sites": [{"facility": "The second affliated Hospital of Zhejiang University School of medicine", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Musculoskeletal Tumor Center of Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Xijing Hospital", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT03359018", "title": "Apatinib Plus Anti-PD1 Therapy for Advanced Osteosarcoma", "status": "COMPLETED", "start": "2018-01-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 43, "sponsor": "Peking University People's Hospital", "conditions": ["Progression-free Survival", "Overall Survival", "Clinical Benefit Rate", "Toxicity"], "cn_sites": [{"facility": "Musculoskeletal Tumor Center of Peking University People's Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University Shougang Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT03416517", "title": "Anlotinib and Irinotecan for Ewing Sarcoma", "status": "UNKNOWN", "start": "2018-01-22", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 47, "sponsor": "Peking University People's Hospital", "conditions": ["Ewing's Tumor Metastatic"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking University Shougang Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking University Third Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "People's Liberation Army General Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT03359005", "title": "Irinotecan and Temozolomide for Ewing Sarcoma", "status": "UNKNOWN", "start": "2018-02-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Peking University People's Hospital", "conditions": ["Ewing Sarcoma"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03462316", "title": "NY-ESO-1-specific T Cell Receptor (TCR) T Cell in Sarcoma", "status": "COMPLETED", "start": "2018-05-21", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 2, "sponsor": "Sun Yat-sen University", "conditions": ["Bone Sarcoma", "Soft Tissue Sarcoma"], "cn_sites": [{"facility": "Sun Yat-Sen Univerisity", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03539172", "title": "Radiotherapy Concurrent With Apatinib in Advanced Soft Tissue and Bone Sarcomas of Head and Neck--RASS Study", "status": "UNKNOWN", "start": "2018-06-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 61, "sponsor": "Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University", "conditions": ["Soft Tissue and Bone Tumor", "Head and Neck Cancer", "Sarcoma"], "cn_sites": [{"facility": "Shanghai ninth people's hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03582527", "title": "PD-L1 Expression in Advanced Osteosarcoma", "status": "UNKNOWN", "start": "2018-06-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 50, "sponsor": "Peking University People's Hospital", "conditions": ["Progression", "Survival"], "cn_sites": [{"facility": "Musculoskeletal Tumor Center of Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03360760", "title": "Timing of Surgery in Nonmetastatic Osteosarcoma of the Pelvis and Sacrum", "status": "UNKNOWN", "start": "2018-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Peking University People's Hospital", "conditions": ["Osteosarcoma of Pelvis"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03932058", "title": "Proteomics Research of Osteosarcoma", "status": "UNKNOWN", "start": "2018-09-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 400, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Osteosarcoma", "Proteomics"], "cn_sites": [{"facility": "2nd Affiliated Hospital of Zhejiang University", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03676985", "title": "A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Limited Stage of High-grade Osteosarcoma", "status": "UNKNOWN", "start": "2018-10-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Lee's Pharmaceutical Limited", "conditions": ["Osteosarcoma"], "cn_sites": [{"facility": "Shanghai Sixth People's Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03909776", "title": "Transcatheter Intra-arterial Limb Infusion of Cisplatin for Extremity Osteosarcoma", "status": "COMPLETED", "start": "2019-01-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 99, "sponsor": "Peking University People's Hospital", "conditions": ["Event-free Survival", "Overall Survival", "Local-recurrence Free Survival", "Pathological Response"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03742193", "title": "Pulmonary Resectable Metastases of Osteosarcoma With Anti-angiogenics and CHemotherapy", "status": "UNKNOWN", "start": "2019-08-11", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 43, "sponsor": "Ruijin Hospital", "conditions": ["Osteosarcoma", "Pulmonary Metastases", "Apatinib"], "cn_sites": [{"facility": "Ruijin Hospital Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03997747", "title": "Cancer Genome Study Using Samples From Patients Treated on Clinical Trial SHR1020-SHR-1210-II-OS", "status": "COMPLETED", "start": "2019-08-13", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 38, "sponsor": "Peking University People's Hospital", "conditions": ["Osteosarcoma"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University Shougang Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT04044378", "title": "Famitinib Plus Camrelizumab & Famitinib Alone & Famitinib Plus Ifosfamide in Advanced Osteosarcoma", "status": "WITHDRAWN", "start": "2019-08-15", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Peking University People's Hospital", "conditions": ["Effect of Drugs", "Progression", "Pediatric Cancer"], "cn_sites": [{"facility": "Lu Xie", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04074564", "title": "MASCT-I Combined With Apatinib and/or Camrelizumab in the Treatment of Bone and Soft Tissue Sarcoma", "status": "UNKNOWN", "start": "2019-11-22", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "HRYZ Biotech Co.", "conditions": ["Sarcoma"], "cn_sites": [{"facility": "Shanghai Sixth People's Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03919539", "title": "Epigenetic Biomarker for Advanced Osteosarcoma Using Famitinib and Camrelizumab", "status": "UNKNOWN", "start": "2019-12-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 40, "sponsor": "Peking University People's Hospital", "conditions": ["Drug Resistance to Famitinib and Camrelizumab", "Biomarkers for Efficacy and Toxicity"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04461223", "title": "Evaluation of Myocardial Injury After Anthracycline Chemotherapy in Osteosarcoma Patients Using CMR", "status": "UNKNOWN", "start": "2019-12-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 55, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Cardiotoxicity", "Osteosarcoma", "Myocardial Injury", "Chemotherapy Induced Systolic Dysfunction", "Doxorubicin Induced Cardiomyopathy"], "cn_sites": [{"facility": "2nd Affiliated Hospital, School of Medicine, Zhejiang University", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04294511", "title": "Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of Osteosarcoma", "status": "UNKNOWN", "start": "2019-12-26", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 75, "sponsor": "Sun Yat-sen University", "conditions": ["Osteosarcoma"], "cn_sites": [{"facility": "Cancer Center of Sun-Yat Sen University (CCSYSU)", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04546243", "title": "Osteosarcoma With Resectable Pulmonary Metastasis: A Retrospective Study", "status": "COMPLETED", "start": "2020-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 127, "sponsor": "Peking University People's Hospital", "conditions": ["Osteosarcoma Metastatic", "Pulmonary Disease", "Resectable Sarcoma", "Survival"], "cn_sites": [{"facility": "Peking University Shougang Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT04351308", "title": "Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma", "status": "UNKNOWN", "start": "2020-05-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Peking University People's Hospital", "conditions": ["Osteosarcoma", "Survival", "Chemotherapy Effect", "Toxicity, Drug"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04690725", "title": "TQB3525 for Advanced Bone Sarcomas With PI3KA Mutations or PTEN Loss", "status": "UNKNOWN", "start": "2020-10-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 29, "sponsor": "Peking University People's Hospital", "conditions": ["Safety Issues", "Efficacy, Self"], "cn_sites": [{"facility": "Peking University Shougang Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05101655", "title": "Construction of Microfluidic Exosome Chip for Diagnosis of Lung Metastasis of Osteosarcoma", "status": "COMPLETED", "start": "2020-10-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 60, "sponsor": "Ruijin Hospital", "conditions": ["Osteosarcoma", "Pulmonary Metastases"], "cn_sites": [{"facility": "Ruijin Hospital Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04690231", "title": "Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory Osteosarcoma", "status": "COMPLETED", "start": "2020-12-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 79, "sponsor": "Peking University People's Hospital", "conditions": ["Effect of Drug", "Toxicity, Drug", "Secondary Resistance"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05194605", "title": "Predictive Models of Treatment Responses and Survival Outcomes in Patients With Osteosarcoma", "status": "UNKNOWN", "start": "2021-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 800, "sponsor": "West China Hospital", "conditions": ["Osteosarcoma"], "cn_sites": [{"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04824352", "title": "Apatinib Plus IE Chemotherapy (Ifosfamide and Etoposide) for Relapsed or Refractory Osteosarcoma", "status": "SUSPENDED", "start": "2021-04-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 44, "sponsor": "Peking University People's Hospital", "conditions": ["Effect of Drug", "Toxicity, Drug"], "cn_sites": [{"facility": "Peking University Shougang Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT04861948", "title": "IBI188 Combination Therapy in Solid Tumors", "status": "TERMINATED", "start": "2021-05-25", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Innovent Biologics (Suzhou) Co. Ltd.", "conditions": ["Solid Tumors", "Lung Adenocarcinoma", "Osteosarcoma"], "cn_sites": [{"facility": "Tianjin Medical University Cancer Institute and Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04900766", "title": "A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Advanced Bone and Soft Tissue Sarcoma", "status": "TERMINATED", "start": "2021-08-11", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 31, "sponsor": "CSPC ZhongQi Pharmaceutical Technology Co., Ltd.", "conditions": ["Unresectable or Metastatic Bone and Soft Tissue Sarcoma"], "cn_sites": [{"facility": "Beijing Jishuitan Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05241132", "title": "Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary", "status": "UNKNOWN", "start": "2021-11-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 27, "sponsor": "Wei Xu", "conditions": ["Cancer of Unknown Primary", "Bone Cancer Metastatic", "Tislelizumab", "Gene Mutation-Related Cancer", "Immune Evasion, Tumor", "Chemotherapy Effect"], "cn_sites": [{"facility": "ChangZheng Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06202599", "title": "Fruquintinib-based Treatment for Refractory Bone and Soft Tissue Sarcomas After Several Lines of TKIs' Resistance", "status": "COMPLETED", "start": "2021-11-25", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 124, "sponsor": "Peking University People's Hospital", "conditions": ["Bone Sarcoma", "Soft Tissue Sarcoma", "Refractory Tumor"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05106777", "title": "Surufatinib in Patients With Osteosarcoma and Soft Tissue Sarcoma", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-12-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 47, "sponsor": "Sun Yat-sen University", "conditions": ["Sarcoma"], "cn_sites": [{"facility": "Sun Yat-Sen Univerisity", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05277480", "title": "Apatinib With Ifosfamide Plus Etoposide for Relapsed or Refractory Osteosarcoma (OAIE)", "status": "COMPLETED", "start": "2022-03-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 81, "sponsor": "Peking University People's Hospital", "conditions": ["Effect of Drug", "Drug", "Toxicity"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}, {"facility": "Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University", "city": "Nanjing", "status": ""}, {"facility": "Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Jiao Tong University Affiliated Sixth People's Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT05615545", "title": "Cryoablation for Advanced Bone and Soft Tissue Tumors", "status": "UNKNOWN", "start": "2022-03-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 30, "sponsor": "Henan Cancer Hospital", "conditions": ["Sarcoma", "Cryoablation"], "cn_sites": [{"facility": "Department of Bone and Soft Tissue ,Henan Cancer Hospital", "city": "Zhengzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06117878", "title": "Safety and Efficacy of NK510 to Treat Osteosarcoma and Soft Tissue Sarcoma", "status": "UNKNOWN", "start": "2022-09-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Base Therapeutics (Shanghai) Co., Ltd.", "conditions": ["Osteosarcoma", "Soft Tissue Sarcoma"], "cn_sites": [{"facility": "Shanghai General Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05941325", "title": "A Single-arm, Open-label, Single-center Prospective Study of Fruquintinib Combined With Envafolimab in the Treatment of Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma", "status": "SUSPENDED", "start": "2023-04-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Shanghai 6th People's Hospital", "conditions": ["Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma"], "cn_sites": [{"facility": "Shanghai No.6 People Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05851456", "title": "A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors", "status": "UNKNOWN", "start": "2023-04-10", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Shanghai Yunying Medical Technology", "conditions": ["Osteosarcoma", "Sarcoma", "Sarcoma,Soft Tissue", "Bone Tumor"], "cn_sites": [{"facility": "Xi'an Honghui Hospital", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05942456", "title": "Soluble B7-H3 as a Biomarker for Osteosarcoma", "status": "UNKNOWN", "start": "2023-06-05", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Peking University People's Hospital", "conditions": ["Biomarker", "Progression", "Osteosarcoma", "Surveillance"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06171282", "title": "A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors", "status": "UNKNOWN", "start": "2023-07-12", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Shanghai Yunying Medical Technology", "conditions": ["Osteosarcoma", "Sarcoma", "Soft Tissue Sarcoma", "Bone Tumor"], "cn_sites": [{"facility": "Shanghai General Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05926492", "title": "A Clinical Study of Surufatinib Combined With Chemotherapy as Neoadjuvant Treatment in Osteosarcoma", "status": "UNKNOWN", "start": "2024-01-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 160, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Osteosarcoma"], "cn_sites": [{"facility": "The Second Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06217003", "title": "Trilaciclib Combined With Chemotherapy for Perioperative Treatment of Osteosarcoma", "status": "UNKNOWN", "start": "2024-02-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "The First Affiliated Hospital of Xinxiang Medical College", "conditions": ["Osteosarcoma"], "cn_sites": [{"facility": "The First Affiliated Hospital of Xinxiang Medical University", "city": "Xinxiang", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06438783", "title": "TQB2928 Injection Combined Anlotinib Hydrochloride Capsule in Recurrent/Metastatic Osteosarcoma and Other Solid Tumors", "status": "TERMINATED", "start": "2024-02-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.", "conditions": ["Osteosarcoma", "Other Solid Tumors"], "cn_sites": [{"facility": "Beijing jishuitan hospital", "city": "Beijing", "status": ""}, {"facility": "Pekjing university people's hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing cancer hospital", "city": "Beijing", "status": ""}, {"facility": "Hunan cancer hospital", "city": "Changsha", "status": ""}, {"facility": "Tianjin medical university cancer institute&hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT05046314", "title": "A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's Sarcoma", "status": "COMPLETED", "start": "2024-03-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Shanghai Pharmaceuticals Holding Co., Ltd", "conditions": ["Sarcoma, Ewing"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Hunan Cancer Hospital", "city": "Changsha", "status": ""}, {"facility": "Shanghai Sixth People's Hospital", "city": "Shanghai", "status": ""}, {"facility": "Tianjin Medical University Cancer Institude & Hospital", "city": "Tianjin", "status": ""}, {"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT06451302", "title": "Risk Stratification Oriented Treatment of Pediatric Ewing Sarcoma: a Prospective Multicenter Cohort Study", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-04-17", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Yizhuo Zhang", "conditions": ["Ewing Sarcoma", "Risk Stratification"], "cn_sites": [{"facility": "Sun Yat-sen University Cancer Center", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06412458", "title": "IM83 Clinical Study of CAR-T Cell Therapy in Patients With Relapsed or Refractory Osteosarcoma", "status": "UNKNOWN", "start": "2024-06-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Beijing Immunochina Medical Science & Technology Co., Ltd.", "conditions": ["Refractory Osteosarcoma", "Recurrent Osteosarcoma"], "cn_sites": [{"facility": "Guangdong Provincial People's Hospital", "city": "Guangdong", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06850506", "title": "Exploring the Expression Level of Cadherin 6 Protein (CDH6) in Primary Malignant Bone Tumor Specimens and Its Clinical Application in Prognosis Assessment", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-09-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 70, "sponsor": "Peking University People's Hospital", "conditions": ["Sarcoma", "Sarcoma, Bone", "Ewing Sarcoma", "Osteosarcoma"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06562673", "title": "Intra-arterial Cisplatin Plus Rh-endostatin Combined With Systematic Chemotherapy in Osteosarcoma", "status": "COMPLETED", "start": "2024-12-03", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Shanghai 6th People's Hospital", "conditions": ["Osteosarcoma", "Bone Cancer"], "cn_sites": [{"facility": "Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital,", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06935409", "title": "Study of HS-20093 Versus Gemcitabine in Combination With Docetaxel in Treatment of Osteosarcoma After Previous Second-line Treatment Failure", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-04-25", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 117, "sponsor": "Hansoh BioMedical R&D Company", "conditions": ["Osteosarcoma"], "cn_sites": [{"facility": "Beijing Jishuitan Hospital affiliated to Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07593573", "title": "the Exploration of MTAP Deletion in Osteosarcoma by Immunohistochemistry", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-12-15", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Peking University People's Hospital", "conditions": ["Osteosarcoma", "MTAP Deletion", "Immunohistochemistry"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 190, "g_fetched": 164, "g_countries": [["United States", 101], ["Italy", 15], ["France", 10], ["Canada", 9], ["Netherlands", 8], ["Australia", 5], ["Spain", 5], ["Germany", 5], ["Belgium", 3], ["Sweden", 3], ["Brazil", 3], ["United Kingdom", 3], ["Turkey (Türkiye)", 2], ["Taiwan", 2], ["Poland", 2], ["Czechia", 2], ["Greece", 2], ["South Korea", 2], ["Egypt", 2], ["Puerto Rico", 2], ["Moldova", 1], ["Austria", 1], ["Chile", 1], ["Colombia", 1], ["Denmark", 1], ["Hungary", 1], ["Israel", 1], ["Slovakia", 1], ["New Zealand", 1], ["Saudi Arabia", 1], ["Russia", 1], ["Switzerland", 1], ["Argentina", 1], ["Costa Rica", 1], ["Mexico", 1], ["Peru", 1]], "g_trials": [{"nct": "NCT07781891", "title": "RAPID: Phase 2 Platform Trial Of Promising Drugs For AYA Patients With R/R Ewing Sarcoma & DSRCT", "status": "NOT_YET_RECRUITING", "start": "2027-02-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "M.D. Anderson Cancer Center", "countries": ["United States"]}, {"nct": "NCT06988007", "title": "Bone Arches: Performance of Pseudo-scanner Sequences in Segmenting the Extent of the Tumour and in Planning Surgical Resection Using the CT Scan as a Reference", "status": "NOT_YET_RECRUITING", "start": "2027-01-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Cliniques universitaires Saint-Luc- Université Catholique de Louvain", "countries": ["Belgium"]}, {"nct": "NCT07560826", "title": "The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma", "status": "NOT_YET_RECRUITING", "start": "2026-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Wake Forest University Health Sciences", "countries": ["United States"]}, {"nct": "NCT07695311", "title": "EWSR1 Immunotherapy in Ewing Sarcoma and DSRCT", "status": "NOT_YET_RECRUITING", "start": "2026-10", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Rabi Hanna", "countries": ["United States"]}, {"nct": "NCT07801222", "title": "A Study to Assess Safety and Efficacy of SOT106 in Patients With LRRC15-positive Advanced Unresectable or Metastatic Osteosarcoma or Soft Tissue Sarcoma", "status": "NOT_YET_RECRUITING", "start": "2026-09-30", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "SOTIO Biotech a.s.", "countries": ["Moldova"]}, {"nct": "NCT07773454", "title": "Study of Zanzalintinib in Children and Adolescents With Relapsed or Refractory Solid Tumors", "status": "NOT_YET_RECRUITING", "start": "2026-09-30", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Exelixis", "countries": []}, {"nct": "NCT07820033", "title": "Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled Trial", "status": "NOT_YET_RECRUITING", "start": "2026-09-14", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University Health Network, Toronto", "countries": ["Canada"]}, {"nct": "NCT07428993", "title": "Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma", "status": "RECRUITING", "start": "2026-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "St. Jude Children's Research Hospital", "countries": ["United States"]}, {"nct": "NCT07516353", "title": "my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults", "status": "NOT_YET_RECRUITING", "start": "2026-08-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Dana-Farber Cancer Institute", "countries": ["United States"]}, {"nct": "NCT07514819", "title": "Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma", "status": "RECRUITING", "start": "2026-08-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "St. Jude Children's Research Hospital", "countries": ["United States"]}, {"nct": "NCT07729059", "title": "\"Exercise Intervention to Increase Physical Activity in Young Sarcoma Survivors (Sport Ist Herzenssache)\"", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Universität Duisburg-Essen", "countries": []}, {"nct": "NCT07662239", "title": "Bridging Adolescent and Young Adult Sarcoma Survivors With Personalized Oncology Exercise Service (AYA-ONE): A Pilot Intervention", "status": "RECRUITING", "start": "2026-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Dana-Farber Cancer Institute", "countries": ["United States"]}, {"nct": "NCT07727434", "title": "Stress and Anxiety Before Biopsy, After Biopsy Results, and During Treatment in Patients With Suspected Bone or Soft Tissue Cancer", "status": "RECRUITING", "start": "2026-07-20", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Istanbul University", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT07725380", "title": "Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma", "status": "RECRUITING", "start": "2026-07-15", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "H. Lee Moffitt Cancer Center and Research Institute", "countries": ["United States"]}, {"nct": "NCT07211737", "title": "NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma", "status": "RECRUITING", "start": "2026-07-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Baylor College of Medicine", "countries": ["United States"]}, {"nct": "NCT07636148", "title": "Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance", "status": "RECRUITING", "start": "2026-07-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Mark C Burgmans, MD PhD", "countries": ["France", "Netherlands"]}, {"nct": "NCT07619950", "title": "EVERolimus and LenvAtinib Versus Everolimus for Bone Sarcoma", "status": "NOT_YET_RECRUITING", "start": "2026-07-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Yonsei University", "countries": []}, {"nct": "NCT06492954", "title": "Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma", "status": "RECRUITING", "start": "2026-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Emory University", "countries": ["United States"]}, {"nct": "NCT07502885", "title": "Deep Phenotyping Gait Deficits in Orthopedic Manifestations of Pediatric Cancer Patients", "status": "RECRUITING", "start": "2026-06-16", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "St. Jude Children's Research Hospital", "countries": ["United States"]}, {"nct": "NCT07321912", "title": "Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma", "status": "RECRUITING", "start": "2026-06-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Milton S. Hershey Medical Center", "countries": ["United States"]}, {"nct": "NCT07492823", "title": "Clinical Applicability of Liquid Biopsy in Chondrosarcoma", "status": "NOT_YET_RECRUITING", "start": "2026-06-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Medical University of Graz", "countries": ["Austria"]}, {"nct": "NCT07560410", "title": "Treatment of Truncated ALK-positive Bone Cancer Using Crizotinib (Xalkori) or Alectinib (Alecensa)", "status": "NOT_YET_RECRUITING", "start": "2026-05-15", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "China Medical University Hospital", "countries": ["Taiwan"]}, {"nct": "NCT06465199", "title": "Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas", "status": "RECRUITING", "start": "2026-05-13", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Milton S. Hershey Medical Center", "countries": ["United States"]}, {"nct": "NCT07628634", "title": "Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors", "status": "RECRUITING", "start": "2026-05-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "University of California, Irvine", "countries": ["United States"]}, {"nct": "NCT07685405", "title": "Identification of Circulating Biomarkers Associated With Extracellular Vesicles in Sarcomas", "status": "RECRUITING", "start": "2026-04-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Istituto Ortopedico Rizzoli", "countries": ["Italy"]}]}, {"batch": 2, "no": 58, "name_zh": "天疱疮", "query_terms": [{"term": "Pemphigus vulgaris", "broad": false}, {"term": "Pemphigus foliaceus", "broad": false}, {"term": "Pemphigus", "broad": true}], "n_total": 11, "n_open": 3, "n_open_precise": 1, "n_broad": 4, "trials": [{"nct": "NCT07681388", "title": "CD19 CAR-T Therapy for Refractory Pemphigus Vulgaris", "status": "RECRUITING", "start": "2026-01-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 3, "sponsor": "Jinbo Chen", "conditions": ["Pemphigus Vulgaris"], "cn_sites": [{"facility": "Traditional Chinese and Western Medicine Hospital of Wuhan, Wuhan, Hubei", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04023149", "title": "Efficacy of Interleukin-2 Gargle in the Treatment of Oral Mucosa Lesion in Pemphigus Vulgaris", "status": "UNKNOWN", "start": "2020-04-02", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 180, "sponsor": "Second Xiangya Hospital of Central South University", "conditions": ["Pemphigus Vulgaris"], "cn_sites": [{"facility": "The Second Xiangya Hospital of Central South University", "city": "Changsha", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04598451", "title": "A Study to Assess the Efficacy and Safety of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus)", "status": "COMPLETED", "start": "2020-12-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 222, "sponsor": "argenx", "conditions": ["Pemphigus Vulgaris", "Pemphigus Foliaceus"], "cn_sites": [{"facility": "Investigator site 110 - CN0860017", "city": "Beijing", "status": ""}, {"facility": "Investigator site 111 - CN0860018", "city": "Chendu", "status": ""}, {"facility": "Investigator site 131 - CH0860027", "city": "Chongqing", "status": ""}, {"facility": "Investigator site 118 - CN0860023", "city": "Fujian", "status": ""}, {"facility": "Investigator site 120 - CN0860022", "city": "Guangzhou", "status": ""}, {"facility": "Investigator site 128 - CH0860053", "city": "Guangzhou", "status": ""}, {"facility": "Investigator site 109 - CN0860021", "city": "Guanzhou", "status": ""}, {"facility": "Investigator site 119 - CN0860024", "city": "Nanjing", "status": ""}, {"facility": "Investigator site 112 - CN0860020", "city": "Shanghai", "status": ""}, {"facility": "Investigator site 108 - CN0860016", "city": "Shanghai", "status": ""}, {"facility": "Investigator site 113 - CN0860025", "city": "Wuhan", "status": ""}, {"facility": "Investigator site 123 - CN0860019", "city": "Wuhan", "status": ""}, {"facility": "Investigator site 129 - CH0860026", "city": "Zhengzhou", "status": ""}], "cn_site_count": 13, "broad_only": false}, {"nct": "NCT05303272", "title": "A Study to Evaluate Efficacy and Safety of Abatacept in Participants of Pemphigus Vulgaris (PV)", "status": "UNKNOWN", "start": "2021-02-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Tongji Hospital", "conditions": ["Pemphigus Vulgaris"], "cn_sites": [{"facility": "Tongji Hospital", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04598477", "title": "A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus)", "status": "TERMINATED", "start": "2021-07-15", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 183, "sponsor": "argenx", "conditions": ["Pemphigus Vulgaris", "Pemphigus Foliaceus"], "cn_sites": [{"facility": "Investigator site 101 - CN0860017", "city": "Beijing", "status": ""}, {"facility": "Investigator site 107 - CN0860018", "city": "Chengdu", "status": ""}, {"facility": "Investigator site 118 - CH0860027", "city": "Chongqing", "status": ""}, {"facility": "Investigator site 120 - CH0860023", "city": "Fuzhou", "status": ""}, {"facility": "Investigator site 119 - CH0860022", "city": "Guangzhou", "status": ""}, {"facility": "Investigator site 116 - CH0860053", "city": "Guangzhou", "status": ""}, {"facility": "Investigator site 100 - CN0860021", "city": "Guanzhou", "status": ""}, {"facility": "Investigator site 113 - CN0860024", "city": "Nanjing", "status": ""}, {"facility": "Investigator site 102 - CN0860020", "city": "Shanghai", "status": ""}, {"facility": "Investigator site 99 - CN0860016", "city": "Shanghai", "status": ""}, {"facility": "Investigator site 112 - CN0860019", "city": "Wuhan", "status": ""}, {"facility": "Investigator site 121 - CH0860025", "city": "Wuhan", "status": ""}, {"facility": "Investigator site 117 - CH0860026", "city": "Zhengzhou", "status": ""}], "cn_site_count": 13, "broad_only": false}, {"nct": "NCT06167408", "title": "Identifying Factors Influencing In-Hospital Relapse in Pemphigus Patients", "status": "COMPLETED", "start": "2022-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 96, "sponsor": "First Affiliated Hospital of Chongqing Medical University", "conditions": ["Pemphigus Vulgaris"], "cn_sites": [{"facility": "First Affiliated hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06654817", "title": "Efficacy and Safety Evaluation of Anti-CD20 Monoclonal Antibody Combined with Azathioprine and Corticosteroids in the Treatment of Pemphigus Vulgaris", "status": "COMPLETED", "start": "2023-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 38, "sponsor": "Chao Ji", "conditions": ["Pemphigus", "Pemphigus Vulgaris (PV)"], "cn_sites": [{"facility": "First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06454357", "title": "A Clinical Study of B007 in the Treatment of Pemphigus.", "status": "RECRUITING", "start": "2024-07-12", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 132, "sponsor": "Shanghai Jiaolian Drug Research and Development Co., Ltd", "conditions": ["Pemphigus"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The Second Xiangya Hospital of Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Chengdu Second People's Hospital", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "Dermatology Hospital of Southern Medical University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Guangdong Provincial People's Hospital", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Shandong First Medical University-Affiliated Skin Hospital", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Ruijin Hospital, Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": "RECRUITING"}], "cn_site_count": 12, "broad_only": true}, {"nct": "NCT06904040", "title": "A Single-center Study of CM313 in Patients With Pemphigus", "status": "NOT_YET_RECRUITING", "start": "2025-04-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Sichuan Provincial People's Hospital", "conditions": ["Pemphigus"], "cn_sites": [{"facility": "Sichuan Provincial People's Hospital", "city": "Chengdu", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT07457944", "title": "Efficacy and Safety of Different Doses of Rituximab Therapy in Pemphigus Patients", "status": "COMPLETED", "start": "2019-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 275, "sponsor": "Ruijin Hospital", "conditions": ["Pemphigus Disease", "Rituximab (RTx)"], "cn_sites": [{"facility": "Department of Dermatology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}, {"nct": "NCT06949241", "title": "A Single Cycle of Intravenous Immunoglobulin as Adjuvant to Rituximab in Patients With Pemphigus: A Retrospective Cohort Study at a Tertiary Referral Center", "status": "ACTIVE_NOT_RECRUITING", "start": "2019-12-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 76, "sponsor": "Ruijin Hospital", "conditions": ["Pemphigus Disease", "Rituximab (RTx)", "Intravenous Immunoglobulin"], "cn_sites": [{"facility": "Department of Dermatology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": true}], "g_total": 10, "g_fetched": 10, "g_countries": [["United States", 3], ["Syria", 1], ["Turkey (Türkiye)", 1]], "g_trials": [{"nct": "NCT07769333", "title": "Rituximab With Corticosteroids Versus Corticosteroids Plus Azathioprine for Moderate-to-Severe Pemphigus Vulgaris", "status": "NOT_YET_RECRUITING", "start": "2026-12-02", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Khyber Teaching Hospital", "countries": []}, {"nct": "NCT07641725", "title": "Comparison of the Efficacy of Clobetasol Propionate 0.05% Mouthwash, Photobiomodulation, and Their Combination in Managing of Oral Lesions in Patient With Pemphigus Vulgaris.", "status": "RECRUITING", "start": "2025-11-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Damascus University", "countries": ["Syria"]}, {"nct": "NCT07384221", "title": "Periodontal Status and Disease Severity in Pemphigus Vulgaris Patients", "status": "RECRUITING", "start": "2025-11-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Saglik Bilimleri Universitesi", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT06663943", "title": "A Randomized Study on Pemphigus Treatment With Humanized CD38 Antibody CM313.", "status": "NOT_YET_RECRUITING", "start": "2025-10-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Chao Ji", "countries": []}, {"nct": "NCT06971172", "title": "Low-level Laser Therapy on Oral Pemphigus Vulgaris Patients.", "status": "NOT_YET_RECRUITING", "start": "2025-06-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Cairo University", "countries": []}, {"nct": "NCT06863454", "title": "Trichoscopy as a Monitoring Tool for Activity and Remission in Pemphigus Vulgaris: A Clinical Study Supported by Immunological Evaluation.", "status": "NOT_YET_RECRUITING", "start": "2025-05-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT06581562", "title": "Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.", "status": "RECRUITING", "start": "2024-05-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "IRIS Research and Development, LLC", "countries": ["United States"]}, {"nct": "NCT04422912", "title": "A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)", "status": "RECRUITING", "start": "2020-09-29", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Cabaletta Bio", "countries": ["United States"]}, {"nct": "NCT02753777", "title": "Autoimmune Blistering Diseases Study", "status": "RECRUITING", "start": "2016-04", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Pennsylvania", "countries": ["United States"]}, {"nct": "NCT04776694", "title": "Compassionate Use or Expanded Access of Dupilumab", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "Regeneron Pharmaceuticals", "countries": []}]}, {"batch": 2, "no": 59, "name_zh": "新生儿持续肺动脉高压", "query_terms": [{"term": "Persistent pulmonary hypertension of the newborn", "broad": false}], "n_total": 3, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT06832163", "title": "Close Loop Smart Weaning for INO With PPHN", "status": "RECRUITING", "start": "2025-10-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Children's Hospital of Fudan University", "conditions": ["Persistent Pulmonary Hypertension of the Newborn", "Inhaled Nitric Oxide"], "cn_sites": [{"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01373749", "title": "Nitro Oxide Inhalation Continued With Sildenafil on Neonatal Persistent Pulmonary Hypertension", "status": "UNKNOWN", "start": "2011-03", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Third Military Medical University", "conditions": ["Persistent Pulmonary Hypertension of Newborn"], "cn_sites": [{"facility": "Department of Pediatrics,Daping hospital", "city": "Chongqing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04379180", "title": "Population Pharmacokinetics and Dosage Individualization of Oral Pulmonary Vasodilators in PPHN", "status": "UNKNOWN", "start": "2020-04-26", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Shandong University", "conditions": ["Persistent Pulmonary Hypertension of the Newborn"], "cn_sites": [{"facility": "West China Second University Hospital", "city": "Chengdu", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 5, "g_fetched": 4, "g_countries": [["France", 1], ["Egypt", 1], ["United States", 1]], "g_trials": [{"nct": "NCT07822750", "title": "Predictors of Outcomes in Pulmonary Hypertension of the Newborn", "status": "NOT_YET_RECRUITING", "start": "2026-09-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT06499363", "title": "Treprostinil in Newborns With Pulmonary Hypertension; a Non-Interventional Study to Collect Data on Drug Utilization, Safety, and Effectiveness", "status": "RECRUITING", "start": "2025-02-25", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Ferrer Internacional S.A.", "countries": ["France"]}, {"nct": "NCT04898114", "title": "Nebulized Magnesium Sulfate and Sildenafil for Persistent Pulmonary Hypertension of Newborn", "status": "RECRUITING", "start": "2021-06-02", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Sohag University", "countries": ["Egypt"]}, {"nct": "NCT00710177", "title": "PTGS1 Genetic Variation and Increased Risk for Persistent Pulmonary Hypertension of the Newborn", "status": "RECRUITING", "start": "2006-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Medical College of Wisconsin", "countries": ["United States"]}]}, {"batch": 2, "no": 60, "name_zh": "嗜铬细胞瘤", "query_terms": [{"term": "Pheochromocytoma-paraganglioma", "broad": false}, {"term": "Pheochromocytoma", "broad": true}], "n_total": 20, "n_open": 8, "n_open_precise": 8, "n_broad": 0, "trials": [{"nct": "NCT04924075", "title": "Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)", "status": "RECRUITING", "start": "2021-08-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 355, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Pheochromocytoma/Paraganglioma", "Pancreatic Neuroendocrine Tumor", "Von Hippel-Lindau Disease", "Advanced Gastrointestinal Stromal Tumor", "HIF-2α Mutated Cancers"], "cn_sites": [{"facility": "Peking University First Hospital-Urology ( Site 1900)", "city": "Beijing", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Sun Yat-sen University Cancer Center ( Site 1905)", "city": "Guangzhou", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Renji Hospital Shanghai Jiao Tong University School of Medicine ( Site 1904)", "city": "Shanghai", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "West China Hospital of Sichuan University ( Site 1906)", "city": "Chengdu", "status": "COMPLETED"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT05069220", "title": "18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor", "status": "RECRUITING", "start": "2021-09-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 150, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Neuroendocrine Tumor", "Neuroblastoma", "Pheochromocytoma", "Paraganglioma"], "cn_sites": [{"facility": "Peking union medical college hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06813742", "title": "18F-mFBG PET Imaging in the Evaluation of Pheochromocytoma", "status": "RECRUITING", "start": "2023-05-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 80, "sponsor": "First Affiliated Hospital of Zhejiang University", "conditions": ["Pheochromocytoma"], "cn_sites": [{"facility": "The First Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07288931", "title": "Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and Paraganglioma", "status": "RECRUITING", "start": "2024-08-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Pheochromocytoma/Paraganglioma (PPGL)"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07182175", "title": "Comparative Study of Perioperative Cardiac Injury in Patients With Functional Adrenal Tumors", "status": "ENROLLING_BY_INVITATION", "start": "2024-09-19", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 150, "sponsor": "Peking University First Hospital", "conditions": ["Primary Aldosteronism", "Adrenal Tumor", "Cushing s Syndrome", "Pheochromocytoma/Paraganglioma (PPGL)"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06683846", "title": "Ivonescimab in the Treatment of Multiple Advanced Tumors", "status": "RECRUITING", "start": "2024-11-20", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 400, "sponsor": "Fudan University", "conditions": ["Pheochromocytoma/Paraganglioma", "Rhabdomyosarcoma", "Paget Disease, Extramammary", "Renal Angiomyolipoma", "Perivascular Epithelioid Cell Tumor, Malignant", "Sarcoma", "Urachal Cancer", "Neuroendocrine Cancer", "Basal Cell Carcinomas", "Sarcomatoid Carcinoma", "Penile Cancer", "Adrenal Cortical Cancer", "Germ Cell Cancer Metastatic", "Non-Clear Cell Renal Cell Carcinoma", "Prostate Cancers", "Clear Cell Renal Cancer", "Urothelial Carcinoma", "Kidney Cancer", "Rare Tumors"], "cn_sites": [{"facility": "Fudan University Cancer Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07195500", "title": "Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Paraganglioma", "status": "RECRUITING", "start": "2024-12-25", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 30, "sponsor": "Nanjing First Hospital, Nanjing Medical University", "conditions": ["Neuroblastoma", "Pheochromocytoma", "Paraganglioma"], "cn_sites": [{"facility": "Nanjing First Hospital", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06429397", "title": "Anlotinib Combined With Benmelstobart for Advanced Pheochromocytoma", "status": "NOT_YET_RECRUITING", "start": "2025-05-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 22, "sponsor": "Sun Yat-sen University", "conditions": ["Pheochromocytoma"], "cn_sites": [{"facility": "Cancer Center, Sun Yat-sen University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07412158", "title": "Development and Clinical Application of a Novel Imaging Grading System for Pheochromocytoma and Paraganglioma (PPGL)", "status": "COMPLETED", "start": "2017-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Peking University First Hospital", "conditions": ["Risk Grading System", "Pheochromocytoma and Paraganglioma (PPGL)", "Quantitative Assessment"], "cn_sites": [{"facility": "Department of Urology, Peking University First Hospital, Beijing, 100034", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05858177", "title": "The Efficacy and Safety of Temozolomide in Patients With MPPGL", "status": "COMPLETED", "start": "2019-10-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 62, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Pheochromocytoma, Metastatic", "Paraganglioma, Malignant", "Pheochromocytoma Malignant"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06669481", "title": "Correlation Between Preoperative Images of PPGL and Intraoperative Hemodynamics", "status": "COMPLETED", "start": "2020-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 159, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Pheochromocytoma", "Paraganglioma"], "cn_sites": [{"facility": "Peking union medical college hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04860700", "title": "The Efficacy and Safety of Anlotinib in Patients With Metastatic Pheochromocytoma or Paraganglioma", "status": "COMPLETED", "start": "2021-04-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 27, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Malignant Adrenal Gland Pheochromocytoma", "Malignant Paraganglioma", "Pheochromocytoma, Metastatic", "Paraganglioma, Malignant", "Paraganglioma, Extra-Adrenal"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04890444", "title": "China Adrenal Disease Registry", "status": "UNKNOWN", "start": "2021-06-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2000, "sponsor": "Shanghai Jiao Tong University School of Medicine", "conditions": ["Cushing Syndrome", "Aldosteronism", "Hypoadrenalism", "Congenital Adrenal Hyperplasia", "Adrenal Adenoma", "Adrenal Incidentaloma", "Adrenal Carcinoma", "Pheochromocytoma"], "cn_sites": [{"facility": "Endocrinology", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05133349", "title": "A Prospective Phase II Efficacy and Safety Study of Anlotinib in Metastatic or Locally Advanced Pheochromocytoma/ Paraganglioma : Open-label Single-arm, Exploratory Trial", "status": "UNKNOWN", "start": "2021-09-14", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Nanjing First Hospital, Nanjing Medical University", "conditions": ["Advanced or Metastatic Paraganglioma/ Pheochromocytoma"], "cn_sites": [{"facility": "The First Affiliated Hospital of Nanjing Medical Univerity", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05883085", "title": "A Study on the Safety and Effectiveness of Anlotinib for Neoadjuvant Treatment of PPGL", "status": "UNKNOWN", "start": "2022-05-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Pheochromocytoma", "Paraganglioma"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05451134", "title": "Predictors and Outcomes of Dysglycemia in Pheochromocytoma and Paraganglioma", "status": "UNKNOWN", "start": "2022-06-30", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 300, "sponsor": "China National Center for Cardiovascular Diseases", "conditions": ["Pheochromocytoma", "Paraganglioma"], "cn_sites": [{"facility": "Xian-Liang Zhou", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05752773", "title": "Prediction of Myocardial Injury After Laparoscopic Pheochromocytoma/ParaGangLioma Resection", "status": "UNKNOWN", "start": "2023-02-06", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 700, "sponsor": "Peking Union Medical College Hospital", "conditions": ["PGL"], "cn_sites": [{"facility": "Peking Union Medical College Hospital,Chinese Academy of Medical Science and Peking Union Medical College", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06015061", "title": "Prediction and Evaluation of Anlotinib Treatment Response Using Contrast Enhanced Ultrasound PPGL Patients", "status": "UNKNOWN", "start": "2023-03-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 20, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Pheochromocytoma, Metastatic", "Ultrasonography", "Paraganglioma, Malignant", "Pheochromocytoma Malignant"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05885399", "title": "The Efficacy and Safety of Penpulimab in the Treatment of Metastatic PPGL Patients Who Fail to Other Systemic Treatment", "status": "UNKNOWN", "start": "2023-04-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 5, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Pheochromocytoma, Metastatic", "Pheochromocytoma Malignant", "Paraganglioma, Malignant"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05885386", "title": "A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGL", "status": "UNKNOWN", "start": "2023-04-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Pheochromocytoma", "Paraganglioma"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}], "g_total": 46, "g_fetched": 39, "g_countries": [["United States", 21], ["Italy", 3], ["Canada", 2], ["United Kingdom", 2], ["Spain", 1], ["Argentina", 1], ["Netherlands", 1], ["Brazil", 1], ["Denmark", 1], ["South Korea", 1], ["Mexico", 1], ["Switzerland", 1], ["Australia", 1], ["New Zealand", 1], ["Puerto Rico", 1], ["Saudi Arabia", 1], ["Germany", 1]], "g_trials": [{"nct": "NCT07743138", "title": "STOMP OUT: A Phase 2 Study To Evaluate The Effects Of Ivonescimab In Patients With Unresectable/Metastatic Adrenocortical Carcinoma (ACC) Or Unresectable Pheochromocytoma/Paraganglioma (PPGL)", "status": "NOT_YET_RECRUITING", "start": "2027-02-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "M.D. Anderson Cancer Center", "countries": ["United States"]}, {"nct": "NCT07714551", "title": "Zanzalintinib in Unresectable and Progressive MPGGs", "status": "NOT_YET_RECRUITING", "start": "2027-01-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Dana-Farber Cancer Institute", "countries": ["United States"]}, {"nct": "NCT07621146", "title": "A Comparison of [68Ga]DOTATATE and [18F]AmBF3TATE for the Staging and Assessment of Neuroendocrine Malignancies", "status": "NOT_YET_RECRUITING", "start": "2026-09-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "British Columbia Cancer Agency", "countries": ["Canada"]}, {"nct": "NCT07538791", "title": "Italian Multicenter Experience With Radioreceptor-assisted Therapy (PRRT)", "status": "NOT_YET_RECRUITING", "start": "2026-08-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Azienda USL Reggio Emilia - IRCCS", "countries": ["Italy"]}, {"nct": "NCT07661420", "title": "211At-MABG in Adults With Advanced Neuroendocrine Cancers", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "University of Pennsylvania", "countries": ["United States"]}, {"nct": "NCT07680205", "title": "An Experimental Study of Belzutifan Impact on Catecholamine Metabolism", "status": "RECRUITING", "start": "2026-04-27", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Cambridge University Hospitals NHS Foundation Trust", "countries": ["United Kingdom"]}, {"nct": "NCT07516275", "title": "Prospective Cohort Study of Pheochromocytoma/Paraganglioma", "status": "NOT_YET_RECRUITING", "start": "2026-04", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Peking Union Medical College Hospital", "countries": []}, {"nct": "NCT07282587", "title": "Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma", "status": "RECRUITING", "start": "2026-01-02", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Jazz Pharmaceuticals", "countries": ["United States"]}, {"nct": "NCT04119024", "title": "Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors", "status": "RECRUITING", "start": "2025-10-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Anusha Kalbasi", "countries": ["United States"]}, {"nct": "NCT07200245", "title": "Cardiovascular Complications After Adrenalectomy for Pheochromocytoma and Non-secreting Tumors", "status": "NOT_YET_RECRUITING", "start": "2025-10-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Central Hospital, Nancy, France", "countries": []}, {"nct": "NCT06503146", "title": "18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection", "status": "RECRUITING", "start": "2025-09-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["United States"]}, {"nct": "NCT06479811", "title": "[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers", "status": "RECRUITING", "start": "2025-08-19", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["United States"]}, {"nct": "NCT06427798", "title": "Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy", "status": "RECRUITING", "start": "2025-02-07", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["United States"]}, {"nct": "NCT07072143", "title": "An International Study on Pediatric Patients With Rare Tumors.", "status": "RECRUITING", "start": "2025-01-25", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Azienda Ospedaliera di Padova", "countries": ["Italy"]}, {"nct": "NCT06607692", "title": "Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).", "status": "RECRUITING", "start": "2024-09-20", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Fundación de investigación HM", "countries": ["Spain"]}, {"nct": "NCT06573723", "title": "Institutional Registry of Rare Diseases", "status": "RECRUITING", "start": "2024-07-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Hospital Italiano de Buenos Aires", "countries": ["Argentina"]}, {"nct": "NCT06041516", "title": "A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors", "status": "RECRUITING", "start": "2024-06-17", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["United States"]}, {"nct": "NCT06377033", "title": "Using the EHR to Advance Genomic Medicine Across a Diverse Health System", "status": "RECRUITING", "start": "2024-06-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Pennsylvania", "countries": ["United States"]}, {"nct": "NCT06444607", "title": "Hereditary Pheochromocytoma Assessment of Tumour Immunologies", "status": "RECRUITING", "start": "2024-06-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Radboud University Medical Center", "countries": ["Netherlands"]}, {"nct": "NCT07167329", "title": "Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial", "status": "RECRUITING", "start": "2024-01-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "José Claudio Casali da Rocha", "countries": ["Brazil"]}, {"nct": "NCT06121271", "title": "Trial of Lu-177 DOTATATE (Lutathera®) in Unlicensed Indications", "status": "NOT_YET_RECRUITING", "start": "2023-12-18", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University College, London", "countries": []}, {"nct": "NCT04788927", "title": "Development of a Predictive Model for the Risk of Metastatic Disease in PPGLs, a Retrospective Cohort Study", "status": "NOT_YET_RECRUITING", "start": "2023-10-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Rigshospitalet, Denmark", "countries": ["Denmark"]}, {"nct": "NCT05636618", "title": "Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors", "status": "RECRUITING", "start": "2023-09-27", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Perspective Therapeutics", "countries": ["United States"]}, {"nct": "NCT06045260", "title": "\"Receptor Radionuclide Therapy With 177Lu-DOTATOC", "status": "RECRUITING", "start": "2023-09-13", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS", "countries": ["Italy"]}, {"nct": "NCT05944237", "title": "HTL0039732 in Participants With Advanced Solid Tumours", "status": "RECRUITING", "start": "2023-07-13", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Cancer Research UK", "countries": ["United Kingdom"]}]}, {"batch": 2, "no": 61, "name_zh": "PIK3CA相关过度生长综合征", "query_terms": [{"term": "PIK3CA-related overgrowth spectrum disorder", "broad": false}, {"term": "PIK3CA related overgrowth syndrome", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 5, "g_fetched": 5, "g_countries": [["Australia", 2], ["United States", 2], ["Belgium", 1], ["France", 1], ["Germany", 1], ["Ireland", 1], ["Italy", 1], ["Spain", 1], ["United Kingdom", 1]], "g_trials": [{"nct": "NCT07679269", "title": "Roll-Over Study of Alpelisib (BYL719) for Continued Access and Long-Term Safety.", "status": "NOT_YET_RECRUITING", "start": "2026-12-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": []}, {"nct": "NCT06789913", "title": "A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)", "status": "RECRUITING", "start": "2025-06-13", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Relay Therapeutics, Inc.", "countries": ["Australia", "Belgium", "France", "Germany", "Ireland", "Italy", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT05983159", "title": "A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations", "status": "RECRUITING", "start": "2024-09-13", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Murdoch Childrens Research Institute", "countries": ["Australia"]}, {"nct": "NCT00001403", "title": "Study of Proteus Syndrome and Related Congenital Disorders", "status": "RECRUITING", "start": "1994-04-27", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Human Genome Research Institute (NHGRI)", "countries": ["United States"]}, {"nct": "NCT04085653", "title": "Managed Access Programs for BYL719, Alpelisib", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "Novartis Pharmaceuticals", "countries": []}]}, {"batch": 2, "no": 62, "name_zh": "真性红细胞增多症", "query_terms": [{"term": "Polycythemia vera", "broad": false}, {"term": "Polycythaemia vera", "broad": false}], "n_total": 21, "n_open": 8, "n_open_precise": 8, "n_broad": 0, "trials": [{"nct": "NCT05870475", "title": "Pegylated Interferon α-2b in Combination With Ruxolitinib for Treating Hydroxyurea-resistant/Intolerant PV", "status": "RECRUITING", "start": "2023-06-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 94, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Polycythemia Vera"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06752746", "title": "A Study of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of 9MW3011 in Patients With Polycythemia Vera", "status": "RECRUITING", "start": "2024-03-21", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 108, "sponsor": "Mabwell (Shanghai) Bioscience Co., Ltd.", "conditions": ["Polycythemia Vera"], "cn_sites": [{"facility": "Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "The Second Hospital of Tianjin Medical University", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT06378437", "title": "A Study of GLB-001 in Patients With Myeloid Malignancies", "status": "RECRUITING", "start": "2024-05-24", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 108, "sponsor": "Hangzhou GluBio Pharmaceutical Co., Ltd.", "conditions": ["Polycythemia Vera", "Essential Thrombocythemia", "Myelofibrosis", "Myelodysplastic Syndromes", "Acute Myeloid Leukemia", "Myeloid Malignancy"], "cn_sites": [{"facility": "The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)", "city": "Hefei", "status": "RECRUITING"}, {"facility": "China-Japan Friendship Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "The First Hospital of Hebei Medical Universtiy", "city": "Shijiazhuang", "status": "RECRUITING"}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Zhongnan Hospital of Wuhan University", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Sheng Jing Hospital of China Medical Universtiy", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Huashan Hospital Affiliated to Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "The Second Hospital of Tianjin Medical Universtiy", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "The First Affilicated Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": "RECRUITING"}], "cn_site_count": 14, "broad_only": false}, {"nct": "NCT06734637", "title": "Efficacy and Safety of Peginterferon in ET and PV.", "status": "RECRUITING", "start": "2024-11-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Zhenya Hong", "conditions": ["Essential Thrombocythemia", "Polycythemia Vera"], "cn_sites": [{"facility": "Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07012109", "title": "Study of BEBT-507 Injection in Subjects With Polycythemia Vera (PV)", "status": "RECRUITING", "start": "2025-06-17", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "BeBetter Med Inc", "conditions": ["Polycythemia Vera"], "cn_sites": [{"facility": "Blood Diseases Hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07232290", "title": "Phase IIa Study of Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia Vera", "status": "RECRUITING", "start": "2025-09-23", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Chengdu Zenitar Biomedical Technology Co., Ltd", "conditions": ["Polycythemia Vera (PV)"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS)", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07445893", "title": "A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV", "status": "RECRUITING", "start": "2026-04-02", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Duan Minghui", "conditions": ["Polycythemia Vera (PV)"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07357727", "title": "A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)", "status": "RECRUITING", "start": "2026-06-16", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 460, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Primary Myelofibrosis (PMF)", "Post-polycythemia Vera Myelofibrosis (PPV-MF)", "Post-essential Thrombocythemia Myelofibrosis (PET-MF)"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Hefei", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Nantong", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Changchun", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Yantai", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Kunming", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Wenzhou", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 17, "broad_only": false}, {"nct": "NCT01178281", "title": "Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence", "status": "COMPLETED", "start": "2010-09-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 267, "sponsor": "Celgene", "conditions": ["Primary Myelofibrosis", "MPN-associated Myelofibrosis"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Jiangsu Province Hospital", "city": "Jiangsu", "status": ""}, {"facility": "Shanghai Ruijin Hospital", "city": "Shanghai", "status": ""}, {"facility": "West China Hospital, Sichuan University", "city": "Sichuan", "status": ""}, {"facility": "Blood Disease Hospital Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT01392443", "title": "Asian Phase II Study of INC424 in Patients With Primary Myelofibrosis (MF), Post-PV MF or Post-ET MF", "status": "COMPLETED", "start": "2010-10-14", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Primary Myelofibrosis (MF)", "Post-Polycythemia Vera (PV) MF", "Post-Essential Thrombocythemia (ET) MF"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Wuhan", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Nanjing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Suzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Chengdu", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Tianjin", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Hangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Jinan", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": ""}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT01243944", "title": "Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: (The RESPONSE Trial)", "status": "COMPLETED", "start": "2010-10-27", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 222, "sponsor": "Incyte Corporation", "conditions": ["Polycythemia Vera"], "cn_sites": [{"facility": "", "city": "Beijing", "status": ""}, {"facility": "", "city": "Hangzhou", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT01317875", "title": "Study of the JAK Inhibitor Ruxolitinib Administered Orally to Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera-Myelofibrosis (PPV-MF) or Post-Essential Thrombocythemia-Myelofibrosis (PET-MF)", "status": "COMPLETED", "start": "2011-03-31", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 69, "sponsor": "Incyte Corporation", "conditions": ["Myelofibrosis"], "cn_sites": [{"facility": "", "city": "Nanjing", "status": ""}, {"facility": "", "city": "Chengdu", "status": ""}, {"facility": "", "city": "Hangzhou", "status": ""}, {"facility": "", "city": "Beijing", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT02386800", "title": "CINC424A2X01B Rollover Protocol", "status": "ACTIVE_NOT_RECRUITING", "start": "2015-03-05", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 279, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Primary Myelofibrosis", "Polycythemia Vera", "Graft Versus Host Disease", "Acute Myeloid Leukemia", "Thalassemia"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Hangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT02663648", "title": "Cell Cycle Regulatory Gene Study in Patients With Myeloproliferative Disorders", "status": "WITHDRAWN", "start": "2016-06", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 0, "sponsor": "Shandong University", "conditions": ["Myeloproliferative Disorders", "Polycythemia Vera", "Essential Thrombocythemia", "Myelofibrosis", "Chronic Myeloid Leukemia"], "cn_sites": [{"facility": "Qilu Hospital, Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03952039", "title": "An Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy in Subjects With DIPSS-intermediate or High-risk Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib", "status": "COMPLETED", "start": "2019-09-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 202, "sponsor": "Celgene", "conditions": ["Primary Myelofibrosis", "Post-Polycythemia Vera", "Myelofibrosis"], "cn_sites": [{"facility": "Local Institution - 555", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 550", "city": "Guangzhou, Guangdong", "status": ""}, {"facility": "Local Institution - 553", "city": "Tianjin", "status": ""}, {"facility": "Local Institution - 557", "city": "Zhengzhou", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT04217993", "title": "Jaktinib for the Treatment of Ruxolitinib Intolerance of Myelofibrosis", "status": "COMPLETED", "start": "2020-01-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 51, "sponsor": "Suzhou Zelgen Biopharmaceuticals Co.,Ltd", "conditions": ["Primary Myelofibrosis (PMF)", "Post-polycythemia Vera Myelofibrosis(Post-PV MF)", "Post-essential Thrombocythemia Myelofibrosis(Post-ET MF)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Medical School of Zhejiang University", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04279847", "title": "Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-02-23", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 140, "sponsor": "Incyte Corporation", "conditions": ["Myelofibrosis", "Myelodysplastic Syndrome", "Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndrome", "Myeloproliferative Neoplasm", "Relapsed or Refractory Primary Myelofibrosis", "Secondary Myelofibrosis (Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis)", "ET (Essential Thrombocythemia)"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Nanfang Hospital_Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital, Zhejiang University School of Medicine (Fahzu)", "city": "Hangzhou", "status": ""}, {"facility": "Henan Cancer Hostipal", "city": "Zhengzhou", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT04717414", "title": "An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-02-25", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 313, "sponsor": "Celgene", "conditions": ["Myeloproliferative Disorders", "Myelofibrosis", "Primary Myelofibrosis", "Post-Polycythemia Vera Myelofibrosis", "Anemia"], "cn_sites": [{"facility": "Nanfang Hospital of Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Nanyang Medical College", "city": "Nanyang", "status": ""}, {"facility": "Xiangya Hospital Central-South University", "city": "Changsha", "status": ""}, {"facility": "Local Institution - 804", "city": "Nanjing", "status": ""}, {"facility": "Local Institution - 818", "city": "Nantong", "status": ""}, {"facility": "Local Institution - 820", "city": "Nanchang", "status": ""}, {"facility": "Nanchang University - The Second Affiliated Hospital", "city": "Nanchang", "status": ""}, {"facility": "Local Institution - 821", "city": "Qingdao", "status": ""}, {"facility": "Local Institution - 816", "city": "Taiyuan", "status": ""}, {"facility": "The Second Affiliated Hospital Of Kunming Medical University", "city": "Kunming", "status": ""}, {"facility": "Beijing Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 802", "city": "Changchun", "status": ""}, {"facility": "Guangdong General Hospital", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital Of Harbin Medical University", "city": "Harbin", "status": ""}, {"facility": "Local Institution - 809", "city": "Shanghai", "status": ""}, {"facility": "Local Institution - 801", "city": "Shanghai", "status": ""}, {"facility": "Local Institution - 811", "city": "Suzhou", "status": ""}, {"facility": "Local Institution - 800", "city": "Tianjin", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "Local Institution - 810", "city": "Zhengzhou", "status": ""}], "cn_site_count": 20, "broad_only": false}, {"nct": "NCT04551066", "title": "To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)", "status": "TERMINATED", "start": "2021-05-24", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 252, "sponsor": "Incyte Corporation", "conditions": ["Myelofibrosis", "Primary Myelofibrosis", "Post Essential Thrombocythemia Myelofibrosis", "Post Polycythemia Vera Myelofibrosis"], "cn_sites": [{"facility": "Affiliated Hospital of Hebei University", "city": "Baoding", "status": ""}, {"facility": "Peking University People'S Hospital (Pkuph) - Institute of Hematology", "city": "Beijing", "status": ""}, {"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": ""}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Guangdong Provincial of People Hospital", "city": "Guangzhou", "status": ""}, {"facility": "Nanfang Hospital", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Zhejiang University", "city": "Hangzhou", "status": ""}, {"facility": "Harbin Institute of Hematology and Oncology", "city": "Harbin", "status": ""}, {"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": ""}, {"facility": "The Affiliated Hospital of Inner Mongolia Medical University", "city": "Hohhot", "status": ""}, {"facility": "Jinan Central Hospital", "city": "Jinan", "status": ""}, {"facility": "The First Hospital of Lanzhou University", "city": "Lanzhou", "status": ""}, {"facility": "Lanzhou University Second Hospital", "city": "Lanzhou", "status": ""}, {"facility": "Jiangxi Provincial of People Hospital", "city": "Nanchang", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": ""}, {"facility": "Jiangsu Province Hospital", "city": "Nanjing", "status": ""}, {"facility": "Zhongshan Hospital Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shenzhen University Hospital", "city": "Shenzhen", "status": ""}, {"facility": "The Second Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": ""}, {"facility": "Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Yantai Yuhuangding Hospital", "city": "Yantai", "status": ""}, {"facility": "Henan Provincial Peoples Hospital", "city": "Zhengzhou", "status": ""}], "cn_site_count": 26, "broad_only": false}, {"nct": "NCT04551053", "title": "To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304)", "status": "TERMINATED", "start": "2021-05-26", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 177, "sponsor": "Incyte Corporation", "conditions": ["Myelofibrosis", "Primary Myelofibrosis", "Post Essential Thrombocythemia Myelofibrosis", "Post Polycythemia Vera Myelofibrosis"], "cn_sites": [{"facility": "Peking University People'S Hospital (Pkuph) - Institute of Hematology", "city": "Beijing", "status": ""}, {"facility": "Xuanwu Hospital Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "The First Peoples Hospital of Changzhou", "city": "Changzhou", "status": ""}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Nanfang Hospital", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Zhejiang University", "city": "Hangzhou", "status": ""}, {"facility": "Harbin Institute of Hematology and Oncology", "city": "Harbin", "status": ""}, {"facility": "University of Science and Technology of China-First Affiliated Hospital (Anhui Provincial Hospital)", "city": "Hefei", "status": ""}, {"facility": "The Affiliated Hospital of Inner Mongolia Medical University", "city": "Hohhot", "status": ""}, {"facility": "Jinan Central Hospital", "city": "Jinan", "status": ""}, {"facility": "The Second Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}, {"facility": "The First Hospital of Lanzhou University", "city": "Lanzhou", "status": ""}, {"facility": "Lanzhou University Second Hospital", "city": "Lanzhou", "status": ""}, {"facility": "Jiangxi Provincial of People Hospital", "city": "Nanchang", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": ""}, {"facility": "Jiangsu Province Hospital", "city": "Nanjing", "status": ""}, {"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": ""}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "Shenzhen University Hospital", "city": "Shenzhen", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Pek", "city": "Tianjin", "status": ""}, {"facility": "Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Tongji Hospital Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "The Second Affiliated Hospital of Xi an Jiaotong University", "city": "Xi'an", "status": ""}, {"facility": "Yantai Yuhuangding Hospital", "city": "Yantai", "status": ""}, {"facility": "Henan Provincial Peoples Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Henan Cancer Hostipal", "city": "Zhengzhou", "status": ""}], "cn_site_count": 29, "broad_only": false}, {"nct": "NCT05485948", "title": "A Study to Access Efficacy and Safety of P1101 in Chinese PV Patients Who Are Intolerant or Resistance to HU", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-10-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 49, "sponsor": "PharmaEssentia", "conditions": ["Polycythemia Vera"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": ""}, {"facility": "The First Affiliated Hospital of Chongqing Medical Universit", "city": "Chongqing", "status": ""}, {"facility": "Nanfang Hospital affiliated to Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": ""}, {"facility": "Huashan Hospital affiliated to Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Ruijin Hospital affiliated to Shanghai Jiaotong University", "city": "Shanghai", "status": ""}, {"facility": "Shenzhen Second People's Hospital", "city": "Shenzhen", "status": ""}, {"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "Institute of Hematology &Blood Diseases Hospital ,Chinese Academy of medical science & Peking Union Medical College", "city": "Tianjin", "status": ""}, {"facility": "The Second Hospital of Tianjin Medical University", "city": "Tianjin", "status": ""}, {"facility": "Zhongnan Hospital affiliated to Wuhan University", "city": "Wuhan", "status": ""}, {"facility": "The First Affiliated Hospital Zhejiang University of Medicine", "city": "Zhejiang", "status": ""}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}], "cn_site_count": 14, "broad_only": false}], "g_total": 62, "g_fetched": 54, "g_countries": [["United States", 27], ["Italy", 9], ["France", 9], ["Germany", 6], ["Spain", 6], ["United Kingdom", 6], ["Australia", 5], ["Japan", 4], ["Canada", 4], ["South Korea", 2], ["Hong Kong", 2], ["Netherlands", 2], ["Poland", 2], ["Belgium", 1], ["New Zealand", 1], ["Austria", 1], ["Bulgaria", 1], ["Croatia", 1], ["Hungary", 1], ["Ireland", 1], ["Israel", 1], ["Serbia", 1], ["Turkey (Türkiye)", 1]], "g_trials": [{"nct": "NCT07765602", "title": "A Study of Rusfertide in Adults With Polycythemia Vera in China", "status": "NOT_YET_RECRUITING", "start": "2027-03-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Takeda", "countries": []}, {"nct": "NCT07734077", "title": "Revumenib in Patients With Myelofibrosis", "status": "NOT_YET_RECRUITING", "start": "2026-12-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "John Mascarenhas", "countries": ["United States"]}, {"nct": "NCT07750574", "title": "Flonoltinib Maleate Oral Regimens in Patients With Myelofibrosis", "status": "NOT_YET_RECRUITING", "start": "2026-11", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Chengdu Zenitar Biomedical Technology Co., Ltd", "countries": []}, {"nct": "NCT07722611", "title": "A Clinical Trial of Bomedemstat in Participants With Polycythemia Vera (MK-3543-025)", "status": "NOT_YET_RECRUITING", "start": "2026-09-21", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Merck Sharp & Dohme LLC", "countries": []}, {"nct": "NCT07734272", "title": "Standardized Documentation and Assessments for Polycythemia Vera: A Quality Improvement Initiative", "status": "NOT_YET_RECRUITING", "start": "2026-08-05", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Massachusetts General Hospital", "countries": []}, {"nct": "NCT07518940", "title": "ENERGIA: Personalized Exercise Program for Fatigue in Patients With Myeloproliferative Neoplasms and Chronic Myeloid Leukemia", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Carmen Fava", "countries": ["Italy"]}, {"nct": "NCT07648030", "title": "A Study of Rusfertide in Japanese Adults With Polycythemia Vera", "status": "RECRUITING", "start": "2026-07-14", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Takeda", "countries": ["Japan"]}, {"nct": "NCT07349134", "title": "WELL-MPN: A Digital Lifestyle App for Patients With MPNs", "status": "NOT_YET_RECRUITING", "start": "2026-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Brigham and Women's Hospital", "countries": ["United States"]}, {"nct": "NCT07429266", "title": "INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)", "status": "RECRUITING", "start": "2026-05-25", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Ono Pharmaceutical Co., Ltd.", "countries": ["Australia", "Japan", "United States"]}, {"nct": "NCT07379125", "title": "Therapeutic RSK1 Targeting in Myelofibrosis", "status": "RECRUITING", "start": "2026-05-20", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Washington University School of Medicine", "countries": ["United States"]}, {"nct": "NCT07529951", "title": "Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers", "status": "NOT_YET_RECRUITING", "start": "2026-05-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Eilean Therapeutics", "countries": []}, {"nct": "NCT07441694", "title": "Study of INCA036978 in Participants With Myeloproliferative Neoplasms", "status": "RECRUITING", "start": "2026-05-11", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Incyte Corporation", "countries": ["Australia", "Belgium", "Canada", "France", "Germany", "Italy", "Japan", "South Korea", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT07447817", "title": "Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias", "status": "NOT_YET_RECRUITING", "start": "2026-05-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "John Mascarenhas", "countries": ["United States"]}, {"nct": "NCT07469891", "title": "A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms", "status": "RECRUITING", "start": "2026-04-29", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Prelude Therapeutics Incorporated", "countries": ["Spain", "United States"]}, {"nct": "NCT07527221", "title": "Safety and Tolerability of ZE74-0282 in Healthy Volunteers", "status": "RECRUITING", "start": "2026-04-16", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Eilean Therapeutics AU Pty Ltd", "countries": ["Australia"]}, {"nct": "NCT06976918", "title": "Research Platform Myelofibrosis and Anemia", "status": "RECRUITING", "start": "2026-02-19", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "iOMEDICO AG", "countries": ["Germany"]}, {"nct": "NCT07282132", "title": "Evaluation of Real-World Data on Ropeginterferon Alfa-2b in Patients With Polycythemia Vera: Insights From a Multicenter Study", "status": "NOT_YET_RECRUITING", "start": "2026-01-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Federico II University", "countries": []}, {"nct": "NCT07341048", "title": "Potential Biological and Physiological Determinants for Exercice in Patients With Polycythemia Vera", "status": "NOT_YET_RECRUITING", "start": "2026-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Hospices Civils de Lyon", "countries": ["France"]}, {"nct": "NCT07203768", "title": "A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes", "status": "RECRUITING", "start": "2025-12-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS", "countries": ["Germany", "Italy", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT07362225", "title": "MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)", "status": "RECRUITING", "start": "2025-09-26", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "MPN Research Foundation", "countries": ["United States"]}, {"nct": "NCT06661915", "title": "A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)", "status": "RECRUITING", "start": "2025-08-14", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["United States"]}, {"nct": "NCT06923670", "title": "Prevalence Of Germline Gene Mutations In Patients With Myeloproliferative Neoplasms With Family History", "status": "NOT_YET_RECRUITING", "start": "2025-05-21", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Fondazione Policlinico Universitario Agostino Gemelli IRCCS", "countries": []}, {"nct": "NCT06517875", "title": "Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis", "status": "RECRUITING", "start": "2025-02-28", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "GlaxoSmithKline", "countries": ["Canada", "France", "Germany", "Italy", "Spain", "United States"]}, {"nct": "NCT06785870", "title": "EVAluation of Erythrocytosis PRospEctive Cohort STudy", "status": "NOT_YET_RECRUITING", "start": "2025-02-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Cyrus Hsia", "countries": ["Canada"]}, {"nct": "NCT06743035", "title": "Ropeginterferon Alfa-2b in Patients With Polycythemia Vera (PV) Without Symptomatic Splenomegaly", "status": "RECRUITING", "start": "2024-12-03", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "iOMEDICO AG", "countries": ["Germany"]}]}, {"batch": 2, "no": 63, "name_zh": "原发性胆汁性胆管炎", "query_terms": [{"term": "Primary biliary cholangitis", "broad": false}], "n_total": 56, "n_open": 15, "n_open_precise": 15, "n_broad": 0, "trials": [{"nct": "NCT06365424", "title": "Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)", "status": "RECRUITING", "start": "2017-04-08", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 117, "sponsor": "Xijing Hospital of Digestive Diseases", "conditions": ["Primary Biliary Cholangitis"], "cn_sites": [{"facility": "Xijing Hospital", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04650243", "title": "Clinical Research of Tapering UDCA in PBC Patients With a Complete Response", "status": "RECRUITING", "start": "2020-01-21", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Primary Biliary Cholangitis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05749822", "title": "Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis", "status": "RECRUITING", "start": "2023-02-17", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 104, "sponsor": "Xijing Hospital of Digestive Diseases", "conditions": ["Primary Biliary Cholangitis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Sun Yat-sen Memorial Hospital", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Jiangsu Province Hospital", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Xijing Hospital", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "Yan'an University Affiliated Hospital", "city": "Yan’an", "status": "RECRUITING"}, {"facility": "Sichuan Provincial People's Hospital", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Tianjin Third Central Hospital", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": "RECRUITING"}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 12, "broad_only": false}, {"nct": "NCT05751967", "title": "Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis", "status": "RECRUITING", "start": "2023-02-22", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 150, "sponsor": "Xijing Hospital of Digestive Diseases", "conditions": ["Primary Biliary Cholangitis"], "cn_sites": [{"facility": "The second hospital of Lanzhou University", "city": "Lanzhou", "status": "RECRUITING"}, {"facility": "Sun Yat-sen Memorial Hospital", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Ying han", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "Sichuan Provincial People's Hospital,", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT06051617", "title": "Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis", "status": "RECRUITING", "start": "2023-09-07", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 402, "sponsor": "Gilead Sciences", "conditions": ["Primary Biliary Cholangitis"], "cn_sites": [{"facility": "Beijing Youan Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Ditan Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": "RECRUITING"}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "Mengchao Hepatobiliary Hospital of Fujian Medical University", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "The Third Affiliated Hospital, Sun Yat-Sen University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Guizhou Provincial People's Hospital", "city": "Guiyang", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": "RECRUITING"}, {"facility": "The First People's Hospital of Yunnan Province", "city": "Kunming", "status": "RECRUITING"}, {"facility": "The Second Hospital of Nanjing", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Shanghai Jiaotong University School of Medicine, Renji Hospital", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Xinjiang Medical University", "city": "Ürümqi", "status": "RECRUITING"}, {"facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of PLA Air Force Medical University", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital, Zhejiang University School of Medicine", "city": "Zhejiang", "status": "RECRUITING"}, {"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "The Third People's Hospital of Zhenjiang", "city": "Zhenjiang", "status": "RECRUITING"}], "cn_site_count": 20, "broad_only": false}, {"nct": "NCT06755151", "title": "Fenofibrate in Primary Biliary Cholangitis: a Real World Study", "status": "RECRUITING", "start": "2024-01-17", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 300, "sponsor": "Xijing Hospital of Digestive Diseases", "conditions": ["Primary Biliary Cholangitis (PBC)"], "cn_sites": [{"facility": "Xijing hospital", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06755541", "title": "Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study", "status": "RECRUITING", "start": "2024-01-30", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 150, "sponsor": "Xijing Hospital of Digestive Diseases", "conditions": ["Primary Biliary Cholangitis (PBC)"], "cn_sites": [{"facility": "Xijing hospital", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06591468", "title": "A Multicenter, Randomized, Controlled Trial of Prednisone Combined With Ursodeoxycholic Acid in the Treatment of Primary Biliary Cholangitis With Moderate to Severe Interface Hepatitis Characteristics", "status": "ENROLLING_BY_INVITATION", "start": "2024-10-30", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 244, "sponsor": "Han Ying", "conditions": ["Primary Biliary Cholangitis (PBC)"], "cn_sites": [{"facility": "Sun Yat-sen Memorial Hospital", "city": "Guangzhou", "status": ""}, {"facility": "Xijing hospital", "city": "Xi'an", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07149675", "title": "PBC Long-term Outcomes Study", "status": "RECRUITING", "start": "2025-05-18", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 4000, "sponsor": "Beijing Friendship Hospital", "conditions": ["Primary Biliary Cholangitis (PBC)", "Long-term Outcomes", "Prognosis", "Multicenter Prospective Study"], "cn_sites": [{"facility": "Liver Research Center, Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07282353", "title": "A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA", "status": "RECRUITING", "start": "2025-12-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 135, "sponsor": "Cascade Pharmaceuticals, Inc", "conditions": ["Primary Biliary Cholangitis"], "cn_sites": [{"facility": "The First Affiliated Hospital of USTC Anhui Provincial Hospital", "city": "Hefei", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": "RECRUITING"}, {"facility": "Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Youan Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "China-Japan Friendship Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Chongqing University Three Gorges Hospital", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "Mengchao Hepatobiliary Hospital Of Fujian Medical University", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "Xiamen Hospital of T.C,M.", "city": "Xiamen", "status": "RECRUITING"}, {"facility": "Peking University Shenzhen Hospital", "city": "Shenzhen", "status": "RECRUITING"}, {"facility": "Shenzhen Third People's Hospital", "city": "Shenzhen", "status": "RECRUITING"}, {"facility": "Affiliated Hospital of Guangdong Medical University", "city": "Zhanjiang", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": "RECRUITING"}, {"facility": "The Fourth Hospital Of Harbin Medical University", "city": "Harbin", "status": "RECRUITING"}, {"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Taihe Hospital of Shiyan", "city": "Shiyan", "status": "RECRUITING"}, {"facility": "Zhongnan Hospital of Wuhan University", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Jiangsu Province Hospital", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "The Second Hospital of Nanjing", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "The Fifth People's Hospital of Suzhou", "city": "Suzhou", "status": "RECRUITING"}, {"facility": "The Fifth People's Hospital Of Wuxi", "city": "Wuxi", "status": "RECRUITING"}, {"facility": "The Third People's Hospital of Zhenjiang", "city": "Zhenjiang", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "The First Bethune Hospital of Jilin University", "city": "Changchun", "status": "RECRUITING"}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "The Fourth People's Hospital of Qinghai Province", "city": "Xining", "status": "NOT_YET_RECRUITING"}, {"facility": "Baoji People's Hospital", "city": "Baoji", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "Linyi People's Hospital", "city": "Linyi", "status": "RECRUITING"}, {"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": "RECRUITING"}, {"facility": "Renji Hospital, School of Medicine, Shanghai Jiao Tong University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Shanghai Jiao Tong University School of Medicine Ruijin Hospital", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Xin Hua Hospital Affiliated To Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Tianjin First Central Hospital", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "Tianjin Third Central Hospital", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "Hangzhou Xixi Hospital", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Ningbo Medical Center Li Huili hospital", "city": "Ningbo", "status": "NOT_YET_RECRUITING"}, {"facility": "Taizhou Hospital of Zhejiang Province", "city": "Taizhou", "status": "RECRUITING"}], "cn_site_count": 42, "broad_only": false}, {"nct": "NCT07296458", "title": "FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy", "status": "RECRUITING", "start": "2025-12-15", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 132, "sponsor": "Xijing Hospital of Digestive Diseases", "conditions": ["Primary Biliary Cholangitis (PBC)"], "cn_sites": [{"facility": "Xijing Hospital", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07449793", "title": "Biochemical Response and Clinical Outcomes in Patients With PBC", "status": "RECRUITING", "start": "2026-02-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 3000, "sponsor": "RenJi Hospital", "conditions": ["Primary Biliary Cholangitis (PBC)", "Primary Biliary Cholangitis"], "cn_sites": [{"facility": "RenJi Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07678645", "title": "The Safety and Efficacy of Upadacitinib in Refractory Autoimmune Related Cholangitis and Atopic Dermatitis With Moderate to Severe Itching", "status": "NOT_YET_RECRUITING", "start": "2026-06-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 44, "sponsor": "RenJi Hospital", "conditions": ["Primary Biliary Cholangitis (PBC)", "Primary Sclerosing Cholangitis (PSC)", "Atopic Dermatitis (AD)"], "cn_sites": [{"facility": "RenJi Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07733882", "title": "Study on Clinical and Pathological Features of Primary Biliary Cholangitis and Risk Factors Related to Disease Progression", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 300, "sponsor": "Beijing Municipal Administration of Hospitals", "conditions": ["PBC"], "cn_sites": [{"facility": "Beijing Ditan Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07795151", "title": "Phase I/II Trial of Human Umbilical Cord Mesenchymal Stromal Cells for UDCA-Refractory Primary Biliary Cholangitis", "status": "NOT_YET_RECRUITING", "start": "2026-08-31", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 68, "sponsor": "Beijing 302 Hospital", "conditions": ["Primary Biliary Cholangitis"], "cn_sites": [{"facility": "Beijing 302 Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01857284", "title": "Safety and Efficacy of Tauroursodeoxycholic Acid Versus Ursofalk in the Treatment of Adult Primary Biliary Cirrhosis", "status": "COMPLETED", "start": "2009-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 216, "sponsor": "Beijing Friendship Hospital", "conditions": ["Primary Biliary Cirrhosis"], "cn_sites": [{"facility": "Beijing 302 Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Ditan Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Friendship Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Youan Hospital", "city": "Beijing", "status": ""}, {"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "Peiking University First Hosptial", "city": "Beijing", "status": ""}, {"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}, {"facility": "First Affiliated Hospital,SunYat-Sen University", "city": "Guangzhou", "status": ""}, {"facility": "Nanfang Hospital of Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Third Affiliated Hospital,SunYat-Sen University", "city": "Guangzhou", "status": ""}, {"facility": "Tongji Hospital", "city": "Wuhan", "status": ""}, {"facility": "85 Military Hospital", "city": "Shanghai", "status": ""}, {"facility": "Eastern Hepatobiliary Surgery Hospital", "city": "Shanghai", "status": ""}, {"facility": "Huashan Hospital", "city": "Shanghai", "status": ""}, {"facility": "NO.3 People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "RenJi Hospital", "city": "Shanghai", "status": ""}, {"facility": "RuiJin Hospital", "city": "Shanghai", "status": ""}, {"facility": "ShangHai Changzheng Hospital", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Public Health Clinical Center", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Zhongshan Hospital", "city": "Shanghai", "status": ""}, {"facility": "Xijing Hospital", "city": "Xian", "status": ""}, {"facility": "West China Hospital", "city": "Chengdu", "status": ""}, {"facility": "First Affiliated Hospital Of KunMing Medical College", "city": "Kunming", "status": ""}, {"facility": "The Sixth People's Hospital of Hangzhou", "city": "Hangzhou", "status": ""}, {"facility": "First Affiliated Hospital of Zhejiang University", "city": "Zhejiang", "status": ""}], "cn_site_count": 25, "broad_only": false}, {"nct": "NCT01662973", "title": "Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis", "status": "UNKNOWN", "start": "2011-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Beijing 302 Hospital", "conditions": ["Primary Biliary Cirrhosis"], "cn_sites": [{"facility": "Beijing 302 Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01440309", "title": "Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis", "status": "UNKNOWN", "start": "2011-11", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Robert Chunhua Zhao, MD, PhD", "conditions": ["Primary Biliary Cirrhosis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02965911", "title": "Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCA", "status": "WITHDRAWN", "start": "2016-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Beijing 302 Hospital", "conditions": ["Primary Biliary Cirrhosis"], "cn_sites": [{"facility": "Beijing 302 hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02916290", "title": "Fuzhenghuayu in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis", "status": "UNKNOWN", "start": "2016-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 200, "sponsor": "Xijing Hospital of Digestive Diseases", "conditions": ["Primary Biliary Cirrhosis"], "cn_sites": [{"facility": "Xijing Hosipital of Digestive Disease", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02916641", "title": "Fuzhenghuayu for Patients With PBC Who Had An Inadequate Response to Ursodeoxycholic Acid", "status": "UNKNOWN", "start": "2016-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 200, "sponsor": "Xijing Hospital of Digestive Diseases", "conditions": ["Primary Biliary Cirrhosis"], "cn_sites": [{"facility": "Xijing Hosipital of Digestive Disease", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02823366", "title": "Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid", "status": "UNKNOWN", "start": "2016-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 104, "sponsor": "Xijing Hospital of Digestive Diseases", "conditions": ["Primary Biliary Cirrhosis"], "cn_sites": [{"facility": "Xijing Hosipital", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03322943", "title": "The Comparison About the Response of Ursodeoxycholic Acid in Primary Biliary Cholangitis Only and Primary Biliary Cholangitis With High Immune Globulin G or Aminotransferase at West China Hospital", "status": "COMPLETED", "start": "2016-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 300, "sponsor": "West China Hospital", "conditions": ["Primary Biliary Cholangitis"], "cn_sites": [{"facility": "West China Hospital", "city": "Chengdu", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02823353", "title": "Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis", "status": "COMPLETED", "start": "2016-04-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 117, "sponsor": "Xijing Hospital of Digestive Diseases", "conditions": ["Primary Biliary Cirrhosis"], "cn_sites": [{"facility": "Xijing Hosipital", "city": "Xi'an", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02917408", "title": "Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital", "status": "COMPLETED", "start": "2016-09", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 769, "sponsor": "Xiaoli Fan", "conditions": ["Cholangitis", "Liver Cirrhosis, Biliary", "Cholestasis", "Liver Diseases", "Liver Cirrhosis", "Bile Duct Diseases"], "cn_sites": [{"facility": "West China Hospital", "city": "Chengdu", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02936596", "title": "Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome", "status": "UNKNOWN", "start": "2016-12", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 53, "sponsor": "Xiaoli Fan", "conditions": ["Hepatitis, Autoimmune", "Cholangitis", "Liver Cirrhosis, Biliary", "Cholestasis"], "cn_sites": [{"facility": "West China Hospital", "city": "Chengdu", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03188146", "title": "Performance of Scoring Systems in Chinese Patients With Primary Biliary Cholangitis (PBC) on Ursodeoxycholic Acid", "status": "COMPLETED", "start": "2017-05-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 57, "sponsor": "Humanity and Health Research Centre", "conditions": ["Primary Biliary Cholangitis (PBC)"], "cn_sites": [{"facility": "Centre of non-infectious liver diseases, Beijing 302 Hospital, Beijing, China.", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03545672", "title": "Early Identification of Myocardial Impairment in PBC", "status": "COMPLETED", "start": "2017-10-23", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 119, "sponsor": "RenJi Hospital", "conditions": ["Primary Biliary Cholangitis", "Cardiovascular Abnormalities"], "cn_sites": [{"facility": "Renji Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03668145", "title": "Mesenchymal Stem Cell Transplantation for Refractory Primary Biliary Cholangitis", "status": "UNKNOWN", "start": "2017-11-08", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 140, "sponsor": "Xijing Hospital of Digestive Diseases", "conditions": ["Primary Biliary Cirrhosis"], "cn_sites": [{"facility": "Changcun Guo", "city": "Xi'an", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03345589", "title": "A Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary Cholangitis", "status": "UNKNOWN", "start": "2018-01-30", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "West China Hospital", "conditions": ["Primary Biliary Cholangitis"], "cn_sites": [{"facility": "West China Hospital", "city": "Chengdu", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03590886", "title": "Gut Microbes and Metabolic Group in Different PBC Patients for UDCA Response", "status": "COMPLETED", "start": "2018-08-22", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 60, "sponsor": "Sun Yat-sen University", "conditions": ["Primary Biliary Cirrhosis"], "cn_sites": [{"facility": "The Third Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03521297", "title": "Probiotics in PBC Patients of Poor Response to UDCA", "status": "UNKNOWN", "start": "2020-01-20", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Sun Yat-sen University", "conditions": ["Primary Biliary Cholangitis (PBC)"], "cn_sites": [{"facility": "Third Affliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04278820", "title": "A Study of TQA3526 in the Treatment of Primary Biliary Cirrhosis (PBC)", "status": "UNKNOWN", "start": "2020-03-20", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 130, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Primary Biliary Cirrhosis"], "cn_sites": [{"facility": "The first hospital of Jilin University", "city": "Changchun", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04167358", "title": "Linerixibat Long-term Safety, and Tolerability Study", "status": "ACTIVE_NOT_RECRUITING", "start": "2020-07-14", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 242, "sponsor": "GlaxoSmithKline", "conditions": ["Cholestasis"], "cn_sites": [{"facility": "GSK Investigational Site", "city": "Beijing", "status": ""}, {"facility": "GSK Investigational Site", "city": "Changchun", "status": ""}, {"facility": "GSK Investigational Site", "city": "Chongqing", "status": ""}, {"facility": "GSK Investigational Site", "city": "Guangzhou", "status": ""}, {"facility": "GSK Investigational Site", "city": "Nanchang", "status": ""}, {"facility": "GSK Investigational Site", "city": "Nanjing", "status": ""}, {"facility": "GSK Investigational Site", "city": "Shanghai", "status": ""}, {"facility": "GSK Investigational Site", "city": "Tianjin", "status": ""}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT04617561", "title": "Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II", "status": "UNKNOWN", "start": "2020-11-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "West China Hospital", "conditions": ["Hepatitis, Autoimmune", "Primary Biliary Cholangitis"], "cn_sites": [{"facility": "Division of Gastroenterology & Hepatology,West China Hospital,Sichuan University", "city": "Chengdu", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05181332", "title": "Predictive Models of Hepatic Decompensation and Survival Outcomes in Pediatric Patients With Cirrhosis", "status": "UNKNOWN", "start": "2021-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 400, "sponsor": "West China Hospital", "conditions": ["Cirrhosis", "Biliary Atresia", "Choledochal Cyst", "Primary Sclerosing Cholangitis", "HBV", "HCV", "Autoimmune Hepatitis"], "cn_sites": [{"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04618575", "title": "Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1", "status": "UNKNOWN", "start": "2021-03-17", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 137, "sponsor": "West China Hospital", "conditions": ["Hepatitis", "Primary Biliary Cholangitis", "Autoimmune"], "cn_sites": [{"facility": "West China Hospital", "city": "Chengdu", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04981756", "title": "PSC Clinical Epidemiology in China", "status": "UNKNOWN", "start": "2021-04-07", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 800, "sponsor": "Beijing Friendship Hospital", "conditions": ["Primary Sclerosing Cholangitis"], "cn_sites": [{"facility": "Beijing Friendship Hospital, Capital Medical Univeristy", "city": "Beijing", "status": ""}, {"facility": "Beijing Youan Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Shanghai Suvalue Health Scientific Ltd.", "city": "Shanghai", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT06309589", "title": "The Effectiveness of Combining Ursodeoxycholic Acid With Vitamin D in Treating Patients With Primary Biliary Cholangitis", "status": "COMPLETED", "start": "2021-05-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Yilihamu·Abilitifu", "conditions": ["Primary Biliary Cholangitis"], "cn_sites": [{"facility": "People's Hospital of Xinjiang Uygur Autonomous Region", "city": "Ürümqi", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04933292", "title": "A Randomised Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome", "status": "UNKNOWN", "start": "2021-06-16", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 78, "sponsor": "Xiaoli Fan", "conditions": ["Autoimmune Hepatitis", "Primary Biliary Cirrhosis"], "cn_sites": [{"facility": "West China Hospital of Sichuan Univerisity", "city": "Chengdu", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04376528", "title": "Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy", "status": "UNKNOWN", "start": "2021-06-16", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 89, "sponsor": "West China Hospital", "conditions": ["Hepatitis, Autoimmune", "Primary Biliary Cholangitis", "Immunosuppression"], "cn_sites": [{"facility": "WestChina Hospital", "city": "Chengdu", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04956328", "title": "Study of Obeticholic Acid（OCA） Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC)", "status": "UNKNOWN", "start": "2021-07-22", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Primary Biliary Cirrhosis"], "cn_sites": [{"facility": "The first hospital of Jilin University", "city": "Changchun", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05050136", "title": "A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-09-22", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 333, "sponsor": "Mirum Pharmaceuticals, Inc.", "conditions": ["Primary Biliary Cholangitis", "PBC"], "cn_sites": [{"facility": "Mengchao Hepatobiliary Hospital of Fujian Medical University", "city": "Fuzhou", "status": ""}, {"facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "The First Affiliated Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Beijing Youan Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Sir Run Run Shaw Hospital -Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT05450887", "title": "Efficacy and Safety of Obeticholic Acid in the Treatment of Primary Biliary Cholangitis", "status": "COMPLETED", "start": "2021-09-23", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 108, "sponsor": "Nanjing Chia-tai Tianqing Pharmaceutical", "conditions": ["Primary Biliary Cholangitis"], "cn_sites": [{"facility": "Beijing Friendship Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06715319", "title": "Obeticholic Acid Versus Placebo, in Combination with Ursodeoxycholic Acid in Patients with Primary Biliary Cirrhosis", "status": "COMPLETED", "start": "2021-10-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.", "conditions": ["PBC"], "cn_sites": [{"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05190523", "title": "Study to Evaluate the Safety and Efficacy of ASC42 Tablets in Subjects With Primary Biliary Cholangitis", "status": "COMPLETED", "start": "2022-04-06", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 98, "sponsor": "Gannex Pharma Co., Ltd.", "conditions": ["Primary Biliary Cholangitis"], "cn_sites": [{"facility": "Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05463445", "title": "Multicenter Observational Study of PSC and IgG4-SC in China", "status": "UNKNOWN", "start": "2022-07-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "RenJi Hospital", "conditions": ["Primary Sclerosing Cholangitis", "IgG4-related Sclerosing Cholangitis"], "cn_sites": [{"facility": "RenJi Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05624294", "title": "Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS0159 in Chinese Healthy Subjects", "status": "COMPLETED", "start": "2022-12-19", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Cascade Pharmaceuticals, Inc", "conditions": ["Primary Biliary Cholangitis"], "cn_sites": [{"facility": "Shanghai Xuhui Central Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05812612", "title": "UDCA in the Treatment of COVID-19 Infection and Its Clinical Prognosis in Patients With Autoimmune Liver Disease", "status": "UNKNOWN", "start": "2023-01-30", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2000, "sponsor": "Beijing Ditan Hospital", "conditions": ["COVID-19 Infection"], "cn_sites": [{"facility": "Department of Hepatology Division 2, Beijing Ditan Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05896124", "title": "CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-08-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 75, "sponsor": "Cascade Pharmaceuticals, Inc", "conditions": ["Primary Biliary Cholangitis (PBC)"], "cn_sites": [{"facility": "The First Affiliated Hospital of USTC Anhui Provincial Hospital", "city": "Hefei", "status": ""}, {"facility": "Beijing Friendship Hospital, Capitai Medical University", "city": "Beijing", "status": ""}, {"facility": "Beijing Youan Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "The Third Affiliated Hospital, Sun Yat-Sen University", "city": "Guangzhou", "status": ""}, {"facility": "The Fifth Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Wuhan Union Hospital of China", "city": "Wuhan", "status": ""}, {"facility": "The Seconed Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "The Third People's Hospital of Zhenjiang", "city": "Zhenjiang", "status": ""}, {"facility": "The First Bethune Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": ""}, {"facility": "Renji Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Shaoyifu Hospital of Zhejiang University Medical", "city": "Hangzhou", "status": ""}, {"facility": "The First Affiliated Hospital,Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 16, "broad_only": false}, {"nct": "NCT05896137", "title": "CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis)", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-08-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Cascade Pharmaceuticals, Inc", "conditions": ["Primary Sclerosing Cholangitis"], "cn_sites": [{"facility": "The First Affiliated Hospital of USTC Anhui Provincial Hospital", "city": "Hefei", "status": ""}, {"facility": "Beijing Friendship Hospital, Captail Medcial University", "city": "Beijing", "status": ""}, {"facility": "Beijing YouAn Hostital, Captial Medical University", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Wuhan Union Hospital of China", "city": "Wuhan", "status": ""}, {"facility": "The Seconed Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "The First Bethune Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": ""}, {"facility": "Renji Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Shaoyifu Hospital of Zhejiang University Medical", "city": "Hangzhou", "status": ""}, {"facility": "The First Affiliated Hospital,Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 11, "broad_only": false}, {"nct": "NCT06174402", "title": "Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-08-21", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 184, "sponsor": "Han Ying", "conditions": ["Primary Biliary Cholangitis"], "cn_sites": [{"facility": "The second hospital of Lanzhou University", "city": "Lanzhou", "status": ""}, {"facility": "Sun Yat-sen Memorial Hospital", "city": "Guangzhou", "status": ""}, {"facility": "Jiangsu Province Hospital", "city": "Nanjing", "status": ""}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": ""}, {"facility": "Nanjing Second Hospital", "city": "Nanjing", "status": ""}, {"facility": "Shengjing Hospital Affiliated to China Medical University", "city": "Shenyang", "status": ""}, {"facility": "Xijing Hospital", "city": "Xi'an", "status": ""}, {"facility": "Yan'an University Affiliated Hospital", "city": "Yan’an", "status": ""}, {"facility": "The Second Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "Tianjin Third Central Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 12, "broad_only": false}, {"nct": "NCT06098027", "title": "Study of [14C]CS0159 in China Healthy Subjects", "status": "COMPLETED", "start": "2023-10-23", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Cascade Pharmaceuticals, Inc", "conditions": ["Primary Biliary Cholangitis"], "cn_sites": [{"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06591455", "title": "A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary Cholangitis", "status": "COMPLETED", "start": "2024-09-14", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Han Ying", "conditions": ["Primary Biliary Cholangitis (PBC)"], "cn_sites": [{"facility": "Xijing hospital", "city": "Xi'an", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06888115", "title": "A Study of the Pharmacokinetics and Safety of CS0159 in Subjects With Hepatic Injury", "status": "COMPLETED", "start": "2025-03-13", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Cascade Pharmaceuticals, Inc", "conditions": ["Primary Biliary Cholangitis"], "cn_sites": [{"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "The Second Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "Renji Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07104201", "title": "Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-03-13", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Xijing Hospital of Digestive Diseases", "conditions": ["Primary Biliary Cholangitis (PBC)"], "cn_sites": [{"facility": "Xijing Hospital", "city": "Xi'an", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 70, "g_fetched": 56, "g_countries": [["United States", 24], ["Italy", 7], ["Spain", 7], ["France", 5], ["Belgium", 4], ["Germany", 4], ["United Kingdom", 4], ["Canada", 4], ["Denmark", 4], ["Switzerland", 3], ["Austria", 3], ["Australia", 3], ["South Korea", 3], ["Netherlands", 2], ["Greece", 2], ["Mexico", 2], ["Finland", 1], ["United Arab Emirates", 1], ["Argentina", 1], ["Brazil", 1], ["Bulgaria", 1], ["Chile", 1], ["Czechia", 1], ["Hungary", 1], ["Israel", 1], ["Lithuania", 1], ["Malaysia", 1], ["New Zealand", 1], ["Poland", 1], ["Portugal", 1], ["Romania", 1], ["Slovakia", 1], ["Thailand", 1]], "g_trials": [{"nct": "NCT07646223", "title": "Vancomycin Efficacy in Response to Dysbiosis in Atypical Colitis", "status": "NOT_YET_RECRUITING", "start": "2026-10-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Tampere University Hospital", "countries": ["Finland"]}, {"nct": "NCT07424677", "title": "Study of Saroglitazar Magnesium for PBC Patients With Incomplete Response or Intolerant to UDCA Therapy", "status": "RECRUITING", "start": "2026-08-11", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Zydus Therapeutics Inc.", "countries": ["United States"]}, {"nct": "NCT07556913", "title": "Elafibranor Pregnancy Surveillance Program: A Study to Evaluate the Safety of Elafibranor During Pregnancy", "status": "RECRUITING", "start": "2026-07-29", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Ipsen", "countries": ["United States"]}, {"nct": "NCT06723275", "title": "LEOPARD Prospective Validation Cohort 1", "status": "RECRUITING", "start": "2026-07-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["Belgium", "France", "Germany", "Italy", "Netherlands"]}, {"nct": "NCT07319169", "title": "The Value of Spleen Stiffness Measurement in Patients With PBC", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Universitair Ziekenhuis Brussel", "countries": ["Belgium"]}, {"nct": "NCT06733519", "title": "TH104 for the Treatment of Pruritus in Primary Biliary Cholangitis", "status": "NOT_YET_RECRUITING", "start": "2026-06-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Tharimmune Inc", "countries": []}, {"nct": "NCT07387549", "title": "A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis", "status": "RECRUITING", "start": "2026-05-14", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Ipsen", "countries": ["United States"]}, {"nct": "NCT07477782", "title": "Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis - Randomized Study Versus Sham Transplantation", "status": "NOT_YET_RECRUITING", "start": "2026-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT07549607", "title": "Clinical Characterization of Patients With Primary Biliary Cirrhosis Treated With Seladelpar in the Real-life Setting", "status": "NOT_YET_RECRUITING", "start": "2026-04-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Leipzig", "countries": ["Germany", "Switzerland"]}, {"nct": "NCT07216235", "title": "Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes", "status": "RECRUITING", "start": "2026-03-24", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Zydus Therapeutics Inc.", "countries": ["United States"]}, {"nct": "NCT07598669", "title": "Austrian PBC Registry", "status": "RECRUITING", "start": "2026-03-18", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Medical University of Vienna", "countries": ["Austria"]}, {"nct": "NCT07607353", "title": "Biodegradable Stents in Primary Sclerosing Cholangitis", "status": "RECRUITING", "start": "2026-03-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "King's College Hospital NHS Trust", "countries": ["United Kingdom"]}, {"nct": "NCT07229911", "title": "A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)", "status": "RECRUITING", "start": "2026-01-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Takeda", "countries": ["United States"]}, {"nct": "NCT07341282", "title": "Investigation of Vancomycin Efficacy in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis", "status": "NOT_YET_RECRUITING", "start": "2026-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "McMaster University", "countries": ["Canada"]}, {"nct": "NCT06699121", "title": "A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC", "status": "RECRUITING", "start": "2025-11", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "LISCure Biosciences", "countries": ["United States"]}, {"nct": "NCT07205874", "title": "Early Diagnosis of Primary Biliary Cholangitis (PBC) in Patients With Positive Anti-Mitochondrial Antibodies (AMA) and Normal Alkaline Phosphatase (ALP)", "status": "RECRUITING", "start": "2025-09-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Hospital Universitario La Paz", "countries": ["Spain"]}, {"nct": "NCT06975150", "title": "Efficacy and Safety of HK-660S in the Treatment of Primary Sclerosing Cholangitis", "status": "NOT_YET_RECRUITING", "start": "2025-08-18", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "CuromeBiosciences", "countries": []}, {"nct": "NCT06825559", "title": "Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease", "status": "RECRUITING", "start": "2025-08-05", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Zydus Therapeutics Inc.", "countries": ["United States"]}, {"nct": "NCT07122206", "title": "Monitoring the Response of Combination Ursodiol and Seladelpar Treatment", "status": "NOT_YET_RECRUITING", "start": "2025-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Methodist Health System", "countries": []}, {"nct": "NCT06905054", "title": "Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation", "status": "RECRUITING", "start": "2025-04-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Mayo Clinic", "countries": ["United States"]}, {"nct": "NCT06443606", "title": "Efficacy and Safety of Bezafibrate 400 mg and Bezafibrate 200 mg as Adjunctive Treatments in Patients With Primary Biliary Cholangitis and Non-optimal Biochemical Response to Ursodeoxycholic Acid Therapy", "status": "RECRUITING", "start": "2025-03-27", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT06886360", "title": "Study with Norucholic Acid Tablets in Patients with Primary Sclerosing Cholangitis (PSC)", "status": "NOT_YET_RECRUITING", "start": "2025-03", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Dr. Falk Pharma GmbH", "countries": []}, {"nct": "NCT06864195", "title": "A Simple Breath Test to Detect Liver Cancer and Monitor Liver Conditions", "status": "RECRUITING", "start": "2025-02-13", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Imperial College London", "countries": ["United Kingdom"]}, {"nct": "NCT07161245", "title": "RELIEF: Multimodal Prehabilitation to Treat Fatigue in Patients With Primary Biliary Cholangitis", "status": "RECRUITING", "start": "2025-02-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Hospital Clinic of Barcelona", "countries": ["Spain"]}, {"nct": "NCT06675604", "title": "LEOPARD Training and Validation Data Collection Study", "status": "RECRUITING", "start": "2025-02-04", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["Austria", "Belgium", "France", "Germany", "Italy", "Netherlands", "Spain"]}]}, {"batch": 2, "no": 64, "name_zh": "原发性生长激素缺乏症", "query_terms": [{"term": "Primary ciliary dyskinesia", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 23, "g_fetched": 23, "g_countries": [["United States", 8], ["France", 3], ["Switzerland", 3], ["Turkey (Türkiye)", 2], ["Greece", 1], ["Mexico", 1], ["United Kingdom", 1], ["French Polynesia", 1], ["Germany", 1]], "g_trials": [{"nct": "NCT07740538", "title": "Malnutrition and Sarcopenia Among Primary Ciliary Dyskinesia", "status": "NOT_YET_RECRUITING", "start": "2026-08-03", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Izmir Democracy University", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT07740551", "title": "Comparison of Individuals With Primary Ciliary Dyskinesia and Healthy Controls", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Izmir Democracy University", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT07699302", "title": "Clearance in Primary Ciliary Dyskinesia", "status": "NOT_YET_RECRUITING", "start": "2026-07-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of North Carolina, Chapel Hill", "countries": ["United States"]}, {"nct": "NCT07566611", "title": "Primary Ciliary Dyskinesia in Adult Bronchiectasis", "status": "RECRUITING", "start": "2026-07-17", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Indiana University", "countries": ["United States"]}, {"nct": "NCT07376187", "title": "Digital Physiotherapy for Pediatric Chronic Suppurative Lung Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-05-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Thessaly", "countries": ["Greece"]}, {"nct": "NCT07531277", "title": "Developing Resource Interventions for Healthcare Professionals and Patients to Improve Knowledge About Fertility in Primary Ciliary Dyskinesia", "status": "NOT_YET_RECRUITING", "start": "2026-04-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Southampton", "countries": []}, {"nct": "NCT06959251", "title": "Glycine and Magnesium+Thiamine for the Treatment of Primary Ciliary Dyskinesia", "status": "RECRUITING", "start": "2025-10-02", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Instituto Nacional de Enfermedades Respiratorias", "countries": ["Mexico"]}, {"nct": "NCT07274631", "title": "A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine", "status": "RECRUITING", "start": "2025-09-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "CHU de Reims", "countries": ["France"]}, {"nct": "NCT07029594", "title": "Thermal Spa Treatment and Improvement of Primary Ciliary Dyskinesia", "status": "RECRUITING", "start": "2025-09-05", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Association Francaise pour la Recherche Thermale", "countries": ["France"]}, {"nct": "NCT07357558", "title": "A Qualitative Study Investigating the Lived Experiences and Impact of Reproductive Issues in Adults With Primary Ciliary Dyskinesia", "status": "RECRUITING", "start": "2025-09-02", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital Southampton NHS Foundation Trust", "countries": ["United Kingdom"]}, {"nct": "NCT04798950", "title": "Bronchi Dilation in Polynesian Patients: Monocentric Retrospective Study", "status": "RECRUITING", "start": "2025-06-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Centre Hospitalier Intercommunal Creteil", "countries": ["French Polynesia"]}, {"nct": "NCT05889013", "title": "Utility of PCD Diagnostics to Improve Clinical Care", "status": "RECRUITING", "start": "2023-10-17", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Connecticut Children's Medical Center", "countries": ["United States"]}, {"nct": "NCT07288827", "title": "Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia", "status": "RECRUITING", "start": "2023-05-04", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Indiana University", "countries": ["United States"]}, {"nct": "NCT05287022", "title": "Use of Nasal Nitric Oxide Testing in Improving Primary Ciliary Dyskinesia Clinical Care", "status": "RECRUITING", "start": "2021-06-14", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Arkansas Children's Hospital Research Institute", "countries": ["United States"]}, {"nct": "NCT04602481", "title": "Living With Primary Ciliary Dyskinesia (Living With PCD)", "status": "RECRUITING", "start": "2020-05-31", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Bern", "countries": ["Switzerland"]}, {"nct": "NCT04611516", "title": "The Ear-Nose-Throat (ENT) Prospective International Cohort of PCD Patients (EPIC-PCD)", "status": "RECRUITING", "start": "2020-03-02", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Bern", "countries": ["Switzerland"]}, {"nct": "NCT03704207", "title": "Utility of PCD Diagnostics to Improve Clinical Care", "status": "RECRUITING", "start": "2017-06-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Vanderbilt University Medical Center", "countries": ["United States"]}, {"nct": "NCT05951478", "title": "DCP (RaDiCo Cohort) (RaDiCo-DCP)", "status": "RECRUITING", "start": "2017-05-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Institut National de la Santé Et de la Recherche Médicale, France", "countries": ["France"]}, {"nct": "NCT02704455", "title": "Registry Study on Primary Ciliary Dyskinesia in Chinese Children", "status": "NOT_YET_RECRUITING", "start": "2016-05", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Beijing Children's Hospital", "countries": []}, {"nct": "NCT02419365", "title": "International Primary Ciliary Dyskinesia (PCD) Registry", "status": "RECRUITING", "start": "2014-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital Muenster", "countries": ["Germany"]}, {"nct": "NCT03606200", "title": "Swiss Primary Ciliary Dyskinesia Registry", "status": "RECRUITING", "start": "2013-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Bern", "countries": ["Switzerland"]}, {"nct": "NCT00943514", "title": "Natural History of Bronchiectasis", "status": "RECRUITING", "start": "2009-08-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "countries": ["United States"]}, {"nct": "NCT00807482", "title": "Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease", "status": "RECRUITING", "start": "2004-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of North Carolina, Chapel Hill", "countries": ["United States"]}]}, {"batch": 2, "no": 65, "name_zh": "原发性胰岛素样生长因子-1缺乏症", "query_terms": [{"term": "Growth delay due to insulin-like growth factor type 1 deficiency", "broad": false}, {"term": "Primary IGF1 deficiency", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 1, "g_fetched": 1, "g_countries": [["Austria", 1], ["France", 1], ["French Guiana", 1], ["Germany", 1], ["Italy", 1], ["Martinique", 1], ["Poland", 1], ["Spain", 1], ["Sweden", 1], ["United Kingdom", 1], ["United States", 1]], "g_trials": [{"nct": "NCT00903110", "title": "Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).", "status": "RECRUITING", "start": "2008-12-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Esteve Pharmaceuticals, S.A.", "countries": ["Austria", "France", "French Guiana", "Germany", "Italy", "Martinique", "Poland", "Spain", "Sweden", "United Kingdom", "United States"]}]}, {"batch": 2, "no": 66, "name_zh": "原发性免疫缺陷", "query_terms": [{"term": "Primary immunodeficiency", "broad": false}], "n_total": 14, "n_open": 5, "n_open_precise": 5, "n_broad": 0, "trials": [{"nct": "NCT06679881", "title": "Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE", "status": "RECRUITING", "start": "2025-02-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 170, "sponsor": "Pharvaris Netherlands B.V.", "conditions": ["Hereditary Angioedema (HAE)"], "cn_sites": [{"facility": "Study Site", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06960213", "title": "STOP-HAE: A Phase 3 Study of ADX-324 in HAE", "status": "RECRUITING", "start": "2025-08-28", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "ADARx Pharmaceuticals, Inc.", "conditions": ["Hereditary Angioedema", "HAE", "Hereditary Angioedema - Type 1", "Hereditary Angioedema - Type 2"], "cn_sites": [{"facility": "ADARx Clinical Site", "city": "Beijing", "status": "RECRUITING"}, {"facility": "ADARx Clinical Site", "city": "Harbin", "status": "NOT_YET_RECRUITING"}, {"facility": "ADARx Clinical Site", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07371663", "title": "An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors", "status": "RECRUITING", "start": "2025-12-03", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 266, "sponsor": "Beijing Tide Pharmaceutical Co., Ltd", "conditions": ["Solid Cancers", "NSCLC (Advanced Non-small Cell Lung Cancer)", "Gastric (Stomach) Cancer", "Endometrial Cancer", "Malignant Melanoma"], "cn_sites": [{"facility": "Beijing Cancer Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07428499", "title": "Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)", "status": "RECRUITING", "start": "2026-04-02", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "ADARx Pharmaceuticals, Inc.", "conditions": ["Hereditary Angioedema (HAE)", "Hereditary Angioedema - Type 1", "Hereditary Angioedema - Type 2", "HAE"], "cn_sites": [{"facility": "ADARx Clinical Site", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "ADARx Clinical Site", "city": "Harbin", "status": "NOT_YET_RECRUITING"}, {"facility": "ADARx Clinical Site", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT03217617", "title": "SCID-X1 Gene Therapy Via Intravenous Lentiviral (Ivlv-X1) Injection", "status": "NOT_YET_RECRUITING", "start": "2027-06-30", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": ["SCID, X-Linked"], "cn_sites": [{"facility": "Shenzhen Geno-immune Medical Institute", "city": "Shenzhen", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02231983", "title": "Clinical Characteristics and Genetic Profiles of Severe Combined Immunodeficiency in China", "status": "UNKNOWN", "start": "2014-09", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 50, "sponsor": "Shanghai Children's Medical Center", "conditions": ["Severe Combined Immunodeficiency"], "cn_sites": [{"facility": "Shanghai children's medical center", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02590328", "title": "Neonatal Screening of Severe Combined Immunodeficiencies", "status": "COMPLETED", "start": "2015-12", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 180000, "sponsor": "Children's Hospital of Fudan University", "conditions": ["Severe Combined Immunodeficiency", "Neonatal Screening"], "cn_sites": [{"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03383380", "title": "Rapamycin Treatment for Activated Phosphoinositide 3-Kinase δ Syndrome", "status": "COMPLETED", "start": "2017-12-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Children's Hospital of Fudan University", "conditions": ["Activated PI3K-delta Syndrome", "Immunodeficiency Primary"], "cn_sites": [{"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04172181", "title": "Multi-center Clinical Study of Cord Blood Stem Cell Transplantation for SCID", "status": "UNKNOWN", "start": "2019-12-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 50, "sponsor": "Children's Hospital of Fudan University", "conditions": ["Severe Combined Immunodeficiency Disease"], "cn_sites": [{"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04286815", "title": "Gene Therapy for X Linked Severe Combined Immunodeficiency", "status": "UNKNOWN", "start": "2020-05-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Children's Hospital of Chongqing Medical University", "conditions": ["Gene Therapy"], "cn_sites": [{"facility": "Children's Hospital of Chongqing Medical University", "city": "Chongqing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05460325", "title": "A Study of Lanadelumab (SHP643) in Chinese Participants With Hereditary Angioedema (HAE)", "status": "COMPLETED", "start": "2022-06-22", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Takeda", "conditions": ["Hereditary Angioedema (HAE)"], "cn_sites": [{"facility": "The Second Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology", "city": "Wuhan", "status": ""}, {"facility": "Yantai Yuhuangding Hospital", "city": "Yantai", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT06346899", "title": "A Study of Lanadelumab (Takhzyro) and Icatibant (Firazyr®) in Persons With HAE in China", "status": "COMPLETED", "start": "2024-07-20", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 115, "sponsor": "Takeda", "conditions": ["Hereditary Angioedema (HAE)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": ""}, {"facility": "The First Affiliated Hospital ,Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "The Second Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Henan Provincial People's Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Tongji Hospital,Tongji Medical College,Huazhong University of Science & Technology", "city": "Wuhan", "status": ""}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "Qianfo Mountain Hospital, Shandong Province", "city": "Jinan", "status": ""}, {"facility": "Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Shanxi Bethune hospital", "city": "Taiyuan", "status": ""}, {"facility": "The Second Affiliated hospital of Xian Jiaotong University", "city": "Xian", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "First Affiliated hospital of Kunming Medical University", "city": "Kunming", "status": ""}, {"facility": "The Second Affiliated hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 13, "broad_only": false}, {"nct": "NCT06560489", "title": "Pharmacokinetics and Efficacy of Multiple Dosing of LP-98 for Injection in HIV-infected Patients", "status": "COMPLETED", "start": "2024-09-02", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Shanxi Kangbao Biological Product Co., Ltd.", "conditions": ["Hiv"], "cn_sites": [{"facility": "Henan Provincial Hospital for Infectious Diseases (Zhengzhou Sixth People's Hospital)", "city": "Zhengzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06846398", "title": "A Phase 2 in Adult Subjects With Hereditary Angioedema", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-02-28", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 25, "sponsor": "Shanghai Argo Biopharmaceutical Co., Ltd.", "conditions": ["Hereditary Angioedema (HAE)"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "The First Hospital of Lanzhou University", "city": "Lanzhou", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Yantai Yuhuangding Hospital", "city": "Yantai", "status": ""}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "First Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}], "cn_site_count": 6, "broad_only": false}], "g_total": 112, "g_fetched": 107, "g_countries": [["United States", 55], ["France", 14], ["Italy", 6], ["United Kingdom", 6], ["Switzerland", 5], ["Australia", 4], ["Turkey (Türkiye)", 4], ["Poland", 3], ["Spain", 3], ["Germany", 3], ["Austria", 3], ["Canada", 3], ["Brazil", 2], ["Denmark", 2], ["Hungary", 2], ["Netherlands", 2], ["South Africa", 2], ["Egypt", 1], ["Algeria", 1], ["Saudi Arabia", 1], ["Slovakia", 1], ["Czechia", 1], ["Greece", 1], ["Norway", 1], ["Romania", 1], ["Ukraine", 1], ["Bulgaria", 1], ["New Zealand", 1], ["India", 1], ["Japan", 1], ["Belgium", 1], ["Argentina", 1], ["Tanzania", 1], ["Israel", 1]], "g_trials": [{"nct": "NCT07446764", "title": "Integrated Health Services (IHS): A Structural Intervention to Improve HIV/STI Screening and PrEP Navigation in Primary Care", "status": "NOT_YET_RECRUITING", "start": "2027-02-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "My Brother's Keeper, Inc.", "countries": ["United States"]}, {"nct": "NCT07218393", "title": "A Study About the Diagnosis and Management of Hereditary Angioedema (HAE) in Egypt", "status": "NOT_YET_RECRUITING", "start": "2026-12-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Takeda", "countries": ["Egypt"]}, {"nct": "NCT07794735", "title": "A Study of TAK-664 in People With Primary Immunodeficiency Diseases Who Have Not Yet Been Treated With Immunoglobulins", "status": "NOT_YET_RECRUITING", "start": "2026-11-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Takeda", "countries": []}, {"nct": "NCT07704281", "title": "Follow-up of the Cohort of Newborns Screened at Birth Using TREC Analysis", "status": "NOT_YET_RECRUITING", "start": "2026-11-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Nantes University Hospital", "countries": ["France"]}, {"nct": "NCT07726069", "title": "Haloperidol For Outpatient Symptom Management in Patients Diagnosed With Cannabinoid Hyperemesis Syndrome in the Emergrency Department", "status": "NOT_YET_RECRUITING", "start": "2026-11", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "University of Illinois at Chicago", "countries": ["United States"]}, {"nct": "NCT07445087", "title": "A Study of Takhzyro in Teenagers and Adults With Hereditary Angioedema (HAE) in South Korea", "status": "NOT_YET_RECRUITING", "start": "2026-10-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Takeda", "countries": []}, {"nct": "NCT07670156", "title": "Upadacitinib in Treatment of JAK/STAT Pathway Disorders With Activating Mutations", "status": "NOT_YET_RECRUITING", "start": "2026-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Lisa Satter", "countries": ["United States"]}, {"nct": "NCT07709728", "title": "Biomarkers for Babies and Young Children With Ataxia Telangiectasia", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Nottingham", "countries": []}, {"nct": "NCT07697118", "title": "Study Evaluating a Gene Therapy for IPEX Syndrome Through the Expression of FOXP3 on Deficient T Cells to Produce Tregs-like.", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT06150833", "title": "IVIG Boya: Safety, Efficacy, and Pharmacokinetics", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Azidus Brasil", "countries": []}, {"nct": "NCT06279949", "title": "Confidential Care and Adolescent HIV Testing", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Yale University", "countries": []}, {"nct": "NCT07660783", "title": "Naive T Cell Deplete Grafts for GVHD Prevention in Non-Malignant Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Fred Hutchinson Cancer Center", "countries": ["United States"]}, {"nct": "NCT07654829", "title": "Safety and Effectiveness of Sebetralstat (KVD900) for Short-Term Prophylaxis Before Procedures in People With Hereditary Angioedema (KONTROL)", "status": "RECRUITING", "start": "2026-08-17", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "KalVista Pharmaceuticals, Ltd.", "countries": ["United States"]}, {"nct": "NCT07215416", "title": "Safety and Efficacy of Mutation-targeted Precision Genetic Therapy for Ataxia-Telangiectasia (A-T)", "status": "RECRUITING", "start": "2026-08", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Timothy Yu", "countries": ["United States"]}, {"nct": "NCT07766304", "title": "Long-term Psychological and Cognitive Evaluation of Children Treated With Allogeneic Hematopoietic Stem Cell Transplantation for Immunodeficiency", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT07698197", "title": "Exercise Intervention and Immunodeficiency", "status": "RECRUITING", "start": "2026-07-17", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Yale University", "countries": ["United States"]}, {"nct": "NCT06519734", "title": "Primitive Immunodeficiency, Intrauterine Devices and Menstrual Hygiene Products", "status": "RECRUITING", "start": "2026-06-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT07603453", "title": "Performance of Clinical Metagenomics in Stool and Urine Samples for Unexplained Diseases Diagnostic and Emerging Diseases Surveillance in Immunocompromised Patients", "status": "NOT_YET_RECRUITING", "start": "2026-06-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT07293364", "title": "A Study to Learn About the C1-Inhibitor Function as Diagnosis for Hereditary Angioedema", "status": "RECRUITING", "start": "2026-05-12", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Takeda", "countries": ["Algeria"]}, {"nct": "NCT07284641", "title": "Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)", "status": "RECRUITING", "start": "2026-05-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Paul Szabolcs", "countries": ["United States"]}, {"nct": "NCT07361926", "title": "Sexual Health Access at Retail Pharmacies: Advancing Pharmacy-based Delivery of Primary STI and HIV Prevention for Cisgender Women", "status": "NOT_YET_RECRUITING", "start": "2026-05", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of Washington", "countries": []}, {"nct": "NCT07263685", "title": "A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE) in the Kingdom of Saudi Arabia", "status": "RECRUITING", "start": "2026-04-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Takeda", "countries": ["Saudi Arabia"]}, {"nct": "NCT07298447", "title": "Donidalorsen Treatment in Children With Hereditary Angioedema", "status": "RECRUITING", "start": "2026-04-21", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Ionis Pharmaceuticals, Inc.", "countries": ["Australia", "Italy", "Poland", "Spain", "United States"]}, {"nct": "NCT07516002", "title": "Immunoglobulin Efficacy and Immune Profiling in Antibody Immunodeficiency", "status": "NOT_YET_RECRUITING", "start": "2026-04-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Peking University People's Hospital", "countries": []}, {"nct": "NCT07526714", "title": "Longitudinal Prognosis of Lymphoproliferative Manifestations in Primary Immunodeficiencies", "status": "NOT_YET_RECRUITING", "start": "2026-04-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Central Hospital, Nancy, France", "countries": []}]}, {"batch": 2, "no": 67, "name_zh": "原发性骨髓纤维化", "query_terms": [{"term": "Primary myelofibrosis", "broad": false}], "n_total": 44, "n_open": 13, "n_open_precise": 13, "n_broad": 0, "trials": [{"nct": "NCT04064060", "title": "A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials", "status": "RECRUITING", "start": "2019-08-12", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 665, "sponsor": "Celgene", "conditions": ["Myelodysplastic Syndromes (MDS)", "Beta-thalassemia", "Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis"], "cn_sites": [{"facility": "Local Institution - 131", "city": "Beijing", "status": "WITHDRAWN"}, {"facility": "Local Institution - 135", "city": "Guangzhou", "status": "WITHDRAWN"}, {"facility": "Local Institution - 132", "city": "Shanghai", "status": "WITHDRAWN"}, {"facility": "Local Institution - 134", "city": "Chengdu", "status": "WITHDRAWN"}, {"facility": "Local Institution - 130", "city": "Tianjin", "status": "WITHDRAWN"}, {"facility": "Local Institution - 133", "city": "Hangzhou", "status": "WITHDRAWN"}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT07802405", "title": "Evaluating Safety ,Tolerability, Pharmacokinetic,Efficacy of WJ01024 or WJ01024 Combined With Ruxolitinib in Patients With Myelofibrosis", "status": "RECRUITING", "start": "2023-11-21", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Henan Cancer Hospital", "conditions": ["MF With Splenomegaly"], "cn_sites": [{"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06164561", "title": "18F-FAPI PET/MRI Imaging in Myelofibrosis: a Prospective Observational Study.", "status": "RECRUITING", "start": "2023-11-21", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 57, "sponsor": "First Affiliated Hospital of Zhejiang University", "conditions": ["Myelofibrosis"], "cn_sites": [{"facility": "The First Affiliated Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06151119", "title": "68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy Evaluation of Myelofibrosis.", "status": "RECRUITING", "start": "2023-11-22", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 90, "sponsor": "The First Affiliated Hospital of Xiamen University", "conditions": ["Primary Myelofibrosis"], "cn_sites": [{"facility": "Bing Xu", "city": "Xiamen", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06122831", "title": "A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)", "status": "RECRUITING", "start": "2023-12-12", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 92, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Myelofibrosis"], "cn_sites": [{"facility": "Guangdong Provincial People's Hospital", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Guangxi Zhuang Autonomous Region People's Hospital", "city": "Nanning", "status": "NOT_YET_RECRUITING"}, {"facility": "Cangzhou People's Hosipital", "city": "Cangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Affiliated Hospital of Chengde Medical College", "city": "Chengde", "status": "NOT_YET_RECRUITING"}, {"facility": "North China of Science and Technology University Affiliated Hospital", "city": "Tangshan", "status": "NOT_YET_RECRUITING"}, {"facility": "Xingtai People's Hospital", "city": "Xingtai", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Hospital of Harbin", "city": "Harbin", "status": "NOT_YET_RECRUITING"}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}, {"facility": "Union Hospital Tongji College Huazhong Unizersity of Science And Technology", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}, {"facility": "Wuhan University Zhongnan Hospital", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}, {"facility": "The Affiliated Hospital of Inner Mongolia Medical University", "city": "Hohhot", "status": "NOT_YET_RECRUITING"}, {"facility": "The Public Hospital of Wuxi", "city": "Wuxi", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": "NOT_YET_RECRUITING"}, {"facility": "Xi 'An Jiaotong University Second Affiliated Hospital", "city": "Xi'an", "status": "NOT_YET_RECRUITING"}, {"facility": "Tai'an City Central Hospital", "city": "Tai’an", "status": "NOT_YET_RECRUITING"}, {"facility": "Central Hospital Of Minhang District, Shanghai", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}, {"facility": "Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Shanghai Sixth People's Hospital", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Heping Hospital Affiliated to Changzhi Medical College", "city": "Changzhi", "status": "NOT_YET_RECRUITING"}, {"facility": "People's Hospital of Tianjin City", "city": "Tianjin", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Xinjiang Medical University", "city": "Ürümqi", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 22, "broad_only": false}, {"nct": "NCT06674382", "title": "Haplo-HSCT for Myelofibrosis", "status": "RECRUITING", "start": "2024-01-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 39, "sponsor": "Peking University People's Hospital", "conditions": ["Myelofibrosis"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06378437", "title": "A Study of GLB-001 in Patients With Myeloid Malignancies", "status": "RECRUITING", "start": "2024-05-24", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 108, "sponsor": "Hangzhou GluBio Pharmaceutical Co., Ltd.", "conditions": ["Polycythemia Vera", "Essential Thrombocythemia", "Myelofibrosis", "Myelodysplastic Syndromes", "Acute Myeloid Leukemia", "Myeloid Malignancy"], "cn_sites": [{"facility": "The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)", "city": "Hefei", "status": "RECRUITING"}, {"facility": "China-Japan Friendship Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "The First Hospital of Hebei Medical Universtiy", "city": "Shijiazhuang", "status": "RECRUITING"}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Zhongnan Hospital of Wuhan University", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Sheng Jing Hospital of China Medical Universtiy", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Huashan Hospital Affiliated to Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "The Second Hospital of Tianjin Medical Universtiy", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "The First Affilicated Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": "RECRUITING"}], "cn_site_count": 14, "broad_only": false}, {"nct": "NCT07317700", "title": "A Clinical Trial of Flonoltinib Maleate for Intermediate or High-Risk Myelofibrosis", "status": "RECRUITING", "start": "2026-02-13", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 105, "sponsor": "Chengdu Zenitar Biomedical Technology Co., Ltd", "conditions": ["MF"], "cn_sites": [{"facility": "West China Hospital Sichuan University", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS)", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07443306", "title": "A Clinical Trial of Flonoltinib Maleate Tablets in the Treatment of JAK Inhibitor Refractory/Relapsed/Intolerant Patients With Intermediate to High Risk Myelofibrosis", "status": "RECRUITING", "start": "2026-03-18", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 64, "sponsor": "Chengdu Zenitar Biomedical Technology Co., Ltd", "conditions": ["MF"], "cn_sites": [{"facility": "West China Hospital Sichuan University", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS)", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07480824", "title": "To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Hepatic Impairment Subjects", "status": "RECRUITING", "start": "2026-04-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Myelofibrosis"], "cn_sites": [{"facility": "The First Affiliated Hospital of Henan University of Science & Technology", "city": "Luoyang", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital)", "city": "Jinan", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT07539779", "title": "Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With Moderate to Severe Myelofibrosis", "status": "NOT_YET_RECRUITING", "start": "2026-05-01", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 196, "sponsor": "Nanfang Hospital, Southern Medical University", "conditions": ["Luspatercept", "Poor Erythroid Engraftment", "Hematological Malignancies", "Myelofibrosis (MF)"], "cn_sites": [{"facility": "Nanfang Hospital, Southern Medical University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07357727", "title": "A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)", "status": "RECRUITING", "start": "2026-06-16", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 460, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Primary Myelofibrosis (PMF)", "Post-polycythemia Vera Myelofibrosis (PPV-MF)", "Post-essential Thrombocythemia Myelofibrosis (PET-MF)"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Hefei", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Nantong", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Changchun", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Yantai", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Kunming", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Wenzhou", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 17, "broad_only": false}, {"nct": "NCT07551427", "title": "A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of TQ05105 Tablets in Subjects With Intermediate/High-risk Myelofibrosis", "status": "RECRUITING", "start": "2026-06-18", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 51, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Myelofibrosis"], "cn_sites": [{"facility": "The First Affiliated Hospital of University of Science and Technology of China", "city": "Hefei", "status": "RECRUITING"}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "Guangzhou First Municipal People's Hospital", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": "RECRUITING"}, {"facility": "Cangzhou People's Hospital rovince", "city": "Cangzhou", "status": "RECRUITING"}, {"facility": "Affiliated Hospital of Chengde Medical College", "city": "Chengde", "status": "RECRUITING"}, {"facility": "The Second Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": "RECRUITING"}, {"facility": "Xingtai People's Hospital", "city": "Xingtai", "status": "RECRUITING"}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Union Hospital Tongji College Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Zhuzhou Central Hospital", "city": "Zhuzhou", "status": "RECRUITING"}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjin", "status": "RECRUITING"}, {"facility": "Jiangsu Provincial Hospital of Traditional Chinese Medicine", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": "RECRUITING"}, {"facility": "Shengjing Hospital Affiliated to China Medical University", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Air Force Medical University", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "Shanghai Sixth People's Hospital", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Heping Hospital Affiliated To Changzhi Medical College", "city": "Changzhi", "status": "RECRUITING"}, {"facility": "Sichuan Provincial People's Hospital", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Chinese Academy of Medical Sciences Hematology Hospital", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Xinjiang Medical University", "city": "Ürümqi", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 24, "broad_only": false}, {"nct": "NCT01178281", "title": "Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence", "status": "COMPLETED", "start": "2010-09-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 267, "sponsor": "Celgene", "conditions": ["Primary Myelofibrosis", "MPN-associated Myelofibrosis"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Jiangsu Province Hospital", "city": "Jiangsu", "status": ""}, {"facility": "Shanghai Ruijin Hospital", "city": "Shanghai", "status": ""}, {"facility": "West China Hospital, Sichuan University", "city": "Sichuan", "status": ""}, {"facility": "Blood Disease Hospital Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT01392443", "title": "Asian Phase II Study of INC424 in Patients With Primary Myelofibrosis (MF), Post-PV MF or Post-ET MF", "status": "COMPLETED", "start": "2010-10-14", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Primary Myelofibrosis (MF)", "Post-Polycythemia Vera (PV) MF", "Post-Essential Thrombocythemia (ET) MF"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Wuhan", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Nanjing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Suzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Chengdu", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Tianjin", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Hangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Jinan", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": ""}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT01317875", "title": "Study of the JAK Inhibitor Ruxolitinib Administered Orally to Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera-Myelofibrosis (PPV-MF) or Post-Essential Thrombocythemia-Myelofibrosis (PET-MF)", "status": "COMPLETED", "start": "2011-03-31", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 69, "sponsor": "Incyte Corporation", "conditions": ["Myelofibrosis"], "cn_sites": [{"facility": "", "city": "Nanjing", "status": ""}, {"facility": "", "city": "Chengdu", "status": ""}, {"facility": "", "city": "Hangzhou", "status": ""}, {"facility": "", "city": "Beijing", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT02386800", "title": "CINC424A2X01B Rollover Protocol", "status": "ACTIVE_NOT_RECRUITING", "start": "2015-03-05", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 279, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Primary Myelofibrosis", "Polycythemia Vera", "Graft Versus Host Disease", "Acute Myeloid Leukemia", "Thalassemia"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Hangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT02663648", "title": "Cell Cycle Regulatory Gene Study in Patients With Myeloproliferative Disorders", "status": "WITHDRAWN", "start": "2016-06", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 0, "sponsor": "Shandong University", "conditions": ["Myeloproliferative Disorders", "Polycythemia Vera", "Essential Thrombocythemia", "Myelofibrosis", "Chronic Myeloid Leukemia"], "cn_sites": [{"facility": "Qilu Hospital, Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03886415", "title": "Jaktinib Hydrochloride Tablets in Intermediate-risk and High-risk Myelofibrosis.", "status": "COMPLETED", "start": "2019-01-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 118, "sponsor": "Suzhou Zelgen Biopharmaceuticals Co.,Ltd", "conditions": ["Myelofibrosis"], "cn_sites": [{"facility": "The First Affiliated Hospital of Medical School of Zhejiang University", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03952039", "title": "An Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy in Subjects With DIPSS-intermediate or High-risk Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib", "status": "COMPLETED", "start": "2019-09-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 202, "sponsor": "Celgene", "conditions": ["Primary Myelofibrosis", "Post-Polycythemia Vera", "Myelofibrosis"], "cn_sites": [{"facility": "Local Institution - 555", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 550", "city": "Guangzhou, Guangdong", "status": ""}, {"facility": "Local Institution - 553", "city": "Tianjin", "status": ""}, {"facility": "Local Institution - 557", "city": "Zhengzhou", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT04217993", "title": "Jaktinib for the Treatment of Ruxolitinib Intolerance of Myelofibrosis", "status": "COMPLETED", "start": "2020-01-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 51, "sponsor": "Suzhou Zelgen Biopharmaceuticals Co.,Ltd", "conditions": ["Primary Myelofibrosis (PMF)", "Post-polycythemia Vera Myelofibrosis(Post-PV MF)", "Post-essential Thrombocythemia Myelofibrosis(Post-ET MF)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Medical School of Zhejiang University", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04617028", "title": "Jaktinib Versus Hydroxycarbamide in Subjects With Intermediate-2 or High-risk Myelofibrosis", "status": "COMPLETED", "start": "2021-02-05", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 105, "sponsor": "Suzhou Zelgen Biopharmaceuticals Co.,Ltd", "conditions": ["Myelofibrosis"], "cn_sites": [{"facility": "The First Affiliated Hospital of Medical School of Zhejiang University", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04279847", "title": "Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-02-23", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 140, "sponsor": "Incyte Corporation", "conditions": ["Myelofibrosis", "Myelodysplastic Syndrome", "Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndrome", "Myeloproliferative Neoplasm", "Relapsed or Refractory Primary Myelofibrosis", "Secondary Myelofibrosis (Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis)", "ET (Essential Thrombocythemia)"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Nanfang Hospital_Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital, Zhejiang University School of Medicine (Fahzu)", "city": "Hangzhou", "status": ""}, {"facility": "Henan Cancer Hostipal", "city": "Zhengzhou", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT04717414", "title": "An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-02-25", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 313, "sponsor": "Celgene", "conditions": ["Myeloproliferative Disorders", "Myelofibrosis", "Primary Myelofibrosis", "Post-Polycythemia Vera Myelofibrosis", "Anemia"], "cn_sites": [{"facility": "Nanfang Hospital of Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Nanyang Medical College", "city": "Nanyang", "status": ""}, {"facility": "Xiangya Hospital Central-South University", "city": "Changsha", "status": ""}, {"facility": "Local Institution - 804", "city": "Nanjing", "status": ""}, {"facility": "Local Institution - 818", "city": "Nantong", "status": ""}, {"facility": "Local Institution - 820", "city": "Nanchang", "status": ""}, {"facility": "Nanchang University - The Second Affiliated Hospital", "city": "Nanchang", "status": ""}, {"facility": "Local Institution - 821", "city": "Qingdao", "status": ""}, {"facility": "Local Institution - 816", "city": "Taiyuan", "status": ""}, {"facility": "The Second Affiliated Hospital Of Kunming Medical University", "city": "Kunming", "status": ""}, {"facility": "Beijing Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 802", "city": "Changchun", "status": ""}, {"facility": "Guangdong General Hospital", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital Of Harbin Medical University", "city": "Harbin", "status": ""}, {"facility": "Local Institution - 809", "city": "Shanghai", "status": ""}, {"facility": "Local Institution - 801", "city": "Shanghai", "status": ""}, {"facility": "Local Institution - 811", "city": "Suzhou", "status": ""}, {"facility": "Local Institution - 800", "city": "Tianjin", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "Local Institution - 810", "city": "Zhengzhou", "status": ""}], "cn_site_count": 20, "broad_only": false}, {"nct": "NCT04562870", "title": "A Study to Evaluate Single Agent Selinexor Versus Physician's Choice in Participants With Previously Treated Myelofibrosis", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-03-17", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 112, "sponsor": "Karyopharm Therapeutics Inc", "conditions": ["Myelofibrosis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Affiliated Hospital of Nantong University", "city": "Nantong", "status": ""}, {"facility": "The Second Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "Suzhou University -The First Affiliated Hospital", "city": "Suzhou", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Sir Run Run Shaw Hospital - Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT04551066", "title": "To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)", "status": "TERMINATED", "start": "2021-05-24", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 252, "sponsor": "Incyte Corporation", "conditions": ["Myelofibrosis", "Primary Myelofibrosis", "Post Essential Thrombocythemia Myelofibrosis", "Post Polycythemia Vera Myelofibrosis"], "cn_sites": [{"facility": "Affiliated Hospital of Hebei University", "city": "Baoding", "status": ""}, {"facility": "Peking University People'S Hospital (Pkuph) - Institute of Hematology", "city": "Beijing", "status": ""}, {"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": ""}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Guangdong Provincial of People Hospital", "city": "Guangzhou", "status": ""}, {"facility": "Nanfang Hospital", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Zhejiang University", "city": "Hangzhou", "status": ""}, {"facility": "Harbin Institute of Hematology and Oncology", "city": "Harbin", "status": ""}, {"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": ""}, {"facility": "The Affiliated Hospital of Inner Mongolia Medical University", "city": "Hohhot", "status": ""}, {"facility": "Jinan Central Hospital", "city": "Jinan", "status": ""}, {"facility": "The First Hospital of Lanzhou University", "city": "Lanzhou", "status": ""}, {"facility": "Lanzhou University Second Hospital", "city": "Lanzhou", "status": ""}, {"facility": "Jiangxi Provincial of People Hospital", "city": "Nanchang", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": ""}, {"facility": "Jiangsu Province Hospital", "city": "Nanjing", "status": ""}, {"facility": "Zhongshan Hospital Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shenzhen University Hospital", "city": "Shenzhen", "status": ""}, {"facility": "The Second Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": ""}, {"facility": "Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Yantai Yuhuangding Hospital", "city": "Yantai", "status": ""}, {"facility": "Henan Provincial Peoples Hospital", "city": "Zhengzhou", "status": ""}], "cn_site_count": 26, "broad_only": false}, {"nct": "NCT04551053", "title": "To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304)", "status": "TERMINATED", "start": "2021-05-26", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 177, "sponsor": "Incyte Corporation", "conditions": ["Myelofibrosis", "Primary Myelofibrosis", "Post Essential Thrombocythemia Myelofibrosis", "Post Polycythemia Vera Myelofibrosis"], "cn_sites": [{"facility": "Peking University People'S Hospital (Pkuph) - Institute of Hematology", "city": "Beijing", "status": ""}, {"facility": "Xuanwu Hospital Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "The First Peoples Hospital of Changzhou", "city": "Changzhou", "status": ""}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Nanfang Hospital", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Zhejiang University", "city": "Hangzhou", "status": ""}, {"facility": "Harbin Institute of Hematology and Oncology", "city": "Harbin", "status": ""}, {"facility": "University of Science and Technology of China-First Affiliated Hospital (Anhui Provincial Hospital)", "city": "Hefei", "status": ""}, {"facility": "The Affiliated Hospital of Inner Mongolia Medical University", "city": "Hohhot", "status": ""}, {"facility": "Jinan Central Hospital", "city": "Jinan", "status": ""}, {"facility": "The Second Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}, {"facility": "The First Hospital of Lanzhou University", "city": "Lanzhou", "status": ""}, {"facility": "Lanzhou University Second Hospital", "city": "Lanzhou", "status": ""}, {"facility": "Jiangxi Provincial of People Hospital", "city": "Nanchang", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": ""}, {"facility": "Jiangsu Province Hospital", "city": "Nanjing", "status": ""}, {"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": ""}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "Shenzhen University Hospital", "city": "Shenzhen", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Pek", "city": "Tianjin", "status": ""}, {"facility": "Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Tongji Hospital Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "The Second Affiliated Hospital of Xi an Jiaotong University", "city": "Xi'an", "status": ""}, {"facility": "Yantai Yuhuangding Hospital", "city": "Yantai", "status": ""}, {"facility": "Henan Provincial Peoples Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Henan Cancer Hostipal", "city": "Zhengzhou", "status": ""}], "cn_site_count": 29, "broad_only": false}, {"nct": "NCT05982106", "title": "To Evaluate the Effect of Food on the Pharmacokinetics of TQ05105 Tablets in Healthy Adult Subjects", "status": "COMPLETED", "start": "2021-07-19", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 16, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Myelofibrosis"], "cn_sites": [{"facility": "Affiliated Hospital of Changchun University of Traditional Chinese Medicine", "city": "Changchun", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04851535", "title": "Study of Jaktinib In Patients With Myelofibrosis Who Were Relapsed or Refractory of Ruxolitinib Treatment.", "status": "COMPLETED", "start": "2021-07-28", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 34, "sponsor": "Suzhou Zelgen Biopharmaceuticals Co.,Ltd", "conditions": ["Myelofibrosis"], "cn_sites": [{"facility": "The First Affiliated Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04866056", "title": "Jaktinib and Azacitidine In Treating Patients With MDS With MF or MDS/MPN With MF.", "status": "TERMINATED", "start": "2021-09-30", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 1, "sponsor": "Suzhou Zelgen Biopharmaceuticals Co.,Ltd", "conditions": ["Myelodysplastic Syndromes", "Myeloproliferative Neoplasms", "Myelofibrosis"], "cn_sites": [{"facility": "79 Qingchun Road", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05020652", "title": "A Clinical Trial of TQ05105 Tablets in the Treatment of Moderate and High Risk Myelofibrosis", "status": "COMPLETED", "start": "2021-11-11", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 107, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Moderate and High Risk Myelofibrosis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Guangdong Provincial Peoples Hospital", "city": "Guangzhou", "status": ""}, {"facility": "West China School of Medicine / West China Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Institute of Hematology & Blood Diseases Hostpital, Chinese Academy of medical sciences & Peking Union Medical College", "city": "Tianjin", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT05153343", "title": "Safety of Flonoltinib Maleate Tablets for the Treatment of Patients With Myeloproliferative", "status": "COMPLETED", "start": "2021-12-27", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 31, "sponsor": "Chengdu Zenitar Biomedical Technology Co., Ltd", "conditions": ["Myeloproliferative Neoplasm (MPN)", "Myelofibrosis，MF"], "cn_sites": [{"facility": "West China Hospital Sichuan University", "city": "Chengdu", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05447260", "title": "A New Prognostic Stratification-based Safety and Efficacy Study of Ruxolitinib in Myelofibrosis", "status": "UNKNOWN", "start": "2022-06-10", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 87, "sponsor": "Qilu Hospital of Shandong University", "conditions": ["Myelofibrosis"], "cn_sites": [{"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06388759", "title": "TQ05105 Tablet for Myelofibrosis Treatment in Ruxolitinib-Resistant or Intolerant Patients", "status": "TERMINATED", "start": "2022-08-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Myelofibrosis"], "cn_sites": [{"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": ""}, {"facility": "The First Affiliated Hospital of Wannan Medical College", "city": "Wuhu", "status": ""}, {"facility": "Union Hospital Tongji College Huazhong University of Science And Technology", "city": "Wuhan", "status": ""}, {"facility": "The Affiliated Hospital of Xuzhou Medical University", "city": "Xuzhou", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Shanghai Sixth People's Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT06024915", "title": "A Study to Evaluate Drug-Drug Interaction of TQ05105 Tablets", "status": "COMPLETED", "start": "2023-09-21", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Myelofibrosis"], "cn_sites": [{"facility": "Shandong Provincial Hospital", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06132243", "title": "Comparative Study on Pharmacokinetics of Two Formulations of Jaktinib in Healthy Adults Under Fasting Conditions", "status": "COMPLETED", "start": "2023-11-29", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 52, "sponsor": "Suzhou Zelgen Biopharmaceuticals Co.,Ltd", "conditions": ["Myelofibrosis"], "cn_sites": [{"facility": "The Third Hospital of Changsha", "city": "Changsha", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06457425", "title": "A Phase II Clinical Trial of Flonoltinib Maleate Tablet in Intermediate-High Risk Myelofibrosis", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-05-06", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 75, "sponsor": "Chengdu Zenitar Biomedical Technology Co., Ltd", "conditions": ["MF,PMF,PPV-MF,PET-MF"], "cn_sites": [{"facility": "West China Hospital Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Hematology Hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06245941", "title": "A Clinical Trial of TQ05105 Tablets Combined With TQB3909 Tablets in the Treatment of Myelofibrosis (MF)", "status": "TERMINATED", "start": "2024-05-13", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 21, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Myelofibrosis"], "cn_sites": [{"facility": "The Second People's Hospital of Hefei", "city": "Hefei", "status": ""}, {"facility": "Hennan Cancer Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Xijing Hospital of the Fourth Military Medical University", "city": "Xi'an", "status": ""}, {"facility": "People's Hospital of Tianjin", "city": "Tianjin", "status": ""}, {"facility": "The First Affiliated Hospital Zhejiang University School Of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT06598956", "title": "To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Renal Impairment Subjects", "status": "COMPLETED", "start": "2024-10-12", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 32, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Myelofibrosis"], "cn_sites": [{"facility": "The First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital)", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06468033", "title": "P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-07-18", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 160, "sponsor": "PharmaEssentia", "conditions": ["Primary Myelofibrosis", "Myeloproliferative Neoplasm"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}, {"facility": "The Second Affiliated Hospital of AMU", "city": "Chongqing", "status": ""}, {"facility": "Southern Hospital of Southern Medical University", "city": "Guangdong", "status": ""}, {"facility": "Guangdong Provincial People's Hospital", "city": "Guangzhou", "status": ""}, {"facility": "Institute of Hematology and Oncology, Harbin The First Hospital", "city": "Harbin", "status": ""}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Union Hospital Tong Ji Medical College", "city": "Wuhan", "status": ""}, {"facility": "Jiangsu Provincial Hospital", "city": "Nanjing", "status": ""}, {"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": ""}, {"facility": "Ruijin Hospital, Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Sixth People's Hospital", "city": "Shanghai", "status": ""}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Hematology Hospital of Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}, {"facility": "The First Affiliated Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 16, "broad_only": false}, {"nct": "NCT06909136", "title": "A Study to Evaluate Safety , Efficacy and Pharmacokinetics of WJ01024 Tablets Combined With Ruxolitinib in Patients With Myelofibrosis", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-07-28", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 33, "sponsor": "Suzhou Junjing BioSciences Co., Ltd.", "conditions": ["Intermediate- and High-risk Myelofibrosis (MF) Patients With Splenomegaly"], "cn_sites": [{"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07342712", "title": "Clinical Trail to Evaluate the Effect of Long-term Treatment With Gecacitinib on Myelofibrosis and Gene Mutation Levels", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-08-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 40, "sponsor": "First Affiliated Hospital of Zhejiang University", "conditions": ["Myelofibrosis"], "cn_sites": [{"facility": "The First Affiliated Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07608666", "title": "Study to Evaluate the Effect of Rabeprazole Sodium Enteric-coated Tablets on the Pharmacokinetics of TQ05105 Tablets", "status": "ACTIVE_NOT_RECRUITING", "start": "2026-07-20", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 17, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Myelofibrosis"], "cn_sites": [{"facility": "The Third Xiangya Hospital, Central South University", "city": "Changsha", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07708272", "title": "QT Interval/Corrected QT Interval （QT/QTc） Clinical Study to Evaluate the Cardiac Safety of TQ05105 Tablets in Healthy Participants", "status": "ACTIVE_NOT_RECRUITING", "start": "2026-07-30", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Myelofibrosis"], "cn_sites": [{"facility": "PKU Care Luzhong Hospital", "city": "Zibo", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 115, "g_fetched": 102, "g_countries": [["United States", 64], ["France", 17], ["Italy", 17], ["Spain", 13], ["Germany", 11], ["United Kingdom", 10], ["Australia", 9], ["Belgium", 7], ["Canada", 7], ["South Korea", 6], ["Poland", 5], ["Romania", 4], ["Czechia", 3], ["Greece", 3], ["Hungary", 3], ["Japan", 3], ["Taiwan", 3], ["Hong Kong", 3], ["Austria", 2], ["Brazil", 2], ["Bulgaria", 2], ["Israel", 2], ["Netherlands", 2], ["Argentina", 1], ["Chile", 1], ["Colombia", 1], ["India", 1], ["Ireland", 1], ["Malaysia", 1], ["Mexico", 1], ["Saudi Arabia", 1], ["Sweden", 1], ["Turkey (Türkiye)", 1], ["Armenia", 1], ["Croatia", 1], ["Georgia", 1], ["Portugal", 1], ["Serbia", 1], ["New Zealand", 1], ["Denmark", 1], ["Puerto Rico", 1]], "g_trials": [{"nct": "NCT07734077", "title": "Revumenib in Patients With Myelofibrosis", "status": "NOT_YET_RECRUITING", "start": "2026-12-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "John Mascarenhas", "countries": ["United States"]}, {"nct": "NCT07424950", "title": "Bomedemstat (IMG-7289) in Combination With Momelotinib in Patients With Myelofibrosis", "status": "NOT_YET_RECRUITING", "start": "2026-11-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "United Lincolnshire Hospitals NHS Trust", "countries": []}, {"nct": "NCT07498205", "title": "Comparing Momelotinib and Ruxolitinib in People With Untreated Myelofibrosis and Low Blood Cell Counts", "status": "NOT_YET_RECRUITING", "start": "2026-11", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "SWOG Cancer Research Network", "countries": []}, {"nct": "NCT07750574", "title": "Flonoltinib Maleate Oral Regimens in Patients With Myelofibrosis", "status": "NOT_YET_RECRUITING", "start": "2026-11", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Chengdu Zenitar Biomedical Technology Co., Ltd", "countries": []}, {"nct": "NCT07805746", "title": "Peri-graft Cytokine Profile: Influence of Hematologic Disease and Donor Type", "status": "NOT_YET_RECRUITING", "start": "2026-09-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": []}, {"nct": "NCT07623161", "title": "A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib", "status": "RECRUITING", "start": "2026-09-02", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Takeda", "countries": ["Argentina", "Australia", "Austria", "Belgium", "Brazil", "Bulgaria", "Canada", "Chile", "Colombia", "Czechia", "France", "Germany", "Greece", "Hungary", "India", "Ireland", "Israel", "Italy", "Japan", "Malaysia", "Mexico", "Poland", "Romania", "Saudi Arabia", "South Korea", "Spain", "Sweden", "Taiwan", "Turkey (Türkiye)", "United Kingdom", "United States"]}, {"nct": "NCT07774455", "title": "Pacritinib Effectiveness in Real-world Settings", "status": "RECRUITING", "start": "2026-08-13", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Swedish Orphan Biovitrum", "countries": ["United States"]}, {"nct": "NCT07518940", "title": "ENERGIA: Personalized Exercise Program for Fatigue in Patients With Myeloproliferative Neoplasms and Chronic Myeloid Leukemia", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Carmen Fava", "countries": ["Italy"]}, {"nct": "NCT07521046", "title": "Tolerability of Ropeginterferon Alfa-2b Add-on to Ongoing Ruxolitinib Therapy in Myelofibrosis (RopeRux in Myelofibrosis)", "status": "NOT_YET_RECRUITING", "start": "2026-08", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "University of Utah", "countries": ["United States"]}, {"nct": "NCT07302776", "title": "TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT", "status": "RECRUITING", "start": "2026-07-21", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Stanford University", "countries": ["United States"]}, {"nct": "NCT07349134", "title": "WELL-MPN: A Digital Lifestyle App for Patients With MPNs", "status": "NOT_YET_RECRUITING", "start": "2026-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Brigham and Women's Hospital", "countries": ["United States"]}, {"nct": "NCT07250646", "title": "A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis", "status": "RECRUITING", "start": "2026-05-21", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Aspera Biomedicines, Inc.", "countries": ["United States"]}, {"nct": "NCT07379125", "title": "Therapeutic RSK1 Targeting in Myelofibrosis", "status": "RECRUITING", "start": "2026-05-20", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Washington University School of Medicine", "countries": ["United States"]}, {"nct": "NCT07529951", "title": "Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers", "status": "NOT_YET_RECRUITING", "start": "2026-05-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Eilean Therapeutics", "countries": []}, {"nct": "NCT07441694", "title": "Study of INCA036978 in Participants With Myeloproliferative Neoplasms", "status": "RECRUITING", "start": "2026-05-11", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Incyte Corporation", "countries": ["Australia", "Belgium", "Canada", "France", "Germany", "Italy", "Japan", "South Korea", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT07020533", "title": "A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant", "status": "RECRUITING", "start": "2026-05-08", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "City of Hope Medical Center", "countries": ["United States"]}, {"nct": "NCT07447817", "title": "Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias", "status": "NOT_YET_RECRUITING", "start": "2026-05-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "John Mascarenhas", "countries": ["United States"]}, {"nct": "NCT07590986", "title": "Identification of MPN-specific Antigens and Anti-MPN TCRs in Myeloproliferative Neoplasm", "status": "RECRUITING", "start": "2026-05", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Université Catholique de Louvain", "countries": ["Belgium"]}, {"nct": "NCT07469891", "title": "A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms", "status": "RECRUITING", "start": "2026-04-29", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Prelude Therapeutics Incorporated", "countries": ["Spain", "United States"]}, {"nct": "NCT07527221", "title": "Safety and Tolerability of ZE74-0282 in Healthy Volunteers", "status": "RECRUITING", "start": "2026-04-16", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Eilean Therapeutics AU Pty Ltd", "countries": ["Australia"]}, {"nct": "NCT07394153", "title": "Pacritinib For Bone Marrow Fibrosis In Patients With Myelofibrosis Who Have Thrombocytopenia", "status": "RECRUITING", "start": "2026-04-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas", "countries": ["Spain"]}, {"nct": "NCT07471503", "title": "Gecacitinib Pre-, During- and Post-HSCT for Patients With Primary or Secondary Myelofibrosis", "status": "NOT_YET_RECRUITING", "start": "2026-03-16", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "countries": []}, {"nct": "NCT07440654", "title": "Efficacy and Safety of Gecacitinib Hydrochloride in Prophylaxis Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelofibrosis", "status": "NOT_YET_RECRUITING", "start": "2026-03-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Nanfang Hospital, Southern Medical University", "countries": []}, {"nct": "NCT07104799", "title": "Momelotinib During and After HCT in Myelofibrosis", "status": "RECRUITING", "start": "2026-02-23", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Massachusetts General Hospital", "countries": ["United States"]}, {"nct": "NCT06976918", "title": "Research Platform Myelofibrosis and Anemia", "status": "RECRUITING", "start": "2026-02-19", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "iOMEDICO AG", "countries": ["Germany"]}]}, {"batch": 2, "no": 68, "name_zh": "原发性硬化性胆管炎", "query_terms": [{"term": "Primary sclerosing cholangitis", "broad": false}], "n_total": 7, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT07678645", "title": "The Safety and Efficacy of Upadacitinib in Refractory Autoimmune Related Cholangitis and Atopic Dermatitis With Moderate to Severe Itching", "status": "NOT_YET_RECRUITING", "start": "2026-06-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 44, "sponsor": "RenJi Hospital", "conditions": ["Primary Biliary Cholangitis (PBC)", "Primary Sclerosing Cholangitis (PSC)", "Atopic Dermatitis (AD)"], "cn_sites": [{"facility": "RenJi Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02703194", "title": "Leflunomide for Maintenance of Remission in IgG4 Related Disease", "status": "COMPLETED", "start": "2016-03", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 68, "sponsor": "Chinese PLA General Hospital", "conditions": ["Immunoglobulin G4 Related Sclerosing Disease"], "cn_sites": [{"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02797665", "title": "Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids", "status": "UNKNOWN", "start": "2016-05", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Autoimmune Pancreatitis", "IgG4-related Sclerosing Cholangitis", "Obstructive Jaundice"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05181332", "title": "Predictive Models of Hepatic Decompensation and Survival Outcomes in Pediatric Patients With Cirrhosis", "status": "UNKNOWN", "start": "2021-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 400, "sponsor": "West China Hospital", "conditions": ["Cirrhosis", "Biliary Atresia", "Choledochal Cyst", "Primary Sclerosing Cholangitis", "HBV", "HCV", "Autoimmune Hepatitis"], "cn_sites": [{"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04981756", "title": "PSC Clinical Epidemiology in China", "status": "UNKNOWN", "start": "2021-04-07", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 800, "sponsor": "Beijing Friendship Hospital", "conditions": ["Primary Sclerosing Cholangitis"], "cn_sites": [{"facility": "Beijing Friendship Hospital, Capital Medical Univeristy", "city": "Beijing", "status": ""}, {"facility": "Beijing Youan Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Shanghai Suvalue Health Scientific Ltd.", "city": "Shanghai", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT05463445", "title": "Multicenter Observational Study of PSC and IgG4-SC in China", "status": "UNKNOWN", "start": "2022-07-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "RenJi Hospital", "conditions": ["Primary Sclerosing Cholangitis", "IgG4-related Sclerosing Cholangitis"], "cn_sites": [{"facility": "RenJi Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05896137", "title": "CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis)", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-08-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Cascade Pharmaceuticals, Inc", "conditions": ["Primary Sclerosing Cholangitis"], "cn_sites": [{"facility": "The First Affiliated Hospital of USTC Anhui Provincial Hospital", "city": "Hefei", "status": ""}, {"facility": "Beijing Friendship Hospital, Captail Medcial University", "city": "Beijing", "status": ""}, {"facility": "Beijing YouAn Hostital, Captial Medical University", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Wuhan Union Hospital of China", "city": "Wuhan", "status": ""}, {"facility": "The Seconed Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "The First Bethune Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": ""}, {"facility": "Renji Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Shaoyifu Hospital of Zhejiang University Medical", "city": "Hangzhou", "status": ""}, {"facility": "The First Affiliated Hospital,Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 11, "broad_only": false}], "g_total": 41, "g_fetched": 40, "g_countries": [["United States", 19], ["Italy", 6], ["United Kingdom", 4], ["France", 3], ["Germany", 3], ["Canada", 3], ["Belgium", 2], ["Netherlands", 2], ["Austria", 2], ["Spain", 2], ["Finland", 1], ["South Korea", 1], ["New Zealand", 1], ["Sweden", 1], ["Denmark", 1], ["Switzerland", 1]], "g_trials": [{"nct": "NCT07646223", "title": "Vancomycin Efficacy in Response to Dysbiosis in Atypical Colitis", "status": "NOT_YET_RECRUITING", "start": "2026-10-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Tampere University Hospital", "countries": ["Finland"]}, {"nct": "NCT06252610", "title": "PET/MRI of Primary Sclerosing Cholangitis", "status": "NOT_YET_RECRUITING", "start": "2026-08-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Massachusetts General Hospital", "countries": ["United States"]}, {"nct": "NCT06723275", "title": "LEOPARD Prospective Validation Cohort 1", "status": "RECRUITING", "start": "2026-07-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["Belgium", "France", "Germany", "Italy", "Netherlands"]}, {"nct": "NCT07387549", "title": "A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis", "status": "RECRUITING", "start": "2026-05-14", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Ipsen", "countries": ["United States"]}, {"nct": "NCT07477782", "title": "Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis - Randomized Study Versus Sham Transplantation", "status": "NOT_YET_RECRUITING", "start": "2026-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT07607353", "title": "Biodegradable Stents in Primary Sclerosing Cholangitis", "status": "RECRUITING", "start": "2026-03-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "King's College Hospital NHS Trust", "countries": ["United Kingdom"]}, {"nct": "NCT07229911", "title": "A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)", "status": "RECRUITING", "start": "2026-01-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Takeda", "countries": ["United States"]}, {"nct": "NCT07341282", "title": "Investigation of Vancomycin Efficacy in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis", "status": "NOT_YET_RECRUITING", "start": "2026-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "McMaster University", "countries": ["Canada"]}, {"nct": "NCT06699121", "title": "A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC", "status": "RECRUITING", "start": "2025-11", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "LISCure Biosciences", "countries": ["United States"]}, {"nct": "NCT06975150", "title": "Efficacy and Safety of HK-660S in the Treatment of Primary Sclerosing Cholangitis", "status": "NOT_YET_RECRUITING", "start": "2025-08-18", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "CuromeBiosciences", "countries": []}, {"nct": "NCT06905054", "title": "Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation", "status": "RECRUITING", "start": "2025-04-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Mayo Clinic", "countries": ["United States"]}, {"nct": "NCT06886360", "title": "Study with Norucholic Acid Tablets in Patients with Primary Sclerosing Cholangitis (PSC)", "status": "NOT_YET_RECRUITING", "start": "2025-03", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Dr. Falk Pharma GmbH", "countries": []}, {"nct": "NCT06864195", "title": "A Simple Breath Test to Detect Liver Cancer and Monitor Liver Conditions", "status": "RECRUITING", "start": "2025-02-13", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Imperial College London", "countries": ["United Kingdom"]}, {"nct": "NCT06675604", "title": "LEOPARD Training and Validation Data Collection Study", "status": "RECRUITING", "start": "2025-02-04", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["Austria", "Belgium", "France", "Germany", "Italy", "Netherlands", "Spain"]}, {"nct": "NCT06865924", "title": "Colangioids to Define the Genetic Factors Involved in Atypical Primary Sclerosing Cholangitis", "status": "RECRUITING", "start": "2024-12-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico", "countries": ["Italy"]}, {"nct": "NCT06670547", "title": "Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde Cholangiopancreatography", "status": "NOT_YET_RECRUITING", "start": "2024-11-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Germans Trias i Pujol Hospital", "countries": []}, {"nct": "NCT06455280", "title": "A Study of SIPLIZUMAB in AILD and LT Patients", "status": "RECRUITING", "start": "2024-09-11", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Elizabeth C. Verna", "countries": ["United States"]}, {"nct": "NCT06519162", "title": "Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome", "status": "RECRUITING", "start": "2024-07-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Chungnam National University Hospital", "countries": ["South Korea"]}, {"nct": "NCT06297993", "title": "Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)", "status": "RECRUITING", "start": "2024-05-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "PSC Partners Seeking a Cure", "countries": ["Canada", "Germany", "Italy", "New Zealand", "United Kingdom", "United States"]}, {"nct": "NCT06286709", "title": "FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis", "status": "RECRUITING", "start": "2024-03-27", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University of Birmingham", "countries": ["United Kingdom"]}, {"nct": "NCT06197308", "title": "Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC", "status": "RECRUITING", "start": "2024-03-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "University of Minnesota", "countries": ["United States"]}, {"nct": "NCT05835505", "title": "Detoxification of the Liver In PSC (Dolphin)", "status": "RECRUITING", "start": "2023-12-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Brigham and Women's Hospital", "countries": ["United States"]}, {"nct": "NCT05876182", "title": "Vancomycin in Primary Sclerosing Cholangitis in Italy", "status": "RECRUITING", "start": "2023-06-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University of Milano Bicocca", "countries": ["Italy"]}, {"nct": "NCT05912387", "title": "Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study", "status": "RECRUITING", "start": "2023-05-31", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Stanford University", "countries": ["United States"]}, {"nct": "NCT05295680", "title": "Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis.", "status": "RECRUITING", "start": "2023-05-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Aparna Goel", "countries": ["United States"]}]}, {"batch": 2, "no": 69, "name_zh": "进行性纤维化性间质性肺疾病", "query_terms": [{"term": "Progressive fibrosing interstitial lung disease", "broad": false}], "n_total": 6, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT05139719", "title": "A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients", "status": "RECRUITING", "start": "2023-02-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 110, "sponsor": "Sunshine Lake Pharma Co., Ltd.", "conditions": ["Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF)"], "cn_sites": [{"facility": "China-Japan Friendship Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02999178", "title": "Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)", "status": "COMPLETED", "start": "2017-01-17", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 663, "sponsor": "Boehringer Ingelheim", "conditions": ["Lung Diseases, Interstitial"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": ""}, {"facility": "The First Hospital of Chinese Medical University", "city": "Shenyang", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT03820726", "title": "A Follow-up Study Investigating Long Term Treatment With Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)", "status": "COMPLETED", "start": "2019-04-16", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 435, "sponsor": "Boehringer Ingelheim", "conditions": ["Lung Diseases, Interstitial"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": ""}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT04308681", "title": "A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis", "status": "COMPLETED", "start": "2020-07-29", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 403, "sponsor": "Bristol-Myers Squibb", "conditions": ["Pulmonary Fibrosis"], "cn_sites": [{"facility": "Local Institution - 0187", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 0183", "city": "Beijing", "status": ""}, {"facility": "Local Institution - 0188", "city": "Wuhan", "status": ""}, {"facility": "Local Institution - 0189", "city": "Shanghai", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT05065190", "title": "A Study to Test How Well a Medicine Called Nintedanib Helps People in China With Progressive Lung Fibrosis", "status": "COMPLETED", "start": "2021-11-25", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 81, "sponsor": "Boehringer Ingelheim", "conditions": ["Lung Diseases, Interstitial"], "cn_sites": [{"facility": "China-Japan Friendship Hospital", "city": "Beijing", "status": ""}, {"facility": "The Second Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Xiangya Hospital, Central South University", "city": "Changsha", "status": ""}, {"facility": "West China Hospital", "city": "Chengdu", "status": ""}, {"facility": "First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Hangzhou First People's Hospital", "city": "Hangzhou", "status": ""}, {"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Hospital", "city": "Hangzhou", "status": ""}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": ""}, {"facility": "Shanghai Chest Hospital", "city": "Shanghai", "status": ""}, {"facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "The First Affiliated Hospital of Wenzhou Med College", "city": "Wenzhou", "status": ""}, {"facility": "Tongji Hospital Affiliated Tongji Medical College Huazhong University of S & T", "city": "Wuhan", "status": ""}, {"facility": "General Hospital of Ningxia Medical University", "city": "Yinchuan", "status": ""}], "cn_site_count": 16, "broad_only": false}, {"nct": "NCT05321082", "title": "A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)", "status": "COMPLETED", "start": "2022-11-16", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1178, "sponsor": "Boehringer Ingelheim", "conditions": ["Lung Diseases, Interstitial"], "cn_sites": [{"facility": "Beijing Chao-Yang Hospital", "city": "Beijing", "status": ""}, {"facility": "China-Japan Friendship Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "The Second Xiangya Hospital Of Central South University", "city": "Changsha", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Guangdong Provincial People's Hospital", "city": "Guangzhou", "status": ""}, {"facility": "First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "status": ""}, {"facility": "NanFang Hosptial", "city": "Guangzhou", "status": ""}, {"facility": "Hangzhou First People's Hospital", "city": "Hangzhou", "status": ""}, {"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Hospital", "city": "Hangzhou", "status": ""}, {"facility": "Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": ""}, {"facility": "The Affiliated Hospital of Inner Mongolia Medical University", "city": "Hohhot", "status": ""}, {"facility": "The First hospital of Jiaxing", "city": "Jiaxing", "status": ""}, {"facility": "Jinhua Municipal Central Hospital", "city": "Jinhua", "status": ""}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": ""}, {"facility": "Ningbo Medical Center Lihuili Hospital", "city": "Ningbo", "status": ""}, {"facility": "The First Affiliated Hospital of Ningbo University", "city": "Ningbo", "status": ""}, {"facility": "Ruijin Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Chest Hospital", "city": "Shanghai", "status": ""}, {"facility": "Zhongshan Hospital Affiliated to Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Huadong Hospital affiliated to Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shanghai Pulmonary Hospital", "city": "Shanghai", "status": ""}, {"facility": "China Shenyang Chest Hospital", "city": "Shenyang", "status": ""}, {"facility": "Shenzhen People's Hospital", "city": "Shenzhen", "status": ""}, {"facility": "The University of Hong Kong-Shenzhen Hospital", "city": "Shenzhen", "status": ""}, {"facility": "People's Hospital of Sichuan Province", "city": "Sichuan", "status": ""}, {"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenxzhou", "status": ""}, {"facility": "Wuhan Union Hospital", "city": "Wuhan", "status": ""}, {"facility": "Tongji Hospital Affiliated Tongji Medical College Huazhong University of S & T", "city": "Wuhan", "status": ""}, {"facility": "Renmin Hospital of Wuhan University", "city": "Wuhan", "status": ""}, {"facility": "Wuxi People's Hospital", "city": "Wuxi", "status": ""}, {"facility": "Second Affiliated Hospital of Xi'an JiaoTong University", "city": "Xi'an", "status": ""}, {"facility": "Affiliated Hospital, Xuzhou Medical college", "city": "Xuzhou", "status": ""}, {"facility": "Yichang Central People's Hospital", "city": "Yichang", "status": ""}, {"facility": "General Hospital of Ningxia Medical University", "city": "Yinchuan", "status": ""}, {"facility": "Yuncheng Central Hospital", "city": "Yuncheng", "status": ""}], "cn_site_count": 41, "broad_only": false}], "g_total": 5, "g_fetched": 4, "g_countries": [["Italy", 2], ["United States", 1], ["Russia", 1]], "g_trials": [{"nct": "NCT07572383", "title": "Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis", "status": "RECRUITING", "start": "2026-05-14", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Peter Caravan", "countries": ["United States"]}, {"nct": "NCT07541638", "title": "Early Recognition of Progressive Lung Fibrosis in Systemic Rheumatic Diseases", "status": "RECRUITING", "start": "2024-11-07", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Fondazione Policlinico Universitario Agostino Gemelli IRCCS", "countries": ["Italy"]}, {"nct": "NCT06537934", "title": "Advanced Mutidimensional and Ultra High Resolution Computed Tomography to Inspect Cardiopulmonary Involvement in Progressive Fibrosing Interstitial Lung Diseases", "status": "RECRUITING", "start": "2024-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS San Raffaele", "countries": ["Italy"]}, {"nct": "NCT06440746", "title": "Efficacy and Safety of Olokizumab in Patients With Progressive Fibrosing Interstitial Lung Diseases", "status": "RECRUITING", "start": "2023-08-23", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "R-Pharm International, LLC", "countries": ["Russia"]}]}, {"batch": 2, "no": 70, "name_zh": "复发性心包炎", "query_terms": [{"term": "Idiopathic recurrent pericarditis", "broad": false}, {"term": "Recurrent pericarditis", "broad": true}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 0, "g_fetched": 0, "g_countries": [], "g_trials": []}, {"batch": 2, "no": 71, "name_zh": "早产儿视网膜病", "query_terms": [{"term": "Retinopathy of prematurity", "broad": false}], "n_total": 7, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT06717412", "title": "Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy", "status": "RECRUITING", "start": "2024-11-29", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 146, "sponsor": "Wang Yusheng", "conditions": ["Retinopathy of Prematurity (ROP)"], "cn_sites": [{"facility": "Department of Ophthalmology, the Second Affiliated Hospital of Xi'an Medical University", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "Department of Ophthalmology, Xijing Hospital, Air Force Military Medical University", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "Department of Ophthalmology, Xianyang Rainbow Hospital", "city": "Xianyang", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT03154723", "title": "Effects of Early Vitamin A Supplementation on the Risk for Retinopathy of Prematurity in Extremely Preterm Infants", "status": "COMPLETED", "start": "2015-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 262, "sponsor": "Huiqing Sun", "conditions": ["Retinopathy of Prematurity"], "cn_sites": [{"facility": "Zhengzhou Children's Hospital", "city": "Zhengzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02977000", "title": "Oral Propranolol Improve Retinopathy of Prematurity Outcomes in Very Preterm Infants", "status": "UNKNOWN", "start": "2016-05", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Huiqing Sun", "conditions": ["Retinopathy of Prematurity"], "cn_sites": [{"facility": "Propranolol", "city": "Zhengzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03115255", "title": "Serum Vascular Endothelial Growth Factor in Infants With Intravitreal Ranibizumab", "status": "COMPLETED", "start": "2017-05-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 17, "sponsor": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": ["Infant, Premature, Diseases"], "cn_sites": [{"facility": "Xinhua Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04985448", "title": "Real World Study of the Effectiveness and Safety of Conbercept Ophthalmic Injection in the Treatment of Retinopathy of Prematurity - Multicenter, Retrospective and Observational Study Based on Real World Data", "status": "UNKNOWN", "start": "2022-09", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "Chengdu Kanghong Biotech Co., Ltd.", "conditions": ["Retinopathy of Prematurity"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05576792", "title": "A 24-week Study Evaluating the Effectiveness and Safety of Lucentis® 0.2mg in Retinopathy of Prematurity Participants in China", "status": "COMPLETED", "start": "2023-01-13", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 62, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Retinopathy of Prematurity"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06729333", "title": "A Multicenter and Prospective Study of Screening Retinopathy of Prematurity in China", "status": "COMPLETED", "start": "2024-12-03", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 4841, "sponsor": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": ["Premature Birth of Newborn", "Retinopathy of Prematurity (ROP)", "Low Birthweight Infant"], "cn_sites": [{"facility": "Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 23, "g_fetched": 22, "g_countries": [["United States", 6], ["Turkey (Türkiye)", 5], ["Spain", 2], ["Germany", 2], ["Switzerland", 2], ["France", 2], ["Canada", 1], ["Norway", 1], ["Saudi Arabia", 1], ["Croatia", 1], ["Netherlands", 1], ["United Kingdom", 1], ["Taiwan", 1], ["Israel", 1], ["Austria", 1], ["Bulgaria", 1], ["Estonia", 1], ["Greece", 1], ["Kosovo", 1], ["Poland", 1], ["Ukraine", 1]], "g_trials": [{"nct": "NCT07502781", "title": "Heterologous Cord Blood-Derived Red Blood Cell for Transfusion in Extremely Preterm Infants", "status": "NOT_YET_RECRUITING", "start": "2027-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Hospital Clinic of Barcelona", "countries": ["Spain"]}, {"nct": "NCT07738874", "title": "Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care", "status": "RECRUITING", "start": "2026-12-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Duke University", "countries": ["United States"]}, {"nct": "NCT07112430", "title": "Fentanyl Intranasal for Retinopathy of Prematurity Screening in Preterm Infants", "status": "NOT_YET_RECRUITING", "start": "2026-09-09", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Marsha Campbell-Yeo", "countries": ["Canada"]}, {"nct": "NCT07661654", "title": "HBM-Based Education for Retinopathy of Prematurity Screening in Parents of Premature Infants", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Aga Khan University", "countries": []}, {"nct": "NCT07093255", "title": "Safety, PK and PD of FLQ-101 in Premature Neonates", "status": "RECRUITING", "start": "2026-04-03", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "FELIQS INC.", "countries": ["United States"]}, {"nct": "NCT07427719", "title": "Retinopathy of Prematurity - Visual Function and Retinal Structure", "status": "NOT_YET_RECRUITING", "start": "2026-04-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Oslo University Hospital", "countries": ["Norway"]}, {"nct": "NCT07701759", "title": "Incidence of Hypoxia During Intravitreal Anti-VEGF (Vascular Endothelial Growth Factor) Injections for Retinopathy of Prematurity (ROP) Under Topical Anesthesia", "status": "RECRUITING", "start": "2025-10-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Minia University", "countries": ["Saudi Arabia"]}, {"nct": "NCT07123948", "title": "The Correlation Between Red Cell Transfusion and Complications of Prematurity", "status": "NOT_YET_RECRUITING", "start": "2025-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Clinical Hospital Center Rijeka", "countries": ["Croatia"]}, {"nct": "NCT06612541", "title": "Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity", "status": "RECRUITING", "start": "2025-02-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Vanderbilt University Medical Center", "countries": ["United States"]}, {"nct": "NCT06649513", "title": "Long-term Ophthalmic Outcomes in Ex-premature Infants", "status": "NOT_YET_RECRUITING", "start": "2024-11-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Erasmus Medical Center", "countries": ["Netherlands"]}, {"nct": "NCT05558059", "title": "Imaging Retinal Vasculature in Infant Eyes", "status": "RECRUITING", "start": "2024-10-03", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Duke University", "countries": ["United States"]}, {"nct": "NCT06672913", "title": "Impact of Standardized Skin-to-Skin Care on Clinical Outcomes in Infants Born ≤ 32 Weeks: A Multicenter Study", "status": "RECRUITING", "start": "2024-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Baskent University Ankara Hospital", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT06315556", "title": "An Observational Study to Collect Data on How Aflibercept (Eylea) Given Using a Paediatric Dosing Device is Used in Preterm Babies With Retinopathy of Prematurity in the United Kingdom (UK)", "status": "RECRUITING", "start": "2024-03-05", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Bayer", "countries": ["United Kingdom"]}, {"nct": "NCT06520410", "title": "Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries", "status": "RECRUITING", "start": "2024-03-05", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Chang Gung Memorial Hospital", "countries": ["Taiwan"]}, {"nct": "NCT06694103", "title": "The Effect of Two Non-Pharmacological Methods on Pain During Retinopathy Examination", "status": "RECRUITING", "start": "2024-02-19", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Sinem Basdemir", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT06067958", "title": "Intranasal Dexmedetomidine for Pain Management During Screening for Retinopathy of Prematurity", "status": "RECRUITING", "start": "2023-12-11", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Assaf-Harofeh Medical Center", "countries": ["Israel"]}, {"nct": "NCT06265363", "title": "Evaluation of the Frequency, Risk Factors, and Outcomes of ROP in Infants With a BW >1500 Grs or GA ≥33 Wks in Turkey.", "status": "RECRUITING", "start": "2023-08-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Baskent University Ankara Hospital", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT03083431", "title": "Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity", "status": "RECRUITING", "start": "2022-09-22", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University of Zurich", "countries": ["Germany", "Switzerland", "Turkey (Türkiye)"]}, {"nct": "NCT04995341", "title": "Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)", "status": "RECRUITING", "start": "2021-08-16", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Duke University", "countries": ["United States"]}, {"nct": "NCT04939571", "title": "European Disease Registry on Retinopathy of Prematurity (ROP)", "status": "RECRUITING", "start": "2021-08-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Medicine Greifswald", "countries": ["Austria", "Bulgaria", "Estonia", "France", "Germany", "Greece", "Kosovo", "Poland", "Spain", "Switzerland", "Turkey (Türkiye)", "Ukraine"]}, {"nct": "NCT04819893", "title": "Study of the Involvement of Fatty Acids in Retinopathy of Prematurity: Relationship Between Retinopathy of Prematurity and the Rate of Expression of Transplacental Fatty Acid Receptors.", "status": "RECRUITING", "start": "2021-04-20", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Centre Hospitalier Universitaire Dijon", "countries": ["France"]}, {"nct": "NCT04420156", "title": "Clinical and Genetic Analysis of ROP", "status": "RECRUITING", "start": "2011-07-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Oregon Health and Science University", "countries": ["United States"]}]}, {"batch": 2, "no": 72, "name_zh": "Rett综合征", "query_terms": [{"term": "Rett syndrome", "broad": false}], "n_total": 3, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT06739434", "title": "GCB-002 in Treatment of Patients With Rett Syndrome", "status": "ENROLLING_BY_INVITATION", "start": "2024-11-11", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Genecombio Ltd.", "conditions": ["RETT Syndrome With Proven MECP2 Mutation"], "cn_sites": [{"facility": "Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06199700", "title": "Esketamine for the Treatment of Rett Syndrome", "status": "COMPLETED", "start": "2023-11-15", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 3, "sponsor": "Children's Hospital of Fudan University", "conditions": ["Rett Syndrome"], "cn_sites": [{"facility": "Xiamen Children's Hospital (Children's Hospital of Fudan University at Xiamen)", "city": "Xiamen", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06856759", "title": "Single-Dose AAV-MECP2 Safety/Tolerability and Efficacy in Rett Syndrome", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-01-14", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 8, "sponsor": "Guangzhou Women and Children's Medical Center", "conditions": ["Rett Syndrome"], "cn_sites": [{"facility": "Guangzhou Women and Children's Medical Center", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 17, "g_fetched": 17, "g_countries": [["United States", 11], ["Italy", 3], ["Australia", 2], ["France", 2], ["Spain", 2], ["Canada", 1], ["Belgium", 1], ["Hungary", 1], ["Japan", 1], ["Poland", 1], ["Colombia", 1], ["Austria", 1], ["Netherlands", 1]], "g_trials": [{"nct": "NCT07257978", "title": "Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome", "status": "NOT_YET_RECRUITING", "start": "2027-07-01", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Fenix Innovation Group", "countries": ["Australia"]}, {"nct": "NCT06840496", "title": "To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome", "status": "RECRUITING", "start": "2026-09-30", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Biomed Industries, Inc.", "countries": ["Australia", "United States"]}, {"nct": "NCT04041713", "title": "A Pilot Study of an Antioxidant Cocktail vs. Placebo in the Treatment of Children and Adolescents With Rett Syndrome", "status": "RECRUITING", "start": "2026-08-24", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Holland Bloorview Kids Rehabilitation Hospital", "countries": ["Canada"]}, {"nct": "NCT07730112", "title": "Adapting a Psychosocial Support Intervention for the Rett Syndrome Community", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Colorado State University", "countries": ["United States"]}, {"nct": "NCT07503444", "title": "A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome", "status": "RECRUITING", "start": "2026-07-14", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "UCB BIOSCIENCES, Inc.", "countries": ["Belgium", "France", "Hungary", "Italy", "Japan", "Poland", "Spain", "United States"]}, {"nct": "NCT07150013", "title": "Rett REVOLUTION Trial: An Exploratory Evaluation of the Safety and Efficacy of Vorinostat in Rett Syndrome", "status": "RECRUITING", "start": "2026-03-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Unravel Biosciences, Inc.", "countries": ["Colombia"]}, {"nct": "NCT07493096", "title": "Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders", "status": "RECRUITING", "start": "2026-03-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Healing Hope International", "countries": ["United States"]}, {"nct": "NCT07569445", "title": "Auditory EEG and Behavioral Assessments in Individuals With Rett Syndrome", "status": "RECRUITING", "start": "2025-07-31", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Rochester", "countries": ["United States"]}, {"nct": "NCT07430046", "title": "Repurposing Mirtazapine in Rett Syndrome", "status": "RECRUITING", "start": "2025-07-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University of Trieste", "countries": ["Italy"]}, {"nct": "NCT06705816", "title": "Cognitive Function in Rett Syndrome During Trofinetide Treatment", "status": "RECRUITING", "start": "2024-12-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Minnesota", "countries": ["United States"]}, {"nct": "NCT06430385", "title": "ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS)", "status": "RECRUITING", "start": "2024-10-21", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Ionis Pharmaceuticals, Inc.", "countries": ["Austria", "France", "Spain", "United States"]}, {"nct": "NCT05932589", "title": "Neurophysiologic Biomarkers in Rett Syndrome", "status": "RECRUITING", "start": "2023-10-11", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Children's Hospital of Philadelphia", "countries": ["United States"]}, {"nct": "NCT05432349", "title": "Rett Syndrome Registry", "status": "RECRUITING", "start": "2022-08-02", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "International Rett Syndrome Foundation", "countries": ["United States"]}, {"nct": "NCT04900493", "title": "The Rett Syndrome Global Registry", "status": "RECRUITING", "start": "2022-01-31", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Rett Syndrome Research Trust", "countries": ["United States"]}, {"nct": "NCT05012475", "title": "Measuring Impact of Computer Gaming on Arm Use in Rett Syndrome", "status": "RECRUITING", "start": "2021-05-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Georgetown University", "countries": ["United States"]}, {"nct": "NCT05740761", "title": "Gene Editing as a Therapeutic Approach for Rett Syndrome", "status": "RECRUITING", "start": "2021-03-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Siena", "countries": ["Italy"]}, {"nct": "NCT04463316", "title": "GROWing Up With Rare GENEtic Syndromes", "status": "RECRUITING", "start": "2018-10-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "dr. Laura C. G. de Graaff-Herder", "countries": ["Netherlands"]}]}, {"batch": 2, "no": 73, "name_zh": "短肠综合征", "query_terms": [{"term": "Short bowel syndrome", "broad": false}], "n_total": 13, "n_open": 4, "n_open_precise": 4, "n_broad": 0, "trials": [{"nct": "NCT07691125", "title": "Phase IV Study of rhGH Injection in Adult Short Bowel Syndrome", "status": "RECRUITING", "start": "2024-07-31", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Changchun GeneScience Pharmaceutical Co., Ltd.", "conditions": ["Short Bowel Syndrome (SBS) in Adults"], "cn_sites": [{"facility": "Zhongshan Hospital Affiliated to Xiamen University", "city": "Xiamen", "status": "RECRUITING"}, {"facility": "General Hospital of Eastern Theater Command", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06512584", "title": "Efficacy and Safety of PJ009 in Patients With Short Bowel Syndrome Requiring Parenteral Nutrition", "status": "RECRUITING", "start": "2024-09-03", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 72, "sponsor": "Chongqing Peg-Bio Biopharm Co., Ltd.", "conditions": ["Short Bowel Syndrome"], "cn_sites": [{"facility": "Beijing Tsinghua Changgung Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Chongqing General Hospital", "city": "Chongqing", "status": "NOT_YET_RECRUITING"}, {"facility": "The Sixth Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The Third Xiangya Hospital of Central South University", "city": "Changsha", "status": "NOT_YET_RECRUITING"}, {"facility": "General Hospital of Eastern Theater Command", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": "NOT_YET_RECRUITING"}, {"facility": "Shanghai Tenth People's Hospital", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi’an", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT07319832", "title": "A Study of Teduglutide in Chinese Children and Teenagers With Short Bowel Syndrome", "status": "RECRUITING", "start": "2026-03-05", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 12, "sponsor": "Takeda", "conditions": ["Short Bowel Syndrome (SBS)"], "cn_sites": [{"facility": "Guangzhou Women And Children's Medical Center", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Shanghai Children's Hospital", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}, {"facility": "Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Children's Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT07704047", "title": "A Clinical Study of FT1 in Patients With Short Bowel Syndrome", "status": "RECRUITING", "start": "2026-08-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 8, "sponsor": "Chongqing Peg-Bio Biopharm Co., Ltd.", "conditions": ["Short Bowel Syndrome", "SBS"], "cn_sites": [{"facility": "General Hospital of Eastern Theater Command", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01974336", "title": "The Preventative and Therapeutical Effect of Ursodeoxycholic Acid(UDCA) to Short Bowel Syndrome Patients", "status": "COMPLETED", "start": "2013-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Jinling Hospital, China", "conditions": ["Short Bowel Syndrome"], "cn_sites": [{"facility": "Jinling Hospital", "city": "Nanjing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02452177", "title": "Preventive and Reversional Effect of Vitamin D on Parenteral Nutrition Associated Liver Disease", "status": "UNKNOWN", "start": "2015-05", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Shengxian Fan", "conditions": ["Liver Disease"], "cn_sites": [{"facility": "Jinling Hospital", "city": "Nanjing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02699320", "title": "Intestinal Microbial Dysbiosis in Chinese Infants With Short Bowel Syndrome With Different Complications", "status": "COMPLETED", "start": "2015-06", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 33, "sponsor": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": ["Short Bowel Syndrome", "Complications"], "cn_sites": [{"facility": "Ethics Committee of Xinhua Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03590418", "title": "Microbial Diversity of Small Bowel Stoma Effluent and Colonic Faeces", "status": "UNKNOWN", "start": "2016-11-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 60, "sponsor": "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": ["Intestinal Failure"], "cn_sites": [{"facility": "Shanghai Xinhua Hospital, affiliated to Shanghai Jiao Tong University, School of Medicine", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06427642", "title": "Efficacy Evaluation of UCB-MNCs in the Treatment of Refractory Neonatal Diseases", "status": "UNKNOWN", "start": "2022-04-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Shandong Qilu Stem Cells Engineering Co., Ltd.", "conditions": ["Hypoxic-Ischemic Encephalopathy", "Bronchopulmonary Dysplasia", "Short Bowel Syndrome"], "cn_sites": [{"facility": "Qilu Children's Hospital of Shandong University", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06523101", "title": "A Study of PJ009 in Healthy Adult Volunteers", "status": "COMPLETED", "start": "2023-02-28", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Chongqing Peg-Bio Biopharm Co., Ltd.", "conditions": ["Short Bowel Syndrome"], "cn_sites": [{"facility": "The Second Hospital of Shanxi Medical University", "city": "Taiyuan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07186608", "title": "Specific Dietary Fibers May Enhance Colonic Adaptation in Short Bowel Syndrome Through Microbial and Metabolic Mechanisms That Drive Functional Compensation.", "status": "COMPLETED", "start": "2025-02-05", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Jinling Hospital, China", "conditions": ["Short Bowel Syndrome"], "cn_sites": [{"facility": "Eastern Theater Command General Hospital", "city": "Nanjing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06973304", "title": "A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome", "status": "ACTIVE_NOT_RECRUITING", "start": "2025-06-26", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 13, "sponsor": "Takeda", "conditions": ["Short Bowel Syndrome"], "cn_sites": [{"facility": "Beijing Tsinghua Changgung Hospital", "city": "Changping", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Dongcheng", "status": ""}, {"facility": "Affiliated Jinling Hospital, Medical School of Nanjing University", "city": "Nanjing", "status": ""}, {"facility": "Zhongshan Hospital, Xiamen University", "city": "Siming", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT07297238", "title": "Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration.", "status": "COMPLETED", "start": "2026-01-24", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Jinling Hospital, China", "conditions": ["Short Bowel Syndrome (SBS)", "Intestinal Failure"], "cn_sites": [{"facility": "Jinling Hospital", "city": "Nanjing", "status": ""}, {"facility": "Jinling Hospital", "city": "Nanning", "status": ""}], "cn_site_count": 2, "broad_only": false}], "g_total": 24, "g_fetched": 20, "g_countries": [["United States", 10], ["France", 5], ["Belgium", 4], ["Denmark", 4], ["Germany", 4], ["Italy", 4], ["Poland", 3], ["United Kingdom", 3], ["Australia", 2], ["Austria", 2], ["Canada", 2], ["Hungary", 2], ["Netherlands", 2], ["South Korea", 2], ["Spain", 2], ["Argentina", 1], ["Brazil", 1], ["Czechia", 1], ["Israel", 1], ["Japan", 1], ["Taiwan", 1], ["Thailand", 1], ["India", 1], ["Finland", 1], ["Norway", 1], ["Sweden", 1], ["Slovenia", 1]], "g_trials": [{"nct": "NCT07742735", "title": "A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF)", "status": "RECRUITING", "start": "2026-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "VectivBio AG", "countries": ["Argentina", "Australia", "Austria", "Belgium", "Brazil", "Canada", "Czechia", "Denmark", "France", "Germany", "Hungary", "Israel", "Italy", "Japan", "Netherlands", "Poland", "South Korea", "Spain", "Taiwan", "Thailand", "United Kingdom", "United States"]}, {"nct": "NCT07392801", "title": "AGE Accumulation in Patients on Long-term Parenteral Nutrition", "status": "RECRUITING", "start": "2026-07-22", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Bordeaux", "countries": ["France"]}, {"nct": "NCT07703371", "title": "Kodo Millet Porridge and Its Effects on Gut Health and Metabolic Syndrome", "status": "RECRUITING", "start": "2026-06-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "JSS MEDICAL COLLEGE, JSS ACADEMY OF HIGHER EDUCATION AND RESEARCH", "countries": ["India"]}, {"nct": "NCT07530055", "title": "Role of the Microbiota in Intestinal Adaptation During Short Bowel Syndrome", "status": "NOT_YET_RECRUITING", "start": "2026-04", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": []}, {"nct": "NCT07197944", "title": "Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS", "status": "RECRUITING", "start": "2026-02-11", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Zealand Pharma", "countries": ["Austria", "Belgium", "Denmark", "Finland", "France", "Germany", "Hungary", "Italy", "Netherlands", "Norway", "Poland", "Spain", "Sweden", "United States"]}, {"nct": "NCT07206004", "title": "Effect of Parenteral Support on FibroScan in Short Bowel Syndrome", "status": "NOT_YET_RECRUITING", "start": "2026-02", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Rigshospitalet, Denmark", "countries": ["Denmark"]}, {"nct": "NCT07713641", "title": "Short-Chain Fatty Acids in Lypopolysaccharide-Induced Inflammation and Executive Function", "status": "RECRUITING", "start": "2025-10-24", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Universitaire Ziekenhuizen KU Leuven", "countries": ["Belgium"]}, {"nct": "NCT07714499", "title": "Resting Energy Expenditure by Gastrointestinal Functional Status", "status": "RECRUITING", "start": "2025-10-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Institute of Oncology Ljubljana", "countries": ["Slovenia"]}, {"nct": "NCT06904872", "title": "Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)", "status": "RECRUITING", "start": "2025-05-29", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Napo Therapeutics, S.p.A.", "countries": ["Germany", "Italy"]}, {"nct": "NCT06877923", "title": "Elemental 028 Extra Case Studies", "status": "RECRUITING", "start": "2025-05-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Nutricia UK Ltd", "countries": ["United Kingdom"]}, {"nct": "NCT06771505", "title": "SBS DISK- Creation of a Quality of Life Tool for Short Bowel Patients Compared With a Validated Quality of Life Questionnaire (SBS QoL)", "status": "RECRUITING", "start": "2025-01-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Hospices Civils de Lyon", "countries": ["France"]}, {"nct": "NCT06668922", "title": "Irritable Bowel Syndrome and Control Volunteers: Diet Challenge", "status": "RECRUITING", "start": "2024-11-28", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University of California, Los Angeles", "countries": ["United States"]}, {"nct": "NCT07400783", "title": "TED_ORG: Study on Short Bowel Syndrome", "status": "RECRUITING", "start": "2024-10-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Meyer Children's Hospital IRCCS", "countries": ["Italy"]}, {"nct": "NCT05535361", "title": "A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome", "status": "RECRUITING", "start": "2023-09-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Eclipse Regenesis, Inc.", "countries": ["United States"]}, {"nct": "NCT05432648", "title": "Fiber Food Introduction in Pediatric Short Bowel Syndrome", "status": "RECRUITING", "start": "2022-05-08", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Children's Hospital of Philadelphia", "countries": ["United States"]}, {"nct": "NCT04775706", "title": "Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects", "status": "RECRUITING", "start": "2022-03-03", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Hanmi Pharmaceutical Company Limited", "countries": ["Belgium", "Denmark", "France", "Germany", "Poland", "South Korea", "United Kingdom", "United States"]}, {"nct": "NCT04629014", "title": "Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure", "status": "RECRUITING", "start": "2020-02-27", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Boston Children's Hospital", "countries": ["Canada", "United States"]}, {"nct": "NCT03530852", "title": "A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB", "status": "RECRUITING", "start": "2018-11-21", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Boston Children's Hospital", "countries": ["United States"]}, {"nct": "NCT05561647", "title": "A Survey to Assess Participants' and Physicians' Knowledge When Using GATTEX (Knowledge Assessment Survey)", "status": "RECRUITING", "start": "2013-08-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Takeda", "countries": ["United States"]}, {"nct": "NCT01793168", "title": "Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford", "status": "RECRUITING", "start": "2010-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sanford Health", "countries": ["Australia", "United States"]}]}, {"batch": 2, "no": 74, "name_zh": "全身型幼年特发性关节炎", "query_terms": [{"term": "Systemic-onset juvenile idiopathic arthritis", "broad": false}, {"term": "Systemic juvenile idiopathic arthritis", "broad": false}], "n_total": 13, "n_open": 6, "n_open_precise": 6, "n_broad": 0, "trials": [{"nct": "NCT03773965", "title": "A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis", "status": "RECRUITING", "start": "2019-04-05", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 190, "sponsor": "Eli Lilly and Company", "conditions": ["Juvenile Idiopathic Arthritis"], "cn_sites": [{"facility": "Beijing Children's hospital, Capital Medical University", "city": "Beijing", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "The Children's Hospital of Chongqing Medical University", "city": "Chongqing", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Childrens Hospital of Nanjing Medical University", "city": "Nanjing", "status": "NOT_YET_RECRUITING"}, {"facility": "Children's Hospital of Soochow University", "city": "Suzhou", "status": "RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT05200715", "title": "AutoInflammatory Disease Alliance Registry (AIDA)", "status": "RECRUITING", "start": "2020-08-06", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 3500, "sponsor": "University of Siena", "conditions": ["Hereditary Autoinflammatory Diseases", "Schnitzler Syndrome", "Behcet Syndrome", "PFAPA Syndrome", "Still Disease", "Autoinflammatory Syndrome, Unspecified", "Uveitis", "Scleritis", "Vexas Syndrome", "Spondyloarthritis (SpA)", "Castleman Disease"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06417502", "title": "Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry", "status": "RECRUITING", "start": "2022-04-29", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 20000, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Autoimmune Diseases", "Autoinflammatory Diseases"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Third Hospital of Peking University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Chidren's Hospital of Chongqing Medical University", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": "RECRUITING"}, {"facility": "The University of Hong Kong Shenzhen Institute of Research and Innovation (HKU-SIRI)", "city": "Shenzhen", "status": "RECRUITING"}, {"facility": "The Second Xiangya Hospital of Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Children's Hospital of Nanjing Medical University", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Children's Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT05609630", "title": "Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.", "status": "RECRUITING", "start": "2023-10-02", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "AbbVie", "conditions": ["Juvenile Idiopathic Arthritis"], "cn_sites": [{"facility": "The Childrens Hospital of Chongqing Medical University /ID# 251539", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "Children'S Hospital Of Soochow University /ID# 251755", "city": "Suzhou", "status": "RECRUITING"}, {"facility": "Xi'an Children's Hospital /ID# 251693", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "Children's Hospital of Fudan University /ID# 251619", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "The Children's Hospital of Zhejiang University School of Medicine /ID# 251754", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT05925452", "title": "To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis.", "status": "RECRUITING", "start": "2023-12-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 290, "sponsor": "Changchun GeneScience Pharmaceutical Co., Ltd.", "conditions": ["Active Systemic Juvenile Idiopathic Arthritis"], "cn_sites": [{"facility": "Children's Hospital Affiliated to Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Children's Hospital Affiliated to Chongqing Medical University", "city": "Chongqing", "status": "NOT_YET_RECRUITING"}, {"facility": "Hunan Children's Hospital", "city": "Changsha", "status": "NOT_YET_RECRUITING"}, {"facility": "Children's Hospital Affiliated to Nanjing Medical University", "city": "Nanjing", "status": "NOT_YET_RECRUITING"}, {"facility": "Children's Hospital of Soochow University", "city": "Suzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Affiliated Pediatric Hospital of Fudan University", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}, {"facility": "Xi'an Children's Hospital", "city": "Xi’an", "status": "NOT_YET_RECRUITING"}, {"facility": "Chengdu Women and Children's Central Hospital", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}, {"facility": "Children's Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT07184450", "title": "Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases", "status": "RECRUITING", "start": "2025-09-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 11, "sponsor": "Chongqing Precision Biotech Co., Ltd", "conditions": ["Juvenile Dermatomyositis (JDM)", "Polyarticular Juvenile Idiopathic Arthritis", "Systemic Sclerosis (SSc)", "Primary Sjogren&#39;s Syndrome"], "cn_sites": [{"facility": "Children's Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03301883", "title": "A Study of Tocilizumab in Chinese Participants With Systemic Juvenile Idiopathic Arthritis (sJIA)", "status": "COMPLETED", "start": "2018-04-26", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 62, "sponsor": "Hoffmann-La Roche", "conditions": ["Juvenile Idiopathic Arthritis"], "cn_sites": [{"facility": "Capital Institute of Pediatrics", "city": "Beijing", "status": ""}, {"facility": "Beijing Children's Hospital, Capital Medical University; rheumatism", "city": "Beijing", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Children's Hospital Chongqing Medical university", "city": "Chongqing", "status": ""}, {"facility": "Sun Yat-sen Memorial Hospital, Sun Yat-sen University; Pediatric Rheumatology division", "city": "Guangzhou", "status": ""}, {"facility": "The Children's Hospibal ZheJiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Chilren's hospital of nanjing medical university; Rheumatoid immunology", "city": "Nanjing", "status": ""}, {"facility": "Shanghai Children's Medical Center; Renal rheumatology", "city": "Shanghai", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical College", "city": "Wenzhou", "status": ""}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT03000439", "title": "A Safety, Efficacy And Pharmacokinetics Study Of Tofacitinib In Pediatric Patients With sJIA", "status": "COMPLETED", "start": "2018-05-10", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Pfizer", "conditions": ["Arthritis Juvenile Idiopathic"], "cn_sites": [{"facility": "Children's Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "Guangzhou Women and Children's Medical Center", "city": "Guangzhou", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology", "city": "Wuhan", "status": ""}, {"facility": "The Second Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "Children's Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "Xi'an Children's Hospital", "city": "Xi'an", "status": ""}, {"facility": "Chengdu Women's and Children's Central Hospital", "city": "Chengdu", "status": ""}, {"facility": "The Children's Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Beijing Children's Hospital, Capital Medical University/Rheumatology Department", "city": "Beijing", "status": ""}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT03651193", "title": "Multi-center Registration Study of Adult Onset Still's Disease in Chinese Population", "status": "UNKNOWN", "start": "2018-11-28", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 150, "sponsor": "Second Xiangya Hospital of Central South University", "conditions": ["Adult Onset Still Disease"], "cn_sites": [{"facility": "The Second Xiangya Hospital of Central South University", "city": "Hunan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04397107", "title": "The Therapeutic Value and Mechanism of Recombinant Human Interleukin-2 on Children With Rheumatic Diseases", "status": "COMPLETED", "start": "2020-08-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 46, "sponsor": "The First Hospital of Jilin University", "conditions": ["Systemic Lupus Erythematosus"], "cn_sites": [{"facility": "Sirui Yang", "city": "Changchun", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05027373", "title": "Safety, Tolerability and Pharmacokinetic of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection", "status": "UNKNOWN", "start": "2021-08-13", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 34, "sponsor": "Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.", "conditions": ["Systemic Juvenile Idiopathic Arthritis", "Periodic Fever Syndrome"], "cn_sites": [{"facility": "Shanghai Xuhui District Central Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05001737", "title": "Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE", "status": "COMPLETED", "start": "2021-12-15", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 33, "sponsor": "Swedish Orphan Biovitrum", "conditions": ["Macrophage Activation Syndrome", "Secondary Hemophagocytic Lymphohistiocytosis", "Still Disease", "Systemic Lupus Erythematosus", "SJIA", "AOSD", "MAS"], "cn_sites": [{"facility": "Beijing Children's Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Friendship Hospital", "city": "Beijing", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT05239702", "title": "Clinical Study of Targeting CD7 CAR-T Cells in the Treatment of Autoimmune Diseases", "status": "UNKNOWN", "start": "2022-02-28", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 75, "sponsor": "Zhejiang University", "conditions": ["Crohn Disease", "Ulcerative Colitis", "Dermatomyositis", "Still Disease", "Autoimmune Diseases"], "cn_sites": [{"facility": "The first affiliated hospital of medical college of zhejiang university", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}], "g_total": 26, "g_fetched": 20, "g_countries": [["United States", 6], ["France", 4], ["Italy", 3], ["Russia", 2], ["Canada", 2], ["Germany", 2], ["Spain", 2], ["Egypt", 1], ["Brazil", 1], ["Switzerland", 1], ["Denmark", 1], ["Netherlands", 1], ["Turkey (Türkiye)", 1], ["South Korea", 1], ["Argentina", 1], ["Finland", 1], ["Greece", 1], ["Ireland", 1], ["Portugal", 1], ["United Kingdom", 1], ["Belgium", 1]], "g_trials": [{"nct": "NCT06718049", "title": "Role of Interleukin 18 (IL-18) and Interleukin 18 Binding Protein (IL-18BP) in the Diagnostic Work-up of Systemic Juvenile Idiopathic Arthritis and Autoinflammatory Diseases: Possible Biomarkers in the Differential Diagnosis of Other Febrile Diseases", "status": "NOT_YET_RECRUITING", "start": "2027-01-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS Azienda Ospedaliero-Universitaria di Bologna", "countries": ["Italy"]}, {"nct": "NCT07814963", "title": "Clinical Features and Treatment of Systemic JIA in Children", "status": "NOT_YET_RECRUITING", "start": "2026-10-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sohag University", "countries": ["Egypt"]}, {"nct": "NCT07737470", "title": "Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": []}, {"nct": "NCT07775612", "title": "Pain-Sleep in Rheumatic Disease", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "The Hospital for Sick Children", "countries": []}, {"nct": "NCT07625384", "title": "Study of the Efficacy and Safety of Goflikicept and Olokizumab as the Second-line Therapy in Patients With Still's Disease", "status": "NOT_YET_RECRUITING", "start": "2026-05-18", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "R-Pharm International, LLC", "countries": ["Russia"]}, {"nct": "NCT07087912", "title": "Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases", "status": "RECRUITING", "start": "2026-03-16", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "University of Sao Paulo General Hospital", "countries": ["Brazil"]}, {"nct": "NCT07517250", "title": "A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients", "status": "RECRUITING", "start": "2026-03-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": ["Switzerland"]}, {"nct": "NCT07349667", "title": "Hypnotherapy for Needle-related Procedural Pain and Anxiety Management in a Pediatric Setting", "status": "NOT_YET_RECRUITING", "start": "2026-03", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Aarhus University Hospital", "countries": ["Denmark"]}, {"nct": "NCT07138898", "title": "Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty", "status": "RECRUITING", "start": "2025-12-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "NYU Langone Health", "countries": ["United States"]}, {"nct": "NCT07077304", "title": "EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases", "status": "RECRUITING", "start": "2025-11-19", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT07203001", "title": "A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease", "status": "RECRUITING", "start": "2025-11-03", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": ["Canada", "France", "Germany", "Italy", "Netherlands", "Spain", "Turkey (Türkiye)", "United States"]}, {"nct": "NCT07126145", "title": "Clinical Autoinflammatory Disease Cohort", "status": "NOT_YET_RECRUITING", "start": "2025-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "RenJi Hospital", "countries": []}, {"nct": "NCT06838143", "title": "Ilaris NIS in Korea", "status": "RECRUITING", "start": "2025-03-29", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": ["South Korea"]}, {"nct": "NCT04833465", "title": "Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions", "status": "RECRUITING", "start": "2021-07-16", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Children's National Research Institute", "countries": ["United States"]}, {"nct": "NCT04402086", "title": "Rheumatology Patient Registry and Biorepository", "status": "RECRUITING", "start": "2020-08-04", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Yale University", "countries": ["United States"]}, {"nct": "NCT02991469", "title": "A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)", "status": "RECRUITING", "start": "2018-08-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Sanofi", "countries": ["Argentina", "Canada", "Finland", "France", "Germany", "Greece", "Ireland", "Italy", "Portugal", "Russia", "Spain", "United Kingdom"]}, {"nct": "NCT03510442", "title": "Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related Conditions", "status": "RECRUITING", "start": "2018-05-21", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)", "countries": ["United States"]}, {"nct": "NCT05927454", "title": "Acostill ( RaDiCo Cohort) (RaDiCo Acostill)", "status": "RECRUITING", "start": "2017-07-11", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Institut National de la Santé Et de la Recherche Médicale, France", "countries": ["France"]}, {"nct": "NCT01962415", "title": "Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT", "status": "RECRUITING", "start": "2014-02-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Paul Szabolcs", "countries": ["United States"]}, {"nct": "NCT07000916", "title": "Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults", "status": "RECRUITING", "start": "2013-09-11", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Université Catholique de Louvain", "countries": ["Belgium"]}]}, {"batch": 2, "no": 75, "name_zh": "系统性肥大细胞增多症", "query_terms": [{"term": "Systemic mastocytosis", "broad": false}], "n_total": 3, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT07562542", "title": "Peripheral Blood KIT-D816V Mutation in Adult Systemic Mastocytosis", "status": "RECRUITING", "start": "2025-05-19", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 50, "sponsor": "The First Affiliated Hospital of Soochow University", "conditions": ["Systemic Mastocytosis", "KIT-D816V Mutation"], "cn_sites": [{"facility": "The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology", "city": "Suzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05504408", "title": "Observational Study for the Evaluation of Incidence of Systemic Mastocytosis in t(8;21) Acute Myeloid Leukemia", "status": "UNKNOWN", "start": "2022-09-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "The First Affiliated Hospital of Soochow University", "conditions": ["Systemic Mastocytosis With AHNMD", "Acute Myeloid Leukemia With T(8;21)(Q22;Q22)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology", "city": "Suzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06013683", "title": "A Registry for Patients With Systemic Mastocytosis in China", "status": "UNKNOWN", "start": "2023-09-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 150, "sponsor": "The First Affiliated Hospital of Soochow University", "conditions": ["Systemic Mastocytoses"], "cn_sites": [{"facility": "The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology", "city": "Suzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}], "g_total": 14, "g_fetched": 13, "g_countries": [["United States", 10], ["Italy", 4], ["Germany", 3], ["Belgium", 3], ["Netherlands", 3], ["Norway", 3], ["United Kingdom", 3], ["Canada", 2], ["Australia", 2], ["Austria", 2], ["France", 2], ["Poland", 2], ["Spain", 2], ["Switzerland", 2], ["Argentina", 1], ["Brazil", 1], ["Colombia", 1], ["Czechia", 1], ["Greece", 1], ["Ireland", 1], ["Portugal", 1], ["Sweden", 1], ["Turkey (Türkiye)", 1]], "g_trials": [{"nct": "NCT07819396", "title": "Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome", "status": "NOT_YET_RECRUITING", "start": "2027-01-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Fred Hutchinson Cancer Center", "countries": ["United States"]}, {"nct": "NCT07757893", "title": "Precision Medicine for Indolent Systemic Mastocytosis (PRISM)", "status": "NOT_YET_RECRUITING", "start": "2026-09-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Mayo Clinic", "countries": ["United States"]}, {"nct": "NCT07264959", "title": "An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)", "status": "RECRUITING", "start": "2026-04-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Blueprint Medicines Corporation", "countries": ["United States"]}, {"nct": "NCT07255638", "title": "A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany", "status": "RECRUITING", "start": "2025-12-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Blueprint Medicines Corporation", "countries": ["Germany"]}, {"nct": "NCT06748001", "title": "Avapritinib Rollover Study", "status": "RECRUITING", "start": "2024-11-28", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Blueprint Medicines Corporation", "countries": ["Belgium", "Canada", "Italy", "Netherlands", "Norway", "United Kingdom"]}, {"nct": "NCT06327685", "title": "Avapritinib With Decitabine in Patients With SM-AHN", "status": "RECRUITING", "start": "2024-03-13", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "H. Lee Moffitt Cancer Center and Research Institute", "countries": ["United States"]}, {"nct": "NCT07142473", "title": "Mastocytosis From Pediatric Age to Adulthood: Local Registry of Cutaneous and Systemic Mastocytosis", "status": "RECRUITING", "start": "2024-01-26", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Fondazione IRCCS Policlinico San Matteo di Pavia", "countries": ["Italy"]}, {"nct": "NCT06210698", "title": "Angioedema Biomarker Research Study", "status": "RECRUITING", "start": "2024-01-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Foundation For Rare Disease Research", "countries": ["United States"]}, {"nct": "NCT04910685", "title": "(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis", "status": "RECRUITING", "start": "2021-11-30", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Blueprint Medicines Corporation", "countries": ["Argentina", "Australia", "Austria", "Belgium", "Brazil", "Colombia", "Czechia", "France", "Germany", "Greece", "Ireland", "Italy", "Netherlands", "Norway", "Poland", "Portugal", "Spain", "Sweden", "Switzerland", "Turkey (Türkiye)", "United Kingdom", "United States"]}, {"nct": "NCT04996875", "title": "(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis", "status": "RECRUITING", "start": "2021-11-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Cogent Biosciences, Inc.", "countries": ["Australia", "Austria", "Belgium", "Canada", "France", "Germany", "Italy", "Netherlands", "Norway", "Poland", "Spain", "Switzerland", "United Kingdom", "United States"]}, {"nct": "NCT01137825", "title": "Registry of Older Patients With Cancer", "status": "RECRUITING", "start": "2009-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "UNC Lineberger Comprehensive Cancer Center", "countries": ["United States"]}, {"nct": "NCT01137643", "title": "Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer", "status": "RECRUITING", "start": "2009-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "UNC Lineberger Comprehensive Cancer Center", "countries": ["United States"]}, {"nct": "NCT06915766", "title": "Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "Cogent Biosciences, Inc.", "countries": ["United States"]}]}, {"batch": 2, "no": 76, "name_zh": "大动脉炎/多发性大动脉炎", "query_terms": [{"term": "Takayasu arteritis", "broad": false}], "n_total": 25, "n_open": 10, "n_open_precise": 10, "n_broad": 0, "trials": [{"nct": "NCT05388682", "title": "Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement", "status": "RECRUITING", "start": "2014-01-19", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 200, "sponsor": "Chinese Pulmonary Vascular Disease Research Group", "conditions": ["Takayasu Arteritis With Pulmonary Artery Involvement", "Percutaneous Transluminal Pulmonary Angioplasty", "PAH Targeted Medication"], "cn_sites": [{"facility": "Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03372980", "title": "A Registry Study on Biomarkers of Takayasu's Arteritis (ARSBTA)", "status": "RECRUITING", "start": "2016-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "Beijing Institute of Heart, Lung and Blood Vessel Diseases", "conditions": ["Takayasu's Arteritis"], "cn_sites": [{"facility": "Beijing Anzhen Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07184814", "title": "Clinical Features and Prognosis of Takayasu's Arteritis With Pulmonary Arteries Involvement", "status": "RECRUITING", "start": "2016-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 150, "sponsor": "China-Japan Friendship Hospital", "conditions": ["Takayasu Arteritis With Pulmonary Artery Involvement", "Pulmonary Arterial Hypertension Associated With Connective Tissue Disease"], "cn_sites": [{"facility": "China-Japan Friendship hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04300686", "title": "A Pilot Study in Severe Patients With Takayasu Arteritis.", "status": "RECRUITING", "start": "2020-03-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Shanghai Zhongshan Hospital", "conditions": ["Takayasu Arteritis", "Tocilizumab", "Adalimumab", "Treatment"], "cn_sites": [{"facility": "Department of Rheumatology in Zhongshan hospital, Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05102448", "title": "Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis", "status": "RECRUITING", "start": "2021-11-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 76, "sponsor": "Shanghai Zhongshan Hospital", "conditions": ["Takayasu Arteritis"], "cn_sites": [{"facility": "Lindi Jiang", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06178419", "title": "Remote Ischemic Conditioning for Cerebral Ischemia in Patients With Takayasu Arteritis (TARIC-1)", "status": "RECRUITING", "start": "2024-01-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 44, "sponsor": "Xuanwu Hospital, Beijing", "conditions": ["Cerebral Ischemia", "Takayasu Arteritis"], "cn_sites": [{"facility": "Department of Rheumatology and Allergy, Xuanwu Hospital, Capital Medical University, Beijing, China", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06498089", "title": "A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's Arteritis", "status": "RECRUITING", "start": "2024-06-28", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 124, "sponsor": "Shanghai Zhongshan Hospital", "conditions": ["Takayasu Arteritis"], "cn_sites": [{"facility": "Zhongshan Hospital, Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06766552", "title": "A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.", "status": "NOT_YET_RECRUITING", "start": "2025-01-30", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 10000, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Ankylosing Spondylitis (AS)", "Psoriatic Arthritis (PsA)", "Nr-axSpA", "Polymyalgia Rheumatica (PMR)", "Takayasu Arteritis (TAK)", "Giant Cell Arteritis (GCA)", "Behcet&#39;s Disease", "Enthesitis-related Arthritis"], "cn_sites": [{"facility": "The Second Affiliated Hospital of Zhejiang University", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07013838", "title": "The Efficacy and Safety of Deucravacitinib in Takayasu's Arteritis", "status": "NOT_YET_RECRUITING", "start": "2025-06-15", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Chinese SLE Treatment And Research Group", "conditions": ["Takayasu Arteritis (TAK)"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07451665", "title": "Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's Arteritis", "status": "NOT_YET_RECRUITING", "start": "2026-04-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 180, "sponsor": "Chinese SLE Treatment And Research Group", "conditions": ["Takayasu Arteritis (TAK)"], "cn_sites": [{"facility": "Beijing Anzhen Hospital Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Xuanwu Hospital Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital of Sun Yat-sen University", "city": "Guanzhou", "status": ""}, {"facility": "Shenzhen People's Hospital", "city": "Shenzhen", "status": ""}, {"facility": "People's Hospital of Guangxi Zhuang Autonomous Region", "city": "Nanning", "status": ""}, {"facility": "Jiaozuo People's Hospital", "city": "Jiaozuo", "status": ""}, {"facility": "The First Affiliated Hospital of Henan University of Science and Technology", "city": "Luoyang", "status": ""}, {"facility": "Union Hospital Tongji Medical College of Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Jiangsu Province Hospital", "city": "Nanjing", "status": ""}, {"facility": "The Second Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": ""}, {"facility": "The First Hospital of Jilin University", "city": "Ch’ang-ch’un", "status": ""}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "The First Affiliated Hospital of Baotou Medical College", "city": "Baotou", "status": ""}, {"facility": "The Affiliated Hospital of Inner Mongolia Medical University", "city": "Hohhot", "status": ""}, {"facility": "People's Hospital of Ningxia Hui Autonomous Region", "city": "Yinchuan", "status": ""}, {"facility": "Sichuan Provincial People's Hospital", "city": "Chengdu", "status": ""}, {"facility": "People's Hospital of Xinjiang Uygur Autonomous Region", "city": "Ürümqi", "status": ""}, {"facility": "The First Hospital of Xinjiang Medical University", "city": "Ürümqi", "status": ""}, {"facility": "The Second Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 20, "broad_only": false}, {"nct": "NCT01066208", "title": "American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis", "status": "UNKNOWN", "start": "2011-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 3588, "sponsor": "University of Oxford", "conditions": ["Wegener's Granulomatosis", "Microscopic Polyangiitis", "Churg Strauss Syndrome", "Polyarteritis Nodosa", "Giant Cell Arteritis", "Takayasu Arteritis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital, Beijing", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03189602", "title": "Pulmonary Artery Involvement in Takayasu's Arteritis", "status": "COMPLETED", "start": "2014-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 51, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Takayasu Arteritis", "Pulmonary Artery Hypertension"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02964364", "title": "China Takayasu Arteritis Registry (CTA Registry)", "status": "UNKNOWN", "start": "2016-08", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "Aimin Dang", "conditions": ["TAKAYASU ARTERITIS"], "cn_sites": [{"facility": "Fuwai Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03893136", "title": "The Registry Study of Takayasu Arteritis in East China", "status": "UNKNOWN", "start": "2016-11-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "Shanghai Zhongshan Hospital", "conditions": ["Takayasu Arteritis", "Mechanisms, Defense", "Pregnancy Related", "Treatment Refusal", "Outcome"], "cn_sites": [{"facility": "Department of Rheumatology in Zhongshan hospital, Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02981979", "title": "Takayasu Arteritis Clinical Trial in China", "status": "COMPLETED", "start": "2016-12-22", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 116, "sponsor": "Jiang lindi", "conditions": ["Takayasu Arteritis"], "cn_sites": [{"facility": "Beijing Anzhen Hospital", "city": "Beijing", "status": ""}, {"facility": "The first affiliated hospital of Nanchang University", "city": "Nanchang", "status": ""}, {"facility": "The First Hospital of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "Zhongshan hospital, Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi", "city": "Ürümqi", "status": ""}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT03199183", "title": "Registration Study of Takayasu's Arteritis in China", "status": "UNKNOWN", "start": "2017-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1067, "sponsor": "China National Center for Cardiovascular Diseases", "conditions": ["Takayasu Arteritis"], "cn_sites": [{"facility": "Chinese Academy of Medical Sciences Fuwai Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03096275", "title": "Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis", "status": "COMPLETED", "start": "2017-03-16", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 138, "sponsor": "Chinese SLE Treatment And Research Group", "conditions": ["Takayasu Arteritis"], "cn_sites": [{"facility": "Hebei Provincial Hospital", "city": "Shijiazhuang", "status": ""}, {"facility": "the Affiliated Hospital of Inner Mongolia Medical University", "city": "Hohhot", "status": ""}, {"facility": "Xijing Hospital", "city": "Xian", "status": ""}, {"facility": "Beijing Chaoyang Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Xuanwu Hospital", "city": "Beijing", "status": ""}, {"facility": "General Hospital of Tianjing Medical University", "city": "Tianjin", "status": ""}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT04366596", "title": "Drug-eluting Balloon for Treatment of Non-atherosclerotic Renal Artery Stenosis", "status": "UNKNOWN", "start": "2019-10-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Hypertension, Renovascular"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04137614", "title": "Drug-coated Balloon for Takayasu Arteritis Associated Renal Artery Stenosis", "status": "UNKNOWN", "start": "2019-11-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Shanghai Zhongshan Hospital", "conditions": ["Takayasu Arteritis"], "cn_sites": [{"facility": "Lindi Jiang", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04161898", "title": "A Study to Evaluate the Efficacy and Safety of Upadacitinib in Participants With Takayasu Arteritis (TAK)", "status": "ACTIVE_NOT_RECRUITING", "start": "2020-02-04", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 56, "sponsor": "AbbVie", "conditions": ["Takayasu Arteritis (TAK)"], "cn_sites": [{"facility": "Xuanwu Hospital Capital Medical University /ID# 248104", "city": "Beijing", "status": ""}, {"facility": "Guangdong Provincial Peoples Hospital /ID# 248350", "city": "Guangzhou", "status": ""}, {"facility": "Shenzhen People's Hospital /ID# 248347", "city": "Shenzhen", "status": ""}, {"facility": "First Affiliated Hospital of China Medical University /ID# 248107", "city": "Shenyang", "status": ""}, {"facility": "Zhongshan Hospital Fudan University /ID# 247159", "city": "Shanghai", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT04299971", "title": "Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients", "status": "UNKNOWN", "start": "2020-03-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 130, "sponsor": "Shanghai Zhongshan Hospital", "conditions": ["Takayasu Arteritis", "Methotrexate", "Inhibition", "Treatment"], "cn_sites": [{"facility": "Lindi Jiang", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05151848", "title": "Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis", "status": "UNKNOWN", "start": "2022-01-05", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Chinese SLE Treatment And Research Group", "conditions": ["Takayasu Arteritis"], "cn_sites": [{"facility": "Beijing Anzhen Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The General Hospital of the People's Liberation Army", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Beijing Shijitan Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Beijing Xuanwu Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT05749666", "title": "Comparison of Tofacitinib and Prednisolone in the Treatment of Active Takayasu's Arteritis", "status": "UNKNOWN", "start": "2023-01-20", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Chinese SLE Treatment And Research Group", "conditions": ["Takayasu Arteritis"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06662721", "title": "Baricitinib for Refractory Takayasu Arteritis", "status": "COMPLETED", "start": "2023-04-03", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Liu Tian", "conditions": ["Takayasu Arteritis"], "cn_sites": [{"facility": "Department of Rheumatology and Immunology, Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07500467", "title": "Upadacitinib for Refractory Takayasu Arteritis", "status": "COMPLETED", "start": "2024-03-19", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 12, "sponsor": "Liu Tian", "conditions": ["Takayasu Arteritis"], "cn_sites": [{"facility": "Department of Rheumatology and Immunology, Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 27, "g_fetched": 17, "g_countries": [["Turkey (Türkiye)", 4], ["United States", 4], ["United Kingdom", 3], ["Canada", 2], ["Brazil", 1], ["France", 1], ["Armenia", 1]], "g_trials": [{"nct": "NCT07737470", "title": "Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": []}, {"nct": "NCT07571577", "title": "Monitoring Disease Activity in Patients With Takayasu Arteritis With the OMERACT Takayasu Ultrasound Score (OTUS)", "status": "NOT_YET_RECRUITING", "start": "2026-07-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS San Raffaele", "countries": []}, {"nct": "NCT07628075", "title": "Long-Axial Field of View (LAFOV) [18F]FDG PET/CT Imaging in Large Vessel Vasculitis (LVV): Protocol Optimisation Study.", "status": "NOT_YET_RECRUITING", "start": "2026-07-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Imperial College London", "countries": ["United Kingdom"]}, {"nct": "NCT07477795", "title": "Phase II Interventional Study Evaluating Efficacy and Safety of Secukinumab in Active Severe Takayasu Patients", "status": "NOT_YET_RECRUITING", "start": "2026-04-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": []}, {"nct": "NCT07087912", "title": "Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases", "status": "RECRUITING", "start": "2026-03-16", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "University of Sao Paulo General Hospital", "countries": ["Brazil"]}, {"nct": "NCT07325357", "title": "Effect of Pirfenidone on TA Fibrosis", "status": "NOT_YET_RECRUITING", "start": "2025-12-20", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Shanghai Zhongshan Hospital", "countries": []}, {"nct": "NCT07077304", "title": "EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases", "status": "RECRUITING", "start": "2025-11-19", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT07351422", "title": "Investigating Management, Perspectives and Attitudes Towards Care in Takayasu Arteritis", "status": "RECRUITING", "start": "2025-10-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Edinburgh", "countries": ["United Kingdom"]}, {"nct": "NCT07276087", "title": "Physical and Psychosocial Parameters in Takayasu Arteritis and Behçet's Disease: A Comparative Study With Healthy Controls", "status": "RECRUITING", "start": "2025-09-11", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "ÖZLEM NUR TOK YAMAN", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT07558382", "title": "Global Initiative on Takayasu Arteritis (GITA)", "status": "RECRUITING", "start": "2025-08-05", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Marmara University", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT07491913", "title": "Biologic Treatment Withdrawal in Takayasu Arteritis Patients in Sustained Remission", "status": "RECRUITING", "start": "2025-06-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Marmara University", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT06887062", "title": "Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)", "status": "RECRUITING", "start": "2025-03-21", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University of Edinburgh", "countries": ["United Kingdom"]}, {"nct": "NCT05904301", "title": "Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases", "status": "RECRUITING", "start": "2023-06-21", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Santé Arménie French-Armenian Research Center", "countries": ["Armenia"]}, {"nct": "NCT02967068", "title": "VCRC Tissue Repository", "status": "RECRUITING", "start": "2016-11", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Pennsylvania", "countries": ["Canada", "United States"]}, {"nct": "NCT02593565", "title": "Vasculitis Pregnancy Registry", "status": "RECRUITING", "start": "2015-11", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Pennsylvania", "countries": ["United States"]}, {"nct": "NCT02257866", "title": "Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis", "status": "RECRUITING", "start": "2014-09-29", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)", "countries": ["United States"]}, {"nct": "NCT01241305", "title": "One-Time DNA Study for Vasculitis", "status": "RECRUITING", "start": "2010-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Pennsylvania", "countries": ["Canada", "Turkey (Türkiye)", "United States"]}]}, {"batch": 2, "no": 77, "name_zh": "腱鞘巨细胞瘤/色素沉着绒毛结节性滑膜炎", "query_terms": [{"term": "Tenosynovial giant cell tumor", "broad": false}, {"term": "Tenosynovial giant cell tumor/Pigmented villonodular synovitis", "broad": false}], "n_total": 9, "n_open": 3, "n_open_precise": 3, "n_broad": 0, "trials": [{"nct": "NCT04192344", "title": "A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor", "status": "RECRUITING", "start": "2020-01-20", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 276, "sponsor": "Abbisko Therapeutics Co, Ltd", "conditions": ["Neoplasms", "Tenosynovial Giant Cell Tumor"], "cn_sites": [{"facility": "Beijing Jishuitan Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Sun Yat-sen University", "city": "Guangdong", "status": "RECRUITING"}, {"facility": "Hebei Medical University Third Hospital", "city": "Shijiazhuang", "status": "COMPLETED"}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "The First Affiliated Hospital of Zhengzhou Universtity", "city": "Zhengzhou", "status": "COMPLETED"}, {"facility": "Jiangsu Province Hospital", "city": "Nanjing", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Liaoning Cancer Hospital", "city": "Shenyang", "status": "COMPLETED"}, {"facility": "Huashan Hospital of Fudan University", "city": "Shanghai", "status": "COMPLETED"}, {"facility": "Shanghai Sixth People's Hospital", "city": "Shanghai", "status": "COMPLETED"}, {"facility": "Xi'an Hong Hui Hospital", "city": "Xian", "status": "RECRUITING"}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 13, "broad_only": false}, {"nct": "NCT07315841", "title": "Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Tenosynovial Giant Cell Tumor Surgery", "status": "RECRUITING", "start": "2026-01-02", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Shanghai Jiao Tong University Affiliated Sixth People's Hospital", "conditions": ["Tenosynovial Giant Cell Tumor"], "cn_sites": [{"facility": "Shanghai Sixth People's Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07707882", "title": "Neoadjuvant Pimicotinib Combined With Surgery Versus Upfront Surgery for Diffuse Tenosynovial Giant Cell Tumor", "status": "NOT_YET_RECRUITING", "start": "2027-10-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 84, "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": ["Tenosynovial Giant Cell Tumor, Diffuse"], "cn_sites": [{"facility": "Department of Orthopedics, The Second Affiliated Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04952896", "title": "Clinical Study of Magnetic Resonance Imaging and Deep Learning of Joint Synovial Disease", "status": "COMPLETED", "start": "2012-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 350, "sponsor": "Peking University Third Hospital", "conditions": ["Synovial Diseases", "Pigmented Villonodular Synovitis", "Gout", "Rheumatoid Arthritis"], "cn_sites": [{"facility": "Peking University third hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04955535", "title": "Screening of Specific Genes for Pigmented Villous Nodular Synovitis", "status": "COMPLETED", "start": "2020-08-03", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 60, "sponsor": "Peking University Third Hospital", "conditions": ["Pigmented Villonodular Synovitis"], "cn_sites": [{"facility": "Institute of Sports Medicine, Peking University Third Hospital, Beijing Key Laboratory of Sports Injuries， Beijing, China", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04488822", "title": "A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT", "status": "ACTIVE_NOT_RECRUITING", "start": "2020-09-25", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Daiichi Sankyo Co., Ltd.", "conditions": ["Tenosynovial Giant Cell Tumor"], "cn_sites": [{"facility": "Beijing Ji Shui Tan Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University Cancer Hospital", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "The Second Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": ""}, {"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}, {"facility": "Shanghai General Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT05212896", "title": "An Exploratory Clinical Study of BC006 in Patients With Advanced Solid Tumors", "status": "UNKNOWN", "start": "2021-11-26", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "Dragonboat Biopharmaceutical Company Limited", "conditions": ["Advanced Solid Tumors (Including GCTTS)"], "cn_sites": [{"facility": "Dragonboat Biopharmaceutical,Co.,Ltd", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05277454", "title": "Clinical Study of HMPL-653 in Treatment of Advanced Malignant Solid Tumors and TGCT", "status": "UNKNOWN", "start": "2022-01-18", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 113, "sponsor": "Hutchison Medipharma Limited", "conditions": ["Advanced Malignant Solid Tumors", "TGCT"], "cn_sites": [{"facility": "Jilin Provincial Cancer Hospital", "city": "Changchun", "status": "RECRUITING"}, {"facility": "Harbin Medical University Cancer Hospital", "city": "Harbin", "status": "NOT_YET_RECRUITING"}, {"facility": "Linyi Cancer Hospital", "city": "Linyi", "status": "NOT_YET_RECRUITING"}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT05804045", "title": "Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-04-27", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 94, "sponsor": "Abbisko Therapeutics Co, Ltd", "conditions": ["Tenosynovial Giant Cell Tumor", "Pigmented Villonodular Synovitis", "Giant Cell Tumor of Tendon Sheath"], "cn_sites": [{"facility": "The First Affiliated Hospital of Bengbu Medical College", "city": "Bengbu", "status": ""}, {"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": ""}, {"facility": "Guangdong Provincial People's Hospital", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Jinan University", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "The Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": ""}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture", "city": "Enshi", "status": ""}, {"facility": "Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Hunan Provincial People's Hospital", "city": "Changsha", "status": ""}, {"facility": "The Second Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "Nanjing Drum Tower hospital", "city": "Nanjing", "status": ""}, {"facility": "Liaoning Cancer Hospital&Institute", "city": "Shenyang", "status": ""}, {"facility": "Weifang People's Hospital", "city": "Weifang", "status": ""}, {"facility": "Shanghai General Hospital", "city": "Shanghai", "status": ""}, {"facility": "The Second Hospital of Shanxi Medical University", "city": "Taiyuan", "status": ""}, {"facility": "Xi'an Honghui Hospital", "city": "Xi’an", "status": ""}, {"facility": "West China Hospital Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "The First Affiliated Hospital of Xinjiang Medical University", "city": "Ürümqi", "status": ""}, {"facility": "The Second Affiliated Hospital Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": ""}, {"facility": "Beijing Jishuitan Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 23, "broad_only": false}], "g_total": 9, "g_fetched": 6, "g_countries": [["United States", 4], ["France", 1], ["Japan", 1]], "g_trials": [{"nct": "NCT07503821", "title": "Synovial Tissue as a Biomarker in the Management of Pigmented Villonodular Synovitis", "status": "RECRUITING", "start": "2026-09", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Nantes University Hospital", "countries": ["France"]}, {"nct": "NCT07499362", "title": "Study of Pimicotinib in Japanese Participants With Tenosynovial Giant Cell Tumor (TGCT) (J-MANEUVER)", "status": "RECRUITING", "start": "2026-03-26", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany", "countries": ["Japan"]}, {"nct": "NCT07075471", "title": "MOVE: Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With Vimseltinib", "status": "RECRUITING", "start": "2025-09-03", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Deciphera Pharmaceuticals, LLC", "countries": ["United States"]}, {"nct": "NCT06239272", "title": "NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)", "status": "RECRUITING", "start": "2024-03-27", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "St. Jude Children's Research Hospital", "countries": ["United States"]}, {"nct": "NCT04635111", "title": "A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment", "status": "RECRUITING", "start": "2021-01-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Daiichi Sankyo", "countries": ["United States"]}, {"nct": "NCT02390752", "title": "Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...", "status": "RECRUITING", "start": "2015-04-29", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["United States"]}]}, {"batch": 2, "no": 78, "name_zh": "地中海贫血（重型）", "query_terms": [{"term": "Hemoglobin Bart's fetalis syndrome", "broad": false}, {"term": "Beta-thalassemia major", "broad": false}, {"term": "Thalassemia major", "broad": true}], "n_total": 51, "n_open": 22, "n_open_precise": 21, "n_broad": 1, "trials": [{"nct": "NCT04064060", "title": "A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials", "status": "RECRUITING", "start": "2019-08-12", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 665, "sponsor": "Celgene", "conditions": ["Myelodysplastic Syndromes (MDS)", "Beta-thalassemia", "Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis"], "cn_sites": [{"facility": "Local Institution - 131", "city": "Beijing", "status": "WITHDRAWN"}, {"facility": "Local Institution - 135", "city": "Guangzhou", "status": "WITHDRAWN"}, {"facility": "Local Institution - 132", "city": "Shanghai", "status": "WITHDRAWN"}, {"facility": "Local Institution - 134", "city": "Chengdu", "status": "WITHDRAWN"}, {"facility": "Local Institution - 130", "city": "Tianjin", "status": "WITHDRAWN"}, {"facility": "Local Institution - 133", "city": "Hangzhou", "status": "WITHDRAWN"}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT04143724", "title": "Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia", "status": "RECRUITING", "start": "2019-11-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 99, "sponsor": "Celgene", "conditions": ["Beta-Thalassemia"], "cn_sites": [{"facility": "Southern Medical University Nanfang Hospital", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Shenzhen Second People's Hospital", "city": "Shenzhen", "status": "RECRUITING"}, {"facility": "People's Liberation Army The 923rd Hospital", "city": "Nanning", "status": "RECRUITING"}, {"facility": "West China Hospital - Sichuan University", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Sun Yat-sen Memorial Hospital, Sun Yat-Sen University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": "RECRUITING"}], "cn_site_count": 6, "broad_only": false}, {"nct": "NCT05745532", "title": "Safety and Efficacy Evaluation of β-globin Restored Autologous Hematopoietic Stem Cells in β-thalassemia Major Patients", "status": "RECRUITING", "start": "2020-12-01", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Shenzhen Hemogen", "conditions": ["β-thalassemia"], "cn_sites": [{"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06314529", "title": "Long-term Follow-up Study of BHC001 for TDT", "status": "RECRUITING", "start": "2022-12-14", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 6, "sponsor": "Bioray Laboratories", "conditions": ["Thalassemia, Beta"], "cn_sites": [{"facility": "The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army", "city": "Nanning", "status": "RECRUITING"}, {"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05762510", "title": "A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia [TDT]", "status": "RECRUITING", "start": "2023-02-22", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 5, "sponsor": "First Affiliated Hospital of Guangxi Medical University", "conditions": ["Transfusion Dependent Beta-Thalassemia"], "cn_sites": [{"facility": "The affiliated hospital of guangxi medical university", "city": "Nanning", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05991336", "title": "Growth and Development-related Outcomes in Children With Transfusion-dependent Beta-thalassemia After Gene Therapy", "status": "RECRUITING", "start": "2023-06-05", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Transfusion-dependent Beta-Thalassemia", "Gene Therapy"], "cn_sites": [{"facility": "Regenerative Medicine Center", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05776173", "title": "Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent β-thalassemia", "status": "RECRUITING", "start": "2023-08-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Shanghai BDgene Co., Ltd.", "conditions": ["β-thalassemia Major"], "cn_sites": [{"facility": "Shanghai Ruijin Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05773729", "title": "Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent Beta-thalassemia", "status": "RECRUITING", "start": "2023-09-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Shanghai BDgene Co., Ltd.", "conditions": ["β-thalassemia"], "cn_sites": [{"facility": "Shanghai Children's Medical Centre", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06219239", "title": "Safety and Efficacy of the Lentiviral Vector in Gene Therapy of Beta-thalassemia Patients", "status": "RECRUITING", "start": "2024-01-04", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 3, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Transfusion-dependent Beta-Thalassemia"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06465550", "title": "A Phase 1 Study of Gene-modified Autologous Hematopoietic Stem Cell (BD211) Treating β-thalassemia Major", "status": "RECRUITING", "start": "2024-01-05", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Shanghai BDgene Co., Ltd.", "conditions": ["β-thalassemia"], "cn_sites": [{"facility": "Sun Yat-sen Memorial Hospital", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": "RECRUITING"}, {"facility": "Shanghai Ruijin Hospital, Shanghai Jiaotong University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT06328764", "title": "CS-101 in Patients With β-thalassemia", "status": "ENROLLING_BY_INVITATION", "start": "2024-03-19", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "CorrectSequence Therapeutics Co., Ltd", "conditions": ["Beta-Thalassemia"], "cn_sites": [{"facility": "The First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06280378", "title": "Β-Thalassemia Treatment with KL003 Cell Injection", "status": "RECRUITING", "start": "2024-04-05", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 41, "sponsor": "Kanglin Biotechnology (Hangzhou) Co., Ltd.", "conditions": ["Transfusion-dependent Beta-Thalassemia"], "cn_sites": [{"facility": "Ruijin Hospital, Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06479616", "title": "A Long-term Follow-up Study in Participants Who Received CS-101", "status": "RECRUITING", "start": "2024-06-18", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 5, "sponsor": "Children's Hospital of Fudan University", "conditions": ["Beta-Thalassemia"], "cn_sites": [{"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06734520", "title": "Clinical Study of Super Transplantation in the Treatment of Severe β-thalassemia", "status": "RECRUITING", "start": "2024-10-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 3, "sponsor": "Guangzhou Women and Children's Medical Center", "conditions": ["Thalassemia Majors (Beta-Thalassemia Major)", "Haplo-identical Donors"], "cn_sites": [{"facility": "Guangzhou Women and Children's Medical Center Affiliated to Guangzhou Medical University", "city": "Guangzhou", "status": "ACTIVE_NOT_RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06298630", "title": "Long-term Follow-up Study of BRL-101 for TDT", "status": "RECRUITING", "start": "2024-12-08", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 45, "sponsor": "Bioray Laboratories", "conditions": ["Thalassemia, Beta"], "cn_sites": [{"facility": "Nanfang Hospital, Southern Medical University", "city": "Guangzhou", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Shenzhen Children 's Hospital", "city": "Shenzhen", "status": "NOT_YET_RECRUITING"}, {"facility": "No. 923 Hospital of Joint Support Force of Chinese People 's Liberation Army Hospital", "city": "Nanning", "status": "NOT_YET_RECRUITING"}, {"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Tianjin Institute of Hematology", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of GUANGXI MEDICAL UNIVERSITY", "city": "Guangxi", "status": "RECRUITING"}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT06772766", "title": "A Multiple Ascending Dose Study of 9MW3011 in Patients With Non-transfusion-dependent β-thalassemia", "status": "RECRUITING", "start": "2024-12-30", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Mabwell (Shanghai) Bioscience Co., Ltd.", "conditions": ["Beta-Thalassemia"], "cn_sites": [{"facility": "The first Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": "RECRUITING"}, {"facility": "Hainan General Hospital", "city": "Haikou", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06678165", "title": "A Pilot Study on the Safety and Efficacy of YOLT-204 for Transfusion-Dependent Beta-Thalassemia", "status": "NOT_YET_RECRUITING", "start": "2024-12-31", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 3, "sponsor": "First Affiliated Hospital of Guangxi Medical University", "conditions": ["Transfusion Dependent Beta Thalassemia"], "cn_sites": [{"facility": "The First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06685536", "title": "A Long-term Follow-up Study in Participants Who Received CS-101", "status": "ENROLLING_BY_INVITATION", "start": "2025-01-18", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 5, "sponsor": "CorrectSequence Therapeutics Co., Ltd", "conditions": ["Beta-Thalassemia"], "cn_sites": [{"facility": "The First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06717932", "title": "A Follow-up Study to Evaluate the Long-term Safety and Efficacy in Participants Who Received CS-101 Injection", "status": "ENROLLING_BY_INVITATION", "start": "2025-05-15", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 8, "sponsor": "CorrectSequence Therapeutics Co., Ltd", "conditions": ["Beta-Thalassemia"], "cn_sites": [{"facility": "The First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07489196", "title": "A Phase 2 Safety and Efficacy Study Evaluating CS-101 in Participants With β-Thalassemia Major", "status": "NOT_YET_RECRUITING", "start": "2026-04-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "CorrectSequence Therapeutics Co., Ltd", "conditions": ["β-thalassemia Major"], "cn_sites": [{"facility": "The First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Ruijin Hospital Shanghai JiaoTong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT03351829", "title": "Gene Therapy of Beta Thalassemia Using a Self-inactivating Lentiviral Vector", "status": "NOT_YET_RECRUITING", "start": "2026-12-31", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": ["Beta-Thalassemia"], "cn_sites": [{"facility": "Shenzhen Geno-immune Medical Institute", "city": "Shenzhen", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02126046", "title": "Unrelated Umbilical Cord Blood Following HLA-haploidentical Hematopoietic Stem Cell Transplantation in Patients With β-thalassemia Major", "status": "UNKNOWN", "start": "2012-09", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Nanfang Hospital, Southern Medical University", "conditions": ["Thalassemia Major"], "cn_sites": [{"facility": "Department of paediatrics，Nangfang Hospital, Southern Medical University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02342145", "title": "Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia Major", "status": "COMPLETED", "start": "2015-04", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 205, "sponsor": "Zhongming Zhang", "conditions": ["Beta-Thalassemia Major", "Graft-versus-host Disease (GVHD)"], "cn_sites": [{"facility": "Liuzhou Worker's Hospital", "city": "Liuzhou", "status": ""}, {"facility": "The affiliated hospital of guangxi medical university", "city": "Nanning", "status": ""}, {"facility": "Hainan general Hospital", "city": "Haikou", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT03101423", "title": "Monitoring of Chimerism After Transplantation in Patients With β Thalassemia Major and the Treatment Strategies for the Reduction of Chimerism", "status": "UNKNOWN", "start": "2016-08-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "First Affiliated Hospital of Guangxi Medical University", "conditions": ["Beta Thalassemia Major"], "cn_sites": [{"facility": "the First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04918056", "title": "Genetic Variants Affecting the Clinical Severity of Beta Thalassemia", "status": "UNKNOWN", "start": "2017-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1300, "sponsor": "Nanfang Hospital, Southern Medical University", "conditions": ["Beta Thalassemia"], "cn_sites": [{"facility": "Southern Medical University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03171831", "title": "Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major", "status": "UNKNOWN", "start": "2017-04-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "First Affiliated Hospital of Guangxi Medical University", "conditions": ["Thalassemia Major"], "cn_sites": [{"facility": "First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03276455", "title": "Gene Therapy for Beta-Thalassemia Major Using Autologous Hematopoietic Stem Cell Genetically Modified", "status": "UNKNOWN", "start": "2017-09-15", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Nanfang Hospital, Southern Medical University", "conditions": ["Beta Thalassemia Major"], "cn_sites": [{"facility": "Nanfang Hospial", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03392298", "title": "Study on the Mechanism of Colla Corri Asini in the Treatment of Thalassemia Patients With Pregnancy Anemia", "status": "UNKNOWN", "start": "2017-12-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 70, "sponsor": "The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine", "conditions": ["Thalassemia", "Pregnancy"], "cn_sites": [{"facility": "the first affiliated hospital of Guangzhou University of Chinese Medicine", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04009525", "title": "Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical Study", "status": "COMPLETED", "start": "2019-07-05", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 823, "sponsor": "First Affiliated Hospital of Guangxi Medical University", "conditions": ["Thalassemia Major"], "cn_sites": [{"facility": "First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04917978", "title": "Association of Hb F Level With Clinical Severity of Beta Thalassemia", "status": "UNKNOWN", "start": "2019-12-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1200, "sponsor": "Nanfang Hospital, Southern Medical University", "conditions": ["Beta Thalassemia"], "cn_sites": [{"facility": "Southern Medical University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04211480", "title": "Safety and Efficacy Evaluation of γ-globin Reactivated Autologous Hematopoietic Stem Cells", "status": "COMPLETED", "start": "2020-10-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Bioray Laboratories", "conditions": ["β Thalassemia Major"], "cn_sites": [{"facility": "Shanghai Bioray Laboratories Inc.", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04929574", "title": "Evaluation of Heart Status in Patients of Beta Thalassemia Using Echocardiogram", "status": "UNKNOWN", "start": "2021-07-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1200, "sponsor": "Nanfang Hospital, Southern Medical University", "conditions": ["Beta Thalassemia"], "cn_sites": [{"facility": "Southern Medical University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05015920", "title": "A Study Evaluating the Safety and Efficacy of the BD211 Drug Product in β-Thalassemia Major Participants", "status": "COMPLETED", "start": "2021-07-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 2, "sponsor": "Shanghai BDgene Co., Ltd.", "conditions": ["Hematologic Diseases"], "cn_sites": [{"facility": "920th Hospital of Joint Logistics Support Force of People's Liberation Army of China", "city": "Kunming", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04925206", "title": "A Safety and Efficacy Study Evaluating ET-01 in Subjects with Transfusion Dependent Β-Thalassaemia", "status": "TERMINATED", "start": "2021-08-17", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 8, "sponsor": "EdiGene (GuangZhou) Inc.", "conditions": ["Transfusion Dependent Beta-Thalassaemia"], "cn_sites": [{"facility": "Nanfang Hospital of Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Guangzhou Women and Children's Medical Center", "city": "Guangzhou", "status": ""}, {"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": ""}, {"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT04205435", "title": "β-globin Restored Autologous HSC in β-thalassemia Major Patients", "status": "TERMINATED", "start": "2021-11-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 2, "sponsor": "Bioray Laboratories", "conditions": ["β-thalassemia Major"], "cn_sites": [{"facility": "Shanghai Bioraylaboratory Inc", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05462548", "title": "The Safety and Efficiency of Luspatercept in Chinese Adults With Transfusion Dependent β-thalassemia: a Real-world Study", "status": "UNKNOWN", "start": "2022-07", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Sun Yat-sen University", "conditions": ["Thalassemia Major", "Transfusion-dependent Anemia"], "cn_sites": [{"facility": "The second affiliated hospital of Sun Yat-sen University", "city": "Guangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05567458", "title": "A Study to Evaluate Luspatercept (ACE-536) in Chinese Participants Who Require Regular Red Blood Cell Transfusions Due to Beta (β)-Thalassemia.", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-10-17", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 94, "sponsor": "Bristol-Myers Squibb", "conditions": ["Beta-thalassemia"], "cn_sites": [{"facility": "Local Institution - 0002", "city": "Maoming", "status": ""}, {"facility": "Local Institution - 0005", "city": "Shenzhen", "status": ""}, {"facility": "Local Institution - 0007", "city": "Liuzhou", "status": ""}, {"facility": "Local Institution - 0003", "city": "Nanning", "status": ""}, {"facility": "Local Institution - 0006", "city": "Haikou", "status": ""}, {"facility": "Local Institution - 0010", "city": "Kunming", "status": ""}, {"facility": "Local Institution - 0009", "city": "Guangzhou", "status": ""}, {"facility": "Local Institution - 0004", "city": "Guangzhou", "status": ""}, {"facility": "Local Institution - 0008", "city": "Haikou", "status": ""}, {"facility": "Local Institution - 0001", "city": "Nanning", "status": ""}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT05577312", "title": "Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia", "status": "ACTIVE_NOT_RECRUITING", "start": "2022-11-02", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 39, "sponsor": "Bioray Laboratories", "conditions": ["Beta-Thalassemia"], "cn_sites": [{"facility": "Nanfang Hospital, Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen Universit", "city": "Guanzhou", "status": ""}, {"facility": "Shenzhen Children 's Hospital", "city": "Shenzhen", "status": ""}, {"facility": "No. 923 Hospital of Joint Support Force of Chinese People 's Liberation Army Hospital", "city": "Nanning", "status": ""}, {"facility": "The First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": ""}, {"facility": "Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT04390971", "title": "Safety and Efficacy Evaluation of ET-01 Transplantation in Subjects With Transfusion Dependent β-Thalassaemia", "status": "COMPLETED", "start": "2023-02-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 3, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Transfusion Dependent Beta-Thalassaemia"], "cn_sites": [{"facility": "The Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": ""}, {"facility": "Affiliated Hospital of Zunyi Medical University", "city": "Zunyi", "status": ""}, {"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT05752123", "title": "A Study to Evaluate the Safety and Efficacy of ET-01 Transplantation in Subjects with Transfusion Dependent Β-Thalassaemia.", "status": "TERMINATED", "start": "2023-02-18", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 2, "sponsor": "EdiGene (GuangZhou) Inc.", "conditions": ["Transfusion Dependent Beta-Thalassaemia"], "cn_sites": [{"facility": "PLA 923 Hospital", "city": "Nanning", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05788562", "title": "The Relevance Between the Level of Fetal Hemoglobin and Short-term Complications in Extremely Preterm Infants", "status": "UNKNOWN", "start": "2023-04-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 92, "sponsor": "The First Hospital of Jilin University", "conditions": ["Fetal Hemoglobin"], "cn_sites": [{"facility": "First hospital of Jilin University", "city": "Changchun", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05860595", "title": "Evaluation the Safety and Efficacy of KL003 Cell Injection in the Treatment of Transfusion-dependent β-thalassemia.", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-05-23", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 3, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Transfusion-dependent Beta-Thalassemia"], "cn_sites": [{"facility": "Regenerative Medicine Center", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06024876", "title": "A Clinical Study Evaluating the Safety and Efficacy of CS-101 in Treating Subjects With β-thalassemia", "status": "COMPLETED", "start": "2023-08-26", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 5, "sponsor": "CorrectSequence Therapeutics Co., Ltd", "conditions": ["Beta-Thalassemia"], "cn_sites": [{"facility": "The First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06041620", "title": "Safety and Efficacy Evaluation of Autologous CRISPR-Cas12b Edited Hematopoietic Stem Cells", "status": "UNKNOWN", "start": "2023-08-31", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 2, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Thalassemia, Beta", "Thalassemia Major"], "cn_sites": [{"facility": "Regenerative Medicine Center", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06026839", "title": "Longitudinal Study on the QoL of Pediatric Patients After HSCT and Its Influencing Factors", "status": "UNKNOWN", "start": "2023-10-30", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 250, "sponsor": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University", "conditions": ["Thalassemia Major", "Acute Leukemia"], "cn_sites": [{"facility": "Sun Yat-sen Memorial Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06065189", "title": "Base-edited Autologous Hematopoietic Stem Cell Transplantation in Treating Patients With β-thalassemia Major", "status": "COMPLETED", "start": "2023-11-07", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 2, "sponsor": "Children's Hospital of Fudan University", "conditions": ["Beta-Thalassemia"], "cn_sites": [{"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05442346", "title": "Safety and Efficacy Evaluation of γ-globin Reactivated Autologous Hematopoietic Stem Cells", "status": "SUSPENDED", "start": "2023-12-25", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 5, "sponsor": "Bioray Laboratories", "conditions": ["Thalassemia Major"], "cn_sites": [{"facility": "Shanghai Bioray Laboratories Inc", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06291961", "title": "A Safety and Efficacy Study Evaluating CS-101 in Subjects With β-Thalassemia Major", "status": "COMPLETED", "start": "2024-04-18", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "CorrectSequence Therapeutics Co., Ltd", "conditions": ["Beta-Thalassemia Major"], "cn_sites": [{"facility": "The First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Ruijin Hospital Shanghai JiaoTong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT06308159", "title": "An Open-label Study of a Gene Therapy Product (Vebeglogene Autotemcel) in Transfusion Dependent Beta-Thalassemia", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-05-11", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Lantu Biopharma", "conditions": ["Beta-Thalassemia"], "cn_sites": [{"facility": "920th Hospital of Joint Logistics Support Force of People's Liberation Army of China", "city": "Kunming", "status": ""}, {"facility": "Kunming Hope of Health Hospital", "city": "Kunming", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06931912", "title": "Growth Evaluation, Health Promotion, and Clinical Management in Children and Adolescents With Thalassemia", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-12-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 385, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Thalassemia Intermedia", "Thalassemia Major", "Growth Delay", "Puberty, Delayed"], "cn_sites": [{"facility": "Regenerative Medicine Center and Red Blood Cell Disorders Center", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06743477", "title": "A Clinical Study of Ultra-transplantation for the Treatment of Major Thalassemia Scheme", "status": "RECRUITING", "start": "2025-08-29", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 5, "sponsor": "Hu Peng", "conditions": ["Stem Cell Transplantation"], "cn_sites": [{"facility": "Yunnan First People's Hospital", "city": "Kunming", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": true}], "g_total": 61, "g_fetched": 44, "g_countries": [["United States", 19], ["Italy", 4], ["Spain", 3], ["Pakistan", 3], ["Saudi Arabia", 2], ["Austria", 2], ["Egypt", 2], ["Denmark", 2], ["Kuwait", 1], ["Oman", 1], ["United Arab Emirates", 1], ["France", 1], ["Turkey (Türkiye)", 1], ["South Korea", 1], ["Angola", 1], ["Argentina", 1], ["Belgium", 1], ["Brunei", 1], ["Cyprus", 1], ["Democratic Republic of the Congo", 1], ["Greece", 1], ["Israel", 1], ["Malaysia", 1], ["Nigeria", 1], ["Portugal", 1], ["Germany", 1], ["Hong Kong", 1]], "g_trials": [{"nct": "NCT07502781", "title": "Heterologous Cord Blood-Derived Red Blood Cell for Transfusion in Extremely Preterm Infants", "status": "NOT_YET_RECRUITING", "start": "2027-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Hospital Clinic of Barcelona", "countries": ["Spain"]}, {"nct": "NCT07660224", "title": "The Effect of Motivational Interviewing on Treatment Adherence and Self-Efficacy Among Omani Adults With Thalassemia", "status": "NOT_YET_RECRUITING", "start": "2026-11-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Oman Ministry of Health", "countries": []}, {"nct": "NCT07614217", "title": "Oral Health Status in Children With β-Thalassemia Major", "status": "NOT_YET_RECRUITING", "start": "2026-11-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Cairo University", "countries": []}, {"nct": "NCT07506863", "title": "A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)", "status": "RECRUITING", "start": "2026-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Agios Pharmaceuticals, Inc.", "countries": ["United States"]}, {"nct": "NCT07721480", "title": "Gene Therapy for Patients With Transfusion-Dependent β-Thalassemia", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Prince of Wales Hospital, Shatin, Hong Kong", "countries": []}, {"nct": "NCT07517133", "title": "A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With α- or β-Non-Transfusion-Dependent Thalassemia", "status": "RECRUITING", "start": "2026-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Agios Pharmaceuticals, Inc.", "countries": ["United States"]}, {"nct": "NCT07599176", "title": "Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors", "status": "RECRUITING", "start": "2026-07-08", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "countries": ["United States"]}, {"nct": "NCT07680803", "title": "Gene-Modified Stem Cell Therapy for Subjects With Transfusion-dependent Beta-thalassemia", "status": "RECRUITING", "start": "2026-07-06", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Fondazione Telethon", "countries": ["Italy"]}, {"nct": "NCT07480980", "title": "Evaluation of Micro RNA-155 Expression in Relation to Alloantibody Formation in Transfusion-Dependent Patients", "status": "NOT_YET_RECRUITING", "start": "2026-07-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT07215975", "title": "A Real-World Study to Evaluate Luspatercept in Adults With Transfusion-Dependent Beta-Thalassemia in the Middle East", "status": "RECRUITING", "start": "2026-06-26", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Bristol-Myers Squibb", "countries": ["Kuwait", "Oman", "Saudi Arabia", "United Arab Emirates"]}, {"nct": "NCT07673302", "title": "Safety and Efficacy of Hemoglobin F Inducers in Patients With Beta Thalassemia", "status": "RECRUITING", "start": "2026-06-20", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Riphah International University", "countries": ["Pakistan"]}, {"nct": "NCT07509996", "title": "Risk Factors Affecting Growth in Thalassemic Children at AUCH", "status": "NOT_YET_RECRUITING", "start": "2026-04-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT07672275", "title": "Transfusion-Related Changes in Oxidative Stress Biomarkers in Neonates", "status": "RECRUITING", "start": "2025-12-12", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Medical University of Graz", "countries": ["Austria"]}, {"nct": "NCT07288762", "title": "Gonadal Function in Thalassemic Patient", "status": "NOT_YET_RECRUITING", "start": "2025-12-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sohag University", "countries": []}, {"nct": "NCT06647979", "title": "Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies", "status": "RECRUITING", "start": "2025-12-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Daniel Bauer", "countries": ["United States"]}, {"nct": "NCT07204015", "title": "Body Composition in Pediatric Patients With Thalassemia Major", "status": "NOT_YET_RECRUITING", "start": "2025-10-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT07207577", "title": "Evaluation of Physiological and Psychological Factors Involved in Exercise Intolerance in Patients With β-TTD", "status": "RECRUITING", "start": "2025-09-04", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Centre Hospitalier Metropole Savoie", "countries": ["France"]}, {"nct": "NCT07157722", "title": "Evaluating the Effect of N-Acetyl Cysteine and Alpha Lipoic Acid in Patients With Beta Thalassemia", "status": "NOT_YET_RECRUITING", "start": "2025-08-30", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Tanta University", "countries": ["Egypt"]}, {"nct": "NCT06980662", "title": "The Effect of Laughter Yoga in Beta Thalassaemia Major Patients: a Randomised Controlled Trial", "status": "NOT_YET_RECRUITING", "start": "2025-06-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Ataturk University", "countries": ["Turkey (Türkiye)"]}, {"nct": "NCT06364774", "title": "ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia", "status": "RECRUITING", "start": "2025-04-14", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Children's Hospital of Philadelphia", "countries": ["United States"]}, {"nct": "NCT07112703", "title": "Effect of Incentive Respiratory Training on Pulmonary Functions and Functional Capacity in Children With B-thalassemia Major", "status": "RECRUITING", "start": "2025-04-07", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Rawan Mohammed Khairy Mostafa Elsawy", "countries": ["Egypt"]}, {"nct": "NCT06512298", "title": "Plasticizer Exposure and Its Consequences on Health", "status": "NOT_YET_RECRUITING", "start": "2024-10-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Medical University of Vienna", "countries": ["Austria"]}, {"nct": "NCT06433570", "title": "Detection of Krupple Like Factor -1(KLF1/ EKLF) DNA Mutations in Beta Thalassemia Patients", "status": "NOT_YET_RECRUITING", "start": "2024-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT06490627", "title": "Unraveling the Impact of Thalidomide at Diverse Doses in Transfusion Dependent Beta Thalassemia", "status": "RECRUITING", "start": "2024-04-22", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "National Institute of Blood and Marrow Transplant (NIBMT), Pakistan", "countries": ["Pakistan"]}, {"nct": "NCT06073860", "title": "A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or β-thalassemia", "status": "RECRUITING", "start": "2024-03-25", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Bristol-Myers Squibb", "countries": ["South Korea"]}]}, {"batch": 2, "no": 79, "name_zh": "血栓性血小板减少性紫癜", "query_terms": [{"term": "Thrombotic thrombocytopenic purpura", "broad": false}], "n_total": 183, "n_open": 64, "n_open_precise": 64, "n_broad": 0, "trials": [{"nct": "NCT04518475", "title": "Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults", "status": "RECRUITING", "start": "2020-08-10", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 224, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Primary Immune Thrombocytopenia (ITP)"], "cn_sites": [{"facility": "Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04993885", "title": "Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies", "status": "RECRUITING", "start": "2021-09-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 52, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Immune Thrombocytopenia", "Autoantibodies", "Evan Syndrome", "Connective Tissue Diseases"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05214391", "title": "A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia", "status": "RECRUITING", "start": "2022-02-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Immune Thrombocytopenia", "Treatment"], "cn_sites": [{"facility": "Chinese Academy of Medical Science and Blood Disease Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05571774", "title": "Construction of a Database for TTP", "status": "RECRUITING", "start": "2022-10-20", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "The First Affiliated Hospital of Soochow University", "conditions": ["TTP - Thrombotic Thrombocytopenic Purpura"], "cn_sites": [{"facility": "the first affiliated hospital of Soochow university", "city": "Suzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05995054", "title": "A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Immune Thrombocytopenia", "status": "RECRUITING", "start": "2023-08-28", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 110, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Immune Thrombocytopenia", "Treatment"], "cn_sites": [{"facility": "Chinese Academy of Medical Science and Blood Disease Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06107582", "title": "Longitudinal Cohort of Pediatric Primary Immune Thrombocytopenia (ITP)", "status": "RECRUITING", "start": "2023-11-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Primary Immune Thrombocytopenia"], "cn_sites": [{"facility": "Chinese Academy of Medical Science and Blood Disease Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06094881", "title": "A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP)", "status": "RECRUITING", "start": "2023-12-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Immune Thrombocytopenia", "Treatment"], "cn_sites": [{"facility": "Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06168851", "title": "Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP)", "status": "RECRUITING", "start": "2023-12-28", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Immune Thrombocytopenia", "Treatment"], "cn_sites": [{"facility": "Chinese Academy of Medical Science and Blood Disease Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06352281", "title": "Efficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP)", "status": "RECRUITING", "start": "2024-02-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "920th Hospital of Joint Logistics Support Force of People's Liberation Army of China", "conditions": ["ITP - Immune Thrombocytopenia"], "cn_sites": [{"facility": "920th Hospital of Joint Logistics Support Force of People's Liberation Army of China", "city": "Kunming", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06281327", "title": "Avatrombopag in the Treatment of Pediatric Immune Thrombocytopenia", "status": "RECRUITING", "start": "2024-03-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Immune Thrombocytopenia", "Treatment"], "cn_sites": [{"facility": "Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06478537", "title": "TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination", "status": "RECRUITING", "start": "2024-06-20", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 56, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06838962", "title": "Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP)", "status": "RECRUITING", "start": "2024-08-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Immune Thrombocytopenia", "Treatment"], "cn_sites": [{"facility": "Chinese Academy of Medical Science and Blood Disease Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06534021", "title": "IASO-782 in Autoimmune Hematological Diseases", "status": "RECRUITING", "start": "2024-08-08", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 16, "sponsor": "Shanghai IASO Biotechnology Co., Ltd", "conditions": ["Autoimmune Thrombocytopenia", "Warm Autoimmune Haemolytic Anaemia"], "cn_sites": [{"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Institute of Hematology, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT06519565", "title": "Safety and Efficacy of PRG-1801 in Recurrent/Refractory Primary Immune Thrombocytopenia (ITP)", "status": "RECRUITING", "start": "2024-08-20", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06787989", "title": "BCMA-CD19 CCAR T Cell Treatment of Refractory Immune Thrombocytopenia Associated with Autoimmune Diseases", "status": "RECRUITING", "start": "2024-08-31", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "iCell Gene Therapeutics", "conditions": ["Refractory Immune Cytopenia"], "cn_sites": [{"facility": "West China Hospital", "city": "Chengdu", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06544499", "title": "A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia", "status": "RECRUITING", "start": "2024-10-18", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 69, "sponsor": "argenx", "conditions": ["Primary Immune Thrombocytopenia (ITP)"], "cn_sites": [{"facility": "Beijing YouYi Hospital-Beijing Friendship Hospital Capital Medical University", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital Of Bengbu Medical College", "city": "Bengbu", "status": "RECRUITING"}, {"facility": "The Affiliated Hospital of Chengde Medical University", "city": "Chengde", "status": "RECRUITING"}, {"facility": "The Affiliated Hospital of Inner Mongolia Medical University", "city": "Hohhot", "status": "RECRUITING"}, {"facility": "The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University", "city": "Huai'an", "status": "RECRUITING"}, {"facility": "Huizhou Central People's Hospital", "city": "Huizhou", "status": "RECRUITING"}, {"facility": "Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "Union Hospital Tongji Medical College of Huazhong University of Science and Technology (HUST)", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Wuxi People's Hospital (Wuxi No.1 People's Hospital)", "city": "Wuxi", "status": "RECRUITING"}, {"facility": "Affiliated Hospital of Jiangsu University", "city": "Zhenjiang", "status": "RECRUITING"}], "cn_site_count": 11, "broad_only": false}, {"nct": "NCT06727669", "title": "Longitudinal Cohort of Thrombosis and Hemostasis Diseases", "status": "RECRUITING", "start": "2024-11-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 3000, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia", "Thrombotic Thrombocytopenic Purpura", "Hemophilia A, Acquired", "Disseminated Intravascular Coagulation", "Thrombophilia", "Deep Vein Thrombosis", "Pulmonary Embolism", "Thrombotic Microangiopathies", "Coagulation Factor Deficiency", "Hemophilia A", "Hemophilia B", "Hemophilia B, Acquired", "Platelet Dysfunction", "Arterial Thromboembolism", "Bleeding Disorder", "Thrombosis"], "cn_sites": [{"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Department of Hematology, Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Department of Hematology, Beijing Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Xinqiao Hospital, Army Military Medical University", "city": "Chongqing", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT06888960", "title": "Safety Study of CC312 in Autoimmune Disease Patients", "status": "RECRUITING", "start": "2024-11-08", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "CytoCares Inc", "conditions": ["Systemic Lupus Erythematosus (SLE)", "Idiopathic Inflammatory Myopathy (IIM)", "Systemic Sclerosis (SSc)", "Rheumatoid Arthritis (RA)", "Primary Immune Thrombocytopenia (ITP)", "Autoimmune Hemolytic Anemia"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06794008", "title": "BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2024-12-26", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Peking University People's Hospital", "conditions": ["Systemic Lupus Erythematosus", "Inflammatory Myopathy", "Systemic Sclerosis (SSc)", "ANCA-associated Vasculitis", "IgG4-Related Diseases", "Antiphospholipid Syndrome", "Acquired Thrombotic Thrombocytopenic Purpura", "Behcet Disease", "Sjogren Syndrome"], "cn_sites": [{"facility": "Department of Rheumatology and Immunology, Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06776510", "title": "A Clinical Study of NAD in the Treatment of Immune Thrombocytopenia", "status": "RECRUITING", "start": "2025-01-15", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Immune Thrombocytopenia", "Treatment"], "cn_sites": [{"facility": "Chinese Academy of Medical Science and Blood Disease Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06722235", "title": "A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia", "status": "RECRUITING", "start": "2025-02-27", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 171, "sponsor": "Takeda", "conditions": ["Immune Thrombocytopenic Purpura (ITP)"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Guangdong Provincial People's Hospital", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": "RECRUITING"}, {"facility": "The First Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": "RECRUITING"}, {"facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Soochow University - Shizijie Campus", "city": "Suzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Nanchang University - Donghu Campus", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Shengjing Hospital of China Medical University - Nanhu Campus", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Shaanxi Provincial People's Hospital", "city": "Xi'an", "status": "RECRUITING"}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Jinshan Hospital of Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "West China Hospital Sichuan University", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences - PPDS", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": "RECRUITING"}, {"facility": "Zhejiang Provincial Hospital of Chinese Medicine - Main", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 16, "broad_only": false}, {"nct": "NCT06826430", "title": "Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune Thrombocytopenia", "status": "RECRUITING", "start": "2025-03-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Juventas Cell Therapy Ltd.", "conditions": ["Autoimmune Thrombocytopenia"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06799611", "title": "An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia", "status": "RECRUITING", "start": "2025-03-03", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Immune Thrombocytopenia (ITP)", "Treatment"], "cn_sites": [{"facility": "Chinese Academy of Medical Science and Blood Disease Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06880081", "title": "Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP)", "status": "RECRUITING", "start": "2025-03-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Chongqing Peg-Bio Biopharm Co., Ltd.", "conditions": ["Primary Immune Thrombocytopenia (ITP)"], "cn_sites": [{"facility": "Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Jining First People's Hospital", "city": "Jining", "status": "RECRUITING"}, {"facility": "Hematology Hospital of Chinese Academy of Medical Sciences", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": "RECRUITING"}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT06873672", "title": "Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China", "status": "NOT_YET_RECRUITING", "start": "2025-04-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 360, "sponsor": "RenJi Hospital", "conditions": ["Quality of Life (QOL)", "Patient-Reported Outcome Measures (PROMs)", "Pneumonia Childhood", "Neuroblastoma (NB)", "Wilms Tumour", "Immune Thrombocytopenic Purpura ( ITP )"], "cn_sites": [{"facility": "Guizhou Medical University", "city": "Guiyang", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06943937", "title": "A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus", "status": "RECRUITING", "start": "2025-04-16", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "China Immunotech (Beijing) Biotechnology Co., Ltd.", "conditions": ["Lupus Nephritis (LN)", "Immune Thrombocytopenia (ITP)"], "cn_sites": [{"facility": "Beijing GoBroad Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06900920", "title": "A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia", "status": "RECRUITING", "start": "2025-04-30", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 199, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Primary Immune Thrombocytopenia"], "cn_sites": [{"facility": "The first affiliated hospital of ustc anhui provincial hospital", "city": "Hefei", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Wannan Medical College", "city": "Wuhu", "status": "NOT_YET_RECRUITING"}, {"facility": "Beijing Chaoyang Hospital, Capital Medical University", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Hospital of Lanzhou University", "city": "Lanzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Nanfang Hospital, Southern Medical University", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Shenzhen Nanshan People's Hospital", "city": "Shenzhen", "status": "NOT_YET_RECRUITING"}, {"facility": "Central People's Hospital of Zhanjiang", "city": "Zhanjiang", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": "NOT_YET_RECRUITING"}, {"facility": "The Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Hainan Medical University", "city": "Haikou", "status": "NOT_YET_RECRUITING"}, {"facility": "Affiliated Hospital of Hebei University / School of Clinical Medicine", "city": "Baoding", "status": "RECRUITING"}, {"facility": "Affiliated Hospital of ChengDe Medical University", "city": "Chengde", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": "NOT_YET_RECRUITING"}, {"facility": "North China University of science and technology", "city": "Tangshan", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Harbin Medical University", "city": "Harbin", "status": "NOT_YET_RECRUITING"}, {"facility": "Anyang People's Hospital", "city": "Anyang", "status": "NOT_YET_RECRUITING"}, {"facility": "Nanyang Central Hospital", "city": "Nanyang", "status": "NOT_YET_RECRUITING"}, {"facility": "Xuchang Central Hospital", "city": "Xuchang", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The First People's Hospital of Ping Ding Shan", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}, {"facility": "Zhongnan Hospital of Wuhan University", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}, {"facility": "The Third Hospital of Changsha", "city": "Changsha", "status": "NOT_YET_RECRUITING"}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": "NOT_YET_RECRUITING"}, {"facility": "Jiangsu Province Hospital", "city": "Nanjing", "status": "NOT_YET_RECRUITING"}, {"facility": "Affiliated Hospital of Nantong University", "city": "Nantong", "status": "NOT_YET_RECRUITING"}, {"facility": "Northern Jiangsu People's Hospital Affiliated to Yangzhou University", "city": "Yangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Ganzhou People's Hospital", "city": "Ganzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of NanChang University", "city": "Nanchang", "status": "NOT_YET_RECRUITING"}, {"facility": "The first hospital of Jilin University", "city": "Changchun", "status": "NOT_YET_RECRUITING"}, {"facility": "Shenjing Hospital Of China Medical University", "city": "Shenyang", "status": "NOT_YET_RECRUITING"}, {"facility": "Qinghai University Affiliated Hospital", "city": "Xining", "status": "NOT_YET_RECRUITING"}, {"facility": "Xijing Hospital", "city": "Xi'an", "status": "NOT_YET_RECRUITING"}, {"facility": "Xi'an No.3 Hospital", "city": "Xi'an", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi'an", "status": "NOT_YET_RECRUITING"}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": "NOT_YET_RECRUITING"}, {"facility": "Shandong First Medical University Affiliated Central Hospital", "city": "Jinan", "status": "NOT_YET_RECRUITING"}, {"facility": "Linyi Central Hospital", "city": "Linyi", "status": "NOT_YET_RECRUITING"}, {"facility": "Yantai Yuhuangding Hospital (Affiliated Yantai Yuhuangding Hospital of Qingdao University)", "city": "Yantai", "status": "NOT_YET_RECRUITING"}, {"facility": "Shanghai Sixth People's Hospital", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}, {"facility": "Affiliated Zhongshan Hospital of Fudan University，Qingpu Branch", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}, {"facility": "Heping Hospital affiliated to Changzhi Medical College", "city": "Changzhi", "status": "NOT_YET_RECRUITING"}, {"facility": "Shanxi Bethune Hospital", "city": "Taiyuan", "status": "NOT_YET_RECRUITING"}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": "NOT_YET_RECRUITING"}, {"facility": "Tianjin People's Hospital", "city": "Tianjin", "status": "NOT_YET_RECRUITING"}, {"facility": "People's Hospital of Xinjiang Uygur Autonomous Region", "city": "Ürümqi", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Xinjiang Medical University", "city": "Ürümqi", "status": "NOT_YET_RECRUITING"}, {"facility": "Kunming Medical University Second Affiliated Hospital", "city": "Kunming", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Zhejiang Chinese Medical University", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Ningbo University", "city": "Ningbo", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 53, "broad_only": false}, {"nct": "NCT06853444", "title": "A Phase 1/2 Study of ESG206 in Patients With Primary Immune Thrombocytopenia", "status": "RECRUITING", "start": "2025-05-08", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 84, "sponsor": "Shanghai Escugen Biotechnology Co., Ltd", "conditions": ["Immune Thrombocytopenia (ITP)"], "cn_sites": [{"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06929299", "title": "A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP)", "status": "RECRUITING", "start": "2025-05-12", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 56, "sponsor": "Jiangsu BioJeTay Biotechnology Co., Ltd.", "conditions": ["Primary Immune Thrombocytopenia (ITP)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Bengbu Medical College", "city": "Bengbu", "status": "RECRUITING"}, {"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "North China University of Science and Technology Affiliated Hospital", "city": "Tangshan", "status": "RECRUITING"}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Xi'an Central Hospital", "city": "Xi’an", "status": "RECRUITING"}, {"facility": "Hospital of Hematology, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT06992128", "title": "Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial", "status": "RECRUITING", "start": "2025-05-22", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 129, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Primary Immune Thrombocytopenia (ITP)"], "cn_sites": [{"facility": "Chinese Academy of Medical Science and Blood Disease Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07057778", "title": "Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITP", "status": "NOT_YET_RECRUITING", "start": "2025-07-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia (ITP)"], "cn_sites": [{"facility": "Peking University Insititute of Hematology", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07072247", "title": "RN1201 Injection in the Treatment of Antibody-Mediated Diseases", "status": "RECRUITING", "start": "2025-07-07", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "The First Affiliated Hospital of Soochow University", "conditions": ["Refractory Immune-mediated Platelet Transfusion Refractoriness", "Relapsed or Refractory Immune Thrombocytopenia"], "cn_sites": [{"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07068425", "title": "Longitudinal Observational Study on Immune Thrombocytopenia", "status": "NOT_YET_RECRUITING", "start": "2025-07-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 2000, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia (ITP)"], "cn_sites": [{"facility": "Peking University Insititute of Hematology, Peking University People's Hospital, Beijing, Beijing 100010", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07064889", "title": "The Combination of Upadacitinib and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia", "status": "NOT_YET_RECRUITING", "start": "2025-07-30", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 132, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06721013", "title": "A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia", "status": "RECRUITING", "start": "2025-07-30", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 68, "sponsor": "Eli Lilly and Company", "conditions": ["Immune Thrombocytopenia (ITP)"], "cn_sites": [{"facility": "Nanfang Hospital of Southern Medical University", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": "NOT_YET_RECRUITING"}, {"facility": "Hematology Hospital of the Chinese Academy of Medical Sciences", "city": "Tianjin", "status": "NOT_YET_RECRUITING"}, {"facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT07063199", "title": "Anti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP)", "status": "RECRUITING", "start": "2025-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Immune Thrombocytopenia", "Treatment"], "cn_sites": [{"facility": "Chinese Academy of Medical Science and Blood Disease Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07083739", "title": "A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults", "status": "NOT_YET_RECRUITING", "start": "2025-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 320, "sponsor": "Chia Tai Tianqing Pharmaceutical Group Co., Ltd.", "conditions": ["Primary Immune Thrombocytopenia"], "cn_sites": [{"facility": "The first affiliated hospital of ustc anhui provincial hospital", "city": "Hefei", "status": ""}, {"facility": "The First Affiliated Hospital of Wannan Medical College", "city": "Wuhu", "status": ""}, {"facility": "Beijing Chaoyang Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "The Second Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "status": ""}, {"facility": "The First Hospital of Lanzhou University", "city": "Lanzhou", "status": ""}, {"facility": "Nanfang Hospital, Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Shenzhen Nanshan People's Hospital", "city": "Shenzhen", "status": ""}, {"facility": "Central People's Hospital of Zhanjiang", "city": "Zhanjiang", "status": ""}, {"facility": "The Second Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": ""}, {"facility": "The Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": ""}, {"facility": "The First Affiliated Hospital of Hainan Medical University", "city": "Haikou", "status": ""}, {"facility": "Affiliated Hospital of Hebei University / School of Clinical Medicine", "city": "Baoding", "status": ""}, {"facility": "Affiliated Hospital of ChengDe Medical University", "city": "Chengde", "status": ""}, {"facility": "The First Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "North China University of science and technology", "city": "Tangshan", "status": ""}, {"facility": "The First Affiliated Hospital of Harbin Medical University", "city": "Harbin", "status": ""}, {"facility": "Anyang People's Hospital", "city": "Anyang", "status": ""}, {"facility": "Nanyang Central Hospital", "city": "Nanyang", "status": ""}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": ""}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "The First People's Hospital of Ping Ding Shan", "city": "Zhengzhou", "status": ""}, {"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Zhongnan Hospital of Wuhan University", "city": "Wuhan", "status": ""}, {"facility": "The Third Hospital of Changsha", "city": "Changsha", "status": ""}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": ""}, {"facility": "Jiangsu Province Hospital", "city": "Nanjing", "status": ""}, {"facility": "Affiliated Hospital of Nantong University", "city": "Nantong", "status": ""}, {"facility": "Ganzhou People's Hospital", "city": "Ganzhou", "status": ""}, {"facility": "The First Affiliated Hospital of NanChang University", "city": "Nanchang", "status": ""}, {"facility": "The first hospital of Jilin University", "city": "Changchun", "status": ""}, {"facility": "Shenjing Hospital Of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "Qinghai University Affiliated Hospital", "city": "Xining", "status": ""}, {"facility": "Xijing Hospital", "city": "Xi'an", "status": ""}, {"facility": "Xi'an No.3 Hospital", "city": "Xi'an", "status": ""}, {"facility": "The First Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi'an", "status": ""}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": ""}, {"facility": "Shandong First Medical University Affiliated Central Hospital", "city": "Jinan", "status": ""}, {"facility": "Linyi Central Hospital", "city": "Linyi", "status": ""}, {"facility": "Yantai Yuhuangding Hospital (Affiliated Yantai Yuhuangding Hospital of Qingdao University)", "city": "Yantai", "status": ""}, {"facility": "Shanghai Sixth People's Hospital", "city": "Shanghai", "status": ""}, {"facility": "Affiliated Zhongshan Hospital of Fudan University, Qingpu Branch", "city": "Shanghai", "status": ""}, {"facility": "Heping Hospital affiliated to Changzhi Medical College", "city": "Changzhi", "status": ""}, {"facility": "Shanxi Bethune Hospital", "city": "Taiyuan", "status": ""}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": ""}, {"facility": "Tianjin People's Hospital", "city": "Tianjin", "status": ""}, {"facility": "People's Hospital of Xinjiang Uygur Autonomous Region", "city": "Ürümqi", "status": ""}, {"facility": "The First Affiliated Hospital of Xinjiang Medical University", "city": "Ürümqi", "status": ""}, {"facility": "Kunming Medical University Second Affiliated Hospital", "city": "Kunming", "status": ""}, {"facility": "Zhejiang Provincial Hospital of Traditional Chinese Medicine", "city": "Hangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Ningbo University", "city": "Ningbo", "status": ""}], "cn_site_count": 51, "broad_only": false}, {"nct": "NCT06948318", "title": "A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia", "status": "RECRUITING", "start": "2025-08-14", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 150, "sponsor": "Takeda", "conditions": ["Immune Thrombocytopenic Purpura (ITP)"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Guangdong Provincial People's Hospital", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": "RECRUITING"}, {"facility": "The First Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": "RECRUITING"}, {"facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Soochow University - Shizijie Campus", "city": "Suzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Nanchang University - Donghu Campus", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Shengjing Hospital of China Medical University - Nanhu Campus", "city": "Shenyang", "status": "NOT_YET_RECRUITING"}, {"facility": "Shaanxi Provincial People's Hospital", "city": "Xi'an", "status": "NOT_YET_RECRUITING"}, {"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Jinshan Hospital of Fudan University", "city": "Shanghai", "status": "RECRUITING"}, {"facility": "West China Hospital Sichuan University", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences - PPDS", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": "RECRUITING"}, {"facility": "Zhejiang Provincial Hospital of Chinese Medicine - Main", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 16, "broad_only": false}, {"nct": "NCT06973356", "title": "Anti CD19/BCMA CAR Gene Therapy for Relapsed/Refractory Immune Thrombocytopenia", "status": "RECRUITING", "start": "2025-08-16", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 18, "sponsor": "Anhui Provincial Hospital", "conditions": ["Immune Thrombocytopenia (ITP)"], "cn_sites": [{"facility": "Hunan Siweikang Therapeutic Co.Ltd", "city": "Changsha", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07065968", "title": "The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2)", "status": "RECRUITING", "start": "2025-08-19", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 132, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia (ITP)"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07174843", "title": "An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases", "status": "RECRUITING", "start": "2025-09", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Shanghai Cell Therapy Group Co.,Ltd", "conditions": ["Idiopathic Inflammatory Myopathies(IIM)", "Immune Thrombocytopenia(ITP)", "Systemic Lupus Erythematosus(SLE)"], "cn_sites": [{"facility": "Shanghai Mengchao Cancer Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07196163", "title": "An Exploratory Study of Golidocitinib in Adult Patients With ITP", "status": "NOT_YET_RECRUITING", "start": "2025-10-30", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 138, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia (ITP)"], "cn_sites": [{"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07206758", "title": "Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia", "status": "RECRUITING", "start": "2025-11-12", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Guangdong Hengrui Pharmaceutical Co., Ltd", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07175493", "title": "A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia", "status": "RECRUITING", "start": "2025-11-18", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 158, "sponsor": "Keymed Biosciences Co.Ltd", "conditions": ["Autoimmune Cytopenia", "Immune Thrombocytopenia (ITP)", "Autoimmune Hemolytic Anemia", "Evans Syndrome"], "cn_sites": [{"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Heping Hospital Affiliated to Changzhi Medical College", "city": "Changzhi", "status": "RECRUITING"}, {"facility": "Blood Disease Hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07189910", "title": "Sequential rhTPO and Eltrombopag Following Glucocorticoids for Severe Adult ITP", "status": "NOT_YET_RECRUITING", "start": "2025-12-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 150, "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": ["Primary Immune Thrombocytopenia (ITP)"], "cn_sites": [{"facility": "Wuhan Union Hospital", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07294365", "title": "A Study of DZD8586 in Adults With Primary Immune Thrombocytopenia (ITP) (TAI-SHAN11)", "status": "RECRUITING", "start": "2026-01-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Dizal Pharmaceuticals", "conditions": ["Immune Thrombocytopenia (ITP)"], "cn_sites": [{"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07297563", "title": "Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)", "status": "RECRUITING", "start": "2026-01-20", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 160, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Immune Thrombocytopenia", "Treatment"], "cn_sites": [{"facility": "Chinese Academy of Medical Science and Blood Disease Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07234019", "title": "Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)", "status": "RECRUITING", "start": "2026-01-28", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 160, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Immune Thrombocytopenia", "Treatment"], "cn_sites": [{"facility": "Chinese Academy of Medical Science and Blood Disease Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07212322", "title": "A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-01-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Systemic Lupus Erythematosus", "Idiopahic Inflammatory Myopathies", "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis", "Sjögren's Syndrome", "Antiphospholipid Syndrome", "Immune Thrombocytopenia", "Systemic Sclerosis"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07416032", "title": "A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C)in Patients With Refractory Primary Immune Thrombocytopenia", "status": "NOT_YET_RECRUITING", "start": "2026-02-20", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 27, "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": ["Immune Thrombocytopenia (ITP)"], "cn_sites": [{"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07362199", "title": "Anti-CD38 Monoclonal Antibody Combined With Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)", "status": "RECRUITING", "start": "2026-03", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Immune Thrombocytopenia", "Treatment"], "cn_sites": [{"facility": "Chinese Academy of Medical Science and Blood Disease Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07362238", "title": "Daratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)", "status": "RECRUITING", "start": "2026-03", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 122, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Immune Thrombocytopenia", "Treatment"], "cn_sites": [{"facility": "Chinese Academy of Medical Science and Blood Disease Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07612319", "title": "Romiplostim for Oral TPO-RA Resistant ITP", "status": "RECRUITING", "start": "2026-03-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "The First Affiliated Hospital of Soochow University", "conditions": ["Immune (Idiopathic) Thrombocytopenic Purpura (ITP)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07400250", "title": "Phase II Study of Orelabrutinib in Combination With Romiplostim N01 in Patients With Primary Immune Thrombocytopenia (ITP) Who Have Received At Least One Prior Line of Therapy", "status": "NOT_YET_RECRUITING", "start": "2026-04-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 28, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Primary Immune Thrombocytopenia (ITP)"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07559331", "title": "High-Dose Dexamethasone Combined With Orelabrutinib Versus High-Dose Dexamethasone Combined With Placebo in Adult Patients With Newly Diagnosed Primary Immune Thrombocytopenia", "status": "RECRUITING", "start": "2026-04-08", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 86, "sponsor": "Shandong University", "conditions": ["Primary Immune Thrombocytopenia (ITP)"], "cn_sites": [{"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07599280", "title": "Universal STAR-T Cell Injection in R/R Autoimmune Diseases.", "status": "NOT_YET_RECRUITING", "start": "2026-05-11", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 6, "sponsor": "Jian Zhu", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "No. 28, Fuxing Road, Haidian District, Beijing, China.", "city": "Haidian", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07597395", "title": "ATRA for Management of Primary ITP", "status": "NOT_YET_RECRUITING", "start": "2026-05-30", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 192, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Peking University Institute of hematology, People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07662525", "title": "Atorvastatin Combined With NAC Plus Romiplostim for Management of ITP", "status": "NOT_YET_RECRUITING", "start": "2026-06-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenic Purpura"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07657793", "title": "Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia", "status": "RECRUITING", "start": "2026-06-07", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 164, "sponsor": "Chinese SLE Treatment And Research Group", "conditions": ["Systemic Lupus Erythematosus", "Immune Thrombocytopenia"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07710248", "title": "SG301-SC Injection Safety Study in Subjects With Primary ITP Patients", "status": "RECRUITING", "start": "2026-06-11", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Hangzhou Sumgen Biotech Co., Ltd.", "conditions": ["Primary Immune Thrombocytopenia"], "cn_sites": [{"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "Nanfang Hospital, Southern Medical University", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Liuzhou People's Hospital", "city": "Liuzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Yulin Red Cross Hospital", "city": "Yulin", "status": "RECRUITING"}, {"facility": "Hebei University Affiliated Hospital", "city": "Baoding", "status": "NOT_YET_RECRUITING"}, {"facility": "Affiliated Hospital of Chengde Medical University", "city": "Chengde", "status": "NOT_YET_RECRUITING"}, {"facility": "North China University of Science and Technology Affiliated Hospital", "city": "Tangshan", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Harbin Medical University", "city": "Harbin", "status": "RECRUITING"}, {"facility": "Pingdingshan First People's Hospital", "city": "Pingdingshan", "status": "RECRUITING"}, {"facility": "Henan Cancer Hospital", "city": "Zhenzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}, {"facility": "Xiangyang Central Hospital", "city": "Xiangyang", "status": "NOT_YET_RECRUITING"}, {"facility": "Siping Central People's Hospital", "city": "Siping", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital)", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Jining No.1 People's Hospital", "city": "Jining", "status": "RECRUITING"}, {"facility": "Heping Hospital Affiliated to Changzhi Medical College", "city": "Changzhi", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital of Xi'an Jiaotong University", "city": "Xian", "status": "RECRUITING"}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": "NOT_YET_RECRUITING"}, {"facility": "Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "Yunnan Provincial First People's Hospital", "city": "Kunming", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "status": "RECRUITING"}], "cn_site_count": 22, "broad_only": false}, {"nct": "NCT07788456", "title": "Multi-target Drugs Sequential Combination Therapy in Adults Patients With Newly Diagnosed Primary Immune Thrombocytopenia", "status": "RECRUITING", "start": "2026-06-22", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 38, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["ITP - Immune Thrombocytopenia"], "cn_sites": [{"facility": "Ethics Committee of Hematology Hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07039422", "title": "Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab", "status": "RECRUITING", "start": "2026-06-26", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Primary Immune Thrombocytopenia", "Warm Autoimmune Hemolytic Anemia"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Dalian", "status": "RECRUITING"}, {"facility": "Novartis Investigative Site", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07687134", "title": "Eltrombopag Plus Telitacicept vs. Eltrombopag Alone for Steroid-refractory/Relapsed ITP", "status": "NOT_YET_RECRUITING", "start": "2026-07-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Ethics Committee of Blood disease hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07811622", "title": "Clinical Study of CHT105 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Nanjing Miracle Biotechnology Co., Ltd.", "conditions": ["Immune Thrombocytopenia (ITP)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01666795", "title": "Autoantibody Specificity and Response to IVIG in ITP", "status": "COMPLETED", "start": "2005-02", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 672, "sponsor": "Shandong University", "conditions": ["Immune Thrombocytopenia (ITP)"], "cn_sites": [{"facility": "Qilu Hospital, Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT00351468", "title": "EXTEND (Eltrombopag Extended Dosing Study)", "status": "COMPLETED", "start": "2006-06", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 302, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Purpura, Thrombocytopaenic, Idiopathic"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Jiang Su Province", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Tianjin", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT00370331", "title": "RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag", "status": "COMPLETED", "start": "2006-11", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 197, "sponsor": "GlaxoSmithKline", "conditions": ["Purpura, Thrombocytopaenic, Idiopathic"], "cn_sites": [{"facility": "GSK Investigational Site", "city": "Jiang Su Province", "status": ""}, {"facility": "GSK Investigational Site", "city": "Shanghai", "status": ""}, {"facility": "GSK Investigational Site", "city": "Tianjin", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT01506414", "title": "Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP)", "status": "COMPLETED", "start": "2009-06", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 91, "sponsor": "Ming Hou", "conditions": ["Purpura", "Idiopathic Thrombocytopenic Purpura"], "cn_sites": [{"facility": "Qilu Hospital, Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03258866", "title": "The Study of Different Dose Rituximab in the Treatment of ITP", "status": "COMPLETED", "start": "2010-01-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 62, "sponsor": "Shandong University", "conditions": ["Purpura, Thrombocytopenic, Idiopathic", "Immune Thrombocytopenia"], "cn_sites": [{"facility": "Qilu hospital, Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01356511", "title": "High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)", "status": "COMPLETED", "start": "2010-09", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 261, "sponsor": "Shandong University", "conditions": ["Purpura, Thrombocytopenic, Idiopathic"], "cn_sites": [{"facility": "Qilu Hospital, Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01668615", "title": "Efficacy of Immunomudulatory Therapy With All-trans Retinoid Acid for Adults With Chronic Immune Thrombocytopenia", "status": "COMPLETED", "start": "2011-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 35, "sponsor": "First Affiliated Hospital of Suzhou Medical College", "conditions": ["Immune Thrombocytopenic Purpura"], "cn_sites": [{"facility": "Jiangsu Institute of Hematology", "city": "Suzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01805648", "title": "Efficacy and Safety Study of Maintenance Treatment With rhTPO in Thrombocytopenic Subjects With ITP", "status": "UNKNOWN", "start": "2011-02", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Peking Union Medical College", "conditions": ["Thrombocytopenia", "Immune Thrombocytopenia", "Idiopathic Thrombocytopenic Purpura"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01317966", "title": "Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia", "status": "WITHDRAWN", "start": "2011-03", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 0, "sponsor": "Ming Hou", "conditions": ["Purpura, Thrombocytopenic, Idiopathic"], "cn_sites": [{"facility": "Qilu Hospital, Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01525836", "title": "rhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITP", "status": "COMPLETED", "start": "2011-05", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 123, "sponsor": "Shandong University", "conditions": ["Purpura", "Idiopathic Thrombocytopenic Purpura"], "cn_sites": [{"facility": "Qilu Hospital, Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01672151", "title": "Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia", "status": "COMPLETED", "start": "2011-11", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 35, "sponsor": "First Affiliated Hospital of Suzhou Medical College", "conditions": ["Immune Thrombocytopenic Purpura"], "cn_sites": [{"facility": "Jiangsu Institute of Hematology", "city": "Suzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01667263", "title": "The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia", "status": "COMPLETED", "start": "2012-06-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 130, "sponsor": "Peking University People's Hospital", "conditions": ["Autoimmune Thrombocytopenia"], "cn_sites": [{"facility": "Beijing Hospital, Ministry of Health", "city": "Beijing", "status": ""}, {"facility": "Peking University People's Hospital, Peking University Insititute of Hematology", "city": "Beijing", "status": ""}, {"facility": "Beijing Tongren Hospital", "city": "Beijing", "status": ""}, {"facility": "PLA Navy General Hospital", "city": "Beijing", "status": ""}, {"facility": "Qilu Hospital, Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT01734044", "title": "rhTPO Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of ITP", "status": "COMPLETED", "start": "2012-07", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 158, "sponsor": "Shandong University", "conditions": ["Purpura", "Idiopathic Thrombocytopenic Purpura"], "cn_sites": [{"facility": "Qilu Hospital, Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01734057", "title": "Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)", "status": "WITHDRAWN", "start": "2012-07", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Shandong University", "conditions": ["Purpura", "Idiopathic Thrombocytopenic Purpura"], "cn_sites": [{"facility": "Qilu Hospital, Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02351622", "title": "Caffeic Acid Tablets as a Second-line Therapy for ITP", "status": "COMPLETED", "start": "2012-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 103, "sponsor": "Shandong University", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Shandong University Qilu hospital", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01719692", "title": "Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia", "status": "COMPLETED", "start": "2012-10", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Immune Thrombocytopenic Purpura"], "cn_sites": [{"facility": "Hospital of Blood disease", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01869049", "title": "The Alteration of Macrophage Function in the Spleen Tissues From Patients With Primary Immune Thrombocytopenia", "status": "WITHDRAWN", "start": "2012-11", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 0, "sponsor": "Shandong University", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Qilu Hospital, Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01882127", "title": "All-Trans Retinoic Acid (ATRA) Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)", "status": "WITHDRAWN", "start": "2013-02", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Shandong University", "conditions": ["Purpura", "Idiopathic Thrombocytopenic Purpura"], "cn_sites": [{"facility": "Qilu Hospital, Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01864512", "title": "Alteration of Different Immune Parameters in Immune Thrombocytopenia （ITP） Patients Receiving Eltrombopag Treatment", "status": "WITHDRAWN", "start": "2013-03", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 0, "sponsor": "Shandong University", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Qilu Hospital, Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01976195", "title": "High-dose Dexamethasone Combining Thalidomide Versus Dexamethasone Mono-therapy for Management of Newly-diagnosed ITP", "status": "WITHDRAWN", "start": "2013-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Shandong University", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Qilu hospital, Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01957176", "title": "A Rollover Study to Provide Continued Treatment With Eltrombopag", "status": "COMPLETED", "start": "2013-10-15", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 22, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Thrombocytopaenia"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02403440", "title": "A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients", "status": "UNKNOWN", "start": "2014-04", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 24, "sponsor": "Jiangsu HengRui Medicine Co., Ltd.", "conditions": ["Purpura, Thrombocytopenic, Idiopathic"], "cn_sites": [{"facility": "West Hospital, Sichuan University", "city": "Chengdu", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02139501", "title": "An Investigation of rhTPO With Different Frequencies in the Management of ITP", "status": "COMPLETED", "start": "2014-05", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 48, "sponsor": "Shandong University", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Qilu Hospital, Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02137681", "title": "A Multicentre Investigation of 2 Cycles Rituximab Compared With Standard Regimen in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP）", "status": "WITHDRAWN", "start": "2014-05", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Shandong University", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Qilu Hospital, Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02153060", "title": "An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP)", "status": "COMPLETED", "start": "2014-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 58, "sponsor": "Shandong University", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Qilu Hospital, Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02203422", "title": "A Multicenter Investigation of Recombinant Human Thrombopoietin (rhTPO) Combining Cyclosporin A Versus Cyclosporin A in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP）", "status": "WITHDRAWN", "start": "2014-07", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Shandong University", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Qilu Hospital, Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02270801", "title": "Recombinant Human Thrombopoietin (rhTPO) in Management of Immune Thrombocytopenia (ITP) in Pregnancy", "status": "UNKNOWN", "start": "2014-10", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Shandong University", "conditions": ["Immune Thrombocytopenia", "Pregnancy"], "cn_sites": [{"facility": "Shandong University Qilu hospital", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02391272", "title": "A Multicenter Study on Recombinant Human Thrombopoietin in Management of ITP in Pregnancy", "status": "COMPLETED", "start": "2015-03", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 31, "sponsor": "Shandong University", "conditions": ["Immune Thrombocytopenia", "Pregnancy"], "cn_sites": [{"facility": "Qilu Hospital, Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01568333", "title": "A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia", "status": "COMPLETED", "start": "2015-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 45, "sponsor": "Shandong University", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Shandong University Qilu hospital", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02556814", "title": "Caffeic Acid Combining High-dose Dexamethasone in Management of ITP", "status": "COMPLETED", "start": "2015-09", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 214, "sponsor": "Shandong University", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Qilu Hospital, Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02868060", "title": "Evaluating the Pharmacokinetics and Pharmacodynamics of Romiplostim in Patients With Immune Thrombocytopenia (ITP)", "status": "COMPLETED", "start": "2015-09", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 16, "sponsor": "Kyowa Kirin China Pharmaceutical Co., Ltd.", "conditions": ["Immune Thrombocytopenia (ITP)"], "cn_sites": [{"facility": "Peking Union hospital", "city": "Beijing", "status": ""}, {"facility": "West China hospital", "city": "Chengdu", "status": ""}, {"facility": "Chinese academy of medical science hematology hospital", "city": "Tianjin", "status": ""}, {"facility": "Wuxi People's Hospital", "city": "Wuxi", "status": ""}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT02868099", "title": "Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP)", "status": "COMPLETED", "start": "2015-09", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 203, "sponsor": "Kyowa Kirin China Pharmaceutical Co., Ltd.", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02642380", "title": "Different Cycles of High-dose Dexamethasone for Initial Management of Primary Immune Thrombocytopenia (ITP)", "status": "WITHDRAWN", "start": "2015-11", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Shandong University", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Qilu Hospital, Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03909763", "title": "Combination of Danazole With Berberine in the Treatment of ITP", "status": "UNKNOWN", "start": "2016-01-20", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 55, "sponsor": "Peking University People's Hospital", "conditions": ["Corticosteroid-resistant or Relapsed ITP"], "cn_sites": [{"facility": "Peking University Institute of Hematology", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02834468", "title": "DEX Combined With RTX, CSA and IVIG in the Management of Newly Diagnosed ITP Patients", "status": "UNKNOWN", "start": "2016-06", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Shandong University", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Qilu Hospital, Shandong University", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT02967328", "title": "RP% Measurement by FCM as a Diagnostic Test for ITP", "status": "UNKNOWN", "start": "2016-11", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Shandong University", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Qilu Hospital, Shandong University", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03013114", "title": "A Single-center Clinical Trial of Bortezomib in Management of Immune Thrombocytopenia (ITP)", "status": "UNKNOWN", "start": "2017-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Shandong University", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Shandong University Qilu hospital", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03033199", "title": "Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia", "status": "UNKNOWN", "start": "2017-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Shandong University", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Shandong University Qilu hospital", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03324087", "title": "Evaluation of HRQoL in Adult With Immune Thrombocytopenia in China", "status": "UNKNOWN", "start": "2017-05-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "Shandong University", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Shandong University Qilu hospital", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03222843", "title": "Multicentre, Randomised Phase III Study of the Efficacy and Safety of Hetrombopag Olamine in Idiopathic Thrombocytopenic Purpura (ITP) Patient", "status": "COMPLETED", "start": "2017-06-30", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 424, "sponsor": "Jiangsu HengRui Medicine Co., Ltd.", "conditions": ["Idiopathic Thrombocytopenic Purpura"], "cn_sites": [{"facility": "Union Hospital Tongji Medical College Huazhong University of Science and technology", "city": "Wuhan", "status": ""}, {"facility": "West China Hospital，Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Hospital of Blood Diseases, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT03304288", "title": "The Combination of Low-dose Rituximab and ATRA as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia", "status": "UNKNOWN", "start": "2017-10-11", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 168, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": ""}, {"facility": "Navy General Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Tongren Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT03201848", "title": "The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia", "status": "UNKNOWN", "start": "2017-11-16", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 216, "sponsor": "Qidong Gaitianli Medicines Co., Ltd", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Guangzhou Women and Children's Medical Center", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital, Sun Yat-sen University", "city": "Guangzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": ""}, {"facility": "Union Hospital of Tongji Medical College, Huazhong University of Science & Technology", "city": "Wuhan", "status": ""}, {"facility": "Wuhan Children's Hospital", "city": "Wuhan", "status": ""}, {"facility": "Children's Hospital of Nanjing Medical University", "city": "Nanjing", "status": ""}, {"facility": "Children's Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "Jiangxi Provincial Children's Hospital", "city": "Nanchang", "status": ""}, {"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": ""}, {"facility": "The Affiliated Hospital of Southwest Medical University", "city": "Luzhou", "status": ""}, {"facility": "First Affiliated Hospital of Xinjiang Medical University", "city": "Ürümqi", "status": ""}, {"facility": "Beijing Children's Hospital. Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Children's Hospital Capital Institute of Pediatrics", "city": "Beijing", "status": ""}, {"facility": "Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 14, "broad_only": false}, {"nct": "NCT03377439", "title": "The Association Between Platelet Reactivity and Bleeding Risk in Adult ITP", "status": "UNKNOWN", "start": "2017-12-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 400, "sponsor": "Shandong University", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Qilu Hospital, Shandong University", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05095896", "title": "The Serum Lipid Profiles in ITP: a Retrospective Study", "status": "COMPLETED", "start": "2018-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 457, "sponsor": "Ming Hou", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Qilu hospital of Shandong university", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03443570", "title": "Rituximab Combining Bortezomib Versus Rituximab in Management of ITP", "status": "UNKNOWN", "start": "2018-03-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 200, "sponsor": "Shandong University", "conditions": ["Immune Thrombocytopenia", "Purpura, Thrombocytopenic, Idiopathic"], "cn_sites": [{"facility": "Qilu hospital, Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03460808", "title": "The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia", "status": "UNKNOWN", "start": "2018-03-10", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 200, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03492515", "title": "Recombinant Human Thrombopoietin(rhTPO) in Pregnancy With Immune Thrombocytopenia", "status": "UNKNOWN", "start": "2018-05-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "Shandong University", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Qilu hospital, Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03603132", "title": "A Study to Evaluate Different Intervals Between Dosing and Feeding on the Pharmacokinetics", "status": "COMPLETED", "start": "2018-07-14", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Jiangsu HengRui Medicine Co., Ltd.", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "The third xiangya hospital Hospital,of central south university", "city": "Changsha", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03252457", "title": "Decitabine Combining Dexamethasone Versus Dexamethasone in Management of ITP", "status": "UNKNOWN", "start": "2018-09-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 200, "sponsor": "Shandong University", "conditions": ["Purpura, Thrombocytopenic, Idiopathic", "Immune Thrombocytopenia"], "cn_sites": [{"facility": "Qilu hospital, Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03664518", "title": "to Evaluate the Efficacy and Safety of Eltrombopag for Immune Thrombocytopenia With Chronic HBV Infection", "status": "COMPLETED", "start": "2018-12-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 48, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Thrombocytopenia Purpura", "Chronic HBV Infection"], "cn_sites": [{"facility": "Ethics Committee of Blood disease hospital, Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03771378", "title": "Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP)", "status": "UNKNOWN", "start": "2019-01-16", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 96, "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": ["Primary Immune Thrombocytopenia"], "cn_sites": [{"facility": "Zhou Yiming", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04368598", "title": "The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP", "status": "UNKNOWN", "start": "2019-04-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 44, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03998982", "title": "Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITP", "status": "UNKNOWN", "start": "2019-06-25", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Shandong University", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Qilu hospital, Shandong University", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04021173", "title": "A Clinical Study of Anfibatide in Acquired Thrombotic Thrombocytopenic Purpura (TTP)", "status": "UNKNOWN", "start": "2019-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 74, "sponsor": "Lee's Pharmaceutical Limited", "conditions": ["Acquired Thrombotic Thrombocytopenic Purpura"], "cn_sites": [{"facility": "Shanghai Ruijing Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03951623", "title": "The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients", "status": "COMPLETED", "start": "2019-08-12", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 45, "sponsor": "Hutchison Medipharma Limited", "conditions": ["Immune Thrombocytopenia (ITP)"], "cn_sites": [{"facility": "Blood diseases hospital, Chinese academy of medical university", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05621330", "title": "Efficacy and Safety of QL0911 in Adult Patients With Chronic Primary Immune Thrombocytopenia", "status": "COMPLETED", "start": "2019-10-18", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 216, "sponsor": "Qilu Pharmaceutical Co., Ltd.", "conditions": ["Primary Immune Thrombocytopenia"], "cn_sites": [{"facility": "Qilu Hospital of Shandong University", "city": "Shandong", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04217148", "title": "The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia", "status": "COMPLETED", "start": "2020-01-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 132, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04214951", "title": "A Study of Eltrombopag and Recombinant Human Thrombopoietin In Primary Immune Thrombocytopenia", "status": "UNKNOWN", "start": "2020-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Peking University People's Hospital", "conditions": ["Corticosteroid-resistant or Relapsed ITP"], "cn_sites": [{"facility": "Peking University Institute of Hematology", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04224688", "title": "A Study to Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)", "status": "TERMINATED", "start": "2020-06-03", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "UCB Biopharma SRL", "conditions": ["Primary Immune Thrombocytopenia"], "cn_sites": [{"facility": "Tp0006 20201", "city": "Bengbu", "status": ""}, {"facility": "Tp0006 20189", "city": "Changchun", "status": ""}, {"facility": "Tp0006 20188", "city": "Changsha", "status": ""}, {"facility": "Tp0006 20186", "city": "Changzhou", "status": ""}, {"facility": "Tp0006 20179", "city": "Fuzhou", "status": ""}, {"facility": "Tp0006 20187", "city": "Hangzhou", "status": ""}, {"facility": "Tp0006 20177", "city": "Jinan", "status": ""}, {"facility": "Tp0006 20185", "city": "Jinan", "status": ""}, {"facility": "Tp0006 20194", "city": "Wuxi", "status": ""}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT04481282", "title": "The Combination of Terbutaline and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia", "status": "UNKNOWN", "start": "2020-07-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04518878", "title": "Fixed Low-dose Eltrombopag and rhTPO for Immune Thrombocytopenia (FLOWER)", "status": "UNKNOWN", "start": "2020-08-31", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04516837", "title": "Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19)", "status": "UNKNOWN", "start": "2020-08-31", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04094805", "title": "A Multicenter Randomized Study of Vitamin D Combined With HD-DXM Versus HD-DXM for the Treatment of ITP", "status": "UNKNOWN", "start": "2020-10-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Shandong University", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Qilu hospital, Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04618328", "title": "A Study of ATRA in the Treatment of ITP", "status": "UNKNOWN", "start": "2020-11", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 80, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Peking University Institute of Hematology", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04278924", "title": "A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia", "status": "COMPLETED", "start": "2020-11-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 41, "sponsor": "Takeda", "conditions": ["Primary Immune Thrombocytopenia"], "cn_sites": [{"facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT04562766", "title": "Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)", "status": "ACTIVE_NOT_RECRUITING", "start": "2020-12-14", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 232, "sponsor": "Principia Biopharma, a Sanofi Company", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Wuhan Union Hospital of Tongji Medical College of HUST - Investigational Site Number: 15601", "city": "Wuhan", "status": ""}, {"facility": "Shengjing Hospital of China Medical University - Investigational Site Number: 15603", "city": "Shenyang", "status": ""}, {"facility": "Shaanxi Provincial People's Hospital - Investigational Site Number: 15607", "city": "Xi'an", "status": ""}, {"facility": "Qilu Hospital of Shandong University - Investigational Site Number: 15605", "city": "Jinan", "status": ""}, {"facility": "Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences - Investigational Site Number: 15602", "city": "Tianjin", "status": ""}, {"facility": "Second Affiliated Hospital of Kunming Medical University - Investigational Site Number: 15604", "city": "Kunming", "status": ""}, {"facility": "Investigational Site Number : 15611", "city": "Hangzhou", "status": ""}, {"facility": "Investigational Site Number : 15608", "city": "Hefei", "status": ""}, {"facility": "Investigational Site Number : 15610", "city": "Nanchang", "status": ""}, {"facility": "Investigational Site Number : 15613", "city": "Tangshan", "status": ""}, {"facility": "Investigational Site Number : 15609", "city": "Wuxi", "status": ""}, {"facility": "Investigational Site Number : 15614", "city": "Zhenjiang", "status": ""}], "cn_site_count": 12, "broad_only": false}, {"nct": "NCT04687072", "title": "A Study to Evaluate the Efficacy and Safety of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia", "status": "COMPLETED", "start": "2020-12-16", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 207, "sponsor": "argenx", "conditions": ["Primary Immune Thrombocytopenia"], "cn_sites": [{"facility": "Investigator Site 0860003", "city": "Beijing", "status": ""}, {"facility": "Investigator Site 0860013", "city": "Beijing", "status": ""}, {"facility": "Investigator Site 0860008", "city": "Bengbu", "status": ""}, {"facility": "Investigator Site 0860055", "city": "Huizhou", "status": ""}, {"facility": "Investigator Site 0860009", "city": "Kunming", "status": ""}, {"facility": "Investigator Site 0860012", "city": "Nanchang", "status": ""}, {"facility": "Investigator Site 0860014", "city": "Shanxi", "status": ""}, {"facility": "Investigator Site 0860015", "city": "Shenzhen", "status": ""}, {"facility": "Investigator Site 0860001", "city": "Tianjin", "status": ""}, {"facility": "Investigator Site 0860006", "city": "Wenzhou", "status": ""}, {"facility": "Investigator Site 0860010", "city": "Wuhan", "status": ""}, {"facility": "Investigator Site 0860002", "city": "Wuxi", "status": ""}, {"facility": "Investigator Site 0860005", "city": "Zhejiang", "status": ""}, {"facility": "Investigator Site 0860011", "city": "Zhengzhou", "status": ""}, {"facility": "Investigator Site 0860058", "city": "Zhenjiang", "status": ""}, {"facility": "Investigator site 0860062", "city": "Zhenjiang", "status": ""}], "cn_site_count": 16, "broad_only": false}, {"nct": "NCT04596995", "title": "A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)", "status": "TERMINATED", "start": "2021-01-06", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 43, "sponsor": "UCB Biopharma SRL", "conditions": ["Primary Immune Thrombocytopenia"], "cn_sites": [{"facility": "Tp0004 20179", "city": "Fuzhou", "status": ""}, {"facility": "Tp0004 20185", "city": "Jinan", "status": ""}, {"facility": "Tp0004 20194", "city": "Wuxi", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT04747080", "title": "The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia", "status": "UNKNOWN", "start": "2021-03-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Peking University People's Hospital", "conditions": ["ITP", "Immune Thrombocytopenia"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04949009", "title": "Avatrombopag in the Treatment of Primary Immune Thrombocytopenia(ITP)", "status": "UNKNOWN", "start": "2021-03-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 400, "sponsor": "Shandong University", "conditions": ["Primary Immune Thrombocytopenia"], "cn_sites": [{"facility": "Qilu Hospital, Shandong University", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04737850", "title": "Hetrombopag for Pediatric Patients With Chronic Immune Thrombocytopenia", "status": "COMPLETED", "start": "2021-03-29", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Jiangsu HengRui Medicine Co., Ltd.", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Beijing children's hospital .Capital medical university", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04683003", "title": "A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-04-14", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 77, "sponsor": "Takeda", "conditions": ["Thrombotic Thrombocytopenic Purpura (TTP)"], "cn_sites": [{"facility": "Beijing Children's Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Tongji Hospital Affiliated to Tongji Medicine University", "city": "Wuhan", "status": ""}, {"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "Institute of Hematology and Hospital of Blood Disease", "city": "Tianjin", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT05353673", "title": "The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia", "status": "UNKNOWN", "start": "2021-06-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia", "Blood Coagulation Disorders", "Thrombocytopenia", "Physiological Effects of Drugs"], "cn_sites": [{"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05333744", "title": "The Combination of Prednisone and Recombinant Human Thrombopoietin for Treatment of Immune Thrombocytopenia in Pregnancy", "status": "UNKNOWN", "start": "2021-06-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04915482", "title": "TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies", "status": "UNKNOWN", "start": "2021-06-06", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 94, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Immune Thrombocytopenia (ITP)", "Autoantibodies", "Evan Syndrome", "Connective Tissue Diseases"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05023915", "title": "A Multicenter Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITP", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-08-21", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 106, "sponsor": "Shandong University", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Qilu hospital, Shandong University", "city": "Jinan", "status": ""}, {"facility": "Qilu hospital (Qingdao), Shandong University", "city": "Qingdao", "status": ""}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05281068", "title": "The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia", "status": "UNKNOWN", "start": "2021-09-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Peking University People's Hospital", "conditions": ["ITP", "Immune Thrombocytopenia"], "cn_sites": [{"facility": "Zhuo-Yu An", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 2, "broad_only": false}, {"nct": "NCT05029635", "title": "Phase III Study on HMPL-523 for Treatment of ITP", "status": "COMPLETED", "start": "2021-10-27", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 272, "sponsor": "Hutchmed", "conditions": ["Primary Immune Thrombocytopenia (ITP)"], "cn_sites": [{"facility": "The First Affiliated Hospital of Anhui Medical University", "city": "Hefei", "status": ""}, {"facility": "The First Affiliated hospital of USTC", "city": "Hefei", "status": ""}, {"facility": "Beijing Chaoyang Hospital of Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "People's Hospital of Peking University", "city": "Beijing", "status": ""}, {"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": ""}, {"facility": "Lanzhou University Second Hospital", "city": "Lanzhou", "status": ""}, {"facility": "Guangdong General Hospital", "city": "Guangzhou", "status": ""}, {"facility": "Southern Hospital of Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "The Second People's Hospital Of Shenzhen", "city": "Shenzhen", "status": ""}, {"facility": "The First Affiliated Hospital Of GuangXi Medical University", "city": "Nanning", "status": ""}, {"facility": "The First Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "Affiliated Hospital of North China University of Technology", "city": "Tangshan", "status": ""}, {"facility": "First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": ""}, {"facility": "Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "Union Hospital affiliated to Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}, {"facility": "Xiangyang Central Hospital", "city": "Xiangyang", "status": ""}, {"facility": "The Third Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": ""}, {"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}, {"facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "status": ""}, {"facility": "Shengjing Hospital of China Medical University", "city": "Shenyang", "status": ""}, {"facility": "The Affiliated Huai'an No.1 People's Hospital of Nanjing Medical University", "city": "Huai'an", "status": ""}, {"facility": "Qinghai province people's hospital", "city": "Xining", "status": ""}, {"facility": "Jinan Central Hospital Affilated to Sandong University", "city": "Jinan", "status": ""}, {"facility": "LiaoCheng People's Hospital", "city": "Liaocheng", "status": ""}, {"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": ""}, {"facility": "Jinshan Hospital Affiliated To Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Ruijin Hospital, Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": ""}, {"facility": "Heping Hospital Affiliated to Changzhi Medical College", "city": "Changzhi", "status": ""}, {"facility": "The second hospital of Shanxi Medical University", "city": "Taiyuan", "status": ""}, {"facility": "Shanxi Provincial People's Hospital", "city": "Xi’an", "status": ""}, {"facility": "West China Hospital，Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "The First Affilicated Hospital of Xinjiang Medical University", "city": "Ürümqi", "status": ""}, {"facility": "Blood Institute of the Chinese Academy of Medical Sciences", "city": "Tianjin", "status": ""}, {"facility": "The second Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}, {"facility": "Zhejiang Provincial Hospital of Chinese Medicine", "city": "Hangzhou", "status": ""}], "cn_site_count": 37, "broad_only": false}, {"nct": "NCT03692754", "title": "Atorvastatin in Management of Newly Diagnosed ITP", "status": "UNKNOWN", "start": "2021-11-01", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Shandong University", "conditions": ["Immune Thrombocytopenia", "Purpura, Thrombocytopenic"], "cn_sites": [{"facility": "Qilu hospital, Shandong University", "city": "Jinan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05116423", "title": "Machine-learning Based Prediction Model in Primary Immune Thrombocytopenia", "status": "UNKNOWN", "start": "2021-11-10", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 100, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia", "ITP"], "cn_sites": [{"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04812925", "title": "A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia", "status": "ACTIVE_NOT_RECRUITING", "start": "2021-11-17", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 173, "sponsor": "argenx", "conditions": ["Primary Immune Thrombocytopenia"], "cn_sites": [{"facility": "Investigator site 860013", "city": "Beijing", "status": ""}, {"facility": "Investigator Site 0860008", "city": "Bengbu", "status": ""}, {"facility": "Investigator site 860055", "city": "Huizhou", "status": ""}, {"facility": "Investigator Site 0860015", "city": "Shenzhen", "status": ""}, {"facility": "Investigator Site 0860001", "city": "Tianjin", "status": ""}, {"facility": "Investigator Site 0860010", "city": "Wuhan", "status": ""}, {"facility": "Investigator Site 0860002", "city": "Wuxi", "status": ""}, {"facility": "Investigator Site 0860011", "city": "Zhengzhou", "status": ""}, {"facility": "Investigator site 860058", "city": "Zhenjiang", "status": ""}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT05124028", "title": "A Study of Orelabrutinib in Patients With ITP", "status": "UNKNOWN", "start": "2021-12-01", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Peking University Institute of Hematology", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05135442", "title": "Efficacy and Safety of Bortezomib as First-line Treatment of Acquired TTP", "status": "UNKNOWN", "start": "2021-12-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Thrombotic Thrombocytopenic Purpura, Acquired"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05328804", "title": "Herombopag + rhTPO in Severe Immune Thrombocytopenia", "status": "UNKNOWN", "start": "2022-01-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 90, "sponsor": "Yin Jie", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Jie Yin", "city": "Suzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05279872", "title": "A Study of Zanubrutinib in Patients With ITP", "status": "COMPLETED", "start": "2022-01-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 20, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia", "Bruton Tyrosine Kinase"], "cn_sites": [{"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05232149", "title": "A Study to Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Immune Thrombocytopenia", "status": "UNKNOWN", "start": "2022-02-21", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 30, "sponsor": "Beijing InnoCare Pharma Tech Co., Ltd.", "conditions": ["Primary Immune Thrombocytopenia"], "cn_sites": [{"facility": "Hainan People's Hospital", "city": "Haikou", "status": "RECRUITING"}, {"facility": "Henan Tumor Hospital", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": "RECRUITING"}, {"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Yichang Central People's Hospital", "city": "Yichang", "status": "RECRUITING"}, {"facility": "Wuxi People's Hospital", "city": "Wuxi", "status": "RECRUITING"}, {"facility": "Affiliated Hospital of Xuzhou Medical University", "city": "Xuzhou", "status": "RECRUITING"}, {"facility": "First Hospital of Nanchang University", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "QiLu Hospital of Shandong University", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT05471050", "title": "The Combination of Tacrolimus and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia", "status": "UNKNOWN", "start": "2022-03-02", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05302024", "title": "Efficacy and Safety of Iguratimod in the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia", "status": "UNKNOWN", "start": "2022-03-22", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05333861", "title": "An Observational, Multicenter Study to Evaluate the Safety and Effectiveness of Hetrombopag in Patients With ITP or AA", "status": "UNKNOWN", "start": "2022-05-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1150, "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": ["Primary Immune Thrombocytopenia", "Aplastic Anemia"], "cn_sites": [{"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05369377", "title": "Zanubrutinib and Eltrombopag as Second-line Treatment in Adults With Primary Immune Thrombocytopenia", "status": "UNKNOWN", "start": "2022-06-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 150, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06523088", "title": "A Study of PN20 in Healthy Adult Volunteers", "status": "COMPLETED", "start": "2022-06-16", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 27, "sponsor": "Chongqing Peg-Bio Biopharm Co., Ltd.", "conditions": ["Chemotherapy-induced Thrombocytopenia", "Immune Thrombocytopenic Purpura"], "cn_sites": [{"facility": "The First Affiliated Hospital of Soochow University", "city": "Suzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05446831", "title": "Baricitinib for Steroid-resistant/Relapse Immune Thrombocytopenia", "status": "UNKNOWN", "start": "2022-07-13", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 35, "sponsor": "Peking University People's Hospital", "conditions": ["ITP", "Immune Thrombocytopenia"], "cn_sites": [{"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05459649", "title": "Combined Steroid and Cyclosporin as First-line Treatment in Adults With Primary Immune Thrombocytopenia", "status": "UNKNOWN", "start": "2022-07-20", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 253, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05506033", "title": "Optimization of Glucocorticoid Taper Strategies for SLE-ITP", "status": "UNKNOWN", "start": "2022-08-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 120, "sponsor": "Fujian Medical University Union Hospital", "conditions": ["Lupus Erythematosus, Systemic", "Purpura, Thrombocytopenic, Idiopathic", "Glucocorticoids", "Adverse Effect of Glucocorticoids"], "cn_sites": [{"facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05522465", "title": "Short-course High-dose Prednisone and Dexamethasone in Children With ITP", "status": "UNKNOWN", "start": "2022-10-11", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 608, "sponsor": "Fujian Medical University Union Hospital", "conditions": ["Immune Thrombocytopenia", "Glucocorticoids", "Child, Only"], "cn_sites": [{"facility": "Children with newly dignosed ITP", "city": "Fujian", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05438875", "title": "The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9", "status": "COMPLETED", "start": "2022-10-12", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 96, "sponsor": "Peking University People's Hospital", "conditions": ["Purpura, Thrombocytopenic, Idiopathic"], "cn_sites": [{"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Tongren hospital", "city": "Beijing", "status": ""}, {"facility": "Department of Hematology, Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Department of Hematology, Beijing Hospital", "city": "Beijing", "status": ""}, {"facility": "Department of Hematology, Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT05583838", "title": "A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts", "status": "COMPLETED", "start": "2022-11-22", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 157, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Previously Treated Primary Immune Thrombocytopenia"], "cn_sites": [{"facility": "The Second Affiliated Hospital of Guangxi Medical University", "city": "Nanning", "status": ""}, {"facility": "the Second Hospital of HeBei Medical University", "city": "Shijiazhuang", "status": ""}, {"facility": "North China University of Science and Technology Affiliated Hospital", "city": "Tangshan", "status": ""}, {"facility": "The Second Affiliated Hospital of Harbin Medical University", "city": "Harbin", "status": ""}, {"facility": "Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital", "city": "Zhengzhou", "status": ""}, {"facility": "The Affiliated Hospital of Inner Mongolia Medical University", "city": "Hohhot", "status": ""}, {"facility": "The Second Hospital of Dalian Medical University", "city": "Dalian", "status": ""}, {"facility": "Xi'an Central Hospital", "city": "Xi'an", "status": ""}, {"facility": "Xijing Hospital of the Fourth Military Medical University", "city": "Xi'an", "status": ""}, {"facility": "Shaanxi Provincial People's Hospital", "city": "Xi'an", "status": ""}, {"facility": "Chinese Academy of Medical Science and Blood Disease Hospital,CAMS & PUMC", "city": "Tianjin", "status": ""}, {"facility": "The Second Hospital of Tianjin Medical University", "city": "Tianjin", "status": ""}, {"facility": "Kashgar District 1st People's Hospital", "city": "Kashgar", "status": ""}, {"facility": "People's Hospital of Xinjiang Uygur Autonomous Region", "city": "Ürümqi", "status": ""}, {"facility": "The first affiliated Hospital of Xinjiang Medical University", "city": "Ürümqi", "status": ""}, {"facility": "The Second Affiliated Hospital of Kunming Medical University", "city": "Kunming", "status": ""}, {"facility": "Yuyao People's Hospital of Zhejiang Province", "city": "Yuyao", "status": ""}], "cn_site_count": 17, "broad_only": false}, {"nct": "NCT05562882", "title": "A Clinical Trial to Assess Safety and Efficacy of Daratumumab in the Treatment of Primary Immune Thrombocytopenia", "status": "UNKNOWN", "start": "2022-12-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Chinese Academy of Medical Science and Blood Disease Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05694767", "title": "A Prospective, One-arm and Open Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia", "status": "COMPLETED", "start": "2023-01-22", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 22, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Immune Thrombocytopenia", "Treatment"], "cn_sites": [{"facility": "Chinese Academy of Medical Science and Blood Disease Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05653219", "title": "A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-02-02", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 152, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Primary Immune Thrombocytopenia"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Wuhan", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Binzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Hangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Jinan", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Tianjin", "status": ""}], "cn_site_count": 7, "broad_only": false}, {"nct": "NCT05653349", "title": "Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-02-03", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 226, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Primary Immune Thrombocytopenia (ITP)"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Guangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shenzhen", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Shijiazhuang", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Luoyang", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Zhengzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Changzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Nanchang", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Kunming", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Hangzhou", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Bengbu", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Dalian", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Tianjin", "status": ""}], "cn_site_count": 13, "broad_only": false}, {"nct": "NCT05718856", "title": "TPO-RAs Combining Anti-CD 20 Monoclonal Antibody Versus TPO-RAs in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)", "status": "UNKNOWN", "start": "2023-02-23", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 166, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Primary Immune Thrombocytopenia (ITP)"], "cn_sites": [{"facility": "Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05852847", "title": "Low-dose Baricitinib Plus Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia", "status": "UNKNOWN", "start": "2023-05-16", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 216, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Friendship Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Luhe Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Tsinghua Changgeng Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "China-Japan Friendship Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The Sixth Medical Center of PLA General Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT05930314", "title": "CNCT19 Cell Injection for Refractory Systemic Lupus Erythematosus", "status": "UNKNOWN", "start": "2023-06-19", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Refractory Systemic Lupus Erythematosus", "Lupus Nephritis", "Immune Thrombocytopenia"], "cn_sites": [{"facility": "Xiaofeng Zeng", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05932524", "title": "Low-dose Baricitinib Plus High-dose Dexamethasone for Patients With Newly Diagnosed Immune Thrombocytopenia", "status": "UNKNOWN", "start": "2023-07-07", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 132, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Friendship Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Luhe Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Tsinghua Changgeng Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "China-Japan Friendship Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Peking University Third Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The Sixth Medical Center of PLA General Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT05885555", "title": "A Study of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of Therapies", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-08-16", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 41, "sponsor": "Novartis Pharmaceuticals", "conditions": ["Primary Immune Thrombocytopenia (ITP)"], "cn_sites": [{"facility": "Novartis Investigative Site", "city": "Wuhan", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Beijing", "status": ""}, {"facility": "Novartis Investigative Site", "city": "Jinan", "status": ""}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT05943691", "title": "High-dose Dexamethasone Plus Hetrombopag vs High-dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial", "status": "UNKNOWN", "start": "2023-09-15", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Shandong University", "conditions": ["ITP - Immune Thrombocytopenia"], "cn_sites": [{"facility": "Shengli Oilfield Central Hospital", "city": "Dongying", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06577909", "title": "Prednisone Plus IVIg vs. Prednisone for ITP During Pregnancy", "status": "UNKNOWN", "start": "2023-10-19", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06148389", "title": "The Safety and Tolerability of STSA-1301 Subcutaneous Injection in Healthy Subjects", "status": "COMPLETED", "start": "2023-11-16", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Staidson (Beijing) Biopharmaceuticals Co., Ltd", "conditions": ["Primary Immune Thrombocytopenia"], "cn_sites": [{"facility": "Beijing Ditan Hospital,Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06190145", "title": "Teriflunomide for Steroid-resistant/Relapse Immune Thrombocytopenia", "status": "UNKNOWN", "start": "2023-12-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06176911", "title": "The Combination of Teriflunomide and Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia", "status": "UNKNOWN", "start": "2023-12-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 124, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06176235", "title": "Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia", "status": "WITHDRAWN", "start": "2023-12-19", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia"], "cn_sites": [{"facility": "Beijing Friendship Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Luhe Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Tsinghua Changgeng Hospital", "city": "Beijing", "status": ""}, {"facility": "China-Japan Friendship Hospital", "city": "Beijing", "status": ""}, {"facility": "Chinese PLA General Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University Insititute of Hematology, Peking University People's Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}, {"facility": "The Sixth Medical Center of PLA General Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 10, "broad_only": false}, {"nct": "NCT06199089", "title": "A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-01-16", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 45, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Immune Thrombocytopenia", "Treatment"], "cn_sites": [{"facility": "Chinese Academy of Medical Science and Blood Disease Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06287567", "title": "Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP)", "status": "COMPLETED", "start": "2024-04-17", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 17, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Idiopathic Thrombocytopenic Purpura", "Immune Thrombocytopenia"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06658834", "title": "A Study of Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP", "status": "UNKNOWN", "start": "2024-06-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 129, "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": ["Primary Immune Thrombocytopenia"], "cn_sites": [{"facility": "Chinese Academy of Medical Science and Blood Disease Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06813157", "title": "Mesenchymal Stem Cells in the Treatment of Refractory Primary Immune Thrombocytopenia", "status": "WITHDRAWN", "start": "2024-11-11", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 0, "sponsor": "Guangzhou Bio-gene Technology Co., Ltd", "conditions": ["ITP - Immune Thrombocytopenia"], "cn_sites": [{"facility": "Dongguan Taixin Hospital", "city": "Guangdong", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06594146", "title": "Study of CM313 (SC) Injection in Subjects With Primary Immune Thrombocytopenia (ITP)", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-11-11", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 62, "sponsor": "Keymed Biosciences Co.Ltd", "conditions": ["Primary Immune Thrombocytopenia"], "cn_sites": [{"facility": "Institute of Hematology & Blood Diseases Hospital", "city": "Tianjin", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06686927", "title": "Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITP", "status": "UNKNOWN", "start": "2024-11-20", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 36, "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": ["Primary Immune Thrombocytopenia"], "cn_sites": [{"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07733037", "title": "Fecal Microbiota Transplantation for Steroid-resistant or Relapsed Immune Thrombocytopenia", "status": "ACTIVE_NOT_RECRUITING", "start": "2026-01-10", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 42, "sponsor": "Peking University People's Hospital", "conditions": ["Immune Thrombocytopenia (ITP)"], "cn_sites": [{"facility": "Peking University People's Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}], "g_total": 141, "g_fetched": 77, "g_countries": [["United States", 16], ["France", 16], ["Italy", 10], ["Spain", 9], ["Germany", 8], ["Czechia", 5], ["Austria", 4], ["United Kingdom", 4], ["Australia", 4], ["Turkey (Türkiye)", 4], ["Poland", 4], ["Hungary", 3], ["Romania", 3], ["Serbia", 3], ["Japan", 3], ["Switzerland", 2], ["Netherlands", 2], ["Egypt", 2], ["Bulgaria", 2], ["Greece", 2], ["Canada", 2], ["Norway", 2], ["Lithuania", 1], ["Brazil", 1], ["Ukraine", 1], ["Iraq", 1], ["Bangladesh", 1], ["Croatia", 1], ["Portugal", 1], ["Taiwan", 1], ["Martinique", 1], ["Reunion", 1], ["South Korea", 1], ["Hong Kong", 1]], "g_trials": [{"nct": "NCT07660172", "title": "A Study of Ianalumab in Addition to Eltrombopag in Pediatric Patients With Primary ITP Who Failed Corticosteroids.", "status": "NOT_YET_RECRUITING", "start": "2027-02-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": []}, {"nct": "NCT07765966", "title": "Phase 1 Dose Escalation Study of RXIM002 in Autoimmune Cytopenias", "status": "NOT_YET_RECRUITING", "start": "2027-02-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "RiboX Therapeutics Ltd.", "countries": []}, {"nct": "NCT07738822", "title": "A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHA", "status": "NOT_YET_RECRUITING", "start": "2026-12", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Cullinan Therapeutics Inc.", "countries": ["United States"]}, {"nct": "NCT07429942", "title": "A Study to Learn More About the Treatment of People With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Who Received Recombinant ADAMTS13 (rADAMTS13) as Part of the Early Access Program", "status": "NOT_YET_RECRUITING", "start": "2026-09-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Takeda", "countries": []}, {"nct": "NCT07798050", "title": "Selective Mediterranean Diet in Immune Thrombocytopenia", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Assiut University", "countries": []}, {"nct": "NCT07700238", "title": "A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)", "status": "RECRUITING", "start": "2026-08-21", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Amgen", "countries": ["United States"]}, {"nct": "NCT07421167", "title": "A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)", "status": "RECRUITING", "start": "2026-08-04", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": ["United States"]}, {"nct": "NCT07669675", "title": "TPO-RA Plus Baricitinib vs. TPO-RA for ITP", "status": "NOT_YET_RECRUITING", "start": "2026-07-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Peking University People's Hospital", "countries": []}, {"nct": "NCT07680010", "title": "Modeling the Early Stages of Autoimmunity Through the Study of Immunological Thrombocytopenic Purpura and Juvenile Lupus", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Bordeaux", "countries": ["France"]}, {"nct": "NCT07587723", "title": "A Real-world Study of Treatment Patterns and Outcomes in Primary Immune Thrombocytopenia Patients Treated With Eltrombopag", "status": "RECRUITING", "start": "2026-06-25", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": ["Switzerland"]}, {"nct": "NCT07622329", "title": "A Clinical Study to Evaluate JCXH-213 in the Treatment of Adults With Primary Immune Thrombocytopenia", "status": "NOT_YET_RECRUITING", "start": "2026-06-18", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "The General Hospital of Western Theater Command", "countries": []}, {"nct": "NCT07574073", "title": "CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refractory Immune-related Cytopenia", "status": "NOT_YET_RECRUITING", "start": "2026-06-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Qi deng", "countries": []}, {"nct": "NCT07476846", "title": "rhTPO Dose Escalation vs Eltrombopag Switch in ITP", "status": "NOT_YET_RECRUITING", "start": "2026-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "countries": []}, {"nct": "NCT07549698", "title": "Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease", "status": "RECRUITING", "start": "2026-06", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "CRISPR Therapeutics AG", "countries": ["Germany", "Spain", "United States"]}, {"nct": "NCT07459114", "title": "TGD001 Treatment in Thrombotic Microangiopathies", "status": "NOT_YET_RECRUITING", "start": "2026-05-31", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "TargED Biopharmaceuticals B.V.", "countries": []}, {"nct": "NCT07353099", "title": "A Study in Children and, Adults With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treated With Adzynma", "status": "RECRUITING", "start": "2026-05-26", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Takeda", "countries": ["Austria", "Germany"]}, {"nct": "NCT07455006", "title": "Safety and Efficacy Study of QL0911 to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients", "status": "NOT_YET_RECRUITING", "start": "2026-04-20", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Qilu Pharmaceutical Co., Ltd.", "countries": []}, {"nct": "NCT07605845", "title": "Safety and Efficacy of GL-2045 in Patients With Immune Thrombocytopenia", "status": "RECRUITING", "start": "2026-04-14", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Gliknik Inc.", "countries": ["United Kingdom"]}, {"nct": "NCT07426107", "title": "Development and Prospective Validation of an AI Model for Prognosis in ITP Patients Undergoing Coronary Revascularization", "status": "NOT_YET_RECRUITING", "start": "2026-02-25", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Xiao Hui Zhang", "countries": []}, {"nct": "NCT07298733", "title": "The Value of Interleukin-1β and Interleukin-33 Genetic Expression in the Pathogenesis and Differentiation of Primary ITP and SLE-Related Thrombocytopenia", "status": "NOT_YET_RECRUITING", "start": "2026-01-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Sohag University", "countries": []}, {"nct": "NCT07104565", "title": "Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders", "status": "RECRUITING", "start": "2025-12-29", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Incyte Corporation", "countries": ["Australia", "France", "Italy", "Netherlands", "Spain", "United Kingdom", "United States"]}, {"nct": "NCT07315373", "title": "Optimal Dose of Zanubrutinib to Treat Adult Immune Thrombocytopenia", "status": "NOT_YET_RECRUITING", "start": "2025-12-25", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Peking University People's Hospital", "countries": []}, {"nct": "NCT07310342", "title": "Physical Fitness of Children, Adolescents and Young Adults With Immune Thrombocytopenic Purpura", "status": "NOT_YET_RECRUITING", "start": "2025-12-15", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Bordeaux", "countries": ["France"]}, {"nct": "NCT07786077", "title": "A Study of Patients' Preferences for Primary Immune Thrombocytopenia Treatment", "status": "RECRUITING", "start": "2025-12-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": ["United States"]}, {"nct": "NCT07278908", "title": "Avatrombopag Combined With All-trans Retinoic Acid in the Treatment of Primary Immune Thrombocytopenia", "status": "NOT_YET_RECRUITING", "start": "2025-12", "phases": ["PHASE2", "PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "countries": []}]}, {"batch": 2, "no": 80, "name_zh": "转甲状腺素蛋白淀粉样变性", "query_terms": [{"term": "Hereditary ATTR amyloidosis", "broad": false}, {"term": "Transthyretin amyloidosis", "broad": false}], "n_total": 22, "n_open": 11, "n_open_precise": 11, "n_broad": 0, "trials": [{"nct": "NCT07336394", "title": "Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques", "status": "RECRUITING", "start": "2010-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "Chinese Academy of Medical Sciences, Fuwai Hospital", "conditions": ["Danon Disease", "Fabry Disease", "Cardiac Amyloidosis", "Noonan Syndrome", "Cardiac Sarcoidosis", "Glycogen Storage Disease", "Idiopathic Cardiomyopathy"], "cn_sites": [{"facility": "Fuwai Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07130565", "title": "Pan-Amyloid PET/CT in Various Amyloid-Related Disease", "status": "RECRUITING", "start": "2023-11-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "Tianjin Medical University", "conditions": ["Amyloid", "Cardiac Amyloidosis", "Amyloidosis"], "cn_sites": [{"facility": "The First Affiliated Hospital of University of Science and Technology of China", "city": "Hefei", "status": "RECRUITING"}, {"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": "RECRUITING"}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT06082050", "title": "Efficacy and Safety of Intravenous YOLT-201 for Transthyretin Amyloidosis Cardiomyopathy", "status": "RECRUITING", "start": "2023-11-02", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 7, "sponsor": "Zhejiang University", "conditions": ["Transthyroxin Amyloidosis Cardiomyopathy"], "cn_sites": [{"facility": "the First Affiliated Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06465810", "title": "Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis", "status": "RECRUITING", "start": "2024-06-25", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1850, "sponsor": "AstraZeneca", "conditions": ["Transthyretin Amyloidosis", "ATTR-CM", "ATTRv-PN", "ATTR", "ATTR-Mixed", "hATTR"], "cn_sites": [{"facility": "Research Site", "city": "Hefei", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Chongqing", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Fuzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Xiamen", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Guiyang", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Shijiazhuang", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Changsha", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Suzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Dalian", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Shanghai", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Taiyuan", "status": "NOT_YET_RECRUITING"}, {"facility": "Research Site", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Shaanxi", "status": "RECRUITING"}, {"facility": "Research Site", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}], "cn_site_count": 20, "broad_only": false}, {"nct": "NCT07103863", "title": "Multimodal Radiomics Model (18F-FAPI PET/CT + CMR) for AL Cardiac Amyloidosis Prognosis", "status": "ENROLLING_BY_INVITATION", "start": "2025-02-13", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 49, "sponsor": "Beijing Anzhen Hospital", "conditions": ["AL Amyloidosis (AL)", "Cardiac Amyloidosis"], "cn_sites": [{"facility": "Beijing Anzhen Hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06940336", "title": "To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid Polyneuropathy", "status": "RECRUITING", "start": "2025-06-19", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Qilu Pharmaceutical Co., Ltd.", "conditions": ["Transthyretin Amyloid Polyneuropathy"], "cn_sites": [{"facility": "Qilu Hospital of Shandong University", "city": "Jinan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07052903", "title": "TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy", "status": "RECRUITING", "start": "2025-07-02", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1750, "sponsor": "Alnylam Pharmaceuticals", "conditions": ["Transthyretin Amyloidosis With Cardiomyopathy"], "cn_sites": [{"facility": "Clinical Trial Site", "city": "Binhai", "status": "NOT_YET_RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Chengdu", "status": "RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Dongcheng", "status": "RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Fuzhou", "status": "RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Haidian", "status": "RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Hangzhou", "status": "RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Hefei", "status": "RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Hexi District", "status": "RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Nanchang", "status": "RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Shenzhen Shi", "status": "RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Taiyuan", "status": "RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Xicheng", "status": "RECRUITING"}, {"facility": "Clinical Trial Site", "city": "Yuanjiagang", "status": "RECRUITING"}], "cn_site_count": 18, "broad_only": false}, {"nct": "NCT07232459", "title": "[18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis", "status": "RECRUITING", "start": "2025-07-21", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 25, "sponsor": "Tianjin Medical University", "conditions": ["Amyloid", "Cardiac Amyloidosis", "Amyloidosis", "Healthy Subjects"], "cn_sites": [{"facility": "The First Affiliated Hospital of University of Science and Technology of China", "city": "Hefei", "status": "RECRUITING"}, {"facility": "The Affiliated Hospital of Qingdao University", "city": "Qingdao", "status": "RECRUITING"}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT07207811", "title": "CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis", "status": "RECRUITING", "start": "2025-10-02", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1280, "sponsor": "Novo Nordisk A/S", "conditions": ["Transthyretin Amyloid Cardiomyopathy (ATTR CM)"], "cn_sites": [{"facility": "Anhui Provincial Hospital", "city": "Hefei", "status": "RECRUITING"}, {"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "FuWai Hospital, CAMS & PUMC", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Beijing University Third Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "Beijing Hospital", "city": "Beijing", "status": "NOT_YET_RECRUITING"}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "China-Japan Union Hospital", "city": "Changchun", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Southern Medical University", "city": "Guangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Guangdong Academy of Medical Science (GAMS) - Guangdong General Hospital (GGH) - Guangdong Neuroscience Institute", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "The Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "status": "RECRUITING"}, {"facility": "The Second Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital of Harbin Medical University", "city": "Harbin", "status": "NOT_YET_RECRUITING"}, {"facility": "The First Affiliated Hospital of Zhengzhou University", "city": "Zhengzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "Huazhong University of Science and Technology - Tongji Medical College - Tongji Hospital", "city": "Wuhan", "status": "NOT_YET_RECRUITING"}, {"facility": "Wuhan University - Renmin Hospital (Hubei General Hospital)", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "Xiangya Hospital", "city": "Changsha", "status": "NOT_YET_RECRUITING"}, {"facility": "The Second Xiangya Hospital of Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "The Third Xiangya Hospital of Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "Nanjing Medical University (NMU) - Jiangsu Province Hospital (First Affiliated Hospital)", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Shengjing University Of China Medical University", "city": "Liaoning", "status": "NOT_YET_RECRUITING"}, {"facility": "Qi-Lu Hospital of Shandong University School of Medicine", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Shandong Provincial Hospital (SPH)", "city": "Jinan", "status": "RECRUITING"}, {"facility": "Renji Hospital", "city": "Shanghai", "status": "TERMINATED"}, {"facility": "Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital (SCH)", "city": "Shanghaishi", "status": "NOT_YET_RECRUITING"}, {"facility": "Shanxi Medical University - First Hospital", "city": "Taiyuan", "status": "NOT_YET_RECRUITING"}, {"facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital, School of Medicine, ZheJiang University", "city": "Hangzhou", "status": "NOT_YET_RECRUITING"}, {"facility": "TEDA International Cardiovascular Hospital", "city": "Binhai", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital Of Chongqing Medical University", "city": "Chongqing", "status": "NOT_YET_RECRUITING"}, {"facility": "Nanfang Hospital, Southern Medical University", "city": "Guangzhou", "status": "RECRUITING"}, {"facility": "Jinan Central Hospital", "city": "Jinan", "status": "RECRUITING"}, {"facility": "The Second Affiliated Hospital Of Nanchang University", "city": "Nanchang", "status": "RECRUITING"}], "cn_site_count": 33, "broad_only": false}, {"nct": "NCT07654855", "title": "Long-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired Subpopulations", "status": "RECRUITING", "start": "2026-09-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 320, "sponsor": "AstraZeneca", "conditions": ["Transthyretin Amyloidosis", "Transthyretin Amyloidosis With Cardiomyopathy", "Transthyretin Amyloidosis With Polyneuropathy"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07789483", "title": "An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy", "status": "NOT_YET_RECRUITING", "start": "2027-11-23", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1180, "sponsor": "Alexion Pharmaceuticals, Inc.", "conditions": ["Transthyretin Amyloid Cardiomyopathy (ATTR-CM)"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Chongqing", "status": ""}, {"facility": "Research Site", "city": "Guangzhou", "status": ""}, {"facility": "Research Site", "city": "Guiyang", "status": ""}, {"facility": "Research Site", "city": "Harbin", "status": ""}, {"facility": "Research Site", "city": "Wuhan", "status": ""}, {"facility": "Research Site", "city": "Changsha", "status": ""}, {"facility": "Research Site", "city": "Nanjing", "status": ""}, {"facility": "Research Site", "city": "Xi'an", "status": ""}, {"facility": "Research Site", "city": "Jinan", "status": ""}, {"facility": "Research Site", "city": "Shanghai", "status": ""}, {"facility": "Research Site", "city": "Hangzhou", "status": ""}, {"facility": "Research Site", "city": "Tianjin", "status": ""}], "cn_site_count": 13, "broad_only": false}, {"nct": "NCT04828993", "title": "The Effect Of Tafamidis Meglumine In Transthyretin Amyloid Polyneuropathy Patients", "status": "COMPLETED", "start": "2021-04-28", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 15, "sponsor": "Pfizer", "conditions": ["Transthyretin Amyloid Polyneuropathy (ATTR-PN)"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}, {"facility": "The First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "status": ""}, {"facility": "NanFang Hospital of Southern Medical University", "city": "Guangzhou", "status": ""}, {"facility": "Huashan Hospital Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Peking union hospital of Chinese academy of medical sciences", "city": "Beijing", "status": ""}, {"facility": "Xuanwu Hospital Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Tiantan Hospital Capital Medical University", "city": "Beijing", "status": ""}], "cn_site_count": 8, "broad_only": false}, {"nct": "NCT04963985", "title": "The Effect of Tafamidis on Transthyretin Stabilization, Safety, Tolerability and Efficacy in Transthyretin Amyloid Polyneuropathy Patients", "status": "UNKNOWN", "start": "2021-06-01", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 10, "sponsor": "Peking University Third Hospital", "conditions": ["Transthyretin Amyloidosis"], "cn_sites": [{"facility": "Peking University Third Hospital", "city": "Beijin", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04814186", "title": "A Study to Assess the Safety and Efficacy Of Tafamidis In Chinese Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)", "status": "COMPLETED", "start": "2021-07-22", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 53, "sponsor": "Pfizer", "conditions": ["Transthyretin Amyloid Cardiomyopathy"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking University Third Hospital", "city": "Beijing", "status": ""}, {"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology", "city": "Wuhan", "status": ""}, {"facility": "The Second Xiangya Hospital of Central South University", "city": "Changsha", "status": ""}, {"facility": "The First Affiliated Hospital of Dalian Medical University", "city": "Dalian", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "The Second Affiliated Hospital of Zhejiang University School of Medicine", "city": "Hangzhou", "status": ""}, {"facility": "Ruijin Hospital, Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "status": ""}], "cn_site_count": 9, "broad_only": false}, {"nct": "NCT05718401", "title": "The Diagnostic Pattern and Prognosis of Multiple Myeloma Patients With Myocardial Amyloidosis Were Evaluated by NMR Based Metabolomics", "status": "UNKNOWN", "start": "2022-11-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "First Affiliated Hospital Xi'an Jiaotong University", "conditions": ["Multiple Myeloma", "Amyloidosis Cardiac"], "cn_sites": [{"facility": "First Affiliated Hospital of Xian Jiaotong University", "city": "Xi’an", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05719337", "title": "Multi-Modality Echocardiographic Techniques in Pathological Left Ventricular Hypertrophy Adults", "status": "UNKNOWN", "start": "2023-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 660, "sponsor": "First Hospital of China Medical University", "conditions": ["Left Ventricular Hypertrophy"], "cn_sites": [{"facility": "the Second Hospital of Hebei Medical University", "city": "Shijiazhuang", "status": "RECRUITING"}, {"facility": "the First Affiliated Hospital of Jiamusi University", "city": "Jiamusi", "status": "RECRUITING"}, {"facility": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "city": "Wuhan", "status": "RECRUITING"}, {"facility": "the Affiliated Hospital of Inner Mongolia Medical University", "city": "Hohhot", "status": "RECRUITING"}, {"facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "status": "RECRUITING"}, {"facility": "Ansteel Group General Hospita", "city": "Anshan", "status": "RECRUITING"}, {"facility": "Benxi Central Hospital", "city": "Benxi", "status": "RECRUITING"}, {"facility": "Chaoyang Central Hospital", "city": "Chaoyang", "status": "RECRUITING"}, {"facility": "Dalian Municipal Central Hospital", "city": "Dalian", "status": "RECRUITING"}, {"facility": "the Second Hospital of Dalian Medical University", "city": "Dalian", "status": "RECRUITING"}, {"facility": "Dandong Central Hospital", "city": "Dandong", "status": "RECRUITING"}, {"facility": "Fushun Central Hospital", "city": "Fushun", "status": "RECRUITING"}, {"facility": "the First Affiliated Hospital of Jinzhou Medical University", "city": "Jinzhou", "status": "RECRUITING"}, {"facility": "Affiliated Central Hospital of Shenyang Medical College", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Dadong Branch of First Affiliated Hospital of China Medical University", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Liaoning Cancer Hospital & Institute", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "the First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "the First Hospital of China Medical Univeristy", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "the Second Affiliated Hospital of Shenyang Medical College", "city": "Shenyang", "status": "RECRUITING"}, {"facility": "Liao Jian Group Tie Mei General Hospital", "city": "Tieling", "status": "RECRUITING"}, {"facility": "Tieling Central Hospital", "city": "Tieling", "status": "RECRUITING"}, {"facility": "Tianjin Chest Hospital", "city": "Tianjin", "status": "RECRUITING"}], "cn_site_count": 22, "broad_only": false}, {"nct": "NCT06194825", "title": "EPIC-ATTR: A Study to Evaluate the Effect of Eplontersen on the Transthyretin Reduction and Long-term Safety in Chinese Subjects With Transthyretin Amyloid Cardiomyopathy", "status": "ACTIVE_NOT_RECRUITING", "start": "2023-12-01", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 64, "sponsor": "AstraZeneca", "conditions": ["Transthyretin Amyloid Cardiomyopathy"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Changsha", "status": ""}, {"facility": "Research Site", "city": "Chengdu", "status": ""}, {"facility": "Research Site", "city": "Chongqing", "status": ""}, {"facility": "Research Site", "city": "Guangzhou", "status": ""}, {"facility": "Research Site", "city": "Hangzhou", "status": ""}, {"facility": "Research Site", "city": "Ha’erbin", "status": ""}, {"facility": "Research Site", "city": "Jinan", "status": ""}, {"facility": "Research Site", "city": "Nanchang", "status": ""}, {"facility": "Research Site", "city": "Shanghai", "status": ""}, {"facility": "Research Site", "city": "Suzhou", "status": ""}, {"facility": "Research Site", "city": "Taiyuan", "status": ""}, {"facility": "Research Site", "city": "Wuhan", "status": ""}, {"facility": "Research Site", "city": "Xi'an", "status": ""}], "cn_site_count": 14, "broad_only": false}, {"nct": "NCT06183931", "title": "Study of ALXN2220 Versus Placebo in Adults With ATTR-CM", "status": "ACTIVE_NOT_RECRUITING", "start": "2024-01-11", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "enrollment": 1181, "sponsor": "Alexion Pharmaceuticals, Inc.", "conditions": ["Transthyretin Amyloid Cardiomyopathy"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Changsha", "status": ""}, {"facility": "Research Site", "city": "Chengdu", "status": ""}, {"facility": "Research Site", "city": "Chongqing", "status": ""}, {"facility": "Research Site", "city": "Fuzhou", "status": ""}, {"facility": "Research Site", "city": "Guangzhou", "status": ""}, {"facility": "Research Site", "city": "Guiyang", "status": ""}, {"facility": "Research Site", "city": "Hangzhou", "status": ""}, {"facility": "Research Site", "city": "Harbin", "status": ""}, {"facility": "Research Site", "city": "Hefei", "status": ""}, {"facility": "Research Site", "city": "Jinan", "status": ""}, {"facility": "Research Site", "city": "Nanjing", "status": ""}, {"facility": "Research Site", "city": "Shanghai", "status": ""}, {"facility": "Research Site", "city": "Tianjin", "status": ""}, {"facility": "Research Site", "city": "Wuhan", "status": ""}, {"facility": "Research Site", "city": "Xi'an", "status": ""}], "cn_site_count": 16, "broad_only": false}, {"nct": "NCT06539208", "title": "A Phase I/IIa，Open-label, Single Ascending Dose and Dose-expansion Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of YOLT-201 in Patients With Transthyretin Amyloidosis Polyneuropathy (ATTR-PN) or Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)", "status": "UNKNOWN", "start": "2024-05-23", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 31, "sponsor": "YolTech Therapeutics Co., Ltd", "conditions": ["Transthyretin Amyloidosis Polyneuropathy", "Transthyrexin Amyloidosis Cardiomyopathy"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}, {"facility": "The Second Xiangya Hospital of Central South University", "city": "Changsha", "status": "RECRUITING"}, {"facility": "The First Affiliated Hospital, School of Medicine, Zhejiang University", "city": "Hanzhou", "status": "RECRUITING"}], "cn_site_count": 3, "broad_only": false}, {"nct": "NCT06527755", "title": "A Study to Assess the PK, PD, Safety and Tolerability of Eplontersen in Healthy Chinese Volunteers", "status": "COMPLETED", "start": "2024-08-06", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 12, "sponsor": "AstraZeneca", "conditions": ["Transthyretin-mediated Amyloidosis"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07338942", "title": "Implementation of Standardized Early Identification and Diagnosis for Transthyretin Amyloidosis (ATTR) in High-Risk Populations", "status": "ACTIVE_NOT_RECRUITING", "start": "2026-04-21", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 4000, "sponsor": "AstraZeneca", "conditions": ["ATTR-CM"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Changlexi", "status": ""}, {"facility": "Research Site", "city": "Changsha", "status": ""}, {"facility": "Research Site", "city": "Chengdu", "status": ""}, {"facility": "Research Site", "city": "Chongqing", "status": ""}, {"facility": "Research Site", "city": "Dalian", "status": ""}, {"facility": "Research Site", "city": "Fuzhou", "status": ""}, {"facility": "Research Site", "city": "Guangdong Province", "status": ""}, {"facility": "Research Site", "city": "Guangzhou", "status": ""}, {"facility": "Research Site", "city": "Guiyang", "status": ""}, {"facility": "Research Site", "city": "Hangzhou", "status": ""}, {"facility": "Research Site", "city": "Harbin", "status": ""}, {"facility": "Research Site", "city": "Hefei", "status": ""}, {"facility": "Research Site", "city": "Jinan", "status": ""}, {"facility": "Research Site", "city": "Nanchang", "status": ""}, {"facility": "Research Site", "city": "Nanjing", "status": ""}, {"facility": "Research Site", "city": "Nanning", "status": ""}, {"facility": "Research Site", "city": "Qingdao", "status": ""}, {"facility": "Research Site", "city": "Shanghai", "status": ""}, {"facility": "Research Site", "city": "Shenyang", "status": ""}, {"facility": "Research Site", "city": "Shijiazhuang", "status": ""}, {"facility": "Research Site", "city": "Suzhou", "status": ""}, {"facility": "Research Site", "city": "Taiyuan", "status": ""}, {"facility": "Research Site", "city": "Wenzhou", "status": ""}, {"facility": "Research Site", "city": "Wuhan", "status": ""}, {"facility": "Research Site", "city": "Xi'an", "status": ""}, {"facility": "Research Site", "city": "Xiamen", "status": ""}, {"facility": "Research Site", "city": "Zhengzhou", "status": ""}], "cn_site_count": 28, "broad_only": false}, {"nct": "NCT07608354", "title": "A Study to Evaluate the Efficacy and Safety of Concomitant Use of Eplontersen and ALXN2220 Compared With Eplontersen and Placebo for Adults Participants With ATTR-CM", "status": "ACTIVE_NOT_RECRUITING", "start": "2026-06-11", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 326, "sponsor": "AstraZeneca", "conditions": ["Transthyretin Amyloid Cardiomyopathy (ATTR-CM)"], "cn_sites": [{"facility": "Research Site", "city": "Beijing", "status": ""}, {"facility": "Research Site", "city": "Changsha", "status": ""}, {"facility": "Research Site", "city": "Chongqing", "status": ""}, {"facility": "Research Site", "city": "Guangzhou", "status": ""}, {"facility": "Research Site", "city": "Hangzhou", "status": ""}], "cn_site_count": 5, "broad_only": false}], "g_total": 114, "g_fetched": 105, "g_countries": [["United States", 29], ["Germany", 20], ["Italy", 19], ["France", 18], ["Portugal", 8], ["Spain", 8], ["Netherlands", 8], ["Denmark", 7], ["South Korea", 6], ["Belgium", 6], ["Argentina", 6], ["Brazil", 6], ["Japan", 6], ["Taiwan", 6], ["United Kingdom", 6], ["Sweden", 5], ["Austria", 4], ["Canada", 4], ["Norway", 3], ["Australia", 3], ["Switzerland", 3], ["Mexico", 3], ["Singapore", 3], ["Hungary", 2], ["Greece", 2], ["Ireland", 2], ["Malaysia", 2], ["Thailand", 2], ["Israel", 2], ["Cyprus", 1], ["Turkey (Türkiye)", 1], ["Martinique", 1], ["Czechia", 1], ["New Zealand", 1], ["Bulgaria", 1]], "g_trials": [{"nct": "NCT07494942", "title": "Impact of a Cardiac Rehabilitation Program on Patients With Cardiac Amyloidosis", "status": "NOT_YET_RECRUITING", "start": "2026-12-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Montpellier", "countries": ["France"]}, {"nct": "NCT07116473", "title": "To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)", "status": "NOT_YET_RECRUITING", "start": "2026-11", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Eidos Therapeutics, a BridgeBio company", "countries": []}, {"nct": "NCT07538518", "title": "PET Imaging Study Using Evuzamitide to Detect Cardiac Amyloidosis in Patients With Inconclusive Nuclear Scans and Elevated TAD1 Levels", "status": "NOT_YET_RECRUITING", "start": "2026-10-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Lorena Saelices", "countries": ["United States"]}, {"nct": "NCT07784712", "title": "Right Ventricular Septal Biopsy to Detect Cardiac Amyloidosis", "status": "NOT_YET_RECRUITING", "start": "2026-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Geisinger Clinic", "countries": []}, {"nct": "NCT07549841", "title": "Exploratory Study Evaluating the Relevance of [68Ga]Ga-FAPI-46 for Staging and Identifying Progressing Patients With Transthyretin Cardiac Amyloidosis", "status": "RECRUITING", "start": "2026-09-09", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Nantes University Hospital", "countries": ["France"]}, {"nct": "NCT07791160", "title": "Study of Acoramidis in Patients With Transthyretin Amyloid Cardiomyopathy", "status": "RECRUITING", "start": "2026-09-07", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Bayer", "countries": ["France"]}, {"nct": "NCT07648303", "title": "Prevalence of Cardiac Thrombi in Cardiac Amyloidosis", "status": "RECRUITING", "start": "2026-09-07", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Centre Hospitalier Universitaire Dijon", "countries": ["France"]}, {"nct": "NCT06921408", "title": "Retrospective Identification of Scintigraphic Cardiac Amyloidosis (RISCA)", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University Hospital, Lille", "countries": []}, {"nct": "NCT07734285", "title": "Detection of Cardiac Amyloidosis Using Right Ventricular Sensing Amplitude in Patients With Left Ventricular Hypertrophy", "status": "NOT_YET_RECRUITING", "start": "2026-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": []}, {"nct": "NCT05974644", "title": "Southeastern ATTR Amyloidosis Consortium: SEATTRAC Family Registry", "status": "NOT_YET_RECRUITING", "start": "2026-09", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Virginia Commonwealth University", "countries": ["United States"]}, {"nct": "NCT07557147", "title": "Single-arm, Multi-center Study Evaluating the Acceptance and Feasibility of a Digital Remote Monitoring Tool Configured for Patients With ATTR-CM: ACO-Monitor", "status": "NOT_YET_RECRUITING", "start": "2026-08-31", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Bayer", "countries": ["Austria", "Germany", "Italy"]}, {"nct": "NCT07591038", "title": "PET/CT Imaging in Carriers of TTR Mutations", "status": "NOT_YET_RECRUITING", "start": "2026-08-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "University of Texas Southwestern Medical Center", "countries": ["United States"]}, {"nct": "NCT07743957", "title": "Selinexor, Daratumumab, and Dexamethasone (XDd) for Light-Chain Cardiac Amyloidosis", "status": "NOT_YET_RECRUITING", "start": "2026-07-13", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Beijing Anzhen Hospital", "countries": []}, {"nct": "NCT07690436", "title": "Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM", "status": "RECRUITING", "start": "2026-07-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "AstraZeneca", "countries": ["Germany", "Portugal", "Spain", "Sweden", "United States"]}, {"nct": "NCT07560306", "title": "[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid Cardiomyopathy", "status": "RECRUITING", "start": "2026-07-07", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Brigham and Women's Hospital", "countries": ["United States"]}, {"nct": "NCT07529860", "title": "AI-based Echocardiography for Detection of Cardiac Amyloidosis", "status": "NOT_YET_RECRUITING", "start": "2026-07-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Germans Trias i Pujol Hospital", "countries": []}, {"nct": "NCT07695701", "title": "Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis", "status": "RECRUITING", "start": "2026-07", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Eidos Therapeutics, a BridgeBio company", "countries": ["United States"]}, {"nct": "NCT07580872", "title": "Early Screening for Cardiac Amyloid Using a History of Bilateral Carpal Tunnel Syndrome", "status": "NOT_YET_RECRUITING", "start": "2026-07", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's", "countries": []}, {"nct": "NCT07577466", "title": "Screening, Characterization, and Longitudinal Follow-up of Patients With Cardiac Amyloidosis", "status": "NOT_YET_RECRUITING", "start": "2026-06-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Heinrich-Heine University, Duesseldorf", "countries": ["Germany"]}, {"nct": "NCT07343999", "title": "EFICAC-TTR Trial: Exercise and Nutritional Supplementation in Transthyretin Cardiac Amyloidosis", "status": "NOT_YET_RECRUITING", "start": "2026-06", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Universidad de Burgos", "countries": []}, {"nct": "NCT07605741", "title": "Fast Cardiac Bone SPECT-CZT in Transthyretin Cardiac Amyloidosis", "status": "NOT_YET_RECRUITING", "start": "2026-05-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Central Hospital, Nancy, France", "countries": []}, {"nct": "NCT07644325", "title": "Concordance for Transthyretin Amyloidosis Between Synovial Biopsy and Anterior Carpal Ligament Biopsy", "status": "RECRUITING", "start": "2026-05-27", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Clinique Saint Jean, France", "countries": ["France"]}, {"nct": "NCT07567508", "title": "Early Detection of Concealed Cardiac Amyloidosis Using AI-ECG and CT-Derived Extracellular Volume in Patients With Atrial Fibrillation", "status": "NOT_YET_RECRUITING", "start": "2026-05", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Samsung Medical Center", "countries": ["South Korea"]}, {"nct": "NCT07689331", "title": "Hungarian National Systemic Amyloidosis Registry", "status": "RECRUITING", "start": "2026-03-08", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Semmelweis University", "countries": ["Hungary"]}, {"nct": "NCT07504289", "title": "CAR-NK Therapy for Cardiac Amyloidosis", "status": "NOT_YET_RECRUITING", "start": "2026-03-07", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "countries": []}]}, {"batch": 2, "no": 81, "name_zh": "肿瘤坏死因子受体相关周期性综合征", "query_terms": [{"term": "Tumor necrosis factor receptor 1 associated periodic syndrome", "broad": false}, {"term": "Tumor necrosis factor receptor associated periodic syndrome", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 1, "g_fetched": 1, "g_countries": [["South Korea", 1]], "g_trials": [{"nct": "NCT06838143", "title": "Ilaris NIS in Korea", "status": "RECRUITING", "start": "2025-03-29", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Novartis Pharmaceuticals", "countries": ["South Korea"]}]}, {"batch": 2, "no": 82, "name_zh": "肿瘤相关骨软化症", "query_terms": [{"term": "Oncogenic osteomalacia", "broad": false}, {"term": "Tumor-induced osteomalacia", "broad": false}], "n_total": 5, "n_open": 1, "n_open_precise": 1, "n_broad": 0, "trials": [{"nct": "NCT07366099", "title": "Al18F-NOTA-LM3 PET/CT in Patients With TIO", "status": "RECRUITING", "start": "2023-03-30", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 40, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Tumor-Induced Osteomalacia"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01524016", "title": "68Ga-DOTATATE PET/CT in Oncogenic Osteomalacia", "status": "UNKNOWN", "start": "2011-12", "phases": ["EARLY_PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 100, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Oncogenic Osteomalacia", "Mesenchymal Tumor"], "cn_sites": [{"facility": "Department of Nuclear Medicine, Peking Union Medical College Hopital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04045834", "title": "Study of the Diagnostic Value of Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor Induced Osteomalacia", "status": "UNKNOWN", "start": "2019-05-05", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 60, "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": ["PET / CT", "PET / MR", "Neuroendocrine Tumors", "Osteomalacia"], "cn_sites": [{"facility": "China, Hubei Province", "city": "Wuhan", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT04689893", "title": "Application of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET/CT in the Diagnosis and Evaluation of TIO", "status": "UNKNOWN", "start": "2020-03-15", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 50, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Tumor-Induced Osteomalacia"], "cn_sites": [{"facility": "Peking union medical college hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05357573", "title": "Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With TIO", "status": "COMPLETED", "start": "2022-09-07", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "enrollment": 9, "sponsor": "Kyowa Kirin Co., Ltd.", "conditions": ["Tumor-Induced Osteomalacia (TIO)"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": ""}, {"facility": "West China Hospital, Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Shanghai Jiaotong University Affiliated Sixth People's Hospital", "city": "Shanghai", "status": ""}], "cn_site_count": 3, "broad_only": false}], "g_total": 3, "g_fetched": 2, "g_countries": [["United States", 1]], "g_trials": [{"nct": "NCT00024804", "title": "A Natural History Study of Bone and Mineral Disorders", "status": "RECRUITING", "start": "2001-11-19", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Institute of Dental and Craniofacial Research (NIDCR)", "countries": ["United States"]}, {"nct": "NCT03775187", "title": "Expanded Access to Burosumab", "status": "AVAILABLE", "start": "", "phases": [], "study_type": "EXPANDED_ACCESS", "sponsor": "Kyowa Kirin Co., Ltd.", "countries": []}]}, {"batch": 2, "no": 83, "name_zh": "Von Hippel-Lindau综合征", "query_terms": [{"term": "Von Hippel-Lindau disease", "broad": false}, {"term": "Von Hippel-Lindau syndrome", "broad": false}], "n_total": 8, "n_open": 3, "n_open_precise": 3, "n_broad": 0, "trials": [{"nct": "NCT04924075", "title": "Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)", "status": "RECRUITING", "start": "2021-08-12", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 355, "sponsor": "Merck Sharp & Dohme LLC", "conditions": ["Pheochromocytoma/Paraganglioma", "Pancreatic Neuroendocrine Tumor", "Von Hippel-Lindau Disease", "Advanced Gastrointestinal Stromal Tumor", "HIF-2α Mutated Cancers"], "cn_sites": [{"facility": "Peking University First Hospital-Urology ( Site 1900)", "city": "Beijing", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Sun Yat-sen University Cancer Center ( Site 1905)", "city": "Guangzhou", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "Renji Hospital Shanghai Jiao Tong University School of Medicine ( Site 1904)", "city": "Shanghai", "status": "ACTIVE_NOT_RECRUITING"}, {"facility": "West China Hospital of Sichuan University ( Site 1906)", "city": "Chengdu", "status": "COMPLETED"}], "cn_site_count": 4, "broad_only": false}, {"nct": "NCT06553339", "title": "A Study of HS-10516 in Patients With VHL Syndrome Associated Tumors", "status": "RECRUITING", "start": "2024-07-19", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 60, "sponsor": "Jiangsu Hansoh Pharmaceutical Co., Ltd.", "conditions": ["Von Hippel Lindau-Deficient Clear Cell Renal Cell Carcinoma"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07557225", "title": "18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors", "status": "RECRUITING", "start": "2026-04-27", "phases": ["NA"], "study_type": "INTERVENTIONAL", "enrollment": 200, "sponsor": "Peking University First Hospital", "conditions": ["Clear Cell Renal Cell Cancer (ccRCC)", "Urothelial Carcinoma (UC)", "Colorectal Cancer", "Cervical Cancer", "Ovarian Cancer", "Head and Neck Cancer", "Hepatocellular Carcinoma (HCC)", "Cholangiocarcinoma", "Non Small Cell Lung Cancer", "Small Cell Lung Cancer", "Breast Cancer", "Pancreatic Cancer", "Endometrial Cancer", "Von Hippel Lindau Disease"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07327164", "title": "Precision Medicine for Neurocutaneous Syndromes in Western China", "status": "COMPLETED", "start": "2000-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1200, "sponsor": "West China Hospital", "conditions": ["Neurocutaneous Syndromes", "Neurofibromatosis Type 1 (NF1)", "Tuberous Sclerosis Complex (TSC)", "Sturge-Weber Syndrome (SWS)", "Von Hippel-Lindau Disease"], "cn_sites": [{"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05534854", "title": "Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes", "status": "UNKNOWN", "start": "2022-10-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 500, "sponsor": "RenJi Hospital", "conditions": ["Renal Tumor Histology", "Kidney Cancer", "Renal Cell Carcinoma", "Familial Renal Cancer", "HLRCC", "VHL Syndrome", "BAP1 Tumor Predisposition Syndrome", "FLCN Gene Mutation", "ALK Gene Mutation", "FH Gene Mutation", "Birt-Hogg-Dube Syndrome", "MET Gene Mutation", "Cutaneous Leiomyoma", "Cutaneous Leiomyomata With Uterine Leiomyomata"], "cn_sites": [{"facility": "Ethics Committee of Shanghai Renji Hospital", "city": "Shanghai", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT05843305", "title": "A Study of BPI-452080 in Subjects With Solid Tumors", "status": "UNKNOWN", "start": "2023-04-28", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "enrollment": 87, "sponsor": "Betta Pharmaceuticals Co., Ltd.", "conditions": ["Solid Tumor", "Renal Cell Carcinoma", "Von Hippel-Lindau Disease"], "cn_sites": [{"facility": "Fudan University Shanghai Cancer Center", "city": "Shanghai", "status": ""}, {"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}, {"facility": "Zhejiang Cancer Hospital", "city": "Hangzhou", "status": ""}, {"facility": "Hunan Cancer Hospital", "city": "Hunan", "status": ""}, {"facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "status": ""}], "cn_site_count": 5, "broad_only": false}, {"nct": "NCT05810246", "title": "68Ga-NY104 PET/CT in Von Hippel-Lindau Disease", "status": "UNKNOWN", "start": "2023-05-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 19, "sponsor": "Peking Union Medical College Hospital", "conditions": ["Von Hippel-Lindau Disease"], "cn_sites": [{"facility": "Peking Union Medical College Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06391879", "title": "Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell Carcinoma", "status": "UNKNOWN", "start": "2023-09-08", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 300, "sponsor": "Peking University First Hospital", "conditions": ["VHL Syndrome", "Renal Cell Carcinoma"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}], "g_total": 19, "g_fetched": 16, "g_countries": [["United States", 7], ["France", 3], ["Brazil", 2], ["Denmark", 2], ["Italy", 2], ["Hong Kong", 1], ["Australia", 1], ["Belgium", 1], ["Canada", 1], ["Chile", 1], ["Czechia", 1], ["Finland", 1], ["Hungary", 1], ["Israel", 1], ["Japan", 1], ["Netherlands", 1], ["New Zealand", 1], ["Poland", 1], ["Russia", 1], ["South Korea", 1], ["Spain", 1], ["Taiwan", 1], ["Ukraine", 1], ["United Kingdom", 1], ["Argentina", 1], ["Mexico", 1]], "g_trials": [{"nct": "NCT07705529", "title": "Pediatric Von Hippel-Lindau Disease: Natural History, Predictive Factors, and Long-Term Functional Outcomes of Central Nervous System Hemangioblastomas", "status": "NOT_YET_RECRUITING", "start": "2026-07-15", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT07554508", "title": "Belzutifan VHL RCC HK Prospective Registry", "status": "NOT_YET_RECRUITING", "start": "2026-05", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Chinese University of Hong Kong", "countries": ["Hong Kong"]}, {"nct": "NCT07405164", "title": "Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)", "status": "RECRUITING", "start": "2026-03-23", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Merck Sharp & Dohme LLC", "countries": ["Australia", "Belgium", "Brazil", "Canada", "Chile", "Czechia", "Denmark", "Finland", "France", "Hungary", "Israel", "Japan", "Netherlands", "New Zealand", "Poland", "Russia", "South Korea", "Spain", "Taiwan", "Ukraine", "United Kingdom", "United States"]}, {"nct": "NCT07171905", "title": "CAT-VHL Exploring the Role of Carbonic Anhydrase IX as Diagnostic and Theranostic Target in Von-Hippel Lindau Disease", "status": "RECRUITING", "start": "2026-02-25", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "IRCCS Ospedale San Raffaele", "countries": ["Italy"]}, {"nct": "NCT06573723", "title": "Institutional Registry of Rare Diseases", "status": "RECRUITING", "start": "2024-07-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Hospital Italiano de Buenos Aires", "countries": ["Argentina"]}, {"nct": "NCT07167329", "title": "Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial", "status": "RECRUITING", "start": "2024-01-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "José Claudio Casali da Rocha", "countries": ["Brazil"]}, {"nct": "NCT05955014", "title": "Data Collection Protocol for Patients With Von Hippel Lindau Disease", "status": "RECRUITING", "start": "2023-08-24", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "M.D. Anderson Cancer Center", "countries": ["United States"]}, {"nct": "NCT06194669", "title": "Mechanisms of Somatic Mutation and Tumor Initiation in Pre-malignant Kidney Tubule Cells", "status": "RECRUITING", "start": "2023-06-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "IRCCS San Raffaele", "countries": ["Italy"]}, {"nct": "NCT05424016", "title": "Propranolol and Von Hippel-Lindau Disease", "status": "RECRUITING", "start": "2023-01-16", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT06523582", "title": "Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients", "status": "RECRUITING", "start": "2022-08-03", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Universidad Nacional Autonoma de Mexico", "countries": ["Mexico"]}, {"nct": "NCT04074135", "title": "Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors", "status": "RECRUITING", "start": "2020-06-02", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["United States"]}, {"nct": "NCT03050268", "title": "Familial Investigations of Childhood Cancer Predisposition", "status": "RECRUITING", "start": "2017-04-06", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "St. Jude Children's Research Hospital", "countries": ["United States"]}, {"nct": "NCT01496625", "title": "National Eye Institute Biorepository for Retinal Diseases", "status": "RECRUITING", "start": "2012-06-18", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Eye Institute (NEI)", "countries": ["United States"]}, {"nct": "NCT03749980", "title": "MyVHL: Patient Natural History Study", "status": "RECRUITING", "start": "2012-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Joshua Mann, MPH", "countries": ["United States"]}, {"nct": "NCT02420067", "title": "Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients", "status": "RECRUITING", "start": "2011-02", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Marie Luise Bisgaard, MD", "countries": ["Denmark"]}, {"nct": "NCT00001238", "title": "Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders", "status": "RECRUITING", "start": "1990-12-05", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Cancer Institute (NCI)", "countries": ["United States"]}]}, {"batch": 2, "no": 84, "name_zh": "血管性血友病Ⅲ型", "query_terms": [{"term": "Von Willebrand disease type 3", "broad": false}, {"term": "Von Willebrand disease type3", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 7, "g_fetched": 7, "g_countries": [["United States", 7], ["United Kingdom", 5], ["Australia", 3], ["Italy", 3], ["Germany", 2], ["Ireland", 2], ["South Africa", 2], ["France", 2], ["Japan", 2], ["Austria", 1], ["Brazil", 1], ["Georgia", 1], ["Belgium", 1], ["Canada", 1], ["Colombia", 1], ["Netherlands", 1], ["Poland", 1], ["Spain", 1], ["Sweden", 1]], "g_trials": [{"nct": "NCT07115004", "title": "Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)", "status": "RECRUITING", "start": "2025-10-15", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Vega Therapeutics, Inc", "countries": ["Australia", "Austria", "Brazil", "Georgia", "Germany", "Ireland", "Italy", "South Africa", "United Kingdom", "United States"]}, {"nct": "NCT06998524", "title": "A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease", "status": "RECRUITING", "start": "2025-06-27", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Hoffmann-La Roche", "countries": ["Belgium", "Canada", "Colombia", "France", "Germany", "Italy", "Japan", "Netherlands", "Poland", "South Africa", "Spain", "Sweden", "United Kingdom", "United States"]}, {"nct": "NCT06754852", "title": "A Study Assessing HMB-002 in Participants With Von Willebrand Disease", "status": "RECRUITING", "start": "2025-02-06", "phases": ["PHASE1", "PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Hemab ApS", "countries": ["Australia", "United Kingdom", "United States"]}, {"nct": "NCT05582993", "title": "A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)", "status": "RECRUITING", "start": "2024-11-06", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Takeda", "countries": ["France", "Ireland", "Italy", "Japan", "United Kingdom", "United States"]}, {"nct": "NCT06610201", "title": "A Study of Bleeding and Treatment in Participants With Von Willebrand Disease", "status": "RECRUITING", "start": "2024-08-30", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Hemab ApS", "countries": ["Australia", "United Kingdom", "United States"]}, {"nct": "NCT05500807", "title": "Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A", "status": "RECRUITING", "start": "2022-11-01", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Bleeding and Clotting Disorders Institute Peoria, Illinois", "countries": ["United States"]}, {"nct": "NCT05437536", "title": "The Severe Von Willebrand Disease (sVWD) Patient Registry", "status": "RECRUITING", "start": "2021-12-10", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "VWD Connect Foundation", "countries": ["United States"]}]}, {"batch": 2, "no": 85, "name_zh": "华氏巨球蛋白血症/淋巴浆细胞淋巴瘤", "query_terms": [{"term": "Waldenström macroglobulinemia", "broad": false}, {"term": "Waldenström macroglobulinemia/ Lymphoplasmacytic lymphoma", "broad": false}], "n_total": 0, "n_open": 0, "n_open_precise": 0, "n_broad": 0, "trials": [], "g_total": 1, "g_fetched": 1, "g_countries": [["United States", 1]], "g_trials": [{"nct": "NCT05724121", "title": "Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax", "status": "RECRUITING", "start": "2023-03-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "countries": ["United States"]}]}, {"batch": 2, "no": 86, "name_zh": "West综合征/婴儿痉挛综合征", "query_terms": [{"term": "West syndrome", "broad": false}, {"term": "West syndrome/Infantile spasms syndrome", "broad": false}], "n_total": 8, "n_open": 2, "n_open_precise": 2, "n_broad": 0, "trials": [{"nct": "NCT06528197", "title": "Construction of Clinical Model of Primary Sjogren's Syndrome Combined Traditional Chinese and Western Medicine", "status": "RECRUITING", "start": "2024-07-04", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1000, "sponsor": "China-Japan Friendship Hospital", "conditions": ["Primary Sjögren Syndrome"], "cn_sites": [{"facility": "Jiaqi Chen", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT06519617", "title": "Study on Optimization and Evaluation of Integrated Chinese and Western Medicine for pSS Glandular Damage", "status": "ENROLLING_BY_INVITATION", "start": "2024-07-13", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 136, "sponsor": "Qingwen Tao", "conditions": ["Primary Sjögren Syndrome"], "cn_sites": [{"facility": "China-Japan friendship hospital", "city": "Beijing", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT07327164", "title": "Precision Medicine for Neurocutaneous Syndromes in Western China", "status": "COMPLETED", "start": "2000-01-01", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1200, "sponsor": "West China Hospital", "conditions": ["Neurocutaneous Syndromes", "Neurofibromatosis Type 1 (NF1)", "Tuberous Sclerosis Complex (TSC)", "Sturge-Weber Syndrome (SWS)", "Von Hippel-Lindau Disease"], "cn_sites": [{"facility": "West China Hospital of Sichuan University", "city": "Chengdu", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01973855", "title": "Chinese and Western Medicine Treatment of Fever Associated With Bleeding Symptoms", "status": "UNKNOWN", "start": "2012-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 300, "sponsor": "Guangzhou 8th People's Hospital", "conditions": ["Viral Haemorrhagic Fever", "Dengue Fever"], "cn_sites": [{"facility": "Xi 'an eighth people's hospital", "city": "XiAn", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT01715376", "title": "Effects of Integrated Treatment by Traditional Chinese and Western Medicine in Reducing Cardiovascular Events", "status": "COMPLETED", "start": "2012-03", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 1042, "sponsor": "Changchun University of Chinese Medicine", "conditions": ["Angina Pectoris", "Coronary Artery Disease", "Coronary Disease", "Heart Disease", "Cardiovascular Disease", "Chest Pain", "Pain", "Signs and Symptoms", "Arteriosclerosis"], "cn_sites": [{"facility": "Jilin Province TCM Institute of Chinese Medicine", "city": "Changchun", "status": ""}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03264638", "title": "A Clinical and Biological Research of Combined Chinese and Western Medicine in the Treatment of PCOS", "status": "UNKNOWN", "start": "2016-10-01", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 315, "sponsor": "Aijun Sun", "conditions": ["PCOS"], "cn_sites": [{"facility": "Lei Li", "city": "Beijing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03435406", "title": "Investigation of the Prevalence of Hepatopulmonary Syndrome in Cirrhosis Patients Caused by Hepatitis B in Western China", "status": "UNKNOWN", "start": "2017-07-27", "phases": [], "study_type": "OBSERVATIONAL", "enrollment": 300, "sponsor": "Southwest Hospital, China", "conditions": ["Hepatopulmonary Syndrome"], "cn_sites": [{"facility": "Department of Anesthesiology, Southwest Hospital Third Military Medical University", "city": "Chongqing", "status": "RECRUITING"}], "cn_site_count": 1, "broad_only": false}, {"nct": "NCT03650452", "title": "A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies", "status": "COMPLETED", "start": "2018-08-08", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "enrollment": 141, "sponsor": "Takeda", "conditions": ["Epilepsy", "Dravet Syndrome", "Lennox-Gastaut Syndrome"], "cn_sites": [{"facility": "Peking University First Hospital", "city": "Beijing", "status": ""}, {"facility": "Capital Medical University (CMU) - Beijing Children's Hospital", "city": "Beijing", "status": ""}, {"facility": "Beijing Children's Hospital,Capital Medical University", "city": "Beijing", "status": ""}, {"facility": "Xiangya Hospital Central South University", "city": "Changsha", "status": ""}, {"facility": "Children's Hospital of Fudan University", "city": "Shanghai", "status": ""}, {"facility": "Shenzhen Children's Hospital", "city": "Shenzhen", "status": ""}], "cn_site_count": 6, "broad_only": false}], "g_total": 14, "g_fetched": 13, "g_countries": [["France", 3], ["United States", 3], ["Australia", 1], ["Brazil", 1], ["Burkina Faso", 1], ["Côte d’Ivoire", 1], ["Togo", 1], ["Cambodia", 1], ["Canada", 1], ["Thailand", 1]], "g_trials": [{"nct": "NCT07585643", "title": "IBIS - Investigating Reliability of BIS and SEDLINE Monitoring in Children With Developmental and Epileptic Encephalopathies (DEE).", "status": "NOT_YET_RECRUITING", "start": "2026-09-03", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Telethon Kids Institute", "countries": ["Australia", "Brazil"]}, {"nct": "NCT07528196", "title": "Study of Xuanbai Shengmai Decoction in the Treatment of Acute Respiratory Distress Syndrome", "status": "NOT_YET_RECRUITING", "start": "2026-08-20", "phases": ["PHASE3"], "study_type": "INTERVENTIONAL", "sponsor": "Southeast University, China", "countries": []}, {"nct": "NCT07355413", "title": "Frailty, Geriatric Syndromes and Care Pathways of Older Adults Living With HIV in West Africa", "status": "NOT_YET_RECRUITING", "start": "2026-03", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "ANRS, Emerging Infectious Diseases", "countries": ["Burkina Faso", "Côte d’Ivoire", "Togo"]}, {"nct": "NCT07358910", "title": "Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective", "status": "RECRUITING", "start": "2025-12-18", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Institut Pasteur du Cambodge", "countries": ["Cambodia"]}, {"nct": "NCT05126914", "title": "Multicentre Real-life Follow-up Study of Rare Epileptic Syndromes in Children and Adolescents", "status": "RECRUITING", "start": "2025-12-11", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT07160075", "title": "HIV Prevention With PrEP Among People on Opioid Replacement Therapy", "status": "RECRUITING", "start": "2025-08-28", "phases": ["PHASE4"], "study_type": "INTERVENTIONAL", "sponsor": "Cara Spence", "countries": ["Canada"]}, {"nct": "NCT06700811", "title": "Ketogenic Diet for Prevention of Epileptic Spasms in Infantile Onset Genetic Epilepsies", "status": "RECRUITING", "start": "2025-08-11", "phases": ["PHASE1"], "study_type": "INTERVENTIONAL", "sponsor": "Heather Olson", "countries": ["United States"]}, {"nct": "NCT06819670", "title": "A Study to Prevent Infantile Spasms Relapse", "status": "RECRUITING", "start": "2025-05-05", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "University of California, Los Angeles", "countries": ["United States"]}, {"nct": "NCT06859619", "title": "Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases", "status": "NOT_YET_RECRUITING", "start": "2025-03-03", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Hospital, Montpellier", "countries": ["France"]}, {"nct": "NCT06266234", "title": "Characterization by Automated System on Infantile Spasmes", "status": "RECRUITING", "start": "2024-02-01", "phases": [], "study_type": "OBSERVATIONAL", "sponsor": "Assistance Publique - Hôpitaux de Paris", "countries": ["France"]}, {"nct": "NCT05962203", "title": "SHIP-AGE: Frailty, Renal Function, and Multi-component Primary Care in Rural Mecklenburg-Western Pomerania", "status": "NOT_YET_RECRUITING", "start": "2023-09-01", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "University Medicine Greifswald", "countries": []}, {"nct": "NCT04289467", "title": "Treatment of Refractory Infantile Spasms With Fenfluramine", "status": "RECRUITING", "start": "2023-06-16", "phases": ["PHASE2"], "study_type": "INTERVENTIONAL", "sponsor": "Children's Hospital of Orange County", "countries": ["United States"]}, {"nct": "NCT04302116", "title": "Vigabatrin With High Dose Prednisolone Combination Therapy vs Vigabatrin Alone for Infantile Spasm", "status": "RECRUITING", "start": "2020-05-18", "phases": ["NA"], "study_type": "INTERVENTIONAL", "sponsor": "Kullasate Sakpichaisakul", "countries": ["Thailand"]}]}]